Operating Unit	Country	ISO3	Indicator	Description	Fine Age	Target Age 2024	Sex	Is Cervical Cancer Partnership	Other Disagg Options	2019 Targets	2019 Quarter 1 Results	2019 Quarter 2 Results	2019 Quarter 3 Results	2019 Quarter 4 Results	2020 Targets	2020 Quarter 1 Results	2020 Quarter 2 Results	2020 Quarter 3 Results	2020 Quarter 4 Results	2021 Targets	2021 Quarter 1 Results	2021 Quarter 2 Results	2021 Quarter 3 Results	2021 Quarter 4 Results	2022 Targets	2022 Quarter 1 Results	2022 Quarter 2 Results	2022 Quarter 3 Results	2022 Quarter 4 Results	2023 Targets	2023 Quarter 1 Results	2023 Quarter 2 Results	2023 Quarter 3 Results	2023 Quarter 4 Results	2024 Targets	2024 Quarter 1 Results	2024 Quarter 2 Results	2024 Quarter 3 Results	2024 Quarter 4 Results	2025 Targets	2025 Quarter 1 Results	2025 Quarter 2 Results	2025 Quarter 3 Results	2025 Quarter 4 Results
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												6,952					5,288				
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			4,343																																		
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			7,087	2,673	2,717	2,581	2,118	21,384	1,904	2,396	1,769	2,098	4,194	2,102	2,425	2,571	2,360	6,371	2,292	2,419	2,790	2,483	11,178	2,804	3,183	2,923	2,687		2,739	3,255	3,009	2,736					3,184
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				602	539	565	521	221	456	568	486	468	966	418	412	555	512	363	450	493	521	365	397	407	407	489	432		412	600	572	462					576
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			9,913	3,969	4,070	4,006	3,174	37,239	3,168	4,088	2,964	3,565	7,301	3,956	4,430	4,607	4,186	14,255	3,879	4,126	4,455	4,135	15,546	4,586	5,627	4,927	4,725		4,651	5,435	4,703	4,609					5,354
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												2,162					2,508				
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			5,429	3,114	3,034	3,072	2,353	45,691	4,008	4,542	3,422	3,514	18,219	3,167	4,684	5,021	4,272	22,383	4,451	4,685	5,295	4,811	31,430	5,938	6,676	6,103	5,724		5,655	6,772	7,026	6,212					5,008
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			4,592	1,630	1,618	1,717	1,621	168	1,261	1,675	1,595	1,376	1,142	1,402	1,389	1,854	1,460	3,541	1,342	1,416	1,501	1,273	4,254	1,303	1,441	1,438	1,417		1,363	1,802	1,976	1,435					1,997
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			4,651	1,239	1,222	1,356	1,009	74	337	587	307	513	4,205	584	506	724	674	5,259	767	682	843	634	1,135	706	1,043	971	1,039	2,452	771	1,796	3,662	1,942	2,693				943
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																										1	155				2						
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				941	834	957	793	257	593	844	713	647	38	574	638	852	727	431	636	666	765	543	843	547	621	623	679		589	818	832	660					898
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female			241	48	79	90	46		43	34	14	6			1		6		5								1					1					
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			1,504	836	893	849	984	33	424	492	334	308	1,791	320	433	518	467	7,504	446	492	452	409	2,109	609	624	472	432		521	875	1,504	1,011					779
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				1,895	2,018	2,042	1,480	44	722	814	552	683	17,927	753	788	980	1,234	4,893	1,094	1,056	1,207	1,091	5,164	1,376	2,142	1,621	1,247		1,059	2,195	3,070	1,816					1,893
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			8,721	5,412	5,443	5,300	4,240	58,929	5,941	7,496	5,605	6,296	17,015	6,516	8,102	8,299	7,214	46,382	7,241	7,698	8,489	7,860	29,619	8,637	10,046	9,264	8,336		8,196	9,815	8,658	8,289					8,998
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			487	436	534	406	245		40	16	1				4	4	1		10					1	9	42	77		225	1	8	5					13
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			4,577																																		
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				548	602	639	511	1,921	343	472	299	372	944	338	348	433	406	596	392	414	451	345	3,013	422	468	444	353		420	473	481	492					513
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												6,928					3,936				
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			1,477	859	864	951	766	544	574	615	386	490	450	395	420	523	544	339	469	558	607	539	4,102	619	656	485	479	4,329	613	693	732	727	7,272				852
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												23,049					32,554				
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			2,352	1,065	1,122	1,148	1,016	240	850	1,160	984	960	60	851	910	1,321	1,106	1,396	979	988	1,118	810	2,342	930	1,070	997	993		949	1,201	1,347	1,056					1,417
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			3,090																																		
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												63,090					43,116				
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			3,095	1,697	1,777	1,839	1,646	79	1,456	1,840	1,714	1,462	2,800	1,399	1,614	2,110	1,654	7,506	1,482	1,602	1,806	1,321	5,681	1,479	1,594	1,540	1,460		1,508	1,833	2,247	1,686					2,315
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				1,423	1,405	1,622	1,298	171	344	690	444	707	7,257	713	696	745	965	7,062	996	813	948	752	3,927	960	1,393	1,285	1,067		987	2,183	3,739	1,874					1,123
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			2,021																																		
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												11,718					9,441				
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			11,505	5,604	5,475	5,332	4,183	50,162	4,797	6,305	4,562	5,329	15,820	5,785	6,746	6,767	6,296	27,765	6,125	6,281	7,178	6,491	19,882	7,003	8,262	7,492	6,714		6,557	7,578	7,215	7,096					7,819
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												57,007					57,874				
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				1,247	1,210	1,275	1,175	8,791	796	1,105	709	864	1,203	997	966	1,025	1,016	2,220	903	887	1,046	848	3,426	1,025	1,176	1,147	872		993	1,157	1,024	944					1,286
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			1,275	902	931	1,004	920	387	757	914	675	766	3	623	680	920	929	289	774	819	914	742	3,515	803	800	864	770	4,819	799	1,004	1,010	849	5,788				1,052
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			4,724	1,795	1,806	1,770	1,904	41	1,402	1,803	1,543	1,311	1,540	1,295	1,478	1,850	1,661	10,417	1,575	1,610	1,618	1,205	6,185	1,412	1,532	1,466	1,640		1,547	1,890	2,186	1,709					2,198
Angola	Angola	AGO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				23	33	30	36		668	16	8	16			1		7		4																		
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			1,702	318	340	300	214	1,818	193	211	178	226	120	196	224	232	192	576	225	235	249	188	458	167	204	197	197		171	177	204	145					195
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			339	29	39	29	29	12	12	37	28	22	73	13	30	21	36	175	20	24	32	25	219	16	23	16	23		20	14	25	26					28
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				88	110	83	66	146	35	83	48	58	63	43	45	63	51	47	46	56	50	47	258	44	57	47	53		49	39	63	52					60
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			99	16	27	19	23	10	3	3	8	1	114	1	10	6	10	132	17	4	7	6	98	6	14	8	6		3	6	9	11					10
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			1,703	334	345	261	187	2,451	230	267	222	255	707	223	290	268	256	778	260	243	259	205	389	219	239	241	224		169	203	216	208					208
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				140	95	109	84	77	64	95	51	68	5	53	62	88	99	47	71	91	80	72	69	54	71	56	90		54	55	65	50					66
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	<10	Retired Age Band	Missing Sex																										1											
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex					4		1		3						1									1					2								1
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												622					386				
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				78	66	66	62	66	30	59	33	49	57	38	45	61	71	23	75	52	67	45	25	40	41	51	40		35	51	50	51					45
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			473																																		
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female			36	12	7	7	6		1	8	2	3							2													1					
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												521					372				
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												993					776				
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			820	187	165	154	110	2,874	157	225	138	147	316	177	204	232	206	817	172	192	194	176	622	155	215	174	159		171	183	174	152					168
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												2,310					2,116				
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			1,098																																		
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			420	126	122	123	95	72	50	81	78	90	5	75	91	90	119	99	94	103	90	77	160	91	81	77	75		66	67	83	75					90
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			358	104	121	109	81	163	69	89	39	71	32	49	51	73	65	55	54	77	88	51	423	70	60	54	59	477	62	61	70	57	667				71
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				231	162	184	141	436	89	117	61	80	54	68	88	100	88	112	105	93	96	83	173	73	75	82	73		69	87	92	85					94
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			636																																		
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			381	52	92	56	54	24	37	78	53	66	141	46	53	80	71	222	68	52	73	57	291	57	49	44	54		36	43	65	39					35
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			460																																		
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			323	52	55	32	38	2,228	42	46	40	46	798	47	62	60	62	283	66	61	38	52	487	67	69	59	45		49	54	68	57					57
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												1,712					2,309				
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			137	87	88	81	76	116	58	76	53	85	1	56	68	69	100	22	82	92	84	51	298	66	42	59	64	394	46	51	52	60	367				69
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				98	124	88	57	14	36	50	29	48	333	61	96	85	105	173	106	95	121	99	279	79	79	59	54		51	64	107	56					35
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			608	112	129	110	92	50	52	86	98	97	63	94	89	132	104	201	112	106	108	83	253	75	82	100	101		83	71	83	73					93
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												114					88				
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				9	3	3	13		1	5		1							1																		
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,057					719				
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				78	87	77	65	51	28	29	20	47	332	31	42	46	69	403	43	41	45	43	226	42	29	25	29		30	40	64	36					28
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			455	72	61	36	44	22	15	17	18	23	185	18	15	25	39	400	26	28	27	21	57	18	15	18	35	118	12	32	33	16	131				19
Angola	Angola	AGO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			1,326	285	270	245	165	1,044	142	161	124	147	82	125	160	189	167	247	142	167	181	141	357	142	134	134	141		168	140	145	143					127
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												254					202				
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												818					718				
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female								1,952	79	130	121	122	613	100	130	134	109	967	105	122	117	106	266	118	113	120	117		80	103	117	105					89
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												316					762				
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female								874	43	55	73	60	90	71	74	74	72	362	64	63	70	68	113	65	64	59	44		70	51	49	66					70
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female								1,237	17	31	24	20	609	24	28	36	19	976	32	31	23	24	243	34	34	16	34		33	25	30	36					18
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex									8				9			1	3	1		3							3			1	1	1					
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex																									1												
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female								335	13	13	12	19	43	10	20	15	14	84	17	7	28	11	29	18	16	25	13		21	17	18	12					19
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																														1							
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female								1,856	61	102	64	78	354	91	95	99	80	1,108	72	82	85	71	325	78	110	102	78		89	96	90	77					62
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female								1,388	49	97	93	113	148	91	94	99	91	541	103	112	130	95	245	100	111	107	95		82	98	84	79					79
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female										1			10						1																		
Angola	Angola	AGO	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female								63	1	2	2	2	17	2	4	2		21	1		4	4	4	2	3	3	4		4	2	1	2					3
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												3,382					3,382				
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												12,629					12,629				
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex									35	45	20	22	236	23	28	41	16	167	31	33	26	27	32	36	36	23	236		25	22	88	49					19
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female								54,655	2,677	2,951	2,520	2,314	14,646	2,648	2,943	2,873	2,343	10,546	2,385	2,629	2,815	2,841	10,546	2,965	3,240	2,940	2,648		2,474	2,880	2,539	2,522					2,493
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female								1,597	16	20	19	17	176	44	19	22	23	125	22	12	21	23	125	31	23	24	21		30	18	18	17					31
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female								20,040	689	733	675	644	3,712	761	720	750	603	2,634	673	714	826	817	2,634	865	863	822	698		712	814	753	682					777
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female								34,761	1,263	1,281	1,221	1,178	6,743	1,546	1,475	1,452	1,240	4,763	1,196	1,281	1,383	1,312	4,763	1,436	1,697	1,524	1,353		1,256	1,471	1,254	1,238					1,285
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female								42,165	1,953	2,139	1,717	1,453	11,252	1,232	2,022	2,021	1,585	8,055	1,886	1,974	1,965	2,044	8,055	2,371	2,363	2,175	2,066		1,982	2,225	2,256	2,052					1,659
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female									6	2	1	1	30	4	7	1	3	22	3	2	2	3			3	2			2	2	7	6					9
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												18,601					18,601				
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex																										1	155										
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female								8,187	161	164	150	156	856	289	186	197	182	623	152	138	198	162	623	205	220	262	175		187	202	163	145					202
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female								46,906	2,079	2,110	1,897	1,761	11,115	2,200	2,238	2,200	1,805	7,866	1,872	2,020	2,201	2,180	7,866	2,343	2,459	2,296	1,929		1,806	2,071	2,050	1,936					2,019
Angola	Angola	AGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female									6	5	4	1															1										
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												821					720				
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female								1,302	18	34	31	21	636	26	32	33	20	978	34	28	24	24	249	38	46	24	26		33	26	33	36					18
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex																										1											
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female								1,953	77	115	78	86	365	93	106	105	78	1,117	77	80	89	74	334	83	116	107	77		87	98	91	76					62
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female								66	1	3	2	2	18	2	3	2		21	1		4	4	4	2	3	3	4		4	2	1	2					3
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												317					765				
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female								919	48	58	82	60	94	77	71	73	67	364	61	66	72	69	115	63	61	58	57		73	52	47	64					71
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												255					202				
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female										1			10						1											1		1					
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex									1				9			1	1	1							2	3	4			1	1	1					
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female								1,461	53	107	102	116	153	101	99	108	101	546	107	117	131	96	250	97	111	109	103		84	99	84	79					80
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female								2,056	93	146	139	131	640	110	152	141	113	975	107	122	122	107	271	119	111	126	114		87	105	115	105					89
Angola	Angola	AGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female								353	12	13	12	19	44	11	18	15	15	84	18	7	27	11	29	18	16	23	14		22	17	18	13					19
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												2					1				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												92					85				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				26	29	9	14		6	7	20	4		2	4	3	4					21	8					10					12				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				1	4	3	2			2		2			2	1	1	10				6	57				3					3					1
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				5	7	6	1		2	1	1	1			1		2	9				7	22				5					4					
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											14					14					4
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				7	13	9	8		3	6	1	4		5	8	6	9	3				14	43				11					7					3
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											1					1					3
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											4					2					1
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				34	37	30	14		4	16	11	10		4	3	13	8					29	7				30					15					12
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											1					1					2
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												45					33				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			214																																		
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				11	6	8	4		1			2										3					1	3				1					
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											4					3					3
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				8	21	12	5		4	1	1	2		3		4		65				11	80				4					7					5
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female										1																											
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											10					3					5
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											3					1					
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			776																																		
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				28	22	22	20		2	4	8	3			5	8	6					33	6				18					12					12
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				13	12	19	12			6	6	8		3	3	5	3					23	5				14					9					10
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				18	15	16	5		3	4	7	3		4	2	4	8	12				16	18				12					8					12
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				32	28	31	17		4	10	7	8		3	5	4	1					31	5				23					12					9
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												44					32				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			658																																		
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												15					3				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												65					48				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											9					4					5
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male					3	3	6			2		1		1	1	1	1	1					10				2										2
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				7	8	6	8				1				2							3															
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												30					24				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				4	3		1									1											1					2					
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				26	36	26	17		10	9	7	13		5	8	9	9					51	9				26					19					9
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				12	21	15	11		8	8	5	8		3	4	9	3					21	12					9					7				
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				17	21	28	16		3	8	6	7		3	9	5	5	44				29	43				20					21					7
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				22	20	29	12		6	7	3	6		9	9	12	10	52				30	42				22					9					2
Angola	Angola	AGO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				18	19	23	15		3	7	10	12		5	7	5	5					23	12				17					12					4
Angola	Angola	AGO	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			617		1,333		1,495	8,228				71	4,755		114		115	1,272		67		143	805		212		323	1,422		244		422	1,282				84
Angola	Angola	AGO	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female												3																									
Angola	Angola	AGO	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			234		193		315	1,082				9	6,500		33		28	820		19		66	317		78		72	501		62		113	422				31
Angola	Angola	AGO	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			1,852		3,610		3,841	21,250				352	2,967		480		382	3,852		327		519	1,827		767		1,157	5,232		736		1,227	4,650				357
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				76	59	92	67		19	18	28	22		13	13	21	17		11	27	29	21	53	20	11	19	16		13	21	20	19					13
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			1,445																																		
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				106	110	130	100		24	28	32	28		19	23	19	33		14	37	28	29	54	19	26	22	14		15	24	20	23					7
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												35					35				
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				259	294	291	261		49	33	67	44	688	55	72	79	66	688	29	62	66	64	688	50	41	40	32		43	50	44	59					17
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				184	221	194	190		40	42	29	30	75	31	47	50	38	75	24	47	44	54	75	27	30	39	34		35	39	34	30					12
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				166	150	151	105		12	16	21	13		4	10	10	8		9	2	9	9	18	23	10	6	3		4	8	10	12					5
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				60	31	26	11								4	1	1													1							
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												938					938				
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			5,259																																		
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				160	196	178	128		33	45	40	32		37	31	37	52		27	50	45	42	85	39	16	46	28		46	39	24	43					15
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				187	158	189	168		22	44	45	32		30	32	36	33		25	39	42	25	58	23	24	29	23		33	36	19	33					16
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			4,892																																		
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				219	204	210	208		29	35	48	50		41	42	62	44		26	38	67	36	101	34	37	43	46		42	46	35	37					15
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				157	148	150	98		23	46	33	35		30	23	36	36		19	34	42	33	69	28	33	26	28		26	34	26	22					8
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												488					488				
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				153	150	187	143		60	43	69	53		47	42	50	55		45	48	60	67	98	65	36	31	53	88	48	46	43	52	88				35
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				120	114	149	130		14	12	25	10		5	12	10	10		3	3	9	15	20	7	14	7	6		2	7	16	14					4
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				217	194	216	186		32	55	61	51	337	34	49	81	53	337	25	53	40	62	337	28	45	34	45		54	51	48	47					16
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												273					273				
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				152	182	211	155		33	36	57	53	350	31	45	47	50	350	32	42	59	39	350	38	37	31	32		38	46	40	55					15
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												462					462				
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				180	151	194	128		16	23	23	16		12	25	11	5		5	15	16	12	28	18	19	22	16	25	17	22	19	18	25				6
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				94	105	90	77		28	25	26	21	144	23	12	23	28	144	20	29	26	18	144	27	14	20	16		24	26	13	26					18
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				190	197	220	182		57	66	66	48		68	55	65	50		27	65	67	52	100	58	46	47	49	90	55	49	40	50	90				27
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				289	292	307	279		46	52	72	63	238	69	51	68	68	238	42	68	59	70	354	35	54	44	48		38	61	41	39					14
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				312	308	328	293		49	72	58	64	468	55	62	77	64	468	37	59	65	66	468	45	50	49	49		53	68	56	54					27
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female										4																											
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												392					392				
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				203	165	218	166		33	38	43	35	175	25	41	51	35	175	27	40	41	47	175	31	27	29	41		51	39	39	42					8
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male										3																											
Angola	Angola	AGO	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												159					159				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			435	461	492	516	701	509	544	524	500		516	598	671	698					789
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				2,069	2,092	2,257	2,348	2,245	731	889	953	943	150	817	918	1,114	1,254	736	1,183	1,264	1,281	1,312	1,495	1,258	1,276	1,269	1,240		1,326	1,493	1,577	1,658					1,733
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			203	218	221	226	282	225	230	225	230		240	291	326	371					427
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			609	124	135	131	138	280	43	63	62	84	899	62	70	73	84	499	80	106	121	111	691	109	115	111	102		118	127	114	123					118
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			1,361	993	985	1,021	1,013	1,514	285	337	358	332	114	312	362	427	513	823	479	525	579	578	956	574	600	594	590		592	639	673	663					671
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												5,642					6,454				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												1,013					1,167				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			278	284	278	286	251	282	281	290	289		315	346	299	310					353
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												1,868					2,138				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				3,161	3,164	3,254	3,301	3,214	1,126	1,269	1,304	1,247	75	1,135	1,172	1,503	1,661	1,050	1,572	1,695	1,701	1,761	1,848	1,704	1,727	1,744	1,729		1,855	1,891	1,941	2,041					2,087
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			776	269	282	265	278	1,400	120	138	156	154	1,441	148	179	246	268	477	276	297	292	319	818	334	333	308	313		301	341	334	330					280
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												2,261					2,583				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			1,970	649	612	625	612	1,059	237	304	314	303	837	300	331	396	434	998	423	449	508	508	1,213	496	505	508	537		528	532	509	521					488
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				690	697	720	693	579	155	182	175	189	2,661	195	214	249	296	683	305	278	314	339	881	347	365	361	323		367	384	395	448					458
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				1,098	1,066	1,134	1,117	1,401	301	356	375	362	709	285	334	406	480	655	464	463	493	520	666	506	518	512	522		535	591	604	622					609
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			3,795																																		
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			1,107	616	645	667	686	256	187	182	198	183	2,717	163	179	212	232	612	244	222	230	260	654	241	260	260	227	351	238	273	278	338	419				354
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				371	406	400	382	298	117	142	108	135	2,058	127	151	173	223	365	253	244	309	358	616	361	382	388	359		339	346	313	363					262
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			529	1,812	1,860	2,047	2,108	2,492	609	705	731	763	40	648	648	788	916	509										1,297					1,476				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			1,839																																		
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												7,096					8,120				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			355	394	401	409	321	384	389	383	390		397	403	406	439					506
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			86	95	104	92	82	110	108	103	96		107	133	140	145					191
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									32	16	11	7		1																							
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			3,999	1,198	1,239	1,202	1,217	3,026	910	1,035	1,049	1,097	1,174	1,100	1,181	1,379	1,522	1,886	1,534	1,685	1,784	1,796	2,090	1,792	1,804	1,841	1,867		1,838	1,919	1,865	1,965					1,871
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			2,682																																		
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			3,131	2,945	2,909	3,019	3,016	3,933	1,342	1,487	1,549	1,514	120	1,320	1,483	1,764	1,965	1,328	1,837	2,002	2,072	2,183	2,257	2,137	2,247	2,237	2,247		2,327	2,477	2,537	2,551					2,499
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex				5	8	10	6	72	13				669		24	6	3		5	9	12	59	18	59	27	26	15	52	37	23	17	18	50				8
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			1,969	534	555	508	544	2,218	490	520	539	593	504	613	659	780	861	1,502	877	948	1,031	1,065	1,700	1,067	1,150	1,138	1,199		1,151	1,220	1,095	1,158					978
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			193	177	181	187	180	238	51	44	46	56	1,430	50	41	59	80	297	81	82	88	89	384	92	84	85	84		100	101	100	109					118
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									147	100	35	12		1																							
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			1,212	235	269	236	233	549	70	118	131	126	1,791	146	121	162	197	818	187	211	241	242	1,073	220	212	222	243		232	256	258	248					236
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			736	785	797	821	849	811	829	825	831		869	978	1,044	1,101					1,198
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			155	171	171	173	122	177	162	165	163		180	224	245	246					244
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			108	128	126	126	179	119	135	137	137		146	187	203	214					257
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												941					1,077				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			1,613	2,774	2,888	3,102	3,162	3,462	982	1,163	1,250	1,274	39	1,095	1,156	1,420	1,601	1,108										2,280					2,604				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												269					309				
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				1,270	1,298	1,336	1,392	1,637	341	384	410	403	116	302	383	438	512	591	490	521	571	577	645	574	599	601	622		631	700	667	651					666
Angola	Angola	AGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			4,295	2,422	2,387	2,297	2,267	3,908	1,456	1,525	1,524	1,581	194	1,451	1,566	1,873	2,061	1,886	1,921	2,138	2,307	2,383	2,581	2,330	2,432	2,371	2,408		2,390	2,447	2,485	2,485					2,426
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								9	5	12	4		8	8	6	5					14
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,396	142	178	147	107	1,455	173	211	183	208	545	169	238	234	200	738	201	212	217	161	369	189	191	190	177		158	182	192	182					229
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								5	7	4	7		6	5	6	5					15
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			506	33	37	19	23	26	15	4	9	12	201	11	12	19	20	379	19	11	23	12	54	11	13	12	22	101	9	26	15	14	110				27
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,461	173	222	181	119	1,079	131	185	148	168	93	147	185	189	156	548	163	174	212	157	435	143	166	158	152		148	167	161	140					192
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												345					312				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			402	82	97	84	65	193	53	40	33	56	26	39	45	56	64	52	49	61	69	44	402					460					559				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			688	93	112	101	56	1,708	142	186	108	126	241	161	172	184	157	776	145	154	162	150	591	150	181	136	157		167	168	162	133					174
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												537					598				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								6	8	11	7		7	9	6	6					14
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			1,109																																		
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				95	70	93	59	91	37	49	36	41	9	35	38	55	49	45	35	41	40	45	66	38	49	42	57		43	51	36	39					74
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												556					629				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			74	9	13	14	7	13	4	2	4		127	1	2	4	7	126	5	5	4	1	94	4	6	2	5		2	5	3	8					8
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								20	15	16	8		13	10	16	18					26
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				59	62	76	51	125	27	36	40	36	70	32	42	49	53	45	42	48	43	41	246	33	43	40	43		40	40	46	36					68
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												58					72				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			1,366																																		
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				142	117	128	99	265	58	73	51	59	42	60	62	87	71	107	66	80	73	74	165	64	67	60	47		62	71	68	75					91
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			369	25	68	39	27	30	22	49	27	34	158	28	30	50	36	211	36	28	32	25	277	34	28	33	23		23	32	44	36					41
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												266					308				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			453	88	94	87	65	85	39	56	38	41	10	45	61	54	68	95	52	55	50	41	152	66	57	47	40		67	51	63	51					90
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								8	8	8	15		11	12	12	15					26
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				48	53	46	32	63	13	31	18	26	369	25	22	25	35	383	25	23	29	28	216	23	23	19	18		29	35	37	25					51
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			558																																		
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			238	27	38	16	20	1,323	32	44	33	43	651	40	51	54	52	269	56	46	31	39	463	63	52	42	30		45	52	62	41					71
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								20	14	20	19		18	17	12	20					36
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				60	99	72	47	16	18	29	23	30	342	32	37	44	59	164	57	48	85	60	264	46	57	60	35		47	51	53	49					64
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			231	13	19	20	8	16	8	16	8	8	78	3	15	9	19	167	9	13	20	12	207	7	17	7	7		12	12	17	18					18
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												1,588					1,914				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			162	59	80	58	56	138	31	47	38	52	3	39	49	47	50	21	39	52	45	36	283					273					308				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			572	84	80	78	58	59	39	63	59	55	72	62	52	74	58	191	52	57	65	47	240	50	54	62	58		61	51	48	55					84
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,511					1,740				
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex				4	8	6	4		1				125		5	7	3		5	10	6	9	18	9	4	5	6	52	6	10	8	5	50				6
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								29	22	17	16		25	32	30	28					46
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			1,147	153	159	166	109	620	105	128	95	104	61	86	124	163	125	235	100	118	130	116	340	107	117	119	101		147	127	134	114					145
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				59	52	59	45	78	20	34	23	35	63	23	32	39	38	22	44	23	45	29	24	32	33	35	26		28	34	35	57					45
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female											1																										
Angola	Angola	AGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								8	4	2	5		3	9	8	5					8
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								65	69	78	83		83	118	131	119					133
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																																20					
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				234	265	270	262		2	7	8	7	791	18	20	25	26	317	49	58	83	98	485	122	127	148	160		163	180	162	194					191
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				2	1	1	1		9				613	15								1	14					20			1	1	22				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				1,461	1,519	1,496	1,410		5	28	36	41	101	98	166	255	313	697	357	455	627	707	1,066	754	821	932	944		981	1,088	1,165	1,288					1,295
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				114	124	131	113		2	2	4	2	1,896	14	34	21	26	92	22	28	31	41	290	51	91	131	132		90	100	108	134					67
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				84	96	101	92		1		4	4	1,212	9	18	25	29	135	46	50	78	88	326	99	105	111	110		112	113	114	138					106
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												371					534				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								121	142	161	157		153	185	214	206					263
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								37	36	51	53		58	68	66	80					107
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								88	90	125	123		141	171	167	149					180
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				1,534	1,696	1,792	1,754			34	35	54	30	129	152	194	233	703	271	350	516	533	993					840					1,038				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								71	78	92	93		116	151	213	207					245
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				83	96	100	88		1	2	2	4	1,690	5	16	14	15	204	16	31	39	53	384	49	43	60	76		86	80	73	106					97
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												2,633					3,259				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												844					1,038				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								268	288	361	379		365	463	648	582					686
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female												3		2																		90					
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												713					912				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												381					461				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				538	575	594	565			2	3	15	670	15	37	45	64	248	74	88	125	136	241	135	154	180	186		213	227	255	281					295
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								169	185	224	224		240	331	377	381					431
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				626	656	646	617		1	12	13	9	109	27	31	42	62	219	66	81	119	121	302	136	159	202	216		235	252	258	249					298
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				470	491	491	474		3	11	33	35	984	95	186	239	269	714	344	403	547	596	941	601	630	745	765		747	755	744	898					848
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				176	185	174	170		4	5	16	11	421	36	82	113	145	474	203	238	303	352	738	371	381	433	456		415	440	400	492					393
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				187	186	221	211				1	2	2,578	6	20	29	20	157	26	40	59	76	279	83	98	107	96	134	77	91	111	152	207				142
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								39	48	56	53		58	90	117	124					139
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				56	63	65	61			1	1	2	1,350	1	1	2	5	69	4	8	16	27	209	33	33	34	25		29	39	48	52					46
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				1,069	1,100	1,165	1,121		2	25	31	44	125	85	96	138	187	491	207	280	404	433	730	439	461	535	515		564	708	827	850					948
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				935	1,016	1,061	1,068			17	19	24	38	60	66	110	134	379	164	188	268	294	403					481					590				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				1,062	1,093	1,074	1,010		10	27	49	68	162	143	207	272	335	911	406	530	759	804	1,159	829	923	1,033	1,024		1,012	1,027	1,144	1,211					1,225
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												2,127					2,746				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												101					129				
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				234	236	244	232			2	2	1	2,477	3	26	36	40	174	45	56	77	76	449	96	116	147	152		115	126	158	168					167
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				428	446	440	410			4	6	18	108	20	35	42	52	297	58	69	108	126	397	129	148	199	223		219	218	238	290					280
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				45	54	52	50			1	1	3	849	3	7	10	9	122	16	25	24	31	265	31	34	40	42		44	48	49	58					51
Angola	Angola	AGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				1,560	1,616	1,658	1,593		1	29	34	49	61	105	123	177	232	641	278	353	518	571	886	614	659	747	721		799	863	987	1,027					1,084
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														2		1					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			871		278		176			93		81								47		42			21		30										
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														2		6					2
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														5		1					3
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			290		174		131			63		55								25		19			15		12										
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																																1					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														3		5					4
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																																3					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																																1					2
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														1		1					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														1		1					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex			110		35		23			1		1								1		2															
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														5		4					2
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														2							
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														6		3					3
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														1		1					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														2		2					1
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														1		2					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														6		9					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														4		6					4
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														4		7					3
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																																1					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																																1					2
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														2		2					1
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														1		1					
Angola	Angola	AGO	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														5		3					3
Botswana	Botswana	BWA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female										1		44			59		214	911		71		469	581		91		712			85		331					
Botswana	Botswana	BWA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					181		789			15		3,064			309		4,288	6,958		639		6,322	10,035		1,736		9,971	3,685		1,147		3,357	5,775				
Botswana	Botswana	BWA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female							44			4		1,605			816		4,383	11,613		1,119		6,093	12,267		2,355		10,750	7,692		1,937		3,744	1,935				
Botswana	Botswana	BWA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					549		891			72		2,480			30		2,068	5,414		132		3,536	3,407		401		6,607	5,813		219		4,198	6,491				
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					2																									1					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			28		75			60		43			38		45			54		48			14		20			34		31					43
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			9		24					29			11		10			16		39			4		35			36		35					29
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																							1							1					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			5		11			8		3			8		9			14		8			3		8			12		8					6
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			36		26			30		40			21		22			45		23			11		29			8		363					43
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			8		15			12		7			9		6			4		9			36		5			20		15					9
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			76		99			103		76			52		38			38		33			84		75			24		35					35
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			3																				1					1		3					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive										1																									
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			40		68			76		58			40		25			25		21			32		30			22		21					18
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		5			4		5			3		5			4		4			1		3					6					3
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected										2			1							2			1		1					2					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			397		695			864		616			637		1,138			1,365		1,300			311		1,109			1,949		1,744					1,596
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			625		1,042			1,130		723			608		1,102			1,285		1,191			427		1,033			1,497		1,185					888
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			85		169			181		136			124		221			357		343			80		301			355		228					201
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					2					1			1												1			2							2
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			552		1,151			1,300		851			505		607			665		593			2,387		2,160			920		991					381
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			6		8			11		3			6		7			3		2			13		7			12		8					2
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1		2					4					1			4		6			5					15		6					3
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative					3					14			4		5			7		13			5		30			13		17					2
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			6		2			5		5			2		7			9		4			6		9			30		5					3
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						7,369					7,367					7,537					7,887														
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			1																																
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			2		5			5		3					3			3		1			15		7			6		3					2
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			6		3			2		1			1		4			6		2			3		3			15		4					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						4,539					4,547					3,908					5,443														
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																									4			5		2					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																							1												
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1							2			2					1		2					1					2					2
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			6		13					13			11		2			4		5			2		8			7		6					3
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																														5					1
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					1					1					2			1		4					1					7					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			5		6					3			3		2			1		11			3		7			3		4					6
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			398		705			763		498			323		459			493		501			1,837		1,733			712		735					366
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			480		1,106			1,197		837			474		615			663		584			1,262		1,435			776		822					299
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													2		1			1					1		1			1		1					1
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			60		60			62		49			54		48			48		31			26		34			5		393					52
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1		1					2					1					2			4		4					244					52
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			5		2			2					1					1		1					3			7		1					1
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					1													2										2		2					1
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			51		61			66		45			46		41			43		29			11		27			9		268					28
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			282		537			491		318			353		551			771		670			260		579			827		688					522
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			3		10			9		7			6		6			6		3			22		8			11		4					7
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2		4			7		4			5		4			7		7			4		8			18		9					7
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			21		35			23		18			14		14			21		21			12		15			27		20					9
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			27		55					67			26		38			46		37			66		376			540		619					2,799
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			702		1,175			1,283		823			771		1,374			1,609		1,430			831		1,332			2,041		1,806					1,354
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			25		48					50			12		14			14		32			693		281			314		317					1,472
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					1																									1					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			658		1,315			1,493		1,000			556		742			784		685			1,769		1,945			894		873					282
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected										2													2												
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			67		96					214			90		88			76		95			93		282			150		200					76
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			345		760			831		680			408		481			508		478			743		1,046			650		654					287
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																												2							
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			74		115			108		68			63		39			23		29			57		59			21		26					27
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		2			8		4			8		3			1		3			3		4			1		15					6
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			35		48			55		33			30		21			23		25			66		38			16		32					28
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			5		4			2		2			2		3			2		3					2					15					5
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1		4								3		1			1		5			3		1					10					65
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																														2					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						6,177					6,174					6,294					6,366														
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			30		21			26		28			34		25			23		23			7		8			3		157					31
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			2		2					3			2										30		5			2		2					18
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			95		136			120		62			73		46			58		40			78		72			37		28					36
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						6,375					6,383					6,548					7,332														
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			10		11			8		11			13		12			13		7			1		7			2		80					4
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			2					3					1										4		1			10		1					
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			24		34			24		11			41		29			36		32			9		24			34		45					50
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						7,936					7,922					8,107					9,275														
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			37		64			55		45			55		44			54		41			25		23			56		51					45
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										20,724					18,601				
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										6,843					5,996				
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1							1													2		2					3					4
Botswana	Botswana	BWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					3			4		4			3		1			1		4			1							5					1
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			37		64			55		45			55		44			54		41			25		23			56		51					45
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					2					1			1												1			2							2
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		2			8		4			8		3			1		3			3		4			1		15					6
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			2		2					3			2										30		5			2		2					18
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1							1													2		2					3					4
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			21		35			23		18			14		14			21		21			12		15			27		20					9
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			6		13					13			11		2			4		5			2		8			7		6					3
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			95		136			120		62			73		46			58		40			78		72			37		28					36
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			5		11			8		3			8		9			14		8			3		8			12		8					6
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1		4								3		1			1		5			3		1					10					65
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			40		68			76		58			40		25			25		21			32		30			22		21					18
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			5		4			2		2			2		3			2		3					2					15					5
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		5			4		5			3		5			4		4			1		3					6					3
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			24		34			24		11			41		29			36		32			9		24			34		45					50
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					2																									1					
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					3			4		4			3		1			1		4			1							5					1
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1							2			2					1		2					1					2					2
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive										1																									
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			74		115			108		68			63		39			23		29			57		59			21		26					27
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			76		99			103		76			52		38			38		33			84		75			24		35					35
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			28		75			60		43			38		45			54		48			14		20			34		31					43
Botswana	Botswana	BWA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			35		48			55		33			30		21			23		25			66		38			16		32					28
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation										2					2			3		1			1		1			8		10					3
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1																									
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																														1					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			30		51			42		20			17		50			17		15			49		17			11							1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			17		25			24		18			12		19			4		7			25		8			10							3
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										9			3		2			10		3			1		3			6		11					11
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																																			1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		1										1							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			3		20			10		10			5		12			6		9			4		2			9							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			8		16			9		2			14		27			11		7			3		3			8		2					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				1					1					2					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			28		35			31		23			10		37			3		11			6		18			5		8					8
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation										6					3			3		2								7		12					8
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							24		1										
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1		4					2			1		2					2								1							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					2													2		2			1		1					2					2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																							1												
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		1																	
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							12		2					2					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												1							1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1					2			3		2			1		3										1					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							1												
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			1		2										2			3		2										3					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		2							1			3		3					2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																																			1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																																			1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			44		48			48		24			8		40			11		30			14		22			9		6					11
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			22		15			16		16			6		24			7		26			8		9			3		8					5
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										7			1		4			5		2					1			7		3					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										2								2												2					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			1		5			2		4					2			1		2			1		1			1		5					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			24		36			32		44			12		29			11		30			22		28			8		15					9
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1					1					1		2			3		6					1					4					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1		1					3			5					6		12															
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1			2										1		2			1							3					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														7					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																									1			1							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			2		7			13		5					12			7		11					5			20		17					19
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									1					2					2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			6		29			21		12			6		31			25		11			5		3			14		1					5
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																														1					2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP										1																									
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP										1																									
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																																			2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			12		19			12		9			1		11			5		10			6		4			5		6					2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1		2					1			3		2			4		7			3							2					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			20		45			44		28			11		35			10		11			48		15			9		2					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														1					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					3								1																						
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1																														
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			1		1			2		1					1			4		3			1					3		5					2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			23		47			32		27			15		23			10		13			39		13			7							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation															1															3					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			6		17			16		6			1		19			19		22			3		6			14		7					10
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					7			3		3			4		13			2		3			1		2			2							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy					3					2																									
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							1		1					1					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation										4								7		2					3			11		20					5
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														1					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			9		18			15		16			14		34			17		17			9		5			17		1					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			2		2					6			2		3			1		1			4		3			3							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1								3												2					1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy										1			1															1							
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														2					2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										11			1		1			8		3			1		5			3		11					9
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																																			1
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			13		8					9			2		9			1		3															
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation										1					1			3		2					1			8		14					9
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													4					1		5															
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																																			2
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										1			1							4			1		2			4		8					6
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					16			9		3					4			8		4			1		3			4		5					5
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										5			1		2			2		1			1		3			6		11					7
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												3		3					3
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			16		19			17		8			13		20			8		9			55		12			6		5					
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					2										2			2		8															
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			1		16			22		16			1		26			27		21			9		6			26		23					21
Botswana	Botswana	BWA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													2		3																				
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												3,790					3,790				
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												3,645					3,645				
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			2,853							27	18	27	941	188	234	140	483	941	237	140	362	210	1,959	277	392	611	637		618	741	973	1,005					284
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			1,280							28	28	51	1,280	202	215	430	687	1,280	380	344	560	458	1,779	429	671	1,027	910		989	1,416	1,297	988					343
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male										70				1	1		7				103			2	3	4			2	18	33	2					2
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female												6	1,175	51	57	73	120	1,175	84	53	86	86	311	94	167	164	182		182	228	312	208					69
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female										23		1		1			2		14	8	31	1		2	1	29	2			39	24						9
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												5,738					5,738				
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			4,804																																		
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			782							54	9	23	244	191	172	136	477	244	251	159	339	174	769	260	496	718	628		634	752	937	775					297
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			779							25	29	56	609	245	284	763	908	609	467	404	677	419	2,117	447	791	1,166	1,116		1,172	1,592	1,294	1,041					439
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex												1	81					81					1,267	3	1	4		1,267	6			1	1,267				
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			312							4		7	153	53	39	30	95	153	68	34	51	32	638	52	132	191	187		134	200	188	139					64
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			3,456								3	20	1,774	25	47	69	157	1,774	80	49	72	76	250	100	189	200	223	250	206	303	307	271	250				77
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			2,853							15	30	25	1,517	149	175	309	482	1,517	277	247	389	289	4,841	329	532	599	663		645	955	853	708					272
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			1,050							13	23	44	980	207	282	614	929	980	483	420	762	504	2,011	549	849	1,227	1,148		1,174	1,640	1,460	1,102					435
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												2,224					2,224				
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												1,427					1,427				
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male										6	10	24	1,030	96	145	87	282	1,030	157	103	220	174	979	157	316	432	465		416	574	851	737					212
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								13,779						1																							
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male										6	10	17	1,012	53	66	65	152	1,012	124	66	97	107	693	93	171	239	244		218	267	476	463					135
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			4,806																																		
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			3,456							2	5	19	1,609	50	86	72	174	1,609	110	74	154	100	2,222	145	226	312	283	2,224	229	303	505	501	2,224				126
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			312							4	5	31	250	104	60	221	275	250	156	124	158	127	1,308	154	262	376	338		386	452	285	220					125
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												3,425					3,425				
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			1,051							48	8	34	560	262	292	199	697	560	363	209	468	265	993	355	588	789	836		790	990	1,263	1,122					389
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			1,279		1					32	36	32	772	229	229	152	649	772	288	220	444	250	1,223	348	554	747	784		714	947	1,246	1,084					380
Botswana	Botswana	BWA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female										3	9	17	1,444	92	78	183	345	1,444	156	134	207	187	586	171	241	374	368		371	666	606	433					168
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				215	249	329	134	410	150	135	40	42	120	52	96	187	173	120	98	72	111	64	1,553	205	340	290	249		280	316	424	460					305
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			48,805	6,229	3,609	1,913	1,440	9,675	1,038	1,024	403	545	2,300	282	404	393	488	2,166	418	492	495	440	1,465	1,596	1,775	1,418	1,563	3,775	1,884	2,191	2,003	2,187	9,451				1,379
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												22,126					21,710				
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				3,866	2,459	1,592	1,635	11,954	1,320	1,218	676	632	1,576	377	689	655	727	1,468	690	737	698	705	3,004	1,624	2,182	1,785	2,076		2,138	2,239	2,412	2,355					1,403
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			18,535	6,121	3,455	1,927	1,396	4,740	1,247	1,492	952	1,026	2,315	874	1,003	1,053	997	4,220	1,005	1,790	1,765	1,620	7,891	3,035	2,944	2,998	3,025		3,645	4,176	4,085	4,213					2,251
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				2,613	1,338	963	884	9,256	739	737	369	324	1,595	224	360	347	394	1,417	381	438	451	422	2,064	920	1,328	1,016	1,131		1,246	1,249	1,441	1,444					879
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			31,425	8,278	5,478	3,074	2,955	15,459	2,163	2,232	1,096	1,122	1,581	778	1,172	1,071	1,110	1,620	1,263	1,046	1,126	935	5,942	2,756	3,266	2,625	2,957		3,246	3,395	3,728	3,525					1,841
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			49,190																																		
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				3,194	2,151	1,094	933	8,128	811	925	486	612	2,479	403	705	548	720	2,806	688	912	1,022	910	2,647	1,971	2,206	1,711	2,058		2,209	2,511	2,605	2,498					1,790
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												14,676					12,799				
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												15,549					18,945				
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			698																																		
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				51	12				39	11	8			5	7	17	13		7		3	3		21	6	28	25		11	38	29	157					48
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			8,078	3,460	814	1,654	1,942	2,987	1,998	157	52	50	295	107	128	134	139	308	76	72	99	72	3,486	219	279	306	308	12,141	319	312	442	458	13,163				223
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				2,067	1,299	718	605	5,570	455	463	230	271	1,885	161	294	244	311	1,878	331	328	396	330	1,427	920	1,007	863	1,009		1,113	1,135	1,184	1,166					812
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			28,892	9,711	6,447	3,291	2,810	14,161	2,601	2,837	1,765	2,040	5,333	1,483	1,992	1,836	2,174	9,174	1,913	3,583	3,571	3,350	11,892	5,268	5,672	4,789	5,389		6,281	6,781	6,755	6,670					4,689
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												7,057					13,253				
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				33	15				39			4		7	11	21	18		15	3	1	2		12	6	9	18		15	12	7	18					74
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												19,317					11,540				
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			32,661	9,939	6,430	3,524	3,562	11,718	2,320	2,370	1,025	1,198	1,896	863	1,239	1,122	1,116	2,041	1,261	1,089	1,061	878	10,024	2,688	3,352	2,736	3,049		3,251	3,332	3,628	3,519					1,773
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			32,865	6,290	4,281	2,266	2,046	10,606	1,796	2,000	1,237	1,366	3,740	1,044	1,492	1,382	1,593	5,994	1,457	2,336	2,438	2,338	16,956	3,668	4,016	3,387	3,634		4,184	4,529	4,663	4,506					3,183
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			9,612	3,270	1,560	930	724	3,814	609	504	120	236	1,356	171	209	244	252	1,395	302	236	373	322	3,928	773	687	684	732		1,099	773	1,217	1,345					394
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				1,895	523	1,010	394	175	889	370	117	180	40	267	330	423	422	40	342	312	330	289	70	663	804	687	685		771	947	1,157	1,347					783
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			2,395																																		
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			27,800	14,446	9,465	4,528	3,642	12,509	3,463	3,873	2,361	2,784	5,623	2,122	2,679	2,482	2,636	10,690	2,373	4,337	4,789	4,160	16,133	7,370	7,574	6,675	7,174		8,136	8,718	8,659	8,940					5,582
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			29,437	13,669	9,354	4,431	3,787	13,459	3,512	3,772	2,419	2,764	6,815	2,070	2,762	2,398	2,665	12,550	2,498	4,512	4,578	4,391	15,390	6,862	7,165	5,997	6,421		7,730	8,304	8,318	7,921					5,412
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			5,260	57	8	3	5		58	47	10	62		35	183	180	202		220	188	175	191		201	83	90	79		278	303	310	279					224
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												10,262					19,483				
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			61,127																																		
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			16,927	8,909	5,708	3,174	2,542	7,497	1,790	1,794	709	950	1,249	617	871	733	685	1,709	794	741	755	637	4,527	2,233	2,542	2,262	2,489		2,625	2,951	3,231	3,063					1,475
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			30,520	6,623	4,016	2,647	2,950	13,780	2,322	2,121	1,197	997	1,537	636	1,022	978	1,110	1,488	1,092	1,042	1,022	956	5,551	2,351	3,087	2,474	2,721		2,760	2,987	3,177	3,002					1,663
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			45,000	6,264	3,502	2,692	1,833	12,645	1,345	1,561	767	677	2,130	344	530	527	597	2,115	499	589	658	659	4,629	1,537	1,990	1,596	1,877	8,077	2,136	2,243	2,357	2,428	10,492				1,422
Botswana	Botswana	BWA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												26,702					25,918				
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			1,329	139	94	75	51	551	29	36	21	21	62	22	38	25	31	63	59	40	29	30	333	48	42	36	53		27	28	24	37					18
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			114																																		
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			3,773	312	207	165	124	1,452	105	112	51	67	472	63	85	73	88	466	67	94	97	91	588	99	137	96	115	675	107	92	84	98	689				48
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			2,499	471	462	318	254	1,271	193	212	124	179	293	127	170	146	132	446	131	154	164	159	726	183	228	158	190		189	188	170	160					124
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			293	5			1		3	2					3		9		3		1	3							1	3	1	1					2
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			4,179	251	176	110	121	1,153	82	62	37	41	503	41	47	58	77	506	52	66	65	68	161	80	121	95	95	352	95	97	64	93	609				50
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												356					351				
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			5,287																																		
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			68																																		
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				18	8	12	3	3	3	1	6	5	2	1	5	2	32	2	9	4	3	1	10	4	7	6	3		4	4	4	5					4
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				333	244	192	153	1,313	149	168	97	92	322	67	158	122	120	312	97	127	128	134	351	138	178	140	133		153	130	94	120					78
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												908					360				
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			578	115	107	78	60	392	23	67	24	36	62	29	28	37	24	102	35	37	56	36	520	60	46	46	63		55	80	61	60					42
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				3	2				20						3	3			2			1			1	1	2		1		1						10
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			2,249	460	403	291	226	1,537	189	244	128	150	381	122	181	152	170	527	136	178	144	168	601	166	250	175	158		184	179	161	143					113
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			1,568	384	320	242	178	1,029	190	172	98	144	168	88	121	112	107	358	103	122	113	126	776	172	211	185	175		169	152	139	138					118
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												642					535				
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				166	139	104	90	627	69	77	54	47	340	44	82	54	72	364	64	69	62	70	140	63	78	72	101		75	76	57	68					52
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				213	177	152	122	948	116	123	92	94	439	65	114	86	116	469	103	114	89	97	222	214	146	106	162		105	107	96	112					74
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			4,111																																		
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			34	29	12	22	8	59	8	3	1		14	8	3	1	3	14	2	2	2	2	476	1	7	5	7	606	9	7	6	2	596				6
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				6					26					2	1	2	1		3					2		1				2							9
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												640					1,061				
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												392					409				
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				208	159	116	117	1,030	99	124	72	69	332	61	85	76	82	300	70	96	103	95	246	89	151	99	139		98	86	90	83					57
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												312					207				
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			2,181	410	335	244	213	1,653	163	164	74	100	261	98	126	133	118	230	155	113	122	103	726	172	171	143	110		111	131	103	103					50
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			2,476	419	324	242	223	1,547	177	183	109	113	261	96	180	130	150	250	181	142	143	168	704	176	250	168	169		140	170	109	123					62
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			3,067	394	321	242	248	1,169	169	191	151	148	437	122	177	145	146	556	129	144	131	156	1,588	177	214	140	168		143	147	135	133					90
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,559					771				
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			2,374	255	188	159	131	1,037	84	106	34	55	183	55	103	69	71	161	96	84	75	72	580	82	117	82	94		79	73	62	77					45
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				20	6	11	1	16	5	7	3	1	6	1	5	1	4	6	1	2	3	2	185	2	3	7	2		1	2		6					3
Botswana	Botswana	BWA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			276	50	16	17	10	236	9	11	3	4	39	4	6	7	9	42	17	7	4	5	207	8	9	9	6		7	6	10	10					3
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex							1																														
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												757					521				
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				326	333	259	269	1,163	229	300	231	270	1,267	260	243	229	208	1,252	206	262	187	178	1,142	207	202	165	167		195	195	165	199					167
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				108	121	88	94	330	80	93	84	97	405	102	92	85	110	337	84	87	80	90	352	78	63	69	95		92	105	97	102					75
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				4	7	4	8	129	4	10	1	5	91	8	7	5	8	44	7	6	6	6	127	6	10	8	7		3	4	9	7					5
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female							1							2	2	1	1				1	1															
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																													1	1		1					
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												2,325					2,000				
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				1		1				1								1		2										1							
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				274	379	262	313	1,400	235	273	218	205	859	207	203	185	179	904	188	206	158	184	1,218	137	191	153	157		168	182	159	184					143
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				360	375	322	356	1,504	240	288	264	256	1,457	254	233	241	192	1,480	207	220	181	213	1,307	171	204	170	188		207	213	181	198					152
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				190	218	177	210	1,069	155	154	125	155	1,385	101	111	99	115	1,511	118	122	106	128	691	85	113	88	85		118	134	102	110					89
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				52	51	36	47	221	32	49	29	36	173	32	24	37	34	177	29	34	46	20	147	31	22	18	19		28	32	30	25					21
Botswana	Botswana	BWA	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												1,545					1,440				
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			4,772		1		2	6,707	1,191	1,276	1,043	1,112	6,300	1,045	1,135	1,020	1,088	6,299	969	1,055	983	1,081	6,299	897	1,078	897	885		1,145	1,253	1,038	1,209					1,009
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			2,344	2	1	3	5	3,270	584	723	554	614	3,109	618	654	600	607	3,099	536	659	526	597	3,072	519	568	483	470		595	712	515	572					494
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			5,085			3	1	6,710	1,240	1,380	1,070	1,081	6,246	1,000	1,032	931	1,053	6,145	898	1,126	1,013	1,005	5,977	860	1,065	908	912		1,190	1,346	1,175	1,276					1,053
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female											1	9		2	3	1	2		1	1	1	3			1	1			1	1		1					2
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												12,408					11,167				
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			2					17	7	6	4	3	15	6	2	3	5	15	4	6	1	5	15	2	1	4	3	15	6	7	5	6	14				7
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			3,738	3	2	2	3	5,261	870	974	817	896	5,003	878	828	833	813	5,004	781	893	756	830	4,977	739	814	708	746		993	1,066	813	1,050					848
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				2	1	1	1	819	171	202	141	182	761	191	207	171	201	689	187	188	170	183	689	173	162	164	158		228	279	131	158					141
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			1,851			1	1	2,328	440	574	449	440	2,165	417	359	410	417	2,062	379	466	436	431	2,023	427	474	389	372		511	609	519	580					454
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female								334	12	18	9	17	316	11	13	11	14	180	13	11	12	14	179	16	20	9	16		9	21	142	146					117
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												8,816					7,934				
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex																													1								
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												4,352					3,917				
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			743																																		
Botswana	Botswana	BWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female														4																	2						
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												2,325					2,000				
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			968	2	1	2	4	1,221	233	300	221	268	1,268	259	243	232	208	1,253	203	271	189	178	1,142	207	202	161	139		195	197	123	119					115
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female												2		2	2	1	1				1	1							1	1		1					
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												757					521				
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			369																																		
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			676			1	1	1,115	159	154	121	156	1,384	105	111	101	115	1,511	117	122	109	128	694	86	113	86	81		119	136	102	111					93
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			1,172	3	2	1	1	1,594	240	288	257	255	1,457	259	233	241	193	1,481	205	222	181	213	1,308	171	204	172	162		215	216	172	207					157
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female														1																							
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female								128	4	10	1	5	91	8	7	5	8	44	7	7	6	6	127	6	10	6	6		3	4	136	144					113
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												1,545					1,440				
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex										1								1												1							1
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				2	1	1	1	353	80	94	78	97	407	102	92	85	110	337	84	86	86	90	352	78	64	72	81		93	108	17	35					20
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			133				1	229	32	48	27	35	173	34	24	37	34	177	29	31	40	20	147	31	22	21	16		28	32	30	25					24
Botswana	Botswana	BWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			1,078		1		2	1,468	239	270	213	204	859	209	203	189	178	904	188	200	152	184	1,221	137	191	155	136		172	190	158	185					147
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			154		111		55			22								290												8		8					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			6,323		426		1,172	3,847		1,918		2,204	3,046		2,144		7,777	2,637		3,876		5,218	3,334		6,483		4,138			3,283		2,349					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					57		71			4																				2		2					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			6,740		4,501		6,115	3,780														92								11							
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												8,495					6,074				
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			158		182		247	205		101			232					290		6					1					24		19					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												399					77				
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female					36		1																														
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			247		209		245	260		86			293					290		4		7			17					44		32					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												198					77				
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					48		30																														
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female					36		70			5																				1		1					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			64		70		82			8																				6		6					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			1,391		195		381	828		219		25	2,609		231		3,098	2,266		1,107		1,187	2,007		856		1,381			818		789					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			111		88		29			18								290												3		3					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			6,316		3,987		2,363	4,120		1,826		3,583	14,812		3,579		5,935	13,953		3,891		9,139	17,356		7,610		10,474			5,401		4,561					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					35		21																														
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male					59		64			2																											
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			1,979		2,015		3,410	1,960		376		1,878	12,313		2,450		4,297	11,725		2,104		7,094	9,294		2,279		5,887			1,432		1,661					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												18,088					13,317				
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			76		46		27			1																				4		4					
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			5																																		
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					47		29			3																											
Botswana	Botswana	BWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male					86																											9					
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												606					606				
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			115	195	236	272	198	305	358	416	485		459	483	461	509					235
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												554					555				
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			65	121	129	115	133	161	221	234	258		226	275	232	281					141
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			24	40	58	64	22	101	110	133	145	85	163	179	193	196	85				107
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			55	98	113	121	52	151	204	281	270		276	287	311	317					198
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																			3		1			2	1		1			1	1						
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																			7	5		1			1												
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			56	101	105	135	90	160	187	279	311		286	288	291	314					123
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			20	34	47	52	14	70	79	96	121		114	128	126	163					113
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			43	52	47	53	135	72	84	102	123		94	110	104	127					49
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												1,576					1,572				
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			33	65	86	102	33	109	154	199	247		212	224	240	270					127
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												863					867				
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												515					515				
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			133	141	152	122	299	123	122	121	122		97	113	113	106					18
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												254					253				
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			55	115	123	111	170	149	186	221	229		212	241	214	226					78
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			2	7	6	7	32	10	10	11	13		8	16	10	16					1
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			180	222	304	323	303	323	368	432	486		425	438	424	447					145
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			87	174	187	217	101	269	314	387	433		396	424	439	442					200
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			31	38	56	68	34	83	101	126	137		140	132	153	172					130
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			13	32	42	60	28	71	99	114	139	60	125	135	141	137	60				96
Botswana	Botswana	BWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			343	478	512	421	797	396	422	397	453		340	288	319	293					93
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																107	113																				
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							9	12		6		14	104	17	38	53	95	209																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					5		22	68		39		69	196	92	150	268	428	319																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					2		14	12		15		21	120	35	69	130	224	214																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							4	7		10		8	14	13	24	63	82	77																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					4		27	27		38		63	72	91	145	214	295	141																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					2		18	14		25		19	47	50	44	68	112	121																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					8		52	68		60		103	427	133	227	381	622	603																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male							8	9		14		16	21	36	56	123	176	94																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					34		219	224		189		234	1,400	261	375	991	1,309	1,581																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							2	4		3		3	1	4	14	39	73																				
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					156		553	609		399		529	3,204	596	988	2,401	3,338	3,594																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					13		40	28		77		123	102	173	233	325	447	178																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					38		107	93		87		147	278	190	277	421	505	353																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					41		98	94		94		132	262	190	267	394	540	329																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male										3						65	30																				
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					26		74	74		106		126	494	253	342	707	1,016	677																			
Botswana	Botswana	BWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male										3		3		6	22	65	110																				
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			20		8		44	46		39		36	395	60	126	192	227	512	240	294	367	208	984	349	412	455	337		367	380	353	318					105
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			14																																		
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							9	10		4		2	97	5	21	26	35	181	33	27	51	35	173	45	58	60	57		60	62	59	45					15
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			14																																		
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												1,860					1,850				
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			44		37		61	62		62		40	214	103	121	141	148	275	160	188	216	116	858	243	263	300	209		246	247	292	264					36
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			46		39		68	62		72		35	233	88	124	151	102	294	118	169	161	94	693	207	241	283	225		192	243	278	249					47
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												2,690					2,684				
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			7				2	3		3		2		1	11	19	24		22	29	35	18	142	49	50	48	43	220	44	55	49	47	220				13
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			444		163		394	481		269		172	3,032	435	771	1,128	879	3,149	560	770	758	393	3,992	669	839	961	677		640	744	608	526					89
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			9							1		1		3	16	34	38		25	37	38	35	108	46	69	72	46	285	71	72	60	101	285				11
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			44		24		50	51		84		38	460	157	199	330	337	577	312	431	509	252	1,513	484	576	611	465		420	494	494	351					85
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			20		5		18	46		28		11	166	36	75	144	140	270	168	163	220	144	506	235	256	264	271		241	262	214	177					63
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												5,629					5,641				
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			20		5		35	18		47		30	87	73	114	104	113	148	143	187	168	89	667	225	238	218	182		207	243	283	223					66
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												1,532					1,522				
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			248		37		177	178		132		75	1,343	210	313	454	353	1,460	239	313	351	188	1,499	325	376	448	317		348	401	322	275					31
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					2		12	10		8		10	113	19	40	63	91	188	62	74	95	69	266	122	119	163	133		113	147	126	93					39
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												1,655					1,649				
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			20		5		22	18		23		21	58	39	64	85	85	119	95	115	143	74	460	187	209	217	164		156	220	219	199					44
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			49		2		16	8		22		5	39	28	16	37	28	100	28	34	29	19	175	48	47	60	36		50	52	97	76					4
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							4	3		6		3	12	9	16	31	24	63	23	42	40	26	81	37	69	56	47		62	67	72	67					18
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												837					857				
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male							8	5		10		8	17	21	26	69	48	78	48	74	97	40	173	102	125	133	120		105	122	152	121					41
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male										2							3			1	1				1		2										1
Botswana	Botswana	BWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																27					1			1			7										2
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				1	1	3	2	57	2	2		1	65			1	1	24				6	10				5					4					
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				29	31	23	25	68	24	13	13	7	41	9	8	6	29	77				64	62				81					70					45
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				7	9	9	12	60	7	5	4	2	50	5	4	5	7	39				22	38				20					25					10
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female									17	1		1																									
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				1		2	1			1				1								2					8										1
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				28	13	18	15	66	15	11	6	3	57	4	3	6	20	74				41	53				49					47					31
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				31	27	26	23	61	19	24	7	7	72	6	5	8	18	80				47	54				46					39					26
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male									9	1																											
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				19	20	14	21	60	11	10	9	5	58	3	4	4	18	79				42	68				39					36					44
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											48					33					35
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											54					44					47
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				9	10	6	9	61	4	2	1	2	59	2	6	4	6	38				19	35				13					5					11
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			706																																		
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											45					32					24
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				3	2	1	4	55					63										2				2					1					1
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			813																																		
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												102					102				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				1		7	3		4	3	1											1										2					1
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												103					100				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				8	12	7	8	61	8	6	1	2	78	1	5	3	6	47				8	23				16					16					8
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												84					76				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											15					29					20
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				34	32	25	27	66	22	17	11	3	42	7	14	12	25	76				74	56				81					95					66
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				25	22	30	27	60	14	14	7	6	46	9	7	10	22	81				51	56				55					49					40
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				2	3	6	2		1					2			2					4					3					4	1				4
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				37	32	20	34	58	20	11	3	5	68	8	6	7	29	64				83	46					53					66				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				39	35	23	19	62	8	14	12	4	80	4	6	10	15	68				33	42				46					43					24
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				14	35	17	10	56	8	7	7	1	61	3	1	13	14	51				29	45				31					33					14
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											26					30					20
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												1					1				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				50	44	43	64	60	31	24	16	10	74	17	28	32	56	70				132	55					62					70				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											31					37					29
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												66					78				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											18					12					21
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												183					227				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												170					204				
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											13					18					17
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex						3	2			1												4					1					2					2
Botswana	Botswana	BWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				38	28	30	38	65	21	24	9	5	39	4	18	8	33	83				66	55				64					76					56
Botswana	Botswana	BWA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female										8		41								1												1					
Botswana	Botswana	BWA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male								29,546		23		14,290	58,325				503	60,141		4,057		1,830	35,598		484		2,183	21,736		6,078		3,448	17,854				2,035
Botswana	Botswana	BWA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female								41,992		40		27,043	82,530				826	85,997		7,777		3,509	50,785		999		4,003	35,470		10,999		6,298	28,923				3,761
Botswana	Botswana	BWA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male										5		33																									
Botswana	Botswana	BWA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex								767		878		303	1,508				19	1,381		20		6	1,438		2		8	887		23		4	1,034				2
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			1,409																																		
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												304					272				
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female								101	15	15	7	7	101	11	9	11	25	101	14	16	17	19	101	18	16	13	23		9	20	15	13					11
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												11					11				
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male								97	1	4			98		4	3	2	97	3	7	3	5	98	7	6	2	3		4	10	8	6					2
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex									2	5		2		5	4	4	6		7	3		6		5	4	5	11	9	9	3	4	8	9				5
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male								109	9	8	3	6	110	5	16	12	16	109	8	11	10	26	109	9	10	7	14		10	22	12	8					8
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female								95	13	11	9	6	95	7	5	22	24	95	18	14	11	19	95	18	15	14	18		19	21	15	18					14
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex									7	3	2	1				1	1		1	2		1		3	1	1	1		3	3	3	7					2
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female								101	12	22	14	5	101	9	11	16	22	101	10	17	14	18	101	16	14	20	21		18	18	19	12					14
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												202					183				
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				1				109	29	21	16	9	109	10	10	9	41	109	18	22	21	28	109	31	29	17	27		30	29	23	22					15
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female								98	26	15	8	10	98	14	18	13	43	98	18	37	32	43	97	38	38	32	31	100	31	32	49	35	93				22
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male								107	29	21	12	4	107	9	19	17	33	107	32	24	23	34	107	29	33	23	22		38	46	29	37					20
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female								100	11	12	3	4	100	4	14	7	15	100	6	8	7	10	100	7	12	12	9		13	16	11	12					7
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												217					195				
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex									7	7	1	2		2	3	4	1		6	7	5	4		6	6	5	6		5	3	2	3					3
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												226					204				
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female								97	4	4	3	2	97	3	6	4	11	97	9	6	8	4	97	5	5	2	5		13	8	5	9					6
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female									34	1	2																										
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				1				109	15	22	7	8	109	8	9	14	34	109	22	17	32	30	109	23	24	30	23		23	31	26	27					7
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male								103	14	14	8	4	103	14	10	11	23	103	12	14	12	23	104	13	20	16	12		30	14	23	23					7
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male								106	27	30	13	9	106	9	22	22	50	106	21	31	32	39	106	25	27	23	22		49	38	28	28					22
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female								102	10	11	8	5	102	4	6	4	23	102	11	16	12	12	102	7	13	13	19		9	15	13	7					10
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												205					186				
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female								101	20	26	12	6	101	11	6	10	24	101	15	16	13	23	101	24	13	13	14		13	19	9	14					9
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												340					308				
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male								108	49	49	27	20	109	29	58	57	102	108	61	75	60	79	108	76	81	60	62	116	102	63	84	72	107				44
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex									4	5	1				2	1	2		3	3	3	2		3	4	1	3		1	4	2	4					4
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male									17	1		3																									
Botswana	Botswana	BWA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			1,132																																		
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												802					773				
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			7,975	3,968	3,980	3,980	3,965	6,400	3,360	3,300	3,332	3,386	6,434	3,560	3,470	3,479	3,348	6,648	3,335	3,255	3,355	3,253	7,243	3,192	3,214	3,188	3,200		3,602	3,488	3,394	3,225					2,794
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			7,372	7,422	7,528	7,665	7,828	7,652	7,863	8,038	8,479		9,830	9,848	10,079	10,236					10,908
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			23,384	20,932	21,655	22,209	22,732	22,681	23,388	24,102	24,782	25,215	22,703	25,429	25,832	26,160	26,707	22,731										34,414					38,583				
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			2,638																																		
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			2,246	1,114	1,110	1,093	1,069	1,873	1,070	1,036	991	965	1,873	931	924	874	833	1,877	790	729	725	657	2,042	615	580	572	499		549	538	475	539					441
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			12,322	7,928	8,081	8,124	8,149	9,747	6,637	6,648	6,759	6,702	9,842	6,867	6,840	6,916	6,671	10,069	6,600	6,307	6,485	6,327	10,555	6,163	6,162	6,144	5,952		7,064	6,834	6,453	6,706					6,007
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			6,176	1,834	1,946	1,980	1,982	5,122	1,736	1,762	1,828	1,831	5,199	1,891	1,918	1,966	1,914	5,251	1,922	1,944	2,064	2,019	5,693	1,999	1,987	2,037	2,042		2,412	2,433	2,343	2,387					2,227
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				17,241	17,425	17,775	18,141	15,331	18,380	18,443	18,164	18,417	15,447	18,861	19,025	18,767	18,867	15,583	19,070	19,223	19,630	19,618	15,486	19,566	19,672	19,860	20,045		23,181	23,170	22,688	22,788					20,983
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			3,817	1,501	1,479	1,425	1,409	2,700	1,317	1,245	1,227	1,234	2,704	1,203	1,207	1,119	1,027	2,749	976	896	892	861	3,181	799	753	773	681		790	773	662	718					626
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												60,301					63,120				
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			13,089	8,011	8,074	8,001	7,946	10,676	7,250	7,259	7,301	7,142	10,710	7,241	7,152	7,153	7,002	10,737	7,016	6,882	6,962	6,792	11,194	6,659	6,507	6,545	6,336		7,138	7,044	6,687	6,562					5,604
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			20,544	18,026	18,012	18,104	18,212	16,599	17,398	17,260	17,265	16,893	16,682	17,248	17,098	17,035	16,849	16,876	16,837	16,368	16,810	16,313	18,055	15,943	15,737	15,686	15,278		17,971	17,613	17,000	16,942					15,277
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			17,448	13,136	13,092	13,091	13,155	13,474	11,478	11,302	11,093	10,993	13,568	11,280	11,192	11,085	10,752	13,796	10,651	10,403	10,712	10,463	14,082	10,103	10,160	10,175	9,940		11,912	11,792	11,337	11,408					10,296
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			4,504	4,712	4,926	5,017	3,123	5,117	5,260	5,330	5,548		6,595	6,718	6,916	7,053					7,174
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			29,787																																		
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			206	13	22	21	17	81	17	24	22	25	114	22	31	24	13	30	11	8	16	9	21	16	14	17	8	14	8	11	6	11	10				4
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			9,944	4,371	4,459	4,431	4,449	8,051	3,803	3,771	3,813	3,690	8,139	3,726	3,653	3,500	3,377	8,199	3,416	3,299	3,428	3,322	8,723	3,230	3,214	3,276	3,169		3,597	3,541	3,450	3,438					3,022
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			8,195	8,364	8,658	8,859	8,416	9,141	9,175	9,325	9,651		11,061	11,208	11,418	11,492					11,306
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			4,590	4,890	5,003	5,081	2,007	5,233	5,479	5,421	5,879		7,004	7,312	7,611	7,662					8,550
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				10,264	10,217	10,353	10,419	11,790	10,190	10,138	10,190	10,166	11,862	10,405	10,194	10,061	9,910	11,922	9,933	9,609	9,974	9,875	12,027	9,854	9,917	10,047	9,876		11,391	11,185	10,927	10,898					9,938
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female							39,746		1	56	13	11		18	205	30	15		358	1	32	35		5	23	18	21										
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												3,040					2,955				
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				8,977	9,174	9,570	9,704	10,442	9,678	9,514	9,689	9,729	10,545	10,108	10,212	10,515	10,902	10,621	11,122	11,114	11,325	11,383	10,645	11,561	11,398	11,477	11,660		13,145	13,038	12,863	12,899					12,420
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				166	165	162	150	261	157	152	161	162	261	181	169	147	125	261	145	143	138	136	267	142	143	146	139		123	113	91	105					78
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			10,856	11,241	11,489	11,745	9,477	12,057	12,226	12,451	12,797		14,781	15,121	15,279	15,655					16,147
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male							22,745			23	6	6		13	321	53	17		228		18	13		6	9	3	4										
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												6,929					6,862				
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			23,624																																		
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			2,061	814	790	748	740	828	772	737	721	727	828	713	699	668	668	828	679	667	665	656	1,269	667	631	650	632	1,337	664	644	559	583	1,302				516
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												19,565					20,178				
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			3,652	3,848	3,995	4,012	2,756	4,074	4,217	4,258	4,406		5,122	5,293	5,427	5,471					5,411
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			3,575	1,362	1,451	1,490	1,512	3,050	1,462	1,409	1,463	1,476	3,050	1,533	1,535	1,526	1,506	3,053	1,545	1,512	1,531	1,533	3,303	1,506	1,522	1,481	1,488		1,720	1,629	1,572	1,535					1,233
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												5,264					5,146				
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			19,976	16,821	17,354	18,001	18,264	19,553	18,427	19,279	19,553	20,029	19,607	20,229	20,565	20,731	21,050	19,657										27,570					30,216				
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				470	465	472	460	640	481	480	471	461	641	472	450	401	348	641	332	326	327	297	809	279	269	270	271		288	287	244	265					219
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				12,097	12,419	12,898	13,304	12,667	13,781	13,970	14,136	14,325	12,746	14,882	15,187	15,526	16,094	12,838	16,687	16,818	17,108	17,339	12,720	17,602	17,731	17,941	18,545		21,114	21,158	21,294	21,709					21,744
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			5,737	5,894	5,989	6,073	6,887	6,136	6,385	6,437	6,805		7,744	7,791	7,909	8,027					8,639
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			3,895	4,133	4,243	4,301	1,771	4,355	4,631	4,550	4,873		5,687	5,999	6,169	6,222					6,614
Botswana	Botswana	BWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												33,114					33,205				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			1,629	120	138	151	112	1,169	101	133	55	75	179	76	91	97	74	157	76	88	82	54	558	66	73	61	67		59	60	50	67					36
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												1,511					754				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			205	9	12	9	4		9	10	4	3	32	1	4	2	3	30	2	1	5	4	20	9	5	2	3	14	1	2	2	1	10				3
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			5,392																																		
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			369																																		
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			485	78	96	80	69	423	26	60	26	45	61	37	51	59	49	100	49	60	60	41	495	52	46	44	39		34	68	53	55					41
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												348					349				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,921	275	316	271	221	1,704	211	291	140	150	369	168	188	175	182	507	172	195	162	126	572	133	186	144	123		145	155	142	119					109
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								14	26	19	21		15	23	17	27					14
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												305					204				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								10	11	5	7		11	7	8	8					6
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								6	10	9	10		15	11	12	10					8
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,968	269	385	282	240	1,435	198	236	130	171	285	174	188	177	163	427	172	204	166	158	700	157	181	160	136		151	162	153	137					109
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				74	109	92	87	722	87	107	73	74	329	74	85	67	89	351	66	81	88	57	143	67	67	79	66		62	77	51	58					60
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			37	17	18	18	10	267	9	13	9	9	39	9	9	8	4	42	3	9	10	3	206	4	5	6	2		5	9	8	12					1
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex				6	10	9	10	111	11	4	4	3	14	5	7	2	2	14	5	5	5	5	464	2	5	5	8	592	4	2	2	1	587				3
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				132	138	130	133	1,059	143	173	128	125	423	105	139	137	123	451	118	146	117	83	218	89	109	89	97		110	104	86	100					78
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			1,364	185	284	209	185	1,770	164	185	107	106	252	120	141	135	113	224	144	113	115	81	699	120	114	129	77		79	100	90	89					54
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												381					403				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female							3,242		7	6	1			3	2	2				2	1	3															
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			1,097	49	81	63	56	705	40	48	26	27	61	27	39	27	23	63	34	34	30	27	318	31	33	29	34		23	23	20	20					19
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			7,019																																		
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			1,977	230	263	223	199	1,696	182	293	147	140	250	147	163	163	149	242	180	167	137	141	682	122	150	142	117		105	136	91	105					53
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			3,127	187	280	189	254	1,333	187	260	184	170	423	173	197	161	143	536	136	197	162	134	1,547	147	154	126	113		129	140	120	104					77
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								44	34	40	38		39	46	30	42					24
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								4	10	10	7		14	7	17	6					4
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												881					357				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				5	13	2	1	6	4	3	3	2	2	1	1	3	5	2	10	7	5	1	8	5	4	4	3		5	3	3	3					4
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			1,441	219	269	235	189	1,076	176	183	123	131	164	135	166	155	130	345	153	164	128	109	741	154	168	133	135		127	145	93	114					104
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								38	41	40	36		52	48	33	53					33
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				106	124	99	101	1,175	101	147	78	84	319	86	78	99	76	291	87	124	111	65	240	86	92	64	80		86	81	61	63					57
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												620					1,037				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				174	177	147	148	1,500	144	233	124	129	312	106	145	122	114	299	103	142	134	107	349	110	134	147	99		129	112	90	97					63
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								17	20	19	18		13	12	15	18					7
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male							1,852		4	3	1			2	3		1		11			2			3	1			1								
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								6	9	12	9		9	12	9	5					12
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				3	8	4	2	44	3	6	7	1	6	4	5	1	3	6		5	2	3	180	2	4	5	1		1		1	3					2
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												622					528				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			5,397	150	169	136	119	1,614	106	173	67	94	455	76	81	80	74	447	70	87	65	77	573					654					674				
Botswana	Botswana	BWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			5,740	136	148	103	113	1,248	99	99	67	60	484	76	65	75	69	489	60	79	69	64	159					343					599				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												672					643				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								7,383	7,576	7,739	8,070		9,289	9,315	9,481	9,478					5,988
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												2,708					2,669				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								3,861	4,027	4,045	4,154		4,807	4,923	5,075	5,075					2,962
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				2	6	9	7		5	4	2	8	110	11	10	9	6	22	6	4	9	4	14	3	4	5	2	14	2	9	2	5	10				1
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				2,763	3,253	3,321	3,273		2,612	2,669	2,496	2,518	6,202	2,714	2,788	2,965	2,889	6,466	2,821	2,829	2,887	2,879	6,433	2,774	2,748	2,693	2,759		2,984	2,768	2,604	2,683					1,369
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								4,924	5,079	5,128	5,302		6,219	6,350	6,542	6,688					3,950
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				10,359	11,872	11,924	11,935		9,545	9,795	8,874	8,722	13,070	9,254	9,569	10,118	9,914	13,480	9,706	9,729	9,925	9,831	13,518	9,495	9,343	9,095	9,052		10,398	10,066	9,804	9,878					5,177
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				1,238	1,571	1,583	1,614		1,347	1,371	1,343	1,285	5,005	1,413	1,527	1,622	1,654	5,140	1,617	1,658	1,748	1,775	5,294	1,739	1,704	1,646	1,727		1,936	1,875	1,887	1,903					1,026
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								4,969	5,296	5,395	5,577		6,662	6,963	7,175	7,219					5,008
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				18,256	20,675	21,243	21,706		20,572	22,393	21,229	21,609	21,899	22,707	23,870	25,194	25,678	22,309	26,402	27,402	28,115	28,808	21,842					32,607					36,600				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								5,908	6,098	6,198	6,371		7,274	7,272	7,413	7,507					4,656
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				8,271	9,335	9,492	9,513		8,514	8,883	8,100	8,001	11,426	8,594	8,884	9,234	9,166	11,685	9,143	9,002	9,164	9,146	11,714	9,154	9,080	9,079	8,942		10,166	9,771	9,660	9,658					4,813
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				14,795	16,710	16,913	16,855		14,689	15,321	14,104	13,780	16,073	14,427	14,987	15,930	15,785	16,512	15,735	15,464	15,668	15,449	17,683	15,136	14,696	14,391	14,123		16,142	15,489	15,175	15,154					7,709
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				114	118	122	120		115	108	102	89	258	102	97	89	83	259	89	100	99	103	233	96	104	103	107		95	86	70	76					34
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				3,210	3,786	3,789	3,791		3,071	3,071	2,770	2,687	7,834	2,818	3,028	3,039	2,955	8,029	2,922	2,887	2,974	2,935	8,032	2,819	2,746	2,703	2,681		2,918	2,741	2,707	2,758					1,312
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				10,448	11,819	12,258	12,594		12,074	12,836	12,122	12,284	12,277	13,000	13,715	14,714	15,345	12,578	15,930	16,169	16,457	16,804	12,625	16,932	16,993	17,226	17,414		19,866	19,808	20,014	20,401					11,376
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female										1	1			1	1	10	1					5															
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				6,212	7,181	7,129	7,060		5,889	6,122	5,554	5,364	10,327	5,719	6,097	6,397	6,326	10,531	6,274	6,205	6,227	6,174	10,679	6,056	5,820	5,691	5,548		6,130	5,824	5,670	5,556					2,532
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												57,129					59,881				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				14,567	16,478	16,763	17,053		15,760	16,750	15,540	15,496	14,878	16,246	16,764	17,742	17,868	15,260	18,102	18,355	18,567	18,784	15,279	18,715	18,609	18,681	18,608		21,445	21,238	20,907	20,976					10,708
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				1,132	1,207	1,144	1,167		1,078	1,046	941	945	2,616	967	952	939	887	2,684	830	744	700	727	2,807	674	628	561	540		619	551	486	554					315
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								11,583	11,714	11,925	12,071		14,002	14,265	14,482	14,699					8,757
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								4,106	4,448	4,485	4,589		5,391	5,633	5,807	5,786					3,876
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				710	715	674	681		679	670	596	586	803	603	595	601	622	814	629	597	581	611	1,134	589	569	569	570	1,103	582	555	497	531	1,085				311
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												6,335					6,443				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								8,686	8,671	8,761	8,924		10,285	10,316	10,591	10,626					5,896
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				5,992	6,982	7,124	7,084		5,366	5,594	5,121	4,960	9,476	5,443	5,680	6,033	5,977	9,817	5,874	5,785	5,821	5,778	10,006	5,591	5,474	5,326	5,288		5,963	5,629	5,511	5,681					2,941
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				394	420	407	416		413	416	385	374	621	368	355	348	316	635	291	283	282	271	741	236	227	217	230		253	244	200	233					126
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												4,920					4,847				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male										1					4	4						6															
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												31,037					31,442				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												18,485					19,126				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				880	937	944	945		941	900	783	750	1,811	785	764	776	745	1,840	705	647	644	628	1,781	539	524	487	433		454	432	382	430					250
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				975	1,174	1,214	1,235		1,162	1,167	1,120	1,104	2,944	1,191	1,273	1,312	1,336	2,996	1,323	1,349	1,331	1,377	2,962	1,325	1,344	1,284	1,288		1,364	1,302	1,253	1,262					559
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				14,238	16,361	16,998	17,198		16,040	17,665	16,676	16,892	18,906	17,743	18,798	19,680	20,074	19,287	20,544	21,281	21,909	22,475	19,775					26,012					28,607				
Botswana	Botswana	BWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				7,370	8,522	8,884	9,036		8,242	8,470	7,948	7,914	10,149	8,397	9,056	9,795	10,209	10,403	10,473	10,475	10,615	10,872	10,539	10,888	10,675	10,672	10,711		12,103	11,815	11,768	11,813					6,166
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														11		8					3
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																																1					
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																																1					
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			158		44		46			42		20			28		63			55		73			67		100										
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														7		18					5
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														1		7					
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														11		17					12
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														4		13					3
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														14		15					5
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														12		4					4
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			115		34		65			70		23			46		88			98		103			120		119										
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														24		18					11
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														8		5					3
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																																1					
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					1		1			3		1								2		1			1		3										
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														5		11					6
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																																1					
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														12		13					9
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														9		7					9
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														4		3					3
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														3		8					3
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														8		7					7
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														24		17					17
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														9		18					4
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														6		4					
Botswana	Botswana	BWA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														11		5					3
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																														32					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												1		9					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																														32					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												3		18					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												17		184					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												1		4					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																												1		14					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												25		198					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												8		15					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	N	 																										1,529					1,825				
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																														2					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																														13					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																												4		27					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																														1					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																														1					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												2		17					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												3		10					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												19		160					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												1		7					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																												1							
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												80		332					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																														33					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												1		57					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																												1							
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												13		109					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												18		209					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	N	 																										778					927				
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												5		23					
Burundi	Burundi	BDI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																												1		6					
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																												1							
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												3		10					
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																														1					
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												2		17					
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												1		4					
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												1		7					
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												8		15					
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												5		23					
Burundi	Burundi	BDI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												3		18					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												2		6					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1							
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												1		15					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												2		1					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP																												1							
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																														4					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												2		18					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																														1					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												2		16					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												2		1					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												1		6					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP																												1							
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												1		10					
Burundi	Burundi	BDI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP																												2							
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			1,062		5	35	35	1,433	5	11	22	63	600	88	110	104	66	695	100	494	544	355	1,438	297	468	368	523		449	678	783	528					449
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				5	2	97	67	563	19	73	156	182	1,368	203	302	242	173	1,520	312	638	927	779	2,732	610	871	629	749		714	1,325	1,374	1,091					685
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												5,694					5,694				
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												12,250					12,250				
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			638																																		
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			849	68	63	185	160	1,716	81	128	248	407	2,856	515	569	490	355	3,165	503	1,250	1,642	1,233	4,962	1,087	1,604	1,421	1,896		1,931	2,337	2,155	1,787					976
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			849	167	149	286	265	1,716	163	145	351	540	5,202	675	683	624	498	5,467	693	1,288	1,736	1,332	8,073	1,156	1,928	1,601	2,396		2,620	2,795	2,764	2,308					924
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			849	6	45	152	163	1,717	74	122	223	284	2,928	334	416	454	249	3,075	384	929	1,133	892	4,597	866	1,100	979	959		929	1,743	1,910	1,338					914
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																1																					
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				3	1	48	35	563	11	44	116	131	696	149	197	247	115	834	189	456	680	496	1,870	438	557	433	527		517	858	818	767					451
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												11,442					11,442				
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												15,879					15,879				
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			849	36	63	141	137	1,716	42	101	246	322	2,262	398	450	380	284	2,552	428	921	1,307	1,025	4,096	856	1,267	1,044	1,317		1,380	1,437	1,487	1,155					713
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			1,062	57	84	422	127	1,440	49	70	98	214	4,140	258	291	274	226	4,310	294	640	876	678	6,090	607	1,033	881	1,176		1,207	1,267	1,393	928					578
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				10	28	68	38	562	8	26	92	95	864	152	158	158	102	1,180	154	452	659	432	2,178	377	523	465	544		494	568	509	392					323
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male				2	7	72	50		12	41	118	100	1,048	151	213	195	131	1,186	211	634	859	537	2,289	537	815	634	758	2,863	624	1,132	1,078	932	2,863				527
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			849	9	23	145	127	1,717	49	104	197	224	2,432	327	415	385	217	2,577	358	757	1,068	845	4,098	818	1,003	834	843		848	1,456	1,707	1,184					894
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			849	13	58	156	162	1,717	57	92	164	304	3,112	351	421	394	247	3,258	421	918	1,243	960	5,030	901	1,120	942	1,019		892	1,602	1,958	1,311					920
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				19	22	96	84	562	21	62	140	184	1,326	276	295	228	175	1,644	248	656	989	716	2,703	588	858	714	838		891	972	938	712					452
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female				12	23	41	47		11	28	70	89	738	115	142	151	88	1,007	136	503	747	475	1,883	367	641	520	622	2,353	541	613	544	459	2,353				329
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								9,558																													
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												11,278					11,278				
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			432			191	12	604	7	10	16	31	1,252	31	45	93	66	1,252	60	629	432	241		211	308	136	302		166	162	168	111					76
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												17,811					17,811				
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			849	105	118	294	265	1,716	136	147	361	550	4,692	743	751	654	499	4,972	662	1,376	2,017	1,475	7,451	1,309	2,050	1,682	2,496		2,674	2,916	2,954	2,448					1,093
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			638																																		
Burundi	Burundi	BDI	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			849		27	127	64	1,717	21	33	82	207	1,744	192	312	271	164	1,901	276	631	1,028	689	3,245	620	892	667	786		685	1,128	1,457	1,040					637
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			24,492	13,463	10,519	8,361	8,550	38,745	13,035	12,934	13,421	13,814	31,090	16,415	16,295	17,706	17,104	38,222	17,360	17,541	18,279	17,453	40,795	17,126	18,648	17,889	17,762		17,453	18,471	19,100	19,804					16,345
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			26,296	9,881	6,717	5,166	5,030	34,454	8,398	7,634	7,966	8,210	32,017	9,264	8,871	9,737	9,292	33,424	9,449	9,068	9,600	9,238	39,514	10,085	9,987	10,146	10,072		10,580	10,428	10,639	11,377					9,431
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												4,101					10,767				
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												100,692					123,475				
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			1,370	945	823	613	599	54	1,240	885	905	788		1,082	864	1,125	924		936	740	997	848		1,229	874	1,112	986		988	887	815	592					518
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			14,842	18,816	14,064	11,152	11,206	36,376	17,614	16,892	17,933	18,284	25,586	21,450	21,246	22,602	22,341	31,780	22,217	22,058	22,711	22,341	43,297	22,139	23,009	22,365	21,243		21,228	22,490	23,009	23,551					20,114
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																																					1
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				2,456	2,487	1,762	1,322	12,608	3,795	3,221	3,450	2,780	30,423	5,163	3,817	3,991	3,352	2,138	3,857	3,890	4,019	3,697	2,976	4,198	3,987	4,106	3,431		4,271	3,726	3,411	2,928					2,038
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			41,714	19,896	14,286	11,036	10,804	37,063	17,601	17,666	19,163	19,821	34,290	23,319	22,926	24,111	23,323	43,551	23,399	23,047	24,381	23,743	47,508	23,907	25,134	24,883	24,321		23,665	25,215	25,722	26,852					20,104
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			5,471	1,879	1,395	1,489	1,371	27,707	1,985	2,554	2,741	2,462	9,899	2,349	2,648	2,603	2,454	4,847	2,147	2,182	2,369	2,392	14,117	2,322	2,504	2,516	2,208	3,407	2,227	2,786	2,707	2,736	7,126				2,003
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			11,730																																		
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			4,259	1,182	875	1,001	962	35,793	1,622	1,894	1,921	1,783	18,825	1,697	1,634	1,946	1,801	21,219	1,472	1,519	1,767	1,614	27,068	1,615	1,714	1,773	1,568	2,510	1,540	1,867	1,984	1,893	6,825				1,328
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			17,154	5,443	3,039	2,336	1,866	8,472	2,522	2,660	2,959	2,796	2,337	2,453	2,468	2,757	2,444	3,563	2,273	1,948	2,057	2,161	1,891	2,216	2,115	2,103	2,179		2,084	2,085	2,121	2,198					1,607
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												4,187					3,064				
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			12,767	8,682	4,847	3,339	2,880	6,355	3,792	4,008	4,616	4,404	1,886	3,913	3,788	4,352	3,945	3,960	3,353	2,961	3,498	3,596	6,227	3,240	3,214	3,302	3,487		3,013	3,180	3,489	3,418					2,423
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				1,424	812	824	828	32,860	1,258	1,698	1,501	1,299	24,055	1,293	1,231	1,368	1,229	6,265	1,250	1,115	1,250	1,117	6,064	1,258	1,318	1,263	1,199		1,072	1,113	1,242	1,293					1,037
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male										4												6															
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex										48				3																							
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												80,380					104,991				
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				830	1,068	639	585	12,969	1,016	1,127	1,550	1,336	5,002	1,420	1,211	1,252	1,015	3,011	903	1,168	1,157	950	682	890	882	773	717		775	870	861	937					603
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				3,516	2,234	1,920	1,940	55,536	3,141	3,409	3,605	3,638	44,859	4,060	4,091	4,349	4,309	30,643	4,097	4,371	4,566	4,310	36,843	4,236	4,853	4,720	4,452		4,507	4,720	5,089	5,065					4,193
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			11,773	2,879	963	705	593	5,365	1,100	1,291	1,114	909	648	973	890	944	757	4,316	843	779	842	797	4,724	1,104	981	1,113	1,095		1,207	1,032	1,093	1,424					861
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												9,130					4,306				
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				3																2							1										
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				3,162	1,886	1,397	1,193	14,925	1,525	1,847	2,068	1,975	3,571	1,722	1,903	1,982	1,721	3,018	1,628	1,665	1,691	1,719	1,249	1,810	1,718	1,667	1,617		1,509	1,825	1,687	1,671					1,187
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			24,067	7,584	3,676	2,698	2,309	27,587	3,321	3,582	3,834	3,763	1,439	3,462	3,330	3,907	3,447	7,063	2,840	2,552	3,103	3,228	5,897	2,779	2,631	3,335	3,357		3,089	2,663	3,068	3,679					2,107
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			1,374																																		
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			13,280																																		
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												86,362					112,616				
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												1,198					4,649				
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			10,383																																		
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				1,745	1,141	912	880	16,637	1,087	1,410	1,365	1,286	2,994	1,165	1,219	1,226	1,204	1,774	980	955	1,000	1,048	847	1,046	1,092	1,066	1,077		1,031	1,029	1,092	1,003					833
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			20,743	8,802	6,508	5,396	5,287	50,179	8,352	8,811	8,825	9,114	46,460	10,615	10,684	11,671	11,207	51,803	11,041	11,419	11,764	11,291	59,397	11,179	12,283	11,850	11,756		11,388	11,929	12,222	12,813					10,853
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			6,554	1,145	890	771	517	12,199	901	1,219	1,351	1,227	5,010	1,053	1,064	1,022	852	5,087	690	880	1,024	909	530	756	702	674	766	1,705	671	721	814	847	7,264				577
Burundi	Burundi	BDI	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			17,172	6,942	4,097	2,816	2,352	7,257	3,057	3,382	3,600	3,490	1,659	3,143	3,070	3,495	3,181	4,697	2,778	2,509	2,852	2,946	5,854	2,858	2,802	2,937	2,837		2,765	2,754	3,043	3,019					1,900
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				22	24	32	38	358	39	37	42	23	991	34	25	20	13	82	22	27	30	21	98	23	12	17	13		13	24	15	14					12
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				59	93	125	110	1,042	99	111	132	131	329	106	93	73	71	234	51	67	77	81	38	54	45	60	50		40	55	43	38					36
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			776																																		
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				37	67	85	93	1,175	111	105	113	89	276	76	76	62	52	226	43	50	47	40	22	45	50	47	36		26	30	40	28					18
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												519					696				
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			20																																		
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												365					170				
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			26	10	6	3	6		8	12	1	2		3	3	6	3		3	2	7	3		11	3	1			3	5	2	4					
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			543	73	104	161	147	495	138	169	192	134	146	109	103	83	81	270	78	70	76	58	190	79	40	58	48		46	62	62	48					32
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			405																																		
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												143					154				
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				3																																	
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			473	72	101	145	155	431	139	146	166	120	164	79	79	70	67	216	56	52	68	63	204	55	50	39	43		47	53	38	36					22
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			325	54	61	146	135	1,945	151	167	171	142	378	115	122	92	73	462	81	87	85	87	872	73	71	67	36	261	49	74	73	66	292				40
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			1,288	127	171	209	202	865	231	267	210	230	322	192	186	182	104	346	142	133	130	107	385	96	92	69	73		63	68	79	90					35
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			1,938	276	235	319	342	462	385	398	430	392	135	288	287	228	222	209	196	201	221	190	244	175	167	151	143		133	170	151	151					92
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,061					250				
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male																						1															
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			75	18	21	29	30	485	25	29	31	28	239	30	23	22	13	228	15	21	19	22	8	12	12	5	2	201	3	8	8	9	227				4
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			172	15	14	17	19	359	19	26	28	15	33	15	18	8	12	261	9	6	15	10	146	14	3	9	4		4	5	5	7					2
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			566	120	163	150	128	354	156	128	106	104	31	107	85	106	58	107	72	64	62	62	231	49	40	64	55		63	58	48	49					35
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			1,348	167	225	277	277	659	285	311	335	306	308	227	221	181	186	379	155	163	177	136	193	118	137	119	107		89	131	105	127					53
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			490	61	88	144	149	1,886	141	195	225	147	963	124	154	108	103	473	102	124	117	94	448	102	82	77	63	428	74	94	75	78	298				52
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				45	59	97	101	1,109	109	130	121	91	244	81	87	69	54	280	73	41	48	39	35	49	38	29	33		38	24	26	35					18
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												359					474				
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												465					709				
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			596	74	103	165	149	580	154	167	206	146	210	108	117	95	74	340	90	69	66	73	64	75	48	57	77		57	55	45	48					41
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			151																																		
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			302	38	54	70	84	1,942	94	84	88	59	115	49	43	48	32	284	35	25	33	19	188	21	22	24	13		20	20	16	13					10
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				89	98	145	159	1,572	129	155	192	154	307	114	120	118	70	324	83	94	79	67	287	72	74	67	60		45	57	67	62					41
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				12	23	21	26	530	33	32	43	31	224	24	22	34	10	149	18	18	17	10	21	19	8	11	11		5	6	13	9					3
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												177					201				
Burundi	Burundi	BDI	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			911	262	308	388	385	632	379	486	429	369	235	318	265	251	244	178	198	210	192	200	452	175	151	134	132		141	150	125	134					99
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				152	128	148	162	326	169	144	166	174	313	176	174	150	169	213	132	113	140	120	398	98	126	99	73		116	99	81	93					78
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																									1						1						
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				154	166	140	164	310	170	203	143	151	209	189	182	167	177	105	113	137	138	115	216	109	112	94	89		97	93	88	63					83
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				114	111	111	123	604	106	116	112	101	350	125	147	119	121	327	97	89	100	111	606	79	90	41	52		71	59	45	58					58
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				45	42	27	26	262	40	30	19	25		37	23	31	17	77	20	17	22	26	88	20	14	23	18		20	14	20	12					16
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												762					407				
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												383					382				
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				8	10	1	10	406	10	7	5	10	282	5	13	8	7	89	6	6	4	6	92	3	7	3	7		3	5	3						7
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				1						1	1																					1					1
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				135	91	117	124	362	111	108	117	110	174	145	102	97	125	103	86	100	91	100	271	57	68	51	71		74	68	76	64					58
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				31	29	34	36	737	33	35	54	43	343	36	47	44	53	372	32	41	40	45	467	32	29	35	30		21	12	21	31					20
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				2	1	2		395	2		1	1	4			1					1	1															
Burundi	Burundi	BDI	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												507					851				
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex										48				3																							
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				837	761	645	629	43,660	1,124	1,180	1,204	1,334	43,661	1,830	1,906	2,032	2,052	23,698	2,019	2,195	2,323	2,157	23,589	1,988	2,236	2,244	2,029		2,152	2,274	2,451	2,464					2,296
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			53,247	7,088	6,260	5,072	5,250	33,775	8,924	8,865	8,554	9,227	33,775	13,604	12,753	12,704	12,955	33,775	13,911	13,465	13,454	13,357	33,775	13,580	13,313	12,520	12,839		13,714	13,865	13,330	14,602					12,252
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			22,760	7,176	6,534	5,227	5,613	24,424	9,104	8,506	8,341	8,872	24,424	12,482	12,276	12,531	12,606	24,424	13,277	13,402	13,249	13,021	24,424	12,670	12,353	11,720	11,442		12,305	12,398	12,367	13,084					12,229
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												78,122					78,122				
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				109	80	84	95	23,160	140	175	159	145	23,160	209	202	217	198	3,978	264	213	276	225	3,950	270	273	262	218		228	225	285	255					255
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			3	5	1			14,635	8	4	7	6	14,635	8	6	4	5	14,635	1	9	9	7		11	10	9	5		7	5	10	11					2
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												68,408					68,408				
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			21,024	2,845	2,431	1,991	2,129	31,411	3,925	3,385	3,072	3,245	31,411	5,033	4,474	4,483	4,666	25,729	5,400	4,981	4,893	4,866	25,710	5,568	5,004	4,518	4,885		5,860	5,226	4,892	5,704					5,422
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			32,324	3,176	3,062	2,694	2,681	45,211	4,297	4,088	4,094	4,446	45,212	6,188	6,092	6,504	6,402	40,430	6,521	6,900	7,031	6,670	40,393	6,288	6,516	6,508	6,483		6,626	6,755	6,848	7,256					6,668
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex				1	2	3	4	203	6	151	13	6	203	50	9	6	19	203	14	6	51	8	203	8	5	5	6	106	10	12	9	12	106				21
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			19,950																																		
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												62,064					62,064				
Burundi	Burundi	BDI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			28,327	5,175	5,148	4,406	4,641	29,817	7,050	6,601	6,600	7,071	29,817	9,743	9,538	10,325	10,348	29,544	10,483	10,810	11,075	10,486	29,544	9,771	10,320	9,818	9,947		10,247	10,379	10,677	11,332					10,069
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			4					400			1		4			1				3	1				1						1						
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				3	4	2	3	412	5	3	4	3	340	1	10	5	3	89	4	5	3	5	92	2	4	3	7		3	5	3						7
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												764					414				
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			171	29	34	20	29	263	37	20	15	21		34	21	26	19	77	23	14	25	25	88	18	13	23	18		20	14	22	12					16
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			651	111	80	99	88	366	101	66	86	93	217	98	94	98	123	103	79	93	86	96	271	62	72	51	71		78	68	81	70					59
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				25	21	16	13	748	13	20	34	38	413	26	33	37	35	374	30	38	26	36	467	23	27	36	30		22	12	21	31					20
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			498	114	91	92	105	329	121	112	127	133	362	149	157	136	153	215	104	114	131	117	398	77	123	99	73		121	99	83	94					79
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												511					855				
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			543	92	82	68	68	612	89	66	71	66	413	92	117	106	111	329	77	74	79	84	606	64	80	41	52		75	59	45	62					57
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												387					383				
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex																																1					1
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			353																																		
Burundi	Burundi	BDI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			396	148	123	95	120	314	123	114	107	127	236	150	156	153	171	106	115	128	133	98	216	95	102	94	89		104	93	94	67					82
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			8	12	11	24	24	20	11	17	21		11	9	32	43					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												92					100				
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			2	4	1	5	4	3					2	3	3	4					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			73	26	50	62	59	93	85	105	74		55	55	74	94					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			83	16	34	46	46	66	85	83	63		62	52	60	78					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			27	4	9	22	37	22	33	28	30		20	10	29	32					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			7	13	9	14	23	16	7	10	16		6	4	23	27					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			9	7	7	9	14	7	8	6	6		3	8	12	15					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												267					274				
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			19	16	25	26	3	11	7	3	8	30	1	6	24	36	30				
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			6	2	12	14	32	3	8	6	4	33	9	8	24	18	33				
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			11	16	20	24	13	20	13	7	11		2	5	19	32					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			17	24	11	20	23	8	21	9	28		10	9	32	53					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			15	7	5	5	39	10	6	6	10		5	1	23	25					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												161					161				
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			62	27	38	43	60	56	58	68	57		36	42	57	89					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			36	16	25	38	60	53	54	57	45		21	33	52	66					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												263					291				
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												86					95				
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												61					61				
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			3	3	11	9	9	1	1	1	2		6	3	4	20					
Burundi	Burundi	BDI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			32	12	26	24	46	27	22	24	31		15	18	47	44					
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													89		1	5	23	199																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													263		5	18	80	441																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													183		2	14	61	442																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													72			1	11	40																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													2		1	1	5	11																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													60		4	5	12	27																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													2			7	46	113																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													374	2	2	13	123	482																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													75	2	1	4	18	38																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													48			2	5	23																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													72		1	3	14	38																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													405	2	2	14	147	195																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													90		2	11	14	13																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													112		5	10	28	310																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													53			2	12	21																			
Burundi	Burundi	BDI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													100				7	134																			
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													72	2		4	7	28	21	16	11	12	87	11	27	33	96		50	79	150	123					
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												228					247				
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													374	2		11	109	363	48	24	77	119	345	103	233	285	345		37	65	366	368					14
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												779					849				
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													183	3	1	12	46	318	19	5	27	38	338	40	84	111	111		137	124	158	146					8
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													405	1		13	134	141	59	25	94	131	327	122	219	305	376		304	344	428	417					11
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													72	1		3	7	31	16	4	11	5	50	16	38	22	43		31	56	110	73					
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													53		1		10	15	36	18	2	16	73	10	12	15	60		37	39	95	91					
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												827					896				
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													90		1	9	3	11	5	9	6	8	10	8	12	7	11	75	6	21	45	50	78				
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												133					148				
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													100		1	1	6	100	1	6	5	4	45	2	12	21	4	73	13	39	17	24	75				
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													2	2			2	8	8	4		5	23	3	7	1	7		11	8	22	21					
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													263	1	4	11	66	318	29	14	50	63	322	57	100	188	190		166	208	227	268					17
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													89		1	5	14	139	6		8	5	96	9	15	14	21		17	22	34	41					
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													75	1		6	10	28	11	11	16	14	37	15	38	34	69		42	66	188	118					
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													112		3	5	16	220	7	7	6	14	120	17	33	51	64		17	31	72	64					1
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													2	1		7	42	86	23	8	36	59	277	31	91	116	150		4	54	175	140					2
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												296					318				
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													60	2	1	2	5	19	5	4	4	4	24	7	11	28	30		24	28	95	50					
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												242					270				
Burundi	Burundi	BDI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													48	1		2	3	18		1	4	3	17	5	22	31	24		14	19	32	33					
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											4					12					5
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			88																																		
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				6	5	4	4	7	2	7		4	7	2	7	5	2	19				9	57				9					6					7
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												36					39				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											7					7					
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				4	5	6	8	7	4	1	2	5	10	8	3	4	3	28				10	62				11					16					2
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												15					36				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				4	10	3	4	7		2	4	11	7	4	3	4	5	20				14	64				12					11					5
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											9					7					3
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				3	6	9	4	29	5	6	5	6	11	1	4	3	6	45				19	87				21					13					1
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												31					28				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex						1		2	1	4		1	11									2	5									3					1
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				7	11	14	10	28	5	9	7	6	11	8	3	2	7	35				24	81				19					19					
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				1	1			27	1		2		8	1	1	2	1	33				5	98									3					
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				7	5	3	10	29	8	10	21	16	22	11	14	9	7	59				40	68					26					24				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			80																																		
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											3					10					4
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				6	8	1	4	27	1	5	3		10	4		1	6	31				7	89				10					7					
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				7	9	10	11	27	8	3	5	10	9	7	5	7	4	36				13	97				24					19					
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			8																																		
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											11					8					4
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				4	3	2		7			1	3	6			1		10				5	59									1					4
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				7	5	8	14	7	7	8	6	11	12	2	9	9	4	63				35	44					14					8				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												30					23				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				1	1	1		2	1	3	1	1	2		3			2				3	7				1	5				1					7
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												43					57				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											1					8					1
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											22					17					1
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				2		4	3	7	1	9	4	2	9	5	9		1	25				24	72				17					8					3
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex								2		2		1	37	1	1	1		1				1	7														4
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				7	7	13	3	7	7	8	3	2	10	6	3	2	4	37				12	69				14					13					3
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				10	7	7	3	7	4	11	6	4	10	5	5	3	2	12				19	64				13					12					3
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				6	7	3	2	24	1	9	8	2	10	12	3	3	3	21				12	77				12					6					1
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				7	3	2	8	23	9	3	18	4	9	7	8	5	3	23				14	76				20					28					
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												1					3				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												32					42				
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex								2		5																											3
Burundi	Burundi	BDI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											8					6					
Burundi	Burundi	BDI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male																						1															
Burundi	Burundi	BDI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			1,393		31		1,298	10,757		3,744		2,860	10,317		2,232		1,569	6,891		1,200		1,013	3,117		907		349	2,114		391		512	1,232				95
Burundi	Burundi	BDI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			2,570		38		2,765	14,304		7,945		5,716	12,992		4,510		2,687	8,611		2,269		1,716	4,849		2,141		763	1,666		715		1,086	1,460				176
Burundi	Burundi	BDI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			221		5		104	2,223		365		410	3,149		511		370	1,769		230		117	697		239		46	328		28		18	363				4
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				2			1	56		4	2			1	2	1	1		1	1	1	2		1	2		2		1		1						
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												552					553				
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			1,383																																		
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				15	30	27	25	391	69	81	70	102	391	94	79	99	81	391	70	63	101	68	391	90	78	89	100		87	83	84	107					80
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				13	19	19	25	257	43	41	33	41	257	26	44	34	35	257	36	33	38	34	257	41	47	48	45		31	65	41	35					35
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				22	38	29	33	386	76	86	57	102	387	103	88	99	95	387	80	78	77	86	387	96	89	106	76		84	78	67	88					82
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				8	7	7	10	257	13	25	25	24	258	18	20	28	18	258	22	26	22	18	258	24	35	32	22		28	39	22	23					25
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				8	13	9	11	396	17	30	20	19	397	30	28	21	24	397	15	21	21	17	397	24	30	29	32		29	30	28	27					25
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				9	21	18	15	396	35	57	55	63	396	79	62	61	50	396	53	50	37	49	396	56	61	57	60		61	66	63	59					58
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												363					366				
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			119																																		
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				8	15	19	15	257	19	16	29	25	258	41	44	29	26	258	30	26	27	30	258	34	31	29	39		20	41	27	34					20
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				16	29	31	26	391	41	62	76	68	394	76	73	75	69	394	52	67	77	81	394	74	84	96	86		71	103	88	91					84
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				4	5	9	2	56	6	12	11	8	60	8	9	8	11	60	10	9	16	4	60	7	14	8	11		8	12	13	17					17
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				23	39	47	25	257	62	64	72	86	257	78	65	99	72	257	60	67	83	63	255	70	89	139	104	174	93	129	86	97	174				74
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												363					364				
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				16	23	17	20	257	30	32	34	44	257	39	46	44	29	257	37	41	33	31	257	31	36	45	46		33	44	39	32					27
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												831					838				
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			873																																		
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												535					539				
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				13	31	23	19	396	50	65	58	71	398	55	64	64	76	398	49	48	47	46	398	50	68	57	57		55	58	64	80					71
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				11	7	11	4	257	18	15	23	26	257	14	19	20	17	257	21	16	15	20	257	22	23	27	30		17	21	27	26					23
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				8	7	2	5	56	15	16	18	12	56	7	15	20	19	56	9	16	18	16	56	14	16	17	23	48	11	12	17	10	48				20
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				1	3		4	56	10	10	10	6	89	14	6	11	3	89	7	10	12	11	89	6	4	10	6		8	17	5	5					3
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				24	20	33	26	381	63	77	69	81	381	88	107	83	107	381	64	79	78	97	381	91	97	126	114		92	105	96	99					102
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												102					102				
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				14	30	14	9	257	23	44	44	34	258	39	37	34	40	258	26	18	29	33	258	38	37	37	35		30	30	36	50					21
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				19	28	17	16	257	27	32	39	44	257	55	47	44	41	257	28	46	45	38	257	41	37	42	58		29	48	38	39					43
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												539					544				
Burundi	Burundi	BDI	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				37	61	63	60	396	118	144	185	166	406	179	208	191	161	406	132	177	171	192	408	164	201	217	181	286	210	229	208	182	288				189
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			2,221	2,908	3,046	3,017	3,557	3,046	3,148	3,161	3,187		3,182	3,253	3,304	3,307					3,442
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			65	21	22	21	21	178	18	22	6	9	254	14	8	13	11	6	12	13	15	11	20	16	13	18	14	24	15	20	20	19	28				10
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				221	231	222	231	1,388	356	340	323	290	2,362	294	256	249	239	2,169	240	234	243	251	949	249	211	220	221		218	205	213	215					192
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			1,856																																		
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			4,121	2,862	2,785	2,972	3,065	3,011	4,111	4,236	4,271	4,332	3,181	5,147	4,784	4,556	4,543	2,841	4,554	4,490	4,547	4,506	4,820	4,501	4,317	4,338	4,210		4,174	4,184	4,151	4,114					3,630
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			494	1,252	1,329	1,424	1,183	1,575	1,800	1,822	1,873		1,904	2,038	2,123	2,152					2,516
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			4,095	3,013	2,949	2,982	3,214	2,880	2,816	2,809	2,776		2,789	2,764	2,778	2,782					2,751
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												1,156					1,286				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												17,712					18,049				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			2,834	1,516	1,432	1,458	1,524	3,634	2,173	2,151	2,225	2,163	3,862	2,370	2,274	2,285	2,197	3,518	2,279	2,104	2,151	2,115	2,213	2,055	1,965	1,981	2,009		1,991	1,901	1,913	1,899					1,779
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			2,043	1,060	1,006	989	1,011	2,264	1,510	1,498	1,477	1,483	2,502	1,516	1,443	1,434	1,393	2,416	1,399	1,387	1,379	1,369	1,680	1,350	1,301	1,250	1,237	1,618	1,203	1,139	1,090	1,063	1,808				913
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												2,320					2,930				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			2,836	983	987	1,058	1,164	2,602	1,550	1,515	1,583	1,556	2,762	1,713	1,692	1,665	1,644	2,540	1,673	1,626	1,709	1,648	1,804	1,697	1,570	1,593	1,577		1,569	1,565	1,592	1,603					1,507
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			5,721	3,987	3,891	4,005	4,039	5,506	5,719	5,676	5,603	5,625	5,694	6,127	6,010	5,926	5,847	5,080	5,745	5,731	5,702	5,643	5,988	5,590	5,555	5,520	5,464		5,485	5,348	5,340	5,233					4,884
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												4,543					4,652				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			799	617	633	607	739	2,738	985	944	941	945	2,822	1,041	972	979	962	2,613	964	949	995	979	1,136	991	964	971	956		973	995	1,012	1,011					892
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				643	596	595	615	1,882	927	890	889	857	2,139	858	827	818	776	2,027	756	706	718	700	1,191	681	599	601	596		584	550	539	539					445
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			6,771	4,308	4,430	4,537	4,625	6,844	6,648	6,906	7,111	7,224	7,660	7,531	7,715	7,736	7,773	6,833										9,040					9,204				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			449	1,060	1,150	1,244	1,019	1,380	1,617	1,654	1,685		1,722	1,838	1,889	1,916					2,197
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			1,662	1,975	1,989	2,027	1,684	2,092	2,238	2,232	2,301		2,311	2,464	2,504	2,545					2,702
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			1,534	1,887	1,869	1,878	1,185	1,878	1,930	1,941	1,928		1,945	2,027	2,101	2,105					2,180
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												7,759					7,774				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				1,609	1,595	1,613	1,648	3,295	2,322	2,320	2,404	2,416	3,561	2,567	2,588	2,548	2,513	3,194	2,555	2,538	2,577	2,593	2,498	2,609	2,555	2,564	2,507		2,491	2,459	2,448	2,413					2,252
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			742	583	600	592	614	1,317	887	863	859	876	1,353	906	923	899	884	1,353	906	853	864	870	1,016	868	855	857	866		847	796	787	797					749
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			3,851																																		
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												4,025					4,179				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				1,770	1,775	1,861	1,917	3,508	2,719	2,744	2,726	2,757	3,750	2,879	2,879	2,899	2,836	3,344	2,812	2,711	2,694	2,644	2,797	2,633	2,670	2,866	2,669		2,674	2,621	2,626	2,620					2,557
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			5,743	4,571	4,551	4,699	4,345	4,581	4,746	4,712	4,696		4,759	4,873	4,914	4,965					5,071
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			1,728	2,300	2,419	2,363	2,673	2,363	2,464	2,492	2,487		2,479	2,519	2,490	2,498					2,458
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												10,104					10,357				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			927	956	966	1,005	1,017	1,514	1,374	1,361	1,334	1,311	1,541	1,446	1,361	1,400	1,345	1,382	1,351	1,256	1,285	1,277	1,532	1,275	1,228	1,229	1,251		1,274	1,252	1,204	1,194					1,011
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				3,145	3,164	3,251	3,329	4,522	4,718	4,949	4,983	5,043	4,652	5,402	5,490	5,491	5,453	4,149	5,489	5,407	5,328	5,256	5,376	5,258	5,352	5,425	5,422		5,415	5,419	5,457	5,482					5,456
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			2,539	2,066	1,989	2,043	2,103	3,240	2,870	3,001	3,041	3,067	3,301	3,691	3,445	3,218	3,183	2,949	3,080	2,975	3,015	2,969	3,264	3,030	2,894	2,841	2,871		2,846	2,756	2,778	2,761					2,131
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			5,376	3,310	3,245	3,280	3,320	5,858	4,789	4,774	4,787	4,923	6,023	5,459	5,235	5,170	5,129	5,375	5,083	5,113	5,184	5,096	5,130	5,111	5,094	5,140	5,179		5,149	5,175	5,125	5,169					4,664
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			5,130	5,208	5,408	5,605	5,659	7,262	8,310	8,745	8,971	9,182	7,562	9,685	10,072	10,063	10,085	6,755										11,726					12,112				
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				3,611	3,631	3,708	3,752	5,199	5,262	5,359	5,388	5,488	5,371	5,962	5,944	5,847	5,796	4,793	5,827	5,974	5,970	6,025	5,897	6,096	6,112	6,088	6,045		6,065	6,056	6,071	6,109					5,691
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			1,874	804	782	842	948	2,061	1,267	1,210	1,253	1,231	2,221	1,354	1,304	1,292	1,291	2,050	1,301	1,270	1,275	1,270	1,475	1,294	1,245	1,242	1,230		1,234	1,174	1,187	1,188					1,110
Burundi	Burundi	BDI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			1,745																																		
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			1,276	245	239	290	319	461	253	277	280	267	102	295	281	223	218	203	196	193	209	191	149	172	159	149	144		140	172	154	152					92
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												171					193				
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			1,046	125	167	215	211	865	171	179	161	161	277	168	188	179	98	338	142	132	126	101	261	103	96	67	75		68	71	80	88					33
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			562	76	88	126	119	579	122	138	155	124	216	102	115	95	76	331	84	69	67	72	63	71	55	56	72		54	60	48	50					42
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			87																																		
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			372																																		
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			429	70	95	110	125	433	89	102	108	92	168	85	78	70	60	212	56	51	61	54	209	47	48	37	44		43	51	39	36					21
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			11	8	8	7	2	50	7	12	4	4	73	12	5	7	4	6	3	2	4	4	24	9	3	5	5	24	6	12	7	7	28				1
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												341					451				
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			131	16	13	19	20	363	17	20	19	14	41	16	14	9	12	255	10	7	14	9	145	7	3	8	3		3	5	4	8					2
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,118	175	226	264	270	656	192	213	209	217	267	229	223	177	185	365	149	168	185	137	103	117	124	121	106		92	130	102	127					54
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				54	60	93	103	1,126	68	104	91	76	198	86	90	67	52	270	74	43	48	41	35	48	37	29	33		34	26	24	35					18
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								15	21	12	8		11	14	14	13					10
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												439					672				
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				87	96	152	160	1,593	95	100	136	109	248	118	117	128	71	314	80	91	83	70	222	76	74	69	57		46	58	68	62					40
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												141					151				
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								10	14	12	5		12	13	13	9					7
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												494					663				
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			712	249	293	390	366	629	250	293	287	257	214	308	265	248	244	178	195	210	192	203	377	181	153	139	130		143	147	123	135					97
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												347					164				
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				18	23	21	23	350	33	33	36	17	978	31	27	22	12	81	20	29	34	19	101	22	13	17	11		13	26	15	14					14
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				12	13	20	21	599	24	29	38	30	246	21	21	32	11	145	18	18	16	9	22	12	7	11	11		5	5	13	9					3
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								47	30	36	29		32	40	34	33					23
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								20	21	13	16		11	23	13	20					12
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			651																																		
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			560	65	91	134	126	492	102	119	146	110	159	106	104	80	75	262	82	75	74	64	192	74	34	57	52		47	64	58	47					33
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				38	71	90	75	1,174	88	90	94	86	276	73	72	62	53	229	42	52	43	37	20	52	47	48	36		29	28	38	29					20
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								17	10	15	11		13	16	10	12					6
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			409	55	83	122	131	1,895	138	168	192	128	926	112	149	110	104	458	101	124	118	91	459					407					285				
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			101	20	28	21	31	548	24	27	30	28	255	32	24	24	12	225	15	21	19	21	8	15	11	5	2	195	4	9	8	9	224				4
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			304	33	42	57	59	1,911	57	59	71	38	123	42	44	48	33	275	33	25	32	17	190	21	26	25	13		19	20	17	12					10
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			540	107	148	144	121	355	105	77	75	79	37	93	83	106	60	100	71	59	62	62	209	52	40	61	55		58	54	47	48					35
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				57	85	99	90	1,038	86	91	114	113	322	107	93	72	69	229	49	67	77	80	36	64	46	61	50		40	51	42	36					38
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								41	32	30	18		32	31	29	32					22
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			480	55	63	145	120	1,961	123	137	139	119	376	112	125	94	66	448	77	86	89	84	880					249					279				
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								14	20	20	9		8	20	18	13					6
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female							1																														
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								6	7	4	4		4	7	13	12					6
Burundi	Burundi	BDI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,005					240				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				69	343	394	459		452	575	570	604	1,298	638	647	678	754	1,218	659	712	720	747	1,400	746	784	669	741		697	651	607	684					574
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								2,136	2,199	2,118	2,311		2,160	2,075	2,029	2,191					1,937
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								4,316	4,212	4,056	4,325		4,185	4,110	4,071	4,436					4,030
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				399	2,036	2,460	3,015		3,302	3,944	4,114	4,310	5,135	4,381	4,528	4,739	5,128	4,325	4,746	5,159	5,316	5,520	4,792	5,551	4,936	4,974	5,448		5,285	5,039	4,982	5,434					4,537
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex							15		34	28	27	1	230	4	2	2	1	6	1	8	4	5	20	6	5	5	4	18	4	2	6	5	26				6
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				87	571	598	742		796	1,026	1,018	1,019	2,343	1,075	1,058	1,104	1,157	2,183	1,083	1,199	1,146	1,211	1,588	1,206	1,186	1,043	1,050	1,406	1,042	961	922	944	1,576				738
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				135	720	885	1,101		1,167	1,546	1,593	1,712	3,368	1,763	1,853	2,067	2,155	2,882	1,868	2,119	2,215	2,280	2,741	2,209	2,233	2,072	2,168		2,087	1,985	1,946	2,077					1,682
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								1,779	2,011	1,898	2,135		2,045	2,100	2,068	2,270					2,150
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				80	476	550	684		716	912	918	883	1,484	910	917	955	1,028	1,252	947	1,021	1,027	1,048	1,661	1,067	1,027	955	1,035		1,018	962	930	993					733
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				144	892	1,069	1,291		1,450	1,852	1,867	1,994	3,566	1,970	2,123	2,378	2,442	3,020	2,229	2,347	2,362	2,392	2,303	2,394	2,382	2,212	2,381		2,262	2,149	2,138	2,285					1,969
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								2,776	2,855	2,704	2,992		2,824	2,787	2,800	2,988					2,723
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				52	340	449	576		595	894	968	995	2,628	1,026	1,025	1,198	1,225	2,296	1,019	1,220	1,377	1,385	2,866	1,400	1,367	1,239	1,329		1,261	1,217	1,241	1,317					1,143
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												3,256					3,744				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				232	1,350	1,764	2,111		2,230	2,778	3,045	3,152	3,021	3,187	3,157	3,260	3,555	2,564	3,326	3,577	3,816	3,855	3,837	3,852	3,600	3,356	3,492		3,328	3,310	3,257	3,483					2,789
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								1,043	1,469	1,317	1,510		1,461	1,519	1,510	1,679					1,690
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				55	255	306	379		399	549	569	606	2,698	615	646	699	687	2,361	636	784	837	810	1,873	821	874	738	836		806	798	786	862					638
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				43	272	397	496		497	673	704	805	2,110	744	771	917	949	1,856	806	994	1,037	1,004	2,424	1,067	1,092	945	1,022		987	922	899	1,001					792
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												9,155					9,341				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				458	2,388	2,947	3,649		4,208	4,786	5,406	5,776	7,164	5,692	6,035	6,587	7,176	6,166	6,611	7,178	7,482	7,721	6,535					8,144					8,351				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				106	600	751	882		898	1,219	1,309	1,417	3,678	1,406	1,504	1,734	1,796	3,179	1,484	1,672	1,795	1,765	2,642	1,699	1,747	1,579	1,688		1,619	1,507	1,471	1,592					1,309
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												16,089					16,330				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				54	286	321	381		390	512	498	547	2,005	544	527	561	571	1,832	520	562	575	562	1,131	553	541	462	491		468	436	431	468					337
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,941					2,399				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												4,107					4,204				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				12	74	92	107		122	166	138	127	2,014	116	102	105	117	1,960	93	156	153	156	915	159	179	121	148		148	127	132	151					119
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												6,990					7,089				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				427	2,087	2,539	3,086		3,323	4,087	4,195	4,287	5,444	4,357	4,476	4,734	5,138	4,584	4,776	5,045	5,023	5,029	4,591	5,034	4,810	4,520	4,838		4,625	4,376	4,340	4,659					3,917
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								1,646	1,705	1,618	1,781		1,723	1,692	1,748	1,887					1,745
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								2,720	2,574	2,310	2,497		2,435	2,293	2,285	2,405					2,082
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				307	1,700	2,160	2,512		2,677	3,206	3,556	3,676	5,766	3,887	3,863	4,054	4,372	4,847	4,053	4,365	4,438	4,471	4,825	4,434	4,353	4,151	4,364		4,268	4,186	4,133	4,490					3,701
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				369	1,767	2,130	2,662		2,992	3,671	3,863	4,006	4,458	4,188	4,298	4,541	4,958	3,751	4,644	4,896	4,880	4,830	4,206	4,762	4,646	4,523	5,010		4,740	4,544	4,525	4,886					4,339
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								1,235	1,650	1,460	1,703		1,650	1,710	1,697	1,919					1,904
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				727	3,369	4,002	5,109		5,935	6,800	7,606	7,791	7,224	7,875	8,037	8,537	9,327	6,096	8,669	9,467	9,933	10,319	9,268					10,689					11,034				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												1,000					1,118				
Burundi	Burundi	BDI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				188	903	1,051	1,253		1,216	1,614	1,790	1,977	3,177	1,986	2,032	2,102	2,341	2,664	2,157	2,325	2,312	2,406	2,628	2,454	2,357	2,150	2,264		2,151	2,110	2,062	2,237					1,582
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														2		3					
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																1					
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														3		3					3
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														7		6					2
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														1		2					2
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														4		3					3
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					4		4			3		2			3		2			2		2			2		1										
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														7		5					2
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					79		57			27		49			36		19			26		20			22		23										
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																																4					2
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														1		2					1
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														2		4					1
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														3		5					5
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														1							
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														1							1
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																																2					
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														3		5					
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														2		4					
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																																1					
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					57		52			35		67			48		35			24		40			44		35										
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														6		4					
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														3		7					2
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														1							3
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														6		5					3
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																																2					1
Burundi	Burundi	BDI	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														2		4					1
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			5,161					402	63	295	325	182	1,064	438	616	224	281	1,254	160	65	792	1,732	2,546	1,126	1,283	769	295		375	1,697	2,333	1,972					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female									10	6	30	86	4,151	60	283	136	44	4,534	7	11	167	528	135	174	255	170	58		74	283	298	256					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female									7	3	18	25		50	205	70	19		2	3	118	320	47	140	181	91	39	221	30	125	119	84	221				
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			2,437					361	80	139	186	299	2,306	426	1,159	493	244	2,689	69	65	832	2,228	1,203	1,009	1,750	1,056	430		350	1,562	1,650	1,375					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			1,912					45	2	12	17	61		134	197	67	10		11	6	39	194	47	110	181	152	49	60	45	136	143	70	60				
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female									15	12	71	111	4,151	122	536	193	65	4,534	27	23	287	1,051	428	411	642	495	157		140	678	637	538					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female									89	175	138	269	1,424	352	929	448	212	1,807	69	55	665	2,008	1,203	987	1,300	1,007	305		332	1,575	1,911	1,435					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			2,451																																		
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			2,700		1			81	12	38	78	197	1,254	390	440	225	77	1,444	82	20	250	735	1,049	562	702	475	193		173	556	778	562					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												3,107					3,107				
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												3,941					3,941				
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												3,743					3,743				
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												1,597					1,597				
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female									52	76	124	250	3,230	359	1,005	378	207	3,613	69	53	778	2,076	1,169	866	1,649	1,213	477		377	1,493	1,485	1,337					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								2,309																													
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			1,992					154		280	1,036	944	836	72	36	13	3	836			4	81		60	91	71	37		5	3	13	3					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			1,452					92	12	293	96	158	973	212	167	119	61	1,163	12	20	86	252	221	191	213	171	92		61	140	235	134					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												2,733					2,733				
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female									24	26	121	167	4,151	224	731	235	131	4,534	40	41	501	1,536	686	592	1,107	674	321		251	1,013	1,083	913					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male								41	9	9	14	84	1,064	118	210	77	23	1,254	12	7	61	229	151	172	231	148	41		57	153	172	125					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male												10			15	2								1	11	1											
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female															15	13								1	6	1											
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			4,782					353	42	217	272	287	1,158	590	762	336	271	1,348	163	52	813	1,823	2,480	1,141	1,438	816	339		407	1,582	2,050	1,636					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male								41	9	25	55	133	1,254	267	362	192	44	1,444	19	12	121	397	201	308	455	368	123		109	320	477	274					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			1,352					81	8	148	61	160	832	136	257	88	39	1,188	13	6	125	1,116	236	387	407	332	103		91	352	375	280					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			2,700		1			81	23	92	192	226	1,254	489	713	291	160	1,444	116	52	555	1,149	1,803	769	1,043	716	260		264	946	1,302	1,072					
Cameroon	Cameroon	CMR	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												2,477					2,477				
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			49,650																																		
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			52,088	17,484	15,593	10,056	11,447	62,745	12,062	15,955	18,128	25,003	21,836	30,413	21,490	22,987	22,456	46,440	18,837	18,529	19,995	19,804	23,281	19,696	19,911	17,990	17,625		17,524	12,711	8,942	10,452					11,127
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				14,912	16,063	10,313	9,015	12,907	7,097	9,259	10,964	11,070	17,817	12,268	10,600	10,031	9,503	60,617	7,833	7,974	7,702	7,060	46,467	7,562	7,628	8,238	8,331		8,846	6,657	4,691	10,728					9,743
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				7,677	7,985	5,169	5,595	127,425	6,366	9,748	10,179	12,263	144,294	14,522	12,295	11,914	11,345	112,444	9,608	9,777	10,093	10,174	71,033	10,388	10,670	10,576	9,703		9,139	7,247	5,085	6,188					6,385
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			65,827																																		
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												14,048					24,081				
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				5,017	5,162	3,393	3,580	127,483	3,956	5,685	6,051	7,509	79,297	9,299	8,036	9,430	6,914	91,208	5,715	5,410	5,693	5,706	47,788	5,807	5,935	5,636	5,540		5,084	3,622	2,617	3,139					3,432
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex						1			5		2				2																						
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				12,636	13,379	8,015	7,159	21,436	5,365	6,641	9,355	10,394	34,762	9,388	8,567	9,808	7,950	81,971	6,268	6,212	6,551	6,177	57,716	5,996	6,740	6,770	6,592		7,235	5,710	4,965	12,171					11,393
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			85,302	32,104	31,482	20,350	22,886	241,297	27,557	33,957	35,075	44,567	75,643	52,960	44,298	42,619	41,931	101,146	35,985	36,595	35,987	36,263	45,980	36,776	39,067	36,124	35,639		35,351	27,948	18,700	25,729					25,821
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			18,809																																		
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												82,160					63,872				
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			123,529	23,823	23,569	16,381	18,347	241,670	20,055	27,409	27,828	34,538	142,385	37,820	33,898	32,529	31,410	165,645	27,354	28,631	27,862	27,801	86,694	27,396	30,639	28,751	26,666		26,248	21,503	14,920	18,116					19,263
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												9,521					16,876				
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												9,368					17,063				
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			22,903	13,384	15,184	9,783	10,669	161,623	10,651	14,897	15,487	18,768	139,199	23,854	20,682	17,362	17,360	157,235	13,780	12,989	13,397	12,741	75,867	14,126	14,115	13,244	12,812	15,578	12,980	9,327	6,641	7,735	73,902				8,598
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			48,957																																		
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			32,428	15,672	13,746	8,402	9,768	15,205	9,894	14,064	16,968	24,039	23,700	30,087	20,119	21,455	20,173	15,793	17,370	17,750	18,552	19,391	16,180	19,062	19,539	17,132	17,939		18,462	12,617	8,966	10,545					9,862
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				8,588	7,855	5,383	5,824	63,018	6,312	9,074	10,091	12,980	63,229	16,307	12,658	12,982	12,915	51,678	11,248	11,767	12,297	11,880	29,227	11,573	11,839	11,237	10,621		10,172	7,517	5,232	6,162					6,883
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				39	10	114	100		285	167	92	24		1	1				3	3					2												1
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				5,888	5,687	3,678	4,114	62,920	4,484	6,420	7,002	8,856	48,711	11,004	8,900	10,995	9,149	46,227	7,670	7,612	7,608	7,702	19,623	7,571	7,659	7,246	6,696		6,630	4,800	3,487	3,846					4,728
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			87,368	14,093	14,344	9,765	10,669	172,785	12,336	17,757	17,679	21,585	174,303	23,983	21,458	20,721	20,188	149,423	17,391	18,040	17,713	17,607	87,508	17,873	19,371	17,938	17,190		16,299	13,201	9,199	11,177					12,688
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			64,276	14,292	13,083	8,810	10,043	64,174	10,223	14,256	16,042	22,260	43,014	27,123	19,443	19,748	20,332	52,791	17,288	17,598	19,096	18,315	29,176	17,920	18,297	17,203	16,597		15,921	11,429	8,082	9,534					9,532
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												70,451					98,280				
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												71,118					113,225				
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			44,722	12,598	13,357	8,865	9,790	115,032	10,972	15,219	17,433	20,590	61,902	25,066	21,366	18,692	19,777	104,888	16,720	17,002	16,932	15,872	37,793	16,199	17,103	16,352	15,492	12,223	15,289	11,536	8,009	9,053	31,236				10,912
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			53,728	20,476	19,378	11,421	12,179	102,969	16,025	17,248	19,416	24,451	43,851	31,134	23,036	23,269	22,799	44,556	19,146	18,205	18,201	18,958	26,703	20,413	19,720	18,237	19,246		21,938	13,818	9,701	16,328					15,633
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			17,910	10,179	9,179	4,755	5,325	9,866	4,710	5,926	7,606	11,770	20,345	17,505	8,865	10,079	8,808	8,271	7,274	6,995	7,330	7,694	16,409	8,079	7,359	6,997	8,360		11,020	5,386	3,901	6,675					5,589
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				31	8	126	124		303	226	123	29				1			3	1					2	1			1	1							
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			58,188	10,970	10,220	6,845	7,455	63,267	8,252	11,165	12,764	16,930	62,010	20,742	15,727	16,020	16,328	55,572	14,145	14,078	14,455	14,169	32,319	14,021	14,079	13,179	12,730		12,231	8,406	6,154	7,068					8,368
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			168,765	12,188	13,315	6,937	6,630	22,866	4,910	6,097	9,090	10,519	54,683	11,311	8,219	11,002	7,863	48,793	5,982	5,886	6,252	6,361	38,019	6,419	6,767	7,050	7,193	35,032	8,703	5,624	4,995	11,654	39,368				10,634
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			122,993	33,753	32,753	22,209	24,930	292,971	27,851	34,658	34,667	43,543	90,677	48,912	43,949	42,018	40,166	146,309	34,496	35,492	34,364	34,358	65,202	33,799	36,976	34,141	32,482		32,256	25,791	18,034	22,761					25,575
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												101,058					187,236				
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								2			2										7
Cameroon	Cameroon	CMR	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			21,674	3,582	3,513	2,106	2,316	303	1,327	1,317	961	837		818	357	1,543	448		292	216	198	251		265	168	278	232		160	64	38	116					29
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												2,064					1,361				
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				370	444	289	276	6,107	374	604	527	647	3,477	682	665	614	656	3,554	618	592	547	526	1,194	469	488	447	358		312	310	239	235					207
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				101	90	86	71	2,025	71	174	184	177	1,695	140	161	148	123	1,274	122	101	93	86	711	70	91	83	62		70	75	58	113					55
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			3,415	262	201	165	119	1,910	245	378	346	393	2,474	448	357	510	384	1,372	362	330	299	287	866	319	264	264	241		216	158	174	248					163
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			6,360	703	736	455	483	5,253	768	1,266	1,040	1,468	4,386	1,586	1,244	1,263	1,271	4,489	1,177	1,097	1,003	997	1,917	1,056	910	819	706		745	602	436	521					447
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			1,615	589	717	508	488	15,813	543	992	924	1,025	10,339	1,083	1,009	788	960	10,927	898	867	801	779	4,993	768	771	678	566	1,386	568	524	412	481	3,940				388
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			1,177	81	87	50	38	2,021	67	112	94	129	2,572	106	130	177	77	1,168	89	83	82	85	901	68	65	92	68	581	66	58	50	81	323				53
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			4,204	544	606	452	390	6,122	577	943	849	1,121	4,290	1,083	964	964	979	4,034	980	902	830	808	2,046	789	748	660	604		506	430	317	312					320
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												457					555				
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			4,821	495	504	406	347	6,202	484	863	781	1,086	3,103	997	918	952	944	3,581	808	852	848	793	1,847	720	785	657	561		528	434	323	353					306
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			3,148	484	526	407	363	11,233	470	875	805	948	4,615	878	853	704	873	6,557	751	801	759	772	2,261	658	716	556	512	928	454	414	326	353	1,281				356
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			1,145	77	75	42	52	857	74	115	100	121	1,350	84	95	129	79	489	80	91	67	82	596	58	66	53	51		59	38	56	61					48
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				1		1	1		4	3	1																										
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												1,232					1,520				
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				116	119	95	62	1,133	101	212	252	233	874	209	185	214	179	952	178	167	162	142	605	128	142	133	117		125	107	90	144					83
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,026					1,296				
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												2,770					544				
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			6,069	874	924	688	627	11,867	860	1,386	1,287	1,587	10,712	1,521	1,394	1,325	1,470	8,697	1,267	1,250	1,181	1,175	4,260	1,009	1,127	922	837		790	686	501	567					429
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				565	616	487	464	11,852	589	1,008	917	1,106	9,492	1,107	988	917	899	7,546	862	865	831	790	3,967	768	765	673	581		535	496	425	447					352
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												2,647					3,681				
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			8,179	1,098	1,102	811	729	11,744	1,047	1,780	1,587	1,899	5,505	1,797	1,623	1,675	1,540	8,071	1,507	1,500	1,378	1,396	2,989	1,217	1,235	1,078	954		919	768	584	665					600
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			2,305	205	200	159	153	1,391	216	359	378	515	1,592	390	342	428	409	970	349	363	363	505	1,022	352	427	349	288		241	191	182	190					135
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												515					266				
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			3,831	357	417	312	280	6,034	410	635	594	874	1,692	750	602	770	716	2,951	666	592	651	678	1,478	632	640	506	441		354	320	243	309					237
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			177																																		
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			459																																		
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				424	425	323	313	11,862	408	636	582	746	5,501	775	668	707	594	6,582	602	571	530	541	2,919	445	477	416	403		350	355	263	260					261
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			3,490																																		
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			8,464	1,054	1,117	808	768	11,959	1,066	1,728	1,607	1,937	8,392	1,905	1,696	1,726	1,700	9,589	1,551	1,503	1,429	1,356	4,029	1,253	1,285	1,108	1,034		948	727	558	671					537
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female						3			5	4																											
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			151	21	19	14	13	1	15	40	15	17		1	5	13	4		3	5	5	5		2	1	3	1		1	2	1	2					
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				464	435	372	363	6,115	483	823	760	983	4,460	909	917	860	874	3,948	784	880	797	770	1,807	741	707	577	549		448	400	292	352					284
Cameroon	Cameroon	CMR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			3,544																																		
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				3	2		2	16	3	1	2	3	634				1	37	6		2	2	13	1	1		2	55		1		2	26				
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				465	507	391	379	4,224	619	574	448	480	4,700	549	565	494	477	738	518	501	413	424	960	476	439	425	395		416	368	328	311					328
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												4,096					2,452				
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												2,377					2,154				
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				346	367	264	259	1,378	450	463	346	361	6,216	377	468	396	378	976	393	407	367	339	1,888	360	378	337	324		325	356	271	233					255
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																										1											
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex															1																						
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																																					1
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																									1		1			1							
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				69	67	52	62	2,416	110	89	82	65	2,468	87	66	95	109	107	74	95	69	89	175	90	73	84	76		68	65	67	77					80
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				646	589	392	432	2,951	624	633	529	517	7,483	606	661	569	490	1,089	536	613	467	472	1,641	534	512	455	481		537	425	364	347					333
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												793					558				
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				100	80	63	53	140	92	110	101	101	2,955	93	132	103	90	479	94	113	104	95	956	90	103	111	96		97	131	95	66					86
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female							1			4																											
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				6	4	2	10	139	14	8	6	21	1,805	6	14	4	12	140	7	10	4	9	325	13	10	8	11		8	10	7	5					8
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				314	300	192	215	5,060	359	351	267	265	4,417	374	330	307	300	386	330	343	273	282	453	324	294	263	241		279	243	186	215					211
Cameroon	Cameroon	CMR	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female					1				2	1		7			1	1	1					1															
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			3,222																																		
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female				7	4	6	3		8	67	6	70		9	20	13	31		10	8	11	10		39	18	4	10		12	5	6	5					19
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												34,853					36,596				
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			29,969	9,465	9,516	6,460	6,546	122,088	9,653	9,639	8,761	9,407	43,500	10,126	11,070	9,475	9,542	25,556	9,118	9,770	8,476	8,775	25,481	8,841	10,295	9,128	8,767		9,108	8,695	6,754	7,389					7,965
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				5		7	15		52	17	12	5														1											
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			54,586	14,374	13,964	9,398	9,453	176,669	14,027	13,378	11,975	13,202	27,991	14,553	14,854	13,129	13,090	20,438	12,637	12,574	11,081	11,730	20,401	11,512	13,150	11,736	11,657		11,871	10,751	8,466	9,760					11,389
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex			1,151			1			5	1	2				2									2			2										
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			45,157	12,403	12,144	8,480	8,498	196,886	13,254	12,536	11,774	12,964	27,175	14,818	14,420	12,757	13,189	17,109	12,786	12,415	11,228	11,760	17,078	11,708	13,388	11,967	12,166		12,204	10,866	8,511	10,634					11,493
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												52,767					55,405				
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												45,560					47,838				
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				767	816	530	552	6,095	1,114	1,079	956	949	18,082	1,024	1,239	1,116	1,057	10,725	959	1,150	1,015	964	10,604	1,138	1,207	1,125	987		1,025	1,179	914	966					1,034
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			18,991	5,515	5,149	3,930	3,989	88,133	7,302	5,734	5,684	6,589	15,182	7,212	6,635	5,989	6,812	10,803	6,295	5,461	5,058	5,921	10,803	5,993	5,640	5,477	5,833		5,991	4,326	3,666	5,119					6,145
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				71	75	63	44	6,092	104	90	77	94	9,374	86	125	86	116	3,721	86	88	82	97	3,691	159	93	92	88		88	97	64	72					77
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			1,215	89	198	72	61	1,492	176	207	135	108	2,444	141	100	114	118	2,444	115	103	95	102	2,444	187	79	126	197	3,056	116	72	59	101	3,209				133
Cameroon	Cameroon	CMR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			12,489	4,038	4,356	2,889	2,862	53,414	4,782	4,849	4,112	4,382	37,482	4,729	5,441	4,655	4,707	22,165	4,545	4,703	4,217	4,260	22,151	4,426	5,301	4,561	4,299		4,401	4,400	3,471	3,580					4,312
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												2,390					2,161				
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			2	2	6			16	4	1	3	2	629		1		1	37	4		2	3	13	1	1		2	55		1		2	26				
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			242																																		
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			463	84	67	57	63	2,499	131	86	92	81	2,455	91	68	95	109	107	75	96	69	100	175	95	75	85	77		68	65	67	75					82
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			2,869	517	513	414	387	4,450	715	581	469	520	4,675	556	588	500	477	744	520	502	422	437	960	493	442	428	395		419	372	325	309					358
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				9	4	4	13	139	19	8	6	4	1,794	6	15	4	12	140	8	10	4	9	325	14	10	7	13		8	10	7	5					9
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female							1		5	1																											
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				101	82	65	58	140	100	116	106	84	2,937	91	134	105	89	480	94	113	104	87	956	94	107	112	96		96	130	95	67					91
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												4,116					2,459				
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												806					559				
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female					1				1	1	1	5			1	1	1					1			1	1	1			1							1
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			1,389	336	313	209	227	5,332	428	349	264	313	4,396	382	351	306	307	388	329	347	275	282	453	332	295	264	244		282	243	186	216					223
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			2,332	597	604	428	443	3,082	745	632	542	533	7,439	618	672	578	492	1,095	537	615	473	465	1,641	547	517	459	487		540	427	365	345					363
Cameroon	Cameroon	CMR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			1,433	364	382	279	280	1,423	526	469	358	347	6,176	379	478	396	379	983	400	410	371	330	1,888	370	382	340	328		326	358	271	232					270
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					66		157	773		350		624	1,336		1,064		1,195	1,412		912		1,592	1,588		1,402		760			1,045		773					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			618		262		519	2,624		204			3,828		168		44	1,744		78		319	1,533		993		1,623			1,349		1,123					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												5,684					5,987				
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			504		180		375	2,433		674		977	3,253		1,251		1,610	2,235		1,405		2,299	2,174		2,100		1,757			1,652		949					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			617																																		
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			504																																		
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																				1		38			5		11			1							
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			889		63		142	128		9			390		199		76	197		16		140	209		145		95	224		248		182	224				
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			2,748		1,246		1,044	5,148		2,014			9,127		665		2,505	6,031		7,598		6,760	6,186		5,111		7,543			11,699		5,159					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			504		125		193	1,731		491		953	2,352		1,382		1,593	2,072		1,482		2,408	2,166		2,181		1,670			1,712		1,125					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																	36					41			2		9										
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			1,983		630		601	3,278		524			7,813		739		2,254	6,314		11,315		6,801	6,370		5,309		12,687			15,992		9,184					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			3,619		1,464		1,781	7,138					1,245		20		111	912		142		428	1,035		1,093		523	997		926		355	997				
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			617		169		163	835		11			1,037		98		62	459		55		196	555		229		216			178		59					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			1,816		550		317	3,586		742		946	4,385		981		1,214	2,407		7,225		5,319	2,418		3,922		8,582			9,716		4,062					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												4,903					5,381				
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			617		178		211	1,384		46			1,485		101		83	535		80		223	508		366		346			249		82					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												1,132					1,132				
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					88		97	361		3			467		62		25	222		32		92	282		115		62			91		40					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			1,482		822		651	3,284		1,597		161	4,164		170		733	2,529		2,714		3,608	2,559		3,394		4,365			6,085		1,686					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					46		125	742		211		418	1,145		698		807	1,080		505		791	1,161		689		628			558		422					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												1,761					1,681				
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												5,909					6,775				
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					87		96	389		2			861		58		40	500		45		136	650		196		126			148		52					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			710		66		135	681		148		297	982		660		266	923		451		812	926		532		476	644		579		347	667				
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			504		94		171	1,142		501		704	1,819		1,309		1,395	1,983		1,140		1,993	2,113		1,658		1,271			1,384		917					
Cameroon	Cameroon	CMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												17,761					16,476				
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												801					665				
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			82	154	222	131	373	83	224	247	254		213	289	323	236					3
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												794					767				
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			245	242	406	423	715	130	404	504	469		372	501	569	524					5
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			20	34	59	28	73	22	31	79	75		41	50	72	55					
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			137	171	262	240	527	105	280	348	402		328	508	551	455					8
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			4	17	13	26	5	7	48	15	16	35	9	28	37	23	12				1
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												1,575					1,893				
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			226	141	318	224	289	101	353	296	300		248	354	414	294					5
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			249	260	496	380	998	133	393	409	470		469	406	559	484					4
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																									2							1					
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			24	4	18	20	28	10	38	38	32		17	39	33	21					
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			3	6	5	2	3	4	3	3	5	20	6	5	8	8	17				1
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												802					1,004				
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			366	189	334	283	345	156	354	295	422		272	408	631	387					4
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			104	97	112	145	167	79	258	234	181		211	246	215	152					2
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												154					271				
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			6	2	3	3	12	4	12	13	3		4	8	13	14					
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			24	14	51	50	89	23	94	98	51		86	73	67	43					2
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																							878			16						1					
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												2,055					2,161				
Cameroon	Cameroon	CMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			53	80	120	63	157	47	112	130	135		100	159	185	110					1
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							33	106					503			11		238																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male							15	87					476					246																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female							14	148		13		95	554	92	115	142	190	559																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female							9	72		8		48	403	43	50	62	73	388																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male							43	133		54		251	567	276	490	665	812	1,461																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male							14	155		25		70	575	93	154	226	276	691																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							3	62				20	390	8	33	36	42	291																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male							26	158		38		178	609	192	212	313	397	1,046																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male							1	35		4		5	345	2	11	14	15	260																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male							17	129		15		44	522	58	61	102	136	450																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female							25	211		24		131	687	150	167	217	289	762																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							4	71		6		32	403	12	28	37	46	323																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female							46	214		37		143	720	203	270	341	422	932																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							1	54		4		21	378	13	3	4	6	260																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female							52	150		24		166	586	216	274	361	464	942																			
Cameroon	Cameroon	CMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male							9	66		8		27	393	23	58	63	72	314																			
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			175				12	91		21		58	484	32	45	71	52	521	69	66	73	96	366	81	136	106	81		51	96	88	66					1
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			175				29	93		34		141	526	74	68	104	83	795	126	111	138	183	637	166	238	150	122		123	186	271	152					2
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female							5	41		6		38	369	23	15	12	10	327	16	43	36	60	278	35	50	74	95		82	83	44	54					
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			166																																		
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								38				11	362	4	8	3	6	259	2	3		1	43	4	3	15	3		3	4	4	2					
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			62					34		2		10	352	3	1	1	2	236	3	8	6	15	16	12	74	11	10	50	14	2	6	1	38				
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			145				17	76		12		34	447	18	16	45	33	356	9	20	33	36	199	24	66	74	39		29	35	29	22					
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												940					739				
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			42					25		3		6	325	2	3	3	1	234	1		2	4	14	4	4	7	3	18	3	2	3	3	7				
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			166				18	84		21		116	501	66	73	84	104	714	94	175	227	324	1,854	212	187	202	219		211	226	209	181					2
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							2	41		4		23	369	7	8	9	9	279	7	18	21	34	148	16	14	39	32		19	22	19	19					
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												701					762				
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male							5	38		6		21	362	4	13	5	9	273	3	10	4	13	71	16	16	20	16		10	27	11	15					
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			145																																		
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			166				4	85		11		63	467	37	34	31	44	439	30	82	96	140	645	95	125	139	140		125	125	103	103					1
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			92				22	53				3	437					238				2				5											
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			241				9	122		21		108	558	72	47	48	71	572	47	111	149	188	922	133	186	182	183		224	180	148	176					1
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												3,867					3,614				
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			241				26	123		34		116	599	96	73	75	76	708	94	183	215	265	1,272	176	213	222	165		217	223	206	222					2
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												2,994					2,966				
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												962					979				
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												182					201				
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			116				7	61					448			3		230					1,439		1	5					1	1					
Cameroon	Cameroon	CMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			145				52	78		50		192	490	100	141	174	146	1,065	145	203	251	237	821	211	236	205	191		120	253	349	178					
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											48					49					84
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				24	20	17	19	275	40	37	29	29	616	26	32	32	18	391				92	458				103					106					89
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			2,029																																		
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											53					44					61
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												148					66				
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				7	3	6	5	40	4	12	7	7	10	13	4	7	6					22	10				23					15					18
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				62	80	72	72	283	84	119	70	67	1,341	88	91	64	61	1,984				240	1,040				250					258					268
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				37	49	42	39	215	78	72	76	58	478	60	62	47	59	288				208	310				209					230					213
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				52	48	46	33	219	50	91	55	59	828	57	48	45	49	616				192	602				187					175					185
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				7	7	6	6	257	16	16	11	5	385	8	11	6	12	28				26	228				35					30					31
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				44	48	57	40	241	75	65	66	66	458	61	80	47	50	499				257	348				219					194					214
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											36					41					59
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											245					204					184
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											39					53					80
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												490					299				
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				8	8	8	5	46	17	14	10	12	15	14	15	4	13	1				25	15				24					25					38
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				6	11	15	7	58	20	14	16	18	61	15	12	15	4	18				30	45				32	34				28	24				37
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												912					893				
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				9	4	10	13	236	19	17	18	21	182	23	14	10	20	50				72	121				67					75					74
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				44	57	40	54	285	54	55	62	49	761	55	57	46	40	964				174	578				174					170					184
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				68	60	56	53	227	99	92	78	76	589	101	81	58	74	618				282	445				263					253					272
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				68	85	89	75	237	127	109	89	111	647	115	88	78	98	530				359	533					358					294				
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												1,100					1,022				
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				7	7	8	9	233	28	12	8	5	191	8	5	6	11	48				17	91				27					25					23
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												303					201				
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											81					69					106
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				58	76	74	55	240	103	106	83	72	659	85	90	73	64	741				277	471				270					282					310
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				12	20	15	22	185	44	40	44	41	220	35	35	29	41	99				99	128				110					114					127
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				58	69	84	53	282	69	104	73	65	1,617	98	103	68	63	1,574				292	1,234					866					699				
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male							1																														
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				87	80	89	86	262	102	104	96	94	1,595	106	78	74	95	2,125				314	1,206				280					265					259
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			2,349																																		
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											36					39					57
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											170					130					140
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				80	82	81	62	245	100	116	98	89	1,127	109	97	69	56	1,538				239	918				214					230					206
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				1		1		47	1	3	3	5			1							5					3										15
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												2,188					1,921				
Cameroon	Cameroon	CMR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												22					18				
Cameroon	Cameroon	CMR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			711		76		142	6,554		115		221	17,297		1,292		1,326	16,008		725		519	5,062		1,336		833	6,280		479		620	3,299				390
Cameroon	Cameroon	CMR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			4,402		2,191		2,401	92,384		1,690		4,283	226,429		23,086		25,171	249,591		17,536		15,252	70,566		35,459		19,838	74,193		10,819		14,989	54,323				9,781
Cameroon	Cameroon	CMR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			5,119		1,052		1,285	49,253		966		2,265	115,679		10,030		11,336	114,447		8,522		8,026	32,236		16,460		10,256	34,427		5,937		7,796	24,460				5,440
Cameroon	Cameroon	CMR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male															1																						
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												4,765					3,812				
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												85					68				
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												686					549				
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			567																																		
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				160	136	107	114	1,530	235	240	250	219	1,790	245	243	215	221	1,769	292	266	202	241	1,769	286	244	286	282		385	410	285	305					367
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				28	37	29	18	366	51	70	66	62	187	65	57	64	50	187	58	68	46	51	187	82	74	60	75	151	108	158	97	105	122				150
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				120	139	74	89	1,483	190	227	220	215	503	219	174	203	237	503	247	254	203	207	503	267	222	310	305		410	441	293	353					419
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male							1		78		1														2												
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				67	47	36	39	1,501	67	77	81	68	377	79	66	73	93	377	98	78	64	83	377	90	85	93	120		170	184	104	121					142
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												8,951					7,161				
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				10	8	5	3	352	8	2	7	11		3	4	4	9		2	9	3	6		16	15	9	4		7	8	5	7					17
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				246	287	216	202	1,524	427	422	422	428	1,954	457	399	404	415	1,933	424	498	436	469	1,936	521	548	520	564	1,550	864	780	608	593	1,239				848
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				29	26	22	16	302	34	52	54	44	63	44	55	36	58	63	46	32	34	46	63	69	44	64	51		77	92	73	49					66
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				76	84	57	97	1,512	131	160	175	192	482	193	135	147	207	482	187	214	178	211	482	218	168	237	241		383	355	253	282					310
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												2,234					1,787				
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			4,515																																		
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												4,080					3,264				
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				139	155	110	103	1,679	207	179	186	188	3,650	173	171	144	131	3,609	164	138	125	167	3,609	155	145	130	167		227	239	178	190					187
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				27	26	15	15	289	17	46	35	43	42	35	40	37	28	42	36	27	36	42	42	64	43	51	47		89	103	86	38					59
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				140	154	121	105	1,526	242	254	201	203	1,935	221	203	216	196	1,914	225	224	189	224	1,914	238	221	263	283		343	363	274	305					350
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				42	44	40	32	1,617	73	83	51	59	940	50	79	65	61	940	78	64	75	74	940	83	84	109	95		126	148	104	107					127
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				71	85	48	66	1,722	115	103	110	92	2,349	87	87	75	79	2,328	82	94	67	94	2,328	99	91	89	123		133	143	80	98					138
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				103	114	88	77	1,526	198	188	163	195	1,438	181	179	158	149	1,417	216	196	146	159	1,417	211	172	205	209		279	261	206	202					250
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				86	94	44	63	1,705	115	140	135	114	1,874	102	97	122	112	1,853	135	137	112	150	1,853	161	123	150	163		227	248	188	171					179
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				148	148	96	121	1,492	208	276	244	216	1,250	239	231	202	241	1,229	250	249	255	259	1,229	274	250	292	296		456	420	300	327					386
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				142	147	135	119	1,722	227	271	231	203	4,616	227	232	183	182	4,575	212	251	176	266	4,583	292	254	236	277	3,665	347	376	270	309	2,932				368
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female									46																2												
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												1,386					1,110				
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				102	119	88	98	1,722	180	179	137	130	4,141	139	140	104	103	4,100	127	144	101	103	4,100	147	121	117	148		165	184	159	130					129
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			6,053																																		
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				126	126	83	78	1,679	160	166	159	152	2,368	121	121	121	129	2,347	160	126	144	144	2,347	158	128	159	146		211	235	184	206					200
Cameroon	Cameroon	CMR	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				136	132	117	110	1,723	190	172	171	150	4,802	153	141	123	167	4,761	158	175	133	144	4,761	161	131	156	183		233	191	167	142					187
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			8,717	8,835	9,201	9,328	11,076	9,710	10,032	10,267	10,362		10,532	10,779	10,980	11,089					12,344
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												113,166					120,084				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			13,914	14,187	14,777	14,937	18,816	15,615	16,051	16,473	16,767		16,886	17,365	17,766	18,036					20,746
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			30,125	22,786	23,231	23,122	23,898	33,480	33,515	33,920	34,039	35,281	42,568	35,775	36,203	37,522	38,337	41,307	38,659	38,988	39,286	39,610	41,365	40,770	41,488	41,613	41,953		42,209	42,351	42,534	42,244					41,074
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			4,534	2,323	2,429	2,422	2,477	16,833	5,766	4,562	4,499	4,905	17,743	5,141	5,171	5,314	5,575	13,042	5,703	5,752	5,984	6,484	9,870	6,960	7,113	7,371	7,423		7,628	7,472	7,475	7,644					7,358
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			10,637	7,242	7,237	7,287	7,467	17,178	11,929	11,902	11,870	12,711	20,657	12,832	12,885	13,306	13,862	16,797	14,024	14,265	14,260	14,599	15,750	15,412	15,422	15,635	15,509		15,794	15,647	15,610	15,383					14,742
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			9,834	9,738	10,197	10,424	7,930	10,776	11,053	11,348	11,603		11,646	11,917	12,032	12,049					13,023
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			19,916	12,718	12,586	12,192	12,456	33,226	21,543	19,534	19,923	21,055	37,118	21,141	20,772	21,441	22,042	31,515	21,473	21,639	21,568	21,918	25,198	23,145	23,199	22,926	23,273		23,541	23,358	23,032	23,094					22,058
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			44,671																																		
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			9,160	10,004	10,599	10,944	6,753	11,505	12,065	12,598	12,977		13,315	13,732	14,238	15,324					16,425
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			3,976																																		
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			5,343	5,839	6,217	6,289	3,223	6,624	7,062	7,372	7,555		7,727	7,980	8,196	8,905					9,368
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												22,752					23,381				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			479	162	112	111	104	764	271	201	144	220	923	145	151	84	93	934	80	72	94	89	735	117	102	100	90	124	89	74	53	56	64				79
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				1,459	1,375	1,251	1,249	3,730	2,231	2,161	2,182	2,368	4,531	2,212	2,046	2,034	1,982	3,838	1,939	1,849	1,817	1,838	3,902	1,836	1,837	1,777	1,778		1,763	1,698	1,668	1,710					1,456
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			2,207	1,052	1,123	1,119	1,216	4,112	2,280	2,246	2,255	2,492	5,544	2,599	2,791	2,855	2,973	4,021	3,013	3,118	3,301	3,674	6,765	3,825	4,076	4,295	4,188		4,217	4,217	4,205	4,201					3,787
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			1,118	976	1,044	1,121	1,132	2,604	1,676	1,664	1,680	1,784	3,859	1,797	1,847	1,893	1,960	2,523	2,042	2,090	2,155	2,203	3,954	2,194	2,291	2,373	2,407		2,403	2,433	2,460	2,520					2,529
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			16,773	14,521	15,530	16,861	17,580	31,654	23,848	25,715	26,900	27,025	34,738	28,405	29,636	30,349	31,044	32,629										36,642					40,899				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				2,528	2,496	2,520	2,513	5,970	3,999	3,853	3,935	4,116	7,519	4,092	4,097	4,070	4,155	5,749	4,091	4,068	3,967	3,955	5,327	3,992	3,920	3,913	3,851		3,842	3,771	3,686	3,694					3,427
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												11,107					9,088				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												22,743					23,036				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			7,918	4,706	4,719	4,585	4,682	17,145	8,402	8,212	8,158	8,822	19,434	9,087	9,098	9,230	9,568	14,784	9,758	10,017	10,413	10,799	12,882	11,386	11,781	11,972	12,025		12,469	12,420	12,245	11,913					10,766
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												51,244					54,756				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				8,265	8,297	8,645	9,023	17,145	13,134	13,566	13,794	14,332	19,804	14,711	15,090	15,632	15,995	17,137	16,440	16,861	17,186	17,426	16,546	18,026	18,427	18,758	18,921		19,123	19,205	19,282	19,340					19,233
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male						3	6		63	129	108	2			1																						
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			10,298	2,835	2,838	2,916	2,870	5,970	4,080	4,111	4,101	4,278	8,380	4,371	4,433	4,496	4,522	5,832	4,605	4,659	4,636	4,706	6,593	4,743	4,804	4,831	4,881	7,046	4,916	4,920	4,934	5,004	7,000				4,825
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			23,529																																		
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			2,925	1,854	1,902	1,934	2,003	5,597	3,498	3,179	3,220	3,410	7,840	3,560	3,559	3,670	3,917	5,275	3,983	3,957	3,956	4,000	5,848	4,172	4,107	4,103	4,142		4,145	4,074	4,031	4,125					3,775
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			12,911	13,525	13,826	14,373	13,341	14,782	14,952	15,400	15,735		15,846	16,010	16,273	16,453					17,395
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female						5	7		60	305	264	5			1																						
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				20,208	21,042	21,374	22,280	33,487	30,432	31,701	32,096	33,212	41,356	33,823	34,590	35,277	35,726	38,330	36,353	37,292	38,235	38,680	39,024	39,968	40,843	41,368	41,792		42,213	42,650	43,064	43,293					43,216
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			27,726	24,343	26,737	28,846	30,024	44,694	40,114	42,221	44,620	44,841	52,853	46,843	49,233	50,256	51,559	53,390										61,238					69,729				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												61,879					64,215				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												11,020					11,051				
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				14,710	15,495	15,995	16,594	33,513	23,429	24,280	24,653	25,272	37,401	26,154	27,221	28,072	28,638	31,553	29,821	30,533	31,215	31,871	31,225	32,664	33,526	34,298	34,929		35,244	35,750	36,093	36,278					38,010
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			21,468	22,427	22,939	23,694	23,224	24,589	24,981	25,664	26,346		26,669	26,997	27,491	27,858					29,410
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			10,759	5,334	5,427	5,022	5,135	14,893	9,906	9,519	9,774	10,623	18,582	10,875	11,035	11,276	11,665	16,183	11,355	11,595	11,697	12,164	14,370	12,826	12,948	12,632	12,884		13,080	13,005	12,701	12,755					10,841
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				9,208	9,314	9,278	9,685	17,171	14,185	14,056	14,215	14,994	20,804	15,208	15,578	15,777	16,114	18,001	16,316	16,813	17,331	17,644	17,428	18,323	18,679	18,890	18,942		19,142	19,204	19,279	19,351					18,489
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			28,528	20,269	20,390	19,800	20,284	33,513	29,914	29,528	29,928	31,742	40,283	31,466	31,542	32,223	32,607	39,382	32,825	33,338	33,537	33,762	35,889	35,481	35,943	35,624	35,860		36,093	36,225	35,799	35,177					32,390
Cameroon	Cameroon	CMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			5,903	5,869	6,172	6,449	4,581	6,648	6,804	6,960	7,130		7,227	7,328	7,407	7,479					7,956
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				522	554	466	463	11,280	676	854	785	881	10,044	1,013	960	946	838	7,160	800	799	789	759	3,775	716	709	658	563		537	477	412	450					343
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								88	118	66	62		76	62	47	47					52
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			4,538	486	491	393	376	5,804	636	760	724	822	4,566	948	877	915	894	3,834	901	824	784	758	1,959	720	672	621	571		486	428	314	323					314
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				377	391	326	314	11,288	449	588	510	594	5,854	705	630	609	560	6,253	566	548	508	547	2,783	435	440	416	398		347	332	273	272					258
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,171					1,445				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			8,369	922	1,042	761	725	11,378	1,136	1,387	1,294	1,537	8,888	1,747	1,607	1,707	1,581	9,117	1,461	1,426	1,401	1,290	3,835	1,228	1,203	1,059	1,005		920	724	552	669					565
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								124	129	115	81		79	102	64	72					60
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			5,491	537	616	409	446	5,019	779	1,014	872	1,172	4,662	1,458	1,211	1,179	1,181	4,267	1,114	1,032	972	928	1,835	993	882	809	681		714	592	473	518					444
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			7,603	853	949	715	700	11,139	1,135	1,362	1,308	1,520	5,846	1,687	1,533	1,583	1,457	7,663	1,406	1,417	1,293	1,321	2,849	1,173	1,201	1,054	955		879	716	579	684					602
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												489					253				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								88	94	75	71		69	55	52	57					54
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				405	448	346	380	5,793	542	677	604	745	4,730	808	835	820	788	3,758	752	798	756	714	1,734	694	673	563	500		422	381	302	330					268
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			1,829	568	696	496	509	15,055	680	905	830	880	10,942	998	1,012	1,027	915	10,385	861	836	812	752	4,810					1,318					3,743				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			1,281	50	39	34	27	863	53	73	51	70	1,460	72	60	54	66	465	61	55	67	77	583	57	74	47	60		56	39	65	60					45
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			548																																		
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				285	338	264	238	5,785	417	507	439	495	3,706	620	594	553	619	3,377	566	562	536	492	1,154	484	455	424	348		311	283	217	233					212
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			4,000	297	305	255	241	5,723	422	452	412	574	1,847	668	524	614	601	2,798	573	555	610	648	1,418	591	627	493	446		332	305	268	334					269
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								335	367	332	275		255	243	181	233					171
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								153	158	123	106		111	110	74	84					83
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			1,415	52	64	61	48	2,006	80	102	93	125	2,848	101	98	96	73	1,136	87	80	70	76	889	69	77	87	62	555	67	53	53	84	308				45
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			3,861																																		
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			6,299	737	797	655	615	11,299	937	1,188	1,064	1,208	11,329	1,411	1,303	1,339	1,359	8,263	1,172	1,192	1,143	1,109	4,053	996	1,083	889	803		792	667	488	563					450
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												973					1,231				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												2,516					3,497				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male						1			9	1		1																									
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				98	133	83	75	1,234	167	207	219	215	1,025	200	197	220	174	931	221	188	205	175	600	147	156	155	136		132	123	96	155					100
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			3,607	404	458	390	359	10,659	578	754	679	762	4,909	792	800	853	815	6,240	691	759	732	733	2,210					882					1,216				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												434					527				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								285	287	246	234		189	186	154	152					157
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			174	64	37	48	46	366	59	67	60	75	173	44	31	30	28	252	68	54	54	53	189	55	47	33	33	126	35	35	11	24	64				34
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				65	79	65	71	2,010	105	148	148	151	1,930	137	157	118	118	1,239	112	94	82	80	705	65	87	86	55		61	72	60	103					50
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			2,384	140	168	105	113	1,375	209	225	227	318	1,725	343	320	332	343	932	318	317	374	480	990	314	403	351	292		238	187	197	215					137
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			3,093	163	170	131	125	1,885	245	278	281	323	2,654	411	322	369	368	1,304	347	320	285	264	842	301	252	258	227		217	155	168	251					169
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												1,960					1,294				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			4,975	395	432	351	300	5,881	532	696	598	767	3,314	914	810	790	829	3,403	692	776	753	745	1,769	637	759	633	531		505	407	347	376					296
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			3,786																																		
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								188	156	135	123		142	94	119	109					100
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female						2			7																												
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												2,631					517				
Cameroon	Cameroon	CMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								85	97	72	59		58	48	35	54					47
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				2,652	3,699	6,856	6,790		5,954	7,122	10,308	14,457	31,845	16,146	16,702	18,419	19,134	26,856	21,693	22,483	20,685	17,660	23,147	19,053	16,721	15,191	20,607		22,164	23,220	22,963	24,479					28,321
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												9,023					8,015				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				3,268	4,366	8,310	8,183		6,237	6,621	10,079	14,169	33,175	15,498	15,706	17,380	18,108	32,871	19,733	20,296	19,037	17,227	26,603	17,466	15,780	14,407	18,311		19,988	20,286	18,780	19,351					20,822
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								8,069	7,057	6,477	8,750		9,455	9,738	9,667	10,366					12,198
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				471	488	583	697		546	578	929	1,244	6,052	1,404	1,430	1,659	1,790	4,352	2,017	2,069	1,992	1,833	4,331	1,860	1,713	1,633	2,070		2,142	2,157	2,049	2,191					2,326
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				1,544	1,965	3,618	3,558		2,892	3,165	4,539	6,717	17,080	7,712	7,946	8,557	9,071	15,222	9,861	10,081	9,761	8,393	12,921	8,931	8,069	7,437	9,411		10,160	10,414	10,231	10,922					11,892
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				3,692	5,013	9,066	9,058		7,507	8,505	12,721	17,945	33,658	20,119	20,297	22,118	22,989	32,833	25,469	26,323	24,508	20,855	28,926	22,006	19,587	17,520	23,594		25,567	26,197	25,836	27,500					30,882
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				202	161	373	401		312	359	573	835	4,361	937	1,004	1,250	1,366	3,348	1,470	1,503	1,553	1,532	5,017	1,592	1,544	1,480	1,895		2,078	2,024	1,999	2,179					2,253
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												19,088					21,070				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				723	1,061	1,885	1,956		1,331	1,433	2,317	3,316	15,054	3,717	3,967	4,742	5,097	13,236	5,391	5,822	5,716	5,215	10,653	5,138	4,848	4,814	5,962		6,218	6,206	5,675	6,001					6,205
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female						15			28		1	14			1		1																				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				2,735	3,455	6,769	6,621		6,061	7,069	10,743	14,624	29,813	16,693	17,356	19,114	19,954	27,882	23,142	24,331	23,064	19,561	23,931					32,279					37,331				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												45,265					50,086				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												9,608					10,107				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								3,802	3,553	3,229	4,469		4,769	5,262	5,322	5,931					7,045
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												20,097					21,385				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								6,831	6,214	5,695	7,962		8,599	9,383	9,633	10,779					12,681
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								5,482	5,102	4,478	6,107		6,504	6,752	6,816	7,241					8,927
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				1,434	1,803	3,254	3,514		2,785	3,278	4,723	7,015	16,605	7,920	8,148	9,130	9,520	14,590	10,707	11,053	10,259	8,774	12,268	9,251	8,247	7,450	10,017		10,894	11,141	10,849	11,467					13,047
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				351	378	795	844		610	663	1,011	1,512	15,516	1,733	1,836	2,191	2,372	10,993	2,658	2,822	2,806	2,617	7,321	2,627	2,560	2,439	3,137		3,406	3,436	3,303	3,462					4,291
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								14,584	12,653	11,297	15,806		17,016	17,817	17,733	18,861					22,140
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				1,146	1,419	2,754	2,677		2,096	2,254	3,292	4,888	17,011	5,502	5,858	6,465	6,991	14,043	7,767	8,053	7,682	6,893	11,680	7,056	6,400	6,003	7,315		7,911	8,034	7,716	7,993					9,070
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				1,864	2,665	4,895	4,938		3,472	3,707	5,745	8,004	31,598	8,927	9,171	10,403	11,017	26,135	11,840	12,372	11,739	10,510	18,681	10,410	9,588	9,070	11,398		12,092	12,293	11,415	11,970					13,570
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				696	752	717	906		788	864	1,413	1,710	6,091	1,813	1,827	1,997	2,141	4,843	2,356	2,424	2,195	1,964	3,977	2,017	1,826	1,752	2,212		2,253	2,237	2,011	2,031					2,224
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				259	182	317	444		389	431	646	798	2,926	849	883	1,074	1,119	2,165	1,297	1,373	1,307	1,159	2,950	1,154	1,082	1,021	1,336		1,410	1,459	1,388	1,480					1,706
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male					1				8	1	2	6		2		1																					
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								6,508	5,895	5,263	7,137		7,621	7,887	7,708	8,229					9,919
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				7	15	16	11		19	3	12	71	782	11	19	10	3	742	4			3	614	2	4	4	5	66	14	6	2	2	36				2
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												54,654					58,739				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				767	822	840	1,102		971	1,019	1,564	1,987	6,485	2,111	2,164	2,416	2,621	4,972	3,025	3,078	2,892	2,552	4,924	2,623	2,500	2,373	2,894	6,036	2,989	3,036	2,831	3,026	6,366				3,336
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				789	871	1,623	1,666		1,280	1,297	1,917	2,963	16,435	3,380	3,629	4,088	4,484	12,347	4,719	5,020	4,866	4,613	9,545	4,901	4,496	4,184	5,390		5,896	6,003	5,766	5,694					6,302
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				262	349	269	416		311	319	441	616	3,742	649	651	740	753	3,177	737	730	637	573	2,919	575	587	603	725		765	741	707	736					709
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								9,491	8,606	7,638	10,292		10,895	11,584	11,700	12,508					15,833
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								3,793	3,477	3,100	4,194		4,578	4,685	4,628	5,041					5,907
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												99,781					109,624				
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				3,858	5,303	9,919	9,628		7,749	8,439	12,570	17,775	34,211	19,700	20,056	21,857	22,867	35,132	25,530	26,032	24,286	21,151	30,661	21,785	19,491	17,532	22,809		24,602	25,228	24,333	25,293					28,103
Cameroon	Cameroon	CMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				4,783	7,011	13,047	12,728		11,258	13,123	21,169	26,975	43,847	30,228	30,972	34,109	35,736	45,547	41,184	43,397	40,014	33,742	42,065					54,011					63,179				
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														17		8					12
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														71		44					35
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														5		3					3
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														12		9					9
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																																1					
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					393		298			331		592			395		405			266		278			312		287										
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														53		37					37
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														9		3					14
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														34		35					33
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														35		15					25
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														26		18					10
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														7		1					3
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														59		39					24
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														4		3					4
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														10		10					15
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														14		9					4
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														24		31					20
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														39		40					18
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														4		2					
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					422		361			383		573			480		409			296		271			321		273										
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														23		20					16
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					26		26			27		50			39		42			10		14			21		14										
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														43		20					23
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														23		12					13
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														8		5					6
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														6		2					2
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														57		34					25
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														56		38					35
Cameroon	Cameroon	CMR	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														51		37					41
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												303					303				
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																		434				23	434	56	220	220	187		22	26	118	334					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																					10	99		2	140				8	9		11					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												1,184					1,184				
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												1,355					226				
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																		98		15	84	48	98						19	39	63	134					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												912					152				
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex																									17		1		16	10	60	479					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																		460		10	112	58	460	6					19	71	82	160					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																		49		14	109	45	49	2					15	39	74	156					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																		565				19	565	78	269	179	227		34	25	207	450					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																						73			13		1				1	2					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												2,835					473				
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																		790				20	790	57	160	173	233		35	22	144	374					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																		268				22	268	130	460	180	149		42	62	119	318					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																									1		3				2						
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												302					50				
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																		411		16	63	38	411						10	39	45	136					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												49					49				
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																		205		16	110	62	205						13	41	50	129					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																		924				23	924	35	111	137	184		28	17	108	244					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																		588				18	588	26	98	141	163		27	17	65	235					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																		856				2	856	10	36	60	99		20	14	41	118					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																		34				9	34	17	168	71	61		18	28	75	96					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												49					49				
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																				4	25	7		1					9	13	18	39					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																		478				14	478	32	140	180	191		25	17	98	291					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																					6									2	2						
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																		362		23	124	63	362	3					26	59	82	131					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																		901				7	901	15	51	57	83		31	8	62	155					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																					7	102		1	30				6	9	14	33					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												2,166					361				
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												1,233					1,233				
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																				2	9	9							3	17	28	28					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																		714		6	44	35	714	1				714	11	31	50	108	714				
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																		1,010				10	1,010	31	75	100	118		32	12	78	212					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																		2,188				7	2,188	12	42	133	169	2,188	52	21	68	152	365				
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												274					46				
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																		722				11	722	17	68	106	127		23	9	54	176					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex																															5	36					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												509					509				
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																		147		29	124	66	147	4					16	51	70	150					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																		1,968				11	1,968	4	41	72	146	1,968	50	25	76	166	328				
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																		97				7	97	21	269	31	111		32	48	244	154					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																		177				20	177	170	580	137	230		80	143	336	383					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																		959		2	91	44	959		1			959	8	34	39	178	959				
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																		411		13	98	54	411		2				11	29	69	179					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																		362		4	60	15	362						9	26	25	93					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																		362		13	61	29	362	1					9	22	33	89					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																		49		9	64	32	49		1				11	31	54	124					
Caribbean Region	Trinidad and Tobago	TTO	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																		411		16	62	53	411	1					18	46	53	115					
Caribbean Region	Jamaica	JAM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																						107			13		3					3					
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			15	9	3																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female					1			13	2	2	3	3	22	1	2	2	1	25	1	3	3				3	2	1		5	4	13	7					14
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				12	5	3	4		8	3	5									1	3	1															
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			193	80	71	73	24	322	131	61	46	6					82		48	96	47	44															
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male							1		2	1	1																										
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			10	1	5	3		14	13	10	3	1																									
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female									7	2	6	6																									
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female										2	1	1																									
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				7	8			11	3	6	1	4	28	4	4		2	25	1	2	4			2	5	3	2		15	12	9	12					20
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			18																																		
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			842	136	104	96	21	1,274	611	335	239	318	196	201	197	194	173	118	149	221	142	156	167	180	257	240	285		364	458	271	224					375
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			1,757	225	164	44	23		2	2	5	4	208	2	10	1	3	35	2	11	4	9	43	1	6	6	1		158	99	77	58					195
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female									1					1		2			3										1								
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			44	7	6	1																															
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female									6	3		1																									
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female					1			7	1	5	1	1	27		3	8	1	25	8	6		2	180			6	5		5	4	17	7					25
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			41	8	5																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												68					187				
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				60	55	11	3	1,103		4	2	1	162	3	5	1	4	269	2	5		6	136	7	6	5	1			2	2	6					
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			25	7	3	1			3	2	2				2	3				1			10			1			3	5	9	3					2
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				7	17	2																															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			364	77	42	51	11	729	375	214	126	208	43	102	87	72	77	10	56	102	95	78	31	80	91	82	170		140	202	125	92					216
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				3	7	1																															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			766	116	86	21	9	1,171	2	1	4	4	171		2	3	1	219	2	6	2	11	128	6	5	3	2		1	2	3						5
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			326																																		
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			59	41	31	6																															
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex				2	2																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												48					99				
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				3	3	6	2		1	1		1									1	1															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female								10	5	3	2	2	28	5	7	4	5	10	3	4	3			2					8	14	20	21					27
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				7	7	8	3	1,703	107	71	29	37	353	16	20	22	20	363	15	14	17	17	475	31	42	36	29		44	33	26	14					19
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			27	17	18	7		7	5	3	4	1	38	2	6	3	2	10	5	2	8	4	40	2	3	6	7		12	11	18	14					26
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female									4	1	2	1			3	1			1	6	4		20	1					2	5	4	2					4
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												1,087					1,007				
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female								20	4	1			17		7	3	4	5	3	5	3		20	2	2	1	1		13	7	9	12					18
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			359																																		
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex										1	1			1	1	3				1											2						1
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			138	78	52	50	12	93	70	57	25	5					21		23	39	20	32															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			2,321	145	155	33	12	1,118	1	8	5	3	263	2	3	4	2	179	3	8	4	4	111	4	2	7	4		3	2	4	3					5
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			40	16	14																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female					1			30	2	2	3		15	1	7	2	2	55	5	1	3			4	1		1	145	5	9	13	10	85				17
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												20					88				
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			132	16	18	3	2	1,713	3	6	5	2	397	2	3	1	5	419	4	2	2	8	265		3	3	2	361	1	2	5	1	225				5
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			274	61	52	68	22	243	92	53	40	12					45		35	52	46	22															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,346					772				
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			515	135	170	183	94	67	293	224	180	50					147		126	182	148	92															
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			53																																		
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			105	9	18	15		51	30	13	21	6																									
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			16	6	7	3		16	3	4	3	3	32	3	3	4	3	25	5	1	2	3		5	6	9	4		13	16	24	28					15
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												334					516				
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female							3			1	1																										
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female									14	31	7	1		5	20	4	7		3	2	3	1		15	22	16	2		1	16	12	715					1,310
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				46	50	45	35	43	67	40	40	11					36		42	46	45	18															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			35	16	12	3		8	4	2	3	3	21	2	2	5	1	5	3	6	3	2	50	5	4	5	4		15	15	19	20					24
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				28	38	30	20	7	56	40	18	9					28		41	45	41	19															
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			33	12	16	15		143	16	11	4	5																									
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				12	8	1																															
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female									6	3	1																										
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			366	148	128	114	30	338	191	118	54	11					97		84	102	83	55															
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			102	38	37	10																															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			703	88	75	86	13	1,695	359	228	151	230	386	129	141	129	91	220	105	162	120	102	301	118	204	205	203		245	298	208	160					270
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				33	27	11	1	1,120	1	3	7	1	159	1	4	3	1	244	5	1		3	119		9	2	4		2	2	1	1					1
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			26	12	5																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				1	3	1		19	2	1		2	21	2	2	3	1	25	1	2		1		2	1	5	4		8	13	12	15					7
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			301	99	86	57	34	115	116	89	39	10					50		47	83	67	36															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male				12	9	6		17	5	2	4	5	15	2	2	5	6	70		1	5	6	380	4	7	1	3	103	10	18	28	17	106				20
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			65																																		
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			13	9	10	4		10	8	4	5	1	43	1	5	2	2	20	3	3	4	5		2	8	5	5		21	13	14	17					23
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				25	36	31	22		59	42	23	20					28		20	36	19	19															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male						27	24		50	34	11	4		8	18	9	31		15	20	5	23		17	9	48	52		38	48	16	849					761
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			98	42	64	52	53	34	123	77	39	15					46		48	40	64	30															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			57																																		
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			810	56	42	26	18		3			1	67		4	2	2	25		7	1	2	9	3	1				83	93	52	22					33
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex				10	2	1	4		2	3							1		2	5	1	1															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex									1		1			3		1				1	1					1											
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				4	2																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female								19	10	4	1	2	31	5	9	5	3	20	6	5	8	1	10	1	1	1	2		7	7	13	20					18
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			196	81	83	84	46	196	131	86	69	29					45		53	83	70	38															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			47	7	8	8	6	3,464	164	94	43	51	738	18	34	22	18	970	7	14	12	15	1,438	15	23	36	22	346	16	28	19	18	264				19
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			133	173	170	47	9	895	2	4	5	4	216	3	1	3	6	135	4	12	6	6	77	3	12	4	3		142	60	55	26					150
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												44					123				
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			351	85	111	121	85	71	161	154	127	42					68		76	129	92	48															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												248					138				
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			18	7	7																																
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			45	9	8	6			7	2	1	2																									
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			91	8	11	12		5	23	12	10	4																									
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			498	152	99	76	45	537	164	128	52	10					79		78	101	72	57															
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			83	28	21	8																															
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				41	48	49	25	86	74	51	19	9					31		45	43	41	25															
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			81	55	26	10																															
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			391	157	159	136	80	500	298	224	164	33					172		150	232	151	104															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									2							2	2		4												2						
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex												1							1					1		1						1					
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female									1	2	3	3																									
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				14	5	4	3	2,067	97	50	17	22	371	6	13	9	9	372	10	16	5	9	551	9	14	10	10		11	23	10	13					12
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												274					194				
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			268	38	38	39	4	1,420	202	127	86	122	354	57	73	69	67	221	55	74	51	69	319	66	124	115	131		156	165	106	81					129
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			119	49	50	12																															
Caribbean Region	Guyana	GUY	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			42	29	57	45	42		72	56	43	17					39		18	39	41	25															
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			119	17	21	21	2	1,349	141	92	36	80	413	35	29	25	28	287	31	34	25	35	392	42	84	60	52		56	74	54	43					60
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female									7	7		1																									
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex														1					1	1	1				1	1											
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female									9	5	6	10																									
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												1,596					1,201				
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex									2	1	1	1		1	1	5				7	6	2				1			1		1	2					2
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex														1					1			1				1					1						
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												729					537				
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												251					278				
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female									5		1	1																									
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				2	4	6		25	6	3		2																									
Caribbean Region	Jamaica	JAM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			1,055																																		
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			38	7	6	10		33	15	5	6	3																									
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female								13	5	1	4	3	12	2	4	6	4	30	5	4	8	6	70	1	2	1	1		13	10	12	15					26
Caribbean Region	Barbados	BRB	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male					3	2		80	3	1	2	2																									
Caribbean Region	Suriname	SUR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			23	14	10	4																															
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			6		1			1	4	1	1																										
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								5	1				4		1			5						1	1	2	1				1						
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female								1					5		1			5	1	1		1	18			1	1										1
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			6	1				6	1		1						1		1		2	1															
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			4	1	1																																
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female					2																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			1	1				4			2	1	7			1		5	2			1		2	1	1					1						
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			224	17	11	2		167	20	9	11	20	38	13	16	7	17	14	5	14	9	3	16	14	15	8	8		4	7	14	2					6
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			3	1																																	
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female					1																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								2	1	1	1		3				1	5																			
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			5		1			4																													
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			4	1	4	1		2	3											1		1															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								2	1				3	1		1	1	6					7				1										
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			11	5	3	2		16	2	2	1										1	1															
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			4	3		1	1	7	3	1	2								1	1	1	4															
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			3	1		1		4																													
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			2	3	2	1	2	80	1	2	1	2	45					27		2		1	9	1	1		1		1	2		2					1
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												6					5				
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			16																																		
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				1	2			101		1			34	1	2			54	1	1			16	5	3					1	1	2					
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				1																																	
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			7																																		
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male							1																														
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			4	3	1																																
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			12	5	5	3		19	5		1								2	1		3															
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female							1																														
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								3					3					1		1			2	1	1				1								
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex					1																																
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			1		1	1	3		2		2								1	2		2															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								2				1	6					2						1						1	1						
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												26					13				
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								5																													
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			4	1																																	
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			3	1	2																																
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								1																													
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female				1	2																																
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			1	1	2																																
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			3					1	1																												
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			38	1	5	2		335	6	8	1	8	69	2	1	4	2	32	2	2	5	6	38	2	5	2	2		1	4	4	2					3
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex											2																										
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			2					8																													
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												17					8				
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			218	13	8	3		334	7	10	8	10	62	8	13	6	5	25	6	15	10	5	28	8	10	6	7		7	8	6	3					1
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			1		1				1														1														
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												75					33				
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			1		1	2		2	2	1			5				1	2	2	1	3	1	4		1	1	2										1
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																			1																		
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			15																																		
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			108	8	1	3		99	3	7	5	4	6	1	7	2	2	2	1	3	3	2	3	6		3	1		2	3	4	2					1
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			2																																		
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female																							2							1							
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				1	4	2	1	3	2										2		6																
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			72	3	5	1		325	12	7	2	1	57	4	5	2	5	25	2	5	4	2	31	6	2	5	6		6	2	6	1					5
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												120					53				
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			24	3	5	5		16	5	2							2		2	1	8	1															
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				1	2			401	4	4	3	1	56	1		1		46	1	3			53	2	4	1	1			1	1	1					
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male						15	2		10	11	3			2	8	1	6			2	1	13		4			18		10	6	2	13					21
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			11	5		1	2	15	2		1	2					1		4			2															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												3					3				
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			1			1		3	4	1	2		9					4	3			2			2	1	2			1	1						1
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			11																																		
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female					1	1	1	1			1										1																
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			18	5	3	4	2	24	5	1	2	1					7		1	3	2	5															
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male					1	1																															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male					1			3	2		1		10		1			5		1				1							1						
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				1	3	1	2	6		1	1									3	1																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								2	4				6		1		1	4			1		1			1			1								
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			12	1	3	4		10	1	4							2				2	2															
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female									1	11	3	1		3	5	1	4			1				5	1	8					3	14					20
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												25					11				
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			4	1	3																																
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			19	2	1		1	99		4	1	1	55	1		1		36	1	4	1	2	13			3	1		1		2						
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			7	1	2			108				1	34			3	1	44	1	3		4	15		3	1											1
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			2					159	1	5	1	1	81	1				84	2	1	1	2	31		2	1	1	37	1	1	2		16				1
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			9	1	1			772	2	4	3	3	114	2	3	2		118	1	1	4	1	138	1	1	3		28		1	1		12				2
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				1				100		3	1		33		1	1		49	1	1		2	14		4						1						
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												4					3				
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			17	1	5	7	3	5	3	1	3	1									3																
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												88					35				
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												1					2				
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			1																																		
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												20					9				
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male					1			392	2	5		1	49	2	2	3	3	41	2	1	3	1	46	1	4	2	2			1							1
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								4			1		1		1	1		11	2								1	12					5				
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			3	1	2			3	2	1	2		4		1		1	1			1		5	2	1	1											2
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			2	1	1																																
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male								5	2		2	1	4				1	14					38		1			8		1			4				
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			4																																		
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			17		1		1				1	1	43		2			7		1	1	1	5		3	2				1	1	2					4
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			9	2	4	3	1	22	1	1	2						1				2	4															
Caribbean Region	Trinidad and Tobago	TTO	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male									1								1																				
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												139					59				
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			4	3	3																																
Caribbean Region	Barbados	BRB	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			4																																		
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex																										1											
Caribbean Region	Jamaica	JAM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			11				1		3				13				1	5		1			1	1					1		2						
Caribbean Region	Guyana	GUY	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				1	3	2			4										1		2	2															
Caribbean Region	Suriname	SUR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			5	1	1																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male					298																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female					256																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																														615		271					
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												175					275				
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												175					275				
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					21																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male					60																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female					380																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male					106																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male					18																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female					425																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					96																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female					87																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male					224																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male					145																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												175					275				
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																														697		287					
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female					47																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												175					275				
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					22																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					149																																
Caribbean Region	Jamaica	JAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female					422																																
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																								1			1		2	2							
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																								1	1	1	1	2				1	11				
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																								1		1	1		4	4		4					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																													1	1		1					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																										1	4		5	5		8					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																																1					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																							10		1	1	3		10	10		12					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												1					6				
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																								7	16	36	95		122	135	199	112					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																												4				40	22				
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												4					22				
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																									1		1		2	2		2					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																							2		1	1	4		7	8		10					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												30					165				
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																							29	1	4	7	7		24	27		41					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																											4		6	1	5	16					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																													1	1		1					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																									1	1	1		2	3		2					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																							21		4	10	25		33	40		54					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																							4									1					
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												3					17				
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												4					22				
Caribbean Region	Jamaica	JAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												18					100				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												7					8				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																							6	1	2	3	7		3	8		6					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																												5		1			6				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																											2				1						
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																											1			2	2	1					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																											1			1	1	2					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																							143	11	14	17	26		14	20	3	12					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												5					6				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												171					190				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																										1	2		2		1	1					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																								1	1	4	2	5	4	1		1	6				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												16					18				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																									1	1	1			3	1						
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																							49	7	9	4	20		11	9	5	11					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																								3	4	5	3		1	4	5	1					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																													2	8	41	4					37
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																							104	13	21	21	16		18	22	5	13					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																								1	1	2	1		4	1		1					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												11					12				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																															10	3					17
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												105					116				
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																							23	3	2	3	1		1	1	3	2					
Caribbean Region	Jamaica	JAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																								1	1	3	2					1					
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			188	192	188	193	161	186	199	197	194		203	208	209	230					243
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			369	380	397	379	549	381	392	384	393		386	380	372	382					393
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female				3	6	7	24		6	8	13	10		6	4	5	5		2	2	4	5		14	12	11	6		14	20	17	13					9
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				285	296	297	298	331	293	360	353	379																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			161	166	171	183	103	189	198	197	196		210	215	207	215					246
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			141	157	168	172	182	170	181	276	274	259																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			2,678	1,629	1,648	1,735	1,812	2,035	1,951	2,012	2,058	2,031	2,444	1,972	1,980	2,041	2,123	2,836										2,579					3,539				
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			739	480	498	517	511	627	542	546	553	530	681	458	448	475	481	810	486	482	498	518	818	513	531	517	522		501	502	501	480					397
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			124	121	140	121	141	178	137	175	168	144																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			605	621	638	656	1,002	651	675	691	701		685	702	716	707					694
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				718	715	738	768	863	807	826	817	818	1,028	743	736	739	727	1,243	735	750	753	728	1,255	733	721	733	733		716	705	713	664					585
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			18	386	389	391	473	570	443	407	406	439	631	456	437	438	429	631	431	434	441	440	571	428	426	446	431		420	419	402	392					398
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				259	283	291	274	441	281	303	298	336																									
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			249																																		
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				638	636	657	661	791	704	704	682	643	878	581	584	601	617	1,070	606	582	596	628	1,081	637	651	650	642		630	630	625	604					517
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			487	387	396	401	371	530	382	393	381	395																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex							1																			1	1										
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			810	854	868	828	1,369	857	825	841	794		810	775	813	795					718
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												1,197					1,716				
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				438	439	440	549	613	549	518	542	549	672	552	541	560	558	672	555	542	544	552	693	539	543	550	559		552	567	532	556					564
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												379					530				
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			1,384	831	821	846	874	1,017	919	911	920	867	1,160	798	801	796	810	1,366	801	821	825	837	1,379	840	836	849	851		828	826	834	814					741
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			31																																		
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			612	616	642	682	1,141	697	721	679	712		715	782	753	730					736
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			9	9	5	2	2	10	4	4	4	4																									
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				99	98	89	73	148	84	85	87	89																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			10	23	24	23	30	35	24	22	21	22	34	20	17	19	16	34	15	15	15	10	37	13	14	14	16		13	13	11	12					10
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			29	165	166	177	242	244	225	201	200	208	270	207	200	212	204	270	200	196	201	206	261	214	207	196	197		204	163	202	210					199
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			96	86	91	87	76	123	82	73	74	68																									
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			46	30	42	40	41	43	44	62	59	50																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			464	266	291	306	320	363	338	351	349	313	427	247	261	268	276	463	268	271	277	281	468	291	281	267	271		270	256	261	236					218
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			92	74	58	76	69	105	70	76	80	74																									
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				282	288	283	280	420	276	306	301	283																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				318	335	346	448	471	424	425	432	438	623	472	489	487	488	623	475	471	477	482	563	478	479	498	487		494	494	466	486					544
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			68	55	53	47	44	63	48	42	53	48	60	45	49	51	45	72	41	45	43	42	73	51	52	51	50		47	50	50	44					47
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			747	781	812	778	1,203	829	831	840	842		856	858	845	830					812
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			2,767																																		
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				15	12	14	12	15	11	17	17	17																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												109					187				
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			30	388	380	361	459	573	407	380	376	382	513	372	368	365	357	513	347	330	299	299	467	271	261	274	266		248	240	222	224					195
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				277	267	261	258	336	260	349	343	371																									
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			18																																		
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			300	309	310	309	483	311	324	320	326		353	374	369	363					418
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			47	45	45	41	37	58	33	33	37	29																									
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			8	10	12	12	8	11	8	9	7	6																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												6									
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			334	233	218	210	215	345	217	217	223	194																									
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			86	73	82	85	67	142	74	73	76	68																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			26	614	623	654	822	914	815	797	808	820	1,271	843	868	886	910	1,271										1,078					1,837				
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			57	46	39	36	35	62	32	29	32	31																									
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								1		2	2	2																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			16	69	75	78	106	102	98	74	83	78	118	74	79	89	81	118	72	66	63	63	115	61	68	58	54		45	48	47	42					40
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			718	577	602	625	638	858	631	692	690	695																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			279	222	225	224	228	302	340	347	321	259	304	244	243	240	225	366	219	214	209	202	370	200	208	208	205		194	188	193	195					164
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			4																																		
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			44	31	33	23	30	43	30	51	50	56																									
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			221	245	228	239	227	291	219	311	305	307																									
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			809																																		
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			200	140	135	156	155	209	148	176	184	162																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												1,517					1,285				
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				116	120	117	93	197	107	104	101	114																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			22																																		
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			262	266	272	266	402	267	271	285	279		279	265	265	257					274
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				2	2	3	4	7	3	4	4	5																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												501					386				
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			40	41	34	37	32	43	29	31	28	28																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			91	82	78	84	81	99	71	71	81	86	110	73	78	76	77	133	72	83	70	61	134	78	78	79	71		70	71	67	60					54
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex							1		2	2	3	3	1	3	4	3	2	1	2	2	3	2	1	1	1	1	1		2	2	2	2					2
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			2,643	1,791	1,817	1,928	1,983	2,177	2,080	2,145	2,183	2,204	2,677	2,101	2,138	2,181	2,241	3,228										2,747					3,557				
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				842	850	918	924	1,060	973	993	998	966	1,228	887	891	893	910	1,478	924	934	940	937	1,493	938	951	939	933		921	909	902	878					777
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												1,806					2,394				
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			767	500	516	534	546	667	608	625	614	579	725	515	506	497	514	873	518	529	525	518	881	507	497	487	504		498	512	505	483					419
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												160					155				
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			268	277	279	289	142	288	299	314	312		322	334	330	323					364
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				5	6	6	6	6	5	6	6	6	12	2	3	3	3	17	1	1	1	1	17	2	2	3	6		5	2	1	1					1
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								1	2	2	2	1																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												2,354					3,726				
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			299	239	260	266	248	338	264	266	268	276																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			43	1,035	1,056	1,035	1,280	1,400	1,224	1,191	1,230	1,235	1,537	1,280	1,301	1,283	1,299	1,537										1,449					1,719				
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			259	268	252	263	220	264	272	268	276		277	288	290	286					326
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			19	289	295	310	372	427	358	333	341	356	496	327	347	349	344	496	336	335	307	306	448	289	295	298	303		297	288	294	287					285
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			417	423	437	466	401	476	486	507	502		513	512	524	514					510
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				778	794	804	823	991	885	905	892	864	1,104	864	879	893	920	1,333	919	902	918	928	1,346	938	933	930	928		942	945	950	900					878
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			253																																		
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			2,161																																		
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			27	494	494	504	663	729	621	588	580	586	759	579	575	566	556	759	551	536	535	524	721	522	513	520	489		490	474	465	441					411
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			17	18	16	18	17	27	16	16	18	17																									
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex					1	1						1																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			29	82	89	107	133	121	126	120	121	126	149	128	125	119	114	149	103	93	102	102	158	100	98	100	88		86	82	80	77					75
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex				1	1	1	10	2	6	6	6	5	12	5	5	5	5	12	5	4	4	5	11	4	3	3	2	6	4	4	4	4					4
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			144	106	101	115	124	158	126	219	207	195																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												3,194					2,589				
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			90	76	68	61	51	100	58	58	56	58																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			11	180	181	182	255	266	246	205	196	189	285	176	173	156	154	285	142	152	149	144	258	140	145	140	126		133	126	120	104					103
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex							4		6	4	4	4	4	2	3	3	2	4	2	2	2	2	4	3	3	4	2		3	3	3	3					3
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex				21	15	17	15	16	15	13	13	11	24	15	13	14	12	29	14	12	13	13	29	11	12	13	28	13	24	13	13	12					10
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			413	404	389	398	658	401	390	395	380		376	374	371	368					403
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			558	409	412	439	456	550	533	555	538	479	607	451	450	445	449	724	443	458	485	472	731	475	477	482	493		472	488	492	484					422
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												513					446				
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			490	381	374	392	402	499	513	539	546	429	535	384	388	405	416	652	395	411	406	403	658	409	404	393	392		379	378	391	376					318
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				93	94	91	77	171	79	79	75	76																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			435	446	462	494	293	496	514	534	563		578	582	597	588					652
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			84	77	72	67	54	101	59	64	64	69																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				11	10	6	3	11	3	3	4	8	12	5	7	1	2	15	2	1	1	2	15	6	8	4	5		3	5	6	6					4
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex				5	5	2		7	10	9	2	2		6		7			1								1										
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			387	399	422	453	456	454	453	492	513		506	522	535	535					541
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			1,111	679	692	730	752	854	792	802	815	787	998	702	697	710	732	1,168	687	685	695	684	1,180	687	694	694	692		691	673	680	651					571
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			51	48	40	43	33	62	37	42	43	49																									
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			381	397	408	433	258	450	464	486	508		527	552	556	565					612
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			577																																		
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			3	22	23	18	37	32	34	20	23	25	42	23	20	16	16	42	14	16	13	15	46	13	13	14	11		10	10	10	7					6
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			69	62	62	62	61	83	63	116	116	113																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												1,565					2,344				
Caribbean Region	Guyana	GUY	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			606	580	600	583	615	685	617	684	680	653																									
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			5						1	1	1	1																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												4									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				345	342	332	402	501	371	376	387	400	559	404	391	407	404	559	396	380	372	387	505	399	429	433	426		424	432	422	436					457
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				355	363	369	480	525	458	437	436	454	641	473	490	486	492	641	496	492	488	484	580	484	479	476	466		470	464	462	461					484
Caribbean Region	Barbados	BRB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				101	106	108	97	132	89	93	90	84																									
Caribbean Region	Trinidad and Tobago	TTO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												620					456				
Caribbean Region	Jamaica	JAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				5	4	9	18		9	10	11	6		2	1	1	1		1	1	3	4		15	15	14	2		16	20	15	10					11
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			11	5	14	5	11	27	8	6	8	5	7	5	4	1	4	42	4	5	3	6		5	4	2			3	2	1	4					
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				1	1	2	1	14																													
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			159	11	26	19	17	64	16	17	17	8	78	12	15	12	10	118	10	14	9	7	170	10	12	11	17		10	13	11	16					12
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			272																																		
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			16	5	6	2	6	9	4	7	4	2																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			197	8	18	8	11	43	22	28	28	19	38	14	20	13	12	63	6	16	10	8	86	13	15	10	13		8	7	19	7					14
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			22	4	8	6	3	34	1	5	3	5																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			257	31	42	40	33	245	31	25	29	38	382	32	27	23	23	559	21	26	37	42	759					66					174				
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			23	6	8	6	4	12	7	2	3	4																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				1						1			1					5													2						
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								1	5		1		4	1		3					1
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			242	23	42	27	28	222	32	41	31	26	345	31	19	22	17	398	25	20	24	21	666					68					171				
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			181	18	34	26	15	78	18	22	19	20	87	13	11	20	16	131	14	14	17	14	190	15	13	10	15		8	7	18	13					4
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			21	7	9	5	5	46	12	9	3	6																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								8	4	4	2		8	8	6	3					2
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												244					58				
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			27	11	11	16	11	12	9	11	3	8	4	8	4	4	6	22	8	4	11	5	46	10	10	6	3		4	6	5	4					6
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								1		1			2			1					
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			21	1	2						1																										
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			10	2	1	2	3	3	1	5	5	2	1	1	3	3	1	4	1	1	1		12	2	2	2	2			1	1	2					2
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			4	2	1				4	1	1			1	3	1																					
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																									1		3					4					3
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												43					56				
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												6					6				
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			40	10	11	19	12	165	12	15	14	12	145	18	7	7	9	226	5	9	5	2	350					59					56				
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male					5	3	6	50	3	2	9	4	123	3	8	5	3	82	6	2	5	2		4	2	7	3		3	2	1	5					2
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				3	3	5	4	13	2	1	1	1																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								6	4	2	6		5	8	6	3					4
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			3																																		
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				4	5	13	14	53	7	5	9	6	120	11	7	5	7	94	6	10	1	5		5	7	4	4		4	7	4						3
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				2	8	1	3	18	4	3	3	2																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female					1	2	11		3	1	3	2			1	1	2		1	1	2	2									1						
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			14	8	7	15	11	57	10	10	13	21	118	17	6	7	9	92	6	11	7	9		11	8	9	7		4	8	9	7					7
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												42					14				
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								6	2	7	2		6	4	1	6					2
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			22																																		
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			4	8	2	4	6	23	5	2	4	3																									
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			4			1	1	2	1																												
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								8	13	8	10		5	6	6	4					3
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex							1	1				1																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			177	20	35	25	26	101	20	18	17	17	125	7	10	18	15	172	11	13	14	15	275	11	11	11	9		7	9	18	7					5
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			45	4	5	4	2	64	2	2	2	2																									
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				2	1			4																													
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												143					73				
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				15	31	21	19	117	8	18	19	9	158	11	10	7	6	254	10	7	12	6	348	8	8	5	5		7	9	7	9					4
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			159	22	16	25	19	63	20	24	25	20	69	16	26	20	21	118	10	20	13	15	153	21	13	12	13		11	17	21	12					9
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			6			2	1	1					2		1			5												1	2	1					
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex												1																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								8	4	7	10		4	12	3	2					6
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				3	8	5	2	10	5	7	3	3																									
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex											1																		1								
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			38																																		
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			26	3	1	6		18		1		1																									
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			21																																		
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			34																																		
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			29	9	10	20	11	25	15	8	6	13	6	14	4	6	5	40	4	6	8	16	34	7	6	5	10		7	4	7	10					8
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			19	2	2	2	2	16		1		1																									
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								1	2	1	3		1	1	2	2					1
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				2	1	2		22	5	1		1																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												43					13				
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			167	17	18	22	22	117	10	21	20	7	147	14	16	12	12	209	8	11	9	11	321	10	9	11	10		5	3	6	10					12
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												226					225				
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				15	30	15	18	94	17	21	16	13	138	12	5	14	14	218	14	11	13	2	292	6	16	6	8		7	6	11	11					9
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			20																																		
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								6	3	2			2	3	3	1					2
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			27																																		
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								1	1	1	2		2	2	3	2					1
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex					1			10		1																											
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				2	7	4	5		5	5	1	1																									
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			14	7	9	6	3	15	7	8	6	5																									
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			7		4	2		3	5	1	1																										
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												135					97				
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				5	3	5	5	47		5	5	3	137	2	6	1		91	2	6	3			1	3	2	4		4	3	4	4					4
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			170	12	28	17	19	44	23	27	14	8	56	11	14	14	10	37	14	8	11	9	109	8	13	13	10		8	9	12	10					10
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			27	1	8	3	9	56	3	2	8	3																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				17	18	13	14	92	11	18	4	22	112	12	16	10	9	195	10	7	8	10	252	14	12	5	8		7	9	6	9					7
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				6	6	13	8	61	5	5	4	2	75	7	1	1	1	99	3	4	3	6	166	6	3	4	5			2	4	3					1
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								6	5	8	7		6	10	6	5					7
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			18	3	7	6	4	20	4	3	3	5																									
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			41	3		3		6	1	4	2	1																									
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			11	3	1	4		1	1	1	1	1																									
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												27					14				
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			27	3	7	11	13	72	9	5	2	5	37	6	5	4	8	111	7	3	2	5	67	5	4	3	3		4	3	3	2					2
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			3	2	1	2	3	2	1	5	1	3	2		1	1	1	7	1	2		2	16			1				1	1						3
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			26	4	10	5	9	110	7	11	8	6	383	10	8	5	4	187	7	6	5	3						82					59				
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			18	12	4	11	7	9	3	11	6	6																									
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			17		2	1		5	1	6	1	2																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male				26		3	10		4		2					1						1		1			1			2		1					1
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			15	8	4	9	4	10	6	4	6	5	3	2	3	5	5	18	1	3	1	5	16	5	5				2	1	2						2
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								2	4	5	1		2	1	4	2					2
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				2	5			21	2		1	1																									
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			10	4		1	3	6		1	2	4																									
Caribbean Region	Guyana	GUY	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			13	4	5	7	10	12	9	4	2	4																									
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			19	6	10	22	12	43	8	11	14	10	92	11	13	10	6	72	11	10	2	10		9	8	6	6		8	11	10	9					12
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			30	7	8	12	15	58	8	11	8	7	13	12	9	6	7	76	1	3	5	4	7	1	2	5	3		3	3	3	5					4
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				3	2	1	1	23			1	1																									
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												118					70				
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			282																																		
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												14					8				
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				8	22	11	17	111	9	17	11	10	151	8	6	6	4	233	8	4	9	13	313	12	5	14	12		6	4	5	8					6
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			51	10	4	8	6	12	4	8	9	3	14	5	7	4	6	23	9	12	8	8	31	5	10	5	3		4	4	2	4					3
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			26	3		4	1	14	1	4	1	2																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex													2					3			1	2		1	1												1
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			136	12	27	18	19	79	19	27	15	17	92	6	8	12	16	150	12	14	12	8	205	8	12	12	14		6	8	12	9					11
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex															1																						
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												117					6				
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								1		1			1								
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								1	2	2	3		2	2	1	3					1
Caribbean Region	Trinidad and Tobago	TTO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex				1									1					2																			
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			37	5	5	3	4	6	4	4	10	4	7	6	4	8	1	12	2	6	3	2	17	5	3	4	5		1	7	6	3					4
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			5	1	1	5		4	3	1	3	2																									
Caribbean Region	Jamaica	JAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								6	8	16	7		3	2	9	7					10
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			16	3	1		2	3	1		2	1																									
Caribbean Region	Barbados	BRB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			21	2	3	3	2	50	3																												
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				79	64	56	54		53	30	9	9																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												459					525				
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex										1																											
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				210	235	221	255		322	301	280	289	595	301	284	320	341	692	333	321	332	362	574	368	374	368	370		362	352	351	352					308
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								333	346	349	354		357	290	342	329					377
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male						55	61		64	75	88	94	138	97	91	97	99	136	77	66	68	70	152	76	71	74	75		71	50	65	61					58
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male						236	317		328	331	335	384	580	379	407	439	419	584	393	308	359	360	566	396	417	424	429		432	354	410	402					440
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				127	95	95	113		130	175	133	92																									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				17	14	18	25		24	28	17	15																									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				30	25	37	33		31	20	22	13																									
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				102	83	80	68		69	42	18	19																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				417	457	427	456		529	515	465	553	872	544	517	544	562	1,064	570	562	540	577	1,088	576	570	585	589		586	549	545	516					491
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												1,334					1,293				
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				2	2				1	1	1				1	1	16		1		2	3		9	6	7	1		3	7	5	8					4
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				265	298	265	306		346	339	293	374	616	370	362	384	389	747	390	377	377	395	694	388	387	377	378		396	376	372	360					335
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female						234	302		317	358	347	387	561	411	421	449	432	568	390	315	366	370	553	417	438	457	453		455	377	429	423					508
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male						180	222		239	251	252	254	449	250	271	295	294	452	271	218	217	207	403	223	241	248	264		259	187	242	223					246
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								230	246	237	257		254	224	260	251					311
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				466	528	516	558		655	645	550	638	1,031	653	661	711	712	1,265	722	703	713	744	1,158	757	759	774	774		777	746	722	700					646
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				359	399	376	397		460	439	364	414	745	425	429	445	459	915	460	433	407	459	859	469	500	514	505		514	470	464	465					418
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male						200	254		267	304	292	331	504	333	333	371	356	509	319	252	282	294	488	339	384	387	400		391	307	392	381					433
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				4	1	2	3		2	1	1	3	10	1	1		2	13	1					3	3	1	1		1	2	1	3					2
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female						307	395		426	461	436	471	702	468	485	494	482	692	437	383	402	388	712	439	454	459	453		445	341	412	383					378
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				95	73	69	66		62	48	22	23																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								271	294	286	306		324	285	340	323					402
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								166	182	182	185		200	161	199	204					235
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				218	249	240	272		277	267	237	296	516	301	306	327	328	619	343	337	348	371	586	368	366	380	362		379	356	372	355					346
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				65	57	59	49		53	34	12	12																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				1,091	1,255	1,150	1,247		1,470	1,480	1,326	1,539	2,262	1,585	1,585	1,726	1,791	2,762	1,852	1,832	1,781	1,972	3,956					2,470					2,999				
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								691	679	670	631		667	633	621	634					598
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																											1										
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				2	1	1	1		1	1	2	2																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				93	102	108	137		152	128	104	143	263	155	164	167	174	312	166	144	159	141	260	145	141	133	123		138	128	138	140					121
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				82	70	63	55		59	33	17	15																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female						227	277		279	298	274	285	476	279	283	304	311	468	271	214	201	207	468	215	225	237	240		220	163	190	181					172
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				81	55	52	76		83	95	63	49																									
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				221	209	190	187		204	124	59	64																									
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				29	24	21	17		24	19	9	8																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				1	1				1	2	2			2	1	1	22		1	1	1	2		10	9	8	3		2	5	7	9					2
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				1	2	1	1		1	1	1	1	11			1	2	14	1			1				1	4		4	2	3	1					1
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								423	422	451	473		498	485	476	488					564
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												2,820					2,987				
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male						707	873		945	1,009	964	1,033	1,412	1,046	1,114	1,179	1,128	1,401	1,061	857	1,017	1,021	1,520					1,300					1,425				
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				459	510	488	511		596	578	500	578	985	587	558	603	611	1,169	616	629	630	670	1,079	673	676	657	657		675	641	627	631					617
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				7	5	1	1		2	2																											
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								251	285	297	296		297	253	314	292					342
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex							5		3	3	3	3	11	4	4	3	3	11	2	3	3	4		3	3	3	2	6	3		4	3					4
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												142					143				
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male						243	291		318	341	311	336	571	351	351	392	377	575	340	281	307	320	549	343	373	384	376		367	306	362	334					353
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				78	68	52	51		58	32	18	15																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male						10	13		10	8	7	9	31	11	11	13	14	30	12	9	5	4	35	7	8	12	10		9	5	6	8					7
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex							2		2	2	2	2	4	1	1	1	1	4	1	1	1	1		1	1	2	1		1								
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				210	164	170	195		215	255	179	139																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female						42	44		41	46	51	41	110	48	55	65	66	108	52	39	44	32	113	41	46	47	46		35	27	36	35					29
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												325					419				
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												6									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				313	276	263	424		450	488	352	245																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								373	387	410	435		461	479	468	476					537
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				1	1	5	5		1	3				1		3																					
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female						448	590		631	692	646	702	1,132	713	761	814	792	1,158	737	599	721	759	1,016					959					1,390				
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												1,382					2,047				
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								548	576	582	596		583	589	578	577					585
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				66	45	77	69		84	134	78	49																									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				103	67	73	83		97	112	82	57																									
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				11	11	9	7		10	8	3	4																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				197	222	201	229		250	255	217	276	467	275	270	300	314	556	304	317	310	313	428	309	300	297	288		285	268	276	269					265
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								327	346	344	362		352	296	340	336					372
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				209	186	121	184		208	252	166	125																									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				147	111	103	144		149	163	104	71																									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				60						259		1																									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				8	9	10	7		9	11	8	4																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								548	575	583	594		602	579	582	571					611
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				27	24	24	21		18	14	6	6																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												4									
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				343	300	280	288		273	158	89	91																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								234	251	261	259		265	206	247	235					258
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex										1																											
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				281	138	135	193		203	240	167	120																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				494	562	509	531		602	589	540	660	934	656	661	700	712	1,141	743	714	699	754	1,181	758	783	768	792		811	774	742	732					739
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female						114	125		134	143	132	138	265	134	133	132	133	260	110	92	94	102	235	106	114	109	112		117	91	104	82					88
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								379	380	412	427		443	436	428	434					453
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				160	121	143	161		176	221	165	122																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								698	701	710	701		747	708	672	692					700
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				274	216	157	229		243	236	204	140																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				358	391	355	385		458	455	402	465	856	504	498	518	522	999	514	509	512	508	863	504	509	535	535		547	492	489	478					452
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				42	28	40	42		55	79	64	42																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				1,040	1,216	1,017	1,229		1,412	1,417	1,266	1,502	2,067	1,557	1,528	1,666	1,722	2,426	1,787	1,802	1,795	1,934	2,907					2,319					2,991				
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				5	7	8	6		4	4	4	6	20	7	7	8	9	25	11	10	13	13		9	9	8	14	13	16	10	12	8					9
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				105	105	110	137		166	160	134	153	370	167	181	181	182	396	173	171	179	188	370	199	192	201	188		187	172	175	159					148
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				29	23	26	31		31	30	33	45	92	47	48	46	38	112	39	42	36	32	128	49	47	49	46		50	46	48	36					34
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								170	180	183	180		195	152	192	202					235
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				372	309	275	408		459	369	359	279																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												557					572				
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				50	45	40	32		36	24	13	14																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												96					136				
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				20	14	15	13		13	14	16	26	52	29	29	32	26	61	28	26	27	29	109	36	29	33	29		36	37	34	28					32
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female						273	346		380	417	425	453	615	465	465	510	473	612	453	362	405	412	669	435	478	487	513		506	404	465	487					523
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								402	400	421	439		452	430	421	429					435
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												1,036					1,397				
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				53	41	35	33		37	21	8	9																									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				34	18	22	29		29	32	36	19																									
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male						91	132		145	153	147	148	250	155	163	181	177	246	157	125	134	135	257	155	173	168	165		173	140	178	170					179
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex													1				1	1	1	1	1								1		1	1					1
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				5	5	4	4		5	4	2	1																									
Caribbean Region	Guyana	GUY	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				51	29	20	40		45	59	36	25																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												437					539				
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female						13	11		10	11	11	13	39	14	11	10	10	38	8	8	8	5	44	7	8	9	9		7	3	5	3					3
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									1	1																											
Caribbean Region	Barbados	BRB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				34	27	22	21		22	17	5	6																									
Caribbean Region	Jamaica	JAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												2,058					3,015				
Caribbean Region	Trinidad and Tobago	TTO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,598					2,243				
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male										2	4	1	14	1				25		4		7	25	8	5	9	10		15	17	58	23					36
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												1,038					3,114				
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												140					948				
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female										16	64	34	100	3	27	52	57	173	33	31	33	48	191	67	51	41	52		137	151	135	107					100
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male										51	60	45	110	13	30	99	108	192	72	69	62	74	212	98	87	111	139		240	347	332	320					204
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male										9	114	31	25	6	2	5	12	45	1	18	8	33	45	72	45	64	110		222	124	227	216					449
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												1,124					1,124				
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												220					491				
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												376					752				
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male										24	186	53	140	5	1	3	20	247	15	8	14	35	247	31	23	24	46	494	81	87	152	73	1,482				279
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												46					126				
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female										5	18	10	76		4	11	9	135	10	15	11	12	148	20	13	25	24	296	46	57	63	48	296				33
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								91														3		5	4				1		4	4					
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male										9	8	3	36	13	6	22	11	72	9	14	24	8	101	18	39	49	37	202	67	83	65	69	404				87
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												1,494					1,494				
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male										56	259	175	163	25	6	8	28	287	11	21	28	58	287	72	74	44	104		235	242	406	223					876
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female										23	26	17	40	26	13	24	17	80	14	20	19	13	112	25	37	36	26		78	59	60	52					105
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																	3			1	2				8	22	17		82	21	39	48					20
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												1,030					3,348				
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female										17	62	40	86	6	1	1	19	152	8	9	16	37	152	27	26	17	17		37	55	88	44					157
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												584					1,168				
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								106														33		18			1				6	4					
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male										9	6	3	3	1	1	2	15	6	7	7	24	19	9	23	62	90	95		291	177	189	238					77
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male										20	43	40	133	9	25	65	46	231	41	37	40	53	254	78	67	58	77		190	221	174	222					173
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male										108	49	47	55	19	41	62	94	103	68	57	70	122	114	143	129	170	232		358	416	408	344					360
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																						1		1													
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												682					1,364				
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male										17	55	27	155	2	20	72	73	264	40	40	38	31	291	54	44	29	42		155	149	128	124					100
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female										15	55	29	128	3	12	38	29	223	17	19	25	29	245	46	36	41	47		123	138	117	105					117
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																						2		1													
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female										14	16	9	35	2	9	27	15	70	8	4	8	140	77	106	34	127	126		217	181	148	134					175
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male										20	19	10	22	3	2	12	15	44	13	17	16	5	61	12	31	57	44		179	124	129	167					129
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male										21	150	63	143	7		8	24	252	27	9	17	42	252	32	32	38	55		130	121	153	119					315
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												652					1,432				
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female										19	11	7	34	27	12	18	9	68	25	12	10	23	95	7	29	30	12		52	60	72	48					90
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female										4	19	11	71	2	3	11	9	126	6	8	5	8	139	9	12	19	11		34	54	41	32					58
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex																										2											
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female										11	38	28	90	5	8	29	23	162	11	14	17	17	178	31	16	26	22		72	75	82	63					48
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female										13	75	37	39	6	5	2	15	69	12	13	17	36	69	37	31	36	66		103	79	215	164					340
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male										47	333	209	136	28	6	13	26	241	24	32	51	73	241	137	90	67	150		354	403	579	473					894
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male										35	227	136	180	26	11	12	38	318	24	17	24	66	318	81	52	35	91		180	185	245	172					373
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												18					678				
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												736					3,680				
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												220					440				
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female										17	16	14	27	9	8	7	6	54	7	6	2	12	76	12	9	20	14		61	44	70	46					79
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male										14	12	3	40	8	8	23	10	80	8	22	27	10	112	26	39	39	31		108	126	77	85					146
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male										44	228	123	72	22	5	6	21	127	8	15	18	44	127	78	77	68	118		348	372	381	439					920
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												392					1,837				
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male										23	34	33	48	15	13	33	30	96	17	20	27	25	135	28	61	55	57		205	162	164	236					148
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												1,362					4,086				
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male										117	57	44	31	47	40	49	88	62	65	46	87	175	68	153	105	226	249		434	539	436	439					395
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female										5	8		24	7	4	9	5	48	2	7	5	6	68	4	12	10	9		30	42	49	29					59
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female										57	142	99	105	16	4	9	32	183	22	31	30	45	183	56	38	47	65		160	197	293	238					661
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female										73	238	147	191	22	6	8	51	336	54	32	50	73	336	98	59	45	103		162	266	329	250					521
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male										13	40	11	108	2	10	29	27	184	11	10	8	27	202	24	24	26	17		76	92	77	79					86
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female										40	143	126	173	16	3	9	31	304	31	20	26	62	304	40	54	42	76		147	195	279	147					503
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male										9	43	25	100	1	10	23	22	170	15	20	17	10	186	36	34	35	53	372	97	101	85	68	372				46
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female										9	46	37	87	1		1	7	155	4	5	14	21	155	18	25	11	15	310	37	52	100	53	930				109
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female										29	122	74	127	13	3	4	23	225	17	18	26	39	225	41	28	37	46		89	98	152	73					167
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female										21	31	15	73	5	11	27	27	136	27	13	11	86	150	71	46	86	91		122	172	126	106					155
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female										2	3	1	19				1	34	1	1	8	4	34	3	7	4	6		8	10	41	17					28
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male										29	29	22	75	19	24	29	30	150	24	37	25	29	210	40	56	49	49		219	191	150	210					287
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female										7	4		28	7	3	5	3	56	7	8	5	3	78	7	19	12	12	156	29	49	33	21	312				42
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female											1					1	4		1		2					2	5		22	12	8	16					5
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male										24	38	11	69	22	17	38	28	138	26	35	43	31	193	35	89	73	54		162	136	126	131					187
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												1,714					5,142				
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male										16	9	20	20	10	3	9	20	39	12	6	3	50	42	24	16	110	54		141	86	81	107					74
Central Asia Region	Tajikistan	TJK	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												206					618				
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female										22	21	6	46	21	11	31	17	92	12	20	17	24	129	26	37	45	16		78	85	75	62					136
Central Asia Region	Kyrgyzstan	KGZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female										4	3	1	15	2		3	4	30	2	1	1	75	33	27	10	55	39		105	65	29	44					37
Central Asia Region	Kazakhstan	KAZ	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female										5	12	7	8	2	2	3	2	16	1	1	4		23	3	5	5	11		66	53	65	49					53
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,698					451				
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			34,575	5,146	5,530	5,323	5,150	149	31	24	10	15	235	19	34	38	30	14	23	38	18	21	279	41	51	27	23		34	23	27	23					21
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												160					184				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												687					222				
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			8,902	2,574	2,589	2,683	2,316	263	48	45	30	31	445	22	16	39	37	23	16	41	22	23	784	42	26	31	25		18	19	24	25					24
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												405					426				
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			4,095	412	1,766	824	1,628	98	47	59	90	70	69	2	2	2			1	2	3		347		4				2	3	3	5					10
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,406					2,395				
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			7,698	1,235	1,312	1,389	1,415			3	1	2						2	2	1	2		14	2	1				1								2
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												307					162				
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												35					117				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			4,900	286	783	518	381	3	3	14	4	9	85	13	3	34	23	7	17			1	954	6	2	6	5		8	4	11	19					7
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			11,698	6,254	8,885	7,521	5,704	38	37	36	45	14	110	14	8	24	25	61	14	8	10	7	57	9	4	16	13		15	9	15	11					9
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			33,534																																		
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			14,874	5,247	6,022	5,709	4,637	178	152	123	101	58	451	36	25	52	92	320	40	11	19	17	440	30	22	15	20		19	20	28	14					14
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			12,227	1,548	2,182	2,136	1,410	1,187	174	224	423	285	622	123	146	85	107	844	142	113	169	125	1,001	102	152	171	188	947	144	223	232	197	184				178
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			14,626	1,371	3,036	1,990	2,534	129	45	90	51	32	345	30	16	63	125	444	38	18	27	13	432	17	22	23	15	688	16	16	19	22	339				12
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				113	86	83											1			1																	
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												721					837				
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			18,399	2,287	2,592	2,556	1,971	1,270	219	236	253	272	823	125	137	79	98	786	107	80	77	88	954	69	98	89	88		75	69	85	125					137
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			5,898	2,897	2,789	2,730	2,554	67	29	25	12	22	90	10	6	19	8	158	13	13	10	10	140	17	17	10	4		12	5	11	5					12
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			4,870	905	1,439	1,389	1,538	6	7	5	5	7	55	2		23	11		12	2	3		479	3	6	3	7		4	8	4	2					2
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			21,824	3,078	3,618	3,399	2,911	174	103	103	71	51	569	35	22	54	104	305	44	28	27	20	558	17	27	31	25		33	26	26	22					16
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				1,388	1,257	1,209	977	407	107	113	77	54	702	96	37	103	63	765	68	33	31	25	650	30	24	33	27		38	46	25	17					10
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				895	1,509	1,382	1,152	480	118	110	151	159	383	32	75	51	48	232	66	52	51	55	473	41	54	45	40		30	42	39	51					74
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			24,278																																		
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												830					457				
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			12,825	4,031	4,306	4,069	3,038	1,396	318	351	344	396	862	169	120	94	112	1,010	90	69	87	74	1,047	80	74	83	71		60	53	112	134					110
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male							2				2	1			6		1		2	1	16	5		6	3	8	5		1		2	5					1
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												10					43				
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				2,807	3,531	3,008	2,652	81	11	12	1	6	110	17	8	25	11	200	15	17	19	13	105	19	19	20	17		14	14	21	14					13
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												2,060					481				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			5,019	1,936	1,961	1,655	2,147	136	71	80	42	51	229	84	22	106	80	532	53	22	25	14	230	35	19	21	26		31	31	16	15					19
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			11,931	1,803	2,905	3,287	1,958	550	95	123	147	268	389	34	38	41	43	1,018	45	48	33	43	369	50	56	58	42	367	44	46	61	64	216				90
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			16,061	2,528	2,301	2,040	2,433	27	10	18	6	9	15	2	4	7	6	147	10	3	5	8	22	4	2	6	2		6	2		2					7
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			8,363	2,599	2,276	1,881	3,608	167	223	313	265	257	117	24	23	21	12	641	71	16	23	13	81	9	9	6	7		13	12	10	21					39
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			6,031	2,978	3,161	2,729	2,972	603	264	437	483	331	321	82	41	55	28	1,413	24	36	44	39	234	22	37	31	27		31	52	24	39					72
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			9,058	1,660	1,926	2,062	1,270	1,557	242	323	533	304	755	163	137	107	141	2,033	158	100	214	142	806	92	152	128	163		131	200	137	168					161
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				2	2	1						1			1		1		3		1				1							1					3
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			22,811	2,977	3,110	3,066	2,796	170	45	55	39	54	255	26	28	36	26	99	28	27	23	16	508	28	38	27	19		18	20	19	13					24
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			20,361	7,564	7,704	8,093	7,525	79	23	15	3	19	170	10	8	15	30	730	16	10	18	13	314	19	31	25	17	245	17	22	18	11	111				31
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			10,539	1,484	3,162	1,533	1,297	48	47	42	40	36	105	32	19	66	28	293	25	8	17	4	105	20	14	11	11		26	20	24	13					14
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				1,225	1,468	1,706	1,074	1,728	232	274	460	256	842	146	156	129	150	560	219	114	246	206	1,200	116	187	167	209		144	262	183	147					127
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			17,207	1,840	1,710	1,533	1,962	266	145	164	96	59	500	96	41	116	105	1,699	44	30	24	22	397	40	30	32	32		29	32	34	25					18
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												813					224				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				1,167	1,056	936	752	272	67	95	46	24	493	82	27	67	57	477	39	24	13	24	453	21	21	17	19		24	44	20	18					10
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			41,275	8,403	8,537	8,559	8,234	92	14	19	8	12	125	12	15	20	18	87	6	11	7	7	70	19	16	14	15		15	14	9	7					3
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				1,227	1,656	1,668	1,269	905	160	183	160	193	568	66	75	64	72	298	66	61	66	49	739	59	75	65	43		51	46	86	101					100
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			8,319																																		
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			9,778	8,040	7,024	6,914	6,257	308	140	176	173	255	166	111	81	40	50	331	29	18	27	22	94	28	17	26	21		21	26	47	69					78
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				624	1,173	853	1,141	110	49	59	46	30	310	25	21	27	68	151	41	12	15	12	336	13	15	19	7		15	16	13	15					11
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												896					254				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				1,425	1,859	1,531	1,440	147	80	98	64	42	413	31	18	28	70	195	39	23	23	21	507	29	16	17	11		26	26	16	17					17
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			7,022																																		
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												1,808					383				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												667					70				
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female											1	5			2	3	3		5	7	6	9		11	12	9	7		5	7	3	5					3
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				3,459	4,121	3,775	3,525	81	15	13	9	18	175	18	14	21	12	8	14	17	14	18	216	23	28	23	19		19	26	22	20					17
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												220					250				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				2	1						1					2			3		1			1		1			2	1	1	2					
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			19,247	6,317	6,632	6,122	6,502	27	14	13	5	16	35	6	5	19	4	80	6	4	4	7	25	9	8	9	4		12	7	7	4					3
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			14,988	1,867	2,110	1,710	1,417	281	82	109	60	35	431	63	24	79	81	1,328	52	21	38	23	487	28	36	33	30	747	41	40	36	22	281				22
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												396					60				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			29,024																																		
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			10,271	1,648	1,586	1,432	1,463	407	93	105	78	46	609	125	36	116	98	1,796	47	31	22	31	476	35	29	25	37		30	57	23	18					23
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				922	1,294	1,381	833	1,276	125	154	345	171	639	103	120	67	123	229	161	110	137	104	946	90	133	145	200		140	121	139	131					166
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			25,059	6,745	8,489	7,622	6,229	124	74	97	79	31	315	19	19	35	69	137	36	18	11	11	239	14	13	19	17		19	29	11	14					13
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			15,540	1,944	2,370	2,410	1,627	1,323	381	465	630	385	640	161	139	107	128	3,095	116	86	191	131	566	68	145	101	101		80	123	89	114					125
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												181					143				
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			23,195	11,307	12,451	12,169	10,742	67	17	7	12	9	130	9	3	17	21	138	11	19	16	15	188	15	30	18	9	135	11	17	16	13	86				18
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			9,681																																		
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				32	34	24	1									2	1																				
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			8,115	2,138	1,928	2,024	1,958		1	2		4		3	1	1	1	9	5	2	1		5		2	2	2			2	1						
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				1,658	1,652	1,717	1,628	145	13	28	14	23	190	17	14	23	31	607	21	15	15	20	350	12	21	16	11		19	15	9	19					17
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				2,097	2,094	2,199	1,984	145	38	42	20	37	365	25	21	24	25	271	21	14	24	26	716	17	28	24	20		19	16	13	11					24
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			3,951	1,526	1,318	812	3,435	74	39	38	53	97	92	57	46	4	8		6	3	6	3	167	5	7	9	5		5	7	3	7					33
Central Asia Region	Tajikistan	TJK	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			21,109	5,659	5,897	6,089	4,247	833	228	275	284	284	470	157	94	63	97	911	73	58	44	61	274	44	53	27	40		44	48	68	102					105
Central Asia Region	Kazakhstan	KAZ	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			22,847	7,378	7,955	7,834	7,537	145	30	36	16	28	230	19	23	28	30	165	23	35	17	20	250	29	26	20	13		22	16	25	14					7
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												17					29				
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				49	23	45	58	317	31	32	12	9	137	8	10	8	13	68	8	11	6	12	80	8	18	7	6		10	8	6	4					5
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			7	1				2		1	2		9			1							41		1		1										
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			166	13	20	29	43	232	17	29	13	8	134	6	5	5	9	95	5	14	8	8	61	6	12	10	14		4	2	7	9					3
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			165	26	41	21	15	48	24	20	4	6	81	7	12	8	16	196	7	3	1	12	31	13	9	6	7		6	7	13	5					3
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			431																																		
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				9	15	17	20	89	8	11	15	3	62	2	11	9	8	28	2	8	5	3	31	5	5	2	5		2	3	2						9
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			276	40	35	32	48	285	46	26	16	8	123	5	12	14	14	242	15	11	18	20	53	12	11	7	11		23	13	11	6					7
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			75	14	7	10	20	31	2	14	8	4	19	5	1	6	4	77	2	3	1	6	8	2	2	3	5		1	3	2	3					2
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			133	21	16	18	27	100	18	13	9	4	63	2	1	4	6	119	4	7	4	7	27	8	10	10	3	35	5	10	10	6	52				7
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			158	23	17	25	21	255	21	27	17	7	140	11	6	11	15	120	9	12	5	5	71	9	10	7	12		7	2	4	8					11
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			258	52	34	39	45	242	41	37	10	9	104	9	15	14	15	368	9	10	10	17	43	6	9	10	13		12	10	5	12					11
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male							2																														
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				20	24	41	38	11	8	6	4	6	73	12	13	7	11	54	6	11	13	18	84	5	8	9	13		7	6	4	2					2
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			295																																		
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female				2	5	3	5	13	1	1	2		15	1			2						13			2	2				1						
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												63					33				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			3	6	2	10	6	2	1	2			7		1	6		16	1	1	1		4		1	2			1	1	1	1					
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			22																																		
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			56																																		
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												66					131				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			37		2		1	1	1	2			14	1		1	2	1				1	78	2	1				1	1		2					2
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												21					29				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			37	13	16	20	12	6	6	1		3	34	2	1	10	19	128	7	4	7		37	8	11	13	4	27	4	8	3	3	52				5
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			128	37	33	30	44	218	25	28	21	16	101	6	8	4	11	100	6	19	10	7	64	8	9	7	8	78	12	14	10	10	46				10
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			45	9	14	11	5	5	8		1	1	26	1	2	8	10	28	3	7	7	3	32	7	11	7	1	23	3	5	2	2	40				4
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			275																																		
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												173					155				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				9	8	5	8	21	7	11	4		50	5	7	3	5	19	7		7	3	27	2	2	3	1				1	2					6
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				16	23	39	37	233	17	20	8	6	104	2	12	13	10	25	8	12	8	10	62	6	9	2	10		4	4	8	2					4
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												158					82				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																	1																				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			122	17	14	15	11	33	6	7	2	3	73	7	5	7	3	39	3	2	2	6	34	6	1	2	2		2	3	3	1					3
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			247																																		
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				1																																	
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			84	13	15	12	11	25	10	20	1	2	56	8	1	3	4	52	1	9	10	3	33	2	9	3	4	63	3	3	6	10	63				2
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												135					173				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				13	15	15	13	6	2		1	1	35	4	6	2	6	2	8	6	4	3	37	7	5	3	1		3		7	3					5
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												113					195				
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												26					55				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												30					41				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				11	10	2	4	6	2	2	1		22	6	2	6	8	34	5	7	4	1	18	10	6	4	5		1	2	1	2					2
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												70					64				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												37					12				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			80	32	36	57	32	20	10	10	5	5	89	7	10	17	13	5	9	25	13	13	93	26	11	12	7		6	4	6	9					4
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			161	19	17	16	17	31	10	8	3		92	3	4	9	6	37	3	5	9	2	45	4	9	2	3		4	5	4	2					4
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												166					66				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			128	15	7	8	21	25	11	8	3	1	37	8	10	13	15	64	4	6	15	10	19	10	9	6	3		6	9	3	5					8
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												61					9				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												2					6				
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			22	5	11	19	8	7	2	1	1	1	25	2	5	1	3	32	1		2		12	3	1	1	2		3	5		1					3
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			82	1	1	1	2	17		1			11			1				1			24		1							2					
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			249	28	18	18	23	74	14	12	7	1	99	11	3	10	7	215	1	7	2	17	38	11	5	4	4		2	8	7	7					8
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			15	14	15	19	24	11	4		1	2	46	3	5	5	8	28	1	11	4	7	43	11	10	1			8	6	3	1					
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				16	9	12	15	27	9	8	4		67	4	4	10	3	24	1	3	5	8	40	6	4	6	1		5	8	4	2					4
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												5					5				
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			51	13	15	11	9	8	7	5	4	3	17	3	9	9	1	35	4		5		8	10	8	5	3		4	6	4	6					6
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				24	29	25	15	73	8	10	6	6	114	9	4	9	3	92	11	13	11	3	52	9	8	3	4		18	6	3	2					7
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			106	30	24	16	21	51	15	13	4	3	70	9	3	6	10	155	8	3	7	4	37	7	4	7	4	68	7	5	8	5	50				5
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												83					41				
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			101	11	9	21	18	153	14	13	8	6	76	4	5	9	6	106	8	5	5	6	19	2	6		2		4	7	2	6					7
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			39	10	3	6	7	2	3	3			3		3	2	3	22	2	1	3	3	4	2		2	2		2			2					
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			57			1												2		1	1		2	2					1								
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				28	21	21	15	50	10	13	2	7	80	1	7	3	3	56	3	6	2	5	36	7	4	2	1		3	6	5	2					4
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												61					112				
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				21	8	16	21	166	16	12	9	10	92	9	5	13	16	34	2	7	6	3	49	7	9	6	1		3	2	4	6					4
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female					2		3		1							1		3	4		1		1		1	1											
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			212	29	24	22	26	111	21	21	8	4	52	7	5	14	6	168	6	11	11	7	17	9	6	9	5		7	7	3	3					8
Central Asia Region	Tajikistan	TJK	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			29	15	6	11	15	55	11	9	4	4	27	1	2	5	7	39	1	2	3	1	8	3	2	3			6	3	2	3					3
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			70	37	21	37	38	13	11	8		3	51	12	14	19	14	13	14	16	12	4	58	11	19	4	6		3	8	3	6					6
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			81	15	13	15	12	23	8	7	1		51		5	2	5	17	2	1	1	1	19	3		3				3	1	1					
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				10	9	22	12	11	2	5	2	1	38	6	7	10	16	112	11	10	4	6	43	8	9	6	4		9	6	4	11					3
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			90	7	16	24	13	5	5	6			18	2	4	9	3	22	7	4	4	1	19	6	7	1			6	1	7	2					1
Central Asia Region	Kazakhstan	KAZ	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			39	13	15	14	18	11	7	2	1		47	5	7	17	12	2	5	9	3	5	48	14	15	5	3		5	3	3	4					3
Central Asia Region	Kyrgyzstan	KGZ	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			12	9	12	5	7	7	2	2	1		18	3	2	4	1	9			1		6	1	1		2		1	2							2
Central Asia Region	Kyrgyzstan	KGZ	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female																										3											
Central Asia Region	Kyrgyzstan	KGZ	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																										1											
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			2	1	1	6		9	5	2	1		3	6	9	10					7
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																				2	1		16	2	4	10	11		10	10	8	10					4
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			3	4	3	4		2	1	4	3		1			1	3				3
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			3	2	5	9	40	8	5	9	7		10	10	13	13					21
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																				2	2		13	1	2	1	1		2	2	2	3					
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												82					58				
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																										4	9		15	2	9	19					28
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																										3	8		15	7	12	17					44
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												131					27				
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																						1	16	2	6	25	23		18	30	21	20					18
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																															1	1					
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			3	1	2	5	14	9	11	10	14		12	16	12	15					11
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																				3	1	2	19	12	12	15	13		10	12	14	21					16
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																										14	18		17	13	24	35					91
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																				1	2	3		4	2	2	2		2		1	5					3
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																				1	1	2	5	2	8	13	9		7	11	10	14					14
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			2	3	1	1	69	6	12	17	14		12	15	15	15					18
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																							1			14	21		21	19	26	36					88
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																						1	3		1	1	2		1	1	1	2					
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																							3			21	20		17	20	20	38					80
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												30					52				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												18					4				
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																							3			9	8		17	14	26	23					55
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																																					1
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																				2		3	24	8	24	32	25		23	21	16	28					21
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																				1		2	14	1	1	6	2		1	3	4	4					2
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																					1	2	4	6	6	5	3		4	3	6	2					7
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																						1															
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												139					18				
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												22					35				
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												104					81				
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																				1		1	20	2	4	12	15		21	17	16	11					6
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																										4	3		4	4	6	7					32
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												80					62				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												35					8				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			3	4	3	7		13	8	7	7		6	7	2	7	8				9
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																					1	1	6	2	4	8	4	12	6	5	2	8	16				3
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			2		7		87	4	7	10	15		7	12	12	16					13
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																										4	3		5	4	9	7					21
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																				1	2	2	26	4	8	4	8		11	13	19	18					8
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																					1	2	29		1	1			3	4	4	2					5
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																							3			9	8		14	7	8	17					24
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												18					48				
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																							3			5	7		16	5	8	18					33
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							2			3	1		19	12	29	34					37
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												14					13				
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																				1	1		18	2	2	2	5		4	2	2	8					7
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												29					41				
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																							4			10	14		33	27	29	36					54
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												18					30				
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																				2	1	1	23	10	7	18	10		18	22	21	30					23
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																											1		6		9	10					13
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																				3	1		24	2	2	6	3		2	5	10	8					6
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																							4			20	15		17	11	22	29					56
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												60					63				
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																						2	4	4	2					1	1						
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												15					21				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			1	4	5	5	7	6	7	6	5		10	6	6	8					4
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																					2	2		1	2	2	2		2	2	4	7					3
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												135					96				
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																				1	1	1	17	6	6	10	11	32	15	18	14	19	32				10
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																																4					1
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			1	1	1	4	15	3	4	4	3		4	4	3	5					3
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																							4			21	22		33	36	56	54					59
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																				1			25	2	2	8	7		4	8	7	11					6
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												45					45				
Central Asia Region	Tajikistan	TJK	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																				1	3		5	2	2	4	2		1		2	5					9
Central Asia Region	Kazakhstan	KAZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																										7	10		14	17	20	29	2				71
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			2	1	1	1		1	1		2		1	3	6	8					3
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												7					10				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								6					7	1	7	7	8	25																			
Central Asia Region	Kazakhstan	KAZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		4																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								3					4					8																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								9					12	2	2	2	2	21																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								3					3				1	5																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female								2					2					4																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								9					14	1	1	1	1	23																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								7					9				1	15																			
Central Asia Region	Kazakhstan	KAZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		3																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								5					7		1	3	5	25																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								4					5	1	2	2	2	16																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								7					9					15																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								2					2					6																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								10					14				3	23																			
Central Asia Region	Kazakhstan	KAZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		6																			
Central Asia Region	Kazakhstan	KAZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		3																			
Central Asia Region	Kazakhstan	KAZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		4																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								9					11	2	2	2	2	19																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								2					2				2	4																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								2					2	3	3	3	6	4																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								5					7	1	1	1	3	12																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female								1					1					2																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								3					4	1	1	3	3	15																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								10					14	1	1	1	2	23																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								3				1	3		1	1	3	9																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								9					12					20																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								9					11				1	19																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								6				2	9	1	3	4	7	27																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								3				2	5	1	2	3	6	16																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								5					7				1	16																			
Central Asia Region	Tajikistan	TJK	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								10					14				1	23																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								4					7		1	2	5	19																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								6					7	1	2	3	8	27																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								3					5	1	3	4	4	10																			
Central Asia Region	Kazakhstan	KAZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		2																			
Central Asia Region	Kazakhstan	KAZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		3																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								4				2	4	1	1	7	8	20																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								4					5		2	3	7	10																			
Central Asia Region	Kyrgyzstan	KGZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								2				1	3	2	2	3	3	14																			
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																							3			4	1		17	15	10	15					15
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																										4	1		3	3	3	15					12
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												41					24				
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		1					4			16	5		7	7	9	22					27
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								3					3				1	5	3	5	3	3	7	1	15	17	7		14	10	9	20					10
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												124					125				
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																										2	3		2	4	5	6					25
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								9					9					13	4	3	2	1	19	1	9	9	5		5	3	7	9					16
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								4					4	1		2		14	2	3	2	2	17		6	2	2		1	6	6	5					5
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		1					3			11	7		3	4	7	11					14
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		2					5			5	8		6	5	15	13					63
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								7					7		1	1	3	18	1	1	8	5		6	7	3	7		3	18	11	9					1
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																											1		5	9	2	7					2
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								2					2	3			3	4	8	5	3	11	8	6	14	4	12		14	6	11	20					11
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		3					6			11	12		17	11	17	16					32
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		1					3			16	11		7	13	9	22					26
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												153					108				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								5					5	1	2	1		10	3	2	1			2	2	3				2	3	6	9				1
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												29					73				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								5				2	5	1	1	1	3	14	1	3	2	2		2	2	2	2		4	8	4	3					5
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								9				1	9	1	2	1	3	25	4	3	2	4	9	3	4	3	4		1	5	7	5					7
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																														1		2					
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								5					5	1	1			13		2					1	2	1		2	1	6	3					2
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																				3										1							
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								7					7				1	16	1		2			2	2	4	9		1	6	8	9					5
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								11					11	2				15	2		2	1	20		6	12	12	38	6	8	17	15	43				9
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								4					4					7	1	2	2	2	9	1	5	6	10	18		3	10	10	31				9
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								14					14	1				19	1		3	2	29	2	6	12	4		11	5	16	15					14
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								11					11				1	15	4	2	2	9	22	4	11	13	9		6	15	22	22					20
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								12					12					16	2		1	2	24		8	15	13		7	6	10	8					12
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												94					89				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								4				2	4			6	2	18	2	4	4	11	81	12	16	8	13		17	26	19	15					18
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								14					14				1	19	4	4	9	5	27	5	15	28	10		5	11	26	25					24
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												165					153				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								3				1	3				2	9	2		3	1	16	1		2	4		1	4	3	4					7
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								14					14	1			1	19	3	1	1	2	29	1	3	13	10		9	11	15	10					2
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												44					63				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																									1	2											
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																										9	7		15	5	8	16					15
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												91					77				
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																										12	2		5	10	12	17					117
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								14					14				3	19	5	3	3	9	27	2	19	18	13		9	26	21	17					26
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												26					56				
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																				3	3						1										
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												156					127				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												27					11				
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												22					9				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												9					31				
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												52					65				
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								2					2				2	4	1	5	4	2	6		1		3		6	2	3	4					1
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												29					86				
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								7					7	1			2	11	8	1	2	1	21	3	13	9	5		8	4	9	20					19
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		1					5			7	5		8	7	21	14					86
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								12					12	2				17	4	3	1	3	27	2	10	9	5		13	11	11	16					11
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female								2					2					4	1	2	2		6	2	3	1	4		1	5	2	4					3
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								2					2					6	2	3	4	10	32	5	13	6	14		8	8	9	9					12
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																																5					
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								7					7		1	1	2	24	4	2	3	1	19	1		2	4		3	4	6	4					6
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																										14	6		5	14	23	18					55
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												74					53				
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																							1			15	10		12	11	23	21					73
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												17					85				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								5					5		2	1	4	10	2	1	8	9		7	6	5	5		3	8	9	9	27				3
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female								1					1					2			1	1	6		1	1			1	3	2	5					1
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								3				1	3	1		1		11	1	11	15	15	106	13	34	22	20		16	33	20	18					14
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								7					7	1	2	1	4	26	1	3	5	2	47	8	7	11	12		7	7	16	11					16
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								9					9				1	13	1	2	5	2	19	2	21	17	12		10	5	11	15					13
Central Asia Region	Tajikistan	TJK	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												27					59				
Central Asia Region	Kyrgyzstan	KGZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								7					7	1	5		1	24		3	4	4	17	4	8	12	7		7	15	10	14					7
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																							1			10	7		8	7	5	14					34
Central Asia Region	Kazakhstan	KAZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		1					3			9	4		8	10	24	17					69
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			433	283	279	288	315	317	312	302	306	298	401	325	329	328	335	382	328	316	322	318	455	312	309	303	298		289	283	275	271					256
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												185					258				
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			116	121	122	120	196	125	128	136	142		143	142	156	155					160
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			38	43	49	50	61	54	54	56	52		55	58	67	66					83
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			188	139	128	94	104	254	127	130	135	128	207	138	150	159	171	258	170	182	194	200	271	209	207	215	227		231	240	256	267					301
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			814	527	541	539	587	564	582	571	601	582	747	623	642	659	670	669	669	645	677	694	795	712	719	724	721		719	714	715	701					719
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			333	222	212	223	217	426	233	230	227	243	427	235	228	225	216	389	221	220	227	222	400	226	218	216	202		199	201	200	195					171
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			44	46	57	60	50	66	76	86	88		88	93	99	105					121
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												1,809					1,809				
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			86	92	97	101	126	104	111	117	125		128	133	138	145					172
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			275	183	187	202	223	187	214	208	228	236	285	261	274	300	326	581										589					651				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			153	159	179	174	184	175	193	210	217		225	240	252	260					304
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			203	150	153	158	172	156	189	184	204	211	221	224	238	255	267	299										510					510				
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			427																																		
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			879																																		
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												755					750				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			440	322	344	353	383	654	426	447	458	471	748	483	491	513	534	637	550	571	600	607	691	609	609	630	642		643	642	648	657					663
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			218	134	138	133	147	228	141	141	144	144	284	142	144	147	158	202	163	161	151	153	219	144	132	140	133		126	129	118	115					108
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			382	243	252	252	268	420	285	304	309	309	503	329	346	355	362	412	353	359	372	397	446	396	397	394	389		398	381	375	383					374
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			94	91	100	103	121	102	111	110	114		117	114	119	130					157
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			27	26	34	38	44	42	51	56	69	94	74	122	141	170	190	105	213	225	231	236	192	244	244	244	232		236	232	226	212					169
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			21	21	26	28	32	44	42	50	54	60	70	72	80	86	89	69	95	97	108	114	92	131	140	148	160		169	186	208	234					334
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				195	195	210	229	159	236	233	246	266	294	298	318	339	357	306	366	363	390	399	373	404	408	419	416		429	443	454	466					505
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			70	43	46	45	46	78	55	59	62	62	97	66	70	74	72	119	77	78	87	86	125	93	100	103	113		114	126	139	148					201
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			40	46	50	58	52	62	63	67	74		80	87	92	90					110
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			411	281	289	290	319	301	336	330	349	346	409	356	362	387	392	398	412	405	435	440	476	461	476	475	475		473	457	477	492					481
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												445					430				
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			497	314	310	264	274	685	281	289	299	290	556	295	293	317	330	637	329	329	344	347	659	363	399	410	410		419	432	450	457					442
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												1,439					1,335				
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			188	186	206	218	265	230	242	266	275		295	306	316	343					411
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			38	24	27	25	28	27	30	32	27	26	35	27	30	33	31	83	32	31	28	27	87	27	30	35	37		43	39	45	46					35
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			22	22	26	24	50	30	31	35	41		40	44	43	39					57
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			55	45	41	40	43	47	43	41	42	39	56	40	39	44	43	82	44	40	44	45	87	43	42	43	47		52	46	52	52					42
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			17	18	21	21	33	21	31	35	33		33	36	37	41					60
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			292	212	213	204	202	495	226	243	260	267	399	282	309	326	338	531										595					587				
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			454																																		
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			56	53	61	64	88	64	65	73	76		73	76	81	82					93
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												1,395					1,430				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				241	248	254	263	464	288	312	329	333	517	355	372	371	388	445	394	402	427	427	482	447	476	486	490		515	529	550	573					631
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			810																																		
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			517																																		
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			341	230	227	209	224	461	243	255	254	252	452	261	269	275	273	566	276	280	287	285	583	288	294	301	300		309	324	329	327					335
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			292	167	159	157	165	199	150	143	153	146	210	144	144	137	126	246	125	123	121	114	263	111	108	102	99		97	93	97	89					97
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			423	242	219	212	218	384	231	238	233	236	418	246	237	249	255	330	253	244	256	258	359	264	260	259	258		257	267	277	269					255
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												2,257					2,270				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			92	85	80	75	76	151	92	94	87	79	150	79	81	82	88	152	85	78	80	76	157	69	76	80	86		88	93	98	109					121
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				127	138	133	146	232	151	158	157	156	283	163	165	174	191	214	196	204	223	225	238	233	242	248	257		255	275	291	296					342
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												1,368					1,228				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				260	260	272	295	657	359	377	394	401	581	414	421	438	444	503	451	483	535	542	557	548	591	591	588		617	628	654	677					721
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												579					545				
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												556					426				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				361	371	364	395	883	475	514	509	528	774	546	560	562	579	732	598	592	625	630	799	629	632	648	646		673	678	680	686					736
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			343	281	282	285	298	669	367	386	391	404	571	401	425	433	437	871	437	435	447	436	894	431	444	429	428		433	435	446	462					469
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			42	44	51	56	75	61	67	68	65		73	75	78	84					111
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			175	176	186	190	238	201	198	209	217		216	232	241	241					283
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			41	44	47	46	59	48	51	52	54		57	61	64	67					82
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				137	139	155	172	256	180	190	202	221	339	225	233	261	261	305	278	294	326	326	328	335	343	350	354		366	369	373	369					426
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												553					402				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												764					764				
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				173	182	186	196	314	208	217	223	232	375	233	249	274	289	310	301	300	303	322	343	342	352	368	388		399	411	427	430					471
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			78	84	88	93	148	101	106	108	119		122	127	131	141					169
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			24	21	24	26	32	33	38	50	56	71	51	82	95	111	122	79	128	137	140	140	124	143	143	143	148		145	137	133	134					100
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			54	42	46	49	54	86	65	73	73	75	107	69	74	74	72	173	73	72	80	80	177	74	71	79	90		93	99	96	99					129
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				112	122	128	136	158	132	139	152	156	175	166	172	178	186	245	205	204	229	235	274	254	273	278	301		316	326	346	342					417
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												730					629				
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			23	25	30	34	32	38	42	45	47		49	52	58	57					77
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			303	232	249	265	287	620	346	387	413	434	562	443	485	512	540	606										905					907				
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			815																																		
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			477	344	340	340	351	792	451	460	474	478	694	490	502	529	539	842	554	574	598	610	880	616	626	655	670		713	701	712	714					714
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												295					363				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			318	343	366	353	279	361	365	384	396		410	425	444	459					512
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			538	375	378	384	392	706	437	441	448	462	782	469	472	465	477	658	469	465	474	456	722	457	453	436	428		424	411	413	415					393
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				222	236	206	232	513	240	262	277	282	455	293	291	300	311	422	309	297	311	319	449	335	351	359	353		371	387	388	400					437
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			19	20	23	23	39	25	32	33	34		37	38	38	40					46
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			139	146	155	170	153	177	185	196	204		210	221	235	244					245
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			60	66	77	84	94	87	92	101	105		110	115	118	123					146
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			218	146	150	149	161	266	184	197	214	222	318	237	246	264	270	335										575					601				
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			154	131	150	160	179	282	200	219	230	238	349	244	258	266	279	411										500					545				
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			2	2	2	3	3	1	4	4	5	6	3	5	5	4	5	14	7	7	10	10	16	13	13	10	10		11	10	9	9					10
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												314					228				
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				338	340	293	324	714	355	370	368	370	645	369	351	369	377	600	387	393	413	397	646	405	394	395	407		411	412	420	415					437
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			123	121	134	147	148	153	154	158	160		170	176	184	188					243
Central Asia Region	Kyrgyzstan	KGZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			94	61	62	57	53	100	52	53	57	55	102	52	54	57	59	86	53	59	60	54	90	61	59	54	50		59	69	75	73					107
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			14	22	25	39	41	42	43	47	50	54	87	59	62	62	62	61	69	77	81	79	73	83	88	98	105		110	112	128	139					188
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			139	150	173	164	230	175	195	199	211		221	236	244	255					308
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												46					71				
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			73	75	79	90	211	91	96	99	102		110	114	126	134					164
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				199	203	219	244	312	257	252	285	306	313	329	327	348	376	610	389	413	456	486	661	528	552	572	587		613	624	652	685					772
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			19	5	5	5	6	5	5	4	6	6	7	5	8	9	11	18	14	13	14	14	21	15	16	14	12		10	9	11	11					8
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				388	392	436	485	311	495	480	540	576	618	610	634	670	697	769	737	743	806	812	874	819	840	844	843		857	853	892	895					911
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			28	28	32	34	56	39	42	46	47		51	54	55	60					81
Central Asia Region	Tajikistan	TJK	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			200	154	144	134	144	309	185	192	193	189	283	196	183	186	200	433	193	195	199	199	441	212	231	226	228		240	250	250	255					276
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												69					81				
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			510	333	324	309	344	348	349	363	360	369	435	365	383	383	385	457	401	390	402	392	539	392	376	353	341		347	345	349	346					352
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												2,483					2,481				
Central Asia Region	Kazakhstan	KAZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			170	124	105	109	120	131	115	115	134	130	153	133	143	138	140	221	134	137	147	147	246	141	147	137	138		142	124	133	132					115
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			17		1		1		1	1	2	1			1	2	3	11	5		2		3	1	1	1				1							1
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				7	7	6	6	57	7	7	6	1	48	5	9	6	8	39	10	6	9	9	26	7	8	8	8		3	9	6	8					13
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			51	7	6	11	9	59	8	10	11	4	49	5	11	8	11	40	4	11	6	5	19	4	4	9	8		3	10	4	4					3
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				8	7	10	10	75	6	11	3	4	64	4	6	13	3	51	3	8	10	16	38	7	9	9	18		16	9	9	6					12
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												3					10				
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												77					16				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			9	4	2	4	5	4	4	6	4	4	3	1	8	4	3	52	4	3	4	3	6	5	15	3	4		8	1	4	4					1
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																									4												
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								10	5	4	4		6	11	7	5					9
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male				1	1	1	1	18	2	2	1	1	11	1	2	2		1	1	4	3		24	1	5	1	3		2	4	2	4					3
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			112	13	9	10	10	141	16	12	10	5	67	9	14	11	8	219	13	7	15	9	37					84					79				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			62	12	11	12	13	114	13	8	5	6	60	4	2	5	4	132	6	11	12	11	27					52					67				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			121	12	15	14	24	267	20	13	11	9	127	13	9	8	13	102	7	18	11	10	58	5	10	13	15		10	4	12	16					8
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								2	2	2	2		1	4	1	6					3
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				14	7	10	11	190	11	6	6	8	88	9	5	8	11	65	2	8	10	6	46	12	8	4	2		7	5	5	7					5
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			205																																		
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			268																																		
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			9						1		1	1						7		1	1		2	2		1	1		2			1					1
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			76	8	7	9	12	87	13	22	8	8	87	9	13	11	12	67	7	6	18	18	42	12	12	12	8		8	10	10	8					14
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												79					72				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			27	10	6	5	8	61	12	9	3	3	26	3	6	4	7	58	3	3	4	6	8	3	4	3	4		5	5	2	4					6
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								5	6	2	6		2	4	4	8					6
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				27	16	18	27	366	24	25	15	12	130	20	18	10	14	130	16	16	14	18	79	14	27	13	7		16	19	14	8					12
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								3		4	2		2	1		1					3
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			233	16	12	11	16	126	15	21	8	6	49	7	9	14	12	204	10	16	9	8	17	11	16	15	18		17	14	14	11					19
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			84	1	1	1		4	4	6	2	1	9	2	1	1	2	1		2	1	1	40	1	5	1	2		2		2	5					2
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			348	64	36	49	63	60	49	39	23	25	84	27	23	30	30	13	23	25	32	35	142	39	20	25	20		21	23	27	15					22
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								3	5	1	2		4	4	3	4					8
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												204					105				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								3	1				1	2	2	1					1
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			256	64	21	28	46	38	32	39	27	23	48	16	25	31	22	40	23	25	21	17	86	23	23	10	12		23	19	17	10					10
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			8	2	1			3	4	3	1	1	14	2	2	4	4	2	4	4	4	6	74	4	2	3	2		4	4		2					2
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								10	5	16	9		9	7	4	12					6
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												63					177				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			245	24	20	20	24	276	22	27	10	12	98	14	30	13	14	386	19	16	19	21	40	18	23	17	18		17	15	15	14					20
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				11	9	6	9	136	10	12	4	9	77	5	9	5	6	105	8	4	8	8	34	20	7	15	9		7	15	7	4					13
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			193	31	15	22	21	32	18	18	11	10	45	9	10	18	16	8	15	6	12	10	88	17	9	13	9		9	12	8	12					10
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				31	9	24	16	18	14	8	5	11	33	13	11	12	16	6	11	8	11	11	68	11	5	12	8		7	11	10	7					3
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			187	22	16	13	18	134	19	27	12	13	78	12	21	16	16	268	17	11	16	17	29	21	19	24	9		16	22	24	12					14
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								2	4	7	1		2	1	1	1					1
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				6	11	16	18	276	11	16	10	7	99	4	8	10	10	49	14	22	16	9	59	9	10	7	11		7	11	16	5					7
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												190					242				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female				2	2	5	3	17	2	2	2	2	15	3	2	1	5	1	4	5	2		13	3	3	4	5		3	2	2	4					2
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												78					53				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								1	2	2	3			4	2	1					4
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			50	9	7	19	12	174	8	9	6	12	73	8	5	9	7	108	9	7	8	6	19	5	7	3	1		5	7	4	7					8
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								2	3	5	1		2	5	6	4					1
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								2	6	1	4		3	3	2	2					4
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			203	20	4	20	13	21	6	8	5	5	24	10	7	4	6	79	5	6	5	5	22	6	10	1	6		5	7	6	2					6
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			93	6	6	6	5	25	13	5	8	3	16	11	12	11	5	48	5	5	12	3	8	13	14	10	8		12	11	12	9					10
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												5					9				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								2	3	4	3		2	4	5	4					2
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			196	12	16	18	20	328	30	22	18	10	117	16	20	18	19	283	21	26	26	27	50	15	18	14	16		30	13	25	19					13
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								5	8	4	5		4	4	5	3					7
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												192					130				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			108																																		
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												237					226				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												28					65				
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								3	6	6	2		4	2	2	1					4
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								1	1	1			2			2					1
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												21					39				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			21	6	2	6	8	6	3	5	2	2	7	1	3	7	4	37	2	1	3	2	7	4	4	5	2		3	4	4	5					
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			87	10	11	11	15	89	11	10	5	7	70	11	8	14	10	67	10	6	9	13	33	12	6	8	8		11	10	14	6					10
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								5	4	8	2		4	5	4	2					10
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				5	3	11	8	104	6	6	6	5	59	4	7	6	6	54	2	7	2	7	29	5	6	6	4		2	1	4	2					8
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			31	19	10	11	7	16	10	11	8	5	24	8	8	14	14	59	10	8	21	12	56					24					64				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			152	25	8	19	18	20	11	8	8	7	32	12	8	13	21	305	9	7	15	16	53					28					81				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				24	9	18	14	33	16	15	12	15	36	14	8	19	19	256	11	19	18	15	65	19	7	20	16		19	15	17	17					20
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			148	15	16	10	15	259	12	14	19	16	96	11	16	11	18	110	9	25	17	14	61					93					65				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				46	17	38	54	33	26	31	23	24	70	26	19	21	19	118	18	27	22	28	123	27	20	30	25		26	23	26	21					20
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			154	29	6	14	24	14	13	19	11	13	17	8	13	12	16	72	7	10	12	7	30	10	24	5	9		12	5	11	4					4
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			206	22	22	15	15	209	22	14	12	6	95	19	11	15	10	293	13	19	17	22	36	24	23	18	17		17	23	21	16					25
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			479																																		
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												46					18				
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				15	17	13	14	200	16	15	10	5	108	8	7	17	8	179	12	22	19	11	50	20	12	14	13		17	18	13	4					13
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								1	2	3			1	2		2					2
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			69	8	5	6	14	72	20	12	11	4	54	11	8	9	11	86	8	13	16	13	33					79					100				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								2	2	3	4		3	7	5	3					4
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			65	7	5	3	4	22	2	7	4	2	18	3	5	6	3	22	2	6	4		6	7	6	1	2		4	4	6	1					3
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			232																																		
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												80					149				
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												103					66				
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			36	6	6	5	12	36	7	9	5	7	19	4	9	8	3	82	5	6	7	7	8	5	9	6	12		6	10	2	6					2
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								8	6	6	11		6	5	14	9					2
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			142	15	13	19	20	287	19	14	13	8	133	14	11	7	13	130	10	12	12	7	68	12	10	6	10		8	5	10	10					10
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								6	8	7	8		9	7	13	7					5
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				15	8	3	6	18	4	9	6	3	20	4	5	8	7	68	9	5	6	5	34	16	7	4	11		10	12	9	6					13
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								1	4	2	3		4	3	3	2					5
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			115	39	13	22	30	33	20	10	12	6	44	13	7	13	9	46	3	11	14	13	82	13	16	7	7		9	10	4	4					6
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								2	2	5	2		4	3	3	4					
Central Asia Region	Tajikistan	TJK	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												31					71				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												21					42				
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			421																																		
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								4	2	3	5		5	4	9	3					6
Central Asia Region	Kyrgyzstan	KGZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			182	16	3	5	11	72	14	20	6	5	35	11	13	14	17	109	12	20	25	16	19	19	21	16	16		12	14	22	19					18
Central Asia Region	Kazakhstan	KAZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												109					308				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				13	20	31	38		43	48	61	85	62	115	134	154	173	101	198	209	214	221	178	225	226	225	213		218	216	208	194					140
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				48	53	50	51		55	70	68	57	127	58	63	60	68	126	67	58	68	59	140	53	64	68	74		73	75	84	96					103
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				110	120	127	148		156	152	170	172	207	182	202	215	218	270	236	254	266	302	319					463					453				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								57	57	65	69		69	79	86	83					94
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								195	130	134	144		159	159	167	175					220
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				37	37	26	30		30	31	32	33	52	34	31	30	31	68	38	36	39	41	78	41	32	29	38		44	35	42	41					39
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								42	46	47	49		51	55	57	61					77
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				87	100	115	122		146	170	193	215	296	217	233	229	224	347	249	249	286	282	390					447					484				
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								75	79	84	88		93	95	99	99					133
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				133	142	156	169		184	191	205	208	317	207	222	241	261	280	279	277	272	295	328	313	324	339	349		364	380	387	404					404
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,613					1,601				
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				96	107	113	126		140	165	179	197	287	190	195	216	204	274	235	251	290	284	308	285	290	304	313		320	326	326	340					371
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				130	136	112	125		122	106	114	100	198	99	106	107	94	212	97	97	99	97	242	120	88	81	76		81	77	74	74					84
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				1	2	3	3		3	4	3	3	3	4	4	4	3	12	6	6	8	10	14	16	11	10	9		9	10	9	8					9
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								69	53	62	69		66	62	65	72					88
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								149	164	181	193		197	206	224	233					273
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				104	103	96	103		123	128	129	140	241	141	139	140	130	341	140	134	139	148	362	154	165	156	168		177	175	198	206					209
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												263					314				
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				208	225	226	246		246	236	246	231	376	246	254	267	283	355	277	279	268	255	434	349	267	261	260		256	257	241	241					228
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				274	279	268	257		321	357	375	396	664	387	391	389	370	587	404	376	400	392	687	361	373	360	359		357	350	351	349					347
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				28	34	35	33		35	42	41	49	83	47	47	54	55	97	59	63	62	64	115	67	76	85	90		93	101	110	126					157
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				167	165	161	158		180	188	191	195	362	190	185	173	146	335	172	166	188	179	374	186	179	173	180		167	163	160	156					146
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								47	38	41	45		44	52	49	52					75
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				134	155	152	149		168	178	202	201	383	210	206	221	220	445	228	232	248	236	502	248	248	245	253		257	261	267	284					250
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								22	23	29	32		34	32	33	36					43
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				206	212	236	251		280	270	285	279	384	286	290	314	327	384	352	356	373	381	458	529	405	408	418		420	412	426	438					439
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				87	93	111	116		118	119	131	133	165	142	149	152	160	216	179	186	199	205	258	304	252	257	263		290	287	302	308					387
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				76	97	79	82		87	95	104	103	177	105	112	122	131	208	143	144	145	162	243	158	174	187	181		196	202	212	227					239
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,268					1,267				
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				130	141	156	169		192	195	208	213	276	230	252	266	276	295	306	313	332	349	357	450	350	364	377		391	390	403	424					473
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												404					385				
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								118	100	101	102		106	105	107	119					148
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				366	380	396	435		441	421	431	412	701	425	448	485	501	645	537	515	536	553	767	714	578	589	600		624	625	602	595					623
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				127	137	162	175		177	168	188	192	267	199	221	239	255	461	295	291	320	346	541					534					577				
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				12	15	25	29		35	40	42	49	73	50	54	55	53	59	60	60	73	75	70	73	79	82	86		101	100	110	121					164
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								23	30	32	37		38	39	38	36					47
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,206					1,097				
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				4	4	5	4		3	2	4	5	7	5	6	7	7	14	9	12	12	13	17	16	13	11	10		9	7	8	10					7
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				140	147	160	161		165	185	216	234	340	234	255	273	292	430	311	324	341	356	497					524					520				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								91	97	105	112		119	120	125	127					146
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				203	216	229	233		252	250	249	247	408	254	257	284	279	429	314	297	318	305	525	402	278	270	273		283	283	282	297					309
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				231	238	253	254		317	353	362	404	658	419	429	428	400	659	437	415	472	451	761	443	475	504	501		511	525	539	559					613
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				104	115	102	118		116	111	112	116	242	119	120	123	129	179	142	135	134	136	207	128	117	120	113		112	105	103	95					93
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				279	308	338	359		383	351	391	407	580	427	457	508	534	707	590	614	646	656	842	896	696	704	733		759	752	771	773					833
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								142	159	173	181		184	198	206	223					263
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				189	178	196	198		256	282	303	329	494	335	345	341	305	466	354	360	421	436	528	419	464	473	455		475	495	511	552					615
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								266	210	227	229		257	274	280	298					372
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												525					484				
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				17	21	23	22		31	45	47	54	60	62	72	76	76	67	84	82	95	94	90	100	112	122	140		144	158	181	206					302
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												674					673				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												489					378				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												279					206				
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								51	35	40	41		47	45	53	54					68
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				12	16	19	25		28	38	49	62	44	73	89	105	114	76	120	131	133	134	118	138	134	135	139		138	132	124	122					87
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								74	61	78	80		81	84	91	95					113
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				179	189	193	188		210	223	241	229	473	205	211	234	250	503	280	268	291	289	573	308	333	349	355		365	371	390	396					352
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								80	83	88	98		105	116	111	120					154
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												1,270					1,202				
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												41					62				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								52	56	61	62		62	66	72	76					87
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								114	121	127	123		133	133	136	140					132
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				173	172	194	185		222	251	278	288	439	299	315	301	287	405	340	335	373	373	457	387	419	418	433		450	479	493	516					573
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				69	79	80	80		83	81	98	87	144	88	94	100	92	190	106	103	105	114	219	141	103	108	110		112	107	104	113					100
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				230	239	232	230		289	309	342	368	588	365	371	384	357	706	406	402	429	429	817	412	431	466	488		502	523	541	554					582
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								107	71	85	83		99	96	111	125					150
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												682					664				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				96	101	110	123		127	134	131	143	241	140	147	154	167	192	177	181	204	200	224	214	221	224	235		239	250	269	270					293
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												645					562				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				110	114	121	126		148	168	188	194	270	202	216	235	246	292	259	273	287	314	337					508					527				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								166	172	182	187		196	197	209	220					217
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				236	247	261	277		333	365	378	401	635	407	416	433	418	579	473	462	519	505	665	518	518	541	552		558	560	553	567					583
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				130	146	153	172		186	205	226	234	386	225	237	244	256	370	276	264	266	276	437	289	308	312	313		338	343	349	354					341
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								287	294	302	314		312	340	363	383					435
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								169	173	187	196		198	204	217	214					233
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				45	46	46	38		37	38	40	46	87	45	39	43	43	74	44	40	45	46	85	48	45	44	44		49	54	61	67					89
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								40	44	50	46		45	47	54	54					76
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				25	30	38	33		45	48	52	53	91	54	55	51	47	137	54	52	55	54	146	55	50	57	59		68	80	79	85					113
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				224	238	228	245		280	299	306	314	550	295	277	287	302	511	336	330	342	346	598	347	347	345	345		352	338	350	367					340
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												2,256					2,200				
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				188	207	216	227		246	254	267	274	427	301	308	317	319	371	314	325	328	345	432	358	364	354	348		364	345	343	349					309
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												63					71				
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				159	180	194	194		230	256	275	305	485	298	312	300	291	695	337	309	333	306	760	297	309	319	328		322	323	319	333					375
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												489					366				
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												165					227				
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												2,013					2,029				
Central Asia Region	Tajikistan	TJK	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				152	158	189	206		251	298	321	366	477	378	405	418	392	544	449	464	542	537	613					808					817				
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				16	17	17	21		22	20	19	17	32	22	17	20	19	64	19	19	15	15	71	15	20	25	29		29	33	34	35					29
Central Asia Region	Kazakhstan	KAZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				135	152	172	196		204	204	218	225	294	239	256	265	289	504	315	333	369	400	616	578	461	480	497		534	548	566	620					708
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				169	170	173	171		188	201	197	196	356	201	204	208	210	294	223	218	228	230	346	241	228	231	229		228	241	245	250					216
Central Asia Region	Kyrgyzstan	KGZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								20	29	33	33		31	32	36	38					54
Central Asia Region	Kyrgyzstan	KGZ	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			34		6																																
Central Asia Region	Kazakhstan	KAZ	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			143		22																																
Central Asia Region	Tajikistan	TJK	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			35		8																																
Central Asia Region	Kyrgyzstan	KGZ	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			128		24																																
Central Asia Region	Tajikistan	TJK	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			139		20																																
Central Asia Region	Kazakhstan	KAZ	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			36		8																																
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																39	47		15		25	37		15	74	77	135		51	117	55	74					103
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male									174	125	230	123	252	95	196	210	201	1,105	271	352	285	233	1,018	392	362	305	317		380	456	450	515					745
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																	5		9		4	13		8	9	38	41		42	14	23	26					
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male									56	12	42	16	452	16	36	54	51	1,685	64	46	43	53	473	100	127	79	59	377	115	67	80	128	5,316				454
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																					1	1		1	2	2	2		2		1	1					12
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																										6	8		8	1	11	4					5
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																						2								2	1	3					13
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																						3		2	1	3	7		8	1	7	8					
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																																					1
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																													2								2
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																																1					
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																	3		3		2	7		8	13	27	36		39	15	12	27					
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																												100					100				
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																									6	22	27		15	5	22	9					3
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												100					150				
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																70	136		60		39	70		26	132	169	218		117	188	118	120					148
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												6,428					589				
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												100					150				
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																																					2
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																																7					16
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female										30			63	12	13	38	35	4	44	45	67	56	98	88	117	99	110		108	86	109	122					471
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												377					907				
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																																6					9
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																																1					
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																									3	27	28		21	11	19	23					8
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																																7					4
Central and South America Region	Peru	PER	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												504					504				
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																									21	111	145		126	64	162	144					13
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																						1			1		1		1	4	5	4					28
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																									6	36	52		33	22	44	44					5
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female										11			130	7	6	13	14	61	13	18	23	13	94	20	32	38	38		28	33	39	37					204
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																6	9		3		7	16		3	23	35	68		52	50	19	47					50
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male									572	328	1,023	599	214	320	625	696	702	966	1,051	954	827	827	2,659	1,576	1,341	1,069	1,105		1,376	1,266	1,427	1,518					1,922
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												9,822					5,246				
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																81	119		53		86	86		20	170	136	275		82	195	92	131					173
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																	10		3	13	1	5		4	5	9	7		8	7	10	6					2
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																																4					
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																8	15		8		9	16		5	30	37	54		19	40	15	20					26
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																									1	14	33		12	8	20	5					1
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																3	26		16	23	19	24		24	18	45	38		40	35	28	28					1
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																																3					2
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																																2					3
Central and South America Region	Peru	PER	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												235					235				
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																39	93		78	124	146	86		86	87	205	161		114	125	115	116					6
Central and South America Region	Peru	PER	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																												5					5				
Central and South America Region	Peru	PER	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												4					4				
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																																4					3
Central and South America Region	Peru	PER	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																												2					2				
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																									10	54	72		45	22	50	44					4
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																									24	101	161		108	91	148	116					8
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																1	5		3	12	3	6		1	2	9	4		7	1	5	5					
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																										1	4		4	1	5	2					3
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												250					313				
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												50					50				
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																																1					4
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																												50					50				
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																					2								4	3	3	5					22
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																			1	1	1	4		3	4	16	12		21	7	24	21					
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																8	12		5	15	10	8		12	10	31	16		18	18	31	18					2
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																																5					5
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																	2		5		4	19		17	6	34	39		41	10	15	42					
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																																13					5
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male									548	270	1,248	584	54	291	543	649	620	266	754	713	517	609	2,209	1,323	1,266	835	914		1,161	992	1,184	1,233					1,545
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																																18					9
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																																15					6
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																																6					2
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																																6					10
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												2,871					6,941				
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								4,998																													
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female										25			12	7		9	7	1	7	11	17	17	23	38	34	24	26		40	31	26	16					436
Central and South America Region	Peru	PER	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												15					15				
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																19	39		12		35	14		3	30	31	53		11	56	37	31					36
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																8	27		13	37	35	22		20	26	51	60		37	42	40	36					3
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																					1	1		4	3	9	7		11	5	8	8					
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																26	83		57	83	108	86		77	81	178	182		136	123	124	129					2
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																	1							1	1	10	5		4		12	7					
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																																3					1
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																										6	5		9	3	4						3
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																									16	44	51		22	22	39	46					2
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female										2			232	9	5	5	7	231	8	7	22	5	238	13	25	6	12	51	16	28	21	27	3,003				168
Central and South America Region	Panama	PAN	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																																21					14
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male									90	66	132	79	234	57	87	77	91	901	149	163	147	119	470	245	208	188	206		223	243	257	287					523
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female										7			119	8	13	14	21	165	39	23	28	18	214	56	34	26	33		44	46	60	58					274
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male									34	45	82	40	179	16	34	34	41	629	58	95	90	50	231	102	129	55	91		142	90	110	131					304
Central and South America Region	Peru	PER	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												176					176				
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female										50			35	17	2	13	29	2	24	66	56	57	61	125	150	94	67		135	87	147	89					407
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												239					2,604				
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																									1												
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male									144	54	290	115		53	88	125	116	53	123	135	95	113	436	316	347	209	277		294	266	285	272					678
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																					1	1		1	1	3	3		4	1		5					18
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																	2					8		1	1	6	5		5	2	1	8					
Central and South America Region	Colombia	COL	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												50					50				
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female										27			83	6	7	30	19	58	42	38	35	33	116	73	56	81	90		95	79	72	71					305
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																										11	17		15	5	23	11					9
Central and South America Region	Guatemala	GTM	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																22	51		38	84	67	49		48	56	115	130		68	72	81	88					3
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																									1		3		1		1	1					
Central and South America Region	Peru	PER	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												59					59				
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												324					238				
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																										4	9		2	3	2	3					1
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																17	35		12		21	28		9	69	40	105		31	66	27	46					40
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female										2			124	10	4	5	5	164	13	9	19	6	182	12	20	9	17		13	17	19	19					136
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																									13	92	117		85	46	106	110					5
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																115	188		71		82	73		28	189	180	354		133	228	124	158					253
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																			1	1												1					1
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																					2			3		3			4	1		3					19
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																										6	19		9	3	11	4					6
Central and South America Region	El Salvador	SLV	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																						2			1	1	1			2	3	4					6
Central and South America Region	Honduras	HND	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																										10	6		3	5	5	2					5
Central and South America Region	Brazil	BRA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male									322	233	533	252	278	188	398	378	398	1,132	613	687	548	452	1,626	883	769	729	810		930	790	887	1,037					1,294
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male																736	527	756	362	294	193	689	1,382	81	451	570	383		219	353	328	306					511
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female					2		1	326		130	50	73	497	168	273	205	200	1,508	383	407	359	445	907	435	343	307	363		405	412	405	457					604
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female					1	4		264	5	11	1	9	515	183	154	279	303	1,666	433	469	418	365	2,170	468	261	476	394		781	819	923	959					1,381
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												2,028					2,997				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			1,266	405	471	438	428	555	340	280	138	317	2,307	564	902	705	867	4,619	787	908	829	822	2,675	817	1,009	710	673		736	993	936	998					706
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female				4	9	4	1	967		88	17	30	1,135	132	175	248	218	3,361	558	572	541	594	2,615	661	427	451	530	5,292	679	640	717	749	10,529				1,026
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			498	79	98	154	114	1,045	125	112	71	153	3,126	206	317	456	305	7,739	465	532	577	514	5,240	817	873	884	682		648	686	628	850					686
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female																2,188	1,205	2,469	1,183	1,135	515	1,891	2,057	226	1,096	1,215	977		580	510	1,026	715					881
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female																	106	194		64		116	20	26	11	13	36		15	23	20	11					153
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												1,876					1,271				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female																	74	137		41		61	20	12	2	14	15		8	8	12	6					83
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male								1,987	279	359	104	180	5,383	138	140	164	261	9,483	296	248	236	273	5,971	368	444	368	398	8,678	367	452	426	420	5,741				438
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male														1																							
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female				2		1		444	2	9	1	17	719	597	325	350	349	2,416	525	572	605	516	1,629	591	370	661	642		1,146	1,108	1,253	1,201					2,226
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			404	93	154	148	115	568	138	132	35	120	1,625	367	551	598	506	2,495	656	773	719	838	2,727	816	1,018	905	1,019		941	1,028	1,064	1,127					1,572
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female						1										1		20	1		1	6	2,347	58	393	245	369		238	313	305	201					4,995
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female									8	7	6	29		2		12				22	1,775	7		510		3	75										
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male								1,220	867	879	373	611	5,664	414	436	549	667	3,450	732	814	625	761	1,860	844	1,043	848	1,032		915	1,090	1,122	1,138					1,148
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								239	1	1		2	378	88	95	208	286	1,314	377	453	420	384	1,897	421	226	358	318		738	721	786	821					1,298
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female						2		546		4		1	645	521	250	161	162	2,021	242	264	316	285	954	244	120	432	260		486	485	550	534					958
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												114					1,505				
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female				1	4	2	1	1,186	2	235	285	197	3,388	1,337	2,023	1,893	628	4,514	387	401	465	561	2,645	665	805	784	798		743	807	1,145	928					1,712
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												6,322					6,059				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												3,860					3,123				
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												45					476				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex																43	24	113	27	17	36	39	128		28	25	16		17	38	26	20					
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male																80	175	233		47		927	122	374	466	330	282		312	411	477	393					596
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												1,368					1,414				
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex					8	4		1,663		9	3	28		49	84	92	87		75	127	112	128	940	96	127	98	149		87	112	172	111					82
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									1		3			1	28	3	6			2	3						11										2
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				36	36	55	41	330	38	38	18	37	1,065	69	166	223	155	5,496	256	361	348	330	3,109	483	509	535	500		357	424	341	524					499
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,834					3,520				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male																126	290	269		83		1,053	378	464	404	441	364		358	498	539	470					914
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									4	26	174	41		13	19	23	14		29	3	1	3			1	2			3			1					3
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female				3	3	2		75					536	1	361	1	4	10,765	481	752	656	805	8,735	709	1,031	1,068	929	3,506	733	781	862	1,120	2,142				1,150
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												8,009					7,946				
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female				2	4	4	2	1,526		357	364	302	3,256	1,932	1,493	1,001	119	4,062	340	215	221	315	628	385	305	335	275		468	289	470	363					677
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			1,033	178	187	177	157	139	178	237	180	263	150	314	307	290	199	1,253	294	304	315	375	1,904	719	2,203	1,608	1,886		991	1,145	948	871					2,489
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									4		108	22		1	2	2											1				13						
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female				4	2	3		95					1,045	2	597	5	6	4,436	226	360	270	318	12,771	343	562	698	478		391	377	479	522					611
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												4,718					3,634				
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female				3	2	1		130		1	0		2,459	1	467	6	7	6,630	212	282	317	360	14,307	410	603	657	508		445	448	421	622					679
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												2,393					2,160				
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			201	88	109	73	81	1,565	90	100	9	77	4,024	852	1,249	1,090	1,081	7,431	1,614	2,337	2,016	1,873	8,302	1,652	1,545	1,443	1,447	11,494	2,201	2,514	2,366	2,856	11,523				3,592
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female														2		1		20		1	4	1	2,838	87	437	313	370		230	278	274	168					6,129
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female																1,639	752	1,384	939	737	419	1,681	745	86	656	657	483		346	282	486	358					340
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female									275	286	62	126	864	106	138	205	244	112	220	272	248	245	259	338	424	451	495		353	363	427	401					368
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male																2,417	1,606	1,008	1,126	1,001	649	1,966	3,944	113	1,199	1,204	864		508	647	720	677					828
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female																		20			1	1	470	37	260	165	202		146	127	160	122					4,501
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female									91	76	29	44	1,696	27	36	58	87	209	57	78	58	73	1,189	97	121	101	129		108	129	138	131					129
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female																2,772	1,378	2,595	1,568	1,428	742	2,663	1,995	196	1,235	1,278	1,027		609	591	958	748					792
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male																10	42	122		29		243	14	78	437	87	67		61	107	101	83					128
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			1,077	293	405	491	396	1,067	405	568	94	299	3,476	546	1,028	951	953	5,813	1,123	1,454	1,249	1,219	4,166	988	1,505	1,555	1,529		1,680	2,083	1,617	1,843					2,095
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex								1,376				1			9	9	2		19	31	33	36		10	56	35	39		31	33	40	37					29
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			1,862	895	934	743	890	1,631	829	962	212	489	7,351	548	1,318	2,137	1,943	8,888	1,911	2,099	1,820	2,076	4,165	1,765	2,474	2,320	2,267		2,046	2,148	2,543	2,682					1,976
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			381																																		
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												11,906					12,178				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												3,063					3,868				
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female						1										2		20		1	3	4	1,118	84	417	353	365		269	297	335	227					6,601
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			743	144	185	235	187	3,294	195	198	113	245	4,965	303	376	493	422	13,760	674	725	731	630	10,614	982	1,147	1,161	807		805	933	853	1,142					784
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			666																																		
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female						1												20			2	4	2,146	46	325	200	257		174	250	242	174					3,549
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												1,994					1,802				
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female					2			5					201	1	279	5		1,330	123	175	171	612	1,667	204	268	341	260		216	190	243	306					365
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			282	64	109	123	136	1,203	119	107	8	68	2,648	86	244	223	264	4,066	287	535	419	461	1,723	273	373	594	441		545	643	577	719					896
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			615	242	267	215	236	247	223	270	208	271	122	291	307	294	208	3,547	303	357	340	431	3,755	707	2,533	1,784	1,964		1,050	951	994	918					2,726
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												1,797					2,863				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												4,751					4,879				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				69	56	38	56	231	200	256	19	32	911	142	171	211	180	1,821	230	178	214	236	470	224	295	214	221		257	258	267	300					262
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			129	91	58	55	57	956	122	128	25	62	2,578	373	511	612	605	4,353	726	616	644	706	1,378	757	640	733	624	6,277	807	831	900	1,035	10,412				1,034
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female									3					2	2	1	1		1																		
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			1,333	433	477	378	461	1,291	491	659	152	395	5,848	428	928	1,641	1,529	7,210	1,512	1,627	1,526	1,438	3,286	1,512	2,038	1,990	1,843		1,811	1,846	2,139	2,191					1,701
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female									124	147	34	71	1,150	57	63	73	130	261	113	89	96	120	792	144	165	182	213		143	180	203	159					157
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				2	1	7	3	836	5	80	86	51	2,795	377	757	737	379	3,912	307	407	446	592	1,473	542	678	677	717		585	677	822	695					1,019
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex				1	1			1,394		39	12	22		42	62	124	137		193	165	192	148		188	135	51	70		52	65	109	78	160				68
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				1	1		1	246		53	9	11	363	82	79	110	139	1,181	237	257	246	281	259	265	335	181	250		270	249	250	311					372
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male								977	326	358	147	231	2,747	174	195	227	286	1,617	313	295	261	336	1,906	364	503	398	428		393	492	494	494					510
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			1,174	245	372	403	325	984	397	437	133	809	2,936	1,626	1,127	1,258	1,075	4,665	1,365	1,589	1,337	1,382	2,498	1,151	1,789	1,799	1,846		1,888	1,993	1,785	1,999					2,443
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female									192	203	62	91	826	71	83	121	155	233	170	158	143	165	106	202	268	299	325		233	259	301	279					254
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,630					1,471				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex																	14																				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												3,974					2,188				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male																1,276	876	695	541	459	308	1,317	976	42	478	450	339		171	269	246	268					300
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female				1	3	3	1	995	2	140	210	112	2,977	764	1,216	1,253	480	4,258	346	399	392	589	1,361	549	662	709	703		698	698	911	796					1,330
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												33					473				
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex														4	1										1	1	3		5	1	14	12					
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male								1,121	551	554	246	395	4,017	250	284	355	435	3,160	444	462	418	448	1,574	552	625	579	613		604	672	749	712					765
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												5,232					5,077				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			387																																		
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex				2	2			4,317		15	23	24		126	50	61	67	548	94	125	82	132	1,250	128	128	117	134	1,605	122	157	135	136	3,657				135
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												2,234					1,371				
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												9,224					10,323				
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												5,503					5,362				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			523	138	120	109	142	372	252	195	42	93	1,243	239	306	328	369	2,015	355	314	313	386	882	419	367	357	352		373	418	417	553					474
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												3,341					1,981				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex																	2	50				3		1	132						3						
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			708	206	135	136	199	2,160	151	155	42	116	6,697	133	416	563	476	6,086	421	560	424	464	1,352	375	577	567	579		655	576	659	661					611
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male								1,028	184	225	82	110	2,137	74	121	126	180	1,180	164	220	157	207	688	221	286	260	271		264	308	322	319					378
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												4,856					10,051				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex																	1	50																			
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												2,246					6,504				
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female				1	2	1		120				1	733	2	399	4	5	2,861	198	287	298	313	3,363	306	548	546	457		321	395	358	513					548
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												4,792					1,528				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male																27	110	160		37		320	23	153	111	155	113		157	214	235	229					574
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												2,283					1,857				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female																707	369	1,284	379	331	160	755	583	85	430	501	390		229	212	408	262					382
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				6	6	2	1	760		44	40	18	2,749	140	395	398	251	4,018	262	363	378	536	664	492	593	662	622		516	570	658	620					793
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			995	161	200	203	212	458	204	196	66	184	1,472	322	485	419	520	3,136	520	563	521	547	1,028	574	637	499	508		525	638	668	711					613
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,939					1,235				
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex															2	4	3		6	9	12	16	160	9	20	42	33		22	27	22	20					20
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male																5	45	160		10		92	19	40	21	33	18		23	38	50	58					184
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				56	65	30	53	818	54	77	38	48	3,601	119	365	430	383	4,852	373	444	447	457	1,314	401	568	602	542		585	582	734	740					800
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				4	2		1	309		58	12	39	442	109	175	163	189	1,459	321	326	371	378	1,255	338	253	253	285		332	361	376	439					482
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female																						3		1	2												5
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female				5	15	14		2,652	2	153	80	29	6,033	249	1,129	1,277	759	8,406	722	1,270	1,271	1,574	3,412	1,523	1,548	1,947	2,042	2,972	1,459	1,706	1,758	1,597	13,950				1,795
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												11,197					13,253				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male																73	235	172		75		755	1,177	305	180	327	276		269	388	434	418					883
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male								750	1,083	1,145	291	534	5,696	470	556	628	835	2,720	787	779	678	766	131	869	1,003	888	917		872	901	1,007	951					980
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												642					2,128				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female																4	31	62		40		166		29	47	9	46		15	23	15	7					78
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female										86	485	17		13	16	17	5		11	1				2	2				1								3
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			142	51	62	93	45	290	68	68	21	70	727	112	96	129	150	2,462	235	304	291	661	3,364	310	477	559	440		329	375	394	592					396
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												946					592				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex								505		1		3		1	6	8	4		15	29	21	25		9	36	35	49		49	31	48	32					27
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex								2,031		3		8		108	111	109	117		149	129	138	106	1,620	131	52	59	89	476	158	182	205	251	483				312
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female					6	3		500		274	111	192	673	304	534	297	258	3,742	488	589	633	667	2,823	690	513	514	520		541	516	572	633					874
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			261	38	62	79	65	769	64	62	43	83	2,082	126	210	310	241	2,111	338	397	408	363	3,755	576	650	705	538		492	475	480	663					593
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female				3	2	1		543		305	124	195	463	120	143	153	238	2,120	367	340	374	312	884	342	492	226	215		242	279	320	422					418
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				1	3			50		1			358		131	5	3	3,656	139	220	185	206	3,582	260	367	425	411		247	298	296	420					449
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female				2	4	8	1	962	1	4		7	1,363	178	226	447	497	3,975	1,331	1,653	1,539	1,408	4,905	1,273	397	599	560	7,279	1,945	1,922	1,978	2,313	7,306				3,167
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			234																																		
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female						1		459	3	7	1	8	830	800	384	358	326	2,615	491	538	553	490	1,566	484	307	553	617		1,026	950	1,079	1,041					1,734
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female																3	118	160		51		64	715	12		8	15	38	10	15	9	4	141				80
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male								172	250	247	54	110	2,005	81	101	113	153	172	151	146	139	165		219	213	218	229		204	192	188	207					211
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			112	25	28	47	18	424	24	20	17	27	1,876	43	521	698	120	13,064	904	965	1,056	1,211	10,850	1,165	1,477	1,536	1,554	5,418	1,134	1,173	1,192	1,663	7,039				1,861
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																																	750				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female																25	140	122		125		435	111	86	49	42	110		28	59	51	26					279
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												2,514					1,462				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				82	57	49	69	289	154	247	29	65	1,019	181	262	269	290	2,101	284	227	315	314	739	294	289	286	249		296	328	342	425					332
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			229																																		
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female					3	2		372	2	9	1	8	417	596	528	439	264	1,474	379	420	405	400	1,366	535	283	467	470		861	803	1,014	1,018					1,642
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												294					778				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												443					1,505				
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				66	79	97	89	462	73	92	26	85	1,328	329	492	518	476	2,188	569	712	668	726	3,058	601	965	779	943		817	914	895	1,006					1,142
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									4		5			4	9	4	17		2	1																	
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																																	118				
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex						1		747		9		2		44	53	78	91		112	41	51	43	160	45	19	21	26		49	37	41	47					82
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male								1,157	1,230	1,291	461	794	9,264	575	679	808	976	3,918	980	1,093	899	1,117	948	1,183	1,387	1,299	1,303		1,204	1,378	1,462	1,435					1,432
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												805					2,223				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female																17	268	122		168		413	3,442	83	30	37	78		36	64	63	37					306
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												2,347					4,741				
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,431					2,879				
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			830	206	233	201	213	1,127	241	313	61	208	4,795	279	616	988	914	6,278	859	997	898	908	2,280	892	1,187	1,189	1,099		1,115	1,171	1,462	1,382					1,204
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female												1						20			3	1	1,689	59	244	165	238		199	204	213	161					2,350
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			276	60	101	65	47	2,981	55	136	51	100	8,272	291	996	1,195	1,009	10,551	959	1,247	1,183	1,331	2,935	1,270	1,494	1,609	1,717	4,571	1,450	1,554	1,901	1,796	12,551				1,871
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			132	20	35	27	34	19	50	46	57	38	15	71	97	71	50	906	84	94	76	102	3,514	313	658	584	792	4,044	455	591	562	407	3,341				2,681
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female					1	1	1	95					667	1	253	1	4	2,010	151	268	248	264	3,292	276	403	484	389		257	330	328	474					504
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female									112	124	21	38	96	49	39	53	54	28	56	70	71	72	51	161	141	123	137		97	91	136	101					116
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex																			2	1	2	4		3	10	8	14		3	7	8	10					6
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			600	120	178	239	196	734	201	242	66	193	1,928	510	783	862	755	3,027	984	1,126	1,004	1,061	3,447	952	1,332	1,385	1,557		1,387	1,597	1,468	1,631					2,007
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex											1			3	1	1				1		1		1	7	7	8		5	2	7	9	1,750				
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female				1	2	3	4	1,312	6	598	586	421	4,064	2,981	2,655	1,901	224	5,493	565	485	462	635	2,278	786	716	802	702		906	794	1,286	1,120					1,785
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female										2	1				17	1	4			2	1						15										
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				30	43	33	38		38	56	46	68	67	108	86	73	56	747	103	132	129	155	1,454	338	904	590	759		376	470	450	399					1,540
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex					3	2		4,142		14	1	20		49	75	85	60		65	86	64	105	928	84	126	99	100		79	103	134	91					91
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				86	116	92	120	971	145	165	64	122	4,379	185	434	608	545	5,170	503	669	555	674	1,138	614	849	794	852		720	786	998	1,019					992
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female																921	509	1,619	560	467	236	942	743	101	559	744	544		334	288	532	420					568
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female																1						41		32	30	11	29		3	2							
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex																59	55	364	49	39	25	58	91	6	91	90	40	841	54	97	66	51	1,900				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			1,622	308	362	336	356	551	242	235	92	252	2,365	494	766	622	744	4,241	661	785	747	734	1,448	774	903	731	656		743	884	892	999					811
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male																1,281	985	837	645	594	348	1,227	4,012	104	753	865	625		308	482	572	550					663
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female									4	3	72					4				2											5						
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male																						33		12	81	22	39		6	4		1					
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male																299	189	813	187	130	87	230	267	32	194	236	180		90	159	164	131					237
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female									347	396	70	139	243	135	137	207	255	89	235	253	233	288	77	298	424	431	439		309	354	390	311					293
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female																630	244	1,559	331	301	164	904	155	63	369	421	343	941	197	199	385	307	1,954				373
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												1,883					3,749				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male																467	351	735	275	219	132	467	863	50	314	424	272		172	212	225	250					348
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female									127	162	34	46	2,419	51	53	76	114	256	105	86	99	120	7,416	177	192	211	200	1,902	142	239	226	193	3,276				155
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female																4	147	150		119		162	64	43	9	19	53		24	35	41	11					197
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												4,689					3,586				
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female					4			515	3	398	197	276	689	291	588	293	279	2,938	531	629	754	685	2,598	721	657	517	503		481	567	566	706					758
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex									1	1				29	31	9	43		72	28	22	27		22		3	2		7	2	1	4					38
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												6,715					8,086				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male																7	77	113		27		205	20	85	32	101	59		77	99	139	114					269
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female														1				20			3	2	3,258	85	206	238	368	1,349	413	268	321	172	773				3,610
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female																446	208	1,072	231	210	98	526	252	61	273	299	260		157	140	242	179					290
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			2,118	885	924	769	838	1,485	869	1,066	195	548	6,651	622	1,209	2,251	2,232	9,213	2,132	2,377	2,156	2,307	5,012	2,047	2,617	2,506	2,445		2,227	2,357	2,666	2,778					2,109
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female																1,436	749	1,992	804	735	331	1,352	1,230	168	830	945	794		480	362	759	541					764
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				46	40	56	55	399	53	52	16	46	1,461	301	395	385	431	2,515	448	558	566	566	2,341	451	827	637	690		641	772	741	901					1,105
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												3,890					5,162				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												4,332					4,937				
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female					1	1		402	2	11	2	7	863	467	245	321	302	2,745	427	478	478	417	1,998	564	325	592	566		1,077	1,021	1,170	1,217					2,052
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male																1	49	177		10		92	64	30	2	27	25	17	25	22	41	36	136				153
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												7,569					14,612				
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male																	1					5		6	2	1			2	3		1					3
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex															1	6		40		3	5	8	240	3	12	10	17		7	11	12	20					13
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												2,635					2,612				
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									13	11	9	30		10	2	14				13	2,104	12		296	1	1	68					1					
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex								1,943		3		3		58	78	116	81		95	44	85	55	845	43	25	26	37		48	51	57	66					70
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												577					2,861				
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex														2		2	1								2	1	2		4	1	6	4					
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female															1			20			5	6	1,539	39	144	104	154		125	144	149	105					1,657
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				22	34	27	19	255	19	11	10	23	1,049	23	121	208	73	3,883	204	297	269	320	2,920	322	400	439	402		309	364	290	405					450
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			346	52	78	85	75	73	93	106	87	103	95	180	138	106	76	954	151	144	149	206	2,047	362	1,175	757	1,025		507	617	594	488					1,957
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex					1	1						4		1		3		226	21	9	11	34	315	28	37	77	29	7	13	21	18	68	1,325				27
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				1		2		50				2	320	1	77	4	1	4,862	130	205	227	217	3,463	199	287	366	315		236	278	247	362					396
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				11	18	31	24	19	26	30	37	41	15	47	80	51	36	773	37	66	55	80	1,233	178	450	249	353		225	246	245	224					1,107
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												4,076					3,875				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex																18	15	161	117	10	17	27	66		36	13	11		12	68	22	14					
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												7,261					5,533				
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			672	111	90	103	96	73	125	117	112	131	65	279	171	205	121	913	221	223	254	295	2,369	647	1,969	1,439	1,937		1,047	1,084	1,006	960					2,401
Central and South America Region	Panama	PAN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			626	179	207	270	256	3,904	258	212	90	273	3,728	317	411	524	428	10,054	572	798	739	681	7,399	992	1,266	1,348	867		848	979	983	1,279					728
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female																														1							
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex						1						1			2	2			8	1	5	4		5	10	16	15		6	3	7	3					2
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												10,401					10,123				
Central and South America Region	El Salvador	SLV	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												140					169				
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male																586	188	1,592	328	230	177	738	118	54	317	385	297	556	141	184	238	241	2,448				307
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex																			4		2						13		17	28	15	9					17
Central and South America Region	Peru	PER	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female																12	232	122		149		275	733	94	14	29	58		29	46	54	25					313
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												1,480					307				
Central and South America Region	Nicaragua	NIC	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			113	87	92	99	91	69	86	103	78	109	169	81	105	89	73	507	124	127	114	174	429	275	1,097	658	681		401	379	361	312					1,599
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male																3,134	1,960	963	1,431	1,260	891	2,871	3,009	155	1,366	1,194	918		489	733	795	733					739
Central and South America Region	Brazil	BRA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female									178	172	38	70	1,737	62	87	99	114	377	124	151	118	151	275	180	192	222	268		175	196	235	212					230
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female				4	4	1	1	1,247	6	398	451	321	3,489	2,080	2,036	1,372	221	5,047	564	477	513	673	2,725	801	828	907	849		829	899	1,335	1,158					2,125
Central and South America Region	Guatemala	GTM	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex					1					67	66	19		22	40	39	63		41	55	42	54		59	47	42	49		42	49	67	47					64
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			597	131	188	186	136	681	138	133	77	62	1,792	159	204	325	312	2,708	264	309	205	255	648	238	366	206	188		212	296	337	374					257
Central and South America Region	Honduras	HND	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female					4	3		457		223	101	122	491	193	386	278	246	1,839	455	488	546	566	1,745	570	409	382	428		466	431	461	550					671
Central and South America Region	Colombia	COL	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												834					360				
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								111		6		1	263	8	9	13	8	253	16	7	5	12	49	8	12	16	6		7	11	14	13					2
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																		4							4												
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female					1	2		125		3	3	3	264	5	12	14	5	245	11	11	10	13	94	17	17	5	17		6	13	8	15					17
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female					1			64	2	2	1	3	87	4	1	5		185	8	6	13	7	97	3	2	7	11		7	7	6	12					3
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			78	17	25	44	45	310	26	23	14	34	408	28	51	45	38	633	36	62	59	64	696	81	88	104	63		55	64	48	58					34
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												31					33				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			18	1	2	3	1	34	2	1	1	4	189	6	23	15	7	819	31	25	23	30	487	18	32	23	24	189	16	20	13	23	450				12
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												140					50				
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female																	1	12				1	13	1			1	2	1	1			6				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												403					634				
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												461					172				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female							1	33		3			46	3	2	4	6	73	3	4	8	7	18	3	12	4	3		7	5	6	5					6
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female					1			62			1	2	82	3	9	8	5	235	13	10	8	6	49	5	6	8	11		5	10	9	2					3
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								120		3	2	1	138	1	5	4	9	212	12	13	11	10	65	12	18	12	9	310	9	13	17	5	232				10
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female							1	38				4	54	6	3	1	6	91	5	2	15	10	31	12	8	9	6		7	3	11	9					3
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female						1		55		1	2	1	62	5	4	9	6	116	9	5	3	6	44	5	16	6	7		6	4	8	8					11
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male																						6				2	2										
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								59				1	73	2	1	5	2	152	4	2	5	6	106	12	1	4	7		7	8	5	2					5
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												65					2				
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												271					275				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								53	1				89	1	4	3	1	174	4	1	5	5	133	2	5	1	3		2	1	3	2					3
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												90					141				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								33					40	2	3	2	3	81	5	4	3	6	128	6	4	4	4		8	7	5	6					4
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												174					139				
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male																81	43	62	50	34	48	64	112	12	54	61	48		28	44	45	56					46
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female					1		1	172		5	3	5	337	12	23	13	18	283	10	12	21	9	159	19	21	11	24		18	13	17	14					16
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												82					79				
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			6	3	11	7	4	7	1	5	4	6	11	8	8	6	4	32	12	4	10	6	33	6	13	11	20		1	13	7	13					5
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex																									1												
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex																8	5	10	1	1	4	1	12		3	1	2		3	1	3	1					
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			22	2	8	10	9	75	11	9	3	10	175	36	43	31	13	158	26	30	23	29	216	32	28	21	22		13	15	20	14					30
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female										1		1	4					1	1	1	2		3	1						2	3	2					2
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female																16	9	62	8	8	19	17	8		10	7	19		7	7	5	13					7
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex																		4																			
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female					1	1		37	1	3			53	4	2	4	17	106	3	9	2	5	144	5	4	4	7		6	7	3	3					4
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex																	3																				
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												149					120				
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												107					146				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			59	20	22	30	21	122	28	28	7	23	371	37	69	56	51	364	45	38	24	32	337	27	46	38	33		28	36	23	41					24
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex														2	1	1				1	2	2		2	1	1	2			1	2						
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												220					313				
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																									1								14				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				2	6	7	5	27	2	3	1	4	106	5	13	20	14	345	17	29	19	28	308	29	28	21	24		27	19	10	17					13
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																																	4				
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			20		13	8	5	7	7	3	5	7	20	12	12	8	8	59	21	17	20	19	131	20	41	19	46		26	17	32	23					19
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			17	2	6	5	5	119	4	3	2	7	318	17	27	27	28	273	33	24	14	29	94	16	18	22	26	284	20	19	19	18	294				22
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male																308	167	82	104	97	73	182	228	21	138	94	88		67	92	94	95					50
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female																	5	8				4	61				2		2	1	1	3					3
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex																4	2	14	2	1	1	1	7		2	3	1		2		2	1					
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female									5	2	2	8				3					13	7					2										
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex																			1					2	1		2				1	1					
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			39	17	28	14	13	18	11	8	14	10	23	15	29	31	18	222	28	34	34	28	296	39	55	39	49		36	36	39	46					25
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			21																																		
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												4					19				
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male								169	20	18	16	20	2,827	23	18	19	33	141	21	35	27	31	82	31	40	34	47		37	55	54	48					77
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female																		1			3	2	198	6	8	6	3	95	2	9	6	7	40				7
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												195					141				
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female																		1			1	1	30		3	1	10		2	4	3	3					1
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																			1		2																
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex								288							1	1	1		1		1		105					8					15				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												33					20				
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male																33	13	128	27	38	65	35	11	3	20	11	21	53	20	16	24	22	111				23
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male								103	30	53	13	26	4,419	20	30	19	38	119	30	38	34	23	8	24	38	40	41		38	54	43	41					93
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												77					41				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												83					32				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			35	7	11	21	14	91	16	13	6	11	213	25	54	51	24	190	47	46	41	32	252	38	44	29	34		27	23	48	24					22
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			75	24	17	28	27	73	18	17	15	25	273	41	44	49	43	289	43	44	76	59	266	37	48	42	21		41	51	45	42					29
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												232					424				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			17	4	5	11	11	22	3	6	1	3	74	11	6	17	11	156	10	16	18	26	268	29	28	31	21		29	31	19	17					13
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												453					293				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex								177																		2			1		1	1					3
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male								277	8	4	3	5	1,361	6	5	1	2	171	12	7	7	9	251	6	8	4	8	285	14	14	13	14	216				34
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female																		1			2	4	131	5	10	7	13		6	4	12	3					3
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								1					24		8	2		86	4	4	9	13	72	3	16	9	7		7	6	4	3					5
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female																9	10	122	15	13	25	11	12	2	7	11	10	32	7	15	13	9	52				6
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male									1	5		2					4																				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												120					129				
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												449					354				
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male																11	12	12		1		20	3	10	4	16	12		14	19	24	20					18
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												144					48				
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				4	1	5	5	146	5	4	7	7	428	16	30	42	32	324	20	35	44	31	112	34	39	35	50		25	32	51	46					41
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male																						1															
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								7					69		7		1	127	11	4	6	8	152	9	7	9	4		7	3	6	3					6
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			31																																		
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												239					70				
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female									2	5		3	11	5		4	5	4	2	3	2	5	5	3	9	7	10		3	13	9	7					6
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												227					252				
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex								248			1	1					2			2	1	6	47	2	4	3	1			2	2	3					1
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex																			1	2	5		8			3	4			2		1					
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												103					64				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			63	21	12	22	22	83	13	13	14	24	319	24	48	74	38	485	36	49	59	59	609	67	50	69	35		32	27	21	32					23
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			31																																		
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female					1			397		7	5	2	583	4	16	11	17	525	12	12	24	17	217	14	18	24	24	260	13	10	18	9	311				23
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female										3		2	46	2	2			11	4	1	3	1	32	9	4	3	5		3	6	9	7					7
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female																		14				2	1							1	2	2					2
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female					2	1		148		9	8	9	291	8	15	16	16	269	12	12	13	16	91	12	21	10	13		8	15	9	19					11
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female																23	25	62	14	12	5	11	31	1	6	7	7		5	4	12	5					2
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			14	4	3	9	6	148	3	9		6	297	3	1	4	5	260	11	9	11	4	117	5	6	3	4		5	9	10	5					8
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female																31	38	75	27	24	23	20	60	3	27	25	13		16	18	22	18					12
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male																1	2	13				1	6	5	1	3	4	1	3	1	5	3	12				1
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			40	10	7	11	11	170	7	18	9	12	462	17	51	47	53	394	55	53	43	38	225	56	55	38	47		37	48	66	57					38
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																																					1
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male																3	5	8				6	2		20	3	2		3	5	3	6					3
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			16	5	2	1	2		1	1	2		6	8	8	2	6	56	14	18	11	10	235	10	15	20	19	527	17	20	21	20	154				22
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female																		1			5	6	94	5	1	6	5		2	4	4	2					3
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female									2	6	1	1	383	2	3	3	3	35		3	6	3	318	6	3	8	3	74	2	6	6	6	146				20
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								135	6	5	4	5	679	1	6	10	8	86	10	6	10	10	81	8	12	16	16		11	13	19	24					39
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male																23	24	12		6		50	167	14	11	29	23		26	17	25	37					21
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												52					28				
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex								624				1		2		1	5				1		52	2	4	3			2	1		2					
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female																		1			1	6	143	2	10	4	11		4	3	11	5					7
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female									2	1		2	176	2	1	4	1	10	2	1	6	3	7	4	8	6	11		2	6	9	10					8
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			29	6	14	8	18	46	8	13	7	16	141	15	31	35	34	128	31	25	22	19	96	20	24	28	32		21	27	26	25					24
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			14																																		
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												1					7				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male											1			1			2																				
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male																	4	12				4	1	1	1	3	2		5	1	2	5					4
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male																293	172	78	117	106	104	205	290	27	168	134	112		94	83	106	133					82
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female									4	2			639	1		2	2	16	6	7	3	5	10	8	6	6	7		4	4	3	9					13
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								73		1			67		1	1	2	131			2		67	1	2		1		6	3		1					3
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male																76	54	62	24	17	13	42	60	1	29	17	10		11	10	7	16					4
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								140	3	7		3	509	4	1	8	6	67	4	8	5	5	29	5	7	8	8		8	10	13	16					33
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												56					64				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												4					32				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												39					23				
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			32	9	5	3	5	327	6	8	1	13	679	13	25	24	29	381	21	38	15	28	111	20	34	29	35		31	34	24	27					14
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												298					274				
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												73					150				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								72		1	2	2	67	1	1	4	3	134	8	5	3	4	38	3	6	5	4		2	5	6	3					3
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												99					62				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female							1	126		2			134	3	4	6	1	248	5	8	7	14	316	11	7	6	5	205	9	7	10	11	232				13
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female																		10					1				1				1	1					
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male									9	6	3	18		4	2	8				2	25	12					1										
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			23																																		
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male								160	44	33	20	31	6,284	25	39	47	49	169	46	44	40	53	41	44	52	60	54		58	67	75	66					116
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			32	8	6	7	5	87	7	9	10	5	209	7	14	13	11	170	9	6	15	10	52	2	6	4	5		2	12	9	14					7
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female																		1			3	1	103	1	3	1	6		7	4	6	4					5
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												56					37				
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female					1			185		2	7	6	354	16	10	12	11	315	16	24	15	13	178	23	24	11	18		13	7	10	18					17
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex																					1	3															
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female																23	12	62	18	15	19	13	27	5	14	12	12		10	14	17	10					8
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female																3	7	8				2	28	2		1				1		1					1
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex																1		2					12			1											
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			94	21	23	47	37	263	29	19	14	28	542	28	47	56	45	863	53	69	56	75	1,059	70	81	62	58		46	46	47	45					40
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female																4	3	8				2	2		3	1	2		1	1	2						1
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												236					339				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			32	7	6	20	16	61	7	7	7	12	216	14	28	44	27	133	30	38	28	29	451	30	35	32	41		21	30	21	20					25
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												506					717				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female				1				9					81		14	1	2	179	6	10	8	7	158	5	15	15	5		8	8	7	6					3
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				3	4	3	5	63	8	4	1	6	142	11	34	18	19	138	20	16	7	26	213	22	22	21	19		19	9	14	12					16
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				4	10	6	3	37	9	13	4	6	116	10	25	36	23	133	24	12	21	13	75	15	20	16	19		19	9	25	21					13
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male																30	37	18		2		59	55	19	19	56	32		23	30	42	42					28
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female																27	24	66	27	12	18	20	30	2	20	17	15		14	20	11	22					5
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												9					28				
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male																2	4	8				9	1	1		10	7		6	4	7	18					3
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female																32	64	75	39	31	21	39	96	5	30	35	24		16	31	34	18					16
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								4					33		3			304	5	5	3	1	191	1	7	7	5		3	5	3						3
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			99	16	31	30	18	72	21	20	7	30	257	44	64	61	43	266	41	55	59	46	164	61	59	58	46		52	49	65	60					44
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female				1				6					55	1	12		1	676	16	10	7	11	448	7	12	12	7	90	5	5	11	10	140				4
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												337					431				
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			89	36	42	34	35	248	20	36	18	28	748	42	113	118	139	557	109	116	101	140	450	133	151	120	111		82	114	128	133					82
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			102	41	28	28	33	224	25	48	16	41	668	64	108	147	168	578	138	131	128	141	626	118	143	119	142		85	113	99	124					58
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male					2		3			1	1	2	6	1	3	8		48	3	8	7	4	74	10	15	8	19		7	13	11	7					7
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								192		3	6	5	412	9	12	10	8	344	21	13	9	15	141	14	14	12	11		9	7	11	8					16
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male																51	33	62	31	35	31	38	71	6	31	29	43		29	18	23	44					27
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												273					128				
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												75					187				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male						2	8	54	2	3	1	1	151	14	19	13	14	159	13	10	11	17	164	9	13	16	9		4	14	8	20					24
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				2	3	1	3	121	1	4	11	3	358	11	27	24	16	304	23	21	27	12	102	16	32	22	36		17	19	16	23					23
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female										1	3																										
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			21	2	4	3	2	452	1	11	7	12	813	21	34	33	29	672	33	45	40	42	211	39	46	34	46	438	24	38	47	35	599				34
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex								176			1	1		2	4	2	3		2	1	5	2			3		2		1	1			5				1
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male																27	17	68	9	14	28	11	23	2	14	10	11		7	12	14	10					13
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female				1				11					272		5			417	10	13	6	18	310	18	12	14	12		12	6	4	8					10
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																								1	1		1		1								
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female					1			4					37		4	1		229	9	3	3	6	141	8	9	6	2		9	5	2	5					2
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								48		1		1	46	11	4	4	2	93	6	4	3	6	88	7	3	5	3		8	7	1	8					2
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												35					3				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												271					134				
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female																	5	10				3	3	1			3				1	1					2
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex								109							1	1							11								1						1
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												29					81				
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			64	13	25	17	17	12	15	16	7	13	31	31	50	29	13	78	24	24	32	37	124	49	82	58	65		35	56	44	41					24
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male								155	16	14	6	11	1,608	7	9	8	11	146	13	13	9	14	71	13	22	20	20		23	32	40	36					61
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female																		1			3	4	69		3	5	13		3	8	3	6					2
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												252					100				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female				1				7					113		8		1	278	6	9	7	5	311	18	18	13	13		6	9	14	11					11
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																1		14	1	1	2	6	18				2	1		2	2	1	53				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			63	8	19	12	10	54	17	12	3	27	166	23	40	38	38	198	36	44	35	42	106	36	55	45	36		40	33	35	39					36
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female									4	1		3	492	1		2	2	12	1	4	3	3	47	3	5	1	3		1	3	4						9
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												641					506				
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																	1	26		1	1		4		3			53	1	1	1	1	15				
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female																43	58	76	42	19	28	25	87	7	26	22	14		25	20	34	22					21
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			64	14	11	14	15	195	20	25	15	31	563	29	68	113	101	452	92	88	95	75	376	75	95	97	83		60	87	80	79					59
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												85					8				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			65	19	13	26	26	114	39	26	21	95	309	102	91	83	51	292	36	70	44	45	203	43	71	35	50		44	39	38	35					32
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												14					19				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex								67				1		1						1	1						2		1		1	3					
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female																		4		1				1													
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female										2						1																					1
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																																	6				
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												15					23				
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex																					1	1			2	1	1			3	1	2					1
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male														1	1		4																				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female															1		1																				
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			42	12	13	15	7	7	16	9	3	10	20	22	14	15	15	57	24	20	26	28	146	34	78	44	73		29	30	51	39					33
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								62				1	82	2	2	3	3	164	5	4	6	3	101	3		2	5		4	4	5	4					5
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												416					319				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				4	6	3	6	32		4	3	7	101	7	23	19	15	115	15	10	13	12	48	12	12	16	9		17	20	17	8					11
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female														2				1			4	1	178	5	8	3	8		6	2	5	6					4
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex								646			1	1		1			2	34	1				64	2		1	1	17	1	2	3		25				
Central and South America Region	Honduras	HND	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female					1		1	42		4		1	60	7	11	3	4	96	6	10	5	5	40	12	14	6	8		9	5	7	5					10
Central and South America Region	Guatemala	GTM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								228		2	1	1	327	3	1	7	6	255	1	5	3	6	42	4	7	5	5		4	5	7	3					9
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												5					18				
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male								22	11	5	2	4	1,673	3	2	1	2	7	6	5	9	3		6	5	10	10		11	12	8	13					16
Central and South America Region	Colombia	COL	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male																169	133	66	85	83	78	138	313	24	111	105	90		54	83	93	117					78
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				3	3	4	4	21	4		3	2	105	1	7	11	4	244	14	8	16	14	212	13	18	13	11		9	12	8	12					13
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				3	4	2	1		1	4	6	2	13	10	8	6	4	46	12	14	16	5	97	10	15	23	27		20	13	20	14					11
Central and South America Region	Nicaragua	NIC	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												416					82				
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			14		1	3	3	200	4	6		4	427	13	30	36	13	465	16	23	14	23	468	22	18	17	18	295	18	32	18	31	324				17
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male											10	3																									
Central and South America Region	El Salvador	SLV	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex								272							1							1	55		2					1							
Central and South America Region	Brazil	BRA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female									2	2	1		323	2	4	6	5	4	5	4	4	6	12	4	8	4	7		12	10	6	9					8
Central and South America Region	Peru	PER	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male																17	29	16		3		32	19	21	26	24	12		16	20	25	38					24
Central and South America Region	Panama	PAN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												385					352				
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female																		1					1														
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex																		1					1														
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female																		5					5														
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female																		7					7				1										
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female																3	1	13	5	8	1	4	13		1	1	1		1	1	1						
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female																4	9	20	11	9	13	5	20		3	1	2			1	2						
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female																	1	11	2		3		11		2		1										
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female																	1	8	5	3	1		8				1			3		1					
Central and South America Region	Colombia	COL	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female																10	8	23	22	4	12	6	23		7	2	3		2	1	2						
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female																		430	36	16	14	17	430		25	22	11		5	4	6	6					
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female																		896	216	205	101	98	896		212	127	109		63	40	71	32					
Central and South America Region	El Salvador	SLV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female																															2	1					1
Central and South America Region	Honduras	HND	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female																																					2
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female																		358	174	144	69	91	358		145	127	76		45	21	62	26					
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female																		287	12	5	1	1	287		13	4	4		2	2	4	2					
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female																		824	127	115	60	71	824		138	68	67		47	25	36	17					
Central and South America Region	El Salvador	SLV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female																																					1
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex																		36	8	9		4	36		2	15	6		4		1						
Central and South America Region	Honduras	HND	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female																										1					2						
Central and South America Region	Honduras	HND	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female																										2					1						2
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female																		179				1	179		7	1	1					1					
Central and South America Region	Panama	PAN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female																																1					
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female																		36				3	36														
Central and South America Region	Honduras	HND	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female																										1						1					3
Central and South America Region	Panama	PAN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female																															1						
Central and South America Region	Colombia	COL	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female																		538	68	69	28	42	538		75	48	36		24	8	28	11					
Central and South America Region	Honduras	HND	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female																															2						
Central and South America Region	El Salvador	SLV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female																															1						
Central and South America Region	Panama	PAN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female																																1					
Central and South America Region	El Salvador	SLV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female																															1						
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female																		7		1			7				1										
Central and South America Region	Panama	PAN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female																																1					
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female																		8	3	2	1	2	8				1			3		1					
Central and South America Region	Panama	PAN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female																															1						
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex																		1					1														
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female																		20	6	8	5	3	20		3	1	2			1	2						
Central and South America Region	Honduras	HND	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female																																					2
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female																		11	1	1		1	11		2		1										
Central and South America Region	El Salvador	SLV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female																															2	1					1
Central and South America Region	Honduras	HND	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female																										2					1						2
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female																		23	9	4	6	4	23		7	2	3		2	1	2						
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female																		5					5														
Central and South America Region	Honduras	HND	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female																															2						
Central and South America Region	El Salvador	SLV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female																																					1
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female																		1					1														
Central and South America Region	Colombia	COL	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female																		13	4	3	2	1	13		1	1	1		1	1	1						
Central and South America Region	Panama	PAN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female																																1					
Central and South America Region	Honduras	HND	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female																										1						1					3
Central and South America Region	Honduras	HND	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female																										1					2						
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male												10					1			7		80			16		14			1		86					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female																	300			208		477	1,113		561		1,304			704		1,480					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female																	179			125		434	840		49		184			104		80					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female												2					2			2		8			4		14			19		119					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female										1		1					1			1		2			3		5			7		64					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male												82			339		82			30		6			22		19			4		41					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male																	299			85		1,056	850		488		840			887		1,010					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male																	124			51		70	333		191		445			194		403					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male												24			6							8			22		52			21		60					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male																	216			72		163	762		322		714			309		590					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex												4								11		8			9		5										
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female												1			1		3			1		2			1		6			8		24					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male												29			3		20			31		44			42		27			50		18					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male												18			135		5			12		2			4		4			2		8					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male												6			3		22			35		68			51		24			54		21					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male												18			96		7			11					3		5					7					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female							1			2																											
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												2,318					3,245				
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex															1		1					1					2			2		2					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male																	77			27		205	95		105		169			184		256					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												6,450					9,675				
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male																	45			10		91	90		30		57			65		109					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female																				14		14			26		51			2		124					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male												3										10			18		15			1		8					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female										3					5		2			4		34			17		56			30		37					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex															5		4					1															
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male												15			1					6		41			15		23			1		7					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male										1																											
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female							1								1		1			9		3			21		43			5		96					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																						3															
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												4,155					5,900				
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female															2		1			1		1			3		7			7		22					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female							1			1					2		3			1		19			5		21			10		9					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male												10			1							5			16		8			1		3					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male												61			2					2		42			20		30			3		120					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female												2			7		1			5		13			19					11		14					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male												20			5		8			1		1															
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																	6					40			22		34			5		64					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																																1					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male												28					36			12		8															
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female							1													4		26			18		33			21		27					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																																2					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female					2										1		4			6		16			20		37			30		52					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male												31			9		47			122		144			74		39			71		37					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female							1								1		1					11			9		10			11		10					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female																				1		10			2		11					19					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female							1					3			8		3			6		7			9		4			3		18					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male												7			1		2			3		2															
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female												3			5		5			8		30			23		1			9		31					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female					1		1								1		1			2		17			15		22			21		22					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female															1		4			12		8			21		61			7		117					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male												10			1		1			1		1															
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female																				2		16			6		17			8		11					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female																	118			51		64	40		4		30	54		34		14	57				
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male												6					1					7			17		19			6		16					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male																	602			189		390	2,644		781		1,438			582		1,238					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female																	2			1		2			8		11			1		37					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female							1					1			6		4			4		11			6					4		12					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male												21			2					1		6			21		50			15		49					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female												1																									
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male												22			5		5			1		1															
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												496					546				
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female																	214			157		361	807		442		901			485		1,079					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																	14					31			77		54			12		65					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male												75			5		21			20		78			81		32			85		44					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male												19			17																						
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female																	109			97		250	398		279		549			342		690					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female																	147			119		161	200		18		87			67		58					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female												1			8		3			8		14			14		2			9		18					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male																	346			111		272	1,274		452		938			439		782					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male												34			513		69			25		1			21		24					35					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female							1								1		2			1																	
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female							1								1		1			3		17			10		17			17		10					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female															1		1			1																	
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male												80			582		84			36		4			22		22					59					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female																						1			2		13			1		28					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female																	447			325		714	1,664		844		1,773			933		2,064					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male												42			14		26			6		4															
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female							1										1			1																	
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female																	637			479		872	2,310		1,234		2,299			1,208		2,549					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female															1																						
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male																	42			29		241	450		99		159			176		182					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male												8			2							7			8		10			1		44					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male																	899			269		531	3,742		1,229		1,961			848		1,473					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female																	88			119		327	171		386		788	173		442		1,119	190				
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male																	462			75		188	935		506		761			314		703					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female							1			1					1					1		7			6					3		2					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female															4		9			3		4			3		36			27		162					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male												34			7		28			44		47			90		33			82		27					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male												16			67		4					5			4		9					11					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male												13			142		7			15					6		13			2		20					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male																	70			67		198	222		324		699	229		296		703	252				
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex																	2					3	30		1			40				3	80				
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																						1					2					2					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												3,900					5,850				
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male																	895			239		542	2,926		1,408		1,949			865		1,661					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male																	235			76		754	380		403		637			674		858					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male												15			2					4		30			5		16					28					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female																				1		8			9		23			2		75					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male												5			1					9		64			18		21					52					
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female																				1		4			3		8					28					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male																	190			47		925	935		437		647			747		874					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												1,661					1,736				
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					1		1			1		1			6					8		17			15		7			6		10					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																	1					5			1		1			5		1					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male												23			4		28			45		53			69		22			54		27					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female																	327			187		398	1,056		651		1,131			655		1,392					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male												4					1					7			12		22					4					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female										1		0			1		4					4			5		19			17		173					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												2,393					3,350				
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex																									1							9					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												3,366					3,534				
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												529					582				
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female																	74			41		60	80		14		38			23		19					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female							1																														
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												1,870					1,954				
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female												1																									
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male												79			1		15			25		44			55		25			78		24					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex																	28			3		57	128		92		118	130		80		135	195				
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male												54			3					7		70			21		23			1		178					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male												8			1		5			1		11			27		36			4		7					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female																	244			149		276	360		36		108			88		84					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												1,461					1,534				
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex															1																						
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												1,528					1,601				
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female																	307			168		412	780		53		145			118		111					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female															1		1					2			1		8			7		58					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female										2		3			5		7			6		37			23		1			7		13					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male												25			4		1					15			20		47			10		32					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female																	34			41		166	250		24		68			41		27					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female							1															1			2		9			14		86					
Central and South America Region	Colombia	COL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female																	703			464		883	2,491		1,085		2,208			1,150		2,572					
Central and South America Region	Panama	PAN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male												20			1					12		79			23		14			3		140					
Central and South America Region	Nicaragua	NIC	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male												57			12		45			15		11															
Central and South America Region	Guatemala	GTM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male												13			315		18			17		1			9		17			3		32					
Central and South America Region	El Salvador	SLV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male												14			1		5			7		6			24		7			33		4					
Central and South America Region	Honduras	HND	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																																1					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female																	108			64		116	90		10		62			44		34					
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male																	49			9		92	42		22		56	61		51		78	64				
Central and South America Region	Peru	PER	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male																	110			38		319	210		177		286			381		465					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			27	8	6	10	23	23	20	15	29		93	91	398	78					115
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												372					720				
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																																	150				
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			13	12	13	21	42	15	12	14	14		10	17	7	12					14
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																														2	3						
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																						2			15	6	1										
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																										1					1						
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																													29	34	49	62					33
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												300					360				
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												2					2				
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			7	13	32	29		12	24	21	24		11	28	18	19					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																							641	1	36	140	154		298	278	324	400					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			8	1	1	2	15	4	5	4	4		25	23	82	22					47
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																													5	18	22	22					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																									6	26	30		54	52	63	80					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																										3	1		2	1	1	1					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												1					1				
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												9					11				
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												20					24				
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																													6	3	10	16					1
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																														1	2	1					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			2		3	5		7	13	3	4			2	2	4					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																								1	2	2			2	2	6	2					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												650					780				
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																											1		1	2		4					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			113	126	121	149	99	138	150	158	204	174	160	172	122	201	368				320
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																																	78				
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																																	326				
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																					47	95	40	59	96	125	106		142	208	214	267					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																													8	2	2	2					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												74					89				
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			183	207	206	249	165	262	249	291	320		258	318	205	334					567
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												7					8				
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																										1	2		3		1	1					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			1		2	3		1	4	2	1		1	2		2					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																					4	7		9	3	2	2		3	4	2	1					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							14	1	2	3	1		2	2	2	4					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												49					59				
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			48	105	104	124		80	153	124	86		90	162	189	199					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												3					8				
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																													15	21	36	51					21
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																																	39				
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																																	11				
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												450					990				
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			86	129	209	161	1,098	140	217	151	90		124	157	206	221					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																													7	5	11	15					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			11	16	14	18		11	24	15	17		26	28	25	37					
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																															2	4					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												16					121				
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												49					180				
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			11	2	2		23	4	3	3	5	1	35	29	78	39	45				46
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												300					360				
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												100					120				
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																													3	4	9	9					1
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																																	54				
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																									3	14	19		45	46	38	56					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																													1	2	1	4	64				1
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																																	147				
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			559	640	583	763	495	683	697	726	820		624	731	452	757					1,271
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			8	9	7	10	51	12	19	21	20		41	24	80	30					18
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																					2	5		5	14	3	1		1	1	2	3					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																										1			2	1		1					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																													28	20	48	49					18
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			65	87	84	107	55	110	108	119	158		120	160	92	186					318
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																													7	16	33	32					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												10					12				
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												20					24				
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																																	24				
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																								2	77	194	214		462	397	423	530					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																										6	12		13	14	12	10					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			77	183	197	205		156	259	250	151		174	267	309	340					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																										1	1		2	1	3						
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												976					1,234				
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												1,713					1,918				
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																						1			2	1	3		1	1	2	4					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																						2				1						3					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																										1	8		11	1	6	4					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			2		5	9		5	15	5	1		3	5	1	5					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			353	413	367	457	339	458	487	505	611		465	544	320	628					947
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																									1				1			1					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																																1					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																					33	59	893	42	55	91	65		70	131	126	177					
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																														1		2					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			19	3	5	5	31	9	21	16	16		82	71	304	72					100
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												74					89				
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																										1	2		6		5	8					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																													14	17	28	29					13
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																																	116				
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																									1					1	1						
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			2	3	4	3	5	3	2	1	5		1	2	5						
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																					41	88	30	46	103	109	109		110	187	194	260					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																															1	1	39				
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			571	624	632	703	553	651	658	700	807		593	685	445	722					915
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																													2	3	9	10					3
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																					24	53		38	60	63	77		71	133	135	181					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												2					2				
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																					17	28		20	28	18	32		29	41	43	47					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												627					753				
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																									1		1		2	2	1	1					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			223	266	247	302	280	272	252	244	268		188	225	150	207					224
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																															6	2					1
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																									1	13	20		20	34	35	35					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																																	587				
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																																	4				
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																													1	4	4	5					4
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			7	22	13	15		24	43	38	20		16	45	45	42					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																													3	6	12	17					5
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			16	46	57	39		50	51	76	45		65	79	95	102					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																								2	36	176	200		459	399	397	486					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																										6	11		16	19	22	20					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																								1	8	15	16		31	35	44	56					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												17					40				
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												550					1,250				
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																													1	2	4	7					
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																														3	1	1					
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																														1	1	2					
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																														1	1	1	3				
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																									2	3	2		2		5	4					
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																													1	5	4	9					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																					4	8		4	4	19	5		6	11	13	23					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							23				6		5		1	3					
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																															1	2					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																																	293				
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																											1		2	1	5	5					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																							8		3	67	91		113	155	128	119					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																									1	2	1		1	1	5	1					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																					8	32		17	36	33	43		53	65	75	103					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																													2	1	1	5					1
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																								1	23	83	83		192	168	172	186					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			17	5	4	6	19	8	12	9	14		36	36	179	42					59
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																					7	14		12	22	13	22		20	37	40	64					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																													1			4					
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			27	21	14	25	50	20	32	28	36		79	77	300	78					90
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												184					442				
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																									16	60	60		117	106	108	121					
Central and South America Region	Panama	PAN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												17					60				
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							10														
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												627					752				
Central and South America Region	Brazil	BRA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												17					65				
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												7					9				
Central and South America Region	El Salvador	SLV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																										1						1					
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																													1	8	22	22					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																											2		1		1						
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																									3	54	85		88	125	103	106					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			3		1	2	19		22	7	3					1					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																									2	30	51		53	76	61	60					
Central and South America Region	Colombia	COL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																													5	1	4	7					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																									1	6	7		10	14	16	10					
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			128	270	331	295		240	309	271	153		197	272	292	298					
Central and South America Region	Honduras	HND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																							504		8	34	74		87	104	92	77					
Central and South America Region	Peru	PER	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																																	3				
Central and South America Region	Guatemala	GTM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																			5																		
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													36					40																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		240																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		15																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													16					16																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																		23																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								96		225		130	313		255		209	467																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		30																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								26		70		63	36		104		96	8																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													256		141	197	323	256																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																		45																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																		50																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		15																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																		15																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																		60																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		267																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								171		520		333	552		578		507	133																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		15																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													38					25																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		150																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													50					55																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								73		212		181	257		335		311	73																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													10					10																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													70					50																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		120																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																		20																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													400					267																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													40		15	32	40	40																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													50					50																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																		10																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													16					16																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													70		8	15	21	70																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		10																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													40		17	14	20	40																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													20					10																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		10																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													126		105	147	218	126																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													10					15																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													26					26																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female										13		13	20		11		13	31																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													316		61	90	162	316																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																		90																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		15																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female										16		10	45		20		14	703																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		30																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female										18		15	32		21		13	45																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																		25																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		40																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													10					5																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													20					20																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													130					30																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													66		62	92	125	66																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								138		401		298	372		525		468	44																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female										28		17	23		22		23	12																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																		15																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								25		114		99	115		157		150	33																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													62					62																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female										24		15	22		29		18	51																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													10					10																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female										16		7	7		15		16	34																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													20					10																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													30		4	10	18	30																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		10																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		55																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female										2		1	9		1		4	26																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		90																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													20					20																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		60																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		15																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								10		13		6	22		17		15	433																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																		15																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													276					240																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													50					120																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													40					20																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								19		53		46	46		59		55	49																			
Central and South America Region	Panama	PAN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													20					23																			
Central and South America Region	Guatemala	GTM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													26					26																			
Central and South America Region	El Salvador	SLV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		5																			
Central and South America Region	Brazil	BRA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female										22		19	31		26		27	341																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																		90																			
Central and South America Region	Honduras	HND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		210																			
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		15					60		1	36	22		10		5	11					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		55				1		29	80	84	115		79	60	77	103					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												126					151				
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																		50				1		4	12	14	15		14	15	19	34					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								15		63		38	138		120		55	46	70	80	75	83	238	86	82	92	82		93	127	77	131					206
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		150					45	40	167	178	236		90	132	110	95					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		5																			
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		267				2	1,828	38	171	207	180		179	198	233	321					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								5		24		12	12		26		11	4	30	29	16	27	47	28	26	21	33	102	38	41	30	44	344				59
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												1,100					1,305				
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													23		1	9	11	23	15	20	20	34		72	37	46	41		13	35	29	28					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																		90						2	28	45	54		24	32	27	41					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								19		105		43	176		154		75	244	90	89	87	114	340	99	72	87	119		115	122	93	181					223
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												750					900				
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																																1					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																													4	12	10	8					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												90					217				
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												3					4				
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																											32		38	60	54	32					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												462					555				
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		15						1	3	27	20		4	2	10	5					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													130					30			2	1	28	1	3	3	7		3	8	5	12					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												1					2				
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												587					604				
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													10					10								1	3		1	4	1	1					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female										2		1	7		1		4	13	2	3	3		5	1	2	3	6		2		6	3					4
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		30					32		2				4		2	3					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		15						1	4	37	27		9		11	12					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																		15													1	1					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													25		2	8	12	25	10	12	24	32		76	55	60	43		26	47	47	61					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		15								10	5		8			2					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													50					55		40	39	40	25	16	30	55	57		34	53	42	50					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												1,367					1,640				
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		240				3		70	208	274	311		209	161	282	263					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													70					50		6	47	21	61	8	11	13	9		9	18	7	17					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												6					7				
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													36					40		1	1	3			1	4	6		3	5	4	15					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													400					267		44	53	97	1,663	25	47	116	108		63	98	119	128					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																				44	13	4			1						1						
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													120		12	34	58	120	65	89	98	139		252	178	175	138		96	134	120	158					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												200					300				
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													20					10				1			3	2	3			7	7	12					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								2		7		3	7		14		6	246	10	7	9	9	30	10	10	10	16		21	18	15	22					35
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																													21	24	36	17					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																													1	2	3	2					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													235		28	62	75	240	122	141	189	203		326	300	257	206		142	254	148	238					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																											10		12	34	40	26					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												150					245				
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		30						1	1	26	21		10		4	6					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																														2	3	1					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																													2	6	5	7					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																											3		7	21	28	15					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												15					15				
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												1,325					1,590				
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																		15							2	11	7		2		4	2					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		10							1				2			2					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																											2		3	3	5	4					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												18					29				
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																											1	20	1	3	1		40				
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																													1	1	2	1					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													20		6	1	6	20	7	6	10	11		32	20	21	18		5	12	6	11					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																												2					3				
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												28					160				
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female										6		3	11		12		3	7	3			1	25	1	5	2	10		11	14	58	25					41
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													10					10				1		2	3	1	2			3	2	4					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													38					25		6	10	18		2	6	27	27		7	30	16	35					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																													4	1	1						
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													276					240		56	60	123	40	34	51	142	109		85	106	81	141					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																		60						8	28	25	40		9	29	18	23					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																											3		5	16	22	10					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												900					1,100				
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												53					87				
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												171					205				
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								28		161		50	168		198		83	22	142	146	115	157	373	146	143	155	163		151	223	150	271					351
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																										1											
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		40						1	1		2				1	7					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																		45						3	7	15	28		7	26	10	5					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													10					10	1	6	7	1		77	6	9	25		15	2	3	18					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												750					900				
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												25					55				
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female										9		6	30		13		6	370	6	9	6	5	29	13	22	11	17		11	15	49	21					31
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												55					79				
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													10					10	1	1				20	2	8	15		9		1	5					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																											8		15	44	50	38					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												20					24				
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																		20						8	10	26	26		25	10	22	22					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		10								1			2								
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												35					42				
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																											21		29	81	56	45					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																		23						18	67	50	68		39	33	44	59					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													40					40		6	1	4		41	14	13	31		11	7	1	25					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		90						24	107	106	159		71	109	73	77					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		10						1	1				2		1	4					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													10					5							1	2				3		2					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																		10													1	1					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																		15						1		10	14		7		2	2					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																											1	60	1		1		65				
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female										9		1	4		3		2	22					9			1	2	1	6	2	17	6	67				10
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												35					80				
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												5					8				
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																		25						12	27	42	35		53	45	61	87					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												70					114				
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								34		209		76	266		247		126	64	175	172	179	188	509	174	176	222	217		204	273	197	343					399
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																															1						
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female										10		6	21		11		11	188	11	11	8	10	34	18	18	12	28		14	25	91	35					39
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												35					42				
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																		90						2	10	15	13		6	17	6	2					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																															2						
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		210					1,290	27	135	186	235		104	147	99	101					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												5					5				
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												20					24				
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												10					25				
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													20					10			2	1			1	1	1		3	7	2	4					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												300					600				
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													264		15	28	51	267	77	109	149	159	2,221	265	252	223	215		144	190	186	211					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female										9		3	19		6		4	27	6	1		2	16	4	5	2	4		8	8	24	9					23
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												15					15				
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												1,428					1,028				
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																											1										
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												20					24				
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																													11	11	17	14					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																													18	29	35	30					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													50					120		43	64	90	38	27	61	95	100		62	81	64	91					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																												1	1			4	2				
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												450					540				
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																													7	11	20	9					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female										8		2	14		9		2	24	9	2	2	4	15	9	5	5	14		19	14	83	29					37
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		120						50	175	221	241		169	142	176	241					
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		60						19	58	53	89		35	47	32	26					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													10					10		2	2	4		18	8	4	19		3	2	4	10					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																													2	2	3	3					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													40					20		5	11	11	3	3	8	13	22		6	19	14	22					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													5					5				2		5	15	14	20			1	2	2					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													20					23		13	24	30	2	6	14	25	35		16	22	29	25					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												9					11				
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													10					15						1		1	1		2	4	3	1					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												1,325					1,590				
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																											2		2	7	14	3					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												476					826				
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																											26		19	48	28	22					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													55		15	28	26	55	40	34	55	77		95	87	86	81		52	49	51	75					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																											3		6	23	20	10					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female										5		5	12		1		6	17	2		1	3	9	3	3	1	4		6	4	10	6					20
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																											1		2	2	5	2					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								5		45		11	54		48		28	20	46	37	38	45	107	48	54	43	46		49	73	43	67					117
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																											6		5	9	6	10					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													30					30		2		1	39	37	16	14	27		9	1	3	12					
Central and South America Region	Panama	PAN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												290					350				
Central and South America Region	Honduras	HND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		15							2	19	10		3			8					
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												50					150				
Central and South America Region	Colombia	COL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																											15		17	23	13	17					
Central and South America Region	El Salvador	SLV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												20					24				
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													10					10			1	1		14		3	8		6	3	2	6					
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													50		3	6		50	4	8	11	12		17	9	11	5		8	12	7	14					
Central and South America Region	Brazil	BRA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								4		17		5	18		14		12	29	14	19	14	16	29	22	21	22	29		23	41	29	36					66
Central and South America Region	Guatemala	GTM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													15					15						3		1	4		7	3	1	2					
Central and South America Region	Peru	PER	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																															2	1					
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male						1																															
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				1	1																																
Central and South America Region	Colombia	COL	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male																	1																				
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				1																																	
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male						1																															
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male					1																																
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				2																																	
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male						1																															
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male					3																																
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				1		1																															
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male					2																																
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				3	1																																
Central and South America Region	Colombia	COL	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female																	1																				
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				1	3																																
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female						1																															
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				1																																	
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			9																																		
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male					1	2																															
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male					2	1																															
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				1																																	
Central and South America Region	Colombia	COL	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female																1																					
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male					1																																
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				1																																	
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				1	1	1																															
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male					2																																
Central and South America Region	Colombia	COL	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male																	1																				
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male						1																															
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			14																																		
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				1	2	1																															
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				1		1																															
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				1	1																																
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				2	1	5																															
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female						1																															
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			13																																		
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			11																																		
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			9																																		
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				1	1																																
Central and South America Region	Nicaragua	NIC	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			6																																		
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			11																																		
Central and South America Region	Colombia	COL	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female																	1																				
Central and South America Region	Colombia	COL	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male																1	1																				
Central and South America Region	Nicaragua	NIC	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			5																																		
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				1	1																																
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				3	2	1																															
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male					2	3																															
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			2																																		
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			2																																		
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				1		1																															
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male					1	2																															
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male						1																															
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female					1	2																															
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				1																																	
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male						1																															
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female					2																																
Central and South America Region	Colombia	COL	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male																	1																				
Central and South America Region	Guatemala	GTM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				1	1	1																															
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female					2																																
Central and South America Region	Honduras	HND	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male					1	1																															
Central and South America Region	El Salvador	SLV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female					1																																
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex					1																																
Central and South America Region	Panama	PAN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				2	1	4																															
Central and South America Region	Colombia	COL	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female																							162		1		1	2									
Central and South America Region	Nicaragua	NIC	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			37												276		210			240		587			81		101			82							
Central and South America Region	Brazil	BRA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female								36					276		8		7	314					383		14		6	693		14		4	864				12
Central and South America Region	Guatemala	GTM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			161		137					238		25			172		490			826		343			798		587			443		603					128
Central and South America Region	Panama	PAN	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex																																					1
Central and South America Region	Nicaragua	NIC	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			68												1,033		840			1,124		1,768			316		335			403							
Central and South America Region	Honduras	HND	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			86		16					62		16			64		216			116		141			79		63			21		51					46
Central and South America Region	Colombia	COL	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex																							12														
Central and South America Region	Honduras	HND	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			161		42					142		45			208		421			238		406			215		138			36		78					128
Central and South America Region	El Salvador	SLV	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex															105												9			10		18					23
Central and South America Region	Panama	PAN	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			282		126					45		26			7		7			480		48			14		20			23		9					25
Central and South America Region	Guatemala	GTM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female																						3															
Central and South America Region	El Salvador	SLV	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			35		30		37			246		151			346		456			164		30			74		108			122		154					289
Central and South America Region	Brazil	BRA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male								158					631		24		18	844		3		3	758		58		9	1,777		38		15	1,905				39
Central and South America Region	Guatemala	GTM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			299		177		2			383		65			229		727			1,490		580			1,648		1,206			883		1,306					501
Central and South America Region	Honduras	HND	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex										4							1			4		7			1												3
Central and South America Region	Colombia	COL	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male																							539		2		7	5									
Central and South America Region	Guatemala	GTM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex					11					6		1			5		6					19			10		9			12		22					6
Central and South America Region	Brazil	BRA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex													7																								
Central and South America Region	El Salvador	SLV	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			66		61		89			421		342			424		792			417		57			246		358			352		345					626
Central and South America Region	Guatemala	GTM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male																						3															
Central and South America Region	Panama	PAN	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			153		38					13		7					3			148		17			2		1			9		5					12
Central and South America Region	El Salvador	SLV	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male										1																											
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			102																																		
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			126																																		
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male																															1						
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female						1																										5					4
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex					2	1																															1
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				2	4	9																									18	4					15
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male																	1																				
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female					4	3																							5		1	1					3
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male																			1																		
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female					3	2																									2	2					1
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				14	25	15																		4	13	14	10				6						6
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male					1																										4	1					2
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male																														1	1						
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				3	2	1																							1		2	2					
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male																															2						
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				3	3	7																															1
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				1	4																																
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				2	2																					3	7										1
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female					3	1																															
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				2	7	1																							3	1	3						
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male																															2						
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				1	7	2																							4		1	2					
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				9	5	3																		2	2	2	4				2						1
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male																					1																
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			21																																		
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				1	3	2																															
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				1																											1	2					1
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				1	1																											3					
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				11	12	9																				3	1				2						
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			3																																		
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex					8	4																				3	12				1						1
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				4	2	3																															1
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				1	5	1																							2		5						
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			28																																		
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				3	3	2																									2						2
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female						1																									1						
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				1	4	3																			2	1	1				1						3
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male																1	1		1		1																
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				4	12	8																							12	8	7	2					2
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female																															1						
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male						2																									4	2					2
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				6	9	6																			2	3	3				2						3
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female					1																								1	2	2	1					2
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				2	4	4																		1	1	3	1										3
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex					3	2																		1		6	11				2						2
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				2	1	6																							2	4	1	3					
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			125																																		
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				1		3																									2	2					5
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				5	4	5																															
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				2	1	7																			5	3					2						5
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				1	1																								2	1	2	1					1
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex																																					1
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				2	4	2																		1	1	3					2						5
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			5																																		
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				5	2																										2	1					
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex																																					1
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			9																																		
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				2	4	2																									3	1					1
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex																																					2
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				6	11	5																															1
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				6	6	2																		2	3	3	4				2						2
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex																															5						3
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female					2	1																										1					1
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			135																																		
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male					3	2																															
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female						3																									2	2					4
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				4	3																																
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male																	1		2	2		1															
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				3	7	8																															1
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male					10	3																															
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female																	1		1																		
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female																															2	1					3
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				6	15	14																		5	5	6	9				12						13
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				2	3	4																															
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				1		3																															1
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				3	7	5																							2	4	2						3
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			133																																		
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				7	8	6																		1	3	3	4				2						1
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female																1			1	1																	
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				1	2	3																		1	2	1	4				2						2
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female																						1															
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex						1																									2	2					2
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex																															1	1					3
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female																			1		1																
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				5	4	1																		1		1	1				1						2
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			66																																		
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex						1																															
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			60																																		
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female					4	2																										2					
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			215																																		
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female																	1		1			1															
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				5	9	4																							7	5	4	6					2
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			45																																		
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				4	3	10																							2	1	2	2					2
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				2		1																									1	1					
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male					2	2																									2	2					2
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex					1																						1										
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				3	1	4																								5	4	1					3
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex																													1								
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female					4																								3	2	4	1					1
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				4	2	1																															
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male					2	2																									2	5					5
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male																															1						
Central and South America Region	Colombia	COL	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male																	1																				
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				4	1	5																			2	3	2				2						2
Central and South America Region	Nicaragua	NIC	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female																															1						
Central and South America Region	Honduras	HND	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			5																																		
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				2	5	1																			5	4	1				3						5
Central and South America Region	Panama	PAN	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				1	3																																1
Central and South America Region	Guatemala	GTM	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				3	8	4																			4	2					2						5
Central and South America Region	El Salvador	SLV	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				4	2																										15	18					13
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female																62	60	133	96	100	78	90	101	30	109	110	113		71	68	73	121					40
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			403																																		
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male																110	118	280		161								125					231				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			706	386	477	499	507	708	532	543	555	539	806	526	527	543	214	1,155	261	277	269	281	1,133	268	277	305	310		291	307	296	311					301
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male																163	165	133	251	273	213	276	215	83	316	350	359		369	386	412	440					153
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex								708	11	6	6	5	4	12	4	8	5		1	1	2	4		5	2	2	2		2	1	2	2					5
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male								1,364	494	1,923	1,973	1,965	7,462	1,982	1,934	1,967	2,040	2,036	2,002	1,967	2,030	2,022	2,062	1,997	2,127	2,139	2,128		2,220	2,156	2,063	2,242					2,016
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			2,311	6,306	6,659	6,757	6,855	2,672	2,688	2,753	2,791	2,842	3,193	2,829	2,861	2,897	1,490	3,769	1,798	1,859	1,923	1,953	3,753	1,936	1,966	2,022	2,019		1,973	1,983	2,017	2,033					2,056
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												39					69				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male															14																						
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								196	72	461	450	369	339	590	641	714	728	350	732	778	773	799	603	809	839	867	871		871	888	899	913					967
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			257	259	264	260	310	266	283	276	286		289	291	305	317					377
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								232	77	543	540	444	440	699	787	862	862	453	876	877	884	899	717	878	882	871	877		870	846	837	824					797
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			100	40	175	193	234	194	87	137	149	211	334	203	224	235	198	532	197	245	238	237	793	227	244	192	296		312	356	359	405					337
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			603	628	653	655	629	683	670	689	684		693	694	714	725					769
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			582																																		
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female																		45		1		5	3	4	15	20	23		29	30	34	37					46
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												810					810				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			916	971	972	968	889	966	1,003	1,027	1,041		1,026	1,033	1,029	1,059					1,103
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								96	2	60	63	58	108	59	52	46	47	111	44	48	50	38	119	42	39	39	28		44	36	36	42					33
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			496					307	55	336	292	218	832	363	408	425	432	839	436	432	438	443	857	436	438	426	421		409	408	401	406					412
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			751	783	754	749	739	767	817	828	840		959	980	882	1,020					1,085
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex																	2	12	3	3	2	3	24	15	17	18	17		19	20	22	23					30
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												403					400				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				2	322	23	5	541	571	546	579	910	1,215	1,233	1,326	1,306	1,298	1,299	1,287	1,304	1,309	1,313	1,007	1,302	1,327	1,346	1,343		1,021	1,047	1,034	1,045					921
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			384	291	327	352	354	339	382	391	397	404	426	415	435	460	104	585	159	146	175	174	673	171	159	165	169		172	191	192	201					170
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																						4	5	4	7	17	17		17	20	22	24					31
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			1,246	7	9	17	15	1,439	1,236	1,253	1,272	1,286	1,532	1,239	1,218	1,238	1,375	1,730	1,580	1,721	1,788	1,801	1,776	1,850	1,864	1,904	1,959		2,030	2,065	2,052	2,108					2,220
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			961	1,407	1,509	1,529	1,554	1,082	1,570	1,576	1,592	1,544	1,338	1,417	1,419	1,440	2,235	2,185										3,105					3,673				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			466	429	480	490	227	506	508	527	505		451	464	469	488					462
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female																2	5	25	5	2		3	33	7	12	26	33		34	35	37	45					64
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												451					470				
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male											1	1																									
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			593	640	615	607	421	637	641	505	731		520	536	533	544					514
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			150	60	245	266	324	263	112	162	167	208	473	206	239	242	241	487	278	409	403	410	597	422	420	368	541		551	647	660	607					618
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			1,155	205	217	149	163	816	177	181	462	225	1,856	278	271	285	292	1,947	259	313	276	278	1,524	281	304	317	329		271	277	279	259					273
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			50	46	182	192	196	186	80	115	134	180	294	149	158	157	164	320	223	401	387	389	567	409	418	367	564		571	669	660	625					677
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			551	797	1,247	874	873	1,655	1,027	1,108	1,028	1,441	2,804	1,902	1,946	1,968	2,005	2,872										2,154					2,294				
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												890					1,272				
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												303					458				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												474					475				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male														21						7																	
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								457	58	459	480	450	730	454	453	445	468	631	462	440	444	438	587	424	439	449	465		521	532	490	564					584
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												2,790					2,800				
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			1,433	1,429	1,445	1,404	2,172	1,484	1,537	1,605	1,574		1,688	1,728	1,566	1,798					1,849
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												830					951				
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			882	909	958	933	1,435	1,015	1,045	1,092	1,080		1,243	1,290	1,181	1,373					1,447
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female															6																						
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			15	26	28	24	176	35	36	35	52		56	55	61	57					67
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female																		34										23					29				
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												284					474				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								326	80	618	587	506	782	771	938	1,076	1,107	782	1,138	1,203	1,237	1,270	1,005	1,280	1,330	1,337	1,349		1,355	1,375	1,378	1,419					1,540
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												1,009					1,606				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												3,805					3,994				
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												688					721				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								389	132	807	832	643	683	1,028	1,167	1,292	1,309	683	1,338	1,419	1,423	1,407	1,050	1,418	1,435	1,423	1,437		1,427	1,398	1,405	1,394					1,372
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												3,438					3,449				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			300	320	328	336	201	327	349	347	369		387	394	409	418					465
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male											2	2			1	1	1																				
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												85					70				
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												17					23				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												2,646					2,684				
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			147	206	213	171	168	542	143	132	131	129	1,114	173	163	156	164	1,127	149	132	133	98	1,022	101	106	126	95		78	88	96	93					89
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			50																																		
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex																		11					4														
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female					3	152	289	206	363	399	394	425	465	681	708	702	722	485	704	685	685	683	440	671	700	671	670		663	664	705	694					652
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			248	302	304	296	161	313	320	321	339		353	353	368	379					387
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female																		15					6		1	4	5		4	3	3	5					7
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			613	664	672	664	446	692	692	666	670		688	678	730	734					700
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			48	4	57	64	59	4	64	75	78		82	84	82	92					15
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																							3		2	1	1		1	1	3	3					4
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												638					640				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			398	413	403	402	333	419	431	399	481		352	357	375	377					296
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex																		12					4				1		1	1			1				
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																				5		7	3	6	8	13	14		14	12	19	21					32
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												391					474				
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			584		13	172	212	280	590	448	442	359	797	626	640	650	648	868	688	750	770	780	822	808	864	807	895		918	943	1,004	993					1,041
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																							3		1	1	2		3	6	6	5					5
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												280					280				
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			283	312	292	338	147	372	346	347	359		417	405	435	435					435
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male																	2	35	3	8		14	8	17	26	37	55		64	69	88	99					130
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			438																																		
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			261	290	288	282	218	303	335	305	330		369	377	391	394					416
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male																1	5	25	6	23		32	2	36	64	109	126		127	152	171	181					239
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			905	895	883	861	1,030	915	914	922	911		1,057	1,058	1,008	1,127					1,216
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			806	2,145	2,300	2,327	2,355	813	1,030	1,054	1,064	1,059	1,640	1,055	1,072	1,086	329	1,918	419	438	445	445	1,675	449	453	460	471		479	499	497	520					526
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			412	440	439	458	536	466	485	511	512		522	532	535	545					576
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male								1,434	539	2,266	2,303	2,314	4,210	2,354	2,335	2,342	2,456	1,925	2,444	2,403	2,381	2,458	2,864	2,665	2,661	2,814	2,790		2,947	2,981	2,898	3,301					3,166
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			124	75	83	78	83	415	71	38	35	32	626	90	98	91	96	630	84	78	74	74	601	74	67	67	60		67	66	61	54					54
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												1,014					1,149				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			1,013																																		
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex								2,741	124	123	130	122	22	165	150	154	148	54	137	172	136	137	137	124	129	126	123	117	117	112	116	111	141				95
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			1,653	1,667	1,682	1,653	2,105	1,668	1,694	1,700	1,697		1,874	1,780	1,717	1,942					1,870
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								1,193	326	1,671	1,654	1,640	1,656	1,617	1,630	1,628	1,668	1,326	1,627	1,606	1,640	1,584	1,618	1,766	1,734	1,848	1,795		1,999	2,097	1,910	2,308					2,380
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			18	45	46	48	206	54	53	58	72		76	97	98	98					105
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female																37	37	133	49	55	48	56	83	12	66	69	88		65	66	70	97					22
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			341	95	167	98	109	1,368	120	137	130	167	2,329	185	188	182	192	2,333	175	212	208	202	1,856	209	205	206	214		180	196	205	201					165
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex								971	40	43	70	76		101	99	99	126		113	95	96	93		78	79	73	77	97	71	72	74	74	83				75
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female																97	98	160	144	141	116	129	149	32	140	154	166		90	91	101	177					42
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												1,170					1,671				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,294					1,373				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			8		10	13	14	2	17	16	14		7	7	9	18					
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male																32	41	133	36	34	24	22	132	6	32	26	31		28	30	34	34					13
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			717	11	340	23	26	621	587	576	611	902	1,317	1,142	1,224	1,237	1,240	1,415	1,241	1,198	1,214	1,213	1,081	1,217	1,218	1,195	1,199		951	942	950	954					780
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												703					703				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												42					48				
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								625	144	913	931	905	759	892	874	900	887	799	885	841	847	814	973	848	839	866	895		1,025	1,002	971	1,047					1,095
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																							4			4	3		3	4	3	4					7
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												2,325					2,571				
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male								1,316	464	2,054	2,120	2,111	2,946	2,149	2,166	2,198	2,225	1,765	2,197	2,137	2,159	2,204	2,647	2,461	2,384	2,475	2,624		2,802	2,842	2,696	3,168					3,138
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			25	1	31	27	56	1	24	23	22		14	15	15	31					5
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female					2	146	361	171	349	419	436	400	395	699	718	731	742	406	720	724	729	726	368	711	709	705	727		767	769	795	792					772
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			1,176	1,220	1,198	1,258	1,182	1,282	1,294	1,309	1,304		1,044	969	1,078	1,133					1,111
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			230	250	260	264	111	288	284	284	292		335	330	344	356					373
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex								61					61					61					47							30	27	35					26
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female																24	22	133	32	35	26	30	105	7	26	27	26		15	18	19	46					5
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			457		1	142	330	233	434	357	364	338	533	548	540	578	571	548	524	503	503	506	498	475	472	465	484		475	462	496	498					437
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								1,146	422	1,883	1,945	1,947	1,816	1,975	1,940	1,929	1,954	1,375	1,959	1,907	1,905	1,941	2,668	2,039	2,146	2,206	2,223		2,428	2,463	2,338	2,661					2,734
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male																299	296	146	429	469	368	470	507	155	525	553	708		564	589	658	752					271
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												7,578					9,643				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			743	2,886	3,224	2,954	2,989	342	2,583	222	196	469	697	254	265	288	296	708	275	273	269	268	700	271	277	269	278		276	278	278	261					238
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female																135	132	160	186	190	137	170	181	54	187	198	210		217	222	232	212					66
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			351	358	359	673	779	552	411	698	724	846	1,193	1,251	1,278	1,360	1,393	1,207										2,062					2,269				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				5	257	20	15	452	388	498	521	654	1,209	879	956	988	1,015	1,305	1,065	1,088	1,068	1,082	984	1,118	1,161	1,172	1,183		904	932	955	959					895
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												242					264				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex															27	28	2		4	2	1			1	1	3	2		3	5	3	6					6
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			134	164	231	245	247	136	255	256	263	271	193	273	281	290	55	323	72	68	84	90	294	86	79	78	72		72	76	71	78					80
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												717					721				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,154					1,243				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												403					445				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex												2		2	2	7	8	44	9	36	40	48	55	22	22	22	24	52	24	25	22	26	136				22
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex								291	2		2	1		4	8	1	6		5		1	2		1	1							1					4
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			881	11	230	10	19	709	539	495	517	685	1,493	833	884	884	878	1,577	810	797	804	790	1,309	792	794	760	752		605	606	588	578					528
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			1,540	14	21	26	25	1,783	2,048	2,114	2,182	2,184	1,995	2,138	2,144	2,206	1,748	2,345	2,015	2,127	2,175	2,227	2,322	2,247	2,273	2,377	2,394		2,374	2,351	2,408	2,429					2,515
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex																		5					2														
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			24	7	20	45	50	53	25	28	28	42	69	41	47	45	49	113	51	45	44	45	130	35	29	17	34		32	35	36	76					43
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			414	446	454	460	232	465	488	503	523		546	552	557	575					617
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								598	108	756	732	706	1,332	672	666	655	664	833	645	629	599	575	772	586	606	610	603		710	675	619	728					722
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			11	1	11	12	23	2	19	20	22		10	11	11	19					2
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex																	12		17	15	14	14	8	25	25	26	25		21	25	27	27					22
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								32					32					32					24							4							10
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			67	113	113	112	270	138	128	126	180		183	207	206	198					231
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			378	424	436	477	327	497	512	521	564		585	584	592	617					636
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												523					550				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												4,455					4,568				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												53					53				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			19	3	23	26	15	3	26	27	26		34	32	33	33					2
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									2																												
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			100	38	181	201	215	248	85	117	146	212	331	195	201	208	184	347	245	409	415	416	658	457	491	434	631		650	730	752	738					832
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												45					81				
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			74	157	147	160	292	173	168	154	221		234	245	266	253					303
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female				42	60	63	61		14	37	40	48		39	43	47	44	4	38	97	100	106	462	98	101	66	116		122	169	171	170					159
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex																										4	22		23	6	6	5					
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												49					76				
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			475		8	123	293	245	395	404	399	394	668	681	675	687	679	689	653	637	671	649	667	663	641	650	699		730	731	769	785					813
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												2,161					2,246				
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												168					170				
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male								2,348	1,033	4,523	4,616	4,648	3,612	4,670	4,680	4,783	4,866	2,749										6,150					7,216				
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			422																																		
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male																15	35	37	40	94		143	163	156	278	387	470		464	490	552	605					698
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex								449																2		1	1										
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			536	551	535	553	814	549	571	622	603		464	498	458	483					457
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								2,652	70	60	62	62	4	92	91	94	90	4	83	82	76	71	69	69	70	67	64		65	65	65	64					54
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			560		7	142	182	266	409	275	279	238	567	431	437	428	391	592	348	337	344	325	537	313	338	322	324		314	315	325	327					335
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex																13	11	32	15	16	15	14	39		15	17	18		17	17	17	22					
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								1,038	26	19	17	21	6	41	33	32	35	6	28	27	26	30	62	30	34	36	36		32	35	37	37					28
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female																		28	1	4		3	2	3	8	16	21		19	16	17	21					24
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			23	50	49	55	123	77	73	74	87		89	95	99	91					132
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male																						5		6	6		3		1								
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			35	76	69	79	216	100	112	106	140		147	150	141	146					168
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female								1,352	427	2,634	2,668	2,674	1,889	2,718	2,705	2,751	2,774	1,741										3,637					4,750				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												1,189					1,182				
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																							7		1	5	5		4	4	6	6					3
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									2	239	27	118		1											1	2											
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			26	30	122	113	117	57	74	66	69	88	128	82	84	88	122	180										975					975				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex																13	14	21	11	7	6	5	34		7	6	6		6	6	6	4					
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												715					735				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												5,299					5,461				
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male																						1		3	6												
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female																74	72	146	104	122	101	124	112	28	126	133	132		93	93	105	151					41
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								183	17	220	211	195	232	178	176	163	172	246	156	156	157	162	266	138	170	164	164		165	158	140	168					151
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			82	13	77	89	70	11	96	86	97		106	106	114	114					25
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male								192	20	101	92	85	1,787	81	74	71	70	281	60	61	62	65	155	57	57	69	71		70	70	62	69					42
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			838	1,107	1,876	1,209	1,180	1,910	1,375	1,505	1,439	2,135	3,453	3,247	3,266	3,312	3,370	3,610										3,589					3,758				
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				39	48	53	49		20	38	47	50		37	42	40	45	3	73	119	115	120	309	123	124	120	188		193	223	231	214					261
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								944	37	32	59	55		87	79	82	66		62	50	52	50		50	50	49	48		42	36	38	36					33
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			426	431	440	446	375	479	468	474	500		550	545	568	575					583
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												1,660					1,812				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			2,052	3,161	3,556	3,256	3,350	946	1,594	1,357	1,354	2,010	2,217	1,936	1,687	1,754	1,819	2,557	1,869	1,893	1,977	2,002	2,483	1,967	2,069	2,065	2,164		1,618	1,638	1,660	1,673					1,658
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			1,097	37	523	47	24	716	858	815	865	1,325	1,562	1,781	1,849	1,857	1,860	1,861	1,837	1,836	1,894	1,905	1,552	1,884	1,935	1,942	1,932		1,515	1,564	1,591	1,611					1,629
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			651	203	223	205	201	353	187	101	101	95	721	133	133	144	148	739	145	158	152	142	715	137	148	145	140		138	141	146	153					149
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			1,369	45	427	51	46	816	711	706	761	1,233	1,899	1,678	1,771	1,829	1,882	2,214	1,938	1,902	2,035	2,047	1,987	2,058	2,125	2,160	2,213		1,713	1,732	1,780	1,840					1,930
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			310	804	940	848	877	717	916	908	910	874	1,201	1,100	1,330	1,470	1,476	1,208										1,996					2,162				
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			873	827	887	920	296	965	972	991	918		837	852	877	885					787
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female																98	107	165	141	157	115	142	177	40	140	144	142		89	87	105	153					51
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male																9	22	36	26	38		60	4	85	130	206	232		253	264	309	346					491
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				9	418	34	28	604	742	712	737	1,202	1,444	1,780	1,895	1,943	1,939	1,643	1,960	2,011	2,020	2,064	1,258	2,070	2,116	2,131	2,092		1,636	1,636	1,668	1,666					1,539
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			3	1		3	4	4	8	15	25		25	28	32	34					34
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				1			3	206	178	178	180	176	281	153	136	146	408	501	451	480	505	519	523	511	536	552	555		543	546	555	554					604
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			767	742	882	274	787	355	472	312	302	327	1,308	495	507	541	536	1,384	483	470	461	484	1,401	472	490	513	493		486	487	519	525					485
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male																57	58	148	89	101	81	96	106	21	121	117	130		142	146	149	161					33
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			364	420	428	718	829	657	421	714	719	820	1,674	1,276	1,374	1,408	1,493	1,680										2,162					2,430				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			42	9	31	38	68	12	41	42	45		30	32	34	48					10
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			653	701	701	682	647	678	709	664	698		722	727	768	768					725
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			878	1,819	1,721	2,218	1,636	323	522	455	465	420	1,209	669	693	720	714	1,278	699	688	716	721	1,207	724	747	756	804		803	801	888	906					961
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			194	113	136	127	130	884	99	52	51	44	1,285	97	97	94	90	1,285	84	89	90	88	1,202	88	84	83	75		78	79	86	82					76
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			484	1,253	1,553	1,321	1,359	1,227	1,405	1,226	1,229	1,193	2,244	1,490	1,869	2,155	2,167	2,248										2,886					3,112				
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex																										5	38		37	11	11	13	48				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex																12	14	52	9	11	9	9	54	2	9	9	8	61	7	5	5	8	61				
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex																											6		3			3					
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male								870	215	824	800	772	5,163	775	724	676	719	1,323	643	628	581	590	894	531	623	618	621		660	665	631	692					602
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			1,164	4,396	5,099	4,593	4,723	615	4,174	561	599	1,136	1,379	720	831	943	999	1,392	1,031	1,086	1,098	1,088	1,403	1,112	1,130	1,138	1,119		1,116	1,112	1,141	1,128					1,116
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			776					532	126	651	648	481	949	793	941	1,074	1,126	949	1,190	1,246	1,271	1,331	1,195	1,323	1,381	1,344	1,367		1,382	1,408	1,460	1,479					1,563
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												5,893					7,863				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			403					270	89	464	484	355	450	570	654	661	664	453	660	667	653	626	540	622	618	630	620		607	603	600	600					545
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												359					360				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male																133	135	133	188	191	171	204	151	36	223	233	245		265	261	272	290					82
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			186	202	208	210	133	221	232	241	250		254	272	267	280					305
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			357	388	391	409	544	405	417	429	434		419	426	438	451					464
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			437			2		440	407	410	415	406	501	406	415	419	455	624	511	532	530	521	601	517	538	543	526		518	523	533	536					547
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			8	15	14	18	120	23	20	22	30		32	40	36	41					59
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			261	281	289	281	453	292	292	309	304		314	333	329	328					356
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								1,454	1	1	2	1		33	33	36	36		32	31	32	33	52	32	32	29	22		20	19	19	18					16
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			551	561	598	559	830	606	605	660	656		724	742	663	776					861
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				21	70	67	72	51	43	36	48	62	135	46	49	52	75	173	108	217	217	232	339	271	270	248	344		344	372	370	349					429
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female																						1															
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				34	158	158	165	49	52	92	126	182	223	159	162	162	139	244	196	338	331	336	445	358	361	368	505		521	543	542	497					598
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female																3	4	20	6	1		2	9	2	5	12	11		17	17	13	15					24
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												1,355					1,648				
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female																	2	30	2	4		13	3	14	19	26	29		27	28	30	35					44
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			735	505	611	179	436	319	215	194	180	152	768	296	293	276	276	833	256	244	234	241	796	236	243	243	244		233	240	243	248					229
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			691	729	741	766	986	804	796	819	838		646	621	689	708					657
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			141	226	235	177	176	306	138	121	122	121	538	167	164	161	147	585	140	122	127	122	518	110	114	114	114		106	110	112	118					99
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				11	377	38	10	504	541	651	683	920	1,326	1,426	1,498	1,515	1,555	1,521	1,608	1,611	1,652	1,624	1,177	1,651	1,678	1,699	1,744		1,403	1,409	1,442	1,467					1,437
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								385	8	11	17	16		31	31	30	38		29	25	24	25		21	20	20	19		17	17	20	18					21
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				1	2	1	2	207	96	97	99	99	261	78	77	82	383	540	408	432	438	423	609	435	452	486	486		485	478	475	488					527
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male																1	5	17	6	5		3	8	2	3	7	10		10	14	13	14					14
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			537		2	4	7	542	729	746	756	753	616	745	747	750	331	851	398	449	439	440	791	444	467	482	487		488	490	515	520					592
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male																23	56	54	67	108		164	230	166	273	414	439		447	433	486	505					556
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			209	232	231	240	193	234	233	255	250		248	250	242	253					259
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			556	593	611	614	903	633	648	664	677		692	721	745	762					828
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male					6	109	280	175	298	384	369	387	471	617	633	625	632	509	633	628	633	631	480	647	621	643	670		702	713	753	764					775
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			1,018	521	606	547	576	680	496	308	316	321	1,675	406	415	429	475	1,704	469	465	469	491	1,759	469	467	461	456		440	454	451	455					406
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			1,152																																		
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex								2					2																								
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								586	1					10	13	9	7		6	7	3	2	11	3	4	5	5		6	5	6	6					9
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								593	149	929	936	928	1,142	910	929	910	932	769	912	879	910	866	1,031	888	919	951	934		1,098	1,119	1,005	1,145					1,277
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			659																																		
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			219	80	108	97	103	952	113	109	110	106	1,490	123	133	141	144	1,501	126	175	132	129	1,289	133	135	138	140		124	123	124	128					117
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									4	195	29	53																									
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			613	636	646	634	1,014	671	749	745	743		867	926	829	976					1,122
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female				38	72	79	84		15	38	40	53		48	50	50	59	4	69	120	116	120	424	128	111	95	175		164	228	230	234					234
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male																401	403	170	554	611	474	584	573	186	628	708	766		507	520	552	816					274
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			10		18	19	24	2	25	29	30		39	39	41	42					6
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female				2	21	5	3		2	9	7	9		7	8	8	8	6	6	25	25	23	87	23	26	15	30		35	51	55	58					48
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female																54	55	266		79								100					104				
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male																14	31	50	35	54		81	10	79	131	175	186		186	179	183	167					179
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			473	500	508	513	354	527	568	586	584		621	621	645	652					712
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			1,781	442	689	425	458	1,050	505	559	498	749	2,478	915	921	943	970	2,717	944	987	986	1,020	2,378	1,012	1,078	1,093	1,155		857	894	960	980					929
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			363	370	389	405	474	401	420	437	447		439	451	458	465					523
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male																1	3	35										15					50				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex								1,543	9	2	5	4		71	67	67	70		68	67	68	66	98	63	62	58	62	72	58	53	49	48	81				38
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			846	865	868	895	984	912	934	1,091	960		733	838	784	811					789
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female											1	1			15	1	1																				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female																						3		3	4												
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male					8	115	354	212	355	356	337	381	549	600	665	680	709	596	717	704	684	714	579	688	735	694	732		750	742	797	799					804
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female														6						2																	
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												4,900					5,690				
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female				8	19	23	28		19	26	31	39		27	28	29	46	7										377					381				
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												1,251					1,306				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			630					461	125	722	679	536	784	827	1,019	1,096	1,107	784	1,097	1,176	1,162	1,194	1,044	1,190	1,216	1,242	1,263		1,284	1,319	1,327	1,347					1,468
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												1,783					2,028				
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			874	925	934	968	1,091	958	959	938	963		970	997	1,029	1,080					1,185
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				15	13	42	44		11	25	29	38		25	24	24	25	2	36	96	97	94	279	105	116	109	158		159	182	181	182					205
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female				31	56	37	32		9	25	18	19		15	15	17	24	5	24	64	63	60	270	61	66	46	74		71	104	96	96					99
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			31	70	74	69	228	77	77	73	106		105	129	126	123					143
Central and South America Region	El Salvador	SLV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			372																																		
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								12					12					12					10							1							7
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female				37	59	78	73		18	53	69	70		49	49	43	62	3	87	155	146	141	373	131	138	123	200		209	233	252	241					232
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			1,320	2,262	2,441	2,293	2,340	791	1,122	840	569	1,110	1,581	794	499	504	501	1,687	477	510	513	497	1,408	466	485	477	467		381	385	387	390					396
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			335	450	509	513	519	338	520	520	524	493	385	446	431	427	952	1,141										1,300					1,470				
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			841	1,746	1,643	1,903	1,569	297	350	224	231	177	697	343	331	287	276	818	276	289	300	286	736	278	287	286	276		299	301	310	315					306
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								306	46	362	345	355	653	338	350	355	360	390	335	293	294	292	419	305	310	332	316		345	348	326	360					366
Central and South America Region	Nicaragua	NIC	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																																	33				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				2	3	10	8	664	470	475	479	494	749	437	431	436	862	915	985	1,043	1,083	1,089	918	1,078	1,130	1,169	1,169		1,189	1,217	1,237	1,239					1,340
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												247					247				
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												4,742					5,186				
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																				1		4	5	2	3	5	8		6	9	8	12					15
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				4	2	11	15	664	871	890	899	903	754	856	823	835	1,083	1,016	1,210	1,326	1,344	1,405	1,086	1,396	1,480	1,517	1,552		1,558	1,547	1,601	1,672					1,781
Central and South America Region	Peru	PER	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female																	3	22	3	5		11	121	9	20	34	36		32	36	34	35					30
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			460	488	495	500	532	511	491	494	526		555	554	586	602					598
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			889	941	946	944	1,765	962	1,128	1,056	1,065		1,234	1,306	1,198	1,359					1,504
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			718	785	806	824	741	826	858	895	908		910	913	909	909					948
Central and South America Region	Panama	PAN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			2,018	1,049	1,169	1,224	1,249	2,271	1,323	1,357	1,399	1,520	2,367	1,518	1,541	1,606	798	2,846	969	988	1,021	962	2,747	962	991	1,005	1,019		983	1,005	986	1,046					1,022
Central and South America Region	Honduras	HND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												667					665				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male																310	324	179	412	402	310	375	474	137	403	409	427		385	394	416	450					148
Central and South America Region	Guatemala	GTM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												99					118				
Central and South America Region	Colombia	COL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex																		2					2														
Central and South America Region	Brazil	BRA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												3,061					4,213				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												641					455				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			26	62	52	36	62	291	7	3	6	10	444	18	18	17	11	376	13	23	14	16	171	27	24	9	21		15	15	10	16					14
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex								222				2			1	1	2									1			1		1						3
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																									8	7	8		5	4	7	5					4
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								3	1	2	3		6	2	5	2					5
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex									3	1	3	1		2	1	1			1	2	1	5		4		2	1				1						2
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								1	1	2	4		3	2	3						3
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male								145	41	160	114	137	5,970	137	170	197	171	161	195	189	188	146	104	178	202	211	221		211	205	250	257					113
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												220					313				
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								19	13	16	18		22	24	42	41					11
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			25	10	20	13	12	473	12	12	3	19	810	17	33	24	19	458	15	42	17	21	104	17	23	26	29		24	33	26	29					13
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male																127	153	78	62	51	27	99	299	23	124	94	73		73	85	89	84					25
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			254	145	103	118	106	371	120	73	37	99	514	62	69	79	93	912	77	78	74	82	983	74	79	87	70		51	65	62	57					67
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								52	3	8	2	3	55	5	7	16	10	95	6	7	9	9	128	5	5	7	4		7	6	7	9					5
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female									2	59	35	45	367	51	45	63	66	34	59	54	73	66	734					373					622				
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			20			2		115	1	19	9	14	243	27	35	39	24	190	36	29	23	32	212	27	29	17	21		23	22	21	19					26
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								126	2	63	37	29	489	23	46	46	54	63	43	55	48	49	67	55	49	65	58		68	76	95	142					41
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			97	28	19	28	25	123	6	6	15	10	171	11	19	26	20	865	26	34	26	38	480					189					450				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			17	16	3	5	14	262	10	10	6	7	426	13	12	20	19	341	12	13	20	12	152	16	16	10	24		16	16	16	12					12
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												14					19				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																									2	2	1		3	8	5	6					3
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			16	7	2	9	2	119	5	1	6	3	309	9	8	10	5	198	5	5	7	4	50	3	4	6	3		5	8	7	13					9
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male																18	49	59	7	10	3	9	59	2	24	12	8		11	10	4	17					2
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex											1				2		5		1	2	1	1		2	1						1						2
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male																147	162	74	66	64	52	122	398	23	148	130	96		95	79	96	119					61
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								62	2	7	3	3	72	11	10	15	11	124	9	9	5	10	144	5	5	13	7		7	8	1	2					3
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			8	5	8	4	4	5	4	6	2	7	14	3	8		3	33	8	2	5	5	30	7	1	5	7		1	10	5	8					1
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			212	94	68	95	55	317	60	44	41	74	385	45	70	79	81	676	71	58	73	72	654	68	84	92	86		50	63	60	72					69
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												39					23				
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												85					8				
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																										1	1										
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			21		7	3		64	7	5	3	1	91	10	11	11	5	132	6	9	7	3	43	7	13	4	5		4	6	12	8					5
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								122	4	60	56	56	654	57	65	65	72	82	66	70	58	102	212	74	81	79	82		94	100	139	161					45
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex										1																					1	2					
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								1		1	4		3	2	2						1
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																									24	27	20		20	24	33	45					12
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female																								1	1						1						
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												179					120				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												82					79				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			58	17	21	27	13	40	13	15	11	30	105	9	12	10	19	305	13	13	11	18	255	18	16	19	8		14	17	15	23					23
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								1	1		1		3	2	4	1					
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												35					3				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			128	6	9	14	12	200	40	18	17	27	206	30	45	51	37	393	37	32	32	48	445	17	39	36	34		35	33	21	23					38
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								4	9	3	6		6	1	1	2					6
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								2	13	5	18		9	7	12	9					4
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												376					1,109				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												149					120				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male																						7					2		1								
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female																15	19	63	13	16	11	15	30	2	20	17	15		14	16	12	19					4
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male																42	48	59	28	21	15	30	137	13	48	46	44		28	38	47	46					26
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												271					134				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			20	9	2	2	6	8		13	1	1	22	10	5	3	4	57	11	18	14	6	204					527					154				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex																6	4	10	1		1		13		3	1			2			1					
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			49																																		
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			8			1		82		10	1	4	124	8	15	11	9	207	9	1	7	12	121	6	5	4	5		2	2	3	5					2
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male																3	10	119	13	15	10	20	11					50					99				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				3	2	7	9	91	23	21	9	17	98	13	22	23	28	365	20	19	34	32	302	25	25	20	27		22	31	20	24					16
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												4					17				
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female					3	1	2	45	4	4		4	73	9	6	1	6	105	6	5	10	8	30	8	11	5	8		7	3	11	5					3
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex								379								1						1	53		1												
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			35			2		28	5	4	6	7	65	13	8	11	12	145	10	7	7	8	148	6	11	6	9		8	6	8	5					14
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								1	3		1			1		1					1
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																																	4				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				3	1		2	9		10	6	1	23	1	3	4		48	2	11	5	7	69	7	5	9	7		5	9	8	1					2
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			7																																		
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female																		7				2	1			3	1		2	3	1	2					2
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male											1																				2						
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			40	10	17	12	20	27	12	14	13	22	63	11	21	15	17	221	12	25	24	15	268	33	28	18	13		31	31	23	16					12
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								6	12	6	8		7	7	9	18					9
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												65					2				
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								98	1	14	4	8	208	21	29	28	16	165	17	21	25	31	213	27	21	20	16		22	10	17	14					22
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			16																																		
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			28	6	7	5	6	21	1		5	1	51	7	7	4	20	728	11	14	4	16	442					90					140				
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female					2	3	2	42	5	3	4	1	61	5	3	4	8	82	1	2	7	8	18	2	6	6	4		7	3	5	7					4
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								2	3	1	2		2	1	3						3
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												83					32				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																									1		2			3		5					1
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								10	17	7	15		10	11	10	11					11
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				2		1	1			2	2	2				3	1	1	1		2	7	89	4	1	2	2		3	3	2						1
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			87	14	29	38	27	82	23	20	10	15	388	34	30	43	32	330	34	35	41	51	241	35	49	33	26		32	38	37	46					33
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex																			2	1	1	1	8	1		4	1					2					1
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				3	1	1	2			1	3	1		3	2	1	2	1		3	2	1	99	1	1		3		6	2	2	2					4
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female									2	25	14	29	311	22	29	25	20	4	26	22	23	31	22	28	33	27	33		34	25	47	38					23
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			33																																		
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female									1	20	6	15	11	10	14	14	20	4	16	13	22	16	5	14	27	27	26		25	22	33	33					11
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex								151							2	1						1	11								1						2
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								6	10	5	3		3	1	2	5					6
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male																1	4	4	1	1		6	1	2	1	5	5		5	6	7	10					5
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			122	39	75	83	56	363	44	55	21	50	888	65	76	92	96	670	83	71	97	99	416	86	106	104	107		58	86	107	99					77
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				6	5	2	10	168	4	10	6	5	330	9	8	8	6	301	13	11	6	14	47	10	8	8	10		4	13	8	16					3
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																										1					2	3					1
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			42	17	17	16	33	663	25	29	15	23	1,005	20	26	15	29	801	31	41	36	34	203					438					539				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				7		1	2	198	10	9	2	6	331	6	8	11	8	292	9	9	13	10	90	18	14	7	10		8	11	8	12					10
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female																1	8	59	6	4	8	6	8		10	6	15		10	8	7	13					3
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male																14	17	8	4	8		35	13	11	23	25	25		14	19	22	22					18
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												144					47				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			18	1	7	7	6	23	6	24	9	3	57	9	9	5	5	58	10	18	18	15	118	18	14	13	18		17	9	21	6					12
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female				1	2	1				4	4	1		2	1		1	1	1	8		4	121	3	2	2	4		5	2	7	1					1
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			64																																		
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			18																																		
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female				1	4	1	2				2	1		3	1			2		3	4	1	189					95					40				
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								3	5	4	4		4	6		2					3
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												271					261				
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male																1	2	6				2	6					1					12				
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male								140	14	93	66	84	1,524	79	82	88	71	139	106	78	90	122	189	88	128	140	145		159	144	193	257					72
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								3	1	5	6		6		5	7					8
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female											1																			1	3						
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								7	9	5	3		5	6	5	1					4
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female					1	2	1		6	1	1	1			2	1		1	2	1	4	4	70	2	1		3		1	3	5	4					1
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								2	1					1							1
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female																																1					
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												81					56				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			41	19	17	28	12	47	12	12	9	44	67	16	17	27	21	164	14	22	19	34	248	24	37	32	24		36	45	28	24					24
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female																36	72	71	24	21	16	33	95	7	26	33	22		15	32	22	12					8
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								1	32	28	27		33	26	39	66					15
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								7	9	7	2		6	7	8	5					3
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex																		2																			
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												1					7				
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												348					599				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												416					287				
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												107					140				
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												99					60				
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female																		2													1						1
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			65	32	40	34	30	51	27	24	14	26	265	16	16	21	16	445	13	14	13	19	278	12	15	16	17		29	9	13	21					24
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												461					158				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																																	6				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								3	6	3	2		2	4	3	4					2
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex																			1			3			1												
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			12	1	1	3	5	95	4	2	2	3	116	5	4	4	7	198	8	6	6	4	90	5	5	3	1		4	4	5	3					6
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			59	9	22	17	29	36	20	10	14	19	90	22	34	16	11	77	12	19	42	29	116	25	33	33	17		23	38	28	20					16
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												4					32				
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			5	3			2	75	1	1	2	3	94	3	4	6	4	150	7	5	3	4	35	2	5	4	5		3	2	6	2					5
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												298					274				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												403					634				
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex								90	1					1	2				1	2	3	1					2				1	1					
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			53		8	6	8	56	8	11	10	9	197	18	21	26	26	147	19	13	24	16	93	23	18	20	28		22	18	21	24					20
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								39	54	44	50		55	51	69	98					22
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			71		13	3	5	65	13	12	9	23	234	22	27	18	23	227	31	31	31	25	101	30	49	28	32		34	33	24	36					28
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								2	9	7	7		4	11	8	9					5
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female									2	30	22	16	616	16	27	37	33	15	28	34	24	30	10	38	31	32	39		39	29	53	45					16
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male					6	3	2	40	5	8	5	1	140	5	16	15	7	131	8	8	9	16	47	12	10	11	5		13	15	16	12					13
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								13	25	12	18		20	22	35	46					15
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								2	1		6		5	4	1	1					3
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female																26	43	71	19	15	13	11	61	1	27	22	10		14	18	14	14					3
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																									2	4	1			3	1	4					3
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												56					37				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex								957			1	2			3	7		40		1			63	1		1	2	17			1	1	25				3
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female																2	3	4		1		3	18	1			3		1	1	1	4					1
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female																	3	4		2		5	43	2	4	3	3		5	4	1	4					4
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												227					252				
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			16																																		
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female																		6		1		2	13					2					6				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												140					49				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex																		2					2														
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male								249	9	82	65	73	1,297	74	70	80	95	163	83	97	106	130	701					506					556				
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								40	24	21	26		42	37	42	75					13
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex								400								1			2		1	1	100					8					15				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								4	1		1		1	1	1						2
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female																	2	5		2		3	3	2		2	3		1	2	2	2					3
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																									4	4	4		3	3	5						1
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male																	2	6	1			1	1	1		3	1		3	2	6	7					2
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			118																																		
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				7	5	5	8	175	9	15	8	9	437	12	21	23	24	366	17	14	23	20	97	13	26	22	25		11	12	20	14					27
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			5	3	1	1	4	191	3	8	3	5	183	6	15	27	7	300	7	13	7	13	316					205					232				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								13	5	7	6		4	7	8	3					12
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												416					82				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								2	2	2	1		1	1	1	1					1
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			32	27	24	18	24	68	4	2	3	3	118	6	8	12	3	262	15	5	8	11	47	7	5	7	10		8	6	9	4					2
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex								365	1	2	3	1					1		1	1	1	6	46	2	1	3	2			1	2						2
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male								21	7	14	9	9	1,585	10	6	7	10	7	12	14	12	6	1	8	10	18	18		14	21	14	16					11
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			28	3	5	5	4	73	3	3	2	5	127	8	6	5	5	212	7	11	9	9	91	6	10	7	12		5	10	3	12					6
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female																3	1	4	2	1		2	2	1	1	2	1		2	3	1	2					2
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			17		1	5	2	54	3	4		1	82	11	8	6	9	112	7	12	6	5	38	14	9	5	7		7	5	4	5					11
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				1	2	1	2	14	2	1	1	6	33	2	7	4	7	324	4	6	5	2	189	7	11	8	4		6	6	6	7					2
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			12	3	8	7	6	135	3	7		3	192	7	6	5	11	243	10	6	9	10	65					310					232				
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			8					72	1	3	4	2	70	13	10	6	10	110	8	4	7	5	86	5	5	6	7		7	10		10					2
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male					8	5	6	47	5	10	7	5	164	12	17	20	14	155	16	14	10	16	74	13	20	11	20		14	11	20	19					15
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								3	4	5	1		2	6	1	6					3
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												124					304				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female																15	15	59	7	11	4	7	27	2	17	11	10		11	14	13	9					6
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female										1																				2	1	1					
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			12	4	9	10	15	92	10	3	3	5	111	9	7	13	7	184	7	4	13	7	92	11	7	9	10		6	10	5	4					6
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								1		6	6		2		2	4					3
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												273					128				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female				3	4		4			5	5	6			2	1	3	1	1	3	1	2	135	3	3	2	1		4	4	6	6					4
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												47					93				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex																		2					12							1							1
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex								226						3	1	1	3		1	1		1					1		1		2		5				2
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male								93	29	132	59	74	4,197	93	82	90	117	113	100	91	79	61	8	82	108	108	101		111	92	123	101					92
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																										1	1		1	1							
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												15					22				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																									3	1			1	3	4	3					
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																									2	2			5			2					2
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												560					1,116				
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								8	1	6	3		4	7	5	2					2
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male																15	19	6	5	10		38	97	7	27	26	26		27	27	24	47					24
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												31					33				
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female										8	8	7	4	6	1	1	4	1	1	8	5	4	5	8	4	4	3		6	6	8	9					5
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												174					139				
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male								153	16	117	129	119	2,683	131	130	127	160	133	173	161	137	198	213	165	169	175	194		189	201	230	289					88
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male														1															3								
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female				2	3	1	2		4	2	2	2		2	1	2	1	1		2	1	3	168	3	4	1	2		7		3	3					4
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			11	8	12	14	3	10	5	1	5	20	25	4	6	10	7	93	5	7	14	14	62	8	11	8	9		12	8	10	11					10
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				1			3	14	3	4	2	4	36	9	5	9	4	242	4	11	9	17	138	7	13	6	4		6	4	5	6					4
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex																5	1	15	1	5	7	8	18	1			2	1		2	1	3	53				1
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female									1	17	24	23	173	24	21	25	29	10	34	23	30	32	7	28	36	32	43		41	34	51	60					19
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				2	3	7	5	91	15	8	5	14	96	15	14	17	18	257	9	16	30	12	208	12	22	17	15		15	15	11	19					20
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			27	8	5	7	16	171	27	30	9	26	520	40	47	51	48	442	37	30	40	44	288	29	38	30	32		29	32	27	42					22
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			170	11	18	14	21	251	87	72	62	50	289	65	58	80	51	520	46	49	66	79	593	63	53	69	35		48	41	32	48					40
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			14	5	6	7	6	311	5	16	9	13	654	22	25	46	18	551	17	22	22	20	465					295					324				
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												33					20				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			172	95	113	130	148	328	49	66	26	70	786	84	76	88	107	695	119	104	108	102	592	88	105	84	107		62	74	85	92					78
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												453					293				
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male																23	34	9	11	14		41	36	16	27	47	27		32	28	34	38					23
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			40	12	13	9	8	35	13	14	7	12	63	11	11	9	13	56	11	13	18	20	138	24	25	24	13		28	19	37	13					18
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																									2		3					2					
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								22	12	13	9		7	6	13	12					8
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												252					100				
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												77					41				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																									1	2	1		1	3	1	2					
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex																		2																			
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			103	58	73	65	60	74	15	22	14	26	354	21	36	47	23	305	31	46	45	42	153	55	51	45	37		46	40	53	54					38
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								2	2	3	4		8	7	7						5
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								83	2	11	4	6	228	17	18	20	21	188	16	8	17	16	164	13	17	14	6		5	14	12	15					20
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												56					63				
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female					2	2	1		2	3		2			1	1		2	1	3	1	2	28	1	1		3		4	2	5	1					2
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								3	6	1	2		3	2	1	3					2
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																									13	13	8		13	13	21	34					9
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																									5	2	4		4	1	2	1					1
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								12	9	6	8		7	6	7	8					7
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female																12	23	59	5	9	2	6	31	1	4	7	7		5	8	9	3					1
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex																2	3	24			1		4		2	1		53	1			1	14				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																										1			4	1							1
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												5					18				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex																6	2	14	2	1	2	1	7		3	3	1		2		1	1					
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												120					129				
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female																		5	1	1			1		1	1	2				1	3					
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female									4	17	12	21	473	20	24	21	26	12	28	30	24	35	99	27	33	39	30		37	43	56	66					19
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male																9	13	6	4	2		14	3	13	8	9	13		10	11	13	21					16
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex																1	1					1			1	1	1			1		1					1
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												84					120				
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								14	10	15	13		23	17	19	39					5
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												215					298				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			4	11	4	8	15	353	5	3	1	1	413	6	5	9	8	308	2	8	3	9	41	8	10	7	6		5	5	5	4					4
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male										8	2																				2	2					
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male																68	124	63	51	62	30	81	385	20	95	95	75		58	74	83	98					38
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male																								2	2												
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			66	8	9	10	16	248	25	26	17	37	548	16	42	43	49	473	37	45	41	40	216	37	46	28	31		17	38	46	41					42
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																									1												
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male																1	4	4	1	1		3	2	1	2	2	2		2	5	5	5					1
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								1	1		1		2		1	1					1
Central and South America Region	Peru	PER	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								1					3	1	1						
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			22	39	10	9	16	302	9	16	4	5	514	9	14	17	14	414	13	14	10	18	133	14	12	11	12		10	12	11	10					12
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex																										1							14				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male																15	11	65	7	6	4	8	23	1	13	9	10		9	13	17	8					6
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			5	3	1		3	220	5	4	2	4	407	4	7	2	6	311	14	7	11	10	101	9	6	8	3		7	8	12	4					8
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female																10	4	116	11	4	8	7	12					30					46				
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			33	24	24	23	52	156	33	41	14	22	419	42	60	86	70	349	49	49	67	61	188	58	55	34	41		49	44	43	41					44
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male																29	30	59	14	15	18	20	74	5	28	23	40		31	14	24	39					16
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			116	7	13	15	24	284	29	30	20	44	671	43	45	75	61	543	60	78	82	57	357	50	72	62	66		49	60	57	62					63
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								5	11	5	7		3	8	3	5					6
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								6	4	10	6		6	4	10	5					8
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								2	2	10	7		1	10	5	3					2
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								11	5	5	7		8	7	4	8					5
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			12	13	1	5	16	232	13	15	10	14	365	8	9	14	12	325	10	13	14	20	88	13	16	12	11		13	14	9	11					11
Central and South America Region	Honduras	HND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			41	8	7	17	6	152	6	11	2	4	483	12	19	15	18	315	22	20	11	22	94					284					294				
Central and South America Region	Brazil	BRA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female										20	21	19	44	20	32	32	26	11	32	20	33	36	60	32	29	43	32		34	41	69	75					17
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																									1	1	1			2	2	4					1
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												467					638				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			10																																		
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												239					70				
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												71					163				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			8	19	11	13	22	613	4	11	5	6	738	7	13	13	11	626	8	13	16	19	204					260					280				
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex								926		2	2			1	2		2		1		1		52	1	5	5			3	1							
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												386					301				
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												103					64				
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			22			3	10	134	8	22	13	13	295	26	42	61	44	228	38	26	46	39	230	43	42	28	32		35	32	54	26					26
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								2	1		1			1	1	1					1
Central and South America Region	Guatemala	GTM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				4	4	5	18	211	14	9	11	17	509	19	27	31	26	392	20	31	30	35	107	35	27	22	42		15	21	40	29					32
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female																37	62	72	21	19	12	24	87	5	23	19	12		19	24	27	11					12
Central and South America Region	Nicaragua	NIC	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				2	4	1	4	7	1	6	8	4	38	9	6	3	2	46	13	16	17	6	87	9	11	10	8		18	12	13	6					8
Central and South America Region	El Salvador	SLV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			2			1		113		2	1	2	94	4	4	6	3	157	2	2	3	1	60	3	2	1	1		4	3		1					3
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			44		2	4	7	33	16	18	12	25	79	8	9	5	12	216	11	13	10	9	153	11	14	15	7		9	16	12	7					15
Central and South America Region	Colombia	COL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																									1					2	3						
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								3	7	7	2		5	3	6	4					3
Central and South America Region	Panama	PAN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												385					352				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								619	614	573	621		630	625	661	668					560
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex													57					57											20	25	24	26					24
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				7					356	382	527	831	1,093	1,081	1,177	1,288	1,360	1,319	1,408	1,409	1,447	1,445	1,066	1,486	1,506	1,535	1,587		1,254	1,286	1,318	1,343					1,289
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								252	238	248	269		300	303	321	323					274
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				20	1	2			401	432	549	800	1,098	865	947	1,007	1,081	1,264	1,072	1,063	1,049	1,069	1,045	1,109	1,081	1,076	1,071		824	833	834	842					680
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				6	2	27	36		38	74	76	118	1,915	109	129	129	137	2,169	131	144	144	142	1,484	141	151	147	155		128	129	134	132					118
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																					1	1									5						1
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									54	331	295	279	595	386	413	439	469	570	460	430	427	321	417	336	273	219	272		344	380	405	433					457
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												2,387					2,475				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								442	415	426	477		488	498	534	539					442
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex													12					12											6								6
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex									1			3			1	5	2		2																		1
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								312	598	477	681		503	491	493	505					474
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								919	793	645	785		911	956	1,074	1,140					1,326
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												37					74				
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								20	18	18	25		22	24	24	16					49
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								1	11	15	17		7	10	10	10					1
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male					61	70	93		68	25	42	53	95	77	78	80	97	145	160	278	314	343	754					868					957				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												198					221				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female																		23	1	1		3	43	3	6	17	21		18	23	32	34					52
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male																90	130	116	155	171	152	180	171	23	161	180	182		181	197	215	236					54
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male					81	87	122		60	74	98	145	247	132	152	145	150	438	170	177	182	197	855	186	163	146	227		234	263	244	155					220
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								1,435	1,244	976	1,239		1,357	1,344	1,479	1,544					1,666
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																										2	2		2	4	4	4					6
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female					15	24	23		8	17	27	28		30	36	40	46	1	54	72	118	89	305	106	84	72	122		102	131	136	77					153
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female					17	32	18		16	13	17	25		25	30	31	36	1	54	88	100	96	219	98	99	99	148		128	157	161	94					183
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																									11	10	13		8	7	6	14					
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female																		30	1	1		4	24					19					27				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									154	172	550	495	660	559	661	850	975	680	1,036	1,066	1,131	1,185	976	1,209	1,242	1,216	1,132		1,221	1,261	1,279	1,273					1,429
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								6	63	80	81		76	85	93	86					18
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								330	412	482	463		496	509	490	508					550
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								301	354	412	404		412	428	433	435					501
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												1,060					1,417				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				28	12	124	154		207	238	364	470	2,034	619	636	668	728	2,433	723	786	767	765	2,152	814	833	863	915		652	680	696	733					714
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												1,608					1,741				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				25	1	331	489		699	698	874	1,329	2,327	1,445	1,595	1,782	1,864	2,594	1,908	1,934	2,008	2,033	2,172					1,942					2,012				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												579					594				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				19	3	451	698		1,020	931	1,139	1,912	2,848	2,413	2,710	2,962	3,043	3,243	3,126	3,217	3,252	3,348	2,640					3,237					3,412				
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												601					672				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												38					39				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male						1,343	2,098		189	185	216	323	965	408	443	475	499	1,158	531	495	515	525	1,134	526	508	546	614		622	634	672	711					660
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																						2		3	3												
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																		2					2														
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								33	29	28	43		38	34	40	21					51
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								180	210	202	216		214	196	194	194					207
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female							1		14	72	85	100	468	222	264	350	275	538	338	358	363	384	553	424	394	417	424		444	418	430	427					401
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				26	6	7			451	445	623	954	1,564	1,227	1,367	1,473	1,606	1,889	1,640	1,649	1,692	1,722	1,807	1,840	1,878	1,927	1,984		1,496	1,491	1,541	1,601					1,694
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												368					396				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex														8	8	5	4		3	5	5	2	7	3	3	4	4		5	3	2	3					7
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								948	774	794	870		887	838	855	856					883
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												867					1,219				
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male									174	538	486	458	4,810	541	552	577	585	1,189	543	527	540	411	640	406	334	227	351		412	472	473	478					436
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				7	2	46	67		78	115	139	172	1,550	183	201	191	214	1,755	180	203	216	216	1,339	228	236	250	256		210	215	226	204					199
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												1,074					1,061				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								1,408	740	762	763		574	570	634	664					595
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male							3		28	137	217	331	1,432	587	659	830	829	1,588	1,036	1,114	1,139	1,254	1,575	1,411	1,427	1,432	1,590		1,689	1,626	1,641	1,684					1,723
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								92	98	87	95		121	113	103	70					143
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																	46		16	9																	
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									63	77	70	115	18	80	97	107	124	44	115	125	114	121	106	114	119	110	99	105	94	90	103	99	132				79
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male							7		112	221	365	490	1,859	692	811	1,056	1,091	2,095	1,347	1,413	1,417	1,556	2,092	1,697	1,734	1,804	1,963		1,991	1,924	1,950	1,963					1,922
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male																		31		3		10	6	16	18	31	41		44	56	63	69					109
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												408					452				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								466	889	895	856		748	784	815	839					743
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female																		26		1		2	2	4	7	12	16		12	13	15	14					20
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male																		23	2	6		18	11	23	50	92	115		97	106	124	135					201
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female																		20		2		6	157	6	9	19	24		19	22	22	21					21
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex																		5																			
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												3,435					3,586				
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female					15	22	25		12	7	13	14		25	30	33	38	2	54	111	120	131	504					340					360				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												76					66				
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex																10	14	46	9	8	9	7	17		8	8	8	47	4	4	5	8	59				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female							225		258	169	201	339	329	417	521	587	625	367	636	647	668	659	336	616	566	606	656		675	682	705	707					616
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female					9	12	17		8	12	11	18		19	17	19	12	1	27	76	80	74	192	88	96	80	123		102	111	127	75					163
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									134	120	421	375	295	440	480	578	675	306	689	689	717	752	577	751	792	790	756		812	825	823	842					911
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								6	29	26	34		20	19	21	34					7
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				15	3	1			506	503	620	1,075	1,192	1,326	1,482	1,606	1,684	1,431	1,710	1,753	1,761	1,800	1,132	1,843	1,862	1,908	1,873		1,437	1,458	1,459	1,478					1,363
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								916	765	646	599		644	660	694	688					717
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												381					433				
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female																66	86	140	115	104	101	107	155	22	106	98	133		91	80	71	141					30
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female																24	32	116	43	43	39	48	41	6	51	40	48		47	48	56	67					16
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												675					880				
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male									427	1,263	1,144	1,104	6,950	1,496	1,522	1,682	1,812	1,838	1,796	1,788	1,831	1,423	2,095	1,512	1,281	966	1,317		1,474	1,579	1,691	1,602					1,623
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female																49	30	126	74	95	29	111	94	20	101	62	90		77	77	72	111					25
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female																42	53	116	72	71	55	78	80	25	86	66	80		58	61	55	92					31
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								646	583	473	576		674	717	789	860					982
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								1	18	23	21		25	29	33	36					3
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male																116	158	116	181	208	24	147	225	58	218	244	291		266	283	322	315					92
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male																14	27	116	25	27	298	17	96	4	22	20	25		20	22	24	18					5
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male							158		258	160	209	328	382	386	454	455	523	461	542	530	555	546	441	529	483	511	573		607	620	644	684					566
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								6	8	12	12		10	10	15	12					25
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male						93	1		27	45	72	87	397	93	69	78	69	490	78	62	80	76	597	92	74	88	96		94	110	104	108					88
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female						59	69		55	10	31	26	553	59	67	68	72	551	73	68	63	57	390	60	57	59	48		52	54	60	54					40
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female																85	68	140	121	138	105	144	212	35	134	108	146		120	116	186	121					37
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male					15	29	64		20	14	16	23	51	49	33	22	38	84	55	30	32	29	131	28	21	7	16		17	22	18	14					27
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male							166		251	153	209	295	447	380	450	507	565	540	598	599	610	602	532	582	598	576	636		611	637	664	676					586
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				1	1	28	33		65	66	77	87	1,235	74	93	108	115	1,395	101	113	104	103	1,025	95	97	105	108		100	100	96	103					93
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								125	102	110	142		146	163	150	99					187
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male						3,278	2,929		3,203	159	492	396	1,202	516	593	729	828	1,219	862	915	946	950	1,284	965	972	943	841		920	954	1,049	1,001					973
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				18	2	819	1,315		171	167	194	349	1,319	297	337	363	387	1,513	371	405	427	417	1,212	397	406	404	390		306	313	313	327					307
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male									1,008	2,997	2,669	2,570	3,424	3,875	4,145	4,328	4,793	2,499	5,119	4,844	5,035	4,247	6,250					5,452					5,657				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex							19			2	1	3		59	62	62	67		64	64	65	62	62	61	58	57	58	67	54	50	48	48	67				38
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												6,758					7,430				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female							92		129	90	113	179	473	235	258	262	301	537	283	267	270	274	494	250	269	276	273		256	266	278	264					244
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female						606	1,183		421	354	453	675	991	747	1,027	1,218	1,276	1,096	1,356	1,531	1,535	1,531	996					1,853					2,050				
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex													32					32											5								8
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								236	471	486	460		413	433	445	466					424
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female														416	58																						
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male									16	73	64	56	1,685	52	61	61	62	265	61	51	53	45	1	52	34	25	38		44	43	48	48					32
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				13	3	6			395	364	424	621	1,243	623	652	691	716	1,415	683	706	680	679	1,227	685	677	653	651		503	507	496	488					422
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																																	27				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,953					2,062				
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									1	44	34	31	94	44	47	42	43	104	49	39	40	28	22	26	19	13	16		24	22	29	25					20
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female							1		34	74	114	155	576	237	221	235	210	698	260	291	313	329	720	354	363	370	403		425	418	432	419					452
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								263	286	262	290		320	322	351	353					309
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									141	150	492	407	382	504	559	686	775	397	812	788	817	839	681	829	802	787	724		783	787	810	798					753
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								66	58	57	86		77	89	95	50					103
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex										3	7	9		9	9	24	25		21	13	12	11		10	9	7	10		7	9	7	7					11
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex									1		13	67	4	6	1				1					1		3	1		2	1							2
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male					49	46	53		40	11	16	31	101	46	37	41	54	144	97	162	201	198	331	240	223	203	272		281	284	292	179					311
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex																		12												1			1				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female						2,203	1,924		1,983	82	171	168	619	184	189	216	241	617	243	224	223	227	577	234	233	236	232		234	241	247	245					200
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male					54	71	89		43	43	70	110	166	94	106	98	99	212	149	241	251	266	468	287	269	308	364		396	430	401	264					432
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male																	1	48	18	39		81	108	95	188	296	349		284	320	329	351					434
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									508	1,291	1,169	1,168	3,882	1,841	1,892	1,983	2,136	1,735	2,269	2,197	2,282	1,875	2,667	2,105	1,830	1,509	1,860		2,062	2,191	2,448	2,448					2,613
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																									1		2		1	1	3	2					4
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								49	41	49	54		55	60	61	41					86
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								902	869	679	870		916	960	1,070	1,126					1,382
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female																		27				7	16	11	16	19	24		22	26	20	28					28
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female					10	19	8		9	16	23	24		30	35	45	27	1	24	50	66	71	338	73	67	49	84		66	108	98	38					72
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									317	1,080	944	878	1,588	1,314	1,386	1,451	1,553	1,227	1,614	1,512	1,540	1,262	1,656	1,435	1,225	1,034	1,216		1,444	1,541	1,693	1,749					2,065
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								362	414	420	459		503	475	493	515					513
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male						1	116		159	162	196	257	643	346	411	447	490	777	545	586	614	636	764	616	628	628	748		752	781	822	832					744
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,044					1,116				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									15	11	36	54		45	61	86	87		83	69	72	71		57	59	55	56	89	62	63	62	67	80				55
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								409	389	402	455		499	490	519	523					438
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												14					15				
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male						199	10		72	158	238	322	2,201	406	457	573	507	2,528	559	601	622	611	2,488	668	618	671	730		723	757	718	715					674
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								453	851	1,001	889		682	768	730	764					699
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									3	33	52	79	264	177	195	279	257	421	306	315	328	384	470	416	422	447	471		490	477	478	458					485
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								540	448	364	447		530	574	587	647					781
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												2,518					2,605				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female																		13							1	3	4		2	2	2	2					7
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								266	528	569	558		428	451	421	447					399
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								226	231	230	259		270	267	276	274					285
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female						1,138	1,697		88	65	84	101	577	130	167	165	215	726	205	214	231	231	683	216	195	220	230		229	233	243	249					222
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female																13	16	116	22	24	116	25	51	1	16	16	20		11	9	14	30					
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												89					114				
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female						174	1		48	78	124	153	1,520	196	187	207	212	1,747	274	286	291	313	1,563	336	336	343	360		376	382	389	410					380
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												917					1,039				
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								1	16	17	20		9	11	12	18					5
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								1,304	1,130	961	1,147		1,264	1,285	1,389	1,471					1,695
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								289	274	296	327		372	375	391	394					317
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male						91	4		5	121	175	304	1,253	604	851	1,251	1,399	1,822	1,666	1,789	1,833	2,112	1,878					2,776					3,276				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												2,098					2,315				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female						666	695		877	221	850	731	1,028	910	968	1,198	1,404	1,226	1,486	1,518	1,620	1,657	1,602					1,798					1,862				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												228					417				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												604					618				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male																	2	33	12	37		89	129	104	192	296	378		340	380	418	435					593
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female						136	452		154	39	99	92	639	87	102	117	124	644	115	121	123	120	577	116	125	115	118		116	113	126	129					121
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												3,100					3,260				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								253	308	335	333		371	381	375	390					453
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												46					61				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female																	2	18	2	2			7		2	6	5		4	8	10	10					17
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												316					332				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								2	2	4	4		4	5	5	9					14
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									430	1,174	1,079	1,042	2,676	1,689	1,772	1,841	2,010	1,583	2,058	2,050	2,077	1,755	2,484	1,908	1,691	1,373	1,688		2,012	2,103	2,344	2,418					2,677
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												44					49				
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												255					345				
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								746	632	462	619		760	828	894	904					1,093
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex									11	6	22	33		26	32	40	42		41	34	31	32		27	40	36	36		31	27	27	25					18
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								621	555	481	540		640	697	768	818					1,044
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female						69	155		47	53	53	74	452	77	80	95	104	519	110	92	100	97	482	85	83	87	90		82	89	94	94					65
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												5,296					5,995				
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male					101	131	151		81	70	123	128	351	152	183	182	186	443	230	294	284	326	726	357	322	275	402		426	476	484	306					436
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,494					1,651				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				34	12	1,175	1,653		333	412	602	910	1,825	1,190	1,312	1,419	1,493	2,239	1,534	1,599	1,625	1,679	2,334	1,717	1,729	1,792	1,886		1,367	1,401	1,395	1,414					1,398
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex																										5	28		21	10	10	7	42				
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female																	16		3	1																	
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex									53	35	40	53	4	50	56	67	63	4	63	56	55	62	53	48	51	51	50		52	51	51	58					45
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex																	3		3	5	4	7	5	11	13	20	18		14	12	11	18					9
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female						6	1			4	6	6		5	6	5	5	2	3	20	22	18	63	15	13	13	18		17	27	31	20					29
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male							2		9	85	95	145	701	351	420	596	555	837	679	738	768	833	801	895	897	918	1,011		1,024	984	1,016	999					1,038
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male					69	83	148		60	48	90	147	246	146	137	136	140	312	195	301	311	347	696	373	374	343	484		501	557	542	340					597
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male						145	363		162	146	165	201	1,079	277	281	299	317	1,256	334	391	316	307	1,327	295	292	332	364		357	350	372	385					310
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												354					465				
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male							1		13	86	128	220	707	494	583	751	660	925	791	898	916	1,023	971	1,115	1,119	1,177	1,295		1,333	1,248	1,306	1,372					1,384
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												4,784					4,761				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												226					226				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								465	551	623	596		639	671	677	709					782
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												623					659				
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male							121		197	166	183	279	540	370	424	451	522	624	510	511	534	537	620	533	482	526	594		604	615	660	655					562
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male									4			79														1											
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male						639	1,204		449	359	517	761	1,354	847	1,035	1,225	1,361	1,525	1,420	1,545	1,612	1,616	1,399					1,949					2,190				
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female					24	21	28		9	21	33	32		36	45	42	43	1	51	101	106	113	264	108	96	97	145		119	129	164	94					161
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female							175		232	169	196	329	386	381	506	546	608	439	600	591	580	608	408	564	591	563	594		574	582	617	607					484
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female																		40		1		2	5	5	10	13	16		12	19	25	28					37
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				11					278	299	391	643	1,008	687	780	858	896	1,168	940	945	976	978	911	1,006	1,057	1,074	1,106		825	845	861	872					825
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male																	1	32	11	15		46	3	52	93	158	199		185	216	248	263					397
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male																		16		1			7		1	3	4		4	6	5	7					5
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex											1	1		29	30	33	33		31	29	29	30	33	31	30	27	21		19	17	17	17					16
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male						418	15		151	252	395	551	2,970	692	767	978	957	3,404	1,146	1,218	1,246	1,277	3,511	1,456	1,417	1,489	1,574		1,605	1,511	1,531	1,538					1,472
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									44	283	235	219	586	279	307	318	341	360	313	283	289	197	404	217	180	138	171		229	243	266	267					257
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												367					386				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								183	233	262	266		275	284	289	282					355
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female									101																												
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								152	141	133	185		181	202	196	129					245
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								3	55	55	55		75	76	75	65					5
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex																12	14	18	11	7	6	5	21		7	4	6		6	6	8	4					
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male																276	399	147	448	408	310	373	515	119	432	409	486		412	433	380	584					162
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									4	37	38	57	244	144	180	243	249	469	299	313	320	334	536	363	345	365	412		428	403	414	411					422
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex																	2	2	1	1	1	4	12	10	11	13	15		13	14	17	18					20
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								174	198	203	220		227	191	199	207					230
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex																	4	14	5	18	22	28	41	20	20	19	17	48	16	16	17	17	102				12
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									237	250	716	627	572	740	799	1,032	1,167	598	1,229	1,258	1,277	1,317	1,021	1,316	1,338	1,307	1,186		1,251	1,285	1,319	1,284					1,255
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												152					164				
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female						43	1		4	93	116	144	361	295	357	526	618	897	739	783	805	920	1,161					1,171					1,327				
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												1,065					1,375				
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female					4	11	6		6	11	17	10		14	15	26	14	1	13	42	40	46	197	45	45	35	49		40	62	60	27					54
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												270					296				
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female																66	75	143	117	110	110	121	182	24	102	70	102		77	67	63	89					27
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male						88	134		89	22	39	29	1,116	71	78	81	74	1,133	64	58	62	67	945	63	60	65	55		61	61	70	70					56
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female																41	48	231	74	72	73	83	61					87					95				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									106	129	286	228	734	249	288	341	358	735	381	365	397	386	691	379	391	376	352		365	371	375	376					373
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												1,129					1,147				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																								1			1										
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									164	131	434	330	386	436	473	557	590	398	617	609	609	586	514	573	576	563	524		546	549	580	573					505
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								588	697	716	795		797	729	742	739					749
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								1,262	1,072	886	861		892	942	949	961					1,121
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												592					677				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								4	5	13	16		12	15	15	20					31
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex																9	11	28	15	15	15	14	17		15	11	18		16	16	20	22					
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female						72	1		26	73	94	129	755	159	136	168	138	930	165	175	184	190	1,063	200	191	211	232		234	225	236	220					211
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male					65	71	121		69	45	66	106	216	100	120	126	162	279	164	273	278	303	607	348	340	297	403		419	466	440	276					511
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												2,653					3,251				
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												4,416					5,100				
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												784					997				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								182	394	372	450		324	328	358	361					280
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												733					756				
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								70	55	65	63		70	77	73	57					113
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male						371	807		447	98	239	237	1,468	264	311	343	337	1,486	339	367	379	383	1,483	395	385	341	316		330	353	381	383					323
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex																										4	15		10	5	5	7					
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male																206	312	156	341	330	393	294	445	79	288	266	309		253	260	291	292					83
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								285	271	265	305		322	325	350	347					307
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex													2																								
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female						44			9	40	50	55	179	61	40	44	37	240	43	36	43	41	269	43	40	49	49		46	44	38	37					49
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male						960	979		1,211	279	1,077	952	1,880	1,161	1,297	1,686	2,029	2,270	2,129	2,173	2,267	2,368	2,718					2,600					2,706				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				18	2	4			561	587	743	1,084	1,290	1,352	1,459	1,520	1,577	1,580	1,584	1,623	1,637	1,649	1,480	1,674	1,681	1,726	1,711		1,332	1,355	1,370	1,399					1,384
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male						62	133		49	54	48	66	904	85	68	86	106	1,027	109	74	81	82	949	75	64	68	69		56	60	63	61					48
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				19	3	3			395	442	531	873	1,014	956	1,043	1,101	1,154	1,169	1,142	1,160	1,178	1,179	960	1,184	1,181	1,221	1,237		909	949	937	949					803
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male																210	286	126	369	281	192	346	454	100	369	363	454		392	415	472	544					172
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									18	188	129	123	181	151	151	165	162	224	157	142	133	87	214	87	79	61	78		106	100	107	102					103
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								394	348	340	355		358	340	370	371					371
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									82	564	468	422	1,150	570	583	585	631	752	651	606	612	442	671	474	412	299	398		492	490	528	551					582
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex																											3		1								
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female									340	1,939	1,710	1,656	1,616	2,357	2,553	2,677	2,958	1,555	3,165	2,907	2,983	2,350	3,039					3,175					3,680				
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								1	20	24	24		17	19	24	33					1
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																									1	1			1	4	6	6					5
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									221	161	505	457	792	551	662	830	984	839	1,066	1,099	1,148	1,203	1,149	1,211	1,259	1,187	1,080		1,163	1,250	1,314	1,310					1,399
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																									1	1	3		4	4	3	6					2
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									144	690	622	577	1,008	786	834	887	934	703	978	887	903	668	964	710	618	502	617		781	836	908	909					1,094
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									408	1,160	1,047	1,006	1,696	1,546	1,574	1,664	1,797	1,256	1,871	1,831	1,883	1,574	2,376	1,706	1,495	1,261	1,453		1,820	1,843	2,041	2,027					2,350
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												4,302					4,749				
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								332	386	372	448		461	454	457	465					489
Central and South America Region	Panama	PAN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,177					1,262				
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								411	501	550	520		589	582	580	594					674
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																						1		1	2												
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									217	214	587	515	658	585	699	910	961	689	973	992	1,034	1,111	1,010	1,102	1,123	1,113	1,032		1,111	1,179	1,184	1,174					1,331
Central and South America Region	El Salvador	SLV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												4,015					4,165				
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male																88	99	207	118	172	175	174	114					125					213				
Central and South America Region	Brazil	BRA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									142	713	612	573	623	732	787	823	881	729	910	844	847	622	942	660	533	413	558		697	770	847	805					911
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												32					57				
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								4	9	15	18		15	19	32	30					34
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male																		31		1		6	17					13					45				
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												647					673				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex									21	12	33	12	6	17	21	19	26	4	16	18	19	16	45	19	19	23	28		24	24	23	24					19
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								603	609	562	610		624	646	680	686					536
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male																43	48	128	66	85	71	87	74	14	88	88	86		91	104	128	123					22
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								2,191	1,179	1,209	1,220		946	900	983	1,026					996
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male																	2	45	15	16		31	46	39	68	108	128		101	119	115	112					135
Central and South America Region	Nicaragua	NIC	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												474					512				
Central and South America Region	Guatemala	GTM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female									2			52																									
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female							149		193	148	186	272	443	296	346	403	428	495	434	415	407	428	462	367	341	351	415		396	400	430	427					310
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female						80	204		79	57	49	82	642	115	142	176	225	754	198	181	172	169	738	171	163	170	182		170	186	186	190					155
Central and South America Region	Peru	PER	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex																		11																			
Central and South America Region	Colombia	COL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female																						1		2	2												
Central and South America Region	Honduras	HND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male														438	42																						
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														1							
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																																3					4
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														2		2					2
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														1		1					
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														1		7					1
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														8		4					7
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														13		17					10
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														5		1					7
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														1							1
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														5		1					8
Central and South America Region	Colombia	COL	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male																											2										
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																																1					2
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														2		2					
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														3		7					9
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														5							
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														7		10					13
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														13		7					11
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																																1					5
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														4		2					
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														1							
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														6		1					11
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														4							1
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																																1					
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			54		23							2			3		3			2		1			2		1										
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														4							5
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														4		6					2
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			101		64					7		5			22		6			15		6			8		21										
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																																					1
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														1		2					5
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male															2		6			5		8			44		37										
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														2		4					3
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														3		3					5
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														1		1					3
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														9		10					18
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														2							3
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																1					
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														3		5					9
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														2		1					1
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			17		18		14			50		28			11		36			18		26			67		62										
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																																1					4
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														6		4					4
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			16		5					12					15		14			7		7			12		7										
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male																														1							
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														2		3					4
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			31		27		15			143		4			23		27			74		47			53		56										
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														3		6					4
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														1							1
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														2		1					1
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																																					4
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														3		2					3
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														1		4					8
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			31		6		4			28		7			46		45			28		26			22		20										
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														11		16					4
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														2		1					2
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														1		2					1
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														10		3					8
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																																					1
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														2							
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														2		1					4
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														11		7					2
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														3		5					2
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														4		5					3
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																					3
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														4		7					
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														1		2					3
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														3		1					
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														4		1					2
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			6							25		38			5		1			19		322			7		24										
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																																					1
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																																1					1
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														6		3					7
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														2		3					9
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														1		2					3
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														11		7					11
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														3		5					6
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																																3					7
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			3							11		17								17		44					10										
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														4		2					10
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														13		2					13
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														14		22					7
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																5					
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex															1		1								1												
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														2		2					3
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																																					2
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														3							6
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														3							1
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																																					5
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														3		2					
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														2		4					7
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														1		1					2
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														6							2
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														1		1					7
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														8		8					2
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														2		2					10
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														5		2					
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																																					2
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female																	2					8			16		17										
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														1		2					7
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														3		3					2
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														1		1					2
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														15		18					7
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														4		3					7
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex										2		1			4							1			1												
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														1							2
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														1							
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																																2					1
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														6		13					8
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																1					
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														2		2					4
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			57		47		37			208		26			75		75			94		107			123		108										
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														18		19					8
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														2		4					5
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														1		4					1
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																																1					2
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														2		7					5
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																																1					1
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														2		1					5
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex																						1															
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														5		3					11
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														1		1					
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																																3					4
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														7		4					18
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														5		4					5
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			9		3		5			15		9			5		18			8		18			34		29										
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																																2					5
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														6							
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																																					2
Central and South America Region	Nicaragua	NIC	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														3		2					
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																					2
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex																	24					1															
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														10		3					5
Central and South America Region	Brazil	BRA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														1		1					1
Central and South America Region	Guatemala	GTM	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female																														2							
Central and South America Region	Panama	PAN	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														5							6
Central and South America Region	Honduras	HND	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														1		2					4
Central and South America Region	El Salvador	SLV	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														5		1					6
Cote d'Ivoire	Cote d'Ivoire	CIV	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female															843		6,716	12,040		6,015		15,691	16,660		5,267		19,115	23,461		23,913		36,041	21,302				
Cote d'Ivoire	Cote d'Ivoire	CIV	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					6,166		15,088			9,107		17,526			9,098		31,244	13,031		18,237		26,395	11,930		9,704		20,917	9,034		16,943		22,489	20,900				
Cote d'Ivoire	Cote d'Ivoire	CIV	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					5,660		9,874			3,874		10,676			8,574		29,363	17,690		19,356		31,686	14,110		11,272		26,077	24,224		28,874		45,631	28,878				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			1,133	5	16	89	103		75	158	929	630	210	454	655	544	437	900	328	674	795	542	2,540	584	1,037	1,777	1,173		2,279	4,975	3,666	6,545					2,352
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												40,096					21,547				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				129	63	324	199		78	235	508	271	712	214	265	263	295	1,243	218	338	376	258	1,226	244	501	529	420		1,754	2,554	1,714	2,764					968
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												35,633					19,153				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												32,766					17,632				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												84,668					45,509				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			42	1	10	37	135		15	51	141	100	186	73	89	92	107	536	59	119	154	113	435	84	244	402	422	21,991	415	841	884	1,550	11,832				637
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			1,476	7	27	128	230		72	172	707	508	393	378	584	478	496	1,090	328	601	753	493	2,244	458	852	1,174	927		1,320	3,158	2,067	3,610					1,571
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								20,818																													
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			1,833																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			16,295	120	7	82	431		98	210	971	575	646	240	393	302	291	20	277	715	482	181	1,485	345	796	906	884		1,843	3,545	2,336	3,876					1,818
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			6,973	176	98	596	555		127	202	1,072	556	1,427	288	425	401	347	1,537	281	803	644	213	1,919	376	870	1,009	1,031		2,052	4,078	3,182	5,029					2,165
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												36,774					19,763				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male				16	3	56	156		39	40	338	156	228	69	100	112	137		52	99	118	48	500	129	292	421	338		645	1,336	957	1,746					945
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			3,059	243	72	390	295		86	227	656	384	991	207	375	315	289	1,390	228	375	428	261	1,383	326	595	674	645		2,658	3,424	2,237	3,721					1,209
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			156																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				7	12	72	194		31	107	336	189	277	176	207	219	281	731	166	250	308	251	1,026	230	438	495	441		534	1,215	787	1,764					707
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			1,179	13	327	148	118		59	129	295	189	597	139	214	185	247	1,461	167	258	279	213	984	155	394	435	360	18,908	1,879	2,733	2,141	2,574	10,166				807
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				3	7	44	130		13	54	162	73	183	99	111	135	136	560	93	164	164	142	695	109	220	241	290		294	687	467	982					376
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female					11	38	67		26	72	302	243	117	176	270	233	174	299	143	288	304	182	1,020	221	525	700	537		1,040	2,297	1,726	3,221					1,302
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												38,858					20,904				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			1,860	16	15	131	244		76	139	1,065	681	405	487	737	635	541	1,089	404	780	946	630	2,783	625	1,126	1,568	1,073		1,686	3,918	2,943	5,109					2,237
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			5,591	303	92	547	470		149	226	926	404	1,401	207	366	338	294	1,618	223	501	433	266	1,526	318	701	830	769		1,386	2,827	2,173	3,624					1,610
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			846	13	15	101	249		56	152	496	292	372	271	354	366	391	988	280	413	444	334	1,606	326	617	750	698		838	1,982	1,313	2,642					1,085
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				40	48	214	135		59	165	351	211	431	141	199	214	242	775	161	250	236	168	955	149	320	328	276		1,116	1,647	1,186	1,649					593
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex						6	19		6	16	9	7	21	57	92	64	30	1,288	12	46	30	11	1,315	27	74	39	61		22	29	46	357					46
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			93,989	25,153	26,561	19,875	15,923	20,918	10,060	10,048	8,196	7,351	51,391	7,314	8,587	8,247	8,939	159,045	8,060	9,759	11,513	11,655	17,668	8,307	9,454	8,796	10,470	154,822	9,262	9,251	9,936	16,353	49,172				12,751
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				1											8												1										
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			151,143	19,658	21,082	17,403	13,678	4,756	8,328	9,466	8,410	7,500	17,116	6,488	7,162	6,949	7,555	16,667	7,331	8,506	8,308	8,982	23,247	8,448	9,715	9,903	11,879		11,556	12,026	12,456	15,473					25,820
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			112,449	25,776	29,383	23,951	18,239	69,310	11,487	12,039	8,635	8,537	165,260	8,488	10,291	9,625	10,718	21,206	9,666	11,101	11,293	11,697	41,473	10,438	12,751	12,782	13,476	236,801	14,944	15,772	17,858	22,733	205,721				25,069
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			66,602	24,021	29,206	21,672	16,886	10,233	11,171	12,062	10,707	9,765	20,241	7,599	8,137	8,107	8,704	23,970	8,915	9,393	9,465	10,206	25,040	9,035	10,027	10,374	12,817		12,062	13,365	14,360	16,931					15,351
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			11,795																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			163,788	96,882	100,173	85,585	74,218	142,877	61,243	63,432	56,867	51,522	187,524	47,147	46,646	44,697	46,662	128,573	48,089	49,852	48,032	47,583	148,457	50,186	50,220	42,922	47,124		49,213	51,606	51,441	56,088					53,556
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			29,200																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												124,318					79,197				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				42,171	40,153	35,776	25,462	17,058	13,987	12,643	10,682	9,738	67,768	10,039	10,701	10,893	11,525	43,103	10,837	11,990	14,681	14,837	8,344	12,618	11,429	11,915	14,511		13,023	12,956	17,017	21,912					17,026
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				15,856	18,457	13,007	10,184	28,630	6,706	7,595	6,970	7,272	29,328	6,889	7,640	7,334	7,620	35,124	6,988	8,405	8,751	9,252	27,211	7,563	8,772	8,303	9,552		8,621	9,515	10,611	12,750					11,999
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												95,308					95,865				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				12,175	13,794	9,696	7,574	25,812	5,087	5,971	5,426	5,176	23,154	5,231	6,218	5,972	6,144	27,729	5,518	6,292	6,391	6,877	26,361	5,695	6,855	6,584	7,626		6,808	7,804	8,510	10,256					10,187
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			11,794	47,286	49,847	42,881	34,568	121,492	26,676	29,205	25,145	24,192	108,757	22,457	23,528	21,969	23,018	71,891	23,096	23,907	23,751	24,221	82,664	23,996	24,253	21,195	23,427		24,096	25,165	24,919	28,698					28,999
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			11,795	100,965	103,435	90,523	79,316	180,663	64,675	66,486	58,763	54,321	125,422	47,108	45,070	43,148	44,327	143,797	45,314	44,468	43,588	44,081	140,470	45,763	43,895	37,776	41,620		43,446	45,000	43,924	49,102					51,022
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			66,599	21,128	24,130	17,901	13,402	14,620	8,795	9,948	8,587	8,685	24,664	7,596	8,352	8,074	8,584	33,144	8,041	9,313	9,149	10,011	31,213	8,549	9,634	9,280	11,269		10,886	12,131	12,883	14,787					13,274
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				1	1		10			1					2					1																	
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			201,519	63,977	65,396	56,368	47,458	76,116	37,813	38,077	32,420	28,870	68,481	26,909	28,449	27,754	27,884	88,201	29,885	29,637	28,832	27,330	85,285	29,249	29,525	25,841	27,058		29,806	30,138	29,558	32,462					32,709
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			227,662																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			11,794	74,584	76,626	65,236	55,535	160,868	44,485	47,154	41,102	38,546	124,097	36,804	36,533	33,348	35,584	107,164	35,547	35,870	35,475	34,920	126,768	36,189	35,649	31,094	34,185		35,891	37,160	35,861	39,761					39,005
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			179,854	15,033	15,984	13,300	9,709	3,880	6,594	6,586	4,673	4,390	12,552	4,098	5,082	4,892	5,147	14,912	5,077	5,714	6,506	6,341	23,847	5,754	6,471	6,456	7,856		7,805	8,111	8,136	10,835					20,637
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												32,803					386,074				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			40,439	6,137	5,953	5,218	3,105	224	2,055	1,865	1,524	1,212		1,229	1,685	1,678	1,869		2,047	2,047	2,382	2,098		1,860	1,814	1,847	2,070		878	905	1,367	1,650					817
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								14	1	1			4								
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												102,186					54,532				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												45,945					61,638				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				27,800	28,693	22,475	17,231	18,655	10,203	9,297	7,594	7,191	215,369	7,595	8,959	8,803	9,950	71,607	8,800	10,334	12,168	12,644	83,000	8,591	9,438	9,179	10,864		9,464	9,462	10,536	17,274					13,448
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												194,748					369,366				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			59,749	19,654	23,131	16,087	12,902	20,911	8,138	9,049	7,854	8,078	27,996	7,294	7,988	7,674	8,053	38,198	7,706	8,824	8,883	9,586	24,560	8,405	9,371	9,006	10,434		9,355	10,068	11,297	13,534					13,761
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			92,197	25,544	29,246	21,097	17,348	48,070	11,278	12,339	10,027	10,047	82,208	9,682	11,588	10,818	11,607	58,830	10,447	12,946	12,867	13,606	92,054	11,215	14,407	13,179	14,633	88,640	13,172	14,710	15,538	20,287	53,632				22,010
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male																										1	10		2								
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				11,410	12,943	10,526	7,523	49,759	5,595	6,354	4,871	4,703	62,205	4,458	5,106	4,982	5,460	14,161	4,998	5,632	5,697	6,085	23,875	5,409	6,074	6,147	6,780		6,931	7,188	8,042	9,953					9,213
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												207,550					207,121				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				20,849	24,033	20,150	15,272	72,595	11,384	12,785	10,819	10,538	101,746	9,857	11,017	10,441	10,597	31,222	10,544	11,773	11,766	11,902	55,584	11,711	12,767	11,369	12,735		12,989	14,034	14,836	17,492					16,365
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			54,582																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												2,650					926				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			919	34	44	38	31		33	17	21	15		17	18	11	22		16	11	8	12		12	9	14	9		3	4	5	6					1
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			16,160	398	331	244	193	853	177	199	196	156	1,961	172	174	148	141	622	143	143	142	107	481	107	146	96	121		117	119	100	99					106
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			5,169	780	737	465	367	1,835	307	383	391	392	1,642	365	347	257	269	1,800	271	279	280	256	1,159	206	266	191	228		203	232	198	191					172
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			14,362	1,346	1,335	886	748	2,971	659	738	638	635	8,776	582	554	510	448	1,306	485	486	500	471	1,513	414	497	402	385		383	435	374	396					354
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			11,885	239	261	166	128	551	88	211	249	199	1,192	210	230	194	182	587	159	180	184	153	794	152	203	187	266		214	207	179	163					150
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												349					3,964				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				897	1,014	514	401	3,302	327	428	362	423	1,217	408	373	344	322	2,279	305	334	306	258	1,587	224	297	241	231		240	251	202	257					198
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			5,138	528	534	355	321	1,254	199	351	373	349	1,324	289	298	247	206	958	182	205	184	168	811	193	190	195	180		208	184	174	142					154
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				261	274	236	165	747	140	145	110	137	1,659	101	143	94	100	650	111	118	96	72	382	102	111	100	80		86	90	79	82					62
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				1,048	1,241	547	490	3,683	389	506	462	509	1,506	505	451	415	346	2,651	354	373	315	308	1,257	310	359	284	277		258	302	262	274					213
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			3,279	2,212	2,287	1,484	1,238	6,924	1,030	1,259	1,087	1,016	3,576	993	908	755	701	1,849	700	701	615	596	1,774	647	588	519	581		530	532	475	477					460
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			2,030	2,165	2,308	1,352	1,111	9,329	938	1,067	878	957	5,798	950	932	792	793	2,015	755	773	689	661	2,268	599	715	542	589		528	558	491	507					450
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,642					1,411				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												604					623				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			2,178	142	163	86	105	1,379	54	73	80	83	1,123	78	76	60	63	2,845	59	68	55	66	555	46	49	42	59	728	48	47	40	34	348				36
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			14,091	89	100	45	35	434	37	54	38	45	1,136	53	49	43	79	616	53	60	57	47	607	53	52	60	77		63	59	46	57					54
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				1,340	1,566	942	782	8,489	616	758	652	721	7,600	743	790	668	598	1,646	538	637	593	526	3,317	501	564	498	479		508	458	465	492					334
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			1,267																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			4,738	1,104	1,146	607	456	2,648	407	503	427	461	1,757	418	435	373	335	2,301	330	349	288	311	1,149	277	348	278	266		260	242	227	245					207
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				200	207	113	128	1,332	82	80	67	77	2,880	89	72	81	58	1,279	61	65	73	70	2,594	46	80	46	43		42	46	41	49					36
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			1,898																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			7,171	1,516	1,714	863	726	6,223	564	659	547	643	5,080	650	694	594	555	4,198	506	569	553	478	5,219	452	512	468	454	3,327	383	479	401	415	1,887				369
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			5,365																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												1,051					457				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			4,341																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												3,869					1,786				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												867					3,285				
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				939	1,027	626	466	5,955	398	448	376	486	4,560	454	476	481	440	1,056	391	402	394	380	1,795	373	398	338	367		350	331	288	339					305
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			8,791	1,445	1,604	1,041	867	9,049	699	835	608	721	14,387	756	789	648	715	1,561	619	698	610	607	2,502	514	700	556	564	7,508	546	536	520	561	9,291				556
Cote d'Ivoire	Cote d'Ivoire	CIV	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			2,847	2,373	2,469	1,510	1,294	9,890	1,062	1,245	1,047	1,080	5,543	1,087	1,024	875	869	2,171	847	761	747	702	2,570	656	717	590	578		590	563	533	526					479
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												3,137					3,343				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												2,053					1,790				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				137	179	152	125	294	136	126	120	104	416	118	157	139	125	420	129	145	122	133	583	135	135	121	107		140	113	133	99					134
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				557	523	413	389	1,132	386	416	289	337	1,403	307	300	279	239	1,016	303	279	275	247	1,213	251	263	220	200		225	204	192	190					200
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				983	981	749	737	2,602	780	738	595	632	2,668	604	552	484	475	1,369	511	462	381	403	1,661	516	425	330	334		389	362	299	277					348
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female					9																																
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				153	127	105	90	189	95	77	74	59	267	89	81	75	55	425	70	63	62	61	435	59	69	40	53		63	61	49	44					56
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																								2													
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				2	2	2	2	3	1	1	1		8		1	1	1	2		2			1		1		1	1	2				2				2
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												1,045					1,379				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				653	694	521	490	2,031	440	465	396	368	2,339	415	451	360	374	971	462	458	367	389	1,473	423	445	309	319		376	349	276	301					313
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								3													
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				2	2		1				2											1															
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				13	26	18	14	125	12	11	10	9	193	9	11	11	11	32	8	10	16	12	59	15	15	8	6		6	9	6	4					13
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				1,043	1,036	806	740	2,748	665	682	568	543	3,160	599	632	498	514	1,443	599	528	471	475	1,828	512	494	374	386		472	407	388	360					368
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			92,234	29,723	27,481	23,895	23,587	68,098	20,386	19,885	16,930	15,627	36,319	14,434	14,396	13,183	13,341	50,841	14,896	13,782	12,841	12,972	54,051	14,779	13,738	11,478	12,094		13,968	12,838	12,197	11,683					13,627
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				4,602	4,941	3,883	3,441	8,697	3,340	3,830	3,236	3,192	6,242	2,941	3,265	2,693	2,731	10,889	3,171	3,434	3,055	2,872	11,216	3,598	3,596	2,838	2,839		3,239	3,430	3,053	2,718					3,444
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			22,389																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			158,592	46,690	44,243	38,062	38,017	114,750	34,709	35,688	30,819	29,338	60,035	26,135	24,919	22,368	23,301	83,808	25,895	25,051	23,049	24,160	84,604	27,268	25,399	20,001	22,085		24,820	23,996	22,386	22,231					24,012
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			71,296	19,449	18,864	15,523	14,366	52,962	13,113	13,893	11,510	11,206	29,628	10,826	10,930	9,375	9,872	37,387	11,228	11,158	9,901	10,511	41,833	11,548	11,038	8,685	9,279		10,291	10,247	8,844	8,878					11,014
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												142,815					147,100				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			168,042	50,173	47,865	41,027	40,946	124,831	36,427	36,338	31,071	30,354	65,480	25,814	23,928	21,360	21,965	86,665	24,469	22,946	21,121	22,043	84,819	24,867	22,140	17,559	19,483		22,013	21,282	19,150	19,219					22,886
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			1,977	651	684	481	568	1,353	476	379	299	308	2,247	287	299	212	227	971	299	240	280	236	989	342	269	230	242	1,016	319	234	219	201	1,043				216
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				1	1		10			1					2					1				14	1	1			4								
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												56,027					57,707				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												157,669					162,400				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			683	195	22	32	27		23	32	36	39		11	15	17	21		21	25	28	25		34	44	20	18		55	30	19	13					14
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				653	599	405	360	4,668	469	541	400	449	4,042	332	342	304	325	1,243	365	406	366	320	1,345	434	402	351	339		418	322	254	203					328
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			112,660	35,450	33,767	28,337	27,328	84,884	24,247	24,992	20,884	20,135	45,047	19,411	18,795	15,906	17,055	64,855	18,968	18,056	16,562	16,984	68,257	19,393	18,084	14,312	15,634		17,658	17,010	15,018	15,019					16,781
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			4,249	1,042	1,029	805	712	2,852	665	667	561	536	3,048	592	619	493	501	1,475	603	520	475	481	1,842	512	494	375	390		465	404	393	362					371
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				135	179	158	129	383	130	125	114	102	446	115	147	136	123	423	130	143	121	134	586	139	133	119	107		134	113	133	98					134
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												1,051					1,412				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												2,065					1,795				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			515	151	125	100	87	269	92	77	70	58	355	88	81	76	53	426	69	62	61	58	441	58	70	40	52		60	61	49	44					55
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			1	1	2	3	2	8	1	1	1		5		1	1	1	2		2			1		1		1	1	2				2				2
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			644																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			4,577	970	978	750	735	2,704	772	739	580	619	2,963	597	538	475	453	1,389	510	458	378	401	1,677	525	425	326	335		383	360	300	274					349
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			2,626	649	686	518	497	2,107	432	464	381	364	2,079	408	443	352	364	986	455	452	371	385	1,483	422	448	308	320		375	353	274	301					314
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												3,154					3,352				
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			12	3	2						1											1		1													
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				11	26	17	12	181	12	11	9	9	132	9	11	11	10	32	8	10	16	12	59	14	15	9	6		6	9	6	4					13
Cote d'Ivoire	Cote d'Ivoire	CIV	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			2,280	565	506	418	394	1,265	379	405	290	330	1,672	298	295	276	237	1,042	299	268	279	244	1,239	245	262	226	196		217	205	190	192					198
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												30,436					30,436				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												20,558					20,558				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			20,539		19,870		13,755	14,585		8,631		7,954	14,585		10,604		7,614	11,343		12,453		7,994	12,598		9,132		13,391			12,665		13,153					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					5,499		9,374	2,248		2,419		1,901	2,249		2,178		2,381	5,849		3,886		3,987	6,062		2,305		3,689			3,090		3,744					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			16,790		9,260		9,001	4,173		3,745		3,199	4,172		3,987		3,461	6,144		4,868		5,446	6,730		3,485		4,362			4,774		7,151					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			25,754		21,322		13,998	19,966		10,910		10,152	19,967		11,168		14,916	12,712		13,970		10,660	11,350		13,136		15,211			15,458		19,897					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			3,887																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					459		1,371	3,798		922		1,869	3,797		2,694		1,914	8,119		2,616		2,331	9,042		1,143		1,366			776		2,142					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			6,481		834		2,673	4,890		1,628		3,094	4,891		4,621		3,848	8,936		4,637		4,035	8,663		2,117		2,153			1,869		3,593					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			12		77		7	3,629		6,102		2,303	3,629		630		761	3,085		4,114		903	1,261		6,521		1,547	1,694		538		1,466	1,694				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			12,995		15,942		7,617	23,043		11,077		12,056	23,043		11,026		12,032	9,931		15,056		5,952	7,219		13,918		12,154			14,625		11,658					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female					131		51	716		285		779	716		1,069		1,109	10,127		1,800		2,451	12,723		1,004		1,251	16,489		683		2,658	16,489				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												20,207					20,207				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			9,307		1,888		3,737	6,521		1,439		3,538	6,521		3,461		3,386	10,424		4,674		6,020	9,902		2,824		3,026			2,142		2,896					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												10,905					10,905				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					192		48	1,596		446		857	1,596		1,482		1,282	6,294		1,798		1,481	6,735		661		909			495		1,388					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			8,298		2,931		2,745	16,164		2,390		5,915	16,164		4,814		4,889	6,191		3,878		1,475	8,902		1,022		599			1,517		2,470					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			16,607		1,900		5,880	16,635		2,299		7,509	16,634		5,113		6,991	8,177		3,331		2,192	9,018		2,878		1,838			2,086		4,729					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			18,829		11,429		10,297	5,055		5,541		4,519	5,055		5,060		5,432	8,464		7,144		5,698	8,614		5,326		6,622			6,585		7,981					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			18,367		3,159		7,105	18,361		1,874		7,083	18,360		6,989		4,792	11,603		6,755		5,002	10,721		3,272		2,724			2,437		3,969					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												22,133					22,133				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			6,785		3,282		3,349	627		1,927		801	627		1,103		1,366	11,383		2,374		3,340	10,676		1,367		2,237	11,148		1,869		3,261	11,148				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					3,108		780	1,795		1,988		1,302	1,795		1,731		1,458	5,015		2,145		2,209	5,016		1,143		2,016			2,299		2,804					
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												22,423					22,423				
Cote d'Ivoire	Cote d'Ivoire	CIV	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			20,965																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			26	53	57	62	124	25	38	95	87		120	176	152	97					16
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												493					1,182				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			18	44	52	57	93	35	45	48	65		88	108	141	96					49
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			45	79	93	108	116	76	85	96	109		110	195	188	175					57
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			41	88	100	137	93	85	109	156	138		162	347	404	453					120
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			81	144	178	215	158	101	111	167	198		220	408	334	296					115
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			11	14	22	24	210	20	39	44	31	52	44	68	73	61	430				44
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			42	43	57	78	26	56	59	66	69		100	162	180	153					59
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			65	97	93	153	74	82	90	128	136		153	282	317	336					124
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												500					1,306				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			64	67	78	115	43	67	66	87	93		122	266	256	214					78
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												368					782				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			13	17	23	31	57	19	18	31	31		53	74	74	53					36
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			291	478	630	793	413	279	305	290	496		527	926	966	1,492					218
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			58	86	123	112	141	62	85	118	132		164	259	255	218					97
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												650					1,021				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												565					2,410				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																					5																
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			74	96	79	105	127	61	85	91	102	162	131	207	232	146	1,316				107
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			288	377	583	699	285	225	218	199	290		367	448	506	622					112
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			78	84	114	159	61	99	129	127	141		158	316	289	254					107
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			66	131	137	151	118	110	131	227	196		198	341	316	245					97
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												6,576					7,839				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								235		7		18	261	7	16	35	78	262																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								543		3		10	929	9	17	44	94	937																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								980		2		57	1,162	61	115	273	603	1,170																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								735		1		3	1,285	2	3	9	19	1,288																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								234		2		10	193	3	14	31	72	194																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								293				6	640	4	15	25	49	646																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female								865				42	1,290	25	42	156	380	1,296																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								433		1		51	254	49	67	110	172	259																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								433				21	362	12	29	56	127	365																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								602		2		22	889	27	40	62	135	896																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								609				11	598	5	24	45	106	598																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								630		5		32	54	25	55	130	141	54																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								663		4		52	105	71	116	257	324	109																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								293		1		1	403	4	3	12	26	409																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								619		3		47	772	73	101	140	292	780																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								433				34	317	27	45	70	139	322																			
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												1,180					3,393				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			353					107		1		36	160	2	28	32	62	166	71	100	107	66	328	91	198	202	247		452	702	643	602					476
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								73		2		8	178		11	16	41	179	31	36	34	39	122	39	73	68	52		101	195	154	207					136
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			534					93		3		8	683	3	10	23	51	693	40	66	53	50	398	63	91	91	113		130	179	216	213					188
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			656					102		1		3	1,285		2	4	10	1,288	12	20	15	11	625	13	31	22	21	122	40	72	42	42	1,288				44
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								74		7		13	228	1	11	18	43	229	58	62	86	55	157	55	119	119	89		199	335	287	304					218
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			500					125				11	598		20	21	61	598	47	58	43	57	389	32	105	95	83	378	117	194	180	204	3,613				139
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			513																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			1,110					137		2		53	650	5	47	158	389	658	375	802	438	371	1,390	247	854	789	710		1,070	1,646	1,224	900					738
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			353					107				31	221	5	21	19	69	229	64	88	76	71	264	88	158	140	211		294	513	479	472					416
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												1,134					2,852				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			524					133		5		20	54	3	32	68	14	54	38	63	46	17	432	64	171	166	226		239	272	253	158					182
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												877					2,059				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			353					107				19	268	5	12	29	71	273	62	75	86	88	232	93	144	147	130		230	417	353	369					276
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			329																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			591					156		4		48	82	8	54	122	64	86	75	156	121	73	410	108	351	294	342		514	705	470	486					484
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																														1							
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			613					99		3		39	489	16	24	38	106	499	72	177	104	126	553	102	198	216	344		341	533	423	455					490
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												15,287					18,397				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												1,482					2,544				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			844					114				37	732	4	13	114	226	738	298	674	470	278	966	200	745	486	405		541	955	806	394					327
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								71				5	545	1	11	10	24	551	23	42	31	32	308	28	64	56	70		58	130	119	117					94
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												1,313					6,198				
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								71		1		2	384	1	1	7	14	390	17	24	21	21	230	9	34	24	29		21	59	67	55					57
Cote d'Ivoire	Cote d'Ivoire	CIV	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			591					95		2		15	592	8	14	21	57	602	52	107	52	57	474	73	139	138	195		239	377	276	310					312
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				60	56	51	54	246	41	59	27	34	315	33	30	40	38	184				125	191				137					129					124
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				1			1	20		1	1				1		1										1					1					6
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				70	61	65	71	236	55	73	43	55	473	45	45	50	48	259				190	237				218					177					172
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											72					68					57
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				13	20	26	11	221	23	27	12	19	101	9	11	20	10	96				49	84				54					42					68
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				14	18	16	6	227	9	9	6	2	84	5	4	5	10	31				21	48				16					17					21
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				66	83	76	58	224	54	62	37	43	237	51	29	51	34	234				163	247				124					124					120
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												505					413				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				59	249	68	70	250	55	51	50	57	481	36	46	70	63	267				231	108					213					218				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												25					25				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				2	4	5		31	7	3	5	2	22	1	3	3	2	26				6	15				7					12					9
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											54					62					45
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				67	68	73	67	245	34	69	52	55	382	48	43	47	47	239				199	248				184					140					135
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												66					73				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				46	75	44	57	251	45	67	43	38	460	35	51	46	38	230				194	187				164					152					170
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											44					36					49
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												172					229				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				40	47	48	44	224	30	35	24	15	225	31	29	28	28	163				90	191				69					75					90
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											132					127					115
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			2,123																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				69	67	53	39	240	40	41	31	37	246	42	29	41	40	224				162	221				139					145					99
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											43					54					46
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			1,902																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				9	8	7	16	219	4	8	11	4	119	9	7	5	2	53				38	60				42					40					27
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												283					293				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				20	22	11	13	246	9	16	14	15	184	17	18	20	13	96				47	127				58					57					47
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											138					125					138
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				9	10	10	10	212	6	6	7	4	201	6	7	3	7	42				27	47				22					22					14
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				91	100	82	66	228	62	50	46	47	332	50	44	49	48	232				192	260				184					152					161
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											63					83					67
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				67	91	90	77	252	49	87	55	63	299	56	70	64	73	304				311	235					264					264				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												69					83				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												495					494				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				43	45	34	35	245	22	42	27	23	202	33	24	22	19	154				110	173				96					107					96
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				17	13	13	8	30	11	14	5	7	122	13	8	10	4	58				23	47				20	31				17	21				25
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				14	9	10	11	31	12	5		5	51	11	6	13	4	40				17	40				20					8					12
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			110																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											56					47					44
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			4,738				5	2,211					2,786		12		273	10,660		1,557		1,482	3,752		473		268	3,474		456		911	3,875				397
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			34,302				58	21,458		52		47	19,415		496		1,882	61,657		9,605		10,123	24,066		1,567		1,799	26,814		5,817		9,016	28,843				4,132
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			27,777				138	57,253		125		111	48,702		1,151		5,058	137,840		29,545		30,953	59,120		4,464		4,094	52,049		12,724		22,303	61,326				9,231
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				190	166	163	147	1,390	140	116	80	86	705	104	102	120	127	454	164	144	158	129	454	127	147	123	125		153	140	130	123					149
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			10,993																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				371	386	377	299	1,322	296	337	276	296	1,698	285	283	317	310	1,307	389	393	392	375	1,307	357	375	303	340		344	378	353	337					334
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				20	15	8	6	238	16	15	8	4		9	9	13	13		7	17	14	8		5	5	8	11		5	7	7	14					4
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			943																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				141	172	152	154	822	128	162	98	128	864	101	104	133	123	520	170	157	136	151	520	147	204	154	160		137	121	157	133					121
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				58	55	64	66	238	67	78	31	33	1,679	59	54	72	58	184	56	54	54	50	184	55	73	42	46		44	50	65	36					40
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				200	239	218	174	793	178	189	129	143	1,077	141	123	143	137	656	182	161	174	179	656	152	193	149	170		149	173	142	138					134
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				359	370	316	253	1,385	301	314	220	244	1,833	271	262	277	271	1,199	325	340	345	331	1,199	279	365	329	291		320	308	344	319					317
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				207	212	218	185	827	159	176	138	123	826	139	124	123	147	644	179	167	164	135	644	149	178	153	155		134	148	144	164					125
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												3,296					3,296				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												1,465					1,465				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				184	214	192	138	836	149	163	103	129	2,573	128	113	129	133	587	178	180	179	171	587	179	162	169	153		152	167	174	144					169
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												1,300					1,300				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												1,058					1,058				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				130	124	116	112	847	103	123	76	93	1,143	81	84	88	105	410	107	113	96	109	410	102	125	134	114		92	101	94	104					92
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												2,581					2,581				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			6,925																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				296	350	317	299	856	263	285	246	236	1,006	238	231	278	264	1,095	312	340	312	321	1,092	287	366	362	289	1,092	347	330	333	279	1,092				362
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												1,539					1,539				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				278	280	278	239	1,388	221	259	193	232	133	228	214	225	227	1,011	279	338	291	294	1,011	319	341	277	278		257	299	283	275					243
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												329					329				
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				553	601	558	522	1,407	450	565	391	425	1,735	453	469	450	501	1,902	578	688	651	623	1,899	553	765	622	598	1,899	589	616	628	574	1,899				660
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				115	92	81	96	238	106	96	59	73	59	98	92	90	67	354	100	95	104	86	354	114	91	70	74	354	94	77	77	67	354				74
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				177	231	185	193	808	156	156	133	140	1,150	140	128	136	150	609	176	173	148	152	609	162	169	182	172		127	140	140	130					129
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				255	248	214	231	1,399	234	242	167	189	1,556	207	213	227	253	842	259	283	273	241	842	230	355	261	252		269	292	259	247					266
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				321	376	293	295	1,366	248	317	252	247	1,486	272	274	292	301	1,147	354	419	366	371	1,147	345	406	348	353		351	370	310	351					314
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				158	172	116	110	845	114	118	98	89	1,928	91	78	109	103	471	138	138	116	111	471	121	116	122	107		106	107	110	110					121
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				38	25	39	38	238	34	37	24	24	1,632	30	47	71	47	145	45	34	27	37	145	45	56	24	39		37	29	32	26					35
Cote d'Ivoire	Cote d'Ivoire	CIV	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				389	408	368	312	1,346	294	361	287	307	1,329	313	297	288	306	1,382	392	425	376	363	1,382	387	418	302	352		307	361	332	302					277
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			27,120	28,667	27,185	27,395	28,075	40,649	24,055	24,525	24,737	24,979	21,931	21,802	21,171	21,126	21,035	26,983	20,355	19,730	19,475	19,384	23,531	19,038	18,930	18,967	19,057		18,932	18,387	18,452	18,475					17,670
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			7,789	7,844	7,908	8,012	9,346	7,661	8,370	8,507	8,751		8,873	8,862	8,973	9,061					9,682
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												6,000					6,457				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			19,369																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												8,389					9,764				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			19,369	3,900	2,972	3,053	3,529	5,400	2,671	2,800	2,791	2,840	7,100	2,331	2,331	2,290	2,284	4,127	2,172	2,174	2,117	2,216	3,193	2,203	2,311	2,383	2,490		2,571	2,593	2,711	2,849					3,154
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			17,724																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												32,540					32,322				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			19,369	5,548	5,201	5,381	5,584	7,792	4,365	4,507	4,656	4,676	11,215	4,006	3,928	3,833	3,821	6,855	3,636	3,456	3,497	3,532	5,008	3,419	3,512	3,520	3,647		3,633	3,575	3,640	3,673					3,630
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			27,120	21,473	18,848	19,273	20,605	29,659	16,298	16,338	16,254	16,387	17,231	12,860	12,396	12,444	12,504	18,138	11,817	11,361	11,241	11,226	14,264	10,978	10,839	10,886	11,030		11,102	10,819	10,917	11,037					11,046
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			30,997	1,396	1,438	1,450	1,490	2,007	1,459	1,440	1,505	1,564	4,429	1,679	1,708	1,699	1,782	2,175	1,795	1,799	1,824	1,859	2,413	1,861	1,943	1,984	2,041		2,026	2,068	2,053	2,088					2,054
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			23,258																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			18,543	19,080	19,280	19,639	19,489	19,079	20,271	20,513	20,929		21,292	21,882	22,247	22,677					24,462
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												31,629					32,756				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			3,757	4,235	4,302	4,454	4,649	4,201	4,900	4,963	5,118		5,168	5,674	5,783	5,943					6,848
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			4,735	5,455	5,548	5,778	5,068	5,562	6,474	6,617	6,802		6,832	7,558	7,775	7,979					9,586
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			40,690	3,013	2,804	2,922	3,176	4,139	2,611	2,622	2,736	2,754	9,938	2,417	2,375	2,406	2,454	3,490	2,323	2,257	2,314	2,342	2,935	2,310	2,328	2,373	2,434		2,449	2,405	2,420	2,455					2,538
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				11,232	11,271	11,473	12,143	15,469	10,963	11,354	11,335	11,383	12,171	11,484	11,532	11,379	11,415	13,363	11,223	11,219	11,240	11,249	12,934	10,788	11,253	11,310	11,405		11,530	11,525	11,531	11,581					11,697
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			32,931	21,826	22,223	22,816	23,769	29,957	21,707	23,257	22,997	23,582	43,703	24,412	25,325	25,527	25,930	26,503										31,937					33,363				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												86,117					84,515				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			8,352	3,764	3,622	3,719	3,813	5,543	3,531	3,533	3,573	3,672	5,499	3,699	3,753	3,786	3,790	6,172	3,798	3,839	3,833	3,832	4,343	3,775	3,775	3,821	3,797	4,742	3,796	3,756	3,764	3,702	4,987				3,566
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			12,242	12,485	12,751	13,034	12,900	12,549	13,782	14,065	14,410		14,740	15,137	15,366	15,625					17,134
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				2,690	2,493	2,560	2,581	3,632	2,015	2,016	1,989	2,029	7,041	1,539	1,491	1,451	1,449	2,684	1,382	1,292	1,279	1,251	1,864	1,305	1,203	1,161	1,169		1,148	1,071	1,064	1,038					936
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												5,222					8,712				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			4,831	4,953	5,090	5,193	5,842	4,917	5,469	5,576	5,738		5,840	6,219	6,377	6,493					6,926
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			2,378	549	408	466	474	903	300	293	285	300	1,062	174	158	111	119	100	76	78	77	76	154	81	81	76	77	86	54	55	54	51	106				56
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			23,259	33,665	32,379	34,941	34,085	46,062	29,913	30,364	30,258	30,330	29,549	27,714	27,566	27,772	27,854	31,223	27,624	27,285	27,202	27,210	30,282	26,757	26,910	26,844	26,973		26,950	26,732	26,678	26,550					26,284
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				4,023	3,817	3,912	3,958	5,642	3,528	3,429	3,499	3,448	11,574	3,227	3,140	3,118	3,064	4,512	2,989	2,871	2,837	2,831	5,456	2,782	2,721	2,705	2,628		2,612	2,504	2,474	2,452					2,303
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			42,621	30,465	31,774	32,330	34,125	42,471	32,909	35,708	35,945	37,038	74,066	37,998	39,840	40,703	41,320	36,124										53,924					63,024				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												9,080					13,212				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			34,873	9,381	8,197	8,540	9,008	12,972	7,144	7,165	7,436	7,619	11,039	6,079	5,863	6,025	6,096	9,406	5,762	5,461	5,541	5,678	7,716	5,745	5,570	5,637	5,747		5,823	5,475	5,583	5,785					5,700
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male																													1								
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				11,901	11,232	11,512	12,004	16,598	10,818	10,745	10,613	10,694	14,739	9,972	9,895	9,870	9,823	13,407	9,625	9,381	9,351	9,339	11,142	9,105	9,156	9,171	9,198		9,089	8,882	8,860	8,871					8,523
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			19,369	8,964	8,684	9,473	9,132	12,140	7,370	7,526	7,552	7,505	14,901	6,326	6,294	6,301	6,359	9,905	6,067	5,981	5,971	5,993	7,501	5,805	5,878	5,904	6,021		6,029	5,865	5,948	5,985					5,904
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				20,290	20,827	21,094	22,148	28,118	21,005	22,210	22,376	23,067	21,601	23,522	24,130	24,493	24,574	22,725	25,136	25,391	25,635	25,984	26,902	25,294	27,038	27,338	27,938		28,326	29,153	29,346	29,784					31,477
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			6,933	7,255	7,408	7,630	7,440	7,464	8,163	8,315	8,599		8,756	9,511	9,746	9,958					11,014
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				29,174	27,621	28,351	29,438	40,603	28,479	29,071	29,263	29,791	28,036	29,310	29,743	30,028	30,264	30,141	30,250	30,684	30,748	31,010	33,613	30,309	31,365	31,499	31,740		31,737	31,859	32,051	32,285					31,774
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			10,135	10,232	10,244	10,341	11,799	9,998	10,597	10,678	10,799		10,903	11,204	11,316	11,462					11,722
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			27,135	1,472	1,358	1,426	1,493	2,205	1,293	1,428	1,506	1,585	5,224	1,669	1,718	1,786	1,778	2,677	1,791	1,886	1,967	2,020	2,729	2,019	2,116	2,224	2,442		2,528	2,597	2,700	2,759					2,982
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								171	187	162	164		148	159	148	145					143
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			14,804	173	189	132	105	558	95	182	118	119	1,145	181	180	159	155	567	137	164	164	134	757	136	197	182	248		182	189	148	153					148
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				178	199	107	119	1,263	78	81	62	70	2,760	82	62	78	62	1,231	59	68	67	56	2,471	47	73	41	41		43	37	38	41					37
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				815	869	488	381	3,143	319	381	319	334	1,163	383	322	330	308	2,165	267	290	269	235	1,514	203	250	236	210		223	212	157	213					192
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								109	126	109	107		86	104	102	85					76
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								79	92	81	80		85	108	69	108					90
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												3,675					1,696				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			8,830	1,308	1,505	817	707	5,900	568	615	475	555	4,822	589	636	557	533	3,987	462	531	506	430	4,976					3,159					1,794				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												333					3,765				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			17,572	63	70	39	32	434	42	50	28	38	1,087	59	53	47	71	594	60	60	54	46	582	53	46	55	67		61	59	50	59					54
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								70	86	70	62		53	84	46	70					59
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			7,142																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			16,069	1,154	1,127	829	661	2,848	631	690	506	543	8,324	526	490	506	416	1,249	466	442	466	434	1,440	383	462	365	364		349	392	340	361					325
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			1,113																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			5,823	942	958	558	444	2,512	381	437	323	366	1,683	376	379	345	314	2,187	286	315	257	270	1,095	247	307	222	231		231	215	216	209					182
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			6,446	376	408	306	259	1,234	224	299	250	258	1,273	263	242	201	177	917	160	177	150	150	777	172	168	153	155		166	148	153	130					151
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,000					439				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								122	176	143	151		123	124	108	125					124
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			5,254																																		
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				894	1,038	515	468	3,485	354	453	361	400	1,448	465	429	388	311	2,517	323	324	295	276	1,194	268	320	256	237		219	254	213	237					193
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				1,206	1,390	880	754	8,061	632	679	561	603	7,221	668	713	649	568	1,567	529	579	539	480	3,151	448	491	426	411		451	404	414	437					331
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,560					1,341				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				813	952	610	470	5,660	407	422	339	397	4,322	415	454	453	431	1,010	389	393	367	336	1,708	336	382	325	340		309	298	266	318					283
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				242	245	202	157	742	138	145	97	136	1,613	97	136	99	101	638	112	114	88	77	372	95	111	92	72		84	90	79	80					59
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								224	275	236	202		242	200	220	239					225
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			6,446	634	576	451	320	1,755	309	316	274	301	1,574	293	299	234	253	1,713	244	257	223	235	1,102	188	230	174	206		179	179	171	172					152
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								69	94	53	67		61	59	79	74					74
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			19,618	336	277	217	182	847	161	185	164	141	1,862	154	154	147	134	599	148	139	137	114	465	92	138	96	117		113	111	103	92					101
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,113	2,081	2,173	1,424	1,155	9,429	1,053	1,089	863	913	5,242	956	934	825	783	2,066	795	707	674	641	2,443	596	648	510	516		530	504	474	485					469
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			10,922	1,322	1,475	1,026	842	8,637	712	800	556	641	13,646	698	736	644	683	1,486	598	669	594	558	2,401					7,132					8,827				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												2,519					878				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								60	71	76	78		55	71	61	72					62
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												825					3,120				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			1,113	1,905	2,040	1,237	1,040	8,891	927	951	757	791	5,490	876	854	757	743	1,914	695	726	634	597	2,156	550	664	497	534		488	479	436	466					426
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												580					587				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			1,259	104	99	102	97	266	76	64	64	72	737	69	57	37	47	100	38	39	42	43	154	48	38	44	39	86	21	30	32	35	106				28
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			2,965	128	146	80	95	1,331	62	66	70	82	1,095	74	69	60	62	2,710	58	59	51	59	536	38	51	41	49	691	44	45	36	34	327				33
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,113	1,880	1,969	1,357	1,137	6,604	1,015	1,158	943	873	3,384	848	840	690	655	1,760	655	643	543	544	1,690	604	530	452	511		504	485	430	445					432
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				21	39	42	48		44	63	78	97	830	92	58	33	46	80	30	43	38	42	106	35	32	39	41	60	41	43	36	29	66				13
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								2,918	3,698	3,866	4,176		4,328	4,341	4,479	4,998					5,768
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								9,496	8,830	9,144	9,391		9,563	9,398	9,630	10,108					10,216
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								9,263	11,339	11,883	12,546		12,898	13,074	13,237	13,847					15,071
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				10,916	13,809	15,080	14,841		15,444	16,108	16,442	16,860	19,703	16,706	18,166	17,958	20,003	21,549	20,503	20,807	22,157	22,562	23,641	21,194	22,712	23,707	24,322		24,911	25,327	25,686	26,732					27,990
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				9,829	13,313	14,617	15,576		14,839	15,796	16,214	16,985	40,995	16,660	18,429	18,711	20,654	23,792	20,947	21,548	22,873	23,397	26,682					27,926					29,938				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female					2																																
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				5,138	6,288	7,060	7,291		7,282	7,813	8,057	8,135	11,471	7,884	8,434	8,143	8,830	11,924	8,955	9,166	9,562	9,617	11,115	8,899	9,545	9,824	9,954		10,068	9,929	10,060	10,381					10,181
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				10,846	13,765	15,663	16,420		15,345	16,352	16,404	16,784	19,764	15,797	16,596	15,210	15,978	25,176	16,047	16,312	17,112	16,909	20,356	15,978	16,313	16,832	16,689		16,890	16,790	16,779	16,589					15,139
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				2,840	3,789	4,261	4,621		4,231	4,569	4,787	4,908	13,962	4,546	4,752	4,177	4,585	8,562	4,543	4,640	4,935	4,955	6,350	4,648	4,887	5,079	5,106		5,151	5,090	5,182	5,198					4,965
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												78,712					78,189				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												5,267					5,726				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								3,976	4,904	5,122	5,678		5,824	6,034	6,086	6,841					8,271
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				14,200	18,152	20,482	21,570		20,448	21,299	21,554	21,786	27,073	20,400	21,744	20,406	22,014	29,356	22,136	22,644	23,877	23,787	26,519	22,467	23,411	24,065	23,959		24,118	24,017	24,108	24,155					22,962
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												4,399					6,409				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				15,542	21,924	23,647	24,920		24,317	25,859	26,371	27,685	67,919	27,022	29,915	30,214	34,054	34,308	34,656	35,604	37,716	39,288	39,459					46,122					53,643				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				2,310	3,033	3,559	3,952		3,590	4,052	4,090	4,210	8,323	3,966	4,146	3,613	3,637	8,521	4,050	4,109	4,373	4,340	6,415	4,214	4,467	4,856	4,688		4,853	4,803	4,899	4,759					4,404
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				643	826	934	1,032		879	932	944	984	6,367	932	970	833	847	2,289	871	932	968	947	1,476	913	918	1,000	926		885	944	897	864					666
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								3,472	4,267	4,586	4,794		4,920	4,944	5,084	5,555					6,023
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								17,844	17,242	17,902	18,453		18,789	18,994	19,404	20,164					21,701
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				524	756	805	914		832	948	916	1,035	3,986	1,015	1,146	1,216	1,321	1,815	1,322	1,320	1,403	1,434	1,942	1,414	1,502	1,595	1,661		1,691	1,722	1,735	1,801					1,670
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												6,929					8,334				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								5,421	6,744	7,092	7,375		7,570	7,498	7,715	7,936					8,467
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				4,908	5,888	6,675	7,652		6,929	7,121	7,401	7,545	13,876	7,239	7,704	7,010	7,546	11,790	7,533	7,623	8,051	7,831	9,610	7,450	7,708	7,989	7,991		8,036	7,861	7,871	7,911					7,249
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				5,946	7,575	8,955	9,428		8,618	9,301	9,359	9,236	15,735	8,593	9,123	8,092	8,537	16,745	8,722	8,961	9,516	9,515	12,254	9,040	9,173	9,497	9,432		9,543	9,554	9,605	9,553					9,093
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								5,292	6,658	7,017	7,380		7,539	7,695	7,845	8,727					9,670
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				1,524	2,012	2,207	2,446		2,208	2,426	2,666	2,735	10,424	2,556	2,733	2,451	2,670	5,823	2,611	2,674	2,824	2,776	4,074	2,610	2,806	2,948	2,951		2,970	3,018	3,067	3,096					2,991
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				793	1,064	1,254	1,352		1,316	1,495	1,372	1,441	9,103	1,456	1,514	1,472	1,702	3,094	1,742	1,736	1,788	1,832	2,453	1,807	1,831	1,983	1,997		2,029	2,084	2,135	2,119					2,025
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				1,591	2,053	2,215	2,354		2,201	2,314	2,299	2,403	5,012	2,462	2,624	2,710	2,784	4,670	2,906	2,784	3,065	3,191	3,550	3,183	3,100	3,241	3,276	4,024	3,247	3,314	3,257	3,273	4,475				2,942
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												8,271					10,241				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				652	912	1,068	1,170		988	1,184	1,200	1,329	6,520	1,254	1,304	1,207	1,356	3,554	1,401	1,466	1,606	1,668	2,571	1,634	1,721	1,875	1,939		1,972	2,043	2,167	2,257					2,509
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				1,592	2,025	2,204	2,386		2,127	2,220	2,144	2,191	10,434	2,167	2,288	2,257	2,332	3,768	2,284	2,562	2,426	2,407	3,848	2,309	2,315	2,393	2,353		2,251	2,266	2,245	2,195					1,895
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												29,719					29,727				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												27,348					29,517				
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				390	567	602	693		617	792	818	870	4,740	875	998	978	1,065	2,328	1,181	1,185	1,309	1,393	2,164	1,434	1,473	1,681	1,759		1,818	1,947	2,067	2,164					2,296
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				14,338	17,856	19,714	21,784		20,623	21,236	21,466	22,188	25,127	21,404	22,932	22,397	24,456	28,470	24,717	25,233	26,437	26,983	29,199	25,376	26,662	27,794	28,128		28,582	28,474	28,470	29,159					28,171
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														18		18					24
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														36		34					28
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														23		10					17
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														3		1					4
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														5		3					2
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					239		257			169		171			858		194			211		137			158		233										
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														33		37					27
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														12		8					12
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														15		11					17
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														5		2					2
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														58		42					45
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														21		12					11
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														3		4					7
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														15		26					23
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														44		30					41
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														1		4					3
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														46		35					32
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														17		11					16
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														31		26					36
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														21		29					27
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														23		18					26
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														45		39					33
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					81		16			13		11			59		20			10		9			6		12										
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														42		53					38
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														41		40					36
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					377		360			198		175			1,404		227			189		144			170		237										
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														22		19					15
Cote d'Ivoire	Cote d'Ivoire	CIV	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														8		12					10
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male				26	16	15	17		41	60	123	203	74	109	66	170	238	1,900	155	423	466	642	4,070	367	168	244	145		243	225	327	532					294
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				11	12	8	8		33	34	87	170	39	95	78	129	168	1,520	137	291	369	432	3,267	244	121	141	149		173	156	254	475					210
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male				35	25	15	26		39	63	120	273	101	99	101	162	241	1,990	204	350	463	601	4,584	418	229	279	191		279	328	347	715					287
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female				5	3	14	13		20	30	42	69	35	29	17	55	64	340	37	129	134	350	761	146	30	21	91	1,140	92	150	116	396	1,598				154
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male				3	2	4	9		6	23	83	135	18	48	18	97	107	570	96	180	233	376	1,232	182	57	39	87	1,708	122	178	92	365	2,400				198
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				6	8	10	7		29	23	71	140	31	57	36	105	128	1,600	133	252	245	300	3,703	171	87	91	99		111	121	129	318					168
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male				47	38	24	16		47	38	48	179	125	51	90	130	139	1,200	202	331	307	416	2,763	336	153	298	247		261	294	342	971					319
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male				45	49	18	28		52	68	90	259	140	115	75	189	207	1,928	190	418	428	594	4,236	399	229	307	232		303	334	406	757					339
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				9	12	10	13		14	30	62	133	44	37	15	74	105	1,292	81	197	167	263	2,832	138	33	39	61		75	92	89	355					128
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female				32	30	47	64		76	60	156	280	173	81	78	168	196	1,600	162	405	704	914	3,693	679	139	205	242		206	212	289	830					391
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												12,905					18,058				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												15,708					21,984				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female				3								450							7																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								5,000																													
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male				15	16	6	6		12	7	21	56	43	19	6	26	48	305	59	115	121	226	644	112	32	50	127		129	105	102	695					238
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												4,061					5,690				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			302	52	48	33	40		81	94	200	291	173	102	82	140	209	1,600	181	665	1,033	1,578	3,549	1,148	304	374	344		360	271	404	1,288					958
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												10,640					14,899				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												5,029					7,043				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				17	25	35	21		20	50	81	177	98	55	54	104	148	1,444	116	323	354	525	3,340	389	87	141	128		123	151	227	546					207
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female				36	42	26	52		46	95	208	324	156	117	55	174	220	1,560	229	659	978	1,381	3,522	1,118	186	335	373		308	547	580	1,041					619
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex							1			5	12	75	1	19	2	14	5	2	40	73	167	261	4	128	33	44	85	9	139	135	65	389	13				114
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male				5								131							1																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female				17	2	18	3		19	36	57	84	40	27	5	52	61	231	88	180	307	520	527	489	69	95	315		174	321	319	934					632
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												14,866					20,817				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female				37	8	20	20		49	80	97	232	85	83	46	114	127	920	224	641	851	1,218	2,146	1,045	225	432	513		393	611	953	1,449					935
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			73,899	5,489	6,334	6,611	6,525	50,493	6,339	8,279	7,197	7,685	33,011	7,207	7,448	8,378	6,686	40,648	7,306	7,807	8,225	7,196	11,436	6,959	4,660	6,304	5,772	15,551	6,828	5,815	5,356	4,906	23,982				5,252
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			43,618	6,771	7,196	6,710	6,047	18,334	6,616	7,783	6,966	7,478	44,455	8,077	8,404	8,270	7,751	32,580	8,261	8,175	8,291	8,228	55,394	8,584	7,544	9,494	10,420		8,763	8,523	7,705	6,682					5,686
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male					1										1												3										
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												19,805					54,643				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			29,832	4,047	4,590	4,242	3,618	9,302	4,053	4,636	3,994	4,035	14,442	4,425	4,587	4,430	4,008	25,833	4,392	4,280	4,392	4,192	38,528	4,280	3,718	4,474	4,734		4,711	4,286	3,970	3,681					3,558
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			38,790	7,523	8,266	8,515	7,742	29,110	7,695	8,765	8,199	8,924	37,322	8,662	9,577	9,182	9,111	38,037	8,363	9,867	10,686	10,488	89,119	8,889	6,981	9,219	9,779	20,584	8,925	8,510	8,832	8,440	47,813				7,980
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			47,306	6,323	6,916	7,527	7,263	32,125	7,377	8,187	7,480	7,996	43,200	8,173	8,710	8,645	8,677	15,005	9,055	9,134	9,464	9,342	43,689	8,917	6,711	8,693	9,516		8,014	7,786	7,530	6,282					5,674
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												144,241					185,962				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				5,334	5,666	6,449	5,966	14,762	5,918	6,594	6,071	6,601	21,046	6,662	7,222	7,117	7,190	34,663	7,557	7,852	8,317	7,938	46,655	7,396	5,511	7,292	8,122		6,664	6,266	6,508	5,595					4,780
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				8,281	8,848	8,880	8,091	60,985	8,626	9,161	8,257	8,390	42,960	8,389	8,427	8,664	7,565	31,878	8,503	8,309	7,747	6,938	49,169	7,430	4,867	6,248	5,743		7,845	7,220	5,869	4,622					5,304
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												39,258					85,699				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				3,624	4,303	4,559	4,254	14,292	4,548	4,989	4,639	4,832	18,103	5,155	5,428	5,290	5,461	23,213	5,502	5,638	6,017	5,755	37,425	5,256	3,841	5,038	5,393		4,733	4,319	4,496	3,841					3,671
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			47,264																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			47,264	14,451	17,020	16,447	15,113	68,676	15,206	16,833	16,764	16,685	87,383	16,870	19,443	19,213	19,104	99,675	18,338	19,165	19,583	19,363	101,280	18,157	13,941	17,669	18,349		17,763	17,810	16,627	15,487					15,256
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												32,498					68,625				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			87,745	30,051	31,877	29,773	27,638	114,616	29,146	31,699	30,719	31,898	151,925	32,013	34,168	33,626	32,913	137,482	31,818	32,716	34,318	33,619	111,346	34,247	25,818	33,525	34,787		36,534	36,271	34,051	30,411					29,945
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			47,264	22,479	25,427	23,735	22,431	76,898	22,832	24,740	24,386	24,335	92,306	24,490	27,344	26,178	25,818	103,648	24,936	26,420	26,519	26,427	117,006	25,720	19,980	25,589	25,921		25,924	25,999	24,737	22,456					22,287
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			38,706	6,332	7,050	7,390	6,467	47,776	6,384	7,090	6,738	7,312	33,364	7,330	8,183	7,533	7,035	21,088	6,789	8,132	8,460	7,954	67,671	7,223	6,221	8,157	7,889	18,464	7,065	7,245	6,776	6,802	46,482				6,336
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				8																						3	4										
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			58,367	18,022	18,623	17,530	16,787	52,702	17,671	16,723	15,933	15,823	57,023	16,534	17,890	18,305	17,633	94,453	18,374	17,270	18,009	18,400	69,176	19,252	13,401	17,519	17,344		19,708	19,383	17,320	16,728					16,796
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																									4				2		2						
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				6,264	7,093	7,541	7,720	66,972	7,305	9,066	7,573	8,268	47,963	7,712	7,842	9,206	7,543	38,181	8,021	8,595	8,682	7,747	64,555	7,224	5,007	6,424	5,526		7,002	5,744	5,226	4,508					4,881
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			47,264	29,197	31,964	29,599	27,633	90,963	28,267	30,962	29,981	30,081	97,747	30,263	33,537	33,403	32,705	95,580	31,603	33,257	33,688	33,138	93,726	32,838	25,148	32,016	32,498		33,893	34,010	32,323	29,092					31,968
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			47,306	7,551	8,291	8,382	8,095	37,518	8,603	8,855	8,082	9,000	53,043	9,204	9,518	9,656	9,352	14,623	9,632	9,979	10,059	9,972	43,549	9,728	7,842	10,002	10,887		9,366	8,915	8,295	7,188					6,178
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			186,751																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			47,306	7,954	8,392	8,121	7,751	50,964	8,105	8,888	8,469	8,852	90,112	9,386	9,956	9,777	9,602	21,491	9,769	10,149	10,100	9,887	43,473	10,392	8,519	10,872	11,416		9,786	10,004	9,332	7,726					7,665
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			25,811																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				7,171	8,661	8,711	7,763	31,565	7,810	8,614	8,800	9,014	37,629	9,073	10,017	9,774	9,519	94,595	9,376	10,220	10,067	9,970	31,337	9,292	7,217	9,254	9,601		8,908	9,040	8,492	8,089					7,284
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												130,118					196,718				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				3,479	4,135	4,248	3,987	32,053	4,120	4,355	4,309	4,489	36,821	4,872	5,128	5,181	4,889	68,535	5,209	4,974	5,119	4,885	16,028	4,785	3,525	4,639	4,359		4,112	4,039	3,705	3,529					3,251
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			47,306																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex											1																										
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												48,914					58,403				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												101,311					168,397				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			7,967	461	516	668	430	510	603	669	417	497		110	199	323	104		9	19	31	23		16	58	43	42		67	12	3	59					1
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			1,880	621	667	700	748	2,500	723	884	834	986	3,443	929	1,089	1,056	993	3,752	907	1,029	1,179	1,107	10,122	941	690	771	711	1,767	580	480	454	431	1,227				319
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			3,028	980	1,028	1,067	1,156	4,542	1,143	1,248	1,161	1,200	3,323	1,378	1,422	1,437	1,466	4,757	1,608	1,445	1,518	1,396	7,038	1,304	847	1,044	1,075		813	728	670	518					437
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			1,067	180	179	193	199	1,208	219	247	217	273	1,402	278	273	351	199	1,261	268	271	422	320	556	242	147	175	182	370	120	114	98	91	253				93
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				416	527	530	592	1,718	574	673	635	644	2,261	743	854	797	859	2,810	846	864	886	856	4,392	747	496	611	523		409	311	312	236					195
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			392																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			3,028	1,021	1,073	1,089	1,122	4,790	1,260	1,257	1,223	1,269	3,313	1,367	1,420	1,493	1,373	3,739	1,463	1,386	1,540	1,480	4,090	1,362	967	1,090	1,063		941	776	783	592					539
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			3,061																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			2,673	502	552	530	672	3,302	689	721	649	782	4,307	805	794	833	864	1,218	825	774	854	850	3,918	832	624	660	665		511	427	393	335					265
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			2,176	718	696	728	646	4,951	715	713	747	759	4,192	818	882	771	745	2,470	777	779	902	802	7,991	655	551	650	707	1,893	508	530	477	466	1,361				354
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			328	88	94	78	94	454	99	117	81	88	433	112	111	148	140	773	99	107	119	123	2,167	109	110	107	137		75	80	60	61					47
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				716	758	802	807	2,395	798	858	807	856	1,574	982	977	904	859	8,175	1,019	1,005	1,001	997	1,863	877	644	780	742		566	570	446	434					309
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,387					995				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				216	210	263	319	1,533	291	387	365	372	1,649	356	364	395	306	1,591	334	351	456	403	2,268	339	170	205	202		201	147	131	138					105
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			498	176	194	164	196	659	204	260	239	277	1,088	272	316	318	289	1,221	299	261	316	352	3,550	354	297	312	304		243	244	200	175					100
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				551	589	668	802	1,673	758	834	787	833	2,213	935	954	1,015	873	3,730	1,063	1,088	1,122	1,083	4,455	941	645	732	708		510	425	426	365					280
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male																											2										
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												829					474				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												1,320					793				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			2,487	715	653	659	698	3,799	825	889	789	837	2,987	973	913	916	892	2,148	917	876	956	913	2,415	881	665	792	742		680	600	538	467					381
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												3,086					2,225				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			813	256	261	271	256	961	288	291	253	258	806	271	275	322	293	1,390	281	219	296	305	1,721	239	219	227	214		164	178	151	142					130
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			2,673	528	571	655	801	3,415	822	906	798	891	4,290	941	952	1,080	1,042	1,378	1,099	996	1,210	1,134	4,346	1,064	701	792	762		530	466	467	338					297
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				298	315	326	396	1,869	355	411	390	424	1,678	404	446	434	345	1,586	371	333	426	469	1,706	430	177	222	296		275	230	225	192					134
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			2,673																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			2,673	320	353	360	411	3,276	464	565	461	528	4,475	499	568	607	638	1,090	594	544	606	592	3,133	648	492	533	557		408	348	329	243					214
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												3,420					2,267				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												4,419					3,192				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				435	507	516	514	2,306	506	612	544	609	1,572	600	685	676	605	4,511	701	694	718	715	1,234	601	430	536	526		401	368	320	311					230
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			3,028																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												461					354				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			3,028	1,064	1,110	1,120	1,146	4,513	1,236	1,351	1,244	1,339	3,362	1,411	1,494	1,478	1,461	4,920	1,556	1,446	1,502	1,564	7,223	1,396	966	1,183	1,059		842	774	740	580					468
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			194	14	7	11	17	8	10	9	3	10		5	8	5	3			1	3	2		1	4	3											
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				131	144	146	153	572	179	170	170	140	1,585	126	134	165	158	666	156	164	171	138	852	141	110	150	105		149	134	108	96					94
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				41	41	55	50	158	57	40	43	41	2,351	36	37	38	44	192	38	46	51	43	335	39	28	37	31		48	35	26	29					36
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				25	48	39	32	286	37	34	56	37	464	40	28	27	29	367	31	40	55	48	276	33	27	27	28		23	38	37	24					18
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												1,071					492				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				1					1		1		222					6					3			1		18					12				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				176	248	186	183	583	197	209	186	178	1,371	193	222	231	217	475	179	195	246	183	735	158	115	118	127		158	155	171	115					136
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				2	1	2	2	281	2	3	5	5	1,146	5	2	2	4	138	4	7	3	3	106	4	4	3	4		5	6	2	5					2
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				106	143	173	130	543	111	157	155	131	675	121	156	135	109	774	123	131	146	145	836	125	89	92	107		94	127	109	65					80
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												985					505				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																									1				1	1		1					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				164	243	199	181	500	171	218	203	168	836	168	215	201	177	622	157	181	165	194	975	166	144	116	113		147	163	154	103					103
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				1	1			1	1	3			222					2						1	3	1		2				1	4				2
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												852					555				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			922																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			922	5,988	7,121	6,996	6,200	35,483	6,107	6,991	6,790	6,155	35,490	6,260	8,108	7,642	7,640	35,490	6,874	8,215	8,438	8,254	34,780	7,526	5,849	7,133	7,195		7,580	8,224	7,567	6,671					7,475
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			32,411	8,513	8,157	8,192	7,933	33,051	8,481	7,367	7,171	6,974	33,035	7,309	8,321	8,298	8,629	33,035	8,906	8,587	9,161	9,274	34,910	9,697	6,305	8,032	8,336		9,285	9,570	8,925	8,062					9,129
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												54,328					60,572				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			351	5	6	8	13	1,098	7	6	11	1	1,099	2	19	17	10	1,099	10	15	20	15	1,108	17	15	20	18	1,108	9	29	14	14	1,236				18
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			416	136	135	99	118	466	122	116	84	69	463	149	138	81	100	463	121	143	129	118	464	109	106	108	91	464	166	163	105	147	512				158
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												78,137					87,125				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female																										3											
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			131,559	13,890	15,216	14,241	13,286	35,608	13,619	14,950	13,919	13,258	35,625	13,629	16,144	15,236	15,527	35,625	14,610	16,104	16,920	16,288	39,699	15,902	11,918	14,757	14,839		16,403	17,404	16,765	14,658					17,789
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				1,792	2,425	2,299	2,020	17,724	1,809	2,360	2,323	2,122	17,720	2,076	2,681	2,376	2,609	17,720	2,142	2,965	2,856	2,883	13,305	2,528	2,098	2,473	2,458		2,489	2,843	2,587	2,510					2,422
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			62,224	14,509	15,237	14,633	13,650	63,646	14,320	15,609	15,196	15,081	63,646	15,019	16,941	16,342	16,334	63,646	15,598	16,862	18,366	17,863	70,741	17,563	12,730	16,330	16,425		18,195	19,207	18,465	15,761					17,289
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				232	355	280	294	17,691	258	308	345	289	17,687	275	381	315	314	17,687	399	371	431	437	6,243	449	330	432	294		363	394	347	343					269
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												105,651					117,799				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex											1														4												
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			922	10,414	11,827	11,237	10,471	35,491	10,508	11,528	11,057	10,268	35,498	10,576	12,454	11,365	11,679	35,498	10,821	12,404	12,908	12,620	38,438	12,146	9,194	11,427	11,548		12,311	13,039	12,524	10,942					11,892
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			264	165	246	201	189	532	182	218	203	166	848	168	218	198	180	634	157	185	168	193	979	174	146	127	121		144	162	154	107					105
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			1,877	177	247	197	187	486	199	213	184	177	1,389	187	224	230	218	486	183	197	253	182	736	159	116	130	129		160	156	171	126					138
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			642	131	143	149	155	607	174	167	174	140	1,604	139	132	163	156	687	154	161	170	140	857	142	111	152	107		149	136	109	97					100
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												1,101					492				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex				2	2			5	1	3			222					2						1	3	1		2					4				1
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												1,007					505				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				25	49	41	38	306	39	34	55	37	464	38	29	26	30	371	31	39	54	49	276	31	28	31	27		23	38	37	23					18
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			152	41	41	55	49	199	55	41	43	43	2,352	38	40	38	44	193	39	48	52	43	335	36	29	41	31		49	35	26	27					35
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			264																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												874					561				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female											1		219			2		6					3		1	1		18	1	1		1	12				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			264	107	143	177	133	587	111	162	156	130	683	116	158	133	108	792	124	133	139	145	839	124	92	102	109		97	128	109	67					81
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				2	2	2	2	301	2	2	5	5	1,146	3	2	2	4	142	4	7	3	3	106	4	4	3	4		5	6	2	5					1
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			1,110		1,077		1,616	1,176		1,889		666	743		818		959	743		913		729	734				150			140		391					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			429		770		1,026	451		1,008		571	265		756		1,073	265		898		766	272				260			182		221					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												1,104					1,104				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			919		713		1,243	973		1,546		512	673		492		499	673		314		474	673				96			87		304					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			142		137		213	150		218		249	80		127		201	80		152		131	80				81	160		95		161	160				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			428																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												1,800					1,800				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			437		1,020		1,636	461		1,894		2,206	272		2,216		2,202	272		1,671		1,706	259		1,680		2,587			1,098		1,061					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					716		1,150	237		1,206		1,417	139		1,353		1,438	139		1,263		1,278	139		1,070		1,881			737		807					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			291		94		376	306		209		123	255		133		199	255		62		142	255				91	510		91		806	510				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					348		443	232		518		463	135		496		644	135		458		466	135				79			91		252					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												1,174					1,174				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			429		472		708	451		740		509	265		551		833	265		786		735	262				133			165		293					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					149		242	232		383		307	135		322		407	135		228		254	135				46			67		250					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					368		502	237		797		787	139		665		739	139		555		544	139		347		688			288		422					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			931		1,813		1,615	985		2,230		2,109	529		2,226		2,188	529		1,510		1,766	537		1,946		3,532			1,349		1,057					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female															4																						
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male															3																						
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			216		231		453	228		551		689	144		392		445	144		164		405	144		160		464	288		271		304	288				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			550		1,100		808	583		1,146		594	323		817		661	323		455		608	323		460		888			328		385					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			437		1,554		2,149	461		2,296		2,733	272		2,792		2,963	272		2,185		2,363	288		2,570		4,211			1,596		1,110					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												1,128					1,128				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			429		1,166		1,313	453		1,240		613	265		829		1,211	265		987		738	252				210			182		307					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			437		1,731		2,100	462		2,464		2,724	272		2,877		3,054	272		2,264		2,322	279		2,909		4,537			1,734		1,435					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			438																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												1,074					1,074				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												2,814					2,814				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			187	149	275	262	1,064	158	78	135	61		74	39	65	47					7
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			857	843	1,117	1,346	1,916	1,071	324	386	363		342	274	300	423					384
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																					3																
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																										3											
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			269	306	418	420	1,367	414	190	226	130		93	77	85	99					17
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												2,502					2,510				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			278	370	374	398	573	299	204	101	207	654	67	137	110	160	660				12
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			106	131	267	170	500	140	95	43	115	536	42	98	72	69	544				9
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			353	324	363	494	1,000	363	168	170	143		76	113	88	109					19
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			697	557	835	771	1,215	494	159	262	232		161	158	160	211					26
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			419	434	648	721	2,005	588	343	293	196		192	170	191	216					96
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			778	790	1,091	1,455	2,161	1,359	573	464	520		437	302	399	474					286
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												4,968					4,988				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			992	988	1,298	1,789	2,120	1,583	431	531	427		360	304	377	509					364
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												2,846					2,862				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			629	632	959	1,033	1,262	818	260	301	275		217	222	234	311					39
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			240	231	441	680	1,623	584	119	190	171		160	149	196	171					263
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			688	675	909	1,089	2,112	996	550	358	406		294	258	342	368					202
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			526	532	735	826	1,191	697	289	273	307		198	193	298	295					31
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			407	453	534	657	1,207	570	283	230	215		148	143	193	209					18
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												4,102					4,110				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												5,980					6,000				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			493	512	683	907	1,188	788	316	281	253		185	150	242	263					39
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												3,906					3,930				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					12		10	139		53		124	707	195	258	417	655	1,221																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					5		6	73		40		68	632	124	153	321	610	1,087																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					46		41	294		160		264	1,194	309	350	618	1,028	2,048																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					42		35	189		123		199	1,200	231	239	459	890	2,053																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					2		2	80		32		60	654	137	121	285	534	1,103																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								77		16		40	548	71	91	190	419	932																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					14		12	160		51		86	945	79	75	174	292	1,589																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					8		8	74		11		25	587	29	42	90	162	987																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female															1	1																					
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					54		53	207		188		265	1,238	283	316	614	1,147	2,124																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					14		13	75		49		83	627	145	186	374	670	1,089																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					17		19	134		47		62	795	64	65	140	246	1,345																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					18		21	136		67		145	714	191	220	404	700	1,245																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					4		4	112		9		14	347	29	36	69	145	592																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					1		3	98		30		54	367	85	91	208	395	618																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					24		20	143		67		107	1,123	146	168	285	541	1,893																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					67		61	265		191		310	1,288	352	415	684	1,224	2,188																			
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								67		27		35	574	31	37	107	286	837	205	192	237	332	1,309	216	163	272	333		281	366	304	265					142
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								123		26		71	568	69	73	125	237	845	252	267	228	354	1,318	378	375	735	596		417	460	405	571					217
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								68		6		11	514	1	15	39	75	738	79	81	96	103	1,158	143	110	172	239		134	204	163	272					107
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								102		17		19	661	18	18	60	115	953	93	108	110	140	1,484	86	69	77	91		134	149	152	133					101
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																															12						1
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												4,747					4,767				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								165		101		79	1,031	82	78	186	536	1,509	328	372	439	649	2,354	430	283	690	652		613	825	883	689					1,232
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								65		13		24	471	24	47	76	269	696	142	147	143	199	1,082	144	120	137	142		173	220	177	156					88
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female								140		39		28	785	22	24	45	112	1,130	82	142	153	159	1,760	158	81	179	376		450	653	799	589					1,029
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												3,040					3,064				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																			4																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								225		119		98	1,023	112	76	175	553	1,479	419	535	586	769	2,305	496	476	787	797		747	1,136	1,131	844					1,720
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												4,570					4,634				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								244		90		96	900	90	77	169	416	1,328	293	398	483	548	2,073	404	330	815	840		833	1,195	1,190	920					1,606
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								147		66		69	1,011	56	54	138	451	1,474	282	306	347	460	2,296	266	231	389	433		418	580	566	508					770
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								130		35		66	578	49	54	135	307	872	310	323	342	442	1,367	433	373	841	657		525	687	610	571					291
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								63		24		36	552	48	62	139	320	825	282	297	291	423	1,291	351	349	605	591		455	553	519	499					231
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								111		3		6	235	11	12	31	82	351	49	49	77	74	554	76	86	57	96	610	82	130	140	139	626				71
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								103		28		36	980	39	47	99	272	1,400	185	207	241	281	2,183	192	130	223	253		252	317	313	268					288
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												3,441					3,481				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								60		28		29	559	35	62	136	302	826	258	251	322	415	1,290	291	222	403	456		404	492	455	356					193
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												7,195					7,247				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								97		24		34	269	17	40	90	211	395	129	138	135	209	625	148	135	137	174	800	202	200	237	175	804				107
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												5,938					5,986				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				5	11	13	14	95	6	12	10	18	1,068	10	8	18	26	65				77	57				58					97					48
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											6					15					18
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				10	6	6	9	123	13	7	9	10	826	8	9	10	17	52				50	60				46					47					51
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											69					177					149
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex							8	22		2						1						2					3					10					3
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				12	23	12	48	20	11	11	8	10	395	12	20	24	26	30				85	36				44					71					58
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				33	36	37	34	122	34	39	31	31	363	31	34	41	41	156				201	124				130					180					176
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				6	8	16	52	22	3	10	6	10	388	12	8	19	19	20				40	25				33					45					40
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				55	52	58	56	122	45	40	35	43	474	44	50	56	39	219				185	189				173					185					173
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											26					31					44
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												436					200				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				46	30	35	39	95	37	29	31	50	593	29	31	46	64	254				179	221				127					143					129
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												235					203				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												711					343				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			1,128																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				36	37	46	36	95	42	39	35	43	557	43	30	36	31	161				177	130				129					189					109
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				6	13	13	3	95	8	8	6	6	1,178	8	8	9	13	74				33	78				30					45					24
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				49	31	55	46	314	38	47	38	60	571	40	64	46	47	200				210	187				171					193					150
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				45	52	43	41	95	37	58	52	43	480	51	62	72	55	155				252	151				104	194				37	103				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				17	16	20	16	20	15	8	8	14	365	15	13	19	25	25				78	33				51	37				52	6				51
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				19	22	16	15	122	16	21	12	21	547	30	16	31	30	76				94	93				82					107					110
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												316					191				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											12					31					36
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											17					23					29
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												79					16				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				48	52	62	46	122	39	47	44	53	347	51	46	76	61	267				221	220				164					202					177
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											21					106					53
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				40	40	47	35	95	35	33	39	52	452	41	51	48	48	242				207	221				146					201					159
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												285					130				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											74					158					107
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				43	56	58	46	122	51	47	36	45	390	43	48	83	58	304				197	239				186					200					170
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				65	46	57	54	122	45	58	46	75	330	67	88	109	91	141				325	146				127	206				39	90				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											23					81					32
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			796																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				38	35	40	33	122	30	43	32	46	419	34	51	49	39	261				172	203				153					211					136
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			142																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				15	18	30	20	95	23	20	15	14	613	16	16	28	18	85				103	85				87					155					94
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												894					387				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			10,699		5,216		3,910	45,420		4,466		10,305	77,002		9,027		14,807	42,244		15,961		17,365	32,692		7,810		10,206	14,733		8,195		8,831	12,811				4,244
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			3,510		3,077		2,149	28,955		2,995		6,649	61,387		6,542		9,639	27,861		11,020		12,273	34,129		5,628		7,596	6,242		5,628		5,549	9,115				3,373
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			1,559		662		271	7,520		982		5,832	16,444		5,902		3,066	8,201		1,806		1,514	4,681		555		748	1,655		919		1,243	1,794				522
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				512	482	482	527	1,489	552	510	521	570	1,516	565	531	536	502	2,124	606	646	674	704	2,318	691	580	756	691		639	771	736	758					734
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												4,341					4,341				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				517	466	525	481	1,495	519	509	499	564	1,516	522	515	569	550	2,124	585	727	711	671	2,318	722	528	736	705		654	787	772	837					866
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				327	297	298	308	1,040	273	329	328	338	1,055	309	348	340	302	1,324	371	404	379	410	1,447	376	304	434	405		377	441	432	437					480
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				396	317	358	359	1,485	348	352	378	389	1,516	372	406	438	377	2,124	438	485	490	538	2,318	473	408	590	552		492	558	565	592					561
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			2,058																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												1,142					1,142				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				330	310	345	303	1,040	321	383	335	411	1,055	432	390	387	392	1,324	392	422	391	481	1,447	438	404	467	473		484	556	502	513					490
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				270	225	240	290	521	260	300	255	299	528	255	298	266	249	528	302	328	334	301	571	373	293	350	381	571	329	384	358	370	571				319
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				191	162	178	189	1,045	170	203	186	238	1,055	206	218	260	177	1,324	249	259	243	244	1,447	246	214	306	251		243	293	272	247					223
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				193	193	168	136	521	169	189	127	185	528	202	180	218	185	528	174	261	214	243	571	269	204	269	269		283	387	300	228					202
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												4,636					4,636				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				214	228	226	209	1,040	242	216	211	238	1,055	223	239	253	215	1,324	230	286	256	241	1,447	295	188	339	298		289	331	287	258					260
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				238	232	249	252	1,040	245	250	261	273	1,055	268	298	312	288	1,324	334	288	323	325	1,447	373	269	373	333		277	333	350	342					273
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			11,669																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				550	452	514	522	1,040	479	584	508	624	1,055	532	668	654	554	1,324	613	749	720	732	1,429	722	673	1,090	772	1,429	679	814	817	739	1,429				663
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male																						15															
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				8	11	26	12	526	8	14	5	9		4	9	6	5		5	3	8	2		4	3	2	1				1	3					2
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				433	356	441	438	1,781	434	484	492	545	1,516	457	548	515	500	2,124	524	663	600	714	2,318	598	493	722	669		654	795	691	642					664
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				249	257	256	215	1,490	267	266	236	295	1,516	264	254	262	260	2,124	298	317	319	345	2,318	373	262	387	392		349	377	375	403					402
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				252	246	242	273	1,044	298	284	253	280	1,055	295	270	310	261	1,324	307	337	371	363	1,447	345	270	393	397		399	374	353	427					465
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			7,876																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				242	198	182	225	521	215	234	178	247	528	216	216	282	228	528	252	355	311	287	571	313	250	360	317		302	391	380	299					249
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												2,894					2,894				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												2,894					2,894				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female																						19															
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				678	700	615	704	1,494	701	869	763	817	1,516	766	896	925	818	2,124	823	1,081	990	1,038	2,316	989	918	1,271	1,098	2,316	916	1,157	1,133	1,075	2,316				1,031
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												4,636					4,636				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				459	449	453	486	1,490	470	498	452	530	1,516	544	571	559	573	2,124	560	647	602	675	2,318	625	460	707	688		710	750	697	766					728
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				278	244	266	299	1,485	288	323	298	345	1,514	329	321	333	316	2,124	333	363	398	401	2,318	414	339	437	384		369	408	452	439					439
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												6,954					6,954				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				311	253	265	312	1,045	283	272	292	307	1,055	281	301	274	222	1,324	309	352	306	337	1,447	308	281	392	358		323	329	344	344					310
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			878	849	991	948	1,023	1,110	1,089	1,259	1,375	1,410	1,508	1,522	1,602	1,688	1,831	2,206	1,837	1,953	2,103	2,190	4,073	2,211	1,343	1,902	2,021		1,855	1,775	1,821	1,626					1,489
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				2,113	2,221	2,270	2,538	5,207	2,883	3,055	3,206	3,501	6,688	3,767	3,840	3,750	3,838	8,059	3,731	3,808	4,273	4,468	9,198	4,559	1,906	2,364	2,539		2,473	2,276	2,247	2,219					1,382
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			3,933	4,599	4,986	5,371	7,484	5,522	3,866	5,024	4,680		4,607	4,416	4,225	4,326					4,395
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			8,626																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			1,817	1,280	1,445	1,276	1,398	2,346	1,646	1,886	2,164	2,402	3,314	2,664	2,929	3,305	3,514	4,395	3,501	3,640	4,071	4,368	6,628	4,532	2,585	3,797	3,770		3,444	3,138	3,268	3,224					2,586
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			8,608																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			473	184	171	139	132	615	132	112	119	141	790	130	138	122	139	228	114	100	132	126	132	110	39	34	222	196	31	64	49	45	106				62
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			4,328	4,949	5,258	5,746	8,798	5,756	4,248	5,643	5,484		5,443	5,304	5,386	5,580					5,448
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			8,782	8,540	9,270	9,682	8,889	9,855	6,619	8,972	8,556		7,924	7,535	7,202	7,326					6,933
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			1,825	2,252	2,363	2,551	3,946	2,627	1,705	2,414	2,522		2,597	2,543	2,494	2,638					3,273
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			8,428																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												36,916					33,011				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			2,807	3,266	3,522	3,760	4,406	3,847	2,826	3,710	3,588		3,567	3,460	3,411	3,577					3,462
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			8,608	4,084	4,532	4,543	5,145	10,962	6,034	6,738	7,468	8,172	14,871	8,929	9,723	10,684	11,497	15,871	11,850	12,651	14,199	14,966	19,210	15,369	8,796	12,121	11,480		10,620	9,881	9,371	8,955					7,779
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				1																																	
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				2,626	2,881	2,796	3,018	5,216	3,393	3,729	3,966	4,279	6,700	4,592	4,934	5,147	5,388	8,070	5,307	5,518	6,136	6,433	9,821	6,339	3,683	4,783	4,516		4,389	4,101	3,917	3,778					3,062
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			3,627	2,231	2,465	2,385	2,555	4,488	2,766	2,916	3,116	3,345	5,700	3,614	3,904	4,215	4,336	6,788	4,336	4,593	5,060	5,331	6,335	5,292	3,295	4,307	4,117	4,220	3,888	3,702	3,759	3,650	3,900				3,421
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			7,591	6,979	7,427	7,928	8,490	9,677	9,169	10,035	10,888	12,036	12,849	12,879	13,938	15,058	15,961	16,086										19,007					17,910				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												14,215					11,535				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			1,708	2,049	2,214	2,343	5,311	2,386	1,516	2,179	2,094		2,271	2,210	2,108	2,237					2,664
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			8,626	10,288	10,812	10,681	11,500	12,147	12,675	13,732	14,642	15,658	14,979	16,762	17,931	19,220	20,347	19,110	20,867	22,114	24,191	25,044	25,875	25,288	15,347	20,307	19,867		18,349	17,465	16,861	16,567					14,913
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												33,220					32,490				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			8,608	2,381	2,607	2,412	2,715	10,954	3,211	3,702	4,071	4,506	14,871	4,928	5,417	5,873	6,240	15,604	6,305	6,717	7,467	7,873	14,200	8,372	4,496	6,427	6,365		5,772	5,367	5,381	4,959					4,365
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			2,060	2,011	2,143	2,188	2,395	2,880	2,632	2,841	3,072	3,205	3,554	3,398	3,522	3,642	3,807	4,783	3,664	3,867	4,221	4,427	6,611	4,511	2,434	3,085	3,090		2,976	2,728	2,739	2,507					2,276
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												47,643					46,540				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			8,608	3,420	3,736	3,591	4,142	10,970	4,820	5,465	6,034	6,661	14,883	7,336	7,977	8,724	9,380	15,731	9,554	10,144	11,373	12,134	18,495	12,413	6,633	9,616	9,299		8,526	7,964	7,386	7,338					6,228
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			8,626	8,479	8,853	8,595	9,405	12,119	10,733	11,677	12,701	13,736	14,860	14,813	15,880	17,076	18,026	18,046	18,024	19,065	21,045	21,987	23,622	22,367	12,560	16,478	15,726		14,664	13,725	13,058	12,688					11,152
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												9,036					7,027				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			9,858	9,491	10,146	10,315	10,629	10,318	7,034	9,160	8,899		8,576	8,450	8,250	8,552					8,406
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				8,796	8,859	9,088	9,342	6,077	10,573	11,448	12,309	13,218	7,405	14,076	14,917	15,901	16,621	14,871	16,980	17,918	19,396	20,394	18,570	20,783	13,087	17,687	16,896		15,968	15,451	14,941	14,846					13,809
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												5,023					5,299				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				6,412	7,415	7,115	8,017	6,042	8,037	8,649	9,117	9,753	7,362	10,372	11,171	11,932	12,762	11,421	13,005	13,719	14,677	15,195	15,082	15,369	10,245	13,245	12,565		11,921	11,506	11,349	11,386					10,762
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			8,626	10,047	10,632	10,462	11,325	12,161	12,460	13,681	14,861	15,947	14,939	17,079	18,259	19,681	20,832	19,226	21,005	22,181	24,454	25,484	26,124	25,631	14,837	20,112	19,098		17,793	16,803	16,250	16,053					14,142
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			11,388	9,749	10,549	10,940	11,530	15,914	12,160	12,787	13,591	14,537	19,490	15,325	16,304	17,297	18,293	21,405										20,337					19,866				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			2,348	2,783	3,087	3,398	4,930	3,366	2,500	3,214	3,015		2,994	2,821	2,747	2,874					2,860
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			7,145	5,515	5,574	5,606	6,132	10,022	6,902	7,499	8,171	8,832	12,533	9,614	10,334	10,970	11,614	14,288	11,244	11,826	12,994	13,591	17,559	13,928	7,715	9,734	9,404		8,391	7,841	7,489	7,533					5,902
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												15,113					14,524				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				3,848	4,673	4,607	5,264	5,476	5,773	6,436	7,014	7,587	7,428	8,198	8,926	9,688	10,616	9,898	10,777	11,501	12,687	13,292	13,985	13,666	8,377	11,173	10,418		9,723	9,015	8,691	8,568					8,054
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				4,518	4,665	4,830	5,337	5,487	6,198	6,943	7,654	8,539	7,444	9,412	10,160	11,120	11,936	10,771	12,246	13,282	14,833	15,736	14,852	15,997	9,549	13,154	12,515		11,735	11,029	10,433	10,223					9,237
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			379	24	14	23	18	154	14	13	33	21	181	10	16	9	22	228	16	7	12	14	132	13	7	12	9	196	4	20	11	16	106				8
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												4,199					3,031				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												802					466				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								51	40	79	48		38	49	41	50					80
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			2,906	296	344	343	348	3,063	433	589	427	504	4,219	468	559	588	565	1,039	587	540	628	583	3,083	637	364	505	501		371	313	316	235					194
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				637	725	742	747	2,191	743	841	806	842	1,482	953	940	883	834	7,767	950	976	992	985	1,828	862	609	738	722		540	557	451	415					289
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			438	161	177	153	162	649	199	219	229	261	1,033	252	260	293	254	1,163	301	247	289	347	3,512	337	204	297	267		218	237	189	180					89
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								63	61	75	35		63	46	35	60					51
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								199	196	205	162		139	127	130	103					84
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								313	247	297	294		237	240	232	213					138
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			2,906	478	489	473	618	3,076	664	684	621	733	4,215	758	748	815	807	1,156	838	739	896	851	3,864	779	510	626	651		515	391	365	324					248
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			2,899	893	1,004	977	1,059	4,329	1,109	1,220	1,116	1,174	3,129	1,327	1,384	1,403	1,450	4,515	1,506	1,389	1,540	1,376	6,905	1,286	789	996	1,048		795	707	655	499					419
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			2,899	1,004	1,073	1,082	1,099	4,332	1,169	1,320	1,230	1,325	3,075	1,373	1,441	1,419	1,388	4,674	1,497	1,410	1,579	1,545	7,049	1,332	892	1,105	1,040		796	767	724	575					465
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			1,987	592	670	660	707	2,715	695	855	830	925	3,430	914	1,054	1,035	950	3,563	941	1,026	1,170	1,071	10,023	141			139	1,681					1,165				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								102	105	95	87		89	76	64	57					41
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				463	486	498	489	2,172	501	597	542	595	1,473	578	662	661	609	4,289	657	639	714	720	1,224	592	412	523	511		401	361	318	307					217
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				188	209	247	280	1,357	288	364	349	359	1,618	356	350	382	297	1,515	329	341	428	395	2,246	328	160	186	201		194	143	133	127					98
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			3,425	154	169	183	178	1,151	214	233	213	257	1,326	277	245	321	186	1,209	258	257	337	314	556	236	144	166	193	366	121	108	97	83	250				82
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			188	63	81	74	82	313	108	110	76	87	427	103	117	146	131	736	105	113	108	113	2,139	122	88	111	131		79	79	58	54					39
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								131	165	173	133		138	135	126	116					81
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				272	298	297	375	1,360	343	395	375	402	1,615	377	448	401	341	1,519	362	316	437	454	1,693	407	159	212	288		261	233	220	177					121
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												2,931					2,113				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			519																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			2,769	684	682	721	648	5,631	695	693	744	748	3,973	778	855	757	730	2,348	717	763	850	768	7,943	108			131	1,801					1,296				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								77	75	93	93		89	90	88	71					63
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												442					345				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			2,906																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			833	222	254	246	236	1,044	280	260	255	249	745	246	256	319	277	1,322	261	225	285	300	1,700	262	193	212	229		177	175	150	137					118
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												3,250					2,152				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												1,252					751				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			2,568	666	616	620	651	3,575	756	837	775	786	2,762	929	887	888	858	2,042	898	853	964	906	2,379	859	581	725	716		659	568	508	450					348
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								454	295	394	296		275	208	218	194					135
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			2,899	989	999	1,023	1,019	4,266	1,176	1,200	1,191	1,245	3,036	1,328	1,421	1,469	1,360	3,550	1,453	1,355	1,592	1,473	4,044	1,321	876	1,014	1,054		912	755	741	583					502
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			2,906	507	554	615	734	3,055	814	855	780	851	4,211	895	937	1,051	994	1,310	1,090	1,029	1,257	1,126	4,296	1,037	621	740	736		502	433	450	319					276
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				490	552	607	730	1,533	721	810	777	828	2,112	896	911	990	857	3,544	1,070	1,067	1,118	1,071	4,385	914	580	720	700		502	393	401	355					267
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			2,899																																		
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,322					948				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				408	480	496	551	1,528	544	640	612	657	2,106	733	836	790	816	2,670	851	863	895	833	4,326	748	457	580	519		387	301	298	226					186
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				4,464	5,667	6,387	7,249		8,028	9,346	9,866	11,173	17,765	11,528	11,929	13,166	14,157	20,077	14,543	15,449	16,716	18,125	22,155	1,695			877	18,250					17,945				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												29,804					29,348				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								8,475	5,713	6,757	6,311		5,664	6,471	6,446	6,872					5,943
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												8,119					6,356				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				470	430	500	562		626	789	983	1,524	6,031	1,473	1,642	2,071	2,519	7,382	2,246	2,317	2,593	2,857	7,293	2,810	1,650	1,451	1,692		1,081	1,512	1,528	1,606					594
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				346	385	485	584		446	548	633	931	1,347	923	930	1,125	1,121	1,928	1,168	1,284	1,330	1,500	3,241	1,441	1,029	1,244	1,138		1,084	1,258	1,220	1,245					991
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				3,952	4,428	5,243	5,841		6,916	8,326	8,912	10,936	13,630	11,338	12,286	13,432	14,407	17,238	14,123	15,933	17,160	18,304	21,439	18,188	12,782	14,762	13,210		11,097	12,800	12,338	12,374					9,453
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				742	841	978	1,136		1,316	1,639	1,890	2,224	5,153	2,217	2,252	2,730	3,045	6,238	2,989	3,265	3,331	3,619	4,651	3,768	2,753	3,186	2,929	3,808	2,533	2,813	2,818	3,003	3,524				2,052
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								7,315	5,011	6,121	5,357		4,784	5,580	5,568	5,795					4,683
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				3,737	4,065	4,795	5,361		6,497	7,858	8,417	10,729	13,607	11,318	12,155	13,677	15,199	17,301	14,135	16,247	17,104	18,031	21,899	17,786	11,550	13,667	12,360		10,279	12,437	11,708	12,001					8,765
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								2,026	1,803	2,485	1,956		1,776	2,073	2,223	2,340					1,908
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male															17											2											
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								4,634	1,427	1,889	1,519		1,801	1,842	2,070	2,089					2,107
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				1,872	2,274	2,876	3,326		2,887	3,710	4,165	5,250	6,623	5,766	6,251	7,220	7,894	9,433	7,930	9,139	9,895	10,784	12,495	10,847	7,292	8,860	8,147		6,954	8,085	7,786	7,871					5,703
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				2,892	3,085	3,865	4,323		5,178	6,199	6,718	8,883	13,544	9,447	10,203	11,443	12,779	16,478	11,511	12,947	13,971	14,922	18,326	14,548	9,591	10,891	9,671		8,218	10,001	9,265	9,533					6,386
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												4,516					4,789				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								3,155	2,788	3,491	2,970		2,774	3,182	3,267	3,382					2,961
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				42	5	4	8		5	37	63	68	718	40	1	42	45	160	58	40	30	39	106	38		5	6	146		57	10	10	98				173
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								3,679	1,300	1,676	1,338		1,392	1,565	1,708	1,697					1,712
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				2,088	2,496	2,967	3,309		2,980	3,740	4,023	4,878	6,608	5,273	5,640	6,347	7,181	8,837	6,954	7,876	8,536	9,254	11,716	9,486	6,263	7,465	6,879		5,818	6,672	6,546	6,621					5,172
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												42,746					42,043				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				600	704	821	949		660	857	970	1,348	2,917	1,543	1,581	1,828	2,209	3,929	2,176	2,466	2,636	2,866	5,139	2,817	1,893	2,248	2,110		1,873	2,162	2,089	2,272					1,604
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female															11											2											
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				1,821	2,063	2,545	2,943		2,644	3,374	3,770	4,878	13,218	5,430	5,992	6,744	7,590	15,000	7,412	8,511	9,137	9,992	16,239	9,920	6,534	7,751	7,255		6,080	7,128	6,720	6,810					4,586
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				672	660	806	972		1,015	1,209	1,358	1,959	3,230	2,023	2,271	2,515	2,797	4,261	2,333	2,682	2,645	2,860	5,162	2,860	1,763	1,933	1,933		1,890	2,140	2,018	2,011					1,339
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				3,202	3,949	4,742	5,423		5,323	6,494	6,825	8,025	11,476	8,646	9,031	10,410	11,266	14,581	11,734	12,624	14,093	15,710	20,587	1,375			596	17,061					16,184				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				1,527	1,756	2,248	2,588		2,099	2,713	3,048	4,108	13,229	4,351	4,540	5,571	6,307	14,907	6,028	6,944	7,427	8,019	15,667	8,020	5,105	6,142	5,568		4,599	5,613	5,244	5,432					3,793
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												33,121					29,819				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												12,761					10,415				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				1,060	1,184	1,501	1,697		1,271	1,550	1,845	2,561	13,216	2,744	3,047	3,545	4,054	14,820	3,820	4,217	4,565	4,992	12,026	4,991	3,180	4,029	3,615		3,143	3,825	3,570	3,686					2,671
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								2,429	2,292	3,017	2,519		2,301	2,753	2,941	3,080					2,547
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								3,513	3,451	4,369	3,629		3,338	3,923	4,185	4,365					4,003
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												13,562					13,130				
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				1,826	1,741	2,150	2,596		3,010	3,652	3,885	5,290	11,363	5,529	6,224	7,169	8,182	13,268	7,237	7,852	8,431	9,209	12,673	9,038	5,887	6,319	5,765		4,725	5,634	5,233	5,354					3,265
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				3,246	3,622	4,262	4,720		4,863	5,877	6,170	7,210	6,731	7,327	7,810	8,551	9,291	9,849	9,268	10,352	10,963	11,599	10,653	11,607	8,245	9,438	8,966		7,485	8,570	8,772	9,175					7,647
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				3,560	4,279	5,046	5,653		6,175	7,179	7,818	9,324	6,770	9,830	10,292	11,501	12,303	12,206	12,152	13,502	14,383	15,353	14,012	15,540	10,943	13,132	11,957		10,018	11,579	11,378	11,819					9,132
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				804	910	1,117	1,287		1,544	1,843	2,151	2,279	6,044	2,547	2,730	3,040	3,579	7,378	3,382	3,767	3,851	4,238	8,305	4,372	3,103	3,516	3,089		2,400	2,958	2,878	2,966					1,668
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														77		75					79
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														29		32					35
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														27		28					15
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					400		344			359		431			485		671			428		548			439		539										
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														32		40					35
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														75		92					79
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														82		83					91
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														25		21					37
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														12		48					23
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														14		19					11
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														14		17					21
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														23		15					38
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														72		69					62
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														11		12					6
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														67		67					69
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														6		23					8
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														1							2
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														45		68					55
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					646		438			450		460			593		789			539		685			631		740										
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														39		44					44
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														80		89					67
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														84		113					85
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														35		32					22
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														50		69					60
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														48		73					92
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					87		64			58		47			66		155			76		112			92		103										
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														78		85					95
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														58		58					51
Democratic Republic of the Congo	Democratic Republic of the Congo	COD	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														16		14					16
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			4,953	1,604	1,909	1,786	1,204	24,877	4,843	5,931	2,840	6,637	18,866	9,390	6,757	5,577	5,361	21,684	4,388	4,907	4,725	3,774	15,857	2,854	3,514	3,262	3,197		3,812	4,273	3,959	4,179					1,993
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			5,443	2,560	2,723	2,563	2,197	17,518	7,335	8,018	4,137	8,177	10,516	11,285	9,489	7,893	9,123	7,553	6,531	8,082	7,528	6,906	5,699	5,832	6,406	6,267	5,693		6,479	6,611	6,830	7,049					3,268
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				40	71	105	83	77	162	149	65	196	122	282	323	284	438		200	318	309	383		214	350	344	343		261	341	287	331					226
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			5,920	998	1,345	1,248	1,204	5,690	3,230	3,717	1,660	3,508	5,484	4,998	4,237	3,521	4,176	5,357	3,022	3,854	4,064	3,603	1,835	3,035	3,855	3,314	3,116	27,573	3,115	3,811	3,692	3,834	23,915				2,898
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			3,016	1,471	1,659	1,583	1,323	9,788	4,863	5,003	2,598	5,316	7,583	5,805	5,516	4,493	5,545	4,125	3,525	4,612	4,010	3,887	3,475	3,293	3,442	3,375	3,148		3,447	3,407	3,514	3,802					1,993
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				684	796	747	581	8,902	1,885	2,438	1,523	3,580	5,976	5,100	3,324	2,739	2,480	7,459	2,140	2,451	2,503	1,887	4,586	1,653	2,056	1,685	1,708		2,115	2,485	2,169	2,329					1,433
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			11,232																																		
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			6,337	1,406	1,793	1,759	1,505	10,527	3,693	4,599	2,680	5,717	6,226	8,225	6,262	4,638	4,923	7,963	4,155	4,889	4,682	4,146	5,704	3,591	4,420	3,761	3,698	35,016	3,840	4,569	4,336	4,289	22,498				2,760
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			5,361	1,250	1,467	1,314	913	18,564	3,489	4,557	2,274	5,339	16,308	7,662	5,396	4,487	4,163	22,397	3,444	3,773	3,916	3,065	15,800	2,419	2,958	2,775	2,809		3,255	3,660	3,364	3,727					1,947
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			6,205	2,032	2,206	2,113	1,846	15,363	6,422	7,337	3,593	7,585	11,360	10,382	8,403	7,348	8,288	8,557	5,790	7,519	7,064	6,271	5,707	5,277	5,970	5,882	5,302		5,774	6,282	6,604	6,802					3,340
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			4,426	1,646	2,057	1,980	1,356	22,803	5,074	6,237	2,964	6,978	11,585	9,561	6,858	5,466	5,494	10,596	4,658	4,835	4,802	3,792	7,329	2,941	3,346	3,044	3,042		3,526	3,809	3,660	3,708					1,592
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				504	730	608	526	7,246	1,314	1,816	1,052	2,386	2,663	3,751	2,251	1,786	1,723	3,503	1,468	1,656	1,633	1,352	1,849	1,194	1,443	1,207	1,199		1,426	1,719	1,606	1,751					1,078
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												192					245				
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												32,187					26,431				
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female														16	2	8	39		12	8	11	12		2	10	7	3		5	4	5	1					2
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				595	740	699	650	5,303	1,862	2,190	1,203	2,630	1,762	3,799	2,842	2,250	2,373	670	1,890	2,294	2,307	1,845	832	1,481	1,948	1,720	1,575		1,916	2,159	2,077	2,366					1,512
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			10,546																																		
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				45	52	112	61	81	135	148	63	283	182	266	297	253	338		131	245	262	276		158	228	355	213		152	224	194	217					171
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male														15	10		34		6	9	6	13		3	10	6	3		7	3	1	6					6
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				377	523	519	486	3,945	1,275	1,494	751	1,793	1,278	2,614	1,796	1,528	1,576	988	1,236	1,446	1,482	1,264	594	1,000	1,291	1,205	1,061		1,274	1,447	1,471	1,537					1,145
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												40,865					29,066				
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												14,877					12,089				
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												36,827					26,344				
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												34,304					24,258				
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												20,102					14,566				
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			5,840	932	1,155	975	715	13,538	2,629	3,218	1,684	4,285	9,428	5,947	4,111	3,429	3,228	13,655	2,634	3,093	2,965	2,368	10,358	1,857	2,390	2,138	2,060		2,520	3,018	2,765	3,043					1,736
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex				5	11	9	4		4	12	6	89		31	16	8	30		21	31	33	37		6	3	6	2		1	2	9	6					
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			633	168	209	167	178	173	339	437	146	397	488	372	457	341	589		279	392	391	440		362	365	620	359	180	279	400	360	400	169				237
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			2,465	816	1,100	1,092	723	9,278	2,816	3,240	1,670	3,727	7,183	4,082	3,368	2,303	2,551	3,310	2,047	2,052	1,765	1,519	2,581	1,139	1,221	1,288	1,083		1,391	1,357	1,415	1,398					703
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			6,809	1,361	1,494	1,414	1,271	11,333	4,356	4,971	2,612	5,362	5,300	7,670	6,107	5,343	5,701	4,317	4,021	5,410	5,118	4,539	2,241	3,769	4,354	4,361	3,869		4,553	4,792	4,836	5,464					2,717
Dominican Republic	Dominican Republic	DOM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			6,120	917	1,100	1,010	880	8,064	2,918	3,157	1,721	3,671	2,933	5,236	4,141	3,445	3,711	1,966	2,687	3,483	3,390	2,889	1,726	2,363	2,853	2,691	2,472		2,935	3,148	3,241	3,392					2,062
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			252	90	93	71	80	1,896	160	141	74	146	1,265	209	217	184	219	1,426	168	132	158	164	1,058	123	163	145	128		98	143	124	122					89
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												919					755				
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				3	3	1	1	6		2	1	11	11	5	5	4	3		5	4	4	3		3	2	1	1		4	1	1	6					2
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				56	65	38	54	681	92	110	58	120	475	152	187	145	128	485	140	133	146	134	308	117	139	105	93		65	91	81	85					52
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male															1		2				1	3				2	1		3			1					
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				29	55	60	43	656	74	63	43	69	211	114	98	110	92	214	91	93	95	102	123	91	101	89	86		53	81	64	81					51
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			33		1		10	6	3	5	1	7	11	6	6	4	12		5	5	3	7		5	10	3	2	15	1	3	2	3	14				2
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				28	39	36	43	332	61	55	25	59	107	98	71	60	75	66	61	72	67	64	39	67	84	72	65		51	47	62	52					32
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																2	1		1		6	2		1		1	1			1	1						
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												242					217				
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			303	63	60	48	53	618	122	110	57	113	201	193	165	166	195	136	114	157	141	135	115	138	130	119	125		84	99	108	104					65
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			285	34	59	58	54	488	116	101	31	104	426	127	159	148	164	350	116	134	140	138	126	95	115	126	98	1,421	87	83	105	104	1,117				64
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			500																																		
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			292	91	52	79	70	1,178	159	152	72	179	690	283	235	213	252	562	168	177	193	208	385	165	182	163	173		138	139	120	161					67
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			237	84	75	85	88	1,383	138	131	83	140	1,366	198	205	177	166	1,385	151	147	140	144	1,065	120	146	123	115		123	146	130	120					80
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			328	64	70	72	68	1,255	156	148	74	124	378	244	222	217	227	285	164	187	207	184	151	165	167	155	162		108	128	114	142					63
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												12					16				
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			135	38	18	19	23	199	39	50	18	45	283	53	62	41	75	271	47	64	57	58	233	50	45	49	59		32	62	43	37					32
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex				1	6	1			1	4		3		5	3		4		1		3	1		1		1						1					
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												312					276				
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			111	15	20	15	28	113	31	26	10	20	221	27	34	27	29	221	23	26	25	23	172	19	20	16	21		15	25	25	23					9
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,776					1,417				
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				42	49	42	51	608	99	98	34	81	143	118	130	99	111	44	112	110	119	94	56	83	91	88	85		55	79	77	85					44
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			236	71	59	67	53	733	153	170	89	122	645	174	165	181	180	492	135	150	173	177	381	151	138	134	190		147	141	88	104					60
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												1,017					835				
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			491																																		
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			286	62	71	80	70	1,613	132	156	66	125	754	183	176	176	195	896	157	157	159	160	695	128	157	126	104		86	132	115	111					69
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				1	2	2	1	12	6	6	6	11	8	11	12	7	6		2	6	6	5		10	3	6	5		9	11	6	4					1
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			306	78	86	72	79	1,191	143	140	73	144	495	219	197	181	239	529	140	168	207	191	384	164	193	123	144	1,473	129	126	114	122	1,164				95
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												1,998					1,571				
Dominican Republic	Dominican Republic	DOM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			198	44	74	62	69	462	89	90	48	99	754	105	136	107	113	685	98	111	90	94	492	116	78	103	73		93	101	81	88					47
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												33,908					33,908				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			1,976																																		
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			2,705		1,342		679	19,889		5,357		3,809	8,260		10,867		14,186	8,260		6,770		5,659	8,260		3,635		3,647			4,503		4,382					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			2,576		830		474	14,365		4,108		3,550	4,214		11,062		14,209	4,214		5,905		5,828	4,214		3,355		3,692			4,629		4,432					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					450		251	6,557		1,909		1,993	3,346		5,306		7,023	3,346		3,318		2,556	3,346		1,944		1,733			2,562		2,337					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			1,800		734		299	7,698		3,065		2,273	1,008		5,889		7,285	1,008		2,782		2,334	1,008		1,317		1,236			1,476		1,380					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			1,332																																		
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					379		163	5,731		1,266		1,321	1,498		3,538		4,708	1,498		2,007		1,608	1,498		1,222		1,073			1,597		1,522					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			2,026		985		494	14,553		3,889		2,986	8,694		8,452		11,150	8,694		5,235		4,472	8,694		2,845		3,036			3,825		3,833					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female															11		26			8		6			22		20			13		1					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												10,388					10,388				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			1,690		697		429	11,217		3,851		3,383	4,648		10,116		13,034	4,648		5,831		5,608	4,648		3,386		3,881			4,815		4,696					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			655		298		163	4,629		1,487		1,671	3,024		4,719		5,632	3,024		2,105		2,066	3,024		1,312		1,021	6,048		1,524		1,508	6,048				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												14,572					14,572				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			1,275		483		329	8,263		2,767		2,464	2,638		7,458		9,694	2,638		4,355		4,240	2,638		2,756		2,931			3,829		3,823					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					237		165	4,181		1,259		1,271	994		3,809		4,663	994		2,106		1,963	994		1,367		1,229			1,800		1,806					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					201		102	3,540		812		900	700		2,352		2,940	700		1,275		1,187	700		768		716			1,093		1,075					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			1,166		569		298	7,927		2,583		3,164	3,458		8,866		11,117	3,458		4,096		3,034	3,458		1,839		1,684	6,916		2,329		2,130	6,916				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												12,292					12,292				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												20,216					20,216				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			3,337		1,289		586	18,715		5,716		3,937	4,186		11,407		14,428	4,186		6,696		5,858	4,186		3,554		3,556			3,994		4,024					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			1,681		724		395	10,372		2,738		2,287	5,264		6,434		8,662	5,264		4,202		3,312	5,264		2,350		2,195			3,119		3,031					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			1,007		372		213	6,278		1,833		1,730	1,274		5,303		6,650	1,274		2,968		2,905	1,274		1,935		1,954			2,648		2,557					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												5,936					5,936				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex					1			92		70		95	98		373		418	98		161		136	98		78		52	196		66		42	196				
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			1,575		477		275	8,457		2,371		2,453	1,932		6,566		8,646	1,932		3,096		2,880	1,932		1,502		1,697			2,002		1,986					
Dominican Republic	Dominican Republic	DOM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male															13		31			8		7			33		12			17		6					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			3	3	4	9	17	10	13	13	10		10	10	13	6					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												97					97				
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			55	113	110	148	186	105	132	213	203		172	210	215	161					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			11	15	11	11	28	18	30	34	12		11	14	18	18					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												93					93				
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			8	14	16	15	53	16	46	53	30		19	30	31	29					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			24	25	17	17	96	24	52	47	33		17	31	29	27					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												172					172				
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			10	20	13	16	52	22	33	28	23		19	23	29	27					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												357					357				
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			12	38	42	51	58	50	55	70	59		43	53	56	56					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			67	114	115	118	284	169	188	239	189		154	199	199	182					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												500					500				
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			2	4	2	2	25	2	28	30	3			5	5	4					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			2	4	6	7	13	7	7	8	12	13	5	6	7	11	13				
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			96	160	163	185	314	191	204	264	223		180	235	233	200					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			15	24	13	13	68	18	63	67	10		15	26	18	22					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																						1		1		1	1		1	1							
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			5	15	20	20	28	40	25	25	17		20	24	24	24					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			19	13	15	20	73	25	61	60	30		22	34	29	19					
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			2	8	9	15	23	16	27	31	26	23	31	31	32	31	23				
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												149					149				
Dominican Republic	Dominican Republic	DOM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			27	50	51	61	86	93	77	104	119		79	106	106	87					
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					45		128	149		166		186	302	230	232	316	403	639																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female							11	34		34		41	105	38	34	48	72	81																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					7		43	25		64		85	73	64	63	82	104	51																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					16		35	59		46		55	197	66	63	96	117	230																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female							18	79		36		70	146	61	59	77	131	232																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								7		9		13	57	11	9	13	17	22																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							16	15		31		52	73	34	41	43	48	48																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					35		81	117		112		124	291	158	151	201	251	620																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					6		20	23		25		25	153	57	71	60	80	159																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female							9	63		38		62	142	53	50	67	82	197																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female							19	70		45		84	148	55	59	74	100	240																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male															1																						
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					1		7	7		16		13	130	20	20	27	36	116																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							3	6		6		11	72	10	11	15	23	18																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					2		5	10		6		5	100	13	20	27	35	149																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female							12	14		17		28	90	25	28	33	40	42																			
Dominican Republic	Dominican Republic	DOM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					40		124	132		194		228	237	213	213	301	404	376																			
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					3		13	18		9		3	112	7	16	7	20	112	3	4	9	7	30	13	17	20	5		8	8	13	6					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												119					119				
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												68					68				
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																						1															
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			100		20		73	117		58		43	249	30	35	61	109	447	27	19	50	53	168	41	63	45	48		49	66	42	59					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												356					356				
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							3	4		3		5	67	2	3	2	8	11	1		1	4	9	5		2	3		5	2		8					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			60				19	76		36		44	130	8	12	7	32	158	4	2	9	23	37	20	11	8	7		15	11	4	23					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female							12	13		7		13	79	4	2	2	11	27	3		3	8	14	11	4	6	5		7	5	2	11					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					2		32	17		29		21	45	7	9	13	23	36	4	6	16	20	38	16	25	14	5		7	12	7	11					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			75				18	88		27		37	134	7	9	10	46	153	3		4	33	53	13	11	12	9		11	7	9	15					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												110					110				
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					1		6	4		5		2	91	2	1	5	12	82	4	4	2	3	14	11	4	9	4		3	3	4	7					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							16	13		17		23	52	2	8		10	32			1	4	14	2	9		3		5	6	1	11					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												255					255				
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			60		14		31	94		37		24	238	9	29	38	63	434	14	11	41	48	101	25	21	31	41		28	24	24	47					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			45				9	70		25		28	129	8	6	8	19	130		1	9	22	30	13	5	10	6		11	11	8	17					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			65		25		71	102		83		48	178	39	29	64	113	263	16	15	56	70	154	63	77	51	48		50	59	66	54					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												65					65				
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male							3	6		4		1	70	5	9	6	10	103	2		5	5	13	10	9	8	4	16	1	4	9	8	16				
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			20				11	31		18		14	97	7	4	9	23	55	2		4	16	26	10	10	13	7		6	8	4	11					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			25		11		16	42		20		13	140	9	12	26	26	161	9	4	18	19	46	24	30	25	18		16	17	17	21					
Dominican Republic	Dominican Republic	DOM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								5		9		4	38	3	2	2	5	15	2	1	9	5	7	3	1	1	2	8		3	2	2	8				
Dominican Republic	Dominican Republic	DOM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female																1																					
Dominican Republic	Dominican Republic	DOM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex								126		3		1	227				3	144		2			74		23		1	125		1			61				2
Dominican Republic	Dominican Republic	DOM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			616		228		416	5,852		490		472	18,100		482		770	22,448		88		73	12,302		156		390	9,804		636		599	10,760				1,018
Dominican Republic	Dominican Republic	DOM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			587		231		378	4,308		467		490	13,930		456		814	18,004		95		21	9,245		144		329	13,251		582		477	9,490				962
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												4,562					5,327				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				21	40	48	50	52	61	56	34	52	60	39	41	48	54	47	54	52	47	47	68	43	47	47	50		56	50	62	66					30
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				1,399	1,345	1,552	1,351	1,948	1,653	1,660	1,715	1,675	2,373	2,041	2,178	2,243	2,365	2,422	2,370	2,435	2,499	2,523	2,851	2,568	2,629	2,702	2,712		2,729	2,769	2,772	2,838					2,334
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			1,433	1,350	1,103	1,350	1,197	2,898	1,400	1,584	1,490	1,510	2,791	1,805	1,966	2,011	2,073	2,806	2,040	2,116	2,203	2,308	3,441	2,364	2,434	2,473	2,545		2,564	2,648	2,840	2,895					2,361
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			699	770	633	796	775	1,501	890	1,128	1,030	1,148	2,487	1,201	1,391	1,421	1,518	2,930	1,463	1,527	1,604	1,683	3,158	1,743	1,793	1,859	1,919		1,933	2,000	2,129	2,216					1,769
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												10,037					11,101				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			47	64	59	92	82	61	100	97	41	83	106	91	92	84	87	90	91	94	92	88	108	87	82	83	86	104	88	92	98	106	106				47
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			3,626																																		
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			136	244	149	268	265	258	205	209	194	351	577	262	293	300	279	676	291	284	289	311	659	316	320	347	360		356	376	433	480					364
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,225					1,521				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			1,842	1,649	1,471	1,758	1,573	1,994	1,799	1,937	1,894	1,903	2,433	2,279	2,418	2,459	2,543	2,555	2,545	2,594	2,728	2,850	3,089	2,878	2,976	3,057	3,084		3,086	3,118	3,267	3,332					2,623
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												5,079					5,882				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				11	18	26	20	147	51	48	30	36	76	16	27	20	24	35	20	19	25	27	26	29	33	31	33		46	38	48	44					28
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			972	969	1,016	1,051	1,294	1,055	1,121	1,131	1,161		1,171	1,194	1,147	1,129					1,102
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			3,912	2,571	2,941	3,171	2,765	3,597	3,500	3,440	3,766	3,833	5,036	4,636	5,006	5,126	5,471	6,005										7,371					8,177				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			1,558	1,613	1,668	1,741	1,159	1,788	1,811	1,839	1,867		1,860	1,921	1,771	1,761					1,619
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			1,424	1,429	1,183	1,475	1,378	2,153	1,528	1,720	1,640	1,708	2,342	1,985	2,198	2,204	2,314	2,439	2,212	2,288	2,403	2,496	3,008	2,520	2,620	2,720	2,764		2,809	2,820	2,992	3,158					2,378
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			1,016	1,054	868	1,083	1,016	2,399	1,162	1,406	1,291	1,381	2,881	1,583	1,729	1,781	1,872	3,179	1,855	1,909	2,050	2,154	3,560	2,181	2,268	2,376	2,451		2,430	2,487	2,622	2,731					2,234
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			413	575	366	526	532	502	536	630	562	672	1,428	659	715	750	778	1,470	740	776	809	865	1,575	902	921	999	1,041		1,048	1,067	1,214	1,283					1,024
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			1,025	1,081	1,134	1,152	2,389	1,167	1,226	1,244	1,250		1,249	1,280	1,191	1,158					1,169
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			1,008	1,067	1,092	1,098	1,730	1,098	1,171	1,188	1,190		1,178	1,225	1,089	1,055					1,212
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												8,886					9,969				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			945	1,143	794	1,067	1,014	1,990	1,042	1,180	1,159	1,291	2,080	1,442	1,628	1,647	1,718	2,276	1,596	1,630	1,709	1,785	2,679	1,798	1,885	2,013	2,060		2,071	2,084	2,283	2,420					1,811
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			76	186	88	137	136	83	115	123	102	249	348	130	148	148	157	467	135	144	159	166	406	165	189	190	205		209	203	247	282					206
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex				8	4	4	9	5	8			3	7	5	2	3	5	5	10	9	6	3	31	2	1		1		13	1		1					1
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			936	943	1,005	1,038	1,132	1,040	1,068	1,066	1,097		1,093	1,104	1,021	998					996
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				1,587	1,397	1,569	1,448	1,214	1,716	1,794	1,763	1,876	2,090	2,150	2,274	2,302	2,424	2,571	2,490	2,587	2,640	2,697	2,835	2,737	2,816	2,869	2,905		2,897	3,006	2,971	2,966					2,619
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			3,510																																		
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												1,571					1,928				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			2,040	2,104	2,216	2,268	1,979	2,306	2,383	2,429	2,429		2,426	2,496	2,388	2,376					2,106
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				1,629	1,470	1,723	1,594	1,622	1,893	1,992	1,989	2,012	2,424	2,333	2,532	2,562	2,717	2,559	2,718	2,747	2,834	2,916	3,186	2,920	3,034	3,087	3,114		3,068	3,118	3,158	3,221					2,655
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male														2		1	5		7	9	3	5		2	4	6	6		25	6	5	6					2
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			1,471	1,518	1,596	1,636	1,463	1,638	1,721	1,761	1,774		1,767	1,799	1,688	1,684					1,585
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												91					103				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			2,019	2,060	2,161	2,199	2,328	2,214	2,289	2,359	2,383		2,349	2,415	2,287	2,300					2,116
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			470	642	424	614	570	1,245	584	676	667	806	1,417	874	962	984	964	1,597	877	906	952	1,012	1,741	1,028	1,105	1,192	1,221		1,292	1,266	1,321	1,372					998
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			3,495	2,271	2,700	2,981	2,677	2,198	3,412	3,451	3,565	3,746	4,332	4,386	4,717	4,927	5,260	5,511										7,086					7,859				
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				1,460	1,334	1,569	1,381	2,622	1,615	1,681	1,736	1,774	2,660	2,111	2,288	2,307	2,413	2,749	2,360	2,431	2,549	2,658	3,075	2,680	2,799	2,881	2,921		2,887	2,894	2,955	2,980					2,438
Dominican Republic	Dominican Republic	DOM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female														1		1	5		7	6	4	2		3	2	3	3		3	2	2	2					2
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			248	68	43	71	76	1,081	101	93	72	146	643	201	202	168	178	529	143	137	139	169	369	138	158	152	128		122	129	126	144					82
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								37	72	74	53		32	30	39	50					40
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												701					721				
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								12	16	15	20		26	21	26	14					28
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												12					16				
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				33	36	50	54	239	47	47	22	55	96	87	63	61	77	63	58	77	58	58	39	58	76	81	62		58	55	71	58					40
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			121	16	11	12	22	20	15	14	5	14	204	27	25	19	21	207	24	20	19	14	169	17	22	21	24		17	20	22	26					10
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			288	62	62	62	77	1,025	108	102	62	114	354	195	175	181	159	270	135	142	167	153	147	141	145	146	129		109	122	109	144					79
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			67	2	2	1	2	32	1	5	1	2		3	6	1	7		6	4		2		2	4	8	3	14	1	2	2	3	15				3
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			257	61	53	79	73	1,589	84	103	63	118	713	145	159	151	154	850	140	150	130	132	667	125	157	123	105		80	122	125	105					84
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								14	11	10	17		15	13	14	12					10
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			245	56	62	63	62	353	74	76	39	112	395	121	125	134	105	328	122	105	140	116	125					1,081					1,062				
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				4	2	2		107	1		1	1		4	3	2	3		1	1	1	4		7	3	4	3		2	5	3	2					
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				43	42	48	52	466	77	74	35	73	132	95	113	90	94	42	107	85	107	85	55	75	100	87	77		47	63	87	80					39
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												184					206				
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				55	64	61	55	1,302	58	66	62	91	439	126	153	132	113	458	121	124	120	126	299	103	127	97	98		66	83	89	88					69
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			459																																		
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								15	16	10	12		17	16	19	17					11
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			259	70	84	72	77	1,276	102	110	70	131	467	170	167	157	174	501	131	164	182	154	375					1,123					1,107				
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												1,521					1,497				
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			195	61	56	87	96	736	85	94	74	122	1,269	139	178	164	141	1,311	144	131	114	119	1,028	108	136	100	127		118	133	142	115					95
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				30	49	49	54	791	47	65	39	60	197	106	82	103	86	203	95	84	90	78	119	95	92	94	76		54	73	59	72					62
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								44	54	28	38		38	36	33	26					27
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			264	55	67	55	49	797	81	76	52	114	190	160	148	134	141	126	117	123	122	114	111	119	116	124	99		91	98	101	102					81
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								20	30	32	27		36	21	38	35					23
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex				1		1	1	2	2	1		2		2		2	1		2		2			1			1		3								
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			207	48	46	66	43	693	82	99	59	120	601	148	139	146	128	467	99	105	113	138	362	102	127	124	119		134	127	83	82					56
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			177	39	52	57	63	143	67	48	51	77	702	99	91	84	100	644	93	93	78	81	477	108	76	103	80		87	85	99	89					59
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								26	21	4	17		24	16	22	16					19
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male																			5	5	2											1					
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			132	20	15	21	15	126	20	27	16	34	258	42	44	34	46	255	36	52	34	35	225	38	41	46	39		31	55	35	27					27
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			442																																		
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female																1	2		2	4												1					
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								71	94	76	66		42	61	54	56					57
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			222	75	63	66	92	1,302	114	104	60	126	1,186	153	172	162	189	1,353	152	127	133	138	1,009	122	152	147	132		107	133	122	121					133
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												776					793				
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												1,352					1,348				
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				1	1	2		31		1		3		1	2	2	4		3	1		2		1	1	3	1		4	1	2	3					2
Dominican Republic	Dominican Republic	DOM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												237					263				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				486	542	648	564		655	638	602	668	2,443	592	632	789	671	2,011	696	749	918	1,043	2,446	1,105	1,093	1,220	1,347		1,389	1,428	1,582	1,676					1,170
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												4,288					4,715				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								1,300	1,025	1,055	1,381		1,466	1,494	1,415	1,421					1,267
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				339	406	477	454		567	570	536	603	2,328	527	575	720	677	2,409	667	734	917	1,045	2,705	1,117	1,118	1,240	1,372		1,377	1,400	1,487	1,587					1,214
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												95					101				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				489	574	695	646		755	745	710	810	3,182	684	736	943	840	2,637	899	941	1,185	1,388	3,092	1,403	1,444	1,635	1,780		1,773	1,791	1,903	2,019					1,503
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												4,776					5,205				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												9,435					9,822				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				881	1,034	1,200	1,120		1,419	1,417	1,310	1,306	1,880	1,177	1,217	1,529	1,431	2,417	1,523	1,548	1,821	2,095	3,012	2,141	2,122	2,286	2,420		2,421	2,468	2,528	2,587					1,958
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								895	748	795	954		1,009	1,043	983	977					887
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				1,656	1,994	2,303	2,100		2,666	2,757	2,685	2,637	4,280	2,414	2,459	3,034	2,759	5,562	3,175	3,360	3,936	4,636	6,379					6,930					7,236				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				27	40	63	41		54	43	44	62	69	49	33	42	38	87	43	44	53	57	107	58	53	54	55	105	54	56	61	70	96				26
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								1,325	1,051	1,083	1,383		1,500	1,516	1,448	1,464					1,204
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																			1		1	2		1	1	1	5		5	6	5	4					1
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								1,692	2,357	2,609	2,078		1,952	1,981	1,879	1,905					1,673
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				804	971	1,091	1,021		1,315	1,359	1,260	1,265	1,467	1,091	1,116	1,410	1,361	2,425	1,409	1,488	1,777	2,063	2,686	2,091	2,076	2,210	2,306		2,347	2,404	2,394	2,452					2,022
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				771	883	1,039	1,057		1,218	1,191	1,114	1,195	2,240	973	1,017	1,328	1,375	2,240	1,306	1,331	1,600	1,852	2,675	1,815	1,801	1,961	2,081		2,112	2,169	2,161	2,244					1,638
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								877	737	739	963		1,001	1,013	933	907					962
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,151					1,346				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				1,552	1,933	2,169	2,104		2,748	2,822	2,670	2,787	2,859	2,456	2,497	3,155	3,123	5,144	3,389	3,407	4,076	4,691	6,280					6,660					6,950				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female																	1		1	1	1	1							1	1	1	1					1
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								1,645	2,339	2,558	2,049		1,921	1,931	1,894	1,894					1,511
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								833	669	672	863		935	926	847	840					786
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				249	279	314	306		321	300	284	297	1,649	263	301	387	317	1,383	338	346	471	527	1,551	588	589	650	720		746	773	860	920					585
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				36	46	69	91		60	61	61	66	219	51	43	59	64	385	54	58	68	90	341	100	115	121	125		131	132	148	176					120
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								820	662	682	881		962	988	939	954					831
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				209	246	308	284		323	310	299	346	981	265	308	380	324	1,215	312	351	434	539	1,352	543	583	619	711		709	747	848	881					675
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				860	974	1,121	1,017		1,266	1,233	1,168	1,229	2,261	1,086	1,086	1,368	1,303	2,393	1,363	1,381	1,644	1,936	2,902	1,979	1,946	2,144	2,279		2,307	2,370	2,528	2,569					1,869
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												1,475					1,708				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				775	902	1,028	954		1,161	1,102	1,059	1,087	2,981	984	1,010	1,260	1,146	2,482	1,209	1,230	1,522	1,808	2,836	1,852	1,851	2,038	2,170		2,177	2,193	2,259	2,292					1,688
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												8,351					8,819				
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				3	10	17	11		17	17	16	18	143	7	5	6	6	35	6	5	6	12	26	10	6	7	13		13	15	21	20					16
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				638	715	852	802		943	920	858	918	3,415	750	834	1,063	967	2,423	968	1,021	1,244	1,517	3,077	1,561	1,549	1,688	1,865		1,872	1,922	2,098	2,175					1,613
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				2	3	2	1		2				6		1	1		5	1	1	1	1	31		1							1					1
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				11	18	35	19		21	18	15	28	56	14	16	17	20	46	21	21	27	24	67	26	23	23	28		29	31	41	45					17
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				672	794	951	855		1,009	963	921	1,001	2,486	828	945	1,126	1,037	2,241	1,040	1,109	1,356	1,559	2,815	1,619	1,641	1,835	1,965		1,989	2,037	2,185	2,323					1,621
Dominican Republic	Dominican Republic	DOM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				74	99	134	100		117	104	112	119	437	101	111	121	95	573	102	107	128	147	563	171	162	179	203		206	200	255	285					204
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														12		19					5
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					19		15			53		19			70		68			89		74			56		58										
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														10		9					8
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex							1			1					2										3		1										
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														3		2					
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														4		1					1
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														9		7					2
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														8		11					3
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														6		6					1
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														17		21					7
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														7		14					2
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																																2					2
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														1		1					
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female																											1										
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																																1					
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														12		16					5
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														2							
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														6		3					2
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														11		15					12
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														1							1
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					24		27			60		34			108		119			177		131			64		96										
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														1		2					
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														14		9					7
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														8		6					1
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														4		3					2
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male																				1																	
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														13		7					6
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														4		6					4
Dominican Republic	Dominican Republic	DOM	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														9		5					5
Eswatini	Eswatini	SWZ	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					7,381		7,788			2,979		3,801			209		4,607	11,099		7,510		12,300	13,131		9,327		15,126	10,295		7,149		10,934	6,724				
Eswatini	Eswatini	SWZ	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female					3,263		5,920			2,077		1,790			488		7,122	7,060		10,973		16,416	5,626		3,278		6,511	6,224		5,212		8,774	5,609				
Eswatini	Eswatini	SWZ	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					5,237		8,075			3,178		3,176			1,324		4,075	15,322		7,687		11,602	5,626		6,165		9,047	11,847		3,215		6,300	9,091				
Eswatini	Eswatini	SWZ	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					4,542		7,537			1,974		2,438			295		7,707	7,862		13,309		18,164	13,131		4,858		8,569	10,363		6,951		11,958	6,972				
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								2																											
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																									3										
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			587		3,293			3,428		733			827		918			1,059		1,482			910		1,206			723		701					328
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			10		28			7		3			2					4		2			3		3			6		2					3
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								39																	1										
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										23,699					23,675				
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			390		1,194			1,198		967			1,749		1,823			2,645		3,981			2,877		3,670			3,527		4,219					3,538
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive										1					1			3		1			4		6			5		9					13
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					1			31															1		1										
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					33			8		26			12		23			41		66			76		86			61		48					28
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					4			4		7			9		2			2		1			5		5			4		3					5
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					3			4					1		1			5		8			1		2			8		4					3
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			23		141			123		33			53		51			47		67			54		46			25		23					23
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					11			7		6			8		6			20		43			40		50			26		27					11
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1		14			9		11			11		9			13		50			37		44			26		22					19
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			11		69			63		12			23		28			20		33			29		38			20		28					14
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			335		1,004			1,085		823			1,327		1,501			1,914		3,529			2,333		3,035			3,037		3,360					3,043
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1		35			4		3			6					11		20			15					7		17					8
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								11																											
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			3		58			2		4			4		3			7		36			18		7			20		13					15
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						8,452					9,428					8,321					5,869														
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								56																											2
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			410		2,300			2,314		474			570		570			763		1,125			680		914			519		529					240
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			25		44			9		11			3		2			6		3			5		6					5					1
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			27		286			327		103			67		99			108		157			124		161			161		149					164
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								37																											
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			2		10			19		5			2		6			5		8			4		8			10		12					8
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			47		192			154		43			47		66			53		78			68		51			35		39					24
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								35		1			1												2					1					
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			4		21			4		3			4		2					6			2		3			6		11					11
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			15		57			32		5			23		11			25		34			30		33			16		21					14
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			704		3,432			3,736		874			876		896			997		1,576			937		1,190			685		712					373
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			35		200			139		22			44		62			54		87			68		77			46		34					30
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			7		21			17		18			16		23			32		64			43		74			83		118					240
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										15,055					15,085				
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						9,070					9,984					9,871					8,549														
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			21		133			72		18			27		37			45		63			76		65			36		26					25
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1								2		1			1		1			1		1					1					2
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			11		12			7		2			1		1			12		5			9		8			18		8					20
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1					1			1		2			2					1		1			1		1					3
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								31																											
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					41			14		29			19		26			30		68			59		72			53		40					31
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					7													2					2		5			4		2					4
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			13		45			45		18			54		46			66		99			120		150			221		161					97
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			5		1			4		1			6		5			3		9			12		5					4
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			155		555			642		530			813		1,032			1,202		2,158			1,460		1,893			1,806		2,065					2,154
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3		10			10		3			5		13			17		23			27		28			43		33					52
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			6		18			29		5			29		29			34		49			52		62			93		75					44
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						4,495					4,935					4,777					4,519														
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			13		56			4		3			6		2			6		8			6					18		14					13
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					2																									1					1
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			99		257			321		228			29		56			74		98			156		109			300		101					462
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			471		2,905			3,148		821			691		902			921		1,352			787		973			673		711					363
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			49		192			246		159			289		342			437		770			519		705			699		833					992
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			30		83			77		20			60		44			56		96			99		130			160		148					116
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			11		54			13		1			5		1			12		23			17		8			14		22					20
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			8		3			7		2			1		5			5		1			5		16			36		7					11
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					41			15		47			32		27			49		69			36		95			61		43					38
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			24		68			79		33			53		59			97		114			141		190			185		188					141
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1		5			1		1								1										2		2					3
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			195		901			685		201			53		63			69		57			131		191			124		47					135
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1		20			1										1										3		3					3
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			230		1,540			1,766		483			436		500			600		895			549		661			457		523					326
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			12		46			38		18			32		25			50		59			62		78			89		74					88
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						9,683					10,591					10,263					7,766														
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			8		32			1					1					43		47			23					4							4
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			10		21			7		8			2		3			2		3			11		5			2		3					5
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1										3					2			1		2					1					3
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			11		24			12		12			3		5			15		3			7		12			8		3					4
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						6,570					7,354					7,127					6,454														
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					3			2		2			1		5			1		4			1		3			4		2					3
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					2								3		1			1		10			5		13			9		17					24
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			12		7			4		4			3					9		4			2					4							3
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			242		931			913		714			1,418		1,593			2,182		3,455			2,581		3,306			3,262		3,666					2,796
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			136		610			525		413			892		872			1,295		1,910			1,509		1,772			1,647		1,836					1,268
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			303		1,350			1,259		266			329		366			410		614			381		414			228		269					137
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1		16			3		2					1					1			3		2			1		3					2
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					10			2		4			6		5			10		22			9		16			14		10					18
Eswatini	Eswatini	SWZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			13		47			9		6			6		2			11		4			4		6			9		10					7
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					3			4					1		1			5		8			1		2			8		4					3
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			8		3			7		2			1		5			5		1			5		16			36		7					11
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			6		18			29		5			29		29			34		49			52		62			93		75					44
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			12		46			38		18			32		25			50		59			62		78			89		74					88
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			11		69			63		12			23		28			20		33			29		38			20		28					14
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1										3					2			1		2					1					3
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			15		57			32		5			23		11			25		34			30		33			16		21					14
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																									3										
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			5		1			4		1			6		5			3		9			12		5					4
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive										1					1			3		1			4		6			5		9					13
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1								2		1			1		1			1		1					1					2
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			23		141			123		33			53		51			47		67			54		46			25		23					23
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3		10			10		3			5		13			17		23			27		28			43		33					52
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			35		200			139		22			44		62			54		87			68		77			46		34					30
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			21		133			72		18			27		37			45		63			76		65			36		26					25
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			24		68			79		33			53		59			97		114			141		190			185		188					141
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			47		192			154		43			47		66			53		78			68		51			35		39					24
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			2		10			19		5			2		6			5		8			4		8			10		12					8
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			11		12			7		2			1		1			12		5			9		8			18		8					20
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1					1			1		2			2					1		1			1		1					3
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					3			2		2			1		5			1		4			1		3			4		2					3
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					4			4		7			9		2			2		1			5		5			4		3					5
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			30		83			77		20			60		44			56		96			99		130			160		148					116
Eswatini	Eswatini	SWZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			13		45			45		18			54		46			66		99			120		150			221		161					97
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							1		2			12		2					1
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												1							1
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					4										3					10			32		55			84		83					80
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					1										1			3		7			32		44			114		79					75
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												1							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												2							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		2		3			17		17			50		38					17
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								1		1			1					3		7			18		14			11		22					12
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			9										2					3		2			11		16			15		16					13
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1			5		4			6		3			2							1										
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			13		21			18		6			14		13			16		17			29		39			43		37					8
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					7			3		2			13		20			20		18			26		31			36		24					10
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																									1										
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							4		3			4		6					12
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP								1		1			1		2					1					1			1							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		4			3		3					10			11		11			9		5			2		1					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			19		70			56		13			15		18			17		26			8		11			3							3
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP								3		2			1		6					1					1			6							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy								1							4								1												
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy								1		1					4			1																	
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												2							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1																				1										
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			4		3			16		6			18		24			13		23			11		19			8		4					4
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			6		18			10		7			17		12			26		33			38		45			66		40					15
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				2								2		3					2
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					2			1		7			2		5								2												
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													2		1			1																	
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													1					4		3			12		12			3		7					2
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													5		3			6		8			24		28			17		14					10
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			15		39			33		18			33		27			42		52			32		25			6		11					8
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							3					2		1					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			7		23			13		16			15		22			37		31			36		68			54		49					20
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													2		2			6										2							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					1								4		4			1		9			31		23			16		13					7
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			5		2					4								18		13			36		18			2							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							1		2			6		2					11
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			10		11			10		4			6		5			11		16			19		17			15		15					4
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			1		3			2					3		4			4		10			5		8			5		10					5
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			9		13			16		9			27		24			38		40			45		34			16		14					5
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			13		62			42		9			6		9			12		9			11		15			3		3					10
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					3			2		2					2			2		3			1		2			2		1					1
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			3		1			7		1								11		6			1					1							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			7		51			54		6			19		34			16		23			19		22			11		6					3
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												2							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												1							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													1					1		2								1							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation								1																											
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1										4			2																	
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					1													2		2			12		12			32		26					41
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			15		35			43		14			30		28			48		50			47		32			11		30					6
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									1			1							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP								1																											
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			6		16			11		2			9		13			2		3			8		5			1		2					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			36		88			77		17			21		29			28		21			12		9			3		3					7
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1		20			19		6			11		12			8		11			9		14			9		6					2
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															1					2			2					2		1					3
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															3			1		11			50		67			104		85					100
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			8		24			23		1			9		6			10		11			7		4			2							9
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														1					3
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				1			2					1		1					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							2		2			1							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			9		8			7		1					1			3		2															
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																																			1
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							1		3										
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1			1		2					4			1		4					1			2		1					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																																			13
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				1			3					1		1					2
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																									5			4		3					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					4										1			1		3			30		31			56		40					68
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy								1		1					1			1					1												
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			4		37			41		7			11		17			22		13			19		20			12		7					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			9					1					7		3			6		9			18		17			11		12					13
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			3		23			18		13			22		12			32		21			13		14			8		8					7
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															1					1			2					1		5					3
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			3		39			38		15			15		23			16		14			11		12			6		3					3
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												1		1					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			9		40			33		8			10		9			12		7			10		5			1							1
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			3					1		1			1					21		18			3		2										
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1			1					1		3			1							1										2
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							1												
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							1		1										
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			22		88			93		14			15		26			31		38			10		9			6		5					11
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					2			2										1		2			1		1										
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														1					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									1			2							1
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			3		5			5		2			1		3			2		1					1										
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																																			1
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			3		53			63		19			18		27			17		21			19		12			9		7					
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							3		1			1							
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		2		1					1			1							3
Eswatini	Eswatini	SWZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									3			7		4					
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex							61	47,056	4		11	995			2				1																		
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			5,590	26	6	89	680	1,520	517	673	2,829	3,194		699	735	955	1,242		897	1,169	1,175	1,392		1,274	2,219	1,700	946		68	810	813	2,619					2,424
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			5,589	40	4	203	1,230	1,723	852	1,262	4,676	5,061		1,275	1,166	1,705	1,971		1,379	1,954	2,077	2,343		2,187	3,355	2,829	1,807		154	1,315	1,471	4,837					3,742
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												69,129					69,129				
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			1,402	40	3	243	1,051	973	923	2,288	4,950	8,590	4,199	1,506	1,230	1,872	2,519	4,242	2,120	2,524	2,878	2,272	4,878	3,814	5,427	3,876	1,874		196	1,942	1,962	6,149					3,325
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			3,096			3	14		22	316	117	306		95	8	328	108		117	563	255	439	2,108	1,311	2,563	1,656	266	5,244	9	254	241	1,102	5,244				347
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												25,085					25,085				
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			5,589	24	5	167	1,803	1,501	704	1,367	3,774	4,830		866	916	1,252	1,232		1,006	1,239	1,268	1,452		1,565	2,262	1,752	936		103	792	1,026	2,327					1,431
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			5,589	59	20	442	1,892	1,888	1,553	2,318	6,853	7,857	11,183	1,790	1,858	2,971	3,071	12,020	2,651	3,158	3,276	3,383	13,823	3,861	5,521	4,019	2,480		237	2,203	2,692	7,692					5,036
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			5,590	35	13	311	2,445	1,978	930	1,870	5,172	6,957	23,117	1,152	1,263	1,804	1,606	22,514	1,287	1,796	1,781	2,048	25,891	2,065	3,229	2,558	1,429		190	1,137	1,340	3,610					1,959
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												13,632					13,632				
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				7	3	14	174	598	166	268	1,023	1,502		237	231	333	450		276	371	360	531		535	1,069	657	302		29	220	229	756					749
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			5,589																																		
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				14	3	49	331	803	296	396	1,752	2,133		376	355	503	707		505	630	669	949		923	1,512	1,048	551		42	388	473	1,545					1,248
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male				6	7	31	327		268	491	1,629	2,745		385	340	462	723		365	479	446	745		1,365	2,444	1,555	436	4,868	43	310	450	1,705	4,868				1,330
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			9,085																																		
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				5	4	40	345	751	274	267	1,174	1,442		242	247	362	389		312	385	394	573		538	963	639	290		121	258	381	861					603
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			5,589	71	8	489	2,504	1,778	1,745	3,086	7,692	10,109	8,490	2,304	2,136	3,362	3,440	9,176	3,246	3,788	3,838	4,163	8,444	4,990	6,707	5,125	3,048		297	2,820	3,174	8,255					6,260
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			5,589	42	12	355	2,932	1,677	890	2,649	6,174	11,097	8,478	1,634	1,141	1,506	1,675	8,457	1,397	1,694	1,703	1,825	9,598	1,983	3,005	2,495	1,288		167	1,194	1,342	3,504					2,010
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			5,589	42	14	365	3,184	1,734	1,123	2,638	6,292	9,571	16,037	1,591	1,392	1,926	1,762	15,796	1,449	2,031	1,957	2,246	18,165	2,343	3,219	2,736	1,604		157	1,325	1,539	4,050					2,202
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												19,430					19,430				
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male						8	106		63	39	107	324		8	34	228	105		83	76	71	71		1,232	2,073	1,360	36		5	36	11	502					2
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												89,156					89,156				
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												12,596					12,596				
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female						15	76		42	31	127	398		8	46	213	159		94	101	73	857		1,271	2,323	1,485	41		9	47	14	479					2
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			5,589	6	1	138	849	1,716	274	1,646	3,611	7,857		963	515	591	768		632	889	1,103	777		1,104	1,837	1,561	673		64	622	620	1,951					1,220
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				10	11	108	672	795	480	489	2,118	2,548		513	527	732	732		561	720	764	909		1,053	1,615	1,250	635		98	549	693	1,639					1,015
Eswatini	Eswatini	SWZ	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female				5	1	25	197		136	619	1,843	3,743		450	358	482	971		475	511	456	721		2,180	4,147	2,321	453	5,547	95	323	411	2,411	5,547				2,010
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				9					3	3																											
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			13	3,800	4,556	3,660	3,634	2,096	2,280	2,805	1,659	2,117	2,106	1,822	1,181	929	1,100	1,783	740	1,163	891	1,173	4,296	857	1,043	874	1,033	1,483	1,672	1,942	2,028	1,008	5,720				1,251
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			10,547	2,628	3,338	2,689	3,052	10,836	1,983	2,764	1,506	2,068	1,668	2,006	1,410	1,380	1,728	2,610	1,097	1,474	1,481	1,674	4,218	1,263	1,736	1,395	1,488		1,838	1,648	1,668	1,210					1,100
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			11,592	3,948	4,732	3,837	4,362	19,374	2,846	4,041	2,064	2,960	3,980	2,866	2,083	2,094	2,443	4,416	1,668	2,214	2,070	2,336	11,449	1,848	2,470	1,882	2,012		2,397	2,238	2,099	1,594					1,321
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			363	3,172	2,931	2,682	3,171	15	2,957	3,120	2,152	4,588		2,823	1,946	1,830	3,298		1,761	1,529	1,569	738		856	1,084	593	924		414	1,512	1,734	2,066					752
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			14,819	12,344	13,361	13,688	13,619	33,218	10,862	13,382	9,807	13,198	13,610	11,877	8,677	9,050	12,208	18,044	7,928	9,016	9,876	9,607	24,550	8,166	9,729	7,392	7,648		10,079	8,977	9,063	6,695					7,047
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			10,911	2,383	2,470	3,431	3,799	9,788	1,937	2,549	1,090	2,792	3,830	1,966	1,655	1,508	1,743	7,323	864	1,227	1,288	1,415	14,703	934	1,038	1,228	1,392		1,908	1,757	2,172	1,313					465
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			4,552																																		
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			5,907	6,174	6,914	5,737	5,931	8,475	4,842	6,330	4,354	5,695	6,446	5,259	4,241	4,261	5,158	8,180	3,856	4,491	4,935	5,429	22,082	4,405	5,223	4,060	4,180		5,150	4,708	4,877	3,554					4,481
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				1,509	1,850	1,598	1,831	5,670	1,113	1,630	892	1,181	1,373	1,169	924	882	949	1,191	705	1,029	927	1,055	1,582	868	1,085	983	1,044		1,163	1,222	1,162	812					726
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				2,880	3,034	2,128	2,001	8,901	1,152	1,438	614	3,607	4,702	929	558	482	376	5,551	392	683	593	555	1,851	483	588	651	733		1,000	1,043	1,290	1,580					546
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				1,325	1,087	930	1,202	13,580	659	936	622	791	1,035	692	537	484	608	697	410	575	508	558	823	454	640	555	589		731	652	737	518					484
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																													6								
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			14,159	5,013	5,781	4,693	5,564	18,081	3,642	4,885	2,593	3,853	2,141	3,585	2,624	2,415	3,132	5,079	1,915	2,550	2,455	2,598	14,898	2,115	2,806	2,177	2,386		3,013	2,679	2,665	1,896					1,508
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			4,005	2,938	3,366	2,789	3,154	7,563	1,797	2,229	1,505	1,897	1,936	1,726	1,114	949	1,309	1,282	746	1,091	897	1,050	3,153	927	1,115	990	1,136	1,506	1,572	1,568	1,650	977	6,037				1,073
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												10,767					11,537				
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			7,032	7,436	8,015	9,042	9,999	22,752	8,443	9,346	7,351	12,457	6,668	10,179	7,344	7,094	10,174	11,720	5,601	6,122	6,780	5,782	25,415	4,441	5,339	4,332	4,529		7,274	6,740	6,752	4,197					3,913
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												7,272					5,398				
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												17,125					10,652				
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				4,965	4,987	2,581	2,389	21,292	1,576	1,877	1,224	3,312	2,050	1,199	1,121	1,057	520	4,648	1,269	1,725	2,036	2,369	3,129	2,152	2,266	2,303	2,743		3,172	3,494	3,396	3,247					2,368
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			12,817	9,692	10,916	9,796	10,056	26,637	8,103	10,211	7,038	9,480	15,982	8,257	6,467	6,891	8,560	13,276	5,930	7,133	7,816	8,128	20,676	6,707	7,782	6,190	6,217		8,041	7,232	7,375	5,412					6,170
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												38,135					36,364				
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				7	2	129	12		3,036		16	1												2	4	3											
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			21,548																																		
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			5,045	3,694	4,129	3,449	3,602	2,390	2,787	3,494	2,619	3,073	4,948	2,706	2,396	2,430	2,576	4,962	2,115	2,548	2,727	3,145	7,886	2,527	3,054	2,379	2,467		3,060	2,754	2,900	2,224					2,660
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			9,710																																		
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			37,099	4,459	5,248	5,089	5,865	15,073	2,697	4,622	993	4,352	39,028	1,730	964	843	1,610	16,028	745	1,106	988	735	4,150	521	563	637	1,340	6,138	1,450	1,119	1,366	1,520	3,019				524
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				2,211	1,436	1,121	1,336	2,323	971	1,130	813	986	1,200	803	574	560	578	1,225	473	622	578	689	1,059	501	635	532	579		776	709	747	579					556
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			41,392																																		
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												20,716					19,791				
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				21		55	4		2,968		32	11												1	1	18											
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												67,954					49,440				
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												6,647					5,316				
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				2,093	2,108	1,819	2,039	2,130	1,444	1,795	1,182	1,445	3,287	1,302	1,080	1,016	1,077	2,246	932	1,147	1,282	1,433	2,288	1,119	1,344	1,177	1,228		1,553	1,365	1,425	850					1,337
Eswatini	Eswatini	SWZ	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			10,085	4,288	4,684	4,554	5,433	11,361	3,419	4,659	2,225	3,839	5,045	3,486	2,400	2,279	3,394	5,075	1,765	2,213	2,109	2,386	16,129	1,818	2,487	1,862	2,094		2,621	2,563	2,447	1,554					1,182
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,555					967				
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												1,616					966				
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			834																																		
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												513					493				
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				206	244	278	275	770	200	246	129	207	213	143	144	138	115	220	94	124	131	104	153	96	109	92	90		81	113	85	102					88
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			1,330	728	808	781	631	4,075	508	720	416	661	859	493	352	355	407	1,035	261	329	244	280	1,014	228	260	206	189		199	217	189	193					184
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				59	55	55	41	565	31	33	30	20	30	12	17	18	13	93	12	31	26	17	73	18	13	17	21		23	26	22	12					14
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			857	353	466	468	449	1,777	326	357	212	343	248	266	215	193	222	430	164	184	143	181	410	131	158	154	118		111	103	118	135					100
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			1,072	333	377	378	406	2,368	253	332	159	290	223	213	183	152	159	581	107	129	116	125	1,007	90	118	114	88		76	99	73	85					55
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			859	75	94	73	126	723	56	69	28	63	416	36	31	14	31	345	17	23	19	20	120	15	9	14	8	96	13	12	8	10	39				3
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				120	99	83	121	323	91	99	63	82	210	97	72	63	50	169	52	58	47	68	93	39	44	43	35		29	37	44	49					33
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			953	525	628	573	509	1,324	395	462	289	457	528	364	290	280	269	849	209	260	194	219	1,169	155	184	160	140		141	157	150	155					124
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			437	48	44	50	82	605	32	42	14	51	310	31	26	17	26	320	9	19	14	9	416	11	16	12	7		8	12	5	6					9
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				146	193	192	182	327	150	138	113	106	620	144	120	98	105	308	78	72	71	85	179	71	75	68	69		50	55	56	55					67
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			11	133	192	168	181	198	118	120	64	84	423	83	81	80	72	227	64	80	85	75	205	51	80	66	42	63	48	52	49	71	369				51
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			438																																		
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			708	125	132	168	201	800	115	162	56	168	650	98	97	72	161	445	55	62	57	65	710	40	56	40	52		25	38	37	21					23
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												214					166				
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male							1		377																												
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			975	417	486	508	496	3,231	350	424	188	360	670	289	214	204	194	632	169	176	171	205	1,047	127	168	139	101		108	122	108	131					103
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												896					843				
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												712					368				
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				44	49	51	54	529	21	35	14	40	65	30	22	20	9	66	12	12	9	18	38	15	14	11	9		15	14	7	4					4
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			853	268	271	278	304	1,948	270	294	181	504	362	306	202	156	243	482	151	136	130	105	916	97	141	101	80		76	92	86	63					65
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			924																																		
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			1,524	706	797	704	683	4,348	558	697	363	725	639	541	380	352	483	1,043	287	296	307	296	1,053	247	324	221	185		211	253	245	218					183
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			371	207	190	199	219	1,192	135	166	112	117	354	93	90	94	93	191	74	86	67	98	259	65	70	67	67	54	43	45	70	74	386				66
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			580																																		
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			6	36	43	33	31	4	24	36	24	62		18	25	27	23		27	33	32	32		22	27	13	15		10	28	17	19					8
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			740	331	406	312	324	342	261	310	212	279	636	230	205	175	183	541	128	135	149	137	480	93	101	87	105		89	95	97	105					95
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												122					56				
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				164	147	130	181	1,907	114	137	90	89	179	106	85	57	59	133	71	89	64	72	91	63	59	49	51		53	34	53	54					56
Eswatini	Eswatini	SWZ	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				6					381		3															1											
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				1		3	1			2	1	2				2	3		2	2		1		2		1	5										
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				300	421	341	315	1,360	345	350	305	301	1,536	299	296	269	644	1,370	393	409	338	417	1,256	331	324	295	290		367	393	416	367					269
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																																					1
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				506	665	604	525	2,933	472	489	480	435	1,190	393	393	393	805	2,172	422	472	401	513	1,785	412	344	286	268		396	411	390	382					286
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												1,571					1,362				
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				493	675	545	499	1,884	483	491	445	455	1,802	417	413	400	863	1,951	490	517	448	548	1,635	431	449	360	363		437	507	490	444					366
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																																					1
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				377	547	428	370	1,712	319	324	320	321	1,735	253	273	247	492	1,531	234	308	275	298	1,271	239	220	196	169		216	274	262	224					202
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				5	11	4	8	35	6	4	10	5	78	7	7	3	10	66	7	8	6	9	63	5	7	9	44		9	12	16	12					5
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				62	92	73	76	35	92	95	83	93	53	96	79	84	176	81	139	134	139	128	79	123	98	99	161		130	146	128	146					136
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																																					1
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												3,578					3,082				
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												1,510					1,763				
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				7	28	3	2	7	1	1	2	2	77	1	1			10		1	4	3	7	2	1		2	25		1	2		8				
Eswatini	Eswatini	SWZ	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				96	205	170	80	524	108	101	114	101	1,187	84	95	71	141	403	62	75	68	75	315	78	70	75	40		69	85	90	58					57
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			8,561	1,474	1,647	1,449	1,366	7,676	1,267	1,249	1,208	1,261	7,676	1,307	1,217	1,159	2,589	5,866	1,348	1,512	1,331	1,637	5,662	1,304	1,221	1,083	1,169		1,353	1,497	1,498	1,301					1,193
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			417																																		
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												2,688					3,356				
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			6,733	1,749	1,958	1,808	1,589	7,410	1,491	1,581	1,492	1,395	7,412	1,486	1,356	1,421	2,714	7,288	1,396	1,667	1,488	1,667	7,033	1,479	1,513	1,293	1,258		1,463	1,689	1,650	1,467					1,329
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			229	34	37	27	26	240	26	124	44	24	238	32	31	32	38	238	17	22	28	31	229	27	27	26	16	237	24	33	31	29	120				22
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female				3		5	5		1	2	1	3		2	1	4	4		5	6	2	3		2		2	2			1		5					4
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			2,762	581	718	614	582	2,587	645	586	506	559	2,590	559	561	483	1,188	2,420	672	772	611	819	2,336	625	623	560	570		700	782	759	695					581
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				9					3	3																											
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				1					560																												
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			4,682	1,084	1,270	1,018	990	3,876	992	976	885	903	3,876	985	882	901	1,975	3,864	1,079	1,192	1,084	1,268	3,727	1,022	1,038	873	937		1,071	1,186	1,204	1,088					933
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			3,614	1,018	1,323	1,192	963	3,843	960	1,100	901	934	3,853	1,065	1,009	990	1,632	3,853	779	1,037	833	1,039	3,716	849	996	828	838		966	1,141	1,065	836					894
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				17	17	10	15	141	11	6	16	13	142	9	15	8	19	113	11	17	15	16	109	10	12	15	17		14	18	18	20					9
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												11,182					9,556				
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				157	174	156	146	139	164	175	156	144	141	179	147	137	313	141	228	223	221	221	137	212	189	161	175		229	267	216	231					220
Eswatini	Eswatini	SWZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												9,802					8,844				
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			823	314	418	340	318	1,425	345	354	306	301	1,540	299	296	269	648	1,376	395	409	344	426	1,260	331	325	299	296		367	393	416	373					272
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			1,185	100	118	169	78	548	113	102	112	101	1,193	87	98	71	145	409	62	75	69	76	319	78	70	72	50		69	85	90	59					58
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				67	94	74	76	51	92	95	83	92	53	103	79	84	177	81	140	134	138	130	79	124	99	100	84		130	146	128	147					137
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			2,113	390	480	440	377	1,790	319	328	327	321	1,747	262	275	247	498	1,545	232	308	270	301	1,284	242	220	197	206		218	274	266	226					202
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			2,342	517	634	607	526	3,065	479	497	473	436	1,205	396	392	394	812	2,186	422	472	402	525	1,797	411	345	288	320		397	412	392	385					289
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												3,592					3,092				
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female									12																												
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												1,587					1,376				
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female				1		4	2			2	1	2				2	3		2	2		1		1		1	1										4
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												1,512					1,764				
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			61																																		
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			53	4		3	2	13	1	2	2	2	77	1	1			10		1	4	3	7	2	1		2	25		1	2		8				
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			1,307	503	652	551	503	1,990	491	499	451	456	1,807	423	413	400	868	1,961	491	516	449	559	1,642	439	451	361	379		437	509	489	447					368
Eswatini	Eswatini	SWZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				7	11	4	8	50	6	4	10	6	78	7	7	3	10	66	7	8	6	9	63	5	7	10	13		9	12	16	12					6
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												29,517					21,387				
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												2,245					163				
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			69		60		133	68		1			125		19		54																				
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					209		322	34		19			168		47		48			53		2			7					31		25					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					530		669	68					184		26		34								1												
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			73		806		2,232	69		580		202	402		131		93			21			24		3												
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			16,650		3,272		11,831	12,887		5,042		5,856	19,108		10,392		11,240	16,040		8,668		8,270	18,634		9,691		3,529			12,046		14,332					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			4,218		1,950		5,016	67		38			4,616		1,238		711			112		2			12		2			77		29					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			14,955		2,783		8,040	67		77			6,984		1,463		459			261		13	24		17		5			272		138					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			138																																		
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					957		439	68		1			193		18		23																				
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female							29			179					2,494		15								3		41			30		4					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												3,988					490				
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					280		217	34		16			143		29		25			24		1			1					18		11					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			9,349		4,876		13,057	814		938			3,368		1,555		338	311		54		1	1,144		56		572			463		779					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			146		661		929	136		3			257		54		46																				
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												8,292					163				
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			13,594		2,812		10,013	10,463		3,979		6,791	15,095		9,002		9,593	12,686		6,980		6,251	7,912		6,556		2,862			9,903		11,163					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			69																																		
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			9,309		7,669		8,916	13,366		3,596		3,655	5,146		4,693		7,154	7,256		8,049		7,072	7,888		8,503		3,143	15,791		9,519		9,993	9,691				
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			69		99		98	67		14			222		31		36			33		3			1		1			13		7					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			14,539		5,948		13,617	14,524		5,493		4,657	21,438		9,963		11,366	17,692		8,541		10,359	21,376		11,998		4,877			12,705		15,699					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			15,466		4,157		10,700	547		293			9,914		1,320		373	157		215		20	230		18		92			268		184					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			10,443		2,173		6,046	67		42			5,418		1,369		609			191		11	24		10		3			114		36					
Eswatini	Eswatini	SWZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male															2,074		7										11			35		4					
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			206	200	228	254	400	220	263	242	241		156	199	189	205					140
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			82	92	104	127	73	124	134	137	124		93	102	112	80					119
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												827					1,807				
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			767	541	924	951	904	1,155	1,498	1,408	1,529		581	949	915	1,763					288
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												741					283				
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			33	24	37	19	91	31	66	66	71		10	27	27	131					4
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			90	80	103	112	79	142	163	157	174	204	128	171	187	113	17				152
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			561	540	751	888	735	1,029	1,128	808	787		521	703	815	811					547
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												4,061					4,923				
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			188	186	199	200	348	185	238	247	223		159	197	236	253					123
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			129	120	145	180	183	173	197	229	223		147	191	230	182					147
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												4,779					8,323				
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			40	56	70	72	59	79	100	97	122		72	105	107	107					85
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												1,627					760				
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			104	104	146	155	129	133	165	180	179		123	146	155	137					123
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			322	345	456	503	427	642	669	491	390		325	477	553	435					385
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			99	97	118	112	66	116	143	150	132	203	114	115	147	96	54				132
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			174	149	241	264	186	312	299	272	241		200	235	268	223					229
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			1,223	1,087	1,632	1,673	1,646	1,953	2,472	1,990	1,894		990	1,389	1,492	2,173					681
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			147	141	131	136	335	122	160	206	207		86	170	156	254					52
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												282					998				
Eswatini	Eswatini	SWZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			928	960	1,205	1,342	1,248	1,587	1,842	1,474	1,283		857	1,104	1,210	1,382					691
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					111		352	830		606		977	1,451	728	1,238	2,072	2,783	2,743																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					26		108	116		167		212	349	157	206	321	385	581																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					33		189	258		238		333	444	230	307	473	551	952																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					32		119	438		248		540	2,725	466	784	1,293	1,717	1,527																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					11		39	241		87		248	128	107	166	192	232	636																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					32		192	425		348		836	412	383	589	760	889	2,220																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					52		232	312		380		581	2,022	326	488	735	850	1,572																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					76		337	722		610		1,092	5,336	865	1,495	2,821	3,619	3,016																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					48		130			144		153	498	104	143	245	282	450																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					17		70	123		91		105	257	67	97	162	180	300																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					59		179			175		160	302	99	144	219	268	430																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					76		279	445		373		436	757	299	465	848	1,078	1,242																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					44		112	228		136		144	660	103	137	217	269	403																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female										17		10																									
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					92		294	788		501		705	939	442	740	1,368	1,763	1,983																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					47		192	220		227		300	608	190	279	445	535	820																			
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male										8		6		1	1	1	1																				
Eswatini	Eswatini	SWZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					54		238	522		439		805	522	416	614	899	1,083	2,154																			
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					16		74	36		106		100	212	91	62	52	48	351	68	111	137	139	390	168	205	220	92		208	229	241	116					63
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												2,182					2,493				
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			328		46		315	690		549		728	4,018	684	742	951	871	2,167	1,402	2,089	1,778	1,754	5,002	1,840	2,123	1,776	875		1,528	1,722	1,391	1,940					946
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female										18		14																									
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			207		56		175	418		338		487	315	277	197	152	156	1,321	256	529	446	521	992	508	732	686	282		350	328	258	552					159
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			329		38		217	273		243		270	534	161	199	264	218	868	304	441	352	393	1,296	381	466	381	190		308	287	338	361					271
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			182		4		26	96		51		140	76	90	40	23	27	294	59	95	93	94	276	101	161	162	49		125	145	141	267					30
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					40		146			81		68	245	29	40	31	30	262	44	63	40	60	200	59	75	60	21	358	54	41	33	50	409				35
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			300		23		111	249		256		381	1,677	378	430	513	465	1,095	840	1,167	1,013	1,110	2,750	1,096	1,312	1,246	584		1,045	1,221	703	1,352					711
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												13,865					15,847				
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												3,725					4,258				
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			182		45		161	244		312		312	1,000	188	187	129	121	1,026	166	361	354	398	1,217	372	562	449	226		259	275	277	335					157
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			152																																		
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			302																																		
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					20		164	124		141		174	430	77	106	114	71	535	142	183	184	167	566	195	216	199	83		151	117	144	129					113
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												10,771					12,310				
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												2,263					2,587				
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			182		23		136	104		189		183	269	119	85	87	70	626	116	214	244	255	695	254	354	308	141		207	232	254	246					123
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												3,951					4,516				
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			207		30		136	328		280		497	249	297	187	125	121	1,233	262	432	396	474	944	517	710	654	254		301	389	295	645					168
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			329		56		321	820		500		650	1,011	522	582	728	630	1,975	1,016	1,630	1,341	1,254	3,791	1,350	1,555	1,337	583		1,079	1,184	1,100	1,256					683
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					22		93			89		87	300	37	39	43	38	316	41	82	69	60	242	130	149	134	63	433	205	274	188	79	494				41
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					15		44	36		55		60	155	33	30	34	20	200	34	60	67	76	180	77	117	130	47		232	249	251	72					41
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male										8		12		1																							
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					26		95	124		78		74	459	36	32	37	39	263	56	85	65	69	221	72	97	79	50		44	46	55	39					41
Eswatini	Eswatini	SWZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			301		61		241	788		402		445	659	251	357	466	375	1,480	533	834	714	771	2,231	738	817	760	331		540	529	551	604					460
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				14	16	18	15	80	17	10	11	14	96	24	21	11	14	76				91	62				49	66					79				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											6					9					39
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				28	10	28	12	97	20	22	20	18	133	19	16	39	14	134				92	101				68					64					120
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											13					6					21
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				40	24	23	34	100	21	22	15	24	128	31	23	26	34	128				129	106				110					120					208
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				27	40	40	26	84	19	16	16	20	72	24	19	15	17	103				103	77				74					85					161
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			21																																		
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												151					166				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											36					131					164
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												345					338				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												289					287				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				33	30	32	41	99	24	32	28	32	133	39	32	25	35	85				167	72				74	89					98				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												6					24				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				6	2	2	5	19	11	2	2	2	22	5	2	2	2	12				3	10				15					10					8
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											18					13					34
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				22	26	8	23	83	24	19	5	18	76	20	16	9	12	111				73	82				77					82					130
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				10	6	1	4	19	4	3	2	1	14	3		1	4	9				6	5				12	5				18	13				14
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				6	5	4	6	19	5	1	5	4	15	2		1		13				3	2				7					23					17
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				39	48	49	55	104	23	30	31	47	100	30	27	25	31	140				133	102				106					116					204
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											13					28					59
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				28	26	24	28	83	42	26	12	21	53	11	16	23	22	93				59	72				56					68					110
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				19	17	19	13	105	14	23	11	13	81	16	13	15	13	92				57	88				36					47					76
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				42	35	27	42	110	24	31	25	33	103	38	17	15	26	132				85	93				101					88					128
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											10					17					38
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												110					115				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												104					108				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				2	6	9	7	99	4	2	1	4	88	3	1	2	3	59				12	24				9					9					9
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											14					94					105
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											19					28					57
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												189					212				
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				8	7	6	11	99	8	10	6	2	99	10	3	3	4	69				28	46				22					16					29
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			1,552																																		
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				1	2	1	1	19	4	2	2	2			6		2					5					8					6					3
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				12	14	8	16	83	19	18	13	8	64	11	15	5	8	78				50	50				45					39					62
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			1,179																																		
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				5	6	3	3	85	4	6	2	2	75	4	1	3	2	49				11	30				13					17					22
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				37	30	36	33	83	33	28	16	23	61	20	17	25	26	103				93	80				69					97					144
Eswatini	Eswatini	SWZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				13	5	5	6	83	12	9	7	6	105	10	7	14	8	106				41	71				48					61					95
Eswatini	Eswatini	SWZ	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			56,052		3,453		5,711	18,054		5,865		8,276	14,828		4,639		7,046	9,913		3,858		5,687	11,205		1,792		1,592	5,135		2,035		1,664	2,816				811
Eswatini	Eswatini	SWZ	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			28,025		6,147		10,895	27,797		10,724		15,862	32,826		9,301		13,266	24,016		6,628		6,687	17,304		3,140		2,673	9,206		3,547		2,592	5,193				1,270
Eswatini	Eswatini	SWZ	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			3,752		342		1,115	2,056		1,132		758	2,061		856		1,046	1,790		368		617	1,238		295		224	597		170		113	242				72
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				13	15	6	12	28	36	8	6	1	28	7	2	6	6	29	1	6	5	6	23	10	10	4	10	25	6	11	7	11	25				10
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												56					58				
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				34	47	42	30	116	20	20	23	21	128	22	28	23	22	129	24	25	30	44	97	26	18	22	22		23	25	25	26					49
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												445					461				
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				34	33	36	25	158	25	47	20	18	172	31	25	19	19	174	20	16	32	33	132	31	21	14	14		26	27	24	19					30
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			2,033																																		
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												333					345				
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				16	20	15	14	154	11	14	5	12	167	12	7	11	12	168	10	9	7	9	128	13	7	11	6		13	13	5	6					9
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			201																																		
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				16	7	6	14	117	14	11	10	8	127	13	8	19	10	129	11	11	13	16	97	13	12	8	22		20	16	11	23					20
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			1,527																																		
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												221					228				
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												221					228				
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				55	48	36	60	164	33	49	29	46	178	50	26	26	34	180	32	32	35	38	136	38	32	32	34		31	44	27	30					44
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male									8																												
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												293					302				
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				23	21	19	26	152	16	28	14	8	166	21	16	12	12	168	24	10	18	22	128	16	15	11	24		20	19	20	8					19
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				38	39	33	40	117	59	34	23	29	128	22	19	30	25	129	19	21	20	23	97	26	14	19	30		29	20	29	17					46
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				16	12	16	7	117	11	12	4	9	128	11	7	9	5	129	5	12	13	10	97	9	5	6	15		17	10	15	5					9
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				2	10	9	7	27	10	4	6	4		3	8	7	10		3	4	7	6		8	5	10	9		10	13	6	1					2
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				29	33	8	25	118	25	21	8	22	129	25	19	11	15	129	13	10	20	31	97	25	9	23	29		20	24	23	29					29
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				45	37	39	37	116	50	36	23	25	128	29	20	31	33	129	33	31	40	30	97	13	18	22	32		35	39	30	24					43
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												307					317				
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				54	60	63	67	158	31	41	41	56	172	41	33	32	42	174	22	53	37	53	132	39	43	32	48		41	50	30	45					55
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				29	17	32	17	153	24	27	25	23	167	23	18	47	18	168	20	27	32	39	128	29	19	19	24		22	22	21	17					34
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				10	7	6	11	28	35	6	8	3	29	8	5	5	7	29	3	2	3	11	23	6	11	10	11		10	18	7	5					6
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				45	31	30	42	154	27	30	21	31	166	36	30	30	40	167	37	33	44	52	127	43	28	35	43		42	44	35	33					53
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				15	17	11	10	29	17	7	12	5	29	3	1	9	5	29	2	13	8	8	23	13	7	11	19		21	26	14	5					13
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female									13																												
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				64	66	60	84	153	54	72	55	57	165	73	60	50	65	167	54	62	61	100	128	63	66	61	80	146	85	91	81	68	152				100
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				26	27	24	23	115	26	30	25	18	126	18	22	19	19	128	23	21	19	26	97	16	21	20	24		25	17	18	13					19
Eswatini	Eswatini	SWZ	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				41	30	35	27	116	24	18	24	23	127	35	36	17	27	129	26	45	34	57	98	37	28	23	52	114	51	39	39	34	118				67
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				2,335	2,672	2,738	2,650	2,991	1,981	2,002	2,042	2,087	2,992	2,077	2,136	2,135	2,151	2,189	2,176	2,203	2,096	2,000	2,412	1,948	1,922	1,828	1,754		1,683	1,616	1,597	1,476					1,204
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			5,336																																		
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												13,263					12,160				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				8,647	8,989	9,264	10,191	9,868	10,544	10,694	10,943	11,106	9,868	11,043	11,298	11,174	11,311	11,374	12,689	13,146	13,096	13,782	12,911	13,926	14,219	14,587	14,969		15,242	15,447	15,978	16,450					17,696
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												35,760					35,265				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			6,692	2,799	2,747	3,160	3,048	5,231	3,382	3,692	3,798	4,094	5,343	4,175	4,355	4,368	4,699	5,019	2,867	2,834	2,938	2,667	4,392	2,662	2,608	2,630	2,606		2,551	2,551	2,508	2,454					2,415
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			4,812	4,806	4,903	5,070	4,814	5,283	5,318	5,444	5,584		5,825	5,895	6,123	6,299					6,954
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			13,180	9,318	9,333	10,101	10,233	11,514	11,177	11,397	11,885	12,517	11,517	12,612	12,991	12,861	13,445	13,379	11,582	11,699	11,847	11,280	12,254	11,094	10,947	10,898	10,741		10,495	10,296	10,314	10,046					9,021
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			3,937	2,894	3,142	3,414	3,340	4,816	3,399	3,616	3,768	4,004	5,102	4,201	4,323	4,418	4,585	5,121	3,506	3,506	3,585	3,256	4,668	3,191	3,225	3,180	3,160		3,084	3,057	2,962	2,889					2,576
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			19,737	18,369	18,302	19,437	19,287	21,110	21,071	21,546	22,335	23,018	21,183	23,098	23,594	23,522	24,257	24,436	20,747	21,543	21,755	21,459	22,187	21,408	21,241	20,986	20,842		20,510	20,480	20,545	20,236					18,756
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female				1							2																										
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			5,526	4,048	4,161	4,210	4,263	4,528	4,986	5,052	5,131	5,170	4,857	5,187	5,240	5,223	5,265	5,596	3,902	3,995	3,823	3,753	4,138	3,633	3,567	3,515	3,385	3,689	3,166	3,094	3,016	2,931	3,336				2,446
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			17,158	13,890	13,752	14,988	14,852	18,424	16,038	16,587	17,291	17,945	19,025	18,149	18,639	18,667	19,570	19,812	15,579	15,656	15,939	14,801	16,767	14,563	14,404	14,314	14,025		13,621	13,512	13,274	12,919					12,038
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			8,690	9,232	9,245	9,913	8,690	10,216	10,190	10,298	10,221		10,201	10,432	10,810	11,105					11,783
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				1,091	1,289	1,323	1,265	1,484	1,255	1,282	1,320	1,359	1,484	1,360	1,397	1,416	1,443	1,468	1,032	1,080	864	761	1,105	754	732	716	722		708	692	700	643					531
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												2,872					2,464				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												10,781					10,442				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			17,337	17,343	17,964	18,713	19,325	19,767	20,955	21,412	22,064	22,771	20,000	22,683	23,235	23,016	23,572	23,501	23,719	24,208	24,126	23,941	24,423	23,927	24,038	24,153	24,107		24,151	24,027	24,088	23,923					23,346
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				6,331	6,599	6,766	7,447	8,343	7,981	8,107	8,373	8,615	8,343	8,578	8,808	8,684	8,948	8,810	9,498	9,940	10,075	10,550	9,772	10,687	10,920	11,133	11,334		11,485	11,644	11,860	12,042					12,531
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			3,080	3,293	3,262	3,450	3,137	3,557	3,675	3,695	3,754		3,825	3,936	4,060	4,174					4,372
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			2,337	1,289	1,372	1,502	1,558	1,777	1,733	1,971	1,896	2,025	2,373	2,043	2,132	2,123	2,228	2,576	2,020	2,118	2,122	2,197	2,991	2,236	2,268	2,303	2,306		2,287	2,307	2,380	2,374					2,342
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				8,708	8,849	9,332	9,685	9,912	10,683	10,923	11,330	11,843	9,912	11,830	12,165	11,953	12,372	12,283	11,800	12,250	12,426	12,845	12,114	13,077	13,137	13,198	13,085		13,087	13,194	13,261	13,299					12,946
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			6,770	7,196	7,338	7,862	6,987	7,977	7,948	7,971	7,862		7,879	8,081	8,405	8,657					9,127
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			22,743																																		
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			4,614	4,733	4,767	4,887	4,631	4,999	5,164	5,501	5,876		6,005	6,037	6,119	6,202					6,779
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			9,740	7,520	7,569	8,401	8,173	11,848	8,604	9,138	9,647	10,153	12,312	10,432	10,759	10,988	11,571	12,206	8,011	8,049	8,508	7,566	9,469	7,437	7,397	7,293	7,065		6,840	6,874	6,878	6,696					6,108
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			17,909																																		
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			15,511	17,189	17,701	18,191	19,962	19,713	20,507	20,737	21,151	21,474	19,713	21,286	21,806	21,539	21,660	21,794										26,443					27,675				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				12,833	13,026	13,458	14,467	14,419	15,458	15,763	16,207	16,601	14,707	16,507	16,979	16,710	17,036	16,970	18,088	19,065	19,032	20,274	18,439	20,816	21,124	21,337	21,613		21,906	22,290	22,733	22,801					23,345
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												37,165					36,961				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												4,825					4,850				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			13,926	13,361	13,809	14,265	15,402	16,501	16,066	16,270	16,659	16,986	16,501	16,924	17,217	16,914	17,197	17,392										21,083					21,811				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			6,125	6,300	6,293	6,346	6,056	6,468	6,660	6,963	7,456		7,701	7,745	7,897	8,034					8,659
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				5																																	
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												59,019					59,418				
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			10,584	6,564	6,424	7,014	6,988	10,408	7,602	7,879	8,268	8,725	10,828	8,841	9,056	9,109	9,614	9,809	6,507	6,481	6,695	6,261	7,774	6,133	5,970	5,803	5,585		5,380	5,327	5,278	5,182					4,497
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			3,741	3,992	3,927	4,268	3,744	4,405	4,592	4,717	4,809		4,793	4,877	4,996	5,117					5,476
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			3,848	3,899	3,936	4,116	3,957	4,279	4,352	4,431	4,539		4,729	4,768	4,852	4,922					5,406
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			307	222	188	220	163	339	274	321	339	389	414	409	427	451	474	102	191	208	106	102	64	103	104	85	66	80	62	47	49	48	44				39
Eswatini	Eswatini	SWZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			2,167	1,857	1,988	2,051	2,237	2,072	2,286	2,350	2,371	2,413	2,347	2,428	2,460	2,459	2,497	2,800	2,392	2,462	2,400	2,358	2,900	2,336	2,333	2,291	2,301		2,273	2,308	2,268	2,240					2,066
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								17	13	15	32		14	13	15	20					18
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			268	30	20	40	48	746	42	34	9	28	303	21	16	13	11	328	7	31	8	16	395	11	11	7	14		10	18	5	6					11
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								10	9	8	5		6	7	8	7					5
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			936																																		
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				143	128	175	148	1,255	197	167	108	162	618	102	96	86	114	315	89	78	82	87	170	73	79	69	109		56	62	52	52					59
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												1,535					919				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			1,628	293	250	368	370	2,602	337	368	179	332	669	202	175	170	188	655	166	192	149	161	994	150	166	136	134		115	120	99	130					103
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,061	560	738	660	537	1,716	525	612	370	580	862	407	313	317	403	1,069	275	359	286	239	963	293	297	228	248		208	228	185	187					189
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				87	92	84	108	416	109	110	59	86	201	73	60	43	58	173	42	61	61	51	88	44	64	49	52		33	49	39	47					29
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												487					468				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			396	183	187	205	178	1,043	210	223	133	220	355	222	157	118	119	497	169	196	164	137	870	118	152	110	104		92	96	94	65					74
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				34	43	45	42	237	26	33	17	42	64	21	15	13	9	69	20	17	17	21	38	19	12	18	18		13	14	12	5					5
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			1,358	205	320	303	263	3,172	221	248	119	241	221	146	145	105	138	599	124	156	96	99	957	83	110	112	103		78	90	72	73					51
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male				2																									4								
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								16	17	30	30		10	21	10	17					11
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			929																																		
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												676					351				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				33	46	34	37	143	35	34	25	35	34	17	25	20	20	87	26	27	23	21	68	22	14	25	26		16	22	15	10					18
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			93	46	47	39	43	494	32	48	22	49	84	22	24	23	24	102	26	23	24	32	64	18	31	18	13	82	7	16	16	15	44				12
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			1,741	242	282	361	340	965	318	316	204	311	243	198	189	149	219	440	150	230	162	146	390	142	140	152	146		109	114	116	127					108
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												115					54				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								48	55	45	53		28	24	34	36					27
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			900	46	51	65	124	162	40	75	25	63	407	32	18	11	25	346	23	18	19	31	112	19	20	15	10	90	11	14	13	7	39				5
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,478					922				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				99	101	102	122	1,090	102	114	82	90	179	61	66	52	72	137	80	82	67	69	86	73	57	64	84		50	36	58	49					56
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												852					803				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												203					157				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			1,757																																		
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female											2																		7								
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			397	89	77	126	134	2,119	82	117	39	116	647	60	48	34	56	459	51	55	47	53	675	34	50	32	54		19	41	33	22					22
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								9	11	7	14		3	8	5	13					10
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			716	128	137	139	180	872	156	147	97	140	347	85	84	73	98	195	62	98	69	82	246					51					366				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								33	59	48	48		19	27	22	32					27
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			797	407	406	516	456	1,332	408	448	304	409	523	281	259	218	269	876	195	281	221	171	1,110	173	201	182	195		158	161	159	167					127
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								8	9	5	4		12	6	6	7					4
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			1,018	531	567	565	577	2,321	543	561	357	554	633	413	326	315	349	1,077	295	412	348	283	1,001	280	321	259	271		224	260	257	237					195
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				159	171	226	203	344	206	225	132	175	207	128	120	103	129	225	100	134	111	95	145	102	111	114	118		89	89	83	102					92
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								11	12	11	20		6	5	12	10					16
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			236	115	149	170	187	893	138	132	71	107	402	58	78	69	73	231	72	98	96	81	195					59					351				
Eswatini	Eswatini	SWZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			1,085	261	253	329	280	1,844	308	334	206	269	604	169	185	146	173	552	122	171	170	114	456	105	119	98	134		91	88	102	97					103
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												9,484					9,372				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				10,673	11,860	11,576	11,823		12,393	12,173	13,657	14,625	14,106	13,321	14,283	16,567	16,483	16,238	17,807	18,930	18,376	18,956	17,258	19,678	19,392	20,462	20,714		21,065	21,725	21,880	22,097					23,012
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				1,967	2,207	2,167	2,233		2,505	2,408	2,538	2,672	4,781	2,664	2,901	3,157	2,788	4,693	2,926	3,050	2,839	2,669	3,923	2,652	2,535	2,669	2,662		2,616	2,627	2,582	2,504					2,358
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				3,001	3,381	3,262	3,253		3,465	3,489	3,638	3,818	4,527	3,870	3,919	4,320	3,575	5,227	3,688	3,827	3,489	3,337	3,835	3,250	3,051	3,131	3,042	3,367	2,905	2,857	2,751	2,677	3,064				2,302
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				7,305	8,235	8,021	8,368		8,722	8,706	9,588	10,151	9,550	9,911	10,615	11,281	11,819	10,870	12,489	13,102	12,693	12,922	12,099	13,245	13,066	14,047	14,593		14,839	15,273	15,558	16,068					17,529
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								9,707	9,126	10,183	10,222		10,204	10,262	10,574	10,893					11,790
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								3,270	3,131	3,335	3,456		3,568	3,784	3,896	4,042					4,248
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								4,861	4,710	5,176	5,301		5,478	5,691	5,879	6,107					6,898
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				5,015	5,511	5,592	5,925		6,443	6,699	7,162	7,688	8,079	7,363	8,000	8,311	8,603	8,415	9,048	9,704	9,362	9,470	9,147	9,755	9,490	10,318	10,577		10,784	11,117	11,247	11,483					12,143
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								4,577	4,395	5,142	5,453		5,606	5,794	5,843	5,918					6,591
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				13,934	15,596	15,528	15,725		16,310	15,734	17,328	18,546	19,068	16,668	18,188	21,494	22,225	20,796	22,803	23,999	23,366	23,888	21,804		564			24,188					25,399				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				650	765	694	639		711	782	792	825	1,436	784	761	868	644	1,373	650	696	600	545	894	536	502	495	487		444	417	404	383					333
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				1,570	1,756	1,885	1,819		2,296	2,351	2,309	2,623	5,117	2,572	2,411	2,641	2,478	4,538	2,438	2,543	2,364	2,177	3,676	2,158	2,010	2,150	2,150		2,129	2,207	2,175	2,191					2,236
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				5,017	5,590	5,377	5,142		6,183	5,655	6,026	6,603	11,652	5,947	6,501	7,430	6,607	11,242	6,661	7,052	6,665	6,233	8,440	6,148	5,862	6,060	5,944		5,778	5,970	5,898	5,811					5,523
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female					1						6	11																									
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												53,997					54,634				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				4,305	4,736	4,954	4,787		5,719	5,186	5,364	5,885	10,282	5,088	5,510	6,354	5,904	9,128	5,701	5,972	5,638	5,265	6,978	5,035	4,665	4,918	4,843		4,721	4,758	4,673	4,595					4,174
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												4,375					4,425				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				9,900	10,796	10,759	10,343		11,872	11,601	12,204	13,201	18,056	12,565	12,973	14,743	13,227	18,625	13,953	14,821	13,794	13,063	15,313	12,766	12,290	12,653	12,486		12,161	12,328	12,022	11,843					11,496
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				1,298	1,453	1,475	1,669		1,750	1,736	1,928	1,921	2,124	2,095	2,202	2,403	1,982	2,535	2,221	2,318	2,166	2,064	2,538	2,078	1,962	2,055	2,077		2,093	2,106	2,039	2,076					1,977
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												2,603					2,256				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				14,006	15,242	15,258	14,542		16,242	15,501	16,969	18,137	20,467	16,515	17,722	20,501	18,376	23,123	19,445	20,702	19,645	19,321	20,330	19,456	18,707	19,327	19,240		19,080	19,307	19,257	19,039					18,384
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								6,088	5,935	6,556	7,057		7,350	7,692	7,752	7,913					8,582
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				46	62	45	38		38	50	45	147	365	173	209	240	178	54	31	54	54	47	32	57	51	39	29	52	21	18	14	11	32				15
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												11,694					10,952				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								7,303	6,761	7,607	7,630		7,723	7,771	8,066	8,303					8,921
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								4,170	4,001	4,362	4,523		4,618	4,821	4,899	5,029					5,454
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				6,659	7,394	7,534	7,573		8,321	8,196	8,785	9,529	9,596	8,617	9,270	10,670	10,269	11,757	10,935	11,740	11,354	11,359	11,323	11,733	11,220	12,007	12,044		12,036	12,432	12,357	12,467					12,559
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												33,944					33,824				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				14,015	15,637	15,493	15,145		16,282	15,590	17,728	18,833	19,244	17,410	18,627	21,499	20,572	22,428	22,786	24,038	22,781	22,213	22,748	22,280	21,537	22,589	22,795		22,881	23,116	22,931	22,976					22,966
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				10,302	11,725	11,914	12,081		12,538	12,306	13,197	14,205	15,977	12,956	14,148	16,654	17,149	16,586	17,534	18,598	18,072	18,376	17,466		481			19,274					19,991				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												32,710					32,354				
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male												4																									
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								3,936	3,781	4,176	4,296		4,439	4,597	4,651	4,789					5,349
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				862	1,003	951	1,071		1,156	1,176	1,288	1,365	1,999	1,338	1,456	1,664	1,636	2,249	1,774	1,911	1,830	1,837	2,495	1,882	1,794	1,948	1,998		2,001	2,048	2,082	2,091					2,148
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				1,745	1,977	2,017	1,923		2,142	2,083	2,041	1,937	2,899	2,171	2,133	2,267	1,880	2,079	1,970	1,995	1,816	1,714	2,252	1,648	1,535	1,537	1,488		1,480	1,503	1,436	1,331					1,123
Eswatini	Eswatini	SWZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				6,607	7,408	7,673	7,591		8,457	8,080	8,615	9,359	11,148	8,353	8,866	10,177	10,160	12,714	10,446	11,112	10,534	9,761	11,338	9,689	9,119	9,744	9,734		9,529	9,528	9,381	9,245					8,582
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														18		21					55
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														13		7					2
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														12		14					5
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														46		68					81
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					38		24			31		32			12		11			5		17			14		28										
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														57		51					52
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														98		76					122
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														3		6					59
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														5		1					2
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														72		83					57
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														47		55					90
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														10		9					13
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														93		78					126
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														17		11					14
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														28		19					38
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														26		17					52
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														30		25					49
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														11		5					6
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														69		58					83
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														4		7					20
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														15		13					44
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					302		291			253		202			204		192			239		295			288		335										
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														47		58					102
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														66		69					96
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														12		9					22
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														38		52					76
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														7		19					42
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														38		40					56
Eswatini	Eswatini	SWZ	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					400		397			282		315			257		286			316		396			380		441										
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													477		1,037			587		1,064			671		645			2,039		1,556					804
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 											29,796					28,278					24,850														
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																				4			9		10			10		24					26
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													271		583			440		760			1,944		4,032			3,265		5,013					4,889
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															2			1		1			2		2			5		8					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													28		55			40		64			137		239			158		252					254
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2										4,331		8,294			4,959		7,499			3,932		2,961			2,315		2,667					1,998
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 											20,439					19,114					20,284														
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													42		51			23		38			21		22			15		13					16
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													2		1			1		1			4		2			2		5					
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													5		9			9		10			13		5			8		14					6
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													8		39			11		39			98		146			90		174					171
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													28		20			45		200			315		299			167		222					187
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																																			1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													5		7			11		55			99		69			59		87					59
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			3										2,558		4,829			3,402		4,575			2,942		2,457			1,784		2,412					1,865
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																							2		1					2					10
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										62,547					50,772				
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																				1			2												
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4		6			5		30			40		37			22		23					26
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2										5,823		10,781			6,555		9,193			5,429		3,998			2,849		3,522					2,589
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																							1							1					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										29,473					22,945				
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																														2					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													4		7			6		10			35		64			61		95					79
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															1			3		3								1		5					3
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative															1			3		2			14		17			33		37					41
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													2,404		5,007			2,845		4,205			2,310		1,774			1,597		1,777					1,445
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 											21,794					28,325					28,778														
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													6		21			20		36			104		273			257		382					456
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													72		101			67		73			39		29			38		24					20
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													2					1		9			18		11			43		36					54
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													33		58			35		113			230		508			1,080		1,330					1,255
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													9		14			17		72			110		109			93		126					96
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													9																						
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													120		299			237		436			1,206		2,526			1,969		2,933					2,956
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																		2		10			27		15			37		54					31
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													35		88			64		142			425		1,019			815		1,295					1,319
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1										184		329			221		300			178		147			113		166					124
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			6										4,764		8,474			5,446		7,520			4,480		3,472			2,377		3,218					2,352
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													20		25			11		34			51		81			84		155					134
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													787		1,722			1,434		1,936			1,416		1,292			901		1,346					1,103
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													13		18			18		25			8		6			15		16					9
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													26		42			23		56			22		23			74		80					11
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 											24,128					19,599					16,743														
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													1		3					4			3		4					5					
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													35		114			84		135			57		65			55		87					59
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative															5			1		15			33		29			10		38					23
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													2		7			6		12			15		21			16		26					25
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													256		487			282		406			208		155			143		164					99
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													55		75			38		56			27		21			20		11					19
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													105		238			114		183			91		85			85		85					49
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													58		88			44		73			35		30			14		24					30
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			1										135		249			244		402			261		254			173		303					231
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													1					1		2			4					1		5					3
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													4		8			1		8			7		10			11		20					24
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																		1												1					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													2		1					1			2		2					3					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																									3			1		1					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 											33,416					34,521					32,041														
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													26		20			44		185			233		226			156		172					196
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													376		711			425		667			332		247			182		244					138
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													3		3			2		12			10		10			9		6					9
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													343		619			361		538			298		241			166		209					142
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4		3			2		20			20		20			12		11					12
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																		1					2							1					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													2		5			2		10			7		13			11		9					9
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													246		566			400		803			2,064		3,933			3,379		5,298					5,511
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													18		49			38		57			95		183			146		246					233
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													97		310			288		456			1,083		2,310			2,291		3,504					3,685
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													26		10			29		150			200		184			122		134					112
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															1			1		11			11		9			6		6					8
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													33		37			13		15			26		6			5		6					9
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													11		7			6		3			3		4			2		1					4
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													7		8			4		12			17		26			18		25					16
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																		1		2			4		1			1		2					4
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													6		3			4		24			26		20			11		21					19
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																				1			4		2			1		2					3
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																		1																	1
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													1																						
Ethiopia	Ethiopia	ETH	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																							1		7			7		12					12
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													5		9			9		10			13		5			8		14					6
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													6		3			4		24			26		20			11		21					19
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1										184		329			221		300			178		147			113		166					124
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													3		3			2		12			10		10			9		6					9
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																									3			1		1					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																																			1
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																				4			9		10			10		24					26
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													35		114			84		135			57		65			55		87					59
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													4		7			6		10			35		64			61		95					79
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															1			1		11			11		9			6		6					8
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													2					1		9			18		11			43		36					54
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4		3			2		20			20		20			12		11					12
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													376		711			425		667			332		247			182		244					138
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													18		49			38		57			95		183			146		246					233
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													28		55			40		64			137		239			158		252					254
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													20		25			11		34			51		81			84		155					134
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													26		42			23		56			22		23			74		80					11
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													105		238			114		183			91		85			85		85					49
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													343		619			361		538			298		241			166		209					142
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													8		39			11		39			98		146			90		174					171
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4		6			5		30			40		37			22		23					26
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															2			1		1			2		2			5		8					1
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													256		487			282		406			208		155			143		164					99
Ethiopia	Ethiopia	ETH	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															1			3		3								1		5					3
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													1		2					4			4		1			3		2					2
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												3		1					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																												1							
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							6		6			9		29					2
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													4		2			1		12			4		5			5		8					4
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													10		25			19		15			27		69			48		75					71
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												4							
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy															1			1		1			1		1			2		3					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				1															
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		2		2			3		3					2					5
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															1			2		4			21		25			20		51					39
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													29		84			44		74			29		31			28		41					39
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													1		23			21		58			39		40			39		32					16
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		3		7			5		3			5		5					7
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																		1		1			2		4			3		1					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		1		1															
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy															1			2		4			1		2			4		1					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													291		449			242		287			145		113			91		113					78
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													1		1			3		4			11		31			24		34					32
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							4		2			8		4					8
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy															1								3		9			2		9					6
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													10		12			5		9			11		28			34		44					40
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												3		4					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									1					3					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP															1			2		8			6		14			11		16					22
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															13			10		28			61		82			66		145					121
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				5			7		6			2		3					6
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												2		5					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															1					2			6		3			8		7					14
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													82		172			78		86			42		34			41		38					30
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1										2		13			3		3			6		5			4		2					3
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													19		25			17		14															
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																														2					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													3		46			67		148			64		80			46		72					35
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																												1		2					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													15		39			16		18			37		78			78		76					105
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		1		1			1		2			1		2					3
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																		2		2			6		8			3		5					3
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP													1		1			3		8															
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													201		336			180		212			122		67			65		76					34
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy															1																				
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																									3			1							1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							10		11			23		17					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													142		245			147		166			98		70			52		69					64
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													3		57			74		193			118		101			76		72					48
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												1		1					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													6		2			1		14			6		13			10		5					5
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																														1					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP													19		31			21		30			19		15			4		8					13
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							4					1		3					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation															29			38		107			74		62			57		77					39
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													4		7			6		4			9		2			6		8					4
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																		2		7			6		2			2		5					2
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																														1					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												2		1					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														1					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation															12			31		53			23		27			23		40					23
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				4															
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				1										3					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									1			6		5					15
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation															5			5		28															
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP															2					3			1		9			8		7					10
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		2		8			9		7			6		5					8
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																														1					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																																			1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															5			5		15			37		43			41		91					56
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												3							2
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													3		5			1		4			5		5			8		9					15
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															4			5		25			65		66			48		96					74
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													3		62			78		253			116		89			88		108					48
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													1		4			1		7			8		6			5		2					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												1							
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				2			4		6					3					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																																			1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									1			1		2					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				5			3		3			2		4					5
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP													6		14			8		14			8		6			11		6					9
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							1		1			5		2					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP													17		22			15		23			14		6			6		4					4
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							4		6			15		17					10
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP													18		27			21		24			9		18			15		6					10
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																				6															
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP													1		1			1		2			4		1			1		1					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													1		3			2		11			9		15			7		14					19
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												1		1					
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1		1					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													1		9			15		30			81		128			66		138					114
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													273		501			287		329			161		129			100		122					71
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							6		3			10		8					23
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													5		26			6		12			22		58			43		60					70
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				1			3		1					1					1
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												3							
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													1					1		1															
Ethiopia	Ethiopia	ETH	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		3		7			14		14			6		9					15
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												37,097					37,094				
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				1	6	4	31	621	48	54	70	148	2,070	141	190	323	401	10,485	364	770	987	962	4,508	1,034	1,371	454	12		286	897	1,112	811					445
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			938	30	160	84	272	2,768	231	337	468	1,321	5,809	1,170	1,359	1,721	2,218	28,288	2,314	3,921	5,368	5,406	3,588	4,368	5,440	2,646	184		1,283	3,624	4,310	3,875					2,678
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			1,054	62	413	231	550	2,776	520	593	839	2,552	8,066	2,244	2,376	2,954	3,554	37,430	3,667	6,433	8,564	8,942	18,388	7,064	7,675	3,531	243		1,844	5,322	5,454	5,059					4,200
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			176	2	32	22	146	1,234	191	230	388	1,016	5,630	752	883	1,196	1,267	24,865	1,693	2,890	3,772	3,543	17,762	3,740	4,114	1,763	96		894	3,008	3,389	2,962					2,168
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			672																																		
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												21,502					21,504				
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				3	12	9	64	621	87	142	184	431	3,761	318	382	640	758	19,173	910	1,666	2,428	2,067	15,079	2,434	3,272	1,275	50		646	2,195	2,645	2,179					1,153
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			339	51	209	85	277	698	216	308	327	985	1,602	933	1,015	742	1,186	11,247	1,375	2,149	2,826	3,136	9,396	2,504	2,620	928	64		740	2,020	1,841	1,671					1,936
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female															6	1	8			23	27	9			2	1	9		8	3	3						12
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			195	1	8	2	16	695	21	19	18	59	1,387	55	40	84	95	8,367	71	180	319	272	6,095	285	218	96		6,097	66	160	303	205	6,097				184
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex					19	4	4		4	38	35	89	2,325	39	10	41	54	14,515	114	388	285	452	11,141	361	462	123	2	11,141	312	386	346	368	11,141				775
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			189	11	23	30	125	1,244	152	133	229	1,009	2,731	706	914	772	866	16,158	972	1,934	2,798	2,988	12,490	2,419	2,358	987	89		557	1,532	1,587	1,533					1,362
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			192																																		
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			45	1	2		17	313	31	35	46	124	2,699	121	136	206	290	13,622	266	476	656	625	8,156	714	647	208	5	8,156	192	533	700	532	8,156				337
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male									9	1						2	3			14	20	9							4	7		1					2
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												21,977					21,978				
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			142		12	9	84	314	100	88	122	320	853	188	245	150	274	8,872	282	555	723	939	9,014	839	731	253	12		211	535	512	419					494
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female					7	4	18	1,392	19	17	28	97	1,073	67	103	124	193	6,733	131	287	390	492	3,925	439	378	144	3		109	319	388	304					252
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												25,546					25,546				
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				2	24	11	65	1,392	49	80	100	268	2,067	193	288	365	471	10,480	410	699	1,132	1,160	10,089	1,002	1,186	529	19		273	814	981	877					674
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			174	4	17	22	105	620	125	190	299	684	5,108	439	646	973	1,080	25,980	1,404	2,635	3,559	3,156	17,507	3,632	4,602	1,927	117		888	2,975	3,627	3,095					1,660
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			222	15	55	30	180	1,243	218	251	412	1,491	5,691	1,114	1,182	1,334	1,457	27,590	1,632	2,939	3,972	4,105	15,110	3,816	4,087	1,768	180		865	2,866	2,882	2,690					2,217
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			764	7	63	38	164	1,392	158	178	250	711	4,649	517	761	1,012	1,290	23,673	1,388	2,254	3,263	3,272	15,744	2,592	3,402	1,434	92		736	2,344	2,748	2,275					1,587
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												29,759					29,759				
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			936	105	539	302	612	2,772	504	594	712	2,926	5,216	2,707	2,945	3,075	3,778	26,618	3,854	6,797	8,458	8,737	16,148	6,524	7,838	3,091	311		1,989	5,310	4,832	4,439					4,634
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex																				20																	
Ethiopia	Ethiopia	ETH	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												32,871					32,872				
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			3	2,556	2,800	3,455	2,915	797	9,213	10,585	6,950	2,311		1,486	2,699	2,935	2,818		1,965	1,955	2,344	2,430		3,062	3,769	3,642	3,673		2,071	3,600	3,610	3,524					5,005
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												81,943					117,578				
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																															13	1					1
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			6,004	6,716	3,000	3,365	3,619	49,303	38,152	34,452	17,995	22,512	17,996	23,958	26,549	22,032	21,457	26,638	17,638	19,730	20,074	15,811	55,217	17,220	19,367	19,610	17,925		17,779	18,230	17,205	17,147					21,733
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												96,878					78,525				
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				6,628	5,692	5,503	6,103	257,969	19,683	15,158	7,287	9,178	28,816	11,453	12,222	11,771	12,760	110,261	9,471	10,837	10,450	8,778	183,256	9,928	11,478	12,416	12,018		11,138	10,700	11,640	12,181					16,401
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			15,411																																		
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			12,971	10,948	6,092	7,103	9,944	27,306	68,148	63,433	40,379	48,003	28,341	50,719	57,725	52,462	55,105	45,624	46,992	54,638	58,725	53,509	44,632	56,185	57,499	61,657	54,382		99,725	110,485	110,963	114,134					136,253
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			27,602	8,773	5,628	5,197	6,117	53,385	25,781	21,612	11,826	13,065	61,907	14,266	16,890	16,241	16,120	303,037	12,863	13,909	15,209	12,073	84,989	12,484	14,112	14,602	14,391	107,688	13,651	13,418	14,160	13,336	94,977				18,853
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			26,199	9,610	5,844	7,050	8,816	8,679	65,105	66,973	34,393	45,196	13,529	48,887	53,679	48,805	49,656	18,339	43,451	46,952	48,743	41,058	34,746	44,458	50,420	51,345	43,389		45,293	48,835	46,602	46,070					50,231
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			7,913	12,084	4,983	5,063	7,921	45,034	66,901	69,297	36,199	45,410	17,113	47,211	56,588	46,801	42,322	18,377	37,638	47,528	46,411	34,520	68,402	36,787	40,934	42,349	36,218		58,910	66,572	63,652	63,595					76,434
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			2,153																																		
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			21,455	6,916	4,173	4,726	6,252	30,958	47,574	45,210	27,322	32,639	32,472	34,116	40,497	36,703	39,185	57,189	33,764	37,609	40,534	36,378	70,714	37,630	39,772	43,987	38,349		61,921	67,880	67,176	67,738					85,885
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female			369	11	2	13	25		297	7	671	13		15	40	194	88		105	75	49	11		54	46	3	23		26	14	16	179					96
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male			492	25	3	21	20		281	8	446	13		14	32	257	75		116	100	65	15		70	53	2	17		23	19	101	107					693
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			16,521	23,244	10,496	10,544	19,148	48,668	135,189	138,774	78,910	99,283	13,543	102,120	111,839	99,190	98,513	14,141	84,257	99,452	103,212	79,364	66,274	82,378	83,485	89,730	76,205		149,587	161,138	156,010	161,952					180,396
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				1,916	1,479	1,636	1,890	28,831	15,759	14,065	7,072	8,982	16,565	9,717	11,612	11,651	12,446	29,344	10,220	12,234	12,536	10,329	66,509	11,543	13,133	13,265	12,673		12,167	12,596	13,156	12,717					17,078
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			10,799	4,369	2,886	2,947	3,160	72,962	19,547	16,994	8,511	11,096	230,013	12,840	14,774	15,464	16,496	63,913	13,557	15,348	16,006	11,931	269,784	13,154	14,674	16,107	14,255	76,899	13,907	14,501	14,709	14,654	50,124				18,836
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			16,113	5,924	3,871	4,927	5,808	12,705	43,922	41,018	21,976	28,795	15,801	29,458	35,519	32,115	33,777	18,150	29,706	33,416	35,419	30,913	37,258	33,585	38,142	39,827	35,580		36,114	38,057	36,686	37,049					41,354
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				2,649	2,074	2,606	2,880	28,036	21,965	19,482	10,740	13,660	14,359	14,019	17,226	17,380	17,252	30,528	14,436	17,655	18,175	15,143	31,154	17,316	19,339	20,324	18,965		18,373	18,493	18,886	18,783					23,394
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				13,621	12,667	12,948	14,739	220,822	89,775	71,546	31,600	37,341	50,054	47,185	43,020	35,044	35,211	24,130	32,357	26,944	28,796	22,996	410,210	26,191	27,937	33,663	30,263		29,083	28,746	28,447	31,393					39,283
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			13,213																																		
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												676,593					1,205,731				
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			42,735	24,666	9,786	11,007	16,520	11,168	110,943	112,379	69,721	86,405	26,402	90,378	94,852	88,904	92,214	30,867	77,134	86,683	93,732	82,307	47,656	83,865	84,558	93,452	80,341		161,631	175,097	169,027	177,561					201,228
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			16,647	4,110	3,015	3,584	4,095	12,836	31,931	29,209	15,898	21,077	17,425	20,751	25,342	24,227	25,909	23,409	21,328	25,321	26,154	22,951	23,515	25,957	29,531	29,985	27,472		27,265	27,930	27,551	27,128					32,501
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												135,899					141,300				
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,451,769					545,129				
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				3,041	2,294	3,001	3,146	38,498	26,806	24,535	14,821	16,714	18,609	17,336	20,962	20,553	21,144	47,271	18,043	20,176	21,837	18,131	99,445	18,825	20,616	22,937	20,210		24,501	28,291	28,547	27,765					36,323
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			11,719	13,501	5,284	5,547	6,920	44,524	75,833	75,042	35,203	44,925	42,578	48,241	57,479	48,148	45,673	11,548	39,850	47,125	46,291	33,716	46,027	37,387	43,061	42,463	35,580		35,638	40,110	37,495	36,338					41,836
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				2,055	1,586	1,656	1,932	41,815	18,527	18,450	8,711	10,621	53,251	10,438	11,949	12,334	13,440	43,321	11,353	12,841	14,047	11,027	134,926	11,836	12,599	13,889	12,453		14,187	14,038	13,900	13,706					18,226
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			10,305	4,800	3,386	3,891	4,294	36,502	23,563	21,836	10,738	15,573	75,527	17,321	20,126	20,464	21,282	68,492	17,582	20,409	20,085	15,129	143,373	16,554	18,330	19,626	18,462	82,289	17,784	18,262	18,445	18,359	37,120				24,010
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												767,603					303,787				
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			17,408																																		
Ethiopia	Ethiopia	ETH	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												75,820					101,549				
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												1,174					921				
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			853																																		
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			568	101	76	58	105	1,919	413	349	184	214	2,651	240	296	269	301	583	256	291	314	231	1,389	251	284	235	270		233	295	318	257					282
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			655	236	193	177	395	2,478	1,054	950	495	738	4,374	821	1,073	1,073	1,037	5,740	813	952	1,160	923	1,638	890	1,060	1,064	796		1,002	1,179	1,071	927					840
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female						1			2						1	2						1					1										
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			47																																		
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			871	135	149	157	191	989	614	569	311	470	2,465	455	558	607	590	2,845	489	559	569	562	796	567	595	540	563		577	573	528	533					504
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				65	48	65	71	2,335	303	285	175	191	2,288	243	292	284	322	3,299	275	346	366	304	2,151	313	354	347	322		278	373	308	335					343
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				35	44	54	56	3,623	290	224	141	209	7,036	224	284	275	289	4,220	233	294	344	292	4,396	303	291	256	253		283	341	291	256					295
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				80	69	84	121	3,475	452	445	228	288	3,197	363	445	443	449	6,036	335	407	455	406	3,488	453	476	495	399		464	526	482	436					455
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				101	107	108	146	2,335	510	438	254	305	2,196	372	465	507	446	3,528	412	462	488	465	1,055	448	477	491	462		466	463	412	450					494
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			850	205	169	143	381	2,502	816	831	571	640	1,458	702	879	817	904	1,210	685	905	931	854	2,264	806	881	875	738		923	1,091	1,082	1,006					1,012
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			215	33	22	22	28	1,859	128	88	50	57	515	64	101	80	106	648	79	78	82	95	1,224	87	91	88	76		75	91	85	79					74
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,487					1,971				
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			618	62	50	57	71	5,303	308	329	177	213	28,261	219	295	349	388	5,018	289	378	385	344	8,198	364	376	356	310	3,478	339	403	409	387	2,030				435
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				109	111	172	113	8,013	226	177	110	106	965	152	208	186	197	453	147	186	168	144	4,344	196	161	165	160		136	134	146	149					169
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												849					1,206				
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			1,193	106	73	73	83	3,785	162	136	71	69	1,068	92	121	117	113	4,779	100	127	103	111	1,137	97	112	86	87	1,556	86	91	88	71	918				111
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			2,600	337	270	264	545	949	1,336	1,321	764	1,051	3,505	1,159	1,398	1,374	1,392	3,642	1,082	1,205	1,323	1,116	1,812	1,068	1,192	1,166	931		1,301	1,423	1,344	1,251					1,319
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			1,526	167	172	167	200	467	719	636	356	557	1,496	609	674	655	639	1,396	471	593	582	514	1,107	461	524	488	444		474	542	568	523					525
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			8	10	25	31	15	14	16	17	7	9		6	10	12	6		7	12	7	10		11	12	18	15		16	13	15	13					13
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			592	84	69	71	107	3,082	432	376	227	306	8,044	374	427	441	467	5,843	319	466	465	401	4,343	450	465	434	340	3,578	432	454	498	494	1,490				467
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			1,163	192	151	173	281	2,817	913	855	448	710	4,981	711	952	941	936	7,059	655	941	1,038	959	2,528	802	1,052	990	732		942	1,008	925	819					783
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male					1	1			1			1				1			1	1																	
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			823																																		
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												1,440					2,018				
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			544																																		
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												4,752					5,166				
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												10,047					10,891				
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				92	67	82	63	17,649	147	123	47	77	548	84	108	109	124	1,802	110	129	117	111	2,502	116	101	102	79		100	92	98	79					104
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			849	162	153	164	210	815	697	614	325	447	2,013	500	606	593	639	1,887	550	595	563	536	1,225	571	607	590	499		565	555	590	528					567
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			289	93	35	54	99	2,031	325	263	144	202	669	221	265	231	264	711	212	280	284	263	2,002	294	314	278	230		333	309	309	311					340
Ethiopia	Ethiopia	ETH	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												5,057					5,051				
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								11	4	3	2		2	1	1	1					1
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	60-64	50+	Female																								9													
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												1,543					7,092				
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				433	441	379	439	2,202	554	519	424	482	1,247	436	504	443	375	2,867	404	446	516	634	2,211	479	517	512	557		501	454	416	451					461
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				94	92	79	76		87	89	75	91	84	63	92	107	78	696	77	55	73	80	1,016	102	66	83	75		73	86	79	80					96
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																								9		1											
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				1			6		2		7	12	60	2	1	18	2		1	1	3	2			3	2						1	253				1
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				1,002	866	776	865	3,331	1,004	910	811	850	933	789	934	854	741	1,691	732	675	780	925	1,305	849	821	763	807		779	737	667	697					702
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				105	62	61	61	1,003	102	89	75	86	940	52	82	71	69	1,685	54	74	114	127	1,904	117	130	121	128		110	90	77	92					88
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				11	5	12	9	570	18	17	9	11	2,203	8	13	14	16	139	4	11	12	17	795	32	25	30	27		17	19	17	12					6
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												4,838					2,579				
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex						2											1									1											
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												2,590					1,123				
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female					1				6	1		2																									
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				1,618	1,470	1,383	1,483	1,394	1,169	1,066	948	958	725	876	1,065	1,065	919	2,167	898	881	962	966	1,810	986	848	814	878		942	811	807	862					849
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female					1	1	1	36	15	26	32	5	7,604	4	1	5	9			1	2	3											18				
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																								9	2	2	1				1						
Ethiopia	Ethiopia	ETH	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				581	551	547	524	536	578	491	458	513	248	489	519	471	500	1,435	422	439	450	484	1,967	539	431	407	434		476	447	428	442					470
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female				2,314	196	369													129										43,400	51,345	52,220	55,248					69,920
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female				1,682	10	12													2										20,672	24,560	24,003	26,216					33,946
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female				4,596	100	124													64										65,697	73,240	74,020	79,160					93,191
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				32																									1,011	1,931	1,695	1,472					2,075
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex																															13	1					1
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female				1																									8	44	16	18	1,800				21
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												345,484					122,583				
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex				7																									332	191	252	161	28,176				164
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female				1,031		58													48										22,756	27,751	28,683	29,055					37,897
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				161																									5,094	7,734	8,350	7,090					10,203
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												206,691					770,928				
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female				4,547	404	276													131										74,299	84,135	84,056	91,144					108,335
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												649,397					280,574				
Ethiopia	Ethiopia	ETH	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female																													14		14	8					15
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female				82																									828	825	837	838					849
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex																														1	4		253				
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				1																									13	8	12	9					6
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female				78																									428	466	457	442					486
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female				32																									70	102	92	80					122
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female				32		1													1										609	704	683	647					708
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				3																									76	81	73	92					75
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												1,548					7,146				
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female																																	18				
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												4,874					2,588				
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female				10															1										385	409	423	422					442
Ethiopia	Ethiopia	ETH	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												2,596					1,124				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					886		1,133	1,350		1,317		1,089	523		765		743	723		416		1,229	796		963		1,552			1,043		1,426					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												6,513					6,745				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												816					844				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female					426		456			315		235			72		104			4		135			35		88										
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												31,910					33,058				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												25,880					26,818				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male							41			28		33			3																						
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					452		741			650		538			110		255			2		257			77		234										
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female					1							34													5												
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					872		1,143			1,130		884			221		222			2		422			151		560					1					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			13,812		4,532		22,554	26,315		12,716		12,352	9,219		6,878		5,050	12,742		5,295		9,897	14,001		7,763		7,157			5,194		5,052					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			8,221		6,940		21,354	10,412		13,224		14,620	4,498		7,970		7,333	6,216		5,766		13,143	15,394		8,613		8,740			6,634		8,315					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					339		1,207	1,352		729		595	524		157		337	724		68		382	800		251		457			364		410					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			4,109		1,469		3,994	7,119		2,902		3,236	2,605		1,804		1,431	3,601		983		2,780	3,959		2,419		3,811			3,348		4,103					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												5,987					6,198				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			8,221		2,466		3,627	10,412		3,727		3,064	4,498		1,070		1,010	6,216		55		1,668	3,537		619		1,421					2					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			828		472		582	1,350		400		330	523		163		79	723		22		242	796		141		198	934		190		252	959				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex					1,671		1,904			333		369			7		13			18					124		32						506				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			8,221		4,708		11,711	10,412		5,762		6,008	4,440		3,556		2,582	6,136		2,178		4,641	6,687		2,843		3,504			2,261		2,479					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			14,762		4,371		21,211	27,677		13,752		14,023	9,719		6,991		4,730	13,434		5,331		11,418	14,773		9,438		10,524			10,034		11,276					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			12,302		2,463		9,838	23,588		6,814		7,622	8,194		3,926		2,826	11,325		2,544		6,296	12,450		5,499		8,195			7,825		9,172					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			8,221		3,805		9,670	10,412		7,511		6,791	4,498		1,992		1,968	6,216		309		3,128	1,568		1,232		2,395					7					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			1,642																																		
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												18,395					19,378				
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			828		1,703		2,380	1,031		2,389		1,891	461		454		648	638		5		900	693		302		856					1					
Ethiopia	Ethiopia	ETH	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			828		1,674		6,105	4,574		3,322		3,087	1,118		2,036		1,187	1,544		1,590		2,381	1,692		1,508		1,797			955		722					
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												2,248					3,124				
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			93	88	86	84	79	61	79	84	78		78	67	67	65					74
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			45	44	67	93	481	94	85	92	101		98	83	93	124					157
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			1,075	923	1,102	1,435	1,349	1,230	1,240	1,586	1,854		1,685	2,057	2,128	2,224					1,836
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												3,524					5,555				
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			27	24	27	34	405	31	35	33	30	584	41	37	49	40	751				44
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			113	96	103	126	205	93	96	99	119		106	91	104	103					95
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			172	128	156	150	79	127	114	121	116		96	99	92	97					78
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			58	52	85	81	322	76	57	50	54		50	74	67	56					59
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			1,368	1,252	1,617	2,125	951	1,648	1,630	2,264	2,996		2,894	3,375	3,814	4,060					3,403
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			17	20	8	8	1	8	6	64	9		59	12	17	18					24
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			18	21	11	16	405	16	14	15	10	584	13	14	12	13	790				14
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												1,323					1,737				
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			25	20	20	38	322	24	17	27	26		28	34	26	30					17
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												184					227				
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			2,077	1,982	2,386	3,006	1,214	2,414	2,377	3,459	4,137		3,701	4,468	4,775	5,081					4,568
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			534	469	580	735	762	716	652	893	1,107		1,055	1,262	1,422	1,540					1,419
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																				1	1									2		3					2
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												406					613				
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			292	224	242	322	648	277	267	344	373		383	441	600	588					585
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			20	21	23	30	481	16	20	18	31		32	34	34	42					38
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			41	38	38	45	322	39	39	37	35		40	48	42	36					49
Ethiopia	Ethiopia	ETH	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												2,367					3,821				
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								247		2		8	1,286	15	28	37	49	974																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					1		14			10		38	373	101	163	202	294	527																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					27		29	251		53		178	1,286	405	656	855	1,179	1,757																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					2		5			5		23	373	40	54	74	88																				
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					29		85	553		407		1,061	2,325	1,705	3,146	4,199	5,598	6,876																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					5		15	247		23		76	1,286	189	354	383	543	1,219																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					2		5	247		7		22	1,286	47	85	93	117	1,219																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							1	247		2		4	1,286	15	20	22	39	249																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					40		62	525		304		794	2,325	1,178	2,125	2,891	3,852	7,337																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							1			3		13	373	22	39	41	66	249																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					5		4			4		26	373	41	67	99	117	286																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													373	33	69	67	93	221																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					1		2	18		15		51	373	204	246	296	351	221																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					3		11			22		83	373	260	318	380	476	755																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					13		38	247		199		453	1,286	692	1,362	1,848	2,464	1,931																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					2		4	6		3		39	373	81	101	129	165	690																			
Ethiopia	Ethiopia	ETH	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male														1			7																				
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					1		4	67		10		41	347	106	88	57	49	171	35	42	38	46	213	24	23	23	25		28	18	31	27					38
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					2		10	60		5		25	347	46	75	50	80	432	39	52	47	38	540	35	47	58	59		42	54	46	52					57
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												811					963				
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					4		9	29		16		66	347	143	108	73	82	610	61	84	60	54	213	37	43	48	59		49	47	51	60					60
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					5		4	216		17		55	1,172	98	156	91	181	976	67	161	174	136	1,771	97	183	170	146		206	245	276	201					228
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							1	37		2		11	347	16	12	12	18	199	14	12	15	14	866	13	15	16	11		13	22	14	14					14
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					30		61	457		247		668	2,119	881	1,537	1,242	1,436	5,525	1,015	1,729	1,759	1,237	3,313	972	2,009	1,870	1,750		2,402	2,344	1,927	2,040					2,132
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					2		3	50		2		28	347	45	49	26	31	545	26	32	41	26	866	26	32	41	35		42	40	32	36					40
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							1	231				5	1,172	8	8	5	10	199	4	4	10	3	1,116	3	4	13	5	1,203	11	10	5	12	1,184				20
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					5		1	57		3		24	347	20	32	25	24	236	14	15	25	22	866	16	22	24	23		17	25	25	30					27
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					2		3	46		3		20	347	17	20	13	21		18	17	18	22	1,116	13	18	25	38	1,203	30	28	25	20	1,185				24
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																									4												
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					2		3	233		4		14	1,172	26	42	25	36	976	22	50	46	42	1,334	21	38	48	31		42	47	49	59					82
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					14		27	209		88		247	1,172	363	671	462	627	1,549	502	750	811	648	3,683	469	824	856	935		1,050	1,016	862	932					1,108
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												5,059					5,701				
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												4,795					4,662				
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												7,548					8,288				
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												332					350				
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								224		2		6	1,172	10	17	12	12	780	9	17	10	14	1,334	11	11	16	11		11	21	22	25					30
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					27		13	229		25		126	1,172	180	310	241	371	1,371	173	389	400	298	2,087	325	482	456	404		516	580	599	566					523
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male														1																							
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					40		40	438		197		489	2,119	634	986	764	914	5,886	594	1,061	1,210	846	2,598	712	1,352	1,346	1,084		1,556	1,666	1,734	1,352					1,196
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												2,806					2,755				
Ethiopia	Ethiopia	ETH	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								18					347	22	25	24	13	171	6	4	5	8	105	1	8	1	1		5	1	5	7					5
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				47	47	37	53	195	47	31	45	29	196	34	41	43	29	21				154	17				174					171					172
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				157	130	152	154	191	97	79	60	71	48	78	72	67	53	61				298	56				294					251					295
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				59	85	66	112	197	98	71	74	92	730	75	80	83	90	379				429	236					458					359				
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				29	25	23	20	195	29	17	20	13	9	11	10	10	8	26				72	18				90					62					54
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												189					18				
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				107	119	105	114	195	112	91	71	99	79	95	122	78	89	89				393	138				379					334					341
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				49	65	63	51	110	45	43	39	41	39	32	30	33	41	55				198	112				215					237					209
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			1,351																																		
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											57					80					68
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				104	110	115	114	111	123	103	76	84	477	88	98	98	94	505				502	410				568					488					478
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											62					61					78
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				11	13	14	5	21	10	8	7	3		2	3	10	9	43				52	42				66					39					47
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				64	62	65	66	196	58	55	52	50	143	64	49	55	51	201				293	225				354					364					359
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				130	133	130	109	111	156	123	83	80	382	80	74	90	84	392				369	350				465					406					409
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				15	26	28	21	21	15	18	23	15	13	9	13	15	18	223				61	152				95	256				58	12				47
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											52					88					71
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												2,309					1,963				
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				17	19	19	20	111	17	22	14	21	12	7	11	9	14	33				72	55				107					76					69
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female				1																																	
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			134																																		
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				105	117	94	121	194	118	89	67	105	128	83	106	82	77	209				412	209				435					393					414
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				183	181	175	183	108	127	106	74	77	195	81	81	78	82	239				329	296				394					336					346
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				53	62	59	62	113	81	58	47	46	3,359	50	34	49	31	308				396	213					514					474				
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											74					88					116
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												237					244				
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				1	1	1	3	21				1		1	1		1					3					6					4					7
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												57					182				
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				38	49	40	46	112	40	51	37	27	695	30	36	36	31	255				228	264				348					279					342
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											377					305					377
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				68	67	53	87	111	81	72	55	60	256	53	62	51	53	416				338	352				448					379					428
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											46					45					71
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												744					684				
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												1,192					805				
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			1,388																																		
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											90					113					116
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				100	137	102	106	195	107	120	82	110	108	73	104	70	106	152				414	165				475					447					403
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				5	3	6	7	21	4	5	7	6	2	4	5	6	1	1				25	1				36					43					40
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											342					288					376
Ethiopia	Ethiopia	ETH	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												138					233				
Ethiopia	Ethiopia	ETH	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female												13																				5					
Ethiopia	Ethiopia	ETH	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			51,073		4,247		4,102	62,944		7,633		9,287	36,998		5,072		5,540	16,150		6,275		5,732	24,526		5,307		5,625	16,423		5,207		4,120	19,219				5,237
Ethiopia	Ethiopia	ETH	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male					52							7								2																	
Ethiopia	Ethiopia	ETH	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			50,130		6,102		6,181	111,316		11,879		15,058	75,133		8,141		9,988	27,911		11,109		9,737	46,015		9,981		10,513	29,511		8,710		8,104	36,136				8,896
Ethiopia	Ethiopia	ETH	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			11,844		731		695	19,256		1,007		984	5,703		483		547	5,733		593		430	8,937		352		497	2,599		678		449	2,334				454
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				767	703	811	791	1,731	843	853	634	836	559	777	736	802	810	930	712	898	1,013	904	1,074	846	1,014	995	984		1,039	1,105	1,214	1,368					1,159
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												1,688					153				
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				1,483	1,442	1,697	1,590	2,199	1,156	1,027	793	974	492	896	896	974	969	893	950	1,046	1,241	1,313	864	1,247	1,192	1,275	1,210		1,332	1,394	1,476	1,330					1,596
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												5,086					6,552				
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				29	17	34	17	804	22	21	23	15		14	27	25	29		45	32	17	47		27	25	34	27		31	32	34	59					47
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				472	405	501	447	804	429	475	342	369	185	369	370	400	351	2,679	358	460	518	459	2,426	437	492	519	528	2,426	531	573	569	535	102				622
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			3,209																																		
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												2,107					2,040				
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				483	410	596	509	1,733	547	592	445	541	2,345	483	540	550	477	3,878	524	623	688	664	3,493	632	731	719	761		807	815	866	824					866
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												829					1,524				
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				324	276	379	334	1,733	399	414	331	358	1,395	359	343	350	318	3,231	310	370	487	496	2,883	447	459	519	538		556	553	516	535					680
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				512	483	594	622	1,740	664	739	473	574	30,937	503	517	576	601	2,558	558	670	797	837	2,269	813	763	963	971	2,269	988	1,054	1,020	1,008	3,879				1,166
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				533	478	560	504	2,249	559	551	395	518	342	472	450	493	432	445	456	570	590	622	419	573	575	679	624		651	675	743	689					774
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				1,228	1,177	1,422	1,312	1,731	1,007	891	722	823	1,903	775	800	826	855	2,214	812	925	1,041	975	2,228	927	969	1,075	1,058		1,150	1,206	1,228	1,391					1,369
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				435	424	486	485	2,260	567	588	402	499	539	493	471	491	438	1,881	466	524	581	629	1,793	550	572	624	727		696	664	735	661					838
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				591	555	689	599	1,732	703	616	553	594	2,230	638	591	637	589	3,111	597	699	732	787	2,804	716	728	819	827		930	862	963	1,014					1,010
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				452	420	459	486	1,733	472	513	372	459	189	369	409	485	466	543	427	539	564	513	602	524	558	564	583		591	685	630	801					719
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			16,794																																		
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				640	640	803	748	2,247	820	740	655	752	438	698	681	727	726	1,144	700	851	939	931	1,243	920	917	970	945		986	1,057	1,182	1,046					1,175
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												8,508					15,563				
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female				1					10								1				9									1	1						
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												1,676					1,941				
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				181	144	230	208	804	227	252	180	185	375	188	198	236	205	446	216	254	301	302	446	329	329	345	324		319	372	359	411					439
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			12,736																																		
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				269	268	337	238	804	272	332	194	195		221	200	267	246	1,272	265	354	399	368	1,242	412	399	444	430		438	459	432	443					481
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				306	315	388	355	2,266	373	389	300	401	840	365	327	383	321	1,749	330	419	432	477	1,744	458	410	502	528		530	559	637	597					718
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				245	239	305	252	1,738	285	333	195	265	5,085	264	246	264	252	2,193	265	314	447	348	2,132	344	358	459	470		469	439	467	440					541
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				886	851	1,021	965	2,244	1,091	1,033	772	879	2,892	900	847	942	896	431	869	1,096	1,167	1,298	410	1,191	1,130	1,155	1,163		1,205	1,280	1,380	1,347					1,375
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												5,032					5,572				
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				714	747	898	908	2,262	1,024	1,088	768	909	9,700	883	862	865	851	2,922	783	1,083	1,177	1,194	2,545	1,073	1,077	1,219	1,229	2,545	1,319	1,423	1,437	1,375	2,956				1,675
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				524	527	603	595	2,249	645	677	524	636	618	536	571	614	540	1,599	549	682	713	751	1,549	709	787	793	817		873	879	934	877					1,023
Ethiopia	Ethiopia	ETH	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				2	2				21			3										2		1			6										
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			13,076	24,192	24,176	23,055	22,307	13,711	20,344	19,524	18,118	17,423	25,778	15,197	14,553	13,975	13,238	20,023	13,051	12,972	12,734	12,255	16,608	12,418	11,620	11,741	11,858		12,195	11,774	12,098	12,149					12,048
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			11,575																																		
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			38,824	30,313	31,681	32,709	34,996	41,977	36,991	39,323	41,677	43,455	44,978	40,347	44,788	44,397	43,102	50,298										58,529					63,580				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												82,973					82,904				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			4,074	4,922	5,928	6,246	5,157	6,275	6,969	7,154	7,391		7,403	9,245	9,430	9,603					11,270
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												164,940					168,608				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			14,205	8,217	7,381	7,780	7,223	15,949	7,283	7,011	6,741	6,492	10,224	5,747	5,740	5,713	5,592	7,417	5,698	5,948	6,021	5,960	7,936	6,111	6,319	6,347	6,490		6,721	7,141	7,369	7,414					7,808
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			13,765	6,635	6,501	6,617	6,482	15,319	6,835	6,759	6,801	6,835	7,417	6,246	6,348	6,176	6,026	7,786	5,907	6,262	6,331	6,357	8,214	6,385	6,317	6,361	6,369		6,428	6,521	6,534	6,644					6,211
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			17,085	8,785	8,590	8,798	8,557	18,778	8,540	8,449	8,158	8,154	9,839	7,523	7,324	7,143	6,974	9,333	6,958	6,992	7,137	7,274	10,504	7,423	7,059	7,209	7,273		7,420	7,383	7,478	7,557					7,116
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			954	283	268	289	222	896	182	140	130	112	842	76	69	70	57	152	49	57	58	65	160	71	70	77	64	190	68	67	57	53	206				77
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												24,178					23,758				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												23,510					24,454				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			6,839	22,410	20,706	19,787	16,767	7,530	16,769	15,289	13,951	12,857	19,368	11,228	10,146	9,834	9,057	14,812	9,154	8,848	8,755	8,367	11,964	7,632	7,168	7,381	7,525		7,890	7,923	8,155	8,231					8,825
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												14,100					14,858				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				7,297	7,156	6,935	6,504	16,716	6,123	5,658	5,248	4,901	8,420	4,328	4,026	3,861	3,509	8,112	3,489	3,419	3,410	3,340	9,313	3,405	3,187	3,245	3,244		3,292	3,160	3,234	3,296					3,238
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			9,424	11,816	13,148	13,969	18,134	14,102	15,040	15,345	15,599		15,746	18,210	18,559	18,663					20,938
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female						2																															
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			15,497	28,058	28,127	27,288	27,121	16,571	26,609	25,851	24,515	24,243	31,336	21,804	21,696	20,836	19,842	27,907	19,107	19,645	19,386	19,178	23,594	19,322	18,674	18,589	18,586		18,652	18,425	18,433	18,529					17,505
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				21,380	22,201	23,076	24,807	36,436	23,805	25,588	25,327	26,172	28,668	24,356	25,742	25,462	24,542	30,250	24,156	26,161	26,584	26,899	29,794	27,280	27,757	27,953	28,075		28,147	30,269	30,110	30,368					30,823
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			96,743																																		
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			3,285	4,097	4,739	5,005	5,567	5,073	5,725	5,903	6,081		6,238	7,639	7,827	7,963					9,566
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				3,088	2,960	3,015	2,835	10,446	2,462	2,106	1,870	1,719	4,317	1,600	1,399	1,434	1,415	2,755	1,468	1,317	1,356	1,377	7,767	1,402	1,255	1,321	1,353		1,425	1,273	1,320	1,381					1,390
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			22,596	24,319	24,072	24,936	22,237	25,837	27,714	28,665	29,603		30,408	33,924	34,397	35,835					38,430
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			8,201	10,494	11,530	12,294	16,767	12,496	13,742	14,003	14,418		14,560	17,344	17,825	18,174					21,572
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			5,905	7,640	8,486	8,927	7,637	9,064	9,616	9,680	9,754		9,817	11,237	11,301	11,545					12,835
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				29,633	33,699	34,740	37,471	51,939	43,518	45,436	47,340	48,734	43,260	45,594	49,276	48,653	47,049	56,311	47,130	51,788	52,665	53,078	57,166	53,389	55,069	55,572	55,765		56,029	61,188	61,275	61,835					62,745
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			20,888	19,431	18,935	19,244	17,754	23,249	16,573	15,595	14,653	14,060	20,485	12,962	12,447	12,552	12,157	16,129	12,581	12,235	12,625	12,952	16,855	13,309	12,995	13,308	13,619		14,139	14,032	14,662	15,062					15,239
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				27,659	27,656	28,753	31,313	51,342	29,505	31,636	31,675	32,835	40,524	30,337	32,948	32,868	31,176	37,916	31,214	34,205	34,789	34,733	40,174	35,106	37,227	37,516	37,422		37,843	43,442	43,855	44,444					48,162
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			45,415	52,360	51,696	51,088	51,248	47,238	50,032	49,080	48,892	48,812	59,225	44,112	44,275	43,449	41,759	56,198	40,642	41,227	41,808	41,284	49,328	41,551	40,003	40,135	39,823		39,813	40,026	40,147	40,378					36,709
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			15,717	52,569	48,571	47,011	41,409	16,891	39,626	36,536	35,412	33,754	47,869	30,414	28,639	27,783	26,621	38,869	26,639	25,277	25,825	25,337	33,131	24,441	22,770	23,405	23,872		24,471	24,347	24,584	25,114					24,006
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			65,207	26,747	28,099	28,798	30,735	69,567	32,692	35,639	36,983	37,932	61,441	35,006	39,522	39,545	38,751	43,879										57,017					66,539				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			68,787																																		
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				21,165	22,454	23,450	24,642	36,430	27,671	28,492	28,030	28,399	28,432	26,446	27,174	26,531	25,521	32,768	24,991	26,180	26,234	26,368	29,985	26,656	26,313	26,273	26,444		26,341	26,595	26,534	26,794					26,145
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				101		1					6									1																	
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			41,755	53,086	55,056	54,812	57,502	45,036	57,388	57,767	58,725	59,539	66,473	54,711	56,839	55,907	53,858	68,701	52,740	55,608	56,337	56,324	63,691	56,532	56,205	56,393	56,254		56,090	57,998	58,123	58,338					54,103
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												77,705					75,573				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			19,663	10,979	10,813	10,650	10,873	21,474	10,856	10,832	10,668	10,437	14,481	9,430	9,182	8,944	8,399	17,324	8,286	8,023	7,932	7,760	15,968	7,682	6,995	6,890	6,793	9,409	6,645	6,478	6,381	6,313	8,706				5,538
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			5,258	6,770	7,242	7,697	7,292	7,932	8,554	8,620	8,720		8,783	10,084	10,110	10,251					11,491
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												7,143					6,559				
Ethiopia	Ethiopia	ETH	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			23,878	24,880	22,832	22,538	21,895	22,630	24,470	24,413	24,256		24,578	27,341	27,381	27,922					29,113
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												1,115					889				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												4,502					4,872				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			826	1,288	1,255	1,090	1,279	1,148	1,225	1,218	754	1,048	3,835	1,056	1,200	1,156	1,157	4,141	983	1,027	1,107	1,026	2,632	1,014	1,060	1,106	990		1,085	1,144	1,134	1,067					1,076
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												4,788					4,781				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,394					1,858				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								58	63	69	74		84	118	117	88					102
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			392	226	267	215	265	2,077	269	244	141	205	723	224	240	223	257	890	205	240	268	243	2,652	288	265	273	229		284	254	282	286					273
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			4,604																																		
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			457	236	233	224	244	1,969	238	202	156	143	2,581	182	203	195	196	698	180	203	222	163	1,698	183	222	196	190		218	218	255	216					230
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												9,520					10,330				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				149	113	115	118	15,175	129	118	40	81	563	75	97	82	104	2,063	84	92	101	90	2,856	99	100	107	70		103	81	104	85					85
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			1,338	359	381	355	410	3,153	385	357	194	306	7,858	325	336	349	395	5,646	300	360	410	378	4,527					3,372					1,411				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								34	64	34	45		57	69	86	79					85
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												1,346					1,897				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			1,020	606	562	542	580	888	600	513	293	424	2,038	438	509	432	491	1,994	419	478	455	430	1,518	449	434	477	435		447	428	451	431					459
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			144	58	56	37	51	254	36	24	36	27	612	34	25	28	19	153	17	33	29	31	160	34	27	45	28	190	28	30	30	22	203				37
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			72	70	80	69	94	2,019	92	63	33	48	523	67	69	60	75	729	52	66	70	69	1,439	64	87	70	66		57	68	87	70					66
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female				1		3																															
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								40	28	28	40		46	56	54	54					69
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				274	278	270	337	2,457	335	291	182	208	2,271	233	253	252	285	3,290	250	295	284	265	2,419	281	301	267	276		260	335	288	315					296
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			2,453	159	147	118	152	3,563	158	122	71	79	1,057	87	110	91	96	4,915	90	104	94	91	1,352	90	88	77	82	1,474	85	74	88	71	888				90
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								46	41	47	39		38	67	48	62					70
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			2,406	921	893	866	998	3,140	1,010	930	521	770	4,758	733	935	901	916	5,977	733	827	990	853	2,302	799	949	920	764		861	984	932	784					702
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								29	29	26	22		41	51	40	31					40
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			1,971	323	306	300	360	5,307	355	334	192	243	29,303	238	293	301	336	4,886	274	341	345	307	8,469					3,284					1,924				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												802					1,146				
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								24	23	30	36		56	41	62	59					83
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			5,135																																		
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			2,235	739	742	686	839	3,267	842	896	466	768	5,334	666	868	803	790	7,489	621	805	915	845	3,402	707	933	909	731		850	875	835	713					703
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								253	252	256	177		199	199	206	217					227
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								265	241	239	209		189	203	210	213					268
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				153	144	143	153	7,155	151	144	78	115	1,000	135	167	168	159	643	132	126	146	137	5,118	141	120	143	136		97	106	121	118					136
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			824																																		
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male					1	1			1						1																						
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			111	806	817	684	804	2,929	813	779	477	685	1,598	681	810	729	835	1,589	702	756	833	825	3,139	861	813	859	752		805	858	949	873					906
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			1,167	554	501	514	588	1,041	572	504	319	451	2,478	425	455	471	505	2,895	398	444	436	442	1,052	452	449	401	474		490	438	470	468					467
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				402	397	393	394	2,466	472	394	249	314	2,215	323	381	388	418	3,503	340	408	400	367	1,310	377	372	405	386		393	362	353	398					449
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				375	362	333	409	3,652	425	428	257	288	3,397	352	417	404	422	6,236	341	372	428	395	4,350	407	406	427	396		403	436	434	413					418
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			463	626	607	537	546	538	534	460	298	430	1,519	421	445	427	441	1,522	388	416	415	421	1,430	379	393	373	413		393	389	441	411					442
Ethiopia	Ethiopia	ETH	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				245	239	227	277	3,779	275	241	143	213	7,326	230	263	273	235	4,160	201	263	276	266	4,931	290	248	278	250		260	315	303	262					270
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												20,493					22,013				
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				11,457	6,543	7,414	7,171		7,790	7,388	6,624	5,981	18,401	5,864	5,384	5,622	5,367	13,705	6,077	5,233	5,269	5,144	9,589	5,200	5,239	5,281	5,261		5,217	5,303	5,328	5,278					5,893
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								4,469	4,416	4,842	5,131		6,154	6,624	6,798	7,091					8,001
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				15,541	15,910	17,242	20,271		21,859	22,791	23,688	22,989	51,267	22,655	25,226	28,078	29,505	40,294	31,059	31,361	34,248	37,184	42,748					49,835					59,711				
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				31,301	33,194	35,816	40,774		41,449	42,415	40,317	38,746	56,135	36,401	36,974	38,045	36,532	51,722	35,414	34,189	35,320	36,102	37,777	37,275	36,822	36,219	34,290		32,272	32,320	31,280	32,087					29,276
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				15,259	15,713	17,481	20,074		21,898	22,568	23,861	22,790	41,361	22,988	26,024	29,136	30,368	46,152	31,705	32,156	33,964	36,110	41,873					51,160					57,415				
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				3,912	3,980	4,506	5,029		5,284	5,413	5,529	5,462	9,381	5,597	5,665	5,874	5,664	8,704	5,602	5,542	5,756	5,897	8,457	6,076	6,170	6,489	6,050		5,808	6,111	5,892	6,253					5,496
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				28,939	34,968	36,832	41,175		42,841	44,112	43,097	42,140	62,978	41,638	42,322	44,940	42,502	63,132	43,514	43,220	45,852	47,219	50,259	48,436	47,884	47,919	46,118		44,430	45,357	44,505	46,002					43,662
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				2,880	2,941	3,202	3,725		3,919	4,137	4,266	4,255	7,079	4,390	4,512	4,800	4,762	7,273	4,743	4,632	4,814	5,101	6,402	5,259	5,282	5,438	5,085		4,957	5,098	5,058	5,186					4,761
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				30	34	9	48		17	12	9	9		5	6	8	1								11	17			32	75							1
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												72,318					75,066				
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												143,883					152,481				
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				12,785	14,528	14,450	15,743		16,746	17,621	17,794	17,899	37,239	18,081	20,355	22,587	22,907	34,856	23,587	23,567	24,576	25,758	32,744	26,231	27,456	28,121	28,084		27,549	29,745	30,473	32,548					37,024
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								3,224	3,374	3,762	4,129		5,200	5,897	6,211	6,470					8,075
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								4,349	4,317	4,828	5,236		6,432	6,946	7,180	7,614					8,801
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												21,111					21,395				
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												67,699					68,295				
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				6,905	6,682	7,292	8,069		8,365	8,424	7,932	7,409	13,848	7,193	6,966	7,117	7,045	14,919	7,103	6,726	6,716	6,595	10,447	6,448	5,930	5,866	5,534	8,188	5,178	5,207	5,095	5,044	7,807				4,332
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								2,885	2,979	3,336	3,785		4,674	5,140	5,390	5,630					7,093
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				3,138	3,244	3,554	3,423		3,441	3,356	2,989	2,740	8,098	2,615	2,624	2,723	2,528	7,119	2,458	2,287	2,319	2,323	7,429	2,371	2,291	2,300	2,243		2,164	2,191	2,167	2,163					2,255
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								22,492	24,031	23,469	22,600		17,902	18,894	19,065	19,486					23,615
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				3,664	3,710	3,008	3,080		3,149	3,257	3,268	3,140	9,207	3,337	3,378	3,753	3,763	6,921	3,972	3,857	4,045	4,135	6,342	4,179	4,293	4,451	4,444		4,386	4,636	4,617	4,794					5,360
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				14,876	20,080	21,595	19,301		21,241	24,303	17,461	15,983	29,728	15,971	15,405	16,046	15,532	25,760	16,341	14,657	15,488	15,602	17,931	15,562	15,307	14,953	14,227		13,591	14,024	13,264	13,556					12,926
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				14,771	18,463	21,916	25,375		27,495	28,760	29,179	28,644	41,015	28,956	31,722	34,505	35,101	51,721	36,097	36,100	38,137	39,494	45,634	40,345	42,219	42,360	42,547		41,814	43,982	44,489	46,027					49,387
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				11,124	11,211	12,626	13,952		13,963	14,115	12,897	11,863	24,469	11,472	10,933	11,011	10,451	18,539	11,307	9,866	9,788	9,828	13,359	10,352	9,968	9,964	9,157		8,767	8,604	8,390	8,542					8,417
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								6,783	7,510	7,993	8,533		10,318	11,646	12,053	12,650					15,674
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				8,083	7,901	8,917	9,726		9,872	9,500	9,611	9,196	19,455	9,038	8,748	9,146	9,411	14,964	8,864	8,844	9,288	9,488	13,815	9,754	9,628	10,006	9,798		9,720	9,972	9,802	10,136					10,701
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				41	44	51	70		24	26	22	17		23	19	21	2								5	11			51	173							2
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				12,030	14,600	16,895	19,221		20,199	20,960	20,498	19,640	26,990	19,253	19,843	20,655	20,309	30,176	20,771	19,758	20,394	20,787	23,202	21,400	21,298	20,775	19,995		19,388	20,124	19,637	20,237					19,545
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								24,737	27,090	26,965	26,850		23,187	24,597	24,966	26,378					32,043
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				169	119	131	89		135	19	14	8	649	4	12	5	74	146	15	22	8	6	150	7	5	18	9	174	8	11	5	6	174				9
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				11,170	13,048	13,932	15,138		15,944	16,466	16,163	15,934	27,201	15,447	16,749	18,293	18,197	27,839	18,609	18,418	19,392	20,335	23,857	20,544	21,187	21,134	20,892		20,602	21,488	21,618	22,240					23,511
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				29,648	24,225	26,208	27,819		27,940	27,094	25,207	23,831	45,368	22,297	21,740	22,083	21,295	35,785	20,494	20,040	20,808	20,265	26,136	20,729	20,023	19,882	18,865		18,143	18,310	17,859	18,800					18,115
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												6,223					5,801				
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				766	663	777	734		779	797	736	756	3,990	733	664	703	665	2,519	675	652	692	684	5,534	692	653	689	640		612	626	628	643					694
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								7,022	7,565	8,329	8,831		10,893	11,542	12,114	12,679					15,183
Ethiopia	Ethiopia	ETH	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												12,303					13,383				
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														114		68					85
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														32		27					52
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female												2																									
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														303		180					250
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														240		182					221
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														132		76					201
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														190		131					169
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														33		28					50
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex			259		84		78			72		60			52		60			54		129			132		171										
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														22		18					32
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			2,607		958		1,047			1,101		675			796		763			915		1,715			1,648		1,989										
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			2,637		922		1,099			1,169		609			600		629			803		1,602			1,681		2,314										
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														55		31					54
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														196		179					193
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														43		22					57
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														231		157					218
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														260		159					197
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														194		170					203
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														140		56					45
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														36		7					43
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														190		115					189
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														138		77					94
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male					1		1					2										1															
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														19		17					26
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														229		146					255
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														128		102					149
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														3		3					5
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														92		44					26
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														54		29					17
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														282		153					174
Ethiopia	Ethiopia	ETH	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														73		47					76
Haiti	Haiti	HTI	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female												273			232		4,156	2,642		2,964		5,629	4,156		2,406		4,329	5,910		5,202		7,296	4,562				
Haiti	Haiti	HTI	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female												36						89				38			6		8	40		8		129	6				
Haiti	Haiti	HTI	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					1,052		1,588			840		1,844			2,290		11,783	8,843		8,487		12,340	11,783		5,097		9,366	12,959		10,625		15,127	10,394				
Haiti	Haiti	HTI	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					3,020		2,878			1,772		8,354			5,581		11,079	9,703		8,422		10,699	11,079		5,187		9,580	11,234		10,870		14,419	10,044				
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								1															1					1							
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1																	1										2					1
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1																									1		2					1
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			5					1		1															12			4		8					1
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								2		3					4					1			7		2					29					4
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																							1												
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1																											19					4
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1																				1												1
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1							3					4			1		5			4		3					4					5
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			9																																
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			3																				1		6			2		4					4
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			2																									1		5					
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected										1																				16					4
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																												1							
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			13					4		2			1		5					2			1		18			13		88					9
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																														1					
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			2										1		1															7					5
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	N	 																										1,855					6,907				
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			2					2		4					1					1			2		1			1		6					1
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			1																											1					
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			2					1							1															12					5
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1																	1					1			1		2					1
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			11		1			8		1			2		2			3		8			5		19			27		125					18
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1							1					1													1		7					2
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																														1					
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			3							1					1			3		2			1		1			8		16					2
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive															1								1					7		9					1
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																									1										
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1					2		4					1					3			3		5					4					
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1							1																									
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1					2		3					2					2			1		3			3		2					3
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			8					5		4			1		5			1		3			2		9			6		67					9
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			4					7					1		4			2		2					1			7		28					5
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																				1															
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected															1																				1
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1																																
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			9					3		4			1		4			3		3			1		6			13		78					6
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			13					2		5			3		2			1		1			3		6			11		78					10
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1					1										1					1		1			1							2
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																														5					
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																				1			2							1					2
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																		1										2		5					2
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	N	 																										3,056					10,981				
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			5					1							2			1		1			2					8		36					2
Haiti	Haiti	HTI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			6					5		2					2			1		1								2		19					16
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive															1								1					7		9					1
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			9																																
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			5					1		1															12			4		8					1
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1																				1												1
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																							1												
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			2																									1		5					
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1							1					1													1		7					2
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			5					1							2			1		1			2					8		36					2
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1																																
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																														5					
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																														1					
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			3																				1		6			2		4					4
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																				1			2							1					2
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1																									1		2					1
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1							1																									
Haiti	Haiti	HTI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1																	1					1			1		2					1
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																																			1
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												2		1					
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			2																																3
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																														2					
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																														2					
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																														1					
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																														7					
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			2																																
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												1							
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												1		2					
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			1																																
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																				2															1
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												1		3					
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			3																																
Haiti	Haiti	HTI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												1		3					
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												1,698					1,851				
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			1,072					1,001	2	74	293	1,496	421	659	597	546	586	3,301	649	1,078	1,423	1,195	3,301	923	748	840	1,470		994	1,050	1,204	1,450					129
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female								472	1	24	59	228	395	144	133	108	111	2,761	149	271	367	365	2,761	331	332	367	398		277	388	454	446					88
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												7,173					7,818				
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			1,072					996		20	36	197	626	85	127	83	91	2,924	92	206	288	216	2,924	155	223	257	458	2,785	297	235	410	334	3,036				139
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			1,072					996		45	148	484	120	296	222	230	183	907	369	425	666	618	907	643	563	811	589		695	435	525	452					53
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female								463	1	11	25	148	394	78	108	72	141	2,754	105	157	228	209	2,754	201	196	209	276		160	195	215	234					79
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male											34	95		109	48	37	12		49	93	99	92		53	24	86	67		40	15	16	50					3
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex											28	166	95	31	129	35	18	399	45	15	30	24	399	40	34	75	66	363	76	137	108	95	396				10
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			1,072					1,005	2	58	234	1,141	448	513	553	462	469	3,456	517	901	1,134	930	3,456	653	578	643	1,086		789	893	986	1,062					96
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			1,072					1,005	1	35	111	711	421	289	266	227	259	4,053	278	489	675	742	4,053	494	411	513	739		470	683	737	831					87
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												7,736					8,432				
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			1,072					1,004	1	28	90	391	699	262	204	226	169	3,835	374	548	624	635	3,835	585	583	675	671		612	531	687	662					125
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												7,962					8,677				
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			1,072																																		
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			1,072					1,004	8	86	248	918	377	654	527	554	385	910	642	1,074	1,507	1,059	910	1,094	837	1,269	1,103		1,237	991	1,190	1,174					109
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			1,072																																		
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex																											50				26						
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male								479	2	22	87	467	225	197	201	153	185	1,600	170	365	418	436	1,600	421	303	331	435		332	446	456	506					68
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male								471	1	7	43	335	227	115	104	88	105	1,730	104	218	264	230	1,730	265	181	196	285		202	238	275	235					52
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												5,541					6,039				
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			1,066					991		16	74	405	560	125	128	102	165	3,619	130	296	323	243	3,619	225	250	254	561	3,821	304	340	371	366	4,164				81
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												1,613					1,758				
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			1,072					1,005	4	109	363	1,430	195	646	616	614	685	1,792	677	1,025	1,476	1,112	1,792	1,156	699	724	1,291		981	1,118	1,324	1,429					128
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			1,072					997		60	189	650	63	367	246	223	329	496	275	427	717	625	496	536	382	450	632		423	561	565	529					50
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female											46	66		53	50	15	12		55	73	59	78		45	53	215	15		11	6	14	40					3
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			1,072					1,004	5	65	169	638	693	481	393	407	272	4,533	506	851	1,018	918	4,533	866	809	934	904		854	733	963	882					106
Haiti	Haiti	HTI	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			1,072					1,004	3	53	207	938	695	648	552	515	370	4,539	667	1,038	1,400	1,051	4,539	1,061	914	1,110	1,152		1,139	864	1,035	1,153					132
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			59,602	22,554	23,210	23,696	20,453	68,108	16,705	18,833	13,459	16,561	45,486	14,402	13,789	14,469	13,991	68,472	11,302	12,956	13,056	11,436	74,773	11,393	11,936	12,333	12,179		9,852	9,391	10,787	12,666					9,009
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			59,601	26,470	29,020	29,688	25,804	67,841	20,946	23,241	16,343	20,575	46,722	17,534	17,034	17,358	17,287	72,770	13,898	15,402	15,917	13,937	78,659	13,356	14,493	14,493	14,841		11,816	11,369	13,561	15,078					10,907
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								12		3	3		4	9	2	1					
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			9,075	14,062	15,158	16,970	15,586	11,606	11,782	11,849	8,871	12,333	9,990	9,842	8,434	9,390	10,747	19,645	7,766	8,303	8,859	8,614	20,095	8,035	7,781	7,714	8,941		6,635	5,920	7,593	8,799					6,803
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												12,752					12,413				
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				3,475	3,428	3,496	3,113	10,545	2,307	2,881	1,634	2,407	3,025	2,324	1,727	1,611	1,506	3,553	1,349	1,641	1,844	1,471	1,709	1,387	1,588	1,472	1,374		1,370	1,236	1,458	1,592					881
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				4,154	3,958	4,388	3,716	32,676	2,458	3,087	1,547	2,466	18,451	1,988	1,546	1,545	1,505	6,159	1,196	1,505	1,639	1,332	5,499	1,236	1,525	1,590	1,539		1,432	1,049	1,355	1,650					1,276
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			1,340	5,624	4,708	4,031	5,583	122	6,723	7,475	3,288	4,412		3,552	2,016	2,088	2,229		2,372	2,163	1,914	1,608		1,550	1,249	1,128	1,553		1,414	1,023	1,274	1,118					1,426
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			13,163	7,081	6,836	6,984	6,444	9,119	4,827	5,862	3,945	6,819	7,676	5,141	4,163	3,973	3,846	7,862	3,428	3,929	4,693	4,456	3,286	4,187	3,889	3,546	3,646		3,121	2,850	3,572	3,849					1,564
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												16,763					17,688				
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				7,038	7,564	8,149	6,720	32,792	5,236	6,147	3,860	5,082	21,214	4,470	3,867	3,939	4,082	25,028	3,324	3,914	5,023	3,614	27,372	3,499	3,834	4,006	4,032		3,470	2,933	3,544	4,024					3,067
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				9,914	9,705	10,328	7,705	2,268	4,398	5,204	2,360	4,359	4,493	3,010	2,615	2,709	2,348	7,687	1,999	2,489	2,440	2,040	4,294	1,387	1,699	2,019	2,238		1,632	1,389	2,005	2,147					1,679
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			33,355																																		
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			31,806	4,886	4,614	4,915	4,079	22,812	3,462	4,003	2,293	3,530	5,883	3,358	2,342	2,241	2,108	5,430	1,922	2,325	2,450	2,115	1,317	2,135	2,108	2,095	2,123		1,913	1,712	1,979	2,248					1,198
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												94,766					80,256				
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			59,601	14,887	15,269	16,300	13,958	67,978	11,063	12,626	8,525	10,897	44,543	9,381	9,094	9,466	9,300	55,681	7,619	8,394	8,887	7,880	60,955	7,659	8,319	8,431	8,476		6,885	6,467	7,710	8,845					6,656
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												157,780					165,983				
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			44,443	5,926	6,600	7,181	5,930	24,871	4,533	5,725	2,981	4,826	6,240	4,094	3,208	3,160	3,150	7,442	2,712	3,209	3,384	2,821	3,205	2,443	3,066	2,545	3,156	3,865	2,480	2,220	2,677	2,871	2,269				2,073
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				2,012	1,383	390	329		233	264	134	142		216	170	117	169		109	110	402	142		123	151	159	116		104	64	72	100					84
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				2,765	2,586	2,875	2,383	10,657	1,714	2,170	1,199	1,731	2,575	1,580	1,167	1,079	1,121	2,926	956	1,147	1,247	943	1,219	939	1,080	979	1,074		940	893	1,005	1,109					683
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			59,658																																		
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			31,806	6,443	6,166	6,597	5,476	22,768	4,704	5,624	3,599	5,404	8,070	4,907	3,490	3,154	3,031	10,921	2,845	3,081	3,383	2,918	1,703	2,929	2,732	2,681	2,863		2,479	2,223	2,661	2,738					1,406
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			15,448																																		
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			10,259	3,059	3,373	3,996	3,638	6,075	2,473	2,732	1,548	2,568	5,531	1,773	1,452	1,473	1,797	7,681	1,127	1,417	1,942	1,851	511	1,098	1,171	1,305	2,015	2,343	1,148	823	1,210	1,499	110				1,243
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												11,538					31,678				
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			31,806	7,948	7,802	7,923	6,758	22,791	5,505	6,792	4,075	6,522	19,784	5,496	4,174	3,772	3,636	12,699	3,247	3,712	4,424	3,776	3,081	3,677	3,717	3,441	3,668		3,178	2,859	3,346	3,725					1,604
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												10,985					14,922				
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			31,852	25,736	29,416	29,749	26,639	34,606	21,119	23,427	16,408	21,117	24,101	18,144	16,772	17,493	17,714	37,133	13,808	15,441	16,387	14,718	40,318	13,355	14,480	14,513	14,967		11,956	11,564	13,782	14,891					10,837
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				2,971	3,378	4,336	3,411	5,983	2,167	2,533	1,116	2,314	5,127	1,410	1,119	1,238	1,354	6,082	763	1,038	1,302	1,190	603	619	851	946	1,076		626	655	840	1,199					1,049
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			53,899	6,391	7,764	8,646	7,363	52,749	5,049	6,331	2,956	5,080	4,986	4,242	3,051	2,939	3,065	4,760	2,456	2,985	3,002	2,691	3,074	2,471	3,188	2,790	3,238	3,511	2,644	2,109	2,504	2,989	1,521				2,365
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												62,724					129,450				
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				4	2		26		1		1			3	1	1				14	6	2															
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			31,920																																		
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			4,792	3,213	3,052	3,525	3,508	2,742	2,225	2,379	1,849	3,347	3,131	2,492	1,890	1,847	1,988	3,760	1,414	1,690	2,092	2,325	1,196	1,936	1,515	1,451	1,607		1,236	1,061	1,349	1,541					909
Haiti	Haiti	HTI	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				179	228	107	157		60	76	29	46		69	38	37	45		37	26	160	30		54	58	11	9		21	14	19	70					16
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												566					289				
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			1,352																																		
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				208	182	247	239	1,155	214	238	166	232	414	174	159	174	163	246	148	168	203	170	148	168	144	175	150		132	110	150	164					85
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			510	153	154	179	180	595	169	192	136	215	200	129	118	124	140	235	109	125	166	112	246	120	95	121	97		83	75	93	82					63
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			2,722	521	541	636	573	2,382	451	533	346	562	831	420	391	382	343	603	282	364	448	341	359	326	374	376	417		291	249	343	363					229
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				256	235	371	350	1,156	249	329	250	359	415	297	248	255	232	263	203	248	309	244	194	240	261	234	260		218	165	197	219					142
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			146	45	49	38	35	216	45	46	28	44	67	40	41	29	32	88	26	42	67	34	114	39	32	43	45		30	30	31	22					13
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			1,221	315	283	409	403	1,403	321	336	189	333	463	250	216	212	206	539	181	215	271	225	177	204	220	205	243		203	198	186	195					140
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				32	34	53	39	35	29	46	17	32	73	29	28	28	42	125	18	26	75	24	41	33	15	35	36		26	17	17	28					24
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			366																																		
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			2,804																																		
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			1,650	285	299	431	367	1,400	319	367	226	343	589	297	269	280	259	626	238	257	385	260	484	222	257	218	281	514	219	213	241	248	253				208
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				6	21	7	8		1	5	1	3		8	3	2	2		1	2	51	1		2													
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,375					1,185				
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				12	164	6	9		5	4	2	1		3	3	1	1			2	64	1			1		2		2								1
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												1,313					1,916				
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			2,387	273	306	348	382	1,769	270	328	197	364	744	280	262	274	263	438	217	238	336	283	591	263	282	287	294	766	209	194	271	280	128				220
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												995					1,301				
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			2,726	488	510	659	583	2,371	465	509	332	548	834	363	398	391	350	635	279	307	434	299	432	310	365	340	759		243	215	339	280					219
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			395	138	153	181	127	395	129	133	90	116	126	117	107	105	126	144	108	116	140	112	448	139	126	111	203		94	82	111	120					109
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			2,724	391	399	508	514	2,357	371	510	379	513	835	353	347	367	351	569	282	330	427	293	272	329	324	293	414		270	236	274	272					201
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												960					1,467				
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			260	19	27	39	33	66	31	32	30	50	96	29	39	35	45	145	25	25	100	50	37	64	34	24	47	54	27	24	29	45					19
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			1,221	298	276	399	407	1,416	313	326	247	362	465	238	245	217	245	565	195	225	283	196	227	220	200	222	194		168	167	200	186					138
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			1,221	240	217	358	309	1,409	239	290	178	261	458	196	189	179	193	518	153	170	227	196	319	194	174	201	158		161	154	153	119					93
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				56	56	140	101	67	47	55	31	52	67	37	45	58	26	114	53	40	230	40	214	83	29	48	64		29	46	35	47					24
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			1,448	379	415	432	403	1,314	272	384	254	298	446	268	249	292	254	391	199	277	319	232	484	245	267	232	350		196	176	238	247					192
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			430																																		
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			20	26	15	47	10		5	11	28	16		3	23	29	29		8	1	182	2		43	4	13	33		1	7	4	4					4
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,558					2,232				
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				213	231	313	271	689	235	295	157	248	226	227	194	179	176	312	158	168	239	168	214	150	196	177	185		173	152	173	171					124
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												486					507				
Haiti	Haiti	HTI	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				203	139	233	205	692	177	190	138	208	222	154	117	151	138	268	126	148	159	101	164	100	120	119	145		138	129	124	153					83
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				1	2	3					1	1		3	1		3		2	4	1	2			5	1	6		4	1							3
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex																					1				2												
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				6	11	8	9	340	6	6	5	8	478	4	6	2	3	79	4	5	12	2	76	7	3	4	5		5	1	3	5					5
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								1	1												
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				56	89	96	61	140	44	50	51	75	356	60	48	73	51	55	51	59	67	42	76	55	54	59	121		45	52	65	70					57
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				294	364	390	327	690	225	282	267	293	1,003	247	277	312	251	961	182	204	260	210	1,035	188	218	242	256		158	152	234	206					174
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				185	239	315	234	687	153	210	157	221	856	203	207	221	207	726	149	182	201	147	973	187	158	182	204		141	113	195	185					146
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female				4	1							1					1										2										
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												1,550					1,500				
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												356					867				
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				62	67	100	69	340	58	76	58	60	632	50	70	73	67	327	57	58	63	61	478	87	76	65	88		56	50	73	61					65
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				253	337	397	290	691	207	245	206	287	721	194	256	271	261	788	162	203	205	183	825	187	194	219	250		140	135	179	164					171
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												1,680					2,274				
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				186	239	247	219	334	147	181	169	166	545	114	153	188	151	280	105	156	186	121	286	124	139	125	253		103	105	132	157					113
Haiti	Haiti	HTI	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				1				529		1						2	1		1																		
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			8,524	6,142	6,827	7,755	7,161	7,821	4,971	4,913	4,726	5,809	7,466	4,240	4,492	5,531	5,523	7,461	3,899	4,386	4,901	4,369	8,230	4,337	4,226	4,600	4,674		3,361	3,290	4,819	5,024					3,694
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			38,918	10,312	12,063	13,334	10,912	34,986	8,280	9,725	8,441	9,630	35,151	6,968	9,595	10,363	9,118	35,150	6,672	8,113	8,890	6,819	39,315	6,511	7,676	8,234	7,226		5,332	6,203	8,553	7,900					5,919
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			38,890	5,764	5,955	6,666	5,324	34,855	4,252	4,890	4,235	4,789	35,122	3,624	4,746	5,425	4,771	27,366	3,558	4,158	4,647	3,819	30,752	3,757	4,224	4,527	4,032		2,899	3,258	4,713	4,682					3,429
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			38,904	9,183	9,810	10,609	8,533	34,984	6,777	7,852	6,989	7,783	35,136	5,746	7,823	8,691	7,392	33,668	5,465	6,819	7,395	5,796	37,648	5,631	6,410	6,944	5,955		4,428	5,092	6,930	6,922					4,841
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex				133	306	203	310		207	183	224	146		139	140	172	171		130	139	197	160		170	210	129	253		166	97	128	146					96
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			29,837	13	9	6	3	27,081	8	10	7	5		10	11	17	16		14	8	7	14		12	12	10	5		15	4	7	25					11
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				73	95	148	47		89	74	55	51		65	94	46	79		46	51	91	79		86	93	126	72		62	31	43	60					38
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				1,662	1,996	2,115	1,681	17,678	1,339	1,633	1,304	1,502	17,192	1,149	1,486	1,641	1,581	12,069	1,254	1,451	1,600	1,289	13,428	1,352	1,504	1,606	1,426		1,028	1,046	1,554	1,647					1,290
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			19,179	9,987	12,526	13,138	11,318	17,457	8,122	9,399	8,631	9,889	17,272	7,161	9,162	10,287	9,065	17,269	6,570	8,027	8,875	7,133	19,253	6,484	7,719	8,308	7,537		5,649	6,359	8,577	7,897					5,793
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				278	247	253	189	17,577	138	187	113	202	16,974	141	168	217	171	2,059	152	145	159	97	2,253	130	171	191	181		86	125	161	227					201
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				4	3		26		1		1			3	1	1				14	6	2		12		3	3		1	9	1	1					
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												76,962					82,045				
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												46,430					37,774				
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												27,484					61,388				
Haiti	Haiti	HTI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			38,875																																		
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			166	61	80	92	51	150	47	49	52	74	349	59	46	64	60	55	52	57	67	51	76	59	75	56	149		44	52	65	66					59
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			777																																		
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female				1	1							1			1		1										2		2								
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				65	80	90	67	344	63	72	55	57	624	49	66	66	60	328	59	62	68	60	478	86	82	62	87		51	52	70	61					66
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			780	187	237	270	219	687	159	199	137	200	854	202	192	209	198	729	151	185	211	143	973	189	181	183	251		133	114	194	188					144
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				4	10	12	6	343	6	6	4	8	470	4	6	3	3	79	4	5	9	3	76	7	3	5	2		6	1	3	5					5
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex				1	2	3				1	1	1		3	1		2		2	1	1	2		1	3	1	4		3	1	2						3
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			380	172	223	214	217	363	148	169	165	162	542	112	145	193	151	282	104	159	187	124	286	128	174	125	280		92	110	134	165					114
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			777	286	360	339	302	706	242	264	250	266	1,007	242	254	293	236	966	188	211	261	211	1,035	188	259	245	281		151	154	220	205					175
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			587	1				541								3	1		2					1	1				2								
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												1,549					1,514				
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			781	238	320	344	282	692	213	240	202	271	727	191	245	267	248	793	161	200	212	177	826	190	233	215	276		137	142	180	161					153
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												1,698					2,307				
Haiti	Haiti	HTI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												364					889				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			45					68				20	68		7		32	68		318		117	68		16		51	487		178		51	487				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			578		25		3	868		59		37	869		158		209	869		1,375		831	869		577		543			1,198		1,784					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			362		32		8	544		8		9	545		44		55	545		1,145		632	545		572		379			628		1,402					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			577																																		
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												10,343					10,343				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			4,394		1,098		1,502	6,592		616		2,563	6,593		2,077		2,562	6,593		2,284		3,108	6,593		2,224		2,503			1,947		3,863					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												15,930					15,930				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												1,815					1,815				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			9,265		1,965		2,732	13,900		1,115		5,303	13,900		4,689		5,492	13,900		4,314		6,349	13,900		4,355		3,776			2,696		4,455					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			578		13		1	868		34		32	869		79		133	869		889		623	869		413		448			1,208		1,771					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female															19		8			5							1										
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					6		1	434		5		7	434		34		67	434		203		319	434		176		178			560		1,214					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					3		3	434		2		1	434		13		21	434		102		169	434		86		109			280		870					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			4,394		1,593		2,218	6,592		945		4,294	6,593		3,451		4,740	6,593		3,524		5,131	6,593		3,431		3,372			2,841		4,925					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			4,392																																		
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												18,408					18,408				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			1,089		165		316	1,637		201		1,161	1,638		989		956	1,638		1,072		1,373	1,638		858		1,252	2,156		754		2,265	2,156				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			75		1			113		4		1	114		11		20	114		75		206	114		116		102	294		459		1,820	294				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												4,034					4,034				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			1,199		40		1	1,799		52		34	1,799		138		143	1,799		1,605		845	1,799		741		537			1,143		1,853					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			578		8		2	868		19		2	869		24		71	869		313		349	869		210		278			810		1,595					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			4,396		2,060		3,138	6,594		1,120		5,299	6,595		4,311		5,604	6,595		4,311		6,090	6,595		4,255		3,824			3,105		5,166					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male										2		647			2,262		59										1					1					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			3,978		334		1,289	5,969		476		2,795	5,970		2,161		2,024	5,970		2,017		3,229	5,970		2,173		2,071			1,611		2,097					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					330		426	3,298		219		1,183	3,298		892		825	3,298		748		1,144	3,298		813		1,101			549		1,389					
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												4,731					4,731				
Haiti	Haiti	HTI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					652		783	3,298		365		1,854	3,298		1,629		1,798	3,298		1,401		2,064	3,298		1,499		1,837			1,327		2,768					
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			229	215	262	402	479	336	409	303	388		314	303	511	652					97
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												1,716					686				
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																									1	14	1		5	2							
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			45	95	48	46	187	70	45	87	90		94	92	91	173					96
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			6	18	13	13	217	22	21	24	25	77	24	25	22	54	26				31
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			118	68	103	145	248	140	140	140	161		103	107	114	182					45
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			31	54	29	18	194	27	33	36	47		40	45	57	86					52
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			144	287	126	198	329	188	206	195	227		195	210	253	430					83
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			129	250	122	165	403	199	225	211	239		204	215	267	425					114
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			112	226	109	151	400	191	148	207	236		217	200	242	350					120
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			53	72	86	97	164	113	74	80	75		59	91	139	196					36
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			79	87	128	167	229	166	157	107	156		145	125	193	287					47
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												1,019					407				
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																									3	2			2								
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												510					201				
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			262	264	290	440	471	373	482	420	538		360	366	565	768					132
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			76	74	49	72	237	66	66	63	57		57	57	68	114					29
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			143	149	207	271	324	250	215	189	226		155	187	291	402					50
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												901					359				
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			83	157	86	90	257	127	121	126	122		140	149	166	297					122
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			26	36	46	35	171	26	34	36	50		45	44	69	110					33
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			25	30	29	31	220	22	32	31	36	95	28	39	59	100	33				30
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												1,274					508				
Haiti	Haiti	HTI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												467					184				
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					1		4	80		20		66	135	114	164	201	232	450																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female							6	442		58		260	673	363	473	627	794	1,260																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					2		11	428		50		248	849	337	494	640	792	1,504																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							3	80		12		26	154	43	67	77	108	479																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								78				17	115	22	45	44	66	432																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male							29	340		93		603	992	758	1,161	1,623	2,048	1,622																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male							13	540		58		364	1,257	483	724	1,022	1,246	2,101																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female														2	2	4	2																				
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male							3	72		10		31	136	52	62	91	135	456																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female							3	268		35		159	376	222	292	384	504	830																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male												1		2	2	2	1																				
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								93		8		29	142	90	105	121	150	471																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female							2	93		10		59	154	95	132	174	233	489																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male							9	87		40		263	214	353	540	739	823	547																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female							11	334		84		383	865	509	708	962	1,238	1,472																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female							8	483		75		303	931	424	597	786	988	1,334																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							2	84		18		141	189	225	305	393	479	525																			
Haiti	Haiti	HTI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male							7	278		27		118	631	188	252	331	414	1,035																			
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female							2	71		10		41	83	36	41	49	62	288	30	64	73	85	361	74	39	73	84		101	79	231	144					115
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																			1			3		2	4				9	7	5						
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								71		4		22	71	25	21	20	28	275	16	34	21	26	243	32	19	35	34		53	35	105	119					68
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			19				3	57		5		24	79	21	21	33	32	285	19	31	34	28	238	53	25	26	51	188	39	53	147	89	238				42
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			117				6	338		48		180	335	118	133	179	179	562	76	199	207	276	776	249	165	233	294		297	240	368	362					199
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												2,032					2,540				
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												2,551					3,189				
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			90				25	454		62		492	537	201	374	509	307	743	233	384	561	788	1,568	1,097	594	503	679		800	748	931	804					229
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			41																																		
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			71				3	203		19		105	173	79	81	110	101	389	57	120	122	139	558	128	76	98	149		170	120	319	239					169
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												1,017					1,274				
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			48																																		
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			22				2	63		12		107	127	78	96	94	109	324	54	85	124	172	515	166	113	116	128		148	152	222	168					93
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			20					59				14	58	10	14	6	16	265	4	19	26	19	184	25	16	24	25	155	29	21	90	53	197				61
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			113		2		14	338		25		189	511	96	150	166	150	550	125	155	206	354	752	385	267	301	401		421	270	489	368					115
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			143				13	670		31		303	595	142	226	316	230	699	162	274	398	524	1,109	603	402	431	600		631	430	658	614					187
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							2	64		6		19	90	16	28	18	21	293	16	29	33	23	225	29	33	29	73		83	33	98	87					28
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			88				11	373		64		286	485	176	221	269	254	702	136	251	326	395	1,063	449	235	235	312		382	383	625	441					206
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					1		3	64		11		58	71	29	47	51	35	272	34	58	100	84	325	92	68	67	107		166	69	203	158					56
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			74				6	222		14		86	409	45	69	88	75	579	73	106	128	175	465	183	116	152	206		271	148	296	245					81
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																2			2					4		18	1		4	1	4						
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												1,797					2,247				
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												3,436					4,296				
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			131				8	450		61		213	479	144	201	232	199	589	105	234	291	363	931	361	196	257	321		377	278	502	483					242
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												928					1,165				
Haiti	Haiti	HTI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			23				10	69		26		222	141	88	197	209	137	331	108	177	274	440	775	452	174	174	229		309	262	372	381					121
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				48	103	71	72	160	49	26	14	32	291	26	38	21	7	143				77	161				66					161					145
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				33	109	65	69	89	35	49	8	30	196	24	26	29	24	60				129	86				66					144					42
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												39					54				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				5	18	6	8	89	13	1	1	2	193	6	6	4	2	33				14	60				16					17					10
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											16					16					30
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												21					22				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				11	17	14	17	7	4	6	1	3	113	2	4	9	3	5				26	14				11					28					16
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											20					31					33
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				23	33	19	15	160	23	15	6	10	347	21	13	8	15	109				80	152				64					129					201
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				1		3	3	3	2	2				1	2							3					6					5					6
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male				4	8				4																							6					
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				46	104	64	68	160	50	46	21	24	282	15	33	26	22	199				151	150				101					236					222
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				7	15	6	17	7	1	3	3	6	115	4	7	7	2	8				36	13				22					21					27
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												217					284				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											64					75					156
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											79					67					57
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				22	52	43	37	89	20	18	13	9	199	10	10	12	15	43				45	76				30					55					36
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			696																																		
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											11					45					13
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				50	79	73	71	89	48	51	16	22	217	32	19	23	27	90				141	41					73					61				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											29					52					66
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				54	113	76	93	89	57	60	38	26	189	18	35	25	30	78				154	94				85					195					85
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				25	61	53	50	160	31	25	15	20	321	20	14	10	8	138				83	152				94					195					183
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			93																																		
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				41	103	62	96	89	53	55	15	31	228	26	30	23	26	91				137	120				102					257					107
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											19					75					14
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			1,184																																		
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				9	16	31	13	7	4	10	4	3	120	5	3	8	2	15				23	13				19	15				19	7				27
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				7	15	13	9	160	11	6		2	268	3	8	9	6	48				26	117				22					38					29
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				40	86	67	83	160	44	52	17	21	266	17	26	24	22	170				130	152				107					188					203
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												282					307				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												543					523				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												96					115				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											15					62					42
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				24	61	65	73	89	44	32	16	22	209	18	20	20	27	77				102	82				100					211					127
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				24	43	27	32	160	21	13	5	10	266	13	12	11	8	81				66	120				47					63					100
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				29	62	46	43	160	31	32	3	14	295	23	26	11	16	114				119	85					146					85				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				18	43	38	37	89	30	17	6	16	206	13	15	5	17	82				118	89				64					118					61
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												133					138				
Haiti	Haiti	HTI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female				2	7				5													1										7					
Haiti	Haiti	HTI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			7,387		2,344		1,766	16,756		2,396		2,914	17,401		3,539		2,318	8,623		2,527		2,193	11,130		2,142		2,240	8,548		1,989		2,223	197				1,176
Haiti	Haiti	HTI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			12,670		3,548		2,792	29,031		3,611		4,305	30,184		5,739		4,226	12,864		4,186		3,611	20,613		3,519		3,855	12,564		3,439		3,254	930				2,100
Haiti	Haiti	HTI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male										11		6					1			2					12		3			11		14					4
Haiti	Haiti	HTI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			1,049		203		85	1,645		122		184	1,937		200		220	1,110		262		164	2,337		320		186	607		153		164	78				268
Haiti	Haiti	HTI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female							6			17		7					1			3					12		1			23		11					9
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			4,092																																		
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				13	24	22	25	123	21	14	8	8		9	8	13	19		12	15	11	11		7	12	10	11		11	4	11	17					14
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				249	217	231	258	586	145	220	108	219	595	166	206	198	165	592	142	187	184	146	442	148	198	216	264		195	216	222	223					98
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				35	63	57	55	119	43	50	21	35	175	32	33	35	39	172	16	28	26	27	108	19	24	34	40		28	36	35	54					34
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				87	107	109	79	997	59	86	39	61	944	59	66	49	41	945	50	66	59	51	704	50	67	82	81		67	65	73	66					45
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				188	197	231	214	894	130	114	75	115	808	107	126	135	127	808	89	131	131	111	599	86	113	129	124		102	100	123	133					86
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												1,121					1,119				
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												874					875				
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				100	113	126	109	586	84	94	77	97	563	87	83	80	89	562	64	107	92	58	412	71	133	123	150		96	120	104	120					77
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				70	76	67	76	1,003	52	65	36	53	897	37	52	37	60	899	32	47	55	38	650	35	45	54	50		60	55	49	62					29
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			577																																		
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				136	209	142	189	1,003	120	153	76	117	922	97	117	123	132	920	102	144	140	106	706	109	176	180	170	706	126	133	145	147	707				105
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												1,398					1,395				
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				102	97	105	111	583	71	66	47	70	539	49	83	75	75	540	59	65	70	45	398	48	69	72	92		73	58	74	72					47
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female				2	5	8	2		9	1									1	1	1	1			1		1					1					
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				160	159	158	143	586	111	176	94	147	600	128	143	124	121	597	91	131	148	118	448	107	161	163	182		151	135	143	150					85
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				2	1	11	9		9	1				1	2	1	3				1					1						1					
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				130	120	141	103	878	100	72	45	61	714	54	71	75	63	715	49	70	70	52	524	52	74	71	85		86	59	79	84					47
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												1,275					1,278				
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				49	73	90	60	119	54	55	18	48	170	51	39	54	56	170	45	55	47	32	107	26	33	45	53		57	46	48	52					35
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												215					213				
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				191	182	173	161	956	112	143	75	96	979	86	89	98	104	978	92	104	109	74	723	82	95	110	143		93	98	112	118					67
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				166	244	226	203	586	193	196	134	186	570	139	162	186	178	571	143	182	186	137	432	147	189	152	236	432	180	202	212	213	433				181
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				243	224	211	167	901	152	144	67	118	889	109	138	85	120	888	91	112	162	103	676	94	128	129	137		110	106	120	146					75
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				225	181	196	140	586	160	164	106	153	545	135	152	143	156	543	112	156	150	130	394	124	189	179	158		174	183	186	173					78
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												793					788				
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			7,007																																		
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				86	102	112	88	586	59	67	44	74	566	58	73	61	65	564	54	58	76	49	418	58	83	86	86		75	76	89	84					48
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				64	60	75	50	123	44	46	43	49	179	39	35	39	46	178	33	41	56	33	119	35	38	52	41	119	50	46	48	44	116				29
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				153	136	128	135	1,003	84	120	67	86	988	76	113	75	95	988	75	91	106	72	736	75	86	99	104		93	84	95	84					64
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				234	194	209	177	582	141	202	107	182	582	159	165	149	160	582	149	176	168	116	432	155	208	176	211		190	157	192	189					120
Haiti	Haiti	HTI	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												2,091					2,094				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			2,149	1,241	1,382	1,496	1,477	2,209	1,490	1,365	1,361	1,489	2,209	1,446	1,443	1,469	1,518	2,315	1,470	1,500	1,569	1,494	2,597	1,524	1,528	1,569	1,599		1,506	1,489	1,506	1,590					1,486
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												8,200					9,755				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			2,583	1,299	1,411	1,482	1,535	1,852	1,468	1,427	1,427	1,487	1,855	1,520	1,590	1,612	1,625	1,982	1,627	1,636	1,650	1,647	1,959	1,693	1,664	1,644	1,678	1,600	1,577	1,589	1,591	1,606	1,325				1,450
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												2,192					2,881				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			7,000	7,134	7,351	7,443	5,220	7,631	7,726	7,957	8,242		8,048	8,177	8,461	8,796					8,321
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			2,853	2,967	3,133	3,183	1,122	3,243	3,298	3,421	3,524		3,600	3,656	3,844	3,997					4,136
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			3,202	3,311	3,468	3,517	1,321	3,418	3,549	3,661	3,731		3,783	3,909	4,115	4,266					4,457
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			4,332	4,470	4,503	4,539	3,608	4,460	4,578	4,620	4,676		4,666	4,657	4,676	4,807					4,788
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			14,415	8,796	9,220	10,199	10,830	14,331	10,981	11,246	11,266	11,830	14,331	12,150	12,449	12,739	12,923	14,429	13,041	13,488	13,726	13,446	14,275	13,389	13,470	13,612	13,919		13,151	13,277	13,629	13,716					12,141
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			5,105	5,256	5,353	5,422	4,325	5,389	5,573	5,707	5,803		5,684	5,725	5,826	5,917					5,898
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			340	86	86	112	114	388	104	92	104	93	393	84	71	70	52	142	52	55	61	59	130	44	38	41	40	122	28	31	42	38	105				47
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			5,438	5,600	5,658	5,727	4,352	5,883	5,866	5,928	6,063		6,031	5,926	5,936	6,137					5,815
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			14,415	6,131	6,210	6,753	7,345	14,341	7,277	7,426	7,309	7,869	14,343	7,750	7,766	7,881	7,861	14,534	7,765	7,892	8,040	7,744	14,462	7,752	7,589	7,679	7,730		7,182	6,936	7,099	7,104					5,831
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			3,517	1,467	1,553	1,640	1,752	3,483	1,703	1,578	1,640	1,707	3,486	1,705	1,667	1,705	1,747	3,659	1,710	1,763	1,807	1,878	3,770	1,795	1,823	1,831	1,807		1,766	1,660	1,660	1,652					1,325
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				1,269	1,268	1,361	1,394	1,369	1,380	1,320	1,331	1,351	1,371	1,322	1,276	1,251	1,237	1,491	1,185	1,192	1,205	1,179	1,484	1,154	1,150	1,179	1,212		1,175	1,149	1,149	1,178					1,015
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			7,752	2,593	2,526	2,840	3,071	7,871	2,952	2,912	2,978	3,076	7,873	3,060	3,071	3,070	3,116	8,227	2,999	3,038	3,106	3,364	7,928	3,156	3,204	3,209	3,283		3,340	3,194	3,157	3,123					2,597
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			10,143	10,041	10,491	11,088	11,849	10,094	12,292	12,784	13,022	13,384	10,097	14,122	14,561	14,944	15,374	10,488										15,325					15,762				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			7,811	3,169	3,330	3,768	3,970	7,719	3,865	3,783	3,800	4,026	7,721	3,867	3,863	3,918	3,879	7,906	3,702	3,798	3,921	3,753	8,009	3,868	3,799	3,815	3,893		3,656	3,528	3,696	3,793					3,163
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			7,752	4,573	4,821	5,290	5,672	7,872	5,681	5,793	5,869	6,030	7,868	6,143	6,212	6,382	6,505	8,250	6,444	6,591	6,715	6,880	8,102	6,698	6,879	6,859	6,957		7,191	6,813	6,761	6,851					5,941
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												18,092					19,833				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			7,752	3,714	3,817	4,184	4,592	7,864	4,555	4,590	4,756	4,966	7,862	4,996	5,044	5,100	5,133	8,278	4,966	5,044	5,129	5,232	8,169	4,997	5,024	5,028	5,047		5,202	4,777	4,831	4,778					4,035
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				6,711	6,942	7,748	7,832	7,113	7,941	8,094	8,005	8,431	7,113	8,650	8,837	8,980	9,166	7,120	9,323	9,616	9,858	9,861	7,027	10,056	10,153	10,325	10,575		10,248	10,373	10,648	10,916					10,821
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			14,365																																		
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				7,581	7,905	8,593	9,117	7,113	9,395	9,774	9,970	10,564	7,113	11,057	11,283	11,508	11,618	7,149	11,656	11,986	12,273	12,136	7,097	12,458	12,571	12,853	13,169		12,737	12,948	13,526	13,774					12,713
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			12,647	11,901	12,501	13,047	13,877	12,483	14,334	14,793	15,226	15,877	12,483	16,659	17,066	17,619	18,037	12,488										18,482					16,460				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			14,415	8,332	8,522	9,454	10,132	14,331	10,018	10,237	10,174	10,813	14,332	10,997	11,215	11,266	11,150	14,480	10,772	11,041	11,267	11,109	14,409	11,151	11,125	11,317	11,535		10,789	10,847	11,029	11,196					9,408
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				4,806	4,692	5,319	5,517	3,906	5,493	5,631	5,722	5,960	3,909	5,937	5,990	6,104	6,143	4,099	6,120	6,296	6,395	6,540	4,117	6,395	6,465	6,570	6,700		6,788	6,625	6,803	6,991					6,473
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			7,702																																		
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				4,747	4,921	5,392	5,703	3,894	5,840	5,960	6,065	6,270	3,897	6,336	6,509	6,647	6,806	4,161	6,763	6,941	7,083	7,102	4,227	7,046	7,190	7,249	7,293		7,536	7,198	7,267	7,250					6,650
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			2,832	2,969	3,020	2,993	1,502	3,001	3,062	3,180	3,303		3,364	3,429	3,559	3,645					3,678
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female				90	39	47	27		17	19	11	15		4	11	4	5		5	5	4	2		2	2	3	3		4	4	3	4					2
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												30,995					31,544				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			1,217	726	740	853	800	1,236	788	791	794	821	1,238	818	822	810	825	1,310	803	804	828	867	1,373	816	853	856	897		894	904	896	905					836
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												2,724					3,071				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			3,207	3,324	3,415	3,415	1,794	3,470	3,521	3,661	3,797		3,881	3,895	4,054	4,203					4,241
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				645	628	702	743	1,368	726	725	712	752	1,369	714	708	726	718	1,472	689	703	725	690	1,640	694	687	644	628		576	579	554	537					387
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				36	15	47	19		8	9	6	18		2	1				6	4	6	4		2	2	2	2		1	1							
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			3,913																																		
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												5,520					7,137				
Haiti	Haiti	HTI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												19,750					22,591				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			2,343	261	308	380	354	1,411	299	361	207	354	564	297	280	292	264	595	248	256	262	241	482					489					233				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												914					1,195				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			678	138	125	148	155	560	153	167	134	171	190	131	108	109	112	226	88	127	143	110	246	99	88	113	93		78	83	88	80					61
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												1,481					2,068				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				187	193	235	239	1,088	207	225	161	242	401	202	161	193	174	237	156	159	160	162	148	164	151	169	163		140	106	138	158					88
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								74	77	94	68		52	57	69	66					59
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			1,508																																		
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				48	23	53	37	100	31	41	14	35	71	27	27	26	45	123	16	28	29	17	41	22	17	33	40		24	21	16	33					22
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				249	243	321	364	1,088	256	316	245	352	402	280	261	266	246	253	225	242	271	222	194	219	269	253	230		223	187	214	231					132
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			2,666	416	462	549	534	2,256	402	459	331	503	797	336	374	373	320	607	284	318	402	276	426	245	323	332	302		231	218	307	274					205
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male				8		1	2		3	4	1			1		1	1														1	4					
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			212	38	46	40	31	204	33	42	33	44	66	39	37	27	28	87	27	31	33	34	114	34	34	41	42		30	21	31	23					13
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,246					1,404				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			1,512	203	215	317	284	1,324	228	274	189	236	438	185	196	163	178	496	144	161	191	169	314	163	166	183	154		152	143	146	119					84
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								48	60	57	60		52	50	59	68					60
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			60	35	36	49	23	122	36	33	30	37	181	37	22	32	17	142	20	22	27	21	132	16	18	12	13	122	12	16	14	14	105				15
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								25	36	31	47		38	33	48	41					26
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			2,664	446	465	585	559	2,255	400	461	361	548	792	431	402	364	351	578	279	344	416	319	357	275	337	361	335		295	257	325	342					219
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								47	43	49	53		41	50	53	60					38
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			779																																		
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,305					1,102				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												948					731				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				210	235	274	249	631	222	281	144	274	218	239	189	181	178	301	157	179	215	164	214	142	193	168	172		156	154	162	162					114
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												464					485				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								116	136	119	136		102	73	124	138					94
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			2,663	316	378	477	497	2,252	353	495	364	519	799	350	332	388	339	546	291	356	398	290	270	287	294	269	335		277	226	273	264					198
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			437	112	153	161	118	341	106	123	92	114	125	107	89	108	116	139	91	122	108	101	448	89	109	108	95		100	86	103	116					111
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female				2	1				3	1		1		2		1	2		1						2		1			1							2
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			1,508	283	270	351	358	1,351	286	328	243	343	448	243	233	209	234	540	184	221	250	189	225	200	188	220	184		154	168	184	170					133
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												537					268				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				173	148	205	210	633	169	199	145	212	221	155	127	143	131	258	117	148	143	112	164	103	99	109	132		136	113	121	146					82
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			1,417	319	360	369	352	1,192	233	360	238	286	428	253	240	271	248	374	216	251	272	195	479	197	236	224	219		196	163	231	231					181
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								34	44	33	44		40	34	45	35					42
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			2,250	291	300	352	381	1,741	269	341	214	352	709	302	263	284	280	419	221	259	326	268	590					731					119				
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			497	23	31	40	38	146	28	37	29	45	93	27	44	30	47	143	28	25	36	45	37	32	27	18	42	53	38	30	27	44					26
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								36	42	34	44		42	49	52	53					39
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								106	108	106	126		90	77	83	91					69
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			1,508	283	300	387	407	1,325	292	306	191	322	446	270	206	239	221	516	192	207	261	241	177	182	206	199	221		207	187	184	196					137
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				36	47	70	58	100	46	63	36	61	67	50	44	67	36	112	49	51	42	41	214	40	25	38	22		28	41	36	35					23
Haiti	Haiti	HTI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			2,662																																		
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								2,135	2,039	2,049	2,378		2,196	2,330	2,420	2,546					2,428
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				2,945	2,982	3,316	3,370		3,422	3,704	3,915	4,715	13,473	4,696	4,688	4,747	4,731	13,331	4,387	4,279	4,466	4,364	11,949	4,329	4,198	3,718	4,345		4,006	3,802	3,784	3,866					3,201
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												2,364					2,701				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												1,893					2,449				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								2,379	2,373	2,340	2,721		2,529	2,696	2,835	3,006					2,968
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								3,135	3,005	2,910	3,253		2,942	3,056	3,088	3,196					3,104
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								3,894	3,756	3,659	4,184		3,813	3,862	4,024	4,115					3,960
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				4,593	4,709	5,476	5,125		5,144	5,464	5,593	6,428	6,690	6,623	6,674	6,819	6,903	6,570	6,546	6,827	7,048	7,059	5,992	7,047	6,914	6,493	7,494		6,893	6,852	7,049	7,395					6,930
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				4,392	4,713	5,041	5,461		5,388	5,871	6,255	7,249	13,466	7,426	7,499	7,526	7,386	13,304	6,860	6,818	7,122	6,927	12,589	6,764	6,618	6,039	7,171		6,442	6,456	6,336	6,525					5,401
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												4,838					6,076				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				8,218	8,354	7,695	9,915		9,731	10,440	11,034	12,466	11,744	13,059	13,267	13,587	13,675	11,531	13,371	13,717	14,202	14,374	10,928					16,824					14,872				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								2,513	2,401	2,403	2,708		2,585	2,664	2,797	3,066					2,911
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												17,790					19,870				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				1,357	1,353	1,611	1,574		1,551	1,666	1,794	2,212	7,256	2,116	2,111	2,148	2,154	7,201	1,927	1,993	2,005	1,960	6,819	2,050	1,850	1,647	2,033		1,845	1,807	1,869	1,943					1,571
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				4,845	5,091	5,352	5,796		5,801	6,263	6,786	7,768	6,694	8,153	8,270	8,315	8,269	6,581	7,872	8,040	8,364	8,399	5,848	8,407	8,344	7,713	9,176		8,397	8,423	8,753	9,123					7,892
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				2,373	2,603	2,911	3,084		3,035	3,210	3,468	3,960	7,403	4,147	4,150	4,109	4,123	7,427	3,901	4,248	4,203	4,335	6,890	4,245	3,947	3,922	4,238		4,111	3,853	3,843	4,038					3,362
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				13	170	5	9		5	9	12	10				30	2		4	3	3	2					1		1		1	1					
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				453	504	618	547		576	689	717	879	2,077	833	800	771	814	2,081	749	773	832	794	2,228	796	785	709	856		801	802	809	858					777
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				501	562	575	656		663	694	747	871	1,302	873	846	859	834	1,316	782	851	870	855	1,282	795	778	723	839		798	823	850	866					690
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								5,714	5,571	5,207	6,119		5,476	5,571	5,740	6,025					5,493
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				203	218	285	225		239	253	260	310	1,302	303	341	387	409	1,307	363	417	408	394	1,436	371	342	324	368		333	306	322	309					210
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												7,203					8,502				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												28,286					28,718				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				1,846	1,956	2,234	2,323		2,278	2,481	2,705	3,001	7,403	3,173	3,229	3,189	3,097	7,435	2,862	3,077	2,870	3,082	6,964	2,995	2,700	2,716	2,930		2,847	2,535	2,639	2,720					2,185
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								4,180	4,048	3,777	4,258		3,871	3,705	3,779	3,970					3,628
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				2,951	3,258	4,034	3,420		3,406	3,499	3,737	4,295	3,666	4,236	4,255	4,397	4,219	3,689	4,098	4,288	4,307	4,462	3,520	4,324	4,133	4,010	4,494		4,107	4,049	4,119	4,366					3,954
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				5,130	5,485	5,724	6,379		6,348	6,952	7,250	8,216	13,470	8,433	8,828	8,921	9,003	13,284	8,702	8,695	8,963	9,008	12,198	8,756	8,610	7,885	9,183		8,295	8,154	8,316	8,503					7,334
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								2,161	2,195	2,137	2,513		2,350	2,388	2,527	2,680					2,809
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				8	84	6	3		3	1	2	3		2		13	3		4	6	2	3					1		1								
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				530	641	649	711		762	819	906	1,020	1,743	1,051	1,102	1,096	1,154	1,766	1,132	1,160	1,206	1,208	1,715	1,166	1,141	1,080	1,182	1,465	1,040	1,105	1,140	1,187	1,194				969
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				6,499	6,718	6,048	8,019		8,028	8,522	8,947	9,948	9,495	10,621	10,769	10,939	11,175	9,493	10,935	11,369	11,499	11,670	9,102					13,978					14,211				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				1,083	1,208	1,373	1,368		1,339	1,467	1,652	1,771	7,404	1,903	1,853	1,890	1,855	7,416	1,638	1,800	1,721	1,863	6,752	1,844	1,658	1,645	1,824		1,821	1,682	1,754	1,773					1,385
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				2,867	3,035	3,164	3,427		3,299	3,608	3,816	4,243	3,661	4,394	4,423	4,520	4,524	3,707	4,241	4,573	4,420	4,666	3,631	4,614	4,375	4,217	4,649		4,470	4,275	4,349	4,450					3,909
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												16,325					17,579				
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				306	334	376	382		394	382	445	481	1,165	511	483	494	514	1,174	471	512	508	514	1,169	501	509	519	549		527	522	551	548					518
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				534	573	617	626		626	686	865	929	3,284	1,193	999	1,019	1,002	3,293	908	961	977	995	3,235	1,021	986	929	1,051		927	878	884	903					682
Haiti	Haiti	HTI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				22	23	56	15		26	16	27	26	491	5	10	25	9	104	13	12	7	9	100	7	5	9	4	86	6	1	5	15	82				8
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														37		49					83
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														12		27					50
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														6		1					5
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					54		44			24		24			25		33			13		23			29		38										
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														6		8					26
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					402		340			377		262			292		220			170		236			344		395										
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														9		10					9
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														4		8					8
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														36		49					105
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														29		47					74
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														14		23					48
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														36		47					88
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														36		34					54
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														8		8					21
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					399		331			364		227			299		278			199		242			235		331										
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														4		7					9
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														21		30					40
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														2		3					1
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														8		4					4
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male					5					1							2																				3
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														35		40					68
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														26		22					61
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														6		14					15
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														6		10					16
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														11		19					69
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														9		6					25
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														36		38					101
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														30		31					28
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														2		4					8
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female					6					2					1							2															3
Haiti	Haiti	HTI	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														8		16					15
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																														8					4
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	N	 																										2,631					3,078				
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												106		194					66
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												4		2					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																														1					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												603		959					197
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																														1					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												802		1,383					309
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												7		3					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																														2					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																														6					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																														2					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																														3					11
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																												1		2					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																												4		190					525
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																														2					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																														3					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																												1							
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																												7		166					452
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																														9					2
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												670		1,146					255
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																												1		1					1
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																																			1
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																														14					3
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																												2		1					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												9		3					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	N	 																										7,253					8,264				
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																												1		24					56
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																												2		83					168
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												28		56					21
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												4		2					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												10		4					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																												2		92					292
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																														8					2
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												424		1,083					242
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																												260		435					108
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative																												7		157					350
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												12		6					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																														1					
India	India	IND	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																														3					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												10		4					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												9		3					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																														1					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												12		6					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																												1		2					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												4		2					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																												2		1					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												7		3					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																														2					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																														3					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive																												4		2					
India	India	IND	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																														1					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														1					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												9		2					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												5		4					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														2					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														1					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												1							
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												2							
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																														1					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												1		1					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												12		2					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												8		2					
India	India	IND	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														1					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female								4									8		8	7	8	10		7	8	5	6		3	8	4	7					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																	2		1	5	4	1			1	3	3			6	5	1					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																								2								1					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female								5					50				49	50	59	37	36	36	188	27	28	33	48		37	43	34	41					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												448									
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female								6									30	42	25	22	14	16	99	11	23	31	24		24	23	28	15					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																	6	10	4	4	3	1	80	3	1	5	5		2	4	8	5					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex																	4			1					1	1					2	4					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male								5					50				124	65	139	153	129	84	289	62	114	96	108		76	78	93	74					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																			6					1			2		1	2	2	5					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												151									
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																			1					4			6			1	1						
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male								4									20	6	25	22	9	6	13	7	11	14	20		13	18	21	17					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																	3		5	14	12	2		3	3	7	3		3	6	9	9					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												189									
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male								4									9		8	18	5	6		5	4	5	3		5	8	3	6					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												328									
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male								5									70	60	83	75	54	48	232	33	54	47	61		46	60	46	45					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male								5									41	49	47	38	26	17	130	13	21	27	26		21	25	31	22					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												122									
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male								33					8				95	12	130	138	138	93	84	75	127	97	105		79	84	97	80					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female								5									28	45	46	30	24	13	115	17	26	24	34		27	35	25	24					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female								39					8				50	7	60	36	36	30	44	25	20	47	44		19	24	36	44					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female								5									8	8	13	16	8	5	16	8	12	12	5		5	9	11	6					
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												146									
India	India	IND	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																	16	10	20	19	22	9	80	42	8	18	18		15	10	10	14					
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												3,963					5,446				
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			6,906																																		
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												26,047					23,771				
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			2,159	1,087	660	649	612	846	116	164	40	83	981	139	272	239	384	920	379	425	409	489	1,581	685	457	498	633		573	666	774	749					652
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex					11	42	38	164	67	91	17	71	377	140	212	176	316	70	257	314	331	364	1,280	241	347	331	374		300	357	496	353					272
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			22,868	8,594	3,770	3,321	3,089	2,248	279	507	232	324	3,535	475	1,093	969	1,920	2,045	1,709	2,064	2,455	3,028	3,721	2,927	2,901	2,685	3,077		2,654	3,273	3,072	3,071					2,540
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex						6	1		1										3	9	1	5			28	2			10	7		2					7
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				1,498	859	721	650	2,489	160	230	85	171	3,489	323	631	637	1,175	7,620	1,095	1,182	1,382	1,419	6,734	1,775	1,627	1,559	1,858		1,899	2,343	2,145	2,177					2,687
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex					89	101	46	198	131	149	28	138	1,310	174	318	329	544	1,240	437	504	604	568	1,655	475	580	558	579	2,330	579	674	950	724	3,180				417
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			1,032	583	306	278	341	946	62	85	10	65	1,034	112	183	172	265	500	276	294	327	314	1,468	399	426	364	465		396	486	666	617					581
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				621	374	301	365	1,888	116	172	60	142	2,637	253	507	502	867	6,160	877	938	1,015	1,062	5,752	1,300	1,216	1,205	1,492		1,498	1,945	1,674	1,704					2,060
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			32,005	6,777	865	799	827	3,015	252	339	63	232	3,964	433	799	824	1,220	7,385	1,361	1,573	1,683	1,667	5,984	1,888	1,855	1,839	2,026		2,140	2,584	2,428	2,474					2,799
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												16,163					17,158				
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												22,062					14,405				
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												23,736					10,368				
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female						9																															
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex					62	37	41	198	99	107	20	88	1,165	176	298	249	424	670	384	437	484	466	1,198	387	538	428	541		429	536	747	611					310
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												5,323					6,465				
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			18,397	7,154	2,748	2,389	1,990	2,869	265	390	168	286	3,960	455	899	953	1,828	3,570	1,614	1,885	2,230	2,670	4,078	2,642	2,765	2,413	2,664		2,441	2,843	2,668	2,681					2,540
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												1,622					1,811				
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			14,863	5,530	2,984	2,611	2,659	1,613	263	437	190	275	2,177	338	829	561	1,185	1,055	1,042	1,401	1,419	1,927	2,145	2,162	2,047	1,739	2,144		1,943	2,186	2,212	2,327					1,640
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			32,268	11,780	2,653	3,209	2,695	2,753	193	283	70	190	4,608	381	687	710	1,051	2,690	1,185	1,460	1,598	1,431	3,606	1,776	2,069	2,025	2,133		2,031	2,508	2,247	2,214					2,175
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male						131	101										1			2																	
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			11,360	4,693	1,628	1,610	1,392	1,998	144	207	44	110	2,973	251	478	486	757	1,440	723	931	991	855	2,712	1,176	1,408	1,332	1,503		1,340	1,788	1,578	1,610					1,372
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			1,266	285	165	144	222	1,717	118	153	46	106	2,759	211	456	424	745	8,270	717	933	1,033	1,017	15,640	1,671	1,244	1,307	1,577	8,018	1,727	2,360	1,905	1,917	10,834				1,838
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			1,894	441	60	70	120	1,463	83	118	26	59	1,879	155	295	203	432	5,190	446	570	639	651	11,801	960	732	824	1,101	4,734	1,038	1,499	1,266	1,335	13,803				1,161
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				3,049	413	370	516	2,154	160	238	41	160	3,059	302	564	524	803	7,060	881	1,090	1,145	1,102	6,547	1,368	1,269	1,358	1,577		1,642	1,994	1,917	1,777					2,298
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			20,359																																		
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			11,483	3,707	1,686	1,550	1,328	2,905	200	300	150	207	4,735	356	763	807	1,604	6,925	1,546	1,598	1,901	2,124	5,367	2,214	2,322	2,093	2,270		2,245	2,617	2,433	2,422					2,550
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				1,297	189	134	242	1,650	151	172	34	101	2,106	234	447	361	647	4,610	704	818	873	927	8,069	1,147	1,066	1,054	1,315		1,275	1,522	1,450	1,483					1,609
India	India	IND	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			43,013	13,581	2,036	2,144	1,959	3,209	246	316	65	242	4,334	397	741	794	1,191	3,795	1,265	1,468	1,697	1,582	4,616	1,912	1,957	1,859	2,206		2,250	2,594	2,495	2,459					2,733
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female						2																															
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex					1	1	5	31	12	19	1	8	71	5	27	17	36	14	21	34	22	37	94	33	31	48	41		35	19	28	25					18
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			329	110	115	115	120	604	73	83	23	56	802	71	145	134	270	668	210	257	268	355	668	346	320	331	366		313	335	305	356					250
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												3,923					2,481				
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			15	7	7	14	41	302	38	53	14	34	334	64	120	84	191	999	184	245	286	275	2,197	292	266	279	361	938	287	305	276	360	2,601				217
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			131																																		
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex					8	2	2	39	10	9	1	4	249	13	26	19	28	123	32	22	31	31	153	23	42	26	38		22	23	34	33					16
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				35	41	52	66	449	64	94	23	72	581	105	187	120	251	1,360	241	264	303	268	1,225	337	295	323	324		307	310	302	289					207
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			165	39	24	26	38	416	25	52	7	19	578	40	75	66	149	261	117	126	146	155	447	134	178	142	173		150	132	132	157					115
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			239	99	105	95	104	605	53	71	29	45	916	80	138	144	270	1,252	239	280	303	290	810	326	336	303	368		306	313	334	370					220
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex					7	3	4	40	12	9	1	3	276	14	24	20	30	225	29	29	41	21	195	31	29	27	35	153	25	25	26	37	450				11
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												4,404					1,680				
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			222	57	51	67	95	630	83	107	33	63	769	107	190	168	298	1,434	276	302	323	341	1,041	345	335	311	348		297	293	314	315					199
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			44	7	7	11	13	199	9	12	3	6	220	10	20	16	26	96	29	23	34	37	193	45	42	25	37		43	35	41	41					31
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				16	13	21	45	340	65	77	20	34	387	98	149	116	222	880	198	262	275	298	1,460	295	308	294	322		280	285	301	298					188
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												144					272				
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			477	87	98	114	115	485	50	84	26	59	720	65	117	116	279	383	202	265	279	292	620	311	319	337	364		275	348	336	377					272
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												4,619					4,268				
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			80	11	22	15	24	174	16	12	4	5	201	8	19	21	31	173	42	27	28	26	202	44	32	29	33		37	35	45	63					26
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male						8	13													1																	
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			345	36	38	39	38	583	47	52	18	38	907	76	99	86	196	496	168	169	175	176	609	190	221	181	179		147	183	161	169					114
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			147																																		
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex																			1	1					2				1			1					
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			366	57	77	82	94	338	42	50	8	43	446	42	98	53	173	199	138	149	148	217	376	177	225	195	221		237	223	205	230					172
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												878					1,043				
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			17	13	22	26	41	352	50	60	18	42	490	69	154	133	300	1,582	274	351	383	394	2,596	433	447	436	451	1,473	410	444	409	474	2,007				287
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												2,671					3,045				
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												608					893				
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				26	44	40	67	387	40	63	21	51	484	63	140	115	249	1,171	227	252	266	264	973	302	298	272	299		284	295	263	281					184
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				62	77	84	83	518	49	68	22	45	675	103	141	110	253	1,446	216	244	272	246	1,091	289	320	286	288		311	319	301	329					223
India	India	IND	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			289	49	60	48	90	670	65	92	28	56	865	97	182	127	231	738	179	232	240	243	761	273	262	244	279		237	233	231	226					141
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			1	1	9	6	195	19	55	134	148		154	172	150	167					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																						3	9			1	2		2	2	3	3					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			4	6	11	13	81	15	14	29	26		29	36	25	37					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												128					210				
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												168					99				
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																							7	2	2	5	3		4	6	4	8					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												166					101				
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																				2	5	4	92	8	20	52	55		62	90	78	99					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			4	6	9	19	131	31	28	37	48		66	88	74	107					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			7	7	20	31	200	46	42	58	92		97	102	92	138					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																							5		1	2	1	52	2				72				
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			1	2	2	2	11	3	4	4	4		9	14	8	10					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																					1	1	36	6	19	41	43		37	48	45	60					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																							3		1	4	4	52	6	5	4	8	72				
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																				1	1	1	5	4	13	18	19		21	25	24	34					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																				2	12	18	174	19	17	32	46		45	45	45	66					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												262					187				
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												197					221				
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																				1	3	5	22	7	7	12	14		17	19	18	26					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												100					120				
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																				3	9	15	123	21	56	138	145		154	158	165	180					
India	India	IND	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																					1	1	6	1	8	25	38		33	37	41	39					
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													13					15																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								52				6	174	2	3	3	7	179																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													4					5																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								4					68					63																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													123					121																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								7					169				1	164																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													10					10																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								41					30					18																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													6					5																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								53					109			1	4	111																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								46				1	162					151																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								16				1	16				1	13																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								4					38					38																			
India	India	IND	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								52				3	58	2	2	2	4	57																			
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								52				6	170		1	1	4	179	4	15	11	33	280	46	56	47	54		47	60	45	31					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												464					538				
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												167					197				
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								46				1	157					151	2	10	8	24	222	21	36	27	27		33	37	20	10					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								7					165				1	164	1	9	2	20	278	76	112	73	68		80	78	29	27					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												460					405				
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												337					234				
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													6					5					7	1	3	3	6	52	2		4	2	98				
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												255					465				
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													13					15			3	2	35	1	3	4	3		7	4	1						
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								52				3	54				3	57	3	5	7	6	109	13	24	8	16		16	15	15	12					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								16				1	14				1	13	1		1	1	14	3	5	3	7		11	5	2	3					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								4					67					63	2	4	2	7	139	30	46	30	40		42	37	36	25					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								53					105			1	3	111	2	3	14	17	170	32	28	25	43		41	44	33	23					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								41					27					18	1	2	2	5	28	8	8	7	11		11	10	7	6					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													4					5				5	15	15	11	12	10		9	15	12	8					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													123					121	4	7	6	13	173	73	104	63	66		55	67	36	23					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																						2	19	6	8	3	7		6	4	2	3					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																						1	18	1	3	2	1	63				3	94				
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													10					10		1			30	9	21	19	7		15	7	3	4					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								4					35					38		3		8	68	30	37	18	23		29	27	19	19					
India	India	IND	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												197					171				
India	India	IND	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male								45,346		9,082		42,187	111,060		8,693		14,476	27,151		8,638		7,722	54,166		10,429		6,982	60,250		5,344		5,117	76,366				5,345
India	India	IND	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female								47,061		9,692		53,298	116,133		9,691		11,950	27,733		9,140		7,575	70,686		10,158		6,295	80,012		4,878		4,013	64,622				4,738
India	India	IND	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex								4,386		443		2,494	9,846		348		227	1,611		286		324	3,931		339		245	3,217		205		220	2,732				103
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			3,978	3,657	2,936	3,363	3,477	12,214	3,466	3,504	5,438	5,377	12,127	5,458	5,422	5,580	5,767	7,484	6,005	6,059	6,295	6,633	8,677	6,659	6,791	6,674	7,090		7,254	7,232	7,509	7,620					4,246
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												126,288					125,829				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				12,168	18,443	18,970	19,363	30,013	19,215	19,434	35,165	35,358	30,620	36,282	37,012	37,093	38,075	43,066	38,598	39,269	39,336	40,322	48,105	40,966	41,607	40,524	42,469		42,452	42,821	43,469	43,260					28,025
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				1,409	342	352	352	2,503	352	359	516	453	2,941	451	438	418	429	1,783	462	462	481	504	1,680	506	495	521	528		519	475	530	528					269
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			20,474	18,187	12,294	12,440	12,453	33,034	12,079	11,994	21,645	21,069	36,699	21,163	20,705	20,777	20,960	36,197	21,026	21,197	21,211	21,861	31,709	21,856	21,848	21,451	22,188		22,173	22,312	22,565	22,564					13,729
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			10,152	8,936	4,719	5,209	5,445	20,416	5,505	5,558	9,022	8,921	21,847	8,922	8,527	8,915	9,164	15,471	9,438	9,814	10,137	10,617	14,714	10,757	11,086	10,961	11,690		11,926	12,243	12,648	12,862					7,802
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			8,132	8,480	9,359	9,522	10,444	9,991	10,350	12,472	11,267		11,882	12,346	12,485	12,977					8,598
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				15,660	17,020	17,132	17,147	31,544	16,467	16,315	28,877	28,418	37,430	28,681	28,639	28,036	28,321	43,394	28,338	28,595	28,228	28,815	39,304	28,810	28,843	27,945	29,162		29,072	29,044	29,290	29,059					17,409
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												51,998					50,029				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			15,356	15,929	16,946	17,294	20,752	18,015	18,512	19,564	19,642		20,351	20,892	21,385	22,125					13,860
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			21,342	19,149	13,040	12,840	12,810	35,920	12,595	12,381	23,513	23,190	36,441	23,333	22,672	22,552	22,498	37,330	22,338	22,346	21,643	22,203	32,050	22,147	21,914	21,056	21,489		20,903	20,969	20,917	20,363					12,017
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			4,700																																		
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				7,542	13,275	13,924	14,409	21,330	14,587	14,928	27,035	27,174	22,385	27,802	28,935	29,156	30,239	29,439	30,978	32,008	33,361	34,361	36,514	35,295	36,330	35,370	37,706		38,131	39,019	39,983	40,525					27,533
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			7,873	7,413	15,659	16,399	17,112	24,637	17,011	17,590	34,340	34,623	16,133	33,738	36,672	36,391	38,522	38,051										50,051					65,594				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			10,690	11,255	12,347	12,438	14,737	13,083	13,643	15,705	14,644		15,549	16,007	16,325	17,173					12,683
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												16,970					17,627				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												14,962					18,165				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			8,201	7,368	3,761	3,936	4,014	15,771	3,897	3,904	6,921	6,872	16,062	7,064	6,953	7,093	7,315	12,335	7,395	7,527	7,534	7,789	11,204	7,925	7,961	7,758	7,931		7,826	7,709	7,788	7,693					4,233
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												111,377					101,147				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			2,193	2,066	2,134	2,315	2,343	5,693	2,214	2,169	3,678	3,605	7,150	3,568	3,572	3,507	3,536	5,663	3,512	3,567	3,498	3,554	5,555	3,547	3,454	3,204	3,344		3,291	3,175	3,278	3,243					1,656
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			11,977	11,020	24,743	25,401	26,310	33,551	26,221	27,023	49,423	49,142	23,804	48,552	51,668	51,302	53,732	56,623										69,573					75,070				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			3,898	4,148	4,873	4,779	4,932	5,096	5,312	8,039	5,847		6,409	6,755	6,704	7,310					5,801
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			28,793																																		
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			5,590	5,848	6,530	6,655	7,447	7,031	7,334	9,269	7,986		8,538	8,909	9,030	9,528					6,962
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			25,231	25,943	26,674	27,641	26,897	28,217	28,842	27,870	30,307		30,850	31,315	31,987	32,336					19,689
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												5,320					3,353				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				2,752	1,189	1,183	1,170	4,816	1,183	1,181	1,959	1,832	7,100	1,847	1,733	1,790	1,783	4,282	1,763	1,726	1,730	1,730	3,522	1,708	1,700	1,619	1,616		1,605	1,567	1,609	1,585					833
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			4,376	3,919	2,384	2,367	2,362	6,938	2,317	2,284	3,911	3,882	10,566	3,842	3,697	3,751	3,688	7,190	3,655	3,617	3,560	3,518	6,314	3,498	3,420	3,101	3,297	6,469	3,229	3,094	3,213	3,153	5,388				1,571
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male														661	645	660																					
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			16,469	14,611	7,089	7,104	7,061	27,121	7,067	7,018	12,857	12,534	27,528	12,549	11,959	12,068	12,242	24,610	12,327	12,440	12,208	12,581	19,631	12,737	12,830	12,523	12,989		12,658	12,792	12,839	12,703					7,458
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			82	60		3	4	215	2	3	3	2	67	2		1			2	2	2	3			2	2	4		2	1	3	5					4
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			2,831	2,562	2,020	2,162	2,221	6,113	2,135	2,133	3,482	3,412	8,264	3,399	3,385	3,289	3,338	5,066	3,296	3,324	3,275	3,291	4,972	3,342	3,314	3,100	3,244		3,130	3,008	3,089	3,035					1,636
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												42,918					46,107				
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			16,572	14,554	7,842	8,200	8,392	27,494	8,179	8,213	14,554	14,381	29,987	14,149	13,706	14,040	14,366	25,647	14,544	14,807	15,073	15,629	22,439	15,838	16,056	15,914	16,709		16,933	17,318	17,650	17,733					10,404
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female														678	667	684																					
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			19,988	20,798	22,181	22,603	20,820	23,563	24,496	25,119	26,032		26,980	27,768	28,349	29,165					19,857
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			6,611	6,960	7,862	7,824	7,661	8,271	8,541	13,324	9,362		10,055	10,673	10,605	11,537					8,089
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			19,852	18,171	18,846	19,034	19,134	37,993	18,753	18,660	34,478	34,133	35,952	35,038	34,756	34,351	34,434	49,687	34,399	34,712	34,147	35,134	47,402	35,282	35,126	33,848	34,780		33,849	33,906	33,845	33,301					20,625
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			21,114																																		
India	India	IND	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				10,866	17,043	17,483	17,675	25,817	17,241	17,329	30,166	29,777	20,856	30,166	30,271	30,188	30,717	37,477	31,059	31,528	31,949	32,777	39,572	33,051	33,133	31,858	33,719		33,657	33,641	34,075	33,961					21,026
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			1,592	333	351	370	409	3,116	381	339	249	236	1,394	411	690	346	596	3,866	612	665	717	775	9,994					2,289					6,892				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												8,982					6,627				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			2,402																																		
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				398	412	418	435	3,178	370	370	301	332	1,928	437	603	375	603	4,739	653	572	633	596	3,457	552	589	635	618		531	500	546	512					236
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				338	366	403	445	3,526	341	329	249	337	2,235	450	661	361	590	4,921	603	571	641	658	6,284	606	567	592	600		568	558	592	485					255
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								190	179	173	185		167	190	176	142					63
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								299	260	300	294		272	291	268	291					129
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female														5	14	14																					
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			1,544	416	493	461	465	4,053	394	388	355	432	3,105	497	626	461	630	3,831	639	613	718	690	2,621	624	618	638	715		597	594	641	643					315
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				36	29	27	39	261	28	42	16	29	253	36	56	35	54	80	64	71	71	77	280	58	58	73	62		37	34	47	40					27
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			277	78	78	86	73	760	74	41	32	58	708	69	82	61	73	658	107	78	91	98	711	95	62	86	79		87	92	109	123					45
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				439	449	449	440	3,634	406	344	335	346	2,619	503	653	357	609	5,547	599	597	601	672	4,253	559	595	634	613		564	555	586	554					296
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								433	447	453	488		418	423	449	424					210
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			1,185	371	369	400	452	3,981	384	344	304	375	3,229	436	499	401	548	1,335	552	568	647	672	1,654	610	588	659	680		594	647	726	686					338
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				255	264	266	341	2,633	289	258	233	233	1,579	408	588	312	541	3,433	553	554	601	648	6,215	558	557	589	596		494	505	587	531					238
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male														13	10	16																					
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												10,465					9,209				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			767	215	214	243	237	3,110	184	200	204	257	2,524	286	355	255	380	602	350	348	388	352	1,452	318	331	345	337		299	297	288	316					149
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			1,918	454	491	489	471	4,768	409	386	292	392	3,086	509	639	440	631	4,748	655	610	635	674	4,267	621	584	598	598		489	491	549	487					238
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								118	134	148	136		126	107	136	134					54
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,806	386	340	376	432	4,724	323	285	258	324	3,614	407	551	318	484	2,111	467	464	500	504	2,651	466	416	451	442		418	389	468	336					167
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			394																																		
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								339	321	336	363		293	370	378	349					170
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								191	179	200	204		203	191	205	185					102
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												308					335				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												1,211					2,764				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,333	280	303	315	286	4,448	238	229	233	284	4,115	322	406	280	403	1,321	429	374	367	368	1,426	332	372	408	365		302	295	304	316					161
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								77	90	83	75		78	75	75	70					40
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			2,639																																		
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			6			2	1	40	2	1	6		3	2	2	1			1	2		2			2	2	1				1	3					1
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								133	114	129	135		117	107	118	112					58
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			2,215	471	487	507	599	4,163	584	558	435	451	2,059	663	1,018	538	937	6,204	927	954	1,045	1,092	12,725					4,770					5,561				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			618	197	200	253	285	2,698	236	231	174	221	2,219	250	331	217	329	700	363	320	416	475	1,319	346	365	444	427		424	423	485	450					226
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				37	27	42	48	456	27	34	23	25	694	42	56	31	54	399	64	47	62	52	470	38	63	51	43		61	52	74	71					29
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												9,632					5,244				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			312	73	69	90	91	808	97	71	51	57	655	70	116	61	117	317	108	98	106	103	723	134	98	110	118		113	85	119	96					63
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			449	74	75	74	65	749	61	46	21	31	883	58	65	55	77	762	61	75	77	68	725	61	80	62	64	357	62	58	66	64	846				17
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												1,919					2,595				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												6,384					6,864				
India	India	IND	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			1,407	388	422	447	500	4,172	415	398	320	392	2,751	468	576	408	585	2,274	629	611	665	713	2,079	650	623	706	698		621	627	666	646					344
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								3,592	3,490	5,964	3,787		4,513	5,395	5,189	5,706					4,502
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				1			9		1				57						1		1						1		2	1							
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												4,885					3,032				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								5,061	4,879	6,754	5,448		6,326	7,323	7,061	7,460					5,497
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				540	694	738	1,171		1,141	1,275	1,569	1,189	9,506	1,283	1,491	1,843	1,994	5,705	1,961	1,917	2,094	2,097	5,618	2,460	2,378	2,105	2,370	5,911	2,395	2,421	2,646	2,637	4,752				1,312
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				1,044	1,217	1,779	3,362		3,080	3,779	5,053	4,204	22,510	4,397	5,522	7,246	7,910	20,638	7,523	7,002	7,423	7,830	17,974	8,643	8,185	8,018	8,311		8,890	9,640	9,997	10,009					6,403
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				1,433	2,606	3,778	6,224		10,558	13,069	16,795	15,344	24,494	15,522	20,044	25,143	27,868	32,736	26,471	25,607	27,525	27,867	43,636	31,167	29,557	28,948	30,577		33,390	35,164	36,922	36,741					25,242
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								7,287	7,161	9,062	7,779		8,881	10,136	9,974	10,418					6,970
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												13,568					16,020				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												37,395					40,619				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				1,965	2,598	3,743	6,646		10,108	12,151	15,938	13,929	29,345	14,492	17,838	22,455	24,179	38,939	22,889	21,989	23,249	23,657	42,855	25,962	23,746	23,229	23,995		25,804	27,236	27,968	27,399					17,983
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				300	94	87	179		111	131	170	100	2,563	126	134	138	143	1,521	148	145	161	171	1,365	196	207	199	208		251	255	301	302					136
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								17,624	17,165	18,065	18,651		21,102	23,289	23,629	24,229					17,252
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				1,743	1,864	2,676	4,916		6,255	7,552	10,388	8,668	29,928	9,137	11,165	14,294	15,384	31,959	14,373	13,375	14,177	14,442	29,171	15,751	14,497	13,865	14,244		15,151	16,174	16,599	16,229					10,260
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				242	464	561	851		997	1,110	1,400	1,131	7,510	1,208	1,513	1,822	1,949	4,044	1,853	1,843	2,038	2,081	4,482	2,354	2,291	2,089	2,265		2,292	2,326	2,432	2,424					1,323
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				233	424	561	803		972	1,089	1,340	1,121	7,298	1,193	1,434	1,821	2,046	4,106	1,951	1,986	2,124	2,181	5,079	2,512	2,352	2,112	2,320		2,398	2,414	2,578	2,540					1,346
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												113,599					113,917				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				754	687	942	1,797		1,966	2,625	3,165	2,872	16,818	3,012	3,749	4,941	5,446	13,060	5,271	5,062	5,651	6,067	13,428	6,761	6,515	6,466	6,778		7,609	8,409	8,888	9,154					5,935
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				385	464	655	989		1,328	1,759	1,933	1,823	10,608	1,905	2,425	2,970	3,285	6,002	3,157	3,076	3,460	3,714	7,901	4,218	4,164	4,023	4,238		4,621	4,831	5,311	5,365					3,088
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								9,574	9,327	11,233	10,049		11,670	13,287	13,325	13,934					10,452
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								13,233	13,122	13,996	13,849		15,659	17,310	17,678	18,211					11,919
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				448	378	422	656		555	576	719	471	6,273	521	609	830	986	3,500	960	868	928	963	3,121	1,096	1,071	987	1,033		1,095	1,123	1,187	1,223					649
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												45,487					44,768				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												15,221					15,590				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				2,528	2,789	3,985	6,399		8,784	10,458	13,187	11,815	30,352	12,303	14,698	18,072	19,446	32,925	18,331	17,528	18,676	19,024	35,731	20,988	19,790	19,154	19,895		21,417	22,694	23,774	23,480					14,816
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												101,644					91,744				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				979	2,231	3,224	5,035		9,137	11,858	16,165	14,842	14,145	14,682	19,949	24,761	27,833	29,769	27,187	27,004	31,186	31,458	43,707					45,597					58,573				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				932	2,066	3,022	4,658		8,213	10,543	13,221	12,192	19,647	12,187	15,873	19,908	22,056	22,986	21,388	20,827	23,258	23,578	33,449	26,504	25,597	25,311	27,063		30,060	32,416	33,746	34,076					24,427
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				581	733	987	1,828		1,702	2,114	2,512	2,275	13,295	2,413	3,119	4,049	4,537	10,342	4,264	4,157	4,509	4,802	10,208	5,384	5,161	4,999	5,149		5,610	5,704	6,194	6,077					3,532
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				2,566	1,961	2,960	5,238		5,776	6,812	8,923	7,851	29,535	8,297	10,125	12,655	13,639	30,578	12,917	12,361	13,294	13,764	28,790	15,136	14,179	13,840	14,240		15,592	16,572	17,311	17,383					11,306
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								21,592	21,013	20,372	22,111		24,574	25,930	27,079	27,205					17,383
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				1,582	1,205	1,821	3,303		3,402	4,253	5,545	4,958	24,043	5,148	6,497	8,217	8,957	21,813	8,570	8,170	8,960	9,429	20,388	10,427	9,818	9,623	9,918		10,990	12,253	12,718	12,985					8,021
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				2,031	3,177	4,552	6,415		9,774	11,727	14,598	13,479	17,806	13,468	16,491	20,118	21,665	28,624	20,686	20,204	21,773	22,237	36,056	24,581	23,395	22,367	23,949		26,029	27,186	28,655	28,547					18,530
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				2,308	4,752	6,937	8,743		14,351	18,218	23,831	22,340	20,404	22,036	28,508	34,776	38,548	44,239	37,487	37,087	41,524	42,504	59,992					63,078					68,084				
India	India	IND	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								5,720	5,652	10,080	6,173		7,225	8,682	8,196	8,946					6,276
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														130		281					96
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														119		242					63
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														63		140					33
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														10		22					4
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														38		82					30
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														19		42					9
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														38		55					17
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																																1					1
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male										1,749		1,276			2,116		1,987			2,463		2,321			1,935		2,009										
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														64		154					46
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														93		159					45
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														110		200					57
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														25		53					24
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male																														296							
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														58		101					34
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														9		22					6
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														124		265					72
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														148		284					98
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														17		33					15
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female										1,344		653			1,245		843			1,480		1,379			996		1,093										
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														88		145					66
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														1		7					1
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														31		71					26
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex										100		25			30		31			42		28			31		41										
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female																														211							
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														29		68					27
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														79		142					40
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														94		213					72
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														8		19					6
India	India	IND	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														7		16					3
Kenya	Kenya	KEN	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					23,762		35,674			34,977		62,723			18,515		67,406	63,092		51,184		91,048	70,920		30,571		75,492	94,640		43,605		75,619	84,484				41,284
Kenya	Kenya	KEN	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					32,654		41,226			50,063		94,032			57,668		123,778	48,425		112,626		128,945	55,166		57,551		108,107	72,639		75,156		102,867	58,835				70,123
Kenya	Kenya	KEN	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					22,932		42,419			31,750		49,713			45,188		75,915	81,228		113,906		119,341	124,118		106,541		134,645	121,840		89,592		134,170	127,450				83,232
Kenya	Kenya	KEN	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female					5,043		874			7,600		10,851			2,978		10,222			2,294		14,063			1,724		7,353			3,091		6,960					4,596
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			9		1			6		1			176		118			94		55			86		68			74		34					34
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative										2								4		5			55		21			4							3
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2		1			3		17			68		78			45		72			82		129			126		118					90
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																				2			1												
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													19										11												
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2		1			2		10			66		72			57		42			92		121			134		117					94
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1										2					3					4		10			3		10					1
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1					2		2			68		53			107		165			114		283			204		219					207
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1		9			8		13			57		110			182		322			354		470			482		585					400
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2		1								24		401			57		30			66		65			97		76					68
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			11		5			3		4			144		225			120		95			119		92			60		58					44
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													2		8			4		5			9		6			6		7					3
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			12		5			3		5			137		278			112		110			111		113			89		69					78
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					2			1		2			12		14			14		14			10		18			18		12					7
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								2					11		15			10		19			11		24			11		11					13
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																				1			1		1										1
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative										1			61		40			76		111			106		245			191		179					183
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1												2			3		7			1		2			2		1					8
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			10		3			1		3			33		59			34		42			82		79			134		101					87
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1										1		2			1		2					3			1		2					4
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			5		2			5		9			112		202			96		80			103		87			81		65					52
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			10		6			6		3			267		338			267		188			183		163			119		91					65
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			11		16			5		5			101		134			111		99			59		73			58		62					45
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			820		417			368		326			15,028		22,599			16,073		15,234			12,872		11,590			9,236		9,121					6,793
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			979		561			500		326			17,927		26,882			20,928		19,667			16,126		15,208			12,707		11,713					8,330
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			216		104			145		141			1,358		2,339			3,973		6,594			7,108		9,679			10,969		12,631					10,900
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					1			1					66		22			47		86			33		116			47		56					64
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			2										14		5			6		7			15		8			7		10					5
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			236		126			204		194			2,418		4,572			5,931		9,477			10,830		16,185			18,594		21,043					20,789
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													1										3												
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			371		222			256		282			3,186		5,384			7,190		11,280			13,246		18,263			20,488		23,804					22,712
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			784		627			513		336			14,875		21,141			17,066		15,785			12,470		12,274			10,322		9,604					6,394
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													2		2			6		2			2		1			3		2					1
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			410		273			249		184			6,977		9,827			7,620		6,856			5,458		6,131			5,674		5,333					3,646
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		1			1					4		3			8		7			7		4			8		7					4
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			7		6			7		2			78		90			89		115			81		45			42		54					33
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected								1					2										1		4			1		1					1
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													33		36			61		58			69		177			73		132					94
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			579		248			196		183			10,020		15,950			11,430		10,668			9,929		8,967			7,458		6,944					5,106
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 											51,594					55,072					56,857														
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1										3		6			31		23			33		64			26		23					36
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 											65,450					67,009					62,596														
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			12		9			3		3			188		279			148		126			134		135			96		84					67
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			17		15			34		12			404		542			410		300			293		205			174		158					117
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			926		691			615		462			19,238		27,231			20,604		19,445			15,555		14,840			12,167		11,322					7,473
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3					1		2			79		464			186		131			193		261			243		215					233
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative								1		2			80		69			81		225			125		297			199		196					208
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected					2								32		47			33		25			18		33			24		23					18
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			623		225			201		168			5,628		7,671			3,917		4,282			4,858		4,202			3,681		3,400					2,583
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			4		4			6		6			99		91			177		172			200		246			248		224					221
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			15		27			30		13			286		279			273		197			176		149			132		127					93
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2		1								14		24			7		21			26		26			43		39					28
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			4		2			10		5			120		155			230		202			246		320			338		338					338
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1					2		1			64		75			96		83			124		246			145		134					198
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													3		7			2		7			6		4			4		6					2
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1								6		14			9		13			11		12			6		12					7
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1										4					7		2			4		3			1		1					7
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1					6		7			112		197			232		195			229		297			299		300					345
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 											45,579					44,953					47,981														
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			5		2					1			25		28			17		35			47		38			41		52					38
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			1										4		41			3		76			87							4					
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													6		7			9		16			8		4			10		9					9
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			20		18			17		9			477		573			524		354			269		243			203		168					132
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			8					1					3		9			3		6			13		4			6		1					2
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													6		1			2		3			4		2			1		2					2
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										112,190					101,659				
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 											66,080					68,626					71,698														
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 											63,290					68,485					63,730														
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										202,047					203,794				
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					1			2		5			43		29			29		37			57		84			60		88					46
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			6		11			5		4			91		130			79		71			73		64			48		35					39
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			9		17			15		3			411		498			419		274			268		164			145		117					110
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													3		4			1		5			2		3			6		4					4
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																									2										
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1		4			2		5			19		13			36		28			43		53			39		40					38
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			214		56			34		27			1,264		1,808			1,364		1,222			989		1,377			1,128		1,289					648
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative															8			1		9			22												
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			336		179			230		234			2,985		5,077			7,290		12,381			13,799		20,018			22,584		25,517					23,142
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			305		155			190		229			2,407		4,162			5,989		10,493			11,195		15,479			17,081		19,179					16,956
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			64		37			50		44			560		860			1,339		2,278			2,332		3,343			3,992		4,534					3,667
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			268		93			174		149			1,267		2,384			1,986		3,399			4,449		5,630			6,207		7,650					6,884
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3		8			2		3			65		51			93		86			104		113			139		125					113
Kenya	Kenya	KEN	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1										2		10			4		4			7		7			12		18					10
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3					1		2			79		464			186		131			193		261			243		215					233
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		1			1					4		3			8		7			7		4			8		7					4
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			4		4			6		6			99		91			177		172			200		246			248		224					221
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3		8			2		3			65		51			93		86			104		113			139		125					113
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								2					11		15			10		19			11		24			11		11					13
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			15		27			30		13			286		279			273		197			176		149			132		127					93
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1												2			3		7			1		2			2		1					8
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1					6		7			112		197			232		195			229		297			299		300					345
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1										4					7		2			4		3			1		1					7
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													19										11												
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													2		2			6		2			2		1			3		2					1
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1		4			2		5			19		13			36		28			43		53			39		40					38
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			10		6			6		3			267		338			267		188			183		163			119		91					65
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			17		15			34		12			404		542			410		300			293		205			174		158					117
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			9		17			15		3			411		498			419		274			268		164			145		117					110
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			9		1			6		1			176		118			94		55			86		68			74		34					34
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					2			1		2			12		14			14		14			10		18			18		12					7
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			4		2			10		5			120		155			230		202			246		320			338		338					338
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			11		16			5		5			101		134			111		99			59		73			58		62					45
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			2										14		5			6		7			15		8			7		10					5
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2		1								24		401			57		30			66		65			97		76					68
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													6		7			9		16			8		4			10		9					9
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																									2										
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			20		18			17		9			477		573			524		354			269		243			203		168					132
Kenya	Kenya	KEN	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1								6		14			9		13			11		12			6		12					7
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																																			1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							1												
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							18		19			14		11					11
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		1					1			3		4			15		10			13		15			3		4					3
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			5		7			9		2			198		194			134		71			64		28			26		20					10
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2										5		23			47		50			64		45			68		53					56
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP													1					1		1			6					1		2					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								1		1			15		26			84		89			108		78			74		58					84
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													3		20			35		75			69		127			187		174					174
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			5										5		8			8		11					1										
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			12		21			17		3			118		104			104		51			55		24			18		14					4
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													1		1			2		1															
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													2		2					7			2		1										
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													5		22			38		91			92		145			197		212					186
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													1		3			7		3			4		2			1							
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																									1										
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							2					1							
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP															8																				
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												4		1					2
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		1		11			3		12			2		6					7
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1												2					5			3		3										
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2					4		1			22		41			91		108			132		111			122		97					75
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		1		2			2		8			3		5					2
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP															1			1					1							1					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1										2		2			4		3			1		1			3		4					4
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												7		1					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													2		5			2		18			12		23			34		25					30
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				4															
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP								2		1			3		1			15		7															
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		1					3			26		65			54		63			58		57			23		25					9
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							1												
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1		1			4		2			17		15			30		26			16		17			21		13					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP													1					2		1			4												
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							1		1			1		1					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1					3		1			23		55			44		42			45		52			38		26					16
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							1					1							1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP															3			1		2			2		4			2		3					3
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													3					4		6					3										
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							12		6			10		1					6
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			1					2					22		33			110		116			128		128			121		102					89
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													5		28			20		15			17		27			8		27					11
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			3		2			1					12		51			31		39			31		78			30		20					11
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																									1					1					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													8		19			24		9			20		19			14		16					7
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			11		9			19		5			192		187			144		88			72		57			26		27					5
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			1										7		2			10		15															
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			5		3			2		1			129		150			84		57			34		31			26		15					10
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP															3			1					3		1					5					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							3		2			9		4					2
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2							1			4		17			27		26			27		36			34		42					31
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												1		1					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1					2		1			19		24			25		19			15		17			10		3					4
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							1		1										1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													1		1			3		10			9		20			8		8					7
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							1		1			4		5					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							1		1			15		7					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									1										
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													2		10			20		46			40		52			77		88					68
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													1					4		1			2												
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP															14			8		4															
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													9		7			10		10			21		12			14		13					3
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												2		1					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			1					2		1			17		21			62		60			76		88			92		86					67
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													12		25			21		14			21		11			10		22					10
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																				2					2			1		1					3
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															4			1		7			6		17			2		7					4
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy								2					5		8			2		5			2		4			2		1					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1								1					4		1			1							1					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		1					1		5					1					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												3		1					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															1					1															
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												4							1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			4		3								18		12			35		22			19		25			10		8					4
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			1							1			1		13			15		36			61		90			133		113					112
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			5		12			4		2			42		45			63		30			18		20			10		9					2
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							3		2			3		1					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP								3		2			11		20			14		13			9		6			4		4					6
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP															3			3		1			1					4		3					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			2					2					53		68			30		17					1										
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			3		1			8		4			9		20			23		11			13		10			7		5					3
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															2			2		9			5		24			7		8					2
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									1			1		2					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2										1					1		2			3		1			5		6					4
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							5		3			1		3					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					1								3		5			5		4			6		8			4		5					5
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							1							1					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													2		6			3		6			4		7			2		1					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy															6																				
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					1					1			9		17			42		62			88		110			133		132					139
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							6		1			4		2					1
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			1																																
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					1			4		1			18		8			32		8			7		8			8		4					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															4			3		9															
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			16		13			11		4			195		219			187		93			76		52			32		19					11
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		2			2		2			19		32			59		55			39		48			35		23					14
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							5		3			4		4					5
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														2					
Kenya	Kenya	KEN	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							3		14			28		29					18
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				423	971	1,869	2,720	10,498	1,597	1,946	2,260	2,105	32,244	1,902	1,492	809	1,655	34,043	2,535	1,536	2,204	423	34,043	1,077	2,489	1,587	449		2,314	2,387	681	263					2,397
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			14,222	305	580	919	2,018	6,769	1,826	1,988	2,365	2,400	242,856	1,921	1,549	948	1,873	240,886	4,688	2,447	2,766	822	240,886	1,341	3,328	2,016	508	240,886	2,709	3,098	915	338	173,142				2,785
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				794	1,859	3,244	4,212	10,498	2,866	3,151	3,974	3,790	45,805	3,150	2,720	1,610	2,911	47,719	4,435	2,718	3,591	890	47,719	2,015	4,524	2,999	793		4,160	4,640	1,380	574					4,074
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			42,141	715	1,194	2,272	3,064	21,144	2,974	3,330	4,815	4,940	16,226	3,333	2,725	1,773	3,182	16,340	6,681	4,165	4,114	1,162	16,340	2,025	5,302	3,185	823		5,023	4,805	1,976	569					4,442
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			14,006																																		
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female				138	1	125	108		78	61	12	18		9	42	6	27		33	13	12	4			8	1				28	1	11					
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			42,122																																		
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												135,470					97,370				
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			42,167	1,312	3,082	4,961	5,834	21,122	4,334	4,811	5,851	5,661	64,304	4,891	4,379	2,467	4,771	67,085	8,155	4,386	5,612	1,495	67,085	3,217	7,054	4,857	1,412		6,360	7,249	2,609	888					6,556
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			227	17	147	118	299	201	295	311	465	724	7,903	179	153	131	177		795	271	234	62		83	164	91	34		185	48	32	8					55
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male				169		97	132		50	81	12	37		5	3	1	54		31	5	13	2			10	1			1	25	1	2					
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			14,007	2,348	3,343	5,033	8,178	6,768	6,994	8,150	8,595	9,663	58,397	7,770	7,439	4,024	8,062	56,796	11,373	7,517	8,789	2,756	56,796	5,019	11,396	8,458	2,159		12,125	13,239	4,435	1,625					10,587
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			14,034	1,886	2,707	4,497	6,816	6,787	5,804	7,019	7,556	7,849	72,644	6,993	6,782	3,511	6,745	71,993	9,733	6,375	7,837	2,333	71,993	4,583	9,951	7,106	1,884		10,292	11,032	3,752	1,324					8,582
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			13,997	536	857	1,443	2,600	6,669	2,302	3,037	3,088	3,252	16,826	2,491	2,034	1,014	2,335	16,268	3,834	2,260	2,577	706	16,268	1,230	3,422	2,235	508		3,774	3,415	1,144	668					2,865
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												148,847					106,985				
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												48,947					35,180				
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				410	775	1,361	2,508	3,382	1,790	1,952	2,288	2,328	90,896	1,975	1,779	1,043	2,038	90,919	3,021	1,951	2,331	571	90,919	1,268	2,837	1,837	520		2,834	2,930	877	375					2,890
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			42,138	2,225	4,886	6,976	8,034	21,124	6,076	7,189	8,618	8,156	63,637	7,095	6,365	3,632	7,155	66,039	10,614	6,471	8,515	2,390	66,039	4,498	10,356	7,343	2,034		9,288	10,693	4,066	1,269					8,992
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												261,838					188,201				
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex				700	159	17	208	195,260	77	325	341					80	2															4					
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												65,627					47,168				
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			42,121	2,976	5,486	7,461	9,655	21,121	7,486	8,804	10,529	10,321	67,833	8,539	8,165	4,529	9,007	69,431	14,083	8,588	10,559	3,027	69,431	5,583	12,502	9,353	2,507		12,358	14,380	5,493	1,701					11,976
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			14,005	1,206	1,908	3,521	4,800	6,768	4,142	5,122	5,642	5,724	81,871	5,155	4,869	2,694	5,231	81,458	7,488	4,776	5,886	1,624	81,458	3,468	7,320	5,250	1,439		7,053	7,743	2,514	928					6,378
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			14,015	2,181	2,707	4,539	6,661	6,769	6,300	7,382	8,212	8,360	34,042	6,708	6,309	3,360	6,672	32,679	10,063	6,485	7,883	2,266	32,679	4,355	10,813	7,702	1,862		10,415	12,290	4,333	1,631					8,839
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			42,132	232	550	941	2,012	21,108	1,542	1,692	2,137	1,740	61,497	1,654	873	574	1,296	65,049	2,681	1,476	1,973	424	65,049	1,108	2,418	1,474	374	65,049	2,200	2,227	477	188	46,748				2,034
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			42,010	2,959	4,390	7,373	8,761	21,016	7,745	8,691	10,918	10,793	48,858	8,452	8,070	4,760	9,235	49,287	14,840	8,990	11,115	3,129	49,287	5,640	14,523	10,272	2,651		13,362	15,767	6,780	1,969					12,107
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												128,789					92,569				
Kenya	Kenya	KEN	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				764	1,244	2,302	3,752	3,382	2,991	3,618	4,163	4,174	89,610	3,565	3,278	1,877	3,796	89,461	4,980	3,347	4,228	1,127	89,461	2,288	5,186	3,635	1,052		5,199	5,523	1,891	654					4,937
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				86,855	72,510	59,935	46,171	93,849	27,095	22,457	16,230	19,191	78,975	16,900	20,073	15,842	13,641	55,544	9,523	15,387	9,014	6,075	1,411	9,165	11,087	13,272	13,073		16,022	15,472	14,539	11,792					8,966
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,434,543					1,188,484				
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				54,128	52,655	50,435	48,667	133,797	33,642	29,195	20,394	24,605	235,652	22,744	24,461	19,749	20,240	123,021	16,053	19,388	14,419	10,291	40,528	13,987	15,874	20,218	21,953		23,414	26,933	22,754	21,242					18,325
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				78,399	73,277	68,997	66,093	133,578	45,061	42,709	30,103	36,739	282,560	33,898	36,160	28,288	28,804	152,208	22,817	29,575	21,411	15,556	76,968	20,663	22,983	28,498	30,991		33,114	39,644	33,664	31,419					25,999
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				567	17	9	12		10	4	10	7		7	24	36	8		1	5	7	1			9				1			1					3
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				65,517	64,305	56,571	51,733	152,610	35,972	33,657	23,241	27,245	150,133	24,669	26,805	20,734	21,078	243,163	16,881	21,598	14,903	10,869	90,638	14,111	16,594	21,121	22,767		24,283	28,176	23,237	23,200					19,739
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			1,277,705	153,192	148,294	132,021	116,417	136,188	80,067	72,347	51,705	66,883	120,209	64,292	64,564	47,247	54,495	31,726	38,150	46,335	41,446	24,883	73,480	37,332	39,746	51,036	59,667		64,068	77,868	67,059	72,496					46,514
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			59,954																																		
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			68,647	1,410	1,400	707	581	1,295	501	384	214	209		284	246	242	268		279	709	366	258		307	226	244	162		156	128	141	79					180
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				105,310	101,758	91,128	81,596	162,617	56,466	54,211	39,998	46,618	183,097	42,175	45,347	35,084	35,951	306,542	29,895	37,636	27,240	21,922	160,111	27,281	32,497	42,131	45,618		47,977	56,068	49,550	49,848					42,045
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			60,748	91,653	95,702	94,706	86,147	96,825	55,257	49,373	33,053	40,188	456,884	37,001	39,886	32,660	32,460	274,200	26,109	32,222	24,255	17,416	56,852	23,084	27,031	34,347	36,594	129,491	38,914	47,359	39,555	39,275	113,493				33,063
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			188,419																																		
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			121,730																																		
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			1,855,489	385,879	380,100	347,290	303,834	592,042	239,654	234,120	193,159	213,363	433,700	189,649	218,553	170,344	170,784	672,564	148,409	172,460	142,329	121,548	720,800	159,672	201,537	255,573	280,897		302,138	351,663	319,734	327,791					264,050
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																										2			13			1					82
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			365,402	100,408	93,839	88,934	84,989	271,320	58,754	54,001	37,736	47,485	274,093	42,405	46,026	36,421	37,750	107,264	29,950	37,529	27,567	19,760	118,983	25,984	29,799	37,058	40,594		43,649	51,799	43,390	40,214					34,038
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			119,317	168,246	162,096	148,446	132,301	491,236	97,441	94,735	73,714	83,709	303,040	73,713	84,404	67,156	69,954	404,711	59,892	68,949	55,294	47,889	348,077	59,984	73,439	94,499	103,630		108,794	124,228	112,037	112,839					99,058
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												394,460					353,502				
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												620,162					512,943				
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			56,358	104,200	108,617	98,801	89,540	219,180	57,130	51,241	32,409	37,421	242,403	35,197	38,255	29,483	28,223	393,238	23,846	29,252	21,041	14,519	130,863	19,601	23,124	29,523	31,800	115,718	33,649	40,973	32,573	34,133	140,801				28,301
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			460,770	128,069	123,137	114,347	107,193	271,231	73,497	68,283	48,599	60,103	266,715	54,764	58,621	45,822	47,313	82,941	36,093	41,603	33,925	24,784	181,188	32,546	36,509	45,371	49,473		53,309	64,357	54,999	50,478					40,260
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												2,133,723					1,848,817				
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				564	51	19	34		37	34	24	34		12	48	52	68		53	10	8	2		3	5		6		2	2	3	12					
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			438,436	227,937	220,853	208,755	174,969	236,370	133,002	122,760	101,710	117,649	240,785	109,384	122,331	95,995	88,177	304,234	79,160	90,148	68,747	58,134	398,370	73,561	94,442	118,157	128,769		147,417	167,494	154,487	149,273					132,092
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				71,404	65,328	51,391	38,961	96,942	23,967	22,010	15,408	17,861	54,807	16,061	20,788	15,646	15,271	21,182	11,783	14,906	11,434	8,359	90,759	11,251	14,401	16,981	15,527		16,256	18,499	16,492	14,656					11,850
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			118,929	116,923	100,597	79,383	63,472	207,352	42,556	34,592	25,274	30,570	147,347	30,929	29,828	22,604	18,588	98,671	15,447	23,753	12,118	8,427	6,091	12,669	13,780	17,628	17,261	107,275	31,054	35,880	33,559	25,640	104,520				17,112
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			117,705																																		
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												343,265					865,317				
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												363,245					164,440				
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			537,484	131,394	112,433	106,357	91,709	126,231	55,012	45,345	31,118	47,790	195,519	38,289	35,450	24,290	27,096	54,228	19,526	24,337	16,177	9,891	38,592	18,045	17,598	22,422	25,702		35,896	35,077	34,360	27,931					21,150
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			324,720	337,746	330,820	303,771	267,691	881,932	204,615	196,595	159,022	174,754	509,637	153,440	176,491	143,772	147,671	601,735	126,914	143,408	118,693	105,574	830,855	132,054	163,197	209,593	228,555		244,825	276,599	255,861	258,346					232,276
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			364,349	257,481	252,642	230,953	204,042	580,510	154,548	151,836	121,730	134,462	424,972	119,765	134,918	107,322	108,758	536,356	93,185	106,092	87,591	77,255	586,864	96,890	117,539	149,632	162,906		172,235	196,215	179,126	182,577					157,928
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				2											3																						
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												91,636					75,173				
Kenya	Kenya	KEN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			420,864	146,763	142,611	130,942	121,018	234,229	83,714	74,221	53,470	66,549	215,484	60,076	65,384	50,759	53,987	36,146	41,191	47,350	39,506	28,057	242,411	37,132	42,007	52,848	57,825		64,617	76,739	66,394	59,023					50,483
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												6,568					5,945				
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			1,945	1,573	1,851	2,093	2,353	4,048	1,682	1,827	1,474	1,598	23,540	1,416	1,786	1,494	1,287	10,823	1,221	1,449	1,137	790	2,229	1,074	1,249	1,396	1,203	3,075	1,235	1,272	1,133	1,110	3,148				983
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				1		1	1									2	1																				
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			11,596	4,608	5,237	5,439	6,031	17,371	4,559	5,112	4,006	4,218	9,812	3,624	4,445	3,582	3,311	10,893	2,795	3,233	2,625	1,959	11,723	2,413	2,759	2,927	2,432		2,291	2,687	2,164	1,996					1,660
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			11,936	320	352	256	313	2,937	216	245	145	194	3,442	152	160	151	150	1,530	130	184	125	83	765	100	147	143	107		100	152	100	99					99
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			2,249																																		
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			11,107	2,677	2,804	3,010	3,436	10,875	2,451	2,623	1,928	2,148	13,581	1,899	2,154	1,718	1,722	3,414	1,486	1,595	1,247	878	6,944	1,151	1,261	1,330	1,126		1,117	1,322	1,048	999					834
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			1,649	516	567	517	494	4,894	363	400	281	329	6,049	311	383	328	294	3,643	233	432	249	169		257	275	306	202	1,702	221	252	212	168	1,543				128
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			653	23	36	24	29	84	22	15	10	15		12	10	11	9		2	9	2	4		4	10	4	6		3	2	3	2					3
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			3,543																																		
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				1,282	1,296	1,571	1,875	5,374	1,399	1,480	1,079	1,185	13,736	1,056	1,327	1,117	1,042	5,066	986	1,063	853	596	1,723	798	853	966	796		872	875	755	647					656
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												1,718					3,107				
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				3	1	1	1				1	1				2	1																				
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			18,797	5,376	5,906	5,975	6,346	24,419	4,944	5,408	4,268	4,565	8,051	3,838	4,820	3,973	3,698	7,358	3,241	3,490	2,874	2,023	16,099	2,671	3,021	3,090	2,678		2,632	3,028	2,467	2,138					1,949
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				592	651	682	716	2,403	491	574	362	371	1,565	409	549	388	396	792	300	382	350	213	3,487	316	377	381	339		275	335	274	246					210
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												1,705					1,395				
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			9,354	1,893	2,088	2,154	2,443	7,480	1,723	1,879	1,320	1,479	7,756	1,237	1,583	1,269	1,294	991	1,114	1,091	904	623	9,073	852	933	1,002	914		943	977	881	761					671
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			4,072																																		
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												12,927					10,722				
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				1,959	2,138	2,368	2,732	5,383	1,859	2,207	1,618	1,778	15,695	1,586	1,913	1,510	1,443	6,197	1,253	1,439	1,143	838	3,025	1,109	1,253	1,270	1,085		1,053	1,198	989	923					911
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			12,554	1,323	1,503	1,460	1,355	3,831	1,155	1,139	859	964	2,153	824	931	807	774	2,044	630	782	611	427	5,935	585	775	779	704		672	814	696	552					480
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			4,661	3,050	3,392	3,653	4,193	16,675	3,073	3,476	2,802	2,890	9,730	2,601	3,130	2,710	2,672	11,124	2,267	2,645	2,063	1,493	8,100	1,952	2,258	2,438	2,036		1,976	2,167	1,867	1,610					1,497
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			314																																		
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			51,329	4,501	5,307	4,904	5,085	11,758	4,051	4,518	3,490	3,831	5,323	3,335	3,864	3,042	2,900	3,991	2,632	2,786	2,264	1,612	6,198	2,285	2,650	2,732	2,456		2,348	2,748	2,246	2,012					1,757
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				2,037	2,220	2,478	3,087	5,862	2,071	2,394	1,738	2,006	9,436	1,782	2,070	1,649	1,541	11,222	1,475	1,649	1,347	949	5,163	1,242	1,277	1,425	1,191		1,069	1,307	1,092	1,013					958
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				1,179	1,378	1,526	1,876	5,547	1,293	1,505	1,088	1,237	7,527	1,063	1,336	1,128	1,082	9,073	995	1,140	883	666	2,899	882	957	1,051	895		926	986	776	748					711
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			30,303	967	1,268	990	1,079	3,639	825	864	600	704	2,587	627	779	584	544	626	530	578	453	250	2,481	419	479	473	433		435	521	488	394					358
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			1,762	1,527	1,776	1,967	2,312	8,958	1,595	1,897	1,317	1,496	11,574	1,335	1,773	1,441	1,259	15,165	1,219	1,554	1,203	842	4,710	1,193	1,322	1,412	1,263	3,572	1,234	1,335	1,183	1,198	5,085				1,124
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												16,360					11,052				
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												9,974					5,067				
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			9,422	2,332	2,579	2,927	3,302	10,974	2,303	2,684	1,988	2,109	15,028	1,907	2,344	1,798	1,778	4,457	1,679	1,761	1,400	928	4,728	1,276	1,507	1,486	1,245		1,328	1,437	1,240	1,091					934
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				580	520	598	593	2,425	389	463	328	332	3,325	310	438	281	308	2,226	284	366	263	170		269	330	276	255		228	242	187	189					134
Kenya	Kenya	KEN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												8,634					10,405				
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				1	6	1	2		2	1	12	3	5	5	1	1	1	1	3	3	2																
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex									2																												4
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				670	725	728	694	2,251	654	682	620	587	2,831	470	669	619	519	3,294	537	583	506	428	3,321	536	597	582	585		535	650	595	537					454
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												13,468					11,874				
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				381	609	444	451	682	420	581	539	537	1,750	409	544	483	396	1,364	421	509	421	372	1,356	367	464	523	421		430	506	384	454					364
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				3,377	3,928	3,551	3,472	14,696	3,351	3,920	3,468	3,385	13,596	2,817	3,432	2,980	2,953	14,607	2,770	3,130	2,558	2,391	14,648	2,466	2,908	2,794	2,475		2,418	2,892	2,396	2,442					2,026
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				3,900	4,119	3,852	3,763	18,536	3,496	4,097	3,666	3,639	14,615	3,002	3,770	3,312	3,307	15,655	3,187	3,404	2,961	2,489	15,634	2,570	3,182	2,982	2,827		2,626	2,974	2,577	2,523					2,224
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				1,663	2,089	1,805	1,661	6,899	1,608	2,223	1,829	1,843	6,879	1,515	1,885	1,704	1,722	6,553	1,660	1,942	1,650	1,463	6,550	1,483	1,820	1,739	1,718		1,533	1,850	1,543	1,598					1,334
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				59	66	34	45	571	37	44	30	26	168	42	45	39	25	1,031	33	46	38	37	1,038	33	37	48	44		30	43	50	51					34
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												9,498					8,034				
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								5	5	2	1		2		2	2					
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				2,806	3,093	2,992	2,757	13,995	2,660	3,025	2,873	2,696	11,304	2,193	2,904	2,521	2,331	9,932	2,389	2,564	2,258	1,850	9,933	2,070	2,404	2,398	2,269		2,037	2,406	2,126	2,097					1,750
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female															1																						
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				17	11	11	18	2	9	10	16	11	46	16	17	7	6	52	11	7	12	9	35	4	9	7	11	38	7	4	12	4					9
Kenya	Kenya	KEN	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												26,916					21,414				
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				66	34	13	10		7	24	15	27		5	21	7	6		38	2	3	1		2	3				2	1							
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			159,333																																		
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				5,755	6,338	5,386	5,264	17,573	4,577	6,278	5,767	5,297	15,422	4,557	5,929	5,278	5,322	14,125	5,042	5,577	4,594	3,956	13,987	4,122	5,655	5,784	5,742		4,925	6,179	5,550	5,803					5,443
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												470,147					470,147				
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			2,617	916	1,090	1,024	843	2,589	688	865	763	709	2,192	781	1,232	1,097	780	2,327	826	693	527	479	2,304	575	588	643	451	2,426	516	591	651	530	2,426				406
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			142,168	33,066	37,695	38,858	35,240	151,480	31,943	35,908	34,723	32,366	133,245	30,573	39,940	36,059	31,224	136,502	32,210	30,586	26,804	21,379	135,206	24,544	32,152	35,944	34,238		31,120	37,502	35,680	34,473					30,600
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				860	676	565	530	17,121	392	581	546	393	15,076	495	523	666	445	9,693	456	481	438	400	9,647	366	559	649	554		502	566	558	627					559
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												479,488					479,488				
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			160,389	22,092	24,579	23,513	21,507	98,667	20,211	25,245	22,997	22,206	86,409	18,498	24,726	22,164	22,609	85,468	21,754	23,333	19,366	16,302	84,663	18,054	22,675	23,999	23,499		21,410	24,828	22,074	22,416					21,372
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex			13	2											3											2											
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			2,735	87	31	28	24	51	10	14	13	9	45	19	24	19	7	43	28	19	22	16		22	30	45	9		29	24	39	33					13
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			164,756	69,518	77,616	72,230	67,827	304,286	62,246	73,386	66,890	64,400	266,926	54,915	71,829	64,967	64,326	271,579	62,022	67,169	54,960	44,618	269,014	50,196	62,787	66,755	64,660		60,459	69,538	62,671	64,394					60,868
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			396,861	78,520	90,442	84,757	81,719	375,804	74,955	89,538	83,906	81,466	330,554	68,420	89,019	78,832	75,846	323,368	73,488	80,509	67,153	52,361	320,308	60,528	78,940	83,878	82,808		76,133	90,748	81,260	83,880					71,196
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			164,779	45,873	51,533	47,700	45,354	200,928	42,436	51,042	46,771	44,831	176,003	37,782	48,517	43,200	42,909	179,322	41,065	44,626	36,786	30,411	177,628	33,783	42,109	43,832	42,718		39,323	46,045	41,161	42,332					38,291
Kenya	Kenya	KEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												113,999					113,999				
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												13,562					12,509				
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			10,311	3,948	4,233	3,894	3,829	19,667	3,526	4,135	3,699	3,658	14,827	3,036	3,797	3,335	3,339	15,870	3,220	3,418	2,960	2,499	15,840	2,574	3,205	2,999	2,845		2,643	2,980	2,574	2,549					2,241
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			10,194																																		
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			18,217	2,850	3,252	3,041	2,784	14,748	2,689	3,046	2,901	2,721	11,477	2,223	2,941	2,529	2,348	10,058	2,437	2,586	2,282	1,864	10,054	2,087	2,414	2,432	2,309		2,062	2,435	2,134	2,103					1,770
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			5,314	669	771	750	701	2,281	666	678	625	585	2,881	480	670	623	527	3,333	550	590	513	432	3,359	537	601	588	595		543	652	596	545					462
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												27,099					22,165				
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			81	16	12	11	17	2	9	10	16	9	45	15	17	7	6	52	9	7	9	9	35	4	8	7	11	38	6	4	13	5					8
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				50	40	34	47	573	37	44	29	27	168	41	44	39	24	1,039	32	46	35	38	1,045	34	37	48	43		31	43	50	50					34
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												9,532					8,212				
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				404	531	451	445	685	425	581	540	533	1,755	405	542	484	395	1,382	420	499	429	372	1,374	366	464	526	419		430	504	383	453					362
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female							1																														
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			10,292	3,399	3,942	3,589	3,497	15,522	3,374	3,932	3,506	3,401	13,759	2,821	3,450	2,996	2,974	14,769	2,797	3,136	2,559	2,398	14,803	2,500	2,921	2,810	2,485		2,427	2,902	2,416	2,448					2,030
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			46	9	5	1	2			1	1	3	5	5		1		1	3	3	2			3	5	2	1		2		2	2					
Kenya	Kenya	KEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			10,294	1,706	2,009	1,814	1,693	7,160	1,620	2,240	1,836	1,857	6,932	1,524	1,902	1,711	1,729	6,642	1,670	1,919	1,662	1,476	6,638	1,484	1,821	1,745	1,740		1,540	1,848	1,539	1,598					1,331
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			13,470		10,801		11,181	14,772		4,063		3,178	14,768		5,838		4,197	14,763		6,112		5,043	14,763		8,970		5,375			8,389		4,885					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			9,731		7,001		6,155	3,701		3,211		1,400	3,693		3,857		3,713	3,699		5,261		5,136	3,699		6,003		4,460			7,086		3,906					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												44,289					44,289				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												24,368					24,368				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					3,089		3,186	14,786		1,819		1,527	14,768		2,968		1,877	14,763		3,223		2,807	14,763		4,005		2,383			5,365		2,177					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			47,968		20,477		26,060	59,095		26,671		34,583	62,430		35,787		43,238	109,403		26,255		35,111	109,403		40,756		34,415			40,266		29,895					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												195,469					195,469				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			18,027		17,067		15,121	4,947		9,542		14,489	4,924		9,036		6,891	5,339		44,499		5,341	5,339		10,858		7,367			9,565		8,396					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female							1,142			8												193															
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			4,708		3,794		3,304	1,252		1,908		664	1,230		1,811		1,607	1,227		3,866		1,692	1,227		3,037		1,472	1,227		3,957		1,713	1,227				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			9,731																																		
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			9,731		10,570		11,553	3,701		7,009		5,400	3,693		6,938		15,999	3,893		6,929		8,129	3,893		7,717		6,620			9,123		5,576					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			54,437		31,632		36,902	147,291		46,604		78,327	209,539		47,096		81,345	83,175		51,440		63,756	83,175		64,000		60,295			60,592		52,774					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					2,936		2,790	3,707		2,007		792	3,693		2,720		2,275	3,699		3,975		2,527	3,699		4,564		2,868			5,473		2,323					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												11,097					11,097				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			13,325		7,162		7,454	14,784		2,942		2,573	14,768		4,978		3,502	14,763		5,133		4,304	14,763		7,803		4,419			7,492		3,908					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			13,325		12,504		14,162	14,776		5,618		3,353	14,768		6,353		4,409	14,847		8,326		6,425	14,847		10,887		5,738			8,494		5,225					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												10,518					10,518				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			40,976		11,437		13,774	231,842		51,256		69,098	54,449		51,846		32,837	135,378		53,987		45,838	135,378		60,025		37,203	135,378		60,917		54,104	135,378				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			13,325																																		
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			9,755		4,832		3,934	3,706		2,360		945	3,693		3,555		2,784	3,699		4,600		3,484	3,699		5,570		3,728			6,201		2,856					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			5,017		3,762		3,676	4,932		1,889		1,097	4,924		2,265		1,790	4,925		3,680		2,066	4,925		3,476		1,602	4,925		5,199		2,953	4,925				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					4,101		5,388	14,770		2,256		2,124	14,768		3,963		2,784	14,763		4,134		3,566	14,763		6,514		3,701			6,761		3,241					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			22,644		13,667		13,622	14,747		4,236		4,764	14,768		6,153		5,592	15,038		27,083		5,585	15,038		11,582		5,211			8,459		4,867					
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												32,646					32,646				
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male							1			26		939			3																						
Kenya	Kenya	KEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					3,124		2,257	3,707		1,661		616	3,693		1,868		2,052	3,699		3,199		1,739	3,699		3,232		2,192			4,411		1,556					
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			4,396	4,137	5,019	4,857	6,925	4,345	4,222	4,589	5,563		4,584	4,605	4,734	4,402					3,214
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			6,626	6,324	7,977	7,834	6,511	6,814	7,567	8,472	8,194		7,777	8,051	8,030	7,983					5,808
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			3,081	3,285	3,479	3,318	6,925	2,954	2,870	3,264	3,926		3,402	3,653	3,749	3,476					2,588
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			483	590	638	635	6,925	615	568	705	1,061		983	925	1,110	927					741
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												6,230					6,495				
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																				1	1			2	1												
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												4,156					10,223				
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			4,230	4,454	5,059	4,740	6,925	4,022	3,966	4,483	5,613		4,881	5,158	5,378	5,146					3,912
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			8,879	8,722	10,598	9,462	41,331	7,561	8,316	9,881	10,771		9,892	10,433	10,969	10,374					6,005
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												5,638					10,177				
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			2,133	2,299	2,434	2,362	6,925	2,235	2,193	2,237	2,466	2,075	2,268	2,406	2,575	2,603	1,774				2,105
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			1,298	1,507	1,609	1,628	5,178	1,454	1,943	1,823	1,979	1,555	1,625	1,705	1,865	1,795	1,140				1,535
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												4,156					7,782				
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			3,184	3,636	3,652	3,335	6,925	2,900	3,079	3,727	4,866		4,291	4,536	4,872	4,830					3,401
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			4,451	5,529	5,381	5,442	6,511	4,736	5,401	5,794	5,893		5,644	6,170	6,225	6,157					4,970
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			1,658	2,344	1,905	1,821	6,925	1,582	1,551	1,601	1,947		1,627	1,817	1,834	1,785					1,409
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												3,905					18,771				
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			2,332	3,597	2,663	2,596	6,925	2,272	2,192	2,308	2,785		2,415	2,515	2,597	2,413					1,924
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																					1			1													
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			7,754	7,216	8,889	8,519	6,511	7,483	7,825	8,830	8,885		8,698	9,210	9,279	9,159					6,882
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			2,854	3,082	3,604	3,214	13,214	2,291	2,428	2,908	3,248		2,888	3,336	3,688	3,652					1,776
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												16,361					20,371				
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			2,866	4,000	3,273	3,277	6,511	2,942	3,454	3,655	3,609		3,446	3,637	3,850	3,752					3,108
Kenya	Kenya	KEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			1,741	2,171	2,056	2,063	5,763	1,892	2,189	2,210	2,246		2,146	2,266	2,346	2,214					1,968
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					4,835		6,984	4,316		6,858		9,148	41,426	8,096	13,377	16,634	21,310	39,358																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					1,618		2,103	4,026		2,355		3,219	5,402	2,662	3,715	4,554	6,237	6,595																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					519		732	2,449		832		1,145	1,059	995	1,383	1,817	2,257	4,932																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					981		1,498	849		1,583		1,943	8,236	1,628	2,301	2,813	3,660	6,595																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					1,989		2,909	5,890		2,819		4,123	5,994	3,534	4,983	6,279	8,437	6,192																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female					9												1																				
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					1,976		2,547	2,676		3,136		4,501	7,269	3,927	5,490	6,923	9,763	6,595																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					2,146		2,578	4,350		3,281		4,489	6,452	3,883	5,413	6,803	9,195	6,595																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					19		16																														
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					1,117		1,547	1,423		1,789		2,388	4,259	2,062	2,803	3,508	4,561	6,595																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					1,219		1,665	1,269		1,746		2,531	4,267	2,435	3,239	4,120	5,252	6,192																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					632		956	1,417		1,151		1,530	3,226	1,353	1,799	2,309	2,979	6,595																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					3,822		5,006	8,414		5,275		7,441	7,727	6,769	9,626	12,239	16,264	6,192																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					713		981	1,139		1,081		1,488	3,129	1,332	1,750	2,258	2,905	5,487																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					1,264		1,548	893		2,153		3,301	8,366	3,030	4,557	5,943	8,812	6,595																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					184		262	594		314		507	9,526	465	828	1,018	1,492	6,595																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					1,468		2,489	1,663		2,426		3,426	16,168	2,747	4,738	6,197	7,809	12,582																			
Kenya	Kenya	KEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					3,012		3,853	6,080		4,401		6,383	7,389	6,004	8,364	10,378	13,547	6,192																			
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												13,418					19,430				
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			920																																		
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			12,722		2,819		4,478	3,245		4,039		3,579	29,587	2,813	6,006	4,394	4,450	28,115	4,443	8,250	5,608	2,432	29,522	4,385	7,870	8,231	6,259		8,106	11,239	7,856	6,291					5,828
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			3,665		996		1,661	834		1,772		1,423	11,545	1,181	2,354	1,833	1,467	8,987	1,464	3,015	2,309	791	9,438	1,536	2,909	3,065	2,791		3,210	4,469	3,387	2,639					2,018
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												9,890					14,858				
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					504		657	1,280		687		784	3,035	409	741	726	1,061	4,710	640	952	758	412	4,945	687	934	1,161	1,034		1,258	1,400	1,190	984					1,133
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female					4												1								1		1										
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												38,960					38,901				
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			2,127		1,997		2,584	6,788		2,398		2,644	5,529	1,950	3,050	2,862	3,541	4,426	2,799	4,941	3,773	2,028	4,651	3,283	4,928	5,935	4,755		5,761	7,335	5,798	4,990					5,639
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					265		467	1,278		400		450	2,305	246	466	473	664	4,710	408	642	502	251	4,945	388	561	739	683		774	970	719	562					670
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			1,540																																		
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					320		423	1,047		359		426	2,230	255	433	481	659	3,920	477	761	590	312	4,116	518	739	865	713		870	1,049	796	689					741
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												9,890					19,521				
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			606		264		347	2,042		306		339	756	182	402	402	439	3,522	432	584	420	242	3,696	324	581	625	543	3,696	613	742	550	474	2,175				422
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			602		472		777	809		611		585	5,880	275	646	620	842	4,710	574	874	621	315	4,945	556	811	990	863	4,945	1,002	1,266	973	861	3,381				812
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												14,835					12,406				
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					559		724	1,149		647		808	3,043	539	849	934	1,081	4,426	890	1,439	1,180	598	4,651	904	1,341	1,583	1,381		1,596	1,915	1,569	1,321					1,415
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			1,264		985		1,256	3,267		1,377		1,549	4,610	964	1,549	1,468	2,080	4,710	1,221	2,108	1,581	837	4,945	1,338	2,059	2,457	2,296		2,723	3,074	2,582	1,981					2,023
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												9,302					35,848				
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			1,537		995		1,104	4,529		1,169		1,383	4,278	911	1,461	1,477	2,016	4,426	1,569	2,620	2,174	1,087	4,651	1,800	2,692	3,249	2,725		3,017	3,748	3,137	2,595					2,869
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			1,235		808		1,030	3,198		969		1,038	3,861	561	1,118	992	1,492	4,710	923	1,436	1,113	576	4,945	949	1,324	1,712	1,640		1,844	2,137	1,648	1,331					1,461
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					6																									1							
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			922		1,005		1,399	2,068		1,424		1,576	5,183	974	1,710	1,664	2,497	4,710	1,414	2,505	2,017	1,018	4,945	1,654	2,496	3,208	3,081		3,416	4,080	3,387	2,541					2,863
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			1,558		1,453		1,869	4,717		1,912		2,423	5,277	1,634	2,499	2,386	2,974	4,426	2,421	3,856	3,121	1,739	4,651	2,734	4,040	4,624	3,847		4,542	5,534	4,389	3,960					4,147
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			302		110		141	627		164		224	6,803	209	270	235	375	4,710	292	473	405	172	4,945	338	639	664	1,033		897	1,087	947	816					552
Kenya	Kenya	KEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			1,809		696		910	1,031		1,073		1,274	5,974	918	1,531	1,691	2,427	4,710	1,409	2,440	2,124	1,028	4,945	1,773	2,763	3,594	3,346		3,744	4,564	4,091	3,223					3,110
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											501					600					553
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male															1																						
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											444					514					424
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				76	86	84	82	310	54	59	63	35	554	43	75	49	61	173				273	202				364					324					293
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											261					412					406
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												1,925					3,036				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												803					818				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											249					398					428
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				101	123	101	113	1,170	91	92	65	66	1,361	71	101	77	69	375				320	496				405					374					300
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				278	365	331	304	1,075	258	294	212	260	513	194	229	218	233	891				905	1,073				1,148					1,088					870
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				288	285	329	410	1,078	306	328	240	330	499	246	338	330	288	889				1,372	1,059					960					2,735				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				439	492	479	510	1,164	385	468	394	492	1,682	400	478	474	386	1,012				1,885	1,175					1,394					3,013				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												2,808					2,380				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											1,391					1,152					983
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				74	53	48	69	1,173	32	46	42	33	1,554	45	57	35	37	412				167	576				217					218					185
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				314	350	346	334	1,165	285	343	243	276	1,196	269	300	293	240	1,454				1,131	1,505				1,560					1,407					1,334
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				403	442	434	445	1,169	291	425	297	379	1,255	329	389	389	356	1,328				1,423	1,496				1,824					1,726					1,511
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				44	6	10	15	257	9	4	9	9		10	6	10	4					28					48					49					43
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female				1																							1										
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				432	453	426	472	1,071	372	382	321	299	537	303	380	318	285	1,270				1,249	1,324				1,574					1,443					1,178
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												2,793					703				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											1,598					1,284					1,093
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				169	164	194	181	1,073	134	170	120	139	905	111	137	119	126	555				485	657				646					610					481
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				401	422	368	382	1,069	300	331	315	285	454	248	312	333	283	1,335				1,309	1,262				1,804					1,718					1,450
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			8,962																																		
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				305	315	299	267	1,072	288	274	234	267	449	246	298	247	245	1,373				1,091	1,335				1,461					1,425					1,319
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				168	224	214	213	1,068	181	212	167	192	526	147	218	179	196	1,335				833	1,306				1,246					1,216					1,098
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			38																																		
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											313					468					497
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												2,862					4,904				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											292					515					480
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				222	234	231	256	1,169	148	198	182	167	1,032	148	203	158	178	670				664	807				758					702					596
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				70	72	82	96	255	51	57	46	47	780	44	47	41	47	302				221	223				369					244					215
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				94	101	100	102	255	77	62	55	51	821	44	61	48	46	251				216	191				375	413				306	421				262
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												1,924					1,005				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				429	443	425	436	1,166	384	415	316	352	1,260	284	373	294	313	1,084				1,180	1,186				1,381					1,228					1,039
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												4,210					5,751				
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			10,381																																		
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				81	66	84	74	1,075	49	44	50	44	1,203	36	42	40	34	336				171	398				252					235					198
Kenya	Kenya	KEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				394	532	488	454	1,168	361	503	404	395	1,281	365	445	340	392	1,321				1,506	1,454				1,827					1,686					1,471
Kenya	Kenya	KEN	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female																	1															1					
Kenya	Kenya	KEN	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			91,499		30,065		25,846	678,078		28,404		25,076	56,196		18,865		6,079	49,400		5,062		13,629	49,124		25,517		31,754	71,404		37,075		32,459	68,739				20,229
Kenya	Kenya	KEN	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			43,135		17,433		13,977	391,519		15,641		15,970	67,668		9,726		3,563	21,628		2,969		8,650	22,600		13,388		16,347	35,317		19,275		16,885	33,562				15,519
Kenya	Kenya	KEN	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			18,442		5,268		3,299	78,742		2,956		2,411	9,123		1,542		575	5,159		358		531	2,762		1,205		2,413	3,133		3,319		2,602	2,797				2,579
Kenya	Kenya	KEN	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male					13										1										1							1					
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				418	385	432	409	1,464	231	357	212	213	1,605	197	235	158	217	1,479	270	294	275	253	1,634	475	415	536	534		378	506	346	436					413
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				99	131	143	93	1,469	93	70	53	44		46	77	86	114		92	134	106	77		115	86	61	81		54	96	132	98					57
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				1	1		1								1	1	4					1			2												
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												7,335					5,949				
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												6,824					7,861				
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				858	1,023	905	895	3,047	781	854	626	719	3,215	570	684	624	688	2,996	616	858	690	571	3,297	724	914	807	798		757	929	767	849					819
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			21,716																																		
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				662	683	656	663	4,706	488	591	414	392	4,934	406	500	415	469	4,656	462	567	484	430	5,121	503	618	659	644		538	708	574	672					563
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				436	418	437	390	1,467	316	402	256	269	1,608	208	322	227	291	1,471	285	365	273	303	1,622	393	451	542	575	3,542	411	475	444	419	2,416				367
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female				1	1		1										3															4					
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				391	457	464	439	3,050	371	412	356	369	3,134	297	400	366	398	2,926	352	511	449	355	3,218	491	527	595	619		454	601	573	579					573
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				578	598	623	581	3,051	460	460	386	397	3,134	319	449	397	406	2,934	434	528	448	379	3,229	411	495	554	531		459	550	510	551					503
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												11,522					8,050				
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				1,399	1,596	1,468	1,530	4,728	1,248	1,542	1,231	1,346	5,061	1,146	1,430	1,289	1,329	4,749	1,271	1,509	1,282	1,181	5,226	1,499	1,677	1,688	1,477		1,366	1,635	1,462	1,612					1,547
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				1,857	2,152	2,109	2,111	4,702	1,619	2,092	1,545	1,847	5,024	1,724	1,981	2,010	1,890	4,624	1,735	2,325	1,772	1,702	5,103	2,067	2,459	2,852	2,407	5,756	2,151	2,801	2,716	2,802	12,964				2,821
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												11,065					9,474				
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												7,458					7,741				
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				925	975	949	956	4,718	804	969	741	799	4,922	767	925	880	808	4,636	799	1,000	830	805	5,098	995	1,191	1,189	1,025		971	1,126	1,062	1,104					1,261
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				939	1,028	862	934	3,042	739	800	683	688	3,219	653	766	699	696	2,984	645	912	719	605	3,281	813	813	881	803		666	939	883	849					841
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				678	578	628	574	3,050	514	541	458	517	3,233	478	539	495	515	2,998	469	691	546	497	3,297	659	665	675	609		500	693	667	728					736
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				1,094	1,236	1,178	1,174	4,695	1,004	1,133	854	928	4,911	820	937	877	863	4,648	840	1,024	876	711	5,114	903	1,069	1,073	1,026		940	1,165	1,039	1,126					957
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			5,724																																		
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												11,728					13,489				
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												17,467					19,787				
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			32,574																																		
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				858	882	815	775	3,040	684	867	632	643	3,127	616	716	625	652	2,937	588	731	619	524	3,229	630	761	746	739		669	849	755	789					696
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				688	693	774	681	1,334	416	655	352	273	1,559	364	707	450	583	1,424	697	799	600	537	1,572	755	891	1,242	922		788	1,178	998	936					892
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				1,375	1,481	1,448	1,447	4,707	1,151	1,298	1,063	1,116	5,055	1,043	1,229	1,106	1,117	4,754	1,068	1,274	1,063	974	5,229	1,179	1,260	1,382	1,299		1,230	1,395	1,248	1,382					1,308
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				1,611	1,820	1,601	1,605	4,693	1,466	1,612	1,259	1,389	4,993	1,242	1,512	1,260	1,346	4,700	1,392	1,565	1,199	1,203	5,170	1,491	1,518	1,657	1,362		1,307	1,612	1,453	1,478					1,320
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				1,082	1,057	1,174	1,229	3,068	911	1,048	758	933	3,222	845	1,036	1,014	932	2,953	888	1,235	1,098	849	3,253	1,227	1,437	1,490	1,547	3,687	1,073	1,661	1,560	1,632	7,842				1,641
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				813	837	730	762	3,050	608	660	595	586	3,151	546	646	617	589	2,937	613	835	687	604	3,231	795	818	891	789		699	869	816	854					924
Kenya	Kenya	KEN	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				1,199	1,319	1,315	1,326	4,689	991	1,306	982	1,109	4,989	995	1,225	1,148	1,135	4,682	1,114	1,348	1,103	1,097	5,151	1,308	1,448	1,518	1,308		1,193	1,484	1,376	1,526					1,397
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			30,258	83,678	87,574	91,961	96,323	35,570	98,087	103,428	106,003	110,885	122,582	112,553	116,035	119,706	121,561	121,894										140,113					152,991				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												26,008					22,640				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												206,081					190,842				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			47,576																																		
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			26,794	11,606	11,478	11,258	11,668	35,452	11,474	12,090	12,504	12,809	14,560	12,891	13,058	12,930	13,224	16,402	13,213	13,650	13,968	14,089	15,421	14,115	14,559	15,116	15,296		15,545	15,870	16,446	16,642					17,035
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			82,231	37,668	38,408	38,184	39,329	97,184	38,170	38,005	37,424	37,218	53,429	36,852	36,608	34,244	34,182	42,011	33,052	32,898	32,080	31,763	39,943	30,899	30,485	29,250	28,891		28,588	28,932	27,798	27,619					25,270
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				83,251	86,819	89,199	92,293	47,846	92,292	94,017	94,730	97,265	103,165	99,372	101,337	105,860	108,283	110,128	109,910	110,806	110,782	111,368	113,686	111,542	113,869	118,489	121,418		123,687	124,253	123,510	123,653					125,642
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			44,160	37,634	37,563	37,755	38,271	42,235	37,333	37,374	37,117	36,935	45,420	37,107	37,088	36,223	35,923	41,579	35,394	35,228	34,147	33,203	37,060	32,068	31,810	30,661	30,169	35,043	29,946	29,926	28,778	28,104	31,842				24,525
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				105,171	108,165	110,733	113,159	50,178	113,798	116,811	118,921	121,079	126,560	122,162	122,546	120,638	120,146	136,951	119,025	120,558	123,561	125,336	127,443	125,831	125,404	123,424	122,362		121,523	123,466	126,876	128,332					127,249
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				26,398	25,996	25,517	24,925	23,213	24,463	24,021	23,548	22,889	29,029	22,432	22,044	21,150	20,749	26,109	20,228	19,936	18,763	18,134	21,416	17,428	17,145	16,157	15,766		15,432	15,254	14,234	13,916					11,850
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			30,960	31,818	34,305	35,802	26,248	37,134	38,270	40,866	41,650		42,441	43,349	45,881	46,512					48,445
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			20,514	22,812	24,097	24,600	11,541	25,277	26,140	28,358	29,020		29,489	30,307	31,969	32,334					36,428
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												184,114					175,664				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			82,087																																		
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			82,011	45,606	46,654	46,743	48,864	96,898	47,677	48,488	48,872	49,145	64,620	48,906	50,021	50,764	51,889	55,367	52,361	52,822	51,773	51,528	56,715	50,738	50,540	50,092	50,077		50,141	49,959	48,097	47,441					44,019
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			36,116	19,037	19,284	19,761	20,560	35,374	20,690	21,050	21,077	21,375	23,426	21,266	21,846	22,401	22,829	24,268	22,971	23,238	23,222	23,059	27,771	22,633	23,011	22,889	23,030		23,136	23,652	22,981	22,824					21,636
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												387,057					392,323				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			145,680	112,354	113,366	115,467	118,218	142,395	117,558	119,492	120,124	121,592	132,132	121,878	124,437	130,288	133,671	137,233	136,571	137,964	138,244	138,298	143,374	137,932	139,311	140,844	142,145		143,137	143,539	141,477	141,080					133,785
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												73,914					77,454				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			50,374	51,727	52,151	52,489	65,093	52,576	53,832	56,078	57,615		58,715	59,832	63,538	64,595					70,478
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			46,533	47,334	49,361	50,765	53,315	51,611	52,320	53,425	53,909		54,015	55,508	57,829	58,418					58,644
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			1,637	866	844	821	831	2,268	763	654	612	623	1,564	588	515	426	371	890	294	389	331	307	628	338	430	378	442	500	274	360	404	366	488				286
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				46,437	49,393	49,998	52,181	47,795	52,419	53,350	53,899	55,250	67,196	55,951	57,089	58,874	60,348	62,377	61,628	62,072	61,916	62,162	63,433	61,640	62,707	64,511	65,625		66,447	66,285	64,938	64,654					64,254
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			145,703	112,598	113,697	114,249	117,009	143,485	115,797	117,345	117,046	118,734	130,877	118,369	118,634	115,116	113,666	133,999	111,108	111,400	110,073	109,965	125,167	108,724	108,205	105,672	104,926		103,993	104,434	101,835	101,173					93,780
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				51,244	52,325	53,677	55,601	48,076	55,319	56,681	58,003	58,624	72,367	58,748	59,404	58,327	58,163	64,840	57,528	57,988	58,771	59,379	62,057	59,188	58,761	57,210	56,664		56,147	56,871	57,691	57,973					55,140
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			193,047	81,860	79,876	78,955	80,351	192,416	78,483	78,383	78,356	79,532	91,131	78,819	80,076	80,862	82,489	89,887	82,138	82,466	79,124	77,608	95,945	74,811	74,707	72,955	72,870		72,115	73,183	69,979	68,889					64,580
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			79,411	121,438	127,863	135,752	141,014	76,695	143,383	150,575	155,351	161,634	158,143	163,851	168,781	174,799	177,986	183,182										201,645					224,745				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			35,165	35,917	36,412	36,674	44,295	36,957	37,832	39,273	40,216		40,735	41,372	41,360	41,808					44,285
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			24,949	27,055	28,785	29,790	17,207	30,517	31,562	34,788	35,591		36,211	37,483	41,190	42,006					48,312
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			20,126	13,691	13,835	14,288	15,048	27,326	14,927	15,462	15,814	16,069	18,904	16,235	16,529	17,065	17,434	18,237	17,602	17,981	18,271	18,577	18,536	18,222	18,419	18,764	18,843		18,965	19,164	19,158	19,138					18,240
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female				548	2		1					4								3																	
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												58,374					54,942				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			52,646	25,132	23,827	23,232	23,522	65,730	22,238	21,753	20,890	20,714	31,565	20,527	20,478	19,418	19,977	26,573	19,581	19,667	18,586	18,378	26,722	17,733	17,603	17,595	17,602		17,780	18,141	17,586	17,520					17,776
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				289	4	2	3							1	1					1																	
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			73,576	75,712	79,774	81,874	78,303	83,585	85,010	86,964	87,976		88,801	91,068	94,590	96,323					100,653
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			100,014	39,555	39,477	39,718	40,969	95,808	40,700	41,730	42,181	42,938	47,573	42,877	43,793	41,799	42,006	48,518	41,307	42,093	40,803	39,983	47,751	39,375	39,966	39,028	38,980		38,996	39,967	38,644	38,665					35,781
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												34,522					38,295				
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				9,826	9,645	9,493	9,699	23,504	9,151	8,472	8,033	8,055	11,613	7,923	7,798	7,298	7,173	9,231	6,958	6,699	6,284	5,890	9,768	5,586	5,551	5,231	5,242		5,173	5,303	5,040	4,946					4,245
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			99,115																																		
Kenya	Kenya	KEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			23,763	23,897	25,305	25,930	17,803	26,538	27,251	28,836	29,067		29,631	30,326	31,031	31,369					32,114
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				494	558	602	643	2,366	465	594	381	406	1,504	417	546	406	407	760	304	418	364	239	2,415	362	442	390	410		263	415	317	303					241
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			1,462	416	420	443	432	4,642	309	377	257	295	5,742	286	336	303	254	3,458	210	288	237	167		239	257	281	178	1,470	213	236	196	150	1,334				132
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												5,649					5,112				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												1,477					2,674				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			2,868																																		
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			10,430	1,929	2,216	2,299	2,697	10,263	1,926	2,200	1,600	1,742	12,912	1,578	1,835	1,465	1,483	3,245	1,270	1,359	1,126	793	4,770	1,029	1,146	1,247	1,068		1,034	1,226	980	915					758
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				1,677	1,970	2,128	2,431	5,718	1,796	2,078	1,589	1,828	8,969	1,624	1,897	1,529	1,411	10,662	1,342	1,466	1,211	885	3,552	1,136	1,233	1,327	1,147		1,005	1,196	991	948					887
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			11,511	4,105	4,559	4,770	5,125	22,087	4,054	4,545	3,628	3,901	7,672	3,388	4,305	3,662	3,440	6,991	3,036	3,398	2,806	1,905	11,057	2,540	2,910	2,976	2,554		2,471	2,948	2,409	1,999					1,854
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								570	550	643	523		508	564	522	477					410
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				934	1,051	1,238	1,577	5,160	1,115	1,170	942	976	13,072	907	1,133	974	916	4,809	901	912	788	523	1,194	735	834	873	782		823	904	721	612					619
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								649	624	619	608		577	596	534	545					488
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			12,588	3,676	4,373	4,533	5,078	15,825	3,807	4,363	3,621	3,836	9,331	3,247	3,958	3,315	2,968	10,349	2,623	3,028	2,442	1,815	8,053	2,358	2,618	2,786	2,331		2,182	2,475	2,017	1,889					1,584
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			33,952	724	706	759	779	3,745	636	637	498	554	2,470	520	661	517	471	598	447	492	421	249	1,811	374	465	428	415		426	480	440	371					328
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								115	167	180	188		181	196	164	153					142
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												8,578					4,358				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			3,705																																		
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								119	165	174	153		163	163	146	149					145
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			10,453	185	236	187	236	2,975	148	220	137	146	3,278	131	128	129	111	1,451	127	119	106	69	561	92	131	130	91		87	129	94	94					93
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			1,773	1,266	1,570	1,707	2,058	3,782	1,425	1,619	1,301	1,347	22,363	1,222	1,592	1,323	1,154	10,281	1,099	1,268	1,024	746	1,564					2,647					2,710				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			13,839	1,031	1,202	1,226	1,147	3,890	1,001	1,028	805	840	2,064	760	869	747	740	1,938	621	738	618	409	4,296	574	795	766	696		658	875	694	540					495
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			10,376	1,683	1,911	2,221	2,490	10,489	1,767	2,091	1,654	1,728	14,282	1,575	1,987	1,617	1,573	4,233	1,528	1,539	1,313	885	3,243	1,194	1,363	1,399	1,182		1,284	1,368	1,138	1,025					847
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												14,069					9,504				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								224	279	293	255		270	279	289	266					258
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male				12																				1		1			2	1							
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				992	1,189	1,422	1,716	5,395	1,175	1,304	1,050	1,123	7,158	1,037	1,252	1,047	1,048	8,618	946	1,052	854	622	2,002	877	929	998	875		903	960	745	734					679
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			8,619	1,445	1,522	1,542	1,824	7,104	1,303	1,527	1,058	1,222	7,377	1,032	1,360	1,124	1,104	943	907	974	833	563	6,236	760	881	946	818		862	942	821	706					618
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			3,725																																		
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			48,223	3,473	4,035	4,140	4,193	10,475	3,378	3,888	3,089	3,327	5,064	2,946	3,558	2,817	2,694	3,792	2,427	2,609	2,157	1,501	4,505	2,145	2,571	2,594	2,334		2,239	2,636	2,140	1,912					1,690
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				477	520	578	571	2,332	394	427	319	320	3,169	280	393	285	295	2,118	253	307	255	161		248	321	265	231		230	248	183	180					133
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												1,467					1,204				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								150	214	227	222		186	215	188	166					150
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female				16												1				3										1		1					
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												7,428					8,950				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				1,436	1,663	1,883	2,109	5,181	1,532	1,797	1,389	1,486	14,925	1,318	1,630	1,334	1,229	5,890	1,139	1,157	1,027	764	2,085	997	1,114	1,169	983		934	1,075	923	867					797
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								189	232	321	265		278	269	243	224					216
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			2,207	255	354	287	294	772	223	237	211	253	713	193	154	152	116	890	117	217	117	138	636	197	249	112	243	502	43	230	203	142	496				140
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			2,132	1,316	1,665	1,866	2,159	8,616	1,497	1,782	1,239	1,408	11,009	1,300	1,627	1,360	1,172	14,403	1,156	1,473	1,166	845	3,275					3,071					4,372				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								124	157	186	151		181	195	162	171					181
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												11,119					9,221				
Kenya	Kenya	KEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			4,164	2,475	2,661	2,894	3,480	16,116	2,559	3,037	2,487	2,517	9,267	2,273	2,840	2,504	2,433	10,567	2,158	2,479	2,001	1,439	5,570	1,856	2,148	2,312	1,976		1,933	2,052	1,802	1,539					1,434
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												31,233					34,374				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								22,128	28,205	30,815	32,245		31,590	33,285	34,125	34,917					29,952
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				26,534	28,376	29,111	31,177		30,451	30,115	31,059	31,244	42,999	31,865	31,120	29,830	24,940	38,983	17,359	12,718	19,358	25,152	35,382	25,137	26,526	26,038	25,772	31,717	25,810	24,889	25,100	24,558	28,835				20,027
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				71,528	79,264	83,346	89,896		89,577	91,365	89,016	93,616	112,451	98,300	98,242	90,406	60,553	114,257	41,792	31,465	38,834	57,074	120,885					127,660					139,459				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				65,761	70,982	74,560	79,322		80,402	77,400	78,018	78,621	97,968	84,647	85,431	80,656	58,490	103,478	40,673	28,044	35,342	50,248	108,099	70,760	88,672	97,483	100,834		98,551	102,423	102,474	103,626					86,392
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												166,377					159,797				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												23,446					20,429				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												185,982					172,336				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				89,950	93,899	94,876	97,238		96,009	96,233	94,153	96,959	124,215	98,057	95,633	87,245	65,142	125,961	43,408	28,827	38,666	52,181	117,718	65,623	77,278	80,690	81,301		79,986	81,074	81,924	82,121					63,120
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				13,439	14,235	14,524	16,005		16,248	16,552	16,541	17,186	22,447	17,338	17,373	17,098	14,268	22,781	10,094	7,571	11,444	15,861	25,564	16,536	17,855	18,359	18,546		18,838	18,354	18,923	19,085					16,950
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				32,563	34,506	35,649	37,820		37,326	38,107	34,764	35,996	58,574	36,574	36,954	34,086	23,405	52,072	15,672	10,534	12,750	18,010	53,430	25,278	32,659	35,571	36,571		36,029	37,653	36,928	36,922					27,327
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				106,903	117,116	124,862	134,670		134,173	136,264	134,051	140,656	150,169	147,404	147,146	135,757	91,203	172,101	62,761	47,922	59,411	87,064	177,697					183,925					204,763				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				58,792	59,764	61,552	62,226		60,941	61,792	58,221	60,653	86,909	60,101	59,465	56,726	43,714	84,479	29,942	19,595	27,448	36,964	89,137	45,167	50,799	53,144	54,176		53,588	53,275	54,705	54,575					42,813
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				7,111	7,448	7,383	7,959		8,161	8,319	8,184	8,704	13,487	9,146	9,371	8,878	7,020	15,668	5,086	3,806	5,078	7,192	14,321	8,626	10,305	11,290	11,743		12,071	12,120	12,667	13,053					12,327
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								16,046	20,460	23,025	23,654		23,140	24,686	25,826	26,297					22,333
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				48	61	10	88		80	90	1	46		79	56	39	79		26	26	32																
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				87,881	93,294	96,018	100,124		99,892	99,476	98,592	101,585	120,130	105,163	103,150	94,693	68,476	128,706	46,142	31,218	39,987	56,691	120,893	78,717	95,197	99,495	100,394		96,491	101,367	104,428	106,549					87,087
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				654	789	756	645		376	270	281	358	1,329	131	135	101	81	512	45	34	57	135	414	153	110	117	100	338	80	69	86	122	326				69
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				40,193	43,471	45,174	47,253		46,330	46,924	44,361	45,726	65,896	47,290	46,408	41,440	27,727	60,616	18,369	13,146	15,371	21,832	58,791	31,444	40,079	42,535	43,042		41,785	44,042	45,355	45,897					35,313
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												65,713					68,583				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				36,201	40,199	42,399	44,947		45,106	43,556	42,716	43,053	61,411	45,854	46,007	42,507	28,990	58,643	20,076	14,585	17,634	25,110	60,305	35,538	45,169	49,832	51,615		50,738	52,738	52,339	52,594					42,240
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				8,805	9,687	10,173	11,318		11,452	11,741	12,522	12,794	17,631	13,361	13,398	13,361	11,364	17,128	8,134	5,883	9,058	12,707	17,582	13,278	14,750	15,283	15,692		15,851	15,718	15,969	16,225					14,606
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								18,693	24,271	28,339	29,608		28,873	31,124	34,052	35,016					33,535
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												351,636					357,011				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								23,641	30,149	34,456	35,499		34,531	36,851	38,656	39,499					34,123
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				6,428	6,658	6,837	6,750		6,378	5,680	5,440	5,278	11,001	5,154	4,835	4,401	3,266	8,656	2,281	1,866	2,822	3,339	8,800	3,280	3,394	3,396	3,414		3,383	3,413	3,484	3,457					2,603
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								34,212	43,276	47,418	49,232		48,090	51,056	53,248	54,588					48,914
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				25,205	26,650	27,574	28,246		28,037	28,558	24,583	25,689	48,118	25,759	25,764	22,339	15,149	39,488	9,892	6,568	7,889	10,901	37,075	14,801	18,918	20,095	20,318		19,984	20,993	20,533	20,750					15,058
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												51,961					48,987				
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				31,176	31,600	31,943	32,769		32,231	32,844	31,261	32,133	45,079	32,507	32,181	29,708	22,677	45,593	15,490	11,005	15,338	20,732	44,593	23,121	26,556	27,820	28,356		28,691	28,509	29,266	29,804					24,323
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								54,199	67,650	72,434	74,120		71,390	75,784	78,681	80,849					69,586
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				13,280	13,903	14,812	15,036		14,867	14,782	11,698	12,383	28,762	12,339	13,036	11,456	8,021	25,400	5,428	3,712	4,645	6,543	24,126	8,669	10,818	11,859	12,153		12,153	12,810	12,773	12,970					10,862
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				281	24	2	42		40	37		14		32	35	28	28		16	11	17						1										
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								14,685	19,046	22,131	23,372		22,847	24,917	26,534	27,074					25,342
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								31,247	39,561	42,455	43,802		42,407	44,844	46,941	47,772					39,263
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				88,684	91,957	94,283	98,119		97,985	98,587	96,298	99,412	125,443	102,089	101,809	98,819	75,880	129,018	52,571	33,985	45,995	63,967	135,649	84,427	102,378	110,377	113,271		111,888	113,850	115,895	116,591					90,919
Kenya	Kenya	KEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				19,120	19,806	20,334	20,774		20,122	19,726	19,214	19,201	27,630	18,648	18,107	16,824	13,702	24,496	9,337	7,173	10,851	13,421	20,443	13,327	13,760	13,196	13,146		12,911	12,248	12,049	11,719					9,240
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														172		279					293
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														94		104					117
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														115		174					160
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														154		283					267
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														306		493					428
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														199		273					251
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														466		585					550
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														129		168					186
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														78		94					127
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														427		601					479
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														492		660					540
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														422		490					511
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														408		619					618
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														527		668					655
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														171		267					276
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														116		248					262
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														358		434					343
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					3,865		3,843			3,265		2,547			2,541		2,233			2,743		2,510			3,372		3,483										
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														14		20					32
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														80		121					127
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														322		503					506
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					467		493			259		222			211		162			261		286			403		414										
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														107		162					170
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														387		567					595
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														338		411					361
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														190		245					264
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														156		241					241
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														79		119					104
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male															1					1																	
Kenya	Kenya	KEN	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					3,241		3,548			2,981		2,255			2,117		2,074			2,500		2,559			3,457		3,483										
Lesotho	Lesotho	LSO	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					5,918		9,675			8,937		10,972			2,510		27,589	13,066		3,044		15,040	13,021		4,143		10,088	4,353		1,593		2,629	5,619				
Lesotho	Lesotho	LSO	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					709		13,676			6,535		6,784			2,039		6,370	10,412		2,441		18,506	18,107		10,938		18,251	14,107		7,062		14,299	8,447				
Lesotho	Lesotho	LSO	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female					1,014															14		367			1,050		1,586			483		221					
Lesotho	Lesotho	LSO	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					1,684		5,924			77		1,434			13,511		25,535	11,428		790		9,076	8,586		6,982		9,002	9,481		2,714		2,762	4,121				
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						10,917					14,183					11,334					12,080														
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			61		287			98		154			173		760			793		1,094			850		1,414			1,554		1,002					661
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			52		49			56		25			24		29			9		15			19		10			14		6					8
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			8		17			20		10			12		20			30		11			17		11			21		16					19
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			508		2,595			2,156		1,351			1,034		1,855			1,177		1,405			996		1,099			915		551					444
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative															3																				
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			290		949			837		792			390		972			882		770			661		157			166		263					58
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			112		197			136		143			52		42			22		29			32		18			111		41					22
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			15		2			3		6			3		3			5		3					3			2		3					1
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		1			1		5					3			1		3			2		4			3							
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1							1					1					4										1					
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			3		3			4		7			14		13			12		37			11		10			14		18					7
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						6,427					8,705					7,926					8,869														
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1		3			4		4					1			6		5			2		2					3					
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			48					2							1			1		1			1		2			1							2
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			5		2			4		8			11		16			9		29			13		14			22		16					7
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative															1					1															
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			26		16			19		8			7		15			2		8			3		5			8		6					2
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										22,667					21,426				
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative					1			2		4			1		6			8		6			11		8			7		11					4
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						11,134					14,118					11,944					13,561														
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			14		3			1		4			3		3			3		3			2		6			1		1					1
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			4		4			6		3			8		5			4		9			8		21			19		9					18
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			661		2,380			2,355		2,474			1,153		2,590			1,463		1,354			1,218		1,067			1,018		687					656
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			9		1			3					3		2					5			2		1			1		2					1
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			27		49			33		33			9		31			17		10			12		1			3		5					2
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			40		51			38		28			24		35			14		11			15		5			8		9					6
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			8		46			27		20			14		42			32		39			40		33			54		50					51
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			16		39			39		39			7		51			40		53			48		53			88		43					62
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			67		233			230		211			98		151			61		68			52		46			73		36					28
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			58		88			59		40			29		32			28		41			45		30			25		15					2
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			723		2,472			2,439		2,794			1,148		2,415			1,533		1,365			1,172		1,016			928		627					612
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			65					1		1								1		3			3		3			1		1					4
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					4			2							1			2		4			2		1			1		5					2
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1					1							1					1			1												
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			393		1,600			1,779		2,049			821		1,931			1,099		980			755		718			709		547					632
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			93		318			201		301			295		1,161			1,229		1,387			1,420		1,948			1,835		1,360					1,413
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			13		9			4		9			14		19			8		22			19		19			25		17					4
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			15		11			11		6			3		8			2		4			1							1					
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			5		1			2		4					7			5		7			5		10			5		6					4
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			12							1					2					1			1		3										
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			13					1																	3										
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			26		45			38		31			25		25			18		12			23		10			16		7					10
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					9																		1					1							
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1		3					1			8		6			4		12			9		5			6		4					4
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			5		6			10		5			20		25			10		37			23		21			16		14					13
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			873		3,092			2,765		3,042			1,349		3,222			1,798		1,661			1,278		1,251			1,188		789					741
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			36		134			117		127			59		70			35		45			51		19			41		21					18
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						9,056					11,856					10,582					11,972														
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			3																																
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			69		181			160		148			79		115			55		47			68		41			78		39					31
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			48					1							2			1							1					1					
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			58		150			112		173			147		654			645		706			729		849			833		671					566
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						8,514					10,965					8,858					8,408														
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			4		9			8		3					11			6		5			9		13			12		13					15
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			103		387			197		363			308		1,271			1,384		1,602			1,397		1,868			1,968		1,388					1,351
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			40		184			143		130			47		57			18		36			36		18			57		27					12
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			43		46			40		33			20		31			17		19			19		15			16		18					4
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										12,607					11,117				
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			37		1										1													1							1
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			11		34			32		29			18		47			38		38			55		45			80		74					66
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			12		8			11		6			4		8			7		12			13		14			24		19					19
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			21		3			4		2			5		2					4					2					1					3
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			52		209			142		284			205		871			940		1,107			1,089		1,396			1,440		1,066					1,289
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3		40			35		18			19		35			18		23			27		28			71		45					42
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			39		1			3		1					1					3			1		1			2							3
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			936		3,343			3,010		3,175			1,432		3,105			1,852		1,740			1,486		1,235			1,117		729					642
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			80		303			221		290			257		1,091			1,152		1,326			1,220		1,575			1,493		1,150					1,035
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			4		10			8		7			7		23			10		39			26		25			19		14					13
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			4		6			4		4			2		3			6		12			9		10			13		10					18
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			16		38			18		30			20		96			118		186			175		45			47		104					28
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2					1							1								1												
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			75		198			189		188			82		100			61		52			45		44			52		39					25
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			41		129			120		110			75		156			214		185			175		58			29		67					21
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			15		58			25		16			7		22			21		25			28		28			87		39					25
Lesotho	Lesotho	LSO	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2		12			4		1			2		2			3		5			3					1		2					1
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			9		1			3					3		2					5			2		1			1		2					1
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			12							1					2					1			1		3										
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			112		197			136		143			52		42			22		29			32		18			111		41					22
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			15		2			3		6			3		3			5		3					3			2		3					1
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3		40			35		18			19		35			18		23			27		28			71		45					42
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			8		17			20		10			12		20			30		11			17		11			21		16					19
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			40		184			143		130			47		57			18		36			36		18			57		27					12
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			11		34			32		29			18		47			38		38			55		45			80		74					66
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2		12			4		1			2		2			3		5			3					1		2					1
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			27		49			33		33			9		31			17		10			12		1			3		5					2
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			21		3			4		2			5		2					4					2					1					3
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			15		58			25		16			7		22			21		25			28		28			87		39					25
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			75		198			189		188			82		100			61		52			45		44			52		39					25
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1		3			4		4					1			6		5			2		2					3					
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			69		181			160		148			79		115			55		47			68		41			78		39					31
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			16		39			39		39			7		51			40		53			48		53			88		43					62
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		1			1		5					3			1		3			2		4			3							
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			8		46			27		20			14		42			32		39			40		33			54		50					51
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			14		3			1		4			3		3			3		3			2		6			1		1					1
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			36		134			117		127			59		70			35		45			51		19			41		21					18
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			67		233			230		211			98		151			61		68			52		46			73		36					28
Lesotho	Lesotho	LSO	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					9																		1					1							
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			38		54			30		19			7		9			16		7			10		8			12		16					4
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			4		12			9		14			3					8		2															
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																												11		7					2
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					1																														
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					10			70		68			29		37			8		26			30		19			37		12					16
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			10		19			15		7					1			6					2		2			2		4					9
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																														2					1
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									2			6		3					4
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation								2		3					10			9							3			3		2					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			8		19			3		5					4			1		1					1			1		6					10
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					2					1																									
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														2					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			50		110			123		46			28		30			109		93															
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			13		30			11		2					2					1			2		2			4		15					8
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					1			1												1															
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					32			97		82			51		91			50		41			49		34			46		25					29
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							74					18		56					15
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												5		2					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy								1																											
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			3		12			4		3			4					3					1		1										
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy								1																											
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			5		5			3		1					1													1							
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							5		2			1		8					6
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			3		9			2							2								1					1							1
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					32			56		74			46		57			23		36			33		20			23		17					19
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1								1																						
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							3					2		2					3
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			5		4			4		7			1		1			6										1							
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					7			12		5					8			2		9			19		11			41		33					28
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					2			1																	1										
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													1		2																				
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												1		3					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												1		2					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy					6			1					1					3																	
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy					3			1															1												
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																									1			17		9					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		1		1			3					1		2					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation								1		3			6		10			10		1			2		3			3							2
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1			6		13			3							2			1							1
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			2		8			5		3			1												1			1							
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			1		6					3			1					5																	
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												2		1					5
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													2		3			5																	
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1			5		7			3					1												
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							1												
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			15		28			18		4			1		7			4		1			1		3			3		3					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																																			1
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					5			7		3					8			1		9															
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							13		4			15		7					2
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												3		2					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							5		2										
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			7		20			13		1			1		5			4					3		1			3		8					8
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			24		42			27		5					1			11		5															
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					8			10		11			2		15			11		27			35		38			63		24					50
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			2		10			3		1			2					10					1					1		1					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					5			9		7			4		11			6		21			31		16			39		29					34
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			23		42			36		21			5		18			13		20			23		7			8		28					2
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			2		2			2		2			1																						
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			2		3																														
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					1			1															1		3					1					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					1			4		1					2			5		4			3		2					1					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			39		34			14		14			2		9			11		8			10		2			3		21					6
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														1					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					1																		1												
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			2		6			4		1			1					1																	
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy								2																											
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							1							1					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									1			7		2					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy								1															1												
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			3		8			6		5			1					1		2			2		2					1					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			30		52			29		7			12		21			18		13			25		9			16		27					8
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			2		9					1			2					6					2												
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					7			20		12			2		7			7		23			30		25			40		39					48
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																																			1
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							3					5		4					5
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										3			4		4			1		4			2		3			2							
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					10			12		19			4		20			16		12			9		1			4		3					
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							14		8			29		6					5
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					18			69		68			30		21			13		13															
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								2		6			1		4			5		6			10		7			15		13					17
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					41			110		99			59		78			42		47			34		38			16		42					27
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy					6			9		1			1					4																	
Lesotho	Lesotho	LSO	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					78			111		127			69		106			36		56			40		37			36		29					20
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			14,152																																		
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								59,180								372			15										27	215							
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			15,202	1,152	1,165	989	2,278	11,470	3,168	5,099	3,591	7,490	11,123	4,746	5,063	5,429	4,812	15,021	5,390	4,888	4,419	5,318	16,188	5,528	5,980	4,719	4,433		4,836	6,995	6,421	6,222					5,413
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			15,679	1,804	1,628	1,430	3,157	11,714	4,755	7,236	4,521	9,795	11,365	6,811	7,136	7,437	6,273	21,559	7,265	6,634	6,129	7,502	23,272	7,700	8,157	6,723	6,544		6,909	9,461	8,947	8,035					7,714
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				298	259	209	395	5,214	611	1,094	877	1,913	5,044	1,677	1,612	1,730	1,610	3,123	1,452	1,124	1,027	1,164	3,373	1,193	1,316	1,125	1,175		1,246	1,709	1,775	1,599					1,458
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				444	387	378	670	5,214	1,172	1,859	1,426	3,109	5,044	2,240	2,243	2,479	2,257	4,705	2,406	1,718	1,680	2,022	5,076	2,093	2,235	1,891	1,971		2,005	2,757	2,860	2,585					2,387
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			2,798	642	542	539	638	3,065	1,053	1,844	1,434	2,859	2,939	3,449	3,040	3,150	2,788	6,089	2,876	1,840	1,819	2,299	6,617	2,189	2,334	2,218	2,510	9,264	2,695	3,595	4,301	3,447	8,172				2,909
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												57,536					48,141				
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			15,611	665	635	568	1,452	14,865	2,359	3,575	2,292	6,084	14,466	11,889	8,664	14,046	15,308	37,637	11,910	8,890	14,150	19,991	40,942	7,535	7,931	12,547	13,020		8,639	10,072	9,922	9,549					8,779
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			13,912	1,049	1,079	1,020	1,950	12,210	2,949	3,908	1,649	4,574	11,689	4,960	3,890	4,858	4,116	8,622	3,146	2,567	3,395	6,677	9,427	2,423	2,692	3,224	3,026		2,677	4,043	4,046	3,529					2,510
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			15,972	1,850	1,777	1,593	3,057	14,432	4,521	6,417	2,674	7,456	13,779	12,424	8,665	11,950	9,068	28,493	7,396	5,160	8,882	18,015	29,916	3,668	4,512	7,126	6,541		4,247	5,847	6,240	5,763					4,002
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			11,172	575	479	450	888	9,031	1,414	2,052	903	3,125	8,646	3,403	2,873	3,532	2,260	9,215	3,572	2,274	2,062	4,897	9,675	2,706	2,411	2,833	3,844		4,221	3,989	4,936	5,678					5,337
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												28,986					23,575				
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												55,366					46,691				
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												137,521					112,461				
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												55,767					43,893				
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				331	363	348	591	6,270	868	1,310	665	1,581	6,002	1,754	1,416	1,759	1,537	3,428	1,245	969	1,234	2,210	3,746	984	1,142	1,230	1,182		1,102	1,665	1,771	1,524					1,271
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			4,501	370	280	273	380	4,961	617	1,903	1,654	3,733	4,807	4,930	4,406	3,979	3,586	8,068	3,505	2,176	2,084	2,560	8,717	2,391	2,993	2,523	2,657	12,205	2,906	3,935	4,427	3,592	10,360				3,512
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				603	694	682	1,141	6,270	1,635	2,355	1,180	2,749	6,002	3,093	2,416	3,009	2,420	5,621	2,060	1,590	2,116	3,867	6,149	1,703	1,832	2,121	2,007		1,664	2,656	2,882	2,562					1,865
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			15,855	2,135	2,165	2,083	3,841	13,379	5,703	7,659	2,973	8,538	12,784	10,609	7,414	9,538	7,890	21,984	6,266	4,363	6,869	13,997	24,080	3,624	4,483	6,141	5,466		3,997	5,720	6,102	5,139					3,778
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			14,891	1,664	1,732	1,563	3,027	12,502	4,533	6,142	2,302	6,779	11,978	7,860	6,058	7,587	6,086	14,294	4,493	3,539	5,211	10,065	15,634	3,355	3,934	4,672	4,269		3,327	5,091	5,417	4,704					3,162
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			32,225	1,757	1,848	1,547	3,339	24,804	4,709	8,067	5,467	10,950	24,081	15,638	13,722	19,360	19,755	49,502	15,375	13,593	20,114	28,071	53,900	11,013	13,824	17,621	16,644		11,043	13,684	12,961	11,784					11,168
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			13,844	744	627	583	1,267	10,756	1,865	3,078	2,352	5,003	10,421	3,213	3,395	3,673	3,429	9,937	3,582	3,076	2,739	3,466	10,725	3,453	3,891	2,999	2,915		3,258	4,535	4,418	4,125					3,891
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male			11																																		2
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			2,852	11	3	2	19	3,115	18	425	515	1,100	2,321	2,873	2,098	2,586	1,827	6,732	2,575	1,566	1,515	2,116	7,243	1,357	1,452	1,760	2,078	8,330	1,799	2,169	2,596	2,559	7,537				1,703
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			13,181																																		
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												28,764					24,762				
Lesotho	Lesotho	LSO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female			29																													4					
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			17,503																																		
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				14,098	13,491	12,199	9,508	7,913	8,606	6,774	2,290	2,012	2,295	2,434	2,052	2,175	1,921	4,610	1,856	1,984	1,796	1,918	30,700	1,827	2,138	1,717	1,776		1,670	1,826	2,004	1,796					1,373
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male					15	2															3	2															
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			95,422																																		
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			66,567	18,173	19,693	18,543	20,875	13,051	18,607	17,058	8,078	6,738	11,242	8,034	6,979	6,830	6,486	10,805	5,294	4,908	4,942	4,985	20,705	5,265	5,737	6,376	5,170		4,823	5,131	5,261	5,560					4,320
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												19,270					14,860				
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			71,057	10,757	10,916	9,539	11,202	21,642	9,575	7,056	1,937	1,240	8,026	1,475	1,088	1,064	1,028	2,789	875	1,021	920	1,057	11,803	1,027	1,262	1,086	1,146	8,491	1,234	1,297	1,568	1,314	8,788				1,126
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			69,371	25,835	30,860	27,750	28,772	25,842	24,532	25,240	12,936	10,809	22,548	11,872	11,259	11,317	9,899	21,593	7,150	7,126	7,086	6,433	29,850	6,140	7,839	7,407	6,378		5,665	6,346	6,110	6,769					5,607
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												52,394					49,105				
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			68,009	15,315	16,222	15,093	15,304	38,505	13,578	9,604	1,594	1,010	46,237	1,644	986	834	607	1,624	637	584	497	504	338	449	569	461	552	5,397	528	466	577	577	3,499				462
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			17,585	8,434	9,026	8,574	9,033	12,366	7,478	6,819	1,774	1,187	5,550	1,627	1,515	1,546	1,309	4,721	1,120	1,439	1,388	1,300	3,995	1,537	2,040	1,804	1,621		1,311	1,595	1,351	1,549					831
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex									1													1															
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				4,101	4,757	4,473	4,651	12,919	3,835	3,344	1,016	661	4,997	1,018	545	595	475	1,615	445	523	432	487	647	526	557	529	622		576	655	589	612					622
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												28,558					24,739				
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			30,291	9,868	10,185	10,180	10,847	4,477	8,758	7,529	1,878	984	2,345	1,708	1,636	1,668	1,290	5,525	937	1,339	1,543	1,685	8,726	1,809	2,144	1,751	1,588		1,394	1,637	1,341	1,736					519
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																													7								9
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												11,977					10,367				
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			8,442	2,549	2,536	2,071	1,282	30	647	379	222	173		128	157	145	147		122	100	77	45		72	55	51	57		55	90	56	38					55
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			70,348	21,032	22,476	18,730	19,826	31,609	16,606	12,423	2,521	1,511	12,482	1,684	1,122	1,070	891	1,387	752	819	727	766	20,206	828	924	729	870	10,776	888	973	960	884	9,661				960
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			29,812	8,593	9,997	9,031	9,670	21,871	8,212	8,022	3,131	2,575	9,593	2,684	2,524	2,577	2,397	5,133	1,844	1,957	1,706	1,774	4,268	1,652	2,075	1,853	1,835		1,866	2,030	1,905	2,125					1,930
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												9,033					6,412				
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			31,003	12,919	15,125	14,131	14,381	21,370	12,498	12,343	5,485	4,378	12,520	4,671	4,382	4,320	4,017	9,439	3,081	3,210	2,929	2,865	9,470	2,720	3,476	2,902	2,907		2,751	3,233	2,937	3,325					2,821
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				14,461	12,106	10,735	9,283	23,592	8,513	5,972	900	698	4,760	1,241	861	827	595	1,626	559	532	486	592	1,001	553	620	595	609		657	612	1,016	890					533
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			20,460	9,976	10,577	10,091	10,533	10,318	8,703	7,983	1,974	1,255	4,147	1,849	1,765	1,807	1,472	6,325	1,118	1,410	1,495	1,396	6,690	1,720	2,163	1,719	1,502		1,377	1,738	1,412	1,536					746
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			51,318	8,299	7,539	7,690	9,526	3,297	8,090	5,732	1,033	498	1,548	1,158	916	907	780	7,247	459	648	1,141	1,579	6,995	1,230	1,172	1,477	833		1,304	1,284	1,901	1,954					257
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			30,345	18,707	22,045	19,949	20,635	22,276	17,322	17,795	8,388	6,885	9,472	7,377	7,216	7,096	6,551	13,770	4,953	4,797	4,307	4,415	16,000	4,142	5,084	4,120	4,158		4,020	4,561	4,410	4,478					3,917
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				5,547	6,358	6,062	6,311	17,623	5,159	5,208	1,673	1,170	7,233	1,315	1,185	1,154	1,044	3,400	897	976	925	939	1,579	973	1,113	946	993		980	1,084	1,035	1,126					1,026
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												20,861					14,910				
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			17,123	5,854	6,202	6,154	6,545	14,442	5,489	4,989	1,434	973	5,785	1,279	1,117	1,135	999	6,388	893	1,176	1,171	1,025	2,154	1,224	1,543	1,372	1,292		1,162	1,399	1,232	1,318					846
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			29,546																																		
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female					8	3											4								1						2						
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												16,541					9,218				
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				3,894	4,112	4,386	4,563	13,593	3,675	3,480	999	676	5,159	862	734	759	673	5,072	618	798	741	792	3,116	758	1,011	928	937		839	987	891	973					728
Lesotho	Lesotho	LSO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				2,573	2,707	3,049	3,020	10,232	2,535	2,258	623	420	3,212	597	461	462	433	5,995	335	475	477	444	3,003	455	669	580	586		546	653	638	620					535
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			924	62	59	63	63	437	37	36	14	11	263	20	14	13	16	55	28	22	18	14		8	13	10	10	156	6	20	12	19	238				15
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			5,366	932	1,074	865	827	1,121	749	871	380	352	636	473	475	423	394	788	342	381	385	391	913	341	469	353	323		292	390	284	287					245
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			4,099	708	709	566	661	1,487	557	512	192	183	1,001	282	260	261	255	1,208	253	260	222	236	379	231	251	202	189		210	240	179	176					117
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				307	323	295	297	1,890	275	281	142	110	1,316	157	149	130	135	575	147	136	134	139	172	146	164	124	133		118	151	120	111					81
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												142					215				
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			657	53	28	33	35	35	36	25	12	9	160	19	13	14	5	124	13	14	9	19	268	19	12	12	13		25	19	30	9					19
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			3,425	624	573	530	578	1,696	560	517	210	224	1,153	271	256	228	228	1,568	237	279	222	227	267	257	261	198	180		223	266	200	197					145
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			5,958	773	929	758	741	2,314	660	767	285	258	1,572	331	393	381	341	476	297	363	319	304	442	265	377	279	240		254	337	260	233					209
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			3,069	488	520	455	439	1,002	368	362	145	130	615	192	179	150	149	1,037	141	133	149	144	459	158	166	124	140		111	162	104	114					84
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												796					558				
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,580					1,166				
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			5,058	927	1,076	865	888	2,081	815	968	449	357	1,142	433	549	422	420	642	383	442	393	385	699	370	478	360	333		342	460	340	296					285
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			232	24	12	20	5	6	15	10	8	1		4	2	7	4		6	6	6	2				2			3	1							1
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			1,046																																		
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				61	47	40	34	218	14	15	11	4	174	15	9	10	11	27	5	18	15	10	5	15	13	6	9		8	8	4	9					4
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,351					743				
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			1,965	297	322	276	309	295	256	227	114	90	296	175	133	137	122	360	126	128	161	160	617	141	152	141	128		124	147	103	183					126
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			1,750	310	318	277	327	2,447	320	256	146	103	1,764	157	161	144	143	449	137	158	142	138	1,488	135	142	112	109	1,190	134	121	125	125	1,091				109
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												868					453				
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			1,409	211	199	158	154	205	142	140	63	36	292	63	64	61	57	502	51	56	52	51	374	48	76	57	51		48	57	51	47					38
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			2,615	346	397	307	333	3,378	318	252	95	116	2,275	149	133	140	155	287	133	120	125	127	2,772	133	142	105	115	1,490	126	138	134	106	1,550				106
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				365	413	379	395	1,542	327	356	137	132	1,007	199	176	176	144	1,003	181	191	186	185	327	170	187	147	152		159	202	153	167					128
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				198	243	197	208	1,431	192	168	65	47	964	96	88	80	81	334	79	99	66	80	88	104	87	77	82		72	104	94	50					49
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			4,318	506	579	489	502	2,331	454	457	198	176	1,565	243	262	253	257	417	247	255	210	248	245	184	281	196	167		190	254	172	148					152
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												1,186					1,292				
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				225	199	205	246	1,181	216	201	76	58	779	101	96	107	99	1,153	81	96	87	91	290	96	112	92	95		95	113	117	94					83
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			3,974																																		
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																	2																				
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			3,941																																		
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												1,774					1,704				
Lesotho	Lesotho	LSO	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				64	50	58	37	79	27	37	8	10	72	12	18	17	15	76	17	14	15	16	392	12	14	12	10		7	18	14	5					4
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				438	504	493	479	2,145	421	572	481	485	938	439	548	414	453	1,502	370	438	356	373	1,961	326	377	320	302		238	332	270	274					282
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				104	157	105	108	355	102	108	104	109	2,083	90	110	89	101	341	80	105	91	96	364	83	112	79	95		72	84	71	87					64
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												1,220					1,260				
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female										5					1																						
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																									1	1											1
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												1,506					1,460				
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																													1								
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				254	321	273	297	1,445	237	300	266	275	734	273	321	289	279	755	251	279	209	209	1,092	229	252	231	220		194	244	196	225					182
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												3,220					3,944				
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex					8	2			1			1	126		4	2		2	2	3			6				3		1			1					
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				59	81	61	107	143	51	85	100	81	212	86	90	89	86	110	67	86	86	102	148	86	82	73	68		50	77	62	61					66
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				464	663	539	542	2,239	491	556	503	560	1,480	503	587	450	456	1,370	354	436	378	378	1,704	338	392	335	318		265	345	255	300					262
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				6	2	6	3	143		6	6	10	299	10	8	6	6	36	6	8	8	6	49	10	6	7	8		3	7	9	3					12
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex					2																																
Lesotho	Lesotho	LSO	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				402	509	424	423	1,314	387	504	389	375	3,705	428	477	379	334	1,135	264	286	246	290	1,402	230	305	252	256		212	285	208	231					220
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex					1				1													1															
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			15,375	2,296	3,081	2,711	2,733	12,997	2,210	3,046	2,848	2,674	10,865	2,668	3,000	2,659	2,504	10,317	1,944	2,330	2,249	2,160	10,615	1,847	2,411	2,165	2,020		1,603	2,130	1,982	2,034					1,873
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			87	1	1					8	2	1		2	1											1				1		1					1
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			10,054	1,752	2,019	1,959	1,999	8,536	1,641	1,962	1,996	1,834	7,115	1,824	2,120	1,962	1,988	4,847	1,572	1,839	1,717	1,730	4,938	1,496	1,729	1,661	1,612		1,311	1,751	1,625	1,626					1,574
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			7,042	1,048	1,300	1,189	1,280	5,939	1,021	1,388	1,307	1,305	7,619	1,164	1,338	1,172	1,209	5,327	991	1,228	1,033	1,090	5,536	930	1,126	992	964		831	1,026	872	969					932
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			3,777	520	694	578	671	3,232	537	692	665	632	3,538	639	614	666	608	2,400	561	640	537	565	2,494	501	606	549	503		462	608	484	546					476
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			205	17	28	40	28	178	27	24	13	26	126	61	32	25	38	126	32	29	18	29	127	24	19	31	32		23	34	23	23					30
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												12,686					12,686				
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												2,911					2,911				
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				158	171	150	179	371	133	202	187	171	304	177	187	190	194	304	153	161	170	190	318	156	175	146	148		112	167	128	149					135
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			10,202	1,618	2,113	1,823	1,992	8,616	1,581	2,174	2,102	1,854	7,466	1,829	2,128	1,803	1,843	6,846	1,442	1,821	1,536	1,596	7,150	1,392	1,800	1,464	1,507		1,240	1,566	1,329	1,435					1,371
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				13	10	14	17	372	3	23	16	20	299	19	24	14	22	96	14	15	12	13	99	19	15	18	19		6	11	18	8					21
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			929																																		
Lesotho	Lesotho	LSO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												15,553					15,553				
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												1,523					1,471				
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												3,229					3,954				
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												1,220					1,261				
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			3,490	399	512	427	431	1,381	372	496	389	365	3,723	433	470	376	335	1,143	270	283	248	294	1,416	232	304	256	258		208	285	207	232					226
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				59	82	61	86	173	53	84	107	82	212	86	89	89	85	110	66	84	86	99	148	84	82	73	69		52	77	62	61					62
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			1							5					1											1				1							1
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				6	2	6	4	174		7	6	10	299	10	8	6	6	36	7	10	8	6	49	10	6	7	7		3	6	9	3					13
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			3,030	440	508	497	503	2,258	415	568	482	481	967	439	538	414	456	1,504	371	437	358	377	1,965	325	373	326	300		238	334	271	274					284
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			918	112	132	104	113	385	89	106	105	99	2,091	84	112	91	103	345	84	96	89	94	370	83	110	80	95		72	84	71	88					100
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			1	1	1	2						1	126		4	3		2	1				6				3		1			1					1
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			3,226	467	650	538	547	2,348	495	569	512	559	1,507	503	583	461	454	1,374	360	437	378	383	1,712	340	395	335	319		269	346	256	302					284
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			1,584	252	322	273	299	1,518	243	300	283	271	747	272	309	291	276	756	254	280	210	208	1,093	226	251	231	217		194	244	196	225					187
Lesotho	Lesotho	LSO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			623																																		
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			3,968		621		2,188	4,096		369			8,438		3,098		1,445	8,071		1,081		1,745	7,756		1,803		5,004			1,791		1,853					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					51		86	570		6			570		1,761		2,930	570		6,260		4,915	570		2,971		7,867			2,653		3,137					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			2,608		41		225	3,442		46			3,442		10,202		7,188	3,442		16,193		13,179	3,442		10,468		24,845	1,423		7,866		9,280	1,567				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												5,719					5,983				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			7,317		3,807		5,306	11,666		2,287		7,803	30,547		9,521		14,534	29,984		8,681		8,016	29,740		10,767		15,453			5,651		6,125					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					80		150	577		8			3,580		2,064		4,137	3,580		8,960		8,439	3,602		5,375		14,900			4,667		5,506					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					1,529		1,504	4,584		2			9,784		1,284		3,266	9,784		4,384		3,690	9,806		2,031		7,529			2,254		2,975					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			14,728		5,232		6,218	18,818		15			24,020		4,616		11,259	23,556		9,417		7,484	23,317		3,563		15,398			4,277		5,683					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			5,218		5,364		5,783	6,878		2			12,466		3,037		8,659	12,153		7,739		6,552	12,117		3,595		13,897			4,303		5,677					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			2,608		181		289	3,442		12			4,498		1,994		6,914	4,216		13,806		13,023	4,129		8,784		26,087			8,228		9,829					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												2,330					2,770				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			951		153		347	1,174		7			1,174		1,347		2,248	1,174		7,512		6,667	1,174		6,770		17,614	485		6,089		7,186	534				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					1,111		869	4,583		3			10,783		758		1,593	10,783		2,689		2,069	10,783		1,314		4,357			1,543		1,993					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female					4		34																														
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			2,608		589		1,015	3,442		2			11,618		1,348		5,604	11,115		15,093		13,210	11,078		9,663		27,398			8,637		10,482					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												13,873					16,651				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			870																																		
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												8,837					9,291				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												12,377					13,296				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			870		147		253	1,144		7			2,144		2,249		5,533	2,144		10,998		10,258	2,166		6,365		18,712			6,006		7,135					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			4,348		3,359		3,834	5,737		4			11,326		2,660		7,936	11,164		7,603		6,672	11,073		3,539		13,790			4,556		5,995					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male					1		21			1																											
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			18,954		1,122		16,231	28,776		4,823		15,397	41,328		10,941		17,465	41,328		10,616		9,643	41,328		13,810		18,711	19,684		12,440		15,043	24,667				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			3,479		2,771		2,597	4,585		2			11,173		1,741		4,770	11,173		5,600		4,767	11,195		2,572		9,922			3,155		4,097					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			17,036		4,012		12,279	27,029		10,724		27,333	36,041		22,800		25,731	35,517		11,210		10,688	35,200		12,160		20,951			6,872		7,258					
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												30,047					35,696				
Lesotho	Lesotho	LSO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			6,954																																		
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			1,176	515	532	576	157	588	698	697	747		660	732	893	841					549
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												10,203					10,203				
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			1,823	798	860	959	440	940	1,079	978	1,111		975	1,037	1,236	1,346					709
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			751	465	446	432	670	373	432	441	483		324	396	504	647					197
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																			1	2	1								2	2							1
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			1,735	1,771	793	861	2,524	678	682	869	906		659	907	1,001	1,236					630
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			499	215	219	236	425	239	272	272	302		292	297	354	319					221
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			382	169	162	173	175	170	191	194	221		203	213	283	282					177
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			780	375	366	418	230	386	416	421	488		400	447	510	579					260
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			515	324	353	264	926	234	318	309	344		253	298	378	500					126
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												2,227					2,227				
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			735	313	320	313	47	338	368	375	354	207	323	386	425	435	207				270
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			547	298	279	308	434	276	296	300	317		287	327	375	413					224
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			105	67	66	59	338	43	84	90	115		57	89	106	158					37
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			2,340	1,762	1,213	1,345	4,065	1,193	1,246	1,418	1,479		1,070	1,273	1,436	1,664					933
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												2,008					2,008				
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																																					1
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			1,575	717	761	846	129	851	907	915	1,004		827	919	1,083	1,061					635
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												1,537					1,537				
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			640	290	277	281	81	290	332	317	300	259	311	389	406	386	259				257
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			807	471	450	445	390	419	463	466	562		402	454	526	632					245
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			766	354	350	389	375	400	429	421	463		454	520	571	529					327
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												1,637					1,637				
Lesotho	Lesotho	LSO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												2,275					2,275				
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					633		372	369		671		2,222	221	907	669	1,623	1,008	2,069																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					783		540	102		784		3,443	139	1,404	771	2,009	1,110	296																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					1,074		679	1,413		1,006		3,702	2,337	1,594	1,014	2,523	1,556	1,194																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					22												3																				
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					584		402	462		552		2,719	1,187	1,140	576	1,458	801	178																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					512		230	1,594		413		1,251	1,071	501	584	1,147	881	2,927																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					275		283	18		397		2,026	18	795	303	872	530	21																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					430		294	1,201		447		1,939	523	734	453	1,133	644	660																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					224		179	713		244		1,334	1,593	513	254	660	311	881																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					1,553		1,390	3,199		2,226		3,662	6,462	1,335	1,329	1,737	3,631	7,662																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					360		263	681		346		1,867	2,270	775	353	934	509	851																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female														4			13																				
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					619		366	41		573		2,262	22	878	530	1,348	791	1,252																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					204		49	7,302		129		313	1,918	89	144	186	191	984																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					142		112	148		174		886	148	368	188	519	227	185																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					294		236	47		318		1,829	92	717	287	825	364	65																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					1,903		1,373	1,282		1,993		4,737	3,078	2,152	1,480	3,166	3,204	12,210																			
Lesotho	Lesotho	LSO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					239		214	811		296		1,386	861	543	274	774	417	1,319																			
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			587		434		309	360		559		343	211	279	436	480	380	1,537	297	380	500	647	1,837	632	754	302	397		544	565	485	518					225
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			994		664		494	1,360		674		383	2,219	377	497	763	668	914	458	645	776	975	1,238	1,041	1,390	849	976		1,223	1,454	1,378	1,278					764
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												4,547					4,547				
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			861		270		255	443		271		176	1,126	127	164	250	223	136	173	220	299	339	504	349	446	310	392		413	525	505	521					329
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			669		239		189	1,153		270		159	497	100	153	207	165	497	114	151	240	271	637	266	368	193	217		217	324	318	285					157
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					51		81	145		83		49	142	36	41	56	54	141	45	51	81	83	567	63	132	61	73		75	116	112	101					78
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					114		134	779		150		117	822	77	90	100	83	1,002	94	110	132	181	1,195	138	216	129	163		141	171	199	189					103
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			1,606		113		145	47		122		70	81	38	41	45	65	49	47	48	49	74	263	78	79	61	75	513	73	81	83	74	513				69
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																	15		1	6	3	1				2											4
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												20,401					20,401				
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			1,152		1,584		1,220	1,224		1,651		868	2,937	891	1,065	1,241	2,439	9,177	991	1,746	1,852	1,885	11,201	1,965	2,775	2,991	2,014		2,123	2,533	2,476	2,553					1,362
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			634		384		277	38		377		210	19	143	264	313	279	928	213	272	359	468	1,060	440	540	276	351		350	503	397	462					201
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												4,449					4,449				
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			899		400		345	98		420		260	125	198	248	418	392	225	302	410	485	573	380	611	813	526	605		686	842	918	895					564
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			1,112		1,490		1,205	3,035		1,992		625	6,132	881	1,094	804	3,315	5,752	954	1,658	1,668	1,653	6,939	2,055	2,361	3,362	2,082		2,195	2,286	2,597	2,415					974
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			714		225		44	6,902		123		36	1,842	61	133	56	125	738	67	122	311	497	944	420	434	130	181		378	428	341	302					86
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												4,011					4,011				
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			872																																		
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												3,270					3,270				
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			675																																		
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					146		149	661		152		108	2,178	71	71	132	109	652	90	117	131	160	1,101	186	226	137	207		176	242	215	259					175
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												3,069					3,069				
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					93		97	691		95		43	1,520	42	34	81	44	675	55	46	53	89	1,265	53	99	87	94		87	99	108	85					78
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			932		125		211	17		166		90	21	53	43	67	85	16	70	59	66	85	160	69	90	79	71	410	77	123	133	132	410				99
Lesotho	Lesotho	LSO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			722		423		233	1,507		391		218	1,023	270	446	421	356	2,193	277	427	638	895	2,517	868	941	288	386		668	725	593	680					237
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											49					80					42
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				63	73	56	61	771	61	44	34	28	239	34	23	37	37	247				172	196				184					232					102
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				29	25	18	26	464	20	13	12	6	292	9	12	13	15	286				46	286				67					52					36
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											286					347					110
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												1,029					1,095				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				28	39	28	44	540	27	37	21	15	285	21	19	15	20	285				124	203				125					122					56
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				103	100	70	103	864	68	63	35	40	405	54	34	45	58	696				245	606				214					203					93
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												1,068					1,203				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				80	80	82	74	793	75	81	44	54	322	54	43	43	53	433				239	361				289					279					125
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				103	84	97	91	875	94	84	62	51	475	75	39	58	76	655				233	521				273					259					121
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				37	37	56	55	540	54	45	17	19	153	32	22	27	37	198				125	155				137					148					93
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											52					72					36
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				5	8	4	6	58	6	4	2	2	235	4	3	3	3	61				12	135				14					10					10
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			6,503																																		
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												284					458				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				8	3	5	12	58	11	11	4	1	218	1	5	4	3	112				15	125				18	45				18	71				8
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											99					94					57
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												473					474				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				55	63	64	45	506	48	36	34	17	232	31	20	20	28	322				98	286				110					114					67
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												652					716				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												52					104				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				67	56	53	62	540	76	73	34	31	188	35	40	41	43	283				185	210				171					167					81
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												592					595				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				69	56	53	91	540	81	58	28	25	479	49	45	40	51	553				244	558					441					493				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				6	3	7	4	641	4	5	1		489	1	2	6	2	295				7	581				13					14					6
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				68	81	57	68	540	60	68	30	33	243	32	25	33	42	349				178	280				145					164					83
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											153					192					75
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											153					218					68
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				41	52	45	40	750	49	24	18	21	508	29	24	13	27	636				106	610				89					77					40
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											77					89					54
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			281																																		
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				16	18	7	9	645	15	13	4	3	384	8	10	6	7	318				44	480				23					35					13
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				1		1	1	58	2	2		1		4	2		2					8					5					7					2
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				136	123	160	184	831	165	156	70	65	629	137	92	97	105	630				587	696					467					544				
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				8	4	8	7	463	6	9	7		424	4	4	3	7	233				21	269				23					18					11
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			3,978																																		
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											204					209					77
Lesotho	Lesotho	LSO	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				4	4	4	3	58	2	6	6	1	169	2	5	4	4	43				17	99				8					7					8
Lesotho	Lesotho	LSO	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			23,649		1,084		3,787	74,485		20,387		10,519	7,978		3,913		3,418	16,225		2,500		2,395	16,205		3,304		3,815	21,069		6,642		3,350	9,563				1,401
Lesotho	Lesotho	LSO	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			10,063		588		1,946	52,036		11,702		6,364	35,863		2,619		1,918	12,733		2,747		2,200	10,354		1,938		2,222	12,161		4,069		2,016	7,076				837
Lesotho	Lesotho	LSO	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			4,621		129		189	5,869		1,108		556	21,916		249		181	886		138		95	1,146		128		666	988		316		107	866				39
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				60	71	65	55	1,132	65	48	22	31	871	38	39	27	49	871	36	42	59	48	871	57	41	37	47		46	47	48	48					40
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				72	69	76	67	676	61	48	36	25	425	38	28	30	36	425	26	44	30	38	425	38	45	35	37		40	43	37	49					36
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												823					823				
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				70	80	64	78	1,132	80	65	41	33	282	44	30	40	47	282	62	56	42	70	282	68	62	56	82		76	87	82	80					47
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				14	9	11	12	1,132	8	7	5	3	898	2	7	7	9	898	6	6	9	7	898	8	17	11	27		15	24	17	17					15
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												404					404				
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				8	8	8	6	97	10	14	8	5	169	2	7	18	7	169	6	25	20	10	169	17	20	20	14		23	31	30	29					38
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				112	125	90	125	1,132	83	97	42	55	860	76	55	56	73	860	80	92	72	73	860	100	74	63	78		90	89	73	82					59
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												1,623					1,623				
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				1		5		97	4	6	1	2		6	3	1	4		4	6	6	2		4	7	3	2		13	5	13	17					9
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				9	15	11	14	676	8	15	16	6	424	7	10	12	12	424	6	8	11	23	424	12	14	21	23		19	17	20	25					17
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												1,731					1,731				
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			686																																		
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				124	110	105	109	1,132	112	96	65	64	741	92	54	76	88	741	78	86	67	90	741	120	78	78	95		101	104	74	118					66
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			9,210																																		
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				80	71	68	72	676	87	84	40	34	299	43	43	41	57	299	54	49	48	57	299	51	51	48	60		68	55	56	46					35
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												823					823				
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				232	203	257	293	1,132	288	262	127	140	1,067	240	187	180	236	1,067	214	254	258	350	1,068	372	326	363	574	1,068	639	536	1,140	429	1,068				412
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												1,528					1,528				
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				87	89	73	90	676	77	73	36	41	398	42	31	42	54	398	45	48	47	66	398	63	40	36	44		47	74	55	47					41
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				4	8	8	8	97	11	10	3	6	235	5	7	14	5	235	17	15	11	17	235	11	24	20	20		22	22	18	30					24
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				10	5	9	18	97	13	18	9	4	221	2	9	8	8	221	8	10	9	15	221	18	23	11	12	221	24	17	23	10	221				21
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				32	43	35	38	676	27	23	18	15	453	17	14	18	17	453	13	16	19	34	453	29	33	26	28		24	25	35	37					23
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				32	42	34	47	676	32	47	20	20	309	25	26	17	27	309	28	30	36	54	309	34	35	32	46		46	33	49	31					33
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			5,484																																		
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				85	90	83	121	676	120	83	44	50	839	95	76	70	85	839	86	106	88	136	838	136	107	101	168	838	222	182	234	154	838				235
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				30	37	17	20	1,132	26	19	11	14	731	17	23	19	18	725	23	19	19	29	725	20	19	19	28		20	26	28	29					23
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				90	98	98	86	1,132	90	98	56	64	505	75	57	56	74	505	80	66	67	82	505	96	106	86	85		102	101	95	100					68
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												877					877				
Lesotho	Lesotho	LSO	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				40	48	62	71	676	60	46	21	19	215	33	27	36	45	215	33	36	37	37	215	44	54	26	52		50	50	50	41					48
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												5,139					4,823				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			20,763	5,076	5,136	5,121	5,143	28,710	5,110	4,376	3,783	3,718	11,104	3,727	3,377	3,336	3,174	7,525	2,938	2,715	2,603	2,580	6,533	2,636	2,483	2,566	2,559		2,459	2,439	2,466	2,526					2,340
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			4,739	5,114	5,139	5,356	4,760	5,391	5,611	5,790	5,799		5,954	6,158	6,108	6,141					5,458
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			6,953	7,062	6,941	7,087	8,626	7,108	7,331	7,583	7,653		7,508	7,578	7,578	7,584					6,750
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			35,041	31,310	32,606	33,379	33,772	28,882	34,630	36,214	36,552	36,739	41,077	36,939	38,167	38,096	38,299	36,745										43,064					45,694				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			34,499	21,036	21,050	21,882	22,097	17,962	22,162	21,945	22,045	22,112	28,363	22,397	22,396	21,833	21,418	22,661	20,855	20,652	20,450	20,386	20,852	20,557	19,860	19,638	19,590		18,972	19,124	19,206	19,319					17,478
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			3,600	1,952	2,031	2,067	2,017	13,497	2,024	2,101	2,153	2,259	2,914	2,320	2,196	2,213	2,199	2,694	2,139	2,193	2,133	2,200	3,202	2,222	2,129	2,130	2,146		2,067	2,028	2,001	1,947					1,847
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				9,543	10,100	10,373	10,367	35,728	10,943	10,382	10,596	10,480	14,081	10,541	10,845	11,033	11,198	11,982	11,594	11,954	12,077	12,240	12,312	12,244	12,627	12,885	12,903		12,935	13,288	13,368	13,506					13,830
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												63,584					66,269				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			7,361	7,847	7,805	8,065	7,811	8,028	8,377	8,366	8,525		8,787	9,052	9,019	9,183					7,975
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			23,277	21,635	21,698	22,129	22,429	21,165	22,602	23,067	23,196	23,103	28,232	23,316	23,905	23,960	23,823	23,884	23,936	23,569	23,510	23,313	23,462	23,473	23,998	23,926	24,045		23,933	23,876	24,077	24,248					22,941
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				1,053	941	937	885	3,593	884	778	750	747	1,327	697	628	587	582	1,010	546	483	480	455	2,028	457	433	424	432		409	399	406	375					371
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			9,178	9,747	9,846	10,175	9,096	10,245	10,930	11,234	11,337		11,657	12,084	12,041	12,240					11,271
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			4,497	4,287	4,346	4,396	4,327	9,060	4,179	4,082	4,021	4,208	5,013	4,141	3,762	3,535	3,563	4,449	3,531	3,412	3,362	3,401	3,834	3,368	3,157	3,127	3,110	3,537	3,020	2,889	2,916	2,831	3,456				2,397
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			9,222	9,846	9,777	9,744	10,363	9,635	9,730	9,856	9,835		10,206	10,437	10,605	10,681					14,332
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			23,654	9,544	8,941	8,847	8,856	29,145	9,110	8,660	8,490	8,518	18,094	8,534	7,944	7,831	7,685	11,837	7,238	6,795	6,638	6,609	9,942	6,658	6,097	5,968	5,942		5,742	5,650	5,657	5,626					4,777
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			5,485	5,848	5,923	5,956	5,419	5,990	6,415	6,600	6,625		6,803	7,085	7,008	6,958					6,554
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												35,019					33,499				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			10,246	10,112	10,106	10,213	12,643	10,121	10,678	10,999	11,056		11,100	11,170	11,259	11,357					9,888
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				13,657	13,813	14,240	14,154	14,371	14,727	14,290	14,757	15,037	17,404	15,003	15,646	16,211	16,421	15,844	16,811	17,340	17,133	17,103	15,533	17,197	17,981	18,284	18,466		18,661	19,019	18,952	19,477					20,166
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			28,671	18,564	19,126	18,792	18,623	11,027	18,678	18,481	16,291	16,708	21,925	16,318	15,962	15,512	15,448	17,713	14,765	14,036	13,482	13,351	15,333	13,524	13,085	13,029	12,828		12,395	12,278	12,551	12,535					11,371
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				16,095	16,952	17,717	17,960	18,990	18,343	19,185	19,598	19,963	23,707	19,928	20,553	20,390	20,109	21,158	20,608	21,453	21,517	21,537	20,844	21,683	22,513	22,962	23,135		23,170	23,418	23,546	23,882					23,248
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			5,832	3,193	3,192	3,217	3,256	3,172	3,261	3,110	3,099	3,209	5,360	3,326	3,070	3,107	3,045	4,164	3,056	2,890	2,944	2,933	3,964	3,038	2,901	2,844	2,849		2,855	2,843	2,804	2,740					2,546
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			19,594	12,547	12,648	12,551	12,819	23,869	12,957	13,093	12,950	12,930	20,794	13,080	13,055	12,926	12,778	15,628	12,769	12,225	11,937	11,982	14,512	12,047	11,638	11,574	11,523		11,332	11,099	11,206	10,906					10,036
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			777	128	109	118	93	1,315	85	69	77	66	520	69	68	66	58	48	44	47	44	47	62	57	43	46	40	68	42	36	44	51	66				33
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			17,264	9,598	9,424	9,396	9,375	5,367	9,318	9,101	8,759	8,599	13,063	8,691	7,939	7,903	7,683	10,156	7,259	6,751	6,721	6,672	8,926	6,832	6,538	6,369	6,406		6,025	6,178	6,278	6,224					5,711
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			7,184																																		
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												40,036					39,497				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			12,581	13,402	13,593	13,233	15,169	13,270	13,498	13,588	13,705		13,953	14,531	14,934	15,020					20,504
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			18,390																																		
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				11,208	11,350	11,864	12,290	16,950	12,446	13,044	13,189	13,489	18,191	13,536	13,555	13,634	13,609	14,899	13,802	14,012	13,955	14,035	15,038	14,122	14,250	14,207	14,167		14,210	14,361	14,399	14,606					13,961
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				2,871	2,786	2,780	2,749	5,793	2,618	2,428	2,423	2,421	3,207	2,349	2,113	2,016	1,961	2,445	1,923	1,776	1,751	1,697	2,016	1,698	1,567	1,519	1,489		1,398	1,270	1,271	1,202					1,018
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												10,854					9,570				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male																															4						103
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												2,310					2,251				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												11,012					9,961				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			22,020	20,556	21,501	21,963	22,143	366	22,853	24,189	24,416	24,718	31,854	24,828	25,521	25,637	25,850	25,077										29,307					30,794				
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			9,461	1,910	1,770	1,811	1,876	22,472	1,820	1,846	1,814	1,825	5,233	1,823	1,766	1,814	1,749	4,099	1,775	1,749	1,719	1,751	3,906	1,816	1,824	2,032	2,051		1,915	2,052	2,068	2,099					2,089
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			25,797																																		
Lesotho	Lesotho	LSO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female																															7						171
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								24	21	24	22		26	26	18	16					15
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			433	42	33	20	30	1,199	33	23	10	7	153	13	11	23	2	119	9	12	13	10	433	16	11	13	21		15	11	9	7					14
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,283					711				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								67	80	59	59		70	64	53	57					66
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												824					430				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			715	40	58	47	45	694	31	39	20	10	251	21	18	17	17	54	20	24	18	17		11	28	12	9	153	10	26	13	13	225				9
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				44	56	46	32	195	26	42	13	13	70	10	26	17	22	74	14	20	18	13	716	20	24	17	15		12	18	13	6					9
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								28	29	18	16		22	30	26	21					14
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								82	87	63	64		42	68	61	52					71
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			3,070	513	651	490	483	1,674	452	482	279	250	1,486	293	328	284	305	396	305	302	239	285	233	243	331	236	211		222	299	220	179					192
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			3,022	427	425	350	349	2,258	298	359	150	125	583	175	155	154	170	986	136	119	132	145	436	146	176	119	126		128	151	103	115					91
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				191	182	188	183	3,283	185	196	103	84	741	116	109	113	109	1,096	97	114	92	123	475	121	122	108	93		103	124	126	111					113
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female																1																					
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								44	41	31	28		42	38	24	32					28
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				369	440	362	359	1,415	350	358	171	163	958	217	202	185	177	953	180	213	205	231	471	181	232	171	184		193	230	181	207					157
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			3,814																																		
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												1,684					1,625				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			3,128	655	666	494	528	2,282	490	489	231	189	951	305	271	252	261	1,148	229	265	226	270	361	250	264	216	199		208	231	176	190					135
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male																					1			1	2	1	1										2
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			5,345	763	945	694	731	1,443	651	772	372	323	1,493	392	419	409	387	453	331	435	372	362	440	330	421	308	274		270	390	275	247					229
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			2,806																																		
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			95	51	41	38	26	110	20	29	29	24	217	31	16	31	24	48	21	28	28	20	62	24	19	20	17	68	16	12	16	18	66				10
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			2,687	337	358	298	323	78	337	300	225	152	1,677	221	206	183	198	427	174	190	165	159	2,710					1,132					1,043				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								23	37	20	32		21	30	23	27					14
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			1,144																																		
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			2,711	848	1,032	773	767	426	726	811	386	348	604	471	478	419	392	749	308	375	372	377	867	341	444	360	300		284	367	309	259					235
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			866	254	315	227	264	286	234	190	98	102	281	144	160	120	120	343	111	131	127	147	584	120	144	119	116		113	151	90	113					90
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			4,632	372	446	316	375	2,379	338	347	126	183	2,162	203	215	189	186	272	165	164	155	184	5,100					1,415					1,486				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			5,949	921	1,066	806	892	975	795	944	454	390	1,086	474	540	426	456	613	392	443	432	411	665	381	473	392	350		356	465	340	302					310
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				358	372	343	315	1,493	301	338	185	143	1,249	192	196	176	182	546	156	199	173	179	185	190	205	163	170		152	171	156	133					125
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								45	39	35	28		35	31	45	31					31
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			3,375	542	558	506	506	1,856	496	501	257	213	1,095	271	272	263	247	1,492	244	283	236	248	253	278	269	204	211		241	274	212	219					182
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				50	45	35	37	381	26	21	14	6	168	14	14	13	10	27	9	14	11	17	13	17	18	5	9		7	9	9	7					4
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			1,299	167	176	119	131	1,993	108	117	55	41	275	55	58	63	48	476	50	43	43	48	353	50	59	53	57		46	51	38	43					32
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												757					531				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												138					206				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												1,500					1,118				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,126					1,233				
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								23	32	29	26		35	35	34	25					14
Lesotho	Lesotho	LSO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				170	206	187	153	1,137	162	186	109	72	916	103	109	107	122	319	107	102	92	107	85	132	119	105	93		86	128	122	72					80
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								12,192	12,064	12,468	12,666		12,789	13,574	13,822	14,117					14,801
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				1,717	1,868	1,992	2,161		2,257	2,322	2,315	2,489	5,018	2,679	2,263	2,451	2,478	3,825	2,499	2,493	2,352	2,450	3,291	2,472	2,417	2,404	2,462		2,473	2,484	2,394	2,328					2,013
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female												2																									
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				2,706	2,791	2,860	3,290		3,190	3,256	3,186	3,399	4,693	3,571	3,050	3,013	3,082	4,240	3,075	2,963	2,771	2,966	2,298	2,906	2,784	2,773	2,812	3,216	2,766	2,645	2,597	2,582	3,123				2,051
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				11,781	13,613	14,749	17,178		17,478	17,642	17,864	17,840	26,541	18,700	18,521	18,514	18,721	21,528	18,080	18,760	18,437	18,248	19,848	18,392	17,858	18,169	17,461		16,826	17,359	17,357	17,605					14,471
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												58,101					60,592				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												9,651					8,622				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				12,138	14,397	14,988	17,401		17,967	18,774	18,791	18,998	26,419	19,699	20,194	20,737	21,152	22,720	21,017	21,089	21,259	21,127	20,271	21,232	21,761	22,212	21,854		21,386	22,059	22,104	22,520					19,417
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				8,364	9,822	9,897	11,444		11,617	11,858	12,068	12,220	16,286	12,712	13,788	14,498	14,808	15,058	14,991	15,663	15,489	15,757	13,444	15,742	16,227	17,070	16,886		16,983	17,687	17,681	18,126					17,208
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												4,506					4,325				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				5,949	6,886	7,121	8,076		8,319	8,504	8,549	8,509	13,177	8,795	9,150	9,477	9,804	10,929	10,127	10,610	10,707	11,055	11,321	11,032	11,381	11,802	11,660		11,689	12,197	12,342	12,323					11,553
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								4,948	5,106	5,365	5,299		5,440	5,713	5,743	5,680					5,205
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				9,618	11,008	12,348	14,239		14,486	16,002	16,283	16,375	22,184	16,934	17,787	17,565	17,937	20,035	18,218	19,226	19,374	19,570	18,011	19,706	20,280	21,229	21,207		20,862	21,668	21,612	22,084					19,927
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				18	17	18	11		17	21	19	14	435	10	13	15	12	34	16	12	16	13	44	17	16	16	14	50	22	12	19	26	42				13
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				1,219	1,262	1,336	1,496		1,389	1,636	1,678	1,760	2,726	2,004	1,775	1,891	1,856	2,530	1,874	1,863	1,754	1,852	3,009	1,914	1,868	1,872	1,871		1,816	1,829	1,796	1,731					1,570
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												31,945					30,517				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								9,391	10,081	10,430	10,538		10,907	11,316	11,424	11,662					10,811
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												36,465					36,074				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								7,538	7,741	7,854	7,931		8,207	8,498	8,527	8,711					7,706
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								9,443	9,796	10,342	10,273		10,310	10,428	10,568	10,735					9,769
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				958	1,042	1,013	1,086		1,127	1,263	1,246	1,322	4,897	1,346	1,354	1,393	1,311	3,698	1,433	1,400	1,322	1,412	3,334	1,397	1,473	1,717	1,740		1,630	1,774	1,777	1,848					1,714
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								8,594	8,662	8,980	8,879		9,188	9,627	9,935	9,881					9,865
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				8,692	10,307	10,501	12,998		13,530	13,656	12,649	13,085	20,533	13,467	13,043	12,789	13,133	16,718	12,431	12,689	11,762	11,580	14,854	11,821	11,310	11,617	11,219		10,721	11,065	11,085	11,105					9,189
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								6,450	6,709	7,032	6,931		6,873	7,050	7,121	7,051					6,429
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male												2																									
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												2,095					2,015				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				5,100	5,269	5,419	6,152		6,385	6,457	6,523	6,649	16,932	6,772	6,467	6,264	6,428	10,743	6,084	5,752	5,480	5,464	8,189	5,463	5,183	5,234	5,079		4,890	4,929	4,959	4,827					3,699
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				6,337	7,153	8,004	9,207		9,270	10,526	10,651	10,870	17,024	11,276	11,506	11,676	12,143	13,830	12,176	12,521	12,267	12,541	14,103	12,593	12,656	13,013	12,673		12,781	13,129	13,340	13,327					11,699
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								5,512	5,841	6,078	6,062		6,280	6,596	6,601	6,533					6,263
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				19,314	22,649	23,774	27,772		28,437	31,303	31,632	31,775	38,438	32,441	34,132	34,363	34,876	35,084	35,073	37,324	37,677	38,668	33,347					39,278					41,678				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				12,094	14,375	15,318	17,653		18,174	20,334	20,102	20,825	29,808	21,560	22,517	22,556	22,963	23,858	23,296	24,992	24,908	25,168	23,612					26,684					28,076				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				4,398	5,110	5,174	5,983		6,372	6,488	6,432	6,377	12,245	6,523	5,876	5,936	6,011	9,364	5,570	5,832	5,608	5,274	8,147	5,562	5,401	5,354	5,374		5,061	5,364	5,410	5,366					4,507
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				460	390	377	463		494	456	448	444	1,241	445	381	377	398	927	376	297	312	317	1,838	301	280	298	329		319	317	318	308					278
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												9,936					9,034				
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				2,024	2,532	2,225	3,328		3,377	3,268	2,696	2,760	10,390	2,874	2,641	2,730	2,528	6,685	2,412	2,234	2,085	2,094	4,679	2,095	2,063	2,122	2,129		1,975	2,058	2,138	2,124					1,822
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				1,730	1,747	1,814	2,067		1,904	1,872	1,851	1,884	2,999	1,963	1,636	1,712	1,687	2,339	1,659	1,536	1,464	1,489	1,751	1,469	1,353	1,354	1,339		1,287	1,164	1,120	1,095					860
Lesotho	Lesotho	LSO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				6,681	7,719	8,473	9,658		9,460	10,033	9,947	10,388	19,460	10,778	10,840	10,917	11,133	14,205	11,088	10,636	10,258	10,437	12,801	10,437	10,287	10,433	9,968		9,978	10,113	10,247	9,824					8,248
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														26		24					22
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														3		7					7
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					616		673			527		287			378		257			319		542			460		499										
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					865		952			794		493			637		374			555		751			755		906										
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														15		17					7
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														6		1					2
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														68		154					41
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														96		89					45
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														105		111					56
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														37		87					29
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														25		25					19
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														81		76					44
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														66		54					30
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														38		89					17
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														56		50					38
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														119		118					68
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														126		136					68
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														21		20					8
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					25		26			69		25			22		17			19		76			65		21										
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														89		70					43
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														6		9					5
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														78		70					53
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														95		78					85
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														7		5					3
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														7		12					6
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														3		3					1
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														19		24					12
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														239		212					132
Lesotho	Lesotho	LSO	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														42		31					20
Malawi	Malawi	MWI	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					1,572		4,204			5,909		5,996			821		16,639	34,769		27,645		69,418	17,587		9,540		29,632	28,035		11,157		29,698	42,330				
Malawi	Malawi	MWI	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					1,415		6,038			8,559		8,572			781		32,174	8,111		23,357		34,056	23,443		3,400		30,648	22,944		8,156		23,999	38,412				
Malawi	Malawi	MWI	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female							27			9					13		372			710		2,376			193		1,144			665		4,219					
Malawi	Malawi	MWI	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					55		983			1,163		1,165			127		5,240	13,324		11,843		34,153	14,241		6,932		23,826	46,618		15,150		49,505	42,070				
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			23		359			492		406			443		505			702		603			586		385			353		370					368
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						11,836					17,488					23,638					22,289														
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								1		2			2		1					2			1		3			1		2					1
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			52		121			214		110			222		140			189		149			103		113			97		79					37
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1		3			6		3			30		16			27		27			56		26			16		14					21
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			82		649			1,619		2,357			4,944		5,012			7,620		8,532			9,037		8,993			10,004		10,558					10,993
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1		1			7		8			12		9			25		27			21		47			36		39					22
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			7		24			66		76			96		63			101		102			114		780			80		128					87
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			3,584		2,536			40		346			56		55			49		72			24		16			21		31					35
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			9		58			195		287			765		936			1,305		1,471			2,475		1,389			1,433		1,346					1,626
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2		10			10		19			41		47			44		62			67		62			74		60					83
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										49,950					50,623				
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			11		15			25		14			60		59			75		79			93		79			86		87					73
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					2								4		3			5		3			22		2			4		2					1
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			185		105					19								1		1					1					11					
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						25,601					24,746					34,748					34,056														
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1					1		2			2		1					5					2			5		3					8
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			152		571			1,226		1,592			2,366		2,203			4,272		5,058			4,590		8,367			6,692		9,687					8,697
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			4		32			68		110			108		76			156		123			141		989			86		111					100
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected					8			1					2					2		2			2					2		1					2
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			46		446			974		1,626			3,524		3,622			5,501		6,439			7,533		6,857			8,126		8,163					7,929
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1		3			24		19			23		19			16		15			16		172			12		27					17
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1		14			40		22			109		132			195		181			183		212			234		191					125
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			397		239			5		41			20		7			42		104			56		73			57		39					17
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1		1			2		1			1		2			1							
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			7					3		1			11		2			4		14			4		4					2
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			4		5			7		13			23		38			39		43			31		39			59		46					48
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			10		114			78		31			40		31			60		57			24		24			75		29					17
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			363		312			552		856			1,999		2,196			3,163		3,911			4,902		4,070			4,768		4,907					4,965
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			20		132			247		136			209		211			203		151			75		95			132		90					66
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			21		107			74		51			58		58			74		62			35		60			84		81					51
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2		7			12		14			40		31			54		99			62		90			79		135					120
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			902		3,411			5,019		2,735			4,474		4,411			5,300		4,841			3,224		3,066			3,339		3,561					2,506
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			474		3,186			6,485		3,600			5,645		5,810			6,744		5,663			3,842		3,722			3,896		4,147					2,850
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			1					3		1			2		1			1		6			1		1					1
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		2					4																				1					
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			8		4										1			2							2					2					
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2		10			32		21			81		78			104		122			109		133			132		123					102
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													4		3			2		1			1		3			1							3
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			14		14			46		48			51		36			45		22			33		830			21		44					100
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			11					1					10		12			11		11			5		8			5		9					9
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2		8			14		10			50		51			59		54			58		80			79		65					94
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			603		2,728			4,486		1,914			2,260		2,958			3,700		3,115			1,538		2,712			2,674		2,635					1,832
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			5		1			10		6			15		4			5		8			4		4					
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		2			3		2			9		8			15		7			8		18			5		7					2
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			250		2,620			4,962		2,407			3,818		4,754			5,178		4,349			2,541		2,508			2,780		3,194					2,538
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		1			1		3			1		2			5		4			3		8										
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			10		52			82		58			156		94			114		54			50		54			43		22					26
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			384		3,394			6,245		3,141			5,244		5,697			6,323		5,523			3,332		3,223			3,537		3,743					2,723
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			48		11					16			1		1			2		3															
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			79		34			4		1			2		1			1		1					1										2
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			18		47			55		20			28		34			35		15			11		12			31		7					8
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			83		805			1,605		2,455			4,952		4,867			7,325		9,212			9,340		10,428			12,470		12,677					13,772
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			17		71			21		11			14		13			26		21			6		5			32		4					11
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			3		21			5		3			8		8			6		6			5		6			9		4					4
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										106,267					103,081				
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			207		1,172			2,797		1,754			2,868		2,538			3,203		2,722			2,145		1,824			1,567		1,594					1,342
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			16		24			30		44			50		47			66		71			47		498			44		89					47
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			63		558			1,243		1,986			4,053		4,155			5,988		7,948			7,567		8,777			10,767		12,099					15,055
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					1			3		1			1		2					5			1		4			2							
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			60		7					2								1		2					1			1		9					
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			28		169			323		166			288		205			257		187			96		126			152		145					76
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								1					2							5			1		6			1							
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						20,237					23,558					33,878					36,374														
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					4										1					1			1		1										
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1		10			22		31			49		100			115		153			742		122			92		91					176
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			7		23			85		115			116		87			129		133			160		1,099			97		106					110
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			5		90			69		44			54		52			61		59			33		32			102		51					21
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive					6			16		4			15		11			20		12			11		17			7		5					3
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			2		58			37		20			18		24			36		16			16		18			51		39					14
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					26			54		95			71		62			88		82			113		821			125		90					99
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			556		3,848			7,733		3,809			6,595		6,848			7,374		5,994			3,786		3,523			3,637		3,703					2,874
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected										13					1																				
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			10		73			63		45			54		55			63		40			33		39			78		48					34
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1																																
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													1		2													1							1
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1					2		3			3					2		2			1		11			2							2
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2		16			28		11			149		105			175		139			163		132			155		135					121
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					2													1		3			1		1			3							
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																							1												
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			20		118			271		164			303		212			233		156			118		100			150		128					82
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			7		79			152		81			132		122			114		79			57		58			63		51					58
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			4		8			12		3			23		26			38		27			25		32			24		31					23
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			5		23			43		24			153		142			187		193			188		184			184		169					160
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						25,600					16,199					26,119					25,175														
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						18,233					21,680					28,704					26,256														
Malawi	Malawi	MWI	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		2			4		5			11		12			8		11			6		11			4		4					2
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		2			4		5			11		12			8		11			6		11			4		4					2
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2		10			32		21			81		78			104		122			109		133			132		123					102
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			20		132			247		136			209		211			203		151			75		95			132		90					66
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2		16			28		11			149		105			175		139			163		132			155		135					121
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			185		105					19								1		1					1					11					
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		1			1		3			1		2			5		4			3		8										
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1		1			2		1			1		2			1							
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			28		169			323		166			288		205			257		187			96		126			152		145					76
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			7					3		1			11		2			4		14			4		4					2
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1		3			6		3			30		16			27		27			56		26			16		14					21
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			5		1			10		6			15		4			5		8			4		4					
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			11		15			25		14			60		59			75		79			93		79			86		87					73
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1		14			40		22			109		132			195		181			183		212			234		191					125
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive					6			16		4			15		11			20		12			11		17			7		5					3
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			10		52			82		58			156		94			114		54			50		54			43		22					26
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			7		79			152		81			132		122			114		79			57		58			63		51					58
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		2			3		2			9		8			15		7			8		18			5		7					2
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			1					3		1			2		1			1		6			1		1					1
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					2								4		3			5		3			22		2			4		2					1
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			4		8			12		3			23		26			38		27			25		32			24		31					23
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																							1												
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		2					4																				1					
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			20		118			271		164			303		212			233		156			118		100			150		128					82
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			18		47			55		20			28		34			35		15			11		12			31		7					8
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			52		121			214		110			222		140			189		149			103		113			97		79					37
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			5		23			43		24			153		142			187		193			188		184			184		169					160
Malawi	Malawi	MWI	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			60		7					2								1		2					1			1		9					
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					2													1		2										4					4
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							6		3			1		5					5
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													1		2			6		3			4		6			11		5					4
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										2			2		1			4		9			3		5										
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation								2					5		6			6		4			3		6			1		3					2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								1							3			4		3			11		1			2		2					1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			11		18			38		22			19		18			6		2			1		1			1		1					
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																																			1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					2								1					1		2					1			1							
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				2															
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation								2					7		2			10		7			2		5			2		3					3
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			8		42			132		66			128		110			131		132			91		94			71		62					27
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2		38			105		43			101		108			91		74			47		49			45		43					42
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					2			7					15		14			18		17			7		16			15		23					11
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					2			16		14			51		64			74		84			75		96			76		97					74
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP								1							1			3		3			2		3			3		3					4
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		3																														
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			18		37			26		16			10		9			5		3					2			2		3					1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					7			20		13			71		91			132		135			138		172			156		144					95
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP															6					1															
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1					1		2			1		2			2		2			2					6		6					1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		2			1		2			3		11			4		4								8		3					1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					13			28		16			102		99			142		144			149		153			135		139					107
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			5		1																														
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							2		4			1							
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			14		58			175		109			191		167			165		155			92		84			102		122					64
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					6			22		7			96		86			138		102			129		115			129		109					83
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							1												2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		2					1										1										1					
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		1																	
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation			8																											1					
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			18																																
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1																																
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation								3		3			9		6			8		21			3		6			3		3					3
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													1		1			2		2			3		1										1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				3			1												1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy					2					1								1										1							
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																		1																	
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			7		43			26		11			16		13			10							3					2					
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					20			56		31			94		72			93		46			40		43			31		21					17
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																									1			1							
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			7		67										1			49		33					1					14					
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					2					1			5		2			4		5			2		1			1							
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							2		1										
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					2			12		1			12		11			16		3			12		7			4		3					2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																		2																	
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																		1					1		2			2		1					
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP													1												1										2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															3			1		2			1		2			1							1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation								1		1			5		4			11		11			5		6			6		4					4
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													7							1								1							3
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			1		5			31		7			23		24			29		16			5		8			8		4					3
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					6			17		9			43		42			55		66			78		63			70		75					51
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		4					2												1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					5			1							1			2		1			1					3							
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			11		80			221		97			201		166			212		170			82		113			110		122					51
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			4		13			5		8			3		6			5		2			1							2					1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					1			3		2			18		10			19		15			41		23			9		14					15
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					3			2		1					1					7			3		1					2					2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			3		57			173		92			155		157			165		137			62		79			88		73					49
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																		3		2			2		2			4		2					1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			102																																
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			12		10			2							1			2																	
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							1		2										
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy								2		1																									
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					1													4					4		1			5		2					2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			13		29			26		13			7		13			4										2		4					1
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					3			1					1																						
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			3		4			1		2			4		10			6		5			1		1			4		2					2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					3			3					2		1			1		3			3		1			2							2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					1													4		4			1		6			7		4					5
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1			1							1			1																	
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			5		12			12		8			2		8			3					1							1					2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					1																														
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP										2			1					10		1			5		8			12		6					3
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																																			2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							11												
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																		1																	
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					3			2		1			1		1					6			3		4					1					2
Malawi	Malawi	MWI	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1																														
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			13,108																																		
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												48,607					81,662				
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male					7		560		205	19,876	29,824	255		648	72	184	143		322	356	36	33		45	126	20	5		49	22	6	1					1
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												235,881					396,281				
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			8,996	352	1,620	1,511	1,682	31,797	1,239	1,199	867	3,168	12,050	4,218	3,116	4,385	4,234	18,571	3,080	1,808	2,552	2,575	17,471	2,416	2,104	2,231	2,754	17,469	2,447	2,780	2,405	2,761	17,469				3,905
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			27,187	711	4,709	7,714	6,365	35,430	6,015	5,667	6,263	28,629	107,352	33,734	25,651	34,732	35,704	116,310	29,950	34,253	35,679	32,447	117,021	28,506	33,894	32,618	36,644		49,964	45,741	56,299	59,449					56,531
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex					1,681	2,975	2,375		1,197	1,134	862	4,003		6,143	4,808	9,444	9,096	32,359	5,165	14,152	4,214	3,200	30,441	3,292	7,746	5,024	6,177	34,640	4,523	4,421	5,988	3,247	34,640				1,326
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				207	1,411	1,795	1,740	27,054	1,417	1,599	1,166	2,970	7,864	4,025	3,386	4,436	4,830	11,966	3,736	3,326	3,151	3,488	11,263	3,245	2,733	2,982	3,663		3,294	3,350	3,243	3,433					4,172
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			2,468																																		
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			1,636	278	983	690	676	8,190	618	575	461	1,990	9,161	2,532	1,873	2,560	2,254	8,148	1,770	960	1,463	1,355	7,670	1,277	975	973	1,218	7,673	961	1,064	970	1,280	7,673				2,342
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			22,159	575	4,257	6,314	6,718	41,381	5,778	7,341	4,640	14,639	25,733	18,209	16,327	19,554	20,800	36,247	18,193	17,063	17,566	17,919	34,097	17,627	15,980	17,738	20,275		21,414	23,001	22,515	20,835					24,101
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												73,520					123,511				
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			22,159	510	3,285	4,026	4,707	45,710	3,950	5,106	3,524	9,313	15,775	11,685	10,362	13,156	13,883	22,925	11,293	10,110	10,478	10,984	21,569	10,475	9,084	10,581	12,113		11,867	12,646	11,873	10,948					12,830
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female					4	1	1,222		227	21,040	34,125	2,114		676	1,419	908	397		599	1,226	344	60		782	991	2,664	456		39	11	5	11					1
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			21,470	393	5,095	8,353	6,515	14,108	4,829	3,745	3,369	18,114	80,595	21,809	15,791	25,011	24,745	106,889	23,471	36,443	37,495	29,343	112,871	18,244	24,037	27,618	31,582		37,036	30,096	37,747	30,876					29,400
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				292	2,222	3,069	3,472	27,068	2,634	3,302	2,346	6,742	11,623	8,465	7,501	9,244	10,306	15,999	8,671	7,108	7,746	8,064	15,050	7,485	6,305	7,543	8,781		8,059	8,786	8,398	8,927					10,831
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												92,132					154,778				
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			4,023	314	1,592	2,100	2,234	15,549	2,112	1,916	2,329	8,637	9,521	9,499	8,112	9,926	9,853	8,315	8,290	7,152	7,383	7,344	7,824	6,835	5,939	6,083	7,135		6,834	5,759	5,697	7,920					12,716
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				211	945	1,083	1,266	6,023	1,072	1,081	1,208	4,617	6,706	5,001	4,563	5,281	5,884	5,956	4,605	3,991	4,149	3,921	5,607	3,822	3,446	3,283	3,839		3,531	3,216	3,299	4,748					8,487
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												16,833					28,279				
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				135	574	659	671	6,022	515	513	581	2,057	3,954	2,536	2,150	2,647	2,826	3,610	2,100	2,040	1,731	1,754	3,400	1,540	1,401	1,342	1,611		1,267	1,228	1,119	1,456					2,778
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			4,023	407	2,080	2,994	3,629	21,681	3,375	3,220	3,643	13,988	24,561	15,844	13,556	16,428	16,511	20,093	14,034	11,985	12,313	12,816	18,898	12,506	11,435	12,078	13,298		13,595	12,090	12,068	17,232					25,925
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			25,967	1,095	7,841	9,767	10,202	22,117	8,049	8,685	5,105	17,480	38,395	24,436	19,993	25,430	25,674	46,986	22,545	23,439	21,154	20,940	44,204	23,129	20,479	22,741	26,726		30,100	34,347	33,320	29,399					32,608
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												72,694					122,122				
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			44,500	822	5,733	7,296	8,972	32,080	7,730	9,149	5,693	17,107	30,414	23,622	20,549	24,538	25,737	40,904	23,101	23,115	22,907	23,994	38,480	24,511	22,323	24,110	27,503		29,765	33,082	31,897	27,897					33,392
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			8,652	459	2,668	3,945	5,054	30,312	5,103	4,783	5,486	20,436	91,497	24,240	20,695	24,880	25,076	70,102	21,128	18,145	19,140	20,017	65,948	19,724	18,612	18,633	20,964		22,211	20,783	20,814	30,826					44,621
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			20,881	1,298	7,205	8,656	9,231	6,368	5,169	4,069	1,935	9,689	30,293	13,540	10,163	13,746	13,879	29,446	11,750	14,898	10,998	9,968	27,702	11,558	10,463	11,810	12,542		13,970	14,467	15,078	15,241					17,635
Malawi	Malawi	MWI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								92,578		3		28		55	36	136	141		86	3	1,085			61	22	243	949		557								
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												114,451					202,376				
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												605,370					308,331				
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				28,978	29,681	20,509	20,460	108,289	24,913	17,665	13,314	16,967	8,170	23,070	21,423	21,179	20,225	5,969	22,372	30,227	26,259	23,276	140,118	24,575	26,928	31,262	40,610		46,014	73,801	76,154	64,794					40,555
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				1,321	224,576	204,325	206,492		153,637	208,532	112,984	101,636		103,223	97,434	94,900	77,416		82,685	45,154	64,277	71,355		48,034	54,718	45,766	38,227		24,098	30,550	15,611	5,554					2,507
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			77,179																																		
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												87,320					48,223				
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			60,950																																		
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												763,203					877,813				
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												644,355					688,421				
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								1		2			203	182	8	9					9
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			101,839	14,455	15,487	13,439	14,684	75,356	15,318	10,800	8,408	10,233	36,237	11,669	10,869	11,209	11,819	19,043	12,383	16,030	15,432	16,315	20,784	16,736	16,808	18,835	19,734		20,821	22,878	22,281	25,048					22,919
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			284,759	24,448	20,203	20,351	29,977	130,656	23,089	15,645	5,260	14,263	46,922	18,903	15,483	17,556	20,370	39,643	20,446	19,048	18,548	17,019	25,103	21,029	22,377	24,890	25,068		27,916	31,123	34,863	45,787					19,925
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				5,889	6,439	5,393	5,587	29,661	5,936	5,136	3,493	4,677	17,461	5,453	4,329	4,424	4,363	16,387	4,847	7,207	6,973	7,305	42,169	8,685	9,416	10,757	10,207		10,475	11,515	11,662	13,215					12,269
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				13,982	21,094	9,835	11,207	68,050	12,517	9,122	3,932	4,757	2,080	10,620	8,163	9,125	6,957	62,999	8,281	10,568	10,070	9,553	48,176	9,532	12,274	13,253	18,354		17,171	33,359	40,337	35,545					18,873
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			160,164	63,398	56,797	60,006	62,394	464,882	70,573	57,022	51,790	64,898	464,460	74,799	72,932	64,958	72,144	450,832	78,367	109,018	97,677	101,050	502,500	112,619	119,818	127,663	134,276		150,720	165,412	163,523	173,414					143,773
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				9,090	10,396	8,626	9,055	39,227	9,818	8,758	6,611	8,107	27,004	8,943	8,045	8,378	7,939	19,867	9,027	13,902	13,554	14,681	12,617	12,994	14,520	17,153	19,624		20,927	23,573	22,877	26,443					23,597
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			117,144	19,022	17,774	17,175	18,815	136,834	18,973	14,207	10,194	12,620	72,211	15,098	14,189	15,369	15,714	25,542	16,337	21,978	20,816	20,925	49,748	23,407	24,035	26,654	27,358		30,342	34,255	33,734	37,315					33,017
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			70,139	19,573	19,616	19,535	20,560	49,572	21,818	18,136	14,916	18,788	19,848	19,911	19,269	19,102	19,193	32,756	20,995	29,823	27,264	29,528	28,330	30,625	30,729	35,144	36,673		39,309	42,565	41,577	46,231					42,176
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			137,915																																		
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			141,486																																		
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			6,608	11,404	10,506	9,317	9,420	75,098	10,410	8,065	4,553	6,341	60,536	7,871	6,523	6,792	6,590	30,296	6,744	11,755	11,165	12,282	584,155	11,961	12,476	16,406	17,116	456,636	17,760	19,771	19,705	23,719	209,102				20,311
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			113,810	42,953	39,629	43,134	45,110	423,563	48,573	39,607	34,578	41,563	411,382	45,891	44,984	42,515	44,797	358,746	49,880	70,366	63,375	67,011	418,864	73,214	75,812	81,470	85,232		93,018	103,124	101,253	106,315					105,815
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			154,602	44,052	40,499	40,677	41,635	313,816	52,696	33,554	32,064	47,025	323,431	57,882	57,393	47,324	53,149	303,234	58,877	79,005	70,636	70,949	309,552	84,121	88,783	87,969	92,362		110,197	115,078	109,398	112,453					101,208
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			17,371	1,013	2,859	997	801	408	1,046	1,989	831	872		858	759	889	628		633	1,300	861	835		735	1,155	573	251		98	182	468	216					138
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			65,585	19,857	22,479	18,270	39,148	139,595	24,708	13,384	4,296	9,626	46,315	17,635	15,117	10,671	10,294	105,426	10,059	10,467	11,643	11,603	40,427	10,515	16,119	14,114	17,199	155,404	19,984	32,841	38,546	31,724	107,987				15,533
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				90,253	447,563	406,669	404,633		316,224	404,478	237,917	222,034		242,807	191,719	190,542	169,205		173,817	86,572	128,549	151,621		94,426	116,381	100,148	83,811		59,647	70,332	42,606	41,601					2,971
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			26,587	10,009	10,583	9,447	10,199	90,780	10,689	7,803	5,242	7,121	58,122	8,708	7,271	7,731	8,143	29,506	8,478	12,773	12,310	13,095	477,630	12,929	13,444	15,677	17,251	283,443	17,847	19,817	19,158	23,820	122,330				21,780
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			95,362	28,567	27,075	27,951	29,055	126,059	31,177	25,486	21,968	26,160	81,814	28,258	27,382	26,474	27,236	94,313	30,272	44,333	40,198	42,759	84,130	46,864	48,712	54,039	56,800		61,388	69,325	68,456	75,503					68,889
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			287,078	35,370	27,946	30,187	35,860	178,151	34,017	26,985	16,785	22,690	117,312	32,291	29,917	33,116	32,715	54,434	32,161	41,910	36,365	36,215	45,648	43,474	45,392	49,115	48,516		58,883	66,818	64,556	67,514					50,978
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												379,233					211,448				
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												63,344					97,981				
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				8,687	9,657	8,501	9,070	71,364	9,431	7,661	5,779	7,339	26,117	8,017	7,668	8,078	7,815	22,983	9,109	11,982	11,843	12,026	12,911	11,980	12,053	13,909	15,359		15,642	18,321	17,750	20,775					17,400
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				1	5	2	1		4	1	1	7		3	1		1			2	1																
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				5,873	6,208	5,663	6,186	65,737	6,338	5,068	3,858	4,946	24,432	5,626	4,715	5,039	5,166	15,247	5,412	7,489	7,321	7,216	21,414	8,342	8,473	9,458	9,686		9,798	10,806	11,180	12,490					11,594
Malawi	Malawi	MWI	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			130,208	28,273	25,416	26,148	29,682	119,977	28,205	21,094	14,366	17,728	83,114	22,815	21,377	22,772	22,774	48,636	24,067	30,738	29,104	29,711	40,345	33,344	33,707	37,771	38,102		43,115	50,370	49,138	50,106					47,580
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	Retired Age Band	Missing Sex										1																											
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				340	427	324	315	2,648	468	311	233	277	330	372	367	327	292	208	364	411	377	259	1,449	290	322	306	275		304	365	302	266					224
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			13,434	2,128	2,006	1,677	1,836	8,580	2,151	1,553	1,316	1,871	6,964	2,199	2,114	1,771	1,964	6,684	2,025	2,226	1,937	1,856	4,723	2,133	1,876	2,115	1,782		2,079	2,012	2,478	1,856					1,438
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												931					516				
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			2,373	337	458	314	502	4,347	357	233	152	266	2,328	304	338	285	221	3,258	197	266	271	226	984	217	184	193	177	2,563	162	196	185	171	1,088				121
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												3,911					7,779				
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			381	416	473	386	410	7,293	432	342	271	319	9,129	356	333	373	311	2,460	365	509	486	436	20,839	381	488	531	512	8,236	449	548	573	578	5,858				485
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			3,159																																		
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			6,938	1,178	1,283	1,178	1,200	4,638	1,276	1,018	772	1,087	1,452	1,269	1,208	1,120	1,098	1,906	1,130	1,341	1,224	1,151	772	1,044	1,141	1,159	1,166		1,224	1,184	1,091	1,050					1,045
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				223	373	231	202	2,746	228	178	125	177	148	245	209	184	161	2,148	170	207	181	173	1,177	169	145	159	149		117	159	149	142					99
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												9,065					11,726				
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			13,148																																		
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												2,876					8,617				
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				96	7,026	5,436	6,024		4,459	8,013	3,524	3,445		3,032	2,428	2,518	2,369		2,295	1,340	1,431	1,546		1,015	1,340	944	887		555	674	376	126					28
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				387	453	402	369	3,156	401	326	251	333	3,045	382	353	371	322	1,496	387	435	455	412	1,542	389	392	401	400		439	449	444	429					421
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			915																																		
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			19,982																																		
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			10,470	1,358	1,459	1,371	1,237	8,767	1,447	946	741	932	4,984	1,118	1,129	1,090	1,085	1,841	1,166	1,319	1,259	1,113	719	1,060	1,072	1,023	962		1,038	1,104	955	987					885
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,198					1,760				
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				577	685	638	592	4,386	700	540	498	591	4,877	637	573	666	550	1,859	626	801	761	700	455	652	673	698	674		790	805	762	731					730
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				873	1,092	884	939	8,460	1,065	813	579	787	4,228	862	949	855	817	2,346	980	1,162	1,014	959	449	868	814	836	883		896	942	896	855					764
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			9,591	2,123	2,119	1,842	1,846	6,090	2,206	1,578	1,331	1,796	5,389	2,090	2,041	1,904	1,848	6,098	2,065	2,210	1,892	1,901	4,920	1,980	1,940	1,964	1,925		2,000	2,067	1,727	1,734					1,699
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			361	15	28	24	9		16	28	10	36		8	50	13	25		8	13	24	35		37	13	12	13		16	18	19	14					7
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			9,307	324	199	152	214	4,262	179	231	87	140	3,013	189	205	170	117	1,616	173	583	146	147	863	145	152	102	122		109	130	120	154					78
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			8,178	1,751	1,812	1,461	1,551	7,579	1,721	1,233	1,033	1,414	3,654	1,572	1,466	1,440	1,336	2,747	1,442	1,688	1,465	1,520	1,302	1,457	1,541	1,546	1,507		1,533	1,644	1,465	1,496					1,291
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	<10	Retired Age Band	Missing Sex																													1	3							1
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			9,548	815	635	564	486	6,743	653	553	370	480	5,966	651	619	558	518	2,810	598	1,283	564	526	1,628	519	522	525	429		494	523	458	456					369
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												4,008					2,061				
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			10,113	1,372	1,432	1,298	1,282	17,151	1,341	900	681	910	10,200	1,101	1,120	1,041	1,035	2,648	1,119	1,464	1,110	1,080	1,750	1,000	1,038	999	957		1,024	1,074	922	975					959
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			4,330	1,308	1,230	1,087	963	10,669	1,142	863	637	772	9,331	1,025	1,006	922	907	4,298	959	1,229	1,044	908	1,455	878	839	869	816		851	911	791	801					669
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			2,291	525	720	617	580	10,568	661	483	346	463	10,275	508	540	573	551	2,950	606	786	712	712	17,587	662	708	728	727	6,461	740	793	786	808	4,215				783
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												15,565					9,496				
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				1,798	9,991	7,980	8,514		6,737	11,314	5,833	4,297		4,894	3,817	3,801	3,546		3,752	1,909	2,159	2,413		1,619	2,126	1,575	1,545		979	1,117	628	432					7
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			11,967	722	714	543	590	5,145	787	460	412	651	5,174	792	710	620	610	4,767	733	783	685	608	2,365	785	685	667	590		736	669	693	632					524
Malawi	Malawi	MWI	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				633	675	625	603	7,977	705	466	424	507	4,605	590	571	585	567	1,595	601	745	703	614	783	640	691	643	586		572	668	595	656					619
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												16,031					10,016				
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female								9			1		12				4	25	2	6	2	4	12	1		80	7	13	3	2	3	5	45				
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex																													1	9	1						1
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female				9,847	9,829	10,457	10,805		9,997	10,411	9,414	10,251		9,290	8,819	8,511	4,706		2,430	1,252	1,785	2,042		1,380	1,998	1,221	1,271		1,030	1,039	700	1,046					57
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female						2		4,509			304	106	4,944				976	2,817	1,337	1,617	1,465	1,562	5,104	1,586	1,442	1,538	1,539		1,450	1,693	1,617	1,600					1,377
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												2,396					6,295				
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female								19			83	18	79				246	37	246	335	306	329	111	284	320	259	325		331	376	402	369					396
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																																					1
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female								21			8	2	74				49	35	33	29	42	36	117	35	33	32	53		40	48	47	28					62
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female						3		13,960			236	107	10,593				870	17,254	1,231	1,582	1,353	1,332	9,034	1,540	1,314	1,443	1,455		1,446	1,496	1,286	1,342					1,150
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												13,032					18,417				
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female						2		1,043			257	85	1,276				822	577	1,007	1,257	1,121	1,172	1,399	1,164	1,068	1,055	1,168		1,081	1,234	1,148	1,147					1,073
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female								18,349			374	116	18,391				992	15,101	1,447	1,772	1,578	1,649	13,423	1,693	1,498	1,679	1,685		1,678	1,651	1,570	1,593					1,500
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex								14			2		126				49	86	3	9	3	5	61	5	5	94	5	106	53	8	3	8	61				12
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																																					1
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																									1												2
Malawi	Malawi	MWI	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female						1		6,337			82	24	2,682				340	10,750	431	544	416	457	3,098	555	468	626	472		596	560	489	538					459
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			996																																		
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			1,208	145	139	140	154	1,387	239	86	124	275	1,381	350	234	203	265	1,389	340	390	279	303	1,389	453	416	398	325	2,094	523	416	338	371	2,095				342
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			186,514	15,225	14,674	15,053	16,998	226,113	20,142	13,661	17,725	24,432	226,038	23,718	24,516	24,525	27,722	221,021	28,843	42,008	33,728	36,234	224,685	39,397	41,830	41,580	40,698		43,123	46,027	41,865	44,263					38,252
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			6,848	3,441	3,604	4,134	4,595	8,014	5,149	3,150	4,690	6,375	8,006	5,394	5,570	6,117	6,464	8,011	6,174	8,676	7,585	8,462	8,019	8,629	8,928	9,449	9,051		9,202	10,045	9,520	9,975					9,547
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			401	12	12	9	26	352	22	21	21	38	346	16	54	17	21	352	15	38	26	26	351	27	40	608	34	351	64	43	47	41	351				37
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												248,689					248,695				
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				93,299	105,302	106,002	109,504		96,070	121,118	90,337	75,009		71,912	74,516	74,576	69,615		67,186	37,128	51,795	60,022		41,766	46,777	40,790	37,873		33,025	35,468	21,706	34,999					1,258
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												357,373					357,378				
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				1	5	2	1		4	1	1	7		3	2		1			2	1			1		2				136	2	2					9
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				672	783	801	924	540	988	679	1,079	1,448	534	1,159	1,203	1,359	1,277	539	1,129	1,902	1,787	1,821	537	1,804	2,135	2,273	2,146		2,221	2,431	2,514	2,587					2,455
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			33,397	6,038	6,158	6,899	7,431	39,678	8,537	5,475	7,357	9,897	39,679	8,669	8,961	9,402	10,288	39,152	10,230	15,002	13,104	14,592	39,677	15,290	16,139	16,595	16,110		16,367	18,558	17,374	18,352					16,996
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												52,749					52,755				
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				94	139	133	181	540	188	99	173	245	522	141	150	169	177	540	144	219	206	228	539	228	251	289	289		299	315	339	327					396
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			119,489	12,046	11,606	11,216	12,387	144,642	17,665	9,172	11,962	19,053	144,642	21,612	20,707	19,375	21,939	143,769	25,129	35,331	25,132	28,083	144,361	35,119	35,168	31,064	31,417		37,983	37,956	31,296	34,724					32,738
Malawi	Malawi	MWI	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			181,018	9,838	10,190	10,701	12,066	219,299	13,707	8,896	11,834	15,801	219,361	14,301	14,756	15,605	17,014	177,172	17,450	25,419	21,297	23,189	180,105	24,377	25,729	25,551	26,183		25,973	28,072	25,399	26,460					27,505
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												13,093					18,589				
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				112	150	156	178	19	221	96	238	316	84	274	280	290	296	37	251	351	309	346	111	289	367	354	331		340	380	405	366					411
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												16,077					10,153				
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			87		3	2	6	14	3		4	4	128	12	4	4	3	86	21	7	4	5	59	7	3	24	5	106	7	10	3	7	61				11
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			536	670	681	736	860	1,043	1,006	459	816	1,314	1,286	1,162	1,087	1,172	1,173	579	1,047	1,275	1,121	1,190	1,404	1,172	1,152	1,243	1,172		1,124	1,254	1,162	1,163					1,093
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex										1																				9	1						1
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			9,626	264	260	228	259	6,336	391	113	239	401	2,746	421	383	409	451	10,777	485	557	425	458	3,100	563	514	508	455		539	567	492	533					458
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			14,599	978	1,003	1,040	1,183	18,389	1,418	586	1,078	1,821	18,608	1,566	1,441	1,492	1,509	15,149	1,490	1,818	1,600	1,671	13,431	1,669	1,660	1,670	1,683		1,674	1,686	1,574	1,604					1,513
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female				5,818	5,857	6,360	6,318		5,096	8,101	5,378	3,425		3,131	3,030	2,966	2,756		2,554	1,271	1,757	2,057		1,366	1,410	1,310	1,404		982	1,078	685	980					55
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			15,027	852	788	831	947	14,506	1,140	508	832	1,474	10,781	1,397	1,242	1,185	1,303	17,304	1,288	1,599	1,390	1,373	9,040	1,539	1,460	1,369	1,436		1,478	1,521	1,303	1,367					1,151
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												2,414					6,320				
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			2,664	911	868	1,019	1,057	4,507	1,370	528	984	1,664	4,994	1,397	1,300	1,330	1,440	2,825	1,387	1,627	1,488	1,604	5,099	1,592	1,606	1,621	1,551		1,462	1,718	1,628	1,606					1,387
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			22	2			1	9	2	2	3	4	12	1	8	3	4	25	2	6	2	2	12	1	1	37	5	13	3	2	3	5	45				4
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				14	24	26	33	19	30	13	25	49	74	32	39	40	38	35	31	31	44	35	116	33	38	43	43		44	47	46	26					63
Malawi	Malawi	MWI	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			77																																		
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			56,862		15,557		13,965	46,090		29,961		4,475	52,632		16,687		22,590	38,675		29,305		51,337	36,161		13,953		47,065			19,718		16,987					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												14,595					50,128				
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			9,332		8,029		7,162	7,895		11,109		6,322	784		6,227		10,703	1,612		2,119		3,379	570		4,608		12,582			3,481		3,868					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			11,420		3,708		6,693	2,692		2,784		2,800	11,540		2,426		4,027	3,944		5,906		2,707	8,512		507		5,091			752		247					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												25,723					23,921				
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			21,285		6,843		13,608	11,242		8,449		4,373	1,686		3,180		12,290	2,770		1,583		2,920	696		608		2,346			733		1,254					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			33,035		10,062		16,821	34,385		48,331		5,336	27,957		39,208		37,484			3,498		3,054			480		4,909										
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			20,215		13,384		11,206	8,924		11,665		5,757	1,113		5,305		17,642	460		2,242		5,862	270		1,384		5,277			1,912		2,618					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					2,686		4,764	2,835		1,953		1,154	8,677		1,486		2,553	4,616		785		865	10,007		460		1,964			727		91					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			10,810		5,295		7,131	2,183		4,319		4,063	5,499		3,641		4,755	2,417		4,755		2,460	8,739		826		4,318			1,218		311					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			8,582		11,590		7,284	2,015		5,526		4,382	3,674		4,786		5,016	1,172		3,854		4,510	5,040		924		5,141			2,286		621					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					1,783		2,942	1,191		1,107		1,217	2,328		490		1,087	4,474		422		260	9,044		251		1,143			297		80					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												2,364					563				
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			304		62		173	227		389		853	169		1,371		561	1,492		399		74	2,589		357		1,038	4,461		462		110	2,660				
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												110,203					105,037				
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			59,401		14,909		14,908	41,125		14,517		5,129	15,295		7,747		16,264	18,132		17,574		25,713	27,844		14,892		33,847			27,164		31,654					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			7,625																																		
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					4,983		10,171	5,905		5,044		2,270	1,161		1,807		5,571	3,230		568		745	763		555		1,809			609		626					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male							6,146			672		925			4,534		2,160			11,250		5,275			1,053							216					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												1,138					238				
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			690		155		1,492	227		544		1,918	110		1,903		2,952	1,137		257		112	220		399		1,185	1,889		363		647	89				
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			12,972		8,899		7,832	8,571		10,796		7,333	153		7,064		13,961	65		1,965		3,057	66		2,279		9,886			2,956		1,852					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female							2,305			945		1,433			6,255		10,812			19,504		8,179			4,313		640					14,827					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			20,544																																		
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					2,588		6,573	4,258		2,780		1,789	275		1,379		3,787	2,299		171		271	657		269		987			353		209					
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												29,616					14,993				
Malawi	Malawi	MWI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			22,735		10,257		18,140	10,631		10,631		4,782	2,587		4,365		11,462	1,173		2,478		2,600	446		983		4,678			1,163		1,311					
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			309	598	633	1,106	2,732	604	626	896	930		1,029	1,101	1,132	1,077					736
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			413	812	793	945	1,471	828	1,041	1,069	1,714		1,817	1,742	1,947	2,043					912
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			147	311	345	681	408	487	589	637	780		1,014	1,003	1,296	1,122					309
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												9,477					8,065				
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			63	74	95	114	262	132	173	171	254	476	289	280	363	367	753				139
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			226	360	405	633	275	469	590	616	810		945	1,097	1,141	979					505
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												1,802					3,313				
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			93	124	194	201	408	157	225	236	338	1,413	402	414	463	475	1,017				247
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			66	112	158	191	316	202	237	227	281		328	326	432	418					219
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			99	135	193	212	322	230	250	272	360		440	413	486	453					234
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			109	179	256	355	227	296	374	339	507		610	658	686	635					243
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																			1			4		5	28	8	3		8	81	14	8					4
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			147	195	247	323	268	322	360	377	494		640	651	754	715					360
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												11,089					9,566				
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			546	1,325	1,279	1,501	2,827	1,191	1,835	2,217	2,250		3,102	2,946	3,012	3,497					1,613
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			289	662	801	826	498	865	1,157	1,084	1,553		1,787	1,857	1,761	1,947					499
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												927					6,066				
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			74	157	221	212	704	250	368	299	457		569	550	461	450					120
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																			2	2	18	15		73	38	16	20		15	81	20	29					17
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			263	448	494	1,136	579	540	696	816	968		1,157	1,129	1,377	1,218					596
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			57	69	98	141	263	133	158	166	227		271	260	295	296					143
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												1,778					6,600				
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			255	515	655	665	372	732	955	796	1,410		1,475	1,441	1,603	1,747					408
Malawi	Malawi	MWI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												3,180					4,742				
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								189					490		12	59	163	891																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								149					287		6	27	68	204																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					8		57	318		46		17	769	14	30	194	310	776																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					30		108	519		75		199	1,670	34	78	504	757	1,514																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								108					287		9	39	122	513																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																6	193																				
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					5		25	177		6			375	6	13	85	187	334																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																1	6																				
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								179					497		9	74	206	849																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					27		29	559		113		147	3,105	28	30	230	420	4,439																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								96					249		5	41	86	453																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					13		80	413		62		99	1,131	18	41	248	414	1,032																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								144					383		11	164	477	705																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					2		3	138					285		16	44	87	249																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					49		74	1,242		227		347	5,908	31	105	724	1,136	5,612																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								52					130		1	33	111	249																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								105					265		8	65	134	480																			
Malawi	Malawi	MWI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								185					520		18	122	371	914																			
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			234		27		151	826		3		16	2,984	6	16	195	239	3,627	1,068	842	1,946	2,132	11,654	844	2,286	3,696	2,746		3,034	1,819	2,634	2,018					1,281
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												3,041					12,750				
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												19,792					17,034				
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								154					231		5	30	51	453	97	81	105	102	1,150	153	192	306	401		383	417	421	425					188
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			518		49		251	1,856		27		44	6,165	20	66	604	515	5,012	1,579	1,125	2,196	1,644	12,772	2,059	4,387	5,490	4,826		6,426	4,236	6,731	5,548					1,988
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												9,683					8,699				
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								175					262		9	42	74	513	117	136	160	111	1,992	178	245	426	521	4,652	501	577	579	584	1,991				231
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												5,839					12,528				
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								74					120		1	23	75	248	333	211	242	107	2,726	415	426	597	699		915	792	775	933					303
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												5,925					7,865				
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								161					242		8	57	81	479	175	163	182	171	1,459	289	335	512	676		625	766	661	697					233
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								218					351		12	154	326	705	992	678	696	468	2,072	1,306	1,262	1,809	2,349		2,953	2,569	2,676	2,602					905
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					5		4	204		1			340	1	11	63	107	328	190	166	249	223	1,146	275	405	516	675		798	851	806	793					392
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																	100		11		1	21		88	45	152	57		202	55	32	79					71
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								176					264		6	23	38	198	67	70	89	75	1,328	117	162	243	254	787	284	325	348	350	1,147				128
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								300					451		12	47	118	891	283	245	222	251	802	390	436	827	910		927	950	873	871					345
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			28																																		
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					2		1	165					266		16	40	43	244	69	94	133	101	1,462	118	174	274	343		401	387	336	381					185
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								282					452		19	111	270	914	679	569	524	417	1,376	912	950	1,326	1,964		2,149	2,122	2,004	2,119					798
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			112		13		84	533		22		12	1,172	9	24	198	208	1,016	483	413	548	700	2,371	756	866	1,309	1,694		1,890	1,949	1,603	1,661					869
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			140		30		87	724		24		23	1,625	22	46	408	314	1,493	778	568	964	776	6,853	1,145	1,454	1,949	2,713		3,136	2,517	2,485	2,501					1,270
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								278					425		9	65	135	846	394	331	370	361	1,637	625	670	977	1,270		1,422	1,439	1,424	1,368					480
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												20,999					37,986				
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			28		8		50	423		16		1	702	5	21	167	142	762	342	309	376	472	1,001	532	602	971	1,113		1,342	1,189	1,147	1,150					547
Malawi	Malawi	MWI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																3	2		4	5	4	1		170	22	74	22		27	29	27	153					2
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female						13		329					354				1	304					271									27					82
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																																32					75
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																																37					112
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex						5		140					192					165					135					144				44	223				121
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female						168		326					354				4	303					271									70					248
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female						88		324					354					302					271									96					352
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												1,310					1,870				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			780																																		
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male				1,166	1,204	1,030	1,068		1,016	1,176	790	827		996	835	945	864					4,409					4,827					3,679					2
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex						3		141					335					165					137									31					97
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												845					1,201				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			2,780																																		
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												566					797				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male						57		429					554				11	476					426									46					287
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male						5		426					554				1	475					426									12					70
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																																30					87
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																																39					112
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																																36					83
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																																30					58
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												327					452				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male						175		429					554				4	475					426									98					544
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												568					801				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female						224		327					354				2	303					271									85					330
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male						21		428					554				9	475					426									28					138
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female				724	936	800	828		762	800	658	607		777	640	730	679					3,650					4,253					2,642					4
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male						212		422					556					478					416					448					628				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																																82					618
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female						127		325					354				1	302					271									117					438
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex						20		142					263					166					136									56					180
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex						4																										5					29
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																																78					443
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												876					1,244				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male						99		430					556				13	476					426									96					459
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female						171		327					354				2	303					271									73					331
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												877					1,248				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female						105		324					354					303					255					286					406				
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male						166		429	1				554				5	475					426									91					657
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female						85		326					354				3	303					271									39					186
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male						145		425	1				556					475					426									106					476
Malawi	Malawi	MWI	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			4,334																																		
Malawi	Malawi	MWI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			127,775		5,432		4,603	28,690		6,782		1,931	152,683		8,017		10,024	11,580		9,082		8,822	16,480		7,783		6,596	9,041		5,540		6,248	8,633				4,786
Malawi	Malawi	MWI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male					8		1			16										31										6							
Malawi	Malawi	MWI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			81,299		10,052		7,624	14,626		10,907		2,806	231,505		13,851		15,779	16,136		13,333		11,765	24,068		9,506		7,886	23,577		6,398		7,410	18,032				5,799
Malawi	Malawi	MWI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female					30		9			13										2										6							
Malawi	Malawi	MWI	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			23,208		515		674	3,575		937		301	22,155		978		1,004	3,590		2,334		323	2,592		274		327	2,795		237		263	1,065				151
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												1,194					1,651				
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female								713			1		710					680		2	3	1	586		8	12	16		153	166	142	138					147
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male								1,120					1,115					1,061					928		1	9	3		83	82	60	82					61
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			1,889																																		
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female								714					709					681			3	1	587		5	8	5		70	98	80	67					58
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female								713					708					680			3		587		10	16	8		122	167	113	165					159
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female								713			4		709					680		8	8		586		4	28	21		166	166	166	185					183
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex								406					371					390		17	4		325		6	9	6	326	95	85	89	98	470				79
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male								1,122			2		1,116					1,063		5	6		930		17	23	24		272	320	263	341					374
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				2,322	2,738	2,555	2,499		2,384	2,470	2,068	2,197		2,377	2,042	2,248	2,116		2,161	2,641	2,653	2,883		2,665	2,591	2,693	2,912		226	345	180	159					4
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												2,804					3,865				
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male					1			1,120					1,114					1,061		10	2		927		13	31	29		319	311	271	338					369
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												1,198					1,657				
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male								1,120			1		1,113					1,061		1	4	2	928		9	9	11		192	161	166	204					182
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex								406			1		398					393			4		323		11	5	11		69	76	58	83					74
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female								712					708					679		6	9		587		4	36	11		172	219	168	168					187
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex								406			1		382					390		40	6		324		14	14	9		114	105	83	98					105
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			10,301																																		
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												1,869					2,577				
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female								712			5		708					679		2		3	586		12	13	9		132	126	127	131					95
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male								1,122					1,118					1,063			2		930		11	29	25		248	244	235	301					272
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male								1,123			2		1,118					1,067		9	12		935		39	48	34	946	634	657	646	803	1,304				779
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male								1,121			2		1,114					1,063		9	4	5	929		7	18	17		234	236	199	298					302
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			6,552																																		
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												667					938				
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex								408																	2				15	31	18	21					33
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												1,871					2,583				
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male								1,120			1		1,115					1,061		8	4		927		19	34	27		323	323	300	360					322
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female								713			1		708					680		3	6		601		42	48	17	609	340	388	395	467	848				436
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												1,798					2,482				
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female				1,371	1,721	1,677	1,634		1,448	1,693	1,367	1,316		1,539	1,276	1,480	1,305		1,382	1,657	1,684	1,978		1,714	1,850	1,835	1,875		114	172	92	87					1
Malawi	Malawi	MWI	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female								712			2		708					679		4	5		586		12	32	16		161	195	161	150					158
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			24,163	24,843	24,987	25,424	29,459	25,575	26,363	27,065	28,232		28,925	28,970	28,897	28,682					30,916
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				43,468	52,146	52,697	82,964	81,611	82,664	83,338	84,890	87,979	91,289	88,130	88,450	91,663	93,158	89,403	93,282	95,040	96,641	98,945	86,308	100,565	101,833	102,095	102,838		104,016	105,056	105,677	105,976					100,543
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												44,303					44,681				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			115,300																																		
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				28,571	34,474	35,164	57,362	60,947	56,851	57,593	58,318	61,577	61,113	62,066	63,147	66,873	70,143	67,448	71,720	73,259	74,063	75,629	66,312	76,181	77,063	77,960	79,933		81,337	82,924	84,332	86,429					89,134
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			34,739	14,521	17,720	17,768	25,397	49,977	24,117	24,360	23,304	22,831	47,890	22,586	22,359	22,694	22,127	29,369	21,949	22,415	22,674	22,593	29,947	22,311	22,192	21,932	21,301		21,173	21,553	21,817	21,373					18,307
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			57,280	24,432	29,098	29,074	42,192	55,711	40,342	39,680	38,824	38,711	51,002	38,070	38,292	39,751	39,754	40,552	40,182	39,727	39,678	39,093	39,652	37,913	37,745	37,428	36,571		36,114	35,990	35,582	34,092					28,238
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			16,731	17,325	17,626	18,718	20,452	18,790	19,292	19,816	21,268		21,586	22,083	22,678	23,820					26,849
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												43,956					36,153				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												153,732					142,356				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												282,161					286,486				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			77,641	40,792	48,807	49,536	81,622	100,213	81,770	83,526	85,780	90,895	100,663	90,880	92,470	97,054	101,283	102,006										124,782					136,696				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			15,885	16,684	17,250	18,443	15,828	18,786	19,110	19,400	20,013		20,256	21,171	22,244	24,101					24,666
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			15,674	6,987	8,888	9,136	13,535	31,848	13,051	13,264	12,691	12,773	35,100	12,732	12,753	13,335	13,288	22,377	13,572	13,836	13,947	13,743	22,916	13,389	13,509	13,589	13,300		13,359	13,341	13,384	13,393					11,209
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			38,722	18,747	23,459	23,493	33,646	46,194	31,125	31,849	30,859	30,630	46,948	30,717	30,912	31,945	31,253	42,220	31,689	32,211	32,116	31,360	45,216	31,278	31,291	31,132	30,146		30,374	30,809	30,806	29,899					24,638
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				8,286	10,853	10,431	16,055	20,682	15,899	15,910	15,589	14,921	14,674	14,557	14,329	14,238	13,702	17,101	13,212	13,207	12,878	12,328	15,631	11,939	11,672	11,442	10,671		10,498	10,347	10,193	9,792					7,976
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			27,493	28,167	28,212	28,689	34,628	28,727	29,406	30,021	31,394		32,066	32,428	32,646	32,967					36,571
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female							208		56	2,281	4,899	2,291		12,888	16,319	1,294	1,313		1,835	348	1,865	1,287		433	725	1,204	2,558		269	1,212	660	117					2
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			14,699	15,345	15,722	16,594	18,637	16,756	17,389	17,873	18,990		19,323	19,801	20,280	21,024					23,154
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				22,885	27,278	27,788	43,197	50,272	42,197	42,842	42,848	44,605	51,643	44,927	45,510	47,858	49,097	47,659	50,012	50,849	51,162	51,889	46,558	51,606	51,958	52,235	52,773		53,262	54,142	54,709	54,712					51,734
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			36,525	11,970	15,015	14,338	21,828	28,455	21,981	21,958	21,857	21,586	26,873	21,867	21,838	22,072	21,864	26,188	22,060	22,132	22,167	21,489	23,780	21,421	21,082	20,661	19,534	20,896	19,409	19,355	19,192	18,226	20,012				15,771
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												31,722					25,609				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			15,243	7,373	9,463	9,287	13,916	28,337	13,403	13,745	13,276	13,139	25,398	13,288	13,403	14,173	14,259	22,231	14,623	14,996	15,216	15,378	23,670	15,682	15,870	15,749	15,369		15,555	15,791	15,759	15,319					13,804
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				27,536	32,714	33,094	48,827	53,167	48,168	48,336	48,873	49,657	56,513	49,136	49,347	50,684	50,625	49,974	50,127	50,995	51,617	52,394	48,436	52,035	52,131	51,809	50,857		50,960	50,968	50,943	49,914					43,218
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			80,790	37,339	44,525	45,218	71,294	94,609	71,192	72,736	74,266	78,676	93,287	79,026	80,375	84,364	87,674	87,328										106,097					116,550				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			14,944	4,253	5,334	5,116	7,923	11,808	7,915	8,084	8,068	8,509	14,820	8,673	8,991	9,521	9,910	13,022	10,186	10,534	10,822	11,082	13,369	11,190	11,412	11,404	11,327		11,576	11,682	11,692	11,628					10,813
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			14,181	4,212	5,159	5,067	7,428	18,154	7,175	7,332	7,188	7,273	21,291	7,412	7,630	7,999	8,127	14,962	8,256	8,393	8,554	8,645	15,982	8,682	8,897	9,052	9,197		9,398	9,739	9,864	9,917					9,469
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			4,071	302	385	378	1,047	2,669	1,274	976	633	555	1,430	589	445	833	393	588	673	349	319	317	372	334	315	309	331	930	346	332	312	356	414				467
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												118,189					112,652				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			112,095	54,439	65,367	65,855	98,396	88,414	96,134	95,095	95,081	95,552	86,990	95,228	95,649	99,279	100,109	87,784	100,780	100,745	99,860	97,738	85,063	97,227	96,542	95,771	94,200		93,977	93,684	92,917	90,109					79,936
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												17,937					15,998				
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			143,300																																		
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			37,102																																		
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			35,903	36,449	37,858	40,258	38,244	40,903	41,243	41,541	42,192		42,590	43,546	44,697	45,895					46,723
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			65,178	29,600	37,650	38,282	56,698	65,448	54,261	54,540	53,771	54,276	65,633	54,635	54,917	57,172	56,719	62,179	57,665	58,092	57,963	56,784	64,608	56,542	56,585	56,141	55,029		55,318	55,171	54,633	52,676					45,983
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male							70		17	1,717	2,600	1,085		6,432	8,214	180	289		809	541	388	688		470	801	656	1,409		152	669	365	76					1
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			13,960	14,917	15,431	16,338	15,467	16,543	16,832	17,003	17,435		17,567	18,689	19,824	21,665					21,896
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				3,560	4,875	4,730	7,563	10,449	6,666	7,214	6,826	6,547	6,745	6,249	6,065	6,167	5,983	6,486	5,585	5,557	5,332	5,116	7,765	4,899	4,703	4,520	4,251		4,117	4,162	4,048	3,883					3,313
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			42,301	42,915	44,560	47,818	48,288	49,001	49,967	50,763	52,462		53,372	54,940	56,519	59,157					63,377
Malawi	Malawi	MWI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			100,366	44,904	54,805	54,713	78,929	81,142	75,208	74,911	73,503	72,754	81,099	71,896	71,368	72,703	70,844	74,942	70,465	71,927	72,071	71,324	73,242	71,784	71,709	71,232	69,367		69,792	71,199	72,307	71,295					65,450
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			9,084	2,087	2,392	2,163	2,656	7,234	2,467	2,717	1,789	1,958	3,479	1,935	1,677	1,862	1,651	2,684	1,770	1,827	1,658	1,688	1,297	1,549	1,636	1,684	1,594		1,599	1,632	1,513	1,508					1,370
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			7,513	2,469	2,730	2,421	3,086	5,778	3,045	3,287	2,308	2,493	5,154	2,610	2,298	2,549	2,325	6,026	2,510	2,541	2,307	2,258	4,906	2,215	2,232	2,169	2,128		2,144	2,236	1,828	1,819					1,710
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				519	552	529	599	3,112	570	653	424	412	2,898	471	407	482	484	1,474	539	529	538	491	1,531	380	429	455	444		477	484	501	492					455
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												890					484				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			20,476																																		
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								112	108	118	127		100	132	140	141					109
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												2,737					8,185				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								182	199	209	209		216	212	177	177					199
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												8,886					11,126				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			8,495	1,616	1,637	1,599	2,081	4,676	1,902	2,075	1,441	1,611	1,391	1,565	1,449	1,518	1,538	1,878	1,558	1,528	1,470	1,435	760	1,288	1,341	1,290	1,294		1,318	1,343	1,209	1,196					1,061
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								67	76	89	112		78	99	97	105					101
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				284	283	333	304	2,818	304	323	225	212	148	274	185	239	189	2,124	187	208	178	165	1,169	136	143	146	146		137	173	142	162					86
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			8,884	160	183	162	170	4,055	183	201	130	127	2,860	126	119	128	95	1,590	138	130	131	117	859	129	137	99	106		105	116	119	107					72
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								112	142	129	135		110	137	121	140					122
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male				33	3,194	2,832	13		491	167	60	23		407	707	25	21		85	31	48	80		6	14	34	38			37		10					
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								273	272	277	252		283	287	264	318					258
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			1,097	345	334	328	410	4,592	330	377	234	266	2,226	254	236	223	205	3,221	218	206	211	205	956	181	176	172	152	2,436	174	205	186	157	1,038				114
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												3,830					7,373				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,139					1,672				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				678	772	757	1,010	7,532	941	1,073	695	746	4,384	850	717	808	786	1,574	813	853	775	784	783	675	658	655	733		643	719	642	656					620
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				840	891	899	1,054	4,181	1,052	1,213	800	847	4,645	907	696	856	834	1,831	879	893	900	881	453	779	875	766	827		859	849	819	832					748
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				1,150	1,303	1,213	1,577	7,997	1,497	1,701	1,102	1,121	4,022	1,204	1,069	1,193	1,141	2,316	1,188	1,186	1,129	1,122	449	1,017	999	960	986		922	1,016	974	925					856
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			3,965																																		
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female				44	4,408	3,979	25		659	270	229	54		587	1,120	28	23		190	47	57	112		19	41	59	60			64		12					1
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			11,126	935	1,104	926	1,045	4,890	1,097	1,198	830	805	4,924	903	737	790	688	4,715	783	805	698	725	2,351	766	803	704	632		742	768	671	621					523
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			4,439	1,088	1,132	1,123	1,446	9,786	1,297	1,441	878	972	8,873	1,100	962	999	944	4,244	1,067	1,032	961	923	1,449	805	869	823	752		829	836	725	728					629
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								127	135	138	146		127	162	167	138					125
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			225	586	716	629	1,711	7,074	848	849	577	578	8,679	567	502	623	602	2,439	588	620	618	640	20,803					8,071					5,562				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			10,334	1,524	1,523	1,517	1,800	15,663	1,633	1,875	1,125	1,213	9,694	1,372	1,130	1,246	1,163	2,621	1,202	1,248	1,113	1,122	1,751	1,000	1,048	996	919		946	1,021	919	904					805
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			14,003	2,637	2,574	2,465	3,010	7,965	2,889	3,290	2,199	2,426	6,626	2,508	2,269	2,287	2,291	6,620	2,433	2,288	2,118	2,113	4,702	2,104	2,021	2,045	1,845		2,016	2,016	1,789	1,780					1,406
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			9,011	607	651	564	663	6,204	720	738	503	539	5,670	612	559	520	526	2,771	556	467	470	494	1,618	431	452	461	400		415	478	381	382					304
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								69	83	80	80		77	95	99	101					80
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								416	384	438	419		388	421	457	447					394
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				437	451	423	430	2,702	446	608	376	386	321	443	412	422	358	216	382	427	368	316	1,452	297	320	286	270		302	367	316	266					241
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			10,733																																		
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												15,252					9,010				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			10,758	1,568	1,836	1,577	2,372	8,440	1,872	2,043	1,257	1,417	4,742	1,487	1,343	1,418	1,448	1,809	1,480	1,468	1,350	1,304	720	1,149	1,187	1,125	1,112		1,044	1,183	999	969					864
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												3,816					1,958				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			2,402	825	936	962	1,260	9,954	1,105	1,243	771	905	9,768	919	777	873	868	2,923	910	973	955	976	17,559					6,136					4,006				
Malawi	Malawi	MWI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			1,278	199	198	189	222	596	335	374	187	239	175	246	189	182	193	587	206	146	158	172	382	158	137	167	170	950	170	173	140	180	419				136
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				3,426	15,771	16,724	17,355		17,679	16,848	15,134	12,478		10,659	9,874	10,205	9,642		8,204	10,447	13,561	13,175		11,009	9,440	9,385	9,302		6,833	5,182	4,194	3,848					3,492
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												15,048					13,685				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												37,606					30,915				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												26,863					21,892				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								3,580	36,419	41,959	41,921		36,241	39,265	42,823	47,875					37,737
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				2,623	8,756	10,878	12,388		13,460	13,250	13,961	11,465	40,713	12,147	12,337	12,672	14,084	27,286	11,287	11,175	9,900	10,659	24,436	10,727	12,954	15,017	14,970		12,402	12,483	13,078	14,416					9,577
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								25	21,052	25,132	24,780		21,478	23,258	25,404	28,017					21,215
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								7	13,302	16,001	15,819		14,047	15,380	16,965	19,068					14,954
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								20	11,318	13,634	13,552		12,000	13,125	14,468	16,196					13,316
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				5,581	21,207	25,178	28,410		30,807	31,492	28,240	28,880	60,599	31,590	32,947	33,569	37,801	58,306	31,246	30,961	28,550	31,928	50,318	32,940	39,636	46,265	46,110		38,989	40,064	40,524	44,880					29,684
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				8,735	41,309	46,624	52,994		59,527	57,948	54,889	50,114	92,471	58,928	62,755	63,860	72,979	97,693	59,000	60,466	56,960	65,564	95,242	67,606				101,888					116,879				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				4,218	18,390	20,698	23,563		26,797	26,015	25,578	23,202	47,491	26,306	27,982	28,646	33,068	45,334	27,236	27,373	25,340	28,108	38,819	27,871	33,926	39,426	39,356		33,181	34,743	37,298	40,873					30,064
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				2,036	7,957	9,814	10,484		11,811	11,696	11,249	11,079	24,793	12,233	12,720	12,809	14,130	24,171	11,520	11,415	10,813	12,421	20,280	12,346	14,421	16,376	16,253	16,755	13,737	14,363	14,477	15,525	17,113				10,661
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				8,710	31,966	38,588	43,310		46,532	47,474	41,593	40,588	76,558	43,686	44,975	45,909	50,037	71,337	40,023	39,366	35,821	40,026	53,245	41,481	50,456	58,964	58,956		49,542	51,508	53,602	59,747					42,477
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				185	340	255	523		672	691	662	561	1,365	540	516	526	599	408	544	731	843	874	250	949	881	1,273	1,301	606	874	824	741	745	268				545
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				8,781	37,892	43,497	49,429		55,457	55,406	51,377	48,688	85,765	55,345	58,366	59,502	66,466	85,428	53,462	53,963	50,275	56,678	62,874	58,157	71,706	84,355	83,770		72,134	76,505	81,203	89,593					64,477
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								23	11,165	13,436	13,354		11,620	12,450	13,839	15,420					12,889
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				3,732	12,207	15,293	16,891		17,756	18,065	16,181	16,398	41,602	17,429	17,679	17,912	20,479	38,756	16,969	16,819	15,412	16,973	34,929	17,652	21,103	24,660	24,460		20,451	21,092	21,477	24,219					16,309
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								10	13,416	16,289	16,111		14,141	15,288	16,772	18,962					15,753
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				4,982	19,506	22,792	25,959		28,989	28,405	28,146	24,801	52,414	27,324	28,464	29,213	32,939	47,341	26,626	26,636	24,407	26,597	36,922	26,687	32,522	37,956	37,943		31,584	32,540	33,837	36,989					24,373
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				642	2,709	3,348	3,718		4,274	4,169	4,085	4,021	12,685	4,600	4,884	4,876	5,767	12,085	4,981	5,105	4,972	5,798	11,129	5,977	7,066	8,186	8,069		6,967	7,466	7,687	8,480					6,093
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												131,480					121,718				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												38,652					38,208				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				1,317	4,280	5,220	6,008		6,575	6,526	7,453	6,004	28,804	6,569	6,737	6,954	8,180	20,222	6,757	6,779	6,122	6,544	18,049	6,577	7,825	9,117	9,085		7,680	7,849	8,046	9,121					11,678
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				1,397	4,840	6,105	6,741		7,348	7,453	6,917	6,934	21,728	7,365	7,531	7,645	8,766	20,046	7,597	7,726	7,137	8,468	18,382	8,788	10,512	12,201	12,116		10,353	10,890	11,104	12,380					9,051
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								38	17,059	20,566	20,364		18,036	19,568	21,019	23,013					16,930
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				569	1,898	2,194	2,302		2,480	2,370	2,247	2,183	6,625	2,283	2,334	2,349	2,628	6,230	2,132	2,173	2,267	2,642	6,419	2,740	3,355	3,782	3,770		3,165	3,210	3,210	3,521					2,491
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								3,811	27,958	31,529	31,518		27,284	28,866	31,217	34,511					26,421
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												234,948					244,944				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				1,726	7,413	7,544	7,828		7,863	7,395	7,240	6,004		5,226	4,703	4,704	4,501		4,061	5,069	6,450	6,221		5,368	4,530	4,297	4,273		3,252	2,457	2,005	1,767					1,479
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				10,566	42,133	49,875	56,848		62,204	62,711	56,603	53,674	83,505	59,512	61,860	63,100	70,206	83,993	56,753	57,023	52,920	58,487	58,885	59,104	70,594	81,458	81,386		67,900	70,649	73,275	79,737					53,267
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				1,446	5,048	6,146	6,560		7,233	7,026	6,894	6,742	14,615	7,561	7,912	7,959	8,810	15,863	7,098	6,883	6,685	7,793	13,113	7,891	9,541	10,771	10,585		9,002	9,177	9,289	10,151					6,663
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				764	2,565	3,073	3,449		3,702	3,650	3,892	3,428	17,299	3,788	3,969	4,034	4,757	13,544	3,978	4,061	3,769	4,171	13,494	4,247	5,104	5,946	5,949		5,112	5,416	5,666	6,473					4,675
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				4,445	15,348	18,562	21,323		23,340	23,038	23,286	19,417	46,641	20,805	21,599	22,122	25,423	38,292	20,878	20,723	18,666	20,063	31,022	19,634	23,480	27,241	27,117		22,201	22,466	22,977	25,114					15,510
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												103,902					96,324				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				7,163	33,359	37,161	42,596		48,145	46,256	44,691	41,360	84,689	48,141	50,636	51,580	59,240	82,900	65,567	49,753	46,942	53,510	82,600	54,288				86,825					99,650				
Malawi	Malawi	MWI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				5,958	27,266	31,212	35,300		40,016	39,394	36,839	34,317	57,527	39,931	42,472	43,239	49,877	64,540	40,829	41,632	39,016	44,453	56,483	44,994	55,500	64,640	64,335		55,458	58,799	64,018	70,888					53,596
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														35		44					31
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														112		143					105
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														9		10					6
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														226		169					137
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														71		55					43
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														62		69					59
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														39		42					34
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														158		129					103
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														90		61					42
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														178		139					131
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														66		51					53
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														45		45					39
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														215		206					187
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														38		44					42
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														180		165					158
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														55		49					46
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														101		84					91
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														154		147					142
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														188		148					131
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														56		65					42
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														49		52					35
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														168		132					121
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male					2,232		2,022			2,089		1,623			1,821		677			1,982		2,422			2,367		2,383										
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														50		44					35
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														46		35					32
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female							1																				33										
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male																	7										30										
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														215		204					165
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														121		81					115
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female					1,595		1,570			1,665		1,277			1,411		562			1,580		2,072			2,092		2,080										
Malawi	Malawi	MWI	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex																	13			48							5										
Mozambique	Mozambique	MOZ	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					24		753			1,862		3,830			5			30,477		16,742		45,285	38,714		12,610		35,471	29,864		10,176		32,539	38,778				812
Mozambique	Mozambique	MOZ	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female					1		12													1,374		3,984			462		1,585			194		359					54
Mozambique	Mozambique	MOZ	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					18		2,164			979		6,019						47,528		6,227		57,393	54,196		15,634		64,210	57,879		12,731		46,941	54,604				4,599
Mozambique	Mozambique	MOZ	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					21		2,494			2,543		6,021			10			53,082		39,913		114,862	61,939		20,385		77,056	67,099		16,437		71,524	62,510				2,814
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										203,731					191,213				
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			31		12			27		52			29		26			94		419			858		1,547			2,073		2,702					1,884
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			13		29			10		5			106		193			324		1,083			636		773			771		1,415					1,464
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			839		1,462			2,409		2,787			3,347		4,215			4,576		3,389			2,984		2,738			1,978		2,070					1,474
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			28		137			369		274			631		548			855		1,042			916		926			934		1,124					642
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			5		2			2		1			4		6			6		13			25		28			18		28					37
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			34		178			25		68			217		243			737		4,692			5,960		6,973			8,703		12,674					15,966
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													2					3		19			22		68			62		56					55
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					15			4		7			104		188			303		752			579		861			487		1,015					1,818
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			7		16			8		2			12		8			13		5			9		3			11		4					
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			1,332		3,904			11,484		14,116			19,201		20,551			24,999		20,500			18,346		16,746			15,517		15,932					9,469
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			140		28			12		14			28		53			256		3,403			3,316		4,102			3,821		5,773					4,724
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			194		587			1,269		1,093			1,614		1,603			2,226		2,282			2,350		2,449			2,357		2,501					1,713
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					1			31		3			3							1			1		2			1		2					4
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			19		3			10		1			4		4			25		175			272		682			630		942					620
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			6		39			3		23			144		115			504		2,401			3,132		3,659			4,647		6,245					10,973
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						44,435					59,431					64,986					74,800														
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			49		81			18		43			163		245			697		5,951			6,875		8,191			10,053		14,950					16,648
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								3		8			2		2			1		1			5		8					6					5
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			138		237			216		229			281		253			270		194			177		195			3,740		103					30
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			14		7			27		2			30		29			66		250			462		844			1,117		1,558					1,799
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						52,052					68,925					77,057					87,673														
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			4,007		303			695		154			117		72			105		121			68		98			205		418					418
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1,018		2,137			2,536		2,478			3,198		4,103			4,459		5,453			5,237		5,620			6,112		4,245					2,030
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			23					6		3			14		58			22		36			37		63					101
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					8			4		2			11		10			23		76			36		60			42		75					80
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			273		650			1,439		1,156			1,879		2,098			2,492		2,556			2,432		2,779			3,000		3,020					2,019
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					1																		2					8		485					90
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2					13		1			14		13			29		140			263		461			673		915					1,074
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			32		2			9		22			17		80			41		90			105		145					228
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			9,245		22,492			32,788		35,574			46,944		51,790			53,614		45,291			40,304		39,265			36,274		25,522					12,896
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			10					1		2			16		38			15		34			41		72					128
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																														6					
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					2								2		1					16			9		4			4		6					5
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					1																									1					
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																									1										1
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			13		31			16					8		8			26		117			249		492			650		843					932
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					10			2		1			9		9			38		84			52		56			13		49					51
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						26,286					29,762					36,598					41,575														
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			16		37			39		3			25		30			74		305			747		1,383			1,833		2,414					2,264
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			58		37			61		53			67		49			38		27			29		32			100		18					6
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						48,783					66,735					77,354					87,422														
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			19		44			67		88			84		83			109		69			68		62			58		61					36
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			761		2,381			7,509		9,576			12,361		13,496			17,368		15,649			14,009		13,163			11,708		12,510					7,027
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			35		164			536		712			969		1,122			938		1,359			1,095		1,186			1,046		1,264					703
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					1			2		4			2		3			1		2			4		5			1		1					2
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			26		50			35		5			36		24			91		310			719		1,149			1,538		2,024					2,185
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			14		32			76		105			82		102			66		49			54		46			52		37					24
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			4		8			22		2			8		11			44		361			309		436			414		574					515
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			37		79			113		109			106		89			106		78			67		78			53		58					30
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					1			3					3		2			2					3		2			1		3					5
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			9							1			1					1		4			7		5			1		3					3
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			44		62			128		107			101		98			102		61			68		59			62		51					26
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		9			22		1			11		19			33		151			66		107			263		303					239
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1		2			7		2			37		59			130		302			261		363			193		334					852
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			106		20			5		3			83		77			226		589			361		412			161		437					465
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			2		5			2					1		1			1		3					3			4		2					1
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					4			3		5			39		106			150		344			472		499			197		344					813
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					6			4		4			62		89			174		389			377		525			297		599					1,241
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			243		1,252			4,500		7,631			11,203		12,584			12,251		12,189			10,754		9,035			7,731		8,448					4,684
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			257		1,106			5,039		6,892			9,158		10,141			13,259		15,084			11,599		9,918			8,983		9,560					5,701
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					2			19		2			3		7			14		60			22		61			75		132					234
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative					1			14		1			6		1			18		1			6		6			54		3,384					448
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1		1								3		2					3			16		9			2		6					9
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			4,233		5,536			10,356		12,841			17,098		20,772			22,767		16,388			14,055		13,163			11,277		10,827					6,576
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			350		15			63		18			9		2			2		11			1		2			31		25					52
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			69		81			187		130			200		224			239		232			240		286			227		275					207
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			343		500			851		792			1,219		1,400			1,498		1,496			1,316		1,577			1,512		1,544					972
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			26					10		22			30		130			59		115			148		222					335
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1					2		2			2		1			7		10			10		11			15		27					41
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			11		3			4		5			2		5			1		13			20		28			30		41					21
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			4		2			3					3		4			4		14			19		24			21		28					36
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					1													1		1			1		2			1							1
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			49					11		3										2					1			1		2					
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										217,145					227,532				
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			17		62			105		114			112		125			115		84			73		98			76		73					48
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						37,454					46,732					51,114					58,652														
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					9			2							1															94					12
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					15			6		6			60		159			235		547			520		709			416		778					1,613
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			13		18			22		63			226		165			585		3,535			4,300		4,999			6,888		9,724					13,503
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																														12					
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			4		4			7		19			139		122			445		2,173			2,814		3,149			4,441		6,238					10,046
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			5					2							12			9		21			20		28			23		46					23
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			118		115			54		100			312		537			1,000		6,620			8,578		10,231			8,867		17,164					13,422
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			99		332			771		764			1,032		1,094			1,479		1,763			1,723		1,816			1,778		1,938					1,173
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			3		2			3		5			5		4			3		18			15		27			22		38					45
Mozambique	Mozambique	MOZ	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,369		5,143			14,115		17,123			23,903		26,395			31,072		23,322			21,242		19,698			18,294		19,085					11,953
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			10					1		2			16		38			15		34			41		72					128
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													2					3		19			22		68			62		56					55
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			1,018		2,137			2,536		2,478			3,198		4,103			4,459		5,453			5,237		5,620			6,112		4,245					2,030
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			26		50			35		5			36		24			91		310			719		1,149			1,538		2,024					2,185
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			14		7			27		2			30		29			66		250			462		844			1,117		1,558					1,799
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					1																		2					8		485					90
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			31		12			27		52			29		26			94		419			858		1,547			2,073		2,702					1,884
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					2			19		2			3		7			14		60			22		61			75		132					234
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					2								2		1					16			9		4			4		6					5
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			69		81			187		130			200		224			239		232			240		286			227		275					207
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			16		37			39		3			25		30			74		305			747		1,383			1,833		2,414					2,264
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			273		650			1,439		1,156			1,879		2,098			2,492		2,556			2,432		2,779			3,000		3,020					2,019
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			26					10		22			30		130			59		115			148		222					335
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			28		137			369		274			631		548			855		1,042			916		926			934		1,124					642
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			13		31			16					8		8			26		117			249		492			650		843					932
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			194		587			1,269		1,093			1,614		1,603			2,226		2,282			2,350		2,449			2,357		2,501					1,713
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			2					13		1			14		13			29		140			263		461			673		915					1,074
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			350		15			63		18			9		2			2		11			1		2			31		25					52
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			35		164			536		712			969		1,122			938		1,359			1,095		1,186			1,046		1,264					703
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																														6					
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			23					6		3			14		58			22		36			37		63					101
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1			32		2			9		22			17		80			41		90			105		145					228
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			19		3			10		1			4		4			25		175			272		682			630		942					620
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			99		332			771		764			1,032		1,094			1,479		1,763			1,723		1,816			1,778		1,938					1,173
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					8			4		2			11		10			23		76			36		60			42		75					80
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		9			22		1			11		19			33		151			66		107			263		303					239
Mozambique	Mozambique	MOZ	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			343		500			851		792			1,219		1,400			1,498		1,496			1,316		1,577			1,512		1,544					972
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			2		2			11		7			16		23			43		37			19		26			28		33					10
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				2					6			2		1					4
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							7		16			10		28					48
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							24		123			127		175					121
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			3		4					1			1		37			109		577			767		1,342			1,514		1,704					1,043
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					3			1					6		19			28		114			30		6			1		2					6
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					1			25		10			16		17			27		40			25		11			2		6					3
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														3					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			187		12			39		15			8		3			5		8			3		2			14		1					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									34			42		81					96
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							1		3			5							6
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1		5			56		27			42		83			117		148			98		88			67		96					34
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																		1					1												
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				19			22		90			139		199					308
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1		1			1		2			10		8			19		64			21		4			1		3					2
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			47		258			552		521			851		881			1,116		927			772		313			143		109					32
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							2		2			1		3					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																									10			4		5					6
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		3		38			150		346			572		815					971
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																									3			1							
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			2		4			33		24			30		63			94		104			68		78			56		69					23
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			6												5			5		20			27		42			26		32					27
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1								3		3			12		48			1												
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							3		30			8		2					12
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			1		11								6		42			150		765			966		1,805			2,042		2,191					1,530
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									73			39		50					54
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			136		301			504		529			957		1,201			1,247		942			720		315			133		89					28
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				1			8		32			40		66					114
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1			1		2			7		18			17		63			15		8			5							4
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							1							1					2
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			146		451			960		811			1,478		1,738			2,028		1,443			1,231		505			285		197					58
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1					7		5			54		12			19		66			121		70			69		65					22
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							1		8			11		16					28
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			14		93			243		177			424		442			713		619			420		105			83		56					1
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																		16		68			103		232			202		246					185
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		1		111			414		1,199			1,752		2,387					1,731
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			19		120			327		425			641		856			748		791			521		229			100		74					33
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			3		5			46		36			47		83			116		147			90		75			66		95					25
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				1					3			6		10					7
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																									5			1		4					1
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																														29					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																		8							8			14		21					54
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									4			6		5					10
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			8		16			16		12			32		29			60		152			305		181			131		120					50
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																									1			6		3					4
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																		48		333			494		1,145			1,310		1,363					855
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				5					6			6		1					10
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			10		5			13		8			31		27			56		181			310		172			153		145					39
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2		3										3			33		316			214		147			225		193					109
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									1					1					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													2		1					13			3												
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			3					2										8		50			62		33			24		35					15
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		4		62			416		1,045			1,598		2,205					2,034
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP								2												2								2		5					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				6			15		48			65		125					210
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			510		1,309			1,585		1,724			2,467		3,429			3,657		3,327			2,790		1,059			663		281					47
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					3								9		52			136		751			941		2,045			2,560		2,612					1,790
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							89		261			317		458					218
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									177			249		366					414
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																												1		1					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									1										2
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			9		1			10		6			34		25			46		102			181		120			96		75					55
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP								1					2		1			5		7			5		3			2		4					5
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				16			5					1							4
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			7		9			11		3			7		9			11		56			97		18			35		17					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																				42			157		541			574		847					571
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			2												7			4		12			7		26			25		23					23
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			83		424			880		815			1,272		1,285			1,741		1,198			1,138		408			182		144					42
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			13		20			11		10			38		21			61		149			287		158			126		106					71
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							70		63			26		24					12
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP															1			4		12			3		17			17		16					6
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																				32			130		37			81		99					63
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		3		79			376		874			1,336		1,840					1,959
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			3		5			20		16			22		23			37		48			33		39			29		54					21
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			12		3			9		3			12		3			29		92			105		89			29		55					6
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																																			1
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							1		30			37		41					50
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													1		5			13		42			7		3					2					3
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							2		8			7		11					3
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																														1					1
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			3		4					1			3		23			54		396			451		857			878		1,102					611
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																									1			1							
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					4			1		7			9		16			30		126			35		6			56		18					6
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																																			1
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		2		18			28		72			99		140					206
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			15		44			30		44			51		135			139		222			173		255			230		116					41
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							5		12			5		5					3
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																				1			11		56			55		49					49
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					4								1		12			131		1,414			1,761		4,082			5,068		3,689					1,822
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																									12			2		5					3
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							1		15			1		9					5
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				10			11		53			38		70					73
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			2												2			5		2			5		1			9		4					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																									73			148		172					213
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			2					1							2			1		13			8		9			5		14					8
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																									15			6		10					6
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																		4		82			279		641			962		1,413					1,620
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																									8			9		3					4
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							3		5			6		12					7
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				2			3		3			3		5					5
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			3										1		3			7		14			30		53			39		36					31
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							1		30			16		9					15
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy										2			4					3		10			14		9			3		6					4
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy															12			11					2					4		20					
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																							4		3			2							
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				24			28		94			192		272					221
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1			1		2			3		8			14		57			8		5			4							3
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			36		46			103		81			152		190			186		132			122		33			19		14					3
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							7		55			48		84					67
Mozambique	Mozambique	MOZ	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												3		369					85
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			1,388				43									664	1,732		462	27	433	2,420		4,981	5,907	13,834	9,161		9,698	16,622	20,017	16,002					22,368
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			923				91									921	2,159		460	21	194	1,713		3,671	5,547	12,821	7,134		6,320	11,400	12,386	10,495					13,715
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			923				51									203	1,149		356	67	366	2,149		5,220	6,352	14,144	10,452		11,233	19,840	24,867	20,023					29,058
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex							3																				1										
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			1,388				29									227	619		175	13	143	739		1,720	2,388	4,694	3,044		3,658	5,881	6,706	5,868					7,875
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male							27									221	544		181	4	46	453		1,252	1,609	3,356	1,749	15,215	1,708	3,067	3,305	2,634	17,496				3,639
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												16,384					18,841				
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			1,388				26									336	913		244	20	240	1,113		2,800	3,587	7,613	5,053		5,288	9,290	10,501	8,919					12,527
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male							25									201	493		82	4	71	434		989	1,770	3,921	2,004		2,071	3,345	3,467	2,860					3,550
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												121,710					139,967				
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			1														13			9	1	13		35	99	209	27		37	87	66	232					351
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												121,710					139,967				
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female							9									147	346		77	5	96	470		1,092	1,395	2,993	1,935		2,589	4,035	4,442	3,892					5,217
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female							3															5		2	6	4	25		5	66	24	4					6
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female							4									78	189		38		54	248		554	718	1,457	881		1,151	1,932	2,079	1,761					2,298
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male							36									458	1,039		218	8	134	915		2,002	3,402	7,757	3,906		4,023	7,131	7,420	6,485					8,548
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												106,495					122,470				
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female							3									62	186		27	3	45	282		655	761	1,216	888	8,191	922	1,753	1,821	1,597	9,420				2,153
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male							8																		24	2	34		6	10	19	49					32
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			923				91									1,776	3,887		734	71	438	3,148		6,354	8,116	20,261	11,570		11,558	18,428	22,901	17,471					24,518
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												32,768					37,683				
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			1,388				30									325	1,304		447	66	583	4,014		7,030	7,946	15,229	11,197		12,260	20,615	25,897	20,996					30,982
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			371				4									44	387		91	43	185	1,089		2,995	3,635	7,368	5,497		6,159	10,840	13,938	11,655					16,741
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			554				5									28	389		165	44	409	2,388		4,831	5,396	9,716	7,706		8,336	15,197	19,300	15,940					25,006
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			1,853																																		
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			2,780																																		
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												45,642					52,489				
Mozambique	Mozambique	MOZ	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			923				69									676	1,538		305	14	177	1,201		2,627	3,978	9,069	4,655		4,587	8,366	8,491	7,327					9,160
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			330,844	9,116	9,586	22,152	28,196	222,272	25,069	25,863	20,913	23,071	191,774	25,382	28,571	30,791	33,126	155,520	33,214	35,009	36,592	38,856	120,875	37,811	37,383	42,801	42,406		40,111	42,720	43,629	44,746					43,988
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			330,536																																		
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				1,074	1,576	13,809	15,353	306,455	12,524	19,255	12,396	18,591	215,641	19,849	20,164	22,653	22,840	162,513	22,182	20,773	22,985	24,640	166,209	20,748	21,542	24,694	24,554		22,249	22,356	23,745	25,272					25,270
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				216,425	303,020	263,776	222,248		100,835	123,954	111,757	126,780		132,900	144,200	142,382	149,060		158,037	179,739	174,154	165,840		160,714	169,625	173,286	169,061		173,433	180,117	174,984	176,882					164,180
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												2,373,054					2,387,558				
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			26,724																																		
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				8,519	9,046	23,132	26,345	410,339	21,178	24,000	20,501	23,513	282,418	25,107	27,166	29,695	31,907	193,720	32,840	33,164	35,165	37,004	251,529	35,406	36,719	42,066	41,721		40,719	39,943	41,509	45,090					46,170
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			287,120	90,197	91,906	78,834	71,672	333,509	69,485	76,226	58,553	65,427	292,051	74,349	79,483	86,461	89,114	235,468	93,089	94,821	99,288	101,091	274,803	99,713	102,392	112,313	112,531		111,302	106,541	107,389	114,987					113,709
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			115,350	4,389	4,262	7,439	7,208	1,666	10,969	13,137	9,091	8,270		8,118	7,680	8,654	10,292		10,779	7,314	6,241	5,972		6,347	5,747	4,777	3,406		3,275	2,829	2,697	3,317					1,946
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			404,554	85,052	84,322	56,202	56,509	504,817	48,160	50,753	42,697	48,943	366,174	52,374	56,077	61,317	67,626	465,013	68,188	71,462	74,977	76,850	659,798	74,042	73,385	83,756	83,508		82,240	89,292	92,227	99,325					99,944
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			404,717	358,219	390,809	370,411	335,360	732,212	269,347	277,882	237,045	274,317	704,636	288,647	291,910	312,736	329,470	749,046	343,174	368,632	395,653	399,808	1,162,871	358,180	376,408	407,026	404,878		393,970	401,017	402,364	417,749					434,194
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				75,517	79,082	60,803	52,655	484,194	45,988	63,245	46,374	44,554	292,298	66,490	78,937	76,306	79,923	192,075	79,306	79,465	82,441	80,328	323,845	74,984	78,943	89,106	91,784		88,884	94,585	97,544	103,698					117,321
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,125,477					949,542				
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Female											2,049	2,093								248	293	882															
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			398,230																																		
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												533,959					786,845				
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			763,298																																		
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				107,274	118,385	72,719	58,057	444,045	50,724	72,489	44,332	54,104	300,797	67,056	76,608	80,623	86,303	235,511	86,119	83,372	87,131	83,627	311,227	77,009	79,585	86,702	84,067		78,890	86,127	89,650	101,402					110,379
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								17													
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,797,768					2,025,559				
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			354,244	100,691	99,129	86,058	77,272	419,323	89,163	92,820	77,027	83,672	402,975	93,567	96,345	104,758	107,109	229,430	113,884	114,011	119,845	124,313	224,901	119,494	126,007	137,927	138,376		139,153	133,555	137,234	143,751					167,756
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												582,661					556,080				
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			256,926	194,905	208,649	219,673	193,271	422,199	151,960	158,257	125,125	147,250	535,924	168,074	180,998	189,308	199,703	948,890	207,031	212,778	227,237	230,760	941,537	220,244	220,251	243,515	238,884		239,538	243,236	250,279	265,048					269,104
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Male											1,911	2,388								251	302	582															
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			354,114	51,989	53,011	36,572	39,719	225,283	34,751	37,366	29,013	32,544	202,599	35,838	40,470	44,206	46,662	193,032	48,477	50,583	53,224	55,615	172,103	51,933	53,829	60,508	61,263		58,551	60,902	63,864	66,527					63,420
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												1,058,781					831,667				
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			167,440	32,609	32,940	32,325	31,954	202,471	30,549	32,457	27,405	31,799	122,115	34,711	35,965	38,497	41,758	159,542	43,010	41,562	45,903	46,724	154,678	44,363	43,942	49,941	48,815	277,392	49,403	48,450	51,897	55,407	342,296				58,775
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			399,294	9,443	10,822	32,587	37,572	495,345	31,848	33,358	27,650	31,999	357,832	34,774	35,930	39,698	43,425	280,430	44,183	45,274	47,661	49,180	377,995	46,525	46,327	52,456	52,014		51,724	55,961	56,200	59,238					58,988
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				2,400	2,159	10,244	12,492	121,696	11,163	13,622	10,538	11,525	103,204	13,216	14,455	15,331	16,931	113,069	16,787	17,110	18,601	19,869	76,677	19,384	19,602	22,235	22,050		20,927	21,171	21,802	22,919					23,529
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Missing Sex											972	877								217	233	270															
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			283,243	90,285	105,456	99,675	105,953	597,390	75,530	64,520	34,682	37,456	364,206	57,295	65,133	67,668	70,403	455,703	73,544	74,267	73,833	75,050	325,722	74,711	75,013	86,538	85,894	760,575	80,851	84,518	86,846	92,784	1,188,052				96,099
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												399,853					603,130				
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			652,258	295,901	320,519	305,530	275,479	676,315	207,027	229,208	191,148	233,820	675,060	250,255	259,788	280,004	297,535	1,142,499	306,620	320,912	338,785	344,941	1,339,003	317,878	326,175	356,452	355,084		347,760	354,020	362,864	380,643					373,490
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			140,005	70,208	72,595	77,984	77,496	290,639	64,622	61,166	37,917	41,147	257,535	52,295	58,345	63,074	60,914	293,716	62,619	66,750	75,136	76,931	332,572	73,990	69,730	84,240	88,045		88,273	69,909	73,109	82,133					79,900
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				8,323	8,472	17,321	21,707	191,262	19,009	22,210	17,550	19,456	172,356	21,106	24,493	26,411	28,566	181,815	28,938	30,803	32,509	34,556	122,278	34,032	34,832	40,437	40,045		38,184	37,189	38,539	40,434					41,153
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			221,097	40,946	40,104	35,556	33,632	322,996	31,013	33,485	27,938	33,897	177,208	35,330	34,159	38,147	41,577	220,525	42,305	40,090	44,242	46,256	212,029	42,041	41,363	47,667	46,107	360,383	45,613	44,269	47,518	50,992	282,270				53,964
Mozambique	Mozambique	MOZ	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				111,679	162,263	43,548	15,593		192,386	171,261	206,890	224,841		230,789	241,879	266,177	298,105		286,432	298,478	324,437	318,323		344,521	348,502	343,636	349,619		336,016	338,290	349,658	398,733					393,080
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												17,904					16,133				
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			60,925	11,075	11,483	9,913	9,625	53,921	9,288	9,893	7,731	8,777	39,856	9,500	10,076	9,500	9,726	34,680	9,793	9,729	9,488	9,123	24,672	8,684	8,647	8,504	7,934		7,794	7,830	7,443	7,461					6,516
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			10,985	908	844	899	1,130	8,003	719	645	402	465	7,589	610	560	635	532	3,851	627	645	706	703	2,973	603	629	629	663		635	571	522	528					449
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			29,768	7,744	7,192	7,172	7,233	39,765	7,815	7,521	5,639	6,084	36,082	6,843	7,425	7,692	7,543	21,965	7,686	7,701	7,950	8,486	14,158	7,438	7,727	7,760	7,389		6,925	7,204	7,035	7,231					7,126
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Female											161	190								24	16	54															
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												39,875					31,386				
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			14,164																																		
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												23,640					23,952				
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			27,665	1,606	1,580	2,930	4,406	43,380	3,427	3,750	2,936	2,990	38,239	3,445	4,031	4,228	4,136	19,832	4,065	4,213	4,349	4,439	14,294	4,029	3,852	4,165	3,882		3,445	3,616	3,257	3,313					3,077
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			1,942	116	160	245	259	99	493	551	433	394		419	322	256	368		405	202	339	221		263	204	309	172		262	128	190	168					203
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												46,454					31,096				
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				906	1,063	1,806	2,306	47,419	1,984	2,166	1,779	1,835	28,640	1,987	2,293	2,459	2,381	16,388	2,200	2,269	2,430	2,520	12,579	2,200	2,227	2,374	2,175		2,065	2,139	2,094	2,023					1,930
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			19,432	2,882	2,830	3,051	2,907	44,165	2,685	2,901	2,292	2,431	24,920	2,715	2,866	3,188	3,160	22,835	2,953	2,834	3,290	3,288	13,545	2,798	2,781	3,005	2,776	18,247	2,624	2,804	2,796	2,747	12,515				2,901
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Missing Sex											20	22								3	4	4															
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			16,835	2,736	2,798	2,663	2,905	29,586	2,481	2,678	2,210	2,224	18,510	2,634	3,026	3,172	3,110	15,671	2,820	2,971	3,324	3,064	11,012	2,839	2,901	3,132	2,789	14,518	2,587	2,759	2,766	2,756	13,830				2,820
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			39,303	7,263	7,324	4,222	5,068	62,214	4,205	4,632	3,347	3,809	33,560	4,148	4,483	4,638	4,758	28,979	4,423	4,812	4,765	4,856	21,069	4,477	4,517	4,570	4,389		3,984	4,326	4,077	4,026					3,676
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			29,838	6,813	7,029	3,933	5,170	43,693	4,226	4,843	3,359	3,562	40,738	4,028	4,590	4,655	4,511	21,897	4,439	4,843	4,829	4,924	15,195	4,545	4,608	4,548	4,339		3,724	3,810	3,868	3,736					3,221
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				174	225	1,122	1,391	33,277	1,176	1,718	1,187	1,317	19,587	1,506	1,641	1,783	1,881	14,898	1,637	1,691	1,802	1,810	9,489	1,449	1,491	1,582	1,523		1,322	1,494	1,392	1,432					1,356
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												5,318					7,838				
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				1,969	2,327	1,485	1,446	15,253	1,220	1,495	926	1,047	11,586	1,272	1,494	1,438	1,387	4,795	1,204	1,201	1,264	989	4,917	2,150	957	874	794		753	856	751	741					701
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			27,725																																		
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				375	294	1,126	1,625	22,722	1,382	1,794	1,306	1,424	19,205	1,604	1,874	2,011	1,925	13,543	1,846	2,000	2,108	1,967	8,239	1,812	1,925	1,948	1,876		1,715	1,681	1,656	1,658					1,703
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			1,433																																		
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				3,337	4,008	1,621	568		3,307	3,210	3,086	3,587		3,326	3,381	3,765	3,867		4,242	3,791	3,964	2,960		3,648	3,760	3,930	3,703		3,693	3,587	3,497	3,708					3,747
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				1,282	1,293	1,859	2,754	36,086	2,274	2,748	1,916	1,939	32,823	2,270	2,734	2,820	2,748	19,547	2,749	3,057	3,139	3,141	10,926	2,860	2,945	3,087	2,943		2,658	2,721	2,608	2,646					2,378
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			38,853																																		
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Male											151	139								10	16	23															
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			21,972	3,495	3,184	2,779	2,878	22,737	3,064	3,093	2,208	2,454	21,012	2,919	3,054	3,003	3,018	11,461	3,105	3,028	3,188	3,074	7,769	2,978	2,882	2,782	2,605		2,558	2,370	2,306	2,267					1,874
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			5,591	1,149	1,287	1,120	1,275	14,821	877	851	632	659	11,587	792	840	866	744	8,547	768	775	898	857	3,506	829	840	857	772	8,521	557	695	654	688	6,335				627
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												11,717					7,081				
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			39,100	1,087	1,286	2,754	3,733	56,696	3,103	3,661	2,559	2,873	30,720	3,206	3,595	3,674	3,623	22,103	3,407	3,595	3,855	3,711	16,986	3,300	3,403	3,465	3,266		3,053	3,252	3,057	2,952					2,807
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												27,133					38,218				
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			39,048	16,059	16,238	15,118	14,335	66,274	14,116	14,396	11,117	12,331	47,906	13,281	13,839	13,774	13,867	35,471	14,038	14,302	14,515	14,172	24,580	12,743	13,128	13,228	12,604		12,281	12,525	12,228	12,167					12,210
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				8,973	9,504	7,383	5,017		2,705	3,781	2,400	2,794		2,851	2,984	2,559	2,235		2,546	2,519	2,278	1,898		2,129	1,917	1,717	1,640		1,585	1,575	1,474	1,325					1,193
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			28,414	4,874	4,738	4,157	3,735	24,127	3,715	3,559	2,662	2,831	21,743	3,322	3,302	3,126	3,159	13,386	3,282	3,268	3,192	3,096	9,342	3,175	2,926	2,895	2,588		2,761	2,620	2,374	2,538					2,337
Mozambique	Mozambique	MOZ	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				1,242	1,230	1,201	1,244	18,555	944	1,465	1,025	1,012	12,261	1,268	1,246	1,357	1,397	3,718	1,283	1,355	1,394	1,326	4,016	1,112	1,165	1,173	1,002		925	1,025	1,059	986					979
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				2,710	2,899	2,542	2,228	27,403	1,921	1,802	1,511	1,546	17,143	1,727	1,734	1,443	1,574	4,571	1,742	1,786	1,524	1,354	10,265	1,562	1,376	1,310	1,108		1,247	1,258	1,070	1,019					947
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female						4		10																													
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female								9,225					7,859					1,986					1,181		10	5											5
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female				27	98				5,286	5,079	5,155	6,223		5,554	5,987	6,349	6,342		6,307	6,504	6,713	7,137		6,415	6,734	6,813	7,077		7,448	7,407	7,052	7,643					7,763
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female							10	20,058				7	17,465					24,129					13,901		171	168			7		5						222
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female								9,222					7,914					4,878					2,838		26	22											44
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												19,276					11,728				
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				16,375	17,685	17,770	16,432	20,319	13,988	15,557	12,865	14,134	22,244	15,583	15,302	14,066	13,497	38,727	14,144	14,667	15,479	14,397	41,892	14,262	14,498	14,419	13,741		13,803	14,384	14,181	13,953					12,950
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				40	56	37	36	1,049	38	22	20	15	1,407	15	17	25	128		94	74	17	16		19	22	26	16		117	16	7	14					8
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female								19,611					16,789					11,871					6,848		104	87			2								113
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												38,610					31,160				
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				7,358	7,730	7,438	6,647	42,961	5,782	6,154	5,525	5,749	44,987	6,173	6,220	5,468	6,185	29,152	7,100	6,807	5,641	5,268	32,631	5,263	5,356	5,247	4,666		4,728	4,777	4,456	4,320					3,630
Mozambique	Mozambique	MOZ	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												68,900					65,835				
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			10,204	3,260	3,299	3,099	2,382	13,024	1,829	1,470	1,176	1,135	13,414	1,422	1,464	1,526	1,360		1,637	1,411	1,213	1,040		1,551	934	895	820		798	794	660	496					523
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female								97,858					100,639					43,082					45,171		26	23											147
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			1,260	231				272																	3												
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			120,221	34		4		205,987					211,519	7	407		82	207,022					221,619		180	184			50		35						2,093
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			256,399	85,188	90,204	86,451	77,105	273,820	49,138	50,293	42,095	43,356	285,750	49,064	51,420	47,650	47,690	357,135	52,943	56,409	53,519	48,517	385,752	51,365	52,962	53,979	49,104		52,703	53,481	49,540	47,892					48,455
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												177,733					181,459				
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female								97,858					100,295					18,207					19,201		10	5											8
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			476,059	162,193	172,497	171,552	160,448	208,455	97,363	105,109	97,413	106,515	218,687	105,567	106,790	106,865	111,373	361,710	113,085	123,926	124,953	121,043	386,064	112,164	116,236	120,365	118,623		119,622	121,300	117,920	123,174					122,366
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			113,524					201,757					207,348	9				102,653					108,800		109	94			2								505
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												991,284					1,012,109				
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												623,714					636,782				
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			330,380	122,530	132,083	129,369	116,731	411,022	70,453	77,497	74,862	79,002	425,165	80,051	83,542	84,287	85,423	563,953	88,318	98,104	94,914	89,660	580,068	86,060	87,926	92,435	89,108		90,444	94,879	89,082	91,360					86,099
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex			353																					17													
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				734	3,803	5	2		184,448	170,238	178,059	190,005		189,206	199,221	206,347	216,967		215,780	222,737	235,715	212,557		244,131	238,419	234,229	244,126		245,183	245,708	254,716	271,002					274,428
Mozambique	Mozambique	MOZ	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			110,510																																		
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female				41	98				5,904	5,903	5,733	6,687		6,047	6,315	6,643	6,858		7,367	6,800	7,117	5,923		6,508	6,869	7,115	7,303		7,619	7,348	7,127	7,684					7,770
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female								9,225					7,991					2,000					1,183		10	5											5
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												69,455					66,199				
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			13,723	34				20,058					17,749	7	81			24,492					14,127		170	168			7		5						221
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female								9,222					8,042					4,934					2,867		26	22											48
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			7,963	2,820	2,977	2,619	2,248	27,403	1,955	1,839	1,507	1,548	17,466	1,718	1,721	1,439	1,436	4,694	1,554	1,578	1,516	1,324	10,526	1,531	1,374	1,317	1,107		1,239	1,248	1,064	1,012					943
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			115					10																	3												
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												39,206					31,388				
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			22,150	7,487	7,940	7,567	6,754	42,961	5,826	6,209	5,559	5,729	45,638	6,154	6,176	5,473	5,538	29,851	6,107	5,933	5,617	5,248	33,245	5,307	5,347	5,240	4,646		4,729	4,776	4,456	4,312					3,654
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			169	43	58	54	41	1,049	42	19	20	15	1,408	16	17	23	17		25	22	17	16		29	22	15	16		8	16	7	14					10
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			13,476					19,611					17,062	9				12,039					6,963		104	88			2								107
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												19,438					11,730				
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			13,413																																		
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex			12																																		
Mozambique	Mozambique	MOZ	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			27,193	16,706	17,922	17,985	16,599	20,319	14,060	15,618	12,897	14,148	22,544	15,555	15,226	14,087	14,354	39,466	15,348	15,752	15,457	14,392	42,434	14,172	14,476	14,413	13,728		13,874	14,359	14,159	13,922					13,000
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												80									
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			45,158		51,382		42,815	40,804		38,789		19,605	75,911		34,052		45,825	53,232		44,965		80,023	18,539		21,537		7,469			6,154		1,599					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												400					240				
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female					531		947			17		38								4							1			1		4					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					120		1,076			2		25															1			1		1					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male					45		5			86																											
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			19		11,318		7,970	4,088		2,757		2,091	1,208				768	150		36		107	660				24			13		145					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			37,088		35,361		40,934	39,697		35,366		17,765			1,360		2,653			2,051		4,299			7,642		5,174			4,197		34					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					155		83					7																				1					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												240					160				
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male					307		752			11		20								2							33			34		205					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female					529		888			29		98						75		6			11				1			1		5					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female					15,977		7,540	365		346		654	10				1	81		1		306	11		1,385		26					7					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female					382		365					15																				1					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female					41		10			116																											
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			15,190		23,704		16,025	11,126		17,632		13,972	33,375		15,451		19,294	30,552		23,419		26,293	6,452		7,501		2,216			1,803		37					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					71		63					5								1							11			8		47					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					77		892					12								2							20			23		121					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male					194		297					13															9			4		27					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male					6,021		1,502	163		80		400	3					75		2		35	11				43			58		432					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male					318		921			41		49						75		4			11				29			47		316					
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												80									
Mozambique	Mozambique	MOZ	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male					4,089		3,672	5,106		865		1,218	347				578	75		4		105	90				52			67		343					
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			125	187	355	621	772	654	568	611	951		918	622	936	862					532
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												1,651					1,853				
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			612	754	1,299	2,135	3,064	2,305	3,038	2,540	2,247		2,647	3,178	3,445	3,397					3,161
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			421	463	774	1,190	2,150	1,272	1,513	1,465	1,345		1,540	1,484	1,864	1,811					1,332
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			53	112	181	299	201	388	393	388	378		421	417	470	523					455
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			803	1,231	2,304	3,760	4,462	3,573	3,984	3,616	3,623		3,985	4,145	4,556	4,685					4,044
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												4,079					4,578				
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			431	489	890	1,283	1,550	1,404	1,912	1,580	1,558		1,698	2,067	2,270	2,393					1,875
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			61	134	178	244	287	310	350	340	361		383	363	437	416					341
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			93	182	335	433	447	567	633	616	669	127	679	679	757	819	90				718
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												4,385					4,925				
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												9,212					18,544				
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			46	88	156	247	188	356	392	388	436	428	415	452	519	581	858				617
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																			4	3		1		1	2		6				1,607	1					
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			161	168	288	425	514	507	546	517	556		592	603	710	673					540
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			522	852	1,585	2,736	2,743	2,695	2,412	2,362	2,668		3,182	2,269	2,688	3,039					2,823
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																			43		1	6		2	3	17	14		1	1	1,202	1					
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			394	530	998	1,517	2,475	1,635	1,797	1,923	1,767		1,900	1,858	2,442	2,337					1,470
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												3,617					3,044				
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			161	229	386	597	870	667	729	657	711		752	746	890	882					624
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			256	352	606	1,044	1,282	1,013	1,135	1,201	1,021		1,180	1,306	1,435	1,424					979
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			119	185	290	423	512	572	637	605	624		652	782	773	794					672
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			216	297	493	725	895	940	993	889	876		1,005	1,093	1,267	1,269					1,057
Mozambique	Mozambique	MOZ	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												6,028					7,472				
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					207		362	1,296		896		1,509	760	1,809	2,623	3,455	4,881	4,903																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					191		1,238	1,054		893		1,545	9,138	2,237	4,016	6,190	8,522	6,835																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					93		189	341		305		629	218	790	1,143	1,502	2,243	1,670																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					115		178	443		270		601	4,420	800	1,069	1,464	2,290	3,555																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					136		246	1,296		421		1,013	541	1,176	1,677	2,223	3,233	3,318																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					182		361	1,302		694		1,446	716	1,912	2,836	3,883	5,303	4,306																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female					11		4																														
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					30		99	5		138		254	22	311	433	576	826	829																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					50		114	1		164		325	2,110	403	587	777	1,234	1,780																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					54		179	5		260		463	96	568	762	997	1,476	953																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					41		104	1,302		173		370	441	548	871	1,239	1,893	1,584																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					10		2																														
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					38		94			98		188	65	228	322	385	610	494																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					75		113			173		327	82	401	583	793	1,155	817																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					24		48			75		163	2,110	216	342	446	669	1,683																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					206		334	1,054		1,059		1,657	14,821	1,938	2,807	3,966	6,331	12,024																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					162		250	1,054		504		1,150	4,748	1,292	1,836	2,544	3,982	5,284																			
Mozambique	Mozambique	MOZ	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					294		1,600	1,054		1,499		2,716	11,217	3,651	5,537	8,054	11,680	9,874																			
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					30		30	1		69		156	2,110	99	145	166	422	1,359	333	332	424	496	1,916	471	476	617	755		779	794	905	902					951
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female					8														37		31	29		41	54	101	8		115	102	85	74					
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			1,084		119		105	932		745		784	14,635	590	824	1,099	2,470	9,094	2,044	2,326	2,671	3,008	11,498	4,016	4,636	5,295	6,327		7,433	6,738	7,965	8,457					11,133
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												4,907					6,856				
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			13																																		
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			1,084		88		73	932		242		460	4,562	377	484	681	1,456	4,370	1,030	1,347	1,373	1,569	5,817	2,097	2,439	2,878	3,461		3,948	3,990	4,613	4,889					6,229
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					38		41	4		107		220	95	120	172	224	468	943	336	423	471	587	1,924	542	608	679	848		882	913	1,063	1,144					868
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												8,068					11,274				
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			467		59		63	386		110		326	4,342	178	262	355	809	2,689	595	616	736	949	3,374	976	1,143	1,339	1,685		1,833	1,874	2,142	2,063					2,713
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					13		11			42		91	2,110	57	85	93	192	1,262	131	149	246	290	752	235	278	279	365		356	365	449	491					418
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			3																																		
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												13,053					18,239				
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					15		20			41		85	65	59	65	63	186	488	121	143	222	257	698	195	233	264	276	2,273	265	261	399	363	3,176				323
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			537		25		13	1,033		74		196	236	199	320	371	492	1,544	526	691	869	1,221	2,905	1,329	1,547	1,844	2,407		2,577	2,421	3,162	4,104					1,698
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					12		17	4		55		124	21	73	90	132	245	828	189	223	274	333	1,066	311	313	394	449		452	493	583	620					462
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												12,136					16,956				
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			1,084		191		972	932		884		1,213	11,031	1,162	1,884	2,475	3,967	7,667	3,004	3,721	4,666	4,946	16,728	6,495	7,485	8,336	9,448		10,767	9,855	11,706	13,357					13,671
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												49,154					68,683				
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			536		87		77	1,030		200		466	357	368	470	513	1,049	3,253	823	1,088	1,288	1,531	4,808	1,425	1,701	1,870	2,301		2,409	2,398	2,754	3,120					2,366
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			1,084		110		700	932		445		641	8,952	693	1,747	2,139	2,366	5,044	1,829	2,783	3,833	3,697	10,271	4,708	5,571	6,468	7,753		7,940	7,162	8,803	10,820					8,408
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			536		117		86	1,030		547		746	556	526	763	778	1,509	4,791	1,408	1,716	1,796	2,183	8,061	2,285	2,673	3,034	3,744		3,914	3,838	4,291	4,912					4,102
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			130		52		73	265		143		327	167	237	318	356	771	1,647	550	666	788	911	3,256	901	982	1,116	1,430		1,391	1,470	1,702	1,775					1,315
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												19,804					27,673				
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					4														1		2	2		15	11	20	1		8	13	8	4					
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					40		30			98		157	82	117	161	198	373	807	286	335	401	512	1,660	420	476	516	573	237	507	581	806	788	333				578
Mozambique	Mozambique	MOZ	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			537		108		77	1,033		406		752	511	623	907	1,047	1,455	4,205	1,671	1,995	2,276	2,682	9,279	2,928	3,648	3,905	4,772		5,018	5,092	6,074	7,144					4,363
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				71	80	89	90	2,632	61	52	44	36	1,415	37	30	39	42	501				208	431				178					172					152
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											159					261					365
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				219	191	244	172	1,120	167	155	125	113	1,177	144	99	106	113	750				543	1,049				500					374					371
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				388	407	497	447	2,149	389	408	333	359	1,982	345	303	351	357	1,521				1,512	1,059				1,535					1,455					1,252
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												849					664				
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			1,630																																		
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												4,952					5,413				
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				723	725	755	737	2,732	699	705	509	473	3,024	504	488	512	497	2,250				2,187	1,385				2,024					1,909					1,768
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				419	440	501	469	2,101	451	430	365	290	2,155	329	271	323	308	1,453				1,292	1,076				1,169					1,094					957
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				172	208	225	193	1,122	155	136	105	98	1,049	106	91	103	87	723				509	1,050				519	767				472	631				313
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				597	630	707	667	2,949	559	641	494	499	6,402	587	489	587	651	1,700				2,730	3,029				1,350	2,571				1,242	2,601				890
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female										1		9																									
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				112	117	127	117	1,119	125	125	81	91	920	95	73	98	90	606				448	838				304					312					242
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male						1						16																									
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				315	311	365	375	2,853	301	344	269	284	2,332	312	263	341	289	1,912				1,370	1,019				1,326					1,416					1,216
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				552	525	649	580	2,129	496	497	409	402	2,525	427	348	359	406	1,540				1,771	1,233				1,633					1,509					1,317
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												3,360					3,278				
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				479	524	574	627	2,760	511	535	403	396	2,668	419	347	402	385	2,045				1,907	1,193				1,816					1,885					1,696
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				27	37	28	24	1,110	32	21	13	22		21	8	8	12					56					36					57					29
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				636	646	663	728	2,705	597	640	459	487	2,903	488	385	451	418	2,120				1,873	1,353				1,801					1,705					1,443
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												3,151					3,269				
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											149					290					338
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												4,528					4,872				
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												1,284					930				
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											207					277					339
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				407	424	436	391	2,687	377	399	281	281	2,568	290	284	287	254	1,546				1,137	1,211				1,050					932					841
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											194					282					325
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											182					309					365
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											868					485					518
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				196	162	160	152	2,669	164	143	133	99	1,922	108	94	110	100	758				447	925				443					420					336
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				562	589	646	611	2,118	532	553	407	394	2,318	429	350	398	417	1,597				1,671	1,197				1,639					1,421					1,272
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			12,571																																		
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				253	222	316	273	2,195	235	286	212	220	1,770	265	206	227	265	1,300				1,278	901				1,217					1,157					922
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											918					527					567
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				110	104	110	100	2,059	104	98	75	77	1,345	62	45	60	61	669				260	384				252					242					193
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											205					286					292
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												1,123					1,012				
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				568	523	715	695	2,276	497	617	444	501	6,326	559	412	530	611	1,548				2,793	2,662				1,527	2,382				1,364	2,617				885
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			13,283																																		
Mozambique	Mozambique	MOZ	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				261	282	278	256	2,080	243	261	239	196	1,608	232	175	224	243	933				819	821				780					695					584
Mozambique	Mozambique	MOZ	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			89,732		6,250		7,412	185,191		12,484		28,405	417,652		38,448		56,955	232,567		68,192		64,243	100,596		58,451		47,850	60,050		40,039		33,161	77,799				22,479
Mozambique	Mozambique	MOZ	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female												1			1		2								1							1					1
Mozambique	Mozambique	MOZ	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			12,634		1,000		1,239	4,089		2,670		5,154	82,752		6,059		10,575	38,780		10,898		14,879	17,742		8,097		5,854	17,244		4,732		3,580	11,546				2,374
Mozambique	Mozambique	MOZ	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male												1			20		1										2										1
Mozambique	Mozambique	MOZ	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			162,629		15,641		18,066	287,591		30,694		62,521	780,870		78,662		121,726	418,903		128,662		111,268	177,824		101,642		79,378	112,873		64,300		54,092	118,515				39,834
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				724	841	1,064	982	4,652	836	852	749	879	4,332	822	752	875	883	3,114	895	823	964	1,071	3,600	929	805	1,019	1,081		1,012	830	949	929					905
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				1,266	1,418	1,474	1,569	5,925	1,341	1,356	1,073	1,189	6,507	1,142	1,144	1,176	1,164	4,647	1,272	1,184	1,315	1,361	4,728	1,323	1,131	1,340	1,348		1,257	1,180	1,282	1,279					1,336
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				98	116	109	117	2,677	136	132	72	83		74	68	87	71		89	77	84	92		75	57	95	84		60	67	78	67					43
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				963	1,129	1,215	1,174	4,570	1,017	1,056	907	928	4,509	970	823	926	1,005	3,234	967	901	991	1,039	4,076	935	917	1,019	1,108		950	921	968	893					862
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			46,058																																		
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				688	784	869	879	2,693	702	759	651	673	2,345	679	555	642	661	3,207	749	674	834	875	3,596	894	755	992	944	3,918	858	732	908	849	4,334				857
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												5,122					5,664				
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												4,538					5,019				
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				1,214	1,311	1,366	1,518	5,865	1,258	1,302	1,180	1,148	6,349	1,201	1,008	1,152	1,100	4,529	1,126	1,168	1,226	1,203	4,607	1,203	1,164	1,244	1,329		1,259	1,159	1,264	1,264					1,246
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				838	929	975	985	4,529	928	924	842	887	4,403	885	783	878	836	3,151	795	795	887	986	3,663	859	759	893	906		863	827	820	762					820
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												13,373					14,787				
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												11,861					13,115				
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				339	405	432	408	4,434	374	437	342	389	3,603	399	302	345	348	2,582	356	377	375	401	1,357	420	418	431	454		428	380	363	409					368
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			42,060																																		
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				1,673	2,232	2,708	2,799	6,380	2,132	2,419	2,189	2,535	9,813	2,588	2,254	2,457	2,995	7,043	2,798	2,651	3,198	3,202	10,363	3,032	2,681	3,457	3,470	11,296	3,137	2,615	3,134	3,207	12,491				3,433
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				576	590	770	774	4,761	541	699	626	680	4,226	727	632	699	808	3,043	768	781	881	979	3,088	876	764	895	950		898	716	855	855					860
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				791	901	1,087	978	2,690	926	864	784	765	2,482	775	628	751	789	3,301	815	847	1,000	1,031	3,598	1,082	723	1,052	956		846	717	950	837					834
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				1	2	1	2		5	2		31																									
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				492	642	754	702	2,689	629	764	574	584	2,159	642	547	636	641	2,944	619	714	710	641	2,974	600	515	661	580		578	506	631	516					619
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												8,434					9,326				
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				1,001	1,060	1,264	1,195	4,602	950	1,012	906	1,030	4,524	1,005	830	879	1,061	3,250	944	939	1,099	1,131	4,193	920	840	1,088	1,117		1,068	908	931	937					965
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				606	690	737	782	5,777	752	762	667	649	5,310	716	686	689	636	3,811	731	669	742	701	3,163	701	651	762	759		738	735	765	703					684
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female										1		17								1						1											
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												7,161					7,919				
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				655	727	908	892	6,201	688	813	725	804	5,944	843	726	847	882	4,266	902	806	960	1,002	3,480	903	918	1,003	1,028		977	859	970	1,076					1,067
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				385	417	458	436	5,704	399	395	357	359	4,757	374	326	322	306	3,401	421	401	360	436	1,537	388	422	489	438		429	418	445	396					416
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				1,577	1,859	2,590	2,856	4,920	1,902	2,259	2,121	2,494	8,811	2,459	1,839	2,267	2,829	6,306	2,640	2,457	3,115	3,540	9,189	2,900	2,521	3,486	3,421	10,017	2,995	2,438	3,044	3,273	11,075				3,255
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				955	1,104	1,137	1,091	5,819	1,100	1,140	901	977	6,012	1,032	935	1,045	929	4,311	1,052	960	1,031	1,010	4,122	975	981	1,022	1,052		1,096	989	1,005	1,026					1,089
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				616	724	725	741	4,481	685	732	729	699	3,619	781	667	729	727	2,587	729	698	794	756	2,808	752	723	820	746		750	715	726	683					626
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			11,078																																		
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				912	1,090	1,191	1,227	5,986	1,059	1,198	966	987	6,187	1,011	889	963	1,020	4,430	1,158	1,059	1,197	1,203	4,060	1,168	1,062	1,249	1,286		1,281	1,152	1,276	1,158					1,302
Mozambique	Mozambique	MOZ	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												9,516					10,523				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			8,156	2,617	2,177	2,295	2,391	7,665	2,529	2,141	2,129	2,068	6,488	2,227	1,894	1,767	1,768	3,182	1,876	1,532	1,521	1,536	1,962	1,557	1,260	1,295	1,278	2,518	1,327	1,165	1,187	1,209	1,754				1,098
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			22,972	12,473	12,010	12,606	13,532	60,331	13,146	12,735	13,732	15,109	44,807	16,223	15,082	16,900	18,841	41,922	20,404	18,663	20,556	21,989	42,987	23,705	21,111	21,978	22,259		22,251	18,857	18,694	18,917					15,445
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			8,269	5,409	5,519	5,688	5,922	21,306	5,926	6,129	6,420	6,864	17,060	7,130	7,231	7,658	8,118	20,012	8,493	8,683	9,133	9,494	21,264	9,775	9,972	10,249	10,537		10,607	10,666	10,691	10,856					11,190
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												199,210					208,519				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			27,297	16,855	17,661	18,305	18,837	39,226	18,938	20,389	20,640	21,328	37,047	21,796	22,738	23,408	24,164	37,315	24,686	26,131	26,865	27,452	36,201	27,964	28,887	29,426	29,714	41,482	29,367	29,807	29,646	29,873	45,812				29,502
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			13,245	14,572	15,186	15,147	8,960	15,925	17,571	18,036	18,399		18,273	19,590	19,549	19,659					21,966
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			23,022	23,870	24,416	24,849	34,883	25,169	26,440	26,915	27,518		27,351	27,842	27,445	27,551					29,363
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			152,031	76,701	74,359	77,694	80,894	136,160	79,202	79,116	83,317	88,886	145,743	92,748	88,451	95,054	102,132	159,878	107,842	101,360	106,938	111,632	161,580	115,529	105,675	108,077	109,932		108,288	93,794	91,290	91,958					74,712
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			78,527	42,734	44,213	45,908	47,849	115,159	46,449	49,163	51,316	54,025	109,989	56,247	57,384	61,142	65,389	97,164	68,238	71,085	75,103	78,352	99,796	80,843	82,135	83,524	85,991		83,955	80,895	78,039	78,345					69,817
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			77,927	50,188	53,478	55,664	57,687	79,368	57,792	62,945	64,986	67,394	89,793	69,289	73,899	76,940	80,152	95,555										136,117					141,508				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<15	Coarse	Missing Sex																			16,728	17,104	17,579	18,104		18,659	19,381	20,328	21,306		22,668	19,072	16,327	17,251					17,835
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Missing Sex				4,613	4,843	4,806	4,915		15,156	11,817	12,125	12,796		13,587	13,930	14,811	15,615																				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												482,899					490,559				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male				17,622	17,705	17,008	17,008		58,663	55,535	57,247	59,596		63,517	65,793	70,427	73,882																				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15+	Coarse	Female																			157,860	163,538	173,711	179,246		185,364	195,170	205,010	213,368		228,869	210,384	196,487	209,720					223,487
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												299,940					329,522				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												67,147					68,675				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			181,260	115,717	119,224	123,117	126,676	164,986	125,507	132,452	135,751	140,543	186,189	143,872	147,514	152,505	158,807	196,184	162,313	170,256	175,892	180,319	200,834	183,639	189,013	190,988	194,247		190,420	190,780	186,154	186,572					179,210
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				21,679	22,291	23,080	23,434	50,161	23,096	23,748	23,859	24,466	43,240	24,801	25,431	26,398	27,487	31,887	27,936	28,420	29,230	29,723	34,782	29,868	29,435	29,772	29,697		29,162	27,992	27,461	27,427					25,322
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			33,193	35,490	36,431	37,199	52,282	37,638	40,789	41,314	42,202		42,081	44,177	43,978	44,085					47,825
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			15,696	17,513	18,137	19,162	13,433	19,120	21,356	21,925	22,492		22,493	24,612	24,670	24,924					28,472
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			78,447	45,184	46,978	49,008	51,215	114,989	50,434	52,651	54,794	57,495	110,425	59,573	63,002	67,170	72,028	96,007	75,559	78,650	82,087	85,142	100,064	87,288	89,199	91,046	93,652		92,080	90,238	87,409	87,604					82,632
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			181,319	103,873	106,626	111,207	115,284	176,062	113,640	117,963	121,927	127,952	196,378	131,900	135,995	144,035	153,364	197,223	160,016	161,755	167,819	173,246	202,784	178,156	175,808	178,348	182,558		178,999	168,761	163,367	163,067					160,634
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				44,097	46,418	48,369	50,189	88,758	51,252	54,780	56,554	58,928	82,449	60,756	64,884	67,740	70,839	95,190	72,936	77,425	80,353	82,804	98,132	84,541	89,780	91,760	94,190		94,009	97,899	97,969	98,961					105,474
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				20,150	19,964	18,469	18,995		124	226	122	91		84	113	2	1		1	1	1	1		3	3	5	5		6	7	9	8					9
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				17,664	16,717	17,349	17,429	41,704	16,524	16,189	16,050	16,611	35,716	17,074	16,185	16,946	17,756	26,598	18,211	16,839	17,319	17,578	28,553	17,570	15,919	15,954	15,943		15,467	13,246	13,018	12,933					10,674
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			80,299																																		
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			14,730	16,060	16,743	17,397	13,961	17,787	18,953	19,387	19,806		19,725	20,794	20,880	21,175					21,418
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			51,438	54,041	55,693	57,333	62,718	58,664	60,582	61,709	63,008		62,960	64,416	64,577	65,304					70,340
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												47,853					52,144				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female				45,577	44,605	41,523	42,135		201	501	251	156		182	203	6	7		6	7	3	5		4	5	5	4		6	6	638	651					78
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												503,343					509,070				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			181,416																																		
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				71,963	76,601	79,212	81,884	126,628	82,886	89,506	91,859	94,572	129,807	97,127	102,888	106,056	109,613	130,184	111,846	118,740	121,970	124,976	135,654	127,218	134,331	136,746	139,803		138,907	142,870	141,855	142,110					142,213
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			105,015	74,453	79,574	82,616	85,746	117,942	87,456	94,427	96,845	100,093	130,575	103,016	109,912	113,849	117,640	147,110										188,961					192,429				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			20,182	21,572	22,387	23,111	20,897	23,770	25,108	25,810	26,321		26,428	27,840	28,179	28,631					30,338
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				26,761	28,278	29,493	30,820	60,970	30,630	33,083	34,595	36,581	60,599	38,078	40,905	43,312	45,865	64,876	47,746	50,477	52,738	54,777	66,409	56,113	58,781	60,257	62,094		61,985	63,033	62,434	63,077					64,617
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15+	Coarse	Male																			80,102	82,918	87,707	92,360		96,956	99,886	106,518	111,902		120,776	110,950	98,983	105,999					110,976
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			181,323	97,909	101,884	105,665	108,909	150,246	109,460	114,049	116,534	120,481	163,531	123,072	129,834	135,467	141,582	164,564	145,977	152,146	156,205	159,719	171,673	162,185	167,972	169,827	172,626		170,647	171,514	168,700	168,821					167,141
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			78,347																																		
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			31,238	33,935	35,365	36,635	41,842	37,674	39,969	40,732	41,534		41,046	42,606	42,445	42,823					45,692
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												192,124					194,267				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				37,840	40,043	41,728	43,514	96,670	43,314	47,078	48,850	50,724	93,904	52,399	55,709	58,317	61,261	89,262	63,366	68,297	71,489	74,174	89,434	76,134	80,950	82,650	85,070		84,110	85,403	83,651	84,199					81,250
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Female				39,584	44,883	42,932	43,698		130,880	112,109	116,973	121,772		129,437	133,949	141,474	149,491																				
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			78,483	28,049	28,195	29,619	31,222	106,179	29,676	29,880	31,899	34,131	86,080	36,102	36,237	40,310	44,411	79,089	47,982	46,703	49,923	52,760	80,222	55,690	51,521	52,555	54,860		53,711	47,953	46,345	46,695					44,848
Mozambique	Mozambique	MOZ	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			47,021	23,399	20,408	21,957	23,127	56,416	22,995	18,780	19,623	21,418	56,598	22,937	19,573	21,590	23,763	58,341	25,724	22,631	24,471	26,229	59,447	27,758	24,263	25,493	26,428		26,859	23,271	23,567	24,356					23,316
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								527	477	522	510		425	507	464	455					445
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			56,797	9,589	9,429	8,667	7,931	48,845	6,751	7,895	6,383	7,035	37,445	7,870	8,382	7,921	8,057	32,963	8,078	7,990	7,867	7,558	21,752	7,186	7,171	6,966	6,397		6,148	6,244	6,004	6,002					5,253
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			5,732	1,372	1,250	1,264	1,171	7,665	1,077	1,106	942	933	2,288	1,020	867	836	899	3,182	843	691	740	708	1,980	634	554	691	612	2,566	595	610	676	655	1,792				633
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								1,111	1,087	1,119	1,071		911	919	1,000	930					979
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			16,768																																		
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								953	953	999	828		857	948	929	905					890
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			14,368	2,781	2,693	2,378	2,276	21,652	1,926	2,136	1,674	1,809	19,965	2,173	2,327	2,221	2,154	10,912	2,185	2,220	2,194	2,156	7,383	2,085	2,055	1,975	1,797		1,657	1,613	1,508	1,506					1,231
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												17,010					15,329				
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			38,615	8,918	8,805	8,487	7,795	63,164	6,534	7,566	6,118	6,705	45,510	7,409	7,939	7,690	8,090	33,717	7,975	8,274	8,179	8,177	23,348	7,629	7,569	7,494	7,085		6,748	6,880	6,460	6,457					6,219
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								449	431	485	401		421	380	383	419					412
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			14,622	2,425	2,390	2,393	2,286	28,449	1,869	2,215	1,836	1,849	17,587	2,150	2,364	2,456	2,469	14,895	2,198	2,301	2,519	2,513	10,500					13,796					13,133				
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			2,882	544	516	403	394	7,672	348	386	234	281	7,202	321	354	363	307	3,664	365	353	386	391	2,824	344	335	338	322		332	314	299	332					322
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								313	302	347	312		302	307	292	313					331
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			25,978																																		
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												25,775					36,306				
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												11,131					6,722				
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male				32	592	69	37		2		2																		1		2	1					
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Missing Sex				223	317	312	288		739	775	693	821		764	770	883	877		976	1,016	1,101	930															
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				1,659	1,709	1,751	1,560	21,849	1,330	1,535	1,339	1,537	18,242	1,627	1,819	1,930	1,881	12,877	1,744	1,851	1,923	1,916	7,824	1,742	1,771	1,826	1,713		1,658	1,611	1,574	1,592					1,600
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			5,165	687	635	630	592	14,088	517	574	452	456	11,002	547	544	620	584	8,176	577	628	682	687	3,358	663	628	672	565	8,094	398	530	489	482	6,015				408
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			26,374	4,845	4,679	4,434	4,060	38,101	3,416	4,033	3,065	3,516	34,237	3,843	4,214	4,108	4,312	20,881	4,229	4,360	4,406	4,604	12,879	4,267	4,154	3,960	3,779		3,281	3,392	3,373	3,021					2,894
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male				1,163	1,545	1,334	1,272		4,422	4,836	4,045	4,423		4,444	4,594	4,993	4,791		5,502	5,336	5,667	5,645															
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			26,316	5,016	5,061	4,696	4,371	41,289	3,723	4,459	3,483	3,758	38,622	4,069	4,618	4,589	4,472	20,805	4,346	4,752	4,737	4,787	14,409	4,494	4,566	4,414	4,262		3,743	3,886	3,850	3,745					3,312
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								488	505	561	484		452	471	437	483					488
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												22,460					22,753				
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			23,642	4,484	4,174	3,885	3,382	20,231	3,080	3,122	2,334	2,541	20,654	2,873	2,998	2,721	2,841	12,737	2,923	2,965	2,860	2,812	8,868	2,790	2,721	2,594	2,347		2,397	2,408	2,188	2,227					2,054
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			38,441	4,558	4,412	4,474	4,108	53,909	3,461	4,130	3,174	3,472	29,178	3,776	3,998	4,265	4,116	21,003	3,997	4,077	4,260	4,231	16,137	3,841	3,804	3,865	3,619		3,501	3,544	3,393	3,316					3,067
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				2,863	2,552	2,610	2,430	45,434	2,154	2,321	1,930	1,972	27,212	2,217	2,449	2,523	2,495	15,583	2,309	2,352	2,542	2,641	11,952	2,332	2,194	2,386	2,207		2,115	2,132	2,133	2,110					1,953
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15+	Coarse	Female																								8,895	9,218	9,591	8,917		9,065	9,574	9,799	10,128					10,258
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				1,726	1,667	1,658	1,554	31,820	1,302	1,593	1,207	1,372	18,605	1,554	1,643	1,785	1,791	14,144	1,619	1,633	1,797	1,805	9,017	1,428	1,500	1,589	1,564		1,366	1,487	1,408	1,455					1,346
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15+	Coarse	Male																								5,395	5,559	5,931	5,370		5,638	5,955	5,801	5,881					6,264
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												37,881					29,815				
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				906	908	917	797	17,978	657	772	583	599	11,652	789	829	910	873	3,619	796	828	863	856	3,835	709	674	720	608		516	536	542	516					546
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								383	397	411	374		344	359	401	376					331
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			38,145																																		
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			38,580	6,739	6,655	6,385	5,862	59,177	4,807	5,755	4,571	4,993	31,879	5,446	5,653	5,595	5,739	27,546	5,464	5,840	5,873	5,770	20,019	5,325	5,468	5,454	5,074		4,886	4,957	4,839	4,779					4,390
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								309	327	370	322		266	287	281	306					384
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												44,133					29,540				
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				1,754	1,733	1,641	1,367	15,029	1,062	1,368	994	1,081	11,006	1,366	1,509	1,449	1,332	4,615	1,235	1,354	1,349	1,167	4,688	1,040	1,131	998	906		837	938	892	830					759
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				2,801	2,596	2,649	2,455	34,673	2,162	2,537	2,015	2,002	31,187	2,303	2,648	2,604	2,549	18,574	2,588	2,709	2,857	2,861	10,378	2,664	2,670	2,801	2,687		2,476	2,657	2,512	2,484					2,250
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			26,258	4,115	4,182	3,953	3,865	41,246	3,172	3,667	3,072	3,208	36,325	3,512	3,940	3,985	3,972	18,849	3,903	4,111	4,168	4,323	13,389	3,962	3,854	4,004	3,698		3,424	3,577	3,268	3,335					3,035
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												5,051					7,443				
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Female				2,555	3,136	2,598	2,286		7,829	8,358	7,342	7,854		7,570	7,939	8,454	8,486		9,591	9,415	9,805	9,680															
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female				72	1,185	102	37		5		5																		3		13	11					1
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<15	Coarse	Missing Sex																								881	893	923	816		833	935	961	954					921
Mozambique	Mozambique	MOZ	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			17,463	2,731	2,601	2,774	2,551	42,283	2,042	2,381	1,807	2,097	23,676	2,404	2,506	2,701	2,725	21,688	2,484	2,361	2,691	2,766	12,903					17,336					11,888				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Female														6,227	5,048	4,772	5,340		5,454	6,532	7,039	6,506															
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												63,580					61,423				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												42,704					46,006				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				13,533	15,721	18,637	21,435		22,883	24,183	23,989	24,220	96,693	26,755	30,459	35,502	40,740	82,624	44,093	47,025	50,517	54,961	95,065	58,357	61,076	62,468	62,488		63,432	65,449	67,325	68,977					60,108
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												434,457					443,691				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				42,129	47,931	55,023	61,229		64,580	68,959	68,435	69,782	171,419	76,740	84,440	95,557	104,276	173,821	108,807	115,427	121,548	129,222	190,792	134,705	140,141	140,721	139,402		141,347	149,031	153,362	156,871					141,680
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								19,849	21,165	21,499	21,473		21,764	23,373	24,407	25,235					26,260
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				5,085	5,605	6,607	7,324		7,956	8,443	8,879	9,637	38,611	11,148	12,389	14,490	16,477	28,627	17,893	18,615	19,614	20,590	33,046	21,731	22,039	22,671	22,586		22,631	22,239	22,842	23,183					19,374
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15+	Coarse	Female																								6,420	6,152	6,552	6,765		6,662	7,050	6,847	4,735					
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				4,299	5,121	6,161	6,983		7,872	8,871	9,450	10,202	32,789	11,713	13,172	14,807	16,100	31,711	17,092	18,546	19,214	20,083	34,400	20,701	22,008	22,401	22,455	38,947	22,614	23,666	24,312	24,766	40,565				22,757
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				2,623	2,603	3,039	3,315		3,527	3,319	3,411	3,677	31,510	4,337	4,620	5,761	6,897	23,144	7,949	7,740	8,448	9,405	27,140	10,672	10,099	10,452	10,612		10,516	9,213	9,497	9,654					6,769
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												173,857					174,755				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				18,786	22,553	26,590	30,237		32,251	35,545	35,541	36,290	82,036	40,005	45,105	51,318	56,576	83,979	59,578	65,473	69,047	73,105	94,699					121,618					126,760				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												451,591					460,815				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												269,242					293,632				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								28,681	30,776	31,115	31,005		31,473	33,815	35,053	36,065					36,566
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				5,838	5,323	6,494	7,513		8,374	6,725	6,918	7,501	48,986	8,661	8,274	10,008	12,055	49,628	13,579	12,497	13,813	15,427	56,480	16,711	14,877	15,508	15,984		16,873	15,451	16,265	17,262					15,465
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15+	Coarse	Male																								3,014	2,978	2,958	3,199		3,177	3,423	3,301	6,352					
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								31,817	34,735	34,865	34,858		35,035	37,358	38,204	39,009					41,217
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				24,823	25,265	28,628	32,106		34,083	33,216	33,606	34,717	130,609	38,695	39,601	46,868	54,438	136,866	59,581	57,477	62,320	68,620	153,507	73,341	67,847	69,499	69,429		72,001	66,181	68,702	71,156					52,954
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				36,536	40,710	46,214	51,534		54,664	56,735	56,710	57,824	177,410	63,631	70,589	81,826	91,882	171,997	98,114	101,220	107,302	115,115	192,650	121,052	122,561	123,754	123,421		126,021	126,118	129,698	133,127					123,722
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								16,088	18,178	18,464	18,593		18,781	20,826	21,608	22,172					25,104
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								12,893	14,306	14,606	14,622		14,858	16,357	16,914	17,243					18,869
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				28,323	33,954	41,304	47,919		51,195	56,810	56,193	57,294	119,843	64,237	72,275	82,253	89,597	129,872	93,765	101,750	106,839	112,081	141,865					169,321					173,997				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				9,141	10,669	12,582	14,467		15,178	16,697	16,902	17,664	53,559	19,715	22,744	26,449	29,593	55,759	31,610	34,384	36,691	39,224	63,096	41,153	43,927	44,840	45,015		45,934	48,765	50,272	52,095					50,552
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				12,140	14,373	17,032	19,618		20,905	23,097	23,175	23,735	82,148	26,111	29,492	33,802	37,988	76,338	40,538	44,412	47,477	51,125	84,961	54,077	58,395	59,354	59,464		60,412	64,209	66,414	68,002					61,543
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								48,168	50,158	50,743	50,591		51,382	53,654	55,453	57,117					59,713
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												177,374					185,868				
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				11,863	13,535	15,796	17,969		19,188	20,201	20,123	20,576	95,625	22,565	24,377	28,276	32,466	82,816	35,469	37,980	41,819	46,674	94,811	50,187	52,276	53,379	53,107		54,555	56,028	57,520	59,164					47,726
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				1,232	1,487	1,763	2,029		2,303	2,534	2,762	3,095	14,491	3,535	4,005	4,502	4,996	17,329	5,357	5,759	6,097	6,550	20,203	6,878	7,260	7,372	7,462		7,657	8,111	8,403	8,551					8,306
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				9	7	5	6		4	5	6	5		5	3	4	4		5	149		1			1	2	2		4	6	5	6					6
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				42	75	49	66		57	43	77	98	5,660	140	135	155	135	1,464	174	145	177	172	1,298	261	199	175	145	1,624	176	182	200	213	1,136				126
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				6,657	7,140	8,343	9,684		10,271	10,108	10,154	10,371	73,687	11,563	12,495	15,191	18,454	65,611	21,052	21,434	24,285	27,750	76,211	30,451	29,762	30,737	31,045		32,407	31,038	32,031	33,312					29,473
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				16,488	19,700	23,639	27,217		29,108	31,780	31,570	32,665	74,625	36,700	41,991	47,992	52,609	83,983	55,430	60,160	63,277	66,796	93,225	69,279	74,016	74,860	75,175		76,134	81,293	83,682	86,230					88,929
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								20,162	21,184	21,395	21,485		21,811	22,885	23,349	23,811					24,454
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				2,432	2,427	2,904	3,346		3,589	3,473	3,566	3,760	37,744	4,400	4,599	5,802	7,163	34,852	8,465	8,316	9,653	11,383	40,849	12,779	11,850	12,420	12,620		13,379	12,091	12,616	13,232					9,921
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Missing Sex														518	439	400	416		392	477	471	414															
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				5	5	4	8		6	6	4	3		2	2	2	2		2	91	2	2		1		1	2		3	5	7	3					6
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				26,538	31,468	37,415	43,046		46,105	50,815	50,325	51,464	118,083	57,487	64,912	73,325	80,106	116,555	83,323	89,504	93,896	98,306	128,871	101,733	108,203	109,194	109,349		110,610	117,093	120,307	122,770					118,217
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Male														2,208	2,093	2,042	2,287		2,218	2,757	3,011	3,048															
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<15	Coarse	Missing Sex																								436	451	429	373		427	377	358	385					
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				35,750	41,939	49,067	55,663		59,040	63,079	62,224	63,146	150,209	69,822	79,322	90,543	99,531	146,748	104,440	110,767	115,519	121,078	163,095	125,483	131,006	131,227	130,492		132,177	137,941	141,522	144,302					136,499
Mozambique	Mozambique	MOZ	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								14,265	15,330	15,577	15,579		15,818	17,188	17,864	18,416					17,988
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														232		187					251
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														666		737					756
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														181		227					207
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														555		597					596
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					776		735			606		449			493		480			570		643			545		551										
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														242		241					267
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					4,383		4,700			4,274		3,646			3,694		3,960			3,872		5,097			3,916		4,629										
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														622		603					608
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														489		548					601
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														29		21					10
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														168		199					218
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					4,369		4,662			4,045		3,458			3,753		3,938			3,935		4,828			4,004		4,505										
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														321		348					422
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														142		122					88
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														135		182					117
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														67		71					63
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														156		219					222
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														169		192					221
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														228		269					268
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														88		97					96
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														739		804					787
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														183		174					136
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female										35																											
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														301		322					382
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														557		558					545
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male												1																									
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														599		595					642
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														452		438					491
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														115		118					92
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														443		448					484
Mozambique	Mozambique	MOZ	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														326		331					343
Namibia	Namibia	NAM	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female							112			29		119			98		393			133		982			304		330					89					
Namibia	Namibia	NAM	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					1,367		4,848			3,971		5,578			5,559		7,082	9,419		6,884		8,901	9,859		5,661		6,274	9,226		789		2,894	11,807				
Namibia	Namibia	NAM	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					430		2,019			848		1,832			1,777		4,600	10,836		4,552		5,559	6,304		2,100		2,401	6,745		371		1,547	5,882				
Namibia	Namibia	NAM	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					3,134		6,483			4,084		3,506			3,900		6,231	8,657		11,880		11,233	9,682		5,843		6,247	11,780		349		860	12,973				
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								1							2																				
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			3		2			9		3			5		12			11		7			3		10			8		7					1
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			59		208			650		654			978		984			691		776			785		1,184			1,147		1,401					346
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								1					2																						
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1		9			5		3			4		3					4			3		3			1		4					4
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1		3			2		4			9		4			7		6			3		5			3		4					
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					1																														
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			6		14			81		55			100		125			87		92			80		125			107		133					42
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			45		137			487		524			727		773			511		544			539		866			887		1,026					328
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					1			5		8			5		2			3		3			4		5			2		1					3
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1		1					1			1												
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					1																														
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					2			2		3			6		3			1					1							1					
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					19			10		13			62		90			117		137			140		179			182		231					113
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								1					2		2			5		1			6		4			6		3					6
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			16					1		4			7		2			4		5			6		5			1		1					4
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			2		1			6		5			9		7			5		5			7		3			6		2					1
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								1					1		2					3								1							2
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					9			12		21			65		70			119		145			132		161			159		161					89
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					5			16		10			11		10			9		13			7		8			10		11					7
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										10,823					10,049				
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					1			5		9			39		64			67		99			85		112			121		123					77
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative								1																											
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			13		18			68		80			134		129			89		122			81		129			102		89					20
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					1			2		1			3		7			3		4			4		10			1		2					6
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			18		43			197		131			194		227			163		170			153		199			178		170					46
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			21		58			132		97			138		184			101		118			78		89			97		81					39
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						9,023					8,912					8,865					10,362														
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive										1			2		1					2					1			2							1
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													3																						
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			34		54			122		124			162		190			111		128			108		128			118		96					50
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1					4			14		25			27		29			33		32			17		24					7
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						11,320					11,834					11,782					10,728														
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								1		3			5		19			12		10			16		12			18		8					9
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								2		3			12		27			31		22			19		31			17		23					6
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			4		18			27		24			37		38			27		38			29		68			59		112					47
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			33		149			306		332			307		353			204		260			294		537			600		767					348
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1					4		2			1		1			1		3			3		3					2					
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						9,698					10,065					10,139					8,311														
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													2		8			6		10			7		11			8		5					8
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			11		35			159		144			211		220			146		178			149		181			172		164					59
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								5							2			1					1		2			1		1					
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			25		72			275		309			362		459			326		395			407		635			628		856					275
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					1					3			3		1			1					2					1							
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			14		68			144		116			150		163			105		125			140		273			287		365					159
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected																				1															
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			10		1			3		1			7		6			6		16			7		9			7		6					14
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													3		1																				
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1					1		2			12		14			23		28			27		19			15		17					10
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			111		360			524		512			622		750			412		597			657		1,186			1,173		1,592					674
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																				1															
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			18		40			154		132			208		216			138		191			143		177			132		153					30
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						9,397					10,836					10,805					11,573														
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			39		4			10		11			22		21			11		22			23		42			17		15					61
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			6					2		4			2		5			2		7			4		2			2							3
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1		3			4		9			8		3			1		2					1			1		4					
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										22,035					21,154				
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			122		229			785		789			1,074		1,172			724		906			840		1,328			1,347		1,615					406
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			122		411			660		614			686		812			460		600			653		1,208			1,200		1,488					666
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative								2		2			4		16			9		18			10		18			14		26					30
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected								4					3							2			1							1					1
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					10			49		35			39		66			29		45			25		38			39		32					18
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					1			2		3			24		35			33		59			47		63			56		66					54
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			99		9			17		13			20		31			20		37			33		58			16		23					38
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			13					5		3			5		3			2		3			4		1					1					2
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								4					3					1		1			2					1		3					
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			13		37			76		80			112		186			90		103			81		107			99		114					43
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								1		1			3		1					4			1					3		3					
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected								1		2			3		1																				1
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			9		23			66		70			91		94			73		67			50		73			60		69					31
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						6,833					6,929					7,095					5,963														
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			118		272			731		756			1,116		1,181			696		925			859		1,345			1,497		1,654					363
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1		7			11		26			80		88			173		159			146		204			190		226					161
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																				1															
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			90		282			516		494			574		590			325		445			491		830			893		1,122					509
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			110		223			590		469			846		959			571		764			737		1,226			1,315		1,417					308
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			9		23			139		115			165		193			115		138			119		164			131		126					43
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			4		5			7		5			13		12			6		12			4		13			1		9					2
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								1							2			1		4					2			3							
Namibia	Namibia	NAM	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative					1								3															2		2					
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					1																														
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					10			49		35			39		66			29		45			25		38			39		32					18
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			13		18			68		80			134		129			89		122			81		129			102		89					20
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								1					2		2			5		1			6		4			6		3					6
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			18		40			154		132			208		216			138		191			143		177			132		153					30
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			21		58			132		97			138		184			101		118			78		89			97		81					39
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			6		14			81		55			100		125			87		92			80		125			107		133					42
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			18		43			197		131			194		227			163		170			153		199			178		170					46
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1		1					1			1												
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			11		35			159		144			211		220			146		178			149		181			172		164					59
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive					1					4			14		25			27		29			33		32			17		24					7
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			34		54			122		124			162		190			111		128			108		128			118		96					50
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			9		23			66		70			91		94			73		67			50		73			60		69					31
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			16					1		4			7		2			4		5			6		5			1		1					4
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1					1		2			12		14			23		28			27		19			15		17					10
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			6					2		4			2		5			2		7			4		2			2							3
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								1							2																				
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					5			16		10			11		10			9		13			7		8			10		11					7
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								1		3			5		19			12		10			16		12			18		8					9
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													2		8			6		10			7		11			8		5					8
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								2		3			12		27			31		22			19		31			17		23					6
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive										1			2		1					2					1			2							1
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			13		37			76		80			112		186			90		103			81		107			99		114					43
Namibia	Namibia	NAM	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			9		23			139		115			165		193			115		138			119		164			131		126					43
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									8			7		43					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP								2					1		1								2												
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			6		22			25		64			101		106			91		72			76		82			99		70					9
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP										1																									
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								32		52			102		127			62		72			58		70			75		63					19
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP								2					6		12			9		12			9		19			9		15					1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																														1					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													1		5			2		3															1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			4		13			48		19			16					1																	
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1			2		14			9		9			5		6					3					2
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													1					3		3			2		2			1		2					2
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								21		40			47		55			32		24			15		26			23		29					8
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			6		17			25		53			74		84			73		72			55		48			74		53					11
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			6		16			42		18			14					1																	
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																														3					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1		5			22		18			71		74			56		68			81		64			61		58					7
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			3		22			17		6			8																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1			1		10			9		11			4		4			4		2					1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			10		19			65		24			15					1																	
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1			2		4			3		8			2		3			3		3					2
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			8		14			16		5			12																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP								1					6		13			16		13			16		9			14		10					2
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					5			12		5			3																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP								1					1		5			2		2			4		6			3		2					1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													1																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													1							2															
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								32		41			47		86			27		38			24		33			31		32					9
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													2					2																	
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																									1			1		26					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																														12					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								19		29			37		85			26		42			17		37			34		38					11
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								3		4			4		3			7		6			4		3			4		4					3
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																														1					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			1		1			6		21			27		46			67		43			24												
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP													1		1					1															
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1		5			37		31			94		78			56		70			81		79			71		55					8
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					2			4		7			6		6			6		6			5		3			12		8					1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					3			22		43			54		43			50		28			33		52			40		45					3
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			18		22			33		12			16																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																									2			1		22					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation															2																				
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			8		29			31		7			15																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													5		2			7		11			9		4			3		5					1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					1																														
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP										9																									
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy										1			4																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			4					5		4			8		13			27		24			10												1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			2		3			16		25			56		53			34		57			52		69			47		50					10
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					1			11		9			39		24			17		41			24		42			36		37					9
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			2		17			16		35			76		80			78		65			71		67			87		136					6
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP								7					5		9			9		13			13		6			7		4					3
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			3		10			23		15			58		41			41		55			44		57			42		72					3
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								34		44			81		107			44		70			52		63			43		60					7
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			3		13			23		7			9																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					2			2					4					2																	
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			2																																
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													1																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										1			1												1			1							1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					6			6		24			31		22			22		31			23		30			23		19					4
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								27		52			61		66			42		48			36		43			41		37					16
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									2			4		15					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP													2		7			7		4			5		2			15		5					3
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								37		38			77		113			49		64			42		60			46		54					14
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														1					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			2					1																											
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					9			30		37			88		80			58		84			75		77			61		70					8
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									2			1		8					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								9		13			15		43			13		16			11		7			17		9					5
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			4		10			33		17			8		1			1																	
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												1		5					
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															4			4		4			1		1										5
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													1																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													3		1			2		1															1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													5																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								13		32			52		68			31		41			25		54			33		27					4
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP													1		1			1					2					2							1
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy													1																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			6		9			17		12			12																						
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								62		47			66		121			68		68			53		68			67		76					15
Namibia	Namibia	NAM	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								23		18			33		76			37		32			38		57			47		68					12
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			4,800	525	406	383	500		145	124	429	810	8,341	1,184	1,794	1,510	1,761	8,441	1,889	2,810	3,025	3,512	8,562	2,529	4,087	3,041	1,460		1,371	2,755	2,715	2,312					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				315	149	85	111		25	32	90	256	3,718	281	433	368	577	3,718	545	745	900	1,098	3,731	830	1,267	1,074	500		425	860	803	698					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				82	75	37	47		6	14	43	119	1,719	91	145	133	174	1,719	257	260	347	444	1,723	313	602	529	225		205	408	387	290					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				22	71	36	27		18	15	38	73	764	55	88	112	201	764	147	254	277	313	764	305	449	355	153		132	257	273	152					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			4,800	223	106	131	251		32	71	228	422	4,314	303	514	452	839	4,432	945	869	909	1,399	4,479	1,030	1,458	1,095	688		504	881	949	783					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			6,000	70	100	108	100		37	64	136	220	2,630	196	371	306	525	2,735	547	722	825	1,018	2,773	728	1,173	947	472		374	687	646	410					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex									2	11	128	36		12	28	16	21		20	11	30	39		29	32	36	15		16	28	26	13					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												7,303					824				
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			3,488	126	119	156	204		53	63	239	353	3,732	292	601	532	932	3,855	1,093	1,163	1,116	1,472	3,894	1,093	1,714	1,208	659		598	1,022	964	740					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			6,769	160	138	176	239		45	94	306	433	4,755	364	688	565	984	4,938	1,058	1,189	1,324	1,642	4,976	1,278	1,916	1,463	671		625	1,141	1,016	822					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												10,989					4,150				
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			2,616	282	112	138	267		72	104	152	469	3,773	562	717	606	561	3,879	789	1,052	1,126	1,457	4,067	1,160	1,417	1,139	571		590	951	974	852					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								73,017				21,732																									
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female							14			2	1	1		3	4	2	32			10	30	18		9	31	18	14		19	40	30	31					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												5,378					1,235				
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			2,400	900	560	512	774		245	201	570	1,121	11,812	1,537	2,320	1,827	2,030	12,222	2,500	3,556	3,913	4,632	12,769	3,417	4,920	3,630	1,696		1,605	3,147	3,171	2,751					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				52	102	63	62		24	27	54	123	1,320	117	208	169	338	1,331	342	499	518	657	1,331	485	743	564	321		232	482	452	320					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			2,093																																		
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			3,000	394	320	200	304		85	63	268	561	5,714	642	902	807	1,010	5,764	1,099	1,524	1,688	2,034	5,794	1,417	2,347	1,640	868		741	1,587	1,494	1,333					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												14,373					3,344				
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			2,400	22	26	17	30		7	22	13	54	745	45	61	65	80	745	131	183	177	259	746	199	411	340	170	790	124	222	235	143	277				
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			4,251	624	403	349	695		181	207	519	1,166	9,735	1,619	2,313	1,928	1,934	10,023	2,372	3,353	3,522	4,225	10,602	3,220	4,234	3,543	1,678		1,454	2,972	3,352	2,801					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			9,600																																		
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												9,846					1,894				
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			2,400	81	50	36	52		8	24	69	221	1,619	62	87	87	204	1,706	206	216	152	288	1,717	192	284	241	135		109	140	160	156					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												19,167					8,792				
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male							8			4	2	4			2					1	33	18		3	14	18	8		8	30	18	19					
Namibia	Namibia	NAM	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			5,400	32	36	25	35		8	16	12	55	1,247	26	68	63	105	1,247	118	181	174	240	1,247	193	349	278	167	1,331	135	218	204	151	143				
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												67,426					63,913				
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				2,114	1,457	1,232	1,353	3,635	825	1,097	805	671	617	716	740	676	649	704	775	815	840	854	765	799	823	779	957		224	241	261	470					42
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			15,734	8,329	9,793	9,427	7,254	12,406	3,095	3,353	2,976	3,616	11,698	3,596	4,161	4,901	4,501	11,926	4,193	4,271	6,599	5,119	14,846	4,658	5,258	5,203	5,016		321	265	201	214					31
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												57,409					61,217				
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												6,479					6,155				
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				970	1,718	2,907	1,683		1,637	750	6,486	5,248		1,828	3,654	3,599	39		24	15	31	18		131	82	117			7	9	10	10					
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			8,656	14,336	17,656	14,845	12,307	25,333	8,641	9,349	7,317	8,131	19,577	8,236	8,747	8,921	8,251	23,106	7,824	8,852	10,706	8,385	25,358	7,417	8,236	7,458	8,891		619	702	488	536					48
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												4,573					726				
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				3,992	4,491	4,089	3,566	10,544	2,641	3,033	2,306	2,537	3,619	2,512	2,601	2,708	2,603	3,591	2,417	2,953	3,480	2,723	10,885	2,380	2,776	2,439	3,182		306	363	239	303					28
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			18,682	3,382	3,465	3,692	3,327	8,797	2,639	3,067	2,387	2,386	1,772	2,413	2,463	2,591	2,277	1,260	2,339	2,490	2,874	2,514	7,644	2,496	2,507	2,469	3,356	7,610	476	502	370	282	2,658				209
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			8,353																																		
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			749	1,423	1,748	2,270	1,026	267	716	32	37	23		35	20	101	36		53	56	103	123		115	84	106	117		46	44	73	43					10
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			10,543	3,853	4,351	4,113	3,971	8,151	2,884	3,544	2,701	2,743	1,364	2,669	2,727	2,809	2,655	1,383	2,459	2,731	3,143	2,773	2,765	2,381	2,537	2,551	3,128		464	520	562	404					127
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			30,428	4,653	5,216	5,727	5,791	24,204	2,937	3,435	2,968	3,338	8,276	2,697	2,692	3,122	3,313	8,185	2,739	3,179	3,981	4,466	8,031	2,758	2,796	2,892	4,137		639	621	873	696					74
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			12,265																																		
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			13,325	6,001	6,651	6,599	6,371	27,956	4,380	5,001	3,817	3,919	9,064	3,786	3,811	3,972	3,779	9,802	3,481	3,720	4,428	4,178	9,912	3,283	3,280	3,317	4,451		657	643	821	578					92
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			20,641	4,442	4,343	4,122	3,630	10,154	2,698	2,936	2,299	2,304	2,996	2,415	2,373	2,277	2,025	1,637	2,068	2,555	2,704	2,259	11,527	2,162	2,458	2,347	3,029	11,486	337	298	183	155	2,962				107
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			26,525	10,031	12,063	10,200	8,525	23,373	6,170	7,125	5,526	6,221	14,475	6,336	6,426	6,643	6,329	17,391	6,157	7,335	8,572	6,655	20,489	5,934	6,810	6,124	7,587		595	676	507	613					48
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			45,188	4,842	5,407	5,248	4,969	7,994	3,716	4,314	3,441	3,488	1,260	3,335	3,578	3,688	3,424	1,561	3,325	3,574	4,082	3,731	2,422	3,080	3,252	3,220	4,189		654	679	698	560					131
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				9,747	9,166	8,503	16,746		18,131	22,133	23,920	23,754		22,227	23,681	21,277	21,106		20,065	22,460	20,515	47,138		26,381	29,052	26,330	28,358		26,152	31,193	32,184	35,085					28,622
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				2,212	2,427	2,308	2,155	10,042	1,618	1,795	1,344	1,532	3,674	1,508	1,494	1,506	1,503	1,755	1,374	1,707	1,930	1,639	9,452	1,429	1,592	1,475	1,869		206	203	146	199					25
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			4,138	2,538	2,072	3,855	3,767	4,318	1,002	947	1,101	575	643	605	654	682	612	737	673	621	823	768	1,080	729	682	670	804	743	149	132	160	94	409				27
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			19,875	15,397	19,054	16,397	13,246	27,601	8,152	9,056	7,214	8,710	23,754	8,151	9,213	10,247	9,303	24,890	8,260	9,561	12,589	9,729	26,154	8,225	9,235	8,547	9,502		616	653	463	537					55
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			24,265	6,838	7,808	6,810	5,982	17,832	4,264	4,642	3,651	4,058	8,626	4,206	4,314	4,439	4,090	10,626	4,000	4,747	5,742	4,445	13,270	3,982	4,518	4,214	4,950		468	481	330	415					35
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				1,874	1,910	1,976	1,792	6,716	1,341	1,669	1,291	1,251	1,328	1,338	1,376	1,438	1,318	1,128	1,267	1,466	1,766	1,420	4,216	1,388	1,325	1,415	1,716		247	277	238	225					71
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												25,776					24,559				
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												18,094					14,176				
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												15,746					13,366				
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				2,844	3,097	2,878	2,730	7,111	2,122	2,491	1,950	1,958	1,407	1,933	1,977	2,087	1,841	1,353	1,859	2,109	2,320	2,078	4,830	1,885	1,891	1,922	2,423		430	456	418	381					92
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				3,848	3,195	3,769	3,031	3,204	1,409	1,705	1,100	1,031	558	1,026	549	1,102	1,030	459	1,215	1,457	1,791	1,729	584	1,579	2,038	1,804	1,995		352	368	364	823					63
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			24,877	2,746	2,454	4,200	4,389	13,058	912	1,239	1,246	1,679	7,792	1,048	1,051	1,244	2,826	8,306	1,800	3,171	5,079	4,394	7,916	1,428	2,840	3,509	6,201		838	2,583	4,356	3,108					52
Namibia	Namibia	NAM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			32,997																																		
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												2,057					1,201				
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			882	127	125	141	120	1,272	138	149	105	145	430	127	110	151	180	353	164	200	167	193	515	156	197	185	231	1,781	136	133	44	22	164				26
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				119	84	85	76	1,357	98	83	72	71	433	67	59	74	96	575	79	111	91	152	509	76	109	110	130		62	57	22	23					3
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			2,656	548	583	538	386	1,136	380	310	308	350	331	354	334	304	294	900	290	315	304	343	994	130	315	255	284		114	114	82	69					15
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			1,309	164	164	183	106	483	75	70	71	87	110	79	93	68	91	172	98	66	78	94	912	111	121	99	83		31	28	18	19					1
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				117	132	131	110	1,025	109	122	75	127	290	104	127	108	128	280	126	137	130	157	323	99	157	138	151		77	69	38	35					12
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male					8	5			68	18	114	9		7	18	16	4		3	2	5	4		7	25	30			1	1		2					
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			1,898																																		
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												624					193				
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			378																																		
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			857	254	280	255	261	1,264	255	226	183	227	302	223	181	219	197	366	244	224	186	230	418	276	218	208	188		96	101	94	55					24
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			1,491	87	74	86	119	581	73	58	54	69	104	51	64	59	51	227	54	45	55	70	281	76	60	49	57		29	24	20	9					5
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			9	29	9	8	15	2	15	1	2			2	4	6	6		1	4	6	4		7	8	9	5		5	2	5	5					
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				38	47	61	53	161	25	28	25	22	35	29	17	34	25	48	27	36	25	41	23	33	47	41	24		18	14	16	60					2
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			2,754	200	221	212	226	957	180	179	138	143	151	142	145	133	132	306	146	138	130	125	278	117	114	147	131		69	52	57	37					4
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			289																																		
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				24	25	22	34	186	22	14	26	16	57	21	11	10	14	269	15	25	11	18	45	13	15	17	18		13	9	3	20					
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			1,820	22	25	21	44	410	15	14	19	11	83	14	17	14	16	117	9	17	13	39	177	17	13	22	18		5	14	1	8					2
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				183	188	167	125	1,423	160	124	97	133	520	129	126	132	98	735	122	148	127	156	748	108	184	157	157		76	87	37	60					
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												1,003					574				
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												1,634					748				
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												221					280				
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												493					10				
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												428					103				
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			1,156	324	281	298	257	1,271	239	225	192	194	229	234	210	201	202	365	226	224	213	307	361	190	179	208	234		107	93	72	57					9
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				368	227	277	423		642	549	780	598		649	670	514	609		411	550	490	1,799		551	631	544	354		355	398	542	593					466
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			57	35	36	49	21	230	19	25	17	12	89	16	11	17	18	199	16	21	21	21	57	16	15	25	18	23	7	4	4		4				1
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			1,402	120	116	127	142	1,662	128	89	81	112	596	108	115	110	125	631	125	171	154	169	775	124	155	191	198	3,453	132	115	31	23	298				11
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			2,411	311	297	295	224	1,958	245	202	178	198	573	184	195	212	175	803	204	236	208	259	822	243	223	228	192		109	112	62	50					7
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			2,569	417	494	485	352	804	296	243	215	236	198	276	272	285	250	608	222	249	235	315	788	344	253	295	233		85	70	86	82					7
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				184	215	228	197	1,040	175	159	120	155	317	167	176	167	174	351	149	195	148	207	372	157	169	178	184		106	106	62	46					18
Namibia	Namibia	NAM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			4,108	400	497	404	309	1,599	333	258	230	288	484	280	282	274	251	880	292	330	252	312	940	159	302	308	319		112	119	89	95					7
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												5,135					4,574				
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				15	109	70		523					719					560					454														
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				9	44	41		486					328					719					745														
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				2	15	9		459					627					113					74														
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												1,691					2,040				
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												4,574					2,437				
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				68	442	248		2,834					4,152					3,073					2,426														
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				46	401	213		2,404					3,098					3,462					2,554														
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex					2	1		1					21															3									
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female				2,395	1,437	1,953	2,704		2,983	3,684	3,420	3,932		3,533	3,371	3,017	3,089		2,799	3,090	2,743	2,730		2,696	2,687	2,337	2,369		2,211	2,592	2,656	2,693					2,157
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				47	393	197		2,350					2,797					2,086					1,619														
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female					1								102																								
Namibia	Namibia	NAM	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				24	246	111		1,614					1,446					3,228					2,431														
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												12,319					11,705				
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												39,761					37,772				
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			7,333	812	1,314	1,170		9,146					9,214					9,593					9,952														
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			3	31	53	45		6					71					72					72					72									
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			18,685	1,856	2,738	2,556		21,257					21,191					21,625					22,104														
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			2,947																																		
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			20,189	1,837	2,822	2,702		23,683					23,893					24,523					23,964														
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			9,384	1,030	1,615	1,583		9,653					11,254					11,071					10,927														
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				11,124	10,057	9,470	18,878		20,095	25,283	24,137	27,182		24,721	25,264	23,233	23,091		21,895	24,327	22,213	22,842		21,714	23,101	20,551	20,056		18,647	22,654	23,315	23,939					20,405
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			2	5	10	4		12					126					126																			
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			12,987	1,310	1,988	1,731		16,457					16,471					16,837					17,317														
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				302	445	412		1,792					1,861					1,849					1,928														
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				40	55	69		1,672					1,732					396					336														
Namibia	Namibia	NAM	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												35,202					33,442				
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			1	1	2	2		1					21															3									
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			2,736	285	444	419		3,013					4,155					3,091					2,429														
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female				2,076	1,508	1,553	2,764		3,182	3,744	3,025	4,505		3,739	3,571	3,116	3,166		2,893	3,229	2,803	2,800		2,928	2,764	2,482	2,392		2,282	2,564	2,667	2,720					2,176
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												4,600					2,460				
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			545	38	45	74		481					328					721					745														
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				12	15	18		458					627					113					74														
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			916																																		
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			3,561	257	393	342		2,558					3,099					3,481					2,559														
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			2,243	227	399	341		2,468					2,800					2,099					1,621														
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			1,437	144	244	211		1,702					1,446					3,238					2,433														
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			2	1	2								105																								
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												5,172					4,604				
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												1,708					2,049				
Namibia	Namibia	NAM	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				90	120	146		519					722					563					454														
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			16,756		1,611		1,984	855		849		528	882		697		406	1,690		398		582	1,558		591		757			708		1,400					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			11,262		2,596		2,949	462		1,137		2,425	362		804		435	807		621		746	880		841		1,108			914		917					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male																						1	76		2		23	108		4		16	108				
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male															15							15	124		9		38			7		28					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female															20							68	114				6			5		5					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												239					239				
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												13,338					8,285				
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			6,755		8										50					3		13	206		17		30			19		31					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												1,135					751				
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			13,064		823		1,844	3,967		800		292	4,116		451		245	3,836		461		455	3,666		371		1,156			977		3,977					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male															1							5	114		3		22			1		18					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			5,427		2,360		2,077	214		865		501	192		516		407	540		369		516	596		537		669			519		468					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female															2							1								5		4					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female							1													2		1															
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			6,910							2					23					2		4	102		11		48			7		46					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			6,828		8										26							36	161				5			8		4					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												1,244					630				
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			39,578		5,837		8,428	9,775		3,255		6,100	17,201		10,992		10,495	19,732		11,588		9,441	19,707		7,613		3,193			3,775		10,402					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			2,336																																		
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			6,054												29							2	111		16		26			3		21					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female															4							72	111							7		7					
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												50,106					38,942				
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male							3																														
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			5,416																																		
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			6,614		6,277		14,608	19,937		10,382		1,825	41,467		17,010		11,624	40,507		19,290		9,517	37,056		17,836		1,865	27,443		4,919		23,415	21,446				
Namibia	Namibia	NAM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			35,684		7,848		12,696	22,919		7,943		5,362	29,567		16,888		13,163	29,117		15,585		10,257	30,043		13,322		3,399			7,264		14,381					
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												8,443					5,636				
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			165	188	244	330	238	182	239	214	224		232	272	241	227					174
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			127	132	206	325	144	220	241	253	288		300	356	343	377					356
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												1,288					999				
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			141	186	355	498	175	411	437	464	546		549	611	625	723					722
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			1,400	1,610	1,654	1,776	3,680	1,489	1,322	1,229	728		777	1,058	1,293	1,772					453
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												863					696				
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			272	327	532	790	264	586	614	654	712		829	970	850	936					1,005
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			106	125	125	161	254	98	101	111	117		86	117	91	94					87
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			19	31	43	30	124	18	13	17	15		26	13	23	11					15
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			193	226	328	411	242	269	331	354	422		406	476	411	445					394
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												2,490					2,113				
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			454	454	721	1,035	365	735	811	850	982		961	1,117	924	1,159					1,081
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																			7	9	21	14		4	13	20	22		13	12	18	12					8
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			444	517	853	1,120	411	836	865	893	936		1,020	1,142	901	1,219					940
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			140	184	242	378	164	304	368	384	473	397	496	577	496	595	290				658
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			192	201	295	371	192	275	314	282	355		357	439	396	465					424
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			480	520	806	1,045	491	690	721	718	796		813	835	952	867					664
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			121	133	217	369	200	371	400	379	512	465	530	605	608	685	370				731
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												1,227					976				
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			844	963	940	972	2,477	821	795	663	428		443	724	909	1,379					166
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												2,048					1,767				
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																			40	8	29	28		20	21	35	14		17	17	41	33					25
Namibia	Namibia	NAM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			226	230	313	424	301	285	278	309	376		340	392	347	358					306
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					663		1,691	2,795		993		2,336	5,474	1,143	2,676	4,310	5,064	9,978																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					315		404	852		283		396	865	204	310	351	461	597																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					325		410	958		383		696	766	479	559	715	898	724																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					2		2			21		42		24	52	52	70																				
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					125		172	440		182		523	440	392	404	563	688	452																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					350		418	1,182		392		681	985	375	558	626	811	879																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					22		35	226		62		196	243	154	114	154	175	233																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					222		251	609		177		274	666	191	232	287	367	510																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					343		454	1,105		362		592	950	330	435	526	663	810																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female					2		2			31		80		48	92	113	145																				
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					311		367	745		254		367	974	248	345	385	457	672																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					608		806	1,029		571		916	1,397	648	867	1,085	1,272	1,357																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					417		540	760		391		583	1,014	404	537	688	810	953																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					271		358	667		304		446	724	277	374	467	562	575																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					643		876	988		617		1,168	1,382	963	1,039	1,349	1,614	1,382																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					277		337	811		264		344	1,140	159	261	321	367	785																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					686		841	756		648		1,314	1,063	982	1,153	1,568	1,903	1,184																			
Namibia	Namibia	NAM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					1,292		2,182	4,338		1,673		3,817	5,876	2,040	4,466	7,325	8,128	11,630																			
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												2,434					2,049				
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												4,021					3,622				
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					92		111	504		95		94	565	45	50	34	50	424	50	78	65	99	580	77	79	90	67		91	126	185	100					65
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			1,234		649		1,342	2,347		880		1,191	5,170	707	1,286	1,300	1,140	8,828	1,042	1,294	1,172	1,323	7,855	1,644	2,149	929	660		1,057	2,244	1,661	2,599					391
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					237		225	666		208		183	854	90	95	131	108	801	98	160	199	257	1,137	166	222	259	257		289	353	246	306					245
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					206		239	804		246		325	659	163	139	137	131	612	117	183	170	199	1,020	166	169	195	207		245	282	173	248					150
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female										10		46		23	21	27	25		30	26	36	33		116	48	21	9		26	15	43	20					13
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					424		507	669		472		624	925	361	335	362	319	1,020	342	581	674	839	2,184	610	642	804	583		799	833	687	913					619
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					21		26	195		47		119	206	27	33	37	21	193	14	37	33	38	534	47	29	37	36		53	60	39	41					26
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					190		237	995		238		304	839	125	148	112	139	742	135	163	183	210	1,246	168	184	216	195		237	286	193	249					188
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					346		471	924		384		529	1,190	303	264	307	223	1,185	249	441	583	628	1,814	477	505	723	546		693	756	777	795					539
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					149		180	546		157		156	612	73	79	83	74	482	65	92	100	126	774	76	116	126	123		134	178	120	155					92
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												1,740					1,457				
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					96		117	702		101		85	949	35	47	41	41	650	40	58	140	85	848	63	85	107	81	920	121	137	112	120	744				111
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												2,492					2,057				
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			3,321		1,209		1,618	3,632		1,329		1,876	5,447	1,091	2,047	2,194	1,724	10,248	1,553	1,855	1,896	1,698	11,382	1,920	2,197	1,445	983		1,299	2,016	1,872	2,765					568
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male										10		22		7	9	10	12		1	2	22	7		27	12	2	3		4	7	1	5					6
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					305		364	902		304		323	1,184	173	181	201	153	1,149	206	281	391	439	1,596	327	406	461	373		440	509	480	517					416
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												4,837					4,394				
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												18,951					15,770				
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					157		187	706		131		119	720	36	66	42	43	500	49	50	76	115	686	79	91	131	101	720	120	162	162	153	589				133
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					166		223	931		196		234	805	101	98	107	85	684	66	121	133	152	991	105	158	169	144		175	204	176	193					135
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					89		128	388		134		286	390	135	112	122	105	379	76	134	133	159	1,096	139	124	149	157		188	207	185	201					130
Namibia	Namibia	NAM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					143		129	678		98		98	820	51	56	43	45	563	49	90	109	127	749	85	121	111	115		116	181	129	171					116
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				13	33	28	21	122	13	51	55	51	130	51	42	60	51	186				302	139				393	177				372	245				411
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												596					795				
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				8	20	19	19	131	11	34	39	41	142	31	41	29	43	234				199	263				228					187					170
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												294					202				
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				4	13	14	11	138	11	29	29	28	146	29	27	28	20	239				156	303				166					176					149
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex							1	25			1			2	4	1	3					10					8					5					6
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												57					50				
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				7	12	15	10	133	5	30	37	22	135	29	33	14	23	156				131	220				137					75					94
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				4	14	11	2	126	6	20	18	13	129	13	17	13	16	92				56	166				78					61					55
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				2		1	1	39		4	1	2	40	5	1	3	2	45				17	24				19	23				20	47				15
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				1	2			18		6	1	4	21	2	4		1	60				11	17				20					22					18
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				2	5	7	1	124		13	10	11	129	9	9	12	9	71				56	192				56					39					32
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												466					496				
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				3	12	14	4	134	6	27	26	18	142	19	15	25	22	245				129	292				139					151					134
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			1,160																																		
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												469					399				
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				7	17	18	19	133	7	56	40	26	142	37	31	30	42	184				185	240				195					151					151
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				10	28	28	26	134	13	48	40	34	144	53	33	41	53	204				233	244				240					181					201
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												605					681				
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				8	31	12	17	136	7	42	42	20	141	31	30	32	28	222				143	280				183					118					140
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				1	4	1		95	2	13	9	6	99	3	5	3	5	69				26	84				22					18					28
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				1	1	2	1	102	1	3	4	1	104	3	5	6	1	43				14	124				8					13					12
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female				224	89	149	148		249																												
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												333					241				
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex					1	1	3	27		6	8	2	27	3	6	2	2	21				25	12				25					200					18
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				5	18	27	22	140	5	46	28	28	153	34	28	30	28	237				195	262				204					142					171
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				5	18	11	8	135	5	32	25	17	141	18	21	21	20	136				89	196				84					84					73
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				8	13	15	17	124	6	29	33	24	128	33	34	35	43	185				215	110				268	150				311	203				311
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																																1					
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			1,660																																		
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male				296	129	206	155		301																												
Namibia	Namibia	NAM	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				8	26	39	22	128	12	54	34	38	139	46	52	36	36	216				214	228				231					230					201
Namibia	Namibia	NAM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			5,604		553		533	3,690		738		361	2,983		391		350	3,000		438		303	323		240		178	1,269		199		192	247				153
Namibia	Namibia	NAM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			28,672		2,881		3,457	32,168		3,141		3,304	22,792		3,283		3,121	23,593		3,339		2,811	3,430		2,101		1,896	7,203		1,730		1,786	2,776				1,863
Namibia	Namibia	NAM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male					2		28			4																											
Namibia	Namibia	NAM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			45,432		5,952		6,458	46,268		5,968		5,292	38,584		5,579		5,099	41,455		5,716		4,701	13,454		3,620		3,201	12,924		2,953		3,098	5,117				3,207
Namibia	Namibia	NAM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female										12																											
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				7	49	25	11	337	6	43	31	24	341	32	33	28	23	345	29	40	44	39	450	56	39	36	46	451	38	28	29	19	452				31
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			903																																		
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												762					766				
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												2,251					2,272				
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				11	21	27	12	284	3	113	68	55	289	43	69	46	65	292	92	94	109	132	379	151	135	84	72		121	134	76	752					74
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				8	20	24	17	357	9	57	48	36	359	36	50	51	26	359	53	45	52	32	478	47	63	41	48		59	40	39	22					44
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				14	52	42	37	452	9	104	75	70	456	72	82	55	85	456	92	83	94	87	606	92	68	90	78		87	89	50	31					78
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												1,079					1,091				
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				10	35	40	38	485	11	79	57	54	487	55	58	59	55	487	75	90	93	92	646	96	92	100	89		92	130	51	25					78
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				6	20	24	19	440	6	42	32	34	442	44	39	33	36	444	39	43	27	57	589	31	52	41	41		46	49	40	22					59
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				5	27	27	24	481	3	48	43	50	483	57	49	41	46	483	78	73	59	66	642	66	69	72	98		81	104	62	81					80
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				46	72	91	76	526	12	228	195	186	526	214	182	222	247	527	233	256	281	341	689	317	302	274	329	691	337	400	198	164	697				315
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				27	62	58	61	556	17	151	108	118	556	128	122	107	168	565	163	161	130	216	750	164	158	153	158		158	207	127	67					175
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				5	17	18	6	284	4	43	31	40	292	31	31	27	31	296	42	41	34	54	383	61	48	46	60		52	43	42	393					52
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				13	41	35	23	443	8	84	64	67	447	52	58	56	60	447	54	82	69	83	594	79	75	71	70		73	76	54	21					69
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				910	412	685	541		1,190															15													
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												1,546					1,563				
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				15	51	37	30	530	10	78	72	68	532	72	58	57	73	534	87	82	76	93	709	85	101	83	106		118	91	66	36					84
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female				552	264	448	357		795															8													
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												1,244					1,258				
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				19	59	39	42	559	12	94	94	87	559	73	93	77	124	565	107	99	121	133	755	124	125	115	146		119	156	81	134					120
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				20	71	74	60	567	21	170	134	102	567	118	127	126	173	576	145	137	158	248	763	164	160	170	206		171	215	129	65					168
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				21	63	57	59	541	20	144	96	104	541	120	128	88	100	541	122	160	106	161	723	149	142	115	147		162	214	118	163					152
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				14	56	31	41	469	9	91	70	47	470	81	63	65	97	470	75	92	100	81	626	95	88	107	102		112	114	64	44					92
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			3,804																																		
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				9	26	17	11	463	6	48	41	32	463	38	34	37	65	463	43	68	47	72	618	50	65	67	68		76	89	53	72					71
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			2,835																																		
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				22	39	56	58	440	6	126	111	81	441	112	116	104	138	441	158	160	139	215	568	182	165	198	191	569	230	286	144	75	574				218
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				2	5	6	2	290		20	11	15		21	13	22	26		47	30	31	49		34	23	23	27		25	1	14	22					12
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												1,310					1,325				
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				21	64	60	56	569	21	146	109	97	569	123	98	103	118	578	135	106	114	115	766	151	125	109	144		154	153	100	43					113
Namibia	Namibia	NAM	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												1,925					1,943				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			2,299	2,095	2,191	2,302	1,970	3,677	1,926	1,974	1,954	2,560	3,232	2,632	2,568	2,642	2,721	3,283	2,669	2,589	2,593	2,572	2,976	2,517	2,445	2,474	2,413		2,350	2,280	2,242	2,198					1,932
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				3,303	3,100	2,992	3,000	3,093	3,006	3,039	3,018	2,064	2,727	1,900	1,852	1,880	1,874	2,638	1,829	1,830	1,793	1,761	1,974	1,753	1,738	1,693	1,668		1,578	1,532	1,522	1,490					1,363
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			4,649	4,769	5,051	5,282	4,575	5,396	5,916	6,162	6,491		6,691	6,902	7,056	7,179					7,613
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			25,068																																		
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			5,798	5,848	6,020	6,178	7,895	6,279	6,455	6,679	6,930		7,118	7,381	7,624	7,830					8,845
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			21,727	20,044	20,493	20,407	19,048	24,751	19,474	20,328	20,152	19,257	21,516	18,943	19,102	19,788	19,864	21,838	19,752	19,578	19,369	19,382	21,240	19,349	19,417	19,272	19,367		19,106	18,887	18,836	18,795					18,410
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			34,473																																		
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male					73										2																						
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			7,938	2,851	2,708	2,718	2,624	6,496	2,892	2,987	2,987	2,516	5,808	2,291	2,320	2,383	2,420	5,983	2,361	2,378	2,365	2,398	2,763	2,434	2,391	2,449	2,466		2,497	2,500	2,594	2,586					2,657
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				8,788	9,082	9,580	8,488	12,506	9,064	9,421	9,324	10,345	11,105	10,589	10,719	11,139	11,487	11,149	11,442	11,382	11,575	11,757	12,136	11,739	11,851	11,896	12,052		12,038	12,029	12,126	12,168					11,902
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				1,493	1,404	1,315	1,361	1,955	1,450	1,449	1,437	864	1,726	778	736	717	709	1,527	673	669	636	627	749	589	599	588	598		586	616	634	663					580
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			19,825	13,197	14,000	15,024	12,883	18,019	13,537	14,194	14,393	17,689	16,044	19,438	19,889	20,736	21,445	16,057										24,787					26,357				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			18,378	17,513	17,207	16,938	16,374	20,951	17,237	17,575	17,367	15,479	18,298	14,643	14,680	14,994	15,112	18,755	14,848	14,909	14,951	15,013	16,458	15,401	15,198	15,221	15,231		15,130	15,154	15,415	15,388					14,266
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			8,987	9,050	9,392	9,697	9,487	9,903	10,206	10,292	10,543		10,658	10,841	11,213	11,443					11,611
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				13,129	14,001	14,769	13,015	18,246	13,560	14,061	14,159	16,546	16,203	17,581	17,934	18,612	19,458	16,420	19,572	19,636	20,084	20,348	20,511	20,559	20,923	21,263	21,630		21,743	21,851	22,188	22,324					22,883
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												5,861					5,526				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												61,741					63,480				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				18,590	19,368	19,889	17,971	22,513	18,398	19,105	18,948	20,302	19,700	20,790	20,908	21,216	21,556	19,994	21,333	21,419	21,535	21,514	22,904	21,762	21,947	22,113	22,413		22,418	22,584	22,732	22,802					21,910
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			4,783	4,836	5,091	5,293	2,960	5,374	5,657	5,759	6,023		6,248	6,465	6,738	6,974					8,124
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female					85										3																						
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			14,415	8,861	8,616	8,479	8,371	13,332	9,126	9,111	9,031	8,097	11,584	7,512	7,501	7,686	7,794	11,702	7,612	7,546	7,363	7,302	8,423	7,311	7,268	7,146	7,134		7,017	6,948	6,994	6,908					6,558
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				10,381	10,482	10,471	9,982	13,909	10,386	10,875	10,679	10,790	12,108	10,426	10,360	10,536	10,541	12,199	10,346	10,249	10,174	10,137	11,206	10,104	10,131	10,116	10,082		10,068	10,029	10,116	10,081					9,522
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			306	247	220	196	247	448	325	284	285	110	558	62	59	50	42	152	42	48	28	37	192	48	57	55	53	206	58	41	36	34	68				33
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												27,987					27,779				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			13,415	13,682	14,392	14,924	13,736	15,283	15,778	15,997	16,482		16,800	17,169	17,655	18,153					18,963
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												3,136					2,266				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			3,177	3,251	3,400	3,497	3,163	3,597	3,791	3,927	4,133		4,301	4,404	4,581	4,693					5,006
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			6,058																																		
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			24,652	18,187	19,062	20,601	17,941	25,356	18,820	19,533	19,722	26,039	22,531	28,138	28,743	29,884	31,076	22,672										37,104					39,180				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			11,694	5,823	5,564	5,458	5,460	10,200	5,985	5,898	6,028	4,923	8,869	4,388	4,366	4,400	4,461	9,037	4,340	4,323	4,285	4,312	4,943	4,300	4,267	4,239	4,191		4,150	4,141	4,147	4,212					3,833
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												8,134					7,331				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			3,667	5,208	5,174	5,069	4,744	4,787	4,647	4,785	4,724	3,759	4,261	3,634	3,579	3,585	3,596	4,028	3,529	3,458	3,322	3,268	3,760	3,197	3,158	2,995	2,939	3,711	2,886	2,778	2,770	2,737	2,995				2,383
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			8,741	8,745	9,015	9,076	11,454	9,241	9,444	9,749	10,114		10,420	10,868	11,303	11,690					13,364
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			3,346	3,578	3,580	3,611	3,316	4,819	3,330	3,393	3,441	3,439	4,218	3,357	3,277	3,389	3,458	4,302	3,408	3,305	3,285	3,206	4,458	3,187	3,104	3,101	3,054		2,970	2,861	2,854	2,810					2,483
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			13,164	12,258	12,118	11,989	11,645	14,381	12,407	12,610	12,462	10,696	12,594	10,041	10,129	10,465	10,542	13,184	10,406	10,371	10,252	10,194	11,811	10,318	10,076	9,931	10,000		9,865	9,771	9,804	9,840					9,340
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			7,522	7,024	6,481	6,529	6,553	8,328	6,891	7,199	7,179	6,193	7,587	5,791	5,716	5,934	5,990	8,006	5,861	5,896	5,834	5,873	6,937	6,016	5,986	6,060	5,982		5,926	5,828	5,934	5,932					5,437
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												30,924					29,338				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			4,391	1,518	1,518	1,630	1,425	4,298	1,489	1,529	1,618	2,057	3,914	2,042	2,071	2,163	2,252	4,054	2,260	2,294	2,342	2,365	2,595	2,393	2,462	2,513	2,604		2,621	2,660	2,733	2,728					2,680
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												12,103					9,949				
Namibia	Namibia	NAM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			3,845	3,897	4,065	4,177	2,023	4,233	4,442	4,558	4,681		4,819	4,947	5,144	5,289					5,962
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																									21	24	25		38	27	41	35					32
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												407					348				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			176	144	164	146	124	589	114	117	103	121	106	109	124	108	119	167	113	108	85	94	912	93	118	100	97		94	92	83	100					45
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,132	497	519	479	400	1,198	447	470	409	422	318	396	401	349	333	858	328	355	314	312	981	272	326	253	294		306	311	283	308					238
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				113	115	115	110	951	111	137	76	84	280	88	79	83	88	269	98	78	86	98	319	84	112	72	77		82	86	80	97					77
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			179	18	21	28	12	516	20	15	14	19	83	8	15	14	14	114	7	15	16	18	177	15	15	17	8		14	16	10	15					7
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				170	196	163	127	1,636	139	138	112	106	496	105	118	106	91	703	91	124	108	101	736	104	153	126	121		95	141	129	141					87
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								1	36	17	33		23	42	39	21					35
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				196	207	175	170	1,069	169	169	103	139	306	122	129	136	134	336	105	156	113	118	366	120	140	118	135		139	148	131	150					106
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			2,240	211	208	192	182	714	172	205	132	145	147	135	153	128	126	294	132	131	108	112	277	85	102	108	114		110	100	104	109					77
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			2,500	290	259	201	227	1,082	222	243	178	171	291	183	180	186	163	352	200	193	159	165	411	177	180	163	164		178	183	179	163					154
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												591					459				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																									13	15	9		12	15	11	10					14
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																									19	19	24		23	16	19	32					19
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female									2																												
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,134	345	435	370	310	1,537	349	364	281	311	463	321	313	284	264	838	290	316	251	249	928	245	283	245	294		274	306	256	290					244
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,955					1,733				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			2,634	320	275	226	222	962	223	240	189	181	222	184	186	159	164	350	181	207	195	160	357	147	164	150	183		169	173	157	183					129
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			90	15	45	18	43	147	31	36	26	29	161	26	29	12	23	152	16	23	17	25	192	28	30	22	20	210	33	12	14	26	68				24
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				31	28	18	30	198	21	19	17	19	57	20	8	14	12	261	14	22	10	15	45	13	13	11	12		14	19	19	15					14
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				44	66	45	54	180	59	46	26	28	35	37	36	31	29	48	28	45	46	43	23	39	41	39	46		58	42	44	52					37
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				125	99	74	87	1,380	106	86	88	77	414	70	62	67	62	550	59	66	81	81	499	68	84	70	95		73	94	68	85					54
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												954					620				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																									16	11	18		13	19	14	9					11
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												210					626				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			1,536	289	291	253	207	1,866	265	267	205	192	545	177	203	207	179	766	183	202	187	173	812	186	200	158	155		225	196	155	200					156
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			3,334	145	138	133	130	1,086	150	134	99	100	414	86	98	94	105	339	118	112	125	116	511	106				1,691					569				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			2,609																																		
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												1,552					1,324				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								2	69	42	61		48	66	46	51					35
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			99	31	37	33	23	240	21	27	15	8	89	15	19	10	15	193	23	18	21	13	57	17	16	14	16	23	19	10	12	21	89				16
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												469					47				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								1	60	30	62		65	60	53	57					49
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			789	375	444	392	344	846	346	397	297	336	192	348	347	342	285	581	288	318	264	254	784	225	259	271	226		252	280	257	273					211
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																									16	17	22		29	20	21	15					18
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			3,540	131	148	122	120	1,552	120	114	89	88	568	102	98	101	82	603	110	109	128	114	768	100				3,281					826				
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			1,299	88	70	67	83	566	70	72	54	59	103	52	65	52	61	220	41	52	32	58	281	44	53	44	35		44	51	46	34					30
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			3,212																																		
Namibia	Namibia	NAM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			322																																		
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				3,078	3,538	3,441	3,272		3,746	3,652	3,375	3,743	8,529	3,811	4,409	4,332	4,364	8,659	3,273	3,344	3,977	4,250	4,433	4,279	4,152	4,180	3,046		3,261	2,988	2,987	3,076					2,734
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								11,834	9,324	10,394	7,993		7,857	8,667	9,274	9,719					11,124
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				10,634	12,933	13,254	13,430		15,427	14,308	14,639	16,863	15,437	16,875	20,142	21,016	21,916	15,467	33,859	33,391	22,312	24,274	20,584					22,840					25,672				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				2,419	2,474	3,088	2,686		3,068	3,574	3,443	3,822	4,059	3,960	4,406	4,822	4,885	4,121	3,666	3,750	4,860	5,232	3,851	5,281	5,271	5,210	2,372		2,382	2,235	2,252	2,213					1,946
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								8,403	10,193	8,979	8,186		8,231	8,364	8,615	8,986					9,361
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				60	87	78	70		72	119	110	139	502	189	175	132	125	110	85	100	113	116	142	147	136	174	5	168	7	1	8	4	48				4
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				10,733	12,563	12,968	12,848		14,733	13,161	13,321	15,046	15,586	14,928	17,616	18,373	19,074	15,764	15,408	16,203	19,654	20,740	18,719	20,909	20,870	20,394	17,225		18,138	17,340	17,840	18,245					18,769
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				1,365	1,522	1,525	1,468		1,810	1,678	1,661	1,821	5,587	2,045	2,315	2,281	2,357	5,714	1,847	1,879	2,216	2,354	2,461	2,373	2,341	2,329	1,731		1,892	1,792	1,833	1,852					1,897
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				7,405	8,548	8,082	7,894		9,272	8,136	7,954	8,904	11,649	8,669	10,409	10,194	10,351	11,727	7,903	8,225	9,717	10,154	10,187	10,161	10,046	8,824	7,847		8,108	7,646	7,699	7,865					7,333
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												57,630					61,831				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				14,308	16,270	16,659	15,990		18,363	17,798	17,825	19,956	18,958	20,172	23,322	23,948	24,748	19,182	19,175	20,075	24,577	25,822	20,861	26,081	26,133	22,970	18,046		18,727	18,047	18,199	18,454					17,945
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				4,026	4,110	4,656	4,275		4,850	6,115	5,954	6,545	7,299	7,107	8,103	8,155	8,544	7,595	6,374	6,670	8,261	8,878	6,162	9,151	9,250	9,365	4,580		4,614	4,399	4,392	4,361					3,920
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												7,484					7,049				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												5,402					5,316				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								12,561	15,277	13,584	13,070		13,400	13,772	14,389	14,992					15,624
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				14,634	17,676	19,305	18,945		20,798	20,482	20,871	23,388	21,681	24,429	28,241	29,058	30,271	21,808	61,095	58,724	32,436	35,142	29,879					33,979					38,156				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female					46										2																						
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								5,731	5,821	5,624	4,834		5,185	5,149	5,548	5,945					6,757
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								5,633	5,799	5,695	5,161		5,438	5,571	5,820	6,053					6,340
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				6,912	8,021	7,953	7,949		9,328	7,905	7,935	9,297	10,679	8,889	10,851	11,035	11,412	10,730	8,824	9,583	11,533	12,155	11,058	12,053	11,866	11,520	9,368		9,495	9,346	9,389	9,573					9,570
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												29,034					28,571				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				601	572	708	625		719	815	753	806	1,660	851	881	888	878	1,466	605	641	793	856	670	835	837	871	382		374	380	390	412					377
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												25,777					26,726				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male					41										1																						
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				1,751	1,824	2,352	2,090		2,334	2,488	2,438	2,742	3,111	2,843	3,056	3,436	3,448	3,150	2,651	2,722	3,490	3,709	2,683	3,745	3,694	3,605	1,975		1,985	1,856	1,838	1,818					1,560
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				8,188	8,324	9,081	8,264		9,488	11,705	10,907	11,920	12,115	12,547	14,203	14,903	15,236	12,535	11,456	11,687	14,224	15,180	10,577	15,334	15,102	15,012	7,811		8,170	7,539	7,370	7,543					7,028
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												11,117					9,570				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												2,828					2,207				
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								8,039	6,332	7,120	5,413		5,644	5,688	5,844	6,141					7,182
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				5,449	6,039	5,960	5,591		6,517	5,941	5,726	6,393	11,140	6,444	7,605	7,515	7,625	11,239	5,789	6,021	7,103	7,462	7,616	7,404	7,196	7,076	5,463		5,468	5,257	5,168	5,202					4,996
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				919	1,067	1,261	1,211		1,410	1,326	1,402	1,600	3,763	1,768	1,980	2,087	2,200	3,865	1,687	1,837	2,401	2,581	2,311	2,595	2,674	2,552	1,932		2,045	2,029	2,064	2,106					1,995
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				2,103	1,941	2,321	1,986		2,194	2,573	2,390	2,418	2,622	2,479	2,576	2,767	2,837	2,478	2,060	2,093	2,600	2,761	1,785	2,796	2,776	2,785	1,416		1,321	1,270	1,274	1,246					1,123
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				3,753	3,501	4,342	3,747		4,094	4,540	4,139	4,553	4,100	4,488	4,869	5,165	5,261	3,845	4,032	4,050	4,876	5,181	3,427	5,175	5,069	5,049	2,484	3,483	2,470	2,366	2,381	2,364	2,909				2,005
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				12,639	12,674	13,179	12,129		14,029	15,766	15,518	17,266	17,605	17,851	20,353	21,165	21,517	17,942	16,217	16,990	20,553	21,692	14,878	22,384	22,183	21,884	12,124		12,868	12,078	11,989	12,171					11,162
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								4,458	4,549	4,398	3,721		3,916	3,912	4,180	4,440					4,869
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				15,384	16,105	17,212	16,114		18,415	19,048	18,883	20,935	20,702	21,226	24,463	26,001	26,625	20,957	20,480	21,158	25,249	26,752	19,287	26,960	26,838	26,168	15,578		16,383	15,100	15,030	15,108					14,757
Namibia	Namibia	NAM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								3,730	3,841	3,752	3,251		3,315	3,501	3,651	3,839					4,124
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														14		9					8
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					142		325			125		154			138		135			113		198			460		282										
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														9		9					6
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														37		23					28
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female					188																																
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														5		9					10
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														9		9					17
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														10		5					10
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														27		30					25
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														3		2					5
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														43		53					48
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														6		10					10
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														33		28					41
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														51		43					52
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					128		342			100		217			178		138			134		159			636		294										
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																																2					1
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														41		52					38
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														26		23					24
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														39		41					40
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														24		25					19
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														9		10					13
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														28		14					21
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														56		64					60
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														17		11					14
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					13		21			9		29			32		10			36		10			96		24										
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														59		50					56
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														51		39					64
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														31		23					35
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														8		11					10
Namibia	Namibia	NAM	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														38		41					49
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																				1			3					53							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													7		9			19		3			26					22		63					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													4							6			20					36							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																		2		1			1					5		10					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected										1			1		10			1		4			16					12		8					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative										1			5		1			6		27			29					83		84					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													17		16			29		36			34					103		66					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								7		5			24		58			68		54			45					101		104					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	 											6,337					13,821					32,830														
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								33		44			109		147			74		114			127					92		225					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive										2			6		23			2		12			5					9		12					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													6																						
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								274		2,000			5,629		8,242			8,283		12,685			15,449					23,505		31,174					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																							1							2					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive										1					1			4		4			1					53		7					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected								1					1		2			2		3			1					8		12					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								2		9			32		20			78		255			387					1,205		2,148					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive															1			4		5			21					6		23					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected										31			35		16			33		65			49					82		71					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected										1			1		1			3		4			4					5		7					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								11		95			227		307			289		386			286					467		521					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								17		35			56		90			234		325			590					1,530		3,541					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	 											8,388					17,761					35,351														
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													2					1		2			23					45							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								10		59			141		194			199		182			141					259		321					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								2		27			40		52			151		399			793					2,087		4,240					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																				1															
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								182		1,210			2,500		3,958			4,349		6,453			7,175					12,729		17,924					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													22		11			32		30			50					91		82					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								275		1,735			4,256		6,655			6,691		10,220			12,249					20,699		28,343					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													1										17					14							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													8		11			7		14			8					28		58					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	 											8,936					19,157					36,216														
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive										1			9		15			20		3			15					27		60					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													2					2		3			1					3		2					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								11		88			218		344			292		320			315					424		468					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1					2		3			1					2		2					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive										2			2					5		9			14					48		14					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	N	 																										176,068					173,900				
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								207		1,928			5,873		8,108			8,214		12,600			15,714					22,274		30,390					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	 											7,886					16,220					33,841														
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								31		394			1,128		1,567			1,910		2,949			4,238					5,676		7,631					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								137		1,405			4,377		5,827			5,849		8,893			11,928					15,902		21,734					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	 											3,189					6,828					28,328														
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected										1			1		4			4		6								12		4					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													2		1								2					5							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													1															1							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive								3		4			13		33			36		13			9					17		32					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	N	 																										115,375					100,277				
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								1					21		10			26		88			110					493		585					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								176		635			1,649		2,188			2,315		3,593			3,802					5,295		8,871					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								4		102			134		344			360		594			847					988		1,610					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative										15			2		1			17					2					4							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													1															14		4					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													2							2			6					68							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													2										1					2							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								25		19			65		119			338		399			528					1,030		2,586					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected								2		54			43		42			65		104			85					133		91					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																												1							
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								15		29			80		55			270		450			982					2,593		5,191					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected								4		51			60		49			81		130			104					150		94					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								8		42			122		227			141		194			187					248		290					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													4		7			16		16			10					72		53					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative								24		34			74		96			284		438			958					2,275		4,966					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													2		4			4		5			8					16		12					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected										43			37		23			43		74			40					54		65					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													20		9			33		19			46					74		55					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected								1		33			32		17			21		83			29					43		58					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected								2		56			43		41			54		94			89					108		89					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													21		5			20		5			33					31		26					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								11		89			263		411			325		408			359					533		537					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected										16			6		4			8		26			6					41		13					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													1		4			1		2			20					1		1					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive								2					7		16			24		9			9					20		21					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4					11		4			6					70		19					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4					3		4			18					15		5					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive															54																				
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected															4					2			20					4		4					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive								1					2		2			10		6			22					13		52					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													5					7		3			13					7		8					
Nigeria	Nigeria	NGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive										2			3		2			4		4			19					37		7					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive								1					2		2			10		6			22					13		52					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive										2			6		23			2		12			5					9		12					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								33		44			109		147			74		114			127					92		225					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													2					2		3			1					3		2					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													7		9			19		3			26					22		63					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive										2			2					5		9			14					48		14					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								7		5			24		58			68		54			45					101		104					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								11		88			218		344			292		320			315					424		468					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								11		95			227		307			289		386			286					467		521					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																												1							
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								8		42			122		227			141		194			187					248		290					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive										1			9		15			20		3			15					27		60					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																				1															
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1					2		3			1					2		2					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive															54																				
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive								2					7		16			24		9			9					20		21					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4					11		4			6					70		19					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive										2			3		2			4		4			19					37		7					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								11		89			263		411			325		408			359					533		537					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive								3		4			13		33			36		13			9					17		32					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive										1					1			4		4			1					53		7					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Positive								10		59			141		194			199		182			141					259		321					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4					3		4			18					15		5					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																		2		1			1					5		10					
Nigeria	Nigeria	NGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive															1			4		5			21					6		23					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP								3							6			4		17			49					27		53					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																												2		3					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										2			1					3		4										9					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							12					3		12					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							39					46		62					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																												2		7					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy								2		3			9		63			12		5															
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				1															
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													3		15			1		3								5		2					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																												1							
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							1												
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				1										2					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																												1		1					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										4			57		104			74		106			94					167		204					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													1		5			2					2					1		3					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy										3			17		46			12		22			6					10		15					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															9			1		2			2					4		16					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP																							7					1		1					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy										3			33		78			24		21			2					22		27					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																												1		16					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							55					37		62					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy										5			27		77			20		43			4					18		22					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																							1					1		5					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													9		16			45		33			26					56		64					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															4					2			2					3		8					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP																							2												
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										3			32		25			33		65			2					11		108					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				1															
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														3					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy										6			18		44			19		22			2					12		23					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				3										2					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													1		2			1		1															
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy										9			23		70			11		25			6					22		41					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP								9										1		1			1												
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															6			10		7			10					13		34					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP																		1		4			7					14		29					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										6			85		156			155		170			190					298		336					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy															5			1					2					2		7					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										2								2		7								1		10					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																				1								1		3					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for Cryotherapy															8					1															
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								1		5			50		69			90		135			85					183		242					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							6							1					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP													1		10			3		24			64					23		58					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation										5			71		121			160		228			190					333		394					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy								1																				1		3					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														1					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													3					1		7								2		2					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		1		1			1							8					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP																		2		14			7												
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP								1							10			2		15			76					37		71					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															11			1		5			4					10		35					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							10					2		6					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		2					1							5					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							5					6		4					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														2					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		3		1			1							4					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		1		4										4					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	N	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				2										6					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																														1					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP																				2															
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - Rescreened, Eligible for LEEP																														1					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																												1		1					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													2		9			2		4			6					10		16					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																		1										1		2					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy															3			2		2			3					6		7					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				1															
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													2		5			2		3			5					19		34					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	N	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				2															
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	N	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							1					6		17					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1										3								1		6					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for LEEP								2					1		2			3		8			24					17		29					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	N	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		1		3										12					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													1		1			1		7			5					8		4					
Nigeria	Nigeria	NGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	N	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								1		7			94		171			184		257			218					388		404					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female								333			5	4	5,814	36	612	688	591	24,102	474	1,966	3,388	3,531	30,124	1,165	2,136	2,703			1,325	966	3,725	3,136					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male								182			24	25	12,165	97	1,361	1,791	1,553	49,011	1,248	4,716	6,089	4,889	61,264	2,886	4,495	6,105			2,986	1,783	6,267	5,607					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												62,428					61,021				
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			212					275				2	9,590	4	468	579	498	41,152	335	1,735	2,733	2,671	51,443	802	1,608	1,743		8,197	1,018	696	3,269	3,177	8,099				
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												73,919					72,770				
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																				1	4	50															
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			476					600		2	87	55	11,635	172	3,986	4,517	4,152	36,898	2,538	10,909	15,091	12,224	46,125	6,075	11,304	14,441			8,782	5,006	19,762	16,599					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			408					513			24	24	12,609	137	2,185	2,351	1,874	46,067	1,263	5,542	8,921	7,632	57,587	3,461	7,878	8,814			4,395	2,652	10,298	9,826					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female								314			6	6	11,147	60	1,174	1,470	1,046	42,808	755	3,616	5,803	5,346	53,511	2,169	3,807	4,527			2,474	1,755	5,971	5,507					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			236					304			53	51	7,603	193	2,574	3,712	3,230	25,945	2,619	9,074	11,979	10,139	32,431	5,792	10,956	11,436			8,369	4,337	16,181	13,525					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			12					15		1			3,041	191	1,628	1,534	1,995	15,721	1,907	6,046	5,973	9,329	19,662	6,746	9,436	15,257		28,968	10,291	7,985	21,759	21,315	28,836				
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								4,625																													
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			406					515			25	18	7,060	123	3,241	3,584	3,618	19,559	2,575	9,772	12,470	11,433	24,448	5,424	10,465	13,938			10,891	4,915	22,373	17,905					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			66					73			5	3	2,660	57	1,562	1,633	1,641	6,269	1,411	4,285	6,147	7,058	7,845	3,670	7,007	10,392			8,032	3,770	15,817	12,933					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			172					225				2	11,540	19	644	606	632	52,352	522	2,038	2,847	2,778	65,442	1,427	1,690	2,242		10,163	1,268	806	3,386	3,186	10,056				
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			300																																		
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			524																																		
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			166					215		3	51	27	11,490	276	2,039	2,417	2,127	47,854	1,725	6,709	8,844	6,666	59,808	4,148	6,459	8,216			4,568	2,592	9,259	8,283					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			80					101			21	17	6,693	160	1,828	2,861	2,398	30,527	2,218	7,569	9,849	8,882	38,159	4,945	9,036	11,841			10,350	4,493	17,954	14,619					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			12					12		1			1,655	55	947	1,260	1,201	7,299	1,281	3,454	6,699	6,358	9,131	3,470	7,258	8,650			7,344	3,281	13,384	10,865					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male								180			10	15	5,616	70	807	952	806	26,554	596	2,565	3,900	3,114	33,191	1,666	2,578	3,304			1,598	1,080	3,783	3,535					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												98,797					96,442				
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			124					162		2	69	55	11,351	224	2,853	3,434	3,136	45,811	2,428	8,912	11,479	8,118	57,264	5,596	8,594	10,619			6,586	3,691	12,549	11,094					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			474					606		4	44	37	13,607	152	3,139	3,676	3,173	47,133	2,027	8,426	12,673	9,580	58,918	4,754	10,261	11,069			6,547	3,891	15,142	13,571					
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																				1	4	74															
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												64,036					62,260				
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												63,800					62,648				
Nigeria	Nigeria	NGA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												67,388					66,774				
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				44,766	27,992	20,497	30,419	195,019	26,083	30,870	22,835	34,356	106,611	31,064	34,336	44,929	90,792	143,423	73,418	59,910	63,944	83,069	324,265	146,901	156,038	155,948			136,194	149,447	137,306	157,946					42,899
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			211,683	93,415	82,453	67,954	87,187	519,655	117,957	150,857	142,346	215,863	509,695	176,207	184,041	192,930	206,444	812,661	196,095	199,651	210,855	193,441	766,476	184,071	228,423	237,850			192,781	208,447	195,181	192,389					144,950
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			126,513	30,839	21,028	14,955	22,783	49,179	34,824	47,958	45,473	69,688	77,321	58,301	56,940	54,764	63,375	149,634	67,101	67,831	67,563	70,838	252,121	89,372	115,473	110,368			92,512	97,886	93,531	88,784					27,762
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			236,010	46,571	30,009	20,623	36,076	156,172	33,549	40,035	38,114	55,650	129,106	45,697	48,454	55,660	102,416	160,729	88,017	77,289	80,560	100,822	324,370	169,738	191,583	188,306		532,060	158,352	176,956	165,755	182,338	498,196				52,998
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												793,011					591,786				
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			273,567	156,261	137,490	119,002	141,769	919,240	173,133	219,592	204,441	314,459	767,407	255,795	270,410	279,530	300,758	1,357,828	290,856	289,119	304,559	283,512	1,035,821	277,339	333,976	325,719			287,803	316,067	294,091	292,436					232,197
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												2,190,417					1,529,228				
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												959,609					658,733				
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				26,121	21,258	16,218	23,182	443,609	41,141	56,748	55,433	81,657	149,765	66,605	66,773	75,487	74,622	337,431	73,746	68,167	71,782	65,786	465,769	66,117	76,541	83,280			58,164	56,677	54,991	57,011					28,940
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			430,042	175,992	151,468	130,766	147,681	625,243	173,979	220,806	204,437	303,541	645,850	237,443	249,718	266,505	304,195	1,132,477	292,435	296,602	307,408	298,668	1,301,153	307,298	373,701	346,470			321,260	349,266	324,856	324,563					248,833
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			159,235																																		
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			463,385	226,937	192,346	166,360	185,029	924,487	214,202	271,290	253,065	383,675	943,714	303,271	326,260	337,147	369,720	1,678,485	360,855	358,414	374,841	348,990	1,601,996	337,583	408,609	383,057			347,068	384,148	355,466	359,672					288,657
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			128,395	48,319	39,640	29,791	39,312	444,849	55,910	68,332	61,315	90,900	239,662	76,028	82,131	87,563	92,778	620,069	99,679	86,988	86,974	87,871	1,602,058	84,463	95,577	98,987		363,483	76,591	79,424	73,037	76,018	177,417				41,643
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				37,933	32,000	24,996	34,126	456,864	59,752	81,061	78,920	116,205	247,957	96,533	100,600	111,070	110,918	494,722	106,423	96,709	107,593	97,318	223,760	100,923	110,616	120,326			85,264	81,490	83,020	84,559					41,267
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female											2											480			9				18								
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			210,080	67,380	56,543	43,308	57,558	322,642	87,530	120,845	116,627	170,851	342,199	140,222	147,401	158,415	172,912	468,855	160,546	148,486	158,567	137,596	359,305	140,506	158,881	154,700			122,361	116,913	117,627	122,806					57,383
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			144,297	48,742	36,991	27,541	39,905	326,203	54,759	65,991	52,834	81,812	221,774	68,187	73,634	81,195	88,371	308,506	96,023	87,372	87,068	90,650	1,731,082	82,445	91,819	100,640		354,761	75,797	80,517	74,882	76,950	321,901				38,867
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			50,374																																		
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				62,941	45,885	33,317	40,762	309,961	33,974	32,552	22,680	32,695	129,873	32,379	37,476	44,237	71,816	188,865	63,243	51,084	55,145	65,063	417,936	108,725	110,977	110,442			112,230	123,082	109,010	127,571					40,142
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												771,002					372,938				
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												768,448					204,722				
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,622,601					1,295,989				
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			183,341																																		
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			406	462	354	339	495	1,844	422	806	458	624		469	503	672	609		600	678	597	534		676	996	1,283			1,271	1,232	1,174	2,115					363
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			179,116																																		
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																									133				738	1	3						69
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex									1		1	21		5		1			1		1	6															
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												3,452,720					2,372,537				
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				27,247	20,075	15,516	23,500	467,558	41,680	58,016	50,716	80,356	243,196	63,795	61,853	68,307	72,287	445,667	70,880	67,478	73,282	67,656	845,861	64,597	79,746	87,552			61,105	61,658	59,359	61,416					34,834
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male											3										2	20			9				13								
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				47,582	38,087	29,685	40,886	406,353	70,587	90,678	83,491	133,716	313,216	105,828	108,600	114,054	124,023	512,172	117,765	115,518	125,485	117,779	530,318	114,074	139,604	191,881			113,003	115,048	112,299	112,343					72,149
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			253,313	59,821	44,738	34,688	43,527	143,004	70,606	104,976	98,926	151,104	278,701	116,798	123,931	130,301	139,493	328,132	142,766	139,890	142,212	120,628	310,502	127,811	156,117	149,785			120,241	123,319	121,137	121,601					45,173
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			166,862	51,854	45,097	35,272	48,616	449,732	74,871	99,755	99,186	141,557	266,104	115,256	122,558	135,021	140,541	506,164	129,666	119,781	127,561	114,044	217,120	114,991	130,292	133,452			101,016	93,483	95,397	96,777					47,931
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			261,745	91,933	68,218	50,822	60,669	251,373	90,425	133,115	125,675	191,834	288,547	151,738	160,822	172,297	181,858	462,765	182,077	174,147	183,500	152,890	451,053	147,481	173,102	165,998			132,528	133,869	132,776	136,928					57,378
Nigeria	Nigeria	NGA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			203,854	77,167	70,593	56,829	65,606	168,416	80,573	105,555	91,903	129,589	211,448	98,147	101,609	102,053	117,206	429,667	122,858	128,418	131,118	140,304	740,343	173,003	214,542	198,073			181,134	202,754	182,894	175,956					110,551
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												15,103					8,640				
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				770	800	882	1,034	11,400	923	934	1,069	856	2,463	793	743	768	1,011	5,940	864	744	722	734	6,173	630	602	592			589	556	510	522					370
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												18,692					20,000				
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												28,876					24,507				
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			6,906	743	759	1,413	1,609	8,943	2,298	3,442	3,566	6,233	7,631	6,320	5,757	5,927	4,807	10,278	4,250	4,223	3,881	2,956	5,174	1,962	2,240	2,081			1,134	1,093	1,288	1,134					1,145
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				1,053	1,047	1,391	1,936	28,724	2,186	2,650	2,686	4,536	3,888	3,896	4,254	3,943	3,213	10,732	3,123	2,737	2,663	2,316	8,066	1,805	1,928	1,911			1,126	1,206	1,113	1,145					995
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				508	527	610	706	10,856	704	716	581	751	2,139	663	656	664	939	4,513	788	612	607	667	4,833	570	603	625			352	334	332	293					224
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			15,885	4,014	4,159	5,457	6,444	40,870	7,504	9,971	9,249	15,020	14,020	14,479	14,858	12,471	10,969	21,715	10,171	8,778	8,430	7,316	7,347	5,557	5,746	5,941			3,482	3,466	3,210	3,372					2,945
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				1,077	1,111	1,659	2,172	23,043	2,597	2,976	2,374	4,125	4,451	3,240	3,756	3,581	3,041	5,883	2,877	2,783	2,476	2,408	11,321	1,718	1,979	1,941			1,402	1,451	1,479	1,464					1,192
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			14,556	2,978	3,075	4,439	4,889	25,469	5,713	8,008	6,878	11,463	11,550	10,334	10,837	9,572	8,792	16,005	7,520	6,752	6,536	5,872	8,603	4,521	4,666	4,843			3,019	3,079	2,882	2,710					2,262
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male											1																										
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												29,947					8,349				
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			8,413	1,728	1,599	2,509	2,905	17,205	3,619	5,457	5,383	9,719	7,540	9,163	9,810	8,971	7,631	14,520	6,939	6,514	5,728	4,751	7,801	2,884	3,389	3,297			1,537	1,492	1,648	1,633					1,968
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			11,960																																		
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			4,900	1,524	1,489	1,801	2,473	27,899	2,549	2,889	2,700	4,394	6,552	3,664	4,269	3,849	3,288	19,915	3,577	3,095	2,747	2,727	28,801	2,195	2,296	2,260		7,300	1,722	1,687	1,593	1,620	5,321				1,321
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			5,946	1,723	1,713	2,621	3,256	20,281	4,057	5,349	5,182	8,687	9,680	7,999	9,138	8,355	6,906	14,694	6,235	5,317	4,760	4,124	6,308	3,108	3,269	3,263			1,521	1,606	1,651	1,633					1,924
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female											2																		1								
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				1,833	1,827	2,734	3,186	23,501	3,942	4,650	4,034	6,893	8,465	6,048	6,391	5,853	4,875	13,895	4,650	4,293	4,368	3,882	8,907	3,112	3,156	3,238			2,287	2,201	2,253	2,264					1,774
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			29,421	5,114	4,764	6,238	6,988	32,517	8,195	10,841	9,970	16,061	13,766	14,874	14,877	13,184	12,079	22,016	11,121	10,404	9,550	8,474	13,242	5,985	6,579	6,662			3,573	3,697	3,445	3,414					3,419
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			15,275																																		
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			9,265	1,737	1,849	2,646	3,307	28,991	3,956	4,938	4,937	7,956	7,194	7,161	7,851	7,346	6,132	16,007	5,605	4,733	4,121	3,679	3,876	2,952	3,062	3,046			1,635	1,724	1,508	1,603					1,593
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			3,311	471	459	512	719	7,154	839	713	496	790	2,391	672	809	691	1,181	5,093	1,113	771	767	843	4,795	878	913	751		1,776	442	396	301	393	1,477				272
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				1,504	1,614	2,080	2,629	29,203	3,016	4,137	4,019	6,547	6,859	5,787	6,574	5,874	4,761	15,769	4,371	3,964	3,807	3,517	3,989	2,704	2,753	2,734			1,623	1,624	1,498	1,556					1,414
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			4,155	824	803	1,094	1,427	5,278	2,024	1,797	1,458	1,960	3,629	1,586	1,808	1,595	1,424	9,039	1,512	1,924	1,845	1,727	9,074	1,504	1,528	1,447			919	1,005	819	845					688
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			2,732																																		
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			2,239	276	269	346	501	2,696	758	786	891	1,294	2,157	1,950	1,755	1,243	893	4,681	931	1,255	1,127	1,043	3,836	767	817	723			448	392	348	351					308
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			1,070																																		
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	Retired Age Band	Missing Sex																						3															
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												12,746					5,175				
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			20,630	2,906	2,918	3,892	4,301	24,991	5,201	6,655	5,545	9,027	9,719	7,691	8,208	6,868	6,533	16,853	6,291	6,263	6,337	5,240	11,112	4,112	4,316	4,423			2,700	2,775	2,715	2,593					2,459
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			9	33	22	24	28	161	68	38	24	40		31	17	35	23		16	32	22	26		19	22	16			16	21	24	10					5
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			6,382	1,705	1,667	2,112	2,733	20,555	2,806	3,375	2,650	4,099	6,990	3,503	3,843	3,714	3,303	9,338	3,427	3,058	2,824	2,957	30,991	2,386	2,452	2,309		8,747	2,026	2,027	2,005	2,068	9,804				1,582
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												3,839					3,573				
Nigeria	Nigeria	NGA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												5,990					5,691				
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																										1											
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												9,564					8,141				
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												24,328					17,079				
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				1	6	1	5	291	3	1		1	82	4	2	3	5	52	4	2	3		88	4	9	4		74	1	1	1	2	27				4
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												5,070					4,106				
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				177	202	173	214	1,061	165	151	144	156	3,944	207	160	108	116	1,837	154	178	154	202	1,827	176	152	170			166	186	138	171					184
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				1,147	1,393	1,256	1,320	4,407	1,070	1,355	1,055	1,214	4,093	1,156	1,556	1,287	1,302	3,835	1,272	1,498	1,425	1,542	4,314	1,393	1,430	1,433			1,275	1,422	1,271	1,148					1,252
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				2,397	2,558	2,343	2,356	11,201	2,014	2,333	1,899	2,324	9,973	1,959	2,458	2,084	2,209	11,316	2,101	2,239	1,924	2,063	9,713	2,009	1,891	1,754			1,638	1,793	1,607	1,448					1,525
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				233	288	230	252	605	205	261	211	297	1,006	301	345	287	292	1,141	316	384	392	433	1,283	406	429	407			379	453	398	307					395
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex														2			24																				1
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				2,195	2,429	2,219	2,319	9,210	1,884	2,360	1,864	2,230	5,385	2,035	2,549	2,160	2,105	7,519	2,017	2,290	2,070	2,348	7,698	2,247	2,122	2,146			1,779	2,093	1,815	1,667					1,674
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								8	4	5			3	3	3	4					1
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				2	2	2	3	67	4	2	1	1	471	5	2	4	2	255	3	6	6	6	1,209	2	2			549	1		4		316				1
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				1,115	1,177	1,067	1,128	5,728	895	1,022	885	1,054	7,400	1,051	990	851	944	6,622	938	1,068	938	1,098	7,091	1,050	965	929			873	976	865	849					787
Nigeria	Nigeria	NGA	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				22	31	23	21	3,315	23	30	20	28	2,521	21	41	33	34	2,765	30	45	53	50	493	48	47	41			50	65	46	42					54
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			2,900	303	517	440	351	24,812	202	432	211	349	1,607	385	215	355	451	2,312	455	465	598	950	4,737	1,031	2,523	945		4,784	1,238	1,198	1,132	1,515	4,695				1,002
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			7,625	93	68	69	104	4,092	81	277	321	348	4,603	188	70	150	297	10,690	461	375	709	789	23,047	758	551	683		23,286	470	626	427	291	23,204				492
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			156,326	37,990	36,115	30,929	35,485	162,412	30,915	35,267	36,547	61,819	147,465	43,656	53,440	46,687	54,955	181,300	57,635	68,844	66,018	67,310	184,228	63,069	87,475	79,342			79,410	97,676	85,816	82,363					93,427
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			292,576	71,928	71,750	64,410	68,520	298,682	56,501	58,316	54,602	92,321	298,497	72,456	79,653	76,122	95,294	332,015	96,276	102,301	106,666	127,856	357,847	120,628	152,483	132,233			145,830	163,478	153,566	152,233					173,961
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex									1		1	42		10		1			1		1	6			133				738	1	1						1
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			33,035																																		
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												480,093					468,581				
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			390,669	75,077	69,138	62,599	68,670	342,128	56,846	65,877	63,505	103,150	320,482	77,567	91,267	83,767	99,405	377,982	98,493	113,422	111,100	116,210	356,808	110,370	145,801	131,334			134,814	162,241	145,852	140,978					160,404
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			574,789	106,880	97,337	87,818	91,879	488,113	75,449	81,603	80,385	133,908	475,698	98,487	119,117	110,364	130,896	541,254	129,652	141,542	138,256	150,234	491,477	140,041	181,200	158,553			167,579	196,719	178,132	177,978					204,573
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												1,523,705					1,466,054				
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												788,363					742,982				
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				11,142	9,378	7,162	7,884	37,567	8,843	9,463	11,773	21,969	43,904	12,890	16,961	13,714	20,403	47,912	18,351	22,628	22,060	22,955	43,869	23,195	35,892	25,564			29,217	34,748	31,110	29,380					34,119
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			52,975	23,061	23,751	22,929	24,033	86,552	19,758	16,578	13,672	26,156	80,583	20,021	19,509	19,900	26,265	80,114	27,770	29,501	33,377	46,239	84,909	46,866	55,314	46,935			55,680	64,751	57,766	56,738					68,122
Nigeria	Nigeria	NGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				1,564	1,404	956	1,016	122,680	1,649	1,961	2,853	4,640	105,941	2,345	3,073	2,293	4,308	138,550	3,968	4,055	4,431	5,072	28,887	5,746	8,269	5,763			6,094	7,287	6,556	6,732					9,290
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			1,255	174	197	169	203	1,132	171	148	145	158	3,780	143	154	108	117	1,839	151	200	153	210	1,835	179	155	172			168	185	142	181					177
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			569																																		
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												24,378					17,202				
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			14,171	2,449	2,595	2,338	2,401	11,664	2,018	2,348	1,943	2,348	9,962	2,100	2,488	2,097	2,220	11,339	2,093	2,337	1,934	2,087	9,784	2,028	1,890	1,759			1,634	1,816	1,607	1,449					1,512
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			3,673	1,160	1,400	1,276	1,333	4,664	1,079	1,378	1,065	1,226	4,504	1,255	1,567	1,301	1,302	3,849	1,318	1,512	1,415	1,552	4,340	1,386	1,440	1,433			1,273	1,427	1,267	1,128					1,249
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			7,225	1,079	1,209	1,062	1,115	6,013	912	1,032	898	1,062	6,946	987	997	859	940	6,633	943	1,117	941	1,119	7,139	1,050	965	934			877	978	864	860					779
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												9,584					8,178				
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			93		3	1	4	66	4	2	1	1	474	3	4	4	2	255	5	6	7	6	1,218	10	6	5		549	4	3	5	4	316				2
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			15	4	7	1	3	281	2	1		1	71		2	3	5	52	4	6	3	1	88	4	9	3		74	1	1	2	5	27				4
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												5,099					4,158				
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				22	30	24	21	3,490	25	24	20	29	2,089	26	41	34	34	2,768	30	48	49	52	493	48	47	40			50	60	47	40					56
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			9,570	2,277	2,440	2,265	2,362	9,637	1,897	2,377	1,908	2,251	5,185	2,151	2,572	2,159	2,102	7,540	2,069	2,364	2,099	2,378	7,752	2,250	2,131	2,149			1,792	2,097	1,816	1,662					1,668
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				233	292	228	259	728	202	264	214	299	996	325	353	283	295	1,141	322	387	387	432	1,289	398	423	412			382	451	398	310					389
Nigeria	Nigeria	NGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex																						3															
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female																				42		53			45					75		111					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female																				135		129			120					137		297					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male																				63		79			41					80		543					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female																				162		210			168					195		457					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female																				19		36			15					24		51					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female																				5		8			10					12		33					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male										15										221		314			335					218		776					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male																				46		87			70					71		253					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male										4										406		576			595					542		2,116					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male										17										356		458			486					311		1,214					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female																				167		181			199					225		561					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male																				254		358			401					411		1,800					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female																				24		30			34					24		134					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male										4										116		152			143					116		594					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male										11										368		610			542					430		1,427					
Nigeria	Nigeria	NGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female										1										83		91			66					91		201					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			1,584	2,375	3,063	4,180	18,121	2,639	2,769	2,675			1,859	3,218	4,274	4,180					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			916	1,324	1,441	1,333	846	931	1,204	1,039			719	949	1,109	1,267					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			413	565	566	586	642	418	606	394			563	488	525	675					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												3,350					3,152				
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			2,209	3,408	5,012	5,803	10,505	3,151	3,492	3,121			2,134	3,485	4,752	4,988					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			2,060	2,799	3,177	2,964	2,350	2,225	2,505	1,962			1,609	2,149	2,627	2,736					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			2,392	3,622	4,637	4,467	2,030	2,965	3,288	2,931			1,938	2,441	3,597	3,519					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			2,853	4,885	5,909	5,644	29,042	3,517	4,138	4,052			2,775	3,149	4,960	5,107					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			1,507	2,288	2,845	2,738	1,280	1,755	1,984	1,679			1,368	1,438	2,073	2,122					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			554	1,192	1,481	917	759	759	1,882	1,722			2,052	2,327	2,712	3,594					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												10,831					10,446				
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												11,708					11,271				
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			238	343	376	600	645	506	664	262		9,576	245	323	338	422	9,285				
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			366	660	1,037	1,161	540	807	1,232	1,180			1,130	1,657	1,909	1,759					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																				2		8		1	1	1				1		2					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												7,577					7,106				
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			2,535	4,297	5,041	4,088	2,342	2,476	3,819	3,490			3,212	3,374	5,370	5,752					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												22,620					21,926				
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			949	1,168	1,217	1,211	464	845	1,016	829			726	792	969	1,153					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			952	1,104	1,347	1,336	399	907	1,068	650		15,794	676	772	903	978	15,327				
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												3,824					3,486				
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																						7		2	1	1			2								
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			1,552	1,971	2,279	2,343	624	1,653	1,952	1,371			1,171	1,518	1,868	1,991					
Nigeria	Nigeria	NGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			2,346	3,236	4,136	4,906	2,756	2,803	3,142	2,543			1,964	2,792	3,953	3,974					
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					9		88	1,912		387		3,277	10,128	2,945	7,042	12,047	17,956	12,322																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					3		9	433		96		788	2,397	892	2,303	3,391	5,073	2,816																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							1	896		17		212	4,880	321	692	833	1,324	3,907																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female															2	5	1																				
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							5	750		42		401	4,105	479	1,337	1,930	2,868	3,876																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					1		36	516		214		2,226	2,857	2,604	6,111	8,849	13,006	7,589																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							11	572		71		546	3,159	572	1,384	2,349	3,780	4,547																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					15		126	2,740		514		4,590	33,217	3,656	8,719	13,837	20,820	36,208																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					1		20	411		170		1,455	2,276	1,715	4,315	6,615	9,535	3,879																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					6		46	993		492		3,934	10,021	2,579	6,513	9,594	14,763	11,841																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					2		3	533		70		557	2,951	829	1,856	2,434	3,932	2,419																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					7		14	796		122		1,048	4,364	1,182	2,640	3,606	5,509	5,101																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male												2				7	8																				
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					5		30	1,284		204		2,004	6,531	1,944	4,648	7,697	10,930	7,749																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					2		9	316		113		669	1,775	446	1,165	1,739	3,089	3,253																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					9		48	536		360		3,766	3,676	3,260	7,985	11,866	17,590	10,119																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					4		102	2,607		324		3,316	14,389	2,589	6,408	10,601	15,993	14,192																			
Nigeria	Nigeria	NGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					10		75	764		476		4,904	10,654	3,522	9,247	14,088	21,192	15,310																			
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					6		22	1,004		388		3,424	8,701	1,721	3,284	3,425	5,224	11,091	5,228	4,891	7,041	5,724	36,242	3,789	5,556	4,874			4,625	6,334	7,973	7,857					2
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					1		8	347		140		1,104	3,180	947	2,197	2,169	2,348	3,536	2,674	2,483	2,452	2,897	1,241	2,069	2,514	1,938			1,865	2,006	3,178	3,627					19
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												12,743					11,615				
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					5		16	1,102		141		1,663	5,879	1,073	2,367	2,474	2,873	7,253	2,738	2,848	3,417	3,031	2,543	2,172	2,453	2,313			1,773	2,543	3,230	3,771					163
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					1		15	458		168		1,743	4,446	1,492	2,996	3,105	3,585	7,015	3,894	3,660	3,883	4,360	4,693	2,865	3,629	3,020			2,488	3,224	4,642	4,915					8
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					4		34	2,023		188		3,051	8,208	1,623	3,447	4,581	5,517	13,297	5,107	6,968	9,455	5,731	4,667	4,609	7,009	7,004			4,804	7,494	10,630	9,269					320
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					7		7	672		85		839	3,810	589	1,437	1,181	1,443	4,770	1,320	1,373	1,514	1,750	1,677	1,203	1,352	1,342			1,105	1,254	1,769	2,405					62
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female								747		11		147	3,535	136	375	367	272	3,653	326	286	311	525	1,282	333	332	198		31,917	307	413	502	642	30,946				3
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					2		1	458		59		420	2,714	435	924	923	840	2,262	1,296	1,164	1,152	1,281	792	796	806	612		52,644	782	729	1,171	1,275	51,085				8
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					15		54	2,269		305		4,099	19,586	2,328	4,480	5,669	6,736	33,889	6,714	7,281	9,554	7,605	58,063	5,180	6,797	6,560			4,581	7,114	8,820	9,660					432
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male												1				4	2		2			15		1					5		1	3					
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												75,403					73,088				
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					10		42	771		326		4,234	11,162	2,301	4,582	4,888	6,701	14,324	6,844	6,797	9,440	8,265	20,999	4,878	6,314	5,843			4,940	7,220	9,380	9,703					10
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					9		32	512		245		3,198	6,669	2,003	4,169	4,118	5,197	9,470	5,605	5,337	6,125	7,018	5,501	4,106	5,131	4,339			3,829	5,049	6,867	7,083					10
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							22	274		33		497	1,768	396	833	1,007	1,361	4,256	1,151	2,329	2,437	1,735	1,503	1,842	3,292	3,357			3,909	4,654	5,956	3,653					88
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												25,253					23,684				
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												39,036					37,578				
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					2		5	154		97		533	1,410	291	568	693	1,334	3,041	1,487	1,594	1,772	1,851	1,070	1,513	3,047	2,380			2,864	2,802	3,197	2,675					3
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												11,170					10,508				
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							4	630		26		328	3,249	225	717	532	646	3,623	541	589	634	825	1,272	464	589	472			475	606	797	1,137					12
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					3		2	375		89		592	2,623	493	1,244	1,156	1,284	2,631	1,326	1,242	1,252	1,582	926	938	1,126	1,064			830	1,037	1,580	1,766					5
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					9		41	1,615		249		2,806	8,158	1,769	3,684	4,261	5,212	11,533	4,910	4,927	6,246	5,096	4,047	3,898	4,568	4,342			3,080	4,369	5,823	6,294					363
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												36,100					34,817				
Nigeria	Nigeria	NGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female															1		1		1		1	3		1	2				1		6	1					
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																																95					96
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				137	147	155	181	625	153	188	112	148	1,665	157	195	193	255	554				994	222									1,062					646
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												1,191					2,253				
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												816					1,555				
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				46	64	48	45	136	32	67	30	43	727	39	61	47	65	150				285	66					129				324	313				200
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				219	238	144	160	624	148	180	81	127	1,041	170	196	153	210	634				972	224									1,309					780
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			4,768																																		
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				121	143	112	124	625	125	142	84	94	615	120	151	152	229	433				1,079	201					385				656	797				428
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				26	32	23	24	125	20	29	16	21	444	20	21	28	31	101				162	64									261					182
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				62	87	66	95	626	81	74	39	72	1,173	76	118	115	206	727				801	246									857					695
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																																101					81
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				124	153	138	149	658	135	141	81	135	634	134	188	171	215	521				1,009	234									1,123					828
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																																112					84
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				23	32	17	20	685	18	22	13	26	1,014	21	33	27	23	468				134	230									154					103
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				95	134	107	92	649	110	95	65	86	876	125	167	149	159	615				818	235									949					697
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				179	195	164	191	627	141	187	105	143	867	177	193	211	258	645				1,114	223									1,338					911
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																																113					122
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				109	127	103	136	630	134	121	75	116	653	114	187	171	179	640				1,000	222									1,297					873
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																																469					353
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				6	2	4	4	446	3		1	6		3	3	5	4					33										56					44
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			4,848																																		
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																																141					108
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												258					560				
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												1,159					2,270				
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				33	44	35	35	643	28	58	17	36	1,115	29	44	44	47	252				211	219									277					181
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			228																																		
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																																148					129
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												571					972				
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				87	89	89	110	646	95	184	94	119	1,060	108	188	155	162	359				634	232									470					294
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				33	32	33	27	254	33	38	26	23	710	29	34	38	31	162				185	94									240					160
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																																504					341
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				55	63	51	62	625	58	77	45	63	1,905	55	86	78	114	498				479	225									667					439
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												796					1,389				
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												773					1,306				
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				50	34	49	50	130	35	50	28	26	520	30	34	30	51	142				184	63									226					133
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				148	195	159	178	651	151	197	107	145	555	183	231	215	258	341				1,248	213					405				756	864				451
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				142	185	163	171	673	154	144	77	123	752	150	175	168	201	450				957	238									916					689
Nigeria	Nigeria	NGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				173	127	102	116	654	97	145	84	120	856	131	147	129	137	402				616	228									729					529
Nigeria	Nigeria	NGA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			13,017		2,608		3,363	67,477		48,825		29,210	20,833		7,570		6,463	20,183		9,676		6,444	22,431		5,163			5,659		3,073		2,069	5,309				1,785
Nigeria	Nigeria	NGA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			163,567		31,796		43,367	345,089		40,450		36,902	117,770		86,387		113,697	144,290		113,529		85,327	124,571		62,341			48,260		28,745		18,171	42,335				15,333
Nigeria	Nigeria	NGA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			355,852		80,197		103,094	670,011		80,344		66,578	195,830		159,410		196,829	194,776		182,686		130,180	193,923		106,817			92,285		49,214		36,494	70,164				29,874
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				706	930	861	863	2,771	869	1,089	709	936	3,159	1,004	1,470	1,586	1,968	3,313	2,082	2,176	1,876	1,725	3,313	1,916	2,013	1,875			1,752	1,768	1,766	1,657					1,711
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				781	646	461	492	2,690	498	584	402	537	2,967	715	819	785	996	3,208	879	1,048	1,271	1,403	3,212	1,581	1,691	1,556			1,467	1,427	1,530	1,402					1,386
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				223	299	242	259	2,945	252	289	187	270	3,225	318	402	369	464	3,445	483	455	547	545	3,447	552	576	649			755	627	674	679					683
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				393	620	445	493	2,682	431	508	396	507	2,941	636	664	705	937	3,191	864	958	1,164	1,261	3,194	1,513	1,538	1,350			1,332	1,408	1,327	1,208					1,223
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			2,823																																		
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												9,598					18,920				
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												2,240					4,686				
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				196	230	267	248	902	192	232	131	142	1,030	261	280	294	385	1,102	328	331	436	479	1,103	455	467	505			667	640	681	736					555
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				1,110	898	709	719	2,844	735	914	566	805	3,157	972	1,193	1,211	1,322	3,283	1,347	1,315	1,637	1,795	3,282	1,970	1,894	1,923			1,839	1,875	1,816	1,848					1,715
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				216	291	295	291	940	287	315	165	232	1,067	303	419	420	562	1,139	501	500	500	652	1,139	698	675	856		1,139	823	775	983	884	2,604				786
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			23,093																																		
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				279	279	297	292	1,281	288	301	196	275	1,466	340	443	397	511	1,578	504	592	611	593	1,581	635	721	682			795	687	776	713					807
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				234	255	275	265	933	244	232	138	184	1,063	283	327	314	408	1,135	388	398	446	514	1,137	538	509	548			766	586	688	625					565
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				27	51	74	46	2,129	20	40	28	19		52	36	50	52		48	70	63	54		65	65	62			70	92	106	86					53
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												4,720					8,036				
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				1,268	1,553	1,358	1,417	2,817	1,499	1,535	1,071	1,483	3,140	1,787	2,590	2,263	2,790	3,356	2,805	2,776	2,917	3,220	3,362	3,234	3,308	3,584		3,362	3,823	4,099	3,791	3,632	7,174				3,841
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				503	613	561	641	2,685	596	759	510	714	2,925	781	1,106	1,118	1,507	3,181	1,543	1,780	1,412	1,321	3,184	1,543	1,671	1,531			1,489	1,404	1,480	1,376					1,325
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												9,860					18,792				
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												6,784					13,022				
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				178	268	243	288	2,672	277	252	189	274	2,887	317	488	556	835	3,201	645	916	1,169	1,388	3,204	1,415	963	1,169			895	964	870	835					914
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				267	373	337	373	2,681	384	399	276	462	2,954	460	748	788	718	3,197	981	955	981	1,150	3,200	1,382	1,400	1,434			1,202	1,347	1,261	1,252					1,185
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				681	846	787	795	2,681	847	830	645	838	2,928	964	1,302	1,231	1,660	3,145	1,643	1,620	1,678	1,836	3,144	2,184	2,006	2,092		3,144	2,320	2,448	2,401	2,294	6,612				2,352
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				470	552	477	517	2,839	554	568	373	551	3,131	625	805	770	974	3,337	913	1,063	1,117	1,100	3,337	1,249	1,291	1,315			1,377	1,336	1,327	1,309					1,190
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				394	460	394	415	2,679	429	418	295	439	2,932	505	709	623	839	3,136	778	866	894	906	3,139	1,120	1,126	1,256			1,299	1,221	1,196	1,258					1,108
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												6,396					10,836				
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												6,595					11,516				
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			15,527																																		
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				378	588	501	524	2,811	503	498	369	544	3,101	627	942	945	1,185	3,288	1,014	1,230	1,519	1,568	3,289	1,643	1,520	1,723			1,449	1,611	1,546	1,448					1,494
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				594	965	762	734	2,844	746	790	580	768	3,156	903	1,209	1,157	1,385	3,285	1,253	1,531	1,770	1,724	3,285	1,964	1,913	1,967			1,777	1,915	1,804	1,676					1,705
Nigeria	Nigeria	NGA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				524	731	643	655	2,838	617	652	512	738	3,159	795	1,167	1,131	1,233	3,286	1,346	1,415	1,643	1,651	3,286	1,887	2,091	1,989			1,792	1,972	1,942	1,845					1,831
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												115,041					115,683				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												283,936					279,260				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			28,245																																		
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			324	482	277	325	320	9,054	299	190	191	482	1,070	396	452	464	537	424	454	203	228	255	172	254	266	218		382	215	283	258	266	304				263
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				30,178	32,592	34,205	37,220	41,801	37,439	39,657	41,624	46,589	51,786	51,678	60,867	64,815	67,965	62,842	73,270	75,686	78,786	81,221	101,605	82,630	83,210	84,752			69,680	67,454	67,907	67,967					73,533
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												212,488					221,336				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				71,271	77,786	82,029	88,604	126,946	89,652	98,508	102,011	108,558	142,670	116,155	136,413	143,423	148,366	162,186	169,509	172,575	180,459	187,970	165,812	193,209	195,348	199,501			174,276	171,462	173,587	174,680					183,270
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			8,149	5,154	5,700	6,527	7,897	17,932	8,694	11,796	15,068	21,073	25,178	24,996	30,782	35,148	39,347	39,050	38,348	43,602	45,800	47,386	48,047	48,257	43,894	43,947			29,131	27,114	26,155	26,671					24,626
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			40,133	30,410	32,148	33,950	37,837	65,309	38,288	41,025	45,456	54,541	73,349	60,259	71,806	78,426	83,982	98,618	88,168	90,678	94,185	96,918	92,346	98,084	96,576	97,569			72,734	66,444	65,420	66,095					68,266
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				46,574	50,986	53,530	57,819	61,911	57,888	62,697	65,007	68,044	66,149	75,565	88,582	92,738	95,678	68,280	105,016	109,132	113,450	116,886	138,811	119,051	120,902	124,315			113,570	114,397	117,257	118,607					134,284
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			5,092	4,176	4,523	4,803	5,180	10,536	5,670	6,413	7,120	8,273	9,527	9,085	10,993	11,781	12,608	18,706	11,964	13,423	14,169	15,155	18,380	15,635	14,755	15,189			13,310	12,800	12,701	12,765					13,038
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				13,000	13,097	13,882	14,814	27,399	14,106	14,633	15,074	16,021	23,098	15,421	17,972	18,433	19,268	25,690	19,289	19,608	19,870	20,256	26,542	20,392	19,990	19,391			16,031	15,164	14,943	14,692					13,221
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			125,203	92,238	96,683	99,328	108,439	143,260	106,666	114,334	122,828	142,144	179,249	151,207	179,598	192,610	203,369	191,547	219,307	222,277	230,034	237,406	177,447	243,222	239,947	241,144			189,361	172,206	169,358	170,137					167,520
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			22,182	21,458	24,559	26,098	43,195	26,828	27,588	28,292			25,821	26,442	27,529	28,054					30,486
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												69,531					74,748				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			17,188	19,856	20,183	21,251	51,384	21,823	22,800	23,961			21,846	22,322	26,638	23,531					28,621
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			85,443																																		
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			34,499	33,422	39,010	41,201	58,923	42,354	43,762	45,417			42,178	43,132	44,387	44,763					52,755
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			13,791	14,732	15,812	17,001	50,399	17,646	18,491	19,287			17,635	17,884	19,867	18,672					22,420
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			80,718	57,116	59,747	62,291	69,375	94,780	68,479	75,537	85,245	104,000	130,007	111,163	132,076	143,875	154,876	138,198	155,267	162,190	167,388	172,040	160,865	175,266	165,795	165,858			125,340	110,792	108,126	108,492					105,233
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			15,742	12,756	13,852	14,572	15,863	27,530	15,644	16,666	16,842	17,721	24,746	18,253	21,092	21,676	22,776	28,081	24,128	25,230	25,918	26,690	25,328	27,185	27,277	27,247		23,298	23,556	23,279	23,147	23,104	23,545				22,284
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												21,140					23,421				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			64,100	52,555	56,622	59,370	64,251	94,042	65,571	71,094	72,269	76,963	97,930	84,321	98,079	102,390	105,700	122,823	10,926	22,737	6,623	1,972						126,426					125,129				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												464,318					465,640				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			28,386	20,598	21,562	23,181	26,352	50,610	27,211	31,117	35,949	45,259	58,466	52,434	64,139	72,092	78,785	83,191	88,500	90,988	96,167	100,535	80,362	102,621	102,625	104,932			73,844	66,576	65,765	67,871					69,766
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												39,772					43,579				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			130,098	93,665	100,578	104,766	114,082	136,522	113,375	121,092	126,960	140,547	165,825	153,163	178,960	189,346	197,218	177,559	206,630	212,906	219,247	225,151	173,209	228,266	226,119	228,145			191,615	181,747	180,249	179,988					184,987
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				5,961	5,958	6,284	7,008	28,738	6,356	6,483	7,123	8,557	20,131	7,719	9,237	9,501	10,054	25,192	9,276	8,467	8,471	8,556	24,483	8,521	7,763	7,385			5,920	5,333	5,304	5,227					4,691
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			48,440	44,701	55,134	59,225	81,696	62,137	62,702	63,857			53,948	53,116	53,633	53,927					58,121
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			18,810	17,021	20,041	21,628	40,343	22,478	22,980	23,504			20,983	21,433	22,193	22,500					24,172
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			28,858	26,886	32,043	34,556	54,270	35,486	36,846	38,005			34,342	34,411	34,850	34,874					39,802
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			26,476	10,095	11,091	12,883	15,224	35,371	15,878	20,469	25,894	35,543	42,771	42,980	53,174	61,221	68,077	68,256	70,946	77,079	81,501	84,705	72,151	86,213	81,626	83,014			55,217	50,931	49,746	50,903					50,845
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			42,131	24,575	25,930	28,081	31,774	52,235	31,358	35,454	40,206	49,513	64,561	50,856	60,205	65,513	71,186	79,383	69,384	75,016	78,197	80,857	112,957	83,287	77,152	76,243			56,968	49,926	48,725	49,168					44,965
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			10,675	7,046	7,168	7,837	8,978	18,179	9,353	10,176	11,262	12,930	16,386	13,389	15,009	15,960	17,071	25,991	16,660	18,381	19,404	20,502	30,867	21,372	20,400	20,618			17,433	16,498	16,193	16,571					16,435
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			63,809	60,454	72,353	77,235	91,090	80,496	81,696	83,678			75,894	76,721	79,027	80,217					88,663
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			79,435	66,200	72,111	75,102	80,968	97,071	83,208	91,097	94,071	96,567	111,563	105,609	123,219	128,071	131,745	125,764	12,804	23,358	5,430	1,928						167,983					169,126				
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				34,624	37,483	39,221	43,247	93,769	44,065	47,483	50,919	58,469	88,906	63,344	75,012	80,966	85,591	116,253	94,348	96,667	101,027	105,510	112,743	107,789	107,697	108,708			83,688	78,211	77,647	78,044					78,528
Nigeria	Nigeria	NGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			163,450																																		
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								1,236	1,207	1,144			1,014	868	964	1,104					838
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								345	313	324			269	252	261	251					214
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				1,088	1,083	1,384	1,689	13,749	2,110	2,861	2,740	4,417	3,961	3,976	4,195	3,974	3,298	10,542	3,144	2,713	2,637	2,288	7,676	1,821	1,812	1,828			1,142	1,182	1,071	1,087					973
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			6,878	1,898	1,780	2,238	3,108	24,907	3,190	4,294	2,919	4,473	6,628	3,998	4,133	4,016	3,629	9,172	3,863	3,246	2,929	3,085	29,461					8,323					9,305				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												5,702					5,406				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			18,444	2,540	2,693	3,880	4,268	17,105	4,921	6,866	5,796	8,912	7,685	7,316	7,725	6,851	6,542	16,836	5,682	6,421	6,239	5,144	10,549	4,191	4,042	4,182			2,719	2,922	2,716	2,567					2,456
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												12,119					4,922				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			11,907	3,993	4,081	5,531	6,539	41,138	7,191	10,908	9,729	15,381	14,058	15,412	15,155	13,087	11,087	21,751	10,805	9,007	8,541	7,233	6,980	5,617	5,315	5,703			3,481	3,355	3,121	3,340					2,921
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								403	326	317			328	322	331	332					229
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				1,503	1,423	2,014	2,819	34,866	3,047	4,289	3,999	6,512	6,764	6,224	6,509	6,046	4,683	15,501	4,726	3,961	3,742	3,514	3,791	2,723	2,565	2,724			1,621	1,577	1,484	1,503					1,367
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								279	237	281			270	214	224	254					172
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				1,190	1,213	1,818	2,062	12,973	2,462	3,246	2,538	3,888	4,374	3,375	3,638	3,407	3,067	5,817	2,857	2,756	2,452	2,363	10,751	1,783	1,833	1,898			1,404	1,436	1,435	1,469					1,156
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			8,381	1,130	1,202	2,257	2,698	12,857	3,208	5,487	5,469	9,900	7,026	8,747	9,602	8,666	7,534	14,271	6,478	6,617	5,721	4,722	7,411	2,789	3,001	3,134			1,488	1,482	1,601	1,597					1,860
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								573	503	496			466	501	485	435					354
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				2,055	1,904	2,820	3,564	35,662	3,865	5,438	4,321	6,853	8,513	6,643	6,487	5,897	4,972	13,700	5,261	4,458	4,424	4,020	8,468	3,172	2,942	3,137			2,353	2,146	2,228	2,283					1,752
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								555	485	506			444	354	386	400					310
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			22,652																																		
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												28,490					7,933				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			6,125	589	687	1,341	1,489	6,231	1,982	3,518	3,623	6,162	6,292	5,980	5,732	5,274	4,584	10,101	3,447	4,278	3,787	2,936	4,921	1,929	1,862	1,909			1,092	1,051	1,237	1,133					1,112
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				602	698	795	1,024	9,583	819	1,084	847	862	1,553	738	882	847	1,055	5,849	885	756	732	719	5,877	651	596	608			566	525	492	533					393
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male																				1																	
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			6,622	1,636	1,702	2,521	3,171	25,050	3,764	4,947	4,866	7,918	7,078	7,157	7,747	7,096	6,005	15,749	5,471	4,597	4,143	3,589	3,687	2,850	2,816	3,017			1,621	1,705	1,545	1,581					1,542
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								1,160	1,110	1,167			836	773	756	774					623
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				451	480	579	706	9,538	640	855	653	728	1,470	690	645	694	950	4,453	765	615	608	611	4,600	580	557	543			360	334	335	290					212
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			10,352																																		
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			14,649	3,061	3,026	4,300	5,158	33,431	5,795	8,725	7,171	11,407	12,204	11,002	10,911	9,483	8,237	15,929	7,607	6,868	6,499	5,863	8,189	4,530	4,297	4,585			3,101	3,107	2,840	2,748					2,239
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			4,742																																		
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			5,802	1,648	1,470	1,816	2,531	28,781	2,648	3,527	3,078	4,691	6,103	4,174	4,392	4,083	3,485	19,555	3,954	3,193	2,793	2,869	27,352					6,937					5,053				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			704	177	160	161	198	1,042	178	123	116	167	195	68	75	77	122	424	69	76	96	141	176	142	139	128		388	128	168	152	130	306				155
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												14,366					8,212				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												3,649					3,391				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												17,783					19,003				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			2,106	351	389	465	668	7,494	585	783	495	730	1,560	634	736	660	1,148	5,007	1,029	701	771	792	4,551	854	797	706		1,693	442	403	303	381	1,411				246
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			931	227	251	327	459	2,805	651	784	779	1,154	1,104	1,360	1,513	947	860	4,592	634	1,099	1,034	1,039	3,646	709	686	626			397	409	373	356					318
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												27,484					23,283				
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			18,412	4,159	4,185	5,799	6,700	27,715	7,745	11,429	10,236	16,332	13,309	14,571	14,884	13,263	12,110	22,047	10,835	10,737	9,563	8,355	12,561	5,960	5,948	6,544			3,671	3,731	3,458	3,375					3,366
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			3,254	741	818	1,089	1,441	4,216	1,757	1,843	1,424	1,800	2,107	1,310	1,575	1,508	1,448	8,979	1,184	1,823	1,829	1,662	8,629	1,518	1,441	1,308			890	1,089	814	863					726
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			5,257	1,452	1,464	2,466	3,136	19,167	3,760	5,303	5,164	8,688	9,145	8,550	9,020	8,285	6,757	14,447	6,469	5,398	4,673	4,089	5,985	3,007	2,913	3,094			1,507	1,561	1,574	1,588					1,821
Nigeria	Nigeria	NGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								244	215	234			240	200	192	216					135
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								20,070	20,204	20,370			17,870	18,154	19,580	20,105					22,095
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								15,570	16,147	16,486			14,857	15,098	17,521	16,698					20,550
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female																					21																
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				11,447	11,676	14,200	21,026		21,569	23,673	25,726	33,490	68,699	38,101	47,268	54,796	62,533	86,738	65,782	69,561	75,670	81,823	69,469	84,690	83,394	82,247			59,467	54,046	55,784	57,299					60,827
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				3,836	4,133	5,002	7,648		8,183	9,303	10,036	11,801	22,861	12,787	14,644	15,627	17,097	21,080	17,663	18,689	20,026	21,444	40,713	22,073	22,138	21,936		20,972	18,695	18,457	18,639	18,937	21,306				18,898
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				7,144	7,176	8,877	13,598		13,979	16,052	17,963	25,004	51,222	29,072	38,449	47,663	55,907	72,627	64,807	69,167	76,947	84,737	64,800	89,020	89,836	89,843			60,218	53,660	56,176	59,484					62,844
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				3,508	3,282	4,099	6,287		6,370	6,767	7,293	9,521	21,029	9,879	11,681	12,658	14,041	19,864	13,531	14,339	15,282	16,181	43,972	16,713	16,491	15,746			12,742	12,069	12,056	12,041					11,164
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				37,405	37,520	44,046	64,110		61,896	70,567	74,649	94,451	166,086	101,233	121,944	140,037	157,557	175,362	168,685	174,684	188,603	202,222	134,749	211,816	209,953	205,457			155,700	141,445	145,041	147,932					149,899
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				13,368	14,557	16,710	23,234		23,896	25,891	27,337	32,175	43,253	36,764	43,822	48,523	53,852	55,114	57,751	59,938	65,007	69,194	74,336	71,622	71,972	71,902			57,867	56,113	58,460	59,510					66,126
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												190,542					198,683				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								23,963	24,411	24,824			22,182	22,690	24,341	25,299					28,045
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								71,307	72,307	72,600			64,920	65,371	69,692	71,790					81,214
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												59,886					66,611				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								31,487	32,197	32,698			29,114	29,035	30,593	31,082					36,320
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				25,456	27,824	31,795	42,385		42,099	49,936	51,972	57,293	88,364	64,480	74,095	80,612	87,380	106,757	98,351	102,503	109,822	116,785	169,772					114,423					113,872				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				4,163	3,251	4,117	6,885		7,215	8,747	10,644	15,867	35,293	19,502	28,336	38,485	45,512	57,469	49,627	55,858	61,692	69,075	53,845	73,355	70,998	71,142			44,261	39,729	42,019	44,265					44,919
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												253,246					255,032				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												419,652					422,515				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				1,592	1,580	1,893	3,352		3,767	4,378	5,633	8,705	19,546	10,935	15,819	22,081	25,638	33,277	26,936	31,374	33,668	37,814	32,889	40,299	37,506	37,403			22,777	20,320	21,193	22,067					20,911
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								38,185	38,941	39,725			36,351	37,005	39,402	40,408					48,760
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												18,417					20,661				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												102,438					105,203				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				21,910	18,843	23,588	36,463		35,575	40,680	45,397	61,508	117,629	67,218	83,951	99,619	113,299	126,377	112,816	120,088	129,784	140,634	126,305	147,936	141,140	137,163			100,148	88,267	89,854	91,671					90,682
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				23,475	25,740	29,076	39,147		40,334	45,558	47,136	52,342	53,852	59,877	69,047	74,225	80,512	62,832	86,999	89,865	96,893	102,153	99,521	105,450	106,716	107,479			96,630	97,215	103,309	106,067					122,623
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				34,493	37,764	43,056	58,024		60,239	68,730	72,167	81,670	136,880	88,804	102,952	112,525	122,916	149,764	138,548	141,310	153,087	163,144	133,065	170,335	171,835	172,101			147,061	144,554	151,636	154,784					167,069
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				7,175	6,462	8,567	14,635		15,208	16,609	18,415	26,790	58,894	28,734	36,421	44,310	49,988	71,084	48,089	52,785	57,244	63,744	84,618	67,763	63,135	61,002			43,366	37,794	37,978	39,409					36,171
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												34,978					38,675				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								19,469	20,157	20,788			18,539	19,027	23,578	21,196					26,326
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				1,235	1,336	1,524	2,449		2,883	3,217	3,695	4,700	8,235	5,411	6,199	7,430	8,983	14,751	8,682	9,472	10,240	11,481	20,536	12,108	11,694	11,945			10,433	9,843	10,030	10,165					10,854
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				33,437	36,820	41,680	56,565		58,666	67,262	69,633	76,085	102,139	85,709	97,828	104,404	112,393	115,275	126,110	132,413	139,855	147,925	179,341					152,295					153,241				
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				28	6	19	42		41	16	8	151	1,033	167	222	161	244	240	189	42	62	50	164	45	49	30		262	32	40	30	46	204				33
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				1,940	1,839	2,222	3,617		4,120	4,633	5,285	7,308	15,089	8,248	9,525	10,544	11,810	22,673	11,649	12,224	13,422	15,364	38,240	16,150	15,696	15,635			13,176	12,366	12,434	12,838					13,127
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				990	755	1,073	1,908		1,803	1,852	2,081	4,020	19,582	3,920	4,875	5,194	6,043	17,444	5,168	4,951	5,569	5,999	40,443	6,132	5,548	5,086			3,867	3,408	3,439	3,479					3,199
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				42,334	45,066	51,483	71,300		72,899	80,805	85,284	100,964	152,421	112,449	131,031	144,652	159,442	163,165	165,227	171,358	182,820	193,276	136,344	199,658	197,859	194,821			160,193	151,869	156,348	158,266					167,529
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								53,841	54,733	54,560			45,375	44,409	46,487	47,387					52,678
Nigeria	Nigeria	NGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				14,316	15,401	17,872	25,603		26,544	29,392	31,408	38,535	86,947	42,492	51,713	58,703	66,083	103,631	73,092	75,906	82,489	89,603	75,380	93,346	93,314	92,139			69,193	64,550	66,541	67,976					70,604
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														539		343					291
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														18		16					27
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														416		313					304
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														62		39					48
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														61		57					48
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														93		75					47
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														587		499					366
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														311		248					216
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														68		52					39
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														359		338					257
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														108		94					78
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					214		199			164		150			129		242			255		278			253												
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														421		345					296
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														71		49					45
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														102		89					80
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														452		391					325
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														122		76					74
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														408		348					303
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														83		103					70
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					1,496		1,408			1,371		1,126			1,314		1,547			2,107		2,361			2,103												
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														380		354					255
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														167		156					146
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														149		107					94
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														629		523					408
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					1,699		1,576			1,482		1,312			1,369		1,869			2,537		3,142			2,453												
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														341		232					220
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														63		69					68
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														96		104					79
Nigeria	Nigeria	NGA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														555		459					364
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																		40		5	5	38	40	173	184	91	154		64	21	131	82					48
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																		2					2								23	1					
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																		83	1	8	6	77	83	214	344	214	262		253	223	433	392					521
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																		20				10	20	18	39	12	10		12	9	18	6					21
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																		83	1	7	12	61	83	130	245	151	155		173	156	321	262					376
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																								4	2		2										
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																		20		2	1	50	20	77	131	73	94		82	96	146	118					214
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																										2					4		45				
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																		4					4			4					8	5					
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																		1					1			2					2	1					
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																		1					1			1					4						
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																		20		1		36	20	49	91	37	32		41	35	52	34					89
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												2,171					10,965				
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																																	132				
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												2,580					12,092				
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex																															22	49					
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																																	91				
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																														983							
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																		2					2								13	6					
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																																	145				
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																		4					4								10	2					
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																		8	1			15	8	27	58	13	3	39	3	6	21	7	1,263				11
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																		1					1			1					1						
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												637					5,263				
Pacific Region	Philippines	PHL	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																		40		7	17	104	40	352	522	299	346		209	168	425	237					314
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male													4,292		27	449	623	4,371	1,433	1,716	1,836	2,072	3,628	1,490	1,522	2,339	1,718		2,384	2,406	3,636	3,641					3,004
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												4,367					3,627				
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			1,269					96	45	11	5	14		12	7	9	17		6	5	18	14		7	12	8	9	154	9	12	11	23	25				16
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												20,758					42,366				
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			1,138					2,926	500	77	68	219	131	141	94	152	164	320	114	84	29	31	111	29	37	47	46		72	42	50	63					95
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			740					2,918	336	101	104	185	197	112	86	108	163	600	61	98	71	69	529	49	82	86	110		113	84	107	122					133
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex					1	21	24		13	2	1	3		4	2	5	2		6	6	6	3		41	11	6	28		77	15	65	90					109
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			260																																		
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Missing Sex					29																																
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male													12,879		66	1,817	2,690	9,398	4,446	6,223	7,141	7,587	10,468	5,221	6,351	7,915	5,973		7,756	8,000	12,234	12,062					9,152
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male																2			5	3				11		89	4		15	4	23	10					483
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			1,403					5,781	989	189	188	417	494	273	139	263	360	600	160	189	125	120	476	83	108	113	136		187	118	133	170					173
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			7,363		17	23	71	10,883	119	177	44	96	8,538	122	145	113	136	17,159	142	178	201	247	3,050	2,088	1,904	1,967	2,731		2,642	2,534	2,898	3,417					3,262
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			122					172	93	25	16	32	99	25	35	23	28	67	17	19	38	17	162	29	37	21	49	178	23	31	49	33	191				45
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												869					484				
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												13,553					18,866				
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			3,142		1	7	5	4,180	27	39	8	20	6,607	16	23	19	22	17,507	30	30	32	29	6,767	1,702	1,856	1,617	2,282	6,377	2,850	3,144	3,056	3,766	6,599				4,072
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male			7,429				54		2	2				2	2	1	51				1				1	4	1		1		1						1
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex						4			39	7	2	5		7	5	6	20		4	11	31	7		9	16	6	8		7	11	13	16					19
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Male				33,158	30,957	29,994	42,196				58,222	82,968		30,053	19,884	19,131	19,920		31,321	22,184	20,296	16,286															
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			1,825					4,841	858	151	199	296	362	208	151	190	321	793	153	169	136	98	588	98	146	116	102		153	131	146	191					206
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex						2			67	10	4	4		12	4	4	23		7	10	29	14		23	10	20	9		23	4	10	22					30
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			645					2,954	284	125	108	192	560	137	113	120	179	453	132	99	100	95	364	80	141	114	122		122	92	135	155					154
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			1,506					3,896	359	186	128	267	591	171	152	188	262	320	164	150	143	137	332	97	166	137	122		163	111	154	179					223
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												806					1,023				
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												384					507				
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female																		14					20		1	67	72		43	103	141	176					154
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex																										2	9		8	14	25	8					25
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex																				4	10	8				21	11		10	16	21	28					33
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex																12	11		17	15	23	35		24	33	141	115	40	89	134	192	229	171				186
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female																		97					350		1	488	580		501	630	1,120	1,453					1,227
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male													430		2	52	65	1,214	301	279	326	352	541	315	295	567	457		489	430	992	993					913
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male													6,438		54	1,042	1,460	10,098	2,874	3,572	3,848	4,298	7,732	2,929	3,049	4,107	3,461		4,430	4,771	6,512	6,412					5,088
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male								525	91	39	41	42	330	35	41	55	55	213	39	59	37	31	252	26	43	35	46		43	30	40	52					58
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex									37	1		1			1	3	1			1	6	1		4	1		1		2	1		2					
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male													430		2	77	79	1,098	290	255	340	360	643	269	354	572	525	801	501	525	1,014	1,331	3,160				1,767
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female			6,180				30		6	2		1		1	4		60		1	3	2				4	2	1		1								2
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female																		25					34			100	102	124	82	149	285	351	157				326
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female																		46					26		2	329	406		358	434	831	1,315					1,117
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male								1,245	117	69	64	72	230	55	46	59	99	470	49	58	54	51	290	32	72	64	67		48	45	67	79					78
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			506			1			128	28	30	119	32	50	23	39	80	43	31	31	8	26	57	10	13	15	25		23	7	12	27					25
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex																										18	15		9	19	24	24					24
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,130					971				
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male													1,288		15	188	252	2,296	656	702	828	987	1,546	750	766	1,213	873		1,126	1,074	1,890	2,009					1,641
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Male				1,331	1,145	2,049	2,247																														
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												124					154				
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												54,539					64,998				
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male																								1,437	1,157	1,160	824										
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												31,311					22,246				
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								433	82	36	26	66	33	47	27	28	42	213	29	38	41	23	272	22	38	20	27		29	35	53	53					55
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			3,268		28	24	103	3,552	56	50	14	31	2,543	19	26	42	20	5,344	40	45	41	28	980	1,345	1,374	1,260	1,825		2,059	1,895	2,187	2,470					3,163
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female								771	177	61	66	110	230	73	49	66	109	577	50	51	45	34	385	45	49	53	50		59	63	73	74					67
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												26									
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												580					863				
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			1,547		9	5	15	1,202	22	32	10	11	7,298	13	22	25	21	17,109	23	21	27	41	2,688	459	309	406	595		672	437	548	727					773
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												21,217					25,031				
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			1,199					3,041	522	133	121	216	461	141	110	157	219	747	110	138	103	76	650	87	111	87	82		122	97	109	148					122
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			1,382			3	4	1,325	10	13	12	2	1,945	5	5	15	10	5,150	17	22	7	13	543	1,095	1,134	1,106	1,358	2,393	1,800	1,920	2,003	2,326	2,551				3,200
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Missing Sex				1,164	860	880	1,180				2,043	2,571		706	249	298	194		502	268	256	454															
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			3,272		16	24	51	3,552	59	44	19	18	2,527	17	29	39	26	5,217	52	33	22	37	931	830	887	765	1,239		1,565	1,294	1,485	1,697					2,029
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female																1										3	2					14					3
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												20					148				
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			7,439		74	54	545	12,502	154	226	65	146	8,523	138	197	169	205	17,193	170	260	259	315	3,041	2,322	2,551	2,426	3,230		3,135	3,329	3,889	4,219					4,401
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			121					696	139	68	51	55	296	62	64	59	79	320	55	78	65	54	574	39	63	64	66	367	61	77	78	101	650				90
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female																		14					175		3	305	331		264	410	670	867					665
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			1,118			1		4,200	387	155	128	312	461	168	109	199	326	343	113	119	103	88	97	82	107	77	60		123	71	105	131					130
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female																		46					223		8	636	671		611	798	1,587	2,296					2,024
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												495					640				
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male													12,879		73	1,641	2,478	13,119	4,312	5,745	6,142	6,720	11,671	4,460	4,754	6,282	5,075		7,055	7,544	10,645	10,465					8,259
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			493			1		1,162	172	95	85	100	362	112	93	91	143	537	84	105	82	72	368	58	95	76	102		60	77	80	113					115
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male													4,293		10	371	796	1,853	1,327	2,000	2,365	2,507	1,914	2,028	2,602	3,709	2,377		2,946	3,124	5,471	4,679					4,154
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female																		14					62			144	171		153	217	327	407					331
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												4,213					6,791				
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												688					874				
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			7,441																																		
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			1,730		1	9	21	1,927	7	11		4	434	9	10	11	6	1,092	16	8	12	12	342	158	117	128	195	88	186	129	191	190	1,330				237
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex					2	16	21		25	20	6	19	399	8	18	19	6	1,099	25	27	19	16	358	187	175	181	224		270	218	164	274					244
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												294					2,088				
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			7,441		24	15	49	11,668	72	101	30	36	8,424	59	70	70	77	17,023	86	83	89	111	2,834	1,130	1,199	1,072	1,456		1,439	1,630	1,782	2,124					2,103
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												6,522					8,023				
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female					5	11	11	3,440	10	13	7	5	2,283	8	15	8	8	5,088	24	16	7	14	741	432	498	468	580		683	652	761	899					1,205
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			133																																		
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female					4	8	20	3,440	27	26	6	12	2,496	7	16	21	22	5,372	28	18	16	27	793	582	627	566	841		843	794	929	1,122					1,281
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex					4	33	47		40	38	6	24	412	14	19	28	24	1,185	57	40	24	33	388	315	267	296	319		388	268	239	369					389
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Female				59,823	51,555	53,983	72,302				90,300	166,149		60,234	17,692	18,924	19,718		31,179	21,944	21,815	14,823															
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			3,272																																		
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female																		97					445	2	1	657	797		669	842	1,427	1,978					1,701
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			7,441		57	35	85	11,670	124	169	55	102	8,447	77	132	127	111	17,150	139	154	187	212	3,052	1,677	1,902	1,823	2,328		2,302	2,503	2,695	3,076					3,215
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male					7	19	25	11,426	65	70	10	38	8,287	32	45	45	53	17,032	54	45	49	71	2,661	821	943	792	1,124		1,124	1,299	1,328	1,655					1,611
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female																								3,489	3,730	3,878	2,510										
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			3,273		20	13	29	3,549	37	35	12	18	2,515	12	32	27	29	5,338	37	33	22	26	853	618	710	632	892		1,063	859	989	1,282					1,426
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			682		8	3	12	614	15	10	2	3	2,143	7	1	5	4	5,092	11	9	6	7	785	578	487	493	696		607	437	597	821					946
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Female				3,053	2,697	4,450	4,387																														
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male					2	5	11	11,380	22	39	16	15	7,507	16	31	21	35	17,185	24	35	34	31	2,484	606	655	589	779		901	970	1,031	1,387					1,373
Pacific Region	Indonesia	IDN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			3,246		5	15	39	2,889	43	52	9	17	2,533	9	14	9	20	5,533	11	34	31	22	895	2,102	1,942	2,005	2,508		1,954	1,512	2,004	2,477					2,758
Pacific Region	Papua New Guinea	PNG	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,266					1,402				
Pacific Region	Philippines	PHL	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												44,543					56,513				
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			302																																		
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female																		2					4			3	5		3	3	12	5					2
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Male				48	90	97	122																														
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female																		1					2			2		8			1		11				
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex																					1					3	1		1		1	2					1
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			90					264	52	23	23	14	40	23	19	19	27	53	12	29	26	21	35	19	24	16	11		24	18	24	32					41
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Female				333	317	255	225				348	803		176	84	114	115		195	212	238	192															
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												52					74				
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female																		4					2			3	2		1	1	3	1					2
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																								1		1	2	2			3	1	14				2
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			302		6	1	5	348	7	4	1	2	93	1	6	1	10	168	6	5	8	8	59	14	23	29	24		20	23	29	25					27
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			302		9	4	10	348	13	6	5		94	3	2	2	7	170	12	6	6	6	65	23	22	19	30		38	30	35	35					29
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								69	6	3	2	3	36	4	5	3	7	14	5	6	5	8	19	5	2	5	3		6	2		7					8
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			27			1		116	15	10	5	7	40	11	16	8	11	36	7	20	12	12	27	8	12	15	11		4	8	10	16					9
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												129					167				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			16																																		
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex						1			1					1	1		2			1	4	1			2		3		1			2					1
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female																		4					6			8	11		4	3	9	11					6
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												2									
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			174				1	174		1			15			1		33	1		1	2	18	2	2	4	5	4	8	9	4	6	59				5
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex						5	6		3												2			3			1		3		1	2					7
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female								39	9	7	4	2	25	3	6	2	6	38	9	6	6	2	28	4	6	4	3		6	9	7	5					8
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,068					1,997				
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												1,085					1,178				
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex					2		3		4	3	1	2	12				1	35	5	1	2	1	20	5	6	6	11		7	8	5	8					1
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												23					32				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			7					74	5	4	7	4	32	7	8	3	7	21	7	13	6	8	33	6	6	7	5	39	8	10	2	8	65				7
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male													90		15	20	27	193	52	56	44	61	166	42	74	80	77		79	79	107	82					90
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male													902		66	214	251	773	324	298	349	393	1,043	314	462	438	529		391	475	658	615					574
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			37					254	18	12	10	13	61	13	17	12	11	29	14	10	18	9	26	11	23	17	10		8	15	20	19					18
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								50	6	6	1	4	4		3	3	2	14	3	6	3	3	18	3	2	1	2		3	4	2	7					3
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			160		2			88	2	2	2		238	2	7	4	6	548	1	4	8	12	174	36	23	31	42		36	28	36	41					35
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			78					7	2			1			1		1											16			1		4				
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Missing Sex				25	21	13	15				21	41		10	2	7	6		11	14	17	23															
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												112					98				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			42					180	23	13	6	13	21	6	8	6	6	40	6	12	6	6	41	2	12	9	13		3	11	14	12					7
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male																								68	70	59	40										
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male													30		2	7	8	91	17	19	20	30	60	23	27	35	37	53	31	20	38	36	222				27
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												11					12				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			74					323	27	22	21	19	64	9	13	14	12	21	8	13	16	9	20	9	13	9	6		15	15	19	18					22
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			69					141	29	11	4	12	50	12	17	16	18	52	5	12	15	11	37	10	15	13	5		8	12	18	26					13
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex									5		2	2		2		2	2		5		4	2			1	3	2		2								1
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male													30		2	6	10	106	22	26	19	22	58	15	22	27	49		22	20	45	25					40
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			300		4	2	19	348	8	5	1	4	98	3	4	4	3	171	3	8	10	7	68	27	31	19	21		30	23	21	19					25
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male													450		54	140	166	845	252	207	257	276	820	182	336	279	385		250	325	404	388					336
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			26			1			2				3	1	1	2	3	3			1	1	7	3		1	3		2		1						2
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex										1		1												2	1					1							
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female																		2					2			1	5		1	2	2	2					2
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male													301		10	29	37	165	68	81	83	83	169	43	90	109	122		96	88	157	158					131
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Missing Sex					1																																
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male																													1								
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												14					93				
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex																										1	2				1	2					1
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			764		5	3	13	1,076	18	20	9	27	286	27	24	16	31	546	35	36	45	62	210	209	200	202	283		246	196	234	262					242
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female																		2					1				1		2		2						1
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female					3	1	2	324	4	1	1	3	88	1	4		1	168	7	6	3	6	55	18	15	12	24		16	21	32	29					32
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			64					108	28	13	3	8	14	7	6	7	8	21	11	7	7	1	6	6	6	4	7		13	4	8	7					15
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			75					288	58	28	15	23	54	34	19	24	21	40	16	24	20	19	29	17	16	23	28		23	22	35	19					34
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												41					60				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			8					33	5	2	1	4	11	2	5	2	3	5	1	1	3	2	16	1	7	5	7	19	3	2	4	2	25				2
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male													300		27	61	71	360	104	110	110	135	385	92	188	153	189		172	197	239	194					200
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			773		6	1	17	1,150	22	11	6	13	278	18	17	13	16	546	11	15	31	27	192	110	101	98	123		103	114	118	109					131
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												873					1,431				
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												3,246					4,659				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Female				117	133	195	209																														
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			65		3	1		37	2		1	1	66					168	1	2	1		50	7	3	6	6		4	6	2	6					5
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male			380				18								1		10										1										
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												334					376				
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			771		18	12	12	1,153	22	16	10	23	282	11	23	19	27	546	32	37	59	57	207	178	182	170	222		191	192	225	180					163
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												48					76				
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												1					10				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												88					59				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			9																																		
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Male				1,115	938	842	961				1,551	2,332		834	664	767	695		976	1,003	1,015	1,194															
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male					2	4	3	1,091	15	9	2	11	275	6	7	12	8	546	12	9	17	27	181	69	57	57	75		65	69	73	81					72
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			57			1		135	17	5	8	7	50	7	8	15	9	23	5	14	8	7	7	11	8	7	5		13	6	10	15					7
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male					1	1	6	1,053	5	6	7	2	235	4	7	6	9	548	6	5	12	11	168	34	36	27	45		51	43	53	41					50
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female																		9					6			3	5		3	4	8	7					3
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																								42	54	50	37										
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			299		1	1	4	278	1	6	1	2	93	1	3		1	171	1	5	5	4	62	16	14	14	12		19	10	16	25					16
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												226					166				
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												2,581					3,769				
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male													902		73	211	259	1,088	357	335	368	429	1,217	311	512	439	589		438	480	672	617					596
Pacific Region	Philippines	PHL	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female																		9					9	2		11	6		1	16	24	2					7
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,611					1,049				
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female					2	1	1	324	1	3	2		71		1			168	3	2	2	3	52	9	15	12	21		15	22	21	27					21
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												214					314				
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			123			2		115	3	3	2		59			1		168	3	6		3	38	14	20	17	32	117	24	21	28	25	120				29
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female			360				11		1	2				1	1		15								1												
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			767		17	12	109	1,507	24	29	12	37	285	26	40	37	43	546	43	59	84	97	208	265	236	250	336		293	295	330	309					288
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												60					72				
Pacific Region	Papua New Guinea	PNG	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								78	11	12	6	3	25	3	7	3	10	31	2	9	8	11	22	3	5	7	6		8	3	10	8					6
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			327			3		373	7	5	1	6	193	5	5	6	1	548	7	9	9	12	458	46	52	52	66	328	59	75	66	95	303				62
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex						3			2	2		2	12					33	1	4			18	1	5	6	7		15	10	7	5					4
Pacific Region	Indonesia	IDN	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			773																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			372																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male					6,794		2,281																														
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			533																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			533																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			109																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			372																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			533																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			263																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female					1,431		366																														
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			53																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			533																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			533																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			53																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			161																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			533																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			372																																		
Pacific Region	Indonesia	IDN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			372																																		
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																													82	98	126	167					
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																																	67				
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																											1										
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												1,029					1,413				
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																									1	1	1					1					
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			171	221	295	364	168	444	458	503	533		657	690	869	868					105
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							9				2										
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																													1	2	1	1					2
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																																1					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																							2			1			2			1					
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			365	508	746	910	576	1,082	1,107	1,184	1,208		1,503	1,691	2,153	2,111					286
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																													2			1					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																							1						1								
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																														2		3					
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												54					105				
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			258	404	592	682	367	832	833	842	982		1,159	1,317	1,581	1,609					162
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												81					165				
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												3					5				
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			12	16	20	34	26	36	38	41	58		77	86	110	112					13
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												148					300				
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																													1	2	3	5					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												3					5				
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																											1			1		1					
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																													314	324	356	450					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																							1				2					1					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																							2						1								
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																							5				2				2	2					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																							5								2						
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																							1			1					2						12
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																													20	38	33	45					
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																				1							1				3	1					26
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												11					18				
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			14	25	40	42	166	44	51	70	76		111	119	155	126					36
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																													8	5	7	15					
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																													5	1	2	1					
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																							1				1		1	2	3	2					1
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																							1				2		3	3	1	3					8
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												3,117					4,434				
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												1,077					4,795				
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																													10	4	10	20					
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																													1			1					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												2					3				
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																													4	5	1	6					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																							2									2					
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																													21	27	19	35					
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																													229	223	238	341					
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																													43	42	38	68					
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							1								1	1					9
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			14	13	17	27	36	37	36	32	31	56	49	49	63	56	95				9
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																																	2				
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																												8	9	12	7	23	10				
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																													1								1
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																													196	192	196	289					
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			58	85	107	124	74	167	163	195	219		264	299	380	383					33
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																																	89				
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												14					23				
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																							8						1	1	1						
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																							6				1				1	1					
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			199	262	394	520	618	565	678	779	768		876	982	1,333	1,297					258
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																													17			4					
Pacific Region	Papua New Guinea	PNG	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												8					13				
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																																					1
Pacific Region	Philippines	PHL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																																	35				
Pacific Region	Indonesia	IDN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																													4	8	9	10					
Pacific Region	Philippines	PHL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													450		6	274	656	943																			
Pacific Region	Philippines	PHL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													75		1	65	111	161																			
Pacific Region	Philippines	PHL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													420		2	161	440	686																			
Pacific Region	Philippines	PHL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													15		1	12	18	80																			
Pacific Region	Philippines	PHL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													75		3	16	43	117																			
Pacific Region	Philippines	PHL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													150		6	132	260	320																			
Pacific Region	Philippines	PHL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													300		5	232	473	715																			
Pacific Region	Philippines	PHL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													15		1	14	24	78																			
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																							1				1				1		5				2
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																															1	2					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																					1		2			1	1		2	2	1	5					5
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																													1	2	3	8					
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												69					115				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																													26								
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																																	87				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																													9	14	19	56					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																							1				1					1					1
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													450		4	158	331	669	484	521	717	615	908	619	718	742	755		848	1,067	1,295	1,246					343
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													300		2	119	196	507	347	347	384	377	583	363	422	495	433		546	609	778	685					200
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																							7		2	1	1		2	2	4	15					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												4,481					11,987				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																																	79				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																													179	250	215	318					
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																							5				1			1	12	16					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																					3		3				3		2		4	9					18
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												324					504				
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																							2				2		2	4	2	2					11
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																													9	8	12	35					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																													67	79	80	114					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																													26	42	38	72					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																																	92				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																													10	22	13	29					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																													10	11	32	87					
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																							24		2	4	7		6	3	8	15					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												893					1,438				
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																							11		1		3		2	2	15	31					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													15		1	8	5	57	15	12	26	17	44	21	26	29	32		29	42	53	51					14
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																										3	1		1		7	5					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																													2	3	3	5	8				
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													75			32	37	114	52	61	69	58	117	66	78	100	69		96	125	155	156					48
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																					3		4							4	5	10					24
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																										2	2		2	2	7	4					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																													4	1		1					
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																							11		1		2		1	1	7	8					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																							1				2		2	1	1	3					2
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												52					87				
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													150		5	60	102	227	174	157	211	172	266	192	222	252	238		253	293	359	346					76
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												6,546					11,084				
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																														2	1						
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																										2			1		4						
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												11					18				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												496					1,226				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																													8	23	27	80					
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												38					63				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																													219	223	191	283					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													420		2	110	256	487	337	403	577	540	957	571	866	781	823		892	1,139	1,665	1,383					402
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																							28		1	3	1		5	3	12	13					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																																	222				
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																							23						1		8	9					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																								1			1			8	3	3					37
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																																	169				
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													15		1	6	10	55	15	12	23	11	56	18	17	23	31	121	18	33	35	36	238				7
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												1,857					3,532				
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																																	70				
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																									1		2		2	2	3	3					
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												15					25				
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																							46				4		3	3	17	12					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																					2		4				4		1	2	13	19					54
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																							8		1	1	3		4	2	14	26					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																													116	153	135	228					
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																											1				1	1					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																													12	13	10	29					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																													2	3	3	23					
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																												45	19	23	22	41	93				
Pacific Region	Papua New Guinea	PNG	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																							38		1	1	5		3	2	5	10					
Pacific Region	Philippines	PHL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													75		2	12	22	83	37	55	96	82	251	97	150	206	198		211	270	462	398					103
Pacific Region	Indonesia	IDN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																													33	46	43	66					
Pacific Region	Papua New Guinea	PNG	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male																												9									
Pacific Region	Papua New Guinea	PNG	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female																												41									
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												847					955				
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male													1,621		1,644	1,670	1,886	1,688	2,558	2,699	3,125	3,280	2,921	3,058	3,337	1,859	4,423		4,478	4,862	5,079	5,359					6,003
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15+	Coarse	Female																			8,523	8,325	8,473	8,573															
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			185					486	310	329	330	362	423	368	360	434	451	528	447	473	490	498	482	516	513	523	525		555	568	581	615					601
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			9	8	9	9	29	7	6	8	13		17	18	17	21					24
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female													71		77	77	86	2										172					197				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			1,753					3,241					3,729					3,775					3,933	5,228	5,351	5,558	6,864		7,218	7,341	7,512	7,690					8,496
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												4,502					7,716				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																							333	303	322	343	414		404	449	472	489					560
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			413					530					168					282					300	306	312	304	373	320	396	390	377	378	532				376
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female													51		55	47	51	11	69	74	83	91	84	77	91	236	123		111	127	138	139					136
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Missing Sex				296	308	296	330		318	322	298	694		678	688	906	919																				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			25	25	24	31	43	33	42	41	45		44	46	45	53					60
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			487					704	569	593	600	646	797	652	650	817	832	788	827	843	884	884	879	926	953	983	990		995	994	998	1,032					1,016
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			1,751																																		
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			1,768					3,396					3,761					3,775					3,936	4,591	4,722	4,839	5,827		6,338	6,005	6,199	6,300					6,768
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												15,346					19,746				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			84	82	87	96	82	101	106	103	110		114	117	123	132					140
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male													97		90	93	93	331	176	200	276	299	197	251	273	1,367	390		381	397	444	476					486
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			47	48	87	90	83	74	83	37	104		111	126	130	133					158
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			165					163					950					1,187					1,222	169	164	178	183		196	186	198	208					207
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			557	567	712	735	745	637	674	437	921		925	973	1,023	1,036					1,110
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Female				3,473	3,652	3,714	3,999		3,980	4,143	4,266	6,135		6,065	5,889	8,390	8,418																				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												158					182				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								235	218	230	233	257	287	260	254	294	307	205	309	307	328	333	327	355	350	347	376		387	383	392	389					408
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female															1		1																				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			290					479	471	507	486	519	594	514	512	609	668	519	663	690	702	725	717	744	753	764	809		849	845	853	913					973
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			54	55	59	61	52	50	50	46	79		77	77	80	80					89
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male															58	19	20		18											5	2						6
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																							1,298	838	879	929	1,087		1,102	1,174	1,223	1,306					1,493
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex												1		1	2	1	3		4	4	1	3		5	4	5	9		8	6	5	6					3
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex													89					33						16	11	10	9		14	4	7	3					5
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female													71		75	77	99	6	165	158	163	155	154	137	141	175	216		223	230	259	262					305
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex															17	20	21		6	9	19	21	17	14	16	8	24	35	22	23	26	23	33				26
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									12	13	13	16		13	11	15	13		10	17	2	2		10	11	14	11		8	7	10	11					61
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male													5,461		5,696	5,637	6,151	5,862	7,674	7,875	8,539	8,779	8,917	8,334	8,806	8,944	11,568		11,425	11,929	12,297	12,599					13,003
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			90																																		
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			493					61	89	102	111	88	99	86	79	101	109	169	97	108	121	106	117	91	108	106	141		92	102	87	81					82
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male													603		646	627	727	780	961	1,012	1,223	1,265	1,201	1,135	1,254	851	1,728		1,726	1,914	2,049	2,204					2,595
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			792					968					1,100					1,190					1,242	1,044	1,014	1,005	1,257		1,353	1,292	1,299	1,292					1,262
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			363					319					3,229					3,775					3,896	298	325	348	299		348	332	324	327					353
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												9					9				
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												675					707				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			249					387	300	329	324	334	420	348	355	432	428	398	425	443	488	492	459	491	532	525	547		542	524	538	573					570
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			484					30	1	2		1	6	1	2	6	5	15	4	6	6	4	7	4	4	5	14	22	6	4	7	5	28				3
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex																	1		2	1	2	4		1	1	6	3		12	12	13	20					12
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			63	61	64	64	55	73	75	76	84		83	85	78	87					101
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			129	138	139	147	116	163	174	179	184		192	197	202	230					276
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												10,262					17,851				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												1,603					1,809				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			792																																		
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Female				1,861	2,533	2,358	2,531																														
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												7,500					10,901				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								3,241					3,668					3,776					3,906	4,401	4,415	4,557	5,202		5,417	5,334	5,392	5,442					5,553
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male													1,729		1,812	1,751	1,846	2,295	2,565	2,619	2,880	3,104	2,947	2,914	3,187	9,393	4,056		3,943	4,074	4,311	4,426					4,529
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			164					57	14	16	14	13	19	16	16	19	15	37	16	14	19	20	23	16	21	20	27		24	23	26	22					20
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			32	34	34	38	33	32	35	29	54		50	55	58	64					66
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			102	103	142	146	154	123	128	76	198		190	205	229	247					302
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			339					361					871					1,188										1,500					1,793				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<15	Coarse	Missing Sex																			918	892	917	759															
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female													112		126	119	122	23	187	177	187	184	193	154	171	360	276		265	280	297	295					332
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female													142		147	150	156	23	205	198	200	211	214	200	214	255	332		316	341	364	371					385
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex													162					290					310	67	65	72	88		100	87	86	84					72
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex																					1									1	4	4					
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			792					968					1,096					1,188					1,232	1,625	1,620	1,638	1,885		2,005	1,840	1,894	1,857					1,760
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			16	19	19	21	14	17	16	5	22		23	23	25	23					26
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			784					771					1,102					1,192					1,240	327	310	315	272		303	273	296	300					287
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								968					1,016					1,188					1,225	977	1,002	1,052	1,286		1,302	1,453	1,518	1,607					1,863
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female													14		13	15	11	11	17	16	15	20	19	12	10	52	21		24	29	34	37					41
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																							109	106	111	120	138		140	147	147	153					182
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								551	295	304	313	372	424	378	358	435	476	597	459	472	498	497	510	530	543	539	569		587	599	604	638					675
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male				11,320	11,875	12,105	13,375		13,946	14,712	14,376	19,134		19,460	19,690	26,370	26,854																				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																							2,077	1,608	1,665	1,723	2,006		2,049	2,158	2,243	2,309					2,596
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			139	145	147	155	197	151	154	151	164		190	189	196	186					203
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																							520	402	411	427	499		514	562	589	622					682
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			578					263	239	257	277	284	324	270	275	335	328	252	315	334	344	313	348	325	357	337	367		351	363	357	347					361
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												10,260					3,309				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								968					1,095					1,188					1,228	1,864	1,885	1,935	2,306		2,359	2,432	2,452	2,479					2,466
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female																								1,229	1,223	1,237											
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female													66		69	69	68	6	94	93	100	105	94	93	101	116	164		176	184	200	202					211
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			405					248	95	105	107	97	123	97	95	126	119	260	108	124	130	118	128	126	122	121	139		114	112	110	114					91
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												140					158				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								3,238					3,351					3,777					3,892	2,867	2,944	3,034	3,620		3,693	3,932	4,105	4,246					4,620
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male													664		688	684	744	766										1,422					1,924				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			50																																		
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male													3,691		3,808	3,836	4,343	3,527	5,452	5,701	6,452	6,634	6,342	6,269	6,793	4,220	8,744		8,850	9,409	9,829	10,279					10,774
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																							526	499	514	553	646		668	667	685	711					850
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												650					469				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			42					251	323	334	334	362	448	367	372	459	510	275										605					806				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			803					968					1,104					1,192					1,245	595	606	587	692		784	727	735	707					697
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			225	242	236	253	246	264	259	261	263		265	273	274	304					327
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												675					993				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												1,821					2,252				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Missing Sex				2																																	
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												16					71				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex																					1	3			1	3	6		4		1	5					2
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									8	7	8	9		12	11	15	16		12	18		2		6	5	9	8		5	4	2	2					39
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female													39		42	45	55	6	71	77	75	83	73	64	76	71	101		99	113	116	127					142
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			581					512	372	418	423	400	473	400	410	485	493	625	447	486	502	478	526	470	514	510	545		519	512	541	522					456
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			18	17	19	17	18	14	18	8	26		24	33	31	32					40
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			57					210	165	173	172	196	216	202	201	222	246	77										297					339				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																							409	230	242	247	300		312	360	378	411					457
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								405	270	275	268	276	344	280	279	353	360	422	353	365	394	372	387	386	403	400	427		454	450	446	483					480
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												24,910					29,567				
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			262	266	351	353	330	342	362	184	494		499	529	540	599					681
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												1,261					1,330				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												3,002					653				
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex																			13	11	16	21	6	14	12	43	26		22	29	35	33					39
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male				1,179	1,924	1,729	1,749																														
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male													4,448		4,632	4,564	4,916	5,317	6,343	6,438	7,103	7,315	7,300	7,107	7,510	13,124	9,805		9,829	10,203	10,650	10,846					10,686
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			1,754					3,241					3,726					3,775					3,916	4,174	4,271	4,417	5,310		5,487	5,689	5,853	6,020					6,740
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male																								3,391	3,416	3,539											
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																							169	166	172	173	194		199	206	214	223					247
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												3,001					2,786				
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex													154					282					300	216	192	201	253		283	273	278	278					220
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			727					700	577	600	611	620	730	647	620	749	786	781	774	834	854	851	829	881	894	902	880		914	966	986	990					1,033
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15+	Coarse	Male																			27,772	28,227	28,811	29,259															
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			741					1,164					2,971					3,777										4,942					5,612				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								192	189	187	189	194	250	194	199	257	278	149	285	290	303	307	303	325	335	326	373		385	394	387	394					462
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												567					632				
Pacific Region	Papua New Guinea	PNG	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			74	72	76	72	97	84	81	77	83		93	98	103	108					132
Pacific Region	Indonesia	IDN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			1,741					3,025					3,762					3,775					3,939	2,196	2,220	2,298	2,015		2,364	2,165	2,306	2,340					2,616
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												13,193					16,977				
Pacific Region	Philippines	PHL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex																			14	13	35	32	26	19	24	34	34		28	32	33	34					43
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			79					20	1			1			1	2	1			2	2	1			1	1	2	15	6	2	2		5				1
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												829					1,545				
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male													658		93	171	207	728	345	342	356	393	991	309	467	402	491		399	525	488	518					460
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female													6		3	2	1	4	3	1	2	3	2	1	2	4	7		7	5	8	10					12
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male													36		1	10	11	86	20	18	23	25	57					51				6	235				
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex																1	2				1			1		2	3	2	1		6		14				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								2	7	5	3		1	2		1					1
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												23					40				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex																	1		1	1	2	2				2	1				2	1					
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								91	79	68	89		81	44	35	42					35
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			46					135	23	27	18	25	20	21	16	22	19	39	19	26	30	32	39	23	23	26	31		19	20	27	24					27
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																														13	4	14					5
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												254					389				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			41					80	1	9	3	1	3	2	3	3	5	3	3	3	3	4	7	1	4	4	7		2	1	5	1					5
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male													320		28	87	100	340	142	134	158	170	366	113	182	175	203		216	213	199	231					198
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male													640		78	163	191	795	307	273	316	320	779	232	343	334	416		367	372	376	379					353
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								107	8	11	10	8	34	10	9	6	14	13	12	15	17	12	18	14	8	6	8		11	12	12	20					13
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												17					120				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								4	3	3	2		5	3	4	5					3
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			670					1,155					269					519					246	259	286	259	290		286	248	273	304					258
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												1,822					1,287				
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male													44		4	11	14	99	21	22	22	29	55	13	34	27	53		40	26	38	47					39
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			290					365					82					164					77	47	49	35	42		55	50	38	44					44
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			673					1,269					266					519					239	248	230	213	270		282	220	250	221					216
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female									1		2	7		6	4	5	3			8		1		7	6	9	2		4	2	3	1					34
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			14																																		
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												267					212				
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male													848		88	217	257	1,025	477	438	451	446	1,156	377	521	488	572		533	555	612	600					523
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								342					81					161					63	47	29	25	38		34	36	37	42					34
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																									2	2	3		1	2	3	1					1
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												39					75				
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								1,175					235					521					194	66	52	47	65		75	54	70	53					56
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			675					1,262					265					519					222	139	136	122	169		149	138	136	143					157
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																									3	1	3			1	1	1					
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																														4	5	8					9
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			291																																		
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								137	14	18	11	9	24	13	12	16	14	29	8	22	18	14	21	11	14	9	15		12	11	17	18					14
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male													106		18	21	33	181	68	52	64	67	158	47	104	85	89		98	109	90	104					83
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female													15		2	4	2	2	4	3	4	3	2	3	4	9	5		7	7	9	4					8
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			285					411					205					521					533					379					376				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												57					107				
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex													20					35					22	3	4	6	8		13	9	1	4					4
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																										4	4		2	6	2	2					
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								340					73					161					60	17	22	18	38		28	24	29	41					27
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												3,083					4,985				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								3	1	2	3		2	2	6	2					
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			675																																		
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																													1		1	3					
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex																					1	3				3	2		5		3	4					
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			144					89					230					521					202	45	58	43	46		32	51	48	43					39
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			58					37					68					161					58	13	7	10	13		12	11	4	9					8
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												106					145				
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female													12			3	2	1	4	1	6	4	2					8					12				
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																														11	12	11					11
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male															3	1	1		1						1				4	4	2						1
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex														1	1		4		1	1		2		4		1	5		3	1	1	3					3
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												50					79				
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			674					1,336					268					519					242	353	294	304	390		357	318	338	341					338
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex																			2	2	3	3		1	2	3	9		2	4	10	5					4
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			287					302					85					164					71	30	39	26	32		43	23	32	39					30
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								8	27	18	21		20	24	22	18					15
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								1,204					258					519					210	100	81	76	101		77	87	86	100					83
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female																1																					
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												2,452					3,920				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												2									
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								113	5	9	7	7	3	4	10	13	8	13	7	9	9	6	17	11	9	5	8		10	10	5	11					3
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								2		5	5		5	3	7	4					7
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male				72	152	117	148																														
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			113					151	34	46	45	40	37	54	38	55	71	50	57	67	66	60	33	65	66	54	63		52	69	63	69					76
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male																								133	162	149				2	3	4					3
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female													16		2	5	2	2	10	2	7	6	4	7	6	8	11		11	14	23	10					13
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								6	7	1	5		3	4	7	5					11
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												10					18				
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female													9		3	4	7	4	8	12	15	14	6	7	17	16	14		18	21	24	25					15
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																														20	17	42					26
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Missing Sex				7	11	11	15		4	1	7	44		10	14	22	12		29	20	37	31															
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Female				122	175	212	220																														
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			61					165	18	31	35	38	47	31	35	43	50	49	35	31	40	39	35	44	40	36	30		31	36	43	46					38
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								153	10	13	17	18	24	22	10	10	25	36	23	14	14	14	27	18	13	10	13		12	21	11	20					10
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								2	5	1	2		9	5	4	3					2
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			28					150	15	22	13	20	37	21	19	23	30	34	15	40	22	22	26	28	24	23	22		19	19	29	28					20
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			76					129	16	19	13	26	47	18	14	26	22	22	7	18	16	15	7	25	14	12	17		20	14	15	17					18
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			154					185					13					33					20	4	1	6	10	4	12	9	6	7	78				4
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female																								34	42	35					4	1					
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								1		1	2			1		2					4
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												1					12				
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			291					364					81					161					67	46	47	52	42		60	32	46	44					45
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								27	29	27	40		35	16	17	12					17
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			125					120					62					161					41					139					149				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			99					113	62	77	54	53	51	48	51	58	79	38	43	55	64	50	28	65	64	60	76		71	56	72	56					72
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																														13	13	18					17
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			6					89	3	5	1	4	10	5	6	5	16	5	6	9	4	7	16					18					37				
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female													12		4	4	4	8	11	10	19	17	9	7	23	22	21		21	23	27	22					25
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			15																																		
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												395					462				
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male				957	848	780	1,114		97	87	1,184	2,283		742	756	1,117	987		1,342	1,360	1,290	1,596															
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																									1												
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								10	13	15	12		9	7	9	13					2
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Missing Sex				1																																	
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex																															2	6					
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female													16			5	3	8	9	8	7	18	6	10	15	12	11		11	17	17	18					20
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,206					2,368				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												46					111				
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex													13					33					20	4	11	5	10		15	14	14	11					4
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			72					45	26	33	24	19	14	18	14	19	36	20	18	23	26	23	6	22	32	24	28		20	23	21	24					28
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			108					134	31	22	33	33	61	24	20	38	29	20	23	28	23	25	19	27	31	16	31		25	38	28	31					35
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female															1		1	2		3	1	3	1	2	4	3	3		5	1	6	2					6
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Female				272	248	211	231		35	27	266	670		177	130	270	238		338	288	307	357															
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												84					86				
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male													116		9	29	29	153	54	67	89	78	161	54	78	84	97		100	105	111	129					113
Pacific Region	Philippines	PHL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																										1											1
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			57					130	26	25	25	28	58	31	26	28	41	28	23	33	41	37	25	32	42	25	25		22	30	31	34					39
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex																		33						3	3	3	4		4	2	2	1					2
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												1,225					1,450				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								10	5	9	3		9	12	13	6					12
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male										1		5		6	6	4	3		1	7		2		4	1	6	1		2								22
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex																					3								2	2	1						1
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																														1	2	2					2
Pacific Region	Indonesia	IDN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			290					365					82					163					75	53	36	45	50		55	49	45	56					49
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												123					247				
Pacific Region	Papua New Guinea	PNG	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			9					87	14	13	15	16	30	11	24	16	23	20	18	30	22	16	31					37					96				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Female				34	84	847	942		1,314																												
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								34	32	9	35		39	54	70	67					93
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												9					37				
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male													1,966			1,469	2,032	2,887	2,746	2,394	2,747	2,665	4,986	3,096	3,101	3,657	5,819		4,953	6,011	6,300	6,241					8,261
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												7,884					6,724				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female																			3					39	48	44	2					43					
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male													2,709					3,243					3,530	698	854	1,219	1,980		2,480	2,714	2,911	3,145					3,631
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female													5			3	3	5	5	9	2	3	11	2	1	21	3		5	6	9	11					15
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												287					339				
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male													217			161	259	379	443	385	406	402	677	439	444	335	801		747	947	1,050	1,125					1,570
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male													2,972					3,242					3,528	1,276	1,458	2,054	3,299		3,864	3,944	4,068	4,229					4,607
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex														3	1	3	4		3	3	1			1	1	1					1	2					
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female										240	200	177	659	197	190	295	375	712	333	452	496	455	756	403	461	295	300		333	477	512	577					439
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex																5	7		5	11	6	8	10	4	6	2	11	18	11	12	11	11	15				16
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								213													638
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female													14			16	23	2	39	64	25	23	41	26	26	28	46		36	49	47	52					89
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female													708					1,019					1,051		283	421	3,749	1,183	851	909	896	1,007	4,932				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								732													2,028
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								132	125	58	203		194	271	284	288					423
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												540					137				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Male				1,145	2,584	3,642	4,174		6,408	7,677	7,630	8,845		8,955	8,435	9,886	12,056		14,693	16,441	16,716	16,418															
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								11	9	11	26		24	36	36	39					42
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex													134					245					265	116	158	175	54		154	151	166	173					180
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												363					382				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																																					532
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												754					863				
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male													1,601			1,174	1,478	2,614	1,868	1,584	2,005	1,939	4,052	2,504	2,593	5,310	5,084		4,405	5,134	5,311	5,188					6,817
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male													1,329			1,043	1,634	1,753	2,221	1,971	2,209	2,208	3,565	2,441	2,453	1,689	4,211		3,896	4,780	5,055	5,107					6,523
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												3,574					3,345				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																			30		1			142	145	71	12		41	141	96	202					
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male										26	29	56		87	115	140	179		144	38	41	42		72	48	30			1	2	1	1					1
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex													140					251					272	183	270	253	18		58	47	47	47					46
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																																					388
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								188	152	101	100		110	150	160	185					167
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female										83	76	82	226	82	90	136	187	137	162	200	229	196	268	161	227	144	156		166	205	233	263					250
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								107	122	91	74		95	116	139	163					145
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female													24			18	17	2	27	89	23	28	54	30	37	33	69		68	85	99	108					126
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Male				17	53	568	670		752																												
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female										192	153	145	383	139	130	210	259	551	239	322	368	334	458	285	370	248	261		276	336	371	430					371
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												71					79				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female													891					1,019					1,109	726	913	1,202	781		1,408	1,391	1,375	1,363					1,436
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								226	202	148	374		376	462	505	515					719
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												6,755					9,279				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex										1					1	1	1		2	1	2	2		1	3	2	1		1	1	1	6					1
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex													77					10								5											1
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male													2,394					3,243					3,583		856	1,219	13,246	3,968	2,685	2,930	3,200	3,413	17,131				
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								6	8	2	10		7	17	22	20					30
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																3	1		2																		3
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female													891					1,019					1,109	396	501	762	894		1,603	1,658	1,649	1,721					2,031
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								5	4	2	11		9	10	7	12					19
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female										14	12	11	89	17	20	31	32	153	29	39	41	38	100	24	31	19	19		21	27	28	27					19
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex																			9	6	10	11	15	11	11	12	12		13	16	15	15					25
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												3,480					5,094				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male										119	108	91	379	91	91	141	178	367	180	271	285	272	421	307	254	166	179		178	259	286	306					224
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male													35			17	19	144	19	12	24	29	103	51	52	537	126		120	140	157	156					201
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								14	15	17	35		33	40	41	39					57
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								45	52	33	36		45	58	60	73					76
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												2,393					1,835				
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												12,930					15,427				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex										3	2	3		1	1	12	19		20	27	18	15		14	9	6	1		2	2	5	13					6
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male										110	98	83	311	77	72	139	178	389	169	231	255	252	342	283	250	169	159		172	229	260	310					232
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												1,124					1,250				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female										147	129	106	427	95	85	142	168	570	152	199	207	205	473	165	205	153	144		142	206	233	246					171
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male										3	2	2	17	2	2	4	5	34	3	4	6	5	20	11	8	5	3		3	10	11	11					5
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male													3,021					3,241					3,530	2,123	2,527	3,136	2,799		3,784	4,052	4,346	4,644					5,386
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female													899					1,021					1,110	1,014	1,224	1,324	554		525	503	480	482					541
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male													3,053					3,241					3,532	3,078	3,540	3,699	852		1,588	1,519	1,705	1,706					2,101
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male										131	120	100	381	102	96	148	194	486	174	234	263	259	436	322	291	194	193		222	287	290	331					271
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male										87	77	78	292	74	66	97	126	233	123	158	165	151	309	182	161	114	104		111	156	181	184					127
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												1,622					1,960				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								103	103	68	79		84	109	112	128					102
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female													771					1,018					1,109	98	108	126	54		100	104	109	116					151
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																																					349
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male													3,026					3,241					3,530	3,555	4,160	5,023	2,456		5,044	5,357	5,739	6,008					6,950
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Missing Sex				1																																	
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female													41			27	39	10	63	162	44	37	107	49	53	139	107		94	110	130	134					201
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																																					175
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex													145					245					266	55	75	108	79	270	227	228	238	247	137				279
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male													2,623					3,241					3,530	419	481	460	364		189	191	220	222					254
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female													826					1,019					1,108	240	286	432	564		864	953	991	1,050					1,471
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								5	7	3	7		8	13	13	15					15
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female													893					1,020					1,110	1,074	1,285	1,463	688		962	933	898	911					995
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								61	68	46	52		53	52	71	87					75
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												7,868					1,720				
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male													622			386	445	1,126	540	435	651	638	1,618	819	918	3,844	1,891		1,662	1,831	1,886	1,921					2,589
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male										109	92	81	259	91	90	158	191	188	174	215	217	219	293	255	218	149	162		166	207	219	252					202
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female										111	105	90	195	92	83	111	153	72	125	208	227	211	254					265					315				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male										24	19	26	111	25	22	31	36	235	36	46	62	56	113	49	46	29	27		28	37	49	52					38
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,429					1,687				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male										165	155	142	404	132	119	207	293	249	250	340	381	353	509					541					745				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female										234	214	199	536	184	181	299	366	476	307	455	494	485	649	418	472	312	327		360	479	521	590					519
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								51	50	33	34		38	44	57	64					52
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								49	46	36	79		90	112	120	142					179
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																																					124
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female													51			53	59	10	77	241	57	56	120	72	71	93	155		144	172	183	178					234
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male													239			203	317	379	502	447	472	453	745					738					1,044				
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male													584			457	685	833	1,129	1,001	1,094	1,148	1,644	1,187	1,183	731	2,009		1,852	2,401	2,569	2,719					3,675
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female													26			20	34	2	62	209	58	62	87	59	50	74	98		88	100	101	124					192
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												601					864				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												141					160				
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female													25			16	24	1	47	81	39	40	68					88					109				
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female										67	65	99		117	149	204	284		249	71	87	79		114	94	53	1					2					6
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female													18			16	14	5	26	52	11	13	46	14	23	74	54		47	60	62	56					73
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female										284	257	230	719	235	211	319	399	727	349	507	582	548	789	445	534	364	369		401	523	582	629					493
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								19	26	21	23		25	27	29	36					33
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												11,772					11,748				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male													3,051					3,241					3,529	4,711	5,427	6,243	2,055		4,671	4,546	4,860	4,956					5,798
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												2,384					428				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female													895					1,020					1,110	521	631	638	255		179	172	174	175					199
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																																					1,153
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Missing Sex				6	31	32	38		76	91	86	121		150	187	185	255		343	400	440	351															
Pacific Region	Philippines	PHL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex																			2	5	6	6	4	7	4	20	6		3	6	8	11					16
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												9					9				
Pacific Region	Indonesia	IDN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Female				159	664	720	887		1,689	1,995	2,067	2,371		2,294	2,094	2,516	3,229		4,144	4,662	4,778	4,391															
Pacific Region	Papua New Guinea	PNG	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex										3	3	3	5	2	1	1	2	14	4	6	6	5	7	5	5	3	2	15	1	2	2	4	24				2
Rwanda	Rwanda	RWA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					11,112		12,106			1,234		13,810					29,023	31,894		25,514		37,331	32,707		25,855		32,043	25,027		24,437		30,280	13,784				
Rwanda	Rwanda	RWA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					4,821		5,587			1,419		5,683			1,326		5,040	6,820		7,138		9,710	21,346		7,593		23,193	41,410		23,096		43,266	29,060				
Rwanda	Rwanda	RWA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					6,998		7,768			1,867		7,792					18,542	23,163		18,825		23,148	21,670		12,520		15,011	14,267		12,264		12,771	7,916				
Rwanda	Rwanda	RWA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female					1,313		1,339			82		284			49		175			627		746			543		827	151		528		880					
Rwanda	Rwanda	RWA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	N	Cervical Cancer Screened - First Time, Cervical Cancer - Negative																																			1
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												7,394					6,358				
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			6,742	727	100	170	674		196	627	527	747	8,654	327	734	953	541	4,285	756	553	744	685	4,331	358	625	756	510		290	283	640	543					728
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								92,705																													
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												6,703					5,764				
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			4,930	338	86	277	1,398		243	867	1,998	2,315	10,378	1,592	1,648	1,788	848	5,140	2,092	1,191	2,020	1,851	5,195	1,707	2,042	1,544	1,275		701	2,047	2,617	1,640					1,518
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			8,216																																		
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male				42	9	14	181		124	143	263	210	589	100	236	488	330	291	663	440	320	375	294	282	281	366	601	294	274	234	335	360	253				293
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												16,822					14,472				
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex							35		30	74	25	14		24	70	186	217		25	26	13	8		1	20	19	15		1	15	10	5					74
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				54	8	21	374		178	287	806	637	1,180	557	728	878	835	584	1,220	617	1,640	1,310	591	941	1,275	1,161	1,287		842	2,987	1,894	1,172					684
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			8,216	13	15	8	254		120	138	201	175	13,155	128	563	749	376	6,514	555	274	199	190	6,584	110	148	356	140		124	156	394	308					470
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			4,930	202	106	172	572		192	592	885	801	9,674	467	583	530	584	4,790	1,326	1,037	1,252	1,086	4,840	896	1,321	968	951		704	1,222	1,562	1,852					543
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			4,930	125	64	77	368		239	519	570	605	2,672	400	745	718	888	1,322	1,418	906	954	683	1,336	523	1,426	1,224	988		527	910	804	955					449
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			4,929	69	19	65	771		149	461	1,342	2,003	1,745	1,584	1,817	1,290	1,069	864	2,252	1,310	3,929	3,279	874	2,267	2,471	2,156	1,958		785	4,012	3,102	2,109					863
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			4,930	104	15	83	940		192	570	1,738	2,999	3,013	1,949	3,731	1,792	1,601	1,492	3,048	1,451	3,698	2,851	1,508	1,867	2,592	1,962	1,382		829	2,605	2,461	1,446					1,228
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																14																					
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				33	5	18	257		152	160	437	275	686	577	505	783	618	339	783	462	617	517	344	370	334	401	443		365	463	260	288					300
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												2,687					2,310				
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																163																					
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												9,661					8,308				
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			8,216																																		
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				84	24	26	253		217	431	476	513	1,511	320	659	841	663	748	854	630	548	447	757	274	522	612	625		537	411	767	436					356
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			4,108	22	2	11	159		83	61	206	175	348	107	268	653	236	172	538	400	205	244	173	130	214	283	478	173	185	163	354	301	148				223
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				71	27	30	149		193	224	327	301	1,186	349	492	611	489	587	580	500	275	228	594	203	249	302	399		289	260	339	490					264
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			9,686	487	65	227	1,224		217	592	895	1,850	20,455	727	1,003	1,430	709	10,129	993	928	877	884	10,238	778	922	974	784		604	516	1,550	704					1,176
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												1,809					1,554				
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			8,216	13		8	90		151	208	132	178	6,120	83	594	770	390	3,031	204	163	170	170	3,063	91	119	232	84		43	51	118	138					121
Rwanda	Rwanda	RWA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			4,108	610	168	355	1,054		222	801	715	900	9,634	437	818	692	680	4,771	1,055	909	1,111	1,019	4,821	730	933	827	895		434	493	1,047	1,272					759
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			54,702	16,405	16,625	13,420	13,059	3,387	1,269	1,212	918	1,120	9,150	2,964	2,502	2,320	2,051	8,613	1,820	2,385	2,259	1,726	4,508	1,343	2,658	2,266	2,022		3,496	3,368	2,231	1,769					2,418
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				11,013	9,996	7,896	7,605	1,984	751	715	895	967	17,152	2,429	2,703	3,036	4,926	16,550	5,264	5,763	6,075	5,001	17,873	5,286	5,568	6,190	5,462		5,958	6,678	6,560	5,923					6,877
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				2,248	3,583	2,156	2,000	2,985	460	482	484	510	134	649	677	593	453	8,554	376	369	296	288	11,571	196	189	198	240		181	227	177	258					152
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			43,066	12,794	12,591	9,872	9,232	1,756	875	450	1,041	901	84,023	6,074	24,015	16,347	12,344	19,802	19,329	29,133	12,121	6,636	45,418	16,640	24,611	11,577	10,829		16,641	21,685	11,209	7,749					10,178
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												5,377					2,355				
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			9,992																																		
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												2,542					6,038				
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			19,439																																		
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			45,527																																		
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												68,170					76,666				
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			61,158	30,185	29,715	26,195	24,730	4,108	1,848	1,530	2,534	2,789	70,301	9,445	10,336	10,975	19,629	68,783	19,585	19,792	20,010	19,389	62,323	18,147	18,530	19,428	18,536		21,357	21,571	20,188	19,601					22,032
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			2,769	680	1,538	553	433	50	65	72	107	70		80	61	84	71		33	47	61	46		18	33	31	43		26	25	12	27					14
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			31,095	5,919	5,543	5,789	3,386	7,451	861	894	848	940	7,875	1,173	4,491	2,743	3,473	11,798	1,089	3,371	868	602	11,141	497	1,396	772	647	7,677	770	897	437	678	3,200				1,175
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																													3	6	1						
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												10,160					11,432				
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				6,292	4,950	3,522	3,534	1,329	377	415	481	492	4,261	763	835	972	1,272	5,952	1,672	1,424	1,564	1,036	8,578	1,396	1,333	1,851	1,456		1,524	1,835	1,646	1,346					1,930
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male						1	2																														
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			73,338	13,193	11,589	16,537	8,841	1,461	353	220	169	165	2,891	703	607	738	448	2,158	330	312	307	419	935	187	924	293	276		547	367	179	212					443
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												6,008					10,201				
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			64,269	25,574	24,765	21,417	20,873	3,823	1,454	1,359	2,029	2,205	62,985	7,701	8,258	8,830	15,364	51,868	16,061	16,827	16,999	15,318	53,877	15,051	15,522	15,814	14,980		17,002	18,169	16,880	16,099					17,262
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			78,417	15,894	15,208	12,082	11,086	2,155	801	848	708	597	7,060	2,408	1,806	1,905	1,326	4,693	1,081	2,287	1,507	1,192	4,570	885	1,778	1,420	1,287		2,740	2,348	1,489	1,283					1,809
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			40,204	8,525	6,828	5,024	4,903	835	342	378	346	394	1,635	365	469	459	383	6,560	606	477	450	354	3,329	475	447	733	773	11,563	892	752	705	592	12,064				891
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												118,263					132,257				
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			102,460	29,711	29,282	25,167	24,102	2,770	1,764	1,456	2,616	2,663	76,096	12,098	14,060	12,785	21,345	100,041	22,427	24,940	20,284	19,188	106,636	20,428	31,577	23,220	21,970		28,269	46,963	28,733	25,004					24,515
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			35,786	8,661	7,833	5,869	5,903	823	627	658	589	579	1,274	957	1,061	1,028	776	8,247	681	704	631	771	8,154	687	837	1,290	1,746	8,435	1,856	1,574	1,352	1,100	8,830				1,143
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			60,831	18,769	19,080	15,904	15,901	3,118	1,149	1,110	1,527	1,670	41,440	5,515	5,936	6,489	11,035	36,950	11,909	12,138	12,024	10,437	39,343	10,798	10,786	11,337	10,659		12,158	13,084	12,300	11,347					12,861
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												160,417					176,712				
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				2		3																							4								
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			57,801	13,691	13,706	11,381	11,306	3,903	1,396	1,334	1,094	1,204	7,142	2,866	2,365	2,322	1,943	7,149	1,769	2,142	1,826	1,748	3,197	1,177	2,328	2,162	2,175		3,277	2,967	2,003	1,515					1,879
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				5,284	4,640	3,526	3,668	1,176	637	659	561	648	1,599	995	988	947	867	3,028	660	665	605	747	3,243	621	733	1,002	1,238		1,378	1,108	994	846					1,156
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				3,250	2,473	2,113	2,181	1,315	828	845	849	908		1,033	1,450	1,404	1,381	10,915	649	662	672	568	2,783	392	482	477	460		433	520	416	596					243
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				7,812	7,175	5,652	5,702	2,305	991	981	821	964	2,744	1,764	1,609	1,495	1,287	2,335	1,129	1,180	1,067	1,160	4,527	958	1,214	1,441	1,704		1,969	1,665	1,356	1,230					1,479
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			54,706	12,264	11,685	9,589	9,468	3,121	1,424	1,330	1,086	1,266	6,175	2,471	2,203	2,120	1,874	2,251	1,642	1,547	1,518	1,553	3,206	1,182	1,683	1,774	2,205		2,396	2,142	1,633	1,394					1,607
Rwanda	Rwanda	RWA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			61,836																																		
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			1,117																																		
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			1,839	243	252	198	198	292	199	210	207	231	554	301	234	262	257	143	236	238	188	169	220	173	178	179	204		219	233	146	151					163
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			1,103	152	145	116	127	285	129	106	84	122	157	125	113	143	123	99	126	123	86	126	98	92	103	95	116		117	109	91	76					69
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			956																																		
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			147	26	20	17	9	268	5	6	4	13	26	8	7	15	13	478	4	7	7	12	511	5	5	3	3	131	2	4	1	7	48				2
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			634	88	102	56	57	190	85	64	70	66	298	81	87	72	50	39	61	83	68	70	134	62	49	38	85		79	40	54	56					59
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				27	37	21	26	104	26	13	15	16	4	20	18	15	18	261	14	10	20	16	501	15	14	14	7		13	17	16	18					27
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												633					611				
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			692	60	59	43	44	115	53	60	36	49	102	68	45	73	49	207	56	45	55	52	241	71	61	60	65	543	60	68	71	44	545				61
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			163	14	9	9	6	144	12	1	5	6	40	10	11	9	5	54	6	7	11	12	18	13	6	7	2		3	6	2	2					4
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												424					451				
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												80					32				
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												64					97				
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				48	52	40	53	100	38	48	48	51	91	39	34	55	44	150	59	56	47	54	230	49	29	41	57		54	51	39	44					42
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			57	12	15	5	3		7	4	7	5		12	2	3	6		3	2	6	2		2	3	2	2		2	5	4	1					3
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			1,238	122	146	104	87	252	112	90	79	125	149	107	108	97	94	200	88	93	82	81	89	78	102	81	70		99	57	77	61					51
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				26	24	6	11	30	15	15	13	4		14	10	19	7	304	5	14	2	9	90	9	9	8	7		9	6	4	10					1
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			1,280	148	146	126	112	240	127	137	141	171	262	134	139	177	162	156	172	124	114	145	289	104	137	153	152		124	162	130	102					113
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			753	73	81	75	47	131	51	52	66	53	82	61	66	80	49	191	60	61	57	98	278	56	67	81	74	390	56	81	75	72	405				56
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												884					939				
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			1,245	167	150	110	126	336	133	103	86	117	146	141	115	120	116	176	117	113	92	91	89	82	127	81	109		119	97	100	80					54
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			1,148	230	222	169	141	327	165	144	188	227	374	226	173	224	171	144	165	189	150	167	132	160	167	176	217		185	194	155	145					156
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			801	72	66	45	48	174	52	47	35	45	100	56	51	61	48	136	34	49	39	35	78	39	32	44	33		40	36	43	29					15
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			44																																		
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				56	67	44	44	106	40	47	34	51	61	55	45	44	49	101	27	34	48	47	98	26	41	57	45		55	44	40	40					39
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			122																																		
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												275					271				
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			1,299	239	287	222	214	337	242	204	238	258	494	245	269	263	224	130	237	237	201	231	167	156	205	197	252		245	223	157	155					167
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												187					177				
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				69	86	58	54	158	62	78	87	66	140	88	77	109	103	145	73	96	89	76	204	75	78	100	80		91	90	83	72					87
Rwanda	Rwanda	RWA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				93	90	79	61	194	80	72	65	88	83	80	63	90	66	87	67	72	75	79	165	93	79	80	84		85	108	69	71					63
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female					1	1		4					2			1				1	1	1						1									
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				162	173	124	142	406	134	149	145	126	623	129	165	150	134	391	109	136	129	133	588	120	126	100	79		100	119	129	98					98
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												801					493				
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												1,337					1,119				
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												434					693				
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex																	1																				
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				8	7	6	4	88	3	8	5	16	29	3	10	9	5	43	7	10	11	15	43	4	7	7	8		8	6	4	6					3
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				126	116	112	107	385	107	108	76	104	458	105	114	113	102	301	93	95	87	98	339	100	82	79	82		98	100	64	77					82
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				190	193	184	171	615	157	200	225	187	753	214	198	165	168	539	157	169	152	148	727	115	152	142	122		147	136	142	138					130
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				41	54	42	57	88	29	52	56	65	212	49	63	76	51	208	58	68	69	63	247	48	51	47	51		45	54	42	56					41
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																									1	1											
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				207	209	196	167	547	176	187	175	183	739	207	212	176	144	530	163	153	153	159	663	119	157	110	116		113	129	109	110					125
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				27	29	42	24	81	18	14	21	25	116	17	25	19	6	72	24	21	18	27	71	27	20	25	20		27	17	21	34					22
Rwanda	Rwanda	RWA	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				1		3	1	3	1				5			1			1				1	1	1												
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			18,644	7,807	8,164	7,358	6,856			124	101	128	30,185	7,301	7,640	7,105	7,346	30,185	7,491	7,759	7,120	6,736	30,185	6,884	7,137	6,306	6,083		6,670	6,702	6,276	6,304					6,521
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			18,367																																		
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			17	27	24	20	26					1	97	9	23	7	72	97	56	7	34	24	97	36	24	18	21		12	10	24	7					23
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex																														6	1						
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			18,497	6,685	6,916	6,121	6,013			79	81	92	25,736	5,856	6,182	5,732	6,028	25,736	6,204	6,341	5,839	5,549	25,736	5,782	6,064	5,248	4,920		5,525	5,599	5,212	5,571					5,266
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			4,651	2,258	2,095	2,072	1,977			23	33	35	8,402	2,554	2,107	2,197	2,396	8,402	2,868	2,260	2,284	2,240	8,402	2,604	2,057	2,111	2,053		2,403	1,892	2,030	2,458					2,418
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												35,123					35,123				
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				283	329	232	250			3	1	12	1,094	272	299	314	231	1,094	293	230	182	209	1,094	173	221	295	176		219	300	294	255					243
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			18,494	4,313	4,861	4,367	4,409			59	46	81	17,950	4,155	4,492	4,301	4,157	17,950	4,471	4,363	4,084	3,711	17,950	3,937	4,197	3,715	3,499		3,863	4,131	3,813	3,946					3,704
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												55,219					55,219				
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			4	1	15	9	12					1	37	3	29	3	10	37	18	7	3	5	36	8	7	47	1	36	8	11	31	5	36				4
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			26,260	7,014	7,264	6,533	6,356			102	73	111	27,169	7,358	7,254	6,470	6,922	27,169	7,069	7,576	6,919	6,487	27,169	6,929	6,971	6,168	6,002		6,828	6,808	6,464	6,910					6,452
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												25,441					25,441				
Rwanda	Rwanda	RWA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				1,550	2,000	1,651	1,520			14	15	31	6,721	1,515	1,788	1,649	1,562	6,721	1,711	1,944	1,772	1,651	6,721	1,658	1,884	1,774	1,506		1,696	2,156	1,983	1,797					1,799
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			677	207	192	174	172			2	2	2	746	209	223	183	151	533	157	153	151	159	663	120	164	101	120		118	134	110	111					127
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			3	1		3	1						5			1							1							1							
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			94	29	33	34	22				1	1	119	20	21	17	6	72	27	22	13	30	71	25	19	26	21		24	13	22	36					23
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			669	179	213	187	178			2	1	1	759	213	195	164	178	543	156	166	161	156	727	115	158	144	117		148	145	141	135					128
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												801					498				
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			668																																		
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female					1	1							2							1	1	1			1	1		1									
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			668	166	165	147	146			1	1		626	132	161	157	138	394	118	134	128	134	588	128	136	102	82		96	116	126	103					99
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			417	127	118	104	113				3	1	465	113	110	115	107	306	96	99	88	92	339	94	82	81	81		105	93	64	75					91
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				47	56	55	54				1	1	212	48	60	75	53	208	57	70	68	68	247	51	51	45	51		48	55	43	60					39
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				8	5	12	4						29	2	12	10	4	43	4	10	11	11	43	4	9	7	8		8	5	2	7					3
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												436					700				
Rwanda	Rwanda	RWA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												1,343					1,130				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												268					96				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			1,542		4,551		1,291	122		356		311	6,310		3,551		2,297	3,929		2,371		1,188	2,397		1,517		1,893			2,403		573					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			1,481		2,146		350	48		22		1	1,100		816		557	569		308		86	187		100		148	569		196		94	1,063				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												61					50				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			1,476																																		
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			5,178		5,000		1,864	104		545		232	8,417		3,151		3,087	3,264		2,247		843	2,250		1,157		1,104			2,271		423					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												2,006					3,853				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male					831		25			12		13																									
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			1,476		3,651		876	203		191		172	5,227		2,934		2,101	3,135		1,844		923	1,796		1,503		1,518			2,340		690					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			2,855		3,422		706								1,606		1,138	1,129		525		349	308		467		1,164			748		193					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												2,756					4,410				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			1,476		2,829		488								1,160		847	857		330		201	234		246		750			643		196					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			1,765		2,957		1,329	83		235		59	2,921		892		2,057	970		406		164	652		212		165			395		39					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female					5,243		218								288		276	277		80		22	75		34		54	11		59		21	9				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			17,462		14,508		1,236	16,434		17,412			38,974		33,462		8,559	42,823		38,445		5,711	49,849		32,935		11,792			28,147		3,934					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			9,035		9,496		885	10,970		9,030			28,717		27,139		3,792	30,884		27,922		707	33,613		23,698		768	22,958		16,158		4	14,031				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			2,950		3,227		683	217		122		140	4,527		2,283		1,516	2,519		1,140		587	1,540		792		1,223			1,299		396					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					1,872		378	142		86		85	1,940		1,466		912	1,400		768		323	720		425		696			806		272					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			1,476																																		
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												2,343					3,639				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			12,295		11,770		1,297	4,715		6,375			6,147		6,766		4,883	9,325		11,522		3,169	29,584		23,112		10,421			40,243		6,367					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					1,254		239	81		35		18	1,060		702		478	719		325		121	388		136		278			304		118					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			2,855		4,806		824			302					2,336		1,364	2,093		1,294		468	571		1,186		1,566			1,283		718					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					1,626		193								381		370	270		78		35	74		44		116			143		23					
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												83,502					70,206				
Rwanda	Rwanda	RWA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					1,927		297								731		740	547		160		97	149		139		377			384		121					
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			47	70	89	163	31	114	124	135	160		218	172	138	101					65
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			165	251	281	423	99	331	370	455	562		814	649	632	453					143
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												4,495					8,214				
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												540					1,614				
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			56	100	64	44	36	46	89	65	86	13	125	132	136	134	81				197
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			18	16	24	59	17	25	33	35	47		47	56	35	28					28
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			478	590	520	363	151	451	513	591	762		890	947	931	878					921
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			3,125	3,021	2,715	2,483	2,519	1,847	2,085	3,122	3,820		3,881	3,365	3,802	4,299					2,268
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																				6																	
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			933	663	756	695	1,053	522	450	708	815		600	429	495	539					529
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			28	33	32	32	12	19	23	26	29	16	29	37	26	20	40				17
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			230	273	385	484	137	486	496	588	809		1,002	911	951	780					292
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			94	147	135	250	72	181	231	278	318		378	354	302	208					140
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			179	235	342	349	67	419	345	424	607		640	587	635	612					233
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												949					4,079				
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			2,038	2,302	1,902	1,562	952	1,691	1,814	2,084	2,611		3,013	2,870	2,877	2,637					1,960
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												192					619				
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												321					1,061				
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												382					2,346				
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			1,476	1,663	1,387	1,050	619	1,185	1,325	1,479	1,902		2,185	2,265	2,248	2,061					1,726
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			1,054	1,166	944	707	430	865	944	1,027	1,410		1,700	1,695	1,598	1,417					1,440
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			28	7	34	21	24	63	32	19	86		156	49	57	92					23
Rwanda	Rwanda	RWA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			198	225	211	130	64	187	214	236	307		319	373	362	290					401
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					9		265	185		320		621	1,411	655	1,289	1,948	1,943	1,755																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male							19	64		5		27	60	59	89	110	108	74																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					9		192	100		226		402	577	484	736	1,026	1,049	718																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male							11	48		12		58	229	129	222	279	198	283																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					6		127	47		100		154	299	214	324	443	481	372																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male							16	77		6		7	30	22	43	60	54	36																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								39		1		3	82	4	14	21	19	95																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							70	39		40		62	139	88	131	195	246	173																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							11	23		16		22	34	25	50	79	78	41																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					16		238	147		370		619	811	617	1,015	1,490	1,483	1,024																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					11		140	185		270		473	3,145	1,520	3,017	3,643	3,065	3,600																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male							1	39		21		68	283	144	249	296	248	329																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male							20	89		7		37	107	89	165	216	162	133																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							20	46		1		3	15	5	11	14	19	18																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					1		19	106		138		209	2,028	589	1,133	1,398	1,339	2,326																			
Rwanda	Rwanda	RWA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male							7	14		2		4	4	12	28	35	41	5																			
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			287		9		156	100		125		176	497	133	227	185	21	560	118	189	74	115	632	159	182	202	183		177	103	143	147					1,056
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			21				5	48		10		48	180	46	104	43	6	203	2	154	84	98	485	83	169	197	157		162	121	118	98					340
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male							11	77		1		7	22	9	19	13	4	25	4	32	15	19	121	11	21	21	19		11	16	20	20					84
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			356		11		111	185		127		205	2,910	1,341	1,395	704	127	2,852	440	967	479	630	3,282	497	1,584	1,017	858		766	1,271	1,092	651					1,832
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							15	46				4	9	2	9	5	1	10	1	9	8	3	70	2	3	2	4		3	5	3	2					33
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												513					487				
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			382		9		233	185		163		302	871	293	507	447	53	984	221	403	217	260	1,341	339	510	374	479		397	300	314	336					1,695
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							30	39		17		22	97	22	38	43	12	110	14	30	12	25	114	36	42	29	29		28	20	16	17					286
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			82																																		
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			21				1	39		21		47	225	62	97	26	3	253	4	149	103	58	243	108	182	203	126		156	93	136	105					303
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												5,961					8,035				
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												1,273					1,212				
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												257					253				
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					6		71	47		52		54	154	52	87	75	11	174	36	88	36	56	241	75	101	94	74		77	76	69	66					714
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												427					419				
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male							4	14		1		3	4	1	10	5	2	4	6	10	4	4	50	3	1	5	3	20	5	2	1	2	20				12
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			287		16		203	147		157		248	779	188	296	315	31	848	168	285	139	188	871	235	288	293	325		286	210	223	275					1,300
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			43				12	64		4		22	54	14	36	37	6	61	3	55	27	33	260	45	37	53	42		40	31	40	41					199
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							8	23		12		7	29	5	30	13	7	32	7	9	4	7	68	6	16	9	27	17	22	27	9	12	16				117
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			86				9	89		6		30	106	31	75	56	4	119	3	114	49	68	361	82	111	108	78		73	53	68	57					215
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												717					709				
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			82		1		18	106		32		71	1,461	555	464	282	60	1,350	177	370	225	286	1,574	228	345	309	261		142	135	163	148					605
Rwanda	Rwanda	RWA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								39		1		2	54	1	20	5		60		7	20	9	88	33	16	24	28		20	21	29	27					71
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											5					5					6
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											10					5					7
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				8	7	7	11	14	5	5	15	3	15	14	11	6	5					41															
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				12	16	6	18	21	8	14	10	11	34	6	8	8	6					46					29					30					39
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											4					2					12
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex					1	1		2		1	2	1	3		1		3					3					2										5
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			251																																		
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				5	8	4	6	14	5	9	6	8	22	6	6	3	9					76					7					14					11
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			8																																		
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male					2	4	8	21		1	2	1	5		1	1						11					9					4					4
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				2			1	2		1	1		9									9										1					
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											18					11					8
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				10	11	9	10	21	8	9	3	7	26	1	6	2	4					34					22					19					18
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				17	28	15	11	21	14	19	9	10	52	8	21	4	7					48					35					19					24
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											13					6					8
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											3					4					5
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				19	19	10	17	21	13	17	10	8	46	10	10	3	7					48					19					16					17
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				8	4	4	2	14	6	7	4	5	13	3	5	1	3					47					8					8					16
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											3					7					8
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				14	16	18	12	21	7	19	11	16	33	16	12	10	10					52															
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				8	8	6	12	14	6	7	4	5	23	3	2	5	6					69					13					5					16
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				3	2	6	1	21	2	1	1	1	5			2						10					2					1					1
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				3	2	5		14		2			10		1		1					6					2					1					4
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			167																																		
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											3					2					8
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				4	5	3	10	14	3	4	7	5	11	7	1	1	7					28					11					3					12
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				6	13	3	3	14	7	8	1	6	19	3	5	2	3					73					6					14					19
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				5	5	2	6	21	3	2	6	2	9	6	16	2	2					34					13					12					12
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex					1	1		1									1										1					1					1
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				8	3	5	7	14	2	2	5	2	17	4	2	1	1					45					2					7					14
Rwanda	Rwanda	RWA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				1	1		1	2	2				3	1	1	1	1					5					5					2					
Rwanda	Rwanda	RWA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female								26,073				83	35,213		1,555		3,692	59,424		17,676		14,243	8,102		7,898		4,887	8,677		2,125		917	4,588				1,364
Rwanda	Rwanda	RWA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex								1,979				54	2,130		69		326	4,690		479		264	1,451		274		198	808		126		24	181				67
Rwanda	Rwanda	RWA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male								15,495				74	20,332		842		2,308	34,735		10,662		8,368	2,873		4,432		3,092	4,869		1,386		589	2,599				1,011
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				14	22	14	1																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				30	20	30	47																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			966																																		
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				11	12	9	6																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				23	26	29	37																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				14	13	12	14																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				46	52	25	46			1																											
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				21	21	27	22																									2					
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			124																																		
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				71	68	51	45							1					1																		
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				3	9	8	3																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				90	88	81	73			1							1													2		1					
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				20	13	12	15																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				14	27	11	16																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			518																																		
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				43	34	22	45							1																							
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				24	11	8	8				1			1																							
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				10	22	14	20			2	1	1					1																				
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				15	17	13	18																														
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				44	41	24	38				1			1																		1					
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				2	12	4	4				1	1																									
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				33	27	27	21					1																									
Rwanda	Rwanda	RWA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				15	30	13	18				1			1			1																				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			2,174	1,815	1,887	1,772	2,016	2,158	1,697	1,780	1,798	1,828	1,938	1,855	1,734	1,765	1,762	2,117	1,712	1,775	1,721	1,738	2,209	1,715	1,757	1,711	1,781		1,741	1,673	1,681	1,696					1,673
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				5,978	6,064	6,164	6,086	3,240	6,005	5,982	5,927	5,905	6,410	6,035	6,163	6,123	6,206	6,410	6,178	6,036	6,165	6,137	6,451	6,155	6,067	6,249	6,202		6,069	6,131	6,152	6,173					6,588
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			32	58	51	70	62	60	59	58	59	59	134	53	43	39	44	24	33	30	34	34	16	35	38	42	34	10	30	27	34	32	22				36
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												1,555					1,300				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				10,540	10,584	10,576	10,617	6,162	10,412	10,790	10,742	10,883	10,909	10,938	11,201	11,223	11,201	10,909	11,293	11,197	11,116	11,171	11,052	11,172	11,121	11,228	11,177		10,973	11,186	11,288	11,363					11,442
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			6,664	4,139	4,076	4,054	4,013	6,534	3,996	3,905	3,933	3,868	4,692	3,966	3,794	3,813	3,909	4,855	3,845	3,828	3,773	3,826	4,909	3,847	3,679	3,636	3,656		3,678	3,505	3,438	3,492					3,434
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												3,424					3,336				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			12,817	7,421	7,409	7,441	7,534	12,393	7,297	7,180	7,378	7,418	8,634	7,550	7,235	7,396	7,519	8,649	7,420	7,284	7,237	7,316	8,784	7,241	7,098	7,143	7,221		7,320	6,771	6,490	6,602					6,794
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				10,756	10,645	10,679	10,370	6,178	10,275	10,457	10,578	10,628	10,820	10,753	10,771	10,816	10,806	10,820	10,779	10,877	10,974	10,993	10,977	11,133	11,100	11,114	11,136		11,064	11,232	11,461	11,635					11,799
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			2,288	2,473	2,572	2,594	1,294	2,691	2,913	3,031	3,014		3,207	3,617	3,646	3,651					4,095
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			2,476	2,768	2,789	2,820	1,570	2,974	3,215	3,301	3,294		3,547	3,899	4,001	4,007					4,462
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												17,482					17,057				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			6,664	6,100	6,123	6,224	6,076	6,525	6,249	5,980	6,027	6,072	7,079	6,043	5,949	5,969	6,074	7,079	5,886	5,660	5,566	5,572	7,091	5,480	5,303	5,315	5,334		5,280	5,052	5,015	5,079					4,978
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				476	473	493	493	1,134	501	460	470	447	634	462	421	436	456	973	457	403	428	427	1,591	429	377	384	375		385	345	308	343					336
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												6,587					6,321				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			3,093	2,508	2,357	2,351	2,310	3,168	2,268	2,132	2,094	2,061	2,463	2,021	1,844	1,819	1,753	3,339	1,757	1,659	1,613	1,571	3,874	1,557	1,467	1,426	1,415	1,768	1,385	1,317	1,271	1,245	1,465				1,142
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												18,977					18,992				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			8,585	8,824	8,847	8,969	7,363	9,271	9,451	9,445	9,389		9,797	10,142	10,048	10,119					10,436
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			12,929	12,389	12,651	13,072	13,683	12,405	13,642	14,319	14,479	14,404	14,222	14,631	15,296	15,303	15,271	14,222										17,306					18,197				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			12,817	9,733	9,636	9,566	9,386	12,382	9,097	9,215	9,531	9,411	10,198	9,375	9,293	9,456	9,531	10,198	9,461	9,423	9,447	9,448	10,231	9,421	9,110	9,072	9,273		9,403	9,404	9,397	9,425					9,266
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				1,272	1,199	1,177	1,188	1,068	1,156	1,099	1,086	1,080	1,217	1,085	1,017	1,019	998	1,607	1,015	953	955	947	1,685	941	900	888	881		854	815	795	798					783
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			12,817	10,824	10,889	10,768	10,509	12,324	10,274	10,351	10,592	10,701	11,108	10,938	10,724	10,775	10,934	11,108	10,827	10,685	10,814	10,822	11,362	10,692	10,734	10,880	10,965		10,790	10,636	10,708	10,757					10,937
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			6,664																																		
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			2,911	3,138	3,293	3,284	2,009	3,317	3,566	3,655	3,620		3,701	3,983	4,072	4,128					4,326
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												6,758					6,509				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			6,057	6,146	6,139	6,106	6,033	6,261	6,201	6,076	6,082		6,256	6,194	6,103	6,175					6,104
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			3,290	3,572	3,660	3,707	2,437	3,721	4,006	4,116	4,136		4,224	4,652	4,753	4,762					5,133
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			12,817																																		
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				5,798	5,649	5,632	5,681	3,279	5,766	5,999	5,989	5,998	6,266	6,052	6,344	6,307	6,372	6,266	6,409	6,447	6,485	6,468	6,430	6,666	6,600	6,643	6,841		6,927	6,891	6,990	7,046					6,958
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			4,340	4,407	4,563	4,591	5,022	4,570	4,787	4,956	4,918		4,970	5,108	5,129	5,207					5,390
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			5,325	4,428	4,325	4,416	5,049	5,268	4,301	4,091	4,232	4,246	5,432	4,287	4,090	4,189	4,414	5,533	4,226	4,263	4,211	4,235	5,856	4,244	4,100	4,100	4,123		4,037	3,817	3,890	3,966					3,716
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			1,813	1,536	1,556	1,533	1,568	1,794	1,539	1,546	1,558	1,552	1,609	1,550	1,517	1,539	1,542	1,665	1,545	1,541	1,527	1,543	1,677	1,517	1,477	1,451	1,443		1,354	1,225	1,225	1,223					1,098
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			14,932	14,683	15,236	15,660	16,311	14,289	16,745	17,915	17,906	17,958	17,383	18,242	19,297	19,335	19,266	17,383										22,423					24,250				
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			2,323	2,051	2,010	2,051	2,098	2,333	2,038	1,978	2,009	2,076	2,529	2,093	2,039	2,081	2,108	2,540	2,063	2,036	2,030	2,072	2,822	2,076	1,951	1,933	1,947		1,862	1,629	1,605	1,692					1,583
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			6,664	2,433	2,445	2,413	2,482	6,477	2,513	2,597	2,563	2,559	3,042	2,662	2,531	2,592	2,644	3,285	2,629	2,636	2,678	2,646	3,358	2,639	2,650	2,717	2,638		2,764	2,556	2,477	2,439					2,629
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			2,189																																		
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			5,446	5,679	5,788	5,981	6,113	6,047	6,491	6,624	6,685		6,689	6,960	7,143	7,183					7,798
Rwanda	Rwanda	RWA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												34,435					34,391				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				68	63	60	37	78	29	51	29	39	171	41	25	33	41	131	21	16	36	37	173	20	28	42	28		44	33	33	44					30
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								13	9	9	8		14	17	21	19					20
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												1,514					1,206				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			991	111	136	100	105	154	86	81	66	72	231	68	68	67	64	310	68	66	64	54	141	62	63	64	57		62	50	57	47					41
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				77	94	76	70	119	62	58	53	52	223	55	60	57	43	126	49	55	51	51	295	78	51	56	60		53	61	53	72					57
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			538	84	89	58	65	133	56	50	48	51	299	51	45	41	25	61	41	37	43	54	340	50	29	27	60		60	49	40	42					41
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				58	57	56	60	78	38	44	36	41	223	38	24	45	35	223	46	32	38	37	368	35	30	33	34		27	34	36	40					35
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												748					600				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,247	245	283	223	200	229	193	181	168	166	624	161	158	159	144	191	153	128	135	130	314	128	142	126	132		138	137	116	111					117
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								5	7	12	7		9	14	10	6					7
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												297					225				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			552	50	43	38	40	98	47	30	29	40	112	39	33	27	24	222	28	23	22	24	138	22	20	29	20		28	22	34	18					18
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			92																																		
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												832					664				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								38	33	30	30		22	22	28	26					20
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			703	76	76	72	58	129	49	46	63	41	274	46	55	52	36	291	48	45	58	60	430					758					592				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			256	19	20	11	8	243	6	4	5	7	155	4	7	13	7	941	7	6	6	5	615	3	14	3	2	222	13	5	6	10	52				3
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,244	219	205	175	139	217	116	127	118	143	485	142	146	121	116	208	104	129	97	107	242	124	123	115	119		115	105	113	121					105
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								7	9	9	8		11	8	12	13					7
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			1,566	262	230	183	182	221	160	177	155	169	582	182	161	129	157	215	143	127	125	113	442	122	108	122	119		139	139	126	104					118
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			51	14	24	16	20	32	11	11	12	10	29	13	7	6	5	24	5	4	13	3	16	4	6	8	4	10	5	6	4	4	22				4
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								6	13	14	11		9	15	13	14					9
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												150					118				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			146	6	12	7	9	76	6	3	2	4	44	4	5	7	5	89	2	3	4	7	46	3	9	5	4		2	3	5	2					2
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												200					48				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				69	72	62	50	96	53	52	58	46	222	62	54	54	69	222	58	59	63	57	381	58	42	63	53		52	64	62	66					69
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												289					264				
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			986	159	148	148	121	204	112	81	86	82	371	96	101	73	92	144	88	80	73	80	157	71	81	78	65		78	78	65	58					51
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				11	13	9	11	30	9	12	7	5	33	10	12	13	7	422	5	9	5	7	114	9	9	8	8		7	18	8	9					
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			986																																		
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			993	165	140	128	131	214	97	77	66	93	317	97	81	73	74	262	80	80	67	90	154	59	91	57	80		80	61	65	57					38
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								3	3	4	5		8	7	11	9					10
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			1,243																																		
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			1,242	144	125	116	107	155	85	92	102	111	331	100	86	115	102	227	106	86	74	103	486	79	86	85	78		74	90	89	77					75
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				36	36	28	28	100	27	15	18	16	54	24	18	9	25	357	19	14	27	20	650	18	16	15	9		14	16	11	21					20
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								35	29	22	30		18	33	23	25					18
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								5	8	11	5		8	6	11	9					14
Rwanda	Rwanda	RWA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			696	65	65	52	52	110	48	58	36	46	314	65	42	54	38	354	46	41	53	42	456					983					793				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								5,728	5,615	5,805	5,876		5,750	5,683	5,788	5,584					5,773
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				3,581	3,929	4,462	4,418		4,504	4,555	4,712	4,298	7,953	5,455	5,731	5,810	6,331	8,151	6,469	6,469	6,731	6,760	6,897	6,313	6,509	6,233	6,328		6,038	5,757	5,868	5,737					6,039
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male						2																															
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				13	6	19	7		20	4	8	10	114	11	12	16	24	16	14	9	16	6	12	10	6	15	11	10	10	17	13	7	18				17
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				1,215	1,205	1,415	1,407		1,436	1,497	1,449	1,477	2,802	1,795	1,766	1,929	2,041	3,014	2,105	2,052	2,058	2,118	2,772	1,974	2,107	2,090	2,102		2,047	1,957	2,024	2,028					2,211
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								5,567	5,900	5,963	6,479		6,184	6,561	6,547	6,473					7,436
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				2,134	2,297	2,370	2,367		2,420	2,433	2,420	2,314	4,331	2,854	2,827	2,807	3,145	4,522	3,141	3,239	3,261	3,222	4,307	3,071	2,978	3,100	3,001		3,004	2,981	2,879	2,946					3,021
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								4,169	4,166	4,300	4,486		4,631	4,774	4,699	4,613					4,996
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												16,401					15,873				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								2,133	2,507	2,579	2,817		2,944	3,315	3,246	3,349					3,844
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				6,958	7,827	8,408	8,358		8,367	8,546	8,652	7,811	10,262	8,952	9,880	9,640	10,535	10,287	10,280	10,056	10,878	10,596	10,277	10,254	10,192	10,183	10,489		10,630	10,713	10,561	10,572					10,873
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				1,214	1,244	1,260	1,315		1,385	1,349	1,396	1,367	2,292	1,433	1,570	1,623	1,698	2,389	1,711	1,638	1,668	1,673	2,543	1,674	1,609	1,589	1,533		1,489	1,411	1,422	1,369					1,338
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				7,062	7,781	7,917	7,795		8,043	8,119	8,151	7,734	10,174	8,804	9,168	9,305	10,327	10,204	10,313	10,294	11,166	10,855	10,123	10,459	10,704	10,580	10,619		10,993	10,995	11,066	11,033					11,325
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				199	182	249	204		224	197	219	214	581	272	261	266	297	800	281	277	288	288	1,275	347	319	290	279		264	256	268	240					254
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								8,694	8,886	9,076	9,299		9,365	9,715	9,655	9,456					10,255
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				3,794	4,149	4,566	4,399		4,474	4,622	4,433	4,074	6,014	4,697	5,184	5,247	5,488	6,045	5,450	5,531	5,801	5,620	6,006	5,614	5,490	5,466	5,718		5,646	5,678	5,594	5,524					5,872
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				5,187	5,735	6,089	5,994		6,006	6,122	6,317	5,843	9,482	7,517	7,646	7,870	8,539	9,617	8,796	8,752	9,285	8,832	9,016	8,557	8,338	8,220	8,466		8,748	8,733	8,584	8,738					8,528
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								3,412	3,784	3,648	4,036		4,053	4,361	4,400	4,435					4,963
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												3,212					3,103				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												6,179					5,873				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								2,858	3,138	3,154	3,372		3,446	3,681	3,685	3,652					4,000
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												6,337					6,059				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				10,736	12,383	12,685	12,815		13,597	14,472	14,726	13,489	16,366	15,277	16,669	16,906	18,307	16,392	18,581	19,515	20,733	20,435	16,430					21,025					22,585				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				3,494	3,790	3,865	3,889		3,959	4,285	4,287	4,021	5,852	4,827	5,223	5,133	5,555	5,908	5,614	5,785	6,108	6,047	5,901	5,782	5,819	5,932	6,169		6,160	6,244	6,206	6,256					6,270
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												32,292					32,006				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				2,185	2,398	2,587	2,543		2,560	2,647	2,760	2,520	4,943	2,982	3,135	3,307	3,599	5,183	3,645	3,651	3,562	3,695	5,086	3,598	3,442	3,443	3,468		3,348	3,310	3,375	3,367					3,268
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				1,690	1,680	1,703	1,699		1,711	1,635	1,581	1,535	2,284	1,625	1,608	1,633	1,617	2,844	1,636	1,518	1,521	1,519	3,091	1,423	1,373	1,369	1,348	1,569	1,237	1,185	1,149	1,143	1,365				1,101
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								2,406	2,754	2,781	3,066		3,174	3,470	3,600	3,583					4,283
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												1,378					1,208				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				6,481	7,173	7,660	7,485		7,642	7,630	7,838	7,341	10,402	8,713	9,344	9,220	10,022	10,475	10,066	10,117	10,752	10,417	10,443	10,057	10,134	10,175	10,452		10,561	10,217	10,203	9,993					10,443
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				3,350	3,666	4,017	3,855		4,006	4,030	4,072	3,823	6,573	4,618	4,631	4,815	5,311	6,674	5,124	4,971	5,131	4,824	6,145	4,612	4,684	4,668	4,677		4,533	4,459	4,466	4,385					4,379
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				1,002	958	1,051	970		1,099	1,102	1,094	1,178	1,800	1,192	1,297	1,393	1,445	1,936	1,504	1,484	1,504	1,513	2,005	1,519	1,554	1,491	1,518		1,426	1,430	1,435	1,460					1,521
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				769	793	832	777		802	707	699	672	1,143	783	783	782	810	1,379	866	776	879	817	1,521	767	803	771	747		710	697	738	725					714
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				8,616	9,699	10,122	10,143		11,097	11,577	11,732	10,662	13,386	12,162	13,277	13,168	13,691	13,412	14,214	14,814	15,581	15,731	13,259					16,229					16,948				
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				983	1,050	1,020	1,063		1,139	1,113	1,150	1,105	1,512	1,243	1,200	1,284	1,342	1,549	1,323	1,349	1,306	1,340	1,544	1,285	1,284	1,290	1,244		1,160	1,093	1,087	1,046					1,023
Rwanda	Rwanda	RWA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												17,795					17,677				
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														1							3
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														7		9					8
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																																1					1
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														4		5					8
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					3		5			1		18			2		6			2		3			8		2										
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														9		4					6
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														7		2					4
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														9		16					15
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																																2					5
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														4		4					11
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														3		3					3
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					135		103	328		96		83			112		63			50		84			79		94										
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														5		9					6
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																																1					
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														7		2					4
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														4		3					10
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														1		1					
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														6		6					5
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														4		1					9
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					63		42	145		45		47			59		44			22		47			26		37										
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														18		21					20
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														3		1					6
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														2		2					8
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														10		14					12
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														10		6					9
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														2							2
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														6		11					8
Rwanda	Rwanda	RWA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														16		16					15
South Africa	South Africa	ZAF	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					1,237		2,722			2,737		27			52		23,639	127,395		18,053		53,317	205,175		18,672		50,633	95,362		32,025		129,622	100,917				
South Africa	South Africa	ZAF	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female															3		503			398		2,681			479		3,081	4,609		2,000		8,794	7,170				
South Africa	South Africa	ZAF	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					11,507		36,148			46,148		21,640			669		46,799	126,565		45,392		103,437	159,522		31,639		104,399	187,396		43,247		130,844	149,389				
South Africa	South Africa	ZAF	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					13,104		50,287			65,223		24,203			6,581		47,634	139,903		43,960		84,181	139,888		17,867		59,183	164,665		29,023		66,594	110,704				
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												354,299					352,884				
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			25,571	1,391	3,365	6,492	10,127		9,974	13,219	7,164	15,608	92,926	17,616	24,711	24,763	27,859	141,467	22,286	27,431	34,691	39,378	141,553	32,686	35,978	38,928	29,010		18,390	18,442	22,008	23,579					8,881
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			47,070																																		
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												49,287					48,682				
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male				4	131	113	127		629	301	188	370		505	519	225	353		183	446	771	1,196		1,359	923	1,185	1,196		548	718	646	688					48
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												404,627					404,164				
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			6,330	196	1,935	3,110	4,157	8,827	2,835	3,375	1,116	3,535	4,504	5,883	6,958	7,980	8,045	12,734	7,879	9,180	11,392	13,660	12,497	10,971	10,115	13,022	10,302		6,848	7,104	8,336	9,061					4,033
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female				1	147	137	228		746	444	136	465		548	693	498	816		594	880	1,162	1,228		832	1,629	2,111	1,498		1,217	1,284	988	841					79
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			22,524	1,882	3,421	9,504	14,778		13,561	19,093	10,263	22,817	36,418	23,859	32,543	31,643	36,506	56,945	28,379	34,453	42,869	47,870	57,036	40,351	44,131	47,963	35,881		21,374	22,057	26,023	27,944					10,959
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			20,889	1,406	3,491	11,938	16,058		13,549	20,478	11,328	23,832	28,782	27,099	37,821	36,607	39,789	43,981	31,897	40,526	46,771	53,844	44,070	45,619	47,612	51,990	39,643		23,006	24,304	28,742	31,601					12,709
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												72,866					72,453				
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			13,236	369	775	1,700	2,965		5,436	7,038	3,897	4,363	109,953	7,964	11,454	9,209	10,309	167,696	7,510	10,029	11,320	14,986	167,761	11,593	11,825	12,993	11,078	232,489	7,211	7,449	8,335	8,597	232,400				4,741
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex				242	140	169	39	108,451	47	539	95	49		6	157	111	343		229	173	207	417		197	183	134	96		40	88	104	96					
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			19,482	1,256	3,140	9,394	12,407	26,851	8,750	11,037	5,034	14,128	21,173	15,004	19,370	19,764	19,967	34,455	16,700	22,070	27,507	29,443	34,252	23,567	25,097	26,599	19,824		12,636	13,501	15,955	16,359					6,391
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				664	1,582	3,165	4,457	14,985	3,775	3,766	2,067	5,516	71,296	5,938	8,075	9,272	9,362	107,239	7,727	10,693	12,793	14,149	107,104	11,519	12,383	13,433	10,520		6,978	7,412	9,092	8,976					3,647
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												291,852					290,710				
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				307	688	1,822	2,682	14,983	2,226	2,267	1,234	3,182	59,247	3,752	5,002	5,666	9,831	90,722	4,701	6,607	8,197	9,101	90,587	7,059	7,754	7,867	6,290		4,171	4,391	5,259	5,298					2,224
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			12,855	474	4,482	5,805	8,026		7,132	9,779	5,802	10,163	2,147	14,668	21,077	20,601	22,968	6,363	19,552	22,930	26,723	31,458	6,427	26,949	25,617	30,021	23,891		14,878	14,941	17,390	20,576					8,554
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			26,223	695	1,777	3,760	6,267		6,481	8,051	4,473	9,471	68,359	11,125	15,043	16,071	18,020	104,680	14,697	17,920	22,842	25,149	104,767	21,422	22,994	25,418	19,274		12,542	12,616	15,478	16,021					6,888
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			29,342	1,546	3,641	7,224	9,751	27,624	7,671	8,867	4,344	12,330	110,153	13,263	17,572	19,100	18,937	163,476	15,530	20,145	25,131	27,648	163,276	22,494	23,833	25,822	18,833		12,316	13,366	16,214	16,232					6,056
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex				67	153	2,731	2,723		928	1,272	933	1,969	1,038	2,892	5,021	4,661	4,414	1,077	4,193	5,516	5,783	7,707	1,033	5,814	4,900	5,123	4,836	1,615	2,555	3,734	4,304	3,876	1,615				1,676
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				444	1,104	2,143	3,624		3,903	4,577	2,261	5,267	60,590	6,555	8,698	9,737	10,683	92,903	8,804	10,728	13,768	15,793	92,964	13,167	13,816	15,916	12,354		7,885	7,903	9,320	9,575					3,887
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			39,682	998	2,506	4,987	6,709	30,474	5,749	6,110	3,086	8,883	32,129	9,103	12,350	13,195	13,227	50,593	10,532	14,304	19,412	20,633	50,392	16,541	16,597	19,568	14,482		9,667	10,492	12,641	12,251					5,735
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												286,351					285,975				
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			31,920	444	1,072	2,112	3,132	19,290	4,672	5,367	3,258	4,730	47,521	6,697	8,755	7,845	7,500	72,750	6,126	8,208	9,805	11,528	72,771	9,778	10,616	11,340	8,977	103,415	5,979	6,623	7,968	7,310	103,041				3,673
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				192	553	1,310	2,364		2,692	3,013	1,512	2,639	56,454	4,048	5,386	5,914	14,959	85,687	5,396	6,630	8,553	9,958	85,755	7,668	7,890	8,562	7,365		4,557	4,507	5,195	5,465					2,246
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			11,810	800	2,278	8,004	9,781	19,641	6,584	9,439	3,584	10,602	12,020	13,175	16,808	17,361	16,795	21,185	15,182	19,490	23,272	26,605	20,980	21,153	21,885	23,927	17,889		11,367	12,539	14,154	15,238					6,239
South Africa	South Africa	ZAF	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			24,632																																		
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			753,421	166,187	214,698	216,847	273,382	1,082,200	233,025	254,019	150,418	223,298	492,592	188,277	205,848	220,739	237,651	734,084	194,085	213,649	206,699	243,746	1,142,098	204,334	215,140	202,685	214,286		210,508	222,901	225,245	362,222					250,556
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				40,417	50,252	62,619	70,702	390,462	57,397	68,216	37,330	48,240	441,218	48,891	56,650	60,305	60,473	184,957	52,378	64,989	70,911	82,381	145,692	73,641	86,351	85,289	82,339		72,816	82,247	96,053	140,361					93,329
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			380,377	91,618	114,303	165,511	130,722	522,729	90,328	109,365	49,254	70,749	828,111	62,871	75,436	79,212	79,038	343,855	66,085	82,447	92,312	107,142	241,580	91,144	98,328	106,998	109,348	789,822	83,883	98,697	129,658	160,286	507,339				120,925
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Female							1,680,568					1,378,296					1,687,615					1,960,004															
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	15+	Coarse	Male																											402,810					12					53
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												1,220,966					1,186,791				
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			421,851	124,384	120,264	166,610	181,805	408,280	164,217	168,432	82,001	123,942	160,916	125,692	120,953	127,767	116,701	391,588	118,714	117,687	130,010	137,111	215,423	136,607	124,618	132,119	132,247		124,426	122,791	132,948	200,249					119,584
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			613,434	287,981	393,526	451,215	603,930	885,508	473,118	508,436	311,754	449,322	611,748	381,862	414,217	444,089	494,476	593,400	378,487	426,255	414,745	500,699	597,835	406,499	418,144	388,492	404,841		413,461	435,925	432,134	687,527					482,080
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				102,959	126,197	125,071	141,771	854,646	135,180	143,705	81,558	125,113	404,567	103,782	111,569	118,984	123,006	610,480	101,457	115,350	113,152	129,409	1,210,056	113,445	123,125	116,007	124,290		119,762	125,115	127,738	211,358					139,974
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												860,137					1,387,234				
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				1		427	15		7	622	20	65		2	16	5	2					5															
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												724,087					681,210				
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			1,577,733																																		
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Male							1,159,606					611,509					832,053					750,072															
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				71,847	91,374	90,228	101,328	627,973	88,461	99,127	52,083	73,705	459,358	65,846	70,944	74,629	75,439	558,518	62,270	70,212	66,783	76,404	907,336	65,689	70,850	64,719	69,889		64,840	68,183	69,155	114,294					78,099
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			304,328	89,587	68,318	117,765	101,393	395,938	113,903	90,543	36,075	59,274	307,678	77,193	65,593	77,947	70,647	234,772	87,290	75,719	95,203	99,292	191,870	107,718	83,900	107,261	101,342		108,451	86,468	123,383	154,236					94,726
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			502,383																																		
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												723,328					520,834				
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			435,072																																		
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	<15	Coarse	Missing Sex																											180,444										1
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			445,508	89,622	125,890	139,030	149,830	1,106,373	133,563	144,823	84,504	106,235	458,726	109,134	108,676	113,418	113,134	569,270	99,211	111,019	106,435	113,194	1,086,527	111,137	114,171	113,044	123,523	1,140,507	113,322	121,389	124,606	213,395	652,976				150,738
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			444,218	166,515	192,883	249,548	299,278	496,756	262,524	274,611	181,188	268,055	299,324	232,661	280,110	293,318	321,226	382,256	254,494	286,690	298,937	362,857	318,501	306,672	316,942	325,018	351,317		315,699	333,887	343,906	517,797					339,311
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	15+	Coarse	Female																											1,219,463					6					54
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				15,588	8,750	6,907	8,907		7,791	6,111	1,364	2,303		394	1,253	2,982	3,325		3,021	3,465	1,824	2,066		2,288	2,316	2,417	1,283		669	946	622	495					65
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			1,035,370																																		
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				8,379	5,143	4,011	5,864		4,585	2,336	312	1,176		305	807	1,852	2,079		2,467	2,284	1,422	1,469		1,631	1,872	2,160	1,308		771	693	782	566					33
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			865,406	102,020	131,713	140,464	157,782	816,432	137,571	156,239	77,797	111,495	188,827	103,942	112,026	115,226	115,038	855,672	100,518	106,458	101,720	107,759	854,146	98,077	104,414	103,532	107,780		94,833	101,581	105,611	158,845					97,979
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												2,136,875					1,327,778				
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			765,140	128,235	156,295	168,089	198,871	470,860	171,786	193,578	96,571	138,318	708,368	129,004	137,795	144,817	141,206	792,453	121,859	131,307	130,816	138,231	533,501	126,111	130,913	129,561	134,087		117,634	123,826	130,518	192,954					113,091
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Missing Sex							241,948					105,160					174,065					252,943															
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				48,452	68,923	69,321	75,825	450,898	67,996	73,770	39,014	55,024	397,838	50,577	56,312	56,919	59,181	326,936	51,269	54,655	51,626	55,241	639,087	51,580	53,431	52,977	55,012		49,439	52,781	55,246	83,286					54,340
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				67,189	79,894	103,449	131,912	239,399	117,822	141,197	81,725	101,137	314,451	109,531	129,860	129,698	135,526	113,066	125,898	150,486	162,095	172,464	92,959	169,372	169,828	162,345	173,269		169,042	183,074	190,599	294,482					181,108
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												527,492					484,614				
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			544,531	138,915	154,740	195,028	222,860	399,026	190,697	208,535	96,906	142,132	188,510	154,195	139,664	149,213	143,817	621,766	126,275	135,154	138,416	145,435	326,384	134,876	137,187	135,121	138,735		123,129	128,378	133,177	203,065					120,797
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												3,171,119					2,085,788				
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			1,380,315	291,334	384,186	465,641	585,930	848,906	474,408	516,766	343,208	505,460	606,579	431,571	474,721	488,717	540,582	716,860	402,068	425,047	464,051	560,791	590,277	453,620	476,944	454,819	483,535		470,360	496,487	502,522	798,401					538,287
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								7		39	17		15	7	21	3					
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			269,133	141,001	185,190	198,813	220,111	1,447,449	194,343	207,754	117,769	155,978	1,359,686	147,125	156,214	158,925	158,854	1,142,885	135,326	157,461	152,499	165,681	2,100,589	162,243	163,673	157,355	181,049	2,010,922	163,342	172,107	171,579	313,057	1,279,545				232,004
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			775,419	230,127	305,573	330,634	428,889	1,015,350	349,739	383,991	239,694	348,292	738,845	292,618	323,532	335,428	379,343	581,808	287,389	326,550	320,652	383,322	852,825	319,306	329,964	306,422	321,826		326,456	339,836	343,101	544,359					369,179
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				67,959	94,411	94,585	107,862	617,699	94,262	105,255	55,561	79,949	420,812	73,842	78,502	81,950	85,095	586,054	72,503	76,408	73,538	79,297	895,768	72,347	78,494	77,143	80,821		71,785	76,364	81,111	121,036					74,462
South Africa	South Africa	ZAF	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex				1,210	5,258	6,432	6,424	1,783	9,663	9,625	6,748	5,288		5,339	3,844	1,449	2,796		3,077	5,403	5,148	4,311		2,890	3,734	3,273	3,051		5,302	3,620	3,678	5,736					2,090
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			59,816	9,132	10,478	11,586	12,622	35,319	9,309	10,042	5,182	6,183	12,993	6,091	6,279	6,042	5,297	40,798	4,762	5,429	4,806	4,764	19,944	4,605	4,622	3,987	3,941		3,881	4,187	3,468	6,422					3,501
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Male							50,194					48,922					41,378					36,592															
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Missing Sex							3,001					2,508					1,791					2,042															
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			28,390	7,040	8,730	8,402	9,704	108,415	8,068	8,372	4,090	5,584	69,617	4,442	4,776	4,499	4,216	93,012	4,044	4,690	3,947	4,431	112,283	4,263	4,604	3,712	4,022	89,046	4,006	4,267	3,737	7,895	58,458				4,941
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			44,912	4,980	5,113	5,511	6,361	26,413	4,440	4,192	2,593	3,181	6,418	2,901	3,046	2,761	2,281	22,701	2,172	2,562	2,216	2,160	10,131	1,984	2,071	1,674	1,818		1,773	1,999	1,544	2,855					1,500
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												29,766					33,162				
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				8,329	9,954	9,931	10,398	91,840	8,601	9,142	4,801	6,108	38,334	5,803	5,784	5,517	5,198	52,613	4,372	5,412	4,609	4,936	66,919	4,527	5,072	4,196	4,167		3,936	4,389	3,842	7,540					4,495
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			83,258	13,414	17,225	16,094	19,403	113,396	13,979	15,461	8,625	11,793	43,236	9,747	10,414	9,748	10,727	61,378	7,685	9,172	7,740	9,209	64,852	7,292	8,045	6,745	6,614		6,204	7,033	5,930	11,400					8,101
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												102,795					70,454				
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				5,244	6,437	6,258	6,840	67,241	5,441	5,873	3,336	3,598	35,724	3,570	3,687	3,532	3,383	44,855	3,074	3,550	2,948	3,274	50,258	3,032	3,235	2,628	2,663		2,545	2,820	2,455	4,864					2,840
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				4,435	6,109	5,788	6,972	49,724	5,680	5,918	3,269	3,516	37,334	3,627	3,949	3,752	3,481	26,489	3,527	4,025	3,488	3,605	38,179	3,475	3,666	3,068	3,208		3,084	3,440	3,014	5,594					3,439
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			86,119	21,178	29,277	27,650	34,235	76,851	23,360	26,184	14,827	20,632	22,999	15,428	16,800	15,325	19,954	29,978	12,283	14,037	11,733	18,248	25,216	10,771	11,704	10,069	9,823		9,458	10,766	8,922	16,862					16,841
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			93,042	10,118	13,125	11,568	14,782	86,927	11,741	12,760	7,056	7,733	20,031	7,683	8,479	8,285	7,829	60,999	7,251	8,235	7,292	7,442	55,488	7,209	7,500	6,201	6,572		6,044	6,767	5,811	10,700					6,028
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				6,806	9,210	9,362	10,411	66,605	8,533	8,913	5,004	5,431	44,966	5,641	6,052	5,754	5,304	43,031	4,905	6,121	5,181	5,407	55,975	5,297	5,732	4,811	5,040		4,731	5,129	4,600	8,735					5,208
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												33,327					32,829				
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			48,874	2,370	2,008	3,171	3,515	13,745	1,497	1,529	692	808	16,843	754	1,080	829	596	15,559	703	994	722	705	8,215	668	735	654	645	5,054	543	607	557	784	4,041				472
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												15,288					14,799				
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			98,887																																		
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			8,653																																		
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				1,222	1,111	1,098	1,180	2,600	1,148	1,205	602	607	3,940	596	671	593	543	5,394	605	728	602	585	3,460	653	687	540	513		508	684	598	862					494
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			97,667	18,596	24,982	23,192	29,148	101,407	20,163	22,008	12,878	17,494	58,806	13,405	14,539	13,421	15,837	46,327	10,457	12,512	10,455	13,373	48,831	10,013	10,677	8,803	8,734		8,036	9,203	8,062	15,447					11,941
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	15+	Coarse	Female																											44,643					3					28
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												142,694					90,424				
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			22,652	1,856	1,664	1,787	2,130	14,740	1,512	1,183	678	841	8,931	934	1,128	916	688	10,557	725	886	664	763	7,478	728	675	648	738		597	731	549	992					513
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			55,962	6,275	7,892	7,037	9,211	24,580	6,809	6,977	4,086	5,711	4,274	4,613	5,447	4,904	5,388	15,208	4,104	4,724	3,846	4,935	10,541	3,905	4,185	3,466	3,615		3,331	3,885	3,117	5,810					4,042
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	15+	Coarse	Male																											26,276					3					12
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			78,027	11,495	14,538	14,790	16,752	47,826	12,886	13,917	7,252	8,041	69,415	8,032	8,721	8,579	7,483	55,472	6,785	7,924	7,034	7,211	35,589	6,923	7,214	5,889	6,192		5,634	6,086	5,338	9,854					5,375
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			45,120																																		
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				670	460	261	177		291	194	47	54		37	121	131	208		138	166	114	98		101	119	106	105		107	90	118	86					
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex				74	118	390	256	31	311	330	135	131		99	38	44	29		56	83	68	45		40	31	33	35		59	55	40	46					36
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Female							75,427					78,425					60,849					59,723															
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												5,264					4,781				
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			158,157	17,516	23,390	21,601	27,627	55,297	18,996	19,924	11,851	16,851	18,158	12,487	15,587	12,608	15,273	30,639	9,703	11,176	9,057	12,656	22,441	8,348	9,260	7,971	7,883		7,449	8,522	7,151	13,987					11,230
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				333	207	154	97		221	139	36	66		49	62	149	166		140	146	117	97		109	137	95	106		98	97	90	71					12
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	Retired Age Band	Missing Sex						18				9	1																										
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			48,730	5,136	7,129	6,990	8,519	98,670	6,828	6,971	3,881	3,941	29,912	4,408	4,637	4,374	4,032	44,902	4,233	4,886	4,064	4,123	59,161	4,293	4,536	3,911	3,951	54,988	3,847	4,297	3,825	7,690	31,707				4,675
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	<15	Coarse	Missing Sex																											1,309										1
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			156,363																																		
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												37,280					51,001				
South Africa	South Africa	ZAF	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				956	1,099	968	997	6,744	869	948	434	387	7,551	457	491	416	420	8,896	467	475	416	480	5,460	444	450	384	356		296	431	340	567					307
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				10,288	12,549	10,637	24,825	43,386	9,608	12,158	10,119	24,076	39,916	10,920	12,388	10,086	23,113	47,735	9,276	11,278	9,645	30,413	43,382	9,617	10,143	8,309	20,342		7,973	8,820	7,973	25,957					18,774
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female				489	443	236	135		139	276	143	171		2	25	6	5		23	23	6	1				2					2						
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				1,054	1,386	921	1,129	395	1,053	1,406	1,113	3,828	1,059	44	115	109	244	868	67	84	47	2,915	446	20	233	34	22	675	19	17	6	971					3,155
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	60-64	50+	Female																															3	491					
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																								3			1				2	499					
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												32,166					22,345				
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				10,361	10,980	9,687	26,344	45,243	10,055	11,904	10,137	21,310	32,141	12,163	11,908	10,539	23,533	29,041	9,404	10,672	8,715	21,441	40,823	8,252	8,582	7,205	14,357		6,574	7,572	6,855	15,287					11,816
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				12,628	15,061	13,321	30,719	61,706	12,296	14,754	12,752	28,782	46,238	14,626	14,126	12,392	28,877	48,720	11,423	14,021	11,535	32,636	51,704	11,316	11,570	10,241	21,760		9,838	10,589	9,339	24,273					17,538
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				6,394	7,881	6,660	13,200	22,576	5,919	7,553	6,219	15,101	21,541	6,787	7,643	6,441	14,001	30,955	5,703	6,364	5,654	20,475	24,436	5,245	5,925	4,974	14,338		4,971	5,035	4,762	18,628					13,792
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																															1	776					6
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												63,110					41,704				
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								9	26	23	19		12	22	17	1,100					12
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				2,026	2,616	2,047	2,605	3,453	1,838	2,694	2,072	5,414	3,756	1,728	1,927	1,649	3,210	5,712	1,363	1,486	1,271	6,805	3,709	1,132	1,486	1,468	5,639		1,379	1,437	1,358	7,407					5,880
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				3,883	3,464	3,060	8,472	14,185	3,554	4,301	3,456	6,754	9,179	4,042	3,819	3,423	7,517	5,827	3,182	3,225	2,463	6,238	13,119	2,597	2,614	2,366	4,465		1,987	2,434	2,194	4,580					3,512
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				767	939	655	870	3,454	635	1,040	692	1,744	2,627	157	183	194	328	5,713	137	219	175	1,895	615	160	295	307	1,915		156	163	150	2,258					1,855
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				147	97	65	343	676	173	74	59	62	509	56	47	55	66	274	79	111	22	132	191	56	67	76	35	260	39	63	33	209					176
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												112,455					75,288				
South Africa	South Africa	ZAF	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex				60	30	106	2		11	40	3					1									1					9	6						
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			326,985	45,140	51,651	49,859	149,700	238,773	44,683	56,483	47,717	117,982	238,775	51,952	54,570	49,274	123,846	238,778	46,098	53,515	46,798	127,680	237,486	44,793	48,062	43,455	45,053		41,061	46,589	41,821	44,537					110,412
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				1,426	1,128	739	443		481	1,408	547	926		47	89	68	556		28	28	28	52		3	3	6	3		1	3	4	6					
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				8,309	10,121	8,576	9,037	12,661	8,223	9,830	8,641	25,373	12,659	5,837	6,523	5,696	12,760	12,659	4,974	5,715	4,634	11,099	13,681	4,180	5,517	5,128	4,823		4,503	5,121	4,890	5,047					10,368
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			245,138	41,476	46,987	44,767	116,494	187,038	39,937	50,490	41,885	100,342	187,045	50,117	53,149	48,085	121,797	187,056	43,215	48,656	43,483	115,428	188,707	41,456	44,989	40,286	40,629		38,647	42,740	40,024	42,161					98,092
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				4,561	5,006	4,295	3,444	12,658	3,493	3,975	3,507	10,998	12,660	632	712	840	1,917	12,671	553	1,030	620	1,180	4,625	544	963	1,120	819		527	695	663	566					873
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			101,448	21,715	26,283	23,244	51,615	77,686	21,683	26,876	22,884	60,725	77,693	20,243	24,067	20,876	48,290	77,695	19,346	22,264	18,994	47,875	79,313	18,288	20,545	18,325	18,754		17,476	18,556	17,039	17,922					41,953
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			202,845	33,916	41,211	36,817	98,189	153,713	34,543	43,833	37,295	95,532	153,720	36,674	41,730	35,932	86,752	153,728	33,542	38,879	34,517	87,910	156,696	34,029	36,480	30,805	31,809		29,769	32,616	30,218	32,374					77,261
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												394,193					331,277				
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												97,638					89,812				
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				3		478	17		7	659	20	65		2	16	5	2					5		7		39	17		15	5	27	3					
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			1,778	5,407	6,188	5,171	4,686	2,323	5,097	4,733	4,390	15,780	4,116	167	271	379	601	4,120	183	348	218	317	4,116	159	942	380	324	4,118	244	202	211	152					490
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			2,301	612	488	930	652	2,844	412	427	318	712	3,252	170	413	313	776	3,256	283	484	327	858	3,253	460	645	691	544	3,255	662	495	465	336					774
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			34,193																																		
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			77,481	17,923	18,834	18,690	36,119	67,129	16,357	21,148	17,269	39,507	67,132	21,418	22,674	20,717	55,506	67,129	19,715	21,004	18,844	52,322	69,172	19,031	21,027	19,563	19,963		18,780	21,176	19,633	20,772					45,781
South Africa	South Africa	ZAF	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												257,885					237,064				
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			7,673																																		
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												63,110					42,044				
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												112,455					75,789				
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				1,088	1,140	986	678	3,420	761	929	729	1,907	3,015	168	179	214	394	5,793	138	215	167	262	615	159	300	313	162		145	167	144	136					193
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			425	1,479	1,633	1,352	1,137	462	1,300	1,185	1,116	4,117	1,029	45	68	107	131	878	71	82	50	32	448	35	262	58	40	675	29	40	32	30					66
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			23,647	3,537	3,216	2,905	8,276	14,432	3,143	4,265	3,341	6,330	9,159	3,900	3,718	3,319	7,403	5,877	3,207	3,397	2,514	5,870	13,164	2,662	2,650	2,435	2,337		2,179	2,474	2,207	2,315					5,499
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex				2		69	2			46	1																				6						
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female				324	430	236	135		139	276	143	180		2	23	6	12		23	23	6	2				2					2						
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			60,964	10,165	12,410	10,492	25,072	44,291	10,093	12,348	10,462	25,089	39,916	11,071	12,260	10,189	23,129	48,337	9,165	11,040	9,297	22,330	43,581	9,267	9,756	7,880	7,986		7,526	8,400	7,596	8,316					24,619
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			68,343	10,106	10,898	9,443	26,896	45,960	9,574	11,961	10,153	21,506	32,122	12,295	11,980	10,401	23,774	29,329	9,449	10,757	8,702	21,098	40,953	8,325	8,647	7,229	7,360		6,674	7,583	6,833	7,364					19,778
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			1,033	107	76	119	183	1,049	58	60	47	43	519	23	33	15	16	277	82	115	17	43	191	55	68	81	35	260	76	70	32	24					17
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				2,270	2,628	2,218	2,525	3,416	2,030	2,631	2,181	5,768	4,321	1,916	2,078	1,857	3,632	5,784	1,427	1,639	1,300	2,873	3,723	1,158	1,530	1,487	1,337		1,347	1,497	1,364	1,385					3,726
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												32,166					22,462				
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			78,660	12,423	14,459	12,865	31,796	63,155	12,043	14,834	12,712	28,856	46,238	14,479	14,351	12,371	29,392	49,079	11,543	13,628	11,885	32,320	51,849	11,637	12,018	10,663	10,969		10,165	10,987	9,638	10,562					33,542
South Africa	South Africa	ZAF	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			30,067	6,494	7,923	6,618	13,342	22,897	6,199	7,560	6,358	15,631	21,947	6,846	7,691	6,721	14,556	31,397	5,778	6,583	5,669	13,348	24,552	5,271	5,959	4,962	5,132		4,886	5,145	4,765	4,915					14,542
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			8,626		3,977		5,723	8,449		2,980		3,831	2,428		1,036		2,937	2,885		1,750		1,944	2,547		2,958		1,976			2,756		2,445					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					2,436		3,494	4,622		1,611		2,194	1,044		655		2,142	2,421		1,174		1,410	1,667		1,831		1,717			2,198		1,810					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												11,201					11,195				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			1,209		3,262		2,850	4,148		1,571		1,380	165		558		1,116	1,111		586		677	108		1,494		1,610	862		1,623		1,502	620				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			1,104		1,852		2,478	4,093		891		1,014	44		432		436	1,111		388		295	112		644		1,095	421		903		1,401	424				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					1,847		2,581	4,465		1,242		1,618	910		604		1,487	1,811		840		985	1,014		1,319		1,132			1,521		1,186					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			38,294		13,767		14,605	25,883		6,287		11,384	14,081		4,074		5,396	16,794		3,266		4,553	21,743		4,351		7,727			5,404		5,992					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			14,712		6,075		7,920	13,849		4,051		5,314	3,428		1,403		4,031	3,264		2,223		3,040	2,887		4,545		3,704			3,452		3,091					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					1,550		2,443	4,688		731		1,316	618		567		273	2,876		620		735	1,896		801		1,109			1,186		1,346					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			10,860		4,516		6,419	8,314		2,523		4,384	2,262		1,745		1,366	7,043		1,505		1,849	6,174		2,092		2,663			2,610		2,953					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					2,353		3,330	4,715		1,279		2,151	622		1,098		968	3,578		1,035		1,279	2,700		1,369		2,052			1,978		2,145					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			34,446		18,740		20,556	44,558		13,178		20,814	14,319		8,917		21,438	17,362		12,146		22,786	18,628		11,432		24,270			11,306		19,013					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												6,465					5,818				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												15,385					11,564				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female					22					18					78		168			27		10,889			119		6,011			1,154		10,928					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			5,385																																		
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			24,788		9,543		9,212	20,295		4,015		6,843	10,662		2,810		3,394	14,001		2,209		2,776	15,055		3,172		4,345			4,009		4,344					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male							3			520		1			127		161			30		13,220			109		5,235			828		9,890					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			172,632		102,880		149,658	211,623		152,802		102,477	368,748		104,275		346,207	289,849		212,212		253,681	288,125		105,680		216,401	291,130		152,425		200,141	285,955				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			63,177		36,469		27,407	48,052		15,259		24,568	278,897		46,281		141,524	216,986		39,832		91,692	222,323		50,993		125,248			56,025		111,670					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			96,899		39,095		74,337	109,516		54,274		50,394	89,615		22,981		113,436	99,528		52,603		90,803	100,446		43,109		110,192			38,494		77,220					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												391,243					403,127				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												123,132					127,601				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			177,134		52,518		93,191	186,432		60,188		68,320	237,791		56,110		249,579	171,421		93,982		153,113	173,391		91,010		164,927			75,855		139,558					
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												34,540					31,031				
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			4,672																																		
South Africa	South Africa	ZAF	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			34,975		17,271		16,991	20,274		6,851		12,649	6,617		3,720		8,547	7,612		3,927		6,444	6,810		7,440		11,291			5,975		7,260					
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			2,900	2,894	2,890	3,233	2,793	3,355	3,852	4,109	4,327		4,893	5,160	4,826	5,145					2,612
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			901	864	1,022	1,251	303	1,319	1,559	1,774	2,042		2,593	2,964	2,968	3,184					1,946
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			12,082	11,969	13,955	17,981	38,376	17,482	19,413	22,307	24,888		29,149	30,736	29,874	31,597					19,740
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			443	748	716	832	2,208	807	967	1,368	1,423		1,454	1,419	2,076	1,925					1,191
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			2,717	2,827	2,893	3,175	2,793	3,366	4,003	4,049	4,598		5,272	5,613	5,457	5,891					3,066
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			6,705	6,442	7,415	9,441	2,952	9,880	11,130	12,506	14,532		18,425	20,272	19,288	21,021					13,989
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												5,574					12,329				
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			4,496	4,405	5,010	6,273	571	6,724	7,673	8,405	9,644		12,951	13,966	14,261	15,338					10,493
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																			1	385																	
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												5,534					16,451				
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			805	789	907	1,039	1,100	1,130	1,306	1,450	1,711		2,018	2,137	2,237	2,464					1,482
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												3,761					9,958				
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			2,978	2,842	3,220	4,077	454	4,485	5,076	5,560	6,458		8,558	9,407	9,682	10,559					6,943
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			846	836	958	1,195	290	1,333	1,594	1,779	2,061	2,635	2,664	3,074	3,039	3,354	2,840				2,347
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												69,407					102,698				
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												2,927					13,321				
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																				455									14								
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			1,930	2,029	2,071	2,315	2,887	2,367	2,752	2,911	3,219		3,573	3,899	3,747	3,988					2,058
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			1,199	1,271	1,458	1,662	1,100	1,854	2,203	2,376	2,659		3,125	3,520	3,574	3,738					2,167
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			8,123	8,635	11,254	14,252	26,125	12,828	12,909	16,561	17,888		18,620	17,539	18,910	19,825					11,876
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			1,084	1,169	1,307	1,466	1,217	1,605	2,082	2,230	2,638	1,934	3,193	3,483	3,585	3,973	3,219				2,382
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			1,514	1,470	1,710	2,160	303	2,370	2,793	3,201	3,787		4,814	5,440	5,659	6,129					3,993
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			2,046	2,100	2,211	2,494	1,759	2,608	3,077	3,346	3,869		4,469	4,859	4,668	4,959					2,791
South Africa	South Africa	ZAF	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												6,492					26,564				
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					312		1,155	510		1,570		3,864	5,693	5,155	9,764	12,357	16,631	4,241																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female							2			2		40		2	14	10																					
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					602		887			12		724			65	65	64																				
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					232		379	196		536		1,469	4,096	1,539	3,193	4,819	5,446	3,602																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					193		397	305		440		941	1,603	1,226	2,196	3,419	4,461	1,098																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					57		267	103		611		1,198	2,116	1,305	2,532	3,332	4,498	1,944																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					133		192	103		639		944	2,119	1,129	1,922	2,632	3,336	1,919																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					393		847	516		1,284		2,907	5,569	3,619	7,323	9,598	13,178	4,241																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					485		787	307		958		1,890	2,408	2,271	4,424	6,857	9,011	1,646																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					34		161	104		417		782	2,116	706	1,388	1,915	2,592	1,944																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					1,333		2,656	1,582		2,961		5,802	8,389	7,129	15,297	23,705	30,329	2,991																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					1,844		5,187	42,489		8,118		19,224	82,712	12,318	32,175	54,974	68,854	81,249																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					714		1,296	402		1,747		4,400	5,486	4,492	9,013	12,037	15,572	4,579																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					817		1,539	1,591		1,794		3,448	2,408	3,885	7,512	11,581	15,177	1,981																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					85		205	305		257		546	1,603	748	1,389	2,116	2,693	1,098																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					2,977		7,783	63,416		9,970		23,389	123,926	16,336	42,178	67,171	82,880	120,601																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					72		129	305		212		414	1,539	805	1,442	2,086	2,566	1,095																			
South Africa	South Africa	ZAF	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					119		542	130		908		2,086	3,173	2,816	5,040	6,450	8,970	3,231																			
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			1,814		1,026		2,130	3,264		2,265		2,566	8,132	3,738	6,725	6,860	6,632	2,633	5,103	5,829	6,116	7,689	8,969	7,109	7,021	7,839	9,375		10,501	11,324	8,464	9,395					8,431
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			1,296		492		1,405	2,079		1,548		2,106	5,327	2,531	4,433	4,065	4,087	4,075	3,229	4,132	4,149	4,324	7,541	4,460	5,391	5,818	6,439		6,280	6,703	5,104	5,940					3,517
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			8,799		2,696		7,654	56,085		8,479		12,718	122,228	7,829	24,887	23,238	20,663	116,283	13,530	20,836	21,910	28,708	116,328	16,778	25,109	26,576	31,894		21,946	26,545	21,020	22,417					13,590
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female							2			2		1			2														30								
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												210,620					307,074				
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			322		35		206	733		300		327	2,029	493	601	646	604	1,042	528	701	752	782	2,923	1,002	888	915	1,012	6,394	1,185	1,212	1,089	1,222	5,026				830
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												19,557					35,316				
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			937																																		
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			649																																		
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												19,956					63,422				
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					129		352	634		302		377	1,467	573	785	982	923	941	813	898	902	1,347	919	1,258	1,247	1,328	1,524		1,982	2,040	1,698	2,065					1,481
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												19,208					49,460				
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			1,814		569		1,160	3,254		1,315		1,370	2,198	1,837	3,017	3,481	3,259	1,673	2,842	3,157	3,522	4,504	1,732	4,325	4,137	4,579	5,551		7,137	7,036	5,783	6,670					5,899
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												14,594					25,866				
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					25		181	733		219		359	2,030	320	540	515	633	1,656	471	667	579	634	2,537	681	694	740	794		903	1,016	850	975					565
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					146		22			5					12				2		1			7													
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			970		104		540	2,148		573		1,001	3,042	1,104	1,788	1,598	2,054	2,793	1,611	2,120	1,904	2,100	4,140	2,046	2,228	2,097	2,406		2,686	2,810	2,425	2,745					1,603
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												9,178					27,685				
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					47		275	2,033		320		563	2,029	622	945	896	952	1,656	874	1,121	1,065	1,196	2,537	1,262	1,264	1,185	1,325		1,677	1,774	1,524	1,656					988
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			6,383		1,811		5,165	38,086		7,270		10,616	81,533	6,997	20,218	22,872	21,693	78,229	15,352	22,864	26,526	34,141	79,204	21,229	32,113	35,904	42,224		21,397	26,046	21,031	23,614					14,696
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			1,376		313		604	635		681		724	2,198	1,098	1,644	2,070	1,877	1,353	1,548	1,824	2,113	2,651	1,379	2,502	2,415	2,594	3,207		3,858	4,094	3,376	4,001					3,404
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			1,296		168		835	3,217		913		1,635	5,406	1,878	3,103	2,995	3,527	3,753	2,435	3,122	2,935	2,976	7,257	3,073	2,955	3,293	3,537		3,895	4,018	3,328	3,830					2,047
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					61		223	633		167		197	1,467	357	498	591	516	941	436	487	509	761	919	699	620	669	773		941	991	824	869					592
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			1,296		274		1,154	2,483		1,249		2,092	5,531	2,619	4,070	3,579	4,007	3,753	2,990	3,858	3,700	3,782	7,257	3,873	3,784	3,944	4,562		4,921	5,129	4,097	4,605					2,424
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			497		66		104	633		148		148	1,414	380	463	506	485	885	421	422	521	684	880	729	632	668	815	8,071	971	990	863	984	6,274				634
South Africa	South Africa	ZAF	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			650		235		390	1,307		430		687	3,989	1,130	1,815	2,046	1,638	3,239	1,644	2,452	2,625	2,374	5,842	3,104	5,135	5,245	5,775		4,346	4,893	3,769	3,649					3,598
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																																798					566
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			42,233																																		
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				1,626	2,013	1,762	1,480	6,271	1,618	1,507	886	869	2,541	1,092	958	1,056	950	7,085				5,844	6,727				4,822					4,057					2,269
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				1,124	1,347	1,306	1,195	5,407	1,163	1,162	618	630	1,918	798	712	768	771	4,278				5,648	4,266				4,546	5,162				11	5,846				
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				294	372	285	177	1,733	229	246	126	136	129	255	196	263	210	945				916	977				661					583					321
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				171	195	162	166	1,597	190	183	75	138	372	307	175	229	202	819				734	924				397					345					187
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				761	911	816	810	2,636	775	699	397	386	1,152	536	479	541	513	3,014				3,612	3,058				3,116					2,594					1,409
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			46,650																																		
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																																1,788					1,108
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												2,919					3,686				
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											673					679					486
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																																943					704
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												23,175					24,669				
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				48	65	63	26	756	82	29	26	38		136	15	18	22					169					95					85					57
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				153	134	131	128	2,398	151	83	76	57	428	150	50	92	76	1,383				514	1,396				418					327					152
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				1,627	2,104	1,952	1,914	7,476	1,772	1,801	1,009	964	1,434	1,135	1,096	1,205	1,109	6,032				8,077	6,081				6,579	7,249				41	7,968				
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				1,877	2,247	2,006	1,798	8,210	1,869	1,737	954	981	4,277	1,170	1,009	1,071	1,080	8,361				5,823	7,685				4,524					3,905					2,369
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				1,047	1,258	1,184	1,035	3,594	991	988	569	588	1,585	717	656	767	671	4,315				4,627	4,202				4,116					3,499					1,994
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											869					760					542
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				1,989	2,442	2,267	1,961	7,474	2,097	1,949	1,151	1,099	2,683	1,430	1,270	1,390	1,501	8,564				8,269	8,081				6,596					5,798					3,419
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				191	220	198	163	505	168	133	98	83	254	264	110	185	141	539				639	577				455	597				371	605				176
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				378	411	335	365	3,296	354	356	187	284	404	553	390	356	420	1,585				1,473	1,681				940					855					530
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male				1		2			6	20	3	2										1										5					
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												15,096					17,346				
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			3,702																																		
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																																1,140					819
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				1,945	1,138	968	910	5,689	907	906	451	506	1,362	801	739	756	575	4,220				2,959	3,825				1,969					1,862					1,121
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												2,115					2,281				
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				855	1,007	765	659	1,739	657	658	349	374	368	593	490	468	499	1,630				2,326	1,640				1,748					1,546					942
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																																1,797					1,087
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											1					2,870					1,841
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												12,812					14,695				
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				86	111	113	101	2,187	123	120	60	48	230	186	101	96	86	849				630	904				407					399					189
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				1,636	2,020	1,872	1,653	5,804	1,719	1,713	1,011	1,002	2,809	1,117	1,027	1,172	1,101	7,004				6,957	6,696				6,153					5,632					3,244
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												15,361					16,761				
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				1,197	1,409	1,427	1,302	4,116	1,362	1,261	703	696	2,054	879	789	864	810	4,799				5,834	4,641				4,767					4,167					2,497
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				1,308	1,564	1,552	1,408	4,517	1,382	1,369	813	796	1,891	1,054	876	1,038	1,005	5,443				5,960	5,411				5,189					4,152					2,397
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female				1		11	1		1	11		2			1																	3					
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				1,368	2,048	1,473	1,170	6,318	1,282	1,271	707	730	1,149	876	803	942	829	6,385				4,370	5,718				3,462					2,889					1,663
South Africa	South Africa	ZAF	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												2,717					2,597				
South Africa	South Africa	ZAF	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			191,633		25,412		42,522	265,389		49,482		56,263	234,631		58,922		50,368	256,256		58,551		55,657	214,204		51,690		54,555	162,752		45,565		44,076	154,912				19,380
South Africa	South Africa	ZAF	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female					35							2																		1							1,014
South Africa	South Africa	ZAF	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male					30																																771
South Africa	South Africa	ZAF	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			369,065		43,946		80,019	453,949		109,956		118,253	376,090		120,407		98,594	382,658		112,780		111,356	346,007		97,208		102,368	291,774		82,132		80,479	306,676				31,299
South Africa	South Africa	ZAF	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			17,426		455		1,117	18,951		1,071		1,465	30,534		1,232		949	27,419		1,107		1,097	17,428		931		889	12,953		772		1,819	16,060				777
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				1,952	2,176	2,055	1,973	6,610	1,929	1,902	1,187	1,205	6,404	1,558	1,343	1,486	1,525	7,035	1,754	1,916	1,797	2,174	7,376	2,007	2,048	1,819	2,152		1,943	1,965	1,461	1,820					1,123
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				1,202	1,349	1,199	1,193	3,964	1,170	1,051	577	639	3,838	817	755	838	814	4,130	1,081	1,195	1,072	1,320	4,331	1,301	1,172	1,125	1,250		1,232	1,149	943	1,150					616
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				827	915	915	956	5,277	1,007	944	451	315	5,166	553	557	772	702	5,134	962	1,161	1,224	1,100	5,402	1,007	1,068	1,037	1,066		946	851	823	867					407
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				1,544	1,612	1,479	1,506	5,275	1,345	1,496	730	971	5,117	1,370	1,083	1,155	1,327	5,329	1,153	1,266	966	1,249	5,584	1,266	1,149	1,038	1,362		1,198	1,150	896	1,227					764
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												18,898					20,398				
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				3,542	3,654	3,430	3,294	13,278	3,176	3,127	1,640	1,930	12,859	2,430	2,011	2,159	2,259	13,231	2,583	2,840	2,513	2,933	13,885	2,826	2,792	2,480	2,968		2,711	2,531	1,965	2,666					1,630
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				973	1,161	1,088	735	2,635	765	825	422	487	2,556	687	631	738	670	2,851	619	797	620	667	2,993	760	739	695	821		740	746	627	798					547
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				629	613	621	571	1,279	546	471	250	297	1,243	524	367	482	514	1,486	248	441	417	491	1,575	505	469	489	439	1,714	474	454	333	466	1,833				304
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			69,937																																		
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												25,451					27,484				
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			10,076																																		
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				1,478	1,729	1,570	1,465	5,284	1,436	1,384	799	868	5,126	1,114	939	1,124	1,050	5,512	1,281	1,525	1,400	1,588	5,783	1,488	1,554	1,495	1,696		1,597	1,532	1,211	1,570					940
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												7,054					7,610				
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				2,345	3,430	2,411	2,016	9,294	2,064	2,080	1,147	1,255	9,004	1,614	1,492	1,609	1,490	9,236	1,601	1,820	1,539	1,799	9,689	1,738	1,746	1,530	1,848		1,661	1,695	1,170	1,569					1,036
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												11,147					9,869				
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												9,062					9,772				
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female				11	3	11	6		11	60		4			5		12																				
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				258	342	259	153	2,596	283	143	99	142		155	84	83	134		294	216	303	149		189	107	106	175		248	165	137	255					105
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				2,690	3,120	2,823	2,679	9,274	2,710	2,791	1,507	1,573	8,980	2,001	1,704	1,936	1,915	9,869	2,475	2,780	2,434	2,847	10,356	2,709	2,866	2,603	3,188		2,950	2,895	2,206	3,004					1,876
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				3,390	3,799	3,504	3,245	11,937	3,261	3,183	1,756	1,905	11,560	2,543	2,198	2,405	2,714	12,271	3,134	3,358	2,933	3,497	12,885	3,330	3,320	2,894	3,694		3,259	3,148	2,375	3,259					1,914
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				3,172	3,634	3,471	3,067	7,949	2,867	2,960	1,503	1,563	7,696	2,207	1,962	2,192	2,096	9,147	2,637	3,209	2,920	3,291	9,602	3,355	3,150	3,042	3,388	10,383	3,126	3,096	2,552	3,187	11,201				2,285
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				624	513	524	483	5,302	532	416	259	195	5,158	241	198	332	361	4,650	371	437	402	413	4,901	517	475	470	475		440	455	383	439					223
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				2,064	2,409	2,225	2,259	6,614	2,189	2,206	1,116	1,253	6,408	1,590	1,362	1,613	1,522	7,210	2,174	2,314	2,042	2,315	7,569	2,197	2,239	1,953	2,454		2,250	2,215	1,735	2,147					1,380
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				4,816	5,528	5,164	5,159	11,940	4,710	4,951	2,640	2,468	11,563	3,509	3,086	3,449	3,430	13,977	4,438	5,183	4,572	5,064	14,684	5,239	5,338	4,905	5,592	15,866	5,156	5,188	4,082	5,263	17,125				3,341
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				1,835	2,124	1,785	1,545	2,630	1,409	1,499	846	917	2,552	1,266	1,138	1,110	1,257	3,361	1,115	1,323	1,100	1,226	3,529	1,251	1,234	1,209	1,231		1,198	1,229	855	1,235					736
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				8	1	3	2		8	73	5	2			2	2				3																	
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				2,919	2,666	2,322	2,312	9,277	2,184	2,243	1,172	1,359	8,987	1,949	1,935	1,824	1,722	9,219	1,822	1,965	1,642	1,983	9,676	1,958	1,825	1,709	2,069		1,869	1,798	1,340	1,966					1,176
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				777	792	756	683	2,628	651	689	296	410	2,546	757	513	616	622	2,665	542	589	532	610	2,795	653	652	625	726		638	661	535	767					458
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			64,772																																		
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												21,072					22,742				
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												33,287					35,933				
South Africa	South Africa	ZAF	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				2,410	2,820	2,424	2,230	9,274	2,298	2,215	1,260	1,321	8,993	1,738	1,503	1,617	1,564	9,346	1,921	2,083	1,785	2,184	9,808	2,045	2,073	1,776	2,147		1,880	1,907	1,440	1,881					1,176
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												226,690					225,321				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female				190			255					1			8	1	2		1	1				1		1	2		2		6	74					
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												1,518,972					1,520,797				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<15	Coarse	Missing Sex																											21,072										
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			135,661	40,965	44,441	46,906	49,219	97,392	50,260	56,328	49,196	48,585	70,025	48,505	50,200	50,487	50,378	75,711	48,843	49,576	49,345	61,906	69,065	49,113	49,052	48,817	49,412		48,398	48,363	47,641	59,694					52,754
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			223,674	210,934	243,461	312,592	274,376	256,435	263,046	266,800	271,630		273,324	281,463	287,248	365,687					382,596
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			158,080	144,354	164,937	209,981	193,857	168,561	173,935	178,023	183,222		186,276	190,555	193,128	247,937					266,556
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male							327,081					332,346					342,425																				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			186,380	56,832	63,227	63,899	66,010	142,170	64,052	71,676	60,621	57,891	137,535	57,373	58,930	58,002	57,571	132,783	55,555	55,544	54,967	64,972	98,058	52,756	50,954	50,587	50,166		48,649	48,630	47,530	58,393					53,117
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				146,622	157,168	166,354	174,517	195,517	177,681	180,347	183,088	184,792	222,872	188,530	198,693	203,321	207,830	228,226	207,807	213,211	214,707	261,725	253,366	216,721	219,329	221,335	224,524		223,627	225,988	226,961	279,173					273,769
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												88,714					95,957				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			827,806																																		
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												235,174					224,418				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			412,915	172,860	188,133	194,476	202,678	341,510	201,614	209,071	201,266	200,745	326,326	201,942	209,506	212,197	213,491	309,099	211,134	213,323	212,170	252,955	299,711	207,687	206,093	204,598	204,535		199,328	197,778	194,990	234,548					209,469
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				180,197	190,881	198,392	207,197	261,990	208,747	212,510	209,266	209,372	294,456	211,232	216,248	217,409	218,085	283,179	216,724	222,908	224,505	273,425	296,487	227,779	231,433	233,832	237,357		235,786	238,095	238,260	290,358					278,814
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				323,704	338,431	354,793	368,427	449,850	377,057	378,742	382,269	387,729	461,620	392,519	402,745	407,311	411,953	473,383	411,091	425,184	430,639	539,612	494,282	443,659	454,028	460,725	470,198		472,307	478,657	483,116	600,961					600,296
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Female							640,818					644,516					679,745																				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			54,368	23,916	25,623	26,794	27,952	38,457	28,518	28,287	28,924	29,038	44,305	29,274	30,640	30,666	30,946	48,061	29,964	30,552	30,826	38,550	43,641	30,047	30,348	30,596	30,609		30,073	29,949	29,553	37,306					33,719
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15+	Coarse	Male																											287,776										
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			88,447	83,388	97,894	127,419	120,777	103,905	108,077	111,275	114,237		117,094	121,639	125,222	163,108					175,750
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												819,386					810,527				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			732,084																																		
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				32,440	33,200	33,708	34,071	47,384	33,471	34,842	31,381	30,397	51,379	29,710	29,724	29,026	28,267	46,217	26,529	26,439	25,575	32,349	38,727	24,031	23,316	23,005	22,433		21,604	21,042	20,388	25,977					23,247
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												43,782					40,568				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				14,520	14,306	14,460	14,387	20,703	14,141	16,268	12,654	11,907	22,910	11,570	11,650	11,451	11,220	21,706	10,552	10,599	10,466	13,265	17,957	10,056	9,804	9,747	9,691		9,460	9,417	9,290	11,922					10,663
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			420,269	267,773	282,463	301,179	313,306	403,355	314,762	338,988	300,901	299,756	389,528	296,573	302,049	303,469	301,901	344,612	292,648	291,814	287,111	350,037	333,440	277,431	273,611	270,066	268,290		259,051	253,369	248,594	304,148					269,993
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			55,120	51,703	60,044	76,454	63,719	63,199	65,754	67,521	69,359		70,713	73,592	75,835	96,577					102,621
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			94,875	87,497	99,297	123,750	109,649	101,513	105,137	107,710	110,758		112,065	114,982	116,957	147,981					160,338
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			141,420	53,910	56,840	58,052	58,950	74,808	58,204	57,441	54,826	53,680	86,416	52,111	52,151	51,091	50,404	81,320	48,313	47,938	46,802	58,507	65,602	44,719	43,883	42,993	42,114	53,562	40,657	39,981	39,517	50,050	48,660				45,753
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			95,903	21,202	27,057	24,136	26,046	70,001	26,084	29,179	26,423	26,104	64,387	26,865	28,662	28,622	29,609	68,032	29,172	30,421	30,869	38,761	50,830	31,305	30,645	31,045	31,437		31,165	31,963	31,836	40,671					39,463
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			584,920	388,177	409,311	431,556	448,534	562,568	454,168	459,201	457,296	463,705	567,513	467,686	483,420	491,950	498,921	563,685	497,110	503,837	504,488	620,221	577,972	502,320	503,071	504,808	508,178		501,694	502,065	500,408	615,483					585,141
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			72,314	65,899	79,526	104,411	112,379	84,635	88,819	92,528	96,223		99,235	103,286	106,922	141,011					160,274
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			12,288	2,315	2,265	2,399	2,346	1,095	2,295	4,741	1,954	1,762	2,593	1,755	1,631	1,571	1,600	2,256	1,544	1,310	1,302	1,692	2,710	1,265	1,099	1,158	1,181	1,260	1,118	939	904	883	1,014				1,129
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				235,007	250,300	264,547	275,909	330,809	282,380	284,377	291,762	298,805	351,242	305,672	319,938	328,673	336,877	373,067	340,456	349,035	353,494	442,602	395,848	359,435	364,993	369,254	375,609		376,699	382,384	386,754	486,703					494,204
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			339,305	126,979	140,435	142,146	147,694	190,172	145,082	155,543	139,498	136,235	247,113	135,108	137,356	136,172	134,059	236,136	129,613	130,827	128,541	151,425	199,195	122,747	119,687	117,272	115,778		111,674	109,729	107,487	128,273					109,206
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			245,526	372,166	391,522	419,266	437,697	532,683	451,099	449,982	477,213	489,835	563,935	503,239	520,649	531,751	541,050	648,170	4,531	67,675								741,819					781,506				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												763,116					726,401				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			584,804	379,051	399,056	418,796	434,602	511,466	439,876	456,950	429,224	430,071	544,490	429,860	438,876	439,482	438,733	501,925	430,007	435,536	433,294	531,407	498,286	426,929	425,226	422,108	420,884		412,983	410,446	407,580	497,674					455,383
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			217,129	230,593	250,578	259,042	271,382	388,043	278,379	279,424	295,095	301,681	340,463	310,060	322,443	329,346	334,452	376,439	2,480	39,320								458,260					471,063				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			437,163	125,568	134,300	142,344	149,708	221,395	149,856	168,651	141,255	139,603	217,247	137,560	140,940	140,145	138,165	192,907	132,192	131,597	129,012	158,019	177,515	124,451	122,653	120,844	120,151		116,260	114,768	112,870	140,234					129,815
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Missing Sex							40,421					32,730					27,836																				
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			132,647																																		
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15+	Coarse	Female																											683,926										
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			141,410	136,184	154,877	193,695	167,742	161,677	165,763	168,590	171,915		172,574	179,105	182,720	228,652					234,173
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				155			266		1	8	1	12		5					3	1				1	2					2	2	54					
South Africa	South Africa	ZAF	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			44,429	40,618	48,734	62,983	53,565	51,576	54,018	56,270	58,164		59,616	61,850	63,728	82,515					92,923
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			182,220																																		
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			71,424	10,218	12,988	12,277	13,352	44,226	11,058	12,082	7,459	7,091	69,492	7,777	8,125	7,678	7,007	53,763	6,443	7,287	6,369	13,425	34,877	6,267	6,795	5,595	5,858		5,342	5,741	5,005	10,946					7,329
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								697	772	637	716		700	716	674	1,475					1,033
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								473	438	408	449		436	469	437	947					786
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												35,401					25,111				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15+	Coarse	Female																											59,613										
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Missing Sex							3,348					4,308					2,269																				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			47,608	7,364	8,724	8,367	9,056	34,105	7,536	8,140	4,795	4,953	12,895	5,286	5,553	5,085	4,768	39,527	4,201	4,752	4,154	8,577	19,544	3,964	4,142	3,674	3,579		3,487	3,845	3,173	7,007					4,722
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				6,598	8,513	8,363	8,654	89,712	7,497	7,988	5,002	4,759	38,340	4,930	5,273	4,971	4,652	50,996	4,241	5,003	4,400	10,124	65,574	4,329	4,782	4,249	4,265		3,853	4,373	3,814	8,588					5,713
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			43,748	4,514	6,611	5,499	6,262	24,888	5,185	5,987	3,609	3,902	4,263	4,112	4,502	3,856	3,799	14,729	3,349	3,940	3,351	7,662	10,333	3,461	3,747	3,132	3,304		3,023	3,512	2,830	6,307					5,083
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								1,073	1,123	1,019	1,063		1,037	1,187	976	2,293					1,572
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male							44,567					36,917					33,351																				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				4,217	5,506	5,325	5,716	65,788	4,741	5,249	3,222	2,970	35,721	3,291	3,413	3,332	3,257	43,466	2,944	3,347	2,890	6,917	49,252	3,040	3,134	2,749	2,764		2,563	2,786	2,459	5,474					3,779
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			77,109	10,960	14,406	13,862	14,105	112,350	11,909	13,441	8,829	8,708	43,238	9,001	9,513	8,942	8,225	59,485	7,381	8,434	7,372	16,560	63,556	6,963	7,576	6,756	6,770		5,958	6,933	5,701	12,769					8,752
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<15	Coarse	Missing Sex																											2,449										
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												135,547					85,907				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			147,175	14,836	20,376	17,833	19,233	57,005	15,955	18,349	11,348	12,235	18,154	11,682	12,963	11,284	10,318	29,686	8,810	10,316	8,783	19,694	21,992	8,105	8,811	7,613	7,824		7,075	8,175	6,699	15,348					11,632
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female				59		6																		1							3						
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								1,244	1,289	1,109	1,158		1,129	1,178	1,050	2,491					1,795
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				6,549	8,231	8,102	8,500	62,001	7,467	7,906	5,309	4,749	44,972	5,415	5,736	5,266	5,027	41,706	4,751	5,383	4,815	10,726	54,859	4,891	5,331	4,726	4,833		4,630	5,104	4,320	9,751					6,865
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								555	528	493	520		569	590	493	1,152					830
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			2,596	1,118	1,101	1,332	1,324	1,105	1,011	912	783	857	1,612	835	691	689	731	2,256	663	543	554	1,331	2,756	555	388	448	475	1,338	422	418	380	546	1,062				707
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			27,707	6,098	7,703	7,305	8,268	105,623	7,321	7,477	4,386	3,732	69,620	4,709	4,747	4,413	4,170	90,163	4,060	4,737	4,076	10,048	110,048	1	7	3	1	84,582					55,538				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												31,651					25,516				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								649	710	592	601		590	626	576	1,312					920
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				4,274	5,237	5,094	5,704	46,367	4,894	5,224	3,449	3,068	37,335	3,596	3,652	3,456	3,355	25,668	3,232	3,699	3,202	7,249	37,413	3,321	3,498	3,064	3,189		3,035	3,268	2,774	6,302					4,390
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15+	Coarse	Male																											35,685										
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								2,073	2,099	1,771	1,887		1,774	1,880	1,643	3,903					2,695
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												4,981					4,542				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												14,513					14,060				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			43,967																																		
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												97,650					66,927				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			53,863	18,660	25,260	23,432	24,264	79,675	20,097	22,918	14,643	15,235	22,995	14,503	15,858	14,377	13,406	29,060	11,303	13,167	11,178	25,207	24,714	10,252	11,244	9,646	9,521		8,728	9,913	8,143	18,280					12,745
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			22,425	956	834	820	1,034	13,671	758	795	450	404	8,724	491	580	498	469	10,226	508	581	527	1,129	7,330	490	520	500	410		489	475	422	1,030					722
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				665	839	716	944	7,806	626	744	385	323	7,541	376	395	365	332	8,630	362	402	361	810	5,336	354	399	354	288		275	313	290	571					438
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			30,572	3,068	3,330	3,172	3,602	26,285	3,012	3,106	1,817	2,020	6,098	2,020	2,339	2,054	1,769	21,966	1,799	2,003	1,706	3,580	9,930	1,660	1,689	1,445	1,533		1,471	1,630	1,321	2,984					2,129
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				726	952	835	1,025	2,484	855	837	488	503	3,940	549	626	572	493	5,218	438	623	555	1,301	3,378	534	576	493	490		480	569	419	848					780
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			47,774	5,409	6,496	6,151	6,993	92,634	6,133	6,345	4,205	3,680	29,911	4,524	4,439	4,008	4,020	43,512	3,865	4,530	3,874	8,993	57,980	1	6	3	1	52,224					30,122				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male				36	1	4	4			1				1																	3						
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			76,005	16,087	21,688	20,193	20,604	101,620	17,341	19,861	12,853	12,908	58,802	12,614	13,612	12,447	11,746	44,882	9,860	11,771	10,007	22,315	47,862	9,529	10,080	8,716	8,594		7,855	8,903	7,733	17,098					11,330
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			112,809																																		
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			45,476	949	1,328	1,107	1,288	13,142	886	1,175	559	479	16,848	527	630	584	503	15,073	464	595	517	1,216	8,054	561	595	500	492	4,772	400	478	421	784	3,844				605
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								2,023	2,082	1,894	1,829		1,841	2,002	1,724	3,966					2,719
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Female							73,731					60,693					52,893																				
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			98,932	9,328	11,788	11,454	12,078	80,708	10,392	11,442	7,130	6,938	20,040	7,528	8,189	7,675	7,304	59,106	6,861	7,759	6,798	14,521	54,382	6,801	7,073	6,257	6,371		5,803	6,687	5,482	11,963					8,167
South Africa	South Africa	ZAF	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												28,268					24,312				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												208,105					207,898				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								138,334	141,878	146,728	153,358		157,551	160,722	161,116	175,332					157,072
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								126,471	129,445	133,120	138,210		140,628	145,450	147,136	156,826					133,443
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				7,335	8,058	7,581	7,663		8,101	9,080	5,841	5,505	19,985	5,377	5,016	4,925	4,921	17,563	4,754	4,534	4,516	5,629	15,765	4,460	4,133	4,255	4,470		4,701	4,888	5,193	6,148					5,193
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male					10	11					1						108,903																				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												38,980					37,884				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15+	Coarse	Male																											176,229										
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				23,533	23,733	25,735	26,236		29,176	31,057	27,426	28,027	64,699	27,985	28,108	28,194	29,053	63,551	29,222	29,290	29,127	36,879	61,784	31,107	30,470	30,935	32,451		32,843	32,672	32,122	34,781					27,422
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												693,197					694,636				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				178,395	182,484	196,067	200,994		216,365	228,398	200,354	201,804	359,577	199,935	198,411	198,214	202,542	314,609	199,863	199,291	197,998	243,962	307,717	202,639	196,639	195,808	198,226		195,107	189,109	184,238	189,873					150,870
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								84,508	87,542	91,126	94,903		98,083	101,893	103,825	114,671					104,416
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				165,494	167,692	182,393	192,194		202,247	206,606	217,606	222,568	309,616	226,149	230,651	235,366	244,476	335,795	246,768	260,083	269,632	342,393	355,751		246	1	2	407,914					445,216				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				116,488	118,478	134,757	139,517		136,237	140,990	135,972	137,421	300,940	137,125	138,500	139,369	144,140	260,083	143,738	144,056	144,810	173,862	264,417	149,828	148,047	148,579	151,146		149,500	147,575	144,395	147,018					115,974
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												201,122					209,198				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				12,174	11,904	13,731	14,223		14,231	15,111	14,574	14,886	58,369	15,044	15,611	15,872	16,706	51,269	17,828	17,729	17,786	22,685	44,463	19,180	19,258	19,765	20,611		21,160	21,713	21,781	23,574					20,365
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				20,283	20,720	20,564	20,586		21,251	22,106	19,671	18,996	45,410	18,629	18,118	17,933	17,884	39,034	17,158	16,818	16,220	20,304	34,748	16,012	15,179	15,175	15,346		15,347	15,162	14,923	16,992					13,092
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				235,215	238,125	253,877	264,827		280,471	285,375	287,484	291,183	421,270	292,792	295,735	298,279	309,483	424,754	309,279	321,915	330,163	416,363	445,188	358,508	364,253	372,747	386,266		393,111	396,841	396,259	416,924					349,949
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15+	Coarse	Female																											446,917										
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				176,290	178,951	191,668	201,129		213,172	217,338	222,527	227,575	317,637	230,841	237,999	243,786	256,260	332,565	258,352	267,444	274,324	345,446	358,367	293,645	296,661	303,236	312,826		317,343	321,104	320,887	342,504					288,930
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,362,161					1,441,615				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												728,283					760,346				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				34,310	34,081	41,122	41,232		37,743	41,169	35,642	34,825	124,876	33,996	33,818	33,434	33,740	102,279	33,663	32,686	32,177	38,591	85,773	32,678	31,732	31,951	32,637		32,332	31,801	31,416	32,696					27,136
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				14,230	13,933	15,030	15,289		16,516	16,312	17,509	17,786	38,015	18,121	18,599	18,814	19,387	39,765	19,625	19,479	19,633	24,842	38,586	20,842	20,906	21,272	21,923		22,168	22,288	21,916	23,336					18,630
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<15	Coarse	Missing Sex																											11,281										
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												77,840					87,713				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								79,764	82,418	85,493	89,461		91,598	93,872	94,504	101,772					90,984
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				264,515	270,066	285,288	293,984		313,693	323,730	303,693	305,222	490,565	303,864	304,696	304,520	311,300	456,518	308,512	313,640	314,973	389,736	455,906	328,183	323,350	323,613	328,104		327,214	323,406	318,361	328,240					262,574
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				276,332	281,092	302,054	316,810		340,483	345,282	368,468	376,776	504,357	383,487	388,943	396,926	412,571	567,965	416,719	439,038	454,937	588,655	628,574	3	463	4	7	660,253					736,485				
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				977	1,005	963	1,173		1,322	2,823	451	154	1,741	132	138	152	134	1,088	137	103	116	140	2,128	97	77	97	106	1,084	114	99	106	135	866				175
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				76,108	78,160	83,531	86,483		94,749	103,024	83,768	84,505	198,192	83,289	82,973	81,998	83,322	167,134	82,439	81,440	80,487	99,338	160,610	82,183	79,524	79,321	80,649		80,161	78,598	76,885	81,778					68,343
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				278,703	283,898	303,008	314,548		333,021	338,362	336,053	340,419	519,631	340,559	346,338	351,776	366,244	506,608	366,943	374,265	379,214	469,377	526,512	398,038	395,862	399,990	408,893		409,348	408,103	402,928	418,988					340,255
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				124,784	125,783	139,895	145,348		145,808	149,504	147,228	148,328	259,392	148,076	148,265	148,401	153,212	246,594	152,911	156,504	159,590	196,028	260,651	171,203	173,296	177,198	182,570		184,003	184,959	183,749	189,536					157,051
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								49,669	51,416	53,492	55,852		57,681	60,053	61,165	66,249					59,308
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								210,364	214,485	219,935	227,136		231,048	237,246	239,621	258,408					225,360
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								67,838	70,996	74,819	79,021		82,402	85,448	87,610	97,788					94,229
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								40,445	42,149	44,424	46,726		48,534	50,351	51,239	56,730					53,690
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				33,685	32,727	34,499	35,275		36,357	35,387	35,409	34,875	74,491	33,706	33,165	32,691	32,756	68,753	32,133	31,740	31,242	39,062	59,319	31,643	30,684	30,566	30,811	48,036	30,679	30,520	30,319	33,138	45,956				26,571
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				1	1	29									5	1	263,452		1	1						1	1		1			1					
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				105,598	106,593	118,752	124,737		127,993	130,352	132,159	134,215	194,795	135,261	139,836	142,553	149,125	204,073	149,520	153,485	156,904	192,691	226,174	167,033	168,531	171,852	177,280		179,227	180,767	180,180	187,716					155,474
South Africa	South Africa	ZAF	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				81,725	82,750	96,394	98,510		92,518	98,238	89,158	88,730	203,537	87,486	86,446	84,970	85,627	192,934	84,661	84,039	82,959	98,438	176,027	83,241	80,615	79,883	80,453		78,899	77,347	75,454	76,376					57,968
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														222		250					321
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														13		31					49
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					13,227		14,647			11,176		8,189			5,640		6,929			8,979		14,865			8,974		15,992										
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														157		195					416
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														1,770		1,996					3,230
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														1,544		1,697					2,935
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														192		254					506
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														1,704		1,973					3,261
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														296		355					569
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														206		291					734
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														90		140					108
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														2,253		2,664					4,412
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	50+	50+	Female																														653		954					
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														119		152					161
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														1,676		1,903					2,926
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														273		368					888
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														101		166					203
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														628		693					1,100
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														102		162					161
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														712		941					2,368
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														442		582					1,343
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														1,470		1,803					2,574
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	50+	50+	Male																														910		1,302					
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														2,314		2,546					4,550
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					937		1,606			1,940		1,524			4,115		4,542			328		464			348		466										
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														429		541					1,255
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male					6																																
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														147		228					452
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														1,054		1,346					1,756
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														678		806					1,328
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														1,150		1,294					2,250
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female							3			1																											
South Africa	South Africa	ZAF	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					16,596		17,549			14,258		10,310			6,713		8,480			11,258		18,163			10,579		18,851										
South Sudan	South Sudan	SSD	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female																		720		631		1,222	1,264				1,578	1,480				2,005	1,420				
South Sudan	South Sudan	SSD	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female																		660		611		911	1,150				1,830	1,342				1,856	1,464				
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																		80			93	37	859	135	203	350	523		386	442	656	626					1,520
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																		900			11	16	115	75	62	97	132		71	72	153	200					464
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																					5	2	56	23	23	50	38	56	13	18	83	84	77				191
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																		180			37	25	527	157	142	246	344		265	301	570	433					1,034
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												1,040					1,105				
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												680					752				
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												473					533				
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												477					537				
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																					40	9	525	60	100	199	323		274	263	450	433					872
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																		80			107	44	489	90	175	258	416		410	394	569	662					1,546
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																		1,074			18	2	80	45	46	62	97	80	44	46	230	153	103				278
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																					24	8	204	36	39	104	192		145	95	292	356					811
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												1,386					1,501				
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												339					378				
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																		1,100			31	29	269	55	107	201	372		323	326	633	610					1,269
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																		100			51	28	133	106	118	199	252		168	184	365	397					825
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																							633	199	46	68	130	633	48	66	142	156	685				198
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																		1,614			7	3	105	38	32	42	75		44	29	73	77					291
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																		252			52	33	191	104	169	250	384		292	330	522	540					1,105
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																		106			27	14	257	101	82	149	250		146	206	247	285					722
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																		336			6	2	101	49	46	60	85		62	61	131	154					356
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																		704			70	40	515	116	206	360	580		495	453	718	871					1,512
South Sudan	South Sudan	SSD	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																		1,374			28	12	105	104	87	103	181		99	163	243	283					636
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			46,329	8,162	8,258	8,597	10,043	131,134	12,007	13,901	12,851	12,699	77,483	11,061	12,343	12,455	14,126	44,570	15,478	15,034	14,101	14,083	69,479	13,938	15,103	17,295	16,298		14,762	17,997	21,163	22,700					27,952
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			27,672	9,031	9,675	9,771	11,568	38,161	13,619	16,470	15,024	15,465	37,621	12,549	13,815	14,861	16,381	19,384	17,549	17,228	17,126	17,185	51,053	16,028	18,331	21,392	19,593		17,493	21,192	25,688	27,079					30,871
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex						49			6	3	71	8				8	2					2															
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				8	17	1	2		11	5	28	5		2		9																					
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male							2		2	1	5	11		1		7	1									1											
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												61,786					25,581				
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				4,048	3,022	3,419	3,664	10,278	4,532	3,659	3,078	3,133	5,600	3,287	2,631	3,249	3,460	24,569	3,796	3,945	3,962	3,776	23,468	3,364	4,265	5,483	4,420		3,088	3,997	5,954	6,732					5,836
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				1,733	1,515	1,656	2,203	5,906	3,183	3,022	2,265	2,580	7,228	2,259	2,167	2,163	3,024	14,183	3,353	3,258	2,994	3,076	14,978	2,991	3,770	3,808	3,597		3,395	4,122	4,935	5,977					7,673
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			1,043	80	127	106	204	199	111	112	81	98		99	66	134	106		42	36	74	28		26	16	95	51		95	46	322	130					60
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												99,152					154,082				
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			3,542																																		
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			9,476																																		
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			600																																		
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			4,013	4,038	3,587	4,041	4,833	25,613	5,792	6,266	5,219	5,891	22,039	5,472	5,369	5,103	6,477	24,798	7,339	6,703	6,476	6,743	68,081	6,641	7,240	8,030	7,698		6,986	8,631	10,443	11,060					13,679
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				1,970	1,556	1,808	2,084	7,193	3,591	3,383	2,576	2,972	11,735	2,728	2,473	2,503	3,056	27,869	3,705	3,441	3,256	3,291	29,970	3,551	4,001	4,391	4,282		3,795	4,813	5,696	6,591					8,071
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												40,078					29,619				
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			6,075	1,572	1,221	1,402	1,764	5,015	2,938	3,148	2,185	2,510	11,043	2,391	2,127	2,257	2,733	38,967	3,077	3,014	2,913	2,868	24,898	3,181	3,472	3,537	3,627	35,077	2,990	4,437	4,790	5,494	49,143				5,832
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												84,485					77,562				
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				1,295	998	1,290	1,757	5,939	2,383	2,250	1,699	1,832	6,543	1,589	1,490	1,552	2,094	6,072	2,409	2,239	2,152	2,349	13,637	2,058	2,718	2,536	2,394		2,311	3,165	3,503	4,335					5,444
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			38,842	6,381	5,929	6,198	7,249	55,706	8,704	9,947	8,387	8,788	51,172	8,285	8,620	8,306	10,404	37,208	10,803	10,494	9,934	10,230	76,459	10,180	11,390	12,658	11,826		10,665	13,194	15,172	16,601					19,354
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			8,807	2,089	1,196	1,600	2,625	12,813	4,013	3,402	2,553	2,969	26,666	2,159	1,819	1,793	2,912	14,866	3,536	2,738	3,090	3,435	14,257	2,740	3,970	4,000	3,325	18,603	3,241	3,882	5,991	7,383	12,078				7,969
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												75,021					80,544				
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			14,987	3,092	2,674	3,047	3,826	38,887	4,636	5,067	3,844	4,242	27,943	3,648	3,350	3,433	4,268	5,709	5,158	5,105	4,754	4,918	23,430	4,430	5,535	5,801	5,202		5,046	5,875	7,378	8,209					10,054
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			2,033	2,452	2,148	2,299	3,185	16,198	4,051	3,825	2,953	3,481	13,357	2,902	2,721	2,959	3,795	13,042	4,067	4,016	3,757	4,006	21,462	3,594	4,518	4,591	4,074		4,084	4,940	5,948	6,771					8,665
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			16,963	6,117	5,791	6,868	8,804	14,801	10,171	11,108	10,311	10,360	15,994	8,590	8,463	9,623	11,814	10,635	12,481	10,664	11,695	12,916	15,316	11,450	12,777	15,659	14,381		12,227	13,532	17,597	19,557					22,102
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			33,242	3,045	3,083	3,181	4,175	48,379	5,072	5,339	4,203	4,662	44,416	3,753	3,721	3,897	4,695	4,699	5,542	5,419	5,162	5,171	13,389	4,779	6,021	6,183	5,393		5,492	6,085	7,453	8,288					11,504
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				2,212	1,194	1,147	1,928	12,321	2,856	2,292	1,726	1,903	4,263	1,616	1,662	1,856	2,553	29,096	3,143	2,666	2,882	2,713	13,665	2,419	2,960	3,084	3,043		2,514	3,129	4,594	5,950					6,105
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																										21			2	2	47	2					
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												82,919					101,957				
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			9,679	1,755	1,449	1,829	2,548	3,475	3,258	3,129	2,363	2,493	7,649	1,984	1,714	1,841	2,710	5,405	3,539	2,552	2,615	3,096	7,199	2,941	3,931	4,249	3,650		3,547	3,424	5,233	5,763					8,195
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			368																																		
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												225,501					188,984				
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				1,526	1,037	1,192	1,451	6,979	2,237	2,363	1,660	1,856	13,244	1,695	1,539	1,509	2,126	23,264	2,251	2,188	2,101	2,106	18,079	2,156	2,497	2,635	2,640		2,271	3,157	3,316	4,547					5,266
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			5,324	1,665	1,638	1,723	2,235	9,899	3,236	3,369	2,393	2,761	12,493	2,471	2,292	2,286	3,208	22,774	3,657	3,821	3,471	3,438	13,181	3,160	3,763	3,854	3,685	17,416	3,312	4,488	5,228	6,151	23,157				6,832
South Sudan	South Sudan	SSD	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			20,497	2,931	2,822	3,038	3,842	12,875	4,746	5,264	4,032	4,513	22,931	3,732	3,488	3,686	4,580	9,493	5,305	4,986	5,075	5,135	8,147	4,616	5,753	6,116	5,410		4,960	5,336	6,998	8,164					10,391
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				73	64	56	85	537	122	100	57	66	849	53	80	80	115	1,302	101	110	94	91	527	84	103	74	80		59	84	83	92					115
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												953					594				
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			2,646	280	265	286	264	3,102	314	344	253	264	3,074	274	298	266	344	850	385	345	280	307	1,980	270	324	268	297		265	278	287	317					274
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			3,017	319	351	365	385	4,733	377	391	318	308	5,319	353	376	345	410	742	431	377	340	344	1,625	289	328	337	287		244	309	367	357					372
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												2,851					3,170				
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			2,319	123	178	132	185	3,084	205	153	121	124	2,947	116	144	147	142	344	159	189	151	139	500	130	172	106	112		97	98	151	117					125
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												485					530				
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			45	2	2	2	2			8	2	7		2	1	3	5		1	1					1	3	1		3		4	2					
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			475	22	16	10	22	612	19	34	14	30	855	22	25	23	30	790	30	25	28	33	373	16	28	32	23	613	13	18	34	33	369				30
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			1,057	61	78	55	80	909	96	76	62	51	1,091	66	70	73	72	739	67	84	71	73	298	54	89	58	81		60	66	75	63					56
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			445	14	16	12	16	328	40	29	10	18	320	10	17	19	20	460	19	21	19	29	158	10	19	16	18		13	16	27	16					15
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				67	56	72	82	350	66	88	57	47	177	47	103	79	70	1,084	66	79	61	65	394	44	72	66	47		44	50	91	59					61
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,673					1,775				
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			5																																		
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				94	75	69	108	391	102	98	84	88	647	62	95	74	120	498	118	117	100	112	483	93	107	94	73		81	98	124	126					114
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			180																																		
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female										1																											
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				107	81	90	116	582	144	145	103	106	901	108	124	129	150	1,992	170	175	146	125	934	125	137	126	133		122	141	133	152					162
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			327	69	70	80	87	457	114	114	74	80	702	86	93	110	92	2,455	114	96	85	73	558	103	84	68	87	622	72	80	84	116	659				113
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			1,006	103	108	114	113	552	139	149	103	119	651	156	116	126	140	155	127	119	112	120	232	90	109	133	108		82	94	131	117					99
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			1,866	271	276	314	291	2,100	312	376	271	263	2,156	266	333	349	364	297	358	343	327	262	1,224	245	253	247	262		210	244	316	289					241
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												4,181					3,587				
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			477																																		
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			1,201	183	198	162	231	2,307	208	251	176	154	2,108	192	175	171	232	440	257	172	194	190	911	161	157	152	159		138	196	183	188					182
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				26	21	36	22	386	24	24	18	28	198	24	23	29	37	1,406	39	50	40	38	324	30	33	44	28		31	28	38	34					21
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			305	188	212	204	216	1,674	236	240	179	200	1,791	213	238	230	255	1,471	285	251	239	215	1,800	237	242	210	195		203	250	251	244					293
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,963					1,971				
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			335	94	102	85	95	686	98	121	87	102	1,005	116	94	109	114	1,402	131	126	126	118	526	97	89	81	96	309	99	87	122	168	512				116
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			122	150	178	155	204	1,125	185	181	134	171	1,210	171	163	192	214	966	230	173	195	203	811	183	194	173	182		153	162	186	202					193
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			11																																		
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male											1															1											
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				99	108	106	106	417	141	131	78	105	670	117	136	135	165	1,169	186	188	164	140	518	123	129	153	135		107	135	138	173					148
South Sudan	South Sudan	SSD	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												912					1,791				
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												2,849					3,174				
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				102	139	144	120	909	117	150	142	129	544	127	144	159	127	1,040	143	148	117	128	1,302	123	108	150	147		134	176	138	173					121
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				185	225	195	228	1,781	178	227	208	201	875	214	212	210	206	1,322	184	201	225	199	1,552	184	178	175	166		190	205	208	245					234
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				58	59	52	74	58	58	62	55	70	187	73	56	65	70	88	59	74	51	73	123	71	48	53	54		55	67	71	71					50
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				5	4	6	9		5	13	14	6	142	11	6	16	6	235	10	6	9	5	31	7	15	3	7		2	12	7	13					12
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female							2				2	1	160			2	1	111	1		1	1	92		2	2	3		1		3	1					4
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																														1							1
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex						6	1																														
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												1,145					1,337				
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				65	54	68	77	219	56	76	56	45	137	52	65	77	54	408	61	56	79	72	474	57	73	50	60		64	73	83	83					90
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				134	203	144	156	212	166	208	190	182	478	200	212	207	180	370	151	176	172	208	787	169	168	150	132		140	196	191	171					181
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				3			2	4	1			2	12	4	2			1	5	4		1	4	2	1	5	3	8	1	3		2	15				
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female													154										188					720					868				
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												852					1,060				
South Sudan	South Sudan	SSD	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																																					1
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			101	899	930	843	1,092	2,774	860	1,150	1,067	1,026	4,151	1,151	1,290	1,056	1,173	4,509	1,158	1,405	1,224	1,280	5,279	1,271	1,264	1,257	1,491		1,126	1,466	1,581	1,703					1,939
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			7,366	3,679	4,076	3,729	4,091	7,649	4,256	5,293	5,028	5,095	7,894	4,858	5,856	5,863	5,870	8,449	5,467	5,831	6,217	6,005	8,867	5,392	6,052	6,366	6,492		5,537	6,415	7,964	7,756					8,400
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			398	55	23	282	74	106	354	90	200	295	142	136	108	158	128	156	43	91	226	379	138	74	358	114	88	141	176	97	142	293	149				123
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female				1	1	6			1				3,603		3			3,960	1	2	4		9,194					9,376		2	1	2	9,847				
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			22																																		
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex						55			6	3	71	8				8	2					2				21			8		47	1					
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												32,739					34,377				
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			3,942	2,454	2,410	2,410	2,598	4,290	2,653	2,965	3,051	3,102	4,307	3,119	3,129	3,394	3,685	4,608	3,286	3,256	3,747	4,246	4,820	3,237	3,749	3,922	3,992		3,344	3,658	4,680	4,988					4,637
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			9,117	1,941	2,076	1,947	1,997	13,636	1,944	2,466	2,202	2,254	13,566	2,305	3,021	2,597	2,558	14,525	2,539	2,825	2,597	2,668	14,620	2,898	2,981	2,899	3,142		2,684	3,274	3,640	3,635					3,995
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				124	112	149	190		281	203	191	124	2,742	195	283	178	184	3,014	214	184	198	149	969	210	190	164	210		160	259	242	300					291
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												10,270					10,784				
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				11	19	20	48		26	76	65	13	3,852	21	49	24	25	4,236	30	29	28	11	3,728	26	31	20	37		16	26	48	59					22
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												14,023					14,725				
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female			8	4	16	1					25																										
South Sudan	South Sudan	SSD	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			20,011	3,149	3,382	3,072	3,550	17,559	3,468	4,270	3,899	3,917	18,192	3,686	4,986	4,714	4,757	19,497	4,608	4,845	4,779	4,365	17,397	4,498	4,854	5,030	5,284		4,435	5,514	6,199	6,389					7,255
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			2	3				5		1		5	14	4	2	1	4	1		1			4		1	3	4	8	68	3	2	2	15				2
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												1,147					1,341				
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			100	60	51	60	62	236	57	76	52	43	141	52	60	59	50	409	63	69	76	72	474	54	79	50	61		67	62	78	74					73
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			413	122	191	138	125	221	160	203	178	170	495	213	211	211	181	372	164	181	164	199	787	173	175	147	143		192	157	189	165					163
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			154	58	58	51	58	59	65	69	55	86	192	80	51	80	81	88	58	65	51	60	123	62	50	60	46		118	73	74	57					54
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female													156										188					720		1			868				
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												2,865					3,188				
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			1,184	173	214	193	184	1,866	180	209	195	185	915	214	216	207	197	1,323	183	208	224	198	1,552	187	177	175	167		189	294	192	232					206
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				5	1	5	7		7	15	14	3	144	7	6	14	4	237	5	7	8	5	31	5	12	3	8		11	16	7	18					8
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex						6																							8								
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female					2		2			2	2	1	163				1	114	1		1	1	92			2	3		1	1	3	1					3
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			898	100	135	123	104	956	122	141	141	109	559	136	142	145	122	1,041	132	138	116	126	1,302	140	110	146	148		135	145	125	164					110
South Sudan	South Sudan	SSD	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												855					1,064				
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			992		368		386	1,449		649		305	1,406		344		1,040	1,796		999		787	1,916		955		762			882		692					
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			408		214		378	596		638		291	577		316		839	1,701		914		757	1,779		853		639			696		605					
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			746																																		
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												2,259					2,323				
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			1,536		248		214	2,243		328		219	2,178		193		651	1,011		600		586	1,113		723		553			748		657					
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			67		60		108	98		148		49	96		98		273	343		249		219	364		197		147			185		159					
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex					1					8		4			3		9			13		7			7					2		5					
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												4,276					4,386				
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male					97		35			110		53			76		222	294		161		213	319		200		183	337		179		199	347				
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			1,451		342		362	2,120		496		284	2,056		298		779	1,372		833		767	2,161		895		667			775		700					
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												2,196					2,258				
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					142		115	545		189		145	530		126		414	574		348		406	652		489		398			467		439					
South Sudan	South Sudan	SSD	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					64		49	545		98		66	530		79		230	283		234		187	318		232		178			236		231					
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																							117		10	18	20		36	44	37	17					20
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												237					269				
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																							50			11	6		9	11	8	2					15
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																							114			19	14		23	34	28	19					22
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																							60			26	10		11	15	7	7					3
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												205					237				
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																							14			12	12		12	6	9	2					22
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																							85			14	20		25	20	20	10					16
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																							61				1		5	10	7	2					
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												229					246				
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																							97		2	22	13		35	23	24	17					15
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																							66		3	14	16		8	15	12	2					4
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																							125		3	16	18		18	36	22	12					20
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																							17			5	7		7	3							9
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							97		12	40	29		39	45	29	22					21
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												336					370				
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																							15			5	8	15	5	4			16				
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																							120		9	32	28		33	46	24	15					26
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																							20			12	12	20	27	15	10	5	20				13
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												272					292				
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																							104			9	9		15	18	10	13					11
South Sudan	South Sudan	SSD	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												144					154				
South Sudan	South Sudan	SSD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		54																			
South Sudan	South Sudan	SSD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		531																			
South Sudan	South Sudan	SSD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		417																			
South Sudan	South Sudan	SSD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		379																			
South Sudan	South Sudan	SSD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		213																			
South Sudan	South Sudan	SSD	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		379																			
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																							304	4	46	57	38		29	51	24	24					106
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												444					457				
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		379					113	21	32	47	13		29	46	34	49					73
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																							100	7	21	26	13		9	27	7	8					64
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												892					907				
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		54					212	12	25	24	16		5	27	4	4					41
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												401					401				
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																							120	1	17	9	7		7	18	7	5					26
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		379					370	6	49	53	27		28	38	26	21					95
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		531					280	18	84	130	51		55	80	54	36					193
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												1,031					1,003				
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		213					368	20	61	80	51		45	59	59	34					115
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																							100	1	8	10	4		6	7	5	2					8
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																								2	14	13	19		6	22	8	3					45
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												601					601				
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																							236	6	34	46	22		26	48	13	20					92
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																							206	4	25	38	13		17	30	7	13					115
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																							113	2		9			3	4	1	5					55
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		417					196	39	89	177	51		82	152	71	52					149
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												712					712				
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																							270	10	39	59	29		45	39	24	36					135
South Sudan	South Sudan	SSD	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																							100		5	4		230		1	2		235				15
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				6	10	17	11	24	11	6	11	17	108	14	20	15	13	28				44	34				37					21					38
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												222					113				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				16	7	15	4	40	17	12	11	10	92	16	32	17	17	37				57	66				83					75					72
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											10					10					17
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				15	19	12	14	56	21	21	23	22	210	19	26	18	26	88				91	93				64					87					83
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												129					76				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			385																																		
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				16	14	15	11	28	17	23	18	11	93	16	24	21	12	42				48	76				54					43					48
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											8					14					17
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				7	14	11	6	30	22	13	7	10	101	9	15	17	18	40				31	68				51					68					58
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												335					298				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				2	4	4	8	14	3	8	4	2	64	2	12	5	7	10				15	5				19					12					14
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												216					175				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female				3						1																											
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			589																																		
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				8	2	9	12	31	10	12	10	7	100	3	8	8	17	46				36	53				30					39					65
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											18					47					77
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				22	26	26	30	60	19	19	20	25	254	23	27	34	27	43				81	157				64					45					59
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				19	10	14	12	30	13	17	13	22	144	13	19	14	16	78				67	130				40					53					44
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												37					90				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				10	8	13	9	25	15	11	13	7	94	12	16	11	13	16				41	17					83					171				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				15	10	19	20	40	17	20	19	16	116	15	13	18	25	32				58	49				55					44					47
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											17					22					22
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex								2			2				1							3					1										
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											24					34					51
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											21					32					37
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male				1										1																							
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												235					188				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												163					72				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			18																																		
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				11	11	14	8	57	17	10	10	18	233	30	24	20	19	51				57	56					58					48				
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				3	2		3	14	4	5		1	71	4	3	3		5				6	17				8	44				7	94				14
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				10	10	8	10	56	9	7	11	7	282	10	10	16	11	28				32	62				52					35					43
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				30	33	41	26	56	37	38	35	24	259	27	37	35	36	72				120	174				114					102					83
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				3	2		1	34	3	2		1	229	1	1	3	1	10				5	51				6					7					11
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				4	2	3	2	24	2	3	1	3	53	4	3	1	3	15				6	27				7					9					19
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											13					24					19
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				25	34	31	32	62	22	33	31	29	227	43	39	35	32	57				108	145				101					100					85
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											13					15					14
South Sudan	South Sudan	SSD	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				2	4	14	4	14	2	6	5	4	77	3	5	5	7	11				18	12				34					22					25
South Sudan	South Sudan	SSD	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			1,139		18			1,385		354		1,417	6,889		902		106	10,375		23		143	5,985		1,771		1,012	7,835		2,401		1,752	11,910				1,868
South Sudan	South Sudan	SSD	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			633		28			2,101		651		3,125	10,387		1,610		206	16,322		40		306	11,026		3,834		2,202	15,460		4,069		3,032	24,670				3,158
South Sudan	South Sudan	SSD	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			337					243		5		19	1,058		32			3,346				2	1,971		87		61	3,056		84		93	1,649				197
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				81	111	115	110	198	87	84	91	77	198	79	107	126	103	202	105	109	107	144	202	110	107	117	116		108	135	150	173					120
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				82	70	69	68	198	58	102	53	74	202	61	95	81	64	203	79	72	46	64	202	68	82	73	91	487	88	85	95	107	515				89
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			1,699																																		
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				64	43	26	36	220	37	45	35	48	223	37	38	38	28	221	37	37	23	41	221	28	27	36	38		40	40	43	55					83
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male									1	1		1		2																							
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												650					686				
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												650					688				
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				6	9	4	8	200	8	11	10			3	1	1	1		5	2	1	1		2	1	1			20	1	12	2					7
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				98	72	57	81	221	94	73	88	78	228	75	76	97	98	229	69	124	60	69	229	71	76	56	80		60	60	79	73					94
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				138	146	130	119	560	147	166	146	170	570	186	196	163	163	570	153	159	147	184	570	142	155	113	159		131	126	139	170					183
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				132	94	102	85	198	91	87	95	75	202	82	103	102	97	202	102	83	71	99	202	127	137	124	135		130	124	144	147					111
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				196	210	196	180	551	203	202	218	249	603	210	231	245	241	602	221	198	241	247	602	200	224	194	226		197	197	239	247					201
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												735					779				
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				91	42	68	59	220	84	65	88	64	230	77	87	97	83	231	66	88	58	59	231	56	81	75	74		80	92	91	89					101
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				59	63	69	64	552	62	109	42	65	553	52	50	70	59	551	67	72	54	72	551	56	58	64	66		64	66	72	69					102
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				100	75	83	91	553	123	116	98	123	558	109	141	113	129	556	92	113	125	110	556	83	90	99	136		95	110	129	141					139
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												1,339					1,419				
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				62	55	40	32	221	88	42	45	74	221	74	83	68	72	221	48	56	47	49	221	64	85	94	101		90	96	99	105					130
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female										2		1																									
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				75	88	106	97	221	118	130	136	121	222	130	147	116	130	221	90	112	88	95	216	101	173	185	250	423	177	197	194	347	449				307
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												887					940				
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				51	37	30	34	222	53	46	43	56	224	44	53	58	47	225	40	46	32	38	225	45	131	105	147		66	101	123	123					119
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				183	202	193	182	552	184	223	184	226	552	232	225	201	221	551	209	234	181	219	551	194	215	191	221		201	201	230	243					209
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				44	30	35	47	222	27	42	41	38	232	48	46	30	56	231	28	31	37	47	231	37	46	59	70		63	62	59	139					75
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				85	70	75	85	551	83	79	90	107	551	84	92	91	82	551	77	94	86	93	551	81	85	84	97		76	97	109	137					144
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												1,300					1,378				
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				139	143	146	131	552	162	186	173	177	563	166	183	185	210	561	178	217	205	192	561	185	185	185	208		201	207	205	202					200
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				74	53	45	37	220	77	78	83	73	230	57	85	75	60	229	58	63	68	57	229	68	66	67	72		74	57	72	86					92
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				182	160	151	171	552	163	171	153	216	579	225	222	192	213	577	159	223	161	189	577	187	195	173	268	659	183	251	227	278	696				309
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			4,239																																		
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												1,842					1,952				
South Sudan	South Sudan	SSD	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			774																																		
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				1,362	1,220	1,303	1,360	1,215	1,403	1,593	1,659	1,878	1,618	1,876	1,983	1,977	2,161	3,723	2,360	2,446	2,578	2,588	3,959	2,556	2,766	2,838	2,921		3,110	3,197	3,364	3,571					3,918
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												2,942					2,012				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			1,227	500	363	358	469	1,772	538	511	550	574	1,998	577	584	642	689	1,983	697	829	899	874	1,920	942	951	1,039	1,023		994	1,078	1,314	1,231					1,280
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				622	563	529	544	767	612	656	656	734	647	722	747	814	823	1,801	852	920	956	998	1,864	995	1,015	1,143	1,137		1,133	1,150	1,206	1,245					1,309
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												5,780					8,933				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			1,000	959	977	1,065	1,409	1,058	1,059	1,058	1,099		1,159	1,238	1,301	1,470					1,642
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			1,147	715	642	650	684	1,670	763	888	906	1,049	1,867	1,127	1,191	1,240	1,317	2,448										2,819					2,669				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				338	331	351	371	791	364	418	420	446	657	416	421	458	490	1,876	503	559	581	611	1,857	578	671	674	639		668	672	699	722					830
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												7,790					10,090				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			1,451																																		
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			835	930	849	819	876	1,212	951	933	1,012	1,150	1,285	1,090	1,105	1,165	1,272	1,237	1,285	1,248	1,286	1,417	1,239	1,527	1,565	1,652	1,603		1,698	1,782	1,824	2,035					2,251
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												8,146					7,773				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												14,252					17,933				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			234	95	90	73	55	367	81	87	96	105	251	160	123	144	139	70	145	171	166	160	124	191	211	177	204	181	204	229	242	245	274				237
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			5,765	3,377	2,927	3,060	3,096	7,917	3,263	3,676	3,917	4,218	7,256	4,305	4,492	4,609	4,757	5,766	5,086	5,349	5,419	5,696	6,640	5,827	6,239	6,333	6,660		7,005	7,128	7,513	7,623					8,250
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			1,177	1,494	1,263	1,353	1,452	1,998	1,534	1,739	1,769	2,023	2,232	2,076	2,160	2,257	2,414	2,823	2,504	2,622	2,727	2,872	3,117	3,001	3,159	3,265	3,314		3,488	3,570	3,737	3,926					4,430
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												4,302					2,685				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			115	155	145	141	332	133	150	148	192		166	176	188	180					221
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			823	813	793	934	1,007	906	894	934	988		969	1,024	1,084	1,256					1,516
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												11,952					14,277				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			1,890	2,309	2,149	2,262	2,402	3,091	2,461	2,790	2,939	3,133	3,386	3,247	3,422	3,526	3,774	4,117	3,959	4,186	4,287	4,630	5,104	4,691	4,973	5,090	5,315		5,483	5,714	5,925	6,215					6,875
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			347	105	65	58	72	486	121	109	102	128	571	178	121	133	141	865	138	181	245	204	866	184	176	228	266		263	278	418	347					366
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			698	832	729	858	853	1,101	912	1,018	1,110	1,205	1,259	1,179	1,273	1,278	1,451	3,504										3,986					3,119				
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			298	321	329	385	845	385	389	386	408		452	450	560	495					587
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				780	616	688	780	837	820	908	990	1,068	1,139	1,008	1,081	1,126	1,203	1,535	1,310	1,411	1,396	1,601	1,734	1,640	1,754	1,788	1,862		1,931	1,987	2,102	2,198					2,630
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			6,357	1,108	964	978	1,125	8,731	1,286	1,290	1,403	1,503	7,603	1,508	1,619	1,606	1,726	4,440	1,806	1,948	2,138	2,055	4,136	2,178	2,237	2,434	2,374		2,386	2,425	2,737	2,746					2,963
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				1,090	832	879	965	830	990	1,188	1,241	1,398	1,186	1,450	1,513	1,524	1,648	2,417	1,824	1,794	1,956	2,086	2,486	2,123	2,236	2,364	2,479		2,599	2,690	2,848	3,067					3,344
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			865																																		
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female												1																									4
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			9,481	3,724	3,516	3,622	3,600	12,466	3,668	4,126	4,459	4,645	11,889	4,803	4,964	5,205	5,472	7,230	5,673	5,744	5,889	6,231	7,504	6,448	6,793	6,988	7,077		7,218	7,459	7,787	7,961					8,982
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			146	187	222	228	387	241	261	260	264		272	298	287	307					369
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			288	376	348	353	1,190	334	357	388	430		384	399	446	437					575
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			2,678	2,819	2,411	2,412	2,491	4,213	2,616	2,745	3,003	3,291	4,347	3,253	3,404	3,630	3,846	3,549	3,860	4,024	4,018	4,388	4,097	4,528	4,704	4,927	4,918		4,927	5,297	5,387	5,751					6,177
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			3,787	1,664	1,395	1,373	1,567	5,357	1,619	1,871	1,961	2,153	4,946	2,162	2,302	2,283	2,459	3,591	2,609	2,610	2,786	2,945	3,839	2,965	3,106	3,135	3,358		3,340	3,442	3,689	3,797					4,174
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male											1			1																							3
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			885	186	153	173	223	1,389	283	221	253	241	1,596	331	335	351	413	1,641	426	472	498	448	1,714	445	477	534	524	2,360	510	541	621	609	1,283				724
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				1,074	901	885	981	1,173	1,020	1,185	1,187	1,224	1,512	1,240	1,344	1,354	1,482	2,679	1,523	1,798	1,816	1,854	2,706	1,846	1,985	1,994	2,093		2,127	2,215	2,321	2,405					2,775
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			113	158	171	166	293	164	181	176	221		194	203	223	247					270
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			974																																		
South Sudan	South Sudan	SSD	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			147	196	241	250	499	230	252	264	275		282	285	341	295					337
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			938	53	46	48	66	660	70	65	48	58	1,033	61	63	72	68	702	71	73	87	75	296	52	72	53	67		49	48	65	56					52
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			473																																		
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			259	75	92	67	97	642	108	128	77	102	955	117	114	107	133	1,329	152	134	117	121	526					298					492				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			929	163	166	150	182	1,032	173	175	109	176	1,146	172	176	169	213	919	223	177	193	199	811	189	207	200	196		157	191	195	219					204
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			2,982	306	362	331	321	4,417	306	356	288	274	5,054	302	371	348	415	700	418	374	343	316	1,590	279	336	341	316		261	346	375	357					373
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			114	22	20	6	5	85	19	26	17	20	42	22	24	35	20	70	26	26	23	23	126	17	18	27	15	180	15	17	25	12	478				20
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				97	97	84	100	521	150	147	85	96	853	103	153	134	172	1,891	187	177	148	129	914	126	141	132	126		148	149	149	155					168
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												1,868					1,873				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			1,282	170	167	154	190	2,054	178	220	146	162	2,005	191	180	164	245	422	245	180	202	204	905	172	174	167	202		155	188	183	190					200
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												913					569				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												465					507				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				70	70	73	89	493	117	100	70	74	803	70	94	83	102	1,238	115	103	97	107	511	96	117	89	114		67	87	103	103					112
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								21	19	21	9		15	14	17	23					20
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								20	13	10	13		9	14	11	12					9
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				27	25	21	33	362	21	26	22	24	185	37	26	32	36	1,336	43	48	37	39	324	29	36	41	30		32	31	29	29					30
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												3,973					3,408				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			118	5	7	13	16	224	27	17	12	13	305	9	10	6	24	437	15	17	27	29	157	16	16	24	27		12	17	9	21					10
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												868					1,700				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male						1								1																							
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			167	90	91	108	98	566	121	130	106	106	623	137	114	129	127	148	126	123	102	110	228	91	101	112	100		79	94	113	118					102
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								16	15	17	10		15	12	19	21					15
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												2,711					3,013				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								66	64	69	62		53	75	63	91					67
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								62	54	71	61		59	56	77	102					85
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			720	8	12	7	28	618	16	26	21	25	807	34	25	21	29	754	24	20	19	19	373	15	29	35	20	596	14	21	34	27	356				24
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				59	66	52	72	338	54	72	49	36	177	47	83	85	88	1,032	78	89	63	82	393	44	75	68	58		44	51	92	67					55
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								10	12	11	10		10	12	12	15					14
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								29	17	23	34		23	18	20	24					23
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				82	72	78	103	376	93	91	85	72	616	77	90	74	127	474	133	112	111	127	481	107	114	111	98		93	107	131	122					125
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			1,682	182	205	215	193	1,465	248	212	162	203	1,698	212	248	220	281	1,396	298	263	244	227	1,754	243	266	236	229		212	262	290	269					324
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female												1																									
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,572	257	249	259	263	2,865	305	296	229	248	2,911	262	295	261	334	803	366	324	296	323	1,934	258	318	281	286		278	293	281	340					288
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				96	93	97	120	370	121	128	81	114	633	122	130	131	174	1,111	175	173	161	161	510	148	140	167	148		118	130	157	172					154
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			336	78	78	80	120	458	108	116	77	82	661	85	97	128	108	2,337	115	112	102	94	557					595					630				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,591					1,690				
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								10	13	7	13		5	4	8	11					13
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			154																																		
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			2,744	120	113	105	168	2,730	172	139	111	124	2,801	131	120	136	130	330	165	187	155	135	498	124	174	120	125		103	107	141	128					128
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			521																																		
South Sudan	South Sudan	SSD	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			1,285	248	252	287	294	1,876	284	329	247	267	2,044	280	305	316	338	279	324	318	293	259	1,201	245	252	264	267		241	275	308	282					256
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												3,378					2,149				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				16	23	41	24		50	67	62	43	395	53	78	71	57	631	139	136	105	140	297	188	160	194	159		166	207	211	226					483
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												2,234					1,594				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								106	114	222	234		185	182	211	302					454
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								97	119	169	204		138	133	139	243					375
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				3	6	5	6		1	6	15	21	199	12	5	10	8	49	8	27	23	26	86	25	36	35	30	120	22	29	23	29	306				30
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								940	1,142	970	998		1,004	1,073	1,138	1,240					1,373
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				78	194	259	276		319	348	312	392	909	339	355	300	351	1,017	485	485	534	593	707	631	627	700	650		629	704	726	712					945
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				42	98	173	106		175	174	178	176	495	229	249	238	257	1,266	285	310	360	392	672	323	398	413	429		392	454	457	505					542
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												6,132					6,226				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												5,698					8,192				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				556	1,332	1,435	1,312		1,525	1,509	1,663	1,618	2,379	1,721	1,867	1,925	2,210	3,166	2,487	2,603	2,867	2,943	4,224	2,938	3,204	3,388	3,476		3,371	3,459	3,491	3,972					3,864
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				207	389	444	385		540	551	501	462	787	498	551	612	656	1,190	826	917	973	943	1,262	894	1,097	1,093	1,124		1,099	1,147	1,136	1,357					1,505
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				356	911	857	757		898	1,009	1,004	937	1,127	1,063	1,153	1,224	1,278	2,700	1,556	1,670	1,736	1,810	2,687	1,819	2,009	2,123	2,199		2,176	2,273	2,189	2,593					2,690
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				63	89	151	109		152	157	144	131	1,122	177	188	198	192	1,207	259	258	308	362	702	342	371	404	387	1,718	311	396	406	469	1,093				605
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				218	545	571	469		601	594	578	508	820	546	652	699	720	1,785	940	1,013	1,233	1,273	1,496	1,171	1,327	1,396	1,401		1,409	1,541	1,568	1,796					1,893
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				312	653	770	613		783	759	842	692	1,563	735	879	949	996	2,173	1,100	1,197	1,241	1,313	1,963	1,325	1,527	1,646	1,681		1,719	1,745	1,849	2,009					2,115
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								99	108	144	146		114	117	128	159					162
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				153	275	416	342		408	514	636	446	5,586	345	459	467	454	3,705	615	646	777	906	1,188	920	845	915	946		1,003	1,084	1,174	1,218					1,476
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				210	477	517	421		541	510	611	493	1,306	577	653	759	809	1,755	909	922	1,153	1,183	1,664					2,125					2,191				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				265	717	820	625		864	738	667	661	878	894	819	865	1,068	2,403	1,233	1,249	1,287	1,294	2,212					2,886					2,590				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				63	85	142	108		157	239	253	182	1,393	115	186	215	191	1,514	260	362	439	518	634	476	429	395	381		440	492	619	663					703
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								776	855	785	826		816	823	863	1,031					1,154
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												10,445					14,436				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				296	788	847	826		1,059	1,154	1,267	1,351	3,086	1,210	1,281	1,238	1,530	2,958	1,644	1,857	1,964	2,106	3,154	2,303	2,243	2,469	2,410		2,304	2,296	2,317	2,433					2,536
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												8,885					11,403				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				629	1,512	1,691	1,544		1,860	1,930	2,169	2,089	8,572	1,976	2,041	2,035	2,375	5,995	2,630	2,930	3,198	3,403	5,658	3,406	3,548	3,772	3,695		3,601	3,738	3,704	3,906					4,200
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				43	70	97	79		93	129	157	148	493	100	122	116	106	1,278	136	149	180	197	713	219	263	284	320		310	331	354	419					282
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								183	319	376	362		254	407	434	568					796
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												4,435					7,215				
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				655	1,570	1,770	1,423		1,921	1,839	2,113	1,989	5,275	2,242	2,309	2,447	2,867	4,716	3,112	3,270	3,555	3,684	5,475	3,664	4,023	4,048	4,093		3,966	4,128	4,145	4,476					4,728
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				243	547	610	583		666	660	810	691	3,590	648	750	826	847	2,960	938	1,076	1,073	1,156	2,264	1,279	1,381	1,519	1,542		1,530	1,599	1,594	1,799					2,001
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								97	78	146	141		105	109	94	127					209
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								203	292	349	355		265	318	313	445					693
South Sudan	South Sudan	SSD	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				263	699	819	631		794	679	690	685	1,051	862	864	883	931	1,976	1,118	1,244	1,299	1,236	1,895	1,204	1,331	1,416	1,530		1,479	1,453	1,457	1,711					1,807
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														11		24					103
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														39		29					237
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														5		2					18
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														2		3					14
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														17		14					194
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														9		17					83
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														9		27					123
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														21		24					218
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																																2					12
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														32		10					164
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female			114		81		65			79		35			101		112			96		67			161		124										
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														5		2					75
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														29		46					157
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														1		4					13
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														7		11					92
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														1		4					17
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																																1					14
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														30		30					91
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														22		13					38
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														5		10					57
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														22		42					144
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														6							14
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																																1					7
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														2		2					23
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														3		1					29
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														1		8					57
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														6		6					27
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male			169		158		109			100		63			179		174			193		147			192		206										
South Sudan	South Sudan	SSD	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex			18		13		6			6		6			26		14			16		53			22		16										
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				2				76			6	16	8	17	3	2	16	19	18	10	25	45	19	19	22	34	31		24	42	54	53					75
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																				1					1	5	4		6	4	5						189
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female								130	8	64	19	89	523	73	128	47	72	1,170	63	60	45	63	1,147	57	76	65	35		75	72	50	34					56
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male									1																	1	3		5	1	2						1
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male								6,370	30	356	212	478	146	422	574	323	630	389	574	588	522	472	325	521	610	549	524		529	669	644	451					281
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			4	1									1			1		6	10											1	1	1					
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												800					1,238				
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			627	42				404		13	59	147	329	61	53	20	104	429	126	155	206	474	362	261	300	798	297		324	358	286	304					405
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																					24	62	517	72	26	158	130		465	188	3	153					14
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																					5	5		9	8	18	12		54	65	39	49					56
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																					2	2	121	2	2	4	6		54	17	1	5					
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																				9		13		44	24	81	71		176	190	84	220					124
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												787					777				
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male								400	25	157	71	191	536	130	214	78	135	1,407	157	137	172	131	1,003	126	152	168	135		149	182	195	111					117
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																					6	25	358	36	11	127	85		318	97	9	47					8
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			20	2	2	7	9	2			2		16	3	6	7	2	21	1	6	7	6	26	3	3	7	11	87	9	8	6	2	138				187
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												2,463					3,487				
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																				1		31		66	124	260	132		347	281	107	314					268
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												160									
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																					22	39	91	38	3	12	4		78	93		49					5
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												290					230				
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			187	36	32	32	51	18	5	7	5	8	96	56	90	76	56	154	18	95	95	54	193	83	103	86	58		72	70	75	62					307
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																					10	14	178	14	2	3	8		44	34		25					4
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												2,235					2,977				
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			474	93	94	107	192	48	16	32	38	34	251	116	209	248	194	409	42	248	278	188	512	273	256	222	138		176	194	232	172					463
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																					2	1	143			1		190	7			2	23				
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male								800	1	43	19	53	117	49	60	47	132	190	94	80	66	78	416	70	94	112	97		78	78	134	83					56
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												183					390				
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																					13	50	156	68	18	32	20		85	36	1	30					
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												607					250				
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																											67		7	98	196	245					
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			140	15				102		3	29	81	76	29	18	9	65	97	58	77	84	199	115	92	95	222	112		111	169	143	162					223
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																					20	28	66	38	8	6	10		85	70	1	45					8
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												504					1,089				
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			33	2				81			11	14	8	9	5	3	20	13	19	6	14	25	23	21	23	17	15	560	46	63	70	95	171				73
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male								260	24	233	106	318	593	195	281	115	249	1,202	263	232	230	245	779	247	270	273	236		285	315	308	185					206
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												1,081					453				
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												3,440					536				
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male									5	45	33	59	580	52	88	36	62	867	89	64	51	42	1,245	69	76	81	40	1,286	75	96	93	56	1,321				56
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																					35	85	480	137	39	241	180		583	214	6	203					14
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male														4						11				122		6	6		3		244	177					
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																					2	6		9	2	7	6		25	54	57	32					29
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male									12	84	33	97	520	63	114	35	56	855	80	76	79	60	793	72	85	100	80		72	99	88	49					65
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												240									
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																					3	19		15	14	61	48		85	81	60	76					146
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												766					965				
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												1,337					1,823				
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																											86		5	325	530	532					
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																						2	127	1	1	6	3	170	51	11		9	76				
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			1,248	226	309	286	538	127	35	65	45	67	782	224	464	468	393	1,162	113	494	529	405	1,451	537	616	520	282		382	557	571	554					687
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												1,399					1,730				
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																					6	10	126	9	1	3	3		31	22		12					2
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female								1,860	44	289	175	383	152	389	432	166	301	361	167	229	159	171	390	201	210	217	161		256	259	259	142					228
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			35	17				30		3	15	81	20	32	106	27	57	26	65	57	118	240	31	127	134	461	246		256	271	170	270					256
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								699																													
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												3,144					2,908				
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female								930	39	313	151	413	282	304	458	165	279	693	167	241	159	208	467	221	225	216	154		205	230	248	116					247
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																					2	3	151	2			1		16	7							
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												217					325				
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female								130	19	100	83	196	603	136	224	65	115	1,098	92	121	109	82	1,123	102	131	127	94		115	125	100	61					127
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																					10	16	72	19	5	4	7		28	27		7					1
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												847					1,518				
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																					3	4		8		3	4	240	36	67	79	217					13
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												1,166					1,638				
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			105																																		
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												1,113					418				
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female														1						1					2	1	10		8	8	4	2					239
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex									2	20	14	20	148	43	91	31		180	33	21	18	12		9	16	13	9		21	7	6	5					6
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																				2				1		3	8		12	20	6	4					271
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male								1,330	50	384	201	498	254	353	605	294	510	581	499	499	470	504	564	434	564	549	456		513	633	643	401					319
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female									2	12	13	16	334	30	44	17	33	496	24	32	19	14	1,019	24	17	20	14	1,051	24	23	26	8	791				19
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																					3	13	206	16	9	44	29		182	45	3	20					5
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																										5	2	45	4	2		1	47				44
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												620					630				
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			868	187	253	219	432	84	27	57	56	48	526	167	380	464	358	771	102	428	470	386	960	457	472	403	257		314	397	401	407					805
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																											3		4	1	2						455
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			347	20				261		9	45	97	192	95	33	19	101	249	82	110	157	318	210	150	194	430	208		190	270	216	246					249
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																				2		2		28			1		1		12	20					
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												1,600									
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				10				54		3	17	41	11	23	9	2	35	22	23	48	40	109	39	43	63	79	48		67	91	92	93					135
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																				1	3	11		9	18	34	23		57	73	53	61					94
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																										3	4		6	7	3	2					233
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex												3					1		1	2		2		1		7	1		5	4		30					5
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																											1		1		2						48
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				11	15	12	14	5	2	3	3	5	38	13	41	40	16	51	9	41	22	16	63	33	43	35	24		38	29	41	28					202
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			633	138	108	45	110	62	8	9	3	14	337	43	99	79	77	537	68	93	144	83	671	93	94	105	125		133	137	129	151					333
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				6	5	6	9	5		3		1	21	4	10	12	7	39	1	9	5		49	10	13	15	9		13	17	12	7					105
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																1										6	3		3	4	1						106
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female									1	30	14	28	306	34	40	18	34	550	28	31	25	23	773	33	28	28	23		25	32	32	15					31
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male								530	36	348	149	394	432	262	441	193	353	751	341	331	325	377	731	305	381	383	347		380	482	456	271					276
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female								400	25	215	135	307	383	196	350	104	205	1,077	129	163	141	157	887	183	183	165	135		156	175	155	122					185
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female								130	11	36	30	77	91	81	91	41	107	133	41	45	47	48	373	43	48	50	51		70	64	56	25					60
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																				1	6	30		45	52	159	61		179	93	74	153					182
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			313	106				192		12	75	172	160	80	79	29	115	211	144	190	224	662	201	342	377	1,133	528		511	530	413	523					507
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								1,056																						10	22	28					
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																					2	3	137	5	3	26	23		103	22	2	9					1
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female									3																	1	1		2	2							5
South and Southeast Asia Region	Nepal	NPL	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												2,660					3,445				
South and Southeast Asia Region	Thailand	THA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												960					1,097				
South and Southeast Asia Region	Laos	LAO	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			101																																		
South and Southeast Asia Region	Burma	MMR	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																					16	20	71	25	4	7	6		68	38		44					
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			20			2	10	73			2	2	845	169	196	246	327	83	9	15	12	10	1,313	7	13	12	5	1,233	325	336	348	394	1,229				594
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female								86					1,275	1,079	1,054	1,391	1,509	25	2	8	15	5	16	7	21	14	14		1,136	1,113	983	1,010					2,230
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			1,925																																		
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female								57					775	243	203	223	354	35	1	2	4	3	23		5	8	10		251	254	289	350					626
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				94	42	46	48	88	70	53	20	33		14	5	17	14		13	19	16	26		22	19	27	31		31	30	37	28					
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								37					525	90	156	126	232	35	3	2	1	7	19	4	4	1	1		161	182	219	231					343
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			4,054	1,255	1,440	1,534	1,634	3,993	1,594	1,485	757	1,972	4,544	946	838	1,500	911	1,813	2,057	2,328	2,661	2,797	4,495	2,621	2,705	2,667	2,693		2,308	2,477	2,481	2,305					593
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			1,033	357	434	431	391	930	295	356	156	403	928	246	212	336	164	140	347	429	401	441	875	360	363	373	388		332	364	454	410					299
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			1,393	507	408	430	371	1,313	366	436	194	345	706	184	195	370	178	157	250	317	370	405	773	344	539	583	593	1,515	447	644	747	556	1,724				89
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			1,231	386	338	367	288	444	292	274	142	236	447	127	113	134	79	49	110	120	120	107	866	109	127	119	141	871	96	125	199	220	237				35
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												1,167					1,407				
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female								839	395	389	15	116	285	112	264	62	92	149	169	156	159	153	308	217	178	148	163		197	178	161	144					109
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male			10																																		
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												4,614					5,133				
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			566			29	203	96	15	32	45	42	1,150	515	615	682	765	1,049	107	257	290	213	758	316	262	231	161		659	645	552	587					805
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												893					1,165				
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												2,395					2,925				
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												11,449					10,382				
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female								87					1,155	561	579	700	828	45	3	9	16	3	13	8	8	11	6		588	553	592	556					1,571
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				10	9																																
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				5,834	6,440																																
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												31,597					48,401				
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female								50					675	162	177	178	258	10	4	1		7	53	1	3	2	5	378	265	259	298	396	469				466
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			1,134	72	59																																
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex														11	16	18	10		12	1				1	1	1	137		2		3	5					114
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female								1,943	381	354	12	146	1,650	107	242	58	109	1,416	220	208	132	106	1,324	218	153	148	110		223	186	162	134					91
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female								33					465	1,301	1,240	2,153	2,253	40	4	11	10	5		7	7	13	14		1,237	1,194	1,037	1,157					2,666
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			1,127	11	10																																
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												2,260					2,566				
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male								3,529	982	956	52	342	1,845	202	426	122	153	1,377	350	459	374	263	844	396	275	219	223		309	322	321	283					229
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			11,200	2	47	42	46	3,148	3,527	3,944	3,081	3,963	5,209	4,308	4,576	3,774	3,503	3,282	4,349	5,564	6,139	5,733	1,945	6,224	6,078	6,323	6,256		6,600	6,757	7,178	6,803					49,915
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Female				9,480	11,352	11,131	12,290																														
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex								322	84	26	1	6	335	19	49	10	24	122	37	33	37	36	242	35	26	28	24		26	19	32	10					17
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			1,156	14	10																																
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female								3,831	1,044	1,126	25	400	1,215	288	534	125	190	1,306	365	463	290	246	979	469	282	275	246		437	337	303	264					231
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								1,769	62	283	123	176	5,720	130	239	106	315	1,151	219	445	478	297	314	496	493	412	414		595	642	500	519					21,180
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Male				843	907	641																															
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			3,475	1,219	1,216	1,188	1,329	5,000	1,159	1,136	553	1,442	4,846	754	705	1,196	768	2,861	1,552	1,646	2,006	2,115	5,192	1,915	2,189	2,237	2,265		1,830	2,010	2,084	1,946					670
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								1,296	149	126	9	45	975	70	135	33	55	651	93	90	78	50	904	97	63	64	58		84	81	72	66					48
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			451	56	46	47	45	201	47	32	27	21		12	14	14	14		6	21	14	26		19	16	23	26		19	23	14	30					3
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male								1,631	213	166	27	77	1,845	77	142	54	68	1,068	155	173	141	117	1,431	178	144	118	77	1,840	152	137	143	139	2,044				117
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			1,134	19	12																																
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Missing Sex				368	278	160	250																														
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female								80					1,030	1,486	1,466	2,042	2,323	50	4	16	15	14	9	7	8	4	15		1,340	1,240	1,140	1,317					2,872
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			1,289	764	915	814	840	543	732	884	391	822	1,033	460	350	569	393	126	777	919	879	921	575	903	993	910	965		929	976	1,131	1,066					325
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			1,134																																		
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,071									
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male								3,321	1,346	1,334	124	734	470	487	953	285	475	436	809	918	690	661	376	966	605	492	428		857	709	649	610					412
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			266			10	67	87	5	7	10	16	1,040	340	346	382	502	1,348	50	102	108	72	360	104	104	85	72		400	387	363	370					556
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			142			1			94	145	99	118		265	401	465	268		59	57	57	69		105	108	111	151		144	95	135	142					7,703
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male						1	10	57		3	1	2	650	126	89	136	190	136	5	13	12	4	531	19	17	19	12		132	153	166	226					275
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex														14	29	13	19		2			10		1	10	9	15		34	31	40	45					37
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male						8	17	82	2	3	4	6	930	131	231	196	266	757	27	46	37	37	208	45	51	32	24		196	246	221	275					394
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female									3							1	2					6		2	6		5		1	2		3					
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												876					4,086				
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex										3	5	1		98	173	137	99		8	12	7	6		16	17	11	15		22	23	19	24					1,871
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				231	249	241	234	1,313	226	216	116	260	1,059	148	128	233	114	184	266	286	351	413	673	359	435	482	549		397	562	659	520					87
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												4,101					4,599				
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Missing Sex				1																																	
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												17,279					38,749				
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female								2,342	758	791	25	292	1,910	222	395	104	157	1,317	273	320	254	205	1,280	372	253	193	163		337	259	239	192					156
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				64	34	30	40	68	43	35	17	24		10	4	13	5		11	11	20	35		18	25	19	25		20	27	24	22					1
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female					1	1	1	1,100	290	709	178	318	3,713	766	717	505	865	960	854	1,085	1,286	1,191	2,313	1,540	1,593	1,480	1,673		1,983	2,026	1,982	2,122					37,097
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female								1,108	81	80	5	43	1,065	58	91	25	52	556	65	86	60	51	1,219	75	59	55	39	1,271	102	65	62	91	1,310				54
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			1,443																																		
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male								1,172	272	220	36	134	370	86	175	59	83	209	163	185	149	142	327	206	157	124	114		200	147	159	152					73
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									1	28		41					1							1	4	1	3			1		5					1
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex														47	36	26	38		4			17		12	9	15	11		40	80	46	65					47
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			1,631	509	547	571	596	3,239	578	546	296	672	2,330	398	336	665	365	1,021	671	776	912	1,033	1,952	851	1,046	1,156	1,228		959	1,076	1,260	1,130					262
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex									9	2				1	2	1	3		2		1	1		3	2	2			3		1						
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex								322	93	32	5	4	470	25	45	22	25	199	34	46	35	23	604	30	26	35	23	326	25	21	39	21	410				13
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												633					773				
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				264	319	342	322	603	277	245	135	329	834	161	148	213	108	121	235	259	284	290	733	249	273	244	258		215	246	277	272					132
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female						1	1	346	348	720	159	317	1,357	1,595	2,752	2,436	2,287	724	743	1,033	1,122	1,010	1,815	1,357	1,399	1,326	1,574		1,972	1,862	1,901	2,089					34,677
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												12,042					21,626				
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			4											21	23	35	34		2		1	8		2	7	4	8		20	41	33	50	223				116
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			5,833		33	32	29	5,902	2,175	2,459	2,070	2,488	9,012	2,808	3,109	2,767	2,685	3,892	3,326	4,201	4,840	4,726	2,187	5,053	5,119	5,175	5,232		5,510	5,949	6,056	6,115					46,277
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female							2	1,578	248	542	161	271	4,786	517	528	332	651	1,121	622	888	1,004	828	67	1,207	1,289	1,154	1,302		1,554	1,688	1,553	1,532					33,741
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female								95	88	160	38	68	310	666	1,146	967	901	464	271	313	324	324	590	465	458	474	679		618	604	689	703					20,374
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male								5,720	1,244	1,156	49	578	1,380	281	541	188	295	877	513	556	429	378	811	548	359	304	300		444	464	479	434					359
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			1,510			65	568	50	35	65	48	82	490	555	760	968	1,140	238	230	508	534	458	239	646	654	506	369		840	942	976	903					1,010
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex								322	45	24	3	6	75	12	37	15	20	27	24	25	21	28	181	20	17	31	14		26	19	14	13					12
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			1,348		4	2		9,136	347	517	419	461	12,282	6,247	9,471	9,066	8,861	6,836	989	1,417	1,516	1,262	7,761	1,439	1,379	1,477	1,550	1,305	1,570	1,843	1,701	1,833	3,363				139,713
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			1,163	29	34																																
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex									2		3	4		146	182	190	122		18	16	6	10		6	17	23	26		23	25	29	15					2,670
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			1,233	624	756	720	688	901	633	592	325	671	1,281	326	347	495	274	420	603	696	724	779	579	729	665	706	709		695	776	835	797					381
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												2,265					2,660				
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			4,434			3	11	556	1,454	1,800	1,173	2,149	1,071	1,954	4,136	2,272	1,687	1,235	1,835	2,847	3,627	3,759	1,230	5,558	4,659	3,279	6,385		7,535	4,734	4,185	6,082					40,420
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			49	4	3				1		1	1		1		2				4		1			1												
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			158																																		
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												1,418									
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			78																																		
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male								1,943	289	244	17	125	1,660	80	147	34	58	1,064	132	156	143	87	909	155	93	93	61		131	127	119	101					129
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												11,628					12,677				
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female						1	1	1,186	115	404	140	241	4,380	242	349	157	399	1,038	318	610	700	422	1,978	751	698	638	721		821	1,002	792	765					22,554
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												2,595					4,532				
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male								2,922	647	655	33	248	1,710	156	271	84	130	1,628	228	284	246	170	1,149	262	187	137	108		252	216	185	198					172
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			1,822	581	741	854	913	586	995	896	436	1,020	989	544	469	750	393	454	1,110	1,183	1,193	1,249	1,086	1,131	1,061	1,019	937		864	863	994	893					198
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			4,012		26	25	8	2,915	1,363	1,551	1,292	1,558	4,053	1,860	2,055	1,797	1,742	2,934	2,080	2,703	2,880	2,820	2,438	3,165	3,107	3,082	3,199		3,413	3,774	3,776	3,899					37,001
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male							1		4,144	5,297	3,800	6,137		5,502	10,976	9,363	7,164		18	8					2	2	7		3	4	1	10					3
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			1,046			34	466	80	28	57	59	60	920	613	868	1,026	1,213	601	191	430	462	396	1,092	513	466	420	305		871	818	755	818					1,205
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female								2,270	1,536	1,548	53	478	490	387	747	193	306	398	468	459	402	336	355	555	411	424	321		573	543	469	437					273
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female								9					135	509	553	1,028	1,154	15	2	1	4	3	3		1	4	7		565	667	546	706					1,710
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male								3,118	1,403	1,421	112	749	810	383	805	276	402	687	694	838	658	539	598	782	522	444	383		713	682	602	597					412
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female									3,565	4,960	2,673	3,916		4,226	7,798	7,694	6,649		4	1					3	1	7		1		2	1					
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												7,223					2,300				
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male					10	9	9	3,174	705	903	817	911	4,720	1,133	1,168	1,056	1,156	3,265	1,307	1,731	1,822	1,845	2,402	2,069	2,029	2,064	2,103		2,188	2,316	2,401	2,441					33,100
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												3,522					1,980				
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male					3	4	6	5,215	361	396	387	419	7,402	583	600	564	631	4,318	636	846	950	892	2,208	1,038	1,021	1,072	1,063		1,177	1,261	1,265	1,307					28,668
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												6,569					6,072				
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												7,372					7,912				
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			2,327	738	821	837	937	4,035	755	800	412	981	3,445	609	530	842	505	1,527	1,068	1,074	1,324	1,430	2,781	1,304	1,464	1,556	1,672		1,338	1,507	1,633	1,510					366
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												1,812					3,219				
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			3,306																																		
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female					1	2	1	145	199	499	163	268	1,096	393	379	245	518	826	454	690	766	613	6,404	957	1,040	815	945		1,170	1,272	1,040	1,055					26,200
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Male				21,885	21,499	22,065	24,996		283																												
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female								2,374	48	343	175	215	7,730	5,711	8,573	7,540	7,886	1,307	611	1,044	986	693	1,316	982	874	894	943	309	1,179	1,175	1,049	1,020					130,476
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female			4																																		
South and Southeast Asia Region	Nepal	NPL	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female								2,077	1,471	1,555	45	576	900	285	641	201	290	819	463	467	384	347	604	535	353	327	264		487	475	386	352					281
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			680	445	492	520	546	110	432	448	200	499	245	290	227	297	200	49	402	484	427	466	429	499	414	475	444		442	433	553	496					122
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,882									
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												7,872					11,705				
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												5,462					6,096				
South and Southeast Asia Region	Thailand	THA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			11,519	1	26	37	43	1,123	3,770	5,824	3,219	4,846	2,306	5,714	9,099	6,032	4,768	2,152	4,279	6,392	5,904	5,893	11,381	6,982	7,573	6,080	6,243		9,230	6,988	6,853	6,729					52,821
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			1,152	649	57																																
South and Southeast Asia Region	China	CHN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				9	17																																
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			1,121	484	545	524	563	928	507	503	253	576	1,389	291	249	389	208	251	468	498	515	555	559	521	551	484	561		463	578	603	597					265
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				186	213	243	224	490	206	155	103	194	534	106	98	118	56	49	146	123	152	198	812	132	177	133	145		131	147	176	212					73
South and Southeast Asia Region	Burma	MMR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				330	372	381	424	2,223	320	375	200	433	1,367	282	218	438	226	410	439	499	630	675	841	596	760	784	911		662	806	977	795					108
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex															1										1	1	1					1					11
South and Southeast Asia Region	Laos	LAO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			693			9	115	13	8	9	3	16	130	121	217	217	300	14	49	100	145	98	38	113	103	100	149		305	311	341	472					525
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								49	16	16	1	9	51	23	21	11	12	56	23	8	22	8	81	16	9	13	11		9	9	17	12					8
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex								10	13	4	1	2	15	1	8	1	3	15	5	6	8	5	20	9	2	1	5		6	5	6	2					
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			3						1	1	4	2		5		4	2		1	2		1			1	2	1			3	1	1					18
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												62					71				
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female						1		18	5	1	8	6	61	16	11	5	20	62	21	27	16	19	214	15	15	16	15		17	12	14	15					329
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												111					268				
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												155					157				
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			55			3	14	26	2	3	5	8	87	27	32	32	47	172	9	18	27	16	55	13	18	18	16		26	32	26	24					30
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								10					33	17	21	14	11	8	4	8	3	5		3	5	4	8		14	22	19	30					27
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female								17					56	5	3	9	7	7		1		3	7		2	2	2		6	4	6	11					8
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								260	4	2	6	3	448	96	62	59	65	114	23	29	22	22	45	19	19	28	25	17	20	24	14	19					711
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			71	31	25	28	19	101	22	25	9	17	120	7	5	25	10	15	21	24	24	28	57	29	29	25	38		21	29	25	36					12
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												62									
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								31	9	8		4	13	8	11	1	6	16	4	5	2		25	5	3	5	2		1	5	2	3					2
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex											1			5	1						1						1			2		2					6
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male								136	47	38	10	16	101	48	43	22	20	102	44	38	40	33	76	40	26	29	16		25	28	37	33					19
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			66	14	10																																
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								11					36	3	3	3	8	7		1		4	6	1	2	1	1		3	4	6	3					8
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,149					1,400				
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				1	1	1		14				1				2					3	1			2	1	1		1	2	1	1					
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								86	43	30	8	19	26	27	39	11	13	33	14	17	15	15	27	22	17	21	15		10	21	13	15					4
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Male				104	88	59																															
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												719					1,302				
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												233					136				
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								111	41	34	12	24	94	35	41	16	21	124	27	35	27	16	103	33	31	22	15		20	23	29	22					14
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male						2	5	25		1	2	6	75	11	20	26	16	101	9	8	12	12	31	8	9	7	7		13	14	20	27					23
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				66	71	68	68	414	43	48	41	66	274	26	19	36	22	42	38	46	67	83	92	60	87	64	96		55	58	71	69					14
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								15					48	2	5	5	6	2	3			5	16	1	1	1	2	15	2	5	3	12	28				7
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												82					89				
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								115	3	4	8	1	195	26	13	8	12	64	10	17	24	28	106	24	18	17	13		9	20	13	27					397
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				22	42	25	33	243	18	23	18	30	155	21	15	17	9	21	18	30	35	51	66	39	33	40	48		32	38	38	40					8
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								26					90	16	23	11	7	5	1	3	6	3	5	3	7	5	5		11	12	18	22					20
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			100	28	23	24	25	243	19	19	8	21	93	13	8	15	10	20	19	13	19	30	67	18	27	30	29	149	22	30	23	28	179				6
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex														2		2	1		2																		
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			100	8	6	9	9	83	10	7	1	10	46	2	1	3	5	6	4	3	8	6	81	5	4	9	9	99	9	8	11	10	17				2
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			142																																		
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			716	243	253	248	272	721	211	214	124	284	924	129	95	181	107	178	182	211	238	334	365	232	277	265	261		187	189	200	193					32
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												533					615				
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male								119	38	48	11	14	42	45	50	18	37	53	58	47	38	48	50	64	37	36	23		51	52	32	35					26
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			54	19	12																																
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								43	8	18	1	6	57	23	19	12	8	51	18	21	18	13	111	24	23	17	8	82	36	18	18	17	71				14
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												788					717				
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male								45	9	10	3	3	18	7	6	5	5	21	14	3	5	12	24	6	12	11	4		8	12	17	16					5
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												294					358				
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												253					190				
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																						4					1		1								
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												321					312				
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex								10	6	6	1	3	3	4	7	5	5	4	2	4	6	4	11	6	1	5	3		3	3	1	2					1
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female								73	25	18	1	13	90	16	28	14	16	102	23	17	18	12	123	19	16	15	13		16	18	18	12					7
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			171	34	25	21	17	166	11	12	10	15	109	12	7	17	8	16	11	22	20	24	86	26	23	24	22		23	19	32	38					21
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												78									
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			47					1,070	17	32	20	37	1,110	151	153	89	95	491	41	33	50	39	212	36	33	38	42	52	43	37	25	40	68				1,106
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								146	35	19	4	14	67	34	37	12	19	92	25	16	16	23	91	30	11	18	23		23	14	11	11					13
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			205			1	25	15	5	13	14	24	45	75	61	74	80	26	41	44	45	44	43	36	47	49	34		59	60	59	53					51
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			130			2	23	24	8	10	10	21	82	64	82	78	78	62	27	33	48	35	158	43	35	42	45		60	60	47	52					70
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												181					193				
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								10	1	1	2	3	16	20	19	11	14	28	3	5	7	5	36	6	4	7	4		19	8	3	9					151
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			248	49	60	52	68	115	36	45	45	66	225	29	27	34	27	49	31	49	67	71	99	50	34	52	57		44	53	31	47					7
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex					1	1		17													1	1		2		2	2		1	1	2	1					
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male								128	35	41	9	17	26	43	43	17	29	36	57	34	40	45	33	54	33	25	17		36	49	42	26					30
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			981	1	6	3	12	151	216	343	213	202	179	308	369	305	215	138	182	212	185	189	407	214	192	175	169		187	178	178	211					1,485
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												726					835				
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male						1		610	15	15	12	18	653	19	23	20	35	300	23	13	25	25	74	19	21	19	23		19	16	22	18					624
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			413		2	5	3	755	111	98	101	96	820	113	157	102	115	263	128	148	123	132	68	122	132	115	117		98	92	107	118					1,432
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male							1	388	42	35	27	25	400	30	40	32	46	224	51	63	55	70	156	49	44	46	50		38	35	37	49					814
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female							1	136	1	1	8	6	256	14	10	2	18	87	15	24	26	19	118	13	11	13	16		8	13	7	18					405
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				9	17																																
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex									2										1																		
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												48					55				
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								79	38	18	4	16	48	26	41	20	26	61	22	19	22	18	63	22	22	24	9		21	21	21	13					9
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,116					652				
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								3					9	6	9	3	1	3	2		2	2	1				3		10	2	4	14					16
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			35		3	2		45	2	1						1				2		2			2	2	1			1		1					
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female						1		38	1	7	2	6	75	43	28	24	29	45	18	17	23	20	81	10	24	24	17		20	16	15	20					384
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			54	72	59																																
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			87			1	9	29	3	11	12	14	98	66	72	63	80	116	17	19	34	33	105	36	19	33	28		40	41	40	54					47
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			48	11	10																																
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			19	2	9	8	5	22	5	2	3	10	27	2	1	7	1	6	4	7	9	13	41	10	2	9	3		12	14	14	6					6
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			52																																		
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex														2	6	2	5		1			6		4	1	4	3		3	10	1	9					4
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												381					135				
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			316	102	112	101	128	585	77	68	46	95	428	56	36	82	49	105	71	84	117	161	179	93	116	145	152		111	100	131	139					27
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female									120	91	85	88		107	109	89	84		3	1																	
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				20	22	20	10	113	14	7	7	13	87	3	4	9	7	14	13	16	12	15	71	12	17	19	21		14	16	21	26					10
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			712	325	282	267	328	887	181	213	133	252	1,072	125	120	164	131	271	235	183	286	358	546	284	283	319	317		223	216	230	241					49
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex															2	2									1		1		1								4
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			454	168	176	184	209	737	118	130	88	191	783	108	63	116	71	150	154	145	219	241	278	168	187	211	234		167	175	167	188					31
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			4																						1												
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Male				1,348	1,119	1,385	1,349		35																												
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												52					242				
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male								63	32	25	11	19	101	27	39	22	22	96	52	46	25	24	147	42	45	32	22	122	43	40	39	32	120				15
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			175	38	27	45	27	166	25	23	12	23	168	12	5	19	5	28	17	21	25	31	47	29	29	35	28		24	24	28	40					19
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								90	46	22	5	19	106	31	32	15	20	101	38	26	30	20	115	24	21	24	13		22	16	15	19					8
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			250			3	2	357	69	78	35	44	355	73	79	46	71	201	68	68	67	77	87	68	73	79	71		73	52	58	81					1,047
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male									362	526	405	439		336	390	314	285		11	1					1		1										
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												158					163				
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												107									
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Missing Sex				3	3	2	5																														
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			70	29	34																																
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																1			1					1			2		1	1		1	13				1
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			192																																		
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								73	25	22	9	9	92	30	24	4	20	91	28	21	20	14	83	19	17	23	14		17	23	19	18					11
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			9																																		
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								26					81	5	4	12	14	9	2	5	7	1	4	4	4	4	1		8	9	20	17					21
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				10	9																																
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								17		1	1	2	54	7	7	11	16	17	1	5	5		57	3	6	7	5		7	9	17	12					15
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								24					74	13	16	13	19	10	3	8	5	3	3	3	5	2	9		20	13	15	24					34
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			1				2	22			2	1	71	11	10	13	12	9	3	6	6	4	117	1	7		3	49	13	14	12	19	74				19
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			307				2	76	64	95	59	69	96	79	75	74	65	79	37	45	47	49	67	54	75	58	54		47	48	48	55					412
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			374																																		
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex															1											1						1					1
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				14	13	13	8	92	12	8	3	9	52	3	3	14	3	6	9	6	11	14	82	10	11	9	12		7	8	9	13					12
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								162	4	1	10	7	254	13	6	7	19	76	11	14	18	19	6	15	28	16	20		15	17	6	20					365
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			1,088		2	5	3	406	196	195	141	163	445	159	198	144	196	223	166	205	204	174	88	174	155	209	198		173	156	150	148					1,707
South and Southeast Asia Region	Burma	MMR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			143	22	39	41	33	161	22	17	8	24	151	11	14	17	11	42	23	20	26	47	52	34	33	33	46		22	33	29	28					20
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male										21		26													1												1
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								194	2	2	5	1	330	6	10	6	21	99	13	14	8	13	23	9	22	9	14		18	19	6	7					385
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												271					262				
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												251					231				
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			40																																		
South and Southeast Asia Region	Thailand	THA	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Female				225	169	155	165																														
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male								219	61	31	11	20	76	25	38	23	32	71	51	32	28	33	72	23	46	35	33		34	31	33	29					17
South and Southeast Asia Region	Nepal	NPL	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex								10	4	4	2		22	6	6	1	2	25	1	12	2		45	4	2	2	3	29	6	1	4	3	30				
South and Southeast Asia Region	China	CHN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			66	62	57																																
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												251					361				
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex															4	1	2		1			3		1	1	1	4		3		1	3					1
South and Southeast Asia Region	Laos	LAO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			42			1	5	4	2	3	2	6	10	10	6	10	7	2	4	3	8	6	8	6	13	5	13		21	10	12	19					13
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male								5,000		1,547		566	372		852		542	258		761		646	228		580		534			669		746					
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male																																8					
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male																									1					1		6					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												991					1,409				
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												2,392					2,820				
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male								400		450		137	1,424		256		162	680		324		219	829		276		229	950		307		357	1,093				
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male																											2					6					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male								1,200		1,411		499	1,386		654		311	950		527		415	661		347		328			389		419					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male								4,000		2,614		943	1,114		1,145		484	544		938		763	497		646		533			701		849					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female										315		87	594		281		175	916		300		262	771		297		265			291		245					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female										354		139	302		390		271	537		422		359	360		404		297			387		379					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female										110		40	356		102		76	350		130		117	723		147		100	829		168		196	811				
South and Southeast Asia Region	Laos	LAO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female																				1																	
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female										240		61	555		193		126	965		240		177	778		246		193			228		175					
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male																									1		1					7					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												614					702				
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male																									1		1			1		1					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female										241		89	178		351		251	243		404		293	239		366		280			376		342					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female										232		68	100		209		141	94		236		198	296		213		273			169		92					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male								2,200		2,281		680	1,489		974		423	840		775		596	514		554		461			531		636					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												614					766				
South and Southeast Asia Region	Laos	LAO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female																	1										1										
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male								600		648		213	1,289		315		130	693		286		234	516		214		201			238		221					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex													255					114							1					20		151					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male								4,800		2,685		817	665		1,265		638	428		1,042		837	367		730		743			865		977					
South and Southeast Asia Region	Laos	LAO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female																																1					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male								1,800		503		126	285		289		188	109		264		208	308		216		212			175		167					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female										373		107	433		347		197	925		387		315	635		342		286			301		270					
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male																																1					
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																														2							
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male																									1		1					6					
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												1,939					2,721				
South and Southeast Asia Region	Laos	LAO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female																				1																	
South and Southeast Asia Region	Laos	LAO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female																				1																	
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female										183		38	324		111		67	423		147		114	537		113		133			137		116					
South and Southeast Asia Region	Burma	MMR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male																											2			1		5					
South and Southeast Asia Region	Laos	LAO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female																				3					1												
South and Southeast Asia Region	Nepal	NPL	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												1,141					1,554				
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			85	88	162	140	459	168	172	165	166		165	204	188	170					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																													1	2	4	4					6
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												629					471				
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																																1					2
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																														1	1	1					2
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			17	20	19	21	12	23	29	29	35		41	53	55	42					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			4	3	6	8	21	12	9	11	10		28	13	21	17					28
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																												6				1					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																																					1
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			122	165	193	217	52	198	228	244	224		200	201	200	218					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												24									
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																													12	20	24	25					
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			61	88	98	101	138	95	94	104	94		94	97	109	111					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			1,249	1,489	2,005	2,134	1,424	2,208	2,411	2,537	2,672		2,884	3,148	3,310	3,534					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			1	1	1	1	1		2	1	5		8	6	6	7					8
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												312					417				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			39	78	90	106	90	119	118	108	112		95	116	124	122					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			240	283	366	394	309	391	474	490	523		588	668	695	774					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												912					724				
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																													5	14	18	17					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																															1	1					3
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																													7	8	2	6					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			12	9	8	14	8	10	7	6	8		8	27	35	23					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												46					70				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												143					193				
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			33	50	52	97	88	83	75	79	105		89	82	65	50					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												58					152				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			28	72	122	146	79	161	170	148	151		113	160	162	154					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			131	166	194	253	140	242	230	232	270		263	297	287	262					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			151	218	316	295	251	268	332	340	351	178	392	459	498	546	36				
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																													2	3	4	2					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			22	29	56	53	44	48	66	57	73		84	97	98	122					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			2	5	7	7	2	8	8	8	9	7	8	12	16	12	4				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												357					486				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			28	25	24	39	84	31	34	30	31		23	28	27	26					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												99					165				
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																													4	10	13	10					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			4	13	12	14	23	18	21	19	25		52	35	37	32					49
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			149	194	237	295	242	278	249	294	374		358	387	321	319					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																				2	2	2	18	3	3		2	6	6	1	2	2					4
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			21	30	67	59	44	57	74	74	82		106	115	146	139					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			21	28	66	57	56	56	67	64	72		88	93	129	142					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																																	5				
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																													4	26	25	30					
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												75					98				
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																																	10				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												156					204				
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			2	2	23	7	30	6	4	6	15		11	8	12	11					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			781	903	1,433	1,333	1,328	1,294	1,464	1,478	1,568		1,566	1,692	1,731	1,813					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												2,357					2,015				
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												42					43				
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			86	99	106	138	82	126	132	144	187		185	230	214	214					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												63					143				
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																																1					
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			43	56	61	62	32	62	60	67	65		55	75	87	86					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																													2	1	2	4					13
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			114	172	203	230	37	177	216	241	246		201	225	265	267					
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			5	10	9	10	116	9	5	8	9	122	12	17	15	11	162				
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																					4						1		1								
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			84	126	150	169	132	169	196	210	205		151	166	156	150					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												23					158				
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																													2	18	23	31					
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			68	151	202	229	58	227	251	235	219		224	240	256	254					
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			16	47	64	88	127	75	84	77	83		71	89	80	91					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												139					176				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			91	144	162	174	92	190	225	248	233		208	217	224	233					
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			35	34	46	61	26	43	41	48	63		66	88	91	93					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												3,956					4,030				
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			12	16	50	39	46	35	35	54	55		66	55	57	58					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												6,754					6,843				
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			536	622	868	903	362	875	1,036	1,083	1,150		1,211	1,323	1,346	1,491					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			4	9	18	17	25	30	23	32	25		51	26	42	48					42
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																														2	4	4					5
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			1	1	1	1	13	1	1	2	2		5	3	3	5					5
South and Southeast Asia Region	Burma	MMR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																													6	9	9	5					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			1,381	1,576	2,221	2,290	1,629	2,275	2,443	2,536	2,684		2,937	3,062	3,224	3,474					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			1	5	12	5		4	11	10	16	1	14	15	25	15					
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			25	66	69	93	35	87	93	77	100		90	72	75	77					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																																	5				
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			2	2	3	4	18	2	6	4	4		3	2	3	5					7
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			7	31	42	48	93	42	53	47	49		53	68	54	52					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												16									
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			11	24	28	40	149	33	40	36	28	154	21	37	28	29	198				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												76					102				
South and Southeast Asia Region	Nepal	NPL	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			115	269	301	357	36	320	347	320	325		297	320	326	319					
South and Southeast Asia Region	Laos	LAO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			12	4	14	17	14	30	25	24	32		49	33	34	47					31
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			3	7	26	22	20	13	23	20	22		19	32	34	38					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												7									
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			12	13	44	26	36	24	38	39	41		51	66	80	90					
South and Southeast Asia Region	Thailand	THA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			822	977	1,384	1,391	821	1,377	1,541	1,586	1,709		1,874	2,180	2,194	2,363					
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								30					231	34	181	214	279	435																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					643		1,047	1,328		1,365		2,083	1,592	1,292	1,701	2,127	2,805	1,574																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								100				9	107	14	20	28	32	33																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					439		1,076	1,377		1,316		2,266	1,623	1,072	1,569	2,119	2,890	1,660																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					2		11			36		47		45	54	64	65	20																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													25																								
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								45					48	6	50	59	103	75																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					117		195	341		229		340	394	243	309	401	475	395																			
South and Southeast Asia Region	Laos	LAO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													4		5	5	6	5																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													15																								
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													13																								
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								100				20	108	55	87	143	164	119																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								100				4	109	8	9	14	18	18																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								3					92																								
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								6					99																								
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					99		126	279		241		334	329	181	244	305	328	350																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female								15					49	25	148	176	224	52																			
South and Southeast Asia Region	Laos	LAO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													28		4	8	8	39																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								217				12	233	22	32	45	53	53																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								25				1	114	15	142	162	275	233																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													48																								
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					721		1,360	1,892		1,832		2,919	2,112	1,652	2,224	2,787	3,522	2,175																			
South and Southeast Asia Region	Laos	LAO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													34		5	5	9	46																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					6		13			31		45		38	48	57	64	18																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					2		11			18		25		20	33	51	53	31																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					3		7			15		19		22	23	21	21	14																			
South and Southeast Asia Region	Laos	LAO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													42		13	22	35	56																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							2			3		4		7	9	10	7	6																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					441		788	892		973		1,439	1,037	910	1,175	1,433	1,804	1,053																			
South and Southeast Asia Region	Laos	LAO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													28					39																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					92		280	256		257		458	305	148	236	389	512	330																			
South and Southeast Asia Region	Laos	LAO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													22		15	28	54	29																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								45					63	22	250	289	509	153																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								15					197	7	73	92	158	302																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					248		373	348		536		801	428	563	721	838	1,078	435																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								5					224	1	21	24	36	339																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								357				16	427	41	79	125	154	94																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													246	2	15	16	25	345																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								40				3	53	8	7	8	9	17																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					9		1			53		54		15	21	24	1																				
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								3					49																								
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													198	7	26	30	42	195																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								45				3	169	47	273	318	445	282																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								5				1	370	23	156	178	246	442																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								554				48	617	86	158	221	280	189																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								5				1	242	6	33	34	63	570																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								5				1	316	10	86	97	129	479																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								60				1	89	72	341	402	548	147																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					4		11			14		24		38	48	51	51	20																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								6					114																								
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					1							1		6	6	6	3	4																			
South and Southeast Asia Region	Burma	MMR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								514				66	812	152	241	383	462	333																			
South and Southeast Asia Region	Laos	LAO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													38		13	26	42	51																			
South and Southeast Asia Region	Thailand	THA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female										3		6		2	4	3	7	12																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								5					269	4	47	50	85	483																			
South and Southeast Asia Region	Nepal	NPL	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								10				1	186	3	36	43	62	218																			
South and Southeast Asia Region	Laos	LAO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													20			1	2	27																			
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								5				1	232	5	27	1	29	412	34	36	37	25	399	51	29	29	24		59	62	38	40					
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								554				48	521	37	72	64	58	136	136	101	136	138	348	54	58	134	137		179	156	123	147					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												13									
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																											8		2	6	5	6					6
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												114					129				
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								5					213	1	20	3	13	248	20	22	19	13	317	29	14	20	12		24	31	20	16					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																											1				2	3					5
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					1							1					1	3	4	4	2	3		5	1	3	5	1	10	1	6	8					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			314		160		355	709		307		313	871	90	129	171	140	796	200	248	257	253	621	255	215	225	272		281	298	284	308					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																											3		1	1		2					2
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												254					406				
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female								5				1	303	9	76	11	32	330	47	39	13	16	451	40	58	38	40		55	55	38	32					1
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							2			1		1		2	3			5	2	12	7	4	15	4	6	11	10		11	16	12	20					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			93		51		205	201		160		197	261	47	69	138	95	249	87	139	149	193	274	205	132	141	246		217	200	144	183					
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								357				16	353	25	36	46	29	66	67	48	31	61	206	20	28	66	70		119	72	75	64					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												510					730				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												1,399					1,342				
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													238	2	13	1	9	251	10	20	16	20	481	25	17	14	9	497	25	21	15	17	558				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male								40				3	39	5		1	1	11	4	1		1	5	3	3		2	10	5	8	7	5	7				
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					4		8			7		9		11	9	3	4	10	12	17	23	28	35	17	22	25	35		33	38	47	56					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												19									
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male								15					186	7	66	19	66	221	58	92	47	70	270	121	63	70	71		107	132	91	72					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								45					48	6	44	9	44	55	60	71	38	59	120	58	46	54	49		67	60	44	56					
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												227					331				
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								45					62	22	228	39	218	112	228	261	127	161	126	251	131	178	151		266	246	182	174					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																																	10				
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													38		13	13	16	48	31	30	33	21	59	25	32	32	55		49	38	46	46					24
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					3		7			9		3		5	2	3	5	7	6	5	11	12	29	18	9	10	21		30	40	28	31					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								30					219	34	147	33	65	305	83	92	53	53	313	113	155	113	94		108	106	127	93					1
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					38		76	271		59		78	333	21	28	63	38	295	22	53	57	61	228	61	61	57	69		75	66	72	75					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												2,639					1,582				
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													42		13	9	13	52	21	27	31	14	63	16	19	9	32		33	27	34	24					14
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male								100				20	108	35	32	55	23	86	106	110	139	147	219	46	80	132	99		137	91	94	88					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													28					36	2	1	2	1	42	1		1		5	1	2	2	2					1
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					3		11			9		5		3	9	15	7	18	12	36	33	36	37	52	33	41	91		84	73	68	99					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					10		12			13		12		6	8	9	12	12	14	39	41	35	35	40	31	34	57		70	54	77	91					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												6									
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																											5		1	2	1	2					3
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																											8		4	5	6	8					2
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													34		5		4	43	7	16	10	10	53	8	10	9	15		11	9	8	14					14
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								217				12	189	11	11	13	9	37	30	14	23	27	65	11	19	33	24		41	31	43	27					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												1,567					3,129				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												150					268				
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			676		326		742	1,492		796		754	1,772	274	307	427	362	1,653	453	648	603	666	1,428	605	521	545	717		649	660	713	693					
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													48														9		26	32	23	58					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													22		15	13	26	27	25	41	55	33	32	42	46	46	77		71	35	45	49					20
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												186					378				
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																																	20				
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			98		40		40	218		86		63	275	22	32	28	25	264	40	57	43	43	165	37	40	33	59	118	54	63	78	67	106				
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												1,040					1,455				
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			500		263		745	1,082		729		793	1,347	278	323	510	414	1,245	411	610	572	642	1,128	688	540	586	676		640	662	574	668					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																											2		1	4	1	2					6
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																						1							1			23					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													4		5		1	5	11	7	10	4	5	5	15	16	27		28	12	21	25					17
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female								15					49	25	123	28	47	45	54	34	42	43	111	82	84	66	63		80	70	73	56					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																														2	1						
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								45				3	164	44	226	45	127	210	108	84	89	102	180	152	173	140	118		121	164	126	106					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												166					351				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												53					295				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male								100				4	82	3	1	5	4	13	6	1	7	3	20	2	1	6	5		20	13	10	2					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												53					101				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male								100				9	82	5	5	8	4	24	7	3	10	11	32	4	7	16	10		26	17	16	10					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					80		149	272		149		164	363	69	80	86	74	326	106	164	137	135	270	175	129	136	157		150	133	159	133					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													20			1	1	25	2		1		30	1		4			5	2	2	4					2
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												4,507					3,882				
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					5		14			32		8		4	9	14	9	12	13	26	35	48	44	58	41	38	77		87	89	100	104					
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								3					49														7		26	15	11	21					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			470		270		528	1,054		498		461	1,318	172	224	320	280	1,166	335	439	476	484	1,132	472	420	404	468		472	498	519	486					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female								10				1	178	2	33	7	19	160	13	10	7	10	291	18	25	10	18		11	13	8	9					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							1			3		3		2	1		2	7	2	21	9	10	26	6	9	11	30		25	9	33	54					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													28		4	4		36	4	4	3	2	42	1	3	5	3		9	2	4	6					6
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male								514				66	612	88	90	144	79	239	246	229	231	305	605	95	159	317	239		339	241	246	226					
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								6					99														11		80	61	50	106					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												484					771				
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																											1		1			2					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												1,214					1,228				
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												247					334				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													15														2		7			3					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male								5					248	4	43	3	35	350	53	58	35	34	291	73	33	50	49		68	86	68	38					
South and Southeast Asia Region	Laos	LAO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																																	15				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													13														1	18			2	2					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male								25				1	112	14	127	20	114	170	115	161	93	85	198	166	90	122	76		170	157	137	115					
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					5		1					2				1				3		2				2	1										
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													25														5		13	7	2	10					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													188	7	19	4	12	143	4	7	5	3	390	1	5	3	3	404	8	2	4	4	333				
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												979					878				
South and Southeast Asia Region	Thailand	THA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			242																																		
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female								3					92														23		33	32	22	22					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female								5				1	353	22	133	22	68	333	50	70	47	50	434	91	125	77	62		86	75	67	42					
South and Southeast Asia Region	Nepal	NPL	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female								60				1	88	71	269	61	147	105	141	109	114	98	128	147	223	174	140		226	229	168	154					1
South and Southeast Asia Region	Burma	MMR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female								6					114														11		65	56	41	47					
South and Southeast Asia Region	Nepal	NPL	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female								530				226	1,020		32			1,026		3		139	1,077		131		21	1,904		6		3	2,258				22
South and Southeast Asia Region	Burma	MMR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female								2,016		40		36	597		53		159			266		268			211		156			93		123					
South and Southeast Asia Region	Nepal	NPL	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male								793				307	1,117		43		5	1,130		5		186	1,107		207		39	2,321		11		10	2,845				39
South and Southeast Asia Region	Burma	MMR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex								244														2															
South and Southeast Asia Region	Nepal	NPL	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex								27				17	135		4			166				16	155		8		2	243				3	224				1
South and Southeast Asia Region	Burma	MMR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male								4,220		137		248	2,576		558		755			1,205		1,261			1,204		1,035			652		770					
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			748					639	230	301	303	327	686	441	391	454	385	756	349	267	255	234	480	145	225	242	210		153	153	167	157					623
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male					633	76	179		12,917	16,410	17,113	15,773		2,535	1,744	2,097	3,064		4,420	9,099	9,451	8,749		11,063	4,694	4,990	9,624		8,760	8,845	8,975	9,203					8,435
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								350	390	421	408	413	396	402	427	434	444	455	438	469	476	459	503	475	493	504	522		526	533	558	569					671
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			30	40	40	29	13	21	23	21	22		24	26	27	27					47
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												5,077					5,640				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			472																																		
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			54	56	57	60	77	66	65	67	72		74	83	88	94					94
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			128			11	17	59	80	69	71	64	68	75	68	74	76	69	138	64	72	74	153	74	77	79	80		95	100	116	119					166
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												2,436					2,589				
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				314	322	342	355	500	224	240	247	245	445	339	345	371	371	310	373	407	428	455	341	438	487	498	512		558	595	606	596					298
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												4,701					4,704				
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			119	139	143	126	54	116	123	126	125		125	142	142	143					122
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								29	118	116	120	120	157	128	135	130	132	170	135	143	158	141	188	151	145	128	135		134	132	135	138					116
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				500	512	560	596	832	371	427	452	473	702	590	580	621	653	617	680	696	741	751	687	783	806	835	872		938	982	1,008	995					486
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			880	892	891	895	840	903	930	944	960		993	1,020	1,029	1,039					1,110
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			455	453	484	499	679	514	537	539	546		548	565	583	593					783
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												3,407					200				
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male								305	474	482	489	502	695	670	722	759	812	759	930	963	1,020	1,062	893	1,112	1,129	1,145	1,192		1,208	1,228	1,265	1,304					1,290
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			32	48	52	40	23	31	28	26	30		31	31	32	31					18
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			960	1,352	1,374	1,519	1,627	1,832	1,315	1,491	1,862	2,088	2,230	1,944	1,988	2,088	2,107	3,176	2,171	2,048	2,179	2,338	3,107	2,536	2,551	2,667	2,764		2,787	2,843	2,847	2,909					918
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			201	212	215	224	283	235	243	253	259		283	293	303	318					372
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												2,843					2,984				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Female				10,359	15,979	16,012	17,479																														
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			5,031	4,079	4,293	4,378	2,393	2,637	3,560	3,717	2,703		2,350	2,369	2,360	2,365					19,719
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			298	312	313	321	314	312	318	337	349		376	383	384	383					554
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												2,423									
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								165	299	313	332	344	455	452	509	524	537	498	553	557	577	599	553	626	638	653	671		683	694	710	727					628
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			1,545	1,352	1,479	1,564	490	896	1,364	1,410	1,265		1,255	1,267	1,288	1,329					6,780
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			597			87	169	260	427	308	294	315	297	433	358	371	392	330	421	414	413	440	432	427	432	476	500		503	499	509	534					893
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex									3	3	5	4		4	2	1	1				4	5			1												7
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			157	154	159	166	160	235	151	149	330	152	248	195	184	182	179	195	159	165	162	169	216	175	174	173	188		178	185	177	180					88
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								107	667	675	676	692	966	910	946	942	967	972	980	998	1,020	1,024	1,165	1,037	1,041	1,067	1,083		1,123	1,151	1,186	1,210					1,321
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			593	604	620	624	591	635	654	663	673		680	714	728	735					893
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,073					1,304				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			1,181	1,008	1,086	1,170	329	747	1,147	1,194	1,001		986	979	1,001	1,031					6,377
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								173	1,065	1,072	1,069	1,066	1,539	1,274	1,291	1,268	1,306	1,546	1,308	1,321	1,352	1,365	1,780	1,381	1,385	1,413	1,441		1,458	1,494	1,518	1,531					1,564
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female								92	812	819	835	838	1,176	1,000	1,013	975	995	1,139										1,438					1,546				
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			238	276	281	305	322	383	294	292	302	306	452	355	325	321	329	430	319	304	305	300	401	298	294	306	319		303	317	322	333					189
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								195	184	179	183	181	222	189	204	206	200	292	196	204	217	229	287	239	244	254	278		280	288	303	311					441
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								687	1,627	1,628	1,647	1,729	512	2,288	2,553	2,436	2,293	671	2,160	1,691	1,672	1,682	2,029	1,046	1,504	1,480	1,095		857	826	831	836					6,811
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								479	523	514	521	516	545	516	557	575	588	617	579	607	622	648	633	645	654	664	672		674	678	689	698					872
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female								286	330	349	350	352	325	336	364	386	392	342										427					517				
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			189	205	205	217	232	212	220	224	227		233	242	249	259					354
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex									133	136	35	36		49	51	49	39		41	38	37	39		33	53	57	57		62	72	80	78					76
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex									1	1	2	9		7	19	21	20		31	34	33	34		35	28	31	41		31	14	16	42					51
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			2,345	2,109	1,934	2,070	753	1,109	1,702	1,864	1,565		1,493	1,489	1,519	1,559					9,314
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			73																																		
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			60	67	70	66	48	54	57	56	56		57	61	60	60					51
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male								352	1,098	1,107	1,117	1,150	1,477	1,367	1,406	1,471	1,512	1,523	1,621	1,668	1,672	1,699	1,681	1,735	1,753	1,769	1,797		1,793	1,811	1,844	1,877					1,621
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												420					550				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								2,432	899	921	983	1,027	2,494	1,368	1,477	1,406	1,311	2,606	1,253	983	1,017	1,037	1,579	660	965	1,008	778		626	632	613	616					5,407
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male				755	634	281																															
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												2,277					2,785				
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								42	264	269	269	272	366	308	311	321	323	375	337	336	344	352	418	361	361	341	343		334	341	321	318					269
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			172	214	233	231	243	251	222	258	273	311	404	358	336	341	348	486	312	336	356	386	515	383	363	370	392		386	403	411	410					99
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				141	140	151	158	214	121	120	129	125	173	166	154	160	189	82	168	184	176	189	155	170	171	177	174		163	175	179	187					121
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												2,731					2,848				
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			82	99	102	82	110	87	99	106	105		121	129	138	134					94
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				200	214	239	252	259	198	207	211	209	289	255	235	239	241	162	230	223	221	225	200	219	227	235	242		236	258	258	261					198
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male								138	1,262	1,283	1,299	1,328	1,698	1,553	1,590	1,525	1,555	1,708										2,117					2,344				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			5						205	240	222	217		234	233	231	185		181	137	126	126		84	105	108	79		66	59	58	62					279
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male								444	697	704	713	737	969	972	986	1,062	1,089	1,039	1,291	1,327	1,356	1,387	1,169	1,407	1,419	1,452	1,480		1,475	1,494	1,518	1,534					1,336
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								160	969	978	973	988	1,360	1,202	1,225	1,200	1,213	1,394	1,283	1,292	1,314	1,335	1,562	1,336	1,360	1,401	1,413		1,440	1,481	1,521	1,528					1,539
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												7,487					175				
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			262			43	77	515	623	617	608	617	585	688	665	687	726	757	727	765	772	780	834	798	839	866	913		932	944	983	1,005					1,729
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												9,120					75				
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			118	126	126	134	145	134	141	147	149		158	153	155	158					202
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex									108	110	106	104		84	98	95	99		83	92	87	86		87	83	82	87		86	80	75	75					101
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			8					64					1																								
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			46	36	32	33	37	58	30	31	31	37	55	59	53	58	56	81	40	34	36	39	106	42	45	46	44		43	50	54	54					18
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male															14	14	14		14	5	4	3		4	4	4	2		2	3	1	2					
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			11																																		
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			21	35	34	22	33	22	27	27	44		27	30	30	39					31
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												1,049					608				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex									62	76	57	61		80	80	91	88		82	65	59	56		34	50	56	56		44	45	44	43					115
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			798	1,081	1,087	1,190	1,280	1,491	941	1,136	1,187	1,251	1,697	1,495	1,553	1,659	1,680	1,740	1,733	1,619	1,686	1,828	1,814	1,933	1,997	2,092	2,142		2,243	2,302	2,314	2,341					986
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								60	206	207	217	223	319	255	270	284	293	338	305	321	335	336	380	341	363	375	377		388	391	408	412					335
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								234	1,106	1,125	1,139	1,146	1,621	1,400	1,426	1,475	1,498	1,623	1,462	1,494	1,533	1,549	1,825	1,567	1,587	1,629	1,645		1,653	1,681	1,700	1,709					1,531
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												1,493					1,927				
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			240	231	242	278	281	363	246	249	259	494	375	318	286	291	276	663	278	230	227	252	600	269	268	267	268		250	256	266	263					155
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				1	1	1	1	54																													
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												855									
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								2,895	2,975	3,008	3,225	3,426	2,806	4,924	5,504	5,532	5,392	3,053	5,273	4,379	4,495	4,677	2,809	2,915	3,853	3,945	3,245		2,755	2,693	2,720	2,759					18,928
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex								10	8	10	11	12	12	19	17	15	17	12	19	18	21	20		22	21	20	20		14	14	13	13					15
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			73	7	8	8	8	91	3	3	4	4	3	4	4	4	2		2	2	2	2		2	3	2	2		2	2	7	2					12
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								684	505	567	601	634	685	784	873	811	723	750	716	519	480	510	528	299	457	469	350		271	267	254	246					2,117
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			93	100	108	109	107	107	115	118	130		134	137	150	161					193
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			592	762	780	844	892	1,182	608	720	739	785	1,074	944	894	990	993	1,115	1,026	905	954	1,174	1,118	1,192	1,256	1,340	1,399		1,521	1,580	1,605	1,648					754
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male				17,705	24,901	26,909	27,015																														
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												598					581				
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex									100	106	105	109		106	111	116	120		100	117	129	130		122	125	121	121		118	115	116	112	150				120
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			185	234	247	248	130	234	251	257	271		293	321	328	333					193
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												1,071					1,236				
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								54	58	48	46	52	62	50	67	67	69	94	62	63	69	71	103	65	70	75	79		86	82	89	105					203
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			122	145	142	160	170	192	119	124	128	125	163	208	198	197	160	82										320					242				
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			302																																		
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			27	37	38	34	43	36	39	41	41		44	47	51	48					79
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex									44	42	44	46		47	51	54	49		51	47	46	41		47	43	44	46		43	47	47	46					48
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			29	44	47	30	49	30	31	34	34		38	41	42	41					15
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female								4,339	4,308	5,166	5,590	5,895	4,124	9,582	10,619	10,960	11,283	4,496										6,775									
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female															1,041	2,690	426		268	226	508	606		323	324	361	367		291	199	218	301					
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								36																													
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								220	233	264	272	286	249	293	304	312	312	312	313	311	306	328	357	334	337	344	355		363	394	396	394					500
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			273	275	280	293	449	297	307	332	342		363	371	378	382					522
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												5,402					5,808				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									9,103	10,083	11,082	10,191		1,600	1,037	1,317	1,775		2,688	6,687	7,401	6,876		8,018	2,538	2,627	8,151		7,351	7,461	7,726	7,875					4,638
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												844					725				
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								203	588	597	611	634	867	804	838	890	932	918	935	970	1,001	1,031	1,068	1,045	1,056	1,087	1,108		1,099	1,118	1,145	1,161					954
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								530	561	577	573	597	603	588	624	638	645	640	628	663	649	652	683	638	628	627	649		655	658	668	716					846
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			1,029					5,711	2,229	2,405	2,641	2,835	6,080	4,041	4,562	4,627	4,564	6,302	4,587	3,974	4,147	4,290	3,836	3,034	3,979	4,074	3,602		3,089	3,103	3,139	3,187					19,107
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			4,022	3,421	3,413	3,670	2,104	2,096	3,201	3,429	2,776		2,521	2,565	2,594	2,610					16,754
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												391					347				
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			36			12	16	431	508	525	548	565	489	577	602	628	636	489										619					752				
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												2,752					3,201				
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			157	167	173	189	164	195	211	223	219		220	224	231	244					311
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			641			153	273	473	747	556	575	624	541	824	687	727	783	617	776	804	820	816	895	843	836	908	943		961	973	1,002	1,025					1,927
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												1,139					1,438				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								4,517	3,128	3,142	3,349	3,547	4,609	5,481	6,246	6,165	6,117	4,931	5,987	4,966	5,038	5,133	3,517	3,150	4,304	4,385	3,459		2,959	2,924	2,927	2,938					20,752
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			49	66	69	73	62	80	82	83	87		87	94	104	104					141
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			159					7,856	5,525	6,700	7,331	7,880	7,981	12,484	14,362	14,477	14,818	8,507										9,547					50				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			2,742					1,342	1,261	1,864	1,767	1,840	1,303	2,400	2,594	2,644	2,376	1,451	2,115	1,734	1,646	1,691	1,851	1,153	1,421	1,419	1,304		1,067	1,080	1,111	1,155					4,896
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												2,811					3,504				
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex								32	405	399	398	399	554	438	415	408	407	581	433	462	471	469	658	462	447	426	431	559	430	429	385	382	470				360
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			6,564	5,495	5,786	5,830	3,900	3,628	4,227	4,366	3,443		2,979	2,889	2,878	2,895					20,772
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			583																																		
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			87	92	102	108	113	106	112	119	125		130	136	139	148					208
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male															1,389	3,456	552		298	295	673	791		361	375	378	412		317	203	222	324					
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								171	190	223	223	237	167	328	345	335	288	203	263	185	171	158	215	93	145	144	111		92	90	88	76					486
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female															6	5	7		7	3	3	1		2	4	2	1		1	1	1	1					
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			3,482					3,157	2,012	2,226	2,410	2,605	3,256	3,651	4,081	4,105	3,948	3,478	3,851	3,363	3,402	3,503	2,480	2,484	3,158	3,229	2,857		2,367	2,382	2,405	2,411					13,530
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			353			99	181	568	720	662	680	731	648	881	787	820	844	765	849	882	903	934	935	972	994	1,016	1,069		1,111	1,120	1,185	1,224					2,154
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			167	231	245	276	302	500	207	231	238	243	310	328	304	303	328	309										510					518				
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male						7	14	332	373	389	401	415	376	411	426	434	440	390	446	466	479	487	516	486	500	508	520		527	547	566	592					825
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								260	1,278	1,296	1,311	1,324	1,753	1,545	1,582	1,567	1,589	1,791	1,624	1,667	1,660	1,695	2,006	1,709	1,739	1,772	1,807		1,854	1,877	1,899	1,918					1,747
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			180	199	204	208	232	212	216	216	224		226	232	238	248					320
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Missing Sex				336	149	176	170																														
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male								89	252	256	263	270	337	327	332	355	362	356	399	402	408	428	399	439	475	470	476		484	497	553	570					475
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			880	1,167	1,251	1,310	1,412	1,491	1,286	1,388	1,436	1,558	2,122	1,736	1,708	1,785	1,804	1,992	1,809	1,850	1,942	2,089	2,037	2,155	2,197	2,266	2,314		2,314	2,337	2,274	2,323					548
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			170	170	176	180	200	182	192	202	211		219	222	229	230					269
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												7,765									
South and Southeast Asia Region	Burma	MMR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			247	256	268	278	280	377	244	254	263	266	337	300	274	277	276	242	258	240	236	265	279	261	244	258	250		249	273	271	285					178
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								296	912	931	934	945	1,291	1,203	1,234	1,288	1,330	1,347	1,266	1,291	1,277	1,298	1,522	1,332	1,340	1,355	1,376		1,396	1,394	1,395	1,414					1,183
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			2,998	2,437	2,407	2,592	1,383	1,454	2,371	2,501	1,853		1,678	1,681	1,693	1,729					14,098
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male						16	34	460	518	506	519	529	521	565	575	587	598	619	608	630	655	668	673	679	696	692	719		724	754	796	807					1,152
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								1,803	592	635	645	667	1,868	923	1,063	1,040	1,015	1,953	1,001	795	799	847	1,103	526	797	799	626		501	494	500	515					4,247
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								3,048	2,934	2,988	3,194	3,361	3,008	4,984	5,668	5,538	5,571	3,297	5,465	4,423	4,519	4,593	3,182	2,653	3,874	3,949	2,832		2,270	2,196	2,213	2,247					17,671
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,428					1,757				
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								2,394	2,744	2,764	2,828	2,902	2,263	4,116	4,428	4,387	4,161	2,515	3,903	3,066	3,057	3,096	2,828	1,812	2,635	2,665	1,937		1,474	1,422	1,409	1,397					10,957
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			1,721	1,455	1,366	1,494	529	867	1,384	1,480	1,106		1,022	1,013	1,023	1,037					8,227
South and Southeast Asia Region	Thailand	THA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			624					2,571	2,381	2,457	2,678	2,824	2,509	4,052	4,664	4,701	4,637	2,730	4,607	3,897	4,014	4,151	2,390	2,862	3,720	3,844	3,294		2,890	2,897	2,941	2,931					19,814
South and Southeast Asia Region	Laos	LAO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								443	449	454	457	453	506	448	468	472	488	587	493	465	464	457	605	458	463	467	483		484	493	497	501					698
South and Southeast Asia Region	Nepal	NPL	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male								248	340	368	376	401	493	545	599	634	667	541	769	800	817	857	607	892	931	954	998		1,005	1,054	1,076	1,101					1,010
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				24	19	24	15	169	10	7	11	16	107	23	9	16	9	20	17	20	23	40	64	24	27	28	27		17	25	31	27					
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			119	11	26	41	19	122	8	9	11	17	100	15	8	15	8	40	17	7	14	31	46	20	25	16	24		15	13	24	16					1
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			41	1	1	4		29	1		1														1												
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			321					94	33	53	30	37	92	35	38	46	31	85	26	22	29	34	51	32	50	55	57		36	52	46	57					400
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male						2	1	19	12	8	10	8	51	9	9	7	9	21	6	11	7	6	110	11	10	14	16		5	8	12	12					21
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																										1			3		1	2					
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								9	8	14	10		10	9	10	7					157
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								19	4	4	4	5	53	3	11	6	6	66	3	4	8	8	47	9	7	9	8		8	1	10	13					12
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												118					211				
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								30	25	27	25		20	26	21	22					10
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male								58	10	13	6	12	60	5	7	6	12	55	17	3	10	14	33	14	14	11	12		10	14	22	22					7
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female								25	21	21	24	25	72	20	35	25	25	87	21	19	27	18	26	23	27	29	24		24	29	26	35					37
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												194					143				
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												987					499				
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												217					356				
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			18																																		
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			1,059					169	147	246	147	146	169	245	221	220	147	170	157	196	168	167	420	158	180	176	182		221	214	171	231					1,599
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												337					358				
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			386	112	92	111	128	507	73	96	72	105	409	87	58	96	76	137	133	122	150	165	240	118	113	141	132		117	123	121	105					10
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,068					1,248				
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			58					1,108	54	76	74	67	1,052	122	93	77	50	669	60	54	65	52	584					90					48				
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			287	82	61	70	66	404	54	36	32	71	258	51	26	57	42	98	72	62	85	120	149	76	75	88	97		90	77	103	86					2
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			120	21	16	20	13	127	10	5	12	7	82	7	6	13	5	15	8	11	9	12	84	14	11	11	8		8	10	12	19					
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								2		1	1		1	1		1					
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																															1						
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												391					249				
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female								130	21	28	19	22	185	45	26	23	19	105	22	28	21	32	98	27	29	27	26		22	36	24	29					346
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								12	9	6	3		9	4	9	10					9
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			111	27	14	32	29	128	14	10	17	17	114	12	3	13	5	26	12	10	8	20	46	16	14	16	21		14	13	14	23					
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				15	16	22	11	84	15	6	5	9	68	5	7	9	4	13	2	7	5	7	69	3	10	12	12		6	5	8	11					1
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								3	9	5	7		7	9	2	6					76
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				47	41	40	30	282	34	20	29	39	165	40	12	33	25	40	43	32	49	59	87	52	48	44	64		43	33	50	47					1
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			59			4	3	4	9	6	6	9	10	15	4	9	7	2	3	6	7	10	61	6	14	13	17		35	13	15	18					25
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																													1		1						
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																									4	1	4		7	3	5	2					9
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex								12	8	9	1	5	21	6	5	6	7	14	6	4	15	9	15	9	4	7	8		4	4	4	3					2
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex															1	1					1						2		1	1							4
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												240					154				
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			70	34	33	41	35	81	16	31	26	44	98	28	12	26	16	46	38	34	50	52	84	34	28	33	40		29	30	29	36					
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												673					1,153				
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			53			3	11	30	21	19	25	21	82	25	19	27	41	181	11	23	27	24	84	24	27	35	32		36	24	31	30					38
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female								108	24	35	19	24	100	37	45	8	27	90	30	28	24	32	38	36	26	34	28		19	24	28	23					12
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												443									
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex									1	1	1			1	3	1	2		1	1	4	2		1	2	2	3		1	1	1	1					2
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female								54	12	20	14	21	171	26	29	22	25	123	38	39	32	34	156					119					108				
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex											4	1		1		1	1				4	3			1												3
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female								39	11	7	2	10	53	10	14	2	14	52	7	7	4	2	37	5	3	9	6		4	9	4	7					5
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex									2			2		6	3	1			3	2	1				1		2		1		1	1					
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			2																																		
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				11	5	14	3	68	8	4	6	6	41	2	1	6	4	6	8	2	1	8	80	4	4	7	1		4	5	5	7					2
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Female				163	196	205	162																														
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male								151	37	44	27	34	148	53	58	24	61	132	67	58	74	61	74	72	56	57	57		54	62	54	55					34
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												59					249				
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male									428	531	356	433		69	48	42	158		208	159	160	174		240	136	123	184		79	41	102	42					32
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								14	14	24	13		15	16	25	14					16
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female								10	11	10	10	16	16	11	18	9	5	35	11	5	10	15	27	3	15	14	4		11	17	4	8					115
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								6	14	18	14		14	12	10	21					239
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												226					213				
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								3	5	1	2		2	1	2	5					1
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								10	8	10	8		8	13	20	11					7
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								12	5	5	5	7	34	4	4	2	4	68	2	4	2	9	46	5	4	6	3		5	7	3	6					5
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								92	23	26	10	25	262	32	31	21	28	223	33	27	31	23	189	21	19	25	27		29	32	33	26					17
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								2	4	3	5		8	5	6	7					13
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			84	9	18	16	10	74	11	11	11	10	75	11	3	14	7	14	15	13	8	23	56	19	12	9	25		15	18	11	23					3
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								6	9	7	5		6	5	9	6					4
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex								12	2	5	1	2	94	13	4	3	6	80	5	15	5	1	63	4	2	4	4	44	9	4	6	6	13				5
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex								12	5	6	2	3	53	6	13	1	5	39	10	11	16	8	30	9	3	7	7		5	9	5	5					4
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male								173	50	43	28	36	290	77	49	30	47	246	62	54	60	44	115	59	37	45	38		34	40	62	58					35
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			291			14	22	15	52	38	24	41	43	84	41	46	49	37	46	43	48	49	84	40	47	80	60		86	44	61	57					90
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												465					388				
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			489	183	133	179	173	626	100	129	103	166	547	122	95	127	109	249	208	147	218	237	498	194	198	210	204		158	167	158	169					11
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			9			1	2	23	11	11	16	15	68	14	9	11	11	10	9	13	10	17	194					75					71				
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female								29	17	17	16	28	85	21	19	16	21	48	9	16	15	14	45	18	23	24	18		16	15	13	31					34
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male				78	71	30																															
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												364					160				
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex											1	3		1	3	5	1		8	11	2	16		5	8	8	15		12		3						3
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												413					639				
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								13	11	10	11		19	17	18	15					5
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												89					118				
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								7	5	4	2		5	2	6	8					
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												125					273				
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			61	4	6	9	13	63	10	2	8	9	38	5	1	3	3	6	3	1	3	4	80					94					15				
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			2						1	1	3	3		3	1	2	1			3	1	2		2		6	1			2	2						14
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								1						1		1					1
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			1,139					443	170	201	165	187	423	205	223	180	161	282	153	236	215	208	133	165	190	200	204		181	160	172	170					1,700
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male								81	33	43	29	44	284	50	53	39	47	233	71	74	58	52	202					175					200				
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female								16	16	6	1	5	46	2	3	7	4	23	3	8	3	4	127					45					25				
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								13	15	10	21		13	18	8	10					213
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								9	11	15	9		8	13	13	8					
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												68					45				
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex										2	1	1		6			1	1	2	2	1	1		1					1		3	4					1
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												1,386					453				
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								4	6	7	3		5	4	7	7					1
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex									2	2		2		2		1	2				1	1		2	1	2	4		1	2	2		17				2
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex									2	2	4	1		3	7	4	2		4	6	2	2		5	2	5	4		3	7	1	4					4
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								1	6	6	15		7	12	7	10					132
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								3	3	4	2		4	2	3	6					3
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female								48	18	24	26	26	73	32	26	15	18	68	19	21	23	32	44	14	27	31	18		27	35	11	26					330
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			152																																		
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female								317	34	43	43	38	427	70	67	51	44	362	33	50	40	38	204					75									
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female								28	7	7	11	12	77	13	4	11	13	82	8	13	14	18	22	11	11	17	12		14	13	17	25					19
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex								12																													
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								62	22	22	9	19	155	34	22	21	22	135	32	14	26	12	114	20	20	22	21		15	22	29	20					20
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												268					108				
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female								185	32	35	20	21	250	54	44	28	36	214	31	29	32	34	144	35	24	43	36		28	27	18	19					22
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												228					380				
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Missing Sex				3	2	5	8																														
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male								278	42	37	25	41	206	34	48	30	56	179	78	47	51	54	96	43	59	64	55		39	45	42	40					35
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male						3	3	28	9	9	7	19	71	14	17	22	9	108	16	14	17	15	62	15	17	17	20		22	12	24	28					30
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												192									
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male				1,131	1,073	1,161	1,124																														
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female								115	41	32	23	40	290	49	36	27	36	243	42	42	44	26	175	28	31	48	22		30	25	29	25					20
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			18	3	3	3	5	17	4	3	3	9	17	1	1	6	3	6	4	2	4	7	40	12	1	6	3		6	8	11	6					1
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								2	4	5	8		3	3	2	5					89
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			211																																		
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			7																																		
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								227	18	29	26	28	313	23	33	23	24	278	20	19	22	25	117	17	29	13	19		25	22	12	17					292
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								139	32	41	35	33	338	59	46	31	42	283	55	53	46	38	157	40	58	49	37		36	42	52	39					29
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male								162	30	44	23	43	110	44	47	27	50	97	70	55	57	58	46	59	55	44	53		45	68	45	29					44
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								92	26	32	17	30	248	42	32	17	43	213	40	36	38	22	120	24	33	35	26		29	36	37	33					27
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								4	2	2	5		5	4	3	1					47
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								2	1	2	4		2		2	2					1
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female								176	18	18	25	18	242	27	31	19	28	135	16	21	21	20	24	12	20	24	25		26	29	20	28					298
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			81	24	24	16	21	169	13	12	11	16	71	16	10	13	11	19	20	11	17	17	67					142					148				
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								2		2			4	2		2					4
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								658	30	36	47	42	615	64	48	40	31	402	37	29	49	36	137	35	27	26	37		28	27	18	28					451
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								1		1			2	1	1						
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								421	77	59	50	55	376	90	66	81	47	295	52	65	69	78	191	46	61	51	67		35	42	32	45					662
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								169	35	27	36	34	244	42	35	27	18	237	21	27	34	24	198	10	24	17	26		21	23	6	18					322
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female								100	39	19	20	25	167	40	54	23	46	148	30	25	41	32	96	29	36	34	24		20	32	29	27					19
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			272					381	80	90	92	82	336	111	122	84	60	265	70	83	85	90	130	61	72	94	91		93	72	63	70					902
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												134					159				
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								1	3	3	1		2	6	1	4					
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												690					725				
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								1	1	1			1	2	1	1					
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female								3	4	4	6	9	9	8	13	6	6	34	5	3	15	11	8	7	15	12	13		11	11	13	20					44
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			461					818	124	114	120	111	777	143	164	117	120	335	101	147	144	121	73	139	144	143	139		131	99	130	126					1,289
South and Southeast Asia Region	Nepal	NPL	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								7	8	11	6		10	11	9	8					10
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								25	26	22	35		42	18	17	26					301
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			288																																		
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female								11	17	17	20	28	32	21	27	20	20	73	18	17	35	30	2	19	29	39	32		16	28	27	39					40
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			111			6	14	32	37	32	42	46	93	67	57	49	44	124	26	30	41	48	147	49	33	52	53		64	34	58	56					76
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												248									
South and Southeast Asia Region	Laos	LAO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			201			12	23	26	46	38	35	58	79	71	63	54	52	81	38	41	62	50	225	51	42	87	72		88	55	52	61					114
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female								39	16	33	29	26	58	45	25	26	24	139	23	33	26	21	375	20	23	20	26		23	14	16	23					268
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex								14																													
South and Southeast Asia Region	Burma	MMR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			431	161	139	152	155	507	107	115	71	174	524	104	68	121	113	165	164	166	177	241	338	172	206	174	179		146	127	133	147					8
South and Southeast Asia Region	Thailand	THA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female									139	161	117	136		29	16	19	38		89	111	47	69		59	60	71	90		31	9	69	34					7
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												2,513					186				
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								5	6	8	17		20	16	12	8					3
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									2,625	2,679	2,919	3,102	4,291	4,323	4,997	4,699	5,062	4,559	4,822	4,154	5,094	5,416	3,480	3,700	3,870	3,902	4,460		3,968	3,717	3,774	3,800					18,944
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												384					524				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female									6,983	7,342	6,743	8,168		408	614	951	1,218		711	5,397	3,754	2,064		5,674	1,725	1,956	101		148	180	384	1,079					3,471
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								234	317	309	343		340	296	335	398					534
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				19	18	19	18		13	27	20	22	41	34	23	31	17	40	14	12	13	16	74	14	17	21	28		27	31	27	27					6
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								57	53	57	63		66	78	81	80					88
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									2,432	2,479	2,754	2,947	2,613	3,798	4,269	4,063	4,357	2,799	4,155	3,648	4,500	4,780	2,599	3,289	3,403	3,430	3,989		3,484	3,245	3,281	3,359					16,992
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				87	97	105	113		81	74	100	93	134	144	121	112	87	41	65	64	85	84	95	82	80	88	138		128	123	103	101					49
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female									3,683	4,153	4,720	5,255	3,878	7,097	8,598	8,348	9,268	4,082	9,001	7,497	7,973	10,137	4,021					6,420									
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex									80	86	73	63		73	65	44	51		41	52	59	58		68	60	65	70		72	65	66	56					80
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								486	1,089	1,026	1,375		1,469	1,442	1,385	1,297					5,999
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				179	193	202	218		215	214	231	218	345	304	238	206	178	215	173	165	179	175	235	180	167	168	230		232	226	213	236					62
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								111	120	130	134		143	138	147	136					185
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									194	221	214	195	232	245	220	168	213	270	213	231	245	261	311	261	272	279	309		315	343	354	327					446
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								392	481	528	538		501	452	492	550					777
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								110	126	139	185		204	228	170	208					74
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									353	352	328	300	469	348	297	246	314	524	295	300	329	345	446	368	357	364	396		384	401	411	385					559
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				829	951	996	1,021		934	983	1,063	1,044	1,713	1,390	1,284	1,073	1,069	1,487	1,064	1,099	1,172	1,187	1,807	1,257	1,174	1,311	1,841		1,900	1,848	1,817	1,845					283
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												507					512				
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				155	171	188	204		129	146	152	158	240	222	158	131	131	150	122	136	148	165	215					239					321				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								724	1,618	1,671	2,012		2,222	1,960	1,986	1,889					8,627
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male									159	191	193	226	640	233	243	221	230	690	219	169	215	238	364	140	161	161	206		186	148	154	152					469
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,762					2,009				
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								9	11	11	19		17	16	14	12					6
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									12	85	99	150	1,052	542	808	903	912	1,259	1,003	1,038	1,108	1,095	1,391	1,086	1,208	1,253	1,259		1,207	1,113	1,159	1,260					1,399
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								753	873	875	928		888	816	809	932					1,054
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									2,518	2,607	2,851	3,027	2,826	4,088	4,677	4,385	4,708	2,986	4,496	3,802	4,809	5,118	3,119	3,427	3,549	3,499	4,141		3,555	3,283	3,319	3,403					16,279
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male						27	120		550	485	496	469	601	726	502	409	563	675	514	590	672	702	765	766	780	805	863		1,372	938	1,003	945					1,823
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									1,900	1,962	2,181	2,358	2,338	3,066	3,505	3,405	3,638	2,503	3,593	3,168	3,878	4,124	2,248	3,008	3,242	3,262	3,774		3,488	3,291	3,372	3,401					17,658
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									7	108	122	161	792	554	654	697	735	924	888	951	1,010	1,034	1,037	1,021	989	983	1,020		977	899	901	1,046					978
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male									16	67	75	101	411	264	398	411	450	468	497	516	538	567	539	610	633	617	677		675	601	601	664					658
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												464					416				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex									84	89	21	23		20	29	18	21		25	24	33	33		29	44	51	56		61	59	68	69					53
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									17	155	187	247	1,176	738	868	968	966	1,390	1,152	1,255	1,279	1,318	1,505	1,272	1,271	1,298	1,348		1,262	1,144	1,113	1,345					1,143
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								14	20	22	40		40	41	30	25					14
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								68	70	69	73		77	80	93	91					122
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									21	135	150	198	1,362	702	960	1,007	1,063	1,618	1,222	1,221	1,283	1,265	1,782	1,318	1,372	1,428	1,501		1,477	1,370	1,296	1,478					1,388
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Male				534	439	361																															
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									445	478	443	408	560	499	408	323	414	597	381	427	484	510	555	516	525	509	528		564	570	584	559					712
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									8	101	123	155	698	398	506	554	590	820	677	736	772	779	911	746	750	791	818		787	723	721	807					687
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									1,742	1,822	2,078	2,292	5,672	2,952	3,358	3,287	3,516	5,926	3,499	3,195	3,901	4,191	2,688	3,180	3,376	3,417	4,069		3,564	3,431	3,498	3,581					16,781
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male									14	109	127	181	1,345	596	1,032	1,143	1,145	1,555	1,271	1,248	1,391	1,456	1,693					1,839					1,986				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									2,296	2,332	2,427	2,519	2,126	3,244	3,591	3,390	3,410	2,260	3,101	2,557	3,255	3,425	2,703	2,324	2,364	2,383	2,773		2,155	2,056	2,077	2,074					9,904
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male						1	11		297	323	303	275	348	351	325	251	300	368	297	318	371	390	422	412	415	425	443		520	482	498	483					720
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male						36	213		315	226	214	199	275	359	183	150	227	302	208	242	275	296	351	297	304	305	319		593	375	379	362					685
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												685									
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												2,034									
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								975	2,226	2,223	2,757		2,700	2,522	2,558	2,446					13,219
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								1,882	3,926	3,918	4,537		4,209	3,799	3,851	3,673					19,220
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex									1	1	1			1																							1
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				717	812	823	847		631	689	728	758	1,304	1,029	925	742	764	823	754	726	816	858	982	883	915	1,038	1,418		1,524	1,494	1,408	1,415					322
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex													1																								
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male						7	22		411	422	384	351	485	460	410	337	372	548	373	431	497	517	542	548	575	584	608		766	643	696	647					1,035
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									31	31	29	28	59	29	32	25	32	75	28	30	39	39	70	42	41	46	49		55	50	53	59					110
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male						1	8		399	446	422	404	456	497	436	337	443	471	400	490	558	587	553					579					705				
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				98	108	117	111		72	83	80	92	125	147	111	98	81	42	60	81	96	98	101					141					171				
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex									22	24	24	23		34	28	26	29		29	23	24	25		22	21	24	26		27	28	29	28					30
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								1,548	3,338	3,331	3,919		3,680	3,434	3,479	3,327					18,453
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												938					1,042				
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								153	179	181	189		190	178	194	211					257
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									666	702	772	816	2,351	1,108	1,108	1,017	1,001	2,429	955	783	1,024	1,079	1,084	765	812	849	982		832	806	835	857					4,501
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								31	36	37	38		43	42	48	46					71
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				180	207	217	234		153	182	170	171	344	251	206	202	186	149	153	168	194	195	199	178	202	244	347		398	404	334	369					105
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									326	352	328	299	367	366	317	247	297	409	282	327	360	362	411	392	426	430	449		466	471	507	481					606
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												2,392					2,426				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									444	470	498	505	1,759	611	767	728	737	1,819	732	588	764	841	765	579	617	609	769		632	610	638	652					3,359
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex									1	27	37	50	307	151	167	165	171	347	199	214	232	232	370	214	242	218	234		214	178	183	194					173
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male									5	40	42	68	291	138	216	229	243	317	324	311	306	309	359	308	298	305	344		303	269	258	371					310
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								181	180	185	192		202	200	209	206					291
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												6,256					163				
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				324	372	376	389		228	273	261	272	540	424	322	291	289	306	262	280	320	339	350	337	375	437	595		666	689	578	595					167
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								51	62	55	98		106	98	87	82					42
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female															6	3	5		2	1	2	1		1	2				1	1	1	1					
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												2,145					2,378				
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female									276	296	283	272	302	332	290	243	260	321	240	300	338	365	389					408					479				
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex									4	13	15	20	124	48	55	42	43	158	71	97	74	71	165	66	85	80	93		70	63	71	71					73
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								94	95	94	112		120	124	134	129					171
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												906					1,079				
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									137	140	107	101	207	132	102	75	107	246	115	128	127	129	196	154	158	160	186		219	225	227	203					312
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												3,010					3,713				
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									428	435	390	340	505	435	402	332	377	557	350	395	466	510	517	528	550	565	584		599	606	618	564					768
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex												1			13	8	7		19	19	632	15		21	12	14	19		14	27	5	16					15
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				106	119	122	116		115	182	118	113	185	169	132	109	103	101	75	81	85	95	133	87	80	89	135		122	122	109	112					27
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												4,550					4,978				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												7,205									
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				729	828	907	974		938	936	1,034	1,042	1,625	1,356	1,188	990	950	946	952	975	1,031	1,018	1,138	1,099	1,012	1,089	1,541		1,625	1,573	1,519	1,550					160
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									3	37	41	82	499	228	285	305	307	519	342	315	355	399	586	381	336	348	355	490	311	257	251	260	411				260
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								38	50	50	78		85	91	72	82					38
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								166	207	213	232		248	230	243	286					365
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									117	135	138	141	157	197	206	201	187	174	170	128	158	146	195	99	105	115	120		114	90	97	87					326
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								138	179	192	198		189	181	206	205					286
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								513	606	610	617		611	547	584	661					795
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									13	155	168	221	1,257	684	957	1,060	1,062	1,477	1,166	1,165	1,223	1,238	1,605	1,208	1,342	1,370	1,395		1,341	1,237	1,150	1,355					1,329
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								613	1,314	1,258	1,585		1,794	1,474	1,621	1,492					6,274
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								1,369	3,049	3,059	3,591		3,687	3,309	3,393	3,203					15,645
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												2,359					2,665				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												8,478					70				
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									7	73	92	129	752	413	628	688	701	881	788	756	853	838	1,028	800	972	1,008	1,053		1,006	896	889	1,122					1,250
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male															8	5	9		9	2	1	2		2	2	2	2		2	2	1	1					
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									15	118	131	199	1,213	591	879	960	997	1,417	1,039	1,044	1,123	1,138	1,563	1,085	1,254	1,264	1,302		1,272	1,158	1,143	1,273					1,361
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												1,078					1,305				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									151	153	143	169		161	176	159	136		134	106	117	123		85	94	92	112		101	85	90	87					242
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male						6	29		46	43	41	41	61	54	42	30	45	65	43	36	43	45	92	51	49	44	46		56	66	74	73					108
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex									49	52	37	43		50	64	55	60		61	50	52	55		32	41	43	53		74	53	50	50					101
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								187	192	196	200		215	206	222	215					317
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												195					253				
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male						13	52		494	486	448	423	545	551	455	358	462	643	470	530	580	600	713	644	683	701	764		1,032	805	843	812					1,499
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male						29	225		578	427	420	406	503	651	414	324	514	553	486	528	590	591	686	658	656	687	721		1,202	794	835	781					1,592
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								8	8	12	27		29	24	20	12					7
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									1,316	1,319	1,352	1,436	482	1,737	2,005	1,822	1,782	551	1,636	1,355	1,730	1,813	1,568	1,276	1,307	1,332	1,463		1,192	1,135	1,136	1,159					5,947
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												2,061					2,526				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									334	378	401	448	642	472	545	515	474	683	460	364	441	457	465	308	318	315	421		345	331	322	322					1,419
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male									915	1,081	1,174	1,317	1,216	1,450	1,613	1,624	1,584	1,312	1,380	1,215	1,395	1,553	1,430	1,044	1,087	1,095	1,302		1,054	996	1,028	1,070					4,080
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												517					480				
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									6	49	51	84	282	126	192	191	190	300	232	226	256	289	337	272	284	269	291		261	234	222	279					243
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex										1			11		2	6	8		4	5	5	4	6	1	4	7	7		5	6	3	3					6
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				109	128	135	151		160	172	187	199	310	249	210	200	166	241	154	180	178	178	296	183	170	182	254		263	258	271	272					26
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								74	103	97	116		112	96	105	124					198
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male									4,704	5,246	6,133	6,954	7,437	9,222	11,397	10,666	12,165	7,891	11,979	10,281	10,850	12,901	6,058					9,005					47				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male									1,530	1,571	1,819	1,977	3,038	2,615	2,941	2,898	2,915	3,219	2,858	2,638	3,053	3,309	2,110	2,440	2,586	2,615	3,092		2,600	2,522	2,560	2,607					11,675
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male					402	18	70		10,144	10,911	10,466	12,201		649	1,008	1,469	2,014		1,217	7,157	3,848	2,643		7,869	3,360	3,871	145		172	240	441	1,408					7,793
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,253					1,463				
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female									6	71	91	127	912	433	686	741	764	1,058	835	802	944	1,017	1,157					1,258					1,321				
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Missing Sex				23	102	95	144																														
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male									15	95	108	133	547	404	476	485	504	672	595	636	672	695	771	739	775	764	808		834	734	766	872					943
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												1,574					2,264				
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									10	62	67	98	393	244	300	323	326	435	394	390	436	452	460	453	459	462	521		499	460	465	513					444
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				473	535	557	582		363	458	462	473	828	613	545	453	441	535	437	434	507	530	611	533	566	661	896		1,035	1,036	913	1,003					260
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								575	1,290	1,339	1,613		1,634	1,514	1,543	1,450					7,705
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				137	153	164	158		125	114	142	143	224	202	158	134	115	80	106	119	141	133	128	118	113	116	188		188	191	161	160					61
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Female				2,548	8,358	9,716	12,273																														
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								259	279	290	311		354	338	340	324					494
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				148	169	177	191		192	221	205	186	283	262	187	157	159	313	144	147	141	142	347	136	128	147	187		182	182	170	177					41
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				1	1																																
South and Southeast Asia Region	Thailand	THA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Male				5,725	14,647	17,189	21,464																														
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												3,986					4,060				
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												1,380					1,766				
South and Southeast Asia Region	Nepal	NPL	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									15	133	155	203	1,014	612	808	853	888	1,212	989	981	1,008	1,037	1,317	1,002	1,042	1,037	1,102		1,065	961	907	1,048					873
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				4	5	7	5		2	2	1	2	3	4	6	2	2		2	2	2	1		2	2	1	2		2	2	1	1					2
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								18	19	18	21		25	43	32	31					10
South and Southeast Asia Region	Burma	MMR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				171	199	216	195		179	158	195	185	257	282	207	183	156	116	122	128	147	149	176	134	119	133	197		193	192	172	171					58
South and Southeast Asia Region	Laos	LAO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									72	79	74	69		92	89	67	66		57	74	95	102		108	108	102	99		94	90	96	89	135				84
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														33		34					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														47		28					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																1					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														1		1					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														25		13					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																																1					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																																1					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														29		26					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														14		11					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male												47			36		123			80		137			106		128										
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														1		4					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														6		6					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														3		2					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														2		5					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														24		12					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														3		5					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														1							
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														2		1					
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female												14			3		14			11		8			6		11										
South and Southeast Asia Region	Burma	MMR	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														1							
Tanzania	Tanzania	TZA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					29,770		44,443			14,033		44,015			33,749		49,645	28,550		24,016		46,116	49,371		21,023		34,116	62,449		33,651		64,582	61,140				23,571
Tanzania	Tanzania	TZA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					36,300		50,555			21,727		46,442			28,876		36,878	28,215		15,240		40,649	55,838		25,550		48,106	41,058		31,738		66,670	44,289				20,581
Tanzania	Tanzania	TZA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					162		3,387			63		62,913			36,915		82,633	31,247				83,661	91,384		1,070		84,993	44,672		2,993		54,801	42,202				
Tanzania	Tanzania	TZA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female																											2,929			1,220		3,561					1,691
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			12		27			28		145			80		105			74		69			73		48			99		88					109
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,091		1,790			7,318		13,544			15,628		14,436			7,180		15,842					4			21		8					18
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1							27			1		4			1		1			10		1			5		1					17
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		2			2		1			1		3			6		2			4		8			5		5					1
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			13		7			7		29			9		35			29		41			40		31			46		43					28
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,171		3,044			5,109		11,017			8,431		9,812			8,301		11,569			9,972		6,372			14,077		20,842					15,348
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			126		81			412		723			1					309		653															
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			4					45		48			3,358		5,422					315															
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			420		512			840		1,649			1,176		1,392			1,447		1,657			1,921		1,313			2,236		2,144					1,340
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			7		6			4		12								10		6															
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3		4			4		14			13		18			18		17			14		28			26		33					11
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			393		518			552		1,213			855		847			817		851			953		659			879		980					528
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1,056		906			1,436		2,941			3,553		5,084			5,484		9,107			15,206		10,046			11,984		9,575					4,597
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			35		48			46		277			122		164			135		154			200		190			247		227					76
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			84		69			65		101			88		328			93		89			160		177			132		95					68
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						67,026					73,992					71,783					73,711														
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			57		42			74		105								41		62					6										
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1					1		28					2								1					2							7
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			6,749		7,452			11,038		26,776			19,687		24,772			24,617		32,415			33,110		21,856			31,251		31,936					18,353
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			5,084		6,206			9,291		22,294			15,014		19,803			17,383		25,138			25,167		17,199			25,051		29,881					17,389
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					3			1		16			4		3			11		9			8		6			2		5					9
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			3,469		4,267			6,433		16,090			10,446		14,453			12,401		18,262			17,638		12,172			18,220		22,977					14,658
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			5		7								1		3					1			5		3			3		2					1
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			335		460			563		988			606		721			678		759			872		607			819		905					466
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								4		16					1			2		1			12		2			8		6					6
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			962		1,272			1,431		3,016			3,021		5,331			4,831		9,652			12,417		10,111			11,908		13,735					6,400
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										336,054					179,809				
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			67		128			129		281			177		199			152		173			134		142			224		252					163
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			6		22			36		58			20		55			34		37			46		59			74		66					39
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1		1					1			2					1							1
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			76		39			37		62			39		67			83		199			77		63			153		345					219
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1,349		1,261			1,838		3,712			3,675		6,020			5,920		11,368			15,917		11,851			14,086		14,793					6,535
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			84		109			110		210			130		186			167		189			219		142			248		279					123
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			99		61			114		98			67		140			140		301			165		190			179		327					209
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected					6			1		5			1		21			1		1			2		9			7		5					6
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			67		54			52		67			87		259			55		59			95		160			117		70					55
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			55		7			11		37			27		56			40		94			49		41			63		78					31
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			22		12			12		10			10		26			7		11			25		48			33		19					8
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			3		1			1		4					7					2															
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			8		20			19		41			19		28			15		17			24		23			34		32					25
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		3			5		16			3		19			7		22			14		22			15		23					5
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			129		123			88		285			282		426			171		688			508		621			929		1,157					215
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			99		121			182		633			290		303			276		335			257		176			341		502					381
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			511		858			1,108		2,206			2,161		3,540			3,890		5,330			7,264		5,178			8,455		11,103					6,763
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			7		10			14		25			11		43			29		21			34		49			39		25					19
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			1,969		2,389			3,771		9,095			7,059		8,441			8,664		11,358			13,251		8,527			12,758		12,218					6,468
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			59		92			99		157			122		286			116		111			105		169			172		161					90
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			149		151			306		549			779		1,250			1,293		1,954			3,366		2,353			3,192		2,243					1,039
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1,199		1,184			1,900		3,424			3,915		5,883			6,227		10,498			16,024		11,513			13,219		12,047					5,859
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						52,295					49,884					51,049					56,821														
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			107		90			123		114			116		210			212		403			233		190			213		398					206
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						64,738					64,460					68,153					71,177														
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			172		256			309		613			366		385			404		404			479		282			490		569					314
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1		3					3			1		2					1			5		18			2		7					1
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			20		1					5			2					1		1			2		2			5		1					
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			7		4			22		21			16		26			16		21			28		18			17		23					10
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected										15			7							3			1		1					1					1
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			10		8			18		10			4		18			14		23			10		14			11		24					14
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			58		64			98		139			106		336			99		107			121		170			166		131					102
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			190		58			113		121			114		192			181		329			244		185			227		231					157
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			3		1			1		21			2		5			6		3			5		8			8		11					5
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			20		7			27		15			16		57			14		41			18		20			18		22					11
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected										12					5			9		2			6		4			2		6					7
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected										6													1												
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		3			16		7			252		207					25															
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			42		40			48		278			104		177			151		173			206		216			253		245					95
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1							9			10		16			6		5			5		5			12		5					8
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			32		22			23		43			33		62			24		80			46		113			57		43					29
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			11		8			14		27			12		30			25		45			31		53			52		60					30
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			2		6			4		10			9		67			14		9			37		11			20		11					8
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			10		9			11		11			8		40			14		18			28		21			31		18					9
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			16		14			22		68			1					62		89															
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						50,639					49,313					59,348					64,257														
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						55,708					64,804					73,316					73,964														
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected															3								1		2										
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			225		227			330		896			457		549			477		601			592		449			621		801					431
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			381		274			716		1,337			1,682		2,550			3,023		4,258			7,452		4,919			5,711		4,266					2,441
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			319		401			543		1,126			669		750			647		815			900		651			847		1,076					487
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			24		50			44		183			67		102			93		108			171		153			158		172					74
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			467		580			945		1,135								4,289		8,873					1			2							
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										186,742					88,502				
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			166		75			131		152			119		209			203		374			279		222			218		320					180
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			11		7			20		24			6		36			16		28			29		15			15		27					13
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			16		29			35		66			115		111			131		268			432		222			459		223					160
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			34		25			38		224			94		136			89		120			187		183			173		185					87
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			6,403		7,335			10,654		26,319			18,529		24,199			22,791		30,038			29,976		20,403			29,075		31,105					18,483
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			3,943		4,779			7,203		17,660			13,703		16,463			16,913		22,094			22,558		15,916			21,673		22,882					13,731
Tanzania	Tanzania	TZA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			2		1			1		22			4		27			6		12			11		10			9		16					18
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			35		48			46		277			122		164			135		154			200		190			247		227					76
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			34		25			38		224			94		136			89		120			187		183			173		185					87
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			335		460			563		988			606		721			678		759			872		607			819		905					466
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		3			5		16			3		19			7		22			14		22			15		23					5
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			2		1			1		22			4		27			6		12			11		10			9		16					18
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			8		20			19		41			19		28			15		17			24		23			34		32					25
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			12		27			28		145			80		105			74		69			73		48			99		88					109
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			6		22			36		58			20		55			34		37			46		59			74		66					39
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			319		401			543		1,126			669		750			647		815			900		651			847		1,076					487
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			16		14			22		68			1					62		89															
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			3		4			4		14			13		18			18		17			14		28			26		33					11
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			11		7			20		24			6		36			16		28			29		15			15		27					13
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			24		50			44		183			67		102			93		108			171		153			158		172					74
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			84		109			110		210			130		186			167		189			219		142			248		279					123
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			42		40			48		278			104		177			151		173			206		216			253		245					95
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1		1					1			2					1							1
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		3			16		7			252		207					25															
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			172		256			309		613			366		385			404		404			479		282			490		569					314
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			225		227			330		896			457		549			477		601			592		449			621		801					431
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			20		1					5			2					1		1			2		2			5		1					
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			7		4			22		21			16		26			16		21			28		18			17		23					10
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			126		81			412		723			1					309		653															
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		2			2		1			1		3			6		2			4		8			5		5					1
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			10		8			18		10			4		18			14		23			10		14			11		24					14
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			393		518			552		1,213			855		847			817		851			953		659			879		980					528
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			20		7			27		15			16		57			14		41			18		20			18		22					11
Tanzania	Tanzania	TZA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			99		121			182		633			290		303			276		335			257		176			341		502					381
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			4		5			2		18			7		1			5		2			4		5			6		9					19
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												2		1					5
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			23		37			33		208			55		92			95		146			143		135			182		148					35
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1																														
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			7		8			6		4			7		5			7		2															1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			350		468			459		743			616		648			654		759			841		533			708		649					296
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		3			3		14			8		12			14		11			12		19			19		15					6
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			3		6			4		8								24		9															
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							3		4			3		12					5
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															6			8		10			24		22			46		41					20
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			4		2			3		10			6		17			12		11			14		2			7		16					5
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			4		11			11		120			28		68			45		56			1												
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			1		1			5		2					13			13		24			43		74			107		208					139
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							3		3			3		4					3
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		3																	2
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																														1					5
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			5		19			18		15			17		20			12		18			29		19			28		19					15
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															1			3					1		1			1		4					1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			2		1								1							2					1			4							
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			3		3					3			57		71			100		59															
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												1		1					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							34		28			48		46					24
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							5		3			8		12					13
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																							3		1			4		10					1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			1					1					1																						2
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			18		38			40		140			48		62			60		91			127		112			106		104					33
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			5		18			28		59			16		32			37		39			49		50			55		42					19
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																																			6
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			1																						1										
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																																			1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			73		107			146		244			181		189			262		314			1												22
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												1		2					1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			2		6			12		6			12		13			10		20			9		3			7		13					7
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1								1										1							1					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			53		102			98		140			113		128			130		159			186		110			190		162					76
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					1			1					4		20			21		31			63		82			127		275					148
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			11		2			16		8			16		55			14		38			21		2			8		12					5
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								1							2			5		5															6
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		1												2					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			13		30			7		17			5		12			7		9			10		8			21		34					26
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy					1					3			2							4			2		2			4		1					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							7		6			18		5					5
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							12		10			33		81					96
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							3		5			3		2					5
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																									2										
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					2			1		1			2					1		1					1			1		3					13
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			4		5			2		20			7		2			1		2			2		7			4		15					13
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																												1		1					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																							1												
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							3		1			3							3
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP													60		60																				
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					1			3							4			9		13															8
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1							1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			4		1			2		3					1					3			4		1			4		7					6
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							4		10			14		11					10
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation			1										1					2					1							1					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			9		3			14		18			13		15			18		20			27		7			7		14					6
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy															1					1			1					1							1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							7		1			10		11					8
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			1												4			1		7			16		23			42		69					29
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							7		27			40		22					31
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							1		1					4					3
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															1					2			2		11			12		13					6
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									1			2		1					6
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			2		3															1			2		1			1		1					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																																			2
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			5		6			4		3			3		3			3		4			2		4			9		22					10
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																												2		5					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			4		2					1			5					2		1					6			4							1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			267		433			500		748			515		584			512		683			796		492			659		537					276
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								2					1		5			9		10			29		47			79		139					96
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			2		2			1					1		4			7		2			3		1			4		1					1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1							7										13															
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			19		22			35		229			56		92			89		156			154		155			163		154					35
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															1			11		1			19		22			21		30					20
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															2			5							1			2		2					2
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															2			1		1			1					3		4					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																									1			4		1					4
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			81		50			363		552			645		423			256		666															
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							129		113			220		293					116
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			13		12			8		18			7		4			23		10			11		7			16		22					17
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															3			8		4			25		31			42		55					27
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									1			2		1					
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			171		196			254		502			394		424			340		535			534		358			493		490					252
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			6		12			6		13			4		5			11		5			13		8			25		37					18
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																		4					2					2		5					1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			3		1			1					5							1					1			1							
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			268		356			473		699			570		628			477		745			799		516			698		652					265
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			9		20			16		18			11		8			17		5			21		13			17		47					18
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			21		20			18		189			51		81			57		113			146		132			107		124					25
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			2		3			2		15			6					2		1			4					5		15					17
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			156		228			283		391			289		300			372		341			430		227			405		351					178
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			2		1								2							2															2
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																									1			2		9					5
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation										1					3			8		8			16		24			29		39					26
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1			2		13			3		30			7		11															
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation								1					1		13			26		29			71		79			136		229					160
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			8		5			15		18			13		30			24		26			31		4			5		16					8
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					1			3					1		14			28		29			63		77			151		245					119
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													176		212																				
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							1		2			1							1
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							4					3		9					10
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			4		4			1		8			3		3			5					9		4			9		20					18
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												3		2					8
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																									1			5		5					21
Tanzania	Tanzania	TZA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP													1															1							
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				91	227	10	15	10,610	45	152	183	673	45,753	1,103	2,021	2,001	1,178	47,106	297	1,421	2,875	4,979	51,824	5,736	5,767	6,188	5,411		5,638	7,354	8,967	8,728					15,432
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												229,495					125,857				
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												229,461					539,274				
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			4,230	479	611	89	581	7,946	291	832	1,214	2,630	69,771	5,083	9,387	9,196	6,414	70,656	1,421	7,712	12,629	25,410	77,726	31,331	32,768	39,398	38,061		45,758	59,073	61,450	62,017					96,964
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				85	196	12	14	6,537	20	123	152	554	67,165	703	2,174	1,765	1,327	70,656	315	1,554	3,100	6,002	77,726	7,550	6,557	7,559	6,986		7,198	9,371	11,938	12,313					20,216
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			1,302	44	102	11	48	2,016	24	89	206	384	69,968	702	2,673	2,440	1,510	70,656	252	1,373	2,880	5,893	77,726	6,995	6,362	8,276	8,642		17,766	31,307	32,278	26,491					27,205
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male												236		7	1	252	125		37	101	211	590		650	811	554	328		1,467	541	269	666					943
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												152,993					807,289				
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female									1			92		1	3	272	127		38	496	209	501		511	663	969	243		1,120	541	286	623					1,513
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				106	117	43	47	10,624	106	177	361	1,293	47,396	3,055	3,955	3,686	2,318	47,106	588	2,823	5,763	11,161	51,824	11,846	11,157	12,922	11,908		12,724	15,930	17,440	16,318					28,909
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			4,318	125	185	29	44	9,175	71	389	461	1,420	68,873	2,801	5,236	4,890	3,752	70,656	792	4,126	7,594	14,482	77,726	17,738	17,406	19,899	18,920		22,588	26,716	29,355	31,102					49,778
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			4,026	257	358	41	312	8,824	154	703	1,006	2,452	68,785	4,757	9,000	8,081	5,736	70,656	1,355	6,457	11,354	22,400	77,726	27,440	28,338	32,363	31,894		37,568	47,263	49,246	48,363					75,970
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			4,326	22	70	3	6	8,371	5	95	97	440	67,105	652	1,432	1,462	1,589	70,656	309	1,429	3,241	7,356	77,726	7,429	6,319	8,094	6,928	114,733	7,171	10,695	12,911	13,078	86,705				21,898
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												344,194					126,836				
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			11,828																																		
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			7,876																																		
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			4,908	824	988	365	511	9,429	627	1,377	3,051	7,715	52,770	13,778	19,454	16,551	10,310	47,106	3,915	13,824	25,072	43,121	51,824	51,701	54,513	62,959	60,110		62,965	74,564	74,582	71,072					103,036
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												152,993					538,622				
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			1,690	276	323	89	156	2,641	189	1,046	1,625	2,616	46,775	5,359	9,617	9,698	6,687	47,106	2,170	6,134	11,681	21,145	51,824	23,689	23,979	27,709	25,867		42,694	50,725	46,782	36,352					38,460
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			3,446	251	410	49	302	4,574	230	520	738	1,879	69,257	3,877	7,437	7,320	4,659	70,656	1,050	5,224	9,180	17,478	77,726	23,057	22,896	28,612	28,544		49,550	82,291	86,103	73,183					80,538
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex				12	3			828		5	5	30		121	113	77	42		7	74	49	69		128	33	4			19	2	3						43
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				30	29	21	40	6,544	44	224	268	1,023	67,520	2,113	3,461	3,397	2,760	70,656	623	3,079	5,461	11,494	77,726	13,256	12,243	14,157	13,434		14,906	18,292	20,653	21,829					36,466
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex				4,488	997	268	373	130,196								8				72	12			56	2												
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			6,684	29	31	11	9	12,028	14	49	73	400	44,949	522	1,067	1,263	1,294	47,106	251	1,225	2,473	5,221	51,824	5,421	4,964	5,446	4,351	76,498	4,853	6,938	8,925	8,531	86,367				13,927
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			5,790	447	677	307	295	11,614	433	998	2,037	5,483	51,334	10,856	14,706	12,503	7,535	47,106	2,332	10,247	19,404	33,600	51,824	39,395	39,683	46,308	43,671		46,495	54,109	54,772	50,030					75,095
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			3,156	867	986	257	438	6,902	568	2,949	4,375	9,233	51,867	17,347	25,420	26,112	18,128	47,106	5,958	16,793	29,843	53,396	51,824	60,509	66,320	79,581	73,010		100,955	118,721	113,607	96,692					104,419
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												229,461					807,943				
Tanzania	Tanzania	TZA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			6,116	288	472	161	153	12,251	226	464	705	2,548	49,613	5,337	7,773	6,718	3,951	47,106	1,119	5,108	9,728	17,665	51,824	20,021	19,759	22,816	22,032		22,735	27,992	29,580	26,088					44,329
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								5	9	4	1		6	4,289	33	44					10
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				60,403	53,052	50,186	43,479	100,887	31,232	32,700	30,763	26,851	145,831	23,768	25,507	24,854	23,453	106,535	18,239	19,214	23,373	28,209	43,553	30,500	32,824	34,885	35,095		35,077	42,330	55,064	64,351					58,376
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			141,226	20,987	11,133	8,739	4,140	1,715	2,709	2,218	2,243	1,941		1,721	4,197	1,761	1,474		723	1,052	788	964		910	939	454	934		1,180	1,137	2,720	3,078					1,723
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			238,301	125,458	55,771	41,580	32,470	131,387	18,354	18,310	14,214	14,494	108,268	11,711	13,349	11,613	10,323	177,455	8,647	9,415	10,961	13,307	128,676	17,660	19,160	17,675	18,632		29,073	47,870	55,452	59,054					36,177
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				104,003	74,119	55,980	33,867	94,622	18,729	21,682	19,128	14,141	86,683	18,742	25,035	26,702	26,261	268,035	19,160	21,023	25,560	33,902	49,053	35,048	36,189	31,369	28,812		28,766	35,192	42,901	50,246					38,569
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												769,712					1,113,263				
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												788,712					219,209				
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												460,760					335,704				
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												1,087,639					1,253,069				
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			408,422	205,882	158,298	146,252	129,079	300,417	83,575	91,718	89,577	80,288	299,828	79,456	87,381	85,762	79,464	194,766	71,907	76,612	85,297	92,425	435,438	155,888	171,160	180,824	179,286		186,695	208,821	232,456	244,130					219,455
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			487,843																																		
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			363,974																																		
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			320,467	97,623	67,959	60,961	52,693	103,432	37,842	38,613	36,274	31,860	134,209	26,801	29,205	28,588	26,934	120,932	21,311	21,906	26,482	31,934	77,720	37,284	39,594	42,926	43,434		48,219	53,179	69,641	77,428					74,234
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												605,846					495,033				
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,355,116					1,407,262				
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				61,792	43,174	36,406	33,585	152,921	21,132	21,574	20,347	18,194	132,523	15,247	16,027	14,995	14,494	22,760	11,202	11,375	13,503	15,995	82,448	17,598	19,310	19,468	19,272		18,969	23,094	28,597	31,287					29,399
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			272,258	98,707	68,662	64,618	57,338	196,402	37,692	41,518	37,619	27,646	248,840	29,196	31,756	30,036	29,963	148,192	22,808	24,602	30,027	37,510	165,739	36,946	41,092	41,947	41,055	45,461	41,005	51,874	67,519	77,805	239,494				69,043
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			396,333	100,001	68,214	62,822	54,656	208,194	33,874	36,032	32,085	24,261	238,961	24,189	25,139	24,282	23,959	58,378	17,912	19,000	23,179	28,556	203,529	28,560	32,756	32,193	31,603	48,350	33,272	42,014	53,473	59,252	461,100				53,198
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			304,484	178,770	89,772	76,438	61,577	154,296	39,848	43,613	38,161	33,274	105,066	28,858	29,245	27,639	23,562	201,142	20,623	19,126	22,846	26,453	212,748	36,907	40,058	43,790	46,273		67,044	107,726	129,676	138,097					82,736
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			245,775	380,893	276,851	244,409	216,190	440,180	142,155	162,277	155,248	134,178	227,519	137,535	147,300	146,696	128,841	173,038	128,093	135,472	149,424	152,885	519,588	255,463	282,325	300,217	291,910		335,378	375,514	406,591	412,242					327,317
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				165,226	104,796	80,597	42,855	139,890	21,953	26,410	22,168	18,290	74,161	19,758	27,831	25,247	23,534	28,296	17,882	20,435	21,909	27,970	117,983	33,232	34,155	27,628	24,775		27,909	36,943	38,681	44,640					31,977
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			123,748	239,095	179,019	155,027	132,440	280,240	86,691	84,915	79,006	68,551	121,205	75,007	76,253	74,625	67,882	72,406	70,836	70,830	80,908	79,787	368,003	125,882	137,960	144,144	140,074		170,705	188,922	198,063	196,378					157,050
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				127,260	18,316	17,403	15,770		10,057	18,431	19,348	14,277		2,124	263	379	2,232		47	346	90	26		124	305	254	421		423	538	878	1,828					4,083
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			735,306	163,562	77,056	52,815	34,843	228,967	17,461	22,646	18,207	13,938	104,108	16,260	24,495	23,285	22,634	342,123	16,165	19,910	21,941	28,510	78,654	29,774	32,922	28,063	25,641	142,446	25,772	36,220	42,146	49,372	162,054				39,725
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			419,863	138,890	106,482	98,300	90,071	273,339	55,983	58,268	58,209	51,094	264,804	49,257	48,913	50,497	49,290	144,966	40,645	44,745	52,208	58,241	390,805	92,490	99,218	105,923	104,809		106,653	117,352	131,628	137,251					130,290
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			342,407	268,338	213,208	201,849	175,367	333,740	112,948	119,010	115,117	100,901	260,089	105,000	116,464	114,281	105,856	196,398	99,997	103,817	111,532	121,615	532,991	209,389	228,473	243,295	241,743		253,921	281,329	309,286	324,930					310,232
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			307,098	126,753	86,002	75,483	63,056	111,025	46,221	49,006	45,218	40,741	138,371	34,997	37,800	35,939	31,965	177,089	25,825	27,215	32,689	37,907	112,966	46,889	50,014	54,992	55,276		60,240	73,857	96,624	108,054					96,385
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			985,363																																		
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												876,073					1,042,766				
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				1	6	5	45		5	15	2	4		2		1	9			21		6															
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				120,528	87,139	38,839	32,857		24,433	41,092	28,927	14,530		16,129	5,362	3,998	1,350		4,284	652	201	34		166	210	329	157		255	192	541	323					172
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			311,001	151,918	99,444	87,341	71,647	150,859	49,978	49,927	46,832	41,271	117,533	35,363	37,504	35,185	31,314	186,908	26,887	26,344	31,402	37,243	201,204	47,482	52,369	57,307	59,360		67,163	82,650	108,328	123,754					110,435
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				61,421	42,140	36,432	32,633	143,102	22,314	23,039	22,113	18,540	143,237	16,559	17,592	17,618	16,766	65,240	12,852	13,381	16,193	20,126	48,485	20,985	22,251	23,867	23,693		23,301	28,246	36,769	42,256					39,299
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				73,961	64,287	58,726	52,258	148,183	33,498	35,940	34,717	30,894	200,458	28,422	27,846	27,185	25,688	62,797	20,541	22,056	25,124	29,432	159,962	36,839	40,453	42,047	41,363		40,922	48,843	58,988	63,078					57,296
Tanzania	Tanzania	TZA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			730,574																																		
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			22,323	8,656	9,138	10,158	10,286	14,607	8,747	9,139	7,724	5,838	14,986	6,332	6,578	6,404	5,564	5,947	4,795	4,979	4,974	5,017	15,812	5,507	5,750	5,399	4,629		4,040	4,186	3,879	3,706					3,673
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			27,909	6,203	6,445	7,272	7,490	16,451	6,308	6,764	5,868	4,386	22,186	4,479	4,596	4,791	4,131	3,443	3,388	3,603	3,539	3,846	12,311	3,915	4,152	3,946	3,406		2,941	3,028	2,985	2,851					2,737
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			19,212																																		
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			49,053																																		
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												15,090					9,002				
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			26,305	7,961	8,151	9,243	9,618	16,209	8,347	8,687	7,746	5,733	19,346	5,828	6,046	6,170	5,190	5,533	4,358	4,705	4,657	4,813	8,485	5,293	5,373	5,218	4,499		3,986	4,071	3,775	3,635					3,267
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			8,777	3,135	2,246	2,388	2,155	15,896	1,932	1,726	1,528	1,082	4,948	1,218	1,289	1,232	1,094	1,615	1,094	1,043	1,027	1,114	14,203	1,292	1,164	1,071	1,032		1,037	968	1,003	951					919
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			17,743	4,412	5,093	6,191	6,525	11,518	5,670	5,695	4,907	3,609	13,031	3,542	3,661	3,781	3,339	12,876	2,455	2,717	2,714	2,874	7,382	2,821	2,829	2,810	2,464		2,082	1,981	1,920	1,867					1,825
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				3,156	3,111	3,538	3,668	16,757	2,893	3,208	2,784	2,173	14,755	2,155	2,389	2,326	2,074	2,555	1,647	1,881	1,868	1,844	7,633	1,882	1,948	1,811	1,651		1,476	1,537	1,520	1,510					1,351
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												39,783					15,823				
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				4,001	4,170	4,964	5,315	14,668	4,350	4,777	4,205	3,293	19,363	3,332	3,333	3,239	2,835	3,283	2,283	2,553	2,666	2,757	7,169	2,775	2,863	2,770	2,385		2,091	2,133	2,170	2,106					1,873
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			1,856	230	150	148	126	190	85	142	78	46		61	50	57	62		49	79	31	40		31	44	14	19		19	15	13	18					15
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												17,422					15,176				
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			27,396																																		
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	<10	Retired Age Band	Missing Sex																																					2
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												9,443					11,710				
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			1,712																																		
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			5,536	955	435	501	469	13,657	453	421	311	237	3,359	225	253	262	195	4,989	202	157	176	173	7,518	194	182	177	148		184	206	167	134					142
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			15,018	4,097	4,291	5,034	5,231	20,038	4,225	4,702	4,066	3,065	21,584	3,161	3,359	3,313	3,053	16,023	2,365	2,713	2,794	2,835	15,636	2,818	2,945	2,831	2,389	3,945	2,128	2,309	2,306	2,348	14,405				2,236
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			16,918	4,558	4,859	5,906	6,197	12,106	5,460	5,800	4,850	3,648	10,437	3,454	3,643	3,642	3,004	15,476	2,433	2,525	2,626	2,819	10,478	2,684	2,713	2,607	2,307		1,959	1,988	1,936	1,812					1,666
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				1,900	564	386	351		214	262	472	212		138	83	81	102		3	16	6	2		12	2	6	9		12	1	1	3					4
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				1,504	1,512	1,452	1,201	4,163	963	1,002	796	594	1,602	800	825	725	554	1,410	523	619	596	538	6,014	556	586	506	415		456	445	436	383					348
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				1,147	1,132	1,091	1,000	3,949	742	773	674	472	4,106	545	662	558	497	12,335	407	416	414	360	1,232	424	499	370	334		333	311	265	274					232
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			16,307	3,710	3,805	4,551	4,759	15,565	4,161	3,991	3,385	2,453	6,698	2,427	2,610	2,595	2,179	11,124	1,808	1,734	1,679	1,792	16,569	1,889	1,911	1,716	1,514		1,317	1,328	1,204	1,257					1,249
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	Retired Age Band	Missing Sex											2																										
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												11,212					2,877				
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			8,026	1,108	903	870	754	6,238	624	621	568	389	4,723	462	554	513	430	13,678	338	374	367	349	2,844	347	391	344	338	1,664	264	303	293	226	1,490				232
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				2,236	1,106	443	438		369	553	807	230		157	56	51	51		54	19	8			4	2	12	6		9	8		4					5
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												30,135					32,395				
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			20,925	7,738	7,267	7,928	7,799	13,446	6,447	6,980	5,951	4,465	9,409	5,097	5,051	5,100	4,122	4,209	3,980	4,049	4,182	4,269	16,820	4,783	4,706	4,279	3,862		3,736	3,702	3,367	3,246					2,723
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			11,756	1,969	1,604	1,847	1,987	14,848	1,629	1,584	1,341	992	4,111	1,013	981	1,060	859	6,300	704	679	750	787	14,761	834	838	780	706		686	660	738	628					446
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				3,119	4,047	4,904	5,512	11,215	4,693	4,834	4,190	3,079	14,910	3,118	3,299	3,232	2,953	12,142	2,162	2,432	2,540	2,613	3,757	2,511	2,592	2,544	2,193		1,792	1,836	1,853	1,851					1,598
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			21,960	4,407	4,054	4,721	4,611	19,817	3,529	4,191	3,640	2,918	26,227	3,011	3,101	3,308	2,712	4,361	2,189	2,430	2,640	2,751	22,518	2,541	2,827	2,742	2,528	5,532	2,237	2,467	2,450	2,556	23,685				2,404
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				2,929	3,159	3,789	4,158	16,422	3,493	3,552	3,010	2,251	12,955	2,325	2,491	2,408	2,209	8,667	1,656	1,880	1,863	1,981	4,503	1,914	1,962	1,886	1,688		1,413	1,383	1,384	1,290					1,319
Tanzania	Tanzania	TZA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												32,132					11,772				
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								15	9	13	18		15	13	19	19					16
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				726	703	650	660	2,518	572	704	707	631	3,759	575	464	511	547	3,053	465	525	498	583	6,578	820	912	930	885		856	842	850	893					987
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																								13	7	5	5		10	3	3	3					5
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				11	13	9	8	130	11	8	10	6	890	6	27	2	10	157	22	2	17	6		12	4	5	42		3	7	6	5					6
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												19,773					26,437				
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex				1	2	3			2			1					1		2					1	1	1	7										
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				3,892	4,212	3,758	3,759	16,079	3,329	3,775	3,564	2,951	14,065	2,838	2,568	2,843	2,713	6,510	2,539	2,506	2,699	2,722	12,285	3,733	3,722	3,378	3,176		3,176	3,241	3,183	3,311					3,299
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												20,428					25,071				
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																								6	1	4	10		8	5	8	10					14
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				2,378	2,414	2,124	2,304	14,142	2,015	2,310	2,351	1,963	11,094	1,727	1,511	1,798	1,881	7,186	1,642	1,682	1,853	1,907	16,055	2,779	2,706	2,733	2,659		2,565	2,485	2,605	2,507					2,738
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				897	951	856	706	2,239	692	670	715	468	2,922	496	647	545	505	522	515	531	561	504	2,783	687	707	593	633		682	689	697	695					624
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				125	109	86	105	2,500	84	91	108	79	2,745	69	217	81	66	383	66	60	84	63	1,184	84	94	108	110		89	76	99	123					111
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												4,449					6,977				
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				3,711	3,744	3,448	3,343	17,235	2,986	3,417	3,385	2,931	14,015	2,583	2,269	2,681	2,559	8,302	2,386	2,441	2,707	2,685	14,871	3,727	3,733	3,611	3,535		3,412	3,471	3,532	3,583					3,556
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				2,952	3,102	2,714	2,549	12,210	2,354	2,777	2,611	2,163	10,941	2,150	2,118	2,068	1,954	3,291	1,926	1,877	1,958	1,939	6,807	2,769	2,780	2,378	2,234		2,374	2,452	2,364	2,350					2,109
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	60-64	50+	Female																								4	4	5	7		3	1	1	10					3
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female				828	837	1,363	1,457		1,023	1,035	1,222	1,401		206	77	123	16		289	108	1									1							
Tanzania	Tanzania	TZA	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				125	34	27	31	656	20	22	26	14	671	21	19	16	25	717	23	28	19	25															
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			409,634	95,213	93,077	105,696	85,127	289,259	59,751	69,264	71,603	63,464	134,832	75,155	80,508	85,784	81,929	131,853	79,239	81,149	79,892	83,356	289,683	123,695	130,589	124,614	122,500		123,960	129,371	125,958	127,165					118,403
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				973	1,188	1,454	1,770	14,834	856	1,069	968	936	53,706	808	647	793	825	5,541	831	833	724	660	10,911	974	1,290	1,125	1,173		995	1,048	1,042	1,060					1,167
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			40,946																																		
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												337,483					337,483				
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			13,653	277	44	59	223	12,352	46	55	56	59	27,339	56	40	31	41	24,258	48	45	38	48		64	88	61	85		126	91	78	173					159
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												424,715					424,715				
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				1	6	5	47		5	15	2	4		2		1	9			21		6		5	25	4	1				5	14					4
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			68,262	57,673	55,378	62,792	49,181	50,191	39,904	38,090	36,651	32,651	39,650	41,308	42,959	44,625	42,502	38,132	44,413	42,863	42,276	42,825	135,032	61,487	64,110	60,144	58,321		63,494	65,557	62,448	62,664					58,859
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				7,384	7,910	9,230	8,917	14,689	5,537	6,688	6,883	6,292	100,961	6,604	5,373	6,367	6,541	46,440	5,235	6,045	5,598	5,820	91,460	8,113	9,503	8,924	8,696		7,734	8,390	8,455	8,664					8,716
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			273,080	50,544	49,785	56,415	50,355	192,474	32,071	36,792	38,506	34,319	199,747	37,967	40,789	43,712	43,504	167,779	40,840	41,669	44,105	45,116	289,726	68,473	71,346	69,549	69,328		66,787	70,766	69,377	70,244					69,958
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												602,531					602,531				
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex			13,653	635	542	387	938	9,743	309	345	321	263	9,275	353	651	736	300	8,392	421	334	390	405		546	486	578	444		514	595	535	650					349
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			341,416	76,268	76,299	86,725	73,737	240,652	47,855	53,183	55,304	48,661	170,774	55,117	61,565	64,708	62,845	160,306	60,476	60,376	61,114	63,256	312,805	96,043	97,823	95,864	95,205		93,126	96,316	94,544	95,536					104,013
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				52,687	55,013	3,172	14,993		24,615	34,370	20,589	14,436		16,043	5,311	3,777	1,202		4,331	287	4	1		6	2	3	4		22	7	2	7					19
Tanzania	Tanzania	TZA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			204,805	27,867	28,512	32,531	29,773	144,795	18,926	20,763	22,052	19,526	174,994	21,531	19,066	22,770	24,502	129,029	20,582	23,477	26,212	27,351	235,112	39,615	39,782	40,491	40,170		38,705	40,144	39,859	39,581					41,065
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			1,177																																		
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			9,014	2,181	2,214	2,436	2,171	9,980	1,318	1,575	1,694	1,575	11,546	1,624	1,487	1,764	1,838	7,191	1,635	1,740	1,899	1,922	16,079	2,740	2,826	2,897	2,820		2,867	2,782	2,772	2,693					2,906
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			18,286	2,944	2,884	3,062	2,457	9,048	1,799	2,149	2,133	1,817	11,245	2,153	2,182	2,120	1,996	3,299	2,033	1,991	1,960	2,022	6,880	2,855	2,956	2,666	2,630		2,627	2,636	2,486	2,550					2,176
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												4,506					7,058				
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												20,551					25,184				
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												19,894					26,623				
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex							2				2														16												
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				567	633	680	632	1,517	327	448	502	510	3,912	493	430	451	455	3,059	380	471	439	472	6,595	621	682	677	636		524	625	598	615					663
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			151	10	4	4	11	243	2		1	4	729	2	5	4	5	717	4	5	4	2		4	2	1	2		3	3	2	11					8
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				54	77	89	87	1,487	46	56	51	56	2,855	55	46	58	32	383	37	35	60	51	1,202	70	66	68	71		55	60	68	78					75
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			12,106	3,496	3,519	3,741	3,187	13,043	2,062	2,466	2,597	2,438	14,380	2,484	2,477	2,690	2,522	8,314	2,365	2,490	2,674	2,643	14,892	3,629	3,762	3,875	3,788		3,539	3,705	3,699	3,708					3,595
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			15,196	3,798	3,986	4,199	3,736	12,117	2,485	2,783	2,824	2,557	14,415	2,815	2,653	2,916	2,636	6,534	2,633	2,492	2,607	2,656	12,336	3,609	3,739	3,561	3,499		3,309	3,431	3,253	3,427					3,383
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female				1,456	1,476	84	371		730	857	621	513		390	205	156	31		175	4	4																
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			2,568	904	811	894	664	1,436	553	480	496	409	2,995	520	540	562	511	523	569	523	477	521	2,861	708	766	689	705		743	688	667	704					636
Tanzania	Tanzania	TZA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex			151	9	10	4	9	152	3	5	5	4	924	2	13	3	5	159	10	2	6	4		6	24	8	4		2	2	6	6					4
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male					140		182			66		213			669		722			2,696		4,495			4,577		5,142			13,458		24,698					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male					302		378			69		291			947		953			4,704		7,139			7,143		8,786			26,093		50,480					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			644		231		197	995		50		24	995		100		150	995		1,259		778	1,522		1,327		1,876			29,548		47,657					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												49,771					41,293				
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					104		19			5					1		43			134		524			347		444			2,305		5,173					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			2,753		420		255	1,930		12		28	1,930		62		82	1,930		779		187	1,142		83		82			73		166					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male					336		210			77		55			391		455			2,914		3,391			3,893		5,728			74,311		120,387					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												244,621					198,896				
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female					75		29			6					2		67			299		642			604		751			3,569		8,071					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female					148		46			974		1,315			326		198			6,080		2,541			1,900		1,967			7,122		15,508					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																									3		1					10					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male					43		77			11		1			164		324			1,468		950			982		1,129	4,877		3,403		9,854	5,014				
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												20,575					23,421				
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												35,998					41,640				
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female					32		8								4		31			63		96			156		268	3,064		1,068		2,908	3,558				
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			158,566		87,671		59,500	255,100		93,921		88,034	255,136		108,420		99,705	255,001		113,101		104,844	268,292		107,056		79,672			113,866		90,510					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			218,254		109,570		78,210	268,591		140,241		127,132	269,530		152,233		150,918	268,183		149,623		147,246	286,259		162,660		136,741			183,871		160,290					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male					695		247			82		333			961		976			4,276		7,972			8,141		8,709			23,266		41,163					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female							11								3		25			82		258			137		245			1,018		2,478					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												447,207					596,709				
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																																10					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female					115		33			9		51			7		134			606		1,417			1,140		1,456			6,156		13,263					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					16		113			11		37			176		435			1,044		1,401			1,340		1,639			3,796		9,454					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					183		179			29		104			428		600			4,738		3,278			3,258		3,654			8,261		17,464					
Tanzania	Tanzania	TZA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												44,717					67,367				
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			360	853	1,638	2,003	50	1,886	2,421	2,524	2,848		2,109	2,363	2,678	2,867					2,234
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			2,068	4,764	7,833	10,043	22,232	11,465	12,206	15,818	17,812		15,485	18,597	23,514	22,395					11,105
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			131	386	655	939		950	1,229	1,243	1,192	1,230	967	1,256	1,650	1,681	2,138				1,912
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			1,918	4,601	7,841	10,581	14,379	9,768	11,978	15,480	16,530		13,469	15,162	18,354	17,678					10,934
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																			1		6	1			6				41	70	69	59					
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			682	1,651	3,244	3,855	113	3,668	4,436	5,248	5,763		4,534	5,124	5,729	5,691					3,997
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			417	981	1,863	2,439	1,608	2,052	2,396	3,420	3,479		2,583	3,512	5,005	5,433					4,971
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												17,109					19,278				
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			209	500	1,001	1,341	5	1,268	1,455	1,604	1,791		1,349	1,539	2,205	2,298					2,539
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																				2	11	3			9	4			253	388	533	404					
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			59	88	155	155	1,256	146	177	209	317		278	488	905	860					695
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			96	306	372	548		521	566	604	607	1,213	528	634	843	813	2,140				782
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			1,358	3,187	5,765	7,636	7,549	7,002	9,012	11,252	12,207		9,959	11,264	13,164	12,948					7,271
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			273	660	1,246	1,635	11	1,568	1,901	2,297	2,406		1,826	2,109	2,874	3,201					3,097
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												30,461					14,995				
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												12,600					42,840				
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			326	873	1,670	2,258	861	2,120	2,513	3,276	3,399		2,593	3,227	4,389	4,866					4,179
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			184	496	724	922		823	1,102	1,040	1,066		892	1,018	1,188	1,243					1,189
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			550	1,518	2,410	2,561	11,333	2,647	3,325	4,377	4,859		4,224	5,964	7,449	6,571					3,053
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												12,425					36,413				
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			115	304	661	810		712	921	968	1,026		802	942	1,327	1,475					1,595
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												30,546					70,686				
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			219	640	1,045	1,498	2,462	1,157	1,423	1,744	2,052		1,814	2,671	4,376	4,761					3,676
Tanzania	Tanzania	TZA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												17,086					25,706				
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					1,137		1,944	13,512		1,851		2,205	64,010	2,270	7,437	10,582	11,413	19,942																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					955		1,940	13,472		1,287		1,707	18,554	2,131	5,157	6,708	7,341	13,486																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					81		148	12		68		192	1,901	201	252	410	501	1,096																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					269		569	2,494		611		611	37,360	824	2,592	3,687	4,074	10,016																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					163		134	3		82		129	1,756	117	313	357	335																				
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					178		438	693		217		306	1,943	208	446	639	755	982																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					212		476	528		251		348	2,068	320	638	941	1,096	1,584																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female														2	1		1																				
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					444		574	2,003		387		611	10,458	654	1,601	1,965	2,034	147																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					97		107	7		60		177	11,759	98	218	263	294																				
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					677		1,049	4,602		712		1,155	16,623	1,291	3,417	4,277	4,586	7,170																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male														6	1	2	1																				
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					203		373	710		223		366	9,053	343	711	943	1,064	59																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					157		233	36		161		256	2,036	239	511	662	761	1,408																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					242		225	215		172		232	8,008	167	461	551	513																				
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					29		67	234		24		43	3,408	35	90	107	173																				
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					180		335	89		205		299	2,144	311	603	846	961	1,619																			
Tanzania	Tanzania	TZA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					87		111			56		160	1,932	139	299	377	374																				
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					182		209	2,048		314		236	35,636	553	1,779	938	491	9,068	1,372	2,050	1,512	1,361	18,897	2,424	2,382	2,598	2,716		5,567	5,757	5,735	4,759					2,574
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			205		203		148	1,573		191		280	10,591	357	956	350	221	147	1,319	2,085	1,708	1,450	189	2,416	2,134	2,174	1,824		2,335	3,019	3,615	3,787					2,767
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					41		82	583		94		156	8,760	199	521	197	114	31	635	1,120	995	799	84	1,143	1,049	1,048	882		1,204	1,426	1,823	2,026					1,396
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			1,365		529		538	11,518		977		915	59,423	1,516	5,384	2,569	1,236	18,090	4,326	6,786	5,322	4,690	37,057	7,527	8,660	9,292	7,938		13,765	16,940	17,006	15,138					7,868
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					100		213	78		95		146	2,098	158	299	262	191	1,541	716	1,389	980	1,090	1,413	1,328	1,495	1,556	1,625		2,113	3,032	3,776	4,386					3,458
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												50,912					108,749				
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			92		135		278	446		113		180	2,053	172	375	308	227	1,496	861	1,547	1,052	1,098	2,679	1,441	1,715	1,668	1,688		2,485	3,771	4,205	5,194					4,314
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					17		41	193		11		29	3,298	19	61	42	51		132	245	221	195	2,085	249	262	277	205		484	693	808	1,116					678
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												21,001					65,909				
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												50,767					23,069				
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												28,517					29,660				
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					103		83	184		77		92	7,650	58	247	90	56		294	531	499	464		484	478	453	376		422	633	792	963					801
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												28,478					39,547				
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male														6	1	2	1		4	15	9	13		6	11	17			51	22	11	23					
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			418		290		251	3,878		345		588	16,285	784	2,144	765	522	6,500	2,531	4,188	3,154	3,131	12,577	4,778	5,128	5,026	3,979		6,039	6,893	7,948	7,721					4,951
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					41		37	7		23		105	10,943	47	137	46	27		147	327	266	262		238	261	318	217	2,024	270	426	572	664	3,295				535
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			1,403		369		417	11,299		615		791	17,509	1,280	3,162	1,378	889	12,331	4,032	6,329	4,789	4,558	23,969	6,552	7,811	7,551	6,181		9,048	10,929	11,777	11,006					7,750
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					93		90			31		45	1,649	52	113	74	50		232	507	415	413		453	475	491	509		522	769	1,083	1,291					1,233
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			92		124		265	584		95		184	1,827	115	283	205	164	879	589	1,129	715	654	4,095	869	1,047	1,194	1,080		2,109	3,622	4,091	5,236					3,065
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					31		83	9		36		102	1,790	122	146	131	85	1,032	389	855	707	664	9	726	798	890	849		948	1,395	1,703	2,102					1,775
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												20,708					56,020				
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female														2	1		1		3	6	6	1		4	4	3			180	99	164	189					1
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			97																																		
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					78		144	23		69		117	1,929	143	238	177	140	1,306	573	987	858	786	20	956	1,061	1,073	1,091		1,311	1,982	2,393	2,804					2,569
Tanzania	Tanzania	TZA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					33		64			16		79	1,813	66	147	88	42		277	541	453	444		503	533	542	528	2,050	632	947	1,251	1,595	3,291				1,405
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											114					153					153
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				47	54	36	57	712	48	44	43	33	369	24	23	21	21	237				128	157				109					97					64
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												2,517					2,773				
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											114					136					130
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											91					89					109
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											67					85					99
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				340	316	276	274	935	312	286	224	229	1,276	253	237	244	218	1,164				900	753				914					806					681
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				90	127	92	66	340	82	111	118	77	72	93	113	82	53	24				246	23				231					154					104
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				451	529	435	473	1,039	399	603	504	398	1,766	459	471	477	471	1,112				1,796	742				265	762				454	919				427
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				246	224	197	225	712	201	280	184	164	998	198	185	179	168	962				704	841				702					631					573
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											690					357					281
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				119	96	95	92	341	81	120	110	79	116	93	92	87	58	115				265	69				213					142					110
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				79	109	54	78	910	80	71	56	51	377	63	66	62	41	142				157	175				201					160					117
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											538					259					186
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				83	100	80	69	702	72	97	76	63	328	70	81	75	63	228				267	215				285					215					183
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				131	115	89	110	383	98	88	92	70	318	74	79	76	77	262				245	181				288	135				219	197				118
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												897					901				
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				254	312	245	268	974	301	331	267	181	985	238	217	242	195	923				892	641				945					783					769
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												2,543					2,856				
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				306	417	358	309	1,037	393	574	459	371	1,488	368	421	438	378	1,125				1,509	950				313	976				385	1,152				364
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				285	229	219	256	755	239	289	232	196	1,249	230	206	227	191	1,375				758	1,102				769					654					608
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												67					64				
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												231					257				
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female									1																												
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				249	261	180	201	868	178	236	206	166	1,069	212	170	194	169	854				710	588				657					612					518
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				358	341	299	328	923	289	336	252	243	1,308	288	227	263	244	1,223				976	771				1,026					880					724
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											61					81					89
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											97					106					123
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												364					436				
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				45	48	45	49	908	50	52	34	19	203	18	30	25	14	177				121	108				92					81					67
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				257	242	162	185	729	173	309	207	188	898	214	208	222	204	629				742	544				808					710					603
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				150	155	122	97	839	118	139	99	89	600	95	96	91	89	403				342	332				351					294					253
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			9,702																																		
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			2,220																																		
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												1,569					1,815				
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				147	144	121	120	745	147	166	104	103	706	131	114	119	95	670				464	597				523					386					337
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			7,549																																		
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				16	8	8	7	323	6	14	5	5		3	9	9	3					16					22					11					10
Tanzania	Tanzania	TZA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				203	221	190	206	751	225	304	188	180	755	222	201	190	159	700				710	531				753					636					557
Tanzania	Tanzania	TZA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female												1																									
Tanzania	Tanzania	TZA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			18,658		4,278		14,162	29,714		10,252		8,373	26,972		7,964		6,123	38,070		4,716		3,111	11,123		3,151		2,599	10,330		1,764		1,412	3,374				1,002
Tanzania	Tanzania	TZA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			82,589		30,920		92,387	177,281		79,913		54,560	202,859		57,605		42,830	157,458		41,509		30,047	98,519		31,995		25,423	89,667		19,028		18,022	38,736				19,515
Tanzania	Tanzania	TZA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male							6													1					1												1
Tanzania	Tanzania	TZA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			150,421		63,739		196,103	262,820		148,035		103,075	306,163		107,132		77,261	182,004		76,140		57,645	130,206		59,797		49,596	101,776		36,422		33,862	89,273				31,801
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				737	847	821	851	4,818	883	1,055	935	784	2,941	850	840	863	842	2,947	872	843	954	1,062	2,954	1,023	1,007	1,055	966		828	870	853	856					999
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				706	700	669	702	4,023	713	756	641	527	1,742	624	645	716	663	1,739	692	713	744	799	1,763	704	806	835	725		693	680	697	652					744
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												9,910					9,910				
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				174	199	148	131	1,848	151	200	126	105		133	177	165	117		124	170	180	156		126	162	161	96		122	149	79	106					59
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				178	234	197	230	2,429	202	231	210	208	1,073	186	173	220	184	1,073	217	239	236	214	1,085	202	235	221	192		181	190	176	192					192
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			8,988																																		
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				601	509	520	578	4,016	517	581	527	437	1,116	536	478	576	495	1,125	493	569	562	640	1,154	628	576	593	611		496	546	456	520					534
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				876	871	785	854	4,076	741	903	836	774	2,904	812	732	847	842	2,891	855	862	915	1,010	2,904	920	979	1,007	915		842	816	794	836					802
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				504	497	523	588	2,920	519	651	538	519	3,805	527	532	592	499	3,828	485	518	585	656	3,842	547	607	574	503		471	501	417	478					546
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male							1				2	1			1		1				2			1	1					3	1	3					
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												7,457					7,457				
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				1,168	1,451	1,366	1,532	4,136	1,357	2,336	1,814	1,958	5,043	1,683	1,828	1,995	2,215	5,062	1,665	1,755	2,132	2,604	5,119	1,853	2,054	2,071	1,849	5,119	1,472	1,474	1,553	1,643	5,119				1,854
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				941	942	879	901	4,294	952	1,003	865	875	3,433	854	818	940	903	3,415	836	917	931	1,039	3,428	953	1,017	958	964		866	903	816	911					907
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female							1				2	1			1		1				1				1							2					
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				910	949	856	966	4,378	914	1,145	907	884	3,530	942	856	1,001	1,017	3,532	939	969	1,018	1,195	3,528	1,034	1,124	1,200	1,056		881	947	891	925					955
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												5,928					5,928				
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				402	413	416	463	2,995	530	637	498	516	1,788	515	472	487	461	1,797	479	510	566	586	1,805	530	536	586	472		445	416	410	443					575
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			32,533																																		
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				2,291	2,455	2,491	2,730	4,874	2,389	3,677	3,037	2,849	5,306	2,952	3,117	3,413	3,583	5,298	2,854	3,188	3,487	3,991	5,334	3,208	3,502	3,511	3,117	5,334	2,708	2,790	2,886	3,102	5,334				3,143
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				405	423	411	435	1,901	514	744	558	591	481	592	489	574	524	476	624	616	753	829	476	527	655	625	526		389	390	402	358					347
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				402	408	351	365	2,622	343	451	357	349	1,242	378	368	398	366	1,231	381	372	415	438	1,227	381	481	416	341		294	350	313	356					342
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												664					664				
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			19,427																																		
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				387	406	397	399	1,978	428	528	407	445	914	418	442	511	437	917	432	450	564	615	921	456	501	554	520	921	394	442	421	413	921				445
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												2,312					2,312				
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				471	510	457	543	2,910	443	747	577	565	1,823	536	511	552	556	1,803	507	571	613	638	1,810	543	628	655	521		442	493	472	482					563
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												1,977					1,977				
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				460	477	476	480	2,767	530	539	437	426	2,611	459	448	534	399	2,582	440	488	506	482	2,601	479	524	544	471		406	440	442	399					458
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				260	280	232	278	3,978	271	302	236	185	811	234	235	219	261	814	267	278	291	286	823	226	275	242	251		228	230	196	215					207
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												4,667					4,667				
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				572	541	543	558	2,842	500	695	528	504	3,330	550	488	548	538	3,320	527	545	639	687	3,327	574	588	601	496		520	459	528	494					574
Tanzania	Tanzania	TZA	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				911	1,157	926	881	1,893	1,080	1,678	1,002	1,128	169	1,378	1,310	1,324	1,157	172	1,135	1,456	1,477	1,304	188	1,049	1,472	1,387	1,042		852	907	724	806					654
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			100,334	90,129	95,935	100,917	108,495	148,840	112,414	117,944	124,034	129,746	144,459	132,117	135,854	140,139	144,992	153,820										180,325					183,212				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				107,299	112,251	114,325	120,861	110,504	124,918	129,852	133,056	137,473	129,525	138,273	141,829	142,719	143,905	146,518	143,739	145,324	148,367	153,062	147,824	156,791	160,000	161,381	149,031		148,623	149,607	151,853	155,015					152,608
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			21,326	7,734	8,770	9,504	10,167	25,997	11,120	12,215	12,146	12,053	27,497	12,484	12,880	12,889	12,732	18,779	12,939	13,160	13,239	13,385	33,729	13,876	14,470	14,425	12,441		12,354	12,525	12,827	12,790					12,591
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				79,386	84,653	89,620	98,348	99,382	100,926	103,968	107,560	110,101	98,534	112,539	116,306	121,652	126,965	118,749	128,338	129,413	131,349	133,745	128,412	136,080	138,563	141,354	133,557		135,728	137,217	138,414	140,099					146,505
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			22,178	14,742	16,235	17,175	17,477	31,191	17,833	19,022	18,623	17,750	32,947	17,870	18,696	18,878	18,767	19,904	19,022	19,244	19,501	19,250	32,523	19,933	20,630	20,405	18,183		18,196	18,527	18,700	17,932					17,376
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			53,709	55,221	56,127	57,903	75,248	59,039	60,754	62,996	62,819		65,119	66,020	65,236	69,247					78,185
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			116,518	65,802	71,746	77,452	81,772	108,314	86,778	91,645	92,881	92,758	99,675	93,865	98,147	100,971	103,045	101,908	103,830	103,819	104,582	105,109	113,530	107,640	111,506	111,980	94,756		91,893	90,326	90,056	88,042					86,456
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												114,981					77,844				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			55,965	30,841	33,913	35,912	38,484	64,281	41,400	44,598	45,277	45,779	69,686	46,397	47,718	47,911	47,571	62,662	47,774	48,015	48,477	49,563	70,778	51,193	52,839	52,542	42,091		39,875	38,869	38,964	38,132					34,863
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			81,314	85,707	89,836	95,622	89,385	99,725	101,791	103,661	97,203		98,739	100,642	103,257	111,403					118,245
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			31,528	32,876	34,718	36,299	28,733	37,547	38,219	40,354	39,206		40,635	40,882	42,449	45,583					52,560
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				46,015	50,182	53,249	59,510	95,690	61,964	64,639	66,275	67,317	86,595	68,183	70,655	73,977	76,877	78,261	77,313	77,449	78,341	79,638	85,797	81,134	82,873	84,206	76,679		76,409	76,160	76,350	75,625					76,571
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				1,222	999	1,940	1,510		1,184	1,076	1,184	663		641	421	203	6		2,161							1											
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female				3,151	2,965	2,915	1,762		1,376	2,749	3,080	1,675		1,501	1,241	857	5		4,218	66																	
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												266,404					232,146				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			34,452	36,088	37,702	39,333	32,798	40,799	41,497	43,242	40,364		41,555	42,341	44,466	47,747					50,807
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			113,635																																		
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				53,145	57,004	57,451	61,784	98,441	64,684	68,402	70,128	71,717	99,722	72,386	74,656	75,199	75,834	86,768	75,621	76,011	77,792	79,721	95,700	81,619	83,717	84,342	73,137		71,192	70,426	71,174	71,950					68,475
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			38,487	39,197	40,090	41,362	55,967	42,207	43,324	45,031	43,911		45,044	45,488	44,764	46,559					51,739
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												50,095					38,154				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			37,812	15,127	17,369	19,982	21,757	44,345	23,684	25,165	24,839	23,999	44,796	24,202	25,320	25,866	25,759	35,253	26,200	26,146	25,901	25,857	50,696	26,441	27,684	27,439	22,302		21,504	21,093	21,026	20,424					19,952
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			14,581	8,465	9,213	9,664	10,214	21,571	10,280	10,761	10,885	11,157	22,577	11,245	11,448	11,909	12,312	16,523	12,424	12,554	12,804	13,039	23,376	13,291	13,494	13,596	12,745		12,909	13,189	13,275	13,398					13,223
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			53,217																																		
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												88,156					80,994				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												35,999					25,811				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												276,620					224,555				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												479,969					468,318				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			134,305	106,994	113,640	119,294	125,448	143,514	128,287	133,398	135,172	136,321	147,880	137,043	142,286	147,511	152,344	143,519	153,344	153,500	154,307	155,501	147,327	158,161	162,303	164,805	150,609		150,136	149,371	149,136	146,380					146,103
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			4,250	572	546	555	555	2,867	492	475	505	424	2,880	324	282	266	259	462	277	277	307	317	634	348	362	336	276	322	247	289	308	296	268				272
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			25,257	26,204	27,326	28,591	26,057	29,559	30,213	31,354	29,129		29,435	29,973	31,399	33,715					35,343
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			25,463	26,206	27,393	28,683	23,549	29,669	30,283	31,678	30,346		31,234	31,569	32,436	34,400					38,711
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			140,818	97,094	102,447	105,821	109,376	138,846	113,807	120,654	123,138	126,143	128,829	127,168	131,128	131,539	131,267	136,126	131,018	132,672	135,607	138,984	142,263	143,837	148,357	149,177	129,356		126,181	125,149	126,916	127,246					122,749
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			35,733	23,470	24,859	25,062	25,710	35,034	25,790	26,505	26,481	26,437	31,604	26,636	27,092	26,919	26,788	40,342	26,856	26,980	27,062	27,136	36,500	27,570	28,094	27,990	25,665	29,101	24,709	25,932	26,906	27,076	25,874				26,252
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			138,827	127,614	134,605	141,727	152,394	168,576	157,491	163,525	172,472	180,683	175,865	184,625	189,161	196,033	202,478	198,560										252,436					272,466				
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			66,645	42,698	46,777	49,714	53,662	78,274	56,936	59,946	60,832	60,735	87,166	61,348	63,645	65,982	67,619	75,299	68,206	67,654	67,757	68,023	84,595	69,385	71,781	72,739	62,400		61,143	59,730	59,342	57,015					54,880
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			49,790	37,155	41,176	43,017	45,725	65,535	48,067	52,717	53,148	53,280	62,603	54,403	56,228	55,681	54,702	59,541	55,001	55,147	55,535	55,574	72,626	58,044	60,927	60,045	49,222		47,933	47,449	47,680	44,821					40,161
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				9,785	10,269	10,200	9,968	23,607	9,972	10,302	9,784	9,351	11,109	9,156	9,124	8,844	8,213	11,221	7,942	7,718	7,623	7,240	16,621	7,254	7,248	6,973	5,865		5,520	5,568	5,608	5,300					4,955
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			55,178	57,503	60,179	63,749	71,076	66,053	67,432	68,745	62,379		61,947	62,664	64,250	68,951					70,384
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			182,026																																		
Tanzania	Tanzania	TZA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				20,368	21,752	22,219	22,584	25,528	22,718	23,267	23,107	22,931	27,452	23,006	23,330	23,074	22,573	35,165	22,354	22,151	21,912	21,589	34,221	21,347	21,403	20,843	18,341		17,294	17,829	17,807	16,831					14,838
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female				561	414	42	28		30	209	264	190		118	108	53				5									3								
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				1,150	1,322	1,254	1,081	4,398	933	1,042	836	679	1,554	745	753	678	556	1,362	593	670	619	581	5,725	598	649	553	439		477	500	462	441					403
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			15,855	3,870	4,559	5,258	5,675	14,090	5,499	5,392	4,726	3,456	9,851	3,139	3,195	3,362	2,852	14,702	2,491	2,506	2,538	2,742	9,968	2,684	2,665	2,499	2,056		1,747	1,859	1,715	1,691					1,484
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male				320	206	21	11		1	85	72	65		48	44	12									1				8								
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								1,363	1,340	1,365	1,021		867	921	961	991					913
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			12,740	5,964	6,749	7,022	6,970	14,952	6,514	7,153	6,048	4,759	8,832	4,897	4,752	5,119	4,294	4,001	4,222	4,260	4,271	4,374	15,978	4,678	4,694	4,186	3,608		3,479	3,627	3,200	3,078					2,672
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												28,629					30,776				
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								401	405	407	333		333	346	336	329					278
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				2,546	2,809	3,287	3,939	15,020	3,592	3,444	3,169	2,324	12,238	2,198	2,269	2,331	2,169	8,237	1,774	1,854	1,910	1,933	4,294	1,912	1,939	1,867	1,587		1,341	1,391	1,329	1,257					1,197
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			14,935	2,729	3,451	4,083	4,113	13,140	3,821	4,022	3,262	2,243	6,331	2,046	2,332	2,250	2,004	10,570	1,695	1,787	1,692	1,803	15,745	1,823	1,949	1,703	1,427		1,203	1,293	1,129	1,246					1,100
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								601	703	604	625		568	618	580	646					566
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			20,302	6,763	7,272	7,977	8,858	18,480	8,231	8,306	7,625	5,677	18,189	5,479	5,592	6,038	5,131	5,259	4,561	4,785	4,704	4,936	8,066	5,123	5,179	5,056	4,126		3,632	3,742	3,572	3,530					3,012
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				2,710	2,905	3,184	3,498	13,255	3,136	3,178	2,934	2,240	13,917	2,176	2,372	2,386	2,168	2,437	1,871	2,014	2,045	1,991	7,268	1,996	2,028	1,939	1,711		1,419	1,631	1,531	1,541					1,332
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			6,500	1,901	2,380	2,588	2,091	9,647	1,953	2,236	1,757	1,142	4,651	1,160	1,290	1,306	1,140	1,552	1,108	1,202	1,119	1,173	13,494	1,334	1,289	1,109	1,027		1,002	1,070	1,057	972					923
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			21,894	5,486	5,922	6,610	7,018	16,621	6,525	6,812	6,198	4,374	20,882	4,225	4,495	4,645	4,242	3,274	3,713	3,953	3,888	3,952	11,706	3,944	4,200	3,969	3,310		2,959	3,034	2,907	2,815					2,529
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				4,225	4,152	4,527	4,930	14,118	4,475	4,520	4,046	3,272	18,294	3,155	3,137	3,262	2,836	3,124	2,542	2,629	2,703	2,804	6,834	2,807	2,876	2,776	2,344		2,012	2,184	2,144	2,045					1,812
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			5,458	339	430	446	374	7,684	376	428	298	181	3,181	178	192	210	160	4,745	163	171	201	175	7,147	184	188	178	123		150	184	148	122					117
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								1,322	1,432	1,325	1,067		1,000	1,064	1,081	1,204					1,045
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			16,796	3,955	4,543	5,569	6,053	14,600	5,732	5,678	4,894	3,593	12,312	3,265	3,368	3,617	3,149	12,241	2,604	2,716	2,753	2,930	7,026	2,782	2,833	2,802	2,334		1,943	2,005	1,854	1,790					1,632
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			40,330																																		
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			8,656	801	773	705	669	4,359	565	612	532	367	4,473	400	422	469	371	13,005	315	358	341	339	2,705	327	360	319	299	1,579	247	271	272	217	1,421				204
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			11,787	1,281	1,486	1,717	1,578	11,073	1,509	1,635	1,328	860	3,883	878	854	1,017	795	5,980	703	721	780	774	14,022	854	846	733	626		621	620	624	585					433
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								478	482	459	354		329	385	393	397					332
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			16,680	7,064	8,423	9,063	9,524	18,139	8,996	9,620	8,075	5,767	14,085	5,938	6,285	6,333	5,567	5,649	5,054	5,322	5,377	5,326	15,027	5,454	5,811	5,392	4,372		3,818	4,122	3,798	3,522					3,536
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			20,665	4,514	4,153	4,489	4,838	16,443	4,101	4,178	3,871	3,283	24,851	3,009	3,069	3,301	2,936	4,155	2,607	2,749	2,888	2,950	21,428	4				5,256					22,502				
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												14,336					8,551				
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			14,728	3,778	4,035	4,593	4,988	18,727	4,482	4,392	4,040	3,169	20,410	3,079	3,224	3,115	2,966	15,220	2,556	2,651	2,696	2,829	14,899					3,750					13,684				
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								419	425	433	400		358	352	362	391					380
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			26,108																																		
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								531	461	552	486		422	473	486	474					399
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												16,551					14,309				
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				3,648	3,903	4,540	5,099	14,039	4,663	4,415	4,148	3,094	14,083	2,821	3,029	3,017	2,712	11,538	2,183	2,409	2,457	2,566	3,590	2,405	2,522	2,483	1,962		1,625	1,713	1,689	1,797					1,395
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				873	895	879	841	3,742	718	714	616	484	3,894	539	561	508	428	11,739	409	380	408	348	1,180	369	384	365	283		279	293	250	257					213
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												30,526					11,184				
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												37,794					15,030				
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			19,391																																		
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								650	656	625	542		525	560	511	507					526
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			2,532	321	368	378	353	1,561	254	263	238	172	1,548	173	89	150	159	462	165	164	167	154	640	192	191	161	126	324	148	164	152	142	486				148
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												8,971					11,124				
Tanzania	Tanzania	TZA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												10,655					2,733				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								34,481	34,484	37,131	35,202		36,701	36,605	37,187	40,745					47,886
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				73,969	80,979	82,468	91,315		93,007	93,696	95,122	98,128	138,150	103,827	108,484	117,422	123,390	138,184	126,914	127,988	130,860	134,694	123,218	139,684	142,011	143,751	130,882		131,228	129,755	128,865	128,541					129,778
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												97,629					68,666				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				13,505	14,737	14,079	16,267		17,016	17,237	17,881	18,683	29,570	19,773	20,296	21,685	21,687	35,398	22,106	21,758	22,310	22,999	22,845	24,284	24,680	24,546	22,267	26,385	21,478	22,085	22,805	23,585	23,449				23,192
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								37,539	37,498	39,044	36,322		37,561	37,924	38,999	42,696					46,588
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				41,742	44,231	45,358	52,019		53,122	54,263	56,825	59,704	93,125	62,486	66,455	73,184	76,772	97,175	79,224	80,397	82,983	85,831	92,718	89,306	91,683	92,002	77,645		75,937	74,283	73,359	72,939					72,458
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												30,274					23,035				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								59,201	59,850	60,976	55,022		54,984	55,196	55,948	60,873					63,626
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												78,762					71,578				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				588	690	313	273		178	144	109	118	2,390	78	43	64	34	340	41	21	21	49	472	94	97	44	48	218	29	31	31	39	314				27
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								26,755	27,013	28,036	26,124		26,605	26,776	27,515	30,104					32,548
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				9,600	9,393	9,771	11,822		12,262	12,776	13,386	13,683	41,848	14,399	15,577	17,357	18,118	31,162	18,882	19,308	19,777	20,157	42,245	21,237	22,078	21,586	17,415		16,763	16,354	16,182	16,116					16,048
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				75,562	84,588	84,207	93,495		95,311	97,112	97,481	101,024	120,995	108,143	111,922	118,520	120,599	141,120	122,615	123,978	128,163	135,070	116,455	141,346	143,303	144,164	131,859		132,094	131,887	132,792	137,746					138,197
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				95,402	107,033	107,072	117,551		123,192	124,763	128,784	135,672	164,280	149,654	154,986	166,525	173,069	191,287	177,625	182,697	190,468	205,240	161,177					231,054					244,829				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				3	36	2	4				24				1	13										1											
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				5,337	5,417	5,211	6,146		6,607	6,869	7,304	7,676	21,104	8,178	8,512	9,335	9,757	14,645	9,949	9,987	10,332	10,867	18,488	11,713	11,844	11,647	10,713		10,876	10,843	10,803	11,296					11,395
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								91,571	93,410	93,611	87,641		89,307	90,216	91,793	100,134					108,450
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				58,931	67,066	68,280	77,049		78,625	79,646	80,340	81,790	92,045	91,024	94,287	102,098	107,337	114,407	110,692	112,244	115,071	119,366	99,740	124,342	125,728	128,011	119,669		122,161	122,384	122,609	125,637					133,820
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				30,009	34,797	36,260	40,728		43,315	43,991	45,698	46,933	80,893	51,335	53,919	59,103	62,279	73,516	64,172	64,678	66,405	69,214	63,296	71,681	72,658	74,117	66,794		66,800	66,365	66,029	66,230					68,466
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				62,386	67,658	69,010	76,481		77,455	78,672	80,877	85,495	120,354	89,767	94,777	100,976	103,065	130,455	104,576	107,143	111,464	117,705	114,075	123,855	127,023	127,147	109,731		107,729	106,247	107,064	109,163					107,061
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								38,213	38,973	40,735	39,434		40,607	40,563	40,132	41,753					46,978
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												434,268					422,949				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				4,622	4,516	4,994	6,198		6,280	6,671	6,946	7,313	25,701	7,867	8,358	9,000	9,207	16,496	9,624	9,849	10,097	10,482	26,419	11,398	11,688	11,514	9,764		9,625	9,651	9,743	10,162					10,249
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												42,248					32,829				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												240,861					209,921				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				3,714	3,825	3,790	4,472		4,159	4,258	4,536	4,842	10,382	4,557	4,949	5,306	5,149	10,462	5,180	4,824	4,834	4,910	13,457	5,247	5,252	5,026	4,261		3,958	3,890	3,880	3,671					3,592
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				25,964	28,045	29,903	35,330		35,381	36,852	37,771	39,081	81,429	41,420	44,092	48,733	51,413	69,514	53,085	53,276	54,637	56,341	65,650	59,155	61,109	61,330	51,923		50,962	49,455	48,711	47,959					46,963
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								54,763	55,549	57,917	57,012		59,277	59,515	59,286	62,644					71,734
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male									1							2						1															
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				20,225	21,642	22,817	26,826		26,672	27,618	29,148	30,965	58,498	32,117	34,978	37,442	38,118	56,563	38,922	39,829	41,127	42,323	61,289	44,702	46,544	46,369	37,893		36,894	36,293	36,314	34,872					31,706
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				17,715	18,752	19,974	23,643		23,445	24,713	26,115	27,155	65,100	29,102	31,142	34,090	34,875	56,551	35,910	36,486	37,989	39,967	55,807	42,288	43,619	42,988	33,939		32,210	31,250	31,141	31,028					28,939
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				32,146	36,236	37,430	42,663		43,251	45,220	46,362	48,308	93,168	51,804	54,444	58,477	59,910	80,839	61,155	61,904	64,338	67,640	68,529	70,534	71,850	72,692	62,389		61,009	59,999	59,922	61,710					60,099
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				62,038	70,127	70,527	78,833		83,666	83,925	88,267	92,800	134,945	102,330	107,441	115,610	121,299	144,775	124,453	127,521	133,851	143,921	118,785					165,051					165,023				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				8,279	8,642	8,860	10,246		10,386	10,404	11,045	11,725	30,787	11,816	12,332	13,436	13,794	18,846	14,135	14,156	14,735	15,002	26,875	15,935	16,189	16,219	14,309		14,405	14,374	14,398	14,232					14,101
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				10,168	11,779	11,868	13,582		13,827	13,868	14,329	15,261	25,683	15,983	16,861	18,000	17,923	30,745	18,052	17,805	17,969	18,222	24,163	18,663	18,751	18,304	15,920		14,887	15,092	15,186	14,694					13,155
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												244,514					202,735				
Tanzania	Tanzania	TZA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								27,587	28,191	29,179	27,492		28,350	28,263	28,635	30,938					35,439
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														57		44					47
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														288		303					260
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														61		51					46
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														356		315					309
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														100		121					129
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														47		22					29
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														279		276					287
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														361		357					329
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														132		120					103
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					2,608		2,109			2,513		2,379			1,881		1,875			2,320		2,750			2,703		2,058										
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														88		83					77
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female							1																														
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					543		416			484		451			373		312			417		420			377		275										
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														292		261					274
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														157		174					173
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														231		254					235
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														58		45					50
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male					1					3					1					1										3							
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														250		227					228
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														304		264					274
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														64		50					38
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														110		111					98
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														125		116					144
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														46		41					30
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														7		6					8
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														293		318					324
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														99		113					102
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														166		152					149
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														222		247					197
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														127		150					170
Tanzania	Tanzania	TZA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					2,410		2,085			2,339		2,289			1,738		1,970			2,349		2,816			2,800		2,171										
Uganda	Uganda	UGA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					24,387		11,821			8,313		46,893			37,965		112,658	114,865		35,653		42,292	77,918		20,425		74,626	46,276		2		41,963	46,276				
Uganda	Uganda	UGA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female					33,070		28,167					25,011			2,501		8,067			1,819		2,968	283		168		2,304					506					
Uganda	Uganda	UGA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					27,854		85,698			18,381		63,522			25,615		57,042	65,004		29,128		158,875	21,973		1,845		17,572	27,199		1		23,087	27,199				
Uganda	Uganda	UGA	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					43,506		72,216			15,528		53,226			13,949		39,341	67,950		16,005		10,513	59,775		14,204		37,665	36,372				26,265	36,372				
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 											54,147					57,120					40,775														
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																		1		11			1		4			20		5					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1		8			4		15			4		3			14		18					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																				3					1			1		3					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													268		871			2,136		2,357			1,760		1,874			3,452		4,682					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 											57,418					61,183					40,660														
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													6		42			90		164			224		149			325		544					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													11		176			184		141			138		63			58		52					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													87		1,324			1,775		2,103			1,789		1,496			1,700		1,818					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													2		143			169		275			323		280			312		450					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													4		28			50		93			142		115			266		368					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																		2		7			7		1			3		7					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													2		1			1		19			11		2			8		2					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													75		1,299			1,607		1,952			1,377		1,073			1,282		1,356					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected															4			7		6			3		2			4		2					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										102,105					138,475				
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 											47,292					52,639					31,579														
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																		2		1			3		2			1		5					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													600		6,232			7,447		6,603			4,977		4,513			4,528		3,834					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													1,312		21,613			30,033		29,954			19,249		16,924			15,903		14,301					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													26		60			79		217			219		163			284		525					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													354		3,012			3,971		3,594			2,468		2,863			2,732		3,015					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															4			3		17			17		12			31		41					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																		11		19			167		7			3		9					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 											61,184					67,168					45,034														
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected															8			6		6			97		8			17		12					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected															7			8		14			72		18			15		18					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													10		100			160		129			132		62			46		29					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													1		19			53		186			212		149			270		407					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													65		355			458		447			390		330			484		437					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													219		1,114			2,605		2,830			2,091		2,005			3,409		4,868					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										79,515					83,410				
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													1		3			9		27			72		9			25		24					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													11		125			217		135			153		52			57		48					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													24		64			99		263			205		163			352		518					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													11		199			221		173			156		60			55		40					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													1,146		19,809			27,959		28,040			17,201		15,026			14,146		12,030					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															23			9		43			32		26			55		60					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													5		15			11		32			30		13			60		79					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													1		3					7			6		2			6		3					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive															5			46		84			128		78			113		168					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													47		835			842		1,132			872		626			727		783					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																				1			9		1										
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													67		1,050			1,161		1,446			1,040		903			1,014		1,051					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													7		9			11		13			33		14			45		51					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													90		1,362			1,801		2,074			1,656		1,343			1,575		1,538					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													342		722			1,316		1,528			1,265		1,359			2,243		3,021					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													12		61			12		22			16		26			43		26					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													12		48			67		175			212		182			411		572					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													3		45			46		53			48		38			70		59					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative															1			1		18			1		4			7		4					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													4		18			33		80			23		29			56		73					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 											36,752					41,212					25,063														
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													7		54			94		65			38		30			28		26					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													1,150		20,782			28,648		29,620			18,997		16,290			16,551		14,337					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															29			27		44			21		28			49		81					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													10		42			73		161			208		164			377		526					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													15		166			213		174			163		70			72		56					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4		23			21		31			24		32			62		80					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative															6			10		101			64		39			75		103					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													29		72			77		211			166		152			266		479					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													193		985			2,643		2,724			1,872		1,886			3,236		4,715					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected															7			5		5			15		5			8		14					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													143		755			1,884		2,496			1,663		1,506			2,527		3,768					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																		1		7			1					8							
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													468		15,194			16,942		17,908			10,719		8,629			8,514		7,245					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													799		12,447			22,036		22,359			13,468		11,488			11,109		9,508					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected													3		47			54		58			23		29			17		10					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													5		21			16		34			35		28			68		78					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													2		3			8		24			110		10			7		19					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													139		301			165		206			193		291			344		384					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative													99		979			806		710			572		555			615		448					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													77		230			178		587			632		568			680		1,087					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													1		1			1		13			7		6			11		5					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected																		1		20			13		3					1					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													15		54			66		187			170		169			228		451					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative													14		37			68		241			149		120			207		398					
Uganda	Uganda	UGA	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected															3			3		18			7		3			15		2					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													10		42			73		161			208		164			377		526					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													67		1,050			1,161		1,446			1,040		903			1,014		1,051					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													2		143			169		275			323		280			312		450					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													90		1,362			1,801		2,074			1,656		1,343			1,575		1,538					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													5		15			11		32			30		13			60		79					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													7		9			11		13			33		14			45		51					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive															5			46		84			128		78			113		168					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													5		21			16		34			35		28			68		78					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															4			3		17			17		12			31		41					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													12		48			67		175			212		182			411		572					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													3		45			46		53			48		38			70		59					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													1		8			4		15			4		3			14		18					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													65		355			458		447			390		330			484		437					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													6		42			90		164			224		149			325		544					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive													4		23			21		31			24		32			62		80					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													75		1,299			1,607		1,952			1,377		1,073			1,282		1,356					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															23			9		43			32		26			55		60					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive															29			27		44			21		28			49		81					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive																		2		7			7		1			3		7					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													47		835			842		1,132			872		626			727		783					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													4		28			50		93			142		115			266		368					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive													1		19			53		186			212		149			270		407					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive																				3					1			1		3					
Uganda	Uganda	UGA	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													87		1,324			1,775		2,103			1,789		1,496			1,700		1,818					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													4		94			47		69			41		43			45		17					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															24			35		72			101		102			224		323					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															16			3		19			24		7			16		44					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															23			10		35			11		17			19		57					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																												1		12					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													2		2										2			6		1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							38		48			22		76					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							2		7			2		23					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP															3			9		23			28		27			18		18					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				3			1		6			11		8					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP															3			11		35			46		29			17		18					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				1			8		3			2		11					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																		9		3															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP															6			8		15			23		29			15		14					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													2		2					9			4		3			2		2					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							6		2					7					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				1			2		3			1		25					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													3		16			16		37			16		13			15		8					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							8		1			2		2					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																				1															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							136		146			107		207					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													6		165			287		317			253		283			414		373					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							19		39			35		51					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													8		510			837		1,164			815		724			790		939					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																														1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				1					6			11		17					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													3		70			44		43			42		38			26		25					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							8		3			7		16					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															3			37		75															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				3			7		2			2		3					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																									1										
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													1		21			26		150			135		125			137		343					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																														1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				3					2			8		14					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy															1								1		1			7		5					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																				1															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP															2			8		23			12		17			11		15					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation															20			25		29			34		31			61		48					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													2		27			9		22			15		12			30		41					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													1		58			22		22			13		20			20		10					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													1		32			47		122			132		136			305		464					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													3		383			564		886			670		530			534		664					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															23			5		27			19		14			11		42					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy															1								3					3		3					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							14		31			25		40					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															23			5		23			28		10			30		48					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																		7		1			1							1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																				3								1		2					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																														4					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							2					1							
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1		1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy															6			4		17															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													2							3					5			4		7					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1		1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							9					1		4					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							18		3			8		32					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																														1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													9		660			1,309		1,693			1,260		1,149			1,260		1,386					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													1		85			65		88			51		40			61		23					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy													1		90			53		72			34		36			39		33					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							9		7			6		9					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							6		17			14		18					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																									1										
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													3		63			84		159															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													10		628			1,326		1,677			1,366		1,328			1,425		1,629					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																				2								1							
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP															1			7		30			18		11			9		22					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		1		1			2		4			2		14					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																		3		9															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation													2		638			1,108		1,552			1,085		904			1,020		1,225					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							1		5			11		11					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												4		2					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							5		1			3		17					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																				1			1												
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP															1			3		3			11		3			6		3					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy													2		4					1			1		5			9		7					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															10			1		15															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																									1										
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															6			9		11			14		13			40		43					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													1		41			47		102			135		153			283		487					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																												2		6					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																		1		1															
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation															4			3		9			4		2			11		17					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																				3			1												
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																														1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																												1							
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							7		3			5		11					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							2		3					3					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							2		3			1		2					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							4		3			9		18					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							1		12			12		16					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																												1		3					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															1			2		1			1					3		4					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							1												
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																		6		6										1					
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							2		2										
Uganda	Uganda	UGA	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															24			49		134			164		128			202		464					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			24,660	253	2,776	9,066	6,038	9,113	4,631	4,838	5,918	9,189	44,459	4,878	11,610	11,288	12,476	49,044	9,556	16,837	28,476	32,258	49,050	26,940	32,761	21,492	20,490		16,117	20,680	20,642	20,018					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male				83	745	1,241	3,154		2,082	2,202	2,364	3,728	13,497	2,078	4,248	4,515	5,018	13,497	3,469	6,262	11,686	12,580	13,494	11,141	12,652	7,879	7,423		6,693	7,209	7,915	9,174					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												85,080					96,615				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				23	202	310	839		719	788	713	1,302	4,535	665	1,299	1,455	1,604	4,535	1,171	2,124	4,765	5,187	4,537	4,789	4,978	2,995	3,056		2,623	3,653	3,824	4,181					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												24,863					31,239				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				74	252	347	780	297	795	999	1,008	1,667	4,163	812	1,681	1,843	2,058	4,163	1,443	3,006	6,133	6,999	4,163	6,330	7,408	4,676	4,944		3,710	4,687	4,795	5,318					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male				172	1,198	1,784	5,431		3,113	3,481	3,763	6,147	21,772	3,232	6,986	7,607	8,077	22,026	5,432	9,818	18,543	19,920	22,025	16,899	18,834	11,960	12,132		10,078	11,699	12,675	14,077					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female				16	40	47	198		226	244	286	816	4,379	233	599	618	789	4,379	713	1,448	3,094	3,675	4,382	3,264	4,073	4,546	2,964	149	2,359	3,369	3,252	3,717	140				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				16	94	102	336	297	380	415	461	909	3,533	287	698	744	913	3,533	731	1,421	3,205	3,583	3,530	3,281	3,415	2,149	2,477		1,928	2,690	2,720	2,846					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			5,121	205	693	996	2,213	2,137	1,933	1,927	2,294	3,635	11,086	1,780	3,748	3,562	4,623	12,632	2,999	5,550	10,883	12,255	12,631	11,181	12,941	8,148	8,303		5,991	7,424	7,697	8,308					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			10,817	450	1,537	2,321	4,053	5,172	3,501	4,161	4,397	6,833	22,615	3,666	7,136	6,896	8,253	25,466	5,780	10,008	18,449	21,235	25,463	18,030	21,902	14,093	13,636		11,015	13,300	13,932	13,731					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												86,994					91,527				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex				5	19	11	99		146	70	90	361	337	162	375	527	862	9,905	419	585	2,929	5,429	9,907	6,622	6,251	5,113	6,134	11,036	3,997	4,986	9,555	8,429	11,876				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												175,627					173,858				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			13,097	492	1,317	1,054	2,814	5,784	2,449	2,587	3,518	5,681	17,053	2,904	6,368	6,644	7,846	25,031	6,042	10,056	18,772	23,215	25,036	21,092	23,685	15,072	15,446		12,414	15,512	18,703	17,079					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								161,844				21																									
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male												5			1																						
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male				26	113	190	553		552	552	636	1,267	5,753	506	1,510	1,204	1,730	5,753	1,176	2,397	5,095	5,901	5,753	5,208	5,588	4,568	3,864	4,844	3,489	4,304	4,551	5,336	4,975				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male				39	299	363	922		893	738	889	1,975	4,499	858	2,237	2,843	3,008	46,714	2,028	3,621	9,315	9,574	46,715	9,973	10,832	6,761	7,646		6,175	7,773	10,961	9,890					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			956	260	1,733	1,889	4,471	25,473	2,912	3,243	3,360	7,029	22,011	3,609	7,113	8,531	8,879	22,543	6,347	11,089	22,875	24,672	22,544	20,893	22,889	14,561	15,198		12,347	14,725	16,057	17,847					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												69,445					69,494				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			1,328																																		
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female												46			1																						
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												144,067					137,055				
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			37,940	1,301	3,928	2,970	7,592	15,182	6,297	7,370	9,036	13,559	43,451	7,752	15,082	14,534	17,054	48,437	12,410	21,445	39,978	44,487	48,434	37,472	43,763	28,868	27,632		23,417	29,757	30,460	29,486					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				49	474	634	1,774		1,407	1,480	1,506	2,655	8,141	1,289	2,729	2,955	3,394	8,141	2,309	4,376	8,757	9,497	8,139	8,338	9,252	5,631	5,434		5,231	5,851	6,315	7,062					
Uganda	Uganda	UGA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			956	956	1,782	2,560	7,211	25,473	4,691	5,607	5,476	9,547	33,581	5,603	9,076	9,733	11,434	33,877	7,168	13,276	24,148	25,389	33,880	21,769	23,643	15,861	15,229		12,611	14,780	15,524	17,675					
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												997,712					632,286				
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			304,902	94,143	90,172	96,619	100,812	226,453	87,645	95,799	66,099	108,385	16,284	74,902	63,299	68,075	64,584	139,861	59,692	67,765	69,429	64,272	268,718	70,398	95,824	102,119	98,445		95,878	109,500	119,965	130,420					45,096
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			138,109	60,501	60,620	58,014	65,491	129,400	53,862	69,758	58,984	59,653	106,401	62,648	57,483	62,187	53,300	135,195	55,156	62,997	61,141	60,186	246,382	61,453	78,069	86,398	86,634		86,609	104,840	120,966	137,627					105,803
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												438,405					661,157				
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female							60,282					10																									
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												461,628					437,679				
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			205,122	70,387	111,081	68,788	59,769	37,170	64,430	65,533	19,890	29,958	15,295	21,524	15,697	22,897	26,686	47,040	19,679	22,589	24,334	22,654	106,952	29,118	41,039	45,814	46,774	82,332	42,317	49,050	65,036	71,255	36,401				30,138
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex				999	983	869	996	1,189	735	2,113	1,297	1,467		6,418	1,364	1,746	1,457		1,398	1,645	5,278	1,621		1,573	1,808	2,245	4,728		5,090	4,949	5,426	4,535					1,233
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			131,095																																		
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												1,133,493					1,245,809				
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			127,707																																		
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			118,899	100,552	102,200	98,420	109,049	289,753	91,283	118,072	99,652	100,008	213,003	110,243	99,525	106,208	89,927	256,453	94,121	107,939	106,888	105,385	468,014	106,647	137,386	147,913	147,781		151,005	188,156	216,720	245,932					196,805
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				17,341	13,548	13,212	19,090	46,193	18,734	25,719	13,733	22,080	8,166	13,109	12,699	18,385	22,598	45,581	16,250	20,769	23,131	20,001	58,576	24,478	35,563	38,556	37,212		32,207	36,896	53,693	51,280					24,027
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												1,404,394					1,415,149				
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				20,501	19,038	19,612	23,280	74,395	20,243	24,060	15,708	20,610	19,133	18,131	15,342	18,509	14,247	39,428	15,541	16,623	17,284	17,480	112,659	17,850	25,157	29,109	27,663		25,671	29,385	32,450	38,960					17,575
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												30,196					90,731				
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Female				536,877	324,939	293,328	351,831		233,138			5																									
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			91,473	29,739	27,133	26,874	33,086	164,214	28,319	36,826	25,138	29,920	51,605	29,737	26,376	30,842	21,124	89,089	25,183	28,298	28,006	29,682	162,431	29,541	43,012	48,193	48,030	367,637	43,588	53,344	51,677	74,880	349,635				34,812
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			322,483	149,983	161,431	152,601	171,640	374,414	144,772	211,827	196,117	199,627	368,704	174,932	162,643	170,979	152,128	437,911	151,893	169,572	170,502	166,686	785,949	169,309	218,251	228,957	229,759		234,576	289,528	330,780	380,268					328,753
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			169,310	65,325	62,509	62,020	69,753	205,559	60,072	71,511	46,208	66,819	17,897	52,050	43,160	51,484	53,139	84,454	45,061	51,601	54,157	51,469	296,688	55,279	77,557	84,672	79,676		73,814	88,056	101,773	104,052					43,320
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				1	1		1		50							1	15			1	2	3															
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			105,575																																		
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			428,279	84,168	82,606	84,284	92,716	306,493	77,866	117,750	59,653	90,458	23,918	66,622	57,583	68,031	67,848	159,208	59,637	65,745	68,262	65,112	338,581	70,245	96,450	104,918	99,273		92,948	108,296	129,166	129,648					51,632
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Male				255,486	231,233	201,291	256,387		172,805																												
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			264,774	214,960	221,170	216,641	232,933	583,229	194,707	246,258	237,963	243,806	518,023	250,020	232,670	239,096	214,907	622,816	206,007	217,064	230,128	225,191	1,062,451	228,644	292,877	307,865	307,663		324,507	395,124	438,903	509,785					396,667
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				15,734	14,988	14,116	19,393	22,037	18,074	25,016	15,735	21,790	5,702	19,730	15,021	19,557	20,541	5,229	15,584	20,687	24,820	18,868	123,842	22,220	31,470	34,050	34,741		32,277	35,415	44,706	42,910					23,211
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				32,147	30,127	30,076	34,972	128,724	30,283	35,808	23,387	33,021	16,762	27,216	22,900	29,023	22,841	56,332	23,663	26,576	27,890	27,314	185,734	28,858	42,313	47,348	44,905		41,324	49,150	52,699	61,902					26,062
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			164,007	142,056	113,957	131,109	138,523	349,226	116,653	147,524	129,016	135,162	277,492	139,570	128,916	136,604	123,896	352,836	121,727	121,974	132,372	125,322	624,400	130,396	163,884	175,073	176,890		178,977	212,295	244,647	281,060					213,732
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			1,737	25,508	24,531	21,610	26,550	9,277	21,341	32,393	23,404	30,141	50,593	24,141	21,479	23,651	22,826	29,656	18,553	21,526	20,363	22,164	35,051	22,934	32,794	38,268	43,406	572,486	36,706	44,851	48,825	59,106	533,127				31,365
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				7,639					12			5																									
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Coarse	Coarse	Missing Sex				45,942	31,631	32,766	50,052		28,233			8																									
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				31,615	29,005	28,051	32,991	29,109	27,176	37,063	30,324	31,733	21,102	30,043	25,897	28,947	25,610	39,322	24,112	29,768	27,906	26,718	89,807	28,206	38,391	44,242	43,162		44,092	51,802	60,635	66,588					41,623
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			193,938	46,733	43,707	43,300	49,005	194,384	42,129	47,542	33,066	45,148	15,538	36,598	30,976	38,277	36,366	74,637	33,091	36,392	37,612	36,575	242,224	38,547	53,682	59,875	56,008		52,178	61,260	69,922	75,569					31,769
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												377,034					250,705				
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			222,907	78,065	72,291	85,697	82,559	210,475	73,795	76,695	44,383	112,180	7,750	54,397	54,867	43,048	40,032	154,896	40,848	49,330	46,762	33,321	123,197	44,892	61,693	61,822	58,884		71,984	93,989	99,044	108,673					31,398
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			185,695																																		
Uganda	Uganda	UGA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				18,083	15,938	15,728	18,923	23,380	15,108	21,928	16,803	18,759	4,993	16,134	13,505	15,387	14,312	24,500	13,297	13,695	14,125	14,616	33,452	14,855	20,701	24,280	23,816		22,516	26,062	30,170	33,726					18,795
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												9,751					7,397				
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			10,124	2,420	2,855	2,558	2,807	15,252	2,379	2,999	2,004	2,442	1,615	2,130	1,929	2,271	1,958	5,192	1,857	2,185	2,165	2,008	13,363	1,917	2,329	2,273	2,188		1,873	2,101	2,079	2,082					1,469
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												12,173					8,390				
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				1,300	1,413	1,250	1,400	2,138	1,199	1,593	1,222	1,428	468	1,147	1,137	1,202	1,093	2,480	970	1,222	1,149	1,092	4,943	1,106	1,401	1,391	1,244		1,208	1,288	1,328	1,231					1,017
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				3					1																												
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			4,445																																		
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												1,408					1,276				
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female							728					3																									
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				309	372	315	447	7,664	326	576	281	340	997	300	508	453	331	5,143	284	390	363	417	2,728	352	421	447	384		309	363	335	569					208
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			15,384	6,492	7,329	6,272	6,676	13,632	5,751	7,300	5,003	6,252	762	5,235	5,525	5,680	4,427	3,284	4,177	4,803	4,530	4,367	21,918	4,489	5,265	5,147	4,830		4,581	5,111	4,665	4,728					3,426
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex				66	46	45	72	328	54	69	33	54		118	64	51	54		51	51	139	76		56	96	66	131		564	139	130	136					101
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				1,048	1,293	1,081	1,253	6,613	1,096	1,538	942	1,174	2,294	995	968	1,079	912	3,304	881	1,062	1,017	939	6,282	895	1,138	1,157	1,083		932	1,160	1,022	1,033					843
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			4,662	1,280	1,167	1,160	1,414	20,890	1,104	1,690	1,103	1,337	7,145	1,178	1,248	1,398	1,061	8,450	1,135	1,316	1,288	1,312	7,938	1,270	1,591	1,644	1,552	12,486	1,271	1,581	1,450	1,518	11,018				1,230
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												10,995					8,393				
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			7,919	2,302	2,656	2,400	2,546	4,003	2,252	2,938	2,129	2,519	573	2,013	2,131	2,178	1,956	3,017	1,825	2,164	1,968	1,879	7,073	1,906	2,306	2,360	2,188		2,003	2,232	2,211	2,177					1,727
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			9,988																																		
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				1,691	1,873	1,662	1,810	8,196	1,590	2,134	1,409	1,748	1,931	1,477	1,382	1,600	1,321	4,219	1,231	1,534	1,515	1,434	10,326	1,486	1,782	1,739	1,593		1,496	1,637	1,649	1,632					1,080
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			8,865	3,716	4,450	3,713	4,250	7,645	3,461	4,518	3,216	3,765	902	3,207	3,243	3,401	2,861	3,520	2,663	3,282	3,004	2,864	11,925	2,867	3,463	3,418	3,314		2,933	3,357	3,081	3,066					2,384
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			6,948	1,650	1,619	1,624	1,610	16,461	1,434	1,547	1,589	1,412	1,944	1,145	950	1,096	1,189	3,841	823	928	853	942	9,868	969	1,089	995	965		985	1,021	1,081	862					529
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			2,912																																		
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Male				7,920	5,078	5,093	4,975		4,177																												
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												13,133					3,535				
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			3,724	296	363	505	411	13,157	304	361	414	511	931	199	219	211	327	3,085	152	190	217	263	3,333	329	255	206	205		305	243	207	242					115
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			387	833	1,199	924	1,139	1,681	943	1,370	1,127	1,241	7,251	1,025	978	1,026	922	3,328	801	1,020	1,025	977	2,185	967	1,160	1,297	1,211	19,064	996	1,238	1,250	1,194	17,967				952
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Female				13,920	7,553	8,488	8,439		5,687																												
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				659	818	729	844	1,246	693	1,070	717	943	925	708	687	745	690	1,899	589	695	702	703	1,877	687	923	883	802		667	862	832	822					644
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			5,402																																		
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												5,271					3,826				
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			9,483	2,312	2,440	2,289	2,393	7,854	2,045	2,298	1,688	2,061	1,355	1,627	1,987	1,844	1,532	1,361	1,410	1,534	1,599	1,438	12,719	1,494	1,834	1,658	1,637		1,593	1,694	1,552	1,626					1,133
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			11,802	2,719	3,352	2,932	3,016	22,987	2,651	3,072	2,422	2,788	2,798	1,970	1,898	2,122	1,933	5,801	1,665	1,992	1,876	1,720	15,596	1,738	2,623	2,045	1,955		1,821	1,782	1,879	1,752					1,281
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			7,906	3,003	3,388	3,019	3,384	16,952	2,734	3,616	2,359	3,104	1,936	2,429	2,159	2,338	2,116	5,926	1,976	2,307	2,151	2,082	15,716	2,107	2,545	2,494	2,371		2,138	2,229	2,247	2,157					1,444
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	Coarse	Coarse	Missing Sex				607	516	539	612		439			4																									
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												27,816					16,197				
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			5,331	287	348	352	342	6,381	388	469	262	263	1,849	233	428	298	285	5,558	224	294	354	302	5,669	326	400	445	363	3,019	348	377	330	475	279				229
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				419	525	459	512	3,737	425	698	436	514	497	495	532	530	414	359	433	539	570	511	5,341	504	548	576	570		572	560	494	479					410
Uganda	Uganda	UGA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			18,362	5,855	6,883	5,777	6,583	10,347	5,513	7,161	4,813	5,836	691	4,916	5,034	5,061	4,278	3,718	4,317	4,740	4,394	4,204	18,821	4,148	4,968	4,975	4,618		4,309	4,610	4,562	4,560					3,600
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												29,692					14,252				
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	60-64	50+	Female																										1											2
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				3,617	3,880	4,189	4,198	24,474	3,703	2,984	2,208	890	11,677	4,074	4,092	4,024	4,550	21,756	3,439	4,878	4,057	4,029	17,694	3,728	4,412	4,415	4,088		3,959	4,706	4,591	4,452					4,050
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																														3		1					
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								2	6	12	8		5	9	8	14					4
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				45	44	45	57	925	39	27	21	22	11,122	43	53	28	15	1,557	33	364	34	44	1,254	36	20	55	35		32	60	78	45					62
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				5,028	5,301	5,694	5,933	25,491	5,398	8,882	9,148	11,890	10,246	5,904	6,244	5,908	5,160	22,304	5,151	4,200	5,227	5,217	23,054	4,854	6,320	5,522	5,292		4,856	5,659	5,194	5,474					5,175
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				4,078	4,599	4,739	4,765	17,130	4,315	5,240	5,346	5,251	15,411	4,962	5,060	4,902	4,382	16,053	3,864	2,544	4,256	4,080	16,948	3,709	4,510	4,247	4,164		3,876	4,666	4,270	4,221					3,588
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				1	1		4		2	10	2	4		4	10	5	41	58	5	32	2	6	6										6				
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				1,814	2,097	2,230	2,202	9,592	1,927	1,520	1,115	459	7,210	2,030	2,276	2,318	2,339	11,172	1,939	3,787	2,240	1,848	10,102	2,028	2,538	2,465	2,325		2,275	2,700	2,731	2,658					2,513
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												9,968					17,955				
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex							3		2					1	1															1							
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female				2,976	4,551	2,212	3,744																														
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				346	388	407	400	935	363	314	223	97	5,611	416	445	416	491	2,846	312	1,918	483	465	3,010	410	476	558	653		486	656	686	580					593
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				6	6	6	26		17	15	14	44		12	13	9	7	597	15	4	11	7	833	3	12	8	3	47	10	8	6	12	13				6
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												43,232					44,625				
Uganda	Uganda	UGA	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				1,165	1,220	1,235	1,358	5,656	1,173	1,239	1,389	1,245	24,018	1,147	1,249	1,138	1,094	3,259	1,063	487	1,097	977	5,677	987	1,157	1,031	1,076		1,056	1,160	1,121	1,090					1,072
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			425,487	100,635	122,960	118,530	119,359	437,531	104,759	130,469	128,272	120,327	497,912	119,265	135,386	132,480	120,051	503,568	109,886	125,711	129,290	120,676	529,961	118,875	141,984	142,331	137,702		128,307	151,413	150,578	148,766					143,150
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												874,218					888,921				
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			219,190	41,701	50,749	48,805	49,746	225,223	43,686	44,451	37,312	33,331	206,972	47,233	52,604	51,718	48,657	209,327	46,013	52,853	54,634	52,145	229,839	51,920	60,054	60,267	58,592		54,660	66,540	66,026	66,791					66,378
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												201,610					204,332				
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex				212	375	312	274		469	446	410	401	1,333	464	513	549	635	1,333	461	581	611	448	1,560	451	583	542	470	1,616	516	619	616	633	1,636				578
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				475	733	628	582	13,125	515	583	539	539	11,595	527	685	616	591	11,723	505	826	652	596	9,444	571	720	663	747		648	849	865	855					1,007
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female				12	47	44	29		30	90	265	53	174	69	48	42	40	172	60	47	27	52	58	42	67	48	37	66	107	81	35	46	63				47
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			90,254	20,394	25,844	24,252	24,521	92,730	21,507	21,868	18,446	16,719	103,553	23,309	26,929	26,432	24,611	104,725	23,410	26,914	27,917	25,028	115,177	25,930	30,376	30,134	29,892		27,590	33,198	32,899	33,329					33,679
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				4,344	5,519	5,140	4,992	13,125	4,229	5,054	4,162	4,072	22,479	4,956	5,915	5,528	5,451	22,741	4,944	6,108	6,498	5,765	25,432	6,162	7,220	6,912	6,626		6,169	8,066	7,722	7,817					7,871
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			283,657	69,922	87,177	83,016	85,995	291,554	76,516	106,981	111,048	108,895	352,413	80,596	92,286	91,043	83,658	356,405	79,577	89,977	93,478	86,979	388,189	86,602	102,428	102,274	99,678		92,332	108,346	107,203	107,140					117,813
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			25,787																																		
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female							62,538																														
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												600,203					608,531				
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				1	1		1		52							1	15			1	2	3															
Uganda	Uganda	UGA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			244,977	57,594	67,455	67,323	66,071	251,720	57,141	66,363	69,190	63,880	279,376	64,721	74,807	75,379	68,914	282,540	63,804	72,346	73,853	65,393	298,222	65,571	75,811	78,184	75,029		70,156	80,282	82,285	80,315					78,039
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												30,021					14,441				
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				369	474	432	430	1,000	409	411	320	376	5,615	407	494	430	452	2,858	390	470	535	519	3,059	461	621	526	555		493	690	606	584					589
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			29,065	6,406	7,207	6,646	7,129	25,839	5,758	7,690	7,582	8,703	10,251	5,778	6,480	5,942	5,615	22,336	5,146	5,642	5,431	5,323	23,262	4,829	5,938	5,617	5,269		4,908	5,675	5,273	5,495					5,264
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			10,437	4,262	5,669	5,136	4,980	17,858	4,583	5,310	4,734	5,253	15,418	4,856	5,145	4,933	4,455	16,089	3,980	4,359	4,204	4,125	17,192	3,763	4,614	4,340	4,081		3,915	4,616	4,323	4,210					3,561
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			5,395	1,245	1,508	1,403	1,380	5,756	1,295	1,281	1,178	1,285	24,031	1,183	1,271	1,187	1,130	3,272	1,118	1,164	1,117	1,008	5,811	1,006	1,223	1,137	1,094		1,063	1,170	1,155	1,077					1,069
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female					1		6		2	4	220	2		2	13	4	5	58	8	2	3	5	8	6	2	6	7		2	19	3	6	6				7
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												10,077					18,100				
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			2,714																																		
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			9,301	2,383	2,688	2,548	2,529	9,560	2,091	2,036	1,671	1,675	7,215	2,051	2,466	2,393	2,309	11,189	2,087	2,336	2,335	980	10,163	2,128	2,679	2,406	2,397		2,321	2,796	2,711	2,666					2,541
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female							2,036																														
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex				4	6	6	7		17	7	9	9		7	10	8	9	606	16	7	10	7	858	4	5	24	5	47	15	10	6	11	13				6
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												43,708					44,702				
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			22,476	4,628	5,149	4,782	4,879	24,474	3,956	3,955	3,190	3,065	11,686	4,182	4,340	4,128	4,093	21,780	3,575	4,242	4,043	4,028	17,819	3,780	4,438	4,216	4,112		3,859	4,647	4,461	4,387					4,079
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex									2																												
Uganda	Uganda	UGA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				36	58	51	61	1,000	46	33	34	59	11,131	54	48	43	49	1,562	39	39	50	51	1,263	42	52	46	44		34	75	58	54					61
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			28,783		16,640		16,110	33,512		12,481		13,555	5,346		13,484		15,953	11,014		19,085		15,621	10,290		22,366		17,809			24,809		33,809					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			65,933		52,449		57,684	75,014		61,238		27,851	6,724		15,199		14,873	5,506		20,227		16,614	5,143		27,095		20,222			29,116		26,776					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			14,850		3,621		4,132	17,291		3,270		3,414	3,753		2,655		2,079	5,506		3,263		2,181	5,143		3,475		2,998			4,344		5,456					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												18,335					18,409				
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												35,671					36,134				
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					5,985		8,310	19,012		6,302		5,782	3,587		5,830		5,666	8,258		7,603		5,346	7,716		8,730		6,330			9,572		13,507					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			6,908		1,305		1,340	8,482		1,468		1,401	2,116		1,015		798	2,748		1,156		792	2,572		1,191		815	5,100		1,484		2,209	5,115				
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			28,420		13,730		14,248	33,192		10,100		10,852	5,250		11,171		12,220	11,014		15,468		12,517	10,290		18,482		13,878			20,081		26,853					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			12,699		3,361		4,325	14,472		3,781		3,795	3,878		3,823		3,532	2,748		4,941		3,262	2,572		5,087		3,516	5,100		5,944		8,219	5,115				
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			97,967		58,508		58,001	147,165		45,176		21,638	30,503		8,374		9,205	3,015		11,651		10,308	1,542		13,727		10,337			14,708		8,892					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			15,844		6,091		5,773	19,118		4,809		5,507	2,876		4,242		3,297	5,506		4,745		3,384	5,143		5,259		4,462			6,680		8,430					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			16,441		15,954		15,113	20,967		11,689		11,899	3,758		11,510		14,237	16,521		16,191		13,558	15,432		19,091		15,698			20,733		17,763					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					3,747		5,697	18,814		3,550		3,441	3,585		3,587		3,510	6,608		4,574		3,158	6,174		4,852		3,423			5,522		7,654					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			16,118		9,191		6,256	20,714		6,099		7,580	2,966		5,642		4,508	13,767		6,232		4,686	12,862		6,789		6,714			9,051		11,537					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			32,298																																		
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												37,722					38,219				
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			34,395		11,248		116,337	130,892		8,469		13,342	12,052		1,088		480	4,080		1,027		398			987		619			938		842					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			7,327		7,112		16,073	27,622		5,071		3,917	13,051		3,279		3,937	5,216		4,748		4,577	3,600		5,645		4,845			6,526		31,645					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												47,894					48,457				
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												40,755					41,251				
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												13,244					13,312				
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			18,087																																		
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					1,216		1,384	11,188		1,275		1,295	2,042		1,042		760	1,655		1,224		804	1,542		1,248		866			1,510		2,074					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					2,648		3,275	11,423		2,535		2,273	2,070		1,825		1,369	2,748		2,108		1,404	2,572		2,202		1,829			2,748		3,638					
Uganda	Uganda	UGA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			26,548		8,905		10,204	29,944		7,642		7,602	6,588		8,025		8,686	11,014		10,977		8,043	10,290		12,787		9,378			13,966		18,803					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			2,961	4,119	6,291	9,145	1,919	7,266	8,563	8,490	7,629		6,907	10,737	12,517	15,255					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												80,666					56,480				
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			3,292	4,344	6,384	9,498	16,115	7,161	9,159	9,217	7,163		6,990	11,118	11,660	12,795					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												15,164					10,624				
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												3,358					2,356				
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			4,518	6,209	8,904	12,181	11,840	10,557	13,097	13,467	10,812		10,831	16,715	18,482	23,147					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			1,366	1,987	2,707	3,636	2,191	2,912	3,661	3,517	2,892		3,034	4,644	4,937	5,836					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												4,850					3,395				
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												19,525					13,672				
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												2,585					1,821				
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			1,365	1,895	2,770	3,910	335	3,104	3,812	3,581	3,036		2,853	4,675	5,671	6,768					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			2,188	2,899	4,659	6,605	2,007	5,250	6,221	5,999	5,089		4,779	7,450	8,585	10,459					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			475	665	922	1,299	59	1,001	1,264	1,189	880	777	961	1,516	1,914	2,390	549				
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			2,659	3,877	5,245	7,061	12,865	5,904	7,198	7,264	5,958		6,205	9,288	9,935	11,777					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			661	948	1,379	1,831	2,142	1,400	1,783	1,776	1,376		1,447	2,291	2,530	3,015					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			330	460	610	887	1,787	675	865	838	604		695	980	1,181	1,382					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			7,081	9,151	13,300	19,403	34,253	15,104	19,215	19,840	15,635		15,238	23,569	25,764	29,801					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			862	1,200	1,655	2,605	307	1,859	2,231	2,193	1,938		1,802	2,970	3,207	3,901					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			200	298	402	488	454	378	464	469	364	5,135	392	658	770	1,023	3,596				
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			2,960	4,019	5,955	8,904	1,135	6,897	8,209	8,040	6,960		6,076	9,561	10,865	13,592					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			823	1,224	1,755	2,583	328	2,014	2,470	2,310	1,895		1,831	2,880	3,498	4,353					
Uganda	Uganda	UGA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			466	645	964	1,378	264	998	1,264	1,181	962		1,020	1,582	1,903	2,325					
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					696		1,456	1,021		2,105		2,806	5,094	1,842	5,927	10,836	14,969	5,904																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					75		149	1,010		244		365	5,982	221	620	1,063	1,377	3,779																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					163		428	512		578		770	5,826	494	1,564	2,861	3,860	986																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					600		1,206	2,021		1,782		2,593	10,743	1,807	4,723	8,169	11,446	28,357																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					176		308	1,015		486		737	7,798	447	1,189	2,070	2,887	4,726																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					950		2,026	2,006		3,344		4,590	10,292	3,122	8,834	14,717	20,544	28,357																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					280		629	1,017		955		1,295	6,188	784	2,484	4,534	6,247	986																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					633		1,534	1,199		2,371		2,752	3,384	1,931	5,971	10,557	14,605	18,331																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					738		1,632	1,394		2,085		2,905	3,317	2,030	6,208	11,368	15,384	3,938																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					571		976	1,020		1,470		1,854	6,054	1,201	3,915	7,270	10,039	5,904																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					120		229	382		318		435	9,131	297	839	1,631	2,163	195																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					1,352		2,815	4,425		4,692		6,342	7,858	4,721	13,214	22,871	30,995	53,600																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					341		670	2,016		1,036		1,409	9,703	952	2,482	4,354	6,042	4,726																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					59		75	197		122		176	10,790	115	333	624	819	947																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					121		252	505		378		461	5,121	279	854	1,619	2,175	788																			
Uganda	Uganda	UGA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					186		430	187		618		862	1,451	533	1,636	3,215	4,353	986																			
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			1,688																																		
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					105		213	759		264		293	4,525	213	496	615	479	634	521	682	758	589	571	640	786	795	494		804	1,139	1,200	1,477					642
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			1,688		769		1,535	3,046		2,461		3,090	9,085	2,000	4,744	4,576	4,893	22,691	4,787	6,560	6,013	4,794	25,729	6,760	7,733	8,664	5,358		7,347	10,539	11,925	13,005					9,261
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			840																																		
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			165		42		55	295		101		119	9,453	81	171	224	147	758	177	209	227	197	857	218	248	279	191	8,939	303	466	539	579	8,943				395
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												33,998					34,010				
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					152		224	1,531		362		488	6,887	285	594	637	628	3,779	674	880	791	654	4,289	817	979	1,053	690		995	1,440	1,551	1,727					1,110
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												8,440					8,454				
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			840		260		554	1,533		736		914	5,490	559	1,471	1,706	1,570	788	1,506	2,073	2,077	1,674	714	2,008	2,417	2,310	1,613		2,293	3,314	3,855	4,259					1,975
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			840		574		1,259	1,536		1,597		2,002	4,480	1,402	3,607	4,164	3,703	4,721	3,609	4,764	5,214	3,962	4,270	4,473	5,457	5,819	3,951		5,011	7,611	8,325	10,014					4,824
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												26,404					26,407				
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			336		109		189	565		263		294	8,033	211	451	650	408	158	516	737	692	579	144	614	742	750	497	1,377	772	1,202	1,286	1,508	1,378				798
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			840		431		835	1,533		1,102		1,319	5,359	901	2,338	2,825	2,447	4,721	2,434	3,443	3,666	2,727	4,270	3,167	3,892	3,973	2,718		3,720	5,049	5,724	6,871					3,178
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												140,501					140,506				
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			1,179		646		1,392	2,096		1,652		2,116	2,867	1,554	3,634	4,376	3,635	3,151	3,473	4,596	4,982	3,938	2,846	4,375	4,865	5,301	3,762		4,586	6,834	7,867	9,545					4,222
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												4,505					4,508				
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					164		302	769		406		534	5,164	362	956	1,050	879	788	915	1,392	1,410	1,077	714	1,325	1,584	1,507	1,015		1,417	2,166	2,432	2,840					1,275
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			1,008		576		1,140	1,800		1,822		1,867	2,930	1,283	3,405	3,742	3,344	14,660	3,708	4,796	5,321	3,367	34,288	5,138	5,670	5,593	3,286		4,350	6,876	7,010	6,932					5,158
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			3,876		1,263		2,245	6,624		3,312		4,457	6,860	3,123	7,064	7,675	6,785	42,873	6,835	9,873	9,994	7,039	67,158	10,349	12,386	12,158	7,255		9,998	15,434	16,083	16,397					11,664
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			1,688		400		905	3,053		1,255		1,809	9,530	1,146	2,390	2,632	2,751	22,691	2,644	3,503	3,306	2,562	25,729	3,542	4,399	4,668	3,037		4,173	5,556	6,234	6,882					5,107
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			165		191		400	284		486		639	1,266	391	948	1,357	1,050	788	1,084	1,286	1,496	1,111	714	1,304	1,493	1,606	1,097		1,432	2,091	2,425	2,956					1,313
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					73		100	1,526		164		247	5,261	150	321	340	247	3,025	306	361	393	332	3,435	366	437	425	292		428	708	676	749					381
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			1,688		259		463	3,050		738		922	8,595	607	1,260	1,444	1,427	3,779	1,293	1,729	1,617	1,404	4,289	1,766	2,080	2,262	1,381		1,960	2,796	3,104	3,370					2,474
Uganda	Uganda	UGA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												5,852					5,864				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												4,099					5,061				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				150	205	217	263	980	177	220	121	169	746	196	246	250	256	779				1,085	810				1,372					1,305					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				95	140	127	139	656	86	110	60	73	1,125	97	134	135	116	324				610	699				594					463					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				313	361	358	416	980	325	383	263	299	1,175	298	388	348	352	1,186				1,669	1,237				2,178					1,955					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			2,482																																		
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				357	389	362	448	1,992	399	415	262	288	1,882	301	397	372	391	1,409				1,736	1,425				1,800					1,925					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				304	360	374	408	1,992	286	308	258	241	1,874	226	278	270	247	1,027				1,159	1,124				1,257					1,191					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			7,746																																		
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												1,233					1,146				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												3,682					4,039				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												1,148					1,031				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				52	66	54	67	1,992	31	34	30	21	547	33	31	39	33	148				170	284				226					219					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				228	293	250	313	980	257	275	173	215	855	214	303	313	279	951				1,382	958				1,637					1,544					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				314	366	301	374	980	298	345	233	276	1,172	289	346	337	304	1,053				1,513	1,133				1,823					1,799					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				426	661	584	698	1,992	550	624	406	508	4,521	529	644	643	672	2,313				3,204	2,033				3,695	3,130				3,897	3,902				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				289	333	357	372	980	323	318	218	288	1,066	283	349	387	352	1,162				1,587	1,201				1,790					1,730					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												3,336					3,315				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												6,805					7,853				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				484	607	578	615	1,992	488	545	399	419	2,185	452	532	532	511	1,771				2,384	1,860				2,339					2,403					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				123	153	163	179	656	117	120	63	72	855	87	115	111	90	441				576	576				540					481					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				23	28	27	35	656	21	27	10	20		15	31	22	18					100					106					90					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				152	165	121	170	656	104	113	73	68	827	56	100	90	83	510				572	587				727	911				587	609				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				143	143	128	123	1,992	104	127	92	89	1,141	96	89	110	93	425				428	537				496					529					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				461	534	506	603	1,992	444	548	388	375	2,138	418	500	424	425	1,553				1,957	1,665				2,228					2,047					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			13,195																																		
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				209	251	229	267	980	187	204	138	177	1,030	196	208	211	198	691				948	828				1,323					1,260					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												1,505					1,883				
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				369	475	446	511	1,992	387	486	338	385	1,904	403	465	419	465	1,470				2,052	1,493				2,303					2,341					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				77	81	77	87	980	62	53	40	61	526	48	75	66	64	236				286	361				451					390					
Uganda	Uganda	UGA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				263	372	430	466	980	376	406	296	375	2,736	390	499	616	509	1,679				2,830	1,700				3,306	2,431				3,276	2,974				
Uganda	Uganda	UGA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			18,857		1,734		9,415	28,567		19,776		4,026	24,968		6,502		5,885	19,602		6,889		3,863	13,188		3,786		2,936	5,465		2,715		2,669	2,762				
Uganda	Uganda	UGA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			115,049		6,769		48,019	152,055		242,688		61,418	190,739		95,772		68,408	134,987		73,939		44,730	70,756		41,476		29,623	67,445		30,099		31,142	44,119				
Uganda	Uganda	UGA	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			54,695		4,769		28,520	154,306		129,050		32,955	129,690		56,272		39,003	93,737		42,829		25,791	70,490		25,757		18,470	39,285		18,842		19,879	30,086				
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												8,686					9,204				
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				321	389	411	476	2,197	331	434	283	378	2,040	407	478	532	568	1,806	481	623	641	634	1,785	645	659	610	574		605	692	621	631					671
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				134	135	214	204	1,517	140	183	152	184		194	275	301	221		257	351	429	381		316	283	261	249		210	193	219	181					188
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				219	285	289	309	4,409	261	305	235	221	1,450	250	256	263	256	1,305	252	339	324	336	1,294	333	344	358	333		321	407	373	422					396
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				498	540	599	625	2,197	548	588	421	557	2,927	502	653	706	689	2,603	710	811	796	809	2,582	816	741	861	764		766	889	799	832					855
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												18,672					19,721				
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												6,540					6,887				
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												4,974					5,259				
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			33,628																																		
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				778	914	965	1,000	4,409	817	1,009	807	849	4,680	803	960	985	985	4,138	966	1,080	1,034	1,062	4,094	1,048	1,097	1,207	1,025		1,016	1,199	1,106	1,216					1,314
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				402	420	386	536	1,515	356	392	311	380	2,268	361	436	461	462	2,039	434	651	643	782	2,010	961	708	773	716	2,648	643	727	691	749	2,765				667
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				446	589	528	629	2,197	455	523	447	534	2,822	529	583	590	552	2,509	546	616	638	668	2,471	741	790	712	730		725	839	729	750					735
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			5,861																																		
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				1,000	1,123	1,078	1,172	4,409	979	1,264	974	1,025	5,632	1,071	1,199	1,164	1,195	4,973	1,117	1,348	1,363	1,416	4,924	1,331	1,404	1,421	1,402		1,335	1,511	1,385	1,483					1,561
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				388	458	443	536	2,197	453	500	376	440	2,367	462	594	632	616	2,107	608	745	734	776	2,081	746	758	770	669		734	798	709	743					779
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			16,641																																		
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												12,143					12,835				
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												7,575					8,023				
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				521	529	578	742	1,517	549	643	457	632	3,113	718	878	982	860	2,811	908	1,422	1,461	1,390	2,787	1,161	1,129	1,073	961		896	863	837	806					700
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				521	575	581	566	4,409	522	678	526	550	2,862	569	595	625	640	2,538	593	662	628	672	2,510	644	709	680	731		745	771	756	745					793
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				242	273	270	301	2,197	247	238	218	246	1,397	209	286	265	271	1,231	253	309	325	348	1,221	390	405	346	375		371	381	437	394					403
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				385	423	473	529	1,517	429	498	349	497	2,355	461	576	582	573	2,112	529	1,038	1,019	1,079	2,088	1,035	821	853	742		728	688	774	728					643
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				788	1,040	1,119	1,245	2,197	1,079	1,191	950	1,279	5,702	1,281	1,515	1,940	1,820	5,049	1,736	2,518	2,286	2,272	4,995	2,211	2,269	2,163	1,883	6,732	1,881	2,499	2,220	2,344	7,114				2,294
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				1,463	2,048	1,960	2,283	4,409	1,982	2,496	1,777	2,359	10,491	2,485	2,893	3,167	3,033	9,331	2,954	3,834	3,625	3,823	9,235	3,787	3,531	3,414	3,229	12,454	3,287	3,941	3,590	4,104	13,147				3,911
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				817	995	936	1,106	4,409	901	1,183	847	1,013	5,036	1,128	1,208	1,201	1,216	4,449	1,136	1,458	1,399	1,428	4,406	1,339	1,398	1,422	1,279		1,320	1,530	1,375	1,612					1,521
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				1,026	1,138	1,122	1,248	4,409	1,029	1,202	973	1,072	5,857	1,152	1,286	1,348	1,292	5,189	1,221	1,536	1,512	1,437	5,135	1,447	1,373	1,406	1,290		1,390	1,541	1,408	1,436					1,572
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				846	939	908	1,075	4,409	922	1,060	788	947	4,897	931	1,095	1,104	1,197	4,342	1,087	1,277	1,309	1,334	4,300	1,184	1,147	1,208	1,090		1,112	1,309	1,232	1,348					1,411
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				542	654	573	688	2,197	569	665	511	624	3,211	595	684	733	712	2,843	748	803	798	832	2,818	866	876	870	851		883	934	886	886					946
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				560	604	620	695	2,197	599	671	510	605	3,213	573	721	709	719	2,840	660	862	858	892	2,810	914	975	940	861		877	921	894	892					938
Uganda	Uganda	UGA	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												5,110					5,417				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			105,048	101,680	102,951	104,167	107,939	98,824	105,348	108,378	106,744	109,745	107,693	107,639	109,069	110,682	112,439	113,503	109,598	109,054	109,863	110,497	123,566	107,866	108,230	109,661	110,708		107,310	107,257	108,817	110,155					108,820
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												239,836					221,171				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												32,099					29,093				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			87,920	68,818	74,035	78,450	81,810	109,441	85,166	91,720	93,560	95,314	115,711	98,920	102,375	104,042	105,094	111,365										118,959					138,084				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												101,257					87,805				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			6,625	1,306	1,043	1,003	989	1,719	1,031	915	748	885	2,651	873	721	761	687	1,108	614	569	556	549	1,440	566	566	545	554	1,072	510	501	502	541	994				385
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Female				28,397	11,996	4,466	12,228		13,469																												
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			44,319	51,275	51,220	51,795	53,474	65,764	52,737	54,776	54,463	55,312	65,193	53,905	52,844	52,626	52,274	62,317	50,848	50,069	50,566	51,073	66,627	50,358	50,345	50,888	51,525		50,038	49,781	50,675	51,291					47,813
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			62,440	63,498	65,037	66,118	52,691	70,467	72,901	73,968	73,799		76,884	78,059	80,139	83,134					87,556
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			17,596	17,646	18,627	18,944	16,092	20,045	20,557	20,981	21,330		22,211	23,173	23,643	23,988					26,106
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			57,819	57,078	57,831	59,760	61,472	74,106	60,302	63,437	63,147	63,757	70,637	64,141	65,254	67,177	68,382	70,301	69,036	68,490	68,680	68,912	75,701	68,011	69,286	70,026	70,640		69,512	69,878	70,556	71,391					71,318
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			14,934	16,176	16,458	17,371	14,430	17,693	18,128	18,732	19,505		20,024	21,086	21,133	21,156					24,564
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				45,577	46,734	49,241	50,992	61,107	52,194	55,199	54,921	55,303	62,190	56,181	56,924	57,826	58,548	59,910	59,355	59,891	60,309	60,687	56,167	61,595	62,651	63,182	63,765		64,397	65,865	66,723	67,469					72,072
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			42,981	23,579	24,924	25,397	25,847	39,637	26,480	27,320	26,897	27,239	34,233	27,538	27,929	28,452	28,532	37,774	28,372	28,793	29,034	29,327	27,332	28,935	29,348	29,477	29,431	26,804	28,981	28,792	28,758	28,680	25,534				26,724
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				21,843	22,198	22,856	23,199	30,395	22,384	23,389	22,493	22,798	27,448	21,763	21,563	21,524	21,438	29,587	20,389	19,784	19,499	19,624	22,511	18,769	18,317	18,300	18,172		17,018	16,811	16,697	16,673					15,293
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			25,623	20,549	20,210	20,235	20,393	30,546	19,142	18,672	18,577	19,331	27,489	17,954	18,048	18,443	18,956	24,609	18,248	18,427	18,883	19,574	42,940	18,777	19,218	19,906	20,493		19,553	19,767	20,614	21,310					21,007
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				11,082	10,143	10,251	10,495	19,128	9,563	9,658	9,257	9,480	13,050	8,928	8,481	8,545	8,645	10,498	7,968	7,774	8,226	7,987	18,014	7,675	7,468	7,703	7,818		7,200	6,991	7,118	7,287					6,477
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												194,874					191,303				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												102,899					92,513				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			122,466	102,983	106,625	107,176	111,564	114,412	113,121	118,102	115,956	117,792	115,722	119,673	124,278	126,485	128,671	122,341	131,458	133,414	133,916	134,943	123,222	136,229	139,587	140,471	141,021		142,556	144,186	145,104	145,886					152,737
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			180,175																																		
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Missing Sex				2,531	1,075	437	1,335		1,426																												
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			73,997	63,742	62,238	62,177	64,494	63,616	61,152	62,616	61,376	64,325	69,921	60,304	59,918	61,511	62,451	68,534	57,627	56,283	57,449	58,813	90,984	55,830	55,653	57,220	58,583		54,989	55,466	56,988	58,691					53,585
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			36,140																																		
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			131,321	88,301	95,432	101,131	105,829	132,205	110,782	118,578	120,326	122,616	139,640	127,446	132,725	134,747	135,666	134,254										156,933					186,146				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			47,687	48,361	49,313	49,642	40,391	52,642	54,571	54,565	54,108		56,416	57,309	58,520	60,894					61,978
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				52,627	54,322	56,932	58,594	71,751	59,648	62,989	62,639	63,787	68,496	64,228	64,623	65,019	65,573	68,732	66,301	67,671	68,461	69,327	67,336	70,719	72,492	73,286	73,665		74,030	75,114	75,880	76,340					73,869
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			6,777	16,500	14,981	15,436	14,843	24,089	14,725	14,376	14,605	14,560	25,437	13,858	13,472	13,681	13,301	21,614	12,823	12,537	12,983	13,268	30,665	12,960	12,954	13,223	13,611		13,090	13,060	13,556	13,912					13,767
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			149,745	115,221	119,123	120,258	124,231	117,251	125,302	129,314	128,401	130,724	122,250	129,619	131,513	132,682	132,089	134,077	132,129	132,989	133,929	135,793	136,438	136,956	138,886	140,421	140,870		140,754	142,768	144,626	146,102					142,715
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			29,812	30,883	31,345	31,304	27,976	31,802	33,125	34,051	34,894		35,973	37,114	38,239	36,964					41,958
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			18,196	19,503	19,877	20,795	16,727	21,145	21,686	22,770	23,262		24,552	25,886	25,911	26,430					31,084
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				83,438	88,325	90,413	94,257	99,142	97,044	101,241	99,900	101,773	96,046	102,880	104,886	105,311	105,624	105,511	108,307	110,119	112,036	113,131	95,689	116,660	119,577	120,375	120,746		123,833	125,953	127,025	127,488					127,311
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				65,409	66,794	68,732	72,156	77,690	73,953	78,399	77,606	78,767	75,384	80,724	83,497	84,023	85,554	82,650	86,933	87,744	88,920	89,221	75,936	91,373	93,092	93,986	94,323		96,139	98,219	99,509	100,631					110,130
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			150,496																																		
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male				14,682	5,307	2,060	6,285		6,831																												
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			4,936	9,460	10,022	10,172	9,998	16,526	10,033	10,071	9,931	10,078	14,447	10,314	10,565	10,853	10,751	17,070	11,210	11,457	11,631	11,804	14,435	11,978	12,418	12,576	12,651		12,786	13,044	13,170	13,269					13,796
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			18,800	33,790	32,126	32,632	32,512	45,495	32,207	31,454	31,212	31,913	48,857	31,278	30,205	30,388	30,476	41,471	29,233	28,584	28,720	29,066	53,112	27,642	27,334	28,013	28,891		27,242	26,884	27,377	27,998					26,968
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			22,398	22,736	24,241	24,634	16,564	26,123	26,689	27,560	27,972		29,379	30,546	31,153	31,515					34,579
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												339,806					350,069				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												39,220					40,249				
Uganda	Uganda	UGA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			38,727	40,478	40,672	40,472	32,141	41,243	42,469	43,586	44,376		45,933	47,609	49,336	47,605					53,860
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			17,738	6,257	6,711	6,174	6,371	9,694	5,253	6,320	4,559	5,266	1,974	4,515	5,133	4,596	4,022	3,534	3,833	4,273	4,183	3,931	17,909	3,879	4,724	4,571	4,366		4,043	4,496	4,324	4,394					3,923
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												26,502					15,433				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			4,571																																		
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			811	300	353	296	322	2,264	265	305	218	354	131	281	271	285	263	1,110	213	241	245	267	1,446	215	248	221	259	1,080	190	205	211	239	984				167
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Missing Sex				110	120	65	248		154			5																									
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			2,524	283	267	275	302	12,483	231	228	138	169	613	145	201	174	148	2,929	110	156	143	146	3,218	178	178	210	167		155	162	166	167					108
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				1,476	1,385	1,309	1,369	6,283	1,138	1,402	908	1,098	1,902	971	1,009	1,015	895	3,133	806	976	932	902	6,010	861	1,115	1,116	1,050		873	1,131	1,031	1,030					958
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								223	292	292	313		263	304	288	300					355
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			10,409	2,989	2,873	2,795	2,856	14,879	2,374	2,768	1,957	2,231	1,765	1,960	2,043	2,071	1,822	4,930	1,721	1,957	1,992	1,930	12,753	1,774	2,198	2,091	2,047		1,775	2,045	1,951	1,967					1,720
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			7,706	3,524	3,311	3,075	3,229	16,751	2,622	3,115	2,091	2,504	1,831	2,088	2,256	2,232	1,878	5,626	1,777	2,040	2,030	1,951	14,971	1,885	2,305	2,294	2,192		1,994	2,089	2,000	2,051					1,685
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												11,572					7,988				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				627	747	711	746	3,578	538	716	469	580	412	531	604	525	468	357	451	547	511	541	5,126	543	566	578	526		419	455	417	457					378
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								99	130	155	151		144	165	169	157					178
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			11,613	3,139	3,045	2,849	2,859	21,581	2,361	2,669	1,878	2,144	1,957	1,677	1,940	1,893	1,614	5,505	1,545	1,786	1,750	1,662	14,859	1,584	1,883	1,932	1,832		1,690	1,765	1,666	1,747					1,504
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			5,357																																		
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								572	705	766	650		525	725	677	643					611
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								146	194	251	236		171	209	314	193					243
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Female				1,277	1,729	834	2,412		1,692			4																									
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												5,037					3,675				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				388	428	442	504	7,308	346	505	264	337	825	311	386	325	303	4,903	274	317	290	311	2,658	315	372	399	293		277	316	310	268					244
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								106	111	146	148		120	166	197	149					165
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								699	902	855	793		698	915	797	873					780
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				1,995	2,036	1,884	1,922	7,679	1,600	1,942	1,355	1,525	1,852	1,326	1,497	1,414	1,273	4,006	1,136	1,344	1,422	1,407	9,852	1,364	1,756	1,594	1,525		1,475	1,589	1,564	1,592					1,227
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			7,670	2,258	2,342	2,276	2,331	7,495	1,770	2,039	1,647	1,792	1,002	1,385	1,674	1,580	1,427	1,308	1,238	1,434	1,399	1,296	12,137	1,264	1,648	1,542	1,501		1,396	1,579	1,584	1,535					1,210
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			7,923	2,992	2,949	2,746	2,687	3,762	2,396	2,799	1,933	2,290	1,999	1,972	2,261	2,091	1,903	2,867	1,819	2,016	1,954	1,875	6,759	1,858	2,319	2,368	2,207		1,999	2,232	2,290	2,132					1,991
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												1,358					1,276				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			285	1,228	1,302	1,223	1,327	1,627	1,019	1,392	866	1,117	5,159	992	1,124	1,019	867	3,166	812	1,080	1,082	966	2,186					18,137					17,084				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			5,388	315	370	342	357	6,080	296	326	225	242	1,287	228	292	258	240	5,298	203	253	282	252	5,442	277	359	412	301	2,896	271	274	312	245	288				249
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			14,136	6,528	6,916	6,517	6,477	12,477	5,332	6,556	4,850	5,614	1,402	4,651	5,448	5,010	4,150	3,124	3,745	4,349	4,362	4,103	20,853	3,885	4,953	4,780	4,531		4,259	4,872	4,657	4,655					3,593
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				1,057	960	990	1,068	1,231	859	1,014	690	860	1,509	714	772	769	649	1,816	647	699	721	710	1,830	689	890	854	795		730	862	903	849					813
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								160	186	213	206		170	186	192	173					195
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				1,657	1,685	1,576	1,542	2,073	1,337	1,581	1,117	1,268	1,631	1,131	1,274	1,208	1,005	2,359	998	1,139	1,187	1,103	4,751	1,134	1,397	1,366	1,220		1,183	1,295	1,280	1,247					1,185
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			7,633	4,342	4,497	4,150	4,332	7,234	3,527	4,352	2,970	3,689	2,270	3,091	3,434	3,077	2,719	3,351	2,599	2,886	2,912	2,782	11,395	2,732	3,407	3,331	3,177		2,811	3,379	3,050	3,119					2,685
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male				728	955	496	1,219		989																												
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								120	182	194	215		140	203	204	210					156
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			6,304	1,578	1,330	1,300	1,365	15,471	1,129	1,276	950	1,024	1,222	837	915	922	837	3,648	706	759	776	816	9,426	766	971	918	846		812	911	856	812					636
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												10,470					7,997				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			4,641	1,615	1,564	1,391	1,624	19,911	1,312	1,643	1,057	1,334	4,744	1,118	1,358	1,317	1,105	8,028	1,053	1,208	1,167	1,230	7,632					11,888					10,479				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												9,080					7,084				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												12,629					3,382				
Uganda	Uganda	UGA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			9,697																																		
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				82,286	85,558	89,053	93,772		95,211	95,674	93,435	95,102	104,451	97,738	98,499	99,266	114,972	110,418	116,614	117,007	120,555	119,166	114,363	117,138	122,375	121,259	124,662		128,626	129,552	129,765	134,191					122,707
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				74,970	78,866	82,083	87,682		88,376	88,155	86,074	87,636	97,199	88,433	87,399	87,079	97,631	102,443	96,081	95,754	96,874	95,908	115,267	92,931	95,102	93,241	96,384		96,841	99,113	100,538	99,862					84,348
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								44,605	47,566	47,924	48,618		50,095	50,502	48,902	54,143					49,779
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				41,635	43,693	45,009	48,085		47,935	47,614	46,555	47,753	63,110	48,453	47,553	47,897	51,709	61,861	49,875	49,560	50,166	49,394	84,483	47,849	49,196	49,607	50,054		49,420	51,664	53,521	53,135					41,411
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												92,875					83,302				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				3,274	1,081		1																														
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				39,095	40,843	43,122	45,387		46,091	46,742	46,169	47,035	61,825	48,347	47,604	46,987	55,426	62,043	55,498	54,938	57,509	56,944	61,559	55,997	59,261	59,337	60,150		62,772	61,506	58,583	63,300					51,414
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												91,394					78,717				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								24,200	25,389	26,432	27,659		28,437	29,342	30,084	32,075					33,680
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				19,611	20,944	21,391	24,391		23,491	23,650	23,507	24,065	30,890	24,749	25,285	26,617	28,645	34,101	29,368	29,583	28,731	29,086	25,202	29,265	28,905	28,689	28,781	24,202	27,735	28,353	28,773	28,357	23,456				23,822
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				6,475	7,029	7,631	8,426		8,548	8,804	8,573	9,083	22,959	9,324	9,411	9,781	9,769	19,509	9,795	9,403	10,056	9,863	28,313	9,616	10,229	10,493	10,273		10,267	10,417	10,338	11,169					9,527
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								20,770	21,788	22,976	23,847		24,477	25,278	26,051	27,711					28,928
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				11,250	12,221	12,953	14,438		14,021	13,767	13,217	13,117	24,809	13,366	13,994	14,530	16,278	22,219	16,698	16,750	17,024	17,339	39,700	18,927	18,849	18,765	19,131		17,803	18,855	19,611	19,954					18,590
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				67,811	70,379	73,845	77,277		79,128	80,308	78,110	80,032	86,688	82,690	82,914	81,558	93,814	95,225	95,205	94,874	99,369	98,572	89,069	97,697	103,660	104,565	106,792		110,353	110,485	109,542	116,588					107,435
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				80,339	84,411	93,786	98,646		101,900	104,512	100,494	104,652	126,039	109,729	110,775	111,814	128,510	121,169	132,799	133,947	140,560	142,430	108,279					141,638					166,821				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								62,840	67,532	68,708	70,683		71,856	73,139	73,523	80,118					68,221
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				52,964	55,425	59,983	62,754		64,251	64,952	62,277	63,526	68,039	65,907	66,882	66,258	76,807	74,605	77,206	76,294	80,423	79,189	69,840	78,418	81,679	82,069	83,238		85,969	85,760	84,149	91,471					85,505
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				32,172	33,836	36,235	38,101		38,349	38,159	37,057	37,415	58,845	37,977	36,951	35,771	41,630	56,254	40,324	39,385	40,828	40,033	61,459	38,708	40,296	39,905	40,350		41,104	40,066	38,689	41,266					31,460
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												35,409					36,098				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				4,967	5,245	5,352	6,054		5,824	5,488	5,239	5,236	11,780	5,322	6,011	5,607	6,732	9,481	6,760	6,399	6,267	6,158	16,649	7,047	7,012	6,437	6,642		6,592	6,558	7,187	7,110					4,808
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				5,673	6,144	6,596	7,711		7,569	7,804	7,778	7,991	13,040	8,155	8,671	9,144	10,019	15,409	10,630	10,740	10,804	11,099	13,285	12,068	12,064	12,415	12,204		11,620	12,326	11,953	12,246					11,628
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								17,182	18,103	18,610	19,318		20,333	20,521	20,391	21,836					22,447
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				185	188	131	82		89	62	67	85	2,446	101	146	20	173	1,074	208	130	176	225	982	27	128	192	668	748	1,080	330	167	3,098	708				9,928
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				36,759	38,642	41,227	43,174		44,127	44,458	43,367	43,959	56,135	45,014	44,730	44,570	51,988	54,077	52,044	51,682	53,314	52,935	51,373	51,713	53,760	53,153	53,703		55,587	55,139	52,852	57,719					48,663
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				91,451	95,189	99,989	105,443		106,284	105,821	102,708	104,254	110,340	106,633	105,244	103,742	118,164	121,011	116,762	116,381	119,554	118,415	127,084	115,896	121,837	120,640	124,878		127,488	129,684	131,501	134,405					120,015
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								35,491	37,124	37,910	38,802		41,539	41,379	41,086	43,908					48,204
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								26,837	28,070	28,482	29,497		31,635	31,483	30,473	32,644					33,355
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												28,983					26,454				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				39,958	41,723	43,577	45,879		46,468	46,567	45,756	46,084	63,749	46,461	46,131	46,297	55,657	63,460	55,464	55,000	57,060	55,800	69,423	53,793	56,043	55,364	55,710		57,442	56,787	53,940	58,277					45,454
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												306,683					318,220				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												175,884					174,024				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				16,785	18,006	19,309	20,731		21,103	21,124	20,463	20,719	44,102	20,550	20,240	20,013	22,632	37,440	22,064	21,573	22,588	22,045	49,041	20,896	21,584	20,905	21,042		21,333	21,289	20,676	22,188					17,078
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								15,511	16,245	16,754	17,336		18,130	18,469	18,255	19,595					19,205
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												216,456					202,785				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				16,973	17,744	18,081	20,394		19,421	19,264	18,814	18,911	24,782	19,099	19,349	19,205	20,605	26,716	20,723	20,066	18,934	18,517	20,757	18,309	17,685	17,055	17,057		16,332	16,488	16,544	16,358					12,725
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				59,849	63,451	68,698	72,853		74,542	76,492	75,218	77,827	104,437	80,901	81,040	81,614	95,819	100,504	98,555	99,144	104,186	104,539	90,982					107,373					124,350				
Uganda	Uganda	UGA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				1,491	509		3																														
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														279		262					266
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														1,144		1,050					960
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														246		229					295
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														929		787					699
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														769		630					508
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														930		803					661
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														187		164					159
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														269		163					176
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														341		210					197
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														821		618					629
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														116		91					89
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														255		179					172
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														940		814					778
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					2,774		3,655			4,176		2,794			3,566		4,495			4,764		6,276			6,292		6,358										
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														303		214					328
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														1,042		936					779
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														1,121		1,037					895
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														629		511					479
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														259		254					241
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														228		162					139
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														1,015		883					842
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														366		328					376
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														14		20					11
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														710		540					433
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					4,658		5,322			5,620		3,774			4,505		5,641			5,636		6,950			6,768		6,398										
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					660		870			709		320			480		639			632		952			895		807										
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														1,004		709					715
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														687		547					518
Uganda	Uganda	UGA	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														302		211					248
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			942							40	248	541	1,002	349	289	335	599	1,202	842	687	594	889		401	626	1,647	1,343		627	959	1,486	1,706					475
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female										25	79	313	1,171	183	57	158	345	1,403	308	327	362	389		374	588	880	1,364		599	1,116	713	871					522
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male									134	24				1	3	1			2	1	7			1	1	135	50		8			43					
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			1,610							71	396	1,414	5,265	647	425	621	1,217	6,311	1,021	1,323	1,565	1,079		1,197	1,703	1,767	2,909		1,494	2,437	1,475	1,734					871
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female										42	145	345	1,648	571	137	181	432	1,976	539	463	458	371		420	1,081	2,133	2,081		820	1,382	1,237	736					528
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female										20	96	209	1,130	659	127	105	309	1,354	920	683	332	427		254	1,257	3,857	2,348		1,018	1,799	1,039	1,094					412
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female										33	113	333	1,391	346	133	161	384	1,667	430	381	467	514		474	894	1,204	1,865		750	1,387	1,117	1,185					701
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female										7	65	232	1,184	62	49	103	229	1,419	240	282	410	456		338	471	785	1,934		674	1,199	672	724					897
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female									143	16				1	1				1		4			1	1	730	137		4			79					
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male										79	248	963	3,702	467	326	562	1,165	4,439	815	1,079	1,231	937		955	1,292	1,624	2,616		1,165	1,936	865	1,058					711
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			1,610							104	452	1,594	6,541	997	649	821	1,594	7,841	1,399	1,666	1,777	1,293		1,350	1,950	2,059	2,877		1,394	2,038	1,468	1,717					700
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female										39	103	154	543	512	156	138	312	652	2,366	1,917	381	903		193	1,453	7,706	4,228		1,422	4,022	2,535	1,944					806
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male										26	154	620	3,353	187	156	283	593	4,018	480	532	818	587		569	753	874	1,778		864	1,319	721	949					501
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex								20,000				67														47			150		924	4,816					
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female										13	68	74	225	61	92	65	168	270	1,744	1,066	181	492		69	552	4,604	2,822		869	1,824	1,697	1,050					392
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex										1	6	6		2	4	13	6		12	9	9	4		2	34	25	35		17	10	3						1
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female										16	54	192	1,024	81	33	91	245	1,228	176	240	323	262		291	338	508	940		415	742	506	503					381
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			636							21	93	490	2,226	147	106	269	506	2,669	363	483	792	694		489	710	803	2,191		833	1,615	693	513					890
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			1,610							164	526	1,434	5,095	913	651	831	1,388	6,109	1,193	1,246	1,509	1,328		1,256	1,797	1,959	2,361		1,224	2,136	1,577	1,591					803
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			2,022							177	624	1,416	2,876	959	917	871	1,766	3,442	1,825	1,756	1,820	1,937		1,419	1,971	3,441	2,993		1,369	2,824	2,582	3,531					1,057
Ukraine	Ukraine	UKR	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			1,610																																		
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			11,578	5,022	9,137	10,522	11,172	35,014	11,131	11,355	9,329	11,662	26,711	10,911	9,805	9,541	8,534	21,770	7,742	4,258	4,347	5,360		5,831	7,794	7,341	7,196		6,894	8,277	3,270	8,456					12,725
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			28,634	4,792	6,261	6,532	8,231	23,074	7,186	7,488	6,150	7,364	6,122	5,522	5,491	5,277	5,033	18,161	3,947	2,846	3,093	3,350		3,184	4,750	4,516	4,614		3,391	3,852	2,018	3,637					4,922
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			41	72	106	135	190		189	219	126	106	88	81	63	68	74	482	36	25	15	10		26	44	43	36		48	22	9	93					137
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			30,454	5,721	8,000	8,398	10,632	68,785	11,061	11,996	10,761	13,530	33,504	10,987	11,029	10,799	10,743	21,201	9,298	7,015	7,616	8,401		7,926	10,212	9,813	9,706		7,767	9,423	6,349	8,852					10,512
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male											1																										
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				2,181	4,049	4,660	5,184	24,002	5,023	4,902	4,361	4,978	27,278	4,292	3,832	3,687	3,653	9,468	3,330	1,849	1,827	2,094		2,473	3,394	3,108	3,126		2,553	2,864	1,655	3,221					4,036
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				46	98	80	114		167	206	60	91	84	74	46	52	52	954	22	16	3	5		6	29	24	24		33	17	4	45					108
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			32,226	2,995	4,073	4,648	5,251	10,981	4,576	4,865	3,974	5,193	2,950	3,878	3,659	3,659	3,372	4,464	2,412	1,562	1,674	1,641		1,858	3,084	3,085	2,967		1,961	2,087	1,205	2,107					3,013
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			24,952	2,608	4,034	4,752	5,319	16,232	4,442	4,204	3,647	4,110	10,016	3,310	2,847	2,712	2,705	17,816	2,289	1,335	1,276	1,443		1,590	2,239	1,838	2,077		1,618	1,883	890	1,768					2,225
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			30,575																																		
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				3,728	5,792	6,266	8,083	45,112	8,213	8,899	8,250	11,071	38,306	8,776	9,015	8,903	9,027	7,172	8,178	6,038	6,327	7,046		6,579	8,809	9,059	9,265		6,942	8,164	5,847	8,068					9,833
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				1,887	3,398	3,925	4,360	22,469	3,948	3,952	3,439	4,028	18,430	3,488	2,948	2,904	2,870	5,854	2,628	1,344	1,266	1,506		1,904	2,488	2,305	2,134		2,126	2,475	1,131	2,581					3,567
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			13,987	964	1,672	1,752	2,013	2,742	1,900	2,213	1,442	2,219	1,258	1,237	1,529	1,459	1,323	201	848	462	471	520		470	750	894	682		568	1,169	213	582					823
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			41,670	1,673	2,619	3,286	3,722	5,151	2,886	2,901	2,486	3,108	3,138	2,080	1,908	1,838	1,996	2,665	1,519	801	940	932		1,013	1,402	1,386	1,537		1,268	1,227	486	1,162					1,710
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				2,801	4,471	4,766	5,703	41,826	5,563	5,913	5,154	6,771	25,898	5,501	5,225	5,108	4,980	6,447	4,601	3,165	3,379	3,587		3,680	5,378	5,493	5,433		4,517	5,788	3,570	5,818					7,969
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			12,343	5,156	10,200	11,948	12,452	26,615	11,899	11,422	9,956	12,507	25,071	12,419	10,373	9,944	8,938	6,693	7,702	3,712	3,350	4,136		5,336	6,596	5,890	5,136		5,441	5,996	1,526	6,941					11,643
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female														1																							
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			26,222	3,108	4,898	5,900	6,849	37,350	6,005	6,092	5,467	6,135	24,218	5,143	4,535	4,439	4,680	18,208	3,930	2,284	2,444	2,598		2,588	3,776	3,171	3,301		2,728	3,089	1,828	2,844					3,132
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			29,448	6,177	8,189	8,575	11,117	46,582	10,766	11,397	10,390	12,769	18,373	9,708	10,047	10,052	10,313	31,285	8,727	6,339	6,651	7,102		6,443	8,284	7,659	7,720		6,394	6,888	4,633	6,387					7,033
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex				9	8	4	5		9		2			2	12	8	4		10	2	9	1		3		9	4		4	8		187					321
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			25,102	791	1,201	1,588	1,659	2,166	1,357	1,324	940	1,322	1,563	624	860	721	720	277	491	255	275	300		320	484	511	459		412	369	135	530					816
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			26,444	2,699	4,612	5,521	6,266	40,572	5,715	5,751	5,041	5,786	32,989	5,125	4,366	4,330	4,313	10,918	3,721	2,232	2,309	2,507		2,878	3,981	3,666	3,660		3,020	3,426	2,102	3,710					4,548
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			26,664																																		
Ukraine	Ukraine	UKR	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				12	44	39	27		52	70	19	27	28	17	8	25	13	2,630	18	6	4			4	15	19	31		24	19	5	20					149
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				263	367	272	390	3,284	438	428	375	461	2,558	356	493	449	436	472	402	360	394	371		288	296	332	273		253	264	269	242					203
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			2,386	148	205	177	249	2,849	268	248	210	240	2,207	203	222	223	232	731	175	135	184	186		145	148	148	132		126	111	117	106					91
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				183	217	180	209	2,937	273	274	220	281	1,722	225	262	226	223	402	191	204	190	210		169	226	227	207		212	195	176	206					165
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			1,878	307	368	275	383	3,339	415	426	352	459	1,227	350	395	397	380	1,965	319	246	276	303		186	163	171	159		139	132	142	120					93
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			855	83	87	82	101	1,040	135	115	83	97	675	89	78	94	77	1,140	59	50	48	71		36	44	38	38		25	33	42	32					23
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			2,151	150	171	153	182	2,583	207	209	209	205	1,626	174	198	206	230	1,161	180	121	123	138		87	100	74	109		80	74	72	52					42
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			3,195	350	428	365	445	4,920	526	479	435	548	2,259	395	453	503	478	1,412	392	346	434	472		337	372	290	301		244	257	229	248					175
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			2	1	2	2	15		1	4			13	1		1	1	36	1	2	1	1		2	4					2	1	3					
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			332	57	45	38	39	550	41	45	36	38	204	40	47	50	30	276	24	17	38	26		12	15	16	17		20	24	25	25					20
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			1,535	190	247	208	256	2,185	257	302	201	227	1,791	166	261	223	239	1,373	207	146	184	236		151	215	218	220		239	220	220	191					202
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				1	1	4			3	5	2	1	12	2	3	1	3	74	4	3	2	1		1	1	2				1	1						3
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex					2	1			2	5	2	5	4	1			1	207	1						1		1			1	2	1					1
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				113	144	197	212	1,654	241	228	174	200	1,842	146	190	186	203	579	177	122	155	155		146	169	137	136		112	118	96	82					105
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			30	9	9	4	9	50	12	8	5	11	109	5	4	6	5	17	8	8	6	7		8	6	2	7		7	7	7	5					5
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			4,300																																		
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			2,686																																		
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex				1	1				2						1	1	2		3		1	1		1		1			1			4					
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			1,258	119	177	192	231	1,577	226	231	165	184	1,747	135	177	156	172	419	163	115	134	169		134	158	171	170		181	189	165	184					177
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			78	9	8	5	2	62	5	8		9	84	5	11	3	8	15	4	1	3	5		3		1	2		4		6	8					3
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			131	30	38	29	45	182	51	50	28	46	214	19	32	22	30	142	14	14	20	21		18	24	17	15		15	13	15	8					9
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			811	122	162	155	159	1,485	169	176	167	198	411	123	138	150	119	1,173	90	76	93	105		58	63	52	70		49	54	53	66					33
Ukraine	Ukraine	UKR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				93	110	123	134	1,487	155	154	109	141	1,299	110	135	138	108	342	116	91	102	101		89	99	104	105		88	108	77	89					92
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			70	87	104	119		136	171	164	207		198	219	227	229					203
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			275	214	286	464		533	519	493	561		584	489	511	491					430
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			142	171	183	227		230	255	263	289		313	313	290	284					280
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			26	29	39	66		73	55	71	64		66	35	43	44					41
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			284	272	315	449		495	530	580	604		679	609	625	653					549
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			104	126	136	202		201	246	284	319		370	313	348	378					361
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			128	144	141	180		181	209	189	204		214	190	155	161					166
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			61	74	79	103		103	95	96	94		100	93	86	89					91
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			30	36	45	53		53	42	38	42		44	50	53	47					39
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			179	221	252	346		382	464	485	507		531	508	522	590					528
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			94	118	144	181		253	263	306	333		370	342	386	421					412
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			47	75	106	121		146	166	176	224		238	249	248	254					256
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			145	103	163	284		293	260	279	320		358	305	360	354					435
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			96	146	177	224		229	252	249	261		247	222	229	253					269
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			190	143	210	349		381	371	332	369		402	351	390	389					409
Ukraine	Ukraine	UKR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			7	11	11	12		12	9	8	10		10	8	10	14					12
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					1		18	22		59		71	222	72	65	95	161	301																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					22		170	423		267		344	949	337	251	396	626	1,299																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					21		126	367		249		286	891	302	217	299	448	1,209																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female							40			65		81	241	68	83	120	226	332																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							6			8		4	22	4	9	10	18	29																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					27		136	615		264		336	925	355	249	386	571	1,262																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female							56			78		79	258	72	101	149	244	353																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female							42			56		52	206	38	40	67	118	285																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female							33			43		34	162	24	33	42	66	224																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					18		127	291		238		310	822	329	255	377	608	1,118																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female							25			54		63	168	44	59	89	163	229																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					3		23	22		49		58	132	51	45	53	92	177																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					4		31	110		75		105	267	103	83	119	201	364																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							16			34		38	110	49	60	72	113	149																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					4		84	110		152		192	558	206	165	244	397	761																			
Ukraine	Ukraine	UKR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							9			24		26	79	28	25	39	76	108																			
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female							40			20		20	120	23	21	38	104	197	85	53	59	77		74	63	61	93		72	53	75	50					38
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female							25			22		13	84	15	15	27	68	140	103	63	53	79		77	87	62	73		76	73	94	88					69
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					1		75	57		59		45	279	40	36	58	110	463	154	93	108	194		157	200	173	190		208	219	260	219					168
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			655		2		124	306		127		80	465	56	75	111	157	771	163	96	167	208		209	173	156	173		196	111	118	123					84
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			25				18	11		37		15	114	15	16	25	61	187	88	59	54	114		100	140	139	139		119	162	181	142					120
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female							9			11		4	41	10	5	11	35	67	58	43	31	51		60	62	73	79		82	96	94	84					69
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			391		2		117	182		123		70	441	57	58	76	152	740	141	92	160	245		210	213	199	182		238	113	165	129					118
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			318				116	144		105		81	415	56	54	80	199	691	208	155	138	229		211	249	246	264		281	243	283	231					178
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female							34			8		7	83	6	13	12	22	137	38	25	13	9		19	16	17	26		35	19	23	29					18
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female							52			28		19	129	22	33	41	88	212	100	74	57	82		98	92	78	97		114	101	111	87					76
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male							28	57		41		30	130	17	19	25	71	214	85	49	62	75		86	129	125	132		107	134	153	118					100
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							6			3		3	12	2	6	3	11	16	13	4	5	7		7	5	6	9		6	9	10	9					10
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			452		1		153	213		103		85	474	53	66	118	221	788	190	149	181	270		231	184	212	252		205	198	168	159					108
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							15			16		6	56	17	13	16	39	92	52	43	40	53		51	49	65	44		76	77	71	56					56
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female							41			17		10	106	10	10	22	50	176	64	35	31	34		32	29	33	48		38	45	49	47					26
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			25				22	11		31		27	67	13	25	20	50	109	74	29	48	78		121	102	92	75		80	33	47	38					32
Ukraine	Ukraine	UKR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			232																																		
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			732																																		
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				23	19	13	16																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				75	90	100	92																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				2	3	3	1																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				36	30	47	52																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				47	63	53	46																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				51	46	46	58																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				15	25	17	12																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				31	39	37	53																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				6	4	5	5																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				3	2	3	3																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				32	34	53	62																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female					1	2	3																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				1		4																															
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				1		2	3																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				23	22	25	24																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				2	2	2																															
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			1,236																																		
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				41	69	50	57																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				4	1	3	4																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				79	91	80	66																														
Ukraine	Ukraine	UKR	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				55	46	58	54																														
Ukraine	Ukraine	UKR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male					1,774		2,019	10,921		2,289		2,348	15,363		2,992		3,032																				
Ukraine	Ukraine	UKR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex					22		18			14		9	332		3		11																				
Ukraine	Ukraine	UKR	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female					1,744		1,953	8,780		2,412		2,032	14,692		2,621		2,303																				
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				7	1	4	1																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				26	21	21	19																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				67	74	70	79																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				72	57	71	81																														1
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				143	154	113	114																								1	1					2
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				8	9	18	10																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				174	181	166	159																								1	2					4
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				57	46	52	43																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				48	53	36	42																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				8	16	8	6																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				151	181	148	124																									1					
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				58	73	60	46																								1						
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				18	22	13	15																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				92	73	79	76																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				142	148	133	122																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				128	118	135	140																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				16	21	13	9																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			4,469																																		
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			2,168																																		
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				8	10	9	9																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				20	31	17	23																														
Ukraine	Ukraine	UKR	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				293	327	254	225																								1	1					2
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			488	298	318	340	335	481	344	360	354	366	466	374	385	380	394	414	400	388	356	465		462	454	444	450		448	448	445	448					446
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			448	398	414	437	438	461	452	471	473	486	609	487	490	472	499	547	517	508	464	580		596	573	567	556		560	552	541	551					541
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex				25	22	25	25		25	22	15	15	26	15	10	14	11		14	11	10	17		18	17	16	19		16	13	10	9					11
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			2,845	2,855	2,705	3,223		3,329	3,405	3,490	3,561		3,670	3,803	3,869	3,999					4,475
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			15,936																																		
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			4,610	2,933	2,910	2,853	2,774	4,720	2,807	2,768	2,700	2,682	3,849	2,592	2,437	2,418	2,346	4,133	2,286	2,087	1,832	2,326		2,236	2,148	2,047	1,989		1,931	1,896	1,841	1,780					1,579
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			1,359	468	516	514	542	2,503	602	622	651	660	1,043	672	649	648	670	1,016	656	627	573	753		741	732	707	667		648	636	641	633					615
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				269	269	262	262		253	251	242	224	256	209	191	172	169	450	158	128	110	139		140	135	135	124		125	127	130	124					111
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			1,294	1,325	1,294	1,629		1,665	1,733	1,796	1,871		1,958	2,031	2,104	2,186					2,428
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			24,545																																		
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				587	577	591	590		600	604	579	570	613	566	555	540	529	695	527	500	435	472		446	427	415	405		396	383	361	355					312
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			12,514	6,910	6,965	6,914	6,804	9,970	6,941	6,994	6,940	6,904	9,393	6,769	6,605	6,557	6,529	8,750	6,450	5,939	5,236	6,521		6,235	5,963	5,713	5,484		5,285	5,014	4,810	4,655					3,834
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			5,533	5,549	5,362	6,683		6,857	7,051	7,290	7,500		7,742	7,979	8,317	8,626					9,425
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			952	964	957	1,123		1,164	1,220	1,292	1,360		1,425	1,468	1,534	1,602					1,974
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			1,503	1,520	1,459	1,745		1,806	1,887	1,992	2,086		2,151	2,210	2,314	2,421					2,689
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				9,563	10,089	10,411	10,662	13,696	11,577	11,942	12,315	12,598	14,719	12,564	13,068	13,266	13,524	14,232	13,836	13,393	12,820	16,066		15,962	15,935	15,867	15,685		15,569	15,431	15,314	15,192					13,975
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male				256																																	
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			4,742	4,724	4,478	5,277		5,341	5,460	5,669	5,810		5,935	6,102	6,293	6,448					6,951
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			2,924	2,943	2,888	3,531		3,592	3,683	3,764	3,864		4,055	4,123	4,265	4,378					4,834
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			1,105	876	883	886	898	1,425	923	963	939	919	1,245	882	842	861	852	1,150	841	795	691	866		861	845	837	824		805	801	799	764					754
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			3,592	1,469	1,532	1,550	1,559	5,656	1,802	1,845	1,879	1,912	2,205	1,836	1,795	1,808	1,855	3,329	1,788	1,707	1,604	2,064		1,960	1,906	1,807	1,794		1,743	1,740	1,701	1,686					1,428
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			7,484	5,624	6,022	6,353	6,803	6,906	7,232	7,593	7,934	8,305	9,561	8,576	8,933	9,328	9,725	9,492																			
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			8,751	5,884	6,267	6,594	6,931	9,701	7,455	7,906	8,294	8,704	9,745	8,925	9,383	9,773	10,218	10,929																			
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				4,465	4,688	4,911	5,147	5,897	5,435	5,652	5,884	6,098	7,184	6,208	6,472	6,723	6,956	7,004	7,227	7,203	6,747	8,021		8,109	8,289	8,465	8,631		8,772	8,893	9,100	9,284					9,771
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			14,352	8,375	8,699	8,867	9,156	10,631	9,541	9,704	9,879	10,069	12,614	10,027	10,160	10,322	10,484	11,744	10,655	10,168	9,225	11,269		11,177	11,008	10,802	10,654		10,409	10,100	9,948	9,709					8,504
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				6,580	6,895	7,175	7,517	7,281	7,975	8,227	8,525	8,771	10,417	8,901	9,213	9,522	9,791	10,170	10,031	9,855	9,122	11,057		11,152	11,350	11,461	11,541		11,668	11,759	11,715	11,814					11,745
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			9,600	4,632	4,823	4,844	4,817	14,233	5,396	5,473	5,553	5,658	6,731	5,570	5,568	5,542	5,592	8,248	5,603	5,240	4,843	6,091		5,843	5,698	5,393	5,094		4,981	4,828	4,637	4,550					3,698
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			17,820	8,693	8,996	9,065	9,173	18,780	9,986	10,168	10,292	10,427	12,708	10,190	10,273	10,454	10,498	12,858	10,487	10,023	9,589	12,303		12,120	11,971	11,590	11,434		11,120	10,878	10,613	10,455					8,999
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex				811	812	817	836		845	844	847	839	872	838	809	800	820	954	797	757	641	806		799	766	721	708		699	690	684	694					659
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Female				212																																	
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			791	817	815	1,008		1,024	1,071	1,154	1,218		1,240	1,283	1,363	1,428					1,682
Ukraine	Ukraine	UKR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				5,707	6,101	6,472	6,831	10,731	7,508	7,842	8,254	8,667	9,520	8,892	9,274	9,731	10,176	9,869	10,503	10,453	10,118	12,552		12,757	13,124	13,423	13,730		14,033	14,172	14,474	14,738					14,681
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				440	483	430	491	3,156	578	533	459	514	2,703	411	518	506	530	477	451	421	447	537		407	451	475	440		416	416	427	393					307
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																									53	65	76		83	83	77	67					59
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			327	74	75	74	71	328	70	76	41	62	232	33	46	41	42	143	26	23	31	36		30	40	40	26		31	25	32	20					22
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			5,462	519	556	511	560	4,463	685	599	568	630	2,378	469	543	595	569	1,429	453	430	492	648		501	560	489	488		403	448	415	404					261
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				3	8	7	5		11	11	4	5	4	3	3	2	4	208	2	2	3	5		4	5	9	3		2	2	13	3					3
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,539	209	203	176	149	1,083	183	160	127	161	713	136	124	142	113	1,153	88	81	69	107		70	74	75	74		50	73	70	57					35
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				248	239	278	291	1,641	320	271	229	259	1,937	173	218	237	274	587	223	169	177	218		191	213	223	207		186	176	155	147					132
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			95	22	15	17	14	86	19	19	9	16	114	9	11	12	14	17	13	8	12	16		16	14	9	12		17	11	14	12					12
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			3,079																																		
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				176	171	187	193	1,312	214	183	155	175	1,368	143	142	167	146	345	143	117	116	149		124	152	167	155		135	164	120	127					124
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex				8	8	13	15		10	7	3	5		7	2	4	6		7	4	4	8		11	5	5	6		5	2	3	3					4
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				7	4	6	6		15	4	2	4	12	5	3	2	5	74	8	6	4	2		5	2	4	5		3	4	5	2					4
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			2,683	346	330	336	372	2,408	354	343	259	328	2,328	254	273	279	315	739	238	162	224	257		222	235	224	217		188	163	189	183					131
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																									19	23	30		17	16	18	24					31
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																									108	104	102		118	124	132	117					97
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																									38	40	43		37	39	36	35					35
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																									18	26	26		25	28	25	32					22
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			130	8	14	11	4	98	8	15	4	10	87	12	13	9	8	15	6	7	6	8		7	5	5	7		8	3	8	11					3
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				251	295	255	286	2,462	327	322	271	320	1,815	271	264	253	281	408	231	235	219	308		281	337	359	312		323	280	315	276					223
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Female				9																																	
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			4,118	390	460	368	400	3,520	488	484	438	513	1,286	404	454	488	453	1,988	372	301	325	427		294	308	309	284		243	263	260	184					130
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			960	43	50	61	54	621	54	63	44	51	214	54	47	59	42	281	35	30	49	49		31	42	36	26		26	46	32	38					26
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			5,080																																		
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																									152	169	172		176	184	187	169					132
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			1,458	274	307	286	306	2,203	331	328	254	267	1,895	214	261	263	301	1,389	231	170	189	337		234													
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			3,498	337	297	311	289	2,286	312	315	286	278	1,718	233	242	271	286	1,176	226	164	143	218		147	169	144	179		139	124	121	93					58
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																									72	83	82		93	81	98	70					62
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			1,341	204	235	281	322	1,563	319	249	194	219	1,843	144	188	191	212	423	182	131	156	240		213													
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			2,537	175	156	187	168	1,444	197	227	225	232	439	140	173	184	175	1,183	129	108	124	171		111	112	98	123		93	100	88	95					63
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex				3	7	6	7		6	6	2	5	13	1	2		2	36	2	7	2	4		5	11	7	6		2	6	4	9					4
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male				7																																	
Ukraine	Ukraine	UKR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																									39	35	38		49	39	36	32					39
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																									1,422	1,574	1,633		1,741	1,777	1,894	2,083					2,324
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																									2,811	2,961	2,994		3,188	3,249	3,427	3,600					4,142
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				232	237	262	275		298	291	281	268	413	271	286	294	310	394	306	293	258	367		375	383	375	382		377	367	371	358					341
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				5	4	5	3		3	4	1	2	26	2	3	7	1		1		1			4	4	3	5		3	3	3	2					3
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				290	348	365	355		398	399	400	403	913	393	422	443	438	833	447	390	335	480		500	527	538	519		529	499	496	481					473
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				279	311	322	316		338	357	366	366	537	380	380	376	404	524	429	403	328	433		444	456	448	463		468	458	458	463					425
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																									4,014	4,354	4,439		4,751	4,863	5,080	5,308					5,916
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				461	457	454	476		488	488	452	410	597	413	435	437	413	639	418	374	313	331		302	312	337	328		325	304	283	286					260
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				5,523	6,218	6,536	6,341		6,782	6,614	6,152	5,917	11,192	6,031	6,599	7,047	6,712	11,693	6,819	6,077	5,513	8,034		8,175	8,471	8,547	8,540		8,484	8,134	7,953	7,792					7,057
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				3,219	3,674	3,984	4,124		4,456	4,445	4,340	4,379	6,319	4,626	5,031	5,402	5,231	6,606	5,094	4,660	4,123	5,459		5,723	6,116	6,535	6,589		6,906	7,089	7,325	7,652					8,280
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				4,111	4,634	5,150	5,318		5,888	5,993	5,823	5,997	8,550	6,390	7,179	7,721	7,606	9,852	7,387	6,847	6,267	8,714		9,420													
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				4,710	5,321	5,734	5,853		6,397	6,391	6,161	6,159	9,183	6,405	7,096	7,558	7,304	9,545	7,112	6,375	5,582	7,503		7,838	8,231	8,745	8,795		9,188	9,191	9,260	9,607					9,770
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				4,647	5,105	5,328	5,103		5,385	5,162	4,766	4,619	8,296	4,596	4,826	4,900	4,646	7,856	4,373	3,758	3,187	4,327		4,359	4,395	4,317	4,144		4,069	3,895	3,789	3,711					3,137
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				155	166	167	175		176	163	149	144	251	141	133	127	127	342	110	96	71	91		88	83	83	80		86	90	88	90					88
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																									926	1,021	1,066		1,136	1,196	1,304	1,360					1,701
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				2,770	3,129	3,336	3,167		3,395	3,253	2,999	2,930	5,916	2,997	3,230	3,415	3,287	6,924	3,445	3,099	2,713	3,887		3,943	4,111	3,997	3,736		3,681	3,474	3,412	3,289					2,829
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																									2,558	2,783	2,758		2,898	3,008	3,177	3,371					3,849
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																									859	929	968		1,037	1,059	1,143	1,232					1,450
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				6,479	7,246	7,896	7,868		8,499	8,347	8,035	7,829	12,987	8,025	9,015	9,570	9,317	13,533	9,383	8,370	7,485	10,664		10,983	11,746	12,030	11,821		12,062	11,672	11,795	11,857					11,197
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																									5,187	5,587	5,649		5,965	6,193	6,588	6,977					7,905
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				3,925	4,438	4,964	5,138		5,713	5,715	5,595	5,643	8,369	5,978	6,745	7,413	7,340	9,350	7,373	6,674	6,097	8,479		8,873	9,401	10,014	10,114		10,704	10,830	11,245	11,684					12,063
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				4,172	4,763	5,172	5,388		5,990	6,070	5,979	6,161	8,397	6,515	7,197	7,701	7,558	8,974	7,234	6,582	5,985	7,818		8,468													
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				460	538	600	562		618	629	592	561	1,101	575	597	608	576	1,040	553	498	407	562		578	572	611	601		626	602	603	603					583
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				689	700	675	713		736	740	711	670	834	675	658	665	702	907	672	598	499	619		603	618	623	615		612	598	590	581					549
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				848	993	1,043	998		1,093	1,083	1,010	958	1,935	926	1,048	1,109	1,052	2,583	1,139	1,014	944	1,347		1,355	1,355	1,322	1,302		1,291	1,275	1,265	1,258					1,125
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				5,858	6,559	6,979	7,089		7,594	7,455	7,157	7,065	11,123	7,159	7,704	8,078	7,775	10,985	7,500	6,731	5,726	7,583		7,709	7,976	8,182	8,089		8,220	7,879	7,860	7,811					7,069
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				1,751	1,949	2,029	1,891		1,980	1,843	1,726	1,673	3,392	1,683	1,724	1,741	1,571	3,382	1,545	1,328	1,076	1,550		1,556	1,609	1,566	1,477		1,479	1,413	1,374	1,411					1,269
Ukraine	Ukraine	UKR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																									1,312	1,461	1,501		1,590	1,647	1,747	1,855					2,097
Ukraine	Ukraine	UKR	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					8		9			6		7			5		7																				
Ukraine	Ukraine	UKR	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					893		788			867		636			491		590																				
Ukraine	Ukraine	UKR	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					438		435			458		336			229		272																				
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												12,907					6,315				
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			98	9		4	11	59	5	14	40	117	2,255	204	89	163	135	3,009	77	52	50	29	4,147	73	177	175	87		118	109	150	109					67
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex							4				3	1				1			1	6	1			6	4	2	1			1	1	1					1
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			3,418	25	6	1	54	1,209	44	47	339	700		1,334	461	834	411		502	411	469	848		601	478	575	384		431	265	631	478					252
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			327																																		
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			85				2			1	2	11	388	18	23	13	17	489	9	8	10	3	639	2	30	31	17	601	16	40	31	17	317				16
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			12,032	87	22	6	280	9,739	222	478	2,436	2,705	4,635	3,556	3,932	2,607	2,321	5,986	2,121	2,198	2,031	2,930	7,115	1,614	2,567	2,578	1,132		2,159	2,106	2,708	1,683					1,748
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			2,182	15		4	15	1,798	9	31	77	176	1,714	250	144	321	208	2,214	61	90	65	72	2,966	129	270	271	157		121	145	220	126					48
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female							1		1	3	3	26	442	16	13	20	23	573	8	9	8	6	786	8	21	41	23		22	24	26	35					25
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				40	8	5	33		26	52	293	295	3,560	415	381	263	436	4,748	232	241	209	222	6,664	167	577	383	143		246	377	335	305					156
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			445	7	1	5	11		1	6	27	41	1,052	98	119	50	76	1,316	76	59	55	49	1,718	34	96	92	39	1,447	54	61	47	50	696				35
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			3,791	4		1	14	3,095	2	14	62	196	255	246	157	306	279	315	112	189	169	92	378	213	385	229	237		216	204	306	167					74
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												854					419				
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male				1,384	161	968									42	2	304			3		2		2	18	28			6	1							1
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			4,018	21		3	11	3,267	7	27	75	255	789	296	185	312	219	971	112	154	97	72	1,161	158	290	284	137		141	190	264	122					89
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			11,340	63	24	4	289	9,192	152	374	1,689	2,926	3,227	4,143	3,304	2,715	2,536	4,048	2,250	2,505	2,306	2,802	4,441	2,169	3,013	2,992	1,660		2,592	2,588	3,341	2,116					1,463
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				7		1	6	3	1	7	6	62	1,087	75	66	80	85	1,391	50	46	22	12	1,884	22	95	111	49		67	81	97	80					44
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												1,626					873				
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex				919	869	28	2,593	66,662	1,877	1,120		763		1,208	189	128	35		196	2,210	1,273	36			402	1,809	1,844		1,280	1,029	894	1,372					
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			93																																		
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			6,544	62	7	9	133	5,300	89	246	1,371	1,547	3,923	1,811	2,223	1,372	1,384	5,133	1,085	1,461	1,345	1,681	6,958	1,105	2,112	1,819	847		1,449	1,588	1,969	1,314					969
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												2,256					1,237				
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			1,138			2	3	402			27	48		44	73	47	24		20	11	60	13		48	89	46	90		69	45	85	64					10
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												12,143					5,854				
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			331	67	6	7	62	256	47	50	558	586	5,761	658	581	594	602	7,846	394	486	536	609	10,943	581	1,016	772	282		606	721	727	540					381
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				12	4	6	18		12	14	71	124	1,568	116	125	44	151	1,961	63	61	75	50	2,546	40	99	81	40		72	84	85	57					67
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												8,166					4,289				
Vietnam	Vietnam	VNM	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female				438	3	127					2				37	1	55			1						3			2		1						
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												3,868					3,614				
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				84	68	73	108		85	57	45	61	114	54	51	47	13	17	23	23	36	36	94	27	22	28	26		13	19	36	15					8
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												43,450					38,978				
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			2,351	870	584	572	650	1,494	568	392	600	754	2,696	559	401	422	112	3,107	244	248	255	284	3,299	318	190	298	221	3,922	227	185	404	301	3,564				321
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			4,716	678	315	267	457	359	339	151	205	364	677	379	227	212	43	799	161	150	208	295	958	223	178	210	239		180	134	273	355					156
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			9,458	3,491	1,444	1,716	2,017	8,878	1,699	1,264	1,601	1,980	12,710	1,441	896	738	255	11,232	538	620	580	666	11,240	663	494	606	520		504	390	655	733					437
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				2,981	1,492	1,895	1,868	9,106	1,340	1,219	1,279	1,685	10,307	1,056	995	978	395	11,003	638	713	796	769	13,035	700	580	760	645		549	427	718	680					508
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex				1		1	2		7		1	6		9	3	1			2	1	3			3	1		2		2		1	1					
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			7,096	2,655	1,221	1,556	1,733	1,248	1,987	1,344	1,615	1,964	1,996	4,483	2,036	2,345	579	2,070	1,815	1,998	2,344	3,034	2,070	2,953	1,611	2,186	1,650		1,487	866	1,413	2,078					597
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												11,769					10,520				
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												97,632					89,571				
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												122					43				
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			42,617	10,796	5,015	7,159	6,767	43,558	5,439	6,756	7,464	8,291	18,094	6,507	6,704	5,535	1,957	12,028	4,475	4,899	5,086	5,918	11,662	5,258	5,516	5,870	3,834		4,523	3,836	5,022	5,358					3,608
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				1,317	455	571	506	1,690	491	318	501	681	3,108	381	379	399	91	3,758	182	202	227	272	4,533	205	176	262	175		172	173	280	281					167
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			2,515	2,087	1,474	1,853	1,800	5,409	1,310	1,133	1,375	1,541	6,483	1,316	1,361	1,401	453	7,650	909	1,038	1,019	996	8,771	980	819	910	905	11,594	743	614	1,087	917	10,058				979
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			4,765																																		
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												8,693					8,216				
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			16,547	4,089	1,942	2,114	2,468	10,832	1,946	1,866	2,157	2,673	8,388	1,953	1,236	1,060	361	6,409	782	735	773	894	5,580	774	704	758	670		616	527	780	895					529
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			4,729																																		
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			18,943	4,048	2,020	2,233	2,620	6,514	2,147	1,648	1,858	2,150	3,244	1,703	1,159	1,071	368	2,638	750	764	777	848	2,218	832	736	784	685		685	522	755	822					572
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				4,558	2,264	3,195	3,066	25,329	2,302	2,493	2,610	3,408	22,759	2,089	1,862	1,625	786	19,250	1,268	1,319	1,452	1,416	20,903	1,424	1,307	1,388	1,118		1,169	1,042	1,372	1,474					994
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				2,147	756	968	1,053	5,842	927	784	1,020	1,354	6,870	845	629	594	181	8,332	361	424	430	466	9,273	436	330	404	393		356	278	477	573					340
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			14,217	2,305	1,475	1,532	1,570	1,378	1,345	875	1,181	1,776	1,043	1,463	1,134	1,016	267	811	747	700	772	864	969	813	689	730	782		713	650	1,018	1,065					506
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			45,004	15,270	8,010	11,026	10,106	25,453	11,746	7,117	8,704	11,079	17,586	9,223	9,167	8,630	2,644	14,399	7,332	7,225	7,757	8,010	13,993	7,645	6,687	7,463	4,933		5,875	4,924	6,420	6,984					4,754
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			18,960	7,712	3,637	4,851	4,788	38,417	3,946	4,282	4,731	5,071	32,750	3,847	3,263	2,903	1,071	19,062	2,128	2,270	2,717	2,766	17,789	2,827	2,523	2,504	2,007		2,380	2,139	2,516	2,606					1,833
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex				114	151	83	87	3,086	75	55	47	73	1,729	48	34	54	13	395	29	11	26	38	1,346	25	17	21	24	903	18	15	37	26	125				22
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			44,977	11,866	6,544	7,789	7,597	10,503	9,537	5,401	7,415	9,670	10,676	11,341	8,851	8,888	2,533	8,589	7,601	7,092	8,077	8,536	8,818	8,718	7,374	8,435	5,711		6,710	5,448	7,511	8,159					4,196
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				409		2									20	12	36			94	55	62		84	40	37	69										
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				63	101	83	113	1,237	55	58	42	47	859	53	41	36	9	196	16	15	20	44	477	16	14	29	25		15	22	59	32					26
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												73,803					67,444				
Vietnam	Vietnam	VNM	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				477		9									42	10	538			445	669	649		557	743	816	756										
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			72	28	26	25	31	56	22	22	27	34	152	15	24	27	8	201	14	13	28	34	200	31	36	37	26	209	27	35	39	31	177				13
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			193																																		
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			423	78	51	80	105	572	79	63	76	78	825	52	34	26	23	766	31	45	42	46	693	38	40	26	36		33	23	35	32					22
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				55		6									42	10									5												
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				172	105	169	178	1,597	115	169	130	159	1,417	109	111	102	36	1,333	98	99	112	102	1,261	119	108	122	97		93	91	88	88					62
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				4	5		2		2	3	1	2	4	3	3	5		5	1	2		2	12		1	3			2	1	2	1					
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				23	14	15	34	72	18	28	22	20	177	20	18	23	8	247	16	16	25	22	263	11	14	29	17		16	18	26	25					18
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			193																																		
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				16		2									20	12																					
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			838	261	204	280	267	2,433	187	214	242	240	2,165	163	176	173	64	1,375	133	150	214	161	1,124	184	143	135	144		140	129	121	136					89
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				56	24	61	49	352	43	35	46	40	393	42	32	22	10	545	20	28	34	35	552	30	26	40	31		38	30	24	32					26
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			637	33	26	29	32	49	24	23	22	32	66	60	13	12	8	61	8	14	19	14	58	26	19	17	22		16	20	17	10					7
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			191	10	6	4	21	1	7	8	6	6	45	12	4	3		58	6	3	13	12	56	2	4	7	7		3	7	6	7					6
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												274					236				
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				85	86	126	116	593	78	97	111	108	578	78	83	80	36	723	77	65	100	90	758	85	76	87	77		78	71	62	68					35
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				3	1	1	7	10	6	3	1	2	24	3	1	3	1	13			2	2	31	4	2	1			3	1							1
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			313	102	69	101	156	59	117	129	145	164	140	305	215	221	33	162	208	197	226	254	137	236	106	107	94		131	63	72	86					69
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												2,746					2,298				
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			1,888	400	301	385	361	2,614	258	284	298	386	1,196	306	342	291	107	896	317	325	331	323	774	302	301	251	202		259	209	206	215					145
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												484					406				
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex				4	5	3	2	43	2	7	4	5	58	8		3		33	2	1	1	3	91	2		3	1	53	1				18				
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												2,394					2,069				
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												14					9				
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			719	77	79	84	83	658	62	72	72	48	539	63	40	43	17	434	39	31	41	56	346	44	33	38	24		26	20	28	25					22
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			215	62	72	114	87	358	72	77	71	95	369	64	69	85	27	497	82	83	94	81	525	107	121	114	101	586	110	100	101	105	473				76
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,757					1,445				
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			2,017	486	365	485	502	713	500	451	533	620	731	886	600	663	149	680	620	548	624	507	591	526	374	374	274		399	315	312	351					261
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												91					84				
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex											1				1	1																1					
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			2,013	623	459	625	570	1,896	929	433	519	628	1,211	705	616	654	161	1,100	580	507	617	508	950	522	373	379	245		334	262	299	260					200
Vietnam	Vietnam	VNM	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			847	83	60	75	80	357	83	53	46	54	204	57	34	42	22	170	32	28	33	38	132	33	24	27	21		26	22	24	21					5
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			13,626		2,190		3,321	12,026		2,635		3,691	9,579		2,626		822	6,695		1,317		1,715	6,720		2,657		1,983			1,061		1,427					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												12,349					9,625				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												2,883					3,529				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												236					458				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			2,475		160		224	41		59		52	78		22		13	426		16		25	818		18		4	594		6		3	170				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			3,015		461		494	1,990		368		401	1,505		569		299	1,041		339		319	4,969		480		268	7,411		274		300	6,392				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			3,106		1,758		1,940	2,534		1,732		1,731	1,924		1,110		482	4,000		496		519	6,196		601		471			515		830					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			13,626		4,222		4,550	12,072		2,871		3,475	9,607		2,889		1,201	6,712		1,993		2,360	8,131		3,297		2,157			1,366		1,512					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			9,294		2,340		3,023	8,309		1,714		2,525	6,633		2,653		1,215	4,591		1,805		2,063	5,060		3,764		2,365			1,134		1,568					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female					6		16								15		15								2		5			6		5					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			1,852		375		1,292	1,470		373		364	1,233		404		287	894		518		582	1,187		667		494			151		279					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					1,002		1,273	1,225		931		1,288	877		741		328	1,781		397		338	5,205		381		353			291		582					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			4,544		1,847		1,830	3,753		1,818		1,532	2,966		1,057		623	5,884		710		689	1,280		944		681			788		1,152					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												443					1,456				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			4,544		2,071		2,258	3,778		2,147		2,505	3,113		1,432		658	5,885		725		754	3,207		890		734			676		1,110					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					438		543	975		332		478	617		293		158	1,146		174		166	2,539		145		132			130		217					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			9,294		1,929		2,406	7,742		1,771		2,533	6,024		1,324		443	4,082		618		890	10,131		1,251		879			628		823					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male					10		24								29		15								5		3			8		3					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			623		199		243	435		131		157	260		173		123	613		117		234	537		201		222			247		420					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			9,294																																		
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			3,106																																		
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					1,174		1,439	3,741		1,164		1,510	2,645		984		296	1,993		351		403	11,833		692		468			433		537					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					632		712	3,127		490		564	2,386		505		147	1,665		212		209	7,319		226		157			153		190					
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												16,794					11,625				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												14,047					10,754				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			1,038		410		450	586		315		404	375		298		132	761		229		212	1,772		236		163	2,625		154		257	2,663				
Vietnam	Vietnam	VNM	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			3,106		882		925	2,587		837		892	2,139		810		621	4,047		795		831	538		1,023		714			1,037		1,560					
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																						3		3	4	3	2		2	2	2	6					
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			162	199	260	288	228	321	317	342	310		367	366	379	366					167
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			173	203	244	274	293	303	267	291	1,257		357	322	284	1,316					79
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												7,488					6,570				
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												809					760				
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												11,003					10,127				
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			329	451	511	562	448	656	731	742	654		776	856	896	805					388
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			24	22	39	52	92	49	25	32	455		92	57	82	461					8
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			2,993	3,449	4,087	4,640	3,817	4,837	4,997	5,148	4,524		5,386	5,474	5,606	4,838					1,846
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			1,939	2,473	2,870	3,199	2,017	3,618	3,899	4,053	3,519		4,213	4,658	4,679	4,000					1,732
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			112	169	224	216	329	266	257	283	1,398		313	289	368	1,816					80
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			569	359	592	933	1,736	950	777	965	887		1,421	661	837	827					224
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												900					841				
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												476					428				
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			142	220	242	284	235	323	371	387	323	410	410	467	477	410	370				182
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												3,127					2,904				
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			2,694	2,749	3,543	4,349	5,098	4,778	5,089	5,279	4,565		5,741	5,791	6,144	5,470					1,930
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			183	210	241	264	233	296	302	337	735		346	337	329	723					88
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																						11		15	12	7	1		5	4	5	3					
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			219	238	276	329	295	383	337	369	1,064		423	370	366	1,225					103
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			142	151	165	195	166	225	208	232	396		267	268	274	418					81
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			43	59	64	75	61	67	79	74	186	104	84	99	92	202	94				30
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			734	1,027	1,183	1,340	840	1,625	1,775	1,872	1,612		1,999	2,245	2,200	1,930					898
Vietnam	Vietnam	VNM	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			57	93	97	103	84	111	125	124	177		128	146	147	187					48
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					39		135	149		206		274	604	289	469	606	678	612																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					7		71	23		118		161	160	128	187	251	294	265																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male							1									9	8																				
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					404		1,249	2,006		1,904		3,236	8,379	3,684	5,443	6,815	5,063	8,767																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					6		31	2		48		74	85	57	86	116	139	124																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					27		236	157		330		692	521	982	1,313	1,746	881	1,491																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					3		25	2		33		55	50	41	65	83	109	76																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					159		415	588		595		783	2,470	812	1,150	1,410	4,613	2,088																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					37		195	68		214		285	367	222	307	387	471	520																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					8		92	363		111		180	1,740	211	304	393	412	1,053																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																	1																				
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					60		194	221		222		306	1,028	236	333	438	483	713																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					384		899	952		1,183		1,672	4,092	1,787	2,655	3,257	5,229	4,249																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					42		166	350		204		290	1,629	246	335	422	401	892																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					21		87	149		119		165	512	168	257	332	364	351																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female							26	2		43		65	46	71	86	104	72	116																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					7		53	127		83		130	429	138	219	304	929	242																			
Vietnam	Vietnam	VNM	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					675		1,613	2,149		2,258		3,305	7,890	3,537	4,927	6,011	3,589	8,441																			
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			496		4		89	186		59		64	1,450	86	113	84	15	488	165	165	130	160	372	83	101	116	495		157	202	233	522					27
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Male			123																																		
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female							27	2		18		27	83	13	28	28	12	63	23	34	43	32	93	26	20	41	32		28	30	50	65					8
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			1,471		334		1,046	1,343		1,109		1,244	6,170	959	1,074	999	266	4,302	1,165	1,085	1,199	1,164	4,304	1,204	1,038	1,066	689		874	794	909	762					402
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			1,471		229		933	1,256		1,076		1,509	6,773	1,280	1,548	1,292	321	4,657	1,469	1,454	1,750	1,736	5,779	1,724	1,432	1,615	1,130		1,347	1,409	1,760	1,411					474
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												2,204					2,016				
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												755					711				
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												926					740				
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			256		75		279	461		250		233	1,999	213	261	230	51	1,057	260	311	312	328	938	304	310	382	224		249	259	347	305					74
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			674		173		592	593		495		589	3,328	477	590	546	150	2,130	615	689	712	709	2,264	718	673	666	454		576	520	594	512					230
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			46				26	2		29		22	44	28	44	13	1	69	61	31	66	73	103	57	17	59	299		78	60	103	268					9
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					7		69	127		51		64	394	40	74	70	26	182	77	89	76	87	253	90	68	90	73		67	61	82	86					23
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			496		13		125	170		70		82	1,350	79	97	78	11	403	85	105	91	120	323	83	85	129	272		105	77	124	302					23
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			46																																		
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male							1			1						9	1					14		8	1	4				4	4						1
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																	1					3		1	1		2		1		1	2					
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												879					811				
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					16		103	127		95		89	484	86	140	131	43	324	123	125	154	153	498	122	126	175	100		109	144	153	172					39
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			62		2		48	114		36		61	330	46	66	76	20	128	95	88	110	93	262	73	91	107	73	397	55	67	110	88	350				21
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			30				23	2		12		23	47	14	20	15	4	42	30	23	38	18	68	17	12	42	36	118	17	22	65	51	112				3
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			86		11		162	38		67		67	311	54	77	73	14	264	62	68	107	94	254	54	88	115	115		61	55	103	167					25
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			128		17		216	83		248		371	394	506	465	411	138	825	574	439	671	870	1,977	1,096	548	705	552		702	442	624	742					84
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												7,594					6,946				
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												9,127					7,874				
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					3		64	23		45		48	141	28	42	58	27	135	36	57	63	59	185	38	56	67	76		33	45	92	103					19
Vietnam	Vietnam	VNM	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			225		24		143	114		77		80	851	67	88	91	23	342	71	87	122	120	327	87	104	141	241		85	74	143	249					23
Vietnam	Vietnam	VNM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			2,325		644		1,273	2,588		1,336		1,010	4,689		861		1,002	2,824		605		655	2,392		823		702	1,114		722		430	757				279
Vietnam	Vietnam	VNM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female																																					2
Vietnam	Vietnam	VNM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			212		9		14	97		18		21	275		77		29	100		16		26	171		52		24	76		30		26	31				11
Vietnam	Vietnam	VNM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male																																					100
Vietnam	Vietnam	VNM	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			4,335		2,777		4,305	10,235		5,004		4,381	12,536		4,581		4,721	7,559		3,063		3,827	5,837		4,771		4,559	6,189		3,776		2,955	4,286				1,605
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												1,229					1,041				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			740					1,832					2,129	2,141	2,265	2,380	2,060	2,151										2,974					2,394				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												33,685					23,587				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			5,898					4,658					5,179	3,712	3,062	3,070	2,957	4,170	2,812	2,492	2,679	2,711	3,826	2,732	2,509	2,584	2,622		2,253	2,034	1,912	1,877					1,234
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			1,161	1,347	1,382	1,415	1,430	1,538	1,737	1,772	1,807		1,926	2,113	2,146	2,176					2,136
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			2,213					511					1,012	1,384	1,162	1,317	1,227	1,491	1,276	1,221	1,289	1,395	1,556	1,569	1,248	1,294	1,336		1,434	1,131	1,104	1,122					770
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Female				25,071	21,395	21,575	21,808		21,964	22,100	22,289	22,279																									
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								14,365					13,269	12,159	11,991	11,781	11,594	13,443	10,894	11,535	11,568	11,707	14,597	12,510	12,806	12,673	12,521		12,747	12,656	12,497	12,389					9,581
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			12,529					5,330					7,814	8,300	8,464	8,763	8,490	9,702	8,984	9,139	9,354	10,059	10,725	10,500	10,061	10,038	10,268		10,510	10,044	10,075	10,127					7,795
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			299	325	329	340	375	376	406	407	416		432	429	439	448					366
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex								28					8	28	6	10	9		27	4	4	8		10	9	9	9		12	4	5	4					4
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			181	240	242	252	231	278	315	322	342		345	398	417	422					381
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Missing Sex				2,805	1,953	1,842	1,789		1,677	1,524	1,520	1,640																									
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			13,265					2,326					4,759	5,129	4,969	5,400	5,207	6,025	5,583	5,146	5,379	5,796	6,591	6,254	5,878	5,857	6,190		6,547	6,063	6,133	6,207					4,380
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			536	588	609	620	667	715	783	776	817		849	969	979	1,009					843
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			1,472																																		
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								4,728					5,311	5,078	5,253	5,085	5,042	5,609	4,640	5,125	5,127	5,276	6,499	5,662	5,976	6,078	6,291		6,260	6,408	6,443	6,450					5,350
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												11,574					7,763				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								2,166					2,487	2,215	2,346	2,160	2,433	2,791	2,233	2,479	2,510	2,633	3,136	2,866	3,110	3,220	3,346		3,345	3,593	3,646	3,730					3,484
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			1,034	1,157	1,156	1,231	1,300	1,304	1,444	1,513	1,604		1,569	1,702	1,740	1,773					1,671
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			5,898					17,208					15,844	11,784	10,397	10,567	10,006	13,287	9,784	9,058	9,028	9,095	12,630	9,320	8,835	8,694	8,703		8,653	8,317	8,223	8,139					6,639
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												15,684					11,397				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								480					511	425	273	286	277	460	265	276	274	274	446	276	230	224	235		227	196	201	198					139
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			728					5,198					5,289	5,354	5,720	5,854	5,240	5,230										7,847					5,864				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												4,194					2,986				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			3,033	3,394	3,467	3,632	3,717	3,896	4,319	4,343	4,462		4,661	5,066	5,216	5,219					4,832
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				14										174	2,752	3,169	2,595		4,780	4,553	4,611	4,604		2,660	2,561	2,572	2,576		3,381	3,388	3,245	3,218					9,202
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												23,306					18,441				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			1,472																																		
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			6,633					398					627	545	461	479	513	587	485	503	603	622	676	562	557	655	675		575	586	594	607					493
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female														43	1,718	1,927	1,608		2,902	2,724	2,736	2,744		1,496	1,457	1,457	1,448		1,979	1,966	1,944	1,945					3,881
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			927																																		
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			1,472					337					474	535	467	452	455	510	461	508	515	509	651	505	508	516	517		507	514	496	498					348
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			447	502	500	521	562	573	628	654	703		699	768	783	800					801
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								210					116	158	99	98	91	229	90	84	80	81	157	84	69	67	71		70	73	74	77					58
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			6,633					1,679					1,884	1,460	1,102	1,138	1,121	1,640	1,084	907	1,023	1,085	1,484	980	868	980	1,005		825	782	759	733					528
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												398					282				
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			911					1,153					1,107	897	618	654	620	987	576	627	625	623	956	632	583	568	565	748	553	486	478	464	506				374
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								7,060					6,930	6,395	6,878	6,378	7,093	7,935	6,423	7,022	7,154	7,244	8,932	7,969	8,676	8,599	8,713		9,036	9,590	9,620	9,686					8,437
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			11,797					7,950					8,128	6,940	7,057	7,105	6,931	7,997	7,097	7,704	7,790	8,364	8,734	8,773	9,661	9,722	9,892		10,213	10,633	10,715	10,743					8,975
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Coarse	Coarse	Male				53,331	48,475	49,863	51,464		52,936	53,640	54,845	55,886																									
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			332	437	441	460	417	529	601	589	598		619	658	679	666					642
Vietnam	Vietnam	VNM	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			2,946					7,813					8,303	6,940	6,259	6,243	6,070	7,722	5,725	5,462	5,466	5,444	7,837	5,729	5,328	5,250	5,239		5,020	4,603	4,500	4,412					2,972
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												2,271					1,607				
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female														34	18	20	12		27	15	26	28		9	12	10	9		10	5	6	3					21
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								14	11	12	9		8	6	9	8					8
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												2,611					1,836				
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			2,242					1,894					1,173	592	593	654	159	1,047	511	396	512	438	904	453	382	399	346		366	263	269	248					148
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			266					28					43	13	1	4	3	56	9	3	17	13	54	7	8	10	7		4	6	7	7					9
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								120					173	19	21	25	8	236	16	14	25	19	251	13	15	32	19		18	16	20	25					21
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								15	14	15	16		11	12	16	14					8
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex														12	1	7	1		1	2		7		5	3	4	3		5	1	2	5					
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			1,060					707					519	56	48	46	23	412	32	36	40	63	328	41	40	46	33		33	12	25	30					22
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								650					553	78	82	95	29	687	63	55	90	87	720	85	84	92	84		85	77	66	74					40
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			402					93					135	227	191	205	30	155	196	157	180	203	130	240	123	137	131		164	82	79	92					65
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								2	5	3	1		3	3	5						5
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								3	3	5	2		2	5	8	7					4
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			2,382					768					705	671	573	635	138	646	561	485	542	467	560	503	374	392	374		404	313	302	298					201
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Female				527	352	429	409		354	283	354	335																									
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								57	73	64	67		56	51	56	54					36
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			266																																		
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								27	27	28	45		31	27	28	32					22
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								402					375	40	34	35	12	517	19	25	29	41	525	33	42	39	39		36	27	27	29					26
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			1,186					397					194	47	33	40	17	162	31	24	36	24	127	37	27	32	28		23	15	22	18					15
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Missing Sex				79	43	29	29		23	29	22	14																									
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												14					6				
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												460					322				
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Coarse	Coarse	Male				2,046	1,677	2,241	2,203		2,105	1,933	2,062	2,408																									
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			2,111					2,800					1,153	322	299	303	97	851	297	239	301	317	735	301	281	282	269		266	204	205	212					121
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			135					107					147	23	20	22	5	191	16	15	27	30	194					198					137				
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								5	6	11	6		7	8	5	8					11
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								1,730					1,366	120	118	117	43	1,265	101	96	116	107	1,196	117	117	126	120		112	99	103	89					54
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			129					469					355	91	65	80	28	471	72	68	85	79	503					556					390				
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			266																																		
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			527					612					796	75	39	35	21	726	35	40	52	54	656	47	45	29	51		36	27	36	37					25
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			56																																		
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			1,059					2,611					2,092	204	206	185	67	1,307	121	129	190	167	1,068	188	156	167	188		159	129	128	145					84
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			1,186					87					64	46	26	19	10	59	14	18	27	23	56	24	19	18	21		18	20	15	12					14
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												1,669					1,181				
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex								10					4	11	1	6	1	5	2	2	6	3	12	6	6	7	1		3	6	4	5					4
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male														81	52	49	35		38	49	74	71		31	29	34	31		13	19	15	20					131
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								12	12	12	14		16	9	15	13					12
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex								21					24	5	6	9	1	13	1	1	5	4	31	2	2	4	4		4	2	3	4					2
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			36					59					58	8	1	2		31	2	1	5	6	88	4	5	5	3	51	1	2	4	5	11				1
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												261					184				
Vietnam	Vietnam	VNM	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												88					68				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male													7,447	6,263	6,005	6,038	4,832	9,284	5,834	5,765	5,921	7,714	10,183	8,062	8,144	8,207	8,761		8,985	8,719	8,938	8,837					6,360
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												364					261				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female													606	377	348	341	263	562	276	272	302	416	642	395	400	457	463		471	478	485	472					378
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Female				19,442	23,490	17,994	18,908		19,191	18,995	18,138	19,088																									
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male													15,146	10,075	8,951	8,529	6,306	12,715	6,604	6,101	6,434	7,712	11,984	7,709	7,282	7,188	7,468		7,542	7,188	7,157	6,949					5,389
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male													5,152	4,406	4,542	4,507	3,518	5,008	3,669	4,205	5,025	5,479	5,913					7,078					5,304				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female													2,076	1,836	1,834	1,856	1,446	2,060	1,441	1,601	1,902	2,202	2,346					2,684					2,169				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												3,792					2,703				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Male				38,973	32,609	39,000	41,814		43,072	43,160	40,639	44,857																									
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male													4,540	3,637	3,375	3,429	2,752	5,766	3,255	2,989	3,163	4,121	6,253	4,464	4,506	4,675	5,071		5,293	4,908	5,110	5,162					3,384
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												30,573					21,429				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								1,213	1,246	1,283	1,434		1,430	1,503	1,518	1,604					1,452
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								3,496	3,699	3,677	4,245		4,190	4,442	4,505	4,689					4,123
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex													499	229	219	214	180	450	145	159	179	169	425	218	211	188	206		206	176	166	116					91
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female													5,165	4,503	4,474	4,422	3,368	5,372	3,371	3,601	4,310	4,908	6,172	5,218	5,289	5,307	5,879		5,773	5,791	5,787	5,961					4,500
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male													7,748	5,365	5,175	5,142	4,004	7,647	4,660	4,949	5,080	6,519	8,292	6,807	7,472	7,618	8,375		8,797	8,945	9,244	9,264					7,466
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female														216	216	456	958		1,894	1,890	449	1,108		35	35	35	35		1,476	1,472	1,408	1,775					3,335
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female													2,419	2,048	2,128	2,089	1,605	2,673	1,623	1,757	2,248	2,497	2,979	2,715	2,733	2,766	3,137		3,069	3,216	3,275	3,450					2,962
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male													6,726	5,799	5,930	5,871	4,621	7,603	4,703	5,125	6,213	6,740	8,477	7,233	7,421	7,282	8,470		8,135	8,446	8,559	8,709					7,250
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male													12,799	10,357	10,141	9,899	7,490	12,870	7,655	7,831	9,051	10,460	13,857	10,930	10,859	10,637	11,525		11,457	11,084	11,011	10,919					7,988
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								1,366	1,481	1,513	1,696		1,680	1,839	1,877	1,939					1,857
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												14,318					10,426				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												20,759					16,493				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex													8	2	2	1	1		1					43	1		1		6	1	3						1
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Coarse	Coarse	Missing Sex				2,084	1,165	1,148	844		821	1,021	1,010	1,153																									
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								274	275	274	313		316	349	368	393					328
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female													455	352	327	320	255	486	240	271	307	311	616	397	396	402	461		456	449	414	354					265
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female													4,991	3,172	2,804	2,624	1,858	3,990	1,859	1,661	1,715	2,139	3,625	2,120	1,962	1,989	1,994		2,004	1,776	1,731	1,648					966
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex													1,086	531	501	513	426	960	341	348	416	405	903	520	531	481	523	670	510	450	423	314	463				235
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												10,046					6,719				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								653	667	661	775		762	846	869	900					729
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female													1,811	1,084	942	878	632	1,569	635	567	602	794	1,408	725	668	743	711		713	663	649	611					381
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female													8,020	6,143	5,624	5,408	3,940	7,396	3,990	3,768	4,076	4,694	7,437	4,855	4,540	4,434	4,650		4,560	4,158	4,036	3,975					2,450
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								554	561	561	643		632	687	714	735					667
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								507	518	521	591		573	597	605	611					536
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male														400	402	850	1,489		3,112	3,297	830	1,885		134	134	134	134		2,517	2,513	2,405	2,852					7,472
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												1,110					942				
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male													967	765	656	694	570	1,427	661	587	625	787	1,477	975	903	963	1,045		1,062	917	902	789					493
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								365	371	359	413		403	401	397	406					312
Vietnam	Vietnam	VNM	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex													115	77	70	61	38	222	36	42	46	45	150	52	44	36	49		49	48	48	48					35
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					30		61			51		53			48		37			26		46			42		65										
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														36		61					30
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														20		11					16
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														14		15					12
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					2		5					3			7		2			3		6			11		3										
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														3		1					1
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														2		1					1
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														3		3					4
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														4		3					1
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														1		4					4
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																																1					1
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														17		15					4
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																																					1
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														33		33					15
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														7		8					8
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														6		4					5
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														1		2					1
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																2					
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														57		67					26
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					251		332			379		355			383		158			203		265			275		409										
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														9		6					2
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														24		29					18
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														3		1					3
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														55		57					35
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														43		55					43
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														1		3					5
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														9		10					7
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														86		77					45
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														1		1					
Vietnam	Vietnam	VNM	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male																																					20
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												209					209				
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																								1	2	2	19		2	7	5	7					1
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																			7	5	5	8	103	4	8	77	68		78	60	62	52					10
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																61	92		106	98	81	195		110	88	119	152		179	97	84	92					30
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												370					370				
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												158					158				
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																					2									6	2	1					
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												474					474				
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female													463					11		17	158	188	12	237	317	186	211		205	227	215	206					14
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																				3	87	133		104	156	102	146		137	141	157	123					49
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female													653					19		19	97	96	20	127	151	125	129		116	165	149	111					13
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																				3	73	149		81	161	113	106		88	91	113	90					45
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female													650			87	49	651	94	68	69	82	716	136	150	137	168		114	85	70	58					31
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																			1						2	7	24		16	1	10	10					
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												349					349				
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male													330			393	195	605	324	282	239	349	666	462	561	499	555		522	523	360	369					234
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																			26		2	2	64	2	5	36	61		86	46	35	41					28
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex																											19										
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												1,653					1,653				
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																			45	2	1	1	59	1	4	13	43		35	39	36	27					3
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male													418					70			2		78	5	4	3	10		3	20	17	13					4
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																12	44		53	9	29	88		50	58	50	38		15	5	2	9					1
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												978					978				
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												659					659				
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male													307					112		2	4	5	123	18	13	19	23		19	46	25	18					4
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												33					33				
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												12					12				
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male													169					190		35	74	25	209	108	78	92	88		74	54	48	100					10
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female													98					85		4		2	94	2	5	1	6	94	1	7	7	2	94				1
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																		409		3	86	87	449	53	130	139	187		153	168	328	264					119
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																			32	3	2	4	81		6	9	45		26	25	35	24					
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																											37		22			1					2
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												1,989					1,989				
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male													280			290	135	651	200	197	207	303	717	392	470	390	363		389	393	188	180					91
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												421					421				
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																		126			24	69	139	32	54	113	133		90	90	215	204					105
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																				5	62	54		61	32	30	52		39	43	40	40					5
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												71					71				
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												390					390				
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male													285					202		14	74	15	222	90	60	61	64		60	70	50	80					6
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male													298					112		4	5	1	124	2	2	6	8	124	10	19	16	8	124				2
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																											5		10								
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																			8	2			151			8	1		4	9	16	12					
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												382					382				
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female													739			242	86	782	145	106	112	144	860	425	292	377	354		290	252	270	279					105
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male													278			87	64	618	117	91	116	166	681	167	171	179	168		207	192	81	87					83
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																					24	4		19	50	29	15		9	12	13	5					32
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female													235					38		1	3	4	41	8	5	5	9		6	22	15	6					4
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																		122			23	80	134	32	55	48	45	134	21	43	74	61	134				98
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																	1		4		9	8		3	10		2					1					
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																		318		3	99	210	349	102	225	182	207		175	174	291	180					83
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																			3	1	1	2	13		2	5	20		12	9	5	1					
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												1,383					1,383				
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																			7			2	22			3	5		3	1	2	1					
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																			4	2	1	2	62	2	6	11	288		16	13	12	14					2
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																			7	4	1	2	62	1	3	24	55		34	19	24	50					7
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																			11		1	1	110		1	6	11		12	13	16	8					
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																			18	2			52		6	9	22		18	18	24	21					
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female													473			44	44	475	48	38	48	63	522	86	81	86	74	522	63	62	56	46	522				26
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												83					83				
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female													737			194	105	755	163	154	117	168	830	373	298	358	434		289	230	219	248					50
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																		280		2	54	80	308	32	83	141	157		119	134	296	237					137
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male													283					181		9	29	14	199	47	35	48	48		29	73	51	42					3
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female													518					26		21	47	63	28	67	100	83	107		96	128	107	87					10
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																	4		8	1	13	3		4	1	1											
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												1,690					1,690				
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female													209			196	82	336	201	140	124	189	370	591	394	482	484		368	347	350	358					114
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																		202		3	50	88	222	37	56	59	37		21	38	58	41					19
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male													280			79	60	493	86	72	98	139	543	134	141	118	148		138	139	91	56					62
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																		89		1	35	44	99	24	46	33	32		8	28	37	30					12
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male													259			46	32	389	53	43	57	72	429	80	80	75	84		76	66	48	49					39
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female													275					53		10	9	18	58	23	51	32	29		23	66	57	43					5
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female													683			126	74	693	89	86	83	87	763	199	167	196	243		172	137	123	113					39
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female													463			52	27	464	40	38	41	33	510	70	66	78	89		65	46	40	34					19
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																		481		6	122	201	529	76	224	208	240		173	224	373	244					112
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																		430		14	288	325	474	219	252	179	219		280	245	372	210					68
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																			17	2		2	29	2	3	13	50		21	31	21	17					2
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																			4	2			113	1		1	5	58	51	3			58				
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																			9	5			179			1	2	90	1	5	5	2	90				
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																		169		9	177	249	187	128	126	99	101		143	117	168	94					25
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																		391		17	317	365	431	265	274	188	161		244	223	360	176					89
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female													527					42		12	27	32	46	35	51	41	47		44	88	49	36					4
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male													543			65	37	632	60	73	50	84	695	95	109	108	87	695	85	87	76	73	695				41
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												145					145				
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male													35			464	199	263	384	245	219	531	289	500	628	695	798		717	544	550	568					200
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												289					289				
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												48					48				
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												50					50				
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male													279					164		3	8	11	181	22	19	15	17		15	48	30	28					9
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																		192		2	42	68	212	21	67	112	128		88	109	204	192					118
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																				9	9	9		21	6	1	11		10	9	14	20					
West Africa Region 1	Burkina Faso	BFA	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																								1	5					2							
West Africa Region 1	Togo	TGO	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																52	26		78	55	60	106		162	86	111	103		154	88	87	69					38
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												17					17				
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																					5									10	1	1					
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																		138		2	25	52	152	17	55	51	43	152	9	17	48	38	152				80
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												618					618				
West Africa Region 1	Benin	BEN	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																		63		6	92	110	69	76	96	80	91		54	91	103	94					26
West Africa Region 1	Senegal	SEN	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																											11					1					
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male								3,848	493	497	533	945	2,583	472	540	516	451	2,279	502	677	699	761	457	607	566	524	432		624	627	582	604					872
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female								4,699	559	659	1,054	1,326	5,177	1,567	1,630	1,451	1,199	378	1,044	1,111	1,088	1,037	1,059	1,084	870	1,099	911		1,210	2,878	2,619	2,042					1,156
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																																5					
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex									6	4	5	6	185	49	15	38	30	957	4	60	46	50	2,980	81	89	88	124	595	139	115	107	122	1,511				165
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male								3,847	574	757	801	1,356	2,809	724	862	751	678	3,906	818	1,047	1,285	1,218	670	871	912	855	720		985	890	910	857					1,023
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male								1,081	109	124	79	126	1,763	361	300	193	181	3,027	41	100	301	596	2,767	316	381	336	349		397	361	406	448					485
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male								1,075	46	58	42	49	2,392	142	127	105	70	2,080	38	86	185	260	2,091	204	226	186	232		231	233	243	270					382
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex								2,343	957	1,166	962	1,264	1,060	1,061	1,284	1,911	1,281	6,128	1,823	1,796	2,147	2,374	6,830	2,209	1,778	1,567	2,185		1,779	1,956	1,814	1,820					1,328
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												6,199					6,266				
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female																		2,020	296	215	301	351	712	248	357	321	384		556	590	446	590					610
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female								11,960	1,164	1,769	1,763	2,811	7,360	1,739	1,816	1,603	1,370	1,835	1,327	1,390	1,555	1,591	2,087	1,662	1,540	1,486	1,384		2,877	2,538	2,450	2,424					3,415
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female								379	21	29	31	32	876	106	83	46	44	95	20	53	152	160	489	127	139	149	265		235	216	251	310					449
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male								1,546	223	279	427	487	2,825	555	573	614	517	1,813	519	559	552	656	2,912	660	655	683	570		676	712	758	725					590
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex																		1,920	332	372	494	401	820	522	520	594	723		816	660	788	837					804
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male																		1,259	136	122	216	338	924	289	381	357	343		409	377	381	663					654
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												27,281					27,466				
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												18,369					20,068				
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male								365	26	36	19	34	1,089	72	74	65	56	1,525	31	68	93	148	1,127	164	160	154	160		192	178	186	209					291
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female									57	1	1	9		2	1	10	3		3	4	7	20			2	4											
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												6,007					5,332				
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female																		627	433	377	409	421	918	376	475	460	520		1,231	1,326	1,237	1,278					1,422
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male																		2,802	244	211	293	492	1,866	372	456	440	396		569	510	556	914					850
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male								3,861	952	1,174	1,316	2,542	3,294	1,482	1,707	1,555	1,487	5,212	1,315	1,704	2,181	2,123	1,928	1,630	1,466	1,510	1,371		1,744	2,095	1,920	1,995					2,488
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												2,159					1,366				
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex								2,882	820	740	724	1,190	1,982	579	985	1,283	1,414	6,050	1,349	1,507	2,011	2,467	280	1,698	1,460	1,284	1,371		1,301	1,263	1,173	1,332					1,496
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female																		891	142	147	188	244	598	220	311	288	314		340	367	349	388					436
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												9,200					6,833				
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male								1,075	242	247	175	261	1,929	658	592	418	437	2,467	73	149	483	1,032	3,099	553	682	585	606		656	600	581	671					722
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female								382	104	107	76	93	1,929	287	231	197	192	347	102	138	309	406	530	422	359	395	515		455	480	643	627					917
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male								366	20	13	12	19	1,089	57	49	32	43	920	25	57	77	89	806	99	86	101	127		143	150	127	142					240
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												1,545					8,376				
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female								4,682	672	777	1,354	1,711	6,531	1,902	1,845	1,734	1,346	269	1,243	1,180	1,394	1,110	2,929	1,436	1,152	1,334	1,136		1,527	3,604	3,393	2,536					1,736
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male								409	87	66	126	144	468	229	197	258	179	2,602	201	174	260	276	1,070	272	245	206	202		258	314	272	260					183
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												417					624				
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male								690	494	552	591	1,284	535	551	451	504	562	3,792	658	806	1,350	1,605	539	1,191	976	786	793		1,101	1,006	848	909					988
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												1,360					475				
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male								3,861	830	1,056	1,085	2,153	2,804	1,307	1,506	1,412	1,186	5,950	1,137	1,586	2,035	2,132	4,315	1,452	1,424	1,312	1,261		1,652	1,694	1,528	1,443					1,470
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																																					3
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male								481	255	223	462	564	1,686	656	652	679	546	1,900	553	518	622	837	2,047	845	741	712	811		931	904	874	861					671
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												5,972					10,036				
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female								976	861	1,130	850	1,992	568	937	767	848	785	2,637	985	901	1,099	1,328	1,209	1,175	1,066	1,025	1,030		1,752	1,750	1,478	1,644					2,193
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												1,830					3,401				
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												13,149					13,236				
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												18,040					18,620				
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male								1,555	295	311	489	576	2,850	677	641	652	553	2,009	568	512	632	662	2,771	750	675	729	649		801	786	846	783					759
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female																		1,691	584	591	525	640	1,086	459	483	542	596		2,095	2,107	2,067	2,024					2,045
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female								11,958	1,344	1,926	1,844	3,364	7,405	1,842	1,832	1,695	1,548	3,202	1,384	1,250	1,548	1,629	2,380	1,602	1,443	1,386	1,447		3,222	3,150	2,824	2,824					4,611
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												1,830					2,536				
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												8,741					2,450				
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female								4,696	267	303	409	521	2,749	669	786	669	634	794	519	558	565	535	2,108	528	511	598	472		688	750	819	746					464
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex								2,729	658	615	611	1,208	1,755	526	811	1,033	1,337	11,607	1,197	1,570	1,875	2,409		1,741	1,647	1,335	1,440	2,981	1,440	1,304	1,170	1,272	9,360				2,036
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												4,765					1,436				
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												778					440				
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female																		1,595	370	276	353	459	2,496	358	406	682	602		1,848	1,918	1,953	1,714					1,753
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female																			2			1															
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												659					2,651				
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex										1	3			18	7	10	6		2	10	16	12		10	10	8	47		27	28	21	55					30
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex									3	5	10	12	104	38	19	54	35	1,232	17	30	50	77	3,830	74	105	63	103		109	71	85	71					126
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male																		4,807	355	293	406	519	2,054	404	564	695	580		861	798	738	1,082					989
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex																		80	790	581	891	635	840	777	620	932	1,042		1,382	1,142	1,223	1,659					1,663
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female																		1,383	301	289	322	446	1,116	398	529	575	635	2,311	698	742	619	804	4,944				1,037
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male								1,078	318	260	239	296	1,560	755	579	349	439	1,256	51	138	444	935	1,495	598	622	535	560		659	513	505	661					559
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex											12	13		22		4						4		2		12	2										
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female									33	46	28	41	474	153	133	107	70	141	54	98	192	237	1,015	193	226	154	286		239	249	299	274					375
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												5,490					8,418				
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												5,702					9,342				
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									1	9		1		1		3	2		2	1	1					24	113		1								
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female								2,004	704	717	1,476	2,044	4,634	1,962	2,072	1,965	1,528	147	1,476	1,348	1,679	1,488	2,671	1,753	1,504	1,595	1,488		2,148	4,540	4,559	3,325					1,687
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												8,886					8,348				
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female								4,697	397	446	703	864	5,267	972	1,096	934	870	632	724	731	784	703	1,272	704	680	707	568		827	1,621	1,606	1,232					826
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male								3,848	705	821	862	1,506	2,789	791	910	841	699	5,485	813	988	1,256	1,317	1,798	869	885	784	781		1,010	1,137	1,045	1,044					1,407
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex									6	3	6	13	44	88	54	78	64	342	33	48	85	126	1,802	81	123	90	192		186	133	187	217					281
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male								425	858	1,065	1,501	2,680	344	1,475	1,526	1,225	1,193	4,042	1,379	1,686	2,433	2,440	1,228	2,028	1,800	1,794	1,839		2,380	2,282	2,308	2,344					2,052
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								11,980	575	612	635	1,020	4,645	531	552	451	444	523	443	513	519	510	2,903	522	545	499	497		515	546	563	518					746
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex																			134	77	157	91		255	208	141	110		255	132	109	133					335
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												4,099					1,950				
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								4,733	151	153	230	309	2,348	395	417	474	379	576	308	348	383	380	2,798	337	297	296	274		327	352	348	373					346
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female											1										2				2	5	2		24	36	38	171					571
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female									14	27	18	17	383	71	72	63	68	153	30	62	96	113	858	123	150	122	168		174	167	159	191					264
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									44	2	2	4		15	1	2	3		4	6	3	25			1												
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female									13	32	21	20	22	142	120	110	78	410	86	173	270	313	2,879	328	364	352	438	1,004	474	520	497	469	3,261				703
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												22,907					24,204				
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male								1,545	211	238	303	416	2,788	483	493	486	485	1,640	475	432	414	528	2,413	536	507	524	470		476	589	601	538					590
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												10,062					11,495				
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female								379	95	84	79	97	1,005	335	257	152	160	237	63	161	347	432	449	456	398	454	808		605	689	702	799					1,076
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex																		1,829	280	364	330	415	590	441	387	444	518	2,660	667	682	909	783	6,558				756
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female								11,974	1,047	1,272	1,354	2,174	7,034	1,278	1,285	1,215	1,076	1,004	959	960	1,093	1,122	2,152	1,131	1,135	1,057	944		1,792	1,858	1,577	1,597					2,441
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex									2		2	12		18	3	14	1		22							14			1	71							
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male								7,632	1,076	1,071	1,146	1,837	5,430	1,104	1,048	873	830	2,110	941	1,373	1,340	1,446	1,553	1,237	1,323	1,255	1,288	2,743	1,195	1,304	1,414	1,515	9,574				1,891
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												6,460					16,786				
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male																		903	188	153	242	351	410	245	268	496	451		523	412	531	603					800
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female																		3,908	693	720	608	732	1,326	657	637	819	843		3,428	3,341	3,287	2,946					3,026
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female								382	130	146	99	126	796	353	353	252	219	529	117	157	418	463	605	491	483	470	807		655	630	739	839					1,143
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male								1,072	66	37	52	58	2,245	234	180	86	90	400	8	43	102	242	398	193	176	148	182		186	151	187	201					181
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female								3,135	1,255	1,793	1,676	3,317	2,092	1,787	1,623	1,648	1,436	3,942	1,537	1,560	1,774	1,838	1,126	1,931	1,881	1,888	1,893		3,866	3,590	3,339	3,647					4,191
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male																		4,091	251	318	327	449	2,198	406	489	503	454		634	571	590	1,012					890
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male																		1,221	259	299	383	527	1,086	436	600	639	684	1,594	797	782	745	900	2,428				1,130
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												3,492					2,384				
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male																		3,180	339	245	336	509	1,360	353	477	620	588		760	772	849	930					1,136
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female																		4,297	641	583	562	774	1,444	687	663	976	964		3,285	3,442	3,567	3,155					3,124
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												8,221					8,583				
West Africa Region 1	Benin	BEN	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male																		1,921	160	144	254	419	1,388	337	382	440	388		483	417	471	714					692
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												9,009					8,411				
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female										19	6	2		3	2	5	1		1	2	1	1		1		23	119		2								
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female								625	279	280	560	856	1,187	904	688	646	672	61	541	437	637	551	1,711	634	476	472	486		774	1,658	1,789	1,353					621
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male								1,542	149	189	216	362	3,070	387	454	504	450	1,111	420	454	401	502	1,912	410	473	530	491		493	557	574	554					502
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex								1,068	133	93	97	124	1,952	168	158	339	387	15,147	400	600	811	781	1,920	568	504	591	474		561	862	789	648					591
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male								1,867	98	118	193	278	4,184	308	355	375	381	695	327	321	347	354	751	286	328	321	295		311	395	418	441					507
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male								2,306	232	288	299	393	2,980	387	462	578	551	1,111	525	420	485	526	891	492	446	405	327	6,967	473	501	507	643	8,989				501
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female								3,682	206	223	265	386	976	444	444	531	535	1,275	475	467	527	453	7,044	522	449	326	312	6,123	433	399	405	465	7,166				363
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex								989	273	173	222	203	1,475	477	149	374	770	3,498	686	1,171	1,241	1,221	2,060	1,012	899	925	753		1,233	1,581	1,227	1,206					1,241
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female								11,979	772	1,003	1,082	1,687	6,513	951	946	817	754	628	727	718	911	859	3,031	918	897	811	776		1,125	995	1,000	930					1,191
West Africa Region 1	Togo	TGO	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female								12,144	1,209	1,246	1,275	2,093	4,728	1,233	1,081	875	838	801	859	957	1,039	1,120	2,740	1,096	1,127	1,136	1,065	1,491	1,112	1,175	1,281	1,324	13,864				1,738
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female								381	56	59	52	72	1,652	177	189	143	149	194	78	123	283	371	621	306	316	287	408		398	430	436	483					703
West Africa Region 1	Burkina Faso	BFA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex								1,003	114	73	49	176	1,428	113	130	392	388	26,332	277	447	736	651	3,000	500	429	420	389	6,621	574	832	729	696	9,401				346
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male								135	18	15	8	20	7	108	111	104	70	1,224	52	119	216	250	1,441	270	273	319	391	770	429	489	421	432	703				696
West Africa Region 1	Senegal	SEN	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male									4	1				1		1				1	12			1	1	1	2		13	8	4	8					16
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								469	168	140	144	212	267	85	92	95	79	291	88	124	106	101	55	104	70	55	50		57	70	37	37					51
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												180					155				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female									9			2		1					3	3	2	1				1											
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								1,451	249	264	241	322	828	182	141	202	126	446	159	96	127	120	361	140	121	120	97		118	113	80	82					79
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex								262	93	86	68	106	105	55	49	88	65	385	61	47	56	46	488	45	38	42	25		41	34	28	19					16
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male								169	49	42	48	48	302	147	66	56	118	139	22	13	29	85	130	40	32	41	37		50	42	34	31					42
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female																		72	114	80	89	96	110	85	93	80	61		85	86	63	70					60
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male																		443	56	31	33	36	262	32	32	27	29		39	26	31	33					17
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male								35	3	7	9	7	37	3	9	4	10	286	7	10	8	24	114	12	11	7	7		7	5	3	4					4
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female											5	1				4											67										
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male								259	90	100	93	95	247	81	90	128	90	145	93	82	86	87	104	86	69	73	48	1,042	72	72	53	58	1,066				48
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								468	147	164	195	186	267	107	134	141	111	461	112	143	171	151	93	120	99	75	46		80	69	61	50					57
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												726					653				
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												418					422				
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male								39	16	6	27	32	148	27	31	25	33	209	23	26	22	38	230	39	26	23	32		30	29	28	26					22
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								391	120	113	111	202	212	85	94	85	75	455	92	86	86	70	174	73	72	88	63		105	95	73	75					49
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												424					188				
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								189	92	86	139	119	423	115	88	141	122	24	141	107	121	127	322	121	119	111	87		130	112	126	122					90
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female								499	105	110	103	96	488	137	127	135	131	90	108	104	74	83	244	81	81	96	71		93	69	78	66					64
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								1,446	360	353	344	438	829	222	232	265	213	166	193	184	192	178	321	157	152	121	87		141	159	116	92					60
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex											2	5		1								2		1		1	1										
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								168	49	53	32	58	289	63	70	76	58	129	44	68	43	39	238	46	63	47	49		50	52	68	49					49
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												323					322				
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								195	29	35	63	45	392	50	58	79	67	81	50	39	40	41	91	34	47	40	38		44	49	44	25					31
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex									2	1	1	2	10	14	13	10	9	35	9	7	11	20	100	13	7	7	31		15	10	16	12					20
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								60	9	15	6	7	211	30	25	25	20	157	15	20	19	20	101	25	25	25	22		27	22	27	19					23
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex																		134	10	20	9	22	30	7	6	17	11	133	17	7	10	11	202				7
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												86					1				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male									1			1		2					1	2		3															
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								1,446	323	375	327	417	829	241	266	251	185	289	197	176	197	174	312	185	165	143	109		187	113	115	123					88
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male								469	160	177	175	182	267	106	103	126	83	603	112	117	126	128	238	85	92	77	59		77	81	56	55					45
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								60	8	1	3	6	211	24	21	11	22	102	11	14	15	18	85	22	16	24	28		21	21	20	29					22
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												16					26				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								1,446	228	168	177	212	829	113	133	118	105	91	107	134	128	98	440	98	81	84	62		74	68	52	49					58
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												948					611				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												220					221				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex								348	70	56	51	89	201	35	33	63	73	377	65	59	53	65	21	48	49	24	26		14	27	16	14					15
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																									1							3					1
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male								169	45	35	38	53	374	96	88	65	72	257	31	28	26	58	262	39	61	42	30		58	47	33	53					44
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex										2	1	1	35	12	8	6	7	99	2	14	8	3	165	3	3	2	7	87	8	6	4	7	164				6
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								25	8	8	3	3	196	38	35	24	31	29	23	27	24	29	47	30	36	29	36		34	34	37	35					46
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								493	131	89	162	139	628	137	143	174	157	34	144	126	122	133	350	129	122	155	125		137	107	122	127					115
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								26	12	14	6	9	320	60	35	54	48	33	39	43	34	52	73	32	40	42	51		50	49	28	46					52
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male																		177	43	30	52	46	175	46	34	45	36		55	44	26	33					26
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												343					205				
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												112					162				
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												146					165				
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female																		232	81	59	65	71	87	72	56	54	62		57	60	50	56					58
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								505	149	118	158	172	656	153	167	183	144	48	145	144	129	121	108	121	91	118	106		107	126	132	113					98
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male																		140	43	51	65	55	139	63	43	48	47	229	57	59	44	56	241				38
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												630					235				
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male																		293	23	19	28	43	172	22	37	26	31		43	22	33	23					29
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												405					301				
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex								116	22	10	10	5	189	11	8	25	27	946	28	24	23	21	96	21	15	16	15		17	19	13	5					8
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male									3					1															1	1		1					
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								506	82	57	72	72	420	80	96	135	97	70	70	79	63	65	351	59	57	51	52		64	71	47	55					52
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male								172	29	18	26	16	341	77	47	29	33	320	22	15	17	37	285	24	29	21	33		21	39	34	42					39
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male								168	60	52	61	49	259	53	64	67	72	180	54	52	49	45	290	69	52	49	70		46	61	65	70					43
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								410	98	78	74	85	174	108	102	147	121	142	120	109	75	89	887	107	81	68	61	744	108	108	77	77	821				60
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male																											56										
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex										3			20	8	9	9	9	127	6	3	5	8	218	10	10	6	7		13	5	5	17					15
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male								921	191	242	210	261	528	155	134	123	132	329	113	168	184	143	167	144	127	117	93	327	100	90	80	65	608				76
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female																		145	45	33	50	54	72	41	48	47	43		46	46	45	37					31
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												766					759				
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male																		377	45	65	36	35	280	31	30	32	29		40	26	40	31					38
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												125					166				
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male																		116	38	26	48	43	117	34	35	32	19		36	34	24	27					26
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female									7	21	10	6	5	81	65	69	53	68	53	61	58	83	371	79	80	74	75	168	77	88	78	89	474				100
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex																		8	29	27	33	22	43	23	24	12	12		22	29	18	19					17
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												210					269				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex								335	57	46	52	52	189	28	20	41	61	725	46	63	59	85		60	60	35	57	75	36	36	29	17	107				20
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												660					643				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male								478	100	120	128	193	267	131	139	141	109	656	63	110	118	121	539	85	67	59	70		85	71	64	41					37
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								25		3	3	4	174	9	10	11	12	17	8	6	7	10	48	6	9	9	14		9	5	13	10					4
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								59	25	18	29	32	116	37	17	35	25	11	32	14	25	31	205	36	30	23	28		32	28	36	45					20
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												304					135				
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								26	11	10	6	5	374	57	41	44	44	57	40	40	33	35	64	57	41	42	39		43	46	25	29					54
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male								83	28	34	41	55	47	22	23	7	21	418	11	14	18	11	65	14	12	15	16		9	8	10	4					7
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male								169	10	6	10	12	435	21	11	12	11	47	4	1	6	14	37	14	6	9	10		17	9	12	15					9
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex												2		1		2	1																				
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female									5	8	3	7	84	36	36	34	37	25	18	17	17	33	120	15	34	24	33		34	32	24	27					38
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex																			14	2	8	4		7	10	2	3		6	1	2	1					1
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex								98	58	21	21	17	151	28	17	43	61	221	66	39	43	38	103	37	32	38	27		32	37	41	42					43
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female																		194	114	128	91	99	128	100	71	61	70		94	73	68	80					67
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex										1	1			9	1	3	1			5	2	3		1	2		9		3	2	1	3					3
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												476					483				
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female																			2			1															
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female																		224	59	64	59	71	139	69	68	55	60	387	74	84	76	60	493				57
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												123					343				
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex								106	12	7	5	4	147	9	10	14	8	1,661	10	15	15	16	150	19	11	12	12	262	15	10	12	10	282				5
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												277					835				
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female																		396	51	46	51	64	159	70	51	45	65		56	66	65	47					45
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male								168	22	18	42	34	259	38	44	27	23	220	25	32	40	38	319	32	38	46	42		41	40	40	35					27
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												686					602				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								118	57	43	39	70	70	25	29	28	23	306	31	20	20	19	187	34	25	30	24		24	19	11	21					20
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male								169	7	10	15	9	463	39	27	28	15	212	20	28	20	40	198	15	21	22	30		30	24	27	25					32
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex																		140	24	15	19	15	44	10	10	7	11		18	14	15	7					8
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												32									
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												392					308				
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								1,472	305	327	285	371	839	206	178	171	166	135	174	174	193	132	415	171	171	141	109	197	153	117	101	96	922				92
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male																		258	66	56	60	45	235	50	30	36	35		59	34	37	42					29
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male								168	32	30	45	48	259	58	45	49	49	200	51	53	44	40	335	56	45	60	53		54	41	66	44					30
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												76					116				
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								498	131	129	135	133	656	140	169	131	143	71	138	123	108	93	149	95	112	96	84		113	107	95	94					79
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								26	7	16	6	13	157	41	42	56	34	65	35	30	46	54	68	35	42	29	53		45	36	32	39					44
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female									7	10	7	13	105	38	42	42	33	24	35	22	24	39	126	36	42	29	51		48	37	42	42					47
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												184					175				
West Africa Region 1	Senegal	SEN	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male								23	10	6	6	9	2	37	40	48	40	161	28	25	30	44	163	40	38	47	44	111	60	54	52	47	66				60
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male								478	64	87	94	183	267	110	91	103	103	573	68	65	77	73	265	60	61	60	40		62	58	58	37					36
West Africa Region 1	Burkina Faso	BFA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												291					289				
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male																		83	5	9	9	21	52	14	14	17	9		20	16	11	8					9
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female								1,445	288	283	310	318	829	203	216	168	161	106	156	145	139	116	463	130	107	104	98		119	82	94	66					76
West Africa Region 1	Togo	TGO	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male								43	48	80	110	118	30	83	85	55	54	446	44	48	80	36	163	62	53	44	40		43	51	51	45					16
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female																		360	78	93	77	81	154	87	82	80	71		91	81	75	55					64
West Africa Region 1	Benin	BEN	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female																		147	19	23	19	28	247	24	20	14	14		19	34	15	17					10
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female																													42	36	41	30					22
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female																													33	27	29	25					23
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																																1					
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female																													40	37	33	33					19
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												28					41				
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												28					39				
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female																														4	46	24					15
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female																														2	9	1					2
West Africa Region 1	Senegal	SEN	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female																													1								
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female																													12	13	8	8					7
West Africa Region 1	Senegal	SEN	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female																													1								
West Africa Region 1	Senegal	SEN	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female																											1		1		2	2					
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female																													34	28	18	12					15
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												407					168				
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												177					143				
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												127					140				
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female																														3	18	5					5
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female																													32	34	37	34					36
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female																													14	16	9	10					10
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																													1								
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female																													22	24	18	15					14
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female																													2	2	3	5					3
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female																														2	30	9					8
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																															1						1
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female																													1	2	4	1					1
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female																														4	53	10					10
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female																													64	45	35	36					50
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												349					81				
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female																													45	32	39	23					28
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	60-64	50+	Female																													1			1					
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex																														2	2						1
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female																													3	2		2					1
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																															1						1
West Africa Region 1	Senegal	SEN	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female																											1										
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female																														1	27	3					2
West Africa Region 1	Benin	BEN	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												67					31				
West Africa Region 1	Senegal	SEN	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female																											1				1	1					2
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female																													7	5	5	12					12
West Africa Region 1	Burkina Faso	BFA	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												12					19				
West Africa Region 1	Togo	TGO	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												128					147				
West Africa Region 1	Senegal	SEN	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female																													1			3					
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female																											7		985	1,186	1,119	1,005					938
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												3,921					3,921				
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female																													89	1,007	751	423					297
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female																			6	10	10	11		35	5	40	170		129	217	192	256					588
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female																											6		2,103	2,299	2,200	2,003					2,047
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												6,136					6,136				
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex																													45		1	96					
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female																													1,151	1,151	957	897					991
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex																																					4
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female																			13	4	7	4		20	7	34	102		91	129	203	197					463
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female																													2	33	3	1					2
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female																													16	15	9	11					17
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female																													617	661	514	464					564
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												13,314					13,314				
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female																													144	2,541	1,815	1,097					682
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex																													10	63	22	17					12
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female																													1								1
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex																													1								
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female																													517	471	431	511					520
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female																													155	199	145	117					144
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female																													34	234	196	94					68
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female																			7	6	6	2		6	4	14	80		71	124	120	123					328
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female																													1,412	1,391	1,174	1,294					1,300
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex																								1		1	1		5	1	2	1					3
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												3,449					3,449				
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												8,637					8,637				
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female																													131	1,960	1,293	813					442
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												7,985					7,985				
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female																											2		134	146	118	155					135
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female																													171	1,190	1,049	731					321
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female																													3	39	24	9					5
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												2,857					2,857				
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female																													4	28	10	154					473
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female																													1	2	4	1					
West Africa Region 1	Togo	TGO	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female																													1,374	1,421	1,185	1,061					1,399
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female																													9	9	6	3					1
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												8,212					8,212				
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female																			1	2		2		6		8	27		19	29	42	36					80
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex																													33	40	52	17					43
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female																											6		2,002	2,324	2,325	2,019					2,049
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female																													201	2,934	2,249	1,372					650
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female																											4		630	710	707	659					776
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female																			3	2	3	4		15	1	17	59		48	66	69	128					216
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female																									1	1	2			4	4	9					13
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female																											1		13	23	21	19					33
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												1,280					1,280				
West Africa Region 1	Benin	BEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female																											7		1,281	1,413	1,372	1,289					1,313
West Africa Region 1	Senegal	SEN	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female																			15	7	9	10		35	8	33	143		131	164	193	270					613
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female																														1							1
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female																											5		28	54	31	33					18
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female																													45	29	35	24					23
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female																													14	15	11	11					7
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												28					40				
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												67					31				
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												412					170				
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female																											2		23	32	17	14					15
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female																											1		4	6	9	8					8
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female																													7	7	4	10					12
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female																													1								
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female																													63	43	35	28					41
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female																													11	29	22	21					19
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex																														2	2						1
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female																			13	4	7	4		16	7	5	10		5	11	6	8					14
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female																													3	2		2					1
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female																											3		8	5	5	5					2
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female																			6	10	10	11		13	5	6	14		6	11	10	12					20
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												179					145				
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female																													2	8	10	4					5
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female																			7	6	5	2		2	4	7	15		7	8	5	8					10
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex																															1						
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female																			1	2		2		5		2	6		4	1		2					1
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												353					84				
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female																									1		1			1							2
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female																											1				1	1					1
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female																													10	21	13	11					11
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female																			3	2	3	4		1	1	3	7		2	1	2	4					
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female																													1		2						
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female																											6		29	43	32	30					23
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female																													12	35	33	33					18
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female																													3	11	5	11					8
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female																													1	3							
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												129					150				
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female																													34	32	36	31					33
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female																											3		18	24	14	11					15
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female																													10	30	17	38					30
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												12					19				
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex																													1								
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female																														1	1	1					
West Africa Region 1	Togo	TGO	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female																													33	27	22	23					21
West Africa Region 1	Benin	BEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												129					142				
West Africa Region 1	Burkina Faso	BFA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												28					42				
West Africa Region 1	Senegal	SEN	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female																			15	7	9	10		13	8	4	18		14	6	8	17					21
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male										51																											
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female										3																											
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male																				190		549			562		722			903		830					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female										4																											
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female										2																											
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male										12		5			10					15					9		88			132		26					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male																				111		232			274		292			308		374					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																				43		132			67		121			168		255					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male																				124		229			266		351			316		411					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female																				193		353			417		510			550		638					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female																				149		271			321		354			386		447					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex																				41		113			232		283			372		297					
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female										2					1										1		1			4		1					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female										3																											
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female										1																											
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female																				91		183			222		289			276		367					
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female																														18		2					
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female										3					1										1		1			8							
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male										2					1					1					3		20			27		10					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male										17																											
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male										80																											
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male																				79		186			178		238			266		241					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male										60																											
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male										63																											
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female																				302		637			730		842			980		1,104					
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male										22		6			8					2					21		90			187		42					
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female										3																											
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																				43		123			82		123			174		449					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female																				188		386			490		648			678		872					
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male										4					5					1					2		33			36		7					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female										1																											
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female										1																											
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male																				99		194			229		285			294		335					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male										11																											
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female										2																				10							
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male										16		2			5					6					3		57			109		21					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male																				46		97			152		174			154		211					
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female										2																				2							
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female										1					1															3							
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female										5										1										4							
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female										3																				7							
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male										19		3			14					11					20		100			231		41					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female										2																											
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female																				198		380			465		575			570		815					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female																				193		365			506		608			645		842					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female																				102		200			298		286			340		286					
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male																				80		216			278		303			297		448					
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male										11					2					1					4		39			40		13					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male										26																											
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex										1										4																	
West Africa Region 1	Senegal	SEN	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male																				122		251			293		380			370		485					
West Africa Region 1	Burkina Faso	BFA	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male										12																											
West Africa Region 1	Togo	TGO	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male										11		1			3					1					12		93			188		37					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																							46	5	11	14	10		21	25	26	29					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																							23	2	14	11	7	8	18	22	24	55	9				
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																					3	9	308	12	12	12	6		6	6	16	22					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												397					397				
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																							52			3	5		17	103	101	82					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												185					203				
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																							42						1	4	1	2					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																							9				8	48	4	14		8	53				
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																							12	4	10	12	21		21	23	13	7					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																							65		1	14	3					4					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																						1	62	1	22	19	44		69	38	36	48					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																						1	8	1	13	23	27		30	42	24	32					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												220					220				
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																							30	8	21	22	19		22	24	52	84					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												59					65				
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																							28	1	18	17	18		18	13	26	28					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																							96					133	3			2	146				
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												65					72				
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							143			13	3		2			2					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							45			4	6		14	111	92	69					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																							20	6	21	14	15		21	31	51	66					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																									1	11	1					2					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							32	6	12	17	14		20	18	32	37					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																				1	4	1	192	3		2	3		1	2	7	9					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																							40	4	10	12	9		17	19	19	35					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																							9				4		1	17	6	3					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																						3	11	4	13	20	24		22	25	22	29					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												105					115				
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																							22				4		7	11	9	11					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												143					143				
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												190					209				
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												32					34				
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												526					526				
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												171					187				
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												32					35				
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												148					164				
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																							25				2		2	15	10	8					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																						1	20	3	21	50	75		126	56	38	64					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																														1							
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												44					48				
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																						3	59		19	34	50		82	42	38	62					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																							23				1			16	20	16					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																						1															
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																							66		7	5	4	13	5	5	8	17	14				
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																							22				1		4	24	6	15					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																						2	60	2	26	16	20		47	29	26	56					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																							70	1	8	15	14		21	24	16	19					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												45					51				
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																				1	2		187		2	3	1		2	2	6	3					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																							30	2	10	10	10		16	18	25	45					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																						2	44	10	27	30	37	73	34	51	48	46	80				
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																							27						2	20	2	3					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																						23	17	29	50	64	102		80	55	62	38					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																										3											
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																							34			3	4		3	18	11	7					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																							15			3	4		14	81	68	51					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																							16	5	20	12	9		23	29	30	47					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																									1	3											
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												308					308				
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																							77		1	15	4			1	1	9					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																					1	1	100		2	18	9			1		6					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																							10	1	3	3	3		6	2	2	2					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																							19	1	2	4	11		19	15	8	15					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																							16			3	6		11	34	17	12					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																						4	89	5	30	32	48		42	38	42	34					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																							15				1		4	15	8	12					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												98					109				
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												133					146				
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												12					13				
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																							43	9	17	18	13		24	21	32	44					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																					1		120			20	8				1	5					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												18					19				
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																						12	25	18	34	41	58		56	51	49	31					
West Africa Region 1	Burkina Faso	BFA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																							8							5	1	3					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																							55		1	15	4		7	3	7	9					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																							13	3	7	8	6		7	8	19	19					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																						1	73	2	18	17	17		37	30	31	46					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																							24	4	18	14	15		32	34	49	69					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																						1	94		3	20	3				2	2					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												131					144				
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																									14	7	1		4	1	3	5					
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												166					182				
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												38					43				
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																					1	2	172	3	4	7	2		1	7	15	21					
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																							21	1	6	18	11		17	15	17	29					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																														1	1						
West Africa Region 1	Benin	BEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																							24	1	9	8	1	7	13	15	18	35	7				
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																							147									2					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																				1	7	3	225	8	12	18	4		5	5	14	28					
West Africa Region 1	Senegal	SEN	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												236					236				
West Africa Region 1	Togo	TGO	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																						9	30	2	16	21	21		35	35	28	29					
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		242																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		119																			
West Africa Region 1	Benin	BEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		62																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		72																			
West Africa Region 1	Burkina Faso	BFA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		39																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																		163																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		187																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																		153																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		167																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		321																			
West Africa Region 1	Togo	TGO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		95																			
West Africa Region 1	Burkina Faso	BFA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		109																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																		144																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		89																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		88																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		82																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		192																			
West Africa Region 1	Senegal	SEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																		58																			
West Africa Region 1	Benin	BEN	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		18																			
West Africa Region 1	Togo	TGO	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		56																			
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																						6	66	25	18	13	43		31	26	31	28					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																						27	79	50	62	75	28		90	140	107	113					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																						1	75	22	22	16	48		27	45	72	32					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																							216	6	6	2	7	44	10	13	13	9	48				
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																								1		1											
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																						6	69	48	80	75	164		75	72	102	93					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												148					164				
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																							28	2	9	9	6		3	16	8	4					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		39				13	86	10	23	10	9		23	46	26	16					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																						1	73	4	11	11	22		8	28	10	3					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																							80	5	9	8	6	25	5	6	2	5	27				
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												105					115				
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																						11	49	18	36	22	30		38	40	34	21					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																						6	145	32	37	21	28		31	21	45	31					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																						6	105	28	57	40	90		50	87	157	69					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		62				11	78	26	37	19	65		34	36	76	55					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																						1	64	9	16	16	42		32	21	27	26					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																						10	197	23	33	26	68		26	36	39	59					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												294					242				
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																						11	39	44	19	30	19		77	49	68	63					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																						2	31	13	9	13	5		7	7	4	19					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		187	3	4	6	6	256	4	2	3	9		8	4	7	6					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																		153	2	3		7		13	8	14	16		22	11	27	28					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		72	9		1			1	3	1	7		2	2	4	1					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												633					697				
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																						7	34	18	31	12	11		15	15	12	14					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																						8	99	9	14	7	5		13	6	8	4					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																						1	43	15	9	5	3		7	14	7	10					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		18				12	155	23	19	14	25		11	11	19	21					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																						5	24	20	28	19	9		25	21	26	15					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												701					573				
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																						2	77	17	20	8	5	26	16	8	16	5	28				
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																									1												
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		192	9	5	9	10	229	11	6	9	20		17	14	16	28					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		119	27	3	4		159	3	13	9	28		9	4	19	28					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		82	18	2			103	9	4	5	6		3	5	6	10					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																			7			2		1	1		3		2	1	1	1					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												215					236				
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																		58	10	2			86	1		5	6		1	1	4	5					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																						9	242	18	17	23	27		20	19	29	19					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																						6	133	15	17	12	12		12	10	16	6					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																						9	96	26	53	30	25		24	24	67	47					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																						10	100	28	34	15	28		34	43	33	29					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												328					360				
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												619					681				
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																		144	5			10	195			1	1		2		1	3					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												41					45				
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												436					480				
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		321	36	6	20	25	408	25	26	20	30		57	28	55	68					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												351					387				
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																						4	53	15	20	10	19		15	20	17	22					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																							135	5	3	2	7		2	14	3	4					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												408					336				
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		88	14	1	1	3	124	6	3	10	10		8	5	8	17					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		109				10	54	24	58	40	46		51	93	70	41					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												313					257				
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		56				15	296	43	44	42	25		46	51	42	46					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																								2													
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												553					609				
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												146					161				
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												59					66				
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																						1	182	12	23	23	25		28	15	39	20					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																						8	26	6	12	5	5		3	9	6	4					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																						4	81	8	19	10	14		15	30	18	7					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												572					629				
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																						5	96	42	45	14	92		48	58	136	81					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		89	20	1	3		135	4	10	12	15		11	5	18	17					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		167	9	9	1	1	190	3	16	9	51		10	11	13	20					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																			2	2				6	4	4	5		1	1	1	2					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																						60	59	98	109	117	49		211	211	260	193					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																						12	146	28	26	18	18	237	23	25	26	11	262				
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																						5	113	13	20	13	18		11	28	20	10					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																						1	317	3	6		6	442	3	6	3	1	486				
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		242	32	13	21	24	300	24	16	19	36		42	36	35	52					
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												125					139				
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																						2	29	6	14	12	13	161	15	16	10	10	178				
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												493					543				
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																						30	51	24	47	25	25		28	62	28	12					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		95				9	195	35	59	57	81		56	49	69	64					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												443					488				
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												105					116				
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																		163	7	3	3	11	250	2	1	2	2		8	4	2	1					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																						23	175	56	99	66	83		106	154	148	87					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												529					435				
West Africa Region 1	Benin	BEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																						4	67	10	14	7	5		5	5	6	4					
West Africa Region 1	Senegal	SEN	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												190					157				
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																						2	234	10	13	9	18		12	11	17	11					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																						32	71	20	36	28	20		30	48	56	18					
West Africa Region 1	Burkina Faso	BFA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																						12	151	76	125	63	113		155	236	276	113					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																						11	207	37	47	53	95		68	79	62	97					
West Africa Region 1	Togo	TGO	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												195					214				
West Africa Region 1	Benin	BEN	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female																																					1
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female																			4	7	1	3		6	2	15	12		17	13	15	18					36
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female																			2						1												3
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female																			1	1	3	1		2	1	2	2		2	3	8	12					12
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female																								3		4	4		9	7	12	19					38
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male																			1	1	1			6		2	8		10	9	21	40					42
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female																										1					1						
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female										1		1							1		2	4			2	3	7		1	1	12	6					4
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex																						3				1	1				3	2					
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female										1	1	1		1		1	1		1	2	1	4		2	2	3	1		1		3	2					
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female												3				1					1	1		2	2	6	4		4	7	5	8					1
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male																			3	10	3	11		6	16												7
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male									1	2	1	1		1	1	1			4	2		3		3	1	2			2	4	2	1					2
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male									1		3	1			2		3		1	3	5	7		9	6	15	11		7	11	13	9					8
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female									1	1		3		2						1	1	8		8	8	10	8		9	4	36	12					15
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female																				2					1												
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male																			2					7	2	9	17		21	12	20	29					65
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male									2	6	3	3		1	3		2		3	2	6	9		6	6	5	4		5	6	5	9					6
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male									3	1	2	2		5	2	2	3		2		3	5		4	3	7	1		1	7	3	3					1
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex																				1				1			1					1					
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex																				2				2		2	5		7	3	5	6					12
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male																				3	2	1		2	4												
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female										2	2			1		1					2			2	3	4	5			2	4	3					3
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex																											1										
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male																			2	7	4			4	1												4
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex																						1		1						2	1	1					
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex																						1		1					1	1	1	2					2
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex									2	2					3				2			4		1	2	3				2							3
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male																						1		2	1	4	2		1	4	5	7					4
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female																			1	2				7		7	6		10	12	18	32					51
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male																				2	1			7	1	17	7		16	20	26	44					84
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex																						1															
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female																				2		1		1	5					1							2
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female									1		2				2	1						1		3		2			1		2	2					1
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female																				1	1	1		5	3												2
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male																								3	2	8	7		9	6	18	17					23
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male																					4			5	2	9	13		11	10	6	16					37
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female									1			2		2							1	2				3			1	1	2	4					1
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female												2		2						2	3	2		2	5	3	4		1	6	5	2					7
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male									1	3		2		1	3		3			1	3	3		5	2	4	1		2	6	7	5					3
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male																			1	1		1		4	2												2
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male									3	4	2			1		2	1		1	1	1	2		3	3	2	4		3	3	3	7					5
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male											2										3	7		6	7	7	8		6	2	7	8					9
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male									1	1	2				1	1	1		2			2		5	6	11	8		5	10	12	14					7
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male										4	5	4			3	2	1		2	5	2	3		4	5	6	1		2	2	3	11					3
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male									1	2		1		2	2	1	1		2	7	4	9		5	12	15	8		7	14	17	14					13
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female																			2	2	3	2		5		3	7		9	7	12	14					20
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male																			2	3	7	1		10	2	16	13		22	19	23	42					105
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex															2	1			4			1				2	1			2		1					2
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female									2	5	2	1					2		1	1		3		3	2	1	1		3	1	1	1					
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female																			1		2			3	2	7	9		4	10	13	25					43
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male																				3		1		8	1	8	15		22	29	29	41					87
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male																			5	1	2	1		2	1					1							2
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female																			3	3		1		4													3
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male									7	2	1	2			1	1			5	1	4	18		19	18	17	18		7	19	36	41					36
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female																			2	3	3	4		8	6					1							3
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female									2	6		1		3	1	5	1		2	2				1	5	3	2		2	2	1	2					1
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male																			2	2		3		3	3					1							
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female											1	2			1	1			1		3	1		5	4	3	3		8	2	2	7					4
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female																			1	4	1			1	4												1
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female																			1	1	4	2		2	3	3	7		7	6	9	11					14
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female											1					1			1		1	3		3	3	2	6		2	2	4	1					3
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male									1	4	2	1		3	1	3	3		3	3	4	7		2	5	3	1		7	4	5	6					5
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female									1	4	1			1		3	2		2			2		1	1	3	1		1	3	1	1					3
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male																											1										
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex																																1					
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female																			1						4	3				5	4	3					1
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male															1				2		6	8		6	9	11	13		7	9	11	14					17
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female									4	6	2	4		3	1	3	1		1	1	2	3		3	1	4			2	1	2	4					5
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female																				2		2		4		4	3		5	8	10	14					28
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex																			1	1				1	2	1	1		1		4	3					1
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female										2	1	3			1	1			2	2	2	1		1	4	3	3		1	1		4					7
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex														1					3	1		2		1		2											
West Africa Region 1	Togo	TGO	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male									2	3		1		1	1	1			3	2		6		5	4	3	2		3	2	7	4					4
West Africa Region 1	Burkina Faso	BFA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male												2		1		1			4	2	2	11		10	8	21	11		10	8	9	17					12
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male																				4				1													
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex																											1					2					
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex																								1		1			2	1	1	1					5
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female																			2	2	2			1													2
West Africa Region 1	Benin	BEN	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male																				3	3	1		2	3												3
West Africa Region 1	Senegal	SEN	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male																			2	2	1			7		8	12		8	10	25	27					46
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male								227	226	278	298	349	266	347	335	336	349	978	397	387	398	399	1,015	405	431	446	445		462	526	527	521					562
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									96	92	68	58		59	55	102	177		50	41	37	31		28	24	17											
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			1,061	1,122	1,132	1,155	1,292	1,176	1,275	1,281	1,272		1,271	1,375	1,366	1,359					1,493
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								2,452	2,422	3,042	2,790	3,149	3,071	3,317	3,364	3,844	3,906	4,296	4,360	4,410	4,446	4,498	4,667	4,534	4,422	4,496	4,433		4,846	4,736	4,699	4,863					4,720
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			243	395	238	359	1,235	724	743	717	660		593	610	614	640					788
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male								1,565	2,201	2,818	2,560	3,876	1,064	3,050	3,333	3,701	3,719	4,398										5,677					6,320				
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												6,177					6,090				
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									1	4	7	5		7	17	16	22		22	16	8			8	4		24			48							76
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male								87	117	160	169	232	638	248	266	302	329	724	359	367	387	415	723	445	450	467	495		549	507	524	551					523
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male								788	448	548	477	588	1,116	615	584	695	735	1,006	794	815	837	869	1,315	920	936	972	1,033		1,059	1,044	1,075	1,118					1,119
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												3,776					4,259				
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male								352	24	31	30	28	578	90	99	105	115	253	102	109	96	138	286	144	144	145	143		185	181	246	240					148
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								4,038	2,895	3,497	3,402	3,704	4,729	3,942	4,131	4,221	4,298	4,473	4,677	4,836	4,874	4,923	4,815	5,001	4,998	5,062	5,106		5,198	5,273	5,270	5,257					5,218
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			1,396	1,412	1,409	1,410	1,307	1,398	1,540	1,571	1,554		1,732	1,958	1,927	1,911					2,116
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female																		1,144	390	385	412	484	1,294	440	448	466	483		529	549	529	582					545
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female																		3,187										4,230					4,551				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male								2,575	2,130	2,591	2,551	2,878	3,015	3,100	3,366	3,415	3,484	3,634										4,553					5,077				
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								120	106	121	130	120	300	323	302	329	456	687	392	364	325	433	767	443	439	446	395		455	474	469	488					611
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male																		970	224	210	227	301	834	304	297	292	310		341	357	348	379					398
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male																		861	1,051	1,029	1,068	1,122	916	972	1,009	1,026	1,018		1,081	1,081	1,082	1,103					1,122
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male								1,295	804	1,021	1,009	1,154	1,517	1,184	1,129	1,229	1,304	1,912	1,383	1,400	1,505	1,563	2,095	1,628	1,618	1,688	1,744		1,788	1,814	1,833	1,848					2,001
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female									636	599	637	652	8	2,442	2,325	2,418	2,395	3,221										3,873					3,725				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male																		1,071	879	845	891	1,028	1,117	883	877	894	892		958	982	959	986					992
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			87	160	101	127	698	270	274	271	292		274	268	277	281					347
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												7,371					7,791				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female																		2,519	2,327	2,276	2,294	2,395	2,684	2,376	2,445	2,489	2,465		2,622	2,680	2,726	2,675					2,799
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									202	102	94	210		95	88	112	128		317	310	332	336		338	328	312											
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex									48	62	48	44	31	170	158	164	139	383	168	189	170	210	590	194	195	165	132		254	188	177	189					184
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								55	60	71	66	66	259	303	288	286	268	365	239	300	257	343	407	328	318	322	327		459	481	456	471					478
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male								352	147	145	155	179	403	351	359	376	412	318	330	263	252	410	435	442	448	429	370		376	371	357	370					427
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								2,452	2,120	2,624	2,275	2,677	3,329	2,768	2,774	3,234	3,303	3,446	3,782	3,699	3,779	3,803	3,789	3,871	3,842	3,891	3,859		4,063	3,899	3,883	3,955					3,785
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												2,832					1,707				
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								55	305	302	309	305	456	1,022	942	984	986	999	995	1,008	901	1,168	1,053	1,150	1,129	1,079	983		1,220	1,227	1,196	1,228					1,369
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female								2,488	3,900	5,207	4,850	4,490	1,487	5,699	6,235	6,818	6,773	6,455										10,100					10,461				
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			1,422	1,476	1,509	1,522	1,725	1,532	1,559	1,588	1,571		1,775	1,787	1,780	1,856					1,813
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								2,452	944	1,198	1,044	1,292	3,193	1,343	1,336	1,691	1,790	1,787	1,981	2,024	2,113	2,196	2,420	2,283	2,315	2,415	2,471		2,543	2,529	2,512	2,512					2,410
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								2,452	2,026	2,494	2,304	2,643	3,127	2,661	2,920	3,302	3,381	3,452	3,801	3,876	3,922	3,962	4,163	3,976	4,230	4,277	4,223		4,733	4,965	4,917	5,211					5,428
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												1,607					1,337				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												8,149					7,419				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female																		1,798	924	874	927	986	2,023	1,004	1,010	989	1,004		1,110	1,154	1,045	1,195					1,142
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			2,814	2,978	2,980	3,017	2,731	3,030	3,109	3,146	3,179		3,228	3,496	3,477	3,467					3,544
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												933					887				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			790	876	941	916	962	905	922	1,010	998		1,080	1,093	1,182	1,084					1,319
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female									284	287	266	294	120	965	902	949	941	1,233	977	971	926	1,081	1,325	1,064	1,090	1,049	1,054		972	995	977	974					1,156
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												1,884					1,992				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male								144	192	267	344	455	169	522	574	618	656	888	688	657	748	762	1,023	807	733	774	809		844	733	775	805					626
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female									322	313	320	328	150	1,097	1,038	1,051	1,042	1,234	1,050	1,060	960	1,184	1,332	1,182	1,172	1,136	1,114		1,178	1,196	1,203	1,204					1,390
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex																		333	136	107	135	183	261	164	147	141	143		150	168	144	178					148
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								1,295	1,043	1,265	1,256	1,410	1,517	1,489	1,496	1,617	1,665	1,918	1,796	1,954	2,070	2,177	1,965	2,272	2,219	2,269	2,284		2,327	2,268	2,289	2,292					2,185
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex								18	65	59	34	43	231	24					12									2					8				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			371	328	318	399	166	370	372	421	420		441	449	495	439					500
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,530					1,706				
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								2,452	1,588	1,913	1,680	1,952	3,329	2,079	2,084	2,543	2,624	2,528	2,871	2,890	3,005	3,092	2,985	3,159	3,070	3,162	3,154		3,250	3,179	3,207	3,183					2,915
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female																			719	576	611																3
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male								788	144	190	201	247	1,116	278	307	344	363	765	408	431	464	493	965	521	514	541	564		635	660	673	683					758
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			1,391	1,437	1,421	1,414	1,042	1,396	1,624	1,610	1,915		1,964	2,164	1,958	1,890					2,032
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								208	141	194	169	247	586	267	209	275	290	686	310	279	316	342	629	392	348	368	393		458	385	398	413					402
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male								352	98	103	116	116	660	303	292	320	332	593	328	324	308	410	772	421	418	411	357		465	473	458	478					633
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female																		1,957	1,873	1,844	1,898	1,981	2,170	1,943	1,988	2,125	2,127		2,260	2,285	2,343	2,297					2,395
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex								561	156	226	225	300	634	303	319	372	371	2,102	428	439	449	448	995	456	459	468	455	918	506	525	500	510	1,115				517
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												788					658				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female																		2,166	1,687	1,626	1,696	1,709	2,497	1,651	1,691	1,631	1,661		1,798	1,852	1,785	1,881					1,835
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			3,019	3,091	3,091	3,093	3,558	3,128	3,279	3,304	3,268		3,771	4,136	4,118	4,258					4,489
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								309	230	323	306	388	647	394	344	398	423	823	372	373	393	398	582	415	318	324	301		314	263	263	252					254
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								55	33	35	33	33	231	125	110	122	119	337	116	131	114	149	381	131	135	120	133		164	163	158	162					172
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male								788	212	274	242	298	1,116	349	371	448	482	793	582	614	635	664	1,119	701	708	759	789		828	821	855	857					826
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								1,295	1,048	1,261	1,260	1,452	1,517	1,511	1,560	1,613	1,670	1,795	1,816	1,848	1,887	1,937	1,814	2,004	2,044	2,061	2,097		2,149	2,234	2,212	2,185					2,256
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male								352	134	160	180	158	452	344	332	348	359	562	369	332	337	437	822	461	470	485	411		606	506	508	533					634
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			1,466	1,412	1,538	1,657	1,428	1,572	1,602	1,680	1,688		1,807	1,840	1,940	1,840					2,001
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female																		2,339	2,188	2,209	2,224	2,204	2,790	2,166	2,239	2,244	2,251		2,467	2,504	2,389	2,516					2,349
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			43	120	56	100	178	216	209	215	285		187	193	210	214					261
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female								4,091	4,224	4,996	4,814	5,480	4,790	5,899	6,393	6,452	6,505	6,303										7,921					8,863				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			910	857	928	951	595	885	911	970	964		1,036	1,059	1,050	1,046					1,073
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex									61	58	51	50	55	210	197	205	199	392	217	237	187	266	547	251	248	233	192	645	276	262	244	255	573				252
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									6	5	4	23		15	13	9	16		13	2	1			2	2		17		2	85							66
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												14,316					13,780				
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,410					1,467				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								1,042	501	641	650	814	1,220	806	758	835	884	1,773	988	949	1,019	1,050	1,898	1,092	963	1,047	1,077		1,164	1,065	1,104	1,142					947
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex									15	27	16	14	16	76	76	76	54	136	66	78	68	127	235	118	109	100	77		311	155	161	159					116
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								788	780	977	877	1,020	1,688	1,048	1,088	1,238	1,285	1,318	1,456	1,381	1,393	1,426	1,607	1,449	1,432	1,459	1,466		1,643	1,634	1,598	1,672					1,700
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								4,038	2,384	2,792	2,664	2,871	4,729	3,045	3,194	3,258	3,297	4,269	3,556	3,770	3,835	3,845	4,594	3,865	3,978	4,020	4,015		4,102	4,342	4,317	4,301					4,593
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												2,473					2,573				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			1,176	1,251	1,262	1,291	946	1,307	1,425	1,436	1,434		1,458	1,601	1,600	1,591					1,683
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								788	665	804	693	800	1,248	852	844	1,000	1,030	1,187	1,166	1,198	1,230	1,253	1,487	1,290	1,291	1,337	1,324		1,424	1,395	1,413	1,447					1,323
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			835	711	837	885	856	539	527	495	360		357	378	373	390					474
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			649	708	711	716	528	727	775	776	771		771	873	886	894					941
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								120	111	111	114	100	300	385	347	364	302	689	382	371	342	445	754	459	454	422	372		447	471	443	460					553
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male																			254	206	213																
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												2,041					1,835				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male																		1,190	577	574	631	744	1,190	704	723	699	723		782	789	745	823					780
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			800	819	823	824	651	828	868	886	880		1,046	1,159	1,158	1,166					1,285
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												2,780					2,739				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								4,038	2,278	2,863	2,761	3,034	4,729	3,198	3,037	3,256	3,416	4,236	3,695	3,724	3,793	3,918	4,445	4,075	3,841	3,947	4,014		4,175	3,847	3,901	3,936					3,655
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												5,289					5,522				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			1,262	1,456	1,386	1,375	612	1,378	1,486	1,495	1,496		1,564	1,801	1,772	1,760					2,016
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex								513	238	325	270	371	600	400	338	358	428	863	445	393	409	449	1,300	473	358	373	452		420	264	275	280					217
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			386	407	392	455	627	510	539	609	614		664	678	753	667					736
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								4,038	3,003	3,604	3,461	3,790	4,729	3,941	3,928	4,105	4,241	4,504	4,525	4,584	4,635	4,765	4,707	4,853	4,746	4,838	4,850		4,989	4,947	4,946	4,982					4,953
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male								55	310	295	288	314	5	1,121	1,032	1,101	924	1,887										2,201					1,376				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			1,510	1,628	1,682	1,721	1,559	1,761	1,753	1,778	1,793		1,808	1,915	1,902	1,906					1,954
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								635	511	688	612	826	2,147	883	788	1,056	1,143	1,454	1,218	1,244	1,354	1,435	1,601	1,508	1,344	1,443	1,502		1,595	1,401	1,434	1,468					1,267
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												2,186					1,876				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex																		358	266	263	264	375	386	289	301	300	328	542	342	356	346	357	638				377
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male																		1,209										2,680					2,789				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			1,870	1,977	1,982	1,970	2,274	1,982	2,041	2,055	2,060		2,081	2,234	2,230	2,223					2,465
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			271	284	278	339	144	329	336	377	372		390	387	430	384					424
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								4,036	1,262	1,606	1,531	1,789	4,726	1,854	1,711	1,865	2,002	3,863	2,099	2,026	2,097	2,181	4,121	2,295	2,063	2,142	2,216		2,295	2,122	2,171	2,212					2,279
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			1,712	1,533	1,771	1,825	1,463	1,141	1,109	1,098	981		898	921	914	928					1,069
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									100	40	37	46		43	41	40	53		106	100	109	112		106	103	98											
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									465	292	222	196		189	175	266	429		142	114	109	101		97	76	62											
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male																		191	173	179	202	241	192	200	211	209	213		227	241	224	247					257
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male																		495	194	185	196	247	454	207	231	272	283		324	315	324	329					340
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			587	674	718	747	363	640	646	684	677		699	721	765	713					794
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			992	1,034	1,046	1,032	507	1,027	1,172	1,174	1,237		1,361	1,505	1,410	1,349					1,505
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												925					926				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												14,496					14,535				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex																			16	8	15	15		4	5	3	4	14	3	5	4	7	12				23
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			99	199	136	180	325	441	444	441	581		290	304	316	346					427
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												3,624					3,753				
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			233	418	189	366	493	564	563	534	601		437	430	437	454					497
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male								1,295	267	359	388	537	1,517	636	634	723	823	1,671	866	846	932	986	1,886	1,022	1,029	1,082	1,108		1,160	1,147	1,179	1,196					1,268
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								592	195	277	268	358	814	373	422	481	491	1,503	541	532	533	523	838	528	560	572	477		479	493	472	459					455
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female																		395	218	209	225	264	637	234	242	228	238		260	270	246	260					237
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												3,444					3,146				
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male																		1,182	356	367	377	460	1,100	419	433	415	425		470	487	487	509					537
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex								922	631	695	675	717	1,080	752	730	765	807	1,836	876	933	960	1,047	1,800	1,074	1,053	1,058	1,082	1,087	1,124	1,065	1,044	1,039	1,184				978
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex																		367	258	245	247	332	331	269	273	282	277		310	313	280	308					293
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								341	330	420	390	439	399	444	432	462	473	873	498	520	524	535	1,028	551	540	553	554		583	608	595	617					646
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male								1,295	460	560	572	820	1,517	844	940	1,053	1,143	1,838	1,225	1,306	1,407	1,509	2,303	1,581	1,518	1,572	1,606		1,679	1,667	1,695	1,700					1,588
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												1,838					1,605				
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex									1	2	2			2	3	2	8			13	6	1		3	3	2	5		148	24	107	55					
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								55	227	250	249	216	497	810	744	710	668	759	715	734	660	832	808	832	826	786	688		1,043	1,045	1,036	1,033					1,198
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			1,136	1,170	1,167	1,167	1,428	1,195	1,287	1,287	1,295		1,524	1,599	1,582	1,646					1,747
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			84	147	71	146	275	281	288	290	304		201	225	212	216					277
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								55	146	170	170	136	210	485	486	500	476	572	487	538	499	629	627	620	592	536	514		790	783	780	790					914
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			613	665	668	671	339	672	759	755	755		786	902	897	877					982
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												1,020					1,132				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												2,240					2,473				
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			2,106	2,229	2,224	2,228	2,960	2,227	2,423	2,433	2,424		2,736	2,882	2,872	2,886					3,255
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												6,490					6,967				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex									40	35	39	35		9														22					18				
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												4,019					3,384				
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male								352	165	196	195	196	497	425	443	486	496	444	412	368	401	539	680	590	633	605	501		510	557	558	574					754
West Africa Region 1	Senegal	SEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												920					785				
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												1,541					1,626				
West Africa Region 1	Togo	TGO	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex								972	520	618	556	600	1,139	606	581	627	693	1,296	752	776	786	832	1,292	867	812	798	816		815	777	750	740					667
West Africa Region 1	Burkina Faso	BFA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male								136	83	120	111	154	158	163	159	181	198	647	213	211	225	244	436	250	227	238	253		304	297	280	282					264
West Africa Region 1	Benin	BEN	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			560	580	549	608	526	610	621	665	677		728	738	799	744					813
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male																		356	36	38	38	33	265	25	28	28	22		33	25	28	28					40
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												261					793				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male																		109	43	31	49	38	113	35	37	27	22		35	27	24	31					30
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male								182	22	17	36	25	246	35	42	27	28	204	24	29	36	34	302	33	36	42	36		39	39	37	31					26
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex																		129	12	11	7	13	32	4	4	12	9	127	12	9	5	11	192				8
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																									14	10	20		23	17	9	14					17
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female																		68	92	77	77	90	104	92	90	76	66		90	79	60	61					58
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female								141	46	51	37	57	66	25	27	31	24	289	31	20	19	19	175	33	25	30	23		21	13	11	21					16
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male								175	10	8	10	11	413	17	11	10	10	47	4	1	3	14	39	11	5	12	8		12	6	11	13					12
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												384					283				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								39	32	36	26		35	38	29	18					15
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												118					328				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex									2	1		1			1					1	1							22					18				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male																		78	8	7	14	14	50	10	8	10	14		12	11	8	9					10
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female								1,645	233	258	249	312	787	182	134	199	128	421	158	99	128	120	342	139	122	118	95		100	94	79	87					67
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								570	111	94	81	94	464	126	127	134	135	86	93	99	78	78	232	72	77	97	80		86	68	74	60					59
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								14	14	6	8		17	7	9	8					9
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								33	30	32	23		27	27	15	13					17
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								21	28	17	15		14	29	14	11					14
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female																																1					1
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male								175	45	34	37	52	355	92	86	65	67	244	34	28	20	47	250	40	56	38	36		52	44	30	47					50
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male								525	57	77	94	168	254	103	90	102	99	541	68	65	79	76	253	60	59	61	41		59	49	56	33					36
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												209					210				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								17	18	18	8		16	10	12	6					14
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female																		341	78	83	68	78	146	72	64	77	80		85	76	67	54					65
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female								26	7	8	3	3	185	28	34	24	30	29	20	26	22	33	50	25	32	29	40		28	34	34	40					26
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex								129	7	7	6	4	140	7	8	12	12	1,580	12	15	14	27	142	16	9	8	10	247	18	11	13	9	266				8
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								18	22	24	21		28	31	13	24					18
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								6	10	7	7		3	6	10	4					11
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								14	19	20	15		12	21	14	14					14
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male								182	29	22	35	41	246	57	39	47	53	194	46	52	44	35	318	52	49	60	60		50	41	66	42					28
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								10	4	12	6		10	10	9	4					7
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex																			12	4	6	1		1	2		3	14	4		4	3	12				3
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												199					255				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female									6	20	10	6	5	70	64	68	52	65	52	58	53	75	366					160					451				
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																									27	14	18		22	24	24	14					18
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male								182	57	53	54	50	246	48	67	66	61	171	48	50	43	38	275	68	49	49	71		42	62	61	65					45
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												174					167				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male								58	34	56	98	112	29	81	83	51	54	425	39	46	79	37	156	62	55	47	38		41	44	49	43					15
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male								22	18	8	23	30	141	20	28	21	23	198	22	25	18	33	218	34	23	22	32		26	29	25	23					17
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex								395	72	54	46	78	191	37	31	66	72	357	64	57	52	64	23	48	45	23	27		15	32	24	15					17
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female																		184	84	90	91	82	120	95	71	60	70		75	67	66	76					54
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male								362	105	86	70	70	235	77	75	125	92	140	91	82	88	76	99					988					1,015				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex								376	46	37	55	44	180	23	19	44	61	687	45	64	59	86		59	61	38	57	71	34	36	29	18	101				21
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												397					401				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male								526	164	156	164	171	254	111	104	119	87	569	107	119	125	127	226	86	92	80	60		79	73	57	51					44
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male								29	4	7	8	9	35	4	8	4	11	272	10	9	6	21	109	12	11	7	9		5	5	3	4					4
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												291					129				
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								569	86	66	68	64	399	87	86	131	109	71	70	79	59	55	334	55	53	48	53		59	66	52	55					47
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																									13	18	16		13	17	14	10					5
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												597					224				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								26	24	26	38		45	34	23	24					33
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male								1,048	182	207	202	238	501	145	131	114	129	312	114	166	178	140	159					310					577				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								7	8	7	6		13	11	4	9					5
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								60	11	2	3	6	200	21	20	11	22	96	12	14	14	15	81	22	14	22	24		13	19	14	22					19
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												653					571				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												170					145				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female								26	11	13	6	10	304	52	35	54	47	32	40	42	30	48	76	25	33	39	51		43	41	23	43					34
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female									10	2				3	1	1																					
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female								570	134	89	141	127	597	118	134	167	143	36	139	129	121	95	333	118	112	150	135		126	104	115	104					109
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female								570	157	119	155	154	623	137	168	174	144	51	135	141	132	112	103	117	87	111	107		97	119	123	95					90
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												453					459				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												16					26				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								75	63	51	47		44	48	39	22					33
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female																		376	43	52	44	58	150	56	44	43	62		41	49	50	45					37
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								6	4	4	10		8	11	12	7					15
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male																		421	39	32	25	40	250	21	25	21	35		36	22	29	33					17
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex										1	2			7	1	3	1			4	1	2		1	1		5		2		1	1					
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male																		166	39	35	44	34	167	37	31	43	36		48	47	28	33					29
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex																		8	17	24	22	17	43	24	19	15	11		14	22	15	12					10
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex								72	57	17	23	17	143	22	22	40	39	208	47	36	41	27	99	32	26	36	29		27	33	31	33					31
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								13	13	16	13		26	19	10	18					15
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female								570	133	125	129	139	623	131	160	136	143	68	126	117	106	79	141	81	104	93	84		99	101	82	76					69
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex									2	2		1	10	14	14	10	10	35	7	9	12	19	101	13	8	8	18		15	12	11	5					23
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								82	36	31	32		32	28	25	27					19
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female								1,645	329	378	320	405	788	233	253	255	184	276	194	174	198	177	300	184	163	147	110		165	111	114	121					81
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male								26	9	7	7	11	3	32	39	47	39	153	30	21	30	40	162					106					63				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								26	28	21	16		33	24	18	14					17
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												32									
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								19	11	7	17		15	22	19	11					10
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								84	81	66	52		67	50	39	45					45
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								1,646	215	188	177	213	788	110	130	116	102	88	106	134	130	99	418	98	82	82	61		73	66	48	49					56
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								526	139	127	141	208	254	82	89	95	80	279	87	123	104	97	56	104	71	57	50		58	77	34	34					51
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												326					195				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								526	124	134	180	183	254	102	127	136	108	437	108	139	171	149	88	116	97	78	45		78	68	63	50					57
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												404					178				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female								1,668	339	331	277	374	797	195	179	176	166	128	174	176	191	131	396					188					876				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												899					579				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female									7	9	7	11	100	34	41	41	32	24	36	20	21	35	125	33	29	29	42		43	39	39	40					32
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												690					620				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male								175	5	9	14	9	440	32	28	28	14	201	21	25	21	33	194	16	17	16	23		29	21	28	22					30
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male									6	1	1	11		4		1					2											2					
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male								175	50	37	48	46	288	134	61	53	111	130	19	12	21	68	126	34	31	35	35		46	31	27	29					42
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												82					1				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												120					158				
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												139					157				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex										2			33	11	8	5	7	98	3	13	8	4	165	7	6	2	10	84	9	7	5	7	156				6
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																									8	3	10		20	7	10	16					7
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female								26	8	16	6	12	150	36	42	57	34	60	33	29	45	45	68	31	38	21	48		37	30	30	35					43
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								31	36	33	31		23	39	37	31					23
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female																		139	43	53	45	56	69	43	44	46	35		55	49	44	40					26
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																									9	18	10		14	9	11	12					4
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female																		220	70	71	70	65	80	60	69	61	53		48	62	47	54					56
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female								573	120	88	72	77	165	109	100	141	133	132	108	106	75	70	844					704					780				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male																		245	44	51	58	45	221	38	36	36	38		56	28	32	44					32
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								1,646	288	287	304	317	788	206	205	171	163	99	155	141	140	117	441	129	105	104	96		114	90	94	61					79
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female								26			2	4	165	7	10	11	11	17	9	6	7	9	51	7	11	10	14		7	5	9	12					
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female																		214	70	69	69	59	135					366					467				
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male								91	18	23	42	37	44	21	22	6	20	398	10	13	17	12	59	15	11	15	16		7	8	10	4					7
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex										2			19	8	9	10	11	122	5	3	4	8	217	9	8	6	6		14	5	4	18					11
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male								175	31	17	26	15	323	64	44	29	28	300	23	19	16	23	276	23	28	18	33		20	35	31	38					27
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male																		133	43	56	48	47	133					217					229				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												74					111				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex																		133	19	17	12	13	44	10	12	6	12		25	17	15	11					5
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex											3	5	50															2					8				
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female								50	29	15	30	30	110	23	20	37	15	14	26	14	22	33	196	38	28	23	28		30	29	32	38					20
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female								146	105	82	129	107	402	107	87	134	106	30	122	103	121	100	307	120	116	107	88		124	107	112	102					83
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex								206	91	70	61	100	99	54	43	58	71	360	61	49	52	47	464	45	39	41	26		38	29	19	17					19
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								104	38	29	38		51	54	34	30					31
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female								1,646	365	369	333	425	788	216	230	268	206	154	192	185	189	173	300	153	153	118	86		130	144	116	87					55
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								182	58	35	42	47	275	54	64	70	56	121	44	66	46	38	227	44	63	47	63		46	52	65	49					44
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								18	15	18	13		12	13	13	17					12
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								182	34	37	52	57	372	47	50	71	83	79	48	39	42	35	86	30	48	38	51		39	47	45	26					32
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male								525	101	87	113	186	254	129	140	149	106	627	63	110	116	118	512	85	67	57	70		84	67	59	34					36
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female																		141	19	17	13	18	235	14	7	12	13		15	12	12	13					9
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								11	7	10	8		6	13	15	21					14
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												308					306				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								11	5	7	7		7	4	10	11					5
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												278					276				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								14	17	14	11		9	11	13	18					22
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								18	16	18	13		21	19	17	16					17
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female								26	10	10	6	5	355	43	40	43	41	54	40	32	31	34	66	46	46	31	23		35	40	24	25					47
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female									17		5	10		4		1			5	3	3											4					
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female									3	6	3	7	80	32	37	34	37	25	16	18	18	27	118	18	32	24	35		30	24	23	30					33
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female								426	107	121	98	186	202	91	98	85	76	429	92	86	88	67	164	73	77	85	63		99	87	69	73					43
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												105					154				
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																									8	13	10		7	20	10	6					11
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												625					610				
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								17	10	12	13		12	17	12	11					12
West Africa Region 1	Togo	TGO	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												371					291				
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								59	10	15	6	6	200	28	24	25	20	152	15	21	20	18	96	25	21	21	21		25	21	22	22					19
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex								137	19	13	8	4	180	14	10	22	23	896	21	24	25	21	92	22	14	13	11		17	20	16	10					9
West Africa Region 1	Benin	BEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male																		277	23	24	20	27	163	20	30	24	29		44	17	29	23					33
West Africa Region 1	Burkina Faso	BFA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male												1		2	1	2																					
West Africa Region 1	Senegal	SEN	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												728					721				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									258	109	179	273	2,917	324	557	939	1,376	3,312	1,750	1,767	1,516	1,871	3,730	2,321	2,747	2,957	2,949		3,177	3,661	3,796	4,038					4,332
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												1,332					1,446				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									262	119	240	304	2,846	347	646	1,069	1,399	4,123	1,830	1,866	1,669	2,094	4,219	2,597	2,732	2,934	2,941		3,125	3,373	3,469	3,522					3,530
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												781					781				
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									10	10	19	19	194	62	58	52	51	345	76	71	84	79	365	98	111	142	149		186	216	240	284					252
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									27	32	46	49	337	76	95	110	103	459	143	133	156	172	670	187	219	211	208		228	281	308	356					362
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male																		349	86	141	129	121	374	116	137	151	172		194	210	234	238					262
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male									60	76	61	107	245	125	205	185	236	759	245	286	301	282	770	311	313	354	355		378	416	430	449					440
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									22	22	73	41	1,011	30	64	142	325	893	233	234	207	303	1,142	392	444	498	540		567	616	676	623					728
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female																		2,988	2,434	2,853	2,552	2,635	2,968					3,800					4,064				
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									15	17	26	35	228	74	75	73	76	622	118	105	127	124	689	147	166	174	160		186	257	278	304					337
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex										1		32	209	1														2					6				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																			12	124	2	4		2	2			10			2	3	10				7
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									2	3	4	7	173	24	23	18	18	321	49	38	46	49	338	44	46	49	69		63	87	93	105					90
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male									24	42	49	82	156	101	237	360	487	661	512	529	594	601	763	647	649	590	628		692	559	608	655					676
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female																		2,012	1,151	1,250	1,355	1,388	2,038	1,107	1,108	1,178	1,244		1,346	1,384	1,414	1,526					1,583
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												856					960				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								373	407	510	514		559	573	584	565					662
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									44	68	100	115	91	276	261	254	252	1,187	419	288	332	329	1,188	371	443	523	556		450	573	618	663					665
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								2,683	945	893	990		1,074	1,260	1,335	1,347					1,371
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																									1,137	1,198	1,194		1,231	1,488	1,397	1,270					1,463
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female																		1,832	1,453	1,618	1,616	1,664	1,815	1,467	1,498	1,691	1,757		1,857	1,884	1,850	1,939					2,136
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								642	676	779	794		837	846	846	881					939
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex									69	13	7	5	739	43	144	156	164	1,035	160	152	157	181	667	237	260	275	234		250	286	266	278					303
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,263					1,309				
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												821					764				
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								641	581	672	668		716	795	810	798					741
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												1,815					1,533				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																									1,027	1,087	1,075		1,175	1,440	1,486	1,490					1,670
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									73	86	93	146	368	170	218	229	293	708	327	343	415	428	893	430	406	417	434		477	476	476	475					505
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									234	346	339	538	1,399	527	901	942	1,154	1,607	1,279	1,380	1,517	1,542	1,555	1,626	1,613	1,739	1,753		1,884	1,862	1,870	1,909					1,864
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male										267	4	3		2	8	10	22		29	32	33	37		32	35	33			9								
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									25	30	80	71	1,131	79	145	225	480	1,094	378	399	351	510	1,310	617	697	742	773		776	869	923	856					895
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								1,764	1,726	1,812	1,839		1,964	1,950	2,003	2,016					1,924
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									57	77	125	114	114	270	271	243	258	1,188	452	343	359	365	1,192	409	464	515	536		528	686	736	812					794
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								376	434	436	492		402	525	562	632					608
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male									21	26	43	48	301	61	73	85	81	268	116	119	123	118	362	121	118	143	188		145	170	188	228					233
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									49	77	73	114	1,399	134	327	526	719	1,486	832	940	1,065	1,150	1,882	1,203	1,306	1,333	1,372		1,483	1,348	1,414	1,489					1,461
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									30	39	67	76	371	205	199	170	164	720	269	209	236	241	727	259	277	302	292		432	580	652	706					664
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												5,634					5,539				
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									496	728	762	1,196	4,360	1,178	2,014	2,141	2,431	4,098	2,691	2,828	3,139	3,222	4,118	3,347	3,242	3,500	3,532		3,840	3,813	3,797	3,878					3,729
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												7,398					6,725				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex									75	9	36	4	588	52	128	132	131	698	103	96	101	132	410	149	95	123	116		134	107	101	119					112
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male									50	63	100	105	4	243	250	234	240	1,783	382	320	336	419	1,809					1,996					1,251				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male									8	17	50	53	1,011	12	35	78	177	645	124	167	175	202	814	261	278	302	332		357	429	500	412					515
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female																112	126		114	93	101	93			65												
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									633	979	985	1,538	4,360	1,565	2,649	2,687	3,121	4,290	3,414	3,620	4,109	4,106	4,317	4,248	4,151	4,392	4,424		4,770	4,544	4,570	4,697					4,548
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male																		1,110	1,496	1,822	1,583	1,656	1,137					2,409					2,508				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female																		1,581	597	628	699	688	1,665	624	635	671	712		777	803	818	916					919
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									123	190	167	268	1,399	291	564	684	859	1,583	937	1,010	1,127	1,159	1,721	1,267	1,318	1,363	1,443		1,571	1,488	1,516	1,572					1,587
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												13,251					13,309				
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								108	125	144	140		114	139	167	198					190
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								2	18	10	2		3	8	2	134					147
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																									795	959	860		914	1,100	1,203	1,222					1,322
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex									42	1																		18					14				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												2,202					2,294				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female																		2,234	1,684	1,762	1,721	1,781	2,285	1,561	1,559	1,690	1,764		1,931	1,950	1,933	2,092					2,115
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male									31	35	53	59	371	102	107	135	133	361	160	159	205	210	548	200	215	232	245		230	300	306	379					447
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									53	76	107	106	347	289	267	266	268	959	371	323	343	363	966	405	440	484	444		542	687	746	834					786
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								243	247	302	323		323	323	320	314					377
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									52	33	171	80	2,926	72	219	376	449	1,717	584	604	547	815	2,101	994	1,127	1,211	1,261		1,304	1,440	1,544	1,397					1,369
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								163	176	180	191		173	214	236	261					264
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male																		959	674	656	755	836	987	610	609	650	676		727	749	727	813					845
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								693	700	830	833		901	927	909	931					1,085
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female																					502																3
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male														1	4	2	3		32		1	1					5		1	46							46
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,353					1,515				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex																		286	268	200	192	267	348	183	177	206	217	467	246	236	256	279	535				299
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												1,770					1,644				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									26	9	64	7	537	14	38	61	98	658	89	81	84	106	506	149	163	182	204		241	222	232	237					250
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												721					598				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																									793	828	823		870	1,048	1,068	992					1,090
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												2,447					1,512				
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female									823	1,310	1,362	2,144	4,417	2,143	3,422	4,346	4,987	6,049	5,499	5,807	6,376	6,512	5,757					7,245					7,926				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									63	7	25	5	575	27	94	120	135	1,287	167	169	165	181	795	213	227	235	249	777	311	328	331	324	955				340
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												1,470					1,231				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								1,199	1,215	1,370	1,392		1,504	1,547	1,525	1,564					1,786
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male									1	2	5	6	431	20	23	24	19	233	37	28	37	43	256	42	45	56	80		84	96	136	149					72
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male																		977	246	286	287	245	942	268	281	286	298		322	338	352	389					428
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									193	221	196	276	997	295	435	373	444	1,453	538	570	647	703	1,139	753	758	793	820	981	892	867	825	831	1,061				847
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								274	292	347	345		362	380	359	360					447
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												13,062					12,567				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male																		783	749	820	843	932	814	703	737	795	803		849	882	889	904					966
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								2,618	2,525	2,737	2,763		2,977	3,081	3,097	3,115					3,035
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								1,338	1,192	1,382	1,390		1,477	1,601	1,577	1,608					1,555
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									444	568	606	881	4,360	895	1,759	1,904	2,285	3,975	2,502	2,768	3,078	3,177	3,750	3,279	3,238	3,270	3,385		3,668	3,218	3,279	3,387					3,454
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								1,129	1,088	1,259	1,273		1,363	1,417	1,429	1,438					1,406
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									645	898	916	1,374	4,360	1,398	2,529	2,480	2,971	4,293	3,266	3,481	3,900	3,953	4,170	4,015	3,960	4,047	4,135		4,518	4,140	4,205	4,342					4,258
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex									20	82	78	75	554	50	141	138	177	662	189	219	265	290	1,072	288	288	252	270		307	168	170	189					218
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								613	598	684	688		723	766	769	777					767
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												3,141					2,856				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									12	8	67	43	1,011	19	50	94	215	675	167	191	181	260	952	311	349	380	414		430	523	589	497					538
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												800					677				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female										776	2	4		13	9	15	64		75	89	83	97		81	87	88			30								
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male																		1,036	429	459	458	504	1,038	459	477	490	530		583	599	598	638					679
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								209	246	260	320		218	257	268	314					279
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex																		292	200	165	171	216	288	154	156	182	177		198	194	214	235					264
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male																		149	123	117	135	116	164	109	119	136	134		148	152	166	186					194
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female									1		7	7		1	2		1		68	5	6	2		3		1	10			28							52
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								476	480	561	561		628	609	609	617					729
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								4	20	4	1		3	11	3	235					208
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												1,960					2,200				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																					192																
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									2	4	4	2	43	47	50	46	34	350	102	59	79	81	463	86	92	110	97	569	122	136	121	153	487				132
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												2,531					2,481				
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												1,690					1,796				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												4,702					4,920				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																									1,623	2,043	1,691		1,852	2,186	2,231	2,302					2,627
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												3,267					3,242				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex																		320	71	87	77	82	228	75	75	70	81		74	82	75	109					117
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									17	27	34	29	228	94	84	80	79	639	131	102	118	126	671	138	158	169	172		187	243	262	304					308
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																			1	2	2	2			1	1			44	6	61	38					
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex										1	2	2	14	3	2	2	3	122	15	14	16	12	191	22	14	11	18		115	67	68	87					46
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									196	238	253	376	4,358	391	830	1,038	1,291	3,545	1,455	1,584	1,772	1,758	3,593	1,762	1,759	1,709	1,794		2,021	1,712	1,786	1,882					2,020
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female																		2,337	1,734	1,867	1,821	1,947	2,232	1,760	1,771	1,919	1,991		2,118	2,211	2,169	2,205					2,470
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female																		315	182	153	165	231	489	125	143	157	166		184	172	182	191					194
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								110	143	154	150		109	124	133	139					156
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female																		931	185	248	291	294	1,101	238	247	277	296		329	360	367	420					417
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male									419	683	727	1,111	2,779	1,150	1,815	2,232	2,544	3,374	2,797	2,900	3,328	3,471	3,285					4,108					4,520				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									29	13	117	38	1,967	34	88	167	271	1,396	298	304	354	472	1,382	597	531	573	668		740	723	801	718					628
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																37	39		39	34	36	28			20												
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								5,010	2,100	1,935	2,257		2,494	3,031	3,178	3,348					3,574
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												3,681					3,118				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									114	53	189	162	3,050	137	325	568	707	2,427	923	978	916	1,280	2,607	1,601	1,718	1,841	1,817		1,808	1,974	2,116	1,898					1,814
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								1,469	1,451	1,469	1,494		1,630	1,653	1,634	1,691					1,659
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									211	92	232	253	3,050	238	472	823	1,020	3,308	1,318	1,356	1,215	1,640	3,341	2,037	2,258	2,408	2,417		2,415	2,537	2,619	2,592					2,632
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												6,545					7,018				
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									8	12	27	25	502	73	81	88	86	517	111	114	123	126	659	141	167	191	189		185	259	276	335					368
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												5,790					6,249				
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												3,301					3,770				
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex									102	124	122	156	1,051	168	316	281	353	1,091	423	469	519	544	1,174	590	571	619	635		697	636	604	609					547
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																									583	613	593		653	833	878	879					1,000
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female									80	107	180	187	7	556	533	516	542	3,101	861	748	763	899	3,147					3,524					3,307				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female									391	149	229	366	1,396	523	964	1,903	3,158	6,195	3,603	3,809	3,134	4,206	7,783					9,109					9,423				
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male									32	7	8	10	143	18	41	54	42	501	75	78	71	104	380	121	123	134	138		181	193	179	181					197
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex										8	9	9	25	27	28	26	27	333	92	52	56	56	480	52	55	62	68		117	111	112	114					86
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male									98	90	134	198	966	289	504	952	1,041	4,197	1,805	1,921	1,666	2,188	3,164					4,961					5,546				
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												1,675					1,448				
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									69	89	82	153	1,124	176	345	441	545	1,515	615	678	783	797	1,624	826	801	770	806		919	800	831	914					1,051
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								996	991	1,116	1,108		1,187	1,229	1,220	1,239					1,193
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									182	296	301	458	1,399	460	798	898	1,116	1,652	1,215	1,325	1,516	1,619	1,624	1,780	1,828	1,904	1,953		2,074	1,926	1,944	1,994					1,927
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								269	297	346	343		307	340	360	422					423
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								486	484	543	560		594	594	579	598					697
West Africa Region 1	Togo	TGO	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male									24	38	37	60	1,399	84	259	418	543	1,362	582	631	736	776	1,520	809	885	878	938		1,003	922	978	1,034					1,002
West Africa Region 1	Senegal	SEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									19	28	44	42	157	113	112	107	110	537	188	162	191	176	563	187	194	232	206		311	407	467	506					495
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									32	21	75	73	1,530	112	175	302	462	1,240	518	533	491	614	1,459	754	816	874	882		952	1,101	1,180	1,187					1,248
West Africa Region 1	Burkina Faso	BFA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male									10	12	23	27	579	19	50	71	99	607	108	133	162	178	613	224	236	260	285		332	348	388	362					353
West Africa Region 1	Benin	BEN	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male																		740	133	156	192	177	701	188	194	198	203		222	226	243	266					305
West Africa Region 1	Senegal	SEN	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male																				1							22										
West Africa Region 1	Senegal	SEN	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female																				1							6										
West Africa Region 1	Senegal	SEN	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex																											6										
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male									68	64	26	5		23	9	78			69	7	5	8		25	6	9	5		74	59	67	78					117
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female																		279				191	279	62	22	90	278		107	113	55	23					252
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																24	3	79	3	3	14	11	432	11	54	18	54		76	38	1	10					6
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												997					1,097				
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female																		128				57	128	23	7	7	75		22	43	21	8					95
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												1,287					1,415				
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												730					803				
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male										4	3					9			2		2	12		22	9	8	4		59	97	79	70					104
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																		103				82	103	11	14	47	163		51	46	36	30					164
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female																		113				14	113	10	2	2	28		11	9	4						54
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												205					262				
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male																96	54	399	16	51	78	75	752	34	211	109	207		294	154	17	55					42
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												1,129					1,242				
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																		87				57	87	11	10	27	118		43	63	33	18					117
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female									19	102	23	17		24	19	37	55		24	9	4	15		25	7	8	3		43	84	85	84					74
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male									165	151	83	26		142	47	211			278	19	30	95		116	69	57	27		163	222	322	216					336
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																						1		1	1	2	11		2		1						11
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												574					863				
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male																		102				148	102	8	21	28	158		74	65	28	17					166
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex																						98							17	40	40	29					
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																		151				40	151	4	3	15	40		17	27	20	11					75
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												486					534				
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female									247	442	388	130		219	175	200	232		214	88	138	46		466	227	236	236		250	352	341	410					280
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female									199	388	365	234		393	356	489	541		289	213	258	300		361	362	296	329		409	625	691	834					642
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male																		49				22	49	1	2	2	17		6	22	2	9					53
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																16	8	158	8	6	27	33	503	3	100	47	102		131	67	3	14					13
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												126					166				
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male															3		4			3	1																
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male																		64				34	64	5	2	10	72		23	19	25	22					72
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male															7	208	161	267	41	78	111	107	542	82	286	130	295		413	148	22	37					58
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female																		295				145	295	29	29	63	180		56	69	46	8					153
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male									5	20	8	4		18	10	77			43	2	11	47		24	15	8	3		88	183	128	214					297
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female															12	54	42	198	30	20	113	67	505	35	242	123	326		451	198	20	43					48
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male									56	42	34	11		43	18	214			133	15	52	124		133	51	28	11		168	235	223	245					451
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female									57	184	57	19		91	97	107	100		60	64	23	71		94	87	42	74		110	175	174	165					209
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male																						7					1										2
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male															17	54	32	25	10	27	51	36	209	21	69	52	122		177	29	1	6					10
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female															33	107	65	291	74	67	260	140	511	98	446	243	596		817	234	13	25					52
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female																		150				146	150	56	18	59	243		68	83	46	14					252
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												278					406				
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male																		40				18	40	6	5	4	29		16	12	27	3					46
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																9	3	91	1	4	3	6	219	8	61	19	71	194	98	38	21	15	213				9
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																		56				8	56	2	3	2	49	56	24	6	9	3	73				53
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female															2	34	26	111	20	10	27	29	397	10	151	64	191		237	131	9	24					25
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female																		175				77	175	18	31	22	122		49	52	35	14					85
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female									466	793	552	346		570	526	664	489		441	241	437	353		890	672	771	625		708	1,010	1,169	1,170					857
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																											16										
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												191					249				
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male									1		8	1		13	2	48			18		6	26		18	7	4	12		64	119	90	130					209
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male									166	139	70	26		123	33	271			189	19	50	111		179	89	52	26		177	289	369	265					513
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male									2	4	6			4	2	7			3		1	15		23	3	6	1		42	91	56	74					96
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female																						13		2					2								
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male																29	19	227	12	13	45	30	604	9	137	63	148		185	90	4	16					30
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												439					603				
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female															3	6	4	86	7	1	5	5	340	1	33	17	70		63	42	10	10					5
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female																		18				19	18	1	1	5	30	18	16	25	2		26				36
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male																17	1	86		3	16	10	256	9	72	16	40	191	90	36	2	14	210				4
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female															23	115	83	247	61	33	165	112	534	76	351	180	451		604	253	25	39					55
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male															20	260	168	71	31	116	183	114	350	98	328	186	307		416	130	10	27					42
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex															4								3		29	6	33	3	64		1	11	3				
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female									309	704	535	267		536	516	632	559		456	288	367	436		774	522	404	432		640	916	1,158	1,195					985
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female															24	25	18	153	17	12	54	50	287	27	159	88	208		329	75	5	10					16
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female																11	13	92	14	8	22	14	381	9	71	37	125		142	62	6	13					12
West Africa Region 2	Sierra Leone	SLE	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male																		77				94	77	4	6	29	56		35	36	11	18					90
West Africa Region 2	Ghana	GHA	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												929					1,023				
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female									98	289	180	70		198	166	164	247		151	189	89	118		169	146	150	127		208	348	408	391					331
West Africa Region 2	Mali	MLI	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female									13	95	5	15		15	22	30	34		18	3		12		17	22	7	3		47	108	79	66					64
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male								1,914	56	74	81	81	1,837	166	320	662	432	1,491	644	580	512	462	2,051	808	693	628	563		1,022	856	708	685					597
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male								298	21	26	33	34	1,582	72	269	392	394	390	463	458	470	335	1,588	612	663	429	534	11,641	911	805	651	568	1,538				516
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				2	409	458	487	3,096	744	521	561	345	719	415	331	480	457	2,144	636	614	591	589	1,475	587	613	350	460		512	506	567	524					578
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex									5	4	11	11	1,134	28	50	208	153	3,083	265	252	246	255	1,640	455	423	284	352		613	629	463	440					430
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female								662	2,466	563	189	683	2,768	1,018	1,870	2,616	1,996	3,482	2,854	2,527	2,813	2,440	2,596	2,203	2,513	2,171	2,700		2,492	3,288	3,235	928					3,263
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			2,048	1,530	1,536	1,342	1,319	12,185	2,391	2,184	1,969	1,661	2,293	2,018	2,008	2,033	2,111	5,365	2,931	2,570	2,571	2,750	14,769	3,193	2,704	1,756	2,504		2,905	2,115	2,048	2,108					3,578
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male																1					1											6					13
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male								2,119	284	430	282	338	6,778	610	909	1,272	1,031	1,010	902	949	873	746	861	1,292	1,216	1,053	741		1,425	1,195	1,093	928					553
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female												568	3,854	2,208	1,393	1,595	1,894	3,763	1,142	2,431	2,311	2,787	4,973	2,177	2,220	2,391	3,469		4,092	4,788	5,473	5,541					6,391
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												7,018					21,800				
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex												205		314	257	75	59		37	133	91	67		52	32	60	56		93	200	275	572					360
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												33,163					36,790				
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female												168	1,277	1,284	778	919	1,011	2,762	627	1,340	1,314	1,561	2,848	1,238	1,177	1,255	2,258		2,547	2,855	3,248	3,484					3,876
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female												268	3,885	1,142	709	809	1,122	3,314	640	1,403	1,226	1,442	3,848	1,309	1,416	1,507	2,228		2,602	3,087	3,175	3,333					3,714
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				752	588	641	651	4,384	911	869	504	541	1,864	487	493	518	586	2,263	778	723	790	759	2,867	1,014	981	636	872		937	617	665	860					1,011
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex																			4	1	1																
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				421	547	618	538	25,434	1,009	950	643	491	3,075	493	490	550	592	2,126	815	784	712	805	5,497	912	740	455	648		809	533	619	800					1,172
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												9,223					3,197				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												7,155					17,370				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male								1,066	1,752	574	377	849	3,882	903	977	1,214	1,105	2,919	960	1,044	1,407	1,655	2,487	976	1,830	1,412	1,762		1,728	2,275	2,761	1,536					1,717
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				1,295	966	1,048	1,006	17,392	1,424	1,808	1,024	909	2,494	871	878	982	989	2,912	1,531	1,410	1,326	1,401	8,720	1,642	1,767	990	1,308		1,511	995	1,080	1,592					2,049
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			901																																		
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male												3		8	5	11	6		9	17	10	9		2	3	12	1		10	21	22	19					5
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female								1,220	105	164	133	223	877	304	568	1,139	806	219	641	548	456	467	1,558	671	560	421	417		723	686	566	560					412
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			598	1,186	767	843	773	1,615	1,081	969	721	677	1,900	539	701	688	718	3,654	1,056	918	940	936	2,959	1,332	1,280	741	1,039		1,195	765	776	915					1,371
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex									142	47	23	360	870	155	655	724	803	3,082	729	681	918	922	746	800	938	839	924	3,774	730	645	702	277	12,650				781
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex															2																						
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female								2,902	440	872	774	1,174	4,401	1,233	1,785	4,572	4,269	1,913	1,868	1,968	1,676	1,685	3,854	2,138	1,612	1,363	1,305		2,287	2,060	1,860	1,753					1,204
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex									2	2				1		54	26		29	19	10	6		39	64	50	22		232	314	75	159					72
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male								2,516	114	193	174	165	4,257	398	923	1,243	1,139	2,002	973	1,157	985	921	1,940	1,297	1,236	1,116	964		1,416	1,199	1,060	917					765
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male												144	1,332	347	266	238	461	1,322	186	504	371	412	1,555	436	419	427	577		662	840	942	942					859
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male												390	2,515	531	412	403	643	2,133	328	803	610	726	2,259	817	807	816	1,003		1,125	1,407	1,658	1,686					1,662
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female								1,164	384	768	703	800	2,193	795	1,119	3,908	3,958	1,213	1,045	1,419	1,178	953	1,139	1,445	1,085	828	838		1,596	1,588	1,263	1,131					683
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			825	627	572	553	514	3,073	1,095	838	415	403	557	401	433	473	418	717	657	566	564	531	575	987	746	415	624		860	390	327	560					779
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												9,367					10,500				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			2,686	2,268	1,674	1,725	1,621	1,734	1,872	1,647	1,607	1,188	1,836	1,000	1,258	1,235	1,317	3,234	1,620	1,446	1,566	1,351	2,573	2,122	2,101	1,247	1,822		1,974	1,100	955	1,264					1,932
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								644	33	82	44	65	428	111	229	428	311	54	332	307	230	217	878	343	292	212	261		429	390	280	265					255
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male								803	1,700	427	215	534	3,154	496	424	634	729	1,813	600	584	789	966	439	705	849	747	957		782	879	1,076	580					844
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												6,257					5,675				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex				339	314	353	355	9,831	1,105	1,074	475	503	1,288	413	399	415	489	4,853	569	509	540	454	848	594	522	278	494	2,479	460	405	369	440	6,252				608
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male								909	683	127	102	341	3,006	493	861	900	965	4,727	971	734	1,352	1,452	3,017	918	1,705	1,169	1,264		1,318	1,598	1,762	1,264					1,649
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex												192		422	204	238	318	2,219	133	345	279	332	311	294	249	410	506		664	731	902	1,595					1,292
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								8	4	2			3	29							
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												9,469					30,323				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			4,238	3,524	3,346	3,099	2,987	12,789	3,975	4,142	3,804	3,507	4,111	4,100	3,996	4,276	4,202	10,473	6,066	5,445	5,266	5,790	30,612	6,876	5,827	4,193	5,853		6,117	4,681	4,514	5,001					8,682
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												3,470					8,846				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female								759	156	61	39	49	2,525	150	739	816	697	1,068	624	691	897	700	213	495	630	454	448		528	828	716	282					925
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male												145	915	261	176	140	180	998	94	285	215	306	675	354	237	200	293		458	550	637	750					796
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			149	2,190	2,220	1,897	1,584	20,039	2,365	1,320	1,466	1,259	546	832	1,027	1,106	1,210	2,167	1,857	1,441	1,637	1,772	7,453	1,937	1,426	856	1,219	943	1,518	1,138	1,493	1,898	2,375				2,938
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex									2	4	6	8	1,426	22	28	229	201	5,621	248	191	229	137	1,503	393	286	217	267	667	444	533	345	359	477				254
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												6,489					3,128				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female								1,068	2,427	512	233	905	3,495	2,387	3,424	3,836	3,389	5,176	3,448	3,231	3,625	3,418	2,891	2,823	3,700	2,806	3,654		3,654	4,442	5,098	1,563					4,401
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex									72	38	8	242	870	126	537	563	663	2,362	489	479	673	673	880	557	657	545	703		480	384	482	181					427
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												9,196					10,622				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			1,866	3,134	3,382	3,437	3,346	15,044	3,740	4,800	3,911	2,985	4,895	3,772	3,322	3,807	3,896	7,985	5,290	5,056	4,954	5,310	31,469	5,664	5,121	3,672	4,883		5,191	4,105	4,022	4,835					7,925
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex												500		1,079	582	480	392	2,708	270	493	289	424	27,194	426	389	316	770		749	1,064	1,320	2,649					1,967
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female								962	2,548	667	321	1,039	2,749	2,043	3,560	4,131	3,556	5,200	3,720	3,582	4,231	3,610	3,057	3,203	4,032	3,259	4,061		3,871	5,169	5,542	1,636					4,755
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female								2,359	871	1,542	1,311	1,710	3,898	2,076	2,862	7,382	6,732	1,926	2,678	2,724	2,268	2,192	2,871	3,107	2,339	2,011	1,943		3,489	3,279	2,942	2,719					1,502
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												2,818					9,685				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female								955	1,263	210	120	414	3,073	1,271	1,702	1,723	1,765	2,925	1,627	1,745	2,138	1,907	5,515	1,498	1,978	1,433	1,860		1,813	2,658	2,538	866					2,432
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			1,094	2,038	2,079	2,178	2,055	16,309	2,547	3,753	2,340	1,854	2,825	2,123	1,981	2,238	2,344	4,677	3,448	2,992	2,960	3,237	19,728	3,481	3,085	2,077	2,750		3,074	2,620	2,673	3,204					5,073
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female								580	33	40	28	49	1,454	117	1,047	986	983	2,198	1,301	1,020	1,234	1,121	2,209	844	803	626	672	6,102	681	1,218	1,112	485	3,518				1,579
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female								1,064	1,958	384	164	751	3,629	2,104	2,794	2,463	2,388	4,653	2,447	2,542	3,109	2,709	6,060	2,333	3,065	2,221	2,846		2,845	3,573	4,329	1,262					3,153
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male										22				96					23																		
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												20,122					26,258				
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												13,556					8,158				
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												2,525					911				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												48,096					65,717				
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex												108		339	210	218	292	1,974	135	406	267	338		323	287	293	493	3,927	569	705	795	1,125	15,286				976
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												22,767					23,359				
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male												94	1,145	278	202	162	260	795	152	345	225	308	962	254	295	278	352		410	519	601	594					548
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female												108	2,214	306	190	214	283	1,324	174	375	298	320	1,399	358	326	298	480		589	679	756	743					690
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male										55	1			25	153	266	259		457	76	25	31		6	54	2	6		1	14	6	8					6
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male												202	1,457	523	318	352	553	1,782	273	672	521	536	1,535	600	593	588	743		980	1,091	1,267	1,197					1,421
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female										56				2,957					33																		
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male								1,037	64	118	79	66	4,780	124	197	310	330	976	215	304	257	208	404	460	420	302	252		586	505	351	337					220
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex				40	40	33	31		145	38	120	63		33	18	32	155		66	153	43	42		71	54	48	49		44	21	166	40					
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female										63	20	1		25	183	92	80		208	127	74	55		14	5	2	5		4	13	12	7					6
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												9,398					8,791				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male								821	301	69	56	194	2,872	242	744	765	935	3,726	957	704	1,148	1,229	827	857	1,391	985	1,079		1,133	1,163	1,389	840					1,317
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female												224	2,348	635	427	473	581	2,095	320	933	703	802	2,386	734	830	773	1,187		1,469	1,645	1,795	1,881					1,843
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex									14	10	10	13	303	29	70	309	531	353	391	480	446	518	1,554	1,059	705	674	889		2,132	1,969	1,354	1,321					1,146
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female								3,830	797	1,338	1,197	1,472	5,485	1,757	2,419	6,079	5,980	2,660	2,581	2,563	2,297	2,178	4,282	2,663	1,941	1,766	1,624		3,121	2,845	2,466	2,210					1,515
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female												115	1,722	216	128	122	191	1,427	120	256	174	206	1,409	185	188	184	225		307	365	391	426					375
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male								1,066	1,510	378	247	686	3,777	864	1,065	1,329	1,293	3,987	1,122	1,095	1,542	1,747	5,663	1,078	1,915	1,672	2,145		1,962	2,268	3,006	1,814					2,172
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																																1					
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												4,570					13,682				
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												9,820					10,994				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				1,061	278	320	347	8,347	616	952	453	306	544	390	261	474	397	6,201	412	495	506	424	357	436	450	232	299		301	290	285	353					408
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male								537	25	40	31	61	1,265	90	849	962	1,021	1,916	1,082	839	1,040	1,363	60	1,021	1,008	905	1,132	5,569	784	866	753	383	3,744				1,438
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			205	1,426	1,376	1,142	1,084	6,482	1,721	1,305	1,048	1,015	540	881	859	1,022	954	1,233	1,576	1,327	1,422	1,611	3,222	1,690	1,474	860	1,180	8,055	1,341	1,138	1,608	1,723	2,440				2,217
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male								1,036	1,166	239	133	569	3,894	713	941	1,092	1,116	4,799	1,134	899	1,341	1,521	4,775	1,060	1,821	1,372	1,817		1,661	1,999	2,500	1,618					1,791
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			500																																		
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female												19		69	1	19	14		6	18	12	3		1	3	17	3		8	25	27	39					5
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												67,735					83,056				
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												14,041					14,528				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												7,014					23,860				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			2,339	1,880	1,371	1,411	1,131	2,074	1,584	1,313	926	885	1,283	801	1,031	1,070	1,051	1,613	1,469	1,309	1,316	1,106	1,464	2,205	2,035	1,281	1,663		1,742	939	764	1,085					1,644
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												6,592					9,652				
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female												328	998	493	333	327	421	372	265	586	299	414	256	334	342	333	470	4,595	556	701	721	756	4,646				619
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male												215	1,145	525	368	343	515	1,564	284	594	491	549	1,603	772	492	540	742		1,001	1,126	1,287	1,326					1,442
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												1,688					1,182				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												5,693					8,920				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex									15	8		111	870	327	629	547	647	906	501	573	754	710	1,549	626	554	439	478		379	353	530	212					416
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			3,849	4,156	4,247	4,425	4,035	15,940	4,492	5,275	4,595	3,964	4,755	4,552	4,118	4,661	4,803	9,057	6,647	6,038	5,932	6,313	36,037	6,690	6,235	4,227	5,936		6,205	4,731	4,509	5,277					9,548
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male								727	100	43	19	99	1,916	102	485	566	676	2,356	640	485	803	794	67	593	847	544	659		765	761	837	474					882
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male												304	704	570	423	374	521	1,139	318	678	411	506	923	384	466	525	529	3,898	772	855	991	1,010	4,508				748
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												6,958					2,232				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female								855	495	126	65	238	3,077	412	1,012	1,050	1,200	2,031	1,005	1,018	1,204	1,068	393	819	1,115	857	993		1,042	1,445	1,380	571					1,487
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male								545	25	25	18	28	896	85	208	340	278	570	329	296	252	198	953	385	307	249	278		512	441	373	331					274
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female								2,157	237	384	266	480	2,382	581	966	2,607	2,095	826	1,127	991	843	808	2,817	1,180	882	690	741		1,360	1,174	992	979					715
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male								1,038	38	39	47	42	1,135	98	271	387	405	950	496	457	396	333	1,697	567	474	423	413		758	689	530	522					378
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female								347	22	59	37	57	301	80	262	482	225	9	319	322	526	314	1,080	550	455	371	338	2,018	782	709	543	459	1,147				404
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male												475	2,515	721	514	540	875	2,072	428	800	722	827	2,118	948	788	803	1,049		1,251	1,633	1,827	1,840					1,988
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				450	466	480	426	2,751	702	792	388	395	2,154	333	376	417	414	1,280	595	577	574	547	2,374	774	702	352	545		612	449	459	615					834
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												6,486					17,482				
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex												2		111	211	125	195		197	205	319	215		348	147	114	98		80	97	130	23					83
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								35			1										
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			1,281	1,730	1,127	1,131	1,136	1,836	1,583	1,356	1,199	934	1,942	845	1,034	1,035	1,106	3,968	1,356	1,327	1,368	1,244	3,170	1,903	1,846	1,266	1,505		1,657	1,023	898	1,217					1,695
West Africa Region 2	Sierra Leone	SLE	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female												424	1,594	2,476	1,522	1,820	2,076	3,075	1,291	2,572	2,430	2,997	4,054	2,199	2,381	2,764	4,032		4,893	5,547	6,246	6,653					6,705
West Africa Region 2	Mali	MLI	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male								3,314	276	365	301	243	5,317	655	1,383	1,710	1,455	1,300	1,235	1,223	1,070	990	1,485	1,494	1,466	1,262	945		1,632	1,329	1,293	1,056					860
West Africa Region 2	Liberia	LBR	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												9,715					7,798				
West Africa Region 2	Ghana	GHA	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female																	1							1							1						8
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male								266	16	19	31	31	217	43	62	121	144	191	187	127	117	92	406	128	121	82	81		95	90	59	83					63
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex									4	3	9	8	144	7	15	42	43	405	88	55	52	52	338	60	41	38	39		48	37	32	31					42
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			77	25	15	31	41	405	18	39	11	7	78	6	11	18	6	86	21	9	21	9	59	14	11	13	7		12	5	9	9					8
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female										2	1				14	2	12		63	6	8	5		4							1	1					
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male												18	113	54	35	34	68	167	22	76	53	64	171	65	62	70	84		72	99	107	128					109
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												993					515				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male														1		1			1	1	1											1					
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												823					690				
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								97	166	35	18	64	300	58	33	46	51	335	45	47	36	25	159	21	39	16	32		24	51	35	14					34
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												1,269					547				
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female								154	17	38	49	36	324	30	62	100	119	156	76	65	64	42	226	61	59	40	38		38	43	33	31					32
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	<10	Retired Age Band	Missing Sex																										1											
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex									2			10	82	27	40	19	21	84	23	32	35	21	47	12	12	8	13		14	17	13	12					10
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								102	6	4	2	4	188	12	55	55	54	227	51	44	66	42	8	30	51	34	52		52	58	34	32					43
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female								133	32	11	9	26	299	37	92	76	100	265	93	100	99	94	36	66	95	86	84		67	116	83	64					77
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												253					352				
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			45	128	108	117	108	841	86	107	55	49	70	78	47	64	76	161	88	97	113	82	288	74	92	69	63	779	61	82	71	77	111				83
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												1,044					1,112				
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex										2	3	5	180	3	6	42	57	733	47	38	28	20	310	50	33	16	24	108	26	35	24	35	81				26
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male								139	123	37	16	33	341	41	16	22	26	174	27	29	37	23	28	28	23	18	18		15	12	15	6					15
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex												7		15	6	3	6		4	9	3	2			4	4	5		6	11	9	11					4
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male								280	22	32	20	42	888	47	63	74	113	137	101	76	58	43	172	69	79	70	47		42	44	33	45					18
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male								342	16	35	34	45	557	55	113	114	148	251	145	130	143	117	383	142	155	72	77		76	83	69	67					69
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			134	137	129	101	89	715	121	123	68	68	452	90	81	82	70	648	136	115	129	133	606	146	130	108	123		147	108	114	131					152
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												570					383				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male												2	77	8	2	2	3	126	4	12	11	11	51	10	7	6	10		13	11	10	17					22
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex												17		47	19	18	14	302	7	27	17	17	1,598	16	10	8	108		20	12	22	65					20
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								470	77	99	126	119	813	151	280	356	453	356	297	287	245	250	850	248	194	157	164		210	201	168	193					142
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												176					556				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female												37	319	115	47	103	139	157	70	137	114	114	160	106	131	136	207		185	225	228	269					210
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			38	213	184	176	129	1,230	128	112	90	84	68	99	77	93	97	147	121	133	149	133	700	140	122	95	117	109	129	120	119	159	116				140
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male												12	97	18	14	23	36	199	17	34	30	38	125	57	28	38	56		55	87	72	77					60
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male								173	71	42	13	68	441	69	131	98	84	461	59	64	91	73	433	46	126	92	102		101	84	79	61					71
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			190	255	221	228	168	762	178	163	115	108	568	161	109	124	118	616	181	197	171	175	825	146	140	137	159		154	124	115	163					160
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male												11	56	58	29	33	64	142	21	53	52	62	117	51	61	60	67	471	66	63	69	89	451				68
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												642					787				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male												31	213	64	51	62	93	262	37	94	83	73	209	95	82	90	84		103	103	125	158					182
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male								72	8	15	21	22	188	38	109	113	174	57	154	173	127	131	316	160	107	82	113	275	94	101	89	91	348				86
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												1,918					898				
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			149																																		
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			355	98	108	120	178	221	53	114	91	53	227	52	40	47	50	306	65	64	41	59	236	38	44	27	50		37	30	37	41					36
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			183																																		
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				84	92	108	100	1,892	93	105	54	43	374	80	47	66	52	141	96	87	76	78	475	76	66	61	78		81	59	58	73					81
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			175	101	96	86	142	222	83	120	97	88	235	58	41	49	54	426	52	50	60	56	304	47	56	54	51		63	50	43	50					59
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			154	220	207	204	168	957	132	147	92	115	354	119	108	93	108	404	148	148	138	144	648	141	125	113	112		145	115	98	125					118
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												128					606				
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex									9	5	6	9	38	19	40	102	133	48	65	105	108	116	325	111	105	93	89		89	91	64	98					83
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				1	27	16	32	399	26	42	21	9	86	28	26	30	27	218	34	54	26	49	86	52	42	35	24		36	29	30	15					23
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												282					235				
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								157	176	53	23	71	348	110	110	142	115	500	140	101	126	87	315	73	142	84	122		82	153	116	86					122
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex									17	4	2	30	82	26	33	36	29	220	13	16	33	12	48	7	5	5	12		8	6	6	2					4
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								123	19	4	13	24	279	37	94	76	67	357	50	53	86	81	80	59	104	77	55		86	77	63	49					62
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male								145	40	26	15	31	301	50	106	118	77	455	56	70	105	68	295	60	112	92	87		99	91	77	52					64
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												561					696				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												971					790				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												1,147					709				
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			270	217	204	183	168	982	145	163	115	95	501	134	111	128	125	709	174	164	165	180	720	195	160	124	190		158	143	128	158					181
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				67	68	93	74	352	48	85	35	32	285	46	36	34	39	170	49	56	61	43	227	59	46	27	34		49	47	42	43					38
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male										2					9	1	8		22	1		3					1				1						
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female								179	136	49	19	89	424	98	137	143	150	498	164	157	164	126	299	94	168	102	133		129	176	156	94					144
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male								93	10	9	14	14	106	27	61	86	102	75	107	88	73	85	195	85	93	57	51		69	70	38	55					55
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												357					436				
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												613					308				
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												331					426				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female												5		5		2	1			2	2			1			1					2					
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex														4	7	3	7		3	13	12	6		6	1		2		1	2	1						1
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male												22	213	76	50	51	95	269	52	83	68	97	302	101	100	110	116		135	140	161	193					146
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female										10				44					3																		
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male												9	97	21	10	22	46	104	26	35	33	39	113	38	38	46	58		25	56	83	75					76
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								288	42	64	54	85	319	124	213	333	279	116	244	212	227	216	554	223	191	111	138		145	162	116	131					113
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												1,465					1,297				
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female								311	46	88	106	125	577	121	196	353	320	258	223	207	160	138	572	221	174	145	126		156	139	145	169					114
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								104	12	9	12	8	246	16	62	46	64	164	58	68	81	51	21	42	47	52	40		29	55	40	40					41
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male								145	4	6	3	8	626	9	15	13	17	123	38	26	24	15	80	27	17	14	15		11	9	6	14					7
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female												54	322	207	114	192	213	220	102	241	230	288	335	209	227	203	290		319	314	367	403					390
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												604					1,016				
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male								177	112	40	19	71	428	85	124	126	100	384	97	75	100	72	432	69	110	105	127		92	81	99	72					85
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male												22	123	69	53	65	83	222	49	101	71	67	220	80	69	74	110		101	117	159	149					166
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												2,058					1,233				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex												7		12	5	5	6	283	13	11	10	4	21	9	4	1	12		12	10	19	35					22
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female								163	30	31	36	57	117	54	110	193	193	34	191	154	154	159	324	177	117	105	92		88	104	77	87					94
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				111	80	96	112	551	71	74	36	53	220	59	47	38	44	283	52	55	84	54	280	72	70	54	68		59	47	46	58					42
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								77	12	13	14	36	41	24	78	124	106	3	95	94	114	138	213	139	101	89	74	326	109	105	62	90	388				76
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												573					1,285				
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												461					671				
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male								427	24	52	35	41	696	53	122	126	152	172	119	127	98	79	295	106	112	102	76		85	72	69	72					53
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												845					322				
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female								82	3	6	2	8	157	19	66	71	82	297	72	52	102	76	281	63	65	72	83	517	76	105	67	54	206				108
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male								177	147	52	27	65	453	86	82	80	74	281	80	80	74	73	195	74	152	93	117		79	72	82	77					52
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								175	98	26	14	57	441	88	143	148	178	448	168	174	203	130	702	98	179	115	183		117	151	157	93					126
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex				2	1	2	3		4	3	5	1		3	1	6	8		3	4	5	2		3	4	3	1		2	4	3	6					
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female								164	63	31	17	36	314	53	133	146	148	372	124	138	157	142	644	97	125	99	140		115	162	113	98					113
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female												32	147	192	105	186	199	259	96	220	171	243	366	144	193	193	328		374	352	389	423					360
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex									24	12	3	34	82	26	21	39	24	264	27	26	19	9	30	6	9	10	8	192	6	7	9	1	253				8
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female												16	88	58	30	42	61	52	29	64	43	47	39	52	43	49	69	522	74	81	62	71	515				52
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				71	19	21	29	1,063	20	33	18	7	65	21	18	17	22	477	21	36	37	14	48	35	34	17	25		20	17	17	27					7
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female												34	189	76	48	57	92	94	45	111	84	80	66	80	103	90	139		125	116	132	159					147
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex				20	12	21	11	813	17	44	11	13	150	7	9	9	12	436	14	22	14	14	43	23	17	13	8	75	17	10	14	18	140				9
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male								142	9	11	21	21	134	30	80	91	129	121	155	123	118	109	334	116	110	77	75		63	70	52	66					52
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female								108	11	17	11	22	58	34	59	80	90	10	121	105	87	65	174	84	74	65	68		77	72	55	53					50
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												1,236					1,315				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female												12	146	25	15	11	26	33	15	52	24	48	23	26	35	36	48		38	54	48	45					41
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex												2		9	5	5	4	251	2	6	6	9		11	7	6	10	79	17	10	13	36	618				19
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												700					1,425				
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			284	104	76	79	134	257	36	62	27	37	161	35	33	45	36	166	36	37	36	33	142	23	27	36	29		44	16	18	18					33
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												779					890				
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex									2	2				1		26	9		23	1	2	3		7	4	5	2		11	19	5	9					2
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male										4				7					3																		
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				225	140	138	117	851	115	102	64	75	296	72	53	78	52	238	106	123	123	111	523	110	99	81	94		96	72	95	85					82
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female												12	173	43	25	33	38	55	20	51	35	49	32	59	58	51	75		64	72	77	89					46
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			171	118	88	98	120	203	51	89	43	53	238	49	41	51	49	411	56	76	61	72	269	74	68	42	59		58	44	48	57					63
West Africa Region 2	Ghana	GHA	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			45	29	27	22	36	1,073	34	64	13	18	262	19	26	32	22	350	39	31	33	32	318	42	35	19	37		31	27	29	26					28
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female								365	56	94	92	117	651	115	265	404	414	258	288	286	232	277	763	279	233	195	167		208	176	136	194					178
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												305					504				
West Africa Region 2	Sierra Leone	SLE	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female												10	116	53	24	68	39	203	27	57	65	87	139	61	45	55	102		95	99	122	110					98
West Africa Region 2	Liberia	LBR	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male								66		3	3	2	140	16	83	71	64	240	60	57	65	89	8	48	60	44	59	510	55	88	45	42	151				57
West Africa Region 2	Mali	MLI	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												324					144				
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female								838	26	7	10	14	130	26	53	57	67	13	86	79	80	75	799	54	73	28	83		101	108	117	180					357
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																																					3
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female													224	48	28	41	36	52	28	65	57	58	36	45	52	50	69		125	97	111	126					125
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												115					172				
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female													211							1		4															
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																									1												
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																																2					2
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female													170			1		33		2	2	1	9	1	1		2		2	4	2	6					2
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female								888	9	3	2	4	170	3	6	10	7	8	11	7	16	12	97	9	16	4	16		18	6	13	37					101
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex																					1				1					1							
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																															1						
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												636					760				
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female								888	1	2	1		166	1	1			6			2		10	4			1		1	2	2	3					15
West Africa Region 2	Liberia	LBR	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female									5																												
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female																																					2
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female													182	10	8	14	12	18	13	18	20	16	8	14	15	14	22		51	32	37	25					34
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												194					238				
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female								842	13	4	7	8	181	16	32	34	35	7	50	41	54	51	450	45	54	15	51		64	63	70	94					240
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	60-64	50+	Female																																					1
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female								888		2			409																								
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female													347	32	13	31	23	136	28	52	64	57	70	54	48	61	58		73	85	101	104					96
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female														1																							
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												205					289				
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female								845	27	10	12	22	208	23	56	57	63	17	86	55	67	80	993	79	71	26	91		85	84	132	138					363
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																																					2
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female													204	8	3	4	5	78	5	7	8	11	19	8	12	7	14		16	19	14	24					18
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female													321	1				33					8							1		1					
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												182					236				
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female								564	18	7	3	17	204	19	32	32	28	6	51	28	52	42	803	38	38	20	48		56	52	83	117					253
West Africa Region 2	Liberia	LBR	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female									3																												
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female													347	8	9	12	13	103	5	29	25	16	47	24	23	25	40		49	36	46	58					49
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex								371	2				39						1				14		1								3				
West Africa Region 2	Sierra Leone	SLE	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												151					103				
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female								396	6	4	2	1	117	6	8	8	9	1	9	12	11	8	362	9	8	6	6		14	13	13	27					57
West Africa Region 2	Liberia	LBR	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female									1																												
West Africa Region 2	Ghana	GHA	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex																																					3
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female															1,539	1,093	1,009		1,021	1,225	1,109	1,171		1,124	1,237	1,048	1,028		1,035	1,034	1,096						1,368
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex																			4	1	1			8	4	2											
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												7,327					9,242				
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female													279	636	408	441	385	666	395	630	692	574	666	590	616	608	899		1,312	1,475	1,536	1,452					1,741
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female															1,154	1,471	919		1,471	1,565	1,270	1,492		1,349	1,471	1,299	1,449		1,358	1,383	1,263						1,517
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female								7,877					1,257	2,645	2,080	2,310	2,546	1,226	3,446	3,320	3,213	3,515	13,616	3,497	3,073	2,136	3,095		3,238	2,973	2,945	3,484					3,635
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female															226	324	393		253	374	285	263		216	206	243	185		286	236	214						416
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												21,474					21,474				
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												4,419					5,169				
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female								5,311					939	2,654	2,299	2,223	2,421	939	3,540	3,261	3,108	3,364	14,144	3,674	3,075	2,014	3,206		3,245	2,998	3,050	3,079					3,781
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female															52	276	131		97	187	207	171		86	101	62	35		83	63	72						179
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female															732	698	634		583	741	684	758		626	695	622	660		663	665	617						929
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female								8,254					458	2		7	2	458	3	24	4	3	8	3	5	1	3	8	3	3		2	8				3
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												8,073					9,364				
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female														62																							
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female																								1													
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female													211							1		30		2	1	3					5	5					
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female													768	1,081	624	684	618	1,722	575	1,139	1,089	1,026	1,722	1,000	995	1,088	1,450		1,933	2,070	2,344	2,237					2,635
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female													353	1,425	743	901	787	816	732	1,339	1,343	1,233	816	1,110	1,232	1,380	1,740		2,507	2,799	2,974	2,850					3,087
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female								4,091					411	1,205	1,081	1,033	1,160	411	1,633	1,494	1,501	1,554	6,504	1,721	1,428	927	1,361		1,431	1,267	1,327	1,050					1,483
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female													449	217	127	120	120	1,021	114	322	233	240	1,021	263	278	254	350		536	636	618	579					620
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex								3,834					39	34	74	38	77	39	60	85	80	48	276	154	60	43	91	285	66	62	55	38	285				31
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female								7,922					1,139	3,179	2,520	2,748	3,083	1,139	4,226	3,822	3,778	4,055	16,849	3,984	3,643	2,312	3,688		3,645	3,282	3,238	3,642					4,580
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex																																1					
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex														14	20	16	1		1	6	24	6		3	4	5	31		20	21	32	38					33
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female								7,922					671	1,332	1,111	1,232	1,336	671	1,952	1,838	1,784	1,951	7,687	1,994	1,719	1,138	1,646		1,757	1,797	1,804	2,214					2,254
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female								8,254					611	279	270	272	293	611	432	478	414	478	1,750	506	475	320	470		473	323	362	691					528
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female															29	1	5		52	10	6	7								12							
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female								8,254					656	34	30	27	31	520	51	88	55	69	216	54	50	39	59		53	26	28	66					51
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex															28	14	13		44	60	13	112		38	67	15	42		23	12	34						36
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												31,684					31,684				
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female													768	521	298	315	307	1,606	302	604	483	503	1,606	533	591	602	813		1,152	1,237	1,251	1,181					1,446
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												10,039					10,039				
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female															34	51	69		51	95	146	89		70	34	41	38		12	67	29						103
West Africa Region 2	Ghana	GHA	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex															2									35			1										
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female													415	30	11	16	14	630	16	45	37	35	630	46	33	38	61		73	69	89	112					95
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female															1,957	2,068	1,768		1,595	1,802	1,576	1,759		1,598	1,783	1,514	1,489		1,501	1,505	1,532						1,981
West Africa Region 2	Liberia	LBR	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female															1,913	2,368	1,749		1,906	2,234	1,972	2,179		1,979	2,311	1,955	1,991		2,072	1,965	1,822						2,287
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female													353	3	3	1		711	1	5	2	5	653	16	4	6	12		16	8	15	23					12
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												202					243				
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												117					174				
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female													182	12	8	14	12	18	14	18	25	16	8	13	17	20	24		45	33	37	28					29
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex																					1				1					1							1
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female								595					204	30	36	32	30	6	52	26	52	47	804	40	44	29	54		59	53	77	73					75
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												190					240				
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female													204	9	4	4	5	80	5	8	8	12	19	8	11	6	16		14	19	12	25					16
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female													211							1		4			1												
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female								887					181	19	36	37	43	7	54	39	54	57	450	56	54	46	46		64	63	51	60					61
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female															1	5	6		5		5	1		3	1	2											
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female															7	5	9		18	13	8	4		3	7	3	4		2	5	2						4
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex								391					39		1				1				14		1								3				
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female															5	6	7		10	2	4	3		1	5	3	3			4	3						5
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex																			6																		
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female															28	17	21		38	43	21	28		11	10	18	17		18	19	12						25
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female													224	73	29	42	36	55	28	66	62	58	37	50	50	45	78		122	100	117	127					130
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female													348	38	14	37	24	142	28	52	70	60	72	62	47	61	60		80	90	103	113					98
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female								890					208	38	66	55	70	17	91	57	67	87	997	81	70	58	91		85	88	91	96					101
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												651					774				
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female													170			1		35		4	1	1	9	2	1	3	2		1	3	2	6					3
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female								932					166		2			6		2	2		10	5	1	4	1			2	1	1					2
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female													348	14	10	14	13	106	6	29	26	17	48	26	24	36	41		47	41	44	60					50
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female								932					170	5	7	11	7	8	11	6	16	13	97	14	12	13	16		17	8	10	16					16
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female													321	1				34					8							1	1	1					
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female								416					117	3	9	8	9	1	10	13	11	9	362	8	9	4	6		12	13	8	11					12
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female															1				3		2	1			3	1	1										
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female														3																							
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female															3				7	2																	
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female															21	12	13		21	20	11	15		5	4	8	12		4	3	7						8
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female															20	29	15		52	19	14	22		18	19	10	9		15	18	12						19
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female								882					130	46	59	55	76	13	89	85	80	82	802	63	70	69	84		98	114	95	106					115
West Africa Region 2	Sierra Leone	SLE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												157					105				
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												208					292				
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex																										1											
West Africa Region 2	Ghana	GHA	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female								932					409																			1					1
West Africa Region 2	Liberia	LBR	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female															25	20	22		35	24	20	19		13	14	14	13		9	10	11						15
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male										54																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																						1			44												
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male										141																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												1,115					1,227				
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male															351		303	132		745		376	158		883		596	198		1,528		857	217				
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female										235																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male															153		315	388		790		517	465		829		670			1,785		1,285					
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												13,716					15,088				
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male															100		227	1,813		686		458	2,175		788		644			1,659		1,277					
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male										198																											
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male										245																											
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female										58																											
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female										202																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female															189		307	380		831		562	455		1,078		739			1,959		1,089					
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male										31																											
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female										107																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female															116		163	134		480		307	161		589		413			1,088		568					
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female															346		1,283	4,552		2,489		1,867	5,463		3,192		2,294			5,643		4,609					
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male															49		140	2,357		474		199	2,829		387		294			889		579					
West Africa Region 2	Sierra Leone	SLE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female																																615					
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																									23												
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female															218		614	1,257		1,374		914	1,509		1,537		1,168			2,957		1,938					
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												9,106					10,018				
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female															308		252	146		780		380	175		865		500	219		1,479		729	241				
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female										310																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male															142		311	897		1,057		619	1,076		929		828			2,155		1,540					
West Africa Region 2	Sierra Leone	SLE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female																																437					
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female										54																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male															145		245	236		666		470	283		667		611			1,474		1,009					
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female										19																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												3,418					3,760				
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex															78		490	249		602		569	299		1,389		838	375		825		513	412				
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male															125		304	1,382		1,006		690	1,658		991		749			2,145		1,571					
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male										120																											
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female										132																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female															315		723	4,592		1,592		971	5,510		1,759		1,271			2,909		2,286					
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male										247																											
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male															125		202	120		478		296	144		522		429			987		598					
West Africa Region 2	Sierra Leone	SLE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female																																241					
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												2,657					2,923				
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female															356		1,092	3,728		2,496		1,928	4,474		2,882		2,089			5,341		4,210					
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												6,256					6,881				
West Africa Region 2	Mali	MLI	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female															333		857	2,342		2,112		1,517	2,811		2,438		1,897			4,373		3,311					
West Africa Region 2	Liberia	LBR	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male										36																											
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																					4	70	40	4	65	106	184		298	370	546	459					297
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																							15	1	5	8	4		13	17	11	11					
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																					60	74	43	261	264	392	436		516	564	718	783					363
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																							49	6	24	43	53		65	128	123	159					
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			283	236	315	533	975	529	574	450	1,500		835	1,419	1,731	930					2,467
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												179					314				
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			6	30	32	35	144	32	11	17	17		31	42	59	71					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																				5	3	61	16	38	26	11	25		8	3	1	3					
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																					1																
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												233					408				
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																					1		23	2	1	6	5		14	15	15	19					15
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			123	122	169	242	1,016	202	229	236	690		375	840	939	578					1,304
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			42	34	61	78	268	12	91	165	303		26	156	251	136					677
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			59	273	272	240	247	179	83	95	86		120	121	202	155					
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												350					490				
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			2	10	2		395	25	5	13	12		4	6	102	13					14
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												1,036					1,452				
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			49	48	37	38	172	26	61	92	141		19	55	220	26					237
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																					9	88	21	3	53	86	139		188	231	257	334					167
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												29					156				
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			4	6	7	13	310	2	24	30	76		1	19	59	18					231
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												325					325				
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																				4	8	6	43	5	12	10	11		6	5	8	6					
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												321					65				
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																							5	1	4	27	29		32	34	42	30					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			11	21	65	99	91	113	142	161	144		38	20	21	30					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			2	3	11	10	21	8	20	15	5		8	8	6	8					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			16	40	65	144	75	138	126	99	106		17	11	16	17					
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			3	3	6	1	198		2	6	18	200		6	20		280				4
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			1	4	12	14	60	21	23	17	16		14	11	6	6					
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																					21	39	51	79	159	182	145		143	223	360	293					243
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																													1	1							
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																															49						
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												247					433				
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																					1	1	29	2	5	5	6		10	9	27	24					22
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																							29	2	8	14	18		25	45	46	61					
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			196	167	243	399	446	325	315	329	948		663	766	1,005	641					965
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												606					850				
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																				5	9	14	46	8	11	13	8	28	6	4	8	3	49				
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												1,470					2,060				
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			38	80	84	100	611	132	76	144	266		164	286	449	253					600
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			9	16	41	67	117	84	62	64	93		13	20	16	18					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			6	10	18	22	29	16	24	27	23		16	8	9	3					
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												400					400				
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												1,098					1,098				
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																				3	4	11	77	8	6	1	4		4	5	11	11					
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																					5	4	40	5	30	26	25		41	40	51	53					30
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												203					203				
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			1		3	2	7	1	4	2	1	15	3	2	2	2	27				
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			35	131	184	153	239	125	50	63	74		76	75	150	106					
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																					20	59	57	140	233	326	387		459	485	726	631					356
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												65					324				
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												94					165				
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			21	19	35	46	384	10	49	58	122		8	59	120	32					402
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			9	21	27	21	531	64	22	35	48		34	74	220	148					100
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			46	32	60	75	357	17	95	123	270		29	120	177	56					602
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			63	312	365	290	115	242	97	114	154		146	180	312	345					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																					1	3	13	4	5	5	2		3	1	3	3					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			2	11	19	28	32	15	40	36	43		18	1	2	5					
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																							35			2	3	374	4	6	14	11	374				6
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																				1	3	1															
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			2	1	2	1	138	1	4	13	16			3	13						15
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												96					495				
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			7	60	57	29	30	45	16	19	20		27	25	50	49					
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																					1	2	34	2		14	5	217	12	13	28	18	217				14
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												650					910				
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			1				65	1	1		2	288	6		1		406				5
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																					17	15	44	36	91	99	53		85	77	118	100					57
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																					26	41	51	78	246	273	194		252	267	338	353					233
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																					2		47	16	15	29	29		51	96	108	76					43
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												400					560				
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																					24	115	51	222	232	375	595		795	870	1,298	1,131					535
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																					9	11	49	23	37	62	80		98	69	104	115					86
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												144					33				
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												626					626				
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																							48	5	14	27	28		56	82	95	119					
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																					43																
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																							23	12	37	77	99		109	182	239	273					
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												730					730				
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																					68	94	32	273	195	440	581		719	797	969	1,037					482
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			1	8	23	22	106	31	36	37	36		8	12	7	9					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												157					275				
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			17	29	54	185	28	173	155	88	120		9	2	8	14					
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			3	3	2	2	226	2	6	21	26		1	13	30	2					69
West Africa Region 2	Liberia	LBR	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																						11															
West Africa Region 2	Sierra Leone	SLE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			324	241	319	588	523	393	472	530	1,838		1,087	1,735	2,155	1,271					2,629
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			2	3	6	3	104	1	2	2	3		2		2	1					
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																														1	1	1					
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												484					96				
West Africa Region 2	Mali	MLI	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																							21	1	1	2	3		2		2	1					
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												62					109				
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			16	25	48	65	84	79	110	125	126		41	18	28	26					3
West Africa Region 2	Ghana	GHA	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			3	17	24	29	55	39	61	68	57		25	6	14	15					3
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													138	3	7	29	33	289																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													87	23	60	137	153	187																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													35	6	9	26	30	90																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													134	68	146	306	358	403																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		38																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													400			104	339	443																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													100				25	307																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																	7	334																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																	3	167																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		30																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													100			6	55	302																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																		18																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													100			9	57	227																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		37																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																		28																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		35																			
West Africa Region 2	Mali	MLI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													161				4	176																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																1		54																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													25			1	5	261																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													160	25	65	153	183	548																			
West Africa Region 2	Mali	MLI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													211					220																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																		14																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		35																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		33																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																	2	116																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													300			48	252	378																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																		17																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													43	15	23	35	49	137																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		22																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													75			7	65	145																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													20	22	83	169	219	281																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													54	35	69	118	139	203																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		26																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													29	3	5	9	10	76																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													213	4	20	72	92	586																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													173		10	36	47	388																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													300			115	288	829																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													29	84	300	564	712	544																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		24																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													40	53	117	218	265	339																			
West Africa Region 2	Mali	MLI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													89				1	45																			
West Africa Region 2	Mali	MLI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													193					117																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													114	86	172	408	476	260																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													114	1	17	53	56	285																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													100			18	61	520																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													100			56	135	877																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																	1	191																			
West Africa Region 2	Mali	MLI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													229																								
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		18																			
West Africa Region 2	Mali	MLI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													211				4	380																			
West Africa Region 2	Ghana	GHA	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													34	121	290	512	646	507																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																		9																			
West Africa Region 2	Mali	MLI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													219				3	369																			
West Africa Region 2	Liberia	LBR	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																		19																			
West Africa Region 2	Mali	MLI	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													153					159																			
West Africa Region 2	Sierra Leone	SLE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																2	13	449																			
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																							35	94	74	81	124		155	208	333	291					
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																		38			92	109	150	109	577	229	233		44	392	513	470					473
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																													2		1						
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													20	22	61	80	42	159	40	33	48	58	171	85	92	90	86		84	6	26	14					1
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												1,235					2,161				
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													100			9	48	162		37	21	87	80	43	66	51	40		17	55	25	137					198
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												1,124					245				
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female													300			48	190	272		137	187	552	137	359	136	170	191		163	178	190	208					267
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													161				4	176	150	188	147	112	176	320	159	100	63		102	203	355	191					
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																							44	21	9	14	7		31	51	73	47					
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																		18			17	12	94	25	73	18	37		1	37	118	52					56
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												149					880				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													213	4	17	52	19	440	10	27	62	45	521	112	83	37	45		88	18	21	32					
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												806					1,132				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													34	113	167	222	124	405	75	93	153	145	410	247	247	226	192		182	49	68	42					11
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													100				24	219		19	12	24	148	32	30	29	20		16	45	7	21					165
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													160	21	42	89	30	497	18	56	96	73	594	190	131	136	87		120	37	27	61					
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																		26			31	38	96	13	89	99	153		66	300	426	240					423
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male																		35			42	50	124	49	124	63	59		13	90	245	85					21
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												157					225				
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												223					1,324				
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male																		35			57	82	129	59	444	204	145		39	183	463	251					69
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																		17			5	5	76		9	12	19	544	3	17	75	35	544				6
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													211				4	380	125	156	98	140	380	243	135	84	38		78	145	292	161					
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female													300			115	182	592		293	207	597	290	587	288	217	230		160	376	309	225					773
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												1,829					1,829				
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																1		39		1			20	1	1			124					175				
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male																		30			90	114	107	128	268	341	265		91	374	706	371					178
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												1,000					1,000				
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													400			104	253	317		229	306	810	160	424	277	293	334		283	436	443	398					706
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													54	30	36	50	17	155	18	24	37	24	153	50	55	33	31		31	20	18	11					9
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female													29	3	2	4	1	54	8		4	1	50	7	9	6	5	76	3	4		3	133				
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male																		22			123	151	85	120	168	466	371		112	467	919	304					216
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												506					506				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												309					542				
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												1,565					1,565				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													173		10	27	10	257	11	12	21	28	302	66	46	38	23		44	13	10	37					
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													138	3	4	21	4	177	3	8	15	11	211	36	24	15	19		32	4	3	14					
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												212					298				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female													29	72	217	269	126	405	102	175	271	260	439	343	316	362	309		263	79	110	57					6
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													40	50	67	100	41	281	40	36	71	71	275	118	126	125	111		79	29	34	39					13
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female																		24			45	40	108	50	218	61	68		8	85	159	110					137
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													75			7	58	104		22	21	51	53	40	42	27	20		8	31	24	95					73
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																	2	82		1	4	10	42	1	4	1			6	2	1						8
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													211					220	7	23	14	13	220	24	18	25	12		24	35	45	27					
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												333					76				
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													229							1	1	1			1		3										
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																	1	136		1	4	14	68	9	5	6	2		5	6	2	7					27
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male																		18			11	5	76	12	17	15	16		1	23	37	32					7
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																							73	40	27	18	42		77	108	163	110					
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													134	55	81	161	49	314	59	102	152	141	375	270	226	152	120		145	30	41	56					
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													89				1	45	26	31	17	18	46	63	21	36	24		59	22	49	21					
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												68					394				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male													114	1	16	37	2	197	12	12	21	12	234	55	22	16	9	137	30	6	7	14	240				
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male																		28			22	17	117	36	34	45	45		15	47	118	77					15
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												2,744					2,744				
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												813					813				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male													114	64	85	236	65	125	53	121	190	171	146	343	325	226	127		106	29	22	24					
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male																	3	119		4	1	5	60	3	2		1	47	2	3			66				8
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female																		19			2	4	94		42	5	6	935	2	22	49	12	935				3
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												472					826				
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female													100			56	88	626		101	129	209	277	193	106	121	111		89	206	149	88					363
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																															21						
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																											1										3
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male													219				3	369	70	96	85	89	369	139	88	58	21		46	75	110	74					
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																							32	5					4	3	6	1					
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female													100			18	30	371		69	47	61	180	60	35	42	29		28	60	44	41					122
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												785					1,374				
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male													193					117	3	5	1	13	117	8	4	8	5		5	3	14	9					
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male													87	19	33	77	19	63	12	37	70	42	73	86	70	90	36		36	1	3	1					
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male													153					159	2	1	1	1	159	3	3	5	3			1	3						
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female																		37			129	95	130	105	595	220	337		85	534	738	559					582
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												1,058					1,482				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												1,166					2,041				
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																2	7	320		22	19	3	161	12	4	12	1		7	13	10	6					15
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																	1	239		20	10	2	121	2	1		1		4	2	2						5
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male													25			1	4	187		5	2	17	95	12	16	8	13		6	21	3	10					66
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female																							23	5	10	6	4		9	16	12	13					
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female																		9			3	3	57	11	8	7	9		1	28	66	31					18
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female													43	13	8	12	15	104	11	11	12	8	100	24	36	23	11		18	12	8	6					4
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female																		33			66	77	129	86	271	90	134		28	222	278	236					208
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female																							76	48	69	47	42		102	152	220	185					
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												744					163				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female													35	6	3	17	4	65	8	9	4	4	61	8	15	9	3		7	1	1	4					
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												486					684				
West Africa Region 2	Ghana	GHA	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												898					1,573				
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												110					154				
West Africa Region 2	Liberia	LBR	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male																		14			49	69	62	63	139	84	102		32	215	283	70					106
West Africa Region 2	Sierra Leone	SLE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male													100			6	50	215		32	21	71	108	49	55	52	34		12	67	16	37					275
West Africa Region 2	Mali	MLI	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female																							10	31	34	47	48		60	50	82	67					
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																																					2
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male														4								21					1					1					3
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female														3								2					1										2
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male														6								24					2					1					7
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex														4								4															1
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male														5								18					2					1					6
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex														4								1															3
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male														8								21															
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female														3								19															
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male														16								34					2										5
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male														1								1															
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female														2								12					2					1					6
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female														5								29					3										16
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male														11								24					2										11
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																																					2
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male														2								17															1
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female														6								33					6					1					6
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male														2								2															
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																																1					
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female														3								23					2					3					7
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female														1								11					1					1					3
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex														14								5															3
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex														5																							
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																																1					4
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											1										2
West Africa Region 2	Ghana	GHA	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female											1																										
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female														5								30					1					4					9
West Africa Region 2	Sierra Leone	SLE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											2					1					6
West Africa Region 2	Sierra Leone	SLE	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex																												32				43	139				84
West Africa Region 2	Sierra Leone	SLE	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male																												550				271	1,407				1,626
West Africa Region 2	Sierra Leone	SLE	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female																												518				440	3,059				2,831
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex															3	4	2		7	4	6	1			1		1		1	5	1						
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male																																					1
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				10	21	4	13			3	1																					8					5
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male														93	93	84	115		100	66	40	104		35	19	28	43		40	49	60						55
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female														191	70	61	67		54	48	70	91		65	27	23	38		38	44	42						51
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex															21	22	16		16	7	12	3		9	3	2	5		11	8	1						5
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex															40	73	34		25	25	30	40		21	12	6	13		6	16	3						23
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				20	22	4	20			3																						6					3
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				19	27	5	13			1	2																					6					6
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male														87	85	91	79		58	69	66	63		34	19	25	56		38	91	55						50
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				52	44	8	41			9																						18					11
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				22	21	7	11				1			5																		2					5
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female												17		12	30	30	27		18	32	25	22		28	30	53	50		41	56	40	45					50
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female														50	38	70	48		33	37	36	45		42	11	12	21		4	39	9						18
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male												10		8	21	18	12		8	27	30	16		23	37	25	36		37	31	31	26					31
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female												21		12	46	41	53		37	65	33	51		61	63	59	72		66	78	80	68					70
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				14	13	4	10			2																						3					4
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male														2			1		2	3	2					2	1				1						1
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female																				1		1			1					2							
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex												8		25	2	1			1	3	2			2	3	4			2	5	6	5					
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				32	34	8	27			6																						10					6
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male														67	93	79	84		66	66	56	70		32	26	31	70		43	65	56						53
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex					8					3																						1					1
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female												11		4	10	12	16		16	16	18	15		13	19	31	16		29	36	35	27					26
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male														8	149	169	114		151	97	87	131		109	77	73	104		88	71	44						59
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				6	5	2	14			3				2																		6					
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male														18	66	57	45		67	42	35	59		41	26	26	58		58	38	38						44
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male														50	80	68	59		73	75	67	66		57	29	33	71		61	61	65						57
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female												26		18	62	29	40		32	37	44	38		48	59	61	49		57	74	53	56					54
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female															6	25	5		10	1	3	2															
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female														14	148	182	123		144	249	93	128		83	45	43	79		66	78	27						54
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				23	20	2	7			3																						3					7
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female														146	63	80	62		58	41	59	87		43	24	23	69		41	73	36						42
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				6	7	2	7																									1					1
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female												7		11	23	13	20		21	13	20	22		24	19	23	39		28	44	46	34					43
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female												19		11	36	25	30		26	37	35	28		33	53	44	55		56	53	47	47					43
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female														137	58	84	91		44	48	68	54		68	12	15	33		28	42	32						25
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male												28		14	45	41	40		25	50	32	20		44	53	59	54		47	81	72	38					46
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male												24		22	52	48	40		28	56	62	37		68	62	69	49		69	81	86	53					70
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male												9		18	46	22	22		24	30	27	30		37	46	44	47		45	56	62	62					48
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female														27	56	56	50		67	51	56	60		43	28	17	39		31	48	15						19
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male														84	82	79	63		71	46	45	49		34	14	16	35		20	23	49						57
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female														49	70	78	57		64	38	72	88		44	29	33	64		43	64	40						33
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male												43		25	74	58	70		46	64	54	39		80	83	88	94		104	103	104	88					83
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male												51		28	76	56	63		49	81	70	72		93	90	115	76		119	167	131	122					92
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				4	6		1			3																						1					
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male												29		20	47	30	37		28	70	48	33		57	57	72	66		93	93	72	64					47
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				15	15	4	16			1				4																		5					3
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				16	24	5	18			1				5																		7					4
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				14	22	9	16			1																						5					2
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex												9		9	8	8	7		4	6	8	12		8	5	13	14		14	20	19	13					15
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female														214	71	120	99		47	41	45	103		57	14	19	45		32	62	39						46
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male														36	44	51	47		27	33	28	51		28	3	11	22		11	8	24						29
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex												8		8	17	10	11		10	14	9	14		13	17	11	9		8	27	16	16					15
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				16	13	2	7			1																						2					2
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male												19		26	57	41	44		35	68	54	42		68	81	75	61		76	117	76	77					76
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex												21		55	6	9	8		8	7	12	3		8	10	5	15		10	16	18	13					12
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female												19		10	22	22	15		13	35	30	16		23	31	45	42		49	41	57	52					25
West Africa Region 2	Sierra Leone	SLE	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female												9		7	8	21	13		8	23	21	16		23	19	29	17		28	37	34	33					28
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male															6	23	5		5	1	2	5		2	1												
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				29	13	3	9			1																						10					12
West Africa Region 2	Liberia	LBR	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex															56	38	38		25	19	10	19		15	3	3	4		7	6	17						9
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				4	13	1	3																									2					2
West Africa Region 2	Ghana	GHA	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				15	1		1			2																						1					1
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male								252	60	113	129	221	1,172	762	609	937	421	1,031	441	626	695	762	1,409	679	700	723	838		1,057	1,136	1,044	1,079					1,189
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			593	770	813	809	1,002	805	843	806	759		794	846	896	927					926
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												2,836					1,756				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male													242	106	14	15	18	355	22	35	34	30	395	52	81	46	53		66	74	118	108					195
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex														182	68	82	51	457	45	96	117	121	1,940	130	138	111	147		150	170	203	255					372
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			1,434	563	187	217	171	1,034	426	522	635	683	2,117	817	883	941	1,008	2,488	1,492	1,578	1,535	1,683	3,107	1,807	1,933	2,070	2,171		705	756	656	710					719
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female														16		4	6		6	6	1	1								4	5	1					
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												3,725					3,825				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												3,674					3,892				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												6,065					4,072				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex									27	33	25	55	322	203	193	214	96	413	98	212	222	232	452	168	199	215	213		229	220	228	210					251
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			56	128	129	124	48	132	148	127	147		163	175	183	178					235
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									2,178	9				37	57	140	1,949		1,980	195	916	865		350	294	244	238		21	35	1	1					
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			1,202	985	1,083	1,101	1,141	1,133	1,183	1,538	1,552		1,130	1,158	1,136	1,157					1,228
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female																															1						50
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male								179	102	134	152	217	897	547	481	435	173	383	184	343	162	155	401	164	157	170	169		135	149	165	150					288
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,907					2,072				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								266	103	139	213	799	2,228	899	1,066	2,536	3,434	2,293	3,214	2,901	3,627	3,908	4,360	3,040	3,076	3,102	3,237		3,282	3,322	3,394	3,314					3,187
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												2,143					2,280				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			37	293	349	357	489	359	364	358	383		344	364	350	364					438
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			829	1,277	1,304	1,385	765	1,415	1,474	1,134	1,145		642	645	653	686					655
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			1,611	1,098	1,141	1,236	994	1,162	1,054	1,085	1,029		1,064	1,096	1,102	1,467					1,743
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												2,542					3,815				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												3,298					3,556				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												1,590					2,612				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male								159	15	42	43	458	1,332	495	701	1,387	1,740	1,358										2,839					2,589				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			7	250	256	253	432	427	421	422	429		327	283	340	453					530
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								315	144	189	356	519	2,820	624	695	1,195	1,729	3,005	1,748	3,075	1,920	2,003	2,319	1,972	2,110	2,165	2,206		2,278	2,316	2,359	2,067					1,463
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												3,304					3,215				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female													502	749	349	359	361	543	369	518	558	583	562	618	632	732	825		856	926	1,009	1,084					1,352
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male													576	363	186	221	306	814	321	455	510	565	1,079	674	688	768	834		944	1,057	1,189	1,365					1,913
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				1,391	1,436	1,404	1,298	2,962	926	1,021	1,140	1,149	1,796	1,353	1,410	1,477	1,529	2,443	2,242	2,343	2,394	2,488	2,835	2,534	2,621	2,711	2,741		1,899	1,923	1,987	2,056					2,053
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male								138		9	7	31	514	190	431	586	360	1,420										1,844					1,784				
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			365	183	131	230	218	1,746	125	151	186	179	1,453	212	229	251	259	1,354	376	412	405	449	1,617	493	525	567	602		187	179	178	200					216
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex									4			2		40	87	81	34		21	37	27	31		25	26	26	25		131	137	134	133					104
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				1,900	1,626	1,534	1,390	1,126	1,200	1,341	1,524	1,526	1,586	1,756	1,819	1,899	2,010	2,750	2,783	2,965	3,029	3,145	3,175	3,235	3,381	3,506	3,562		2,296	2,315	2,331	2,372					2,375
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												3,711					4,995				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male								272	93	137	161	251	1,127	718	610	744	460	816	512	795	574	633	1,199	801	906	882	922		958	1,005	1,027	925					1,017
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								194	9	18	13	40	763	437	721	924	649	1,623	659	882	975	1,044	1,609	1,179	1,066	1,075	1,089		1,303	1,330	1,301	1,115					1,209
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			1,698	2,466	2,475	2,605	1,518	2,637	2,730	2,149	2,179		1,472	1,460	1,496	1,622					1,633
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male													576	337	180	204	283	807	325	453	506	519	987	585	603	707	738		815	894	1,023	1,098					1,671
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex									4		8	72	971	76	171	285	543	1,327	632	437	565	605	1,599	537	578	568	585		599	616	634	674					683
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				707	593	528	484	509	407	463	517	525	1,317	605	628	657	697	1,671	996	1,055	1,100	1,143	1,819	1,193	1,245	1,239	1,258		711	708	726	776					721
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female													363	325	116	116	173	546	294	365	420	431	666	474	516	577	583		727	796	887	1,009					1,435
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			91	200	184	186	115	208	219	222	234		261	280	297	326					428
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male									599	1,224	1,296			5		57								3													
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				892	485	452	406	682	409	463	532	530	1,076	621	664	694	726	1,470	1,077	1,138	1,154	1,208	1,660	1,259	1,337	1,357	1,394		696	685	639	651					655
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			7	614	593	676	1,447	543	493	508	533		547	571	575	811					888
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male																																					26
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			2	569	517	596	699	469	467	477	447		461	479	483	597					713
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								441	216	284	441	765	3,951	896	1,049	2,324	3,268	4,203	3,289	3,788	3,092	3,410	4,756	3,033	3,063	3,113	3,201		3,295	3,301	3,369	3,109					2,762
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			734	605	590	590	464	603	621	916	933		673	701	769	797					821
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male								379	62	115	176	216	3,396	262	360	519	592	3,489	612	1,103	574	752	1,369	727	809	816	801		798	848	850	820					1,213
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			9	322	279	280	346	455	439	432	431		794	816	820	811					796
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								172	120	156	187	281	789	946	854	557	333	612	311	513	176	198	746	519	548	551	599		446	452	459	543					599
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								272	66	108	159	276	1,172	1,420	1,360	1,367	1,046	1,864	962	1,170	1,180	1,290	2,471	1,631	1,674	1,687	1,737		1,721	1,822	1,850	1,838					1,759
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									1,410	2,467	2,635			32		371									1												
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			224	106	80	159	128	552	50	68	76	75	506	84	92	103	99	470	127	137	141	153	508	160	167	189	191		100	107	109	119					130
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			614																																		
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male													278	178	54	71	100	458	122	203	217	217	566	256	280	272	323		355	411	536	523					693
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			1,883																																		
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								236	26	31	39	83	924	705	907	1,009	844	1,959	838	978	1,182	1,265	1,952	1,253	1,291	1,307	1,302		1,377	1,432	1,449	1,537					1,350
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male													363	333	209	268	344	563	379	541	587	622	758	670	699	756	850		921	1,000	1,137	1,249					1,876
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												9,771					4,524				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female													251	561	386	406	400	292										1,396					2,478				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																				199	218	250	296	199	193	203	185		200	208	212	349					422
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												4,571					3,060				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female													544	898	442	482	591	622	537	878	964	992	671	1,047	1,144	1,258	1,336		1,483	1,586	1,688	1,858					2,557
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex														166	42	48	29	430	28	80	111	109	441	110	111	120	134		150	154	172	194					304
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												3,073					2,569				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			106	153	178	191	167	220	222	252	292		298	325	356	373					493
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												4,293					6,003				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																				198	362	430	710	355	353	357	365		377	384	388	486					543
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male								240	29	56	70	116	937	567	591	799	531	1,172	524	650	710	833	1,420	678	697	751	708		841	879	1,012	1,050					1,079
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex									2	2	16	67	247	75	164	350	590	289	759	566	589	636	1,671	702	691	720	744		765	822	840	560					489
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			160	277	292	305	134	318	337	369	413		445	481	495	536					684
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex									1		5	128	1,214	131	142	285	494	1,872	604	872	441	476	650	446	440	621	461	630	459	474	495	566	609				581
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												10,516					9,664				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																				151	217	242	534	197	171	166	173		171	184	184	363					399
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			37	69	77	75	57	74	74	93	102		109	113	133	156					182
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male													167	267	209	234	260	296										1,131					2,062				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female								207	125	205	225	347	926	1,249	1,134	932	673	1,248	679	754	493	572	1,510	1,179	1,224	1,215	1,278		1,397	1,418	1,403	1,329					1,463
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male								303	156	105	115	260	2,715	305	403	737	977	2,896	921	1,295	896	1,076	1,884	1,070	1,126	1,105	1,015		1,013	1,076	1,092	1,021					984
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												3,711					4,085				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex														109	45	47	23	339	52	78	91	96	331	105	102	103	111	195	111	159	144	167	828				233
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			279	493	572	527	587	352	413	419	375		446	467	489	515					549
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female								169	49	70	133	206	1,525	230	198	474	715	1,642	737	1,497	632	658	971	704	663	508	688		678	665	674	579					316
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			365	271	119	133	136	61	144	214	281	329	1,054	372	397	431	471	1,208	599	643	646	704	1,383	735	795	780	820		245	215	217	238					228
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												2,246					1,151				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male								326	25	16	32	57	2,944	71	99	144	268	3,001	255	308	186	221	548	186	203	208	211		203	209	211	211					396
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male														4	1		1		4	4						1				1	4						
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female													418	510	205	211	237	442	194	411	420	439	454	476	500	530	567		619	675	699	741					1,013
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			141	36		12			5	6	9	10	137	14	16	16		8				4	114		5		4	22	42	15	6	18	22				10
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female									5,524	9				82	46	152	3,295		3,341	245	1,421	1,356		530	443	330	442		30	132	246	2					
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			41	53	47	61	39	75	84	95	91		95	102	109	115					148
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												2,828					3,143				
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			606	488	153	167	153	179	222	272	346	422	1,154	507	545	576	610	1,474	814	855	862	915	1,694	953	1,009	1,076	1,097		429	400	386	410					416
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female													866	979	577	665	788	996	847	1,190	1,247	1,284	1,126	1,346	1,488	1,812	1,873		2,040	2,243	2,416	2,688					3,556
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												5,201					4,944				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			65	86	79	85	29	102	110	125	126		145	146	151	162					232
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			318	245	237	237	172	246	245	339	341		313	314	342	391					391
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female								160	2	7	2	36	576	346	653	754	651	2,397										2,680					2,801				
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			2,793	2,243	1,378	1,384	1,184	1,458	1,329	1,508	1,692	1,754	1,833	2,063	2,196	2,318	2,398	3,207	3,513	3,744	3,775	3,941	3,731	4,034	4,223	4,169	4,253		2,345	2,313	2,238	2,329					2,333
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			594	434	507	517	610	524	544	754	753		527	526	494	537					528
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex														58	3	2	5	6	16	8	9	15		16	20	26	26	32	29	37	43	46	84				51
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female								241	50	85	112	198	974	1,298	1,283	1,386	1,054	2,050	1,009	1,094	1,140	1,322	2,599	1,319	1,352	1,332	1,401		1,708	1,796	1,817	1,663					1,655
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			1,620	1,180	1,877	2,260	1,877	1,458	872	935	1,057	1,064	419	1,250	1,311	1,385	1,462	1,546										3,116					1,643				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								186	6	14	12	30	686	235	364	504	316	977	300	507	566	613	966	531	564	527	531		558	589	612	644					719
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			316	113	85	76	86	240	96	126	162	176	830	210	233	263	271	811	350	373	371	409	918	435	463	520	529		174	153	143	133					157
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								221	21	29	19	47	862	317	479	561	344	1,156	349	536	631	711	1,207	595	654	640	683		700	696	764	793					943
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			39	335	476	471	829	863	833	828	841		760	809	849	853					788
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female								48	26	36	13	354	403	383	493	1,146	428	405	1,582	960	1,824	1,854	2,798	1,446	1,540	1,437	1,511		1,550	1,553	1,575	1,807					2,021
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male								114	81	68	47	282	955	302	407	864	331	1,047	1,164	1,121	1,261	1,276	2,232	1,198	1,147	1,154	1,040		1,066	1,106	1,118	1,056					1,209
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female								354	407	208	313	866	3,171	966	1,095	2,736	3,773	3,349	3,620	3,728	3,706	3,946	4,890	3,481	3,508	3,594	3,753		3,848	3,873	3,916	3,809					3,372
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												1,203					1,465				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																				234	322	380	334	306	291	298	298		301	307	310	364					452
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												862					811				
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			2,761	1,537	456	554	451	1,541	828	980	1,119	1,160	2,453	1,403	1,522	1,649	1,735	3,270	2,599	2,799	2,841	3,042	3,862	3,182	3,381	3,619	3,743		1,439	1,432	1,356	1,423					1,509
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												12,866					6,750				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male													278	251	111	120	155	368	183	265	296	318	467	340	356	404	460		482	519	607	656					911
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female													418	934	515	601	763	649	890	1,303	1,397	1,412	976	1,609	1,804	2,066	2,315		2,769	2,931	3,200	3,789					4,951
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male													336	289	178	203	269	482	280	383	432	460	632	497	554	610	690		749	800	841	1,009					1,309
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			732	575	553	553	293	571	579	877	883		666	647	752	889					893
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female								27	19	22	78	570	233	592	886	1,609	2,039	232										3,951					2,871				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			2,092	1,146	1,240	1,365	1,942	1,195	1,058	1,056	1,101		1,122	1,142	1,166	1,294					1,308
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male								260	121	173	176	260	1,182	702	575	698	381	564	354	710	368	401	732	483	555	616	653		635	713	672	682					739
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male								91	64	35	49	285	761	316	405	822	1,070	811	1,115	720	1,080	1,116	1,631	1,065	1,051	1,017	967		984	997	1,002	1,019					1,175
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,389					1,070				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												3,385					2,400				
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			17	200	223	240	196	253	251	254	245		324	336	337	397					396
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												1,146					1,338				
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			772	801	299	270	272	238	281	342	409	440	1,181	524	556	592	622	1,560	950	1,036	1,048	1,116	1,735	1,168	1,215	1,292	1,320		536	516	541	564					542
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			371	299	291	291	234	298	319	457	458		310	300	329	358					365
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex									51	76	49	111	322	291	271	299	150	600	162	333	236	268	618	226	287	302	317	671	305	295	288	302	828				398
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female								272	103	188	206	343	1,127	1,419	1,440	1,236	930	1,637	930	1,042	840	946	1,878	1,278	1,332	1,384	1,425		1,489	1,589	1,687	1,766					1,692
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			9	88	184	178	127	234	235	243	246		301	312	316	318					296
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			3,035	2,450	4,031	4,952	4,016	1,787	1,722	1,925	2,182	2,239	436	2,636	2,754	2,902	3,087	2,696										4,869					3,215				
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												841					1,014				
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			2,505	2,273	887	985	832	1,075	1,233	1,398	1,601	1,627	2,668	1,950	2,036	2,153	2,278	3,758	3,400	3,615	3,664	3,858	4,426	3,973	4,170	4,108	4,209		2,058	2,019	1,946	2,053					2,017
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			3,862																																		
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			66	115	120	122	140	140	139	146	158		186	204	206	215					280
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				217	123	136	1,180	1,718	159	192	206	206	602	248	271	287	296	1,033	431	463	468	485	1,057	526	533	539	558		338	312	275	304					292
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			484	293	172	1,017	1,135	1,256	130	147	171	170	931	206	230	240	289	1,167	407	435	451	466	1,185	496	496	507	503	646	322	325	313	329	430				329
West Africa Region 2	Liberia	LBR	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex									8	9	7	23	322	116	181	178	123	304	96	212	168	196	343	113	137	144	157		113	129	128	144					174
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												10,121					9,190				
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex									1			4		6	16	234	50		95	42	39	40		57	40	48	46		49	54	62	116					39
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male								179	58	78	71	273	1,499	310	436	858	635	1,648	1,114	1,311	1,182	1,233	2,340	1,192	1,154	1,152	1,074		1,082	1,120	1,139	1,073					1,221
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male								483	68	93	202	154	4,327	192	240	278	474	4,364	366	752	319	543	819	514	554	572	598		584	585	606	556					750
West Africa Region 2	Ghana	GHA	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				260	85	97	878	333	99	125	139	145	547	180	195	201	210	654	296	313	1,152	1,192	726	1,226	1,235	332	336		171	176	140	168					177
West Africa Region 2	Mali	MLI	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female								99	59	88	31	597	831	646	670	1,798	2,435	847	2,462	1,881	2,598	2,960	3,570	2,469	2,393	2,430	2,565		2,610	2,603	2,653	2,784					2,742
West Africa Region 2	Sierra Leone	SLE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female													866	1,255	685	803	1,009	1,053	1,095	1,641	1,822	1,933	1,344	2,039	2,291	2,572	2,778		3,177	3,410	3,637	4,171					5,763
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				13	22	26	27	201	10	9	10	11	96	20	17	18	24	210	22	33	35	36	86	37	33	37	22		27	29	20	20					21
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								7	14	15	21		18	23	19	13					25
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female													307	69	39	96	128	150	61	131	121	113	152	112	118	134	183		169	222	216	244					232
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,952					1,171				
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female													307	132	69	141	192	208	93	237	235	235	318	183	199	188	256		294	341	364	372					385
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,091					679				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male								595	14	26	13	38	826	38	52	64	83	127	60	86	37	44	166	104	86	74	39		45	42	44	41					19
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								10	11	15	13		18	18	14	17					27
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex														3	4	4	7	6		4	4	5			2	3	4	32	2	4	6	5	86				8
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male								193	6	16	25	31	199	37	55	100	154	182	147	168	111	87	403	120	109	71	69		88	88	53	77					61
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			1,172																																		
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			139	41	20	23	26	37	37	76	49	50	219	37	27	44	44	293	50	46	41	57	225	42	48	29	47		30	23	31	43					35
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex									29	15	5	33	80	44	56	26	16	252	15	14	48	21	30	7	8	15	11	183	15	14	12	3	241				7
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex										6	9	5	37	8	31	104	87	46	74	74	78	87	320	80	73	51	84		66	39	31	44					78
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												947					489				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male									51	5				5																34	15	5					
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												265					224				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												1,360					1,232				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female								98	13	30	24	21	301	24	51	88	99	148	96	76	58	39	219	90	96	67	32		40	39	29	28					32
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												1,829					852				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								3	6	7	7		6	11	2	2					4
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								6	4	5	5		13	5	8	9					6
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			429	62	56	51	45	664	94	94	71	86	429	84	92	84	76	614	115	118	134	134	579	151	123	99	136		139	142	118	129					167
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male																	1									1											
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female								107	122	36	21	53	279	50	42	48	46	320	33	33	46	21	149	21	43	45	38		47	43	39	16					23
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male													55	30	18	25	53	136	21	45	44	62	113					447					428				
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												782					656				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male								224	1	16	18	23	178	37	96	96	158	54	141	159	122	122	314					250					330				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male								153	67	37	22	65	415	46	76	65	86	437	63	50	90	54	407	48	113	69	81		85	94	66	53					61
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								20	20	22	32		19	18	31	41					30
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								9	14	13	10		25	23	15	20					16
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												1,164					520				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								41	28	19	20		26	38	24	17					34
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male													204	37	19	49	89	254	29	93	73	96	287	96	80	82	103		111	125	138	204					153
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			956	113	214	128	118	1,149	94	159	92	103	75	114	87	95	107	139	119	127	135	121	674					104					110				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												533					661				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex									22	4	1	27	80	33	44	19	19	208	14	10	54	18	46	10	6	4	11		9	6	3	2					3
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex														18	12	13	9	284	7	15	10	6	1,523	9	8	6	16		11	14	21	59					21
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			918	86	106	108	108	939	99	159	94	108	333	120	112	120	120	401	142	155	154	142	616	139	135	103	128		129	110	100	125					133
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								37	32	22	27		28	24	32	21					36
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												610					749				
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male													120	39	38	61	68	211	36	84	80	70	210	65	75	63	100		88	98	156	141					158
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male													74	1	1	5	3	120	3	8	5	10	49	4	6	2	2		8	14	7	21					22
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male								344	10	23	47	42	518	45	89	97	147	239	114	125	127	114	368	143	153	85	74		73	86	69	65					68
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			693																																		
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								102	9	9	12	9	234	32	59	56	61	155	57	62	70	55	19	42	45	58	39		31	64	36	42					47
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												240					334				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female								173	28	47	45	79	297	100	183	279	335	110	253	212	223	207	536	186	151	113	131		138	152	113	124					112
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								8	5	8	9		12	10	8	9					13
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			931	80	79	106	71	991	108	179	107	115	476	122	126	136	110	674	175	185	184	184	687	187	156	126	164		186	148	147	143					187
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								131	27	9	11	21	283	31	94	64	77	252	72	88	100	89	33	73	99	83	83		62	108	88	58					78
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female								233	65	88	86	102	754	131	236	299	418	338	281	278	272	255	812	259	202	166	150		209	194	160	176					133
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												290					479				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								50	28	36	37		35	37	32	19					44
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male																								1													
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex										2	2	2	171	3	8	27	39	695	50	30	27	24	305	44	38	26	29	105	26	36	23	35	78				26
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex										1	5	4	137	4	13	33	53	383	62	43	54	48	330	53	29	35	38		64	41	31	66					39
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												307					137				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								14	14	9	19		11	9	4	11					14
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female								131	124	55	20	64	328	70	69	120	102	475	104	102	130	88	293	76	114	98	125		95	107	98	72					106
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												924					754				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								1	17	10	28		15	28	14	8					16
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												740					847				
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								35	55	38	22		24	30	31	33					27
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male								112	98	33	23	40	317	39	29	18	21	164	32	34	39	7	26	18	24	44	12		21	35	17	6					14
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												165					551				
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												1,176					1,248				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												583					291				
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				33	20	17	24	1,104	14	22	7	10	79	11	14	14	12	454	17	27	28	16	48	27	21	13	24		13	16	11	25					6
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								15	14	14	22		17	23	22	29					26
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			310	63	51	37	62	152	33	67	48	44	228	45	29	39	31	398	52	54	40	65	254	86	51	45	48		54	42	45	58					72
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male								155	94	39	21	77	399	57	73	87	94	367	79	51	87	58	407	67	91	66	104		112	77	100	62					78
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								1	14	14	14		10	20	6	15					18
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female													111	33	30	43	42	194	22	50	58	64	133	57	51	38	57		100	92	119	101					98
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												666					1,352				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												122					576				
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								20	12	9	17		25	17	16	27					9
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male													204	38	40	54	83	248	34	81	71	77	199	74	63	62	66		86	95	120	149					155
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female								13	9	10	15	34	38	22	63	101	110	4	115	81	92	138	204					309					369				
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								20	9	17	17		19	15	24	23					27
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male													92	111	10	28	32	189	14	40	32	30	120	36	28	24	50		44	52	60	71					67
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												544					1,221				
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								37	72	43	44		45	44	44	60					48
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				64	32	42	80	437	48	70	43	37	208	56	47	34	38	275	53	68	64	51	267	64	76	52	57		50	51	38	67					45
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			153	18	14	9	4	809	8	14	9	5	154	5	7	6	7	427	14	18	20	14	42	17	5	11	4	70	12	7	12	18	134				9
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female								153	52	32	19	34	298	56	103	112	131	355	118	120	149	149	602	100	130	108	132		110	140	119	94					99
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			800	107	87	116	109	689	114	178	103	119	543	139	107	144	125	589	150	168	168	169	787	147	137	137	152		159	115	114	181					171
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								2	7	9	8		9	18	8	7					15
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female								188	37	62	78	107	538	105	155	296	265	247	199	182	174	178	548	220	156	136	133		148	151	140	154					109
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male								449	19	42	25	38	648	46	86	106	140	165	70	139	87	69	284	110	113	95	63		82	70	61	67					51
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								9	6	7	10		10	10	7	18					14
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male								404		1	5	10	582	14	16	14	25	118	21	31	22	16	80	45	25	16	13		11	9	6	11					7
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								9	13	9	6		6	9	10	12					17
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								112	18	6	10	16	264	22	55	63	63	340	61	64	73	58	75	52	89	65	46		64	71	55	46					59
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female								155	111	47	25	83	399	83	73	117	103	473	145	139	135	119	279	99	153	116	142		127	180	144	93					134
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female								95	2	6	1	4	148	16	61	67	57	217	50	56	109	66	264					492					195				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																									7	7	8		5	12	4	13					6
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												574					962				
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												992					1,057				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female								155	73	24	17	66	415	72	112	141	128	428	144	132	183	140	657	103	177	131	172		96	149	161	101					123
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								31	26	17	36		19	43	25	34					28
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								95	7	3	1	3	180	27	42	44	46	217	39	39	64	35	8	33	35	31	42		51	57	33	25					43
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								6	7	7	7		12	13	14	9					9
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female													166	27	20	30	34	52	21	42	55	45	31	48	45	46	65		56	87	66	85					61
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								16	14	7	15		26	21	10	9					10
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female													139	28	12	12	29	32	16	49	31	45	22	34	35	36	54		24	39	53	44					49
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex									9	2				2		23	10		4	3	1	4		20	44	40	2		9	10	2	8					2
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female										2	1				9	14	84		44	3	27	9		4	9						2	3					
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												439					636				
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			128	27	9	13	21	153	16	30	24	23	163	23	22	31	30	167	30	32	30	35	137	28	28	33	24		28	17	7	21					30
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male										2					13	5	85		57	1		3			5						1						
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												541					364				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex									8			6	80	18	32	17	12	81	23	19	33	27	45	9	13	7	14		11	21	11	8					8
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												809					306				
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				73	83	69	77	1,898	68	94	52	57	351	76	37	59	43	137	118	94	57	78	454	66	70	52	66		63	53	58	75					80
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male								149		12	25	17	128	20	67	81	126	112	118	118	114	109	322	108	83	61	70		59	71	50	65					51
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				72	69	92	91	720	84	103	74	76	278	108	59	70	77	227	112	109	112	98	497	115	113	63	90		85	73	90	88					90
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												315					405				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								4	9	4	6		12	11	5	7					7
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male								84	1	9	13	17	101	31	53	72	104	69	86	84	76	73	194	88	64	54	48		67	72	38	45					54
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex														5	2	3	4	236	2	3	3	9		7	1	3	17	74	8	6	13	36	611				16
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			97																																		
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex														11	1	5	6	270	7	4	6	6	20	6	4	6	14		9	7	18	31					26
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			59	1	3	3			1	20	5	2	18	6	1	2		8				4	114		7	6	2	22	6	4	8	5	22				9
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female													180	46	36	58	81	90	34	106	89	81	63	89	82	85	115		127	122	136	167					155
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female													139	10	92	141	167	244	85	227	170	184	347	192	179	170	257		354	358	387	374					375
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								12	16	16	15		27	26	12	27					17
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female									34	14				32	1															26	17	1					
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								6	8	8	11		7	9	17	18					11
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female													83	35	27	43	53	47	20	65	44	54	37					497					488				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male								149	33	20	17	29	287	28	55	78	77	430	59	73	80	56	277	63	91	71	67		109	73	79	55					66
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				62	33	54	65	329	38	52	30	23	275	49	36	28	36	170	64	53	52	36	219	53	41	24	34		41	37	41	43					46
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								8	12	6	5		8	8	11	12					6
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			259	46	25	32	47	118	61	71	88	58	227	46	31	36	43	411	46	56	52	50	288	75	50	49	43		48	45	37	41					57
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male													111	23	20	36	58	157	23	70	52	62	163	55	58	55	73		61	85	91	126					108
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			505	95	98	65	84	939	50	67	49	50	79	63	31	53	58	160	75	78	107	84	279					741					106				
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female														2			1				1	4			1	1											
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								7	19	16	23		25	28	23	24					21
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			125	7	2	10	11	356	8	19	8	4	90	5	11	8	4	93	10	10	11	12	57	8	7	12	7		8	2	3	3					5
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								78	52	24	54		38	38	38	32					34
West Africa Region 2	Sierra Leone	SLE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male													92	11	7	18	37	98	17	26	36	36	108	31	44	36	52		33	62	82	66					80
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex									4			1		2	9	7	4		8	8	14	5		6	1	1	2		3	3	1						1
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								91	36	37	34		42	53	30	34					35
West Africa Region 2	Ghana	GHA	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			160	19	17	11	23	1,125	20	43	31	19	253	21	25	33	27	336	41	46	48	42	305	40	39	37	55		40	32	28	31					31
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female								48	23	27	34	54	110	49	104	160	176	33	168	142	145	142	311	142	105	78	86		84	93	75	78					83
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												338					414				
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male								155	110	49	28	76	418	48	44	59	67	266	74	65	76	50	183	83	84	75	112		65	84	74	73					42
West Africa Region 2	Liberia	LBR	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male								85		4	2		133	12	45	57	52	228	40	34	79	72	8					485					143				
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female								25	6	14	10	21	54	29	47	71	95	10	112	97	88	69	166	76	46	55	61		74	71	54	52					48
West Africa Region 2	Mali	MLI	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female								230	44	83	82	101	605	100	222	340	388	247	277	280	270	276	729	258	202	157	157		198	186	129	192					172
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												9,298					8,567				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								860	1,168	1,420	1,443		1,238	1,012	946	933					1,081
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								16	242	310	399		403	309	339	507					428
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				131	243	262	447		173	212	242	280	1,202	397	422	537	552	1,557	473	520	521	419	1,478	387	532	658	637		578	448	417	393					401
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								194	173	208	216		229	258	289	503					479
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								189	200	211	220		224	217	235	355					350
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male																			1																		
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female											41	1,879							3																		34
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												1,433					2,251				
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									7	4	9	5	1,370	9	17	423	118	1,544	326	224	207	229	1,905	383	390	426	433		437	502	532	554					457
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												3,167					4,394				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male													243		8	27	41	329	46	49	31	46	386	47	87	131	160		127	139	99	56					571
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												2,461					2,715				
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex													885	1	2	86	84	1,179	149	79	103	89	1,314	131	164	197	211		204	218	247	322					295
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female													320		1	9	17	475	27	28	29	31	366	42	72	111	167		132	156	125	57					760
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex															1	9	12	261	14	10	11	9	114	31	23	37	19	165	16	10	7	9	598				170
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female													476		21	93	157	575	168	217	117	172	594	161	305	415	561		388	454	290	188					1,794
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female									2	1	13	5	369	4	19	381	781	389	729	894	731	482	2,001	641	597	660	657		673	712	796	1,020					1,143
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				627	776	832	1,204		637	747	800	951	1,458	1,270	1,327	1,649	1,764	2,510	1,471	1,496	1,647	1,329	2,691	1,309	1,792	2,207	2,300		1,938	1,592	1,396	1,305					1,501
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male													501		13	29	57	716	58	63	54	63	878	45	133	193	235		177	197	133	83					1,221
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female																			2					1													
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female													366		10	55	105	561	85	149	140	156	804	154	374	534	644		491	520	377	249					2,998
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									25	10	25	18	3,552	18	60	338	359	3,979	853	519	544	748	3,378	1,060	1,029	1,100	1,161		1,220	1,387	1,468	1,477					1,093
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male									5	3	6	2	2,642	3	9	49	74	2,875	92	110	55	39	440	142	86	74	66		69	68	76	110					94
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									9	2		83	815	77	244	527	619	1,827	630	823	1,014	1,086	1,589	925	1,063	1,098	1,152		1,116	1,057	1,129	1,145					1,150
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male													295		12	33	53	423	41	55	56	65	537	52	118	144	192		141	141	108	72					872
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												2,534					1,559				
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								57	78	69	71		65	61	77	186					218
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex											4		1,108	2	1	91	133	1,616	244	114	108	76	492	118	140	154	162	551	154	164	199	269	542				254
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								294	400	474	489		429	321	322	322					350
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex																2	4	363	4	5	12	7	1,376	10	20	22	15		17	11	8	15					129
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								134	138	171	177		157	172	172	282					279
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									14	7	25	22	2,851	18	61	567	784	3,177	1,200	873	843	959	3,565	1,334	1,291	1,413	1,444		1,493	1,634	1,745	1,931					1,635
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female													219		24	78	137	268	110	160	150	192	284					1,151					2,150				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male									19	4	2	92	827	101	192	266	341	1,013	188	263	631	672	1,230	458	530	541	508		508	661	625	823					828
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																32	851		3	1,115		8		7	10	8	6		7	10	13	38					14
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									24	12	24	10	2,038	17	49	660	1,005	2,191	1,247	1,119	1,003	958	3,278	1,252	1,141	1,257	1,312		1,344	1,432	1,564	1,708					1,622
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female									12	5	15	8	759	20	51	545	1,048	811	1,049	1,098	893	765	2,529	1,009	956	1,026	1,046		1,053	1,176	1,288	1,537					1,496
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female									22	9	7	167	860	147	340	558	650	1,886	530	694	944	1,037	2,231	1,007	1,058	1,190	1,236		1,292	1,234	1,504	1,380					1,386
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								122	118	139	129		117	121	141	221					228
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												5,253					3,609				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								723	315	371	353		347	338	345	330					385
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male									33	18	7	91	1,027	66	103	152	201	470	153	182	361	388	624	271	311	314	405		444	510	461	501					496
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								685	907	1,104	1,121		970	785	716	693					832
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male															82	102	350		370	393	406	407		223	157	1			290	200							
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male												6	460	20	143	236	317	1,312	404	513	609	678	869					1,569					1,605				
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female										5							129				379																
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,192					948				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								109	145	145	205		144	179	102	57					557
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male									3	3	3	2	1,219	15	28	478	402	1,301	673	407	420	464	1,835					2,543					2,295				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				16	30	296	53		11	19	26	27	558	75	75	101	105	838	98	98	210	137	811	107	159	229	215		178	153	49	94					141
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												1,949					888				
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male									14	8	29	10	3,891	13	25	124	101	4,195	139	112	128	46	662	138	206	190	165		145	148	159	180					137
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex									4			2	288	8	29	51	65	341	66	79	182	191	401	104	143	169	219		206	167	173	165					200
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												3,306					3,456				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				5	17	300	39		6	15	14	10	502	705	27	37	28	553	30	30	73	47	576	36	45	66	71		66	54	15	46					70
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												2,886					2,883				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								6	13	25	21		23	18	10	9					112
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								544	458	490	489		491	540	608	745					704
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								32	65	105	133		84	89	58	25					258
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				190	225	273	332		273	369	377	401	2,244	548	590	718	745	2,879	741	748	820	695	3,180	720	992	1,300	1,336		1,167	932	787	629					724
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									8	3	12	8	2,442	15	20	387	137	2,739	282	172	173	163	1,549	287	334	371	369		370	432	455	439					300
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								14	218	246	304		288	258	260	262					383
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				28	41	55	76		42	72	74	56	1,337	71	71	84	118	1,224	101	79	116	67	1,233	58	87	125	137		120	104	66	68					93
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								73	73	81	93		101	98	97	192					189
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								418	568	680	712		598	480	490	484					566
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				507	685	837	1,286		419	462	519	658	383	892	944	1,194	1,175	1,405	1,033	977	1,186	963	1,491					2,668					1,484				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												709					638				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												729					785				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				78	115	148	226		103	132	141	168	1,081	231	246	299	381	1,444	308	309	368	282	1,495	282	387	470	467		440	321	282	240					260
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									7	1	13	5	696	9	19	310	335	768	420	359	315	270	1,287	403	361	396	401		412	428	503	568					533
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												2,650					1,999				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male									34	14	12	129	979	86	140	220	259	687	185	210	449	452	994	410	363	382	450		610	696	845	697					725
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								54	92	82	108		77	91	56	33					375
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female													752		30	110	195	961	204	264	217	279	1,153	240	492	627	1,022		653	795	561	322					3,703
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				57	90	74	105		68	98	104	133	1,058	164	182	232	292	1,366	251	279	274	200	1,420	194	273	334	349		307	266	208	174					207
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												11,353					5,986				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												8,680					3,828				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								23	338	404	530		567	480	594	576					518
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												4,009					2,590				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								189	250	323	326		281	213	192	198					247
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male											20	465							2																		18
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				37	37	256	75		15	28	32	33	856	64	64	83	89	982	64	72	187	119	900	122	177	235	237	577	209	168	35	96	360				171
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								163	232	282	282		265	218	202	228					263
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male													243		3	6	9	389	10	9	13	15	436	14	39	69	93		63	71	61	32					418
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female															176	153	327		328	431	490	490		297	200		1		149	299	13						
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female									35	19	25	233	979	114	211	461	500	1,451	373	445	740	808	1,655	816	760	767	1,003		916	1,099	1,226	1,210					1,355
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male									2			14	614	29	84	167	209	884	204	262	583	604	757	327	367	446	482		449	466	472	459					508
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								298	253	291	339		313	359	400	506					421
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female													752		20	95	171	922	174	232	156	204	959	212	369	511	697		478	545	413	240					2,888
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								9	216	264	282		289	264	275	318					350
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female													366		9	39	73	419	63	106	82	97	314	107	166	221	278		208	229	151	67					724
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								9	160	162	209		210	187	225	252					261
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												3,161					3,390				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												3,658					5,349				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												4,645					4,455				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												2,186					3,254				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex													288	5	21	26	30	273	29	33	121	123	302	65	82	85	132		104	113	107	90					106
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												2,825					3,097				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												1,593					1,706				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male													146		7	40	64	250	57	82	65	72	340					920					1,784				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male									30	7	10	136	1,018	111	173	282	418	876	302	321	587	611	1,188	466	494	513	550		607	681	852	656					711
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									11	2	3	3	1,369	9	18	61	102	1,547	168	132	101	129	762	224	236	231	234		193	254	311	193					127
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								12	26	35	61		33	33	23	16					164
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex											5		225		5	46	28	265	25	98	38	77	1,262	119	164	197	215		244	254	299	192					137
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								5	162	164	209		207	150	213	205					180
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												991					1,141				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								9	14	36	38		22	21	20	7					143
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female												20	674	32	185	371	425	1,528	523	660	860	928	1,284	856	869	910	1,078		1,060	975	822	816					999
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				19	26	28	47		18	30	33	33	759	52	52	67	108	751	84	91	104	71	707	67	85	131	135		133	92	66	57					63
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female									32	15	18	239	1,018	143	289	607	756	1,686	592	770	894	969	2,097	1,136	1,152	1,032	1,324		1,179	1,334	1,430	1,471					1,373
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female													439		14	69	131	513	127	152	125	125	411	123	200	268	349		259	287	187	103					1,072
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male													317		11	26	60	485	60	62	62	67	642	75	139	185	279		224	216	148	86					1,090
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									43	21	19	207	805	96	190	323	380	1,074	260	331	472	515	1,311	695	661	650	838		803	934	988	909					975
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex															2	6	10	339	18	17	10	12	341	6	26	44	26		23	18	9	10					134
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												3,152					3,479				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				31	54	65	91		63	84	89	112	961	116	120	142	170	1,118	139	147	159	106	1,123	100	151	187	200		168	141	104	89					117
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									8	2		34	761	47	123	230	246	1,023	231	276	632	652	1,083	368	525	572	554		561	602	513	527					751
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male										7							110				549																
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								21	31	54	52		51	37	20	17					196
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				1,128	1,464	1,967	2,819		877	1,004	1,124	1,456	399	1,977	2,089	2,642	2,885	2,441	2,388	2,471	2,667	2,272	2,799					4,457					2,932				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female													517	23	220	392	515	2,263	734	968	979	1,120	1,967					2,336					2,525				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male													214		1	2	2	309	5	6	4	4	175	6	15	19	15		10	10	7	3					99
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												8,801					8,146				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												1,014					1,243				
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								376	489	620	661		562	467	458	499					622
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				71	87	100	129		106	177	183	149	1,930	239	251	301	382	2,208	371	338	390	317	2,422	317	480	597	612		551	427	361	262					275
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male													501		5	30	51	713	50	47	28	37	790	38	102	157	194		138	160	116	62					938
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				529	694	778	1,013		480	606	660	768	1,684	1,249	1,316	1,611	1,791	2,880	1,546	1,567	1,711	1,397	3,198	1,372	1,901	2,303	2,312		1,991	1,551	1,389	1,268					1,362
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female									36	8	12	8	2,537	15	39	118	252	2,843	352	327	358	491	1,726	704	725	747	775		765	931	1,002	953					523
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								355	492	600	626		553	434	393	362					414
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male									13	7	6	6	3,054	11	34	308	65	3,337	202	103	167	105	1,130	188	245	240	240		206	231	261	262					192
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																		4							2		1	22					56				
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male									4	1	6	5	874	6	20	348	303	983	399	317	321	268	1,784	434	402	446	453		454	483	530	579					525
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				164	184	232	372		147	185	209	219	986	288	306	378	393	1,347	387	406	421	330	1,398	347	501	589	598		518	413	326	288					351
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female									4	1	7	4	212	12	25	573	597	224	970	652	548	667	3,291					3,550					2,546				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex									25			17	288	14	76	98	148	508	140	165	315	327	528	151	204	221	292	569	288	283	247	186	698				185
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												1,827					1,769				
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female									39	16	15	136	685	41	107	158	197	502	122	133	330	336	648	277	246	227	360		327	366	398	325					453
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male									28	9		65	779	27	70	75	156	324	101	116	231	249	320	118	108	109	155		149	136	122	102					200
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								1,852	598	610	717		712	647	653	641					828
West Africa Region 2	Liberia	LBR	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex																	1				2	2		1	3	6	9		7	7	7	31					7
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				391	657	732	1,248		494	573	625	777	1,645	1,041	1,096	1,367	1,480	2,259	1,242	1,302	1,363	1,120	2,370	1,123	1,542	1,892	1,915		1,618	1,340	1,187	1,164					1,343
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				21	29	40	57		13	16	17	28	466	27	28	32	61	427	46	51	50	32	414	37	73	71	79		70	59	40	52					63
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				367	511	545	710		522	638	674	742	2,435	1,051	1,096	1,318	1,474	3,357	1,304	1,311	1,375	1,142	3,760	1,139	1,574	1,962	1,982		1,714	1,374	1,193	1,011					1,081
West Africa Region 2	Ghana	GHA	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex					1	1	1		120	120	107	120	131		679		1	8				5	84	10	16	1	23	16	22			3	14				3
West Africa Region 2	Mali	MLI	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												2,886					2,128				
West Africa Region 2	Sierra Leone	SLE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								9	24	53	65		47	33	25	17					210
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																																1					17
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																																					2
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																																1					12
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																																					3
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																																					3
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														1		1					5
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																																1					3
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														1		2					6
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														1							8
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														1		1					2
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																																2					13
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																																					4
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																																					2
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														2		1					24
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																																					1
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																																2					4
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																																					2
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																																					4
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																																3					10
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														2		3					15
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																																					3
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																																1					6
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														2							6
West Africa Region 2	Sierra Leone	SLE	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																																					1
Zambia	Zambia	ZMB	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					50,701		138,598			174,312		147,104			40,274		44,829	72,034		30,185		47,758	50,496		29,365		56,649	39,355		26,947		44,702	33,598				
Zambia	Zambia	ZMB	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female															534		9,296			746		3,504			1,217		2,253			2,197		6,000					
Zambia	Zambia	ZMB	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					55,398		117,577			159,613		142,802			77,608		112,666	107,259		38,654		104,909	127,129		67,208		111,500	75,138		41,507		71,517	65,386				
Zambia	Zambia	ZMB	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					5,469		18,284			32,628		35,160			71,266		89,831	53,376		36,239		82,006	80,519		48,408		86,249	56,184		42,497		67,597	48,699				
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						29,985					38,819					42,322					39,666														
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			308		621			800		958			1,403		2,395			3,264		3,645			6,136		8,159			9,221		7,969					9,546
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			24		51			212		127			288		406			624		555			837		1,287			1,519		1,173					994
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						34,903					46,008					50,189					49,017														
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			7		8			40		41			65		87			102		56			55		24			33		23					13
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,253		6,436			5,361		6,426			7,352		7,586			6,239		6,182			8,003		8,664			9,229		6,667					7,585
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			1							1															1										
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			32		50			68		53			164		151			205		156			184		223			256		173					176
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			6		26			15																	2										
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			25		136			27		23			19		2					10					1										12
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			15		8			18		17			25		41			48		48			70		88			100		90					87
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected										1										1			1												
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1					1		3					2			3		2			10		3			14		8					7
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			270		1,094			732		1,006			928		953			934		641			631		534			528		342					264
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1					3		5			1		7			3		2			5		2			5		3					4
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			2		6			7		4			26		17			12		9			7		9			3		5					3
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		9			17		38			50		57			67		27			22		17			13		16					13
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			16		38			57		47			116		142			163		146			145		163			185		133					111
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			2		1			6		12			13		20			18		8			15		7			9		10					6
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			14		28			32		41			87		78			118		123			167		196			220		198					256
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			200		393			700		598			1,448		2,421			3,688		3,505			4,570		6,516			6,351		4,813					4,648
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			35		161			219		167			261		140			103		109			94		95			91		51					74
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			312		920			711		852			852		811			677		517			621		585			594		345					324
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,896		14,744			10,620		10,895			13,800		14,707			12,092		9,384			10,160		12,700			10,879		7,618					7,952
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			301		184			170		167			262		125			94		78			78		81			66		65					72
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive					5			3		4			3																						
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,888		12,238			11,567		12,132			16,211		16,553			15,427		11,313			11,898		14,973			12,457		8,741					8,721
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1		2			1		4			12		7			2		1			4							2					2
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			72		220			537		689			928		930			1,102		1,020			1,229		1,488			1,699		1,196					1,104
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			1,662		12,646			9,412		9,962			11,849		13,199			10,664		8,546			8,497		10,750			8,454		5,841					6,408
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								1		3			2					2		1			1												
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1		2			3		7			17		10			11		9			8		7			4		4					4
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			31		117			191		428			669		1,453			1,315		1,448			1,446		433			369		338					265
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			18		82			194		254			593		1,314			1,019		1,136			1,305		486			354		382					287
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			41		68			80		74			180		211			235		196			267		264			324		181					198
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			22		78			162		359			456		946			853		856			994		273			257		234					185
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			296		1,006			685		889			855		950			724		520			640		617			542		335					269
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			8		88			144		290			609		1,573			1,450		1,667			1,661		496			353		319					218
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			81		223			238		253			273		251			242		199			272		277			308		182					147
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			15		9			17		30			23		39			33		37			37		49			42		51					32
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			6		19			15		53			40		43			48		34			54		64			56		55					35
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			164		87			151		95			135		88			60		51			47		31			45		36					59
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			130		236			234		273			317		341			269		249			268		298			336		185					186
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			225		121			181		137			171		131			100		64			72		73			71		54					60
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						45,599					58,762					63,472					59,228														
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,671		13,405			13,322		15,567			20,147		19,942			20,511		14,331			13,165		15,613			11,656		7,782					7,887
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			7		6			6		54			23		17			21		14			14		25			17		20					19
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		4			4		12			15		9			9		6			8		6			10		3					2
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			7		7			8		53			27		29			26		24			29		35			36		33					24
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										87,375					76,552				
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								1		2																									
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative										6																									
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			1					2		60			18		14			17		21			12		5			15		7					4
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			19		39			51		53			151		167			206		179			215		243			301		175					196
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			3		2			27		8			10		4			10		2			3		2			2		1					
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			10		4			12		10			27		33			47		32			34		13			29		14					16
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			114		239			495		451			1,026		1,854			2,668		2,732			3,228		4,648			4,380		3,183					3,060
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			7		7			16		9			26		34			26		32			31		53			69		71					39
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1		2			23		10			18		26			135		71			106		230			269		186					213
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected																									1										
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			3,093		13,829			11,982		12,997			15,816		16,183			15,127		10,921			11,501		14,207			11,647		7,997					8,453
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						41,934					51,951					56,226					54,808														
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			101		588			431		591			583		564			392		306			376		375			352		230					159
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			4		1			4		10			10		17			13		11			2		5			6		3					6
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			20		106			173		359			590		1,413			1,120		1,300			1,264		414			347		294					216
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1		1			2		1			5		7			5		1			1		1			2		1					4
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						42,529					51,463					56,133					52,058														
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			789		2,029			3,459		3,082			4,533		4,779			4,432		4,005			5,061		5,842			6,280		4,432					3,926
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			274		984			618		746			674		770			586		394			549		556			515		309					260
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										144,795					115,809				
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			4					5		146			13		18			19		7			11		10			8		10					7
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive										10			1		1					3			1		1										
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			405		748			910		888			1,881		3,547			4,818		4,884			6,320		9,063			9,288		6,821					6,962
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			317		677			884		832			2,097		3,250			4,435		4,468			5,671		8,211			8,150		5,646					5,709
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			64		11			24		53			30		28			19		8			12		7			16		9					7
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			7		18			36		28			49		69			81		43			35		15			16		25					17
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative					13			39		122			105		158			108		137			238		57			66		56					37
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			38		68			70		87			155		203			259		184			256		294			368		211					231
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			271		726			837		944			1,706		3,822			5,283		5,448			6,296		9,768			9,252		6,473					6,904
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			12		17			38		44			52		44			70		50			57		59			83		39					46
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			202		119			104		121			204		159			116		116			124		122			127		118					115
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		13			42		23			48		60			89		49			58		21			36		30					17
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			9		37			108		267			386		773			677		666			667		190			170		149					135
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			126		40			191		127			117		101			46		28			39		32			34		22					38
Zambia	Zambia	ZMB	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			10		21			39		37			70		93			103		69			72		37			23		40					22
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			41		68			80		74			180		211			235		196			267		264			324		181					198
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			296		1,006			685		889			855		950			724		520			640		617			542		335					269
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			312		920			711		852			852		811			677		517			621		585			594		345					324
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			12		17			38		44			52		44			70		50			57		59			83		39					46
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			32		50			68		53			164		151			205		156			184		223			256		173					176
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			7		18			36		28			49		69			81		43			35		15			16		25					17
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		9			17		38			50		57			67		27			22		17			13		16					13
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			1					1		3					2			3		2			10		3			14		8					7
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			101		588			431		591			583		564			392		306			376		375			352		230					159
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			10		4			12		10			27		33			47		32			34		13			29		14					16
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			270		1,094			732		1,006			928		953			934		641			631		534			528		342					264
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			19		39			51		53			151		167			206		179			215		243			301		175					196
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			38		68			70		87			155		203			259		184			256		294			368		211					231
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive										10			1		1					3			1		1										
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			7		8			40		41			65		87			102		56			55		24			33		23					13
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			16		38			57		47			116		142			163		146			145		163			185		133					111
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			14		28			32		41			87		78			118		123			167		196			220		198					256
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		4			4		12			15		9			9		6			8		6			10		3					2
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			274		984			618		746			674		770			586		394			549		556			515		309					260
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			130		236			234		273			317		341			269		249			268		298			336		185					186
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive								1		2																									
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			81		223			238		253			273		251			242		199			272		277			308		182					147
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive					5			3		4			3																						
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			7		7			16		9			26		34			26		32			31		53			69		71					39
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			10		21			39		37			70		93			103		69			72		37			23		40					22
Zambia	Zambia	ZMB	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		13			42		23			48		60			89		49			58		21			36		30					17
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							1												1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							37		32			38		36					22
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																									1			3		1					1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1													1												
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation					2			5		6			8		16			17		11			14		10			6		12					3
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			69		206			180		246			373		484			301		250			253		335			328		169					113
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																		1		2			4		2			3		3					1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							2							3					6
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			64		134			98		204			145		111			95		68			73		60			45		32					18
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							1					6		3					4
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							1		1					2					2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					8			6		13			39		65			59		29			38		18			12		20					14
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			1		1			4		6			2		7			9		4			9		14			18		21					16
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							5		10			3		5					8
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							4		8			9		8					14
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									1			1		1					1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							11		13			11		6					9
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																							2		1			2		1					5
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							2					3		2					1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP					1			28		17			87		96			138		101			139		113			131		75					82
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation			1					2		1			2		2			7		8			1		1										
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							3		3			9		9					11
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			12		15			7		7			15		14			20		13			27		20			21		34					13
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					2			12		6			25		43			51		21			22		13			18		8					10
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							14		4			11		6					8
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																														1					
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			9		14			8		18			50		66			67		48			64		68			77		52					47
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										3			12		15			16		7			5					5		7					2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			17		30			57		25			58		47			39		28			2		5					1					
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					6			9		3			5		4			3					2		1			1		2					2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			37		135			186		192			306		468			402		282			248		250			268		167					80
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																									1			1		1					6
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			24		43			40		52			44		39			37		27			38		37			12		14					11
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			79		298			174		197			258		252			274		165			146		146			130		129					107
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					3			4		5			12		39			35		16			8		6			4		8					6
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							1		6			5		5					3
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							1		1					1					
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP					4			14		13			9		16			22		11			21		21			37		16					14
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			1		3			8		5			6		20			28		12			5		1			1							
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation			1		1			2		3			8		13			15		16			10		5			8		5					5
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					3			13		4			5		6			5		4			1		4					6					1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							12		21			33		18					20
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation								2		1			1		2			1		2			1												
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy								1																				1		4					1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			6		4			26		10			42		61			89		70			63		83			69		48					45
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																				3					1										
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1			1		4			6		6			2		2			3		3			4		3					3
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			51		169			129		136			142		187			137		71			103		108			87		80					75
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							78		97			131		85					54
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							2					4		1					2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			48		128			87		119			115		97			61		83			62		56			26		30					19
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			18		131			81		125			115		114			85		61			67		85			49		72					55
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					2			1		1			13		25			32		17			4		1										
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1					14		6			3		5			4		1			1		1			3							1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation															1			2					4		3			5							2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP										1																									
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			1		7			9		12			45		63			52		21			33		13			18		15					6
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			28		152			87		142			148		131			102		111			12		44			1		4					
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			4		13			4		10			17		18			18		15			25		17			21		20					12
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1					4		11			6		6			4		1					2			2		3					
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			4		1			4		10			10		5			14		10			7		7			12		9					1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			16		41			71		89			94		92			75		87			82		103			162		91					49
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			2		10			2		6			17		14			9		15			1		3										
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		7			4		2			2		10			5		4			5		6			3		12					4
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							2		1			3		2					1
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			8		11			3												1					1										
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			9		21			10		11			29		33			18		19			36		24			22		27					15
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							8		15			16		30					22
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			3		8			18		17			59		104			172		114			141		130			156		102					85
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			73		191			103		200			155		113			120		94			80		66			51		19					21
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			5		5			27		8			61		95			114		96			74		99			93		84					73
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			2					22		7			3		7			7		3			2		3			6		2					2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							68		60			48		54					61
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							3		1			9		9					15
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			1		11			10		13			26		50			62		41			55		34			65		42					44
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			3		12			8		6			20		19			17		11			24		23			23		19					12
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			5		14			7		21			30		37			65		33			60		62			64		39					51
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							9		13			17		13					11
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			1					11		12			55		84			129		110			109		122			126		99					98
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			2					2		2			2		3			1																	
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy								1																											
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			9		16			8		16			28		23			19		14			27		15			33		23					19
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			16		44			34		50			40		50			52		22			8		6			5		2					
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			61		118			106		171			129		98			110		107			88		61			38		41					20
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			69		224			146		183			209		209			190		112			109		149			134		105					124
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1			1		4			2		2			1		1					2					2					
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							1					2		5					2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation					2			4		6			4		21			16		12			2		5			3		8					6
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy										6			1																						
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							14		24			14		5					4
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			1		1			5		3			8		10			24		16			12		24			31		27					14
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			4		12			9		18			16		39			50		39			36		41			50		42					32
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			15		37			45		56			70		70			62		42			55		80			70		76					54
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							5		4			6		9					12
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							1		1			5		1					9
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation			1		3			4		2			4		18			15		9			16		4			11		6					2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			59		201			157		175			185		207			203		109			113		143			100		102					104
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			30		75			92		88			87		55			46		49			42		32			37		31					9
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation					1			2		1								2																	
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							7					3		1					2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							3		1										2
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			57		240			152		276			313		376			280		175			205		299			363		196					122
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			3		6			8		12			28		34			84		108			3		13										
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			28		144			122		216			266		289			189		159			159		207			260		128					91
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			68		169			195		220			320		417			264		221			199		264			343		199					104
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							24		18			37		31					37
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					11			3		10			37		50			48		17			17		10			7		13					6
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2		5			4		12			10		13			14		9			12		14			15		14					14
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy					1																														
Zambia	Zambia	ZMB	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			8		15			11		21			43		60			58		38			67		67			84		56					67
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex			18,743	499	3,852	2,632	3,370	8,651	1,831	1,702	974	853	5,484	277	326	163	150	6,583	164	170	164	470	10,887	209	661	723	51	19,326	555	2,075	5,263	4,233	19,326				2,694
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			6,259	812	2,301	2,361	2,600	3,834	1,986	2,156	1,490	1,889	2,763	413	563	410	636	3,318	284	210	514	884	4,532	435	774	780	216	9,676	585	1,375	2,898	3,046	9,676				3,834
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			18,744	2,237	7,433	6,659	7,421	12,304	7,408	6,519	5,022	6,817	8,547	2,158	2,783	1,588	2,463	10,257	1,220	851	2,765	5,248	20,598	4,011	7,687	7,931	1,852		5,626	12,497	21,838	21,404					13,152
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			25,540	2,165	5,282	4,635	5,082	15,676	4,525	4,575	4,293	5,588	8,809	1,327	1,814	1,266	1,739	10,569	832	683	1,733	3,183	9,166	1,610	2,589	3,102	1,144		2,843	5,242	10,401	9,999					8,349
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex				5		4		208,155																								154					
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												55,247					55,247				
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			24,988	4,360	11,438	10,573	11,913	15,320	11,503	11,650	11,316	13,739	12,066	4,412	6,406	4,159	4,736	14,476	2,511	1,812	5,243	9,196	24,775	7,197	10,420	12,818	4,172		9,711	20,906	38,419	34,915					21,991
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				435	2,110	1,704	1,874	7,892	1,786	1,876	1,539	1,952	3,901	424	682	462	982	4,684	338	193	726	1,050	3,844	533	818	946	287		855	1,598	3,420	3,248					2,720
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				603	2,222	1,682	1,880	8,340	2,294	2,538	2,282	3,058	4,148	682	982	681	1,172	4,976	451	288	1,009	1,465	4,180	799	1,148	1,358	359		1,209	2,286	4,932	4,772					4,031
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			25,318	3,293	6,859	7,109	7,935	16,202	8,838	9,921	8,002	11,718	10,725	3,308	4,319	2,552	3,364	12,871	1,640	1,359	4,215	6,894	13,860	4,255	6,385	6,893	2,761		6,817	12,762	23,191	21,528					18,714
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			25,094																																		
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												88,530					88,530				
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												40,445					40,445				
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			6,431	801	2,518	2,500	2,794	3,948	2,420	2,731	2,111	3,071	2,933	733	990	628	936	3,520	414	305	920	1,272	4,760	616	1,332	1,262	340	10,289	1,020	2,150	4,473	4,491	10,289				5,315
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			25,225	2,367	5,290	5,512	5,983	16,828	6,986	7,466	6,727	9,372	10,324	2,720	3,549	2,319	2,882	12,389	1,440	1,265	3,388	5,529	12,323	3,263	4,685	5,593	2,014		5,278	10,339	18,286	17,429					14,789
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			25,459	2,064	4,318	4,267	4,661	16,886	5,157	5,587	5,015	7,145	9,570	1,712	2,364	1,551	2,554	11,487	981	954	2,326	3,740	9,240	1,759	3,133	3,656	1,250		3,328	6,526	12,407	11,534					9,881
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			24,954																																		
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												61,702					61,702				
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female				173	8	347	4		25	20	5	24													2				117	1	15	1					4
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			24,953	2,687	6,834	6,829	8,066	15,884	8,040	9,225	7,186	10,215	10,205	3,074	3,937	2,361	3,013	12,244	1,480	1,227	4,032	6,664	19,869	3,949	6,299	6,617	2,277		6,556	12,080	23,094	22,239					15,345
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			24,959	3,809	9,825	8,625	9,502	15,574	9,249	9,181	8,278	11,408	11,281	3,356	4,340	2,592	3,466	13,538	1,752	1,400	3,992	7,510	15,842	4,114	5,886	7,336	2,753		6,945	13,471	25,776	23,455					19,936
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				1,275	3,621	3,386	3,529	7,892	3,038	3,029	3,003	3,536	5,015	745	1,033	848	1,377	6,017	461	348	1,155	2,007	6,507	1,089	1,642	1,971	540		1,753	3,038	6,768	6,648					5,290
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male				54	6	317			39	23	4	27													10				85		6	5					5
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												42,636					42,636				
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												68,018					68,018				
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			25,160	2,581	6,925	5,929	6,592	15,538	6,450	6,488	5,757	8,176	9,645	2,064	2,764	1,702	2,451	11,571	1,359	1,098	2,690	5,073	12,530	2,834	4,031	4,964	1,755		4,703	9,068	17,148	16,476					13,955
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				1,475	3,734	3,365	3,756	8,340	3,837	4,341	3,942	5,214	5,522	1,323	1,648	1,140	1,594	6,628	771	500	1,657	2,885	7,050	1,507	2,265	2,628	870		2,467	4,588	9,078	8,652					7,167
Zambia	Zambia	ZMB	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			12,519	1,311	4,444	3,947	4,691	7,973	4,272	3,918	2,752	4,583	5,215	1,182	1,750	829	1,164	6,256	612	482	1,908	3,318	17,976	1,803	2,829	3,148	838		3,214	5,921	13,176	12,607					7,932
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				19,876	23,123	18,586	14,491	21,786	12,538	13,045	9,366	9,802	27,797	9,219	9,349	8,477	7,274	32,955	8,022	8,564	8,648	9,263	26,942	8,933	10,397	10,904	12,415		12,057	16,015	17,302	19,901					16,331
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																								3	1		2		16	28	34	41					16
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			93,937	115,270	104,817	89,337	69,578	85,542	59,627	62,840	52,569	52,584	96,459	50,547	51,969	50,333	45,635	169,951	46,855	51,477	52,734	56,519	269,990	60,818	69,437	73,101	84,303		83,335	107,724	114,555	125,885					105,419
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												363,599					117,795				
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			126,620	41,079	37,906	28,726	20,789	52,581	15,416	16,512	11,370	11,869	43,183	10,866	11,231	9,668	8,499	35,643	9,152	9,954	10,123	10,600	167,658	10,659	12,072	12,357	14,594	207,730	13,646	17,947	19,368	23,779	235,602				72,305
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			142,104	84,259	72,900	76,561	54,440	66,545	33,635	26,636	21,829	22,645	76,191	17,382	16,256	16,869	12,545	25,935	15,154	17,118	21,993	35,515	69,621	33,684	27,228	35,563	48,850		56,458	56,163	58,916	57,361					34,952
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			182,839	156,004	138,950	111,987	79,876	108,889	74,254	71,488	55,625	57,628	120,004	59,102	60,236	56,980	54,456	188,151	62,664	67,356	67,841	87,444	373,269	93,915	96,992	95,100	111,110		113,773	145,987	149,939	166,095					138,676
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex				12,269	12,104	8,705	5,327	405	3,588	3,482	2,079	1,866		1,668	1,354	1,150	1,053		862	1,747	1,360	1,567		557	648	789	996		910	1,665	1,690	1,416					512
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			93,488	81,156	75,036	65,442	51,227	89,292	42,487	44,122	36,090	36,492	74,097	34,328	35,202	34,397	30,755	126,254	32,009	33,822	34,413	37,101	161,751	38,558	43,510	46,233	52,665		51,454	65,617	68,983	76,834					64,919
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				23	463	306	4		8	4	5			1	108	45	24		29	5		12		22	26	7	20		10	29	4	4					12
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			119,438	69,863	66,775	60,847	49,680	34,860	38,734	40,455	32,225	34,900	32,935	34,279	36,252	33,545	27,605	33,321	29,623	32,837	33,758	34,609	95,955	35,071	41,212	44,665	49,063		49,221	62,797	62,919	68,487					48,164
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			361,632																																		
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				17,403	21,092	19,002	16,160	28,127	15,024	15,365	11,652	12,790	30,724	12,787	13,572	12,628	10,579	25,135	11,164	12,460	12,328	12,803	19,198	12,134	14,172	15,331	16,869		16,218	20,532	21,059	24,642					19,106
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												478,212					220,804				
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												190,534					77,572				
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			93,541																																		
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	<05	<05	Missing Sex			74,251																																		
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												816,051					607,459				
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				48,138	43,240	38,705	30,817	35,361	22,104	23,545	18,302	19,901	34,330	19,797	20,936	19,381	16,280	30,848	16,948	19,034	19,376	20,367	27,815	19,848	23,187	24,700	27,179		26,005	34,213	34,146	39,621					26,633
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												280,223					62,446				
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				16	57	7	4		7	1	2			2	3				2																		
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				99,104	83,604	53,723	30,415	38,175	26,097	24,784	19,371	17,343	13,814	19,422	18,254	16,430	17,764	18,451	23,322	36,053	42,027	62,232	85,532	45,142	32,476	31,104	37,897		37,444	70,365	103,818	103,041					66,517
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			120,023	94,186	88,934	80,700	64,873	137,589	52,016	53,041	40,570	43,952	65,816	43,620	43,674	41,405	33,229	32,577	37,220	40,184	40,880	42,124	128,533	44,070	51,039	54,303	60,706		62,413	76,920	75,997	81,111					60,093
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				24	379	210	8		14	2	1	1		1	16				1	1	5			28	44	14	46		53	149	6	15					9
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			183,928	221,388	197,187	162,192	121,638	149,947	110,025	118,643	98,384	98,158	159,190	96,384	98,184	92,825	83,383	283,715	88,580	95,775	95,995	101,415	511,698	111,627	135,209	141,737	158,240		166,130	210,457	217,304	234,166					184,510
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			202,264	107,725	99,540	91,243	71,284	106,170	54,076	53,436	40,451	40,913	56,252	38,153	34,738	34,980	28,983	33,240	35,215	37,819	38,446	40,288	116,875	43,925	51,908	56,739	66,094		70,956	81,356	83,932	86,302					57,597
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				74,090	69,915	44,892	25,589	75,305	19,706	18,421	12,651	12,305	35,118	12,431	13,172	12,851	13,161	41,340	14,486	27,071	39,229	71,078	6,167	47,564	27,340	27,156	32,933		29,081	53,592	65,545	87,446					56,014
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			128,615	103,064	89,067	81,855	48,215	83,597	31,664	26,560	14,138	13,488	47,114	12,242	12,720	12,477	13,046	41,516	14,926	26,168	37,027	70,773	3,805	52,584	29,126	29,986	36,849	434,253	32,252	55,973	71,509	96,894	39,798				46,482
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			155,158	35,053	34,104	29,060	23,172	71,226	17,739	19,617	14,158	15,286	37,093	14,309	15,865	14,089	12,792	41,099	13,150	14,603	14,655	15,170	100,494	15,434	17,672	18,385	21,430	182,956	19,541	25,098	25,521	31,560	82,664				95,971
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												434,411					260,081				
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												572,964					439,175				
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			93,957	163,986	149,796	126,509	101,028	113,718	89,474	93,437	77,547	77,686	130,943	75,240	78,076	75,126	67,161	230,532	70,179	75,411	76,786	81,422	362,164	87,859	101,100	104,262	118,534		120,155	152,748	158,051	171,813					153,857
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			119,754																																		
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			120,053	52,618	52,067	48,308	39,418	39,487	30,839	32,022	24,921	26,575	35,710	26,384	27,827	26,279	22,012	32,085	23,444	25,963	25,897	27,096	40,813	26,648	31,080	32,806	35,792		35,008	44,962	45,027	50,106					36,263
Zambia	Zambia	ZMB	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				56,193	48,707	41,201	30,214	33,878	22,720	23,648	18,597	18,628	40,120	17,611	17,693	16,929	14,933	61,925	15,956	17,058	17,667	18,874	64,495	19,340	22,353	23,836	27,023		26,674	35,410	37,998	42,811					33,138
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			11,734																																		
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			15,014	9,714	9,458	8,479	8,909	5,018	7,995	7,416	6,212	6,221	8,300	6,241	6,587	6,000	5,005	9,783	5,106	5,807	5,511	5,205	4,899	4,523	4,590	4,106	4,269		4,025	4,322	4,139	3,961					3,421
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			12,762	5,522	5,696	5,450	5,568	7,298	4,802	4,350	3,731	3,755	9,932	3,552	3,819	3,686	3,130	11,610	3,030	3,436	3,252	3,309	2,853	2,678	2,732	2,501	2,410		2,234	2,446	2,204	2,183					1,741
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			9,793																																		
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				1,490	1,317	1,091	953	1,408	768	721	667	589	783	649	620	456	427	1,941	629	539	530	497	4,366	497	455	400	367		429	481	443	433					339
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				4,167	4,033	3,710	3,709	7,527	2,988	2,593	2,214	2,226	8,771	2,182	2,229	2,186	1,749	10,966	1,866	1,994	2,126	2,120	2,399	1,583	1,691	1,586	1,538		1,425	1,571	1,492	1,347					1,119
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												6,788					1,355				
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			19,308	8,994	8,801	7,345	7,073	3,697	6,189	5,930	5,209	5,022	5,481	4,939	5,270	4,942	3,965	5,706	4,288	4,664	4,359	4,392	7,691	3,987	4,016	3,740	3,618		3,850	4,226	3,843	3,877					2,844
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												28,460					5,231				
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			11,647	2,611	2,396	1,967	1,989	1,621	1,576	1,387	1,100	1,082	2,131	1,149	1,135	1,097	808	2,310	874	896	965	916	5,304	780	885	775	800		744	891	743	721					585
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	<05	<05	Missing Sex			2,105																																		
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	Retired Age Band	Missing Sex									2																												
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				8	23	18	1		1		2				1					1				2	4	3	2		1	2							
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												12,650					6,536				
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			15,813																																		
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				1,058	1,011	819	771	2,673	639	542	453	383	1,603	402	481	406	367	3,929	401	403	441	384	313	352	305	280	285		269	267	248	280					236
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				967	1,641	1,416	1,621	4,934	1,592	1,366	1,239	1,209	6,692	1,205	1,325	1,260	1,039	8,252	1,050	1,187	1,068	1,176	1,919	920	971	863	902		773	924	845	774					621
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												5,624					5,128				
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			14,491	2,052	2,149	1,856	1,917	8,043	1,445	1,444	1,213	1,267	8,698	1,175	1,237	1,258	1,040	10,418	1,049	1,193	1,174	1,161	17,128	1,086	1,017	931	981	15,376	893	968	955	988	13,178				961
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			11,324	3,019	2,852	2,346	2,250	1,786	1,963	1,682	1,351	1,256	2,378	1,403	1,434	1,351	1,140	1,888	1,277	1,456	1,408	1,373	7,248	1,294	1,393	1,200	1,194		1,341	1,426	1,269	1,317					1,148
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				5,237	4,762	4,450	4,521	4,587	3,291	3,184	2,462	2,572	5,874	2,563	2,997	2,841	2,330	6,967	2,271	2,470	2,447	2,405	2,264	1,972	1,990	1,875	1,821		1,637	1,881	1,642	1,645					1,235
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												16,716					3,231				
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												2,692					610				
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			2,112	1,402	1,117	895	868	2,569	688	525	474	443	2,292	394	467	389	333	5,398	406	446	427	405	181	367	332	283	276	2,769	255	271	266	253	918				222
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				1,342	2,072	1,907	2,183	3,770	2,079	1,990	1,655	1,707	5,275	1,582	1,893	1,852	1,491	6,077	1,501	1,637	1,551	1,496	1,599	1,216	1,310	1,207	1,162		1,127	1,210	1,071	1,078					887
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			15,938	5,021	5,695	5,149	5,384	3,967	4,329	4,024	3,289	3,348	5,872	3,222	3,651	3,614	2,831	6,565	2,895	3,121	3,073	3,062	3,181	2,484	2,433	2,272	2,258		2,169	2,283	2,083	1,934					1,585
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			4,766	980	850	546	536	856	487	286	295	248	1,320	236	263	252	200	1,061	200	225	237	274	1,167	204	224	215	185		190	223	160	167					125
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			13,893	7,371	7,536	6,730	7,205	6,125	6,073	5,882	4,806	4,928	9,030	4,735	4,987	4,769	3,962	10,573	4,101	4,674	4,394	4,418	5,877	3,686	3,623	3,446	3,379		3,157	3,637	3,298	3,306					2,570
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			22,980	2,344	2,612	2,299	2,412	7,232	1,810	1,880	1,473	1,612	7,064	1,464	1,806	1,703	1,389	9,080	1,411	1,548	1,514	1,529	9,812	1,380	1,378	1,293	1,246	12,143	1,195	1,247	1,218	1,198	3,571				1,231
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												2,188					3,760				
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				10	16	14	3				1	1												1	3		1		3	2		1					3
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	<10	Retired Age Band	Missing Sex																															1						1
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			15,865	4,643	4,784	3,964	4,248	2,715	3,574	3,298	2,592	2,580	3,472	2,617	2,788	2,625	2,001	3,482	2,132	2,324	2,303	2,103	7,633	1,883	1,785	1,670	1,631		1,651	1,770	1,538	1,573					1,298
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex				260	184	181	201	9	101	64	64	87		53	58	44	57		19	34	33	27		25	42	37	52		39	38	48	35					15
Zambia	Zambia	ZMB	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			15,863	5,453	5,709	4,924	5,266	3,439	4,337	4,087	3,256	3,454	4,636	3,267	3,765	3,527	2,796	5,479	2,804	3,133	3,072	2,891	7,904	2,470	2,509	2,360	2,270		2,226	2,489	2,184	2,186					1,738
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				3,162	3,459	3,397	3,095	10,290	3,233	3,524	3,426	3,370	14,039	3,340	3,382	3,128	3,229	8,518	2,987	3,078	2,976	3,121	9,511	3,046	3,177	2,896	2,859		2,812	3,058	3,179	3,357					3,398
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				2,768	2,673	2,416	2,328	7,904	2,332	2,529	2,554	2,384	11,319	2,410	2,445	2,326	2,187	10,506	2,186	2,243	2,087	2,131	6,467	2,169	2,298	2,048	2,055		2,043	2,317	2,186	2,401					2,211
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				37	49	49	46	6	54	99	72	55	1,044	73	74	58	64	189	57	76	51	81	363	51	64	74	67		64	66	59	65					81
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				4	20	6	4	8	1	9	4	15		4	1	7	2		2	5	5	5				3				1	2						
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												9,224					11,282				
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												21,585					23,523				
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				1,764	2,021	2,175	2,255	12,524	1,800	2,207	2,168	2,040	8,239	1,918	2,027	2,058	2,158	4,119	1,898	1,887	1,907	2,036	7,299	1,849	2,014	1,945	1,975		1,826	2,020	2,121	2,147					2,238
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												11,601					12,181				
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female					19	4	3																														
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				503	520	592	589	6	511	642	619	586	3,162	533	584	568	574	1,348	532	554	552	602	2,216	524	605	664	667		567	740	729	735					796
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				2,918	2,903	2,974	2,814	10,629	2,535	2,886	3,014	2,835	11,241	2,865	2,755	2,825	2,745	5,995	2,556	2,721	2,611	2,719	8,911	2,625	2,839	2,821	2,778		2,655	2,995	3,125	3,207					3,454
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								1	3	2	2		3	1	4	2					4
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				19	26	10	8	46	13	3	10	19		6	7	8	5		4	20	8	9		11	10	10	8		11	9	7	9					7
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	65+	50+	Female																								1													
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				802	677	677	569	2,653	661	573	626	555	3,376	637	579	517	614	7,088	657	730	629	634	1,570	686	714	613	637		761	795	699	705					728
Zambia	Zambia	ZMB	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex					13	1			1		1									1											1	1					
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			56,553																																		
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			119,210	29,886	30,904	29,984	28,282	93,230	27,942	30,064	29,561	30,276	119,263	27,680	30,155	30,271	29,653	109,399	28,882	30,270	30,400	31,635	107,213	30,958	33,355	32,762	32,668		31,077	34,954	35,892	37,426					45,146
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex				900	1,009	699	635	621	687	701	424	538		524	579	505	524		852	789	642	792		847	750	707	759		1,030	973	683	674					702
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				16	57	7	4		8	1	2			2	3				2					3	1		2		16	2	8						
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			876	30,751	31,113	27,539	26,148	89,153	27,262	25,918	23,141	24,957	115,785	26,391	29,118	26,061	27,199	97,601	31,119	32,709	29,096	30,486	95,390	33,500	36,240	31,779	32,630		35,639	37,800	33,900	36,006					42,554
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												81,094					81,906				
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female					68	60			3								1					12		4													4
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			93,012	20,324	20,485	20,040	18,667	66,317	18,265	19,669	19,781	19,809	79,710	18,390	19,229	19,980	19,813	75,402	18,632	20,207	20,330	21,428	73,831	20,668	22,668	22,772	22,678		21,281	24,387	26,093	27,015					30,184
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			87,770	40,102	40,193	37,587	35,215	127,391	34,854	39,268	38,512	39,118	153,327	36,886	40,521	38,894	37,607	143,077	37,717	40,853	39,454	40,096	140,219	40,494	45,181	42,711	42,581		41,707	48,010	48,175	50,120					52,412
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			65,770	12,266	13,275	12,903	12,880	66,319	11,586	12,501	12,843	12,680	51,664	11,114	12,018	12,821	12,639	50,231	11,603	11,972	12,214	12,850	49,186	12,232	13,414	13,679	13,600		12,297	14,056	15,048	15,646					17,083
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female			83	75	52	60	45	126	58	63	22	42		25	12	28	28		34	32	30	43		38	40	32	36		24	30	38	50					49
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												287,218					290,088				
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				3,447	4,107	3,838	3,489	43	3,270	3,781	3,782	3,619	15,888	3,170	3,524	3,655	3,607	15,264	3,327	3,693	3,774	3,892	14,953	3,480	4,112	4,432	4,350		3,770	4,589	5,035	5,104					5,522
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				468	561	520	433	43	521	601	481	489	3,396	414	548	527	434	2,303	404	523	494	612	2,267	370	497	551	526		451	575	581	580					701
Zambia	Zambia	ZMB	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												220,711					222,919				
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			8,275																																		
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			11,493	3,005	2,951	2,676	2,566	8,256	2,468	2,601	2,565	2,475	11,375	2,434	2,458	2,372	2,209	10,526	2,248	2,297	2,145	2,159	6,467	2,218	2,338	2,069	2,082		2,072	2,333	2,224	2,441					2,237
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			604	927	815	767	723	2,805	705	635	599	581	3,398	650	592	542	617	7,093	677	760	649	643	1,570	696	720	623	635		765	790	695	711					741
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			11,911	3,027	2,984	3,167	2,970	11,181	2,696	2,976	3,034	2,912	11,344	2,905	2,800	2,847	2,785	6,025	2,608	2,774	2,649	2,761	8,912	2,666	2,879	2,849	2,775		2,660	3,013	3,195	3,251					3,476
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			13,663	3,426	3,579	3,657	3,285	10,800	3,397	3,642	3,479	3,448	14,130	3,316	3,398	3,169	3,270	8,557	3,036	3,113	3,037	3,185	9,511	3,090	3,222	2,922	2,906		2,829	3,068	3,187	3,362					3,419
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female			9	5	9	7	7	16	2	6	2	12		4		7	2		3	6	5	5		2	5	4	3		5	2	3	2					4
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												11,609					12,210				
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												9,291					11,408				
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			10,538	1,907	2,091	2,288	2,349	13,206	1,901	2,235	2,198	2,114	8,353	1,963	2,053	2,090	2,152	4,139	1,922	1,907	1,916	2,070	7,299	1,857	2,060	1,955	2,015		1,844	2,035	2,147	2,173					2,256
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex									2																						1						
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex				15	17	14	12	58	11	9	11	18		5	7	8	7		5	13	7	9		9	10	9	8		11	9	7	8					7
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												21,691					23,680				
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female					6	6											1																				
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				45	45	52	62	7	68	84	74	60	1,083	71	76	53	64	189	55	85	52	78	363	52	65	76	62		64	63	57	63					81
Zambia	Zambia	ZMB	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				534	468	639	630	7	578	655	644	638	3,261	542	590	595	574	1,349	535	571	561	605	2,216	528	617	661	678		576	738	737	748					798
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Male																												20,324					31,608				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			122,684		139,481		146,472	158,889		98,444		79,803	143,933		74,488		24,419	77,264		72,809		79,533	77,498		50,653		37,066	77,915		41,274		33,792	116,891				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Female																												13,309					20,322				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male			62,615		64,427		26,609	38,844		35,405		23,121	5,103		11,644		6,719	4,678		9,153		15,323	4,389		12,432		26,027			18,300		18,532					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male			62,458		53,215		66,305	48,419		74,783		43,887	11,675		35,060		23,927	12,135		38,986		37,103	10,376		39,054		55,875			43,789		36,063					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			63,027		188,810		172,945	89,569		136,546		79,083	103,339		146,820		54,984	98,547		110,312		149,046	95,669		129,743		111,566			120,780		96,252					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female					63		121			159		9			73					14		26,759			156		6			450		199					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-34	25-34	Female																												27,297					43,212				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male			62,668		33,800		49,408	43,843		55,348		34,607	6,051		25,235		17,113	6,203		19,168		28,953	5,529		28,653		45,922			34,842		32,074					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Female			62,149																																		
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male			127,284		67,758		75,987	76,795		90,968		49,728	22,152		48,796		25,489	24,505		38,654		70,566	25,898		50,505		65,424			57,592		43,951					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-49	35-49	Male																												12,185					18,639				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male					54,562		12,291	10,819		18,391		13,585	3,103		3,856		2,557	2,646		4,107		7,485	2,307		5,703		14,134			8,902		9,962					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female					21,136		16,260	18,587		19,728		13,759	5,106		5,795		3,286	4,649		4,564		8,596	4,295		7,988		22,067			13,734		14,388					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												194,846					291,395				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												50,582					75,026				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male			62,722		44,982		56,739	57,562		61,849		38,498	24,255		37,306		22,555	25,335		47,254		94,831	27,126		65,755		50,118			66,993		60,556					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male					15,011		22,489	18,634		28,027		20,671	5,106		7,806		4,921	4,649		7,276		11,919	4,331		9,359		21,777			14,117		15,357					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male			5,861		7,179		9,722	10,941		20,979		15,856	4,354		2,978		1,978	3,521		3,578		6,970	3,551		4,421		13,526	3,920		8,874		10,832	5,884				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female			6,169		8,552		10,332	12,671		12,594		9,738	6,153		2,396		1,627	5,345		2,413		4,330	5,359		3,759		13,220	6,092		7,861		9,705	9,130				
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male					47		30			123		73			49					200		22,758			145		9			410		700					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			296,961		212,052		180,659	161,800		162,933		112,856	97,099		150,424		60,924	141,894		100,868		122,785	150,881		125,261		136,787			128,796		85,403					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female			62,297		24,929		23,119	43,047		27,996		17,599	6,103		9,609		5,390	6,376		6,825		12,177	5,225		12,154		31,414			18,586		18,645					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female					10,430		10,384	10,261		12,880		9,079	3,103		3,201		1,977	2,646		2,464		5,223	2,307		4,659		14,693			8,245		8,706					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female			62,678		30,965		30,735	55,565		36,908		23,300	9,052		14,975		10,909	10,288		13,585		19,837	8,343		20,771		42,711			28,491		28,095					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female			123,448		76,514		41,862	70,613		48,457		34,500	16,583		24,823		14,454	17,997		25,673		26,866	14,563		28,176		53,969			36,635		33,435					
Zambia	Zambia	ZMB	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Retired Age Band	35-49	Male			61,037																																		
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Male																						3								2							
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			1,003	1,179	996	949	956	773	857	938	951		879	960	1,005	1,209					493
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			3,594	3,280	2,866	2,893	4,189	2,198	2,737	4,136	4,390		4,279	4,544	4,788	5,602					1,567
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			4,323	4,294	3,432	3,489	4,243	1,507	2,835	4,108	4,496		3,421	4,903	5,095	5,638					1,902
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			920	721	515	620	1,045	324	570	915	1,201		1,099	1,190	1,339	1,200					285
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												6,061					6,279				
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			1,838	1,927	1,588	1,554	1,933	1,355	1,465	1,749	1,785		1,717	1,901	1,954	2,279					1,033
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												9,775					10,014				
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			2,578	2,491	2,047	2,020	2,920	1,678	2,024	2,523	2,618		2,424	2,623	2,694	3,149					986
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			1,197	1,271	1,043	1,035	1,132	831	915	1,121	1,119		1,050	1,170	1,236	1,297					488
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			2,970	2,825	2,319	2,387	4,350	1,600	2,249	3,409	4,107		3,853	4,219	4,182	4,659					1,200
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			4,766	4,782	3,840	4,032	6,666	3,076	3,912	4,821	5,421		5,196	5,554	6,650	7,584					3,057
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			1,791	2,012	1,650	1,639	1,904	1,327	1,591	1,774	1,862		1,625	1,750	1,887	2,197					695
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			1,634	1,600	1,408	1,337	1,213	1,003	1,204	1,260	1,305	1,155	1,225	1,348	1,541	1,617	1,187				630
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			10,902	11,093	9,272	10,292	10,230	4,398	7,029	10,839	11,665		8,853	12,979	13,651	14,933					3,792
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												13,630					14,152				
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												6,501					6,607				
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												5,265					5,248				
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			2,772	2,779	2,444	2,288	3,225	2,008	2,199	2,573	2,932		2,517	2,765	2,889	3,459					1,600
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			3,145	2,983	2,564	2,554	3,064	1,996	2,531	3,264	3,393		3,401	3,666	4,048	4,826					1,397
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																						1		4						3							
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			3,709	3,654	3,127	3,147	3,971	2,592	3,167	3,646	4,229		3,909	4,170	4,784	5,819					2,392
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			809	885	739	679	743	556	655	689	678	710	645	775	816	899	730				422
Zambia	Zambia	ZMB	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												5,500					5,654				
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					459		1,402	1,409		1,714		2,167	2,623	2,336	3,083	3,803	4,982	2,366																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					882		2,238	1,626		2,650		4,236	15,276	4,531	6,523	8,441	10,858	13,749																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					731		1,745	1,515		2,238		3,427	2,416	3,550	4,906	6,212	8,035	2,037																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					824		2,155	1,393		2,577		3,989	4,211	4,506	6,230	7,627	10,367	3,800																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					1,052		2,608	1,668		3,429		5,432	15,645	6,150	8,661	11,434	15,200	16,871																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					457		1,120	1,233		1,492		2,363	6,079	3,089	4,979	7,459	12,167	5,516																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					214		553	372		462		801	2,628	985	1,609	2,028	3,306	3,252																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					1,012		2,450	1,515		2,926		4,623	5,648	5,221	7,438	9,300	13,171	4,585																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					674		1,910	1,446		2,466		3,365	8,354	3,515	5,085	6,336	8,214	7,777																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					437		1,142	196		1,578		2,098	733	1,996	2,515	2,998	4,008	439																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					604		1,539	1,531		1,778		2,467	2,620	2,626	3,407	4,097	5,679	2,140																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					11		3								3	1																					
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					1,257		2,806	2,290		3,895		6,516	33,369	8,500	12,958	17,837	28,997	33,119																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					143		455	713		1,105		1,264	1,178	1,353	1,765	2,138	2,785	1,317																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					178		585	278		844		1,050	895	992	1,356	1,644	2,209	1,129																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					805		1,662	743		1,993		3,522	5,573	4,368	6,288	8,086	12,283	4,596																			
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female					4		7								1	1																					
Zambia	Zambia	ZMB	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					180		573	740		1,201		1,584	1,690	1,676	2,227	2,664	3,511	1,599																			
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					268		915	1,539		827		930	2,109	1,001	1,033	1,056	1,017	1,920	980	1,240	1,203	1,208	4,671	1,198	1,892	2,049	1,742		1,943	2,893	2,588	2,412					1,180
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												21,001					20,957				
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												25,884					26,378				
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												24,160					25,034				
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					81		238	778		545		489	919	544	535	559	479	1,065	517	612	644	696	2,458	595	877	957	896		881	1,408	1,119	1,092					480
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					323		732	1,338		1,096		1,483	4,668	1,539	2,748	3,235	3,579	4,468	2,959	3,409	3,254	3,169	11,057	3,872	7,742	7,556	6,271		7,732	10,566	9,102	7,398					4,935
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female			2,157		635		1,503	2,241		1,478		2,151	12,175	2,095	2,535	2,832	2,356	11,126	2,445	3,136	3,414	3,295	10,599	3,180	5,835	5,797	5,241		5,740	9,131	7,794	6,840					4,146
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												38,905					40,008				
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			1,435		871		1,823	2,290		2,710		3,973	26,700	4,270	6,316	7,377	8,755	26,804	6,343	7,564	7,472	6,586	24,720	7,138	17,011	16,998	13,112		17,125	23,334	19,469	15,848					7,156
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												21,905					22,556				
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					136		271	402		325		535	2,160	538	806	839	702	2,636	574	880	809	929	3,821	988	1,919	2,264	2,487		2,361	2,862	2,327	2,076					590
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					343		1,017	1,199		931		1,166	1,942	1,224	1,234	1,298	1,174	1,735	1,134	1,626	1,429	1,570	4,865	1,483	2,499	2,805	2,639		2,714	4,141	3,058	2,847					825
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					123		308	801		610		673	1,258	660	761	792	701	1,298	716	967	883	939	2,930	873	1,374	1,614	1,629		1,575	2,323	1,802	1,776					518
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												54,837					56,547				
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female			431		484		1,116	1,595		1,277		1,594	6,662	1,571	1,889	1,948	1,681	6,293	1,765	2,131	2,105	2,136	7,974	2,124	3,530	3,537	3,171		3,329	5,105	4,425	4,118					2,486
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female					4		6								1							37		3					1	1							1
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					132		357	302		354		410	710	389	413	478	364	912	394	469	457	488	1,926	440	642	675	655	2,771	698	948	859	863	2,850				361
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male			436		591		1,500	2,065		1,544		2,165	3,188	2,113	2,464	2,503	2,115	3,079	2,000	3,057	2,905	2,898	7,755	2,769	5,558	5,961	5,705		5,758	8,346	6,429	5,839					1,646
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					343		708	211		739		843	468	776	836	877	753	354	747	1,010	924	970	3,188	913	1,391	1,570	1,595	4,537	1,565	2,225	1,919	1,839	4,670				610
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male			91		547		1,077	1,215		1,264		1,701	1,780	1,600	1,849	1,940	1,660	1,652	1,680	2,233	2,000	2,153	7,105	2,106	3,759	3,884	3,845		3,848	5,501	4,342	3,894					1,104
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					650		1,242	808		1,370		2,232	4,803	2,326	2,876	3,117	2,503	3,721	2,314	3,445	2,981	3,162	13,260	3,204	7,096	7,642	7,754		7,065	9,471	7,464	6,373					1,776
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Retired Age Band	35-49	Female			94																																		
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male					11		3								2		1																				
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			1,442		726		1,766	1,877		2,015		2,888	11,905	3,059	3,787	4,249	3,555	13,653	3,572	4,714	4,943	4,654	16,736	4,826	8,760	8,465	7,594		8,469	13,012	10,972	9,663					6,036
Zambia	Zambia	ZMB	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			2,561		765		1,635	1,668		1,830		2,756	4,317	2,659	3,193	3,448	2,810	3,708	2,627	3,815	3,584	3,531	10,943	3,535	7,365	7,752	7,476		7,306	10,422	8,127	6,885					2,152
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			9,387																																		
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				239	232	265	249	1,354	266	298	213	256	766	297	291	377	325	990				1,111	944				1,325					1,277					1,301
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												68					82				
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											159					264					302
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			6,436																																		
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				396	360	348	320	1,363	325	362	252	297	1,101	446	383	411	364	1,200				1,492	1,291				1,666					1,521					1,448
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												657					811				
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												4,035					4,231				
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				348	203	169	213	737	198	199	156	181	673	241	174	208	178	905				817	927				981					816					854
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			1,365																																		
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				212	185	191	182	732	175	222	166	141	976	241	173	195	175	873				736	800				868					720					703
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				5	5	3	7	41	8	5	3	5		20	12	5	7					46					36					30					57
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				125	136	110	121	716	136	119	93	77	705	154	113	105	111	450				426	499				493					416					408
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												1,829					2,132				
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											111					165					181
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				264	228	203	225	1,333	194	227	191	161	970	223	186	210	189	779				687	715				798					634					651
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											83					139					138
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											796					560					545
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				123	131	137	146	739	155	137	132	128	497	175	152	183	163	576				713	570				817					662					693
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											86					166					214
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				38	50	31	36	1,158	32	35	23	24	310	40	33	38	22	136				100	206				155					128					108
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												2,660					3,036				
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male				23	21		2		1	5	1											3										5					
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female				6	6				1	2		2										4										7					2
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												1,994					2,074				
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				138	154	170	203	730	207	229	182	194	997	259	317	381	339	660				1,168	651				630	772				38	776				591
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											561					288					316
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				238	212	211	233	721	232	245	186	171	854	259	257	274	213	1,019				897	975				997					890					845
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				254	185	230	207	733	227	284	179	157	860	261	204	200	218	965				840	904				1,037					839					942
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				369	345	317	334	1,360	350	363	230	261	1,241	349	292	345	314	1,306				1,117	1,129				1,345					1,244					1,220
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												406					476				
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				42	52	43	43	631	36	41	23	33	295	46	44	41	31	177				177	259				217					142					157
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											89					173					179
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				47	69	44	68	218	78	59	53	41	245	74	45	56	44	239				212	253				215	170				216	180				187
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											145					200					230
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				32	32	31	26	218	42	35	28	24		53	50	32	48					212					272					176					246
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				33	30	31	30	218	36	23	32	26	20	51	52	34	53	96				196	147				236					1,543					168
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				441	425	389	394	1,357	396	429	284	328	1,484	397	397	403	386	1,591				1,418	1,405				1,666					1,436					1,433
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				258	260	243	293	1,367	281	347	261	343	1,200	472	612	539	469	948				1,783	972				1,017	1,160				33	1,183				835
Zambia	Zambia	ZMB	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				95	100	62	86	1,330	63	87	64	56	861	103	75	87	74	303				249	379				315					274					227
Zambia	Zambia	ZMB	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			52,538		10,256		14,083	104,395		41,183		63,677	164,362		61,908		74,373	142,208		62,665		56,722	44,766		48,845		46,863	86,424		47,009		57,569	67,645				33,013
Zambia	Zambia	ZMB	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male					1		49																														3
Zambia	Zambia	ZMB	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			5,508		1,513		2,047	15,134		4,403		8,209	21,732		6,511		9,328	24,366		7,785		6,014	8,140		4,631		3,791	10,293		3,291		4,557	9,328				2,297
Zambia	Zambia	ZMB	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female					8		7															1															1
Zambia	Zambia	ZMB	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			49,742		15,029		19,640	184,245		66,383		102,757	278,105		99,971		119,354	243,379		101,875		94,254	70,383		80,658		80,798	147,212		82,242		95,537	127,276				58,390
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				30	26	25	34	432	50	42	27	39		116	111	76	71		107	169	107	41		119	210	139	87		104	78	101	70					166
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												514					514				
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			18,949																																		
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				161	212	118	207	416	212	166	137	170	689	232	223	233	226	683	281	268	301	159	775	333	391	308	285	854	219	231	248	226	854				351
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												2,439					2,439				
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				384	435	347	350	1,548	345	420	308	305	1,691	532	424	469	409	1,671	511	465	462	288	1,923	501	496	442	485		443	428	389	441					556
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				641	631	550	596	2,844	633	690	514	616	2,438	792	739	780	809	2,408	945	787	710	511	2,773	938	896	782	796		797	749	603	744					924
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				348	431	327	390	1,546	396	390	314	326	1,674	500	508	505	430	1,658	497	537	472	298	1,913	510	567	491	486		447	461	428	479					477
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				124	191	125	138	2,830	139	158	118	137	595	162	166	179	157	589	171	179	175	135	673	269	232	208	207		208	208	160	203					267
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				193	260	225	221	1,542	248	238	232	276	1,046	356	377	393	353	1,038	482	419	390	232	1,194	427	417	405	421		344	343	328	388					427
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				380	385	369	368	1,545	382	440	292	333	1,676	476	451	428	451	1,655	442	442	439	314	1,910	497	580	499	490		497	463	428	495					528
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				351	396	297	312	2,841	332	390	309	312	1,360	515	398	417	405	1,343	442	450	381	298	1,544	533	497	419	463		442	485	424	456					442
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				844	892	758	774	2,842	798	857	629	790	3,283	958	1,056	968	1,035	3,241	1,080	1,009	934	631	3,728	1,098	1,175	1,026	1,061		1,001	932	870	981					1,144
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				371	401	396	557	1,538	574	662	517	728	1,806	935	1,150	1,152	1,166	1,797	1,106	1,171	1,086	694	2,066	1,274	1,467	1,310	1,194	2,275	929	1,025	1,058	1,040	2,275				1,386
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												6,836					6,836				
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												9,730					9,730				
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				109	129	103	145	416	183	161	102	135		273	262	187	239		505	516	446	315		656	899	600	586		523	533	505	459					812
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				243	346	258	296	1,546	295	322	260	255	1,258	405	329	347	329	1,240	363	349	329	243	1,428	428	405	336	360		327	357	335	376					350
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				112	116	75	115	416	108	113	106	109	424	167	200	163	220	418	272	304	273	187	470	337	473	387	321		240	255	235	230					361
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			1,679																																		
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				705	683	513	610	2,841	640	760	559	717	2,533	856	924	877	895	2,506	1,026	1,010	935	602	2,884	972	1,046	966	1,015		905	928	836	1,045					1,028
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				153	170	133	140	1,543	147	166	124	125	647	193	156	177	160	641	203	194	208	150	732	267	221	210	223		206	162	189	177					232
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				821	824	689	721	2,840	784	837	589	712	3,040	947	947	967	926	2,989	993	926	857	600	3,440	1,093	1,072	933	1,049		996	993	830	1,061					1,087
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				300	409	353	344	1,545	332	340	267	348	1,597	430	428	420	357	1,568	466	437	427	271	1,804	430	538	485	438		414	441	385	421					480
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												5,405					5,405				
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			10,508																																		
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female				12	12	2	1		1	3		1												16	24	8	9		9	12	8	6					8
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												4,216					4,216				
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				499	477	477	501	2,834	534	591	436	607	1,977	670	762	812	796	1,940	816	776	775	453	2,233	772	859	763	810		806	777	638	842					961
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				707	670	683	794	2,827	885	1,023	883	1,351	2,856	1,615	1,993	1,774	1,796	2,823	1,749	1,831	1,798	980	3,233	1,878	2,012	1,919	2,052	3,564	1,525	1,648	1,537	1,836	3,564				2,124
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												2,376					2,376				
Zambia	Zambia	ZMB	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				33	31		2		4	7	1													23	23	4	9		11	6	6	2					6
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												355,292					325,684				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				31,372	35,412	35,079	36,958	55,608	53,007	55,585	58,246	59,354	61,717	60,290	62,896	65,566	66,562	66,808	68,345	69,678	69,934	70,483	62,643	69,397	70,313	71,007	71,617		71,748	72,855	73,432	73,484					70,283
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			9,358	11,296	11,509	11,760	16,675	12,005	17,656	18,031	18,229		18,573	19,975	21,603	22,676					23,677
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				58,578	64,613	69,823	74,795	68,098	60,819	64,754	66,443	69,045	69,896	69,954	71,606	72,382	71,446	75,769	71,147	73,289	74,176	75,097	71,592	74,368	74,307	74,198	74,030		73,666	74,684	75,283	75,858					67,793
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			72,830	69,707	75,367	80,134	86,213	92,852	90,500	95,492	100,732	103,838	102,843	107,958	111,312	114,325	116,462	112,407	37,774	34,022	35,632	36,166		36,148	6	5	11	150,441					171,260				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												81,927					84,854				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			99,961	80,546	82,773	85,944	89,761	90,319	92,296	96,388	98,563	100,437	103,852	101,665	103,942	105,270	104,253	112,398	104,117	106,954	109,533	111,555	109,565	110,413	110,857	111,109	111,325		111,458	114,157	115,369	116,913					111,272
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			93,841	86,215	90,187	94,866	101,527	96,972	103,946	108,158	112,054	113,559	117,481	115,204	118,246	120,726	120,933	126,884	122,265	123,143	123,558	124,142	118,387	121,956	122,518	122,244	122,275		122,025	122,537	121,054	120,535					112,603
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			28,019	14,280	16,220	15,833	16,276	25,350	17,257	16,937	16,752	16,621	19,819	16,349	16,296	16,667	16,591	21,277	16,686	16,949	17,414	17,638	26,297	17,381	17,611	17,551	17,621		17,535	18,019	17,661	17,847					16,823
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			59,231	39,563	42,990	43,382	44,105	54,103	46,057	47,489	48,628	49,873	52,022	50,028	50,597	50,466	48,612	57,108	46,861	46,973	47,861	48,136	59,617	46,006	45,809	44,865	44,615		44,135	44,830	45,111	45,654					40,357
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				6,888	7,355	7,371	7,524	13,571	7,587	7,652	7,550	7,343	8,715	7,038	7,012	6,737	6,439	10,483	5,857	5,672	5,724	5,615	13,136	5,456	5,400	5,178	4,997		4,860	4,837	4,569	4,636					4,176
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			60,083	58,177	62,981	67,629	73,174	93,309	76,196	80,764	86,351	89,857	84,682	92,556	95,450	98,838	99,715	93,050	34,222	29,864	31,414	31,957		31,518	11	8	19	127,286					129,416				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			60,738	36,005	36,909	39,122	40,299	55,388	40,730	43,068	43,876	45,692	48,868	44,706	46,248	46,110	45,107	53,481	44,321	45,275	45,692	45,987	57,819	44,492	44,566	43,394	43,005		42,576	43,211	43,632	43,653					38,581
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			20,362	10,865	12,089	12,865	12,620	24,570	12,917	12,935	13,329	13,417	17,108	12,992	13,063	12,679	12,269	19,104	11,730	12,178	11,845	12,088	22,407	11,724	11,643	11,581	11,583		11,526	11,960	12,134	12,312					11,544
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			7,445	9,229	9,480	9,812	15,422	10,091	15,526	16,216	16,699		17,094	17,865	18,827	19,306					21,547
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			19,957	23,148	23,920	24,245	37,891	24,516	36,502	37,743	38,831		40,212	41,077	42,168	42,694					45,645
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			70,013	47,089	49,029	53,372	56,868	66,116	57,301	60,035	61,606	62,901	66,843	62,140	64,002	65,274	64,928	72,051	64,743	65,491	65,447	65,767	69,265	63,741	63,413	62,464	62,190		61,867	61,599	60,978	60,380					54,069
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			31,521																																		
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			22,132	18,331	19,462	19,940	20,332	22,393	21,047	22,000	21,949	21,992	24,100	21,901	21,954	21,746	21,417	28,853	21,151	21,206	21,249	21,116	21,222	20,872	20,787	20,478	20,241	24,760	19,911	19,664	18,732	18,773	21,078				17,127
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				13,770	13,872	14,183	14,717	21,182	14,894	15,293	15,188	15,058	17,166	14,719	14,896	14,835	14,670	20,692	14,610	14,629	14,754	14,582	15,685	14,131	13,806	13,428	13,222		12,979	12,801	12,171	12,186					10,548
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			14,802	869	877	958	1,116	3,451	957	708	713	702	1,933	579	379	428	356	546	254	304	379	299	430	317	310	318	320	552	328	340	314	346	486				293
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			137,667																																		
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												24,898					23,552				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			79,745	67,872	73,001	72,008	75,874	75,612	81,433	83,178	86,735	89,899	91,960	91,108	92,436	94,307	93,326	100,323	92,623	93,158	94,755	94,841	97,967	90,903	90,455	89,059	88,149		87,355	87,763	86,861	87,308					80,780
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				90,348	93,300	100,052	106,351	90,553	90,594	95,019	98,202	100,337	102,859	103,276	105,422	106,118	105,466	112,207	106,312	109,507	111,746	113,515	104,062	114,329	115,591	116,189	117,355		117,919	120,275	122,997	124,307					118,444
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												28,997					27,286				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				37,537	50,459	45,826	47,678	65,027	68,491	71,148	73,801	75,511	77,579	77,836	80,355	83,314	85,039	84,584	88,631	90,732	91,402	92,013	79,280	92,229	93,705	95,447	96,730		97,583	99,330	100,952	101,857					101,425
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female					216	243	4																														
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			43,138	45,006	44,144	45,781	46,994	47,942	64,192	65,182	66,285		66,983	69,083	71,831	73,298					74,872
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			8,918	10,808	11,444	11,747	25,867	12,175	17,648	18,746	19,445		20,086	20,845	22,086	22,799					25,527
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												220,325					206,626				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			11,476	13,234	13,769	14,187	23,533	14,639	21,416	21,677	21,903		22,254	23,489	25,226	26,289					28,811
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												74,728					70,038				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			16,062	19,253	19,897	20,113	32,468	20,434	30,884	32,249	33,193		33,899	34,762	35,544	35,847					37,880
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												228,888					201,371				
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			38,913	24,276	25,469	24,783	24,603	39,917	27,050	27,236	27,927	29,049	33,599	27,302	27,920	27,440	26,731	36,538	25,888	26,497	26,077	25,675	42,203	24,387	23,913	23,268	23,204		22,929	23,081	22,949	23,059					20,946
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			17,496	7,273	8,036	8,535	8,995	14,418	9,465	9,754	9,846	9,899	11,819	9,955	10,015	10,251	10,285	12,703	10,494	10,818	10,975	11,182	12,081	11,144	11,306	11,272	11,403		11,446	11,690	11,475	11,589					10,957
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			36,435	38,776	38,143	39,416	40,500	40,763	54,208	54,606	55,112		55,332	57,172	59,363	60,404					59,285
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male					62	83																															
Zambia	Zambia	ZMB	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			150,583																																		
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				3,999	4,247	4,066	3,921	4,373	2,809	2,719	2,195	2,312	5,575	2,274	2,611	2,501	2,069	6,620	2,132	2,244	2,225	2,180	2,215	1,777	1,761	1,566	1,643		1,513	1,714	1,433	1,493					1,073
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												5,341					4,979				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								54	67	47	76		109	90	89	121					79
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												15,879					3,143				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												6,454					1,323				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				861	834	673	645	2,611	589	495	444	369	1,537	376	465	377	338	3,749	362	382	421	382	300	340	273	260	261		242	262	228	241					187
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												27,041					5,080				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			6,915	6,865	6,742	5,796	5,486	3,529	5,010	4,791	4,341	4,241	5,196	4,294	4,664	4,233	3,579	5,427	3,883	4,040	3,673	3,885	7,589	3,499	3,529	3,224	3,199		3,284	3,619	3,371	3,500					2,456
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			4,464	1,781	1,795	1,449	1,440	1,577	1,234	1,128	977	965	2,029	994	1,083	991	715	2,200	792	821	851	798	5,218	706	712	691	720		630	726	664	668					442
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								64	67	50	64		99	101	95	114					114
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			4,039	2,224	2,274	1,921	1,794	1,739	1,624	1,380	1,224	1,110	2,257	1,298	1,323	1,207	1,072	1,804	1,199	1,300	1,231	1,215	7,182	1,191	1,266	1,087	1,070		1,190	1,307	1,171	1,209					962
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			15,005	2,097	2,182	1,961	1,922	7,728	1,449	1,442	1,194	1,274	8,259	1,247	1,292	1,263	1,043	9,902	1,084	1,163	1,106	1,137	16,975	323	358	290	216	14,608					12,783				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								138	116	122	130		177	208	196	227					198
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			13,342	4,880	5,040	4,776	5,063	7,038	4,032	3,844	3,327	3,361	9,417	3,227	3,556	3,336	2,898	11,027	2,905	3,048	2,898	3,015	2,791	2,423	2,413	2,326	2,235		2,038	2,317	2,026	1,991					1,568
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								108	104	88	122		139	173	163	171					146
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			10,022	4,590	4,518	4,119	4,154	3,233	3,498	3,416	2,767	2,912	4,399	2,802	3,276	3,070	2,430	5,204	2,510	2,775	2,725	2,604	7,596	2,216	2,155	2,055	1,998		1,970	2,234	1,934	1,920					1,442
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			14,356	6,423	6,420	5,979	5,988	5,768	5,170	4,918	4,138	4,193	8,561	4,259	4,536	4,428	3,534	10,049	3,707	4,201	3,836	4,078	5,727	3,289	3,253	3,092	3,112		2,969	3,390	2,999	3,082					2,284
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			4,449	500	515	416	395	833	348	279	271	236	1,256	195	257	245	185	1,020	190	216	190	241	1,171	183	178	171	157		156	190	155	154					101
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female					14	19	5													1											4						
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			3,484	809	915	793	713	2,463	610	529	475	422	2,198	396	456	385	327	5,132	371	408	416	390	169	338	292	268	252	2,650	252	256	235	221	910				167
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				1,015	942	895	828	1,405	703	638	551	509	753	583	568	441	399	1,866	543	487	483	463	4,232	430	432	375	332		358	425	409	380					277
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				1,743	1,799	1,635	1,746	3,599	1,788	1,789	1,471	1,504	5,011	1,377	1,726	1,696	1,368	5,772	1,432	1,458	1,424	1,385	1,567	1,136	1,230	1,113	1,056		1,031	1,088	978	961					729
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								51	64	57	89		137	97	114	104					103
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			7,051	3,590	3,580	3,154	3,203	2,604	2,885	2,707	2,244	2,170	3,306	2,345	2,539	2,288	1,753	3,306	1,983	2,053	2,003	1,919	7,398	1,713	1,594	1,457	1,490		1,467	1,597	1,376	1,425					1,068
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								445	369	339	450		514	558	550	562					430
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			25,876	2,055	2,269	2,236	2,152	6,995	1,699	1,767	1,372	1,494	6,712	1,382	1,679	1,590	1,306	8,631	1,328	1,432	1,377	1,449	9,637	428	456	413	267	11,536			4		3,473				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			21,563																																		
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								547	509	461	540		647	719	639	635					540
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												2,105					3,673				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												12,020					6,340				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			10,803																																		
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male					4	7	1													2									1		2						1
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			164	323	295	387	377	418	237	197	255	282	126	155	171	137	137	546	90	180	146	124	450	124	128	158	153	560	134	129	138	174	488				134
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			24,111																																		
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												2,565					603				
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			11,056	7,803	7,873	7,180	7,266	4,837	6,589	6,241	5,216	5,260	7,875	5,402	5,816	5,363	4,521	9,294	4,738	5,204	4,950	4,663	4,772	4,127	4,190	3,789	3,791		3,768	3,960	3,721	3,706					2,984
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								49	56	52	88		102	85	78	92					85
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			11,189	4,281	4,644	4,364	4,496	3,828	3,574	3,403	2,853	2,983	5,581	2,832	3,209	3,143	2,494	6,237	2,637	2,788	2,734	2,745	3,105	2,268	2,125	2,023	1,965		1,933	2,047	1,816	1,771					1,348
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				3,861	3,727	3,490	3,487	7,200	2,673	2,326	2,034	2,074	8,314	1,981	2,101	1,995	1,628	10,417	1,733	1,871	1,841	1,987	2,341	1,467	1,499	1,505	1,404		1,305	1,445	1,368	1,296					943
Zambia	Zambia	ZMB	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				1,157	1,511	1,332	1,480	4,725	1,377	1,320	1,212	1,229	6,356	1,136	1,294	1,191	985	7,839	1,016	1,115	1,007	1,095	1,893	858	949	800	856		695	875	765	747					568
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								11,717	17,451	17,314	17,932		19,203	20,347	21,511	22,664					23,229
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				5,580	9,823	10,426	11,577		12,060	13,545	14,706	15,646	31,018	15,900	15,861	16,039	16,374	33,868	16,142	15,909	15,759	17,461	34,762	16,825	16,910	16,226	17,264		16,645	16,669	16,904	16,978					14,296
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												63,839					63,153				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				3,647	6,459	6,950	7,430		7,888	9,047	9,740	10,652	18,164	10,506	10,299	10,898	10,867	19,789	11,008	11,246	11,117	12,789	22,107	12,504	12,728	12,365	13,028		12,844	13,074	12,745	13,158					11,727
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				9,788	17,144	18,993	22,511		24,106	26,521	29,528	31,825	47,979	31,827	31,260	32,200	32,748	52,800	31,822	31,065	30,645	34,534	51,533	32,670	32,905	31,441	33,300		32,641	32,443	32,882	33,271					28,223
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				17,912	47,870	57,986	72,352		64,330	69,983	74,757	78,195	95,787	79,831	78,734	80,943	81,446	103,855	80,388	82,353	82,766	93,421	87,063	95,279	98,044	95,312	99,646		100,508	102,608	104,271	106,434					93,987
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								37,327	52,727	52,101	54,689		57,875	60,196	62,001	64,028					60,994
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								30,228	42,393	41,861	44,054		46,795	48,200	50,011	51,822					47,254
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				2,133	4,108	3,980	4,265		4,568	5,321	5,894	6,589	10,877	6,672	6,609	7,287	7,296	11,846	7,485	7,811	7,835	8,754	9,576	8,711	9,067	8,771	9,188		9,346	9,368	9,175	9,401					8,185
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				2,907	818	476	18		121	4	1										2																
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				12,045	31,582	37,103	47,977		39,990	44,195	47,249	49,470	65,124	50,041	49,042	50,224	51,237	70,321	50,469	51,334	50,695	58,045	61,470	57,781	59,747	58,041	60,697		59,930	60,862	61,617	62,929					52,116
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				165	341	121	135		159	89	60	118	1,842	50	52	40	45	324	25	38	34	56	318	44	41	34	36	406	53	69	49	47	310				43
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				7,260	15,845	20,270	23,966		35,675	39,077	42,214	43,824	57,475	44,313	44,041	45,879	47,501	62,030	48,063	50,038	49,704	56,305	52,841	56,231	57,704	56,692	59,883		59,497	60,405	61,552	62,236					54,699
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				22,303	40,058	49,806	59,654		63,945	70,429	76,606	80,359	95,786	83,974	84,234	87,358	89,598	104,291	89,921	93,473	95,293	109,173	113,584	34,518	5,681	5,720	6,338	127,521					154,025				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				4,220	6,071	6,755	8,014		8,448	9,307	9,772	10,085	15,943	9,879	9,629	10,043	10,146	18,296	10,384	10,238	10,237	11,169	13,584	10,918	10,875	10,464	10,687		10,545	10,236	9,745	9,711					7,747
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				13,034	23,003	26,674	33,537		34,728	38,378	41,475	43,084	62,173	42,896	41,776	42,805	43,813	66,909	43,292	44,112	43,675	49,165	59,270	48,098	49,200	47,265	49,768		48,864	48,653	48,875	49,021					40,245
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								15,834	24,162	24,532	26,364		28,640	29,384	30,181	30,863					30,019
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				9,132	16,420	18,101	21,984		22,670	24,998	27,237	28,821	45,307	28,757	28,140	28,754	29,388	49,380	29,090	29,162	29,210	33,033	49,207	32,398	32,920	31,766	33,398		32,780	33,150	33,451	33,865					27,690
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				2,656	4,847	4,770	5,214		5,457	6,176	6,700	7,350	15,636	7,592	7,447	7,736	7,614	17,488	7,543	7,579	7,427	8,419	17,547	8,012	8,222	8,065	8,674		8,438	8,556	8,689	8,993					8,034
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								7,771	12,376	12,478	13,482		14,516	15,162	16,005	16,721					17,222
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				9,965	22,313	27,788	32,367		48,172	52,545	56,818	59,304	72,211	60,449	60,100	62,239	64,166	78,294	64,965	67,885	68,472	77,241	66,125	77,545	80,082	79,343	83,146		83,607	85,384	86,424	88,206					81,342
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												189,143					190,835				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								9,647	14,102	14,456	15,775		17,120	17,750	18,891	19,522					20,246
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												195,633					187,663				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				23,708	39,980	46,344	56,772		59,743	65,080	70,691	73,559	96,630	74,174	72,691	74,502	76,059	104,214	75,012	76,169	77,557	87,431	95,674	87,305	89,685	86,776	91,148		90,489	92,924	93,222	95,629					84,347
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				1,463	438	252	17		69	3																											
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												69,844					79,091				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				18,570	32,558	40,096	48,869		52,484	57,507	63,464	66,351	78,922	69,129	69,140	71,955	74,138	86,117	74,589	77,353	78,840	90,591	88,409	29,815	5,496	5,465	6,141	108,103					119,810				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												24,660					25,355				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				18,152	31,145	35,341	44,172		45,990	49,816	55,757	60,122	85,428	61,355	60,890	62,629	64,840	92,852	64,148	64,769	65,918	72,614	84,723	69,667	70,253	67,038	70,305		68,715	68,802	68,095	68,445					60,275
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								19,661	29,173	29,744	31,837		34,912	35,875	36,268	37,138					36,518
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												21,210					20,188				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				25,813	45,195	53,234	65,575		70,144	76,618	82,819	86,358	109,440	86,999	85,371	88,228	89,946	117,794	89,445	91,747	91,382	101,056	97,896	100,462	102,071	98,295	102,904		101,807	102,707	101,271	102,070					88,022
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												303,050					303,479				
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								9,400	14,150	13,912	14,623		15,786	16,792	18,176	19,462					18,882
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				5,764	9,961	10,135	11,516		12,244	13,981	15,010	15,971	22,363	15,894	15,537	16,087	16,490	25,568	16,105	15,957	15,731	17,077	14,018	16,909	17,082	16,377	16,930	20,949	16,734	16,341	15,560	15,525	19,388				13,243
Zambia	Zambia	ZMB	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				1,378	2,698	2,275	3,626		2,985	3,181	3,393	3,899	8,109	3,726	3,587	3,592	3,632	9,288	3,071	2,842	2,832	3,239	12,438	3,065	3,045	2,976	3,064		2,961	3,040	2,818	2,808					2,553
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														93		97					584
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					2,844		1,806			2,816		1,852			2,580		3,320			3,460		1,710			2,428		2,985										
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														199		143					529
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														58		66					67
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														248		232					505
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					198		101			221		105			260		231			281		136			188		217										
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														151		114					450
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														129		100					401
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														65		65					90
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														107		81					160
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														79		50					143
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														199		151					585
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					1,730		1,276			2,146		1,221			1,770		2,921			3,008		1,644			2,042		2,555										
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														49		58					414
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														171		157					547
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														162		132					541
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female					6					4																				1							
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male					21		2			6																											
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														263		278					505
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														52		45					95
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														33		40					206
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														192		164					631
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														66		33					120
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														49		28					280
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														5		3					19
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														195		172					409
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														44		33					302
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														254		263					522
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														302		326					593
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														35		29					250
Zambia	Zambia	ZMB	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														75		42					77
Zimbabwe	Zimbabwe	ZWE	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	15-19	15-19	Female					146,200		41,339			26,306		35,186			19,865		48,875	42,933		25,630		57,100	43,804		22,769		61,190	26,026		22,218		71,529	26,959				
Zimbabwe	Zimbabwe	ZWE	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	20-24	20-24	Female					99,223		20,329			11,548		16,527			14,767		34,453	27,888		16,435		39,938	35,334		15,769		38,250	2,514		11,509		39,517	4,238				
Zimbabwe	Zimbabwe	ZWE	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	10-14	10-14	Missing Sex					40,328		32,670			38,312		48,726			20,117		72,180	71,995		32,897		69,834	61,423		27,300		71,077	27,072		28,279		55,850	28,259				
Zimbabwe	Zimbabwe	ZWE	AGYW_PREV	DREAMS beneficiaries that have completed any DREAMS service	25-29	25-29	Female					1,252		1,971			1,651		3,214			1,123		4,226			1,462		5,171			625		3,056			842		4,025					
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			61		160			211		143			238		220			198		197			182		195			218		197					72
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					3					8								7																	
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			11		31			35		25			39		55			74		81			71		112			113		93					59
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			129		191			339		300			539		753			568		442			414		429			431		448					168
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			24		15			32		12			31		86			82		91			108		138			136		158					115
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			14		16			14		21			42		38			44		58			44		49			72		61					15
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			90		210			239		211			330		212			160		182			124		135			146		190					43
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			20		82			117		86			177		186			221		252			239		324			632		390					222
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	 						60,866					35,201					26,270					31,238														
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			88		213			271		201			327		436			457		686			573		627			850		772					419
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			13		5			15		23			29		47			56		59			56		71			64		63					37
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1		1			2		9			8		1			2		9			4		6			6		5					
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1,094		1,999			2,719		2,904			6,328		8,543			11,791		12,849			11,739		14,937			15,918		18,169					8,139
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected								1		11			9		2			4		4			7		7			2		2					
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		7			7		8			14		27			32		41			31		41			42		43					14
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			10		37			60		94			117		329			359		341			289		1,250			437		541					308
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			48		108			121		77			119		169			82		89			91		65			48		45					20
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			46		142			143		157			292		311			422		445			507		585			901		790					374
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			22		71			48		39			52		88			46		31			53		35			37		24					10
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative													20		7			30																	
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			67		223			259		219			341		451			440		590			651		774			1,043		972					527
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			14		26			31		34			39		55			45		81			48		71			85		94					39
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive								4		2			2		4			9		6			2		6			10		11					5
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-34	25-34	Female	Y	 																										94,403					84,504				
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			34		70			86		97			130		371			432		429			434		1,400			579		720					404
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			864		1,722			2,330		2,954			5,681		7,394			8,340		11,050			11,906		14,881			12,193		13,917					10,174
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			216		499			713		498			758		786			464		441			361		395			346		426					146
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected					1					1								3					2					1							
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			2		4					4			6		10			5		7			4		8			8		8					1
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			1,167		3,017			6,095		6,050			7,305		9,553			6,578		5,811			4,774		4,925			5,134		5,425					2,305
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			58		120			130		97			114		192			106		93			115		58			56		50					24
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			2		1					4			9		13			7		9			12		19			11		8					2
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			3		1			1		2			2		7			2		2			9		7			4		18					1
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			5							1			3		5			4		8			7		14			10		12					2
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative								5					4		37			3					2							3					
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	 						35,077					46,741					50,633					51,355														
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			4		18			36		16			34		36			25		21			25		23			18		16					2
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	 						53,946					51,279					51,869					53,528														
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			15		22			36		39			39		86			95		81			84		100			96		77					49
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			148		160			176		194			456		969			1,058		1,286			1,291		1,423			1,678		1,797					934
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			18		23			32		52			48		126			160		125			145		426			197		246					176
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			481		516			702		884			1,771		3,076			3,708		4,513			4,553		5,581			6,490		6,922					4,016
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			6		11			20		25			25		50			79		53			69		89			102		66					48
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1		3			6		5			9		12			13		8			7		10			15		13					11
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected								1		1			3		2			1		2			2		1					1					1
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		22			32		21			34		79			108		110			110		123			116		114					56
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			19		26			34		20			40		75			61		67			68		88			101		71					49
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			135		298			516		374			551		577			452		380			360		355			401		432					181
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													3		1																				
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-49	35-49	Female	Y	 																										176,685					183,237				
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			7		11			14		5			15		17			18		20			13		20			37		22					10
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			13		25			36		189			32		45			52		37			26		34			30		37					13
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			662		1,152			1,447		1,733			3,395		5,365			6,583		7,745			7,696		9,014			10,442		11,588					6,603
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected			1		1					12			8		21			11		21			12		6			2		5					2
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			17		43			77		83			85		327			247		229			248		691			280		377					262
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,108		5,866			9,883		9,159			12,732		14,489			9,237		8,076			6,092		6,000			5,581		6,090					1,638
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			242		570			854		612			868		806			566		518			455		416			462		495					166
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			4																																
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			38		48			107		138			134		1,840			2,974		1,956			946		1,109			4,857		4,898					367
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			858		1,912			2,473		3,468			6,723		10,812			13,356		16,446			15,680		18,700			22,056		24,379					12,596
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		1					4			5		11			18		15			15		17			15		9					6
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		2										1			5		1			2		1										1
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			46		109			77		68			95		125			63		53			84		57			30		37					13
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			229		501			652		470			648		656			516		421			371		378			379		391					166
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,428		5,021			7,739		6,286			11,070		10,681			7,025		5,571			4,185		4,168			3,980		4,219					998
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			147		341			504		419			525		567			369		296			257		256			264		306					73
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,628		6,377			11,192		10,024			13,699		15,690			9,924		8,548			6,489		6,757			6,276		6,541					2,340
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			660		1,153			1,945		1,724			2,859		3,749			2,771		2,334			1,965		2,118			2,259		2,345					822
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			9		10			12		12			18		52			51		55			69		113			74		90					36
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	45-49	35-49	Female	Y	 						31,620					40,000					37,924					42,971														
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			14		28			32		35			59		49			67		81			63		104			100		91					42
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	 						63,111					45,191					41,281					41,253														
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative			9		38			31		44			68		172			206		186			187		652			273		325					124
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected													1																						1
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected			1		1					10			4		3			1		2			1		2			2		4					2
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Negative																							1												
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Negative			1,019		1,919			2,520		3,429			6,376		9,925			12,051		15,227			14,923		18,480			21,425		24,048					13,366
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,214		4,938			8,495		7,776			10,137		11,883			7,764		6,632			5,328		5,424			5,346		5,563					2,089
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		1			12		10			16		27			33		31			28		45			56		38					20
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Suspected															10																				
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Negative			2,396		5,891			10,193		9,467			13,243		14,419			9,077		8,225			6,227		6,526			6,310		6,729					2,204
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Suspected													8										1												
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected			76		140			141		88			136		154			92		94			121		82			79		68					39
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Suspected					7			11		7			7		11			7		9			11		7			5		4					2
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			58		150			182		115			222		301			298		353			378		417			549		521					241
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN	HIV-positive women on ART screened for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			28		71			96		69			121		184			199		216			263		270			374		395					197
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		2										1			5		1			2		1										1
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			20		82			117		86			177		186			221		252			239		324			632		390					222
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			28		71			96		69			121		184			199		216			263		270			374		395					197
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			90		210			239		211			330		212			160		182			124		135			146		190					43
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive								4		2			2		4			9		6			2		6			10		11					5
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			58		150			182		115			222		301			298		353			378		417			549		521					241
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			11		31			35		25			39		55			74		81			71		112			113		93					59
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			4		22			32		21			34		79			108		110			110		123			116		114					56
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		1					4			5		11			18		15			15		17			15		9					6
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			242		570			854		612			868		806			566		518			455		416			462		495					166
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			61		160			211		143			238		220			198		197			182		195			218		197					72
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			67		223			259		219			341		451			440		590			651		774			1,043		972					527
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			3		1			12		10			16		27			33		31			28		45			56		38					20
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			1		7			7		8			14		27			32		41			31		41			42		43					14
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive					3					8								7																	
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			13		5			15		23			29		47			56		59			56		71			64		63					37
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			135		298			516		374			551		577			452		380			360		355			401		432					181
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			46		142			143		157			292		311			422		445			507		585			901		790					374
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Cervical Cancer - Positive			88		213			271		201			327		436			457		686			573		627			850		772					419
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			6		11			20		25			25		50			79		53			69		89			102		66					48
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			147		341			504		419			525		567			369		296			257		256			264		306					73
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			13		25			36		189			32		45			52		37			26		34			30		37					13
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Cervical Cancer - Positive			15		22			36		39			39		86			95		81			84		100			96		77					49
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive													3		1																				
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			216		499			713		498			758		786			464		441			361		395			346		426					146
Zimbabwe	Zimbabwe	ZWE	CXCA_SCRN_POS	HIV-positive women on ART who screened positive for cervical cancer	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Cervical Cancer - Positive			229		501			652		470			648		656			516		421			371		378			379		391					166
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																												1							
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							2							3					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							2		6			12		15					5
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																														1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			89		116			224		125			127		115			124		71			45		41			17		31					2
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							1		3			6		12					2
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			6		10			19		20			49		69			74		92					11			6		18					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			25		48			57		54			136		118			154		170			186		292			288		331					220
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation			4					1					10		29			14		15			16		34			25		26					5
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			3					4		3			3		2			14		12			6		2			2		4					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			34		42			86		93			123		186			120		117			111		108			89		101					61
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																												3		3					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2										4		9			17		16			9		10			9		14					6
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			13		29			33		33			48		78			62		68			54		49			37		32					19
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			3		9			6		6			6		6			28		9			4		7			4		9					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1		1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																							15		10			7		4					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1		3			2		4			4		6			12		12			8		7			6		7					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													1		1																				
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation										1			8		15			19		24			27		58			41		43					30
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			1		12			16		16			22		9			23		12			17		8			4		2					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			1		6			1		15			79		150			150		123			133		133			148		190					83
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			1		3			8		5			4		3			14		5			2		7			2		2					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			2		3					5			44		112			137		169			187		226			277		339					142
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			19		37			66		44			77		87			98		78			69		38			19		24					3
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							4		1			12		11					17
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													1		1			4		2			1		4			3		5					2
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation								1		1			10		30			54		53					14			17		15					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			14		27			40		28			41		38			56		37					1			2		2					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy					7			5		7			9		5			7		5			4		3			4		1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation			1										7		8			14		9			14		21			11		14					11
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			21		30			31		84			89		141			122		95					6			1		6					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													6		3			5		8			8		20			11		12					7
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																									1			1		1					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			67		70			116		176			180		246			180		154			168		124			101		133					67
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation													1																						
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			1					1		5			4		11			7		12			9		17			11		5					5
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			90		187			251		136			162		164			117		74			62		37			23		23					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							50		79			87		82					35
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation										1			11		43			78		67			89		126			155		202					79
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																				1															
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																							29		12			10		6					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation					2					8			52		98			138		144			216		308			325		412					199
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			2		3			2					12		21			31		43			22		58			29		32					20
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									1			1		1					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			15		47			90		66			99		80			95		98			90		50			23		41					3
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			3		3			9		7			11		6			14		7			9		4			3		3					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			24		46			63		43			76		55			63		58			44		29			17		19					3
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			5		6			2		3			16		8			20		25			26		34			46		41					27
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													1		2			8		4			1		7			5		3					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			4		1			2		2			5		12			26		24			12		44			19		22					14
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			13		26			43		23			47		24			31		37			30		9			18		15					2
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1			9		23			18		12			25		26			29		35					12
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation													1		10			2		5					3			2		1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			3		2			2		5			3		12			15		23			8		25			11		19					15
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			32		56			72		38			34		33			48		37			32		16			14		13					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			58		94			142		203			225		304			262		233			185		193			138		152					74
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation																							6		9			15		20					17
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																									1										1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			11		14			2		17			130		263			178		152			134		150			153		210					55
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			46		47			97		123			152		257			187		141			129		138			120		100					27
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			30		53			47		30			33		63			45		30					1					1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy								2		1			2					3		1										1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							31		30			22		17					10
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							5		3			9		8					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																									1										1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			14		42			21		35			97		63			96		112			123		163			204		230					150
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation										1			5		14			9		9			11		20			18		18					6
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							1		2			5		10					7
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							6		12			24		23					22
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy					1			3		9					1			3		7															
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																														1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																							3		1			2							
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy										1			1		2			4		4			4		2			1		1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			7		19			5		27			124		230			154		146			112		154			120		183					52
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy																							1												
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			4		4			4		7			11		30			18		18			14		44			12		22					15
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP																							78		113			73		108					90
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP			69		90			135		218			253		341			257		206			173		162			139		172					63
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			70		148			204		113			138		163			108		69			55		37			21		24					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							45		57			29		35					6
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			38		77			138		88			85		130			90		49			48		44			11		19					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	60-64	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																									6			2		8					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			1		1					4			26		61			116		121			175		228			264		301					134
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Thermocoagulation																							1		7			3		4					1
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	Unknown Age	Unknown Age	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																				3															
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	35-39	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy			31		68			94		75			96		98			106		109			93		48			28		16					3
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			10		9			1		13			71		146			115		94			94		103			86		117					25
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	40-44	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			22		45			49		46			131		136			150		176			236		329			319		373					327
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			2		5					2			42		73			63		44			54		78			78		94					43
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			8		9			3		17			104		192			165		149			126		167			114		186					71
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation			3		3			1		4			24		67			42		45					10			7		5					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	65+	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Thermocoagulation																							1		2			1		4					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for Cryotherapy			1					2		1			4		26			21		12			27		22			2		5					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	45-49	35-49	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			10		24			25		40			70		95			124		133			187		295			304		301					225
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP			6		9			17		20			43		54			50		60			76		129			161		159					95
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP					1			1					4		1								1												
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	25-29	25-34	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy			45		96			175		71			100		97			90		58			48		22			19		19					2
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for LEEP																							2					4		8					4
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - First Time, Eligible for Cryotherapy																									1			1		1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50-54	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP																							4		12			3		5					6
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	30-34	25-34	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Thermocoagulation			4		1					4			29		65			93		110			111		177			194		248					107
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	50+	50+	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP			1		1			1		1			5		3			5		19										1					
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	15-19	15-24	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for LEEP								2		1			2		1			2		2			2		1			2		3					3
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	20-24	15-24	Female	Y	Cervical Cancer Screened - Follow Up, Eligible for LEEP													2		5			5		8			5		8			6		3					2
Zimbabwe	Zimbabwe	ZWE	CXCA_TX	HIV-positive women on ART who screened positive for cervical cancer and received cervical cancer treatment	55-59	50+	Female	Y	Cervical Cancer Screened - Rescreened, Eligible for Cryotherapy																												1		3					
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Male																												46,178					46,177				
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Male			6,454	5,118	5,048	4,053	3,654		3,172	4,392	3,361	5,744	17,875	6,340	6,540	8,643	8,320	17,874	8,285	7,928	5,405	8,280	29,350	8,603	9,874	9,550	8,997		8,471	11,452	8,357	5,989					5,196
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Female																												63,708					63,709				
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	35-49	35-49	Female																												39,077					39,077				
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Male			34,484	4,950	4,772	3,917	3,569		2,951	4,104	3,360	5,532	17,208	5,721	6,087	7,887	7,544	17,208	7,224	6,938	4,697	6,971	28,309	7,177	8,312	7,968	7,589		6,971	9,524	7,058	4,999					4,012
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	15-24	15-24	Male																												41,971					41,971				
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Female			4,913	2,406	2,764	2,201	4,906		2,238	2,460	2,288	4,749	12,279	5,268	7,542	9,385	7,892	12,280	8,143	8,806	5,032	7,713	20,459	8,104	9,743	10,193	8,113		8,184	12,031	7,448	5,077					2,741
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	15-19	15-24	Male			3,240	1,826	1,684	1,258	2,929		1,059	1,295	829	1,891	7,699	2,365	2,953	3,600	3,142	7,698	3,006	3,031	2,123	2,751	12,703	3,009	3,656	3,375	3,258		3,290	3,849	3,095	2,047					1,455
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	10-14	10-14	Missing Sex				5	91	50	14		19	31	42	45	160	137	206	215	30	161	39	34	68	9	269	17	72	16	34	269	32	13	4	6	269				14
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	25-29	25-34	Female			8,628	5,723	6,115	5,130	4,448		4,230	5,380	4,777	7,766	21,418	7,894	8,478	11,009	10,965	21,418	10,906	10,935	6,836	10,035	35,200	9,868	11,559	10,679	9,897		9,893	13,550	9,060	6,065					5,941
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Male																												57,659					57,659				
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Female			9,342	6,155	6,810	5,710	7,522		4,765	6,041	5,147	9,036	26,201	9,670	11,119	14,439	13,484	26,201	14,433	15,545	9,473	14,180	43,249	13,476	16,979	16,472	14,269		13,626	20,560	12,857	8,939					6,939
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Missing Sex						10		299,876																7													
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Female			22,336	1,355	1,292	1,388	1,389		1,363	1,679	1,058	2,630	5,427	2,792	3,486	4,950	4,334	5,428	4,400	4,182	2,820	4,006	9,004	3,819	4,363	4,529	4,107	9,005	3,787	4,515	3,722	2,487	9,005				1,524
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Female			29,016																																		
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Female				3	24	3	6		8	7	6	7		3	12	5	4		4	1	4	3		15	19				5	19		1					3
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	25-34	25-34	Female																												64,687					64,687				
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Female			29,016	3,338	3,602	3,078	2,710		2,566	3,417	2,956	5,398	12,729	5,108	4,917	7,665	7,632	12,730	7,537	7,409	4,690	6,768	21,054	6,573	7,803	7,078	6,804		6,481	8,393	5,944	3,994					3,649
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	35-39	35-49	Male			34,484	3,592	3,912	3,267	3,045		2,647	3,434	2,906	4,872	13,817	4,800	4,511	6,875	6,399	13,818	6,401	6,187	4,215	6,113	22,721	6,398	7,197	6,914	6,720		5,900	7,330	5,556	3,782					3,508
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Male				2,328	2,464	2,079	2,011		1,672	2,246	2,073	3,445	8,882	3,431	3,677	4,942	4,771	8,882	4,621	4,443	3,069	4,597	14,657	4,767	5,657	6,036	5,256		4,779	5,936	4,686	3,063					2,630
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	Unknown Age	Unknown Age	Male				3	16	3	2		6	6	19	9		7	7	10	7		2	35	3	5		6	1	6			3	45	7						6
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Male				1,462	1,442	1,208	1,218		1,055	1,358	1,233	2,126	5,333	2,144	2,242	3,178	2,943	5,334	2,917	2,818	1,824	2,876	8,800	2,989	3,503	4,030	3,665		3,101	3,392	2,907	1,787					1,657
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	30-34	25-34	Female			29,016	4,739	5,247	4,248	3,682		3,452	4,475	3,968	6,818	17,920	6,640	7,236	9,320	9,063	17,919	8,949	8,812	5,653	8,453	29,487	8,240	9,386	8,366	8,279		7,999	10,639	7,500	4,970					4,633
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	40-44	35-49	Female				1,875	1,940	1,688	1,408		1,417	1,884	1,794	3,296	6,911	3,317	3,698	4,888	5,185	6,910	4,916	4,893	3,178	4,800	11,433	4,805	5,522	5,287	5,127		4,675	5,953	4,505	3,022					2,480
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	Retired Age Band	35-49	Male			34,484																																		
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	20-24	15-24	Male			14,828	4,517	4,289	3,322	5,653		2,951	3,797	2,872	5,525	17,783	6,111	7,053	9,005	8,866	17,784	9,017	9,295	5,990	8,653	29,268	9,225	10,975	10,672	9,781		9,649	12,900	9,608	6,731					5,020
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	45-49	35-49	Female				1,047	1,056	906	972		1,024	1,133	998	1,983	3,986	2,051	2,332	3,403	3,073	3,986	3,155	3,025	2,009	2,798	6,590	2,927	3,432	3,253	3,025		2,817	3,449	2,634	1,724					1,469
Zimbabwe	Zimbabwe	ZWE	HTS_SELF	Number of individual HIV self-test kits distributed	50+	50+	Male			32,679	1,527	1,556	1,452	1,489		1,364	1,700	1,368	2,705	6,026	2,611	3,253	4,439	4,183	6,028	4,017	3,957	2,759	3,907	9,947	3,881	4,604	5,102	4,526	9,947	4,014	4,746	4,232	2,603	9,951				2,073
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Female																												305,559					227,630				
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Male			146,358	35,916	35,733	36,447	38,651	85,536	29,948	29,680	7,650	9,651	63,845	13,461	15,632	18,228	20,823	9,334	13,134	15,416	11,948	12,462	24,100	12,405	13,892	13,396	12,522		14,354	18,798	19,358	19,839					14,122
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Female				10,341	9,358	8,677	8,579	30,388	7,523	6,763	2,383	3,423	71,706	4,344	3,701	3,708	3,357	32,367	3,565	3,932	3,984	4,128	19,557	3,789	4,443	4,474	4,683		4,574	5,338	5,992	6,795					6,716
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Male			50,030	31,626	31,839	30,563	32,681	79,739	26,206	25,138	8,055	9,564	86,516	12,180	12,863	14,589	16,729	11,925	11,287	13,698	11,019	11,896	13,325	11,287	13,000	12,553	12,398		13,318	16,517	17,214	17,651					14,939
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Female				489	262	243	13		36	125	83	84		18	19	4	11		2	6	6	7		8	15	3			2								4
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	Retired Age Band	Missing Sex				5	2	1			20	6				1	1	11	5			3		1															
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Female				17,130	17,004	15,348	15,709	61,740	12,757	12,982	6,285	8,162	104,081	9,636	8,747	8,723	8,210	50,393	8,000	9,630	9,060	9,956	32,691	8,904	10,903	10,744	10,913		10,687	12,726	13,613	14,770					14,413
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Male			98,788	25,952	26,531	33,647	40,866	108,927	24,729	22,169	2,832	5,295	26,657	8,694	11,033	17,484	17,736	8,004	8,295	8,761	4,714	5,814	20,664	4,319	4,885	4,531	3,992		4,647	6,206	6,871	6,839					4,594
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	40-44	35-49	Male				12,303	12,382	11,895	11,576	205,713	9,581	10,112	4,176	4,880	16,940	5,816	5,567	6,421	5,929	25,968	5,180	5,744	5,799	6,036	10,987	5,757	6,450	6,644	6,747		6,526	7,450	8,272	9,207					8,714
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	<01	<01	Missing Sex			7,176	7,104	7,651	8,086	6,484	185	6,608	6,659	4,507	4,822		4,595	4,177	4,050	3,758		3,731	2,862	2,230	2,583		1,918	2,246	1,580	3,475		1,821	2,487	3,436	3,434					4,699
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	10-14	10-14	Missing Sex			86,165	37,661	39,759	54,095	56,297	208,346	35,777	37,606	2,422	3,243	5,189	4,758	3,793	4,066	3,021	14,295	3,256	3,777	2,969	3,064	24,006	3,187	3,775	4,021	4,271	36,985	3,856	4,003	4,576	7,123	61,011				6,187
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	45-49	35-49	Male				7,732	7,760	7,714	7,548	101,450	6,377	6,225	2,621	3,114	9,471	3,561	3,431	3,916	3,554	21,954	3,264	3,656	3,778	3,839	10,228	3,558	4,074	4,063	4,312		4,058	4,575	5,456	5,839					6,148
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	<10	Retired Age Band	Missing Sex																									3												
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	15-19	15-24	Female			24,642	62,208	65,579	56,360	51,923	22,313	46,870	49,699	30,441	35,890	13,741	40,477	43,079	41,426	39,580	32,016	39,400	45,390	39,691	43,808	54,187	41,965	47,788	46,001	45,487		45,426	53,889	53,315	52,887					47,573
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Male			163,664	19,393	19,311	18,694	18,631	67,046	15,401	16,155	6,040	7,168	26,584	8,399	8,090	9,518	9,005	25,282	7,741	8,518	7,912	8,373	9,272	7,822	8,923	8,686	8,942		8,478	9,669	10,188	10,858					10,631
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	01-09	Missing Sex			75,035																																		
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	05-09	01-09	Missing Sex				11,118	9,863	10,698	6,943	56,419	5,770	4,963	1,775	2,155	4,494	3,203	2,941	3,458	2,179	8,014	2,405	2,547	2,358	2,361	19,290	2,215	2,654	2,321	2,906		2,251	2,590	3,398	6,206					4,973
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Female			138,186																																		
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	01-09	01-09	Missing Sex																												169,875					105,090				
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Male			178,407	26,974	25,370	24,198	24,408	44,350	19,503	20,171	7,139	8,174	24,026	9,728	10,079	11,876	12,119	19,632	8,957	10,329	8,764	9,336	11,823	9,172	10,179	9,816	9,778		10,082	11,750	13,219	13,394					12,034
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Male																												39,900					32,586				
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Female																												291,875					214,672				
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	25-34	25-34	Male																												53,731					19,397				
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	Unknown Age	Unknown Age	Male				78	108	17	29		53	8	13	9		16	20	1	9		2	7	9	11		9	10	259				2		2					1
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	35-39	35-49	Female			138,951	34,085	38,592	33,991	33,129	54,750	28,525	30,878	17,290	20,488	100,338	23,853	22,296	22,518	21,164	71,470	20,764	23,722	21,752	23,565	54,556	21,712	25,274	24,234	23,860		22,759	26,120	26,913	28,118					27,881
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	Retired Age Band	35-49	Male			160,768																																		
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Male			149,528	14,451	13,364	13,043	11,567	110,324	10,504	10,418	4,060	4,882	46,620	6,046	5,263	5,735	4,845	38,185	4,982	5,483	5,688	6,018	33,386	5,439	6,536	5,845	6,813	19,520	6,215	7,769	8,815	10,359	83,203				10,423
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	20-24	15-24	Female			65,367	87,967	96,539	80,218	73,209	82,256	65,858	74,301	45,545	52,206	33,336	59,350	59,854	58,779	54,870	160,487	54,037	64,920	57,730	63,055	174,204	58,971	68,934	65,722	64,334		63,111	74,623	74,975	76,516					70,339
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	30-34	25-34	Female			153,910	54,792	58,655	49,328	47,337	78,951	41,025	45,026	25,963	30,581	79,334	34,455	33,150	32,560	30,368	112,207	29,754	34,002	30,888	33,478	111,378	30,691	35,615	33,814	34,026		31,889	37,036	38,006	38,892					40,205
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	25-29	25-34	Female			60,584	68,251	74,108	62,299	59,325	76,211	51,925	57,609	33,840	39,195	51,250	44,058	42,683	41,842	40,184	119,968	39,537	45,364	40,828	44,033	121,930	40,819	47,774	45,588	46,230		44,248	50,575	51,055	52,171					55,520
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	15-24	15-24	Male																												84,263					53,371				
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	01-04	01-09	Missing Sex				14,415	14,615	14,290	11,073	18,825	9,781	10,185	5,854	7,071	2,609	7,630	7,700	8,453	7,238	3,817	7,284	8,026	7,662	8,698	48,846	7,775	8,588	7,144	7,877		7,445	8,577	9,574	11,313					10,562
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	50+	50+	Female			102,204	18,725	15,497	14,534	11,794	43,560	10,068	10,681	3,498	4,799	53,365	6,384	5,046	5,147	4,146	55,160	4,461	4,864	5,143	5,547	38,258	4,942	6,166	5,338	6,289	31,243	6,164	6,883	8,382	9,669	111,757				9,637
Zimbabwe	Zimbabwe	ZWE	HTS_TST	Individuals who are tested for HIV and received their results	35-49	35-49	Female																												104,758					134,355				
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	<01	<01	Missing Sex			411	188	183	168	144	30	145	98	91	68		99	83	70	72		83	65	50	73		34	38	49	47		31	40	47	46					58
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Male				58	19	2				2	1	1		1		1	1				2				1												
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Male																												4,834					1,869				
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Male																												5,270					4,684				
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	01-09	01-09	Missing Sex																												3,082					1,732				
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	01-09	Missing Sex			4,637																																		
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Female			6,722	1,021	866	884	914	6,444	869	785	399	543	6,039	575	566	625	569	8,694	583	581	547	643	4,011	539	648	593	582	3,481	502	512	490	519	11,557				559
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Male			10,514	2,310	2,263	2,164	2,117	9,025	1,951	1,833	962	1,208	3,428	1,276	1,299	1,370	1,190	4,098	1,276	1,295	1,164	1,327	1,482	1,203	1,312	1,224	1,179		1,041	1,110	939	965					973
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	Retired Age Band	Missing Sex				1																2																	
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Male			10,514																																		
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Female				799	782	833	778	3,760	732	684	325	458	4,293	493	519	599	499	4,821	498	489	443	522	2,137	488	496	546	445		418	445	401	406					437
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Male			10,772	2,467	2,221	2,163	2,044	5,904	1,823	1,879	938	1,193	2,996	1,184	1,284	1,242	1,033	3,077	1,093	1,169	993	1,184	1,471	1,056	1,085	995	1,014		984	966	886	879					834
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	25-34	25-34	Female																												8,928					3,485				
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	05-09	01-09	Missing Sex				426	339	438	256	4,401	231	221	97	116	155	132	139	201	127	1,097	114	130	140	159	1,173	121	128	117	91		92	104	79	113					87
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	35-49	35-49	Female																												5,196					8,021				
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	45-49	35-49	Male				1,009	969	994	983	13,742	921	935	538	643	1,547	614	719	739	678	3,550	673	686	609	707	1,591	627	658	662	669		528	559	560	517					560
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	Unknown Age	Unknown Age	Female				60	25	47	2		1	8	8	6		2		1								1	1												
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	35-39	35-49	Female			9,760	2,372	2,543	2,372	2,269	7,104	1,957	2,120	1,217	1,547	4,896	1,481	1,602	1,658	1,408	6,593	1,341	1,434	1,218	1,463	2,508	1,363	1,404	1,252	1,232		1,121	1,224	1,016	1,063					1,016
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	Retired Age Band	35-49	Female			9,769																																		
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Female			7,155	3,757	3,946	3,322	3,063	3,951	2,954	3,076	1,833	2,188	1,528	2,506	2,570	2,476	2,196	2,388	2,147	2,425	1,989	2,193	2,934	2,213	2,351	1,989	1,925		1,893	2,101	1,861	1,805					1,679
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	10-14	10-14	Missing Sex			439	422	429	481	383	8,169	309	318	134	158	314	178	156	221	164	1,974	141	174	143	177	1,346	151	175	141	118	1,776	96	141	142	143	2,635				124
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Male				1,651	1,584	1,598	1,541	28,151	1,363	1,430	765	957	2,710	979	1,010	1,088	901	4,259	950	1,020	958	1,024	1,637	983	1,020	979	942		894	952	892	934					820
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	30-34	25-34	Female			12,827	3,486	3,422	3,095	2,926	7,384	2,557	2,801	1,504	1,985	3,649	1,887	1,971	2,025	1,676	5,256	1,686	1,863	1,541	1,752	2,081	1,602	1,706	1,507	1,387		1,442	1,585	1,333	1,293					1,289
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Female			1,866	1,682	1,715	1,417	1,343	1,601	1,325	1,309	693	899	657	1,037	1,068	1,013	916	1,486	945	1,036	816	944	2,350	888	906	839	784		774	913	792	757					679
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Female			6,622	3,761	3,963	3,376	3,210	6,972	2,867	3,075	1,791	2,227	2,429	2,153	2,402	2,221	2,001	3,346	1,977	2,248	1,842	2,111	2,331	1,950	2,148	1,915	1,819		1,816	2,001	1,704	1,692					1,663
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	01-04	01-09	Missing Sex				363	431	418	311	1,176	288	305	131	171	147	204	221	222	159	464	183	215	158	202	2,428	208	196	138	174		143	179	142	136					165
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Male																												3,648					1,979				
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	15-24	15-24	Female																												5,726					1,463				
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	50+	50+	Male			9,903	1,194	1,084	1,147	1,172	15,069	1,107	1,046	557	678	6,887	690	737	769	630	5,964	744	756	681	881	3,834	794	803	714	736	2,440	609	763	663	641	9,685				697
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	40-44	35-49	Female				1,377	1,344	1,288	1,339	8,846	1,183	1,190	659	808	5,880	864	828	903	835	6,439	784	828	789	898	2,427	799	911	798	728		721	743	713	689					660
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	15-19	15-24	Male			958	248	290	274	240	3,296	220	212	86	112	933	140	139	124	96	1,114	98	96	82	90	589	99	110	76	72		66	100	79	79					68
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	20-24	15-24	Male			4,691	861	872	787	802	2,910	680	737	307	407	2,226	430	472	443	447	1,296	400	455	378	447	1,295	383	389	381	352		369	397	332	356					296
Zimbabwe	Zimbabwe	ZWE	HTS_TST_POS	Individuals who tested positive for HIV	25-29	25-34	Male			2,198	1,686	1,588	1,553	1,463	4,394	1,370	1,349	644	855	2,994	952	967	894	841	1,861	854	814	672	832	1,516	814	840	699	743		736	763	652	675					632
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	25-34	25-34	Female																												12,186					13,728				
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	20-24	15-24	Female				2,086	2,200	2,009	2,074	38,141	1,785	2,114	1,708	1,954	72,529	1,897	2,085	1,946	1,920	4,925	1,757	1,985	1,721	1,756	5,053	1,693	2,061	1,815	1,697		1,640	1,772	1,602	1,656					1,653
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	10-14	10-14	Missing Sex				12	9	7	4		8	3	3	5		35	8	9	6		13	3	6	12		8	8	3	4		5	10	16	9					12
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	<10	Retired Age Band	Missing Sex					1				2	1		1		1					6	1					3												
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	60-64	50+	Female																															1	1					
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	35-39	35-49	Female				1,969	2,273	2,166	2,296	8,107	1,977	2,125	1,924	2,212	7,291	1,946	2,047	1,836	1,856	4,137	1,754	1,831	1,610	1,724	5,001	1,550	1,837	1,638	1,577		1,442	1,567	1,381	1,353					1,364
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	40-44	35-49	Female				447	463	523	590	4,070	489	547	524	649	3,684	559	583	553	534	2,208	480	558	551	531	2,469	533	574	586	584		532	566	566	515					504
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	35-49	35-49	Female																												7,433					7,507				
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	50-54	50+	Female																								2	6	3	5			4	6	7					6
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	30-34	25-34	Female				2,839	3,033	2,724	2,956	34,091	2,443	2,641	2,274	2,650	39,961	2,377	2,313	2,207	2,192	8,696	1,901	2,270	1,973	2,031	8,255	1,797	2,122	1,806	1,755		1,756	1,877	1,698	1,639					1,690
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	15-19	15-24	Female				797	844	702	770	2,786	718	723	552	700	8,910	734	762	713	710	805	698	760	634	746	555	679	788	687	650		636	761	692	632					621
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	Unknown Age	Unknown Age	Female							1							2						3										2		1					
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	45-49	35-49	Female				40	50	39	47	3,883	39	63	37	62	7,560	33	46	40	42	521	55	52	44	38	526	49	54	47	53		45	50	50	42					56
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	50+	50+	Female				5		6	5		3	10	3	2		7	1	2	1		5	4	2	1				1			1								
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	15-24	15-24	Female																												4,172					4,182				
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	25-29	25-34	Female				2,498	2,766	2,348	2,492	33,348	2,280	2,494	2,063	2,282	47,029	2,177	2,270	2,139	1,971	5,923	1,979	2,077	1,905	1,926	6,228	1,776	2,168	1,911	1,878		1,820	2,017	1,708	1,738					1,892
Zimbabwe	Zimbabwe	ZWE	PMTCT_ART	HIV-positive pregnant women who received ART	55-59	50+	Female																								1							2	2					4
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	40-44	35-49	Female				1,755	1,939	1,970	2,746	8,506	1,798	2,269	2,077	2,459	49,720	2,376	2,327	2,241	2,274	10,536	2,027	2,399	2,112	2,344	10,394	2,177	2,502	2,604	2,285		2,207	2,479	2,369	2,231					2,271
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-19	15-24	Female			12,289	18,380	20,080	18,263	16,312	13,867	16,631	18,330	15,659	17,206	13,957	17,707	19,826	19,050	18,756	13,408	18,282	20,249	17,973	19,229	13,409	18,072	20,818	19,229	18,300		17,864	20,484	19,075	18,092					18,700
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Unknown Age	Unknown Age	Female				1	1	11	8		3			1		6	2	1				1										1							
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-49	35-49	Female																												36,552					36,553				
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-34	25-34	Female																												118,180					118,178				
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	Retired Age Band	35-49	Female			15,537																																		
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	25-29	25-34	Female			60,054	18,083	20,247	18,297	18,294	67,052	16,882	20,264	16,973	18,745	66,373	18,062	18,856	18,455	18,022	61,998	17,517	19,858	17,334	18,185	61,233	17,332	20,199	18,340	17,390		16,770	19,009	17,556	17,098					18,843
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	20-24	15-24	Female			93,128	24,023	26,367	23,946	22,320	97,476	22,198	26,860	22,751	24,703	84,780	23,995	26,427	25,562	24,656	82,553	23,693	27,100	23,863	25,455	82,039	24,065	28,106	25,765	24,055		23,054	26,319	25,131	24,526					24,902
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	50+	50+	Female				11	9	5	106		22	25	8	18		18	7	10	11		17	8	5	10		8	12	10	17		11	5	11	9					5
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	15-24	15-24	Female																												95,448					95,448				
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	<10	Retired Age Band	Missing Sex				6	3	1			21	8				1	1	11	5			3		1			3												
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	35-39	35-49	Female			15,537	7,988	9,355	9,034	9,780	16,797	8,275	10,029	8,725	9,771	46,911	9,298	9,474	9,394	9,280	24,625	8,957	9,607	8,502	9,337	24,120	8,411	9,825	9,123	8,389		7,875	8,746	8,203	7,797					7,846
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	30-34	25-34	Female			60,054	14,893	15,790	14,420	15,379	67,052	13,324	15,788	13,385	15,103	70,322	14,537	14,781	14,418	13,734	58,260	13,293	14,726	13,043	14,023	56,947	12,761	15,039	13,490	12,679		11,927	13,416	12,854	12,408					12,826
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	10-14	10-14	Missing Sex				226	249	268	239		218	199	172	185		297	302	227	278		278	314	223	246		204	272	240	245		209	274	246	256					229
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT	Pregnant women attending antenatal care who know their HIV status	45-49	35-49	Female				177	173	177	636	8,506	156	213	161	224	33,058	165	179	161	166	2,067	169	201	167	160	2,039	147	194	188	190		161	190	141	161					175
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-34	25-34	Female																												12,193					13,835				
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	<10	Retired Age Band	Missing Sex				1	1					2										2																	
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-39	35-49	Female			2,383	1,981	2,293	2,135	2,282	8,536	1,981	2,173	1,952	2,225	7,266	2,001	2,022	1,833	1,854	4,192	1,749	1,839	1,614	1,739	5,018	1,567	1,834	1,660	1,588		1,446	1,570	1,396	1,353					1,372
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	25-29	25-34	Female			9,630	2,509	2,797	2,395	2,530	35,011	2,308	2,579	2,104	2,289	47,003	2,163	2,290	2,165	1,979	6,003	1,988	2,099	1,908	1,921	6,263	1,782	2,177	1,951	1,892		1,801	1,999	1,716	1,738					1,896
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	50+	50+	Female				5		1	7		2	10	4	1		6	2	4	1		5	4	2	2		2	3	5	5		1	3	3	3					1
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Retired Age Band	35-49	Female			2,383																																		
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	20-24	15-24	Female			12,068	2,110	2,248	2,006	2,056	40,168	1,796	2,236	1,750	1,961	72,532	1,874	2,096	1,948	1,903	4,979	1,793	1,988	1,730	1,791	5,097	1,692	2,077	1,900	1,720		1,651	1,793	1,644	1,683					1,652
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	40-44	35-49	Female				449	480	510	618	4,482	488	559	519	657	3,741	584	558	545	535	2,241	467	556	544	536	2,472	544	579	606	582		532	571	561	513					504
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	30-34	25-34	Female			9,630	2,855	3,111	2,737	2,957	35,154	2,474	2,688	2,294	2,638	39,916	2,439	2,321	2,227	2,179	8,808	1,924	2,267	1,957	2,054	8,278	1,801	2,128	1,864	1,742		1,763	1,884	1,722	1,648					1,710
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	Unknown Age	Unknown Age	Female						1	1							2						1										1							
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	45-49	35-49	Female				40	53	42	49	4,285	40	60	36	70	7,634	32	45	41	43	519	55	54	45	38	526	44	51	50	48		46	45	36	35					48
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	35-49	35-49	Female																												7,468					7,543				
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	10-14	10-14	Missing Sex				17	13	8	5		6	3	3	4		11	10	8	7		9	5	7	9		4	8	5	4		3	11	16	5					8
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-24	15-24	Female																												4,221					4,217				
Zimbabwe	Zimbabwe	ZWE	PMTCT_STAT_POS	HIV-positive pregnant women attending antenatal care	15-19	15-24	Female			1,350	826	852	722	734	3,313	726	794	565	685	8,911	665	774	742	720	811	710	786	643	738	557	673	778	735	650		636	762	698	632					612
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Male																												8,915					8,914				
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Male																				60		54			63		44			212		129					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Male																				184		142			210		265			566		384					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Male																									1					6		7					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Female																				742		738			1,091		1,036			2,484		1,913					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Male																				161		113			164		154			312		239					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	10-14	10-14	Missing Sex			8,602		25,935		12,037	53,411							143					2		1,870			488		979			1,876		1,248					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Female			34,011		22,595		17,544	32,237		21,071		5,660	49,472		35,553		39,415	54,925		41,866		68,924	44,738		62,282		86,408			54,178		80,855					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	30-34	25-34	Female																				618		644			851		897			2,077		1,643					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	Unknown Age	Unknown Age	Female																									9		2			5		9					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Female																				188		161			315		254			840		763					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	50+	50+	Female																				263		126			230		153			281		245					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	45-49	35-49	Female																				149		78			129		96			327		299					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	40-44	35-49	Male																				79		81			115		161			325		243					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-24	15-24	Female																												89,787					96,184				
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Male																				196		173	2,603		246		1,399			1,830		2,306					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Male																				152		85			140		209			448		313					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	35-39	35-49	Female																				409		374			578		570			1,535		1,232					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	15-19	15-24	Male																				113		80	855		97		1,373			1,547		1,994					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	20-24	15-24	Female			29,362		12,010		7,822	15,238		11,050		4,429	42,481		25,795		27,067	35,895		31,409		49,863	38,683		40,915		62,343			32,496		46,242					
Zimbabwe	Zimbabwe	ZWE	PP_PREV	Individuals from priority populations who completed an HIV prevention intervention	25-29	25-34	Male																				214		166			195		367			642		387					
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Male																			613	646	694	813	1,505	832	945	1,043	1,126		1,071	1,085	1,342	1,407					551
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Male																												2,683					3,007				
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Male																			300	335	390	455	561	487	494	586	677		670	702	831	818					332
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Male																			661	757	875	850	1,831	885	1,031	1,170	1,255		1,105	1,330	1,600	1,648					664
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Female																			2,418	2,755	3,587	3,580	8,523	3,999	4,517	4,339	5,569		4,557	5,051	6,771	7,595					1,692
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	30-34	25-34	Female																			1,755	1,825	2,032	2,241	2,496	2,502	2,546	2,614	2,842		2,733	3,069	3,518	3,825					1,683
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Female																												3,095					4,826				
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	45-49	35-49	Female																			599	695	667	787	1,349	817	879	935	983		1,029	1,132	1,258	1,375					560
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Male																			134	156	177	185	1,173	160	187	239	285		223	260	369	336					114
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	Unknown Age	Unknown Age	Female																			3	1	1				1		1										
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Female																			504	522	560	613	773	643	716	779	846	506	875	1,008	1,092	1,226	841				525
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Male																												2,335					2,424				
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Male																			566	617	693	824	1,285	849	918	1,067	1,090		1,028	1,100	1,283	1,345					543
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Male																			460	497	550	625	909	712	760	869	967		933	1,038	1,152	1,192					515
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-24	15-24	Female																												13,022					13,509				
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	15-19	15-24	Female																			1,286	1,447	1,802	1,852	5,654	2,329	2,565	2,597	3,235		2,540	3,060	3,992	4,352					703
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-49	35-49	Male																												2,322					3,100				
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-34	25-34	Female																												4,023					5,411				
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	40-44	35-49	Female																			959	1,021	1,136	1,276	1,661	1,355	1,512	1,568	1,708		1,817	2,063	2,302	2,558					1,042
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	35-39	35-49	Female																			1,442	1,612	1,761	1,984	2,189	2,185	2,303	2,422	2,652		2,554	2,873	3,368	3,665					1,568
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	25-29	25-34	Female																			1,710	1,878	2,122	2,177	2,857	2,374	2,479	2,562	2,973		2,901	3,144	3,730	4,128					1,800
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	50+	50+	Male																			460	481	548	642	534	724	791	842	943	570	985	1,083	1,164	1,383	957				531
Zimbabwe	Zimbabwe	ZWE	PrEP_CT	Individuals that returned for a PrEP follow-up or re-initiation visit during the reporting period	20-24	15-24	Male																			584	728	784	799	2,481	793	878	1,015	1,277		1,070	1,181	1,456	1,474					496
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male												1		3		1																					
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male					223		277	130		468		647	888	335	612	719	904	1,855																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					164		312	348		453		551	713	329	666	1,104	1,619	1,405																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					258		391	412		609		716	713	430	837	1,371	1,912	1,963																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male					69		128	431		140		176	127	186	361	631	972	306																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					127		211			217		311	2,846	230	414	820	1,264	2,565																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					428		658	386		977		1,426	3,085	986	1,681	2,860	3,981	3,643																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male					554		753	367		1,173		1,587	954	773	1,288	2,036	2,734	3,382																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					231		347	61		476		703	2,914	536	904	1,546	2,210	2,915																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					52		109	208		127		162	713	146	254	459	704	685																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female					673		1,021	535		1,662		2,668	3,047	1,562	2,766	4,281	5,771	4,523																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female					400		1,040	718		1,519		2,458	3,635	1,439	3,647	5,170	6,343	7,888																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male					288		493	435		757		950	688	511	947	1,661	2,361	2,171																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female														5		3	14																				
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female					50		99			130		177	515	157	326	672	1,045	882																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					569		944	471		1,392		2,151	2,968	1,308	2,235	3,566	4,937	3,775																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female					1,000		1,370	1,681		2,388		4,216	4,090	2,862	5,818	8,327	10,123	11,258																			
Zimbabwe	Zimbabwe	ZWE	PrEP_CURR	Individuals receiving pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					119		210	276		234		283	713	218	392	752	1,138	903																			
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Male			34		104		258	158		338		188	587	132	234	136	204	1,492	211	337	369	482	1,931	535	504	460	357		571	599	570	555					186
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Male			99		334		613	447		782		407	715	358	522	521	654	2,821	763	1,401	1,236	1,682	4,228	1,826	1,893	1,576	1,419		1,843	2,214	1,989	2,151					1,001
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Male					92		198	427		290		89	489	142	261	337	486	1,088	539	775	785	1,006	2,324	1,010	1,029	924	837		877	1,324	1,178	1,281					821
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Female			1,732		407		602	715		853		988	2,643	752	1,001	1,190	1,493	3,291	1,676	2,277	1,958	2,438	4,217	2,170	2,426	2,766	2,761		2,811	3,879	3,604	3,989					3,452
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Male																												6,047					8,741				
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Female					101		142	81		190		216	2,226	222	283	462	639	2,125	650	806	775	929	2,493	804	907	952	1,034		1,007	1,382	1,419	1,502					1,297
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Male			51		32		67	525		82		30	76	68	139	225	350	233	277	392	414	561	1,047	481	504	487	503	1,535	490	766	760	827	2,132				565
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	40-44	35-49	Male					51		103	337		145		51	481	84	146	276	355	679	393	503	500	674	1,727	712	703	698	628		755	976	943	1,015					643
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Female																												33,231					40,016				
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Male																												6,878					11,115				
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-34	25-34	Female																												11,050					19,710				
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Male					124		316	505		383		95	525	202	344	405	529	1,539	626	855	877	1,099	2,731	1,154	1,341	1,111	974		1,127	1,534	1,440	1,548					905
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	50+	50+	Female			61		29		43			51		45	397	53	139	253	347	633	327	361	336	428	1,152	349	450	391	458	1,352	425	564	581	696	1,787				514
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Female																	2		3		1	2		11		1	1					1					2
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	20-24	15-24	Female			680		660		900	2,171		1,586		1,794	3,203	1,592	2,645	2,233	2,133	9,016	3,094	4,770	3,603	4,591	13,749	4,530	5,482	6,330	6,059		5,615	9,430	7,456	6,616					3,795
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Male					35		49	254		61		25	481	58	95	150	236	510	234	340	325	420	1,039	363	434	407	407		443	517	510	606					400
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	25-29	25-34	Male			429		201		416	532		507		203	525	238	405	508	643	1,767	724	1,143	1,055	1,400	3,270	1,521	1,636	1,432	1,285		1,554	2,036	1,797	2,001					1,132
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-24	15-24	Male																												5,711					8,976				
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-49	35-49	Female																												8,417					12,901				
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	30-34	25-34	Female					335		545	627		692		730	2,572	532	751	953	1,342	2,765	1,513	1,786	1,571	1,973	3,886	1,894	1,928	2,096	2,158		2,154	3,162	2,977	3,234					2,764
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	15-19	15-24	Female			205		255		1,014	946		1,135		950	2,941	884	2,018	1,425	1,329	6,244	2,037	2,872	2,023	2,975	9,221	3,285	4,137	4,238	4,128		4,112	7,463	5,978	4,915					2,104
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	45-49	35-49	Female					51		74			84		86	2,225	68	151	270	417	1,879	412	436	430	528	2,085	394	455	469	510		509	642	669	764					605
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	Unknown Age	Unknown Age	Male																				1	1	1															2
Zimbabwe	Zimbabwe	ZWE	PrEP_NEW	Individuals newly enrolled on pre-exposure prophylaxis to prevent HIV infection	35-39	35-49	Female					215		370	514		437		453	2,713	409	563	817	1,105	2,690	1,156	1,387	1,246	1,600	3,605	1,449	1,598	1,650	1,653		1,725	2,320	2,267	2,446					2,188
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-09	01-09	Missing Sex																												299					310				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Missing Sex			399																																		
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Female				141	223	126	149	509	134	125	80	69	770	89	69	102	76	1,026				411	922				374					400					206
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Male				145	166	146	129	759	164	122	76	84	1,247	95	100	89	97	922				325	827				378					380					209
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	10-14	10-14	Missing Sex				57	54	40	44	155	46	25	20	19	286	25	25	21	10	171				73	171				95	145				61	203				31
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Male				275	308	239	301	735	241	218	135	140	850	183	182	207	194	1,184				816	1,033					1,023					1,165				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Female																											83					95					54
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Female																												2,730					3,195				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Female				235	253	132	161	491	135	147	89	86	1,003	101	58	102	97	926				448	794				366					355					154
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Female			5,432																																		
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Male				62	83	61	61	785	61	50	39	16	1,250	52	36	38	48	613				187	659				171					184					100
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	60-64	50+	Male																											121					141					74
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Female																												1,219					1,847				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	01-04	01-09	Missing Sex				20	45	21	17	150	17	20	15	14	303	15	16	7	5	82				61	144				73					57					22
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Male				1	1		1																														
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Male																											420					475					249
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-29	25-34	Female				156	134	100	118	503	101	118	71	58	1,049	75	70	83	58	786				306	665				298					318					152
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Female				57	45	54	36	501	35	29	18	16	1,125	23	17	24	15	684				87	503				79					75					26
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Female																											103					124					67
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Female				243	256	160	211	494	167	157	88	88	792	124	100	117	104	921				458	941				445					436					203
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	55-59	50+	Male																											172					233					164
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Coarse	Coarse	Male			7,818																																		
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-39	35-49	Male				341	437	260	330	752	322	270	177	154	1,328	240	165	207	172	1,251				870	1,153				851					883					497
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-19	15-24	Male				35	51	31	31	776	33	23	20	15	1,450	18	16	15	23	1,050				62	545				63					45					17
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Female																												959					1,309				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	15-24	15-24	Male																												1,049					1,148				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	35-49	35-49	Male																												2,731					3,331				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	<01	<01	Missing Sex				4	21	7	3	154	4	9	2	6		6	1	4						17					12					13					8
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	05-09	01-09	Missing Sex				24	21	25	19	150	15	16	8	9	292	15	12	18	9	106				68	167				45					39					13
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Male				189	213	170	210	733	197	157	118	93	1,252	149	110	137	154	1,011				563	800				585					605					322
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	45-49	35-49	Female				109	80	94	97	504	100	81	62	62	885	87	73	79	77	934				342	907				357					325					171
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Male																											153					198					127
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	25-34	25-34	Male																												1,209					1,869				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	Unknown Age	Unknown Age	Female					1		1					1										1										1					
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50+	50+	Female				156	142	145	150	507	148	142	84	94	842	129	126	127	108	689				630	856					855					917				
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	30-34	25-34	Male				326	278	233	254	752	229	213	143	124	1,236	166	136	143	129	1,100				592	898				692					670					347
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	20-24	15-24	Female				85	80	74	59	494	71	56	57	42	1,193	45	39	46	38	716				197	584				184					225					96
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	50-54	50+	Female																											302					262					148
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	40-44	35-49	Male				287	269	227	239	746	217	227	179	136	1,211	161	170	187	163	1,134				754	1,040				819					897					499
Zimbabwe	Zimbabwe	ZWE	TB_ART	Individuals with TB and documented HIV-positive status who are on ART	65+	50+	Female																											132					129					72
Zimbabwe	Zimbabwe	ZWE	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Male			21,536		6,388		7,658	190,690		19,982		24,235	340,207		26,895		51,220	101,195		62,690		41,029	117,911		38,460		37,217	94,813		36,844		27,331	42,681				2,982
Zimbabwe	Zimbabwe	ZWE	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	<15	<15	Missing Sex			2,503		759		1,132	32,141		2,202		2,857	51,154		2,491		4,445	15,213		5,651		3,003	15,922		3,751		2,755	18,680		2,947		1,923	6,178				210
Zimbabwe	Zimbabwe	ZWE	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Female					7		2			21					37		3			2		9			2		2			11		4					
Zimbabwe	Zimbabwe	ZWE	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	Unknown Age	Unknown Age	Male					4		1			10		81			30		2			7		5			4		1			19		12					
Zimbabwe	Zimbabwe	ZWE	TB_PREV	Individuals on ART who completed a standard course of TB preventive therapy	15+	15+	Female			17,730		10,668		12,902	279,188		31,802		39,749	514,738		45,028		84,713	159,436		98,487		66,969	200,801		63,931		62,499	149,703		62,131		47,129	97,434				4,424
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Male				290	302	250	268	1,542	264	251	148	152	1,750	199	191	180	195	1,749	184	170	174	221	1,749	242	213	176	241		267	266	234	296					322
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Female			6,993																																		
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Female																												2,550					2,549				
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	<01	<01	Missing Sex				48	46	22	25	305	20	23	15	12		26	19	19	8		26	16	12	20		20	17	12	17		32	55	32	27					17
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Male				485	447	362	426	1,553	354	364	236	209	1,744	295	253	259	238	1,742	258	264	257	309	1,742	311	297	278	332		359	342	316	333					423
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Female				219	270	171	200	1,190	166	178	103	102	1,418	132	102	148	101	1,418	134	140	138	162	1,418	119	135	137	120		162	148	125	160					169
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Female				128	92	95	67	1,186	78	72	32	38	1,183	56	40	45	34	1,183	52	48	42	44	1,183	39	46	42	49		49	59	59	49					48
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	15-19	15-24	Male				92	113	55	69	1,599	72	60	41	39	1,599	46	29	29	45	1,599	44	32	30	40	1,599	55	41	27	42		44	39	36	39					45
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Missing Sex			1,383																																		
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	25-29	25-34	Female				249	219	157	178	1,190	149	191	116	92	1,325	128	117	125	105	1,325	109	122	117	116	1,325	123	97	128	150		135	139	119	156					138
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Male																												5,215					5,217				
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Male				636	551	456	509	1,503	435	477	269	371	2,137	399	396	412	427	2,136	445	435	405	492	2,140	445	451	424	611	2,142	527	608	543	606	2,140				711
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	10-14	10-14	Missing Sex				90	104	55	74	305	62	55	33	39	319	37	50	52	28	319	37	32	40	48	319	52	68	39	36	319	60	41	40	36	313				61
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	05-09	01-09	Missing Sex				64	43	50	44	305	50	51	19	26	309	32	27	38	21	309	47	29	39	42	309	42	28	28	40		46	27	34	40					27
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Female				324	283	216	266	1,269	216	232	125	120	1,331	188	136	157	155	1,330	171	136	161	160	1,331	145	145	173	186		158	162	138	157					187
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	35-49	35-49	Female																												4,111					4,112				
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	Coarse	Coarse	Male			10,369																																		
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	30-34	25-34	Female				329	272	185	238	1,232	193	214	126	125	1,395	147	104	139	146	1,394	143	147	151	166	1,394	122	137	134	165		135	145	115	131					167
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	50+	50+	Female				358	300	295	320	1,190	281	224	133	185	1,513	217	222	258	217	1,512	329	268	298	324	1,514	295	319	299	319	1,513	313	326	306	367	1,514				431
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Male																												3,491					3,491				
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Female				179	125	123	123	1,190	142	113	83	84	1,363	118	97	109	101	1,363	107	106	112	120	1,363	114	118	128	140		126	97	112	146					157
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	01-04	01-09	Missing Sex				89	89	49	47	305	46	52	50	37	315	57	58	46	25	315	56	59	51	36	315	51	60	45	52		63	81	60	60					55
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	15-24	15-24	Male																												3,203					3,202				
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	01-09	01-09	Missing Sex																												624					627				
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Female				3	1		1		1			2									4	1							1								
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Male				180	171	123	140	1,503	143	129	95	72	1,605	115	92	113	93	1,604	107	109	100	126	1,604	124	116	128	135		159	132	126	184					175
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	45-49	35-49	Male				327	303	241	281	1,503	260	218	169	178	1,521	231	190	203	228	1,521	226	203	201	248	1,521	211	220	210	284		273	263	233	286					326
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	25-34	25-34	Female																												2,719					2,715				
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	40-44	35-49	Male				402	366	323	367	1,503	293	346	244	222	1,749	240	265	310	260	1,749	294	313	274	361	1,749	355	353	329	406		384	414	378	448					485
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	35-39	35-49	Male				532	528	378	486	1,637	470	416	250	281	1,947	359	276	347	299	1,946	347	366	352	383	1,946	363	364	370	396		383	413	409	446					501
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	20-24	15-24	Female				170	159	115	122	1,286	126	143	84	70	1,366	102	91	98	82	1,366	82	95	93	107	1,366	92	83	86	98		128	113	95	100					124
Zimbabwe	Zimbabwe	ZWE	TB_STAT	Individuals with TB who know their HIV status	Unknown Age	Unknown Age	Male				5	1		2					3		1	1						2				2	257											
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	<01	<01	Missing Sex			2,599	1,579	1,505	1,325	1,355	3,874	1,137	1,072	1,412	1,430	2,653	1,527	1,317	1,261	1,183	1,966	1,278	1,216	1,359	1,972	276	1,359	1,143	994	940	243	861	912	918	825	190				669
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Female																			20,078	28,919	30,104	30,953	50,748	31,008	32,584	36,413	37,550		38,822	39,473	39,325	40,347					54,480
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Male			16,098	13,170	12,920	12,320	11,955	18,685	11,706	11,929	14,736	15,040	17,216	14,531	14,659	14,590	14,957	21,347	14,800	14,765	14,729	14,432	16,030	14,351	14,552	14,323	13,925		13,813	13,710	13,585	13,402					12,629
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Male			62,023	42,771	35,414	23,672	25,269	66,479	23,946	23,147	28,662	29,593	42,156	28,172	27,619	27,313	28,118	35,215	28,649	27,849	27,893	28,029	31,530	28,571	27,780	23,039	22,602		22,153	21,651	21,938	21,843					20,206
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Male			60,537	53,984	51,878	50,760	53,188	68,666	53,392	54,374	64,314	64,491	77,018	64,181	63,306	63,336	64,445	76,349	65,210	64,375	64,443	64,653	70,362	64,611	63,586	58,563	57,227		55,912	54,573	54,011	52,881					47,075
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	01-09	Missing Sex			32,912																																		
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Male			60,637	55,001	44,647	39,261	40,874	66,429	40,019	38,512	46,991	47,228	62,019	46,354	44,287	43,805	44,301	57,950	45,201	44,468	44,065	44,118	49,605	44,101	42,404	36,934	36,124		35,131	34,583	34,506	34,060					30,037
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Female																			13,873	21,241	22,487	23,080	23,974	23,208	24,226	26,678	27,592		28,213	28,831	29,132	29,948					38,067
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-29	25-34	Female			115,753	85,952	72,931	60,946	63,486	121,696	58,736	62,667	74,206	74,284	81,485	73,292	72,110	71,960	72,529	62,710	73,496	72,446	72,789	73,949	73,977	74,863	73,465	67,378	68,131		67,359	66,557	67,584	67,650					62,788
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Male				39,386	53,697	50,944	52,383	50,322	53,098	54,401	67,893	67,950	69,795	66,568	69,429	69,495	71,221	65,033	70,774	71,809	71,527	71,556	75,385	71,219	71,537	70,220	70,417		69,723	69,444	69,502	69,276					67,861
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Female																			13,711	19,678	22,232	21,088	21,677	21,878	23,558	26,579	27,763		28,447	29,599	29,640	30,667					45,470
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Male																												38,906					38,860				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Male				41,814	53,473	52,456	54,801	64,520	55,336	55,744	68,309	68,603	77,052	68,844	68,641	69,586	69,783	78,780	70,120	70,479	70,579	70,941	77,494	70,872	71,840	69,353	68,330		67,782	67,797	68,216	67,858					64,592
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Female			86,636	90,346	93,422	98,679	100,068	101,367	102,361	106,397	131,291	133,291	135,164	134,063	142,964	143,102	144,411	160,479								6,853	871	162,531					191,705				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	10-14	10-14	Missing Sex			26,756	22,677	22,512	22,888	22,000	33,871	21,513	21,926	27,009	27,389	37,319	27,074	27,202	27,405	27,325	37,503	27,480	26,851	26,925	26,604	28,847	26,766	26,230	26,544	24,988	28,855	24,389	23,905	23,441	22,789	27,950				19,132
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	45-49	35-49	Female				53,956	70,237	70,092	71,030	63,330	70,842	74,207	91,347	92,980	93,255	92,156	95,127	96,391	97,350	88,690	97,110	100,060	98,847	100,138	101,353	100,965	101,810	104,404	106,772		107,179	107,705	107,777	109,165					111,638
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-19	15-24	Female			27,841	22,088	20,748	19,282	19,714	28,767	18,458	19,097	23,067	23,642	26,134	23,185	22,749	23,230	23,367	28,015	24,007	23,229	23,648	23,620	26,606	23,922	23,248	22,121	21,734		21,914	21,012	20,800	20,849					18,319
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	60-64	50+	Male																			10,333	16,159	16,684	17,491	18,461	17,092	17,936	19,000	18,948		19,344	19,575	20,222	20,314					25,552
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Female																			100,161	84,375	81,431	82,383	62,620	83,502	87,279	83,240	89,695		92,400	93,277	94,610	95,920					87,525
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Male			60,190																																		
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Male			22,827	17,739	16,592	13,587	13,387	25,526	13,750	12,702	16,464	16,779	25,252	16,420	16,861	16,735	17,299	24,442	17,691	17,470	17,580	18,160	20,042	17,874	17,887	17,039	16,333		15,942	15,945	15,985	15,829					14,488
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Male				6	1				228	226	191	170		320	143	293	90		54	80	128	166		82	52	5	4		4	2							1
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	40-44	35-49	Female				57,752	79,385	81,863	83,016	70,209	84,008	86,164	106,832	106,307	109,027	105,757	107,829	108,472	108,565	119,075	109,089	111,607	111,640	113,032	120,826	114,231	116,590	118,892	120,761		121,701	121,384	121,188	122,139					122,191
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-39	35-49	Female			104,291	85,119	90,405	89,665	93,203	107,770	93,449	98,121	117,680	116,391	118,854	116,367	118,465	118,340	119,561	122,626	119,259	118,565	118,605	119,488	126,316	119,652	119,172	116,336	117,270		115,481	113,524	113,383	112,358					103,892
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50+	50+	Male			85,112	74,306	75,628	77,853	78,106	97,321	80,973	83,632	104,911	105,236	113,191	106,519	111,458	112,719	113,987	110,981								5,303	674	127,405					145,574				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	30-34	25-34	Female			104,859	116,511	82,383	81,156	82,070	126,071	78,770	81,316	97,060	96,468	103,854	96,819	93,276	93,552	92,804	98,242	92,951	92,311	93,004	94,213	98,140	94,553	93,249	87,778	87,994		86,364	84,953	85,543	85,483					78,794
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Female																												172,708					162,367				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-09	01-09	Missing Sex																												29,909					23,294				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Unknown Age	Unknown Age	Female				11	1				352	377	417	282		395	314	185	87		58	92	239	251		115	64	3	3		1	3	2						32
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	15-24	15-24	Female																												80,368					68,264				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	50-54	50+	Male																			78,484	65,639	63,868	64,327	51,335	64,670	67,039	62,482	66,767		67,829	67,519	68,776	70,033					61,552
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Male																												217,926					205,485				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	35-49	35-49	Female																												343,157					351,678				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	55-59	50+	Male																			14,371	21,876	23,377	23,567	40,442	23,674	24,508	26,969	27,286		28,421	28,772	29,425	29,753					41,334
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	01-04	01-09	Missing Sex				8,176	7,565	7,322	6,988	17,136	6,489	6,372	7,513	7,859	12,827	7,408	7,207	6,995	6,856	9,319	6,653	6,627	6,540	6,394	10,707	6,419	5,963	5,390	5,055		4,951	4,775	4,718	4,457					3,723
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	65+	50+	Male																			11,307	15,562	17,069	17,023	16,328	16,567	18,093	20,381	21,295		21,499	22,080	22,340	22,568					32,785
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	Retired Age Band	35-49	Female			103,773																																		
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	05-09	01-09	Missing Sex				17,741	17,577	17,129	16,917	22,049	16,166	16,199	19,551	18,820	24,132	18,324	17,261	16,991	16,719	21,188	16,756	15,839	15,697	15,444	18,866	15,628	14,625	13,283	12,635		12,172	11,690	11,382	10,701					8,439
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	25-34	25-34	Male																												81,470					66,887				
Zimbabwe	Zimbabwe	ZWE	TX_CURR	Individuals currently receiving antiretroviral therapy (ART)	20-24	15-24	Female			64,209	50,150	46,401	39,330	41,075	66,995	37,869	39,632	47,830	48,728	51,758	48,094	46,774	47,881	48,262	44,850	48,793	47,665	49,101	50,076	50,756	50,823	49,503	45,138	45,525		44,374	43,690	43,602	43,420					38,055
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Male			11,707																																		
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Female																								358	358	333	320		296	290	293	275					268
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Female																								53	68	81	69		55	64	66	74					69
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Male																												4,594					1,775				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Female																								44	81	62	79		78	71	68	70					75
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Male				914	943	987	941	12,628	917	910	553	584	1,469	592	676	713	608	3,363	665	650	606	669	1,518	593	655	621	616		511	555	535	502					516
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Female																												5,443					1,393				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Male			2,269	1,370	1,490	1,291	1,233	5,163	1,216	1,259	606	783	2,847	852	914	830	821	1,771	777	776	653	767	1,443	781	800	635	677		695	717	605	629					595
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Male			5,041	724	711	626	631	2,868	611	668	277	382	2,114	395	417	397	414	1,224	344	403	310	409	1,225	352	363	321	326		369	355	294	313					278
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Male				1,427	1,469	1,475	1,392	22,339	1,325	1,386	734	885	2,573	937	1,002	1,028	862	4,042	914	986	915	977	1,569	968	980	927	882		888	907	846	903					790
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Female			1,692	1,274	1,321	1,175	1,142	2,249	1,108	1,175	637	822	619	879	971	915	820	1,405	832	900	756	876	2,231	817	849	754	737		708	838	714	696					659
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Male																								127	128	133	159		119	141	116	131					167
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	<01	<01	Missing Sex			502	212	192	179	182	593	159	152	134	92	15	141	123	123	101	310	141	151	130	126	278	77	106	100	124	248	115	92	87	83	192				119
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	01-09	Missing Sex			5,220																																		
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-19	15-24	Male			1,144	208	242	179	164	2,836	150	177	69	103	887	113	116	120	97	1,059	86	90	56	80	553	78	95	68	70		71	81	64	65					54
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-04	01-09	Missing Sex				280	375	304	256	1,905	242	262	141	160	140	196	210	230	149	459	191	191	170	219	2,278	205	204	149	176		141	151	129	118					133
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	15-24	15-24	Male																												3,463					1,880				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Female																												4,935					7,617				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-29	25-34	Female			2,954	3,003	3,292	2,959	2,795	8,399	2,655	2,879	1,628	2,079	2,305	2,027	2,269	2,113	1,890	3,176	1,914	2,123	1,779	2,011	2,218	1,879	2,112	1,839	1,763		1,735	1,956	1,632	1,618					1,615
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	60-64	50+	Male																								63	74	82	66		52	68	54	74					75
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	55-59	50+	Female																								74	104	113	112		88	90	84	102					130
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50-54	50+	Male																								490	515	412	417		350	455	386	361					325
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	25-34	25-34	Female																												8,478					3,313				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Male			11,060	1,123	1,057	1,056	1,072	13,585	936	1,014	560	656	6,541	671	728	744	609	5,657	704	716	684	822	3,633					2,318					9,201				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	40-44	35-49	Female				1,249	1,312	1,238	1,203	9,195	1,129	1,179	640	747	5,587	792	835	892	830	6,115	758	787	798	887	2,309	779	901	748	720		721	735	716	673					632
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	10-14	10-14	Missing Sex			582	352	344	340	253	6,171	219	273	123	142	298	179	158	216	153	1,868	131	157	126	159	1,283	135	164	134	124	1,681	93	123	127	126	2,503				106
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Male			11,718	2,033	2,135	2,009	1,963	7,701	1,834	1,830	951	1,157	3,250	1,187	1,296	1,311	1,115	3,886	1,197	1,241	1,101	1,258	1,409	1,142	1,266	1,148	1,111		991	1,040	895	896					870
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-49	35-49	Male																												5,006					4,446				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	45-49	35-49	Female				728	752	787	734	5,070	716	717	339	490	4,082	514	526	587	506	4,583	489	482	432	530	2,019	476	475	515	438		415	447	417	400					428
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Male					10	3	3		1	13				1											1												7
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Female			9,883	2,949	3,081	2,858	2,654	8,792	2,454	2,636	1,443	1,854	3,472	1,714	1,802	1,904	1,558	4,984	1,617	1,755	1,494	1,651	1,985	1,583	1,660	1,411	1,379		1,412	1,507	1,287	1,247					1,242
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	35-39	35-49	Female			9,884	2,113	2,281	2,182	2,146	7,664	1,882	2,063	1,194	1,424	4,646	1,358	1,521	1,598	1,362	6,265	1,273	1,380	1,223	1,391	2,384	1,333	1,375	1,170	1,190		1,126	1,218	1,005	1,021					952
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Unknown Age	Unknown Age	Female					21	1			6	3				2	1		1			1	1	2				1											12
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	01-09	01-09	Missing Sex																												2,925					1,644				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	30-34	25-34	Male			11,718	2,240	2,048	2,009	1,857	6,058	1,671	1,785	908	1,142	2,840	1,099	1,216	1,218	1,010	2,927	1,047	1,137	950	1,115	1,400	1,009	1,058	922	929		959	938	818	827					788
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	50+	50+	Female			7,671	966	843	889	858	8,287	749	759	408	513	5,730	566	573	622	540	8,252	574	584	569	634	3,798					3,306					10,981				
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	65+	50+	Male																								64	79	69	65		72	71	79	65					80
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	20-24	15-24	Female			3,192	3,037	3,244	2,908	2,776	4,652	2,695	2,878	1,694	1,994	1,451	2,248	2,315	2,294	2,077	2,271	2,021	2,274	1,931	2,061	2,787	2,063	2,261	1,854	1,842		1,764	1,983	1,738	1,735					1,591
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	05-09	01-09	Missing Sex				333	282	304	257	5,140	218	238	89	108	148	132	130	187	119	1,043	118	112	129	143	1,118	116	124	114	75		98	91	77	102					83
Zimbabwe	Zimbabwe	ZWE	TX_NEW	Individuals newly enrolled on antiretroviral therapy	Retired Age Band	35-49	Female			9,868																																		
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	<01	<01	Missing Sex				113	242	200	453		645	189	789	497	2,522	429	476	380	364	178	329	352	456	356	204	412	453	154	302	152	303	429	375	567	116				289
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Female																												73,427					62,492				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Male																												199,840					188,030				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Male				12,627	15,186	15,829	20,511		21,185	24,589	26,661	29,624	72,466	29,673	28,267	28,823	32,480	73,768	34,761	38,003	42,828	46,068	70,492	46,148	46,536	48,422	47,068		49,221	50,002	50,455	50,702					49,427
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Male																								15,423	15,134	15,922	16,278		17,133	17,514	18,585	18,119					20,324
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Female				7,349	9,993	10,087	12,167		13,822	14,555	15,464	17,056	48,763	17,588	16,808	17,646	19,956	41,985	21,014	22,447	25,984	28,999	45,263	29,657	29,618	28,680	28,516		28,924	29,292	30,017	30,844					28,179
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Female				20,773	25,702	25,335	31,133		33,760	36,288	37,805	41,887	97,678	43,487	40,308	40,983	45,096	91,970	47,348	51,082	55,940	61,229	89,269	62,247	62,481	61,957	61,121		62,158	63,062	63,283	64,035					62,029
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Male																												76,428					61,113				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Female				30,128	36,367	37,719	49,578		52,829	59,596	65,714	75,937	126,768	78,910	80,076	84,346	92,556	150,270	98,130	107,426	114,346	127,597	144,338	8,033	8,622	9,758	9,498	148,778	9,595	10,175	10,830	11,906	173,569				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Female																								53,224	54,716	55,340	57,462		60,776	61,943	62,735	63,367					77,633
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Female				24,998	31,307	31,517	40,012		43,147	47,678	50,678	55,993	111,589	58,387	56,516	57,411	63,981	114,809	67,723	72,062	78,638	85,416	115,040	87,976	86,618	86,691	82,326		88,011	88,064	88,720	88,712					84,306
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Female				4,207	5,434	5,554	6,619		7,224	7,776	7,824	8,764	24,653	9,057	8,617	9,084	9,908	26,218	10,369	10,853	12,349	13,976	23,383	14,103	13,756	14,029	13,796		14,616	14,245	14,109	14,710					13,805
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Male				223	637	710	592		261	310	269	336		421	132	149	240		231	303	268	137		478	594	60	97		494	348	330	154					5
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-04	01-09	Missing Sex				898	1,380	1,266	1,375		1,334	1,502	1,494	1,667	12,151	1,767	1,529	1,891	2,109	8,718	1,988	2,066	2,263	2,516	8,491	2,830	2,740	2,363	2,419		2,640	2,720	2,719	2,911					2,325
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-34	25-34	Female																												161,221					148,637				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Female																								21,520	21,502	22,830	23,981		26,180	27,245	28,412	28,548					35,502
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-19	15-24	Male				2,893	3,668	3,862	4,643		4,980	5,218	5,352	6,195	16,106	6,442	6,093	6,588	7,195	19,974	7,594	7,844	8,623	9,694	14,440	9,659	9,745	9,673	9,801		10,125	10,146	9,989	10,255					9,790
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	60-64	50+	Female																								22,910	22,392	23,382	24,174		25,809	26,250	27,915	27,772					31,048
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	05-09	01-09	Missing Sex				4,255	5,665	5,305	5,690		5,941	6,408	6,307	7,009	22,887	7,008	6,223	6,001	6,700	19,816	6,633	6,588	7,674	8,053	16,727	8,480	8,026	8,262	8,136		8,522	7,945	7,908	7,692					6,336
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-49	35-49	Female																												314,450					321,805				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50-54	50+	Male																								38,128	39,121	39,750	39,961		41,833	42,928	43,078	44,377					52,610
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	15-24	15-24	Male																												34,889					35,276				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	30-34	25-34	Male				7,455	8,586	9,116	10,853		12,302	13,923	13,382	15,169	58,114	14,755	13,517	13,919	15,628	54,245	17,135	18,887	21,383	23,187	44,889	21,878	22,099	22,268	21,627		21,696	21,638	21,688	22,215					20,665
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Female				18,914	26,452	25,877	32,346		34,901	38,786	41,699	48,494	87,434	49,877	49,549	51,410	57,298	83,065	59,995	65,249	69,761	76,797	92,262	80,365	80,822	82,416	83,954		88,379	89,373	90,377	92,201					93,778
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Female																								30,587	30,499	31,626	32,977		36,023	36,280	37,365	37,889					45,551
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	35-39	35-49	Male				10,796	13,193	13,856	17,538		19,088	21,058	21,700	24,424	72,247	24,850	22,881	23,757	26,681	71,474	29,001	31,372	35,562	37,497	63,992	36,815	37,567	37,709	39,083		36,327	36,556	36,254	36,701					34,063
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	45-49	35-49	Male				12,320	16,870	17,322	21,425		22,952	25,048	27,525	30,614	65,887	31,363	30,092	31,947	36,358	60,917	38,189	41,471	46,635	49,340	68,570	50,275	50,521	51,629	50,562		52,936	53,374	53,601	54,451					53,926
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	01-09	01-09	Missing Sex																												26,640					21,009				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	40-44	35-49	Female				22,741	27,691	28,117	37,430		38,966	45,762	48,360	54,037	101,979	55,993	54,434	55,795	61,756	111,504	64,412	70,092	76,882	84,738	110,018	87,804	89,968	92,045	91,918		97,106	98,179	100,480	100,876					101,210
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	20-24	15-24	Male				2,436	3,218	3,540	4,044		4,857	5,025	5,003	5,672	23,395	6,201	5,684	6,249	7,066	22,878	7,598	8,009	8,962	9,734	17,786	9,692	10,061	10,023	10,092		10,208	10,112	10,215	10,608					10,060
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	10-14	10-14	Missing Sex				6,038	7,719	7,500	8,487		9,227	10,194	10,684	12,073	35,372	12,616	12,100	13,152	14,761	35,092	14,534	14,993	17,079	18,136	25,815	18,488	17,851	18,153	17,554	26,117	18,064	17,861	17,590	17,999	25,067				14,972
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	50+	50+	Male				22,003	25,448	26,802	35,313		37,519	42,005	47,130	53,450	105,667	56,156	55,279	59,054	67,453	103,898	69,885	77,024	85,486	91,953	114,406	5,933	6,226	7,177	6,875	116,699	6,778	7,197	7,497	8,220	131,566				
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Female				12,922	15,840	16,299	19,996		22,444	23,440	24,287	27,198	76,753	28,170	26,607	27,181	30,603	58,703	32,309	35,085	39,661	44,290	66,888	43,684	44,856	44,495	44,406		46,402	47,137	47,710	48,869					48,048
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	65+	50+	Male																								16,147	16,273	17,025	18,051		19,542	19,875	21,397	21,223					25,278
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	55-59	50+	Male																								21,193	21,282	22,591	23,570		25,164	25,732	27,009	26,779					33,373
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	Unknown Age	Unknown Age	Female				651	1,018	1,096	1,088		511	606	500	551		779	113	230	433		425	581	457	251		871	1,202	119	197		891	651	604	295					19
Zimbabwe	Zimbabwe	ZWE	TX_PVLS	Individuals on ART with a documented suppressed viral load result (<1,000 copies/ml) in the past 12 months	25-29	25-34	Male				4,036	4,394	4,912	5,738		6,935	7,270	7,205	8,228	39,237	8,385	7,694	7,805	8,836	32,955	9,924	10,298	12,218	13,566	28,220	12,522	12,893	13,026	13,027		13,393	13,273	13,496	14,036					13,723
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	<01	<15	Missing Sex																														3		5					6
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Male																														47		71					76
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Male																														155		217					205
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	<15	<15	Missing Sex					187		188			149		108			92		84			143		124			246		81			16							
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Male																														9		22					23
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Male																														289		368					435
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Male					3,015		2,896			2,400		1,480			1,610		1,679			2,000		2,266			2,095		1,991			322							
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	15+	15+	Female					2,079		1,764			1,650		1,060			987		1,064			1,286		1,536			1,298		1,197			232							
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	50-54	15+	Female																														88		104					132
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Male					1		1			2		1					1																				1
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	10-14	<15	Missing Sex																														25		18					34
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Female																														92		149					178
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	15-19	15+	Female																														32		29					42
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	45-49	15+	Male																														188		243					293
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Male																														56		79					120
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	20-24	15+	Female																														99		92					92
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	01-04	<15	Missing Sex																														11		24					12
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Female																														108		133					148
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Male																														222		264					347
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	65+	15+	Female																														50		47					93
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	35-39	15+	Female																														154		182					206
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Male																														65		98					126
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Male																														36		58					71
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	Unknown Age	Unknown Age	Female					5		10					1					2																				
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	55-59	15+	Female																														32		68					80
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	60-64	15+	Female																														21		54					57
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	25-29	15+	Male																														124		163					187
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	30-34	15+	Female																														122		137					171
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Male																														283		358					416
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	05-09	<15	Missing Sex																														14		16					12
Zimbabwe	Zimbabwe	ZWE	TX_TB	Individuals on ART who were started on TB treatment	40-44	15+	Female																														131		194					172
